PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hendel, A; Bak, RO; Clark, JT; Kennedy, AB; Ryan, DE; Roy, S; Steinfeld, I; Lunstad, BD; Kaiser, RJ; Wilkens, AB; Bacchetta, R; Tsalenko, A; Dellinger, D; Bruhn, L; Porteus, MH				Hendel, Ayal; Bak, Rasmus O.; Clark, Joseph T.; Kennedy, Andrew B.; Ryan, Daniel E.; Roy, Subhadeep; Steinfeld, Israel; Lunstad, Benjamin D.; Kaiser, Robert J.; Wilkens, Alec B.; Bacchetta, Rosa; Tsalenko, Anya; Dellinger, Douglas; Bruhn, Laurakay; Porteus, Matthew H.			Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells	NATURE BIOTECHNOLOGY			English	Article							SOLID-PHASE; T-CELLS; CCR5; OLIGONUCLEOTIDES; PHOSPHONOACETATE; SYSTEMS; GLOBIN; GENES; LOCI; HIV	CRISPR-Cas-mediated genome editing relies on guide RNAs that direct site-specific DNA cleavage facilitated by the Cas endonuclease. Here we report that chemical alterations to synthesized single guide RNAs (sgRNAs) enhance genome editing efficiency in human primary T cells and CD34(+) hematopoietic stem and progenitor cells. Co-delivering chemically modified sgRNAs with Cas9 mRNA or protein is an efficient RNA- or ribonucleoprotein (RNP)-based delivery method for the CRISPR-Cas system, without the toxicity associated with DNA delivery. This approach is a simple and effective way to streamline the development of genome editing with the potential to accelerate a wide array of biotechnological and therapeutic applications of the CRISPR-Cas technology.	[Hendel, Ayal; Bak, Rasmus O.; Clark, Joseph T.; Wilkens, Alec B.; Bacchetta, Rosa; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Kennedy, Andrew B.; Ryan, Daniel E.; Kaiser, Robert J.; Tsalenko, Anya; Bruhn, Laurakay] Agilent Res Labs, Santa Clara, CA USA; [Roy, Subhadeep; Lunstad, Benjamin D.; Dellinger, Douglas] Agilent Res Labs, Boulder, CO USA; [Steinfeld, Israel] Agilent Res Labs, Tel Aviv, Israel	Stanford University; Agilent Technologies; Agilent Technologies	Porteus, MH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	laurakay_bruhn@agilent.com; mporteus@stanford.edu	Hendel, Ayal/GMW-7991-2022; Huang, ZhiXin/H-5123-2017; Bak, Rasmus O./AAH-9748-2021	Huang, ZhiXin/0000-0003-0705-1970; Bak, Rasmus O./0000-0002-7383-0297; Hendel, Ayal/0000-0002-3388-6202; Bacchetta, Rosa/0000-0002-0606-6268; Clark, Joseph/0000-0001-7764-6000	Myotonic Dystrophy Foundation; Danish Council for Independent Research, Medical Sciences [DFF-1331-00735B, DFF-1333-00106B]; Amon Carter Foundation; Laurie Krauss Lacob Faculty Scholar Award in Pediatric Translational Research; US National Institutes of Health [PN2EY018244, R01-AI097320]; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120766, R01AI097320] Funding Source: NIH RePORTER	Myotonic Dystrophy Foundation; Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Amon Carter Foundation; Laurie Krauss Lacob Faculty Scholar Award in Pediatric Translational Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.H. was supported by the Myotonic Dystrophy Foundation. R.O.B. was supported through an Individual Postdoctoral grant (DFF-1333-00106B) and a Sapere Aude, Research Talent grant (DFF-1331-00735B), both from the Danish Council for Independent Research, Medical Sciences. M.H.P. gratefully acknowledges the support of the Amon Carter Foundation, the Laurie Krauss Lacob Faculty Scholar Award in Pediatric Translational Research and US National Institutes of Health grant support PN2EY018244 and R01-AI097320. We thank R. Perriman, and Porteus laboratory members and C. Carstens, S. Laderman and Agilent laboratories members for helpful input, comments and discussion.	Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; Dellinger DJ, 2003, J AM CHEM SOC, V125, P940, DOI 10.1021/ja027983f; Dellinger DJ, 2011, J AM CHEM SOC, V133, P11540, DOI 10.1021/ja201561z; Eckstein F, 2014, NUCLEIC ACID THER, V24, P374, DOI 10.1089/nat.2014.0506; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Threlfall RN, 2012, ORG BIOMOL CHEM, V10, P746, DOI 10.1039/c1ob06614e; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Yi GH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.52	24	605	722	9	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					985	U232		10.1038/nbt.3290	http://dx.doi.org/10.1038/nbt.3290			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26121415	Green Accepted			2022-12-25	WOS:000360990900027
J	Kim, E; Moore, BS; Yoon, YJ				Kim, Eunji; Moore, Bradley S.; Yoon, Yeo Joon			Reinvigorating natural product combinatorial biosynthesis with synthetic biology	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; MODULAR POLYKETIDE SYNTHASES; HETEROLOGOUS EXPRESSION; ESCHERICHIA-COLI; GENE-CLUSTER; DIRECT CLONING; HOMOLOGOUS RECOMBINATION; STREPTOMYCES-COELICOLOR; SECONDARY METABOLITES; STRUCTURAL DIVERSITY	Natural products continue to play a pivotal role in drug-discovery efforts and in the understanding if human health. The ability to extend nature's chemistry through combinatorial biosynthesis-altering functional groups, regiochemistry and scaffold backbones through the manipulation of biosynthetic enzymes-offers unique opportunities to create natural product analogs. Incorporating emerging synthetic biology techniques has the potential to further accelerate the refinement of combinatorial biosynthesis as a robust platform for the diversification of natural chemical drug leads. Two decades after the field originated, we discuss the current limitations, the realities and the state of the art of combinatorial biosynthesis, including the engineering of substrate specificity of biosynthetic enzymes and the development of heterologous expression systems for biosynthetic pathways. We also propose a new perspective for the combinatorial biosynthesis of natural products that could reinvigorate drug discovery by using synthetic biology in combination with synthetic chemistry.	[Kim, Eunji; Yoon, Yeo Joon] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Ewha Womans University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Moore, BS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu; joonyoon@ewha.ac.kr		Moore, Bradley/0000-0002-4652-1253	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MISP) [2013R1A2A1A01014230]; Intelligent Synthetic Biology Center of the Global Frontier Project - MISP [20110031961]; High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; National Research Council of Science and Technology through the Degree & Research Center program [DRC-14-3-KBSI]; US National Institutes of Health [R01-CA127622, R01-GM085770]; NATIONAL CANCER INSTITUTE [R01CA127622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085770] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MISP); Intelligent Synthetic Biology Center of the Global Frontier Project - MISP; High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; National Research Council of Science and Technology through the Degree & Research Center program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rathwell for critically reading this manuscript. Research in Y.J.Y.'s laboratory has been supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MISP) (2013R1A2A1A01014230), the Intelligent Synthetic Biology Center of the Global Frontier Project funded by MISP (20110031961), the High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, and the National Research Council of Science and Technology through the Degree & Research Center program (DRC-14-3-KBSI). Combinatorial biosynthetic work in B.S.M.'s laboratory is supported by US National Institutes of Health grants R01-CA127622 and R01-GM085770.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bachmann BO, 2014, J IND MICROBIOL BIOT, V41, P175, DOI 10.1007/s10295-013-1389-9; Baltz RH, 2014, ACS SYNTH BIOL, V3, P748, DOI 10.1021/sb3000673; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Bian XY, 2012, CHEMBIOCHEM, V13, P1946, DOI 10.1002/cbic.201200310; Birmingham WR, 2014, NAT CHEM BIOL, V10, P392, DOI 10.1038/nchembio.1494; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Brown S, 2015, P NATL ACAD SCI USA, V112, P3205, DOI 10.1073/pnas.1423555112; Charlop-Powers Z, 2014, CURR OPIN MICROBIOL, V19, P70, DOI 10.1016/j.mib.2014.05.021; Chiang YM, 2013, J AM CHEM SOC, V135, P7720, DOI 10.1021/ja401945a; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cobb RE, 2014, J IND MICROBIOL BIOT, V41, P469, DOI 10.1007/s10295-013-1358-3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conrado RJ, 2012, NUCLEIC ACIDS RES, V40, P1879, DOI 10.1093/nar/gkr888; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunn BJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0297; Dutta S, 2014, NATURE, V510, P512, DOI 10.1038/nature13423; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Evans BS, 2011, CHEM BIOL, V18, P601, DOI 10.1016/j.chembiol.2011.03.008; Feng ZY, 2011, P NATL ACAD SCI USA, V108, P12629, DOI 10.1073/pnas.1103921108; Feng ZY, 2010, J AM CHEM SOC, V132, P11902, DOI 10.1021/ja104550p; Fischbach MA, 2007, P NATL ACAD SCI USA, V104, P11951, DOI 10.1073/pnas.0705348104; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Gibson DG, 2014, NAT METHODS, V11, P521, DOI [10.1038/nmeth.2894, 10.1038/NMETH.2894]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giessen TW, 2012, FEBS LETT, V586, P2065, DOI 10.1016/j.febslet.2012.01.017; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; HOPWOOD DA, 1985, NATURE, V314, P642, DOI 10.1038/314642a0; Huang KX, 2009, APPL MICROBIOL BIOT, V82, P13, DOI 10.1007/s00253-008-1784-8; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Johnson MNR, 2014, J AM CHEM SOC, V136, P11240, DOI 10.1021/ja505442h; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Komatsu M, 2013, ACS SYNTH BIOL, V2, P384, DOI 10.1021/sb3001003; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Koryakina I, 2013, ACS CHEM BIOL, V8, P200, DOI 10.1021/cb3003489; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Kries H, 2014, ANGEW CHEM INT EDIT, V53, P10105, DOI 10.1002/anie.201405281; Kushnir S, 2012, ANGEW CHEM INT EDIT, V51, P10664, DOI 10.1002/anie.201202438; Li CX, 2009, METAB ENG, V11, P319, DOI 10.1016/j.ymben.2009.06.004; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Liu J, 2015, ACS SYNTH BIOL, V4, P559, DOI 10.1021/sb5003136; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Mutka SC, 2006, BIOCHEMISTRY-US, V45, P1321, DOI 10.1021/bi052075r; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nguyen KT, 2006, P NATL ACAD SCI USA, V103, P17462, DOI 10.1073/pnas.0608589103; Olano C, 2010, NAT PROD REP, V27, P571, DOI 10.1039/b911956f; Ongley SE, 2013, NAT PROD REP, V30, P1121, DOI 10.1039/c3np70034h; Osswald C, 2014, ACS SYNTH BIOL, V3, P759, DOI 10.1021/sb300080t; Park SR, 2013, NAT PROD REP, V30, P11, DOI 10.1039/c2np20092a; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Robles O, 2014, NAT PROD REP, V31, P318, DOI 10.1039/c3np70087a; Rodriguez E, 2003, J IND MICROBIOL BIOT, V30, P480, DOI 10.1007/s10295-003-0045-1; Ross AC, 2015, ACS SYNTH BIOL, V4, P414, DOI 10.1021/sb500280q; Ross AC, 2013, J AM CHEM SOC, V135, P1155, DOI 10.1021/ja3119674; Roy AD, 2010, J AM CHEM SOC, V132, P12243, DOI 10.1021/ja1060406; Ruffner DE, 2015, ACS SYNTH BIOL, V4, P482, DOI 10.1021/sb500267d; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Shao ZY, 2011, MOL BIOSYST, V7, P1056, DOI 10.1039/c0mb00338g; Siegl T, 2013, METAB ENG, V19, P98, DOI 10.1016/j.ymben.2013.07.006; Song MC, 2014, NAT PROD REP, V31, P1497, DOI 10.1039/c4np00057a; Sugimoto Y, 2014, ANGEW CHEM INT EDIT, V53, P1560, DOI 10.1002/anie.201308176; Sundermann U, 2013, ACS CHEM BIOL, V8, P443, DOI 10.1021/cb300505w; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Temme K, 2012, NUCLEIC ACIDS RES, V40, P8773, DOI 10.1093/nar/gks597; Thaker MN, 2015, ACS SYNTH BIOL, V4, P195, DOI 10.1021/sb300092n; Thirlway J, 2012, ANGEW CHEM INT EDIT, V51, P7181, DOI 10.1002/anie.201202043; Uguru GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067509; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang P, 2012, ANGEW CHEM INT EDIT, V51, P11136, DOI 10.1002/anie.201205426; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Whicher JR, 2014, NATURE, V510, P560, DOI 10.1038/nature13409; Whicher JR, 2013, CHEM BIOL, V20, P1340, DOI 10.1016/j.chembiol.2013.09.015; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; Xu W, 2014, NAT PROD REP, V31, P1474, DOI 10.1039/c4np00073k; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Yan Y, 2013, ANGEW CHEM INT EDIT, V52, P12308, DOI 10.1002/anie.201305569; Zhang HR, 2010, CHEM BIOL, V17, P1232, DOI 10.1016/j.chembiol.2010.09.013; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhou M, 2012, FEMS MICROBIOL LETT, V333, P169, DOI 10.1111/j.1574-6968.2012.02609.x; Zhu XJ, 2015, NAT CHEM BIOL, V11, P115, DOI [10.1038/NCHEMBIO.1718, 10.1038/nchembio.1718]	98	144	146	3	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					649	659		10.1038/NCHEMBIO.1893	http://dx.doi.org/10.1038/NCHEMBIO.1893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26284672	Green Accepted			2022-12-25	WOS:000359954700008
J	Nakamura, H; Arai, Y; Totoki, Y; Shirota, T; Elzawahry, A; Kato, M; Hama, N; Hosoda, F; Urushidate, T; Ohashi, S; Hiraoka, N; Ojima, H; Shimada, K; Okusaka, T; Kosuge, T; Miyagawa, S; Shibata, T				Nakamura, Hiromi; Arai, Yasuhito; Totoki, Yasushi; Shirota, Tomoki; Elzawahry, Asmaa; Kato, Mamoru; Hama, Natsuko; Hosoda, Fumie; Urushidate, Tomoko; Ohashi, Shoko; Hiraoka, Nobuyoshi; Ojima, Hidenori; Shimada, Kazuaki; Okusaka, Takuji; Kosuge, Tomoo; Miyagawa, Shinichi; Shibata, Tatsuhiro			Genomic spectra of biliary tract cancer	NATURE GENETICS			English	Article							MUTATIONAL LANDSCAPE; PATTERN DISCOVERY; PD-1 BLOCKADE; IDENTIFICATION; CARCINOMA; FUSIONS; SIGNATURES; ALIGNMENT; RECEPTOR; SUBUNIT	The incidence of biliary tract cancer (BTC), including intrahepatic (ICC) and extrahepatic (ECC) cholangiocarcinoma and gallbladder cancer, has increased globally; however, no effective targeted molecular therapies have been approved at the present time. Here we molecularly characterized 260 BTCs and uncovered spectra of genomic alterations that included new potential therapeutic targets. Gradient spectra of mutational signatures with a higher burden of the APOBEC-associated mutation signature were observed in gallbladder cancer and ECC. Thirty-two significantly altered genes, including ELF3, were identified, and nearly 40% of cases harbored targetable genetic alterations. Gene fusions involving FGFR2 and PRKACA or PRKACB preferentially occurred in ICC and ECC, respectively, and the subtype-associated prevalence of actionable growth factor-mediated signals was noteworthy. The subgroup with the poorest prognosis had significant enrichment of hypermutated tumors and a characteristic elevation in the expression of immune checkpoint molecules. Accordingly, immune-modulating therapies might also be potentially promising options for these patients.	[Nakamura, Hiromi; Arai, Yasuhito; Totoki, Yasushi; Shirota, Tomoki; Elzawahry, Asmaa; Hama, Natsuko; Hosoda, Fumie; Ohashi, Shoko; Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Tokyo, Japan; [Shirota, Tomoki; Miyagawa, Shinichi] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano 390, Japan; [Kato, Mamoru] Natl Canc Ctr, Dept Bioinformat, Tokyo, Japan; [Urushidate, Tomoko; Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Hiraoka, Nobuyoshi; Ojima, Hidenori] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Hiraoka, Nobuyoshi; Ojima, Hidenori] Natl Canc Ctr, Clin Labs, Tokyo, Japan; [Ojima, Hidenori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan	National Cancer Center - Japan; Shinshu University; National Cancer Center - Japan; University of Tokyo; National Cancer Center - Japan; National Cancer Center - Japan; Keio University; National Cancer Center - Japan; National Cancer Center - Japan	Shibata, T (corresponding author), Natl Canc Ctr, Div Canc Genom, Tokyo, Japan.	tashibat@ncc.go.jp	Shibata, Tatsuhiro/ABA-8234-2020; Shibata, Tatsuhiro/AAO-1278-2021	Arai, Yasuhito/0000-0001-6306-9409	Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer), National Cancer Center Research and Development Funds [26-A-5]; MEXT [26461040]; Yasuda Medical Foundation; National Cancer Center Research and Development Fund, Japan	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer), National Cancer Center Research and Development Funds(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yasuda Medical Foundation; National Cancer Center Research and Development Fund, Japan	This study was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare and the Japan Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer), National Cancer Center Research and Development Funds (26-A-5), MEXT KAKENHI (grant 26461040) and the Yasuda Medical Foundation. The National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. The supercomputing resource 'SHIROKANE' was provided by the Human Genome Center, The University of Tokyo.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Arai Y, 2014, HEPATOLOGY, V59, P1427, DOI 10.1002/hep.26890; Babur O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0612-6; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li ML, 2014, NAT GENET, V46, P872, DOI 10.1038/ng.3030; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-10; Pilarski R, 2014, GENE CHROMOSOME CANC, V53, P177, DOI 10.1002/gcc.22129; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050	41	653	680	5	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1003	+		10.1038/ng.3375	http://dx.doi.org/10.1038/ng.3375			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26258846				2022-12-25	WOS:000360394100010
J	Arrowsmith, CH; Audia, JE; Austin, C; Baell, J; Bennett, J; Blagg, J; Bountra, C; Brennan, PE; Brown, PJ; Bunnage, ME; Buser-Doepner, C; Campbell, RM; Carter, AJ; Cohen, P; Copeland, RA; Cravatt, B; Dahlin, JL; Dhanak, D; Edwards, AM; Frye, SV; Gray, N; Grimshaw, CE; Hepworth, D; Howe, T; Huber, KVM; Jin, J; Knapp, S; Kotz, JD; Kruger, RG; Lowe, D; Mader, MM; Marsden, B; Mueller-Fahrnow, A; Muller, S; O'Hagan, RC; Overington, JP; Owen, DR; Rosenberg, SH; Roth, B; Ross, R; Schapira, M; Schreiber, SL; Shoichet, B; Sundstrom, M; Superti-Furga, G; Taunton, J; Toledo-Sherman, L; Walpole, C; Walters, MA; Willson, TM; Workman, P; Young, RN; Zuercher, WJ				Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Mueller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.			The promise and peril of chemical probes	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE; TARGET ENGAGEMENT; POTENT INHIBITOR; IDENTIFICATION; HYDROLASE; MECHANISM; AGONIST; CELLS	Chemical probes are powerful reagents with increasing impacts on biomedical research. However, probes of poor quality or that are used incorrectly generate misleading results. To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.	[Arrowsmith, Cheryl H.; Brown, Peter J.; Edwards, Aled M.; Schapira, Matthieu] Struct Genom Consortium, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Audia, James E.] Constellat Pharmaceut, Cambridge, MA USA; [Austin, Christopher] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Baell, Jonathan] Monash Univ, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3004, Australia; [Bennett, Jonathan] Merck Res Labs, Discovery Chem, Boston, MA USA; [Blagg, Julian; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England; [Bountra, Chas; Brennan, Paul E.; Knapp, Stefan; Marsden, Brian; Mueller, Susanne] Univ Oxford, Struct Genom Consortium, Oxford, England; [Brennan, Paul E.; Knapp, Stefan; Mueller, Susanne] Univ Oxford, Target Discovery Inst, Oxford, England; [Bunnage, Mark E.; Hepworth, David; Owen, Dafydd R.] Pfizer, Worldwide Med Chem, Cambridge, MA USA; [Buser-Doepner, Carolyn] GlaxoSmithKline, Collegeville, PA USA; [Campbell, Robert M.; Mader, Mary M.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Carter, Adrian J.] Boehringer Ingelheim GmbH & Co KG, Corp Dept Res Networking, Ingelheim, Germany; [Cohen, Philip] Univ Dundee, Sir James Black Ctr, Dundee, Scotland; [Copeland, Robert A.] Epizyme Inc, Cambridge, MA USA; [Cravatt, Ben] Scripps Res Inst, Dept Physiol Chem, San Diego, CA USA; [Dahlin, Jayme L.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Dhanak, Dashyant] Janssen Res & Dev, Spring House, PA USA; [Frye, Stephen V.] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Gray, Nathanael] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA; [Grimshaw, Charles E.] Takeda Calif Inc, San Diego, CA USA; [Howe, Trevor] Janssen Res & Dev, High Wycombe, Bucks, England; [Huber, Kilian V. M.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Kotz, Joanne D.; Schreiber, Stuart L.] Broad Inst, Ctr Sci Therapeut, Cambridge, MA USA; [Kruger, Ryan G.] GlaxoSmithKline, Canc Epigenet, Collegeville, PA USA; [Lowe, Derek] Vertex Pharmaceut, Boston, MA USA; [Mueller-Fahrnow, Anke] Bayer Pharma AG, Berlin, Germany; [O'Hagan, Ronan C.] Merck Res Labs, Oncol Discovery, Boston, MA USA; [Overington, John P.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Overington, John P.] Stratified Med, London, England; [Rosenberg, Saul H.] AbbVie, N Chicago, IL USA; [Roth, Brian; Willson, Timothy M.; Zuercher, William J.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Ross, Ruth; Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Shoichet, Brian] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA; [Sundstrom, Michael] Karolinska Inst, Struct Genom Consortium, Solna, Sweden; [Sundstrom, Michael] Karolinska Univ Hosp, Dept Med, Solna, Sweden; [Sundstrom, Michael] Karolinska Inst, Solna, Sweden; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Taunton, Jack] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Toledo-Sherman, Leticia] CHDI Fdn, CHDI Management, Los Angeles, CA USA; [Walpole, Chris] McGill Univ, Struct Genom Consortium, Montreal, PQ, Canada; [Walters, Michael A.] Univ Minnesota, Minneapolis, MN USA; [Willson, Timothy M.; Zuercher, William J.] Univ N Carolina, Struct Genom Consortium, Chapel Hill, NC USA; [Young, Robert N.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Monash University; Merck & Company; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford; University of Oxford; Pfizer; GlaxoSmithKline; Eli Lilly; Boehringer Ingelheim; University of Dundee; Scripps Research Institute; Mayo Clinic; Johnson & Johnson; Janssen Pharmaceuticals; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Johnson & Johnson; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; GlaxoSmithKline; Vertex Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Merck & Company; European Molecular Biology Laboratory (EMBL); AbbVie; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Medical University of Vienna; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; McGill University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Simon Fraser University	Arrowsmith, CH (corresponding author), Struct Genom Consortium, Toronto, ON, Canada.	aled.edwards@utoronto.ca	Baell, Jonathan/E-5844-2017; Knapp, Stefan/AAG-2347-2019; Superti-Furga, Giulio/AAE-5681-2019; Dahlin, Jayme/AAM-2306-2021; feinstein, doug/M-9414-2019; Huber, Kilian V. M./L-6921-2015; Overington, John P/G-8607-2015	Baell, Jonathan/0000-0003-2114-8242; Knapp, Stefan/0000-0001-5995-6494; Huber, Kilian V. M./0000-0002-1103-5300; Overington, John P/0000-0002-5859-1064; Arrowsmith, Cheryl/0000-0002-4971-3250; Edwards, Aled/0000-0002-4782-6016; Carter, Adrian/0000-0001-6564-7161; Brown, Peter/0000-0002-8454-0367; Dahlin, Jayme/0000-0003-4151-9944; Brennan, Paul/0000-0002-8950-7646; Muller-Knapp, Susanne/0000-0003-2402-4157; Walters, Michael/0000-0001-5650-9277; Young, Robert/0000-0002-8235-6080	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103893] Funding Source: NIH RePORTER; Cancer Research UK [11566] Funding Source: Medline; Medical Research Council [MR/K000985/1, MC_UU_12016/11] Funding Source: Medline; NIGMS NIH HHS [R01 GM103893] Funding Source: Medline; Wellcome Trust [106169, 100294, 104104] Funding Source: Medline; MRC [MR/K000985/1, MC_UU_12016/11] Funding Source: UKRI	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Cherblanc FL, 2013, J MED CHEM, V56, P8616, DOI 10.1021/jm401063r; Cherblanc FL, 2013, NAT CHEM BIOL, V9, P136, DOI 10.1038/nchembio.1187; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Garnier JM, 2014, EXPERT OPIN THER PAT, V24, P185, DOI 10.1517/13543776.2014.859244; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Knapp S, 2014, CURR OPIN PHARMACOL, V17, P58, DOI 10.1016/j.coph.2014.07.015; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Liu XS, 2012, CLIN CANCER RES, V18, P510, DOI 10.1158/1078-0432.CCR-11-1973; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pinelli A, 2005, J MED CHEM, V48, P5509, DOI 10.1021/jm0502844; Sassano MF, 2013, J MED CHEM, V56, P2406, DOI 10.1021/jm301749y; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Thirumurugan P, 2013, CHEM REV, V113, P4905, DOI 10.1021/cr200409f; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zeiger E., 1993, ACCOUNT RES, V3, P45; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	39	517	524	1	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					536	541		10.1038/nchembio.1867	http://dx.doi.org/10.1038/nchembio.1867			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26196764	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000358255300003
J	Hong, SY; Moreno-Navarrete, JM; Wei, XJ; Kikukawa, Y; Tzameli, I; Prasad, D; Lee, Y; Asara, JM; Fernandez-Real, JM; Maratos-Flier, E; Pissios, P				Hong, Shangyu; Moreno-Navarrete, Jose M.; Wei, Xiaojing; Kikukawa, Yusuke; Tzameli, Iphigenia; Prasad, Deepthi; Lee, Yoonjin; Asara, John M.; Fernandez-Real, Jose Manuel; Maratos-Flier, Eleftheria; Pissios, Pavlos			Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization	NATURE MEDICINE			English	Article							HIGH-FAT; 1-METHYLNICOTINAMIDE MNA; LIPID-METABOLISM; GENE-EXPRESSION; TRANSGENIC MICE; ADIPOSE-TISSUE; DIET; NAD(+); STEATOSIS; SIRTUINS	Nicotinamide N-methyltransferase (Nnmt) methylates nicotinamide, a form of vitamin 83, to produce N-1-methylnicotinamide (MNAM). Nnmt has emerged as a metabolic regulator in adipocytes, but its role in the liver, the tissue with the strongest Nnmt expression, is not known. In spite of its overall high expression, here we find that hepatic expression of Nnmt is highly variable and correlates with multiple metabolic parameters in mice and humans. Further, we find that suppression of hepatic Nnmt expression in vivo alters glucose and cholesterol metabolism and that the metabolic effects of Nnmt in the liver are mediated by its product MNAM. Supplementation of high-fat diet with MNAM decreases serum and liver cholesterol and liver triglycerides levels in mice. Mechanistically, increasing Nnmt expression or MNAM levels stabilizes sirtuin 1 protein, an effect that is required for their metabolic benefits. In summary, we describe here a novel regulatory pathway for vitamin B3 that could provide a new opportunity for metabolic disease therapy.	[Hong, Shangyu; Wei, Xiaojing; Tzameli, Iphigenia; Prasad, Deepthi; Maratos-Flier, Eleftheria; Pissios, Pavlos] Beth Israel Deaconess Med Ctr, Div Diabet Endocrinol & Metab, Boston, MA 02215 USA; [Moreno-Navarrete, Jose M.; Fernandez-Real, Jose Manuel] Inst Invest Biomed Girona, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Moreno-Navarrete, Jose M.; Fernandez-Real, Jose Manuel] CIBERobn, Madrid, Spain; [Kikukawa, Yusuke] Takeda Pharmaceut Ltd, Osaka, Japan; [Lee, Yoonjin] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Takeda Pharmaceutical Company Ltd; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center	Pissios, P (corresponding author), Beth Israel Deaconess Med Ctr, Div Diabet Endocrinol & Metab, Boston, MA 02215 USA.	ppissios@bidmc.harvard.edu	Moreno-Navarrete, José María/H-9772-2015; Moreno-Navarrete, José María/ABG-5548-2021; Fernández-Real, Jose Manuel/AGH-3599-2022	Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Kikukawa, Yusuke/0000-0002-5603-3181	Takeda; US National Institute of Health [DK028082, DK083694]; Boston Area Diabetes Endocrinology Research Center (BADERC) [DK057521]; Instituto de Salud Carlos III [FIS-PI11/00214, FIS-PI12/02631]; Fondo Europeo de Desarrollo Regional (FEDER), Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK028082, P30DK057521, R01DK028082, R01DK083694] Funding Source: NIH RePORTER	Takeda(Takeda Pharmaceutical Company Ltd); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes Endocrinology Research Center (BADERC); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER), Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank F.F. Liu, D. Adams, A.M. Real and M.J. Lee for technical assistance and J.S. Flier for advice. We thank S.M. Spiegelman and P. Puigserver (Dana-Farber Cancer Center, Boston, MA) for the donation of the Sirt1 and FoxO1 adenoviruses, D.E. Cohen (Brigham and Women's Hospital, Boston, MA) for lipoprotein analysis and R. Ortiz (University Hospital of Girona, Spain) for the pathology evaluation of the human liver biopsies. This work was supported by grants from Takeda, the US National Institute of Health DK028082 (E.M.F.), DK083694 (P.P.), Boston Area Diabetes Endocrinology Research Center (BADERC) grant DK057521 (P.P.), and by grants FIS-PI11/00214 and FIS-PI12/02631 to J.M.F.R. from the Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER), Spain.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bartus M, 2008, PHARMACOL REP, V60, P127; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bryniarski K, 2008, EUR J PHARMACOL, V578, P332, DOI 10.1016/j.ejphar.2007.09.011; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chlopicki S, 2007, BRIT J PHARMACOL, V152, P230, DOI 10.1038/sj.bjp.0707383; Dong SX, 2013, CELL METAB, V18, P380, DOI 10.1016/j.cmet.2013.08.012; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; FELSTED RL, 1967, J BIOL CHEM, V242, P1274; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Ghazalpour A, 2012, MAMM GENOME, V23, P680, DOI 10.1007/s00335-012-9411-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; KANGLEE YA, 1983, J NUTR, V113, P215, DOI 10.1093/jn/113.2.215; Kannt A, 2015, DIABETOLOGIA, V58, P799, DOI 10.1007/s00125-014-3490-7; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Peng LR, 2015, J BIOL CHEM, V290, P8904, DOI 10.1074/jbc.M114.612796; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Scheller T, 1996, PHARMACOGENETICS, V6, P43, DOI 10.1097/00008571-199602000-00003; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/nchembio.1352, 10.1038/NCHEMBIO.1352]; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/nchembio.1204, 10.1038/NCHEMBIO.1204]; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang R.-H., 2011, J CLIN INVEST; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yan L, 1997, BIOCHEM PHARMACOL, V54, P1139, DOI 10.1016/S0006-2952(97)00325-0; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	53	144	147	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					887	894		10.1038/nm.3882	http://dx.doi.org/10.1038/nm.3882			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26168293	Green Accepted			2022-12-25	WOS:000359181000015
J	Aravamudhan, P; Goldfarb, AA; Joglekar, AP				Aravamudhan, Pavithra; Goldfarb, Alan A.; Joglekar, Ajit P.			The kinetochore encodes a mechanical switch to disrupt spindle assembly checkpoint signalling	NATURE CELL BIOLOGY			English	Article							MICROTUBULE ATTACHMENT; MITOTIC SPINDLE; BUDDING YEAST; CHROMOSOME CONGRESSION; PROTEIN ARCHITECTURE; NDC80 COMPLEX; MPS1; RECRUITMENT; PHOSPHORYLATION; KINASE	The spindle assembly checkpoint (SAC) is a unique signalling mechanism that responds to the state of attachment of the kinetochore to spindle microtubules. SAC signalling is activated by unattached kinetochores, and it is silenced after these kinetochores form end-on microtubule attachments. Although the biochemical cascade of SAC signalling is well understood, how kinetochore-microtubule attachment disrupts it remained unknown. Here we show that, in budding yeast, end-on microtubule attachment to the kinetochore physically separates the Mps1 kinase, which probably binds to the calponin homology domain of Ndc80, from the kinetochore substrate of Mps1, Spc105 (KNL1 orthologue). This attachment-mediated separation disrupts the phosphorylation of Spc105, and enables SAC silencing. Additionally, the Dam1 complex may act as a barrier that shields Spc105 from Mps1. Together these data suggest that the protein architecture of the kinetochore encodes a mechanical switch. End-on microtubule attachment to the kinetochore turns this switch off to silence the SAC.	[Aravamudhan, Pavithra; Joglekar, Ajit P.] Univ Michigan, Biophys, Ann Arbor, MI 48109 USA; [Goldfarb, Alan A.; Joglekar, Ajit P.] Univ Michigan, Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Joglekar, AP (corresponding author), Univ Michigan, Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	ajitj@umich.edu		Joglekar, Ajit/0000-0002-0607-5332	Burroughs Wellcome Fund;  [R01-GM-105948]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105948] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Murray (Harvard University, USA), B. Glick (University of Chicago, USA), D. Drubin (University of California, Berkeley, USA), M. Winey (University of Colorado, Boulder, USA) and S. Biggins (Fred Hutchinson Cancer Research Center, Seattle, USA) for sharing reagents, and I. Cheeseman, J. DeLuca, M. Duncan, R. McIntosh, and Y. Yamashita for comments on the manuscript. We also thank L. Humphrey and S. Han for help with imaging and data analysis. A.P.J. is supported by the Career Award at the Scientific Interface from the Burroughs Wellcome Fund. This work was financially supported by R01-GM-105948.	Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Aravamudhan P, 2013, CURR BIOL, V23, P770, DOI 10.1016/j.cub.2013.03.042; Ballister ER, 2014, J CELL BIOL, V204, P901, DOI 10.1083/jcb.201311113; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; Espeut J, 2012, J CELL BIOL, V196, P469, DOI 10.1083/jcb.201111107; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fraschini R, 2001, MOL GENET GENOMICS, V266, P115, DOI 10.1007/s004380100533; Funabiki H, 2013, CHROMOSOMA, V122, P135, DOI 10.1007/s00412-013-0401-5; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Heinrich S, 2012, J CELL SCI, V125, P4720, DOI 10.1242/jcs.110387; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hsu KS, 2011, CURR BIOL, V21, P214, DOI 10.1016/j.cub.2010.12.048; Ito D, 2012, P NATL ACAD SCI USA, V109, P209, DOI 10.1073/pnas.1114647109; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Joglekar A, 2013, CELL MOL BIOENG, V6, P369, DOI 10.1007/s12195-013-0290-y; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kim S, 2010, P NATL ACAD SCI USA, V107, P19772, DOI 10.1073/pnas.1009000107; Kuijt TEF, 2014, CHROMOSOMA, V123, P471, DOI 10.1007/s00412-014-0458-9; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; MCINTOSH JR, 1991, COLD SH Q B, V56, P613; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Pagliuca C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007640; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Petrovic A, 2014, MOL CELL, V53, P591, DOI 10.1016/j.molcel.2014.01.019; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Ramey VH, 2011, MOL BIOL CELL, V22, P4335, DOI 10.1091/mbc.E11-07-0659; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Sacristan C, 2015, TRENDS CELL BIOL, V25, P21, DOI 10.1016/j.tcb.2014.08.006; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Scott RJ, 2005, MOL BIOL CELL, V16, P4362, DOI 10.1091/mbc.E05-01-0011; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Tien JF, 2014, GENETICS, V198, P1483, DOI 10.1534/genetics.114.167775; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Varma D, 2012, NAT CELL BIOL, V14, P593, DOI 10.1038/ncb2489; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Zhang G, 2012, J CELL SCI, V125, P3243, DOI 10.1242/jcs.104208; Zhou HX, 2004, BIOCHEMISTRY-US, V43, P2141, DOI 10.1021/bi036269n	63	86	89	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					868	879		10.1038/ncb3179	http://dx.doi.org/10.1038/ncb3179			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26053220	Green Accepted			2022-12-25	WOS:000357353400008
J	Wang, J; Sun, CX; Gerdes, N; Liu, CL; Liao, MY; Liu, J; Shi, MA; He, AN; Zhou, Y; Sukhova, GK; Chen, HM; Cheng, XW; Kuzuya, M; Murohara, T; Zhang, J; Cheng, X; Jiang, MM; Shull, GE; Rogers, S; Yang, CL; Ke, Q; Jelen, S; Bindels, R; Ellison, DH; Jarolim, P; Libby, P; Shi, GP				Wang, Jing; Sun, Chongxiu; Gerdes, Norbert; Liu, Conglin; Liao, Mengyang; Liu, Jian; Shi, Michael A.; He, Aina; Zhou, Yi; Sukhova, Galina K.; Chen, Huimei; Cheng, Xian Wu; Kuzuya, Masafumi; Murohara, Toyoaki; Zhang, Jie; Cheng, Xiang; Jiang, Mengmeng; Shull, Gary E.; Rogers, Shaunessy; Yang, Chao-Ling; Ke, Qiang; Jelen, Sabina; Bindels, Rene; Ellison, David H.; Jarolim, Petr; Libby, Peter; Shi, Guo-Ping			Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter	NATURE MEDICINE			English	Article							SODIUM-CHLORIDE COTRANSPORTER; IL-18 RECEPTOR; GITELMANS-SYNDROME; INTERFERON-GAMMA; DEFICIENT MICE; IFN-GAMMA; T-CELLS; EXPRESSION; PROTEIN; ACTIVATION	Interleukin-18 (IL18) participates in atherogenesis through several putative mechanisms(1,2). Interruption of IL18 action reduces atherosclerosis in mice(3,4). Here, we show that absence of the IL18 receptor (IL18r) does not affect atherosclerosis in apolipoprotein E-deficient (Apoe(-/-)) mice, nor does it affect IL18 cell surface binding to or signaling in endothelial cells. As identified initially by co-immunoprecipitation with IL18, we found that IL18 interacts with the Na-Cl co-transporter (NCC; also known as SLC12A3), a 12-transmembrane-domain ion transporter protein preferentially expressed in the kidney(5). NCC is expressed in atherosclerotic lesions, where it colocalizes with IL18r. In Apoe(-/-) ice, combined deficiency of IL18r and NCC, but not single deficiency of either protein, protects mice from atherosclerosis. Peritoneal macrophages from Apoe(-/-) ice or from Apoe(-/-) ice lacking IL18r or NCC show IL18 binding and induction of cell signaling and cytokine and chemokine expression, but macrophages from Apoe(-/-) ice with combined deficiency of IL18r and NCC have a blunted response. An interaction between NCC and IL18r on macrophages was detected by co-immunoprecipitation. IL18 binds to the cell surface of NCC-transfected COS-7 cells, which do not express IL18r, and induces cell signaling and cytokine expression. This study identifies NCC as an IL18-binding protein that collaborates with IL18r in cell signaling, inflammatory molecule expression, and experimental atherogenesis.	[Wang, Jing; Sun, Chongxiu; Gerdes, Norbert; Liu, Conglin; Liao, Mengyang; Liu, Jian; Shi, Michael A.; He, Aina; Zhou, Yi; Sukhova, Galina K.; Chen, Huimei; Zhang, Jie; Cheng, Xiang; Ke, Qiang; Libby, Peter; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wang, Jing; Sun, Chongxiu; Gerdes, Norbert; Liu, Conglin; Liao, Mengyang; Liu, Jian; Shi, Michael A.; He, Aina; Zhou, Yi; Sukhova, Galina K.; Chen, Huimei; Zhang, Jie; Cheng, Xiang; Ke, Qiang; Jarolim, Petr; Libby, Peter; Shi, Guo-Ping] Harvard Univ, Sch Med, Boston, MA USA; [Wang, Jing] Tsinghua Univ, Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci,Dep, Beijing 100084, Peoples R China; [Sun, Chongxiu] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Gerdes, Norbert] Univ Munich, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Liu, Conglin] Zhengzhou Univ, Affiliated Hosp 1, Inst Clin Med, Zhengzhou 450052, Peoples R China; [Liao, Mengyang; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Cardiol, Wuhan 430074, Peoples R China; [Cheng, Xian Wu; Kuzuya, Masafumi; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Cheng, Xian Wu; Kuzuya, Masafumi; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan; [Jiang, Mengmeng; Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Rogers, Shaunessy; Yang, Chao-Ling; Ellison, David H.] Oregon Hlth & Sci Univ, Div Nephrol, Portland, OR 97201 USA; [Jelen, Sabina; Bindels, Rene] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Jarolim, Petr] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; Nanjing Medical University; University of Munich; Zhengzhou University; Huazhong University of Science & Technology; Nagoya University; Nagoya University; University System of Ohio; University of Cincinnati; Oregon Health & Science University; Radboud University Nijmegen; Harvard University; Brigham & Women's Hospital	Shi, GP (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021; Gerdes, Norbert/E-2787-2010; , David/X-5730-2019; Bindels, René JM/B-9824-2013; Kuzuya, Masafumi/I-1583-2012; Murohara, Toyoaki/M-4958-2014	Libby, Peter/0000-0002-1502-502X; Gerdes, Norbert/0000-0002-4546-7208; Bindels, René JM/0000-0003-1167-1339; Chen, Huimei/0000-0001-7788-1334; , ChongXiu/0000-0001-8425-5024; Ellison, David/0000-0003-2915-265X; Shi, Michael/0000-0003-3243-4439	US National Heart, Lung, and Blood Institute [HL60942, HL81090, HL88547, HL34636, HL80472]; American Heart Association Established Investigator Award [0840118N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088547, R01HL060942, R01HL081090, R01HL034636, R01HL080472, R37HL034636] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by grants from the US National Heart, Lung, and Blood Institute (HL60942, HL81090, HL88547 to G.-P.S.; HL34636, HL80472 to P.L.) and by an American Heart Association Established Investigator Award (0840118N to G.-P.S.).	Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Bostonjoglo M, 1998, J AM SOC NEPHROL, V9, P1347; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; French AR, 2006, CYTOKINE, V35, P229, DOI 10.1016/j.cyto.2006.08.006; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Gjata M, 2007, Hippokratia, V11, P150; Glaudemans B, 2012, EUR J HUM GENET, V20, P263, DOI 10.1038/ejhg.2011.189; Griffon N, 2003, MOL BRAIN RES, V117, P47, DOI 10.1016/S0169-328X(03)00283-3; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hulthe J, 2006, ATHEROSCLEROSIS, V188, P450, DOI 10.1016/j.atherosclerosis.2005.11.013; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; Kinoshita K, 2004, J IMMUNOL, V173, P5312, DOI 10.4049/jimmunol.173.8.5312; Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Lauwerys BR, 1999, CYTOKINE, V11, P822, DOI 10.1006/cyto.1999.0501; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; Miyauchi K, 2009, DIABETES RES CLIN PR, V83, P190, DOI 10.1016/j.diabres.2008.11.018; Morris RG, 2006, AM J PHYSIOL-RENAL, V290, pF1416, DOI 10.1152/ajprenal.00421.2005; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Riveira-Munoz E, 2007, J AM SOC NEPHROL, V18, P1271, DOI 10.1681/ASN.2006101095; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Sugiyama M, 2008, CLIN IMMUNOL, V128, P103, DOI 10.1016/j.clim.2008.03.501; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Tzanakis I, 2004, MAGNESIUM RES, V17, P102; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Yang SS, 2010, HUM MUTAT, V31, P1304, DOI 10.1002/humu.21364; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zhang MZ, 2012, AM J PHYSIOL-RENAL, V302, pF433, DOI 10.1152/ajprenal.00292.2011	48	63	67	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					820	+		10.1038/nm.3890	http://dx.doi.org/10.1038/nm.3890			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26099046	Green Accepted, Green Submitted			2022-12-25	WOS:000357604600026
J	Chen, HJ; Sun, J; Huang, ZL; Hou, H; Arcilla, M; Rakhilin, N; Joe, DJ; Choi, J; Gadamsetty, P; Milsom, J; Nandakumar, G; Longman, R; Zhou, XK; Edwards, R; Chen, JL; Chen, KY; Bu, PC; Wang, LH; Xu, YT; Munroe, R; Abratte, C; Miller, AD; Gumus, ZH; Shuler, M; Nishimura, N; Edelmann, W; Shen, XL; Lipkin, SM				Chen, Huanhuan Joyce; Sun, Jian; Huang, Zhiliang; Hou, Harry, Jr.; Arcilla, Myra; Rakhilin, Nikolai; Joe, Daniel J.; Choi, Jiahn; Gadamsetty, Poornima; Milsom, Jeff; Nandakumar, Govind; Longman, Randy; Zhou, Xi Kathy; Edwards, Robert; Chen, Jonlin; Chen, Kai Yuan; Bu, Pengcheng; Wang, Lihua; Xu, Yitian; Munroe, Robert; Abratte, Christian; Miller, Andrew D.; Guemues, Zeynep H.; Shuler, Michael; Nishimura, Nozomi; Edelmann, Winfried; Shen, Xiling; Lipkin, Steven M.			Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting	NATURE BIOTECHNOLOGY			English	Article							COLON-CANCER; PREIMPLANTATION DEVELOPMENT; GENOME ANALYSIS; MOUSE MODELS; EXPRESSION; RECEPTORS; CELLS; CHEMOSENSITIVITY; CHEMORESISTANCE; MECHANISMS	Current orthotopic xenograft models of human colorectal cancer (CRC) require surgery and do not robustly form metastases in the liver, the most common site clinically. CCR9 traffics lymphocytes to intestine and colorectum. We engineered use of the chemokine receptor CCR9 in CRC cell lines and patient-derived cells to create primary gastrointestinal (GI) tumors in immunodeficient mice by tail-vein injection rather than surgery. The tumors metastasize inducibly and robustly to the liver. Metastases have higher DKK4 and NOTCH signaling levels and are more chemoresistant than paired subcutaneous xenografts. Using this approach, we generated 17 chemokine-targeted mouse models (CTMMs) that recapitulate the majority of common human somatic CRC mutations. We also show that primary tumors can be modeled in immunocompetent mice by microinjecting CCR9-expressing cancer cell lines into early-stage mouse blastocysts, which induces central immune tolerance. We expect that CTMMs will facilitate investigation of the biology of CRC metastasis and drug screening.	[Chen, Huanhuan Joyce; Rakhilin, Nikolai; Joe, Daniel J.; Choi, Jiahn; Gadamsetty, Poornima; Bu, Pengcheng; Wang, Lihua; Xu, Yitian; Shuler, Michael; Nishimura, Nozomi; Shen, Xiling] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Chen, Huanhuan Joyce; Sun, Jian; Huang, Zhiliang; Arcilla, Myra; Longman, Randy; Guemues, Zeynep H.; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Hou, Harry, Jr.; Edelmann, Winfried] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Milsom, Jeff; Nandakumar, Govind] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Zhou, Xi Kathy] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Edwards, Robert] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Chen, Jonlin; Chen, Kai Yuan; Bu, Pengcheng; Shen, Xiling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA; [Munroe, Robert; Abratte, Christian; Miller, Andrew D.] Cornell Univ, Coll Vet Med & Biol Sci, Ithaca, NY USA; [Guemues, Zeynep H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Cornell University; Cornell University; Yeshiva University; Cornell University; Cornell University; University of California System; University of California Irvine; Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai	Lipkin, SM (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	xs66@cornell.edu; stl2012@med.cornell.edu	Nishimura, Nozomi/AAV-2425-2020; Choi, Jiahn/E-8284-2018; Joe, Daniel J./F-1128-2015; Nishimura, Nozomi/P-8908-2015	Nishimura, Nozomi/0000-0003-4342-9416; Choi, Jiahn/0000-0001-7344-767X; Joe, Daniel J./0000-0002-1945-8236; Nishimura, Nozomi/0000-0003-4342-9416; Bu, Pengcheng/0000-0002-3208-0354; Gumus, Zeynep/0000-0002-7364-2202	National Science Foundation (NSF) [1137269, NSF 1106153, NSF GRFP-2011131053]; National Institutes of Health (NIH) [R01 GM095990, CA098626, NIH 2UL1-RR024996, NIH UH2TR000516]; Defense Advanced Research Projects Agency [19-1091726]; NATIONAL CANCER INSTITUTE [R01CA098626, R01CA076329, P30CA013330, R56CA098626] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000516, UL1TR001414, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK099381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114254, R01GM095990] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank other members of the Lipkin laboratory and Shen Laboratory for helpful discussions. We also thank the Cornell BRC imaging and Stem Cell and Transgenic Core Facilities. This work was supported by the National Science Foundation (NSF) 1137269, NSF 1106153, NSF GRFP-2011131053, National Institutes of Health (NIH) R01 GM095990, CA098626, NIH 2UL1-RR024996, NIH UH2TR000516, Defense Advanced Research Projects Agency 19-1091726, and generous donations by Matthew Bell and Fred Greenberg.	Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Cao ZW, 2014, CANCER CELL, V25, P350, DOI 10.1016/j.ccr.2014.02.005; Chen C, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-8; Chen HJ, 2012, J CLIN INVEST, V122, P3184, DOI 10.1172/JCI62110; DANCIS J, 1972, ACTA ENDOCRINOL-COP, P347; Ebert MPA, 2012, NEW ENGL J MED, V366, P44, DOI 10.1056/NEJMoa1009473; Eds Johan Auwerx S.L.A., 2013, CURRENT PROTOCOLS MO; Ellis Lee M, 2004, Clin Colorectal Cancer, V4 Suppl 2, pS55, DOI 10.3816/CCC.2004.s.009; He K, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-41; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Kabelitz D, 2003, CRIT REV IMMUNOL, V23, P339, DOI 10.1615/CritRevImmunol.v23.i56.10; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; Maekawa M, 2005, DEVELOPMENT, V132, P1773, DOI 10.1242/dev.01729; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Meurens F, 2007, IMMUNOLOGY, V120, P544, DOI 10.1111/j.1365-2567.2006.02532.x; Meurens F, 2006, VET IMMUNOL IMMUNOP, V113, P313, DOI 10.1016/j.vetimm.2006.05.014; Nagy A., 2003, MANIPULATING MOUSE E; Okumura K, 2006, ONCOL REP, V15, P875; Schneider JS, 2009, STEM CELL REV REP, V5, P369, DOI 10.1007/s12015-009-9089-6; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; THIEL H, 1980, SURG GYNECOL OBSTET, V150, P587; Wagner M, 2009, J GASTROINTEST SURG, V13, P1781, DOI 10.1007/s11605-009-0948-x; Walters S, 2013, INT J CANCER, V132, P676, DOI 10.1002/ijc.27651; Youn BS, 2001, BLOOD, V98, P925, DOI 10.1182/blood.V98.4.925; Yu CR, 2000, J IMMUNOL, V164, P1293, DOI 10.4049/jimmunol.164.3.1293	29	23	23	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					656	+		10.1038/nbt.3239	http://dx.doi.org/10.1038/nbt.3239			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26006007	Green Accepted, Green Submitted			2022-12-25	WOS:000356019700026
J	Babak, T; DeVeale, B; Tsang, EK; Zhou, YQ; Li, X; Smith, KS; Kukurba, KR; Zhang, R; Li, JB; van der Kooy, D; Montgomery, SB; Fraser, HB				Babak, Tomas; DeVeale, Brian; Tsang, Emily K.; Zhou, Yiqi; Li, Xin; Smith, Kevin S.; Kukurba, Kim R.; Zhang, Rui; Li, Jin Billy; van der Kooy, Derek; Montgomery, Stephen B.; Fraser, Hunter B.			Genetic conflict reflected in tissue-specific maps of genomic imprinting in human and mouse	NATURE GENETICS			English	Article							DNA METHYLATION; EVOLUTION; EXPRESSION; IDENTIFICATION; MECHANISM; SEQUENCE; RESCUES; GROWTH	Genomic imprinting is an epigenetic process that restricts gene expression to either the maternally or paternally inherited allele(1,2). Many theories have been proposed to explain its evolutionary origin(3,4), but understanding has been limited by a paucity of data mapping the breadth and dynamics of imprinting within any organism. We generated an atlas of imprinting spanning 33 mouse and 45 human developmental stages and tissues. Nearly all imprinted genes were imprinted in early development and either retained their parent-of-origin expression in adults or lost it completely. Consistent with an evolutionary signature of parental conflict, imprinted genes were enriched for coexpressed pairs of maternally and paternally expressed genes, showed accelerated expression divergence between human and mouse, and were more highly expressed than their non-imprinted orthologs in other species. Our approach demonstrates a general framework for the discovery of imprinting in any species and sheds light on the causes and consequences of genomic imprinting in mammals.	[Babak, Tomas; Zhou, Yiqi; Fraser, Hunter B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [DeVeale, Brian] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Tsang, Emily K.; Li, Xin; Smith, Kevin S.; Kukurba, Kim R.; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Kukurba, Kim R.; Zhang, Rui; Li, Jin Billy; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [van der Kooy, Derek] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	Stanford University; University of California System; University of California San Francisco; Stanford University; Stanford University; University of Toronto	Fraser, HB (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	hbfraser@stanford.edu		Babak, Tomas/0000-0003-0879-0134; Montgomery, Stephen/0000-0002-5200-3903; Zhang, Rui/0000-0001-9000-5021	US National Institutes of Health (NIH) grant [1R01GM097171-01A1]; US NIH grant [U01HG007593]; Hewlett-Packard Stanford Graduate Fellowship; US National Science Foundation grant [OCI-1053575]; Common Fund of the Office of the Director of the US NIH; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute of Mental Health; National Cancer Institute/SAIC-Frederick, Inc. [10XS170]; Roswell Park Cancer Institute [10XS171]; Science Care, Inc. [X10S172]; Laboratory, Data Analysis and Coordinating Center (LDACC) [HHSN268201000029C]; SAIC-Frederick [10ST1035, HHSN261200800001E]; University of Miami grant [DA006227]; University of Chicago [MH090951, MH090937]; University of North Carolina, Chapel Hill [MH090936]; Harvard University [MH090948]; National Institute on Drug Abuse; National Institute Neurological Disorders and Stroke;  [MH090941]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090937, R01MH090941, R01MH090948, R01MH090936, R01MH090951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hewlett-Packard Stanford Graduate Fellowship; US National Science Foundation grant(National Science Foundation (NSF)); Common Fund of the Office of the Director of the US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute/SAIC-Frederick, Inc.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Cancer Institute; Science Care, Inc.; Laboratory, Data Analysis and Coordinating Center (LDACC); SAIC-Frederick; University of Miami grant; University of Chicago(University of Chicago); University of North Carolina, Chapel Hill; Harvard University; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Fraser laboratory for critical evaluation of the manuscript. This work was supported by US National Institutes of Health (NIH) grant 1R01GM097171-01A1. H.B.F. is an Alfred P. Sloan Fellow and a Pew Scholar in the Biomedical Sciences. The work of S.B.M. and J.B.L. was supported by US NIH grant U01HG007593. E.K.T. was supported by a Hewlett-Packard Stanford Graduate Fellowship. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by US National Science Foundation grant OCI-1053575. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the US NIH. Additional GTEx funds were provided by the National Cancer Institute, National Human Genome Research Institute, National Heart Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health and National Institute Neurological Disorders and Stroke. Donors were enrolled at Biospecimen Source Sites funded by National Cancer Institute/SAIC-Frederick, Inc. subcontracts to the National Disease Research Interchange (10XS170), the Roswell Park Cancer Institute (10XS171) and Science Care, Inc. (X10S172). The Laboratory, Data Analysis and Coordinating Center (LDACC) was funded through a contract (HHSN268201000029C) to the Broad Institute. Biorepository operations were funded through an SAIC-Frederick subcontract to the Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-Frederick (HHSN261200800001E). The Brain Bank was supported by a supplement to University of Miami grant DA006227. Statistical Methods development grants were made to the University of Geneva (MH090941), the University of Chicago (MH090951 and MH090937), the University of North Carolina, Chapel Hill (MH090936) and Harvard University (MH090948).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babak Tomas, 2012, Methods Mol Biol, V925, P79, DOI 10.1007/978-1-62703-011-3_6; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Grubb SC, 2014, NUCLEIC ACIDS RES, V42, pD825, DOI 10.1093/nar/gkt1159; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; Li X, 2014, AM J HUM GENET, V95, P245, DOI 10.1016/j.ajhg.2014.08.004; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pereira V, 2009, GENETICS, V183, P1597, DOI 10.1534/genetics.109.110247; Potes CS, 2010, PHYSIOL BEHAV, V100, P511, DOI 10.1016/j.physbeh.2010.03.001; Renfree MB, 2009, ANNU REV GENOM HUM G, V10, P241, DOI 10.1146/annurev-genom-082908-150026; Schaller F, 2010, HUM MOL GENET, V19, P4895, DOI 10.1093/hmg/ddq424; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Spencer HG, 2014, HEREDITY, V113, P112, DOI 10.1038/hdy.2013.129; Tran DA, 2014, NUCLEIC ACIDS RES, V42, P1772, DOI 10.1093/nar/gkt1042; Tzouanacou E, 2003, MOL CELL BIOL, V23, P8553, DOI 10.1128/MCB.23.23.8553-8562.2003; Wang X, 2011, GENETICS, V189, P109, DOI 10.1534/genetics.111.130088; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wilkins JF, 2002, P ROY SOC B-BIOL SCI, V269, P1841, DOI 10.1098/rspb.2002.2096; Wilkins JF, 2001, P ROY SOC B-BIOL SCI, V268, P1861, DOI 10.1098/rspb.2001.1651; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Wutz A, 2001, DEVELOPMENT, V128, P1881; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736	43	115	121	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					544	U158		10.1038/ng.3274	http://dx.doi.org/10.1038/ng.3274			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25848752	Green Accepted			2022-12-25	WOS:000353635800020
J	Curtis, J; Luo, Y; Zenner, HL; Cuchet-Lourenco, D; Wu, CX; Lo, K; Maes, M; Alisaac, A; Stebbings, E; Liu, JZ; Kopanitsa, L; Ignatyeva, O; Balabanova, Y; Nikolayevskyy, V; Baessmann, I; Thye, T; Meyer, CG; Nurnberg, P; Horstmann, RD; Drobniewski, F; Plagnol, V; Barrett, JC; Nejentsev, S				Curtis, James; Luo, Yang; Zenner, Helen L.; Cuchet-Lourenco, Delphine; Wu, Changxin; Lo, Kitty; Maes, Mailis; Alisaac, Ali; Stebbings, Emma; Liu, Jimmy Z.; Kopanitsa, Liliya; Ignatyeva, Olga; Balabanova, Yanina; Nikolayevskyy, Vladyslav; Baessmann, Ingelore; Thye, Thorsten; Meyer, Christian G.; Nuernberg, Peter; Horstmann, Rolf D.; Drobniewski, Francis; Plagnol, Vincent; Barrett, Jeffrey C.; Nejentsev, Sergey			Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; IMMUNE-RESPONSE; ARF GAPS; ARCHITECTURE; EXPRESSION	Human genetic factors predispose to tuberculosis (TB). We studied 7.6 million genetic variants in 5,530 people with pulmonary TB and in 5,607 healthy controls. In the combined analysis of these subjects and the follow-up cohort (15,087 TB patients and controls altogether), we found an association between TB and variants located in introns of the ASAP1 gene on chromosome 8q24 (P = 2.6 x 10(-11) for rs4733781; P = 1.0 x 10(-10) for rs10956514). Dendritic cells (DCs) showed high ASAP1 expression that was reduced after Mycobacterium tuberculosis infection, and rs10956514 was associated with the level of reduction of ASAP1 expression. The ASAP1 protein is involved in actin and membrane remodeling and has been associated with podosomes. The ASAP1-depleted DCs showed impaired matrix degradation and migration. Therefore, genetically determined excessive reduction of ASAP1 expression in Mycobacterium tuberculosis-infected DCs may lead to their impaired migration, suggesting a potential mechanism of predisposition to TB.	[Curtis, James; Zenner, Helen L.; Cuchet-Lourenco, Delphine; Wu, Changxin; Maes, Mailis; Alisaac, Ali; Stebbings, Emma; Kopanitsa, Liliya; Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Luo, Yang; Liu, Jimmy Z.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Lo, Kitty; Plagnol, Vincent] UCL, Genet Inst, London, England; [Ignatyeva, Olga] Samara Oblast TB Dispensary, Samara, Russia; [Balabanova, Yanina] Robert Koch Inst, Berlin, Germany; [Balabanova, Yanina; Nikolayevskyy, Vladyslav; Drobniewski, Francis] Univ London Imperial Coll Sci Technol & Med, London, England; [Balabanova, Yanina; Nikolayevskyy, Vladyslav; Drobniewski, Francis] Queen Mary Univ London, London, England; [Nikolayevskyy, Vladyslav; Drobniewski, Francis] Publ Hlth England Natl Mycobacterium Reference La, London, England; [Baessmann, Ingelore; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Thye, Thorsten; Meyer, Christian G.; Horstmann, Rolf D.] Bernhard Nocht Inst Topical Med, Dept Mol Med, Hamburg, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cambridge; Wellcome Trust Sanger Institute; University of London; University College London; Robert Koch Institute; Imperial College London; University of London; Queen Mary University London; Public Health England; University of Cologne; Bernhard Nocht Institut fur Tropenmedizin; University of Cologne; University of Cologne	Nejentsev, S (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	sn262@cam.ac.uk	Nikolayevskyy, Vladyslav/HFZ-7738-2022	Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Kopanitsa, Liliya/0000-0002-3752-2887; Barrett, Jeffrey/0000-0002-1152-370X; Luo, Yang/0000-0001-7385-6166; Plagnol, Vincent/0000-0002-5597-9215; Ignatyeva, Olga/0000-0003-2020-4206; Maes, Mailis/0000-0002-0266-6557	Wellcome Trust [088838/Z/09/Z, 095198/Z/10/Z, 076113, 085475, 090355]; EU Framework Programme 7 Collaborative grant [201483]; European Research Council Starting grant [260477]; Royal Society [UF0763346, RG090638]; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre	Wellcome Trust(Wellcome Trust); EU Framework Programme 7 Collaborative grant; European Research Council Starting grant(European Research Council (ERC)); Royal Society(Royal Society of London); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	The study was supported by Wellcome Trust grants 088838/Z/09/Z (to S.N., J.C.B., F.D.) and 095198/Z/10/Z (to S.N.), EU Framework Programme 7 Collaborative grant 201483 (to S.N., F.D., R.D.H., P.N.), European Research Council Starting grant 260477 (to S.N.), and Royal Society grants UF0763346 (to S.N.) and RG090638 (to S.N.). S.N. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science and is also supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113, 085475 and 090355.	Apt A, 2009, TUBERCULOSIS, V89, P195, DOI 10.1016/j.tube.2009.02.002; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Ehlers JP, 2005, CLIN CANCER RES, V11, P3609, DOI 10.1158/1078-0432.CCR-04-1941; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Gotz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060642; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Roberts LL, 2014, IMMUNOLOGY, V141, P39, DOI 10.1111/imm.12164; Szeszko JS, 2007, HUM GENET, V121, P155, DOI 10.1007/s00439-006-0293-z; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	31	103	109	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					523	U128		10.1038/ng.3248	http://dx.doi.org/10.1038/ng.3248			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25774636	Green Accepted, Green Submitted			2022-12-25	WOS:000353635800016
J	Bergert, M; Erzberger, A; Desai, RA; Aspalter, IM; Oates, AC; Charras, G; Salbreux, G; Paluch, EK				Bergert, Martin; Erzberger, Anna; Desai, Ravi A.; Aspalter, Irene M.; Oates, Andrew C.; Charras, Guillaume; Salbreux, Guillaume; Paluch, Ewa K.			Force transmission during adhesion-independent migration	NATURE CELL BIOLOGY			English	Letter							CELL-MIGRATION; LEUKOCYTE MIGRATION; CORTICAL TENSION; TRACTION FORCES; CYTOKINESIS; MICROSCOPY; MECHANICS; STIFFNESS; DYNAMICS; INVASION	When cells move using integrin-based focal adhesions, they pull in the direction of motion with large, similar to 100 Pa, stresses that contract the substrate1. Integrin-mediated adhesions, however, are not required for in vivo confined migration2. During focal adhesion-free migration, the transmission of propelling forces, and their magnitude and orientation, are not understood. Here, we combine theory and experiments to investigate the forces involved in adhesion-free migration. Using a non-adherent blebbing cell line as a model, we show that actin cortex flows drive cell movement through nonspecific substrate friction. Strikingly, the forces propelling the cell forward are several orders of magnitude lower than during focal-adhesion-based motility. Moreover, the force distribution in adhesion-free migration is inverted: it acts to expand, rather than contract, the substrate in the direction of motion. This fundamentally different mode of force transmission may have implications for cell-cell and cell-substrate interactions during migration in vivo.	[Bergert, Martin; Aspalter, Irene M.; Paluch, Ewa K.] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Bergert, Martin; Desai, Ravi A.; Aspalter, Irene M.; Oates, Andrew C.; Charras, Guillaume; Paluch, Ewa K.] UCL, Inst Phys Living Syst, London WC1E 6BT, England; [Erzberger, Anna; Salbreux, Guillaume] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Desai, Ravi A.; Oates, Andrew C.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Desai, Ravi A.; Oates, Andrew C.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Charras, Guillaume] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Charras, Guillaume] UCL, Dept Cell & Dev Biol, London WC1H 0AH, England	University of London; University College London; University of London; University College London; Max Planck Society; MRC National Institute for Medical Research; University of London; University College London; University of London; University College London; University of London; University College London	Salbreux, G (corresponding author), Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany.	salbreux@pks.mpg.de; e.paluch@ucl.ac.uk	Charras, Guillaume/F-8571-2014	Charras, Guillaume/0000-0002-7902-0279; Aspalter, Irene Maria/0000-0002-6155-9006; Desai, Ravi/0000-0002-4217-3351; Salbreux, Guillaume/0000-0001-7041-1292; Paluch, Ewa/0000-0003-4691-2323; Bergert, Martin/0000-0002-3222-8929; Erzberger, Anna/0000-0002-2200-4665	Medical Research Council [MC_UP_1202/3, MC_UU_12018/5, MC_UP_1205/1] Funding Source: Medline; Wellcome Trust [WT098025MA, 098025] Funding Source: Medline; MRC Laboratory for Molecular Cell Biology (LMCB) [Paluch ERC Research Grant] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [MC_UU_12018/5, MC_UP_1205/1, MC_UP_1202/3] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC Laboratory for Molecular Cell Biology (LMCB)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Artym VV, 2010, IMAGING CELLS 3 DIME, V10, P1; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Byun S, 2013, P NATL ACAD SCI USA, V110, P7580, DOI 10.1073/pnas.1218806110; Clark AG, 2013, BIOPHYS J, V105, P570, DOI 10.1016/j.bpj.2013.05.057; Deserno M, NOTES DIFFERENTIAL G; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Friedl P, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm2825; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Gabriele S, 2010, LAB CHIP, V10, P1459, DOI 10.1039/c002257h; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Heit Bryan, 2003, Sci STKE, V2003, pPL5, DOI 10.1126/stke.2003.170.pl5; Heuze ML, 2011, METHODS MOL BIOL, V769, P415, DOI 10.1007/978-1-61779-207-6_28; Iwadate Y, 2008, BIOTECHNIQUES, V44, P739, DOI 10.2144/000112752; Kam L, 2001, J BIOMED MATER RES, V55, P487, DOI 10.1002/1097-4636(20010615)55:4<487::AID-JBM1041>3.0.CO;2-7; Kawamura R, 2013, LANGMUIR, V29, P6429, DOI 10.1021/la4012229; Khatau SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00488; Koga H, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015010; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Moeendarbary E., 2013, NAT MATER, V12, P1; Mohan K, 2012, EXP CELL RES, V318, P1428, DOI 10.1016/j.yexcr.2012.03.028; Morin TR, 2014, EXP CELL RES, V326, P280, DOI 10.1016/j.yexcr.2014.04.015; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Norstrom M, 2011, SOFT MATTER, V7, P3228, DOI 10.1039/c0sm01157f; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Preira P, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4802272; PRETZLER G, 1991, Z NATURFORSCH A, V46, P639, DOI 10.1515/zna-1991-0715; Renkawitz J, 2010, EMBO REP, V11, P744, DOI 10.1038/embor.2010.147; Ricart BG, 2011, BIOPHYS J, V101, P2620, DOI 10.1016/j.bpj.2011.09.022; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Schwarz US, 2013, REV MOD PHYS, V85, P1327, DOI 10.1103/RevModPhys.85.1327; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Style RW, 2014, SOFT MATTER, V10, P4047, DOI 10.1039/c4sm00264d; Tanimoto H, 2014, BIOPHYS J, V106, P16, DOI 10.1016/j.bpj.2013.10.041; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106	50	189	191	6	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					524	+		10.1038/ncb3134	http://dx.doi.org/10.1038/ncb3134			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25774834	Green Accepted			2022-12-25	WOS:000351920500022
J	Kim, HU; Ryu, JY; Lee, JO; Lee, SY				Kim, Hyun Uk; Ryu, Jae Yong; Lee, Jong Ok; Lee, Sang Yup			A systems approach to traditional oriental medicine	NATURE BIOTECHNOLOGY			English	Article							DRUG-COMBINATIONS; NATURAL-PRODUCT; MECHANISMS; INTEGRATION; TARGETS; IMPACT; CELLS; TCM		[Kim, Hyun Uk; Ryu, Jae Yong; Lee, Jong Ok; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn,Plus Program BK21, Ctr Syst & Synthet Biotechnol,Inst BioCentury, Taejon 305701, South Korea; [Kim, Hyun Uk; Lee, Jong Ok; Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioInformat Res Ctr, Taejon 305701, South Korea; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, Taejon 305701, South Korea; [Kim, Hyun Uk; Lee, Sang Yup] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Technical University of Denmark	Kim, HU (corresponding author), Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn,Plus Program BK21, Ctr Syst & Synthet Biotechnol,Inst BioCentury, Taejon 305701, South Korea.	leesy@kaist.ac.kr	Kim, Hyun Uk/F-4509-2018; Lee, Sang Yup/C-1526-2011	Kim, Hyun Uk/0000-0001-7224-642X; Lee, Sang Yup/0000-0003-0599-3091	Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [New Bioactive Compounds] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability		Agren R, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.145122; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Ding M, 2007, J PHARM PHARMACOL, V59, P1027, DOI 10.1211/jpp.59.7.0016; Dobson PD, 2009, DRUG DISCOV TODAY, V14, P31, DOI 10.1016/j.drudis.2008.10.011; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Gujral TS, 2014, P NATL ACAD SCI USA, V111, P5048, DOI 10.1073/pnas.1403080111; Hawkes D, 2014, TRENDS PHARMACOL SCI, V35, P111, DOI 10.1016/j.tips.2014.01.002; Hebar A, 2013, EXPERT REV CLIN PHAR, V6, P23, DOI [10.1586/ECP.12.71, 10.1586/ecp.12.71]; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jayaseelan KV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-106; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jung JY, 2011, KOR J MED HIST, V20, P1; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khanna V, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-30; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim TY, 2010, METAB ENG, V12, P105, DOI 10.1016/j.ymben.2009.05.004; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu X, 2013, TRENDS PHARMACOL SCI, V34, P620, DOI 10.1016/j.tips.2013.09.004; Ma XH, 2009, DRUG DISCOV TODAY, V14, P579, DOI 10.1016/j.drudis.2009.03.012; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; McCarty MF, 2006, MED HYPOTHESES, V66, P1093, DOI 10.1016/j.mehy.2004.11.046; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; Oh C, 2013, KOR J MED HIST, V22, P1; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Spink BC, 2003, BIOCHEM PHARMACOL, V66, P2313, DOI 10.1016/j.bcp.2003.08.019; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; van der Greef J, 2011, NATURE, V480, pS87, DOI 10.1038/480S87a; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Xu ZG, 2011, NATURE, V480, pS90, DOI 10.1038/480S90a	37	60	61	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					264	268		10.1038/nbt.3167	http://dx.doi.org/10.1038/nbt.3167			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748918	Bronze			2022-12-25	WOS:000350766900022
J	Danjou, F; Zoledziewska, M; Sidore, C; Steri, M; Busonero, F; Maschio, A; Mulas, A; Perseu, L; Barella, S; Porcu, E; Pistis, G; Pitzalis, M; Pala, M; Menzel, S; Metrustry, S; Spector, TD; Leoni, L; Angius, A; Uda, M; Moi, P; Thein, SL; Galanello, R; Abecasis, GR; Schlessinger, D; Sanna, S; Cucca, F				Danjou, Fabrice; Zoledziewska, Magdalena; Sidore, Carlo; Steri, Maristella; Busonero, Fabio; Maschio, Andrea; Mulas, Antonella; Perseu, Lucia; Barella, Susanna; Porcu, Eleonora; Pistis, Giorgio; Pitzalis, Maristella; Pala, Mauro; Menzel, Stephan; Metrustry, Sarah; Spector, Timothy D.; Leoni, Lidia; Angius, Andrea; Uda, Manuela; Moi, Paolo; Thein, Swee Lay; Galanello, Renzo; Abecasis, Gonaalo R.; Schlessinger, David; Sanna, Serena; Cucca, Francesco			Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels	NATURE GENETICS			English	Article							FETAL-HEMOGLOBIN; GENE-EXPRESSION; GENOTYPE IMPUTATION; HEMATOPOIETIC STEM; DNASE-II; GLOBIN; BCL11A; VARIANTS; PROTEIN; METAANALYSIS	We report genome-wide association study results for the levels of A1, A2 and fetal hemoglobins, analyzed for the first time concurrently. Integrating high-density array genotyping and whole-genome sequencing in a large general population cohort from Sardinia, we detected 23 associations at 10 loci. Five signals are due to variants at previously undetected loci: MPHOSPH9, PLTP-PCIF1, ZFPM1 (FOG1), NFIX and CCND3. Among the signals at known loci, ten are new lead variants and four are new independent signals. Half of all variants also showed pleiotropic associations with different hemoglobins, which further corroborated some of the detected associations and identified features of coordinated hemoglobin species production.	[Danjou, Fabrice; Zoledziewska, Magdalena; Sidore, Carlo; Steri, Maristella; Busonero, Fabio; Maschio, Andrea; Mulas, Antonella; Perseu, Lucia; Porcu, Eleonora; Pistis, Giorgio; Pitzalis, Maristella; Pala, Mauro; Angius, Andrea; Uda, Manuela; Sanna, Serena; Cucca, Francesco] CNR, Isti Ric Genet & Biomed, Cagliari, Italy; [Sidore, Carlo; Busonero, Fabio; Maschio, Andrea; Porcu, Eleonora; Pistis, Giorgio; Abecasis, Gonaalo R.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sidore, Carlo; Mulas, Antonella; Porcu, Eleonora; Pistis, Giorgio; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Busonero, Fabio; Maschio, Andrea] Univ Michigan, DNA Sequencing Core, Ann Arbor, MI 48109 USA; [Barella, Susanna; Moi, Paolo; Galanello, Renzo] Osped Reg Microcitemie, ASL8, Cagliari, Italy; [Menzel, Stephan; Thein, Swee Lay] Kings Coll London, Dept Mol Hematol, London, England; [Metrustry, Sarah; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Leoni, Lidia; Angius, Andrea] Parco Sci & Tecnol Sardegna, Res & Dev Sardinia CRS4, Ctr Adv Studies, Pula, Italy; [Moi, Paolo; Galanello, Renzo] Univ Cagliari, Dept Publ Hlth & Clin & Mol Med, Cagliari, Italy; [Thein, Swee Lay] Kings Coll Hosp Natl Hlth Serv NHS Fdn Trust, Dept Hematol Med, London, England; [Schlessinger, David] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Michigan System; University of Michigan; University of Sassari; University of Michigan System; University of Michigan; University of London; King's College London; University of London; King's College London; University of Cagliari; King's College Hospital NHS Foundation Trust; King's College Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Danjou, F (corresponding author), CNR, Isti Ric Genet & Biomed, Cagliari, Italy.	fabrice.danjou@irgb.cnr.it; fcucca@uniss.it	sanna, serena/H-3009-2019; Maschio, Andrea/AAX-8185-2020; Moi, Paolo/AAC-3161-2019; Mulas, Antonella/B-4231-2015; Sidore, Carlo/AAV-7967-2020; Menzel, Stephan/U-6906-2019; Angius, Andrea/P-9549-2015; Steri, Maristella/AAX-8760-2020; Pala, Mauro/AAY-4774-2020; Uda, Manuela/AAC-2645-2019; Danjou, Fabrice/D-1563-2014	sanna, serena/0000-0002-3768-1749; Sidore, Carlo/0000-0001-7504-7477; Angius, Andrea/0000-0003-2596-6461; Steri, Maristella/0000-0001-5869-3872; Uda, Manuela/0000-0002-4890-6456; Danjou, Fabrice/0000-0002-4976-2327; Menzel, Stephan/0000-0002-1590-9108; CUCCA, Francesco/0000-0002-7414-1995; Zoledziewska, Magdalena/0000-0002-3033-6133; MOI, Paolo/0000-0001-7879-8057; maschio, andrea/0000-0002-4238-9144; Pala, Mauro/0000-0002-3165-5291; Mulas, Antonella/0000-0002-6856-1483; Pitzalis, Maristella/0000-0003-4975-6987	US National Institutes of Health (National Institute on Aging); National Human Genome Research Institute [HG005581, HG005552, HG006513, HG007022]; National Heart, Lung, and Blood Institute [HL117626]; US National Institutes of Health, National Institute on Aging [N01-AG-1-2109, HHSN271201100005C]; Sardinian Autonomous Region [cRP3-154, 7/2009]; grant FaReBio "Farmaci e Reti Biotecnologiche di Qualita"; PB05 InterOmics MIUR Flagship Project; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; Medical Research Council, UK [G0000111, ID51640]; British Society for Haematology; US National Institutes of Health (National Heart, Lung, and Blood Institute); US National Institutes of Health (National Human Genome Research Institute); King's College London; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626, U01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005552, U01HG006513, RC2HG005581, R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; Medical Research Council [G0000111] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish; MRC [G0000111] Funding Source: UKRI	US National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Sardinian Autonomous Region(Regione Sardegna); grant FaReBio "Farmaci e Reti Biotecnologiche di Qualita"; PB05 InterOmics MIUR Flagship Project; Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Society for Haematology; US National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health (National Human Genome Research Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); King's College London; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is dedicated to Antonio Cao, Renzo Galanello and Maurizio Longinotti, who devoted their scientific lives to understanding, preventing and treating hematological diseases in Sardinia. We are also grateful to M.S. Ristaldi and M.G. Marini for knowledge and insight that they freely shared with us. Finally, we thank all the volunteers who generously participated in this study and made this research possible. The SardiNIA study was funded in part by the US National Institutes of Health (National Institute on Aging, National Heart, Lung, and Blood Institute, and). This research was supported by National Human Genome Research Institute grants HG005581, HG005552, HG006513 and HG007022; by National Heart, Lung, and Blood Institute grant HL117626; by the Intramural Research Program of the US National Institutes of Health, National Institute on Aging, contracts N01-AG-1-2109 and HHSN271201100005C; by Sardinian Autonomous Region (L.R. number 7/2009) grant cRP3-154; by grant FaReBio2011 "Farmaci e Reti Biotecnologiche di Qualita"; and by the PB05 InterOmics MIUR Flagship Project. The TwinsUK study was funded by the Wellcome Trust; the European Community's Seventh Framework Programme (FP7/2007-2013); and the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Genotyping in the replication cohorts was performed by the Wellcome Trust Sanger Institute and National Eye Institute via the US National Institutes of Health/Center for Inherited Disease Research (CIDR). S.L.T. was supported by the Medical Research Council, UK (grant G0000111, ID51640), and S. Menzel received funding from the British Society for Haematology (start-up grant).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bae HT, 2012, BLOOD, V120, P1961, DOI 10.1182/blood-2012-06-432849; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Danjou F, 2015, HAEMATOLOGICA, V100, P455, DOI 10.3324/haematol.2014.113886; Danjou F, 2012, HAEMATOL-HEMATOL J, V97, P989, DOI 10.3324/haematol.2011.053504; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Freson K, 2003, HUM GENET, V112, P42, DOI 10.1007/s00439-002-0832-1; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Goh SH, 2005, BLOOD, V106, P1466, DOI 10.1182/blood-2005-03-0948; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Hirose Y, 2008, BIOCHEM BIOPH RES CO, V369, P449, DOI 10.1016/j.bbrc.2008.02.042; Holmfeldt P, 2013, BLOOD, V122, P2987, DOI 10.1182/blood-2013-04-493973; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Jarvik GP, 2010, J LIPID RES, V51, P983, DOI 10.1194/jlr.M000125; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2013, BRIT J HAEMATOL, V160, P101, DOI 10.1111/bjh.12084; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Origa R, 2014, BLOOD CELL MOL DIS, V52, P46, DOI 10.1016/j.bcmd.2013.06.004; Perseu L, 2011, BLOOD, V118, P4454, DOI 10.1182/blood-2011-04-345736; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pistis G, 2015, EUR J HUM GENET, V23, P975, DOI 10.1038/ejhg.2014.216; Porcu S, 2011, MOL CELL BIOL, V31, P4144, DOI 10.1128/MCB.05532-11; R Core Development Team, 2013, R LANG ENV STAT COMP; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Satta S, 2011, HAEMATOL-HEMATOL J, V96, P767, DOI 10.3324/haematol.2010.037333; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; STEINBERG MH, 1991, BLOOD, V78, P2165; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wright FA, 2012, PHARMACOGENOMICS, V13, P343, DOI [10.2217/PGS.11.185, 10.2217/pgs.11.185]; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	82	50	50	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1264	+		10.1038/ng.3307	http://dx.doi.org/10.1038/ng.3307			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26366553	Green Accepted, Green Published			2022-12-25	WOS:000363988200010
J	Akera, T; Goto, Y; Sato, M; Yamamoto, M; Watanabe, Y				Akera, Takashi; Goto, Yuhei; Sato, Masamitsu; Yamamoto, Masayuki; Watanabe, Yoshinori			Mad1 promotes chromosome congression by anchoring a kinesin motor to the kinetochore	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; FISSION YEAST; CELL-CYCLE; CENP-E; PHOSPHORYLATION; MICROTUBULES; BUB1; ATTACHMENT; PROTEINS; GENE	For proper partitioning of genomes in mitosis, all chromosomes must be aligned at the spindle equator before the onset of anaphase. The spindle assembly checkpoint (SAC) monitors this process, generating a 'wait anaphase' signal at unattached kinetochores of misaligned chromosomes. However, the link between SAC activation and chromosome alignment is poorly understood. Here we show that Mad1, a core SAC component, plays a hitherto concealed role in chromosome alignment. Protein-protein interaction screening revealed that fission yeast Mad1 binds the plus-end-directed kinesin-5 motor protein Cut7 (Eg5 homologue), which is generally thought to promote spindle bipolarity. We demonstrate that Mad1 recruits Cut7 to kinetochores of misaligned chromosomes and promotes chromosome gliding towards the spindle equator. Similarly, human Mad1 recruits another kinetochore motor CENP-E, revealing that Mad1 is the conserved dual-function protein acting in SAC activation and chromosome gliding. Our results suggest that the mitotic checkpoint has co-evolved with a mechanism to drive chromosome congression.	[Akera, Takashi; Goto, Yuhei; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Akera, Takashi; Goto, Yuhei; Sato, Masamitsu; Yamamoto, Masayuki; Watanabe, Yoshinori] Univ Tokyo, Grad Program Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Goto, Yuhei/AAX-5076-2021	Goto, Yuhei/0000-0002-5597-158X; Akera, Takashi/0000-0002-8406-9333; Watanabe, Yoshinori/0000-0002-5488-4812	JSPS Research Fellowship; MEXT KAKENHI Grant [25000014]	JSPS Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Yeast Genetic Resource Center (YGRC) for yeast strains, S. Hauf for critically reading the manuscript, J. Pines (Gurdon Institutein UK) for hMad1 RNAi information and all members of the Watanabe laboratory for their support and discussion. This work was supported in part by a JSPS Research Fellowship (to T.A.) and MEXT KAKENHI Grant Number 25000014 (to Y.W.).	Acar S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2348; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; Drummond DR, 1998, J CELL SCI, V111, P853; Emre D, 2011, J CELL SCI, V124, P1664, DOI 10.1242/jcs.081216; Espert A, 2014, J CELL BIOL, V206, P833, DOI 10.1083/jcb.201406109; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Grishchuk EL, 2007, MOL BIOL CELL, V18, P2216, DOI 10.1091/mbc.E06-11-0987; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Heinrich S, 2012, J CELL SCI, V125, P4720, DOI 10.1242/jcs.110387; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Moyle MW, 2014, J CELL BIOL, V204, P647, DOI 10.1083/jcb.201311015; Murray AW, 2011, NAT CELL BIOL, V13, P1178, DOI 10.1038/ncb2348; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Sacristan C, 2015, TRENDS CELL BIOL, V25, P21, DOI 10.1016/j.tcb.2014.08.006; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Schweizer N, 2013, J CELL BIOL, V203, P883, DOI 10.1083/jcb.201309076; Silva PMA, 2014, FEBS LETT, V588, P3265, DOI 10.1016/j.febslet.2014.07.011; Su XL, 2013, NAT CELL BIOL, V15, P948, DOI 10.1038/ncb2801; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.9786-9801.2004; Vitre B, 2014, MOL BIOL CELL, V25, P2272, DOI 10.1091/mbc.E14-01-0698; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Windecker H, 2009, EMBO REP, V10, P1022, DOI 10.1038/embor.2009.183; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435	55	37	37	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1124	+		10.1038/ncb3219	http://dx.doi.org/10.1038/ncb3219			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26258632	Green Accepted			2022-12-25	WOS:000361113700006
J	Koehnke, J; Mann, G; Bent, AF; Ludewig, H; Shirran, S; Botting, C; Lebl, T; Houssen, WE; Jaspars, M; Naismith, JH				Koehnke, Jesko; Mann, Greg; Bent, Andrew F.; Ludewig, Hannes; Shirran, Sally; Botting, Catherine; Lebl, Tomas; Houssen, Wael E.; Jaspars, Marcel; Naismith, James H.			Structural analysis of leader peptide binding enables leader-free cyanobactin processing	NATURE CHEMICAL BIOLOGY			English	Article							DISCOVERY; HETEROCYCLIZATION; BIOSYNTHESIS; MECHANISM; INSIGHTS; ATP	Regioselective modification of amino acids within the context of a peptide is common to a number of biosynthetic pathways, and many of the resulting products have potential as therapeutics. The ATP-dependent enzyme LynD heterocyclizes multiple cysteine residues to thiazolines within a peptide substrate. The enzyme requires the substrate to have a conserved N-terminal leader for full activity. Catalysis is almost insensitive to immediately flanking residues in the substrate, suggesting that -recognition occurs distant from the active site. Nucleotide and peptide substrate co-complex structures of LynD reveal that the substrate leader peptide binds to and extends the beta-sheet of a conserved domain of LynD, whereas catalysis is accomplished in another conserved domain. The spatial segregation of catalysis from recognition combines seemingly contradictory properties of regioselectivity and promiscuity, and it appears to be a conserved strategy in other peptide-modifying enzymes. A variant of LynD that efficiently processes substrates without a leader peptide has been engineered.	[Koehnke, Jesko; Mann, Greg; Bent, Andrew F.; Ludewig, Hannes; Shirran, Sally; Botting, Catherine; Lebl, Tomas; Naismith, James H.] Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Houssen, Wael E.; Jaspars, Marcel] Univ Aberdeen, Dept Chem, Marine Biodiscovery Ctr, Aberdeen, Scotland; [Houssen, Wael E.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Houssen, Wael E.] Mansoura Univ, Fac Pharm, Dept Pharmacognosy, Mansoura, Egypt; [Naismith, James H.] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Naismith, James H.] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu 610064, Peoples R China	University of St Andrews; University of Aberdeen; University of Aberdeen; Egyptian Knowledge Bank (EKB); Mansoura University; Sichuan University; Sichuan University	Naismith, JH (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.	naismith@st-andrews.ac.uk	Naismith, James Henderson/AAB-8614-2020; Houssen, Wael/K-7926-2016; Naismith, James Henderson/H-3408-2012; Koehnke, Jesko/M-4861-2017; Koehnke, Jesko/AAC-7363-2021	Naismith, James Henderson/0000-0001-6744-5061; Houssen, Wael/0000-0001-9653-5111; Naismith, James Henderson/0000-0001-6744-5061; Koehnke, Jesko/0000-0002-7153-1365; Koehnke, Jesko/0000-0002-7153-1365; Shirran, Sally/0000-0003-3516-3507; Lebl, Tomas/0000-0002-0269-3221; Jaspars, Marcel/0000-0002-2426-6028; Ludewig, Hannes/0000-0003-1130-1442	European Research Council [339367]; UK Biotechnology and Biological Sciences Research Council [BB/K015508/1]; Wellcome Trust; University of St. Andrews [094476/Z/10/Z]; MALDI TOF-TOF Analyser [WT079272AIA]; BBSRC [BB/K015508/1, BB/M013669/1, BB/K015176/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M013669/1, 1098674, BB/K015176/1, BB/K015508/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1245361] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of St. Andrews; MALDI TOF-TOF Analyser; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grants from the European Research Council (no. 339367, J.H.N. and M.J.), the UK Biotechnology and Biological Sciences Research Council (no. BB/K015508/1, J.H.N. and M.J.) and the Wellcome Trust, which funded the purchase of the TripleTOF 5600 mass spectrometer at the Biomedical Sciences Research Complex Mass Spectrometry and Proteomics Facility, University of St. Andrews (grant no. 094476/Z/10/Z), and the MALDI TOF-TOF Analyser (grant no. WT079272AIA). We acknowledge use of the Diamond (beamlines I02 and I24) and ESRF (beamline ID29) synchrotrons. J.H.N. is a Royal Society Wolfson Merit Award Holder and a 1000 talent scholar of the Chinese Government at Sichuan University.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Agarwal V, 2012, CHEM BIOL, V19, P1411, DOI 10.1016/j.chembiol.2012.09.012; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bent AF, 2013, ACTA CRYSTALLOGR F, V69, P618, DOI 10.1107/S1744309113012931; Blunt JW, 2014, NAT PROD REP, V31, P160, DOI 10.1039/c3np70117d; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Donia MS, 2011, CHEM BIOL, V18, P508, DOI 10.1016/j.chembiol.2011.01.019; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Dunbar KL, 2014, NAT CHEM BIOL, V10, P823, DOI [10.1038/NCHEMBIO.1608, 10.1038/nchembio.1608]; Dunbar KL, 2013, J AM CHEM SOC, V135, P8692, DOI 10.1021/ja4029507; Dunbar KL, 2012, NAT CHEM BIOL, V8, P569, DOI [10.1038/NCHEMBIO.944, 10.1038/nchembio.944]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goto Y, 2014, CHEM BIOL, V21, P766, DOI 10.1016/j.chembiol.2014.04.008; Houssen WE, 2014, ANGEW CHEM INT EDIT, V53, P14171, DOI 10.1002/anie.201408082; Houssen WE, 2012, CHEMBIOCHEM, V13, P2683, DOI 10.1002/cbic.201200661; Koehnke J, 2013, ANGEW CHEM INT EDIT, V52, P13991, DOI 10.1002/anie.201306302; Koehnke J, 2013, CHEMBIOCHEM, V14, P564, DOI 10.1002/cbic.201300037; Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340; Leikoski N, 2010, APPL ENVIRON MICROB, V76, P701, DOI 10.1128/AEM.01061-09; Long PF, 2005, CHEMBIOCHEM, V6, P1760, DOI 10.1002/cbic.200500210; Majmudar JD, 2011, CHEMBIOCHEM, V12, P2723, DOI 10.1002/cbic.201100612; Mayer AMS, 2013, MAR DRUGS, V11, P2510, DOI 10.3390/md11072510; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; McIntosh JA, 2010, J AM CHEM SOC, V132, P4089, DOI 10.1021/ja9107116; Melby JO, 2014, BIOCHEMISTRY-US, V53, P413, DOI 10.1021/bi401529y; Melby JO, 2012, J AM CHEM SOC, V134, P5309, DOI 10.1021/ja211675n; Milne BF, 2006, ORG BIOMOL CHEM, V4, P631, DOI 10.1039/b515938e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nielsen DS, 2014, ANGEW CHEM INT EDIT, V53, P12059, DOI 10.1002/anie.201405364; Oman TJ, 2012, J AM CHEM SOC, V134, P6952, DOI 10.1021/ja3017297; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Ruffner DE, 2015, ACS SYNTH BIOL, V4, P482, DOI 10.1021/sb500267d; Schmidt EW, 2009, METHOD ENZYMOL, V458, P575, DOI 10.1016/S0076-6879(09)04823-X; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	43	112	113	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					558	U48		10.1038/nchembio.1841	http://dx.doi.org/10.1038/nchembio.1841			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26098679	Green Accepted, Green Submitted			2022-12-25	WOS:000358255300009
J	Levy, J; Cacheux, W; Bara, MA; L'Hermitte, A; Lepage, P; Fraudeau, M; Trentesaux, C; Lemarchand, J; Durand, A; Crain, AM; Marchiol, C; Renault, G; Dumont, F; Letourneur, F; Delacres, M; Schmitt, A; Terris, B; Perret, C; Chamaillard, M; Couty, JP; Romagnolo, B				Levy, Jonathan; Cacheux, Walfran; Bara, Medhi Ait; L'Hermitte, Antoine; Lepage, Patricia; Fraudeau, Marie; Trentesaux, Coralie; Lemarchand, Julie; Durand, Aurelie; Crain, Anne-Marie; Marchiol, Carmen; Renault, Gilles; Dumont, Florent; Letourneur, Franck; Delacres, Myriam; Schmitt, Alain; Terris, Benoit; Perret, Christine; Chamaillard, Mathias; Couty, Jean-Pierre; Romagnolo, Beatrice			Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth	NATURE CELL BIOLOGY			English	Article							AUTOPHAGY GENE ATG16L1; REGULATORY T-CELLS; TUMORIGENESIS; CANCER; MICE; INFLAMMATION; MOUSE; PROGRESSION; ACTIVATION; EXPRESSION	Here, we show that autophagy is activated in the intestinal epithelium in murine and human colorectal cancer and that the conditional inactivation of Atg7 in intestinal epithelial cells inhibits the formation of pre-cancerous lesions in Apc(+/-) mice by enhancing anti-tumour responses. The antibody-mediated depletion of CD8(+) T cells showed that these cells are essential for the anti-tumoral responses mediated by the inhibition of autophagy. We show that Atg7 deficiency leads to intestinal dysbiosis and that the microbiota is required for anticancer responses. In addition, Atg7 deficiency resulted in a stress response accompanied by metabolic defects, AMPK activation and p53-mediated cell-cycle arrest in tumour cells but not in normal tissue. This study reveals that the inhibition of autophagy within the epithelium may prevent the development and progression of colorectal cancer in genetically predisposed patients.	[Levy, Jonathan; Cacheux, Walfran; Bara, Medhi Ait; L'Hermitte, Antoine; Fraudeau, Marie; Trentesaux, Coralie; Lemarchand, Julie; Durand, Aurelie; Crain, Anne-Marie; Marchiol, Carmen; Renault, Gilles; Dumont, Florent; Letourneur, Franck; Schmitt, Alain; Terris, Benoit; Perret, Christine; Couty, Jean-Pierre; Romagnolo, Beatrice] Univ Paris 05, CNRS, Inst Cochin, UMR8104, F-75014 Paris, France; [Levy, Jonathan; Cacheux, Walfran; Bara, Medhi Ait; L'Hermitte, Antoine; Fraudeau, Marie; Trentesaux, Coralie; Lemarchand, Julie; Durand, Aurelie; Crain, Anne-Marie; Marchiol, Carmen; Renault, Gilles; Dumont, Florent; Letourneur, Franck; Schmitt, Alain; Terris, Benoit; Perret, Christine; Couty, Jean-Pierre; Romagnolo, Beatrice] Inst Natl Sante & Rech Med INSFRM, U1016, F-75014 Paris, France; [Cacheux, Walfran] Inst Curie, Dept Med Oncol, F-75248 Paris 05, France; [Cacheux, Walfran] Inst Curie, Dept Genet, Pharmacogen Unit, F-75248 Paris 05, France; [Lepage, Patricia] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Lepage, Patricia] AgroParis Tech, Micalis UMR1319, F-78350 Jouy En Josas, France; [Crain, Anne-Marie; Couty, Jean-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, UFR Sci Vivant, F-75013 Paris, France; [Delacres, Myriam; Chamaillard, Mathias] Univ Lille Nord France, F-59000 Lille, France; [Delacres, Myriam; Chamaillard, Mathias] Ctr Infect & Immun Lille, Inst Pasteur Lille, F-59800 Lille, France; [Delacres, Myriam; Chamaillard, Mathias] CNRS, Unite Mixle Rech, F-59046 Lille, France; [Delacres, Myriam; Chamaillard, Mathias] Inst Nat Sante & Rech Med, F-59045 Lille, France; [Terris, Benoit] Univ Paris 05, Hop Cochin, AP HP, Serv Anat & Cytol Pathol, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Romagnolo, B (corresponding author), Univ Paris 05, CNRS, Inst Cochin, UMR8104, F-75014 Paris, France.	beatrice.romagnolo@inserm.fr	Perret-Mayeux, Christine/L-3297-2017; Lepage, Patricia/D-4362-2014; Terris, Benoit/P-1497-2017; Romagnolo, Béatrice/D-5017-2017; Chamaillard, Mathias/L-6542-2013; Couty, Jean-Pierre/P-5268-2017	Lepage, Patricia/0000-0002-9501-6771; Romagnolo, Béatrice/0000-0001-8772-3604; Chamaillard, Mathias/0000-0002-0243-9717; Marchiol, Carmen/0000-0002-9666-7939; COUTY, Jean-Pierre/0000-0003-3492-9136; Renault, Gilles/0000-0003-2273-1229; Trentesaux, Coralie/0000-0003-3387-4890; perret, christine/0000-0003-4710-7051	Institut National du Cancer; Comite de Paris de la Ligue Contre le Cancer; Cancer Research Personalized Medicine (CARPEM); Poste d'acceuil INSERM; Ministere de la Recherche et de la Technologie; la Fondation Arc; Inserm; Fondation pour la Recherche Medicale ('Equipe FRM')	Institut National du Cancer(Institut National du Cancer (INCA) France); Comite de Paris de la Ligue Contre le Cancer; Cancer Research Personalized Medicine (CARPEM); Poste d'acceuil INSERM; Ministere de la Recherche et de la Technologie; la Fondation Arc; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale ('Equipe FRM')(Fondation pour la Recherche Medicale)	We thank M. Komatsu (Niigata University, Japan) and S. Robine (Institut Curie, France) for a generous supply of mutant mice, S. Pham, P. Mariani, Y. Bieche, S. Vacher, B. Violet, M. Foretz, B. Radenen-Bussiere and V. Maillet for technical help and for helpful discussions. We are grateful to the staff of Cochin's animal housing facility and in particular to F. Lager and I. Lagoutte. This work was supported by Institut National du Cancer, the Comite de Paris de la Ligue Contre le Cancer, la Fondation Arc, and by the Cancer Research Personalized Medicine (CARPEM). W.C. was supported by Poste d'acceuil INSERM, M.F. and F.D. by CARPEM, and J.L. held a fellowship from the Ministere de la Recherche et de la Technologie and was also financially supported by la Fondation Arc. This work was also supported by funds from Inserm and by grants from the Fondation pour la Recherche Medicale ('Equipe FRM 2013' to M.C.).	Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, CURR TOP MICROBIOL, V335, P141, DOI 10.1007/978-3-642-00302-8_7; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grimm WA, GUT; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Loddenkemper C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-52; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Serebrennikova OB, 2012, P NATL ACAD SCI USA, V109, pE1082, DOI 10.1073/pnas.1115098109; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Xiao H, 2010, GASTROENTEROLOGY, V139, P574, DOI 10.1053/j.gastro.2010.04.043; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zeineldin M, 2013, BBA-REV CANCER, V1836, P80, DOI 10.1016/j.bbcan.2013.01.001; Zhan Y, 2013, CANCER RES, V73, P7199, DOI 10.1158/0008-5472.CAN-13-0827; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	58	115	119	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1062	U440		10.1038/ncb3206	http://dx.doi.org/10.1038/ncb3206			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26214133				2022-12-25	WOS:000358847700013
J	Morrison, C				Morrison, Chris			'Financial toxicity' looms as cancer combinations proliferate	NATURE BIOTECHNOLOGY			English	News Item																			0	7	7	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					783	784		10.1038/nbt0815-783	http://dx.doi.org/10.1038/nbt0815-783			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252117				2022-12-25	WOS:000359274900002
J	Ratner, M				Ratner, Mark			Microbial cocktails join fecal transplants in IBD treatment trials	NATURE BIOTECHNOLOGY			English	News Item																		2014, NAT BIOTECHNOL, V32, P401; 2015, GASTROENTEROL, V149, P102; 2015, NAT BIOTECHNOL, V33, P228	3	22	23	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					787	788		10.1038/nbt0815-787	http://dx.doi.org/10.1038/nbt0815-787			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252119				2022-12-25	WOS:000359274900004
J	[Anonymous]				[Anonymous]			Alnylam, Dicerna tussle over RNAi tech	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					791	791		10.1038/nbt0815-791a	http://dx.doi.org/10.1038/nbt0815-791a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252122	Bronze			2022-12-25	WOS:000359274900035
J	Alakbarzade, V; Hameed, A; Quek, DQY; Chioza, BA; Baple, EL; Cazenave-Gassiot, A; Nguyen, LN; Wenk, MR; Ahmad, AQ; Sreekantan-Nair, A; Weedon, MN; Rich, P; Patton, MA; Warner, TT; Silver, DL; Crosby, AH				Alakbarzade, Vafa; Hameed, Abdul; Quek, Debra Q. Y.; Chioza, Barry A.; Baple, Emma L.; Cazenave-Gassiot, Amaury; Nguyen, Long N.; Wenk, Markus R.; Ahmad, Arshia Q.; Sreekantan-Nair, Ajith; Weedon, Michael N.; Rich, Phil; Patton, Michael A.; Warner, Thomas T.; Silver, David L.; Crosby, Andrew H.			A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome	NATURE GENETICS			English	Article							RAT	The major pathway by which the brain obtains essential omega-3 fatty acids from the circulation is through a sodium-dependent lysophosphatidylcholine (LPC) transporter (MFSD2A), expressed in the endothelium of the blood-brain barrier. Here we show that a homozygous mutation affecting a highly conserved MFSD2A residue (p.Ser339Leu) is associated with a progressive microcephaly syndrome characterized by intellectual disability, spasticity and absent speech. We show that the p.Ser339Leu alteration does not affect protein or cell surface expression but rather significantly reduces, although not completely abolishes, transporter activity. Notably, affected individuals displayed significantly increased plasma concentrations of LPCs containing mono-and polyunsaturated fatty acyl chains, indicative of reduced brain uptake, confirming the specificity of MFSD2A for LPCs having mono- and polyunsaturated fatty acyl chains. Together, these findings indicate an essential role for LPCs in human brain development and function and provide the first description of disease associated with aberrant brain LPC transport in humans.	[Alakbarzade, Vafa; Chioza, Barry A.; Baple, Emma L.; Sreekantan-Nair, Ajith; Weedon, Michael N.; Patton, Michael A.; Crosby, Andrew H.] Univ Exeter, RILD Wellcome Wolfson Ctr, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Alakbarzade, Vafa; Warner, Thomas T.] UCL, Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Inst Neurol Studies, London, England; [Hameed, Abdul] IBGE, Islamabad, Pakistan; [Quek, Debra Q. Y.; Nguyen, Long N.; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Dis, Singapore, Singapore; [Baple, Emma L.] Univ Southampton, Fac Med, Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Baple, Emma L.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Cazenave-Gassiot, Amaury; Wenk, Markus R.] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Ahmad, Arshia Q.] IUPUI, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Ahmad, Arshia Q.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Rich, Phil] St George Hosp, Dept Neuroradiol, London, England; [Patton, Michael A.] St Georges Healthcare Natl Hlth Serv NHS Trust, Southwest Thames Reg Genet Serv, London, England	University of Exeter; University of London; University College London; National University of Singapore; University of Southampton; National University of Singapore; Indiana University System; Indiana University-Purdue University Indianapolis; St Georges University London	Crosby, AH (corresponding author), Univ Exeter, RILD Wellcome Wolfson Ctr, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England.	david.silver@duke-nus.edu.sg; a.h.crosby@exeter.ac.uk	Cazenave-Gassiot, Amaury/E-4536-2014; Crosby, Andrew H/E-2218-2015; Chioza, Barry/C-1586-2008; , WaNgtJ/AAR-7045-2020; Warner, Thomas T/A-1454-2013; Nguyen, Long/AAY-6172-2021	Cazenave-Gassiot, Amaury/0000-0002-3050-634X; Crosby, Andrew H/0000-0003-3667-9054; Chioza, Barry/0000-0002-3546-1726; Warner, Thomas T/0000-0001-6195-6995; Weedon, Michael/0000-0002-6174-6135; Silver, David/0000-0002-7289-9890; Nguyen, Long N/0000-0002-9857-2239; Alakbarzade, Vafa/0000-0002-1661-4280	UK Medical Research Council [G1002279, G0900205, G1001931]; Newlife Foundation for disabled children; Singapore Ministry of Health's National Medical Research Council [CBRG/069/2014]; Singapore National Research Foundation Competitive Research Program [2007-04]; National University of Singapore's Life Sciences Institute; Medical Research Council [G1001931, G1002279] Funding Source: researchfish; MRC [G1002279, G1001931] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newlife Foundation for disabled children; Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Singapore National Research Foundation Competitive Research Program(National Research Foundation, Singapore); National University of Singapore's Life Sciences Institute(National University of Singapore); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the families for participating in this research. The work was supported by UK Medical Research Council grants G1002279, G0900205 and G1001931 and by the Newlife Foundation for disabled children (to A.H.C., M.A.P. and E.L.B.), the Singapore Ministry of Health's National Medical Research Council grant CBRG/069/2014 (to D.L.S.), Singapore National Research Foundation Competitive Research Program grant 2007-04 (to M.R.W.) and the National University of Singapore's Life Sciences Institute (to M.R.W.).	BAISTED DJ, 1988, BIOCHEM J, V253, P693, DOI 10.1042/bj2530693; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Rozen S, 2000, Methods Mol Biol, V132, P365; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	12	91	92	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					814	+		10.1038/ng.3313	http://dx.doi.org/10.1038/ng.3313			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005865				2022-12-25	WOS:000357090300021
J	Furlow, PW; Zhang, S; Soong, TD; Halberg, N; Goodarzi, H; Mangrum, C; Wu, YG; Elemento, O; Tavazoie, SF				Furlow, Paul W.; Zhang, Steven; Soong, T. David; Halberg, Nils; Goodarzi, Hani; Mangrum, Creed; Wu, Y. Gloria; Elemento, Olivier; Tavazoie, Sohail F.			Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER METASTASIS; ATP RELEASE; ACTIVATION; MECHANISMS; TRAUMA; GROWTH; DEATH; STEPS	During metastatic progression, circulating cancer cells become lodged within the microvasculature of end organs, where most die from mechanical deformation. Although this phenomenon was first described over a half-century ago, the mechanisms enabling certain cells to survive this metastasis-suppressive barrier remain unknown. By applying whole-transcriptome RNA-sequencing technology to isogenic cancer cells of differing metastatic capacities, we identified a mutation encoding a truncated form of the pannexin-1 (PANX1) channel, PANX1(1-89), as recurrently enriched in highly metastatic breast cancer cells. PANX(1-89) functions to permit metastatic cell survival during traumatic deformation in the microvasculature by augmenting ATP release from mechanosensitive PANX1 channels activated by membrane stretch. PANX1-mediated ATP release acts as an autocrine suppressor of deformation-induced apoptosis through P2Y-purinergic receptors. Finally, small-molecule therapeutic inhibition of PANX1 channels is found to reduce the efficiency of breast cancer metastasis. These data suggest a molecular basis for metastatic cell survival on microvasculature-induced biomechanical trauma.	[Furlow, Paul W.; Zhang, Steven; Halberg, Nils; Goodarzi, Hani; Mangrum, Creed; Wu, Y. Gloria; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Soong, T. David; Elemento, Olivier] Cornell Univ, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA	Rockefeller University; Cornell University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Halberg, Nils/AAF-8153-2019	Halberg, Nils/0000-0002-2943-3147; Furlow, Paul/0000-0002-0754-4962; Goodarzi, Hani/0000-0002-9648-8949	NIH MSTP grant [GM07739]; Anderson Cancer Center Fellow at Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH MSTP grant; Anderson Cancer Center Fellow at Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Alarcon, N. Pencheva, A. Nguyen, J. Ross and Saeed Tavazoie for comments on previous versions of this manuscript. We thank C. D. Allis, B. Chait, T. Kapoor and V. Ruta for their insightful comments on this work. We thank C. Zhao of the Rockefeller Genomics Resource Center and J. Xiang of the Weill Cornell Medical College Genomics Resources Core Facility for assistance with next-generation RNA sequencing. We thank S. Chandarlapaty at MSKCC, USA, for providing the BT549, MDA-MB-468 and HCC1806 breast cancer cell lines. We thank V. Shestopalov at University of Miami, USA, for providing the PANX1-null mice. J. Massague at MSKCC, USA, generously provided metastatic sub-lines. P.W.F. is a biomedical fellow in the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program supported by NIH MSTP grant GM07739 and an Anderson Cancer Center Fellow at Rockefeller University. N.H. is an Anderson Cancer Center Fellow at Rockefeller University. S.F.T. is a Department of Defense (DOD) Era of Hope Scholar, a DOD Scholar-Innovator Award Recipient and a Rita Allen Foundation Scholar.	Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hu XC, 2000, ONCOLOGY-BASEL, V59, P217, DOI 10.1159/000012164; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li A, 2011, CELL PHYSIOL BIOCHEM, V28, P1135, DOI 10.1159/000335865; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MURTHY SM, 1989, CANCER, V64, P2035, DOI 10.1002/1097-0142(19891115)64:10<2035::AID-CNCR2820641012>3.0.CO;2-L; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; WEISS L, 1989, INT J CANCER, V44, P143, DOI 10.1002/ijc.2910440125; WEISS L, 1992, CANCER METAST REV, V11, P227, DOI 10.1007/BF01307179; WEISS L, 1992, INT J CANCER, V50, P103, DOI 10.1002/ijc.2910500121; Wong CW, 2001, CANCER RES, V61, P333; ZEIDMAN I, 1961, CANCER RES, V21, P38; Zhang M, 2012, J PHYSIOL-LONDON, V590, P4335, DOI 10.1113/jphysiol.2012.236265	43	86	90	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					943	952		10.1038/ncb3194	http://dx.doi.org/10.1038/ncb3194			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26098574	Green Accepted			2022-12-25	WOS:000357353400014
J	Iglesias-Bartolome, R; Torres, D; Marone, R; Feng, XD; Martin, D; Simaan, M; Chen, M; Weinstein, LS; Taylor, SS; Molinolo, AA; Gutkind, JS				Iglesias-Bartolome, Ramiro; Torres, Daniela; Marone, Romina; Feng, Xiaodong; Martin, Daniel; Simaan, May; Chen, Min; Weinstein, Lee S.; Taylor, Susan S.; Molinolo, Alfredo A.; Gutkind, J. Silvio			Inactivation of a G alpha(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis	NATURE CELL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; HIPPO SIGNALING PATHWAY; YAP PATHWAY; HEDGEHOG; DIFFERENTIATION; MERLIN; ALPHA; KINASE; GROWTH; PHOSPHORYLATION	Genomic alterations in GNAS, the gene coding for the G alpha(s) heterotrimeric G protein, are associated with a large number of human diseases. Here, we explored the role of G alpha(s) on stem cell fate decisions by using the mouse epidermis as a model system. Conditional epidermal deletion of Gnas or repression of PKA signalling caused a remarkable expansion of the stem cell compartment, resulting in rapid basal-cell carcinoma formation. In contrast, inducible expression of active G alpha(s) in the epidermis caused hair follicle stem cell exhaustion and hair loss. Mechanistically, we found that G alpha(s)-PKA disruption promotes the cell autonomous Sonic Hedgehog pathway stimulation and Hippo signalling inhibition, resulting in the non-canonical activation of GLI and YAP1. Our study highlights an important tumour suppressive function of G alpha(s)-PKA, limiting the proliferation of epithelial stem cells and maintaining proper hair follicle homeostasis. These findings could have broad implications in multiple pathophysiological conditions, including cancer.	[Iglesias-Bartolome, Ramiro; Torres, Daniela; Marone, Romina; Feng, Xiaodong; Martin, Daniel; Simaan, May; Molinolo, Alfredo A.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Chen, Min; Weinstein, Lee S.] NIDDK, NIH, Bethesda, MD 20892 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Diego; University of California System; University of California San Diego	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gutkind, J. Silvio/J-1201-2016; Weinstein, Lee S/I-5575-2015; Iglesias-Bartolome, Ramiro/H-4460-2014	Gutkind, J. Silvio/0000-0002-5150-4482; Iglesias-Bartolome, Ramiro/0000-0002-0792-1254; Martin Izquierdo, Daniel/0000-0002-8880-9087	Intramural Research Program at the National Institutes of Health, National Institute of Dental and Craniofacial Research; Swiss National Science Foundation (Advanced Postdoc Mobility fellowship, SNF); Margarete und Walter Lichtenstein Stiftung;  [DK54441]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551, ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, ZIADK043313] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, National Institute of Dental and Craniofacial Research; Swiss National Science Foundation (Advanced Postdoc Mobility fellowship, SNF)(Swiss National Science Foundation (SNSF)); Margarete und Walter Lichtenstein Stiftung; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program at the National Institutes of Health, National Institute of Dental and Craniofacial Research. R.M. was supported by grants from the Swiss National Science Foundation (Advanced Postdoc Mobility fellowship, SNF) and the Margarete und Walter Lichtenstein Stiftung. S.S.T. was supported by grant DK54441.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen LM, 2007, AM J PHYSIOL-RENAL, V292, pF27, DOI 10.1152/ajprenal.00193.2006; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Crowson AN, 2006, MODERN PATHOL, V19, pS127, DOI 10.1038/modpathol.3800512; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fuchs E, 2013, EMBO REP, V14, P39, DOI 10.1038/embor.2012.197; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Huang JH, 2014, J CELL BIOL, V205, P325, DOI 10.1083/jcb.201309141; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Laulajainen M, 2008, ONCOGENE, V27, P3233, DOI 10.1038/sj.onc.1210988; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Levitsky KL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02937; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Milenkovic L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3117pe14; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Molinolo AA, 2012, CLIN CANCER RES, V18, P2558, DOI 10.1158/1078-0432.CCR-11-2824; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Niemann C, 2002, DEVELOPMENT, V129, P95; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Petersson Monika, 2013, Methods Mol Biol, V989, P45, DOI 10.1007/978-1-62703-330-5_5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; Regard JB, 2013, NAT MED, V19, P1505, DOI 10.1038/nm.3314; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Scoles DR, 2008, BBA-REV CANCER, V1785, P32, DOI 10.1016/j.bbcan.2007.10.001; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	64	105	105	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					793	+		10.1038/ncb3164	http://dx.doi.org/10.1038/ncb3164			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25961504	Green Accepted			2022-12-25	WOS:000355277500011
J	Kortum, F; Caputo, V; Bauer, CK; Stella, L; Ciolfi, A; Aawi, M; Bocchinfuso, G; Flex, E; Paolacci, S; Dentici, ML; Grammatico, P; Korenke, GC; Leuzzi, V; Mowat, D; Nair, LDV; Nguyen, TTM; Thierry, P; White, SM; Dallapiccola, B; Pizzuti, A; Campeau, PM; Tartaglia, M; Kutsche, K				Kortuem, Fanny; Caputo, Viviana; Bauer, Christiane K.; Stella, Lorenzo; Ciolfi, Andrea; Aawi, Malik; Bocchinfuso, Gianfranco; Flex, Elisabetta; Paolacci, Stefano; Dentici, Maria Lisa; Grammatico, Paola; Korenke, Georg Christoph; Leuzzi, Vincenzo; Mowat, David; Nair, Lal D. V.; Thi Tuyet Mai Nguyen; Thierry, Patrick; White, Susan M.; Dallapiccola, Bruno; Pizzuti, Antonio; Campeau, Philippe M.; Tartaglia, Marco; Kutsche, Kerstin			Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome	NATURE GENETICS			English	Article							VACUOLAR H+-ATPASE; DE-NOVO MUTATION; CANTU SYNDROME; DIFFERENTIAL EXPRESSION; POTASSIUM CHANNEL; V-ATPASE; SUBUNIT; ACIDIFICATION; K(V)10.1; PHYSIOLOGY	Zimmermann-Laband syndrome (ZLS) is a developmental disorder characterized by facial dysmorphism with gingival enlargement, intellectual disability, hypoplasia or aplasia of nails and terminal phalanges, and hypertrichosis(1-4). We report that heterozygous missense mutations in KCNH1 account for a considerable proportion of ZLS. KCNH1 encodes the voltage-gated K+ channel Eag1 (K(v)10.1). Patch-clamp recordings showed strong negative shifts in voltage-dependent activation for all but one KCNH1 channel mutant (Gly469Arg). Coexpression of Gly469Arg with wild-type KCNH1 resulted in heterotetrameric channels with reduced conductance at positive potentials but pronounced conductance at negative potentials. These data support a gain-of-function effect for all ZLS-associated KCNH1 mutants. We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H+ ATPase, in two individuals with ZLS. Structural analysis predicts a perturbing effect of the mutation on complex assembly. Our findings demonstrate that KCNH1 mutations cause ZLS and document genetic heterogeneity for this disorder.	[Kortuem, Fanny; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Caputo, Viviana; Paolacci, Stefano; Pizzuti, Antonio] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Bauer, Christiane K.] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Hamburg, Germany; [Stella, Lorenzo; Bocchinfuso, Gianfranco] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Rome, Italy; [Ciolfi, Andrea; Flex, Elisabetta; Paolacci, Stefano; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Aawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, Hamburg, Germany; [Aawi, Malik] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Aawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, Virus Genom, Hamburg, Germany; [Dentici, Maria Lisa; Dallapiccola, Bruno; Tartaglia, Marco] Osped Pediat Bambino Gesu, Ist Ricovero & Cura Carattere Sci, Rome, Italy; [Grammatico, Paola] Univ Roma La Sapienza, Osped San Camillo Forlanini, Dipartimento Med Mol, I-00185 Rome, Italy; [Korenke, Georg Christoph] Klinikum Oldenburg, Zentrum Kinder & Jugendmed, Neuropadiat, Oldenburg, Germany; [Leuzzi, Vincenzo] Univ Roma La Sapienza, Dipartimento Pediat & Neuropsichiatria Infantile, I-00185 Rome, Italy; [Mowat, David] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Mowat, David] Univ New S Wales, Univ New South Wales Med, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Nair, Lal D. V.] Saveetha Univ, Saveetha Med Coll & Hosp, Dept Pediat, Madras, Tamil Nadu, India; [Thi Tuyet Mai Nguyen] Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Thierry, Patrick] Ctr Hosp Intercommunal Haute Saone, Serv Pediat, Vesoul, France; [White, Susan M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [White, Susan M.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Campeau, Philippe M.] Univ Montreal, Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada	University of Hamburg; University Medical Center Hamburg-Eppendorf; Sapienza University Rome; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Heinrich Pette Institute; IRCCS Bambino Gesu; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; Klinikum Oldenburg; Sapienza University Rome; University of Sydney; University of New South Wales Sydney; Saveetha Institute of Medical & Technical Science; Saveetha Medical College & Hospital; Universite de Montreal; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Universite de Montreal	Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany.	marco.tartaglia@iss.it; kkutsche@uke.de	Stella, Lorenzo/A-7996-2010; , Malik/AAB-7437-2021; Nair, Lal Devayani Vasudevan/J-5275-2019; Flex, Elisabetta/A-5958-2017; Tartaglia, Marco/K-2955-2018; Campeau, Philippe/J-8614-2015; Bocchinfuso, Gianfranco/E-9014-2011; Dentici, Maria Lisa/AAC-7654-2022; Ciolfi, Andrea/J-4954-2018; Dallapiccola, Bruno/K-8692-2016	Stella, Lorenzo/0000-0002-5489-7381; , Malik/0000-0002-5993-7709; Nair, Lal Devayani Vasudevan/0000-0002-5364-6919; Flex, Elisabetta/0000-0002-6802-1356; Tartaglia, Marco/0000-0001-7736-9672; Campeau, Philippe/0000-0001-9713-7107; Bocchinfuso, Gianfranco/0000-0002-5556-7691; Dentici, Maria Lisa/0000-0002-9505-5906; Ciolfi, Andrea/0000-0002-6191-0978; PIZZUTI, Antonio/0000-0003-3245-1925; Dallapiccola, Bruno/0000-0002-5031-1013; /0000-0002-5551-7520; Bauer, Christiane K./0000-0002-2078-3503; Leuzzi, Vincenzo/0000-0002-2314-6139	Deutsche Forschungsgemeinschaft [KO 4576/1-1, KU 1240/5-1]; Istituto Superiore di Sanita (Ricerca Corrente); Ministero della Salute (Ricerca Finalizzata) [RF-2010-2312766]; Ospedale Pediatrico Bambino Gesu (Gene-Rare)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Istituto Superiore di Sanita (Ricerca Corrente); Ministero della Salute (Ricerca Finalizzata)(Ministry of Health, Italy); Ospedale Pediatrico Bambino Gesu (Gene-Rare)	We are grateful to the patients and their families who contributed to this study. We thank I. Jantke, S. Cecchetti and S. Venanzi for skillful technical assistance, T. Kock for site-directed mutagenesis, A. Hasse for CHO cell transfection and injection, R. Bahring, J.M. Schroder and E. Neumann for help with the oocyte experiments, P. Meinecke for discussing clinical phenotypes and A. Podolska for help with ATP6V1B2 sequencing. G.B., L.S. and M.T. acknowledge CINECA for computational resources (whole-exome sequencing data and structural analyses). The KCNH1/heag1 clone was kindly provided by S.H. Heinemann (Friedrich Schiller University Jena). This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 4576/1-1 to F.K. and KU 1240/5-1 to K.K.), Istituto Superiore di Sanita (Ricerca Corrente 2013 to M.T.), Ministero della Salute (Ricerca Finalizzata RF-2010-2312766 to B.D.) and Ospedale Pediatrico Bambino Gesu (Gene-Rare to B.D.).	Abo-Dalo B, 2008, CLIN DYSMORPHOL, V17, P181, DOI 10.1097/MCD.0b013e3282f2514c; Abo-Dalo B, 2007, AM J MED GENET A, V143A, P2668, DOI 10.1002/ajmg.a.32034; Alavandar G, 1965, J All India Dent Assoc, V37, P349; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Brownstein CA, 2013, EUR J MED GENET, V56, P678, DOI 10.1016/j.ejmg.2013.09.009; Campeau PM, 2014, AM J MED GENET C, V166, P327, DOI 10.1002/ajmg.c.31412; Castori M, 2013, EUR J MED GENET, V56, P570, DOI 10.1016/j.ejmg.2013.08.004; Chacon-Camacho OF, 2011, AM J MED GENET A, V155A, P1716, DOI 10.1002/ajmg.a.34030; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; Correa JD, 2011, ISRN DENT, V2011, DOI DOI 10.5402/2011/497850; Davalos IP, 2005, GENET COUNSEL, V16, P283; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fuster DG, 2008, KIDNEY INT, V73, P1151, DOI 10.1038/ki.2008.96; Garg V, 2012, J GEN PHYSIOL, V140, P307, DOI 10.1085/jgp.201210826; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Jacquinet A, 2010, AM J MED GENET A, V152A, P2322, DOI 10.1002/ajmg.a.33574; Kim HG, 2007, AM J MED GENET A, V143A, P107, DOI 10.1002/ajmg.a.31544; Kohl T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026329; LABAND PETER F., 1964, ORAL SURG ORAL MED AND ORAL PATHOL, V17, P339, DOI 10.1016/0030-4220(64)90506-7; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mortensen LS, 2015, J PHYSIOL-LONDON, V593, P181, DOI 10.1113/jphysiol.2014.281600; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Ninkovic M, 2012, FEBS LETT, V586, P3077, DOI 10.1016/j.febslet.2012.07.055; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Simons C, 2015, NAT GENET, V47, P73, DOI 10.1038/ng.3153; Stefanova M, 2003, AM J MED GENET A, V117A, P289, DOI 10.1002/ajmg.a.10174; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Thouta S, 2014, BIOPHYS J, V106, P1057, DOI 10.1016/j.bpj.2014.01.035; Ufartes R, 2013, HUM MOL GENET, V22, P2247, DOI 10.1093/hmg/ddt076; van Bon BWM, 2012, AM J HUM GENET, V90, P1094, DOI 10.1016/j.ajhg.2012.04.014; VANDYKE RW, 1993, AM J PHYSIOL, V265, pC901, DOI 10.1152/ajpcell.1993.265.4.C901; VANHILLE B, 1994, BIOCHEM J, V303, P191, DOI 10.1042/bj3030191; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; White SM, 2011, AM J MED GENET A, V155A, P2512, DOI 10.1002/ajmg.a.34184; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Wynn Richard L., 2009, General Dentistry, V57, P105; Yang Y, 2013, J NEUROSCI, V33, P16586, DOI 10.1523/JNEUROSCI.2307-13.2013; Yuan YY, 2014, CELL RES, V24, P1370, DOI 10.1038/cr.2014.77; Zhang YY, 2014, J CELL PHYSIOL, V229, P202, DOI 10.1002/jcp.24435	51	134	141	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					661	667		10.1038/ng.3282	http://dx.doi.org/10.1038/ng.3282			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915598	Green Submitted			2022-12-25	WOS:000355386500019
J	Walkup, GK; You, Z; Ross, PL; Allen, EKH; Daryaee, F; Hale, MR; O'Donnell, J; Ehmann, DE; Schuck, VJA; Buurman, ET; Choy, AL; Hajec, L; Murphy-Benenato, K; Marone, V; Patey, SA; Grosser, LA; Johnstone, M; Walker, SG; Tonge, PJ; Fisher, SL				Walkup, Grant K.; You, Zhiping; Ross, Philip L.; Allen, Eleanor K. H.; Daryaee, Fereidoon; Hale, Michael R.; O'Donnell, John; Ehmann, David E.; Schuck, Virna J. A.; Buurman, Ed T.; Choy, Allison L.; Hajec, Laurel; Murphy-Benenato, Kerry; Marone, Valerie; Patey, Sara A.; Grosser, Lena A.; Johnstone, Michele; Walker, Stephen G.; Tonge, Peter J.; Fisher, Stewart L.			Translating slow-binding inhibition kinetics into cellular and in vivo effects	NATURE CHEMICAL BIOLOGY			English	Article							TARGET RESIDENCE TIME; DRUG-TARGET; PSEUDOMONAS-AERUGINOSA; LPXC; EFFICACY; MECHANISM; IMPACT; FLUOROQUINOLONES; DEACETYLASE; AGENTS	Many drug candidates fail in clinical trials owing to a lack of efficacy from limited target engagement or an insufficient therapeutic index. Minimizing off-target effects while retaining the desired pharmacodynamic (PD) response can be achieved by reduced exposure for drugs that display kinetic selectivity in which the drug-target complex has a longer half-life than off-target-drug complexes. However, though slow-binding inhibition kinetics are a key feature of many marketed drugs, prospective tools that integrate drug-target residence time into predictions of drug efficacy are lacking, hindering the integration of drug-target kinetics into the drug discovery cascade. Here we describe a mechanistic PD model that includes drug-target kinetic parameters, including the on- and off-rates for the formation and breakdown of the drug-target complex. We demonstrate the utility of this model by using it to predict dose response curves for inhibitors of the LpxC enzyme from Pseudomonas aeruginosa in an animal model of infection.	[Walkup, Grant K.; You, Zhiping; Ross, Philip L.; Hale, Michael R.; O'Donnell, John; Ehmann, David E.; Schuck, Virna J. A.; Buurman, Ed T.; Choy, Allison L.; Hajec, Laurel; Murphy-Benenato, Kerry; Marone, Valerie; Patey, Sara A.; Grosser, Lena A.; Johnstone, Michele; Fisher, Stewart L.] AstraZeneca Res & Dev, Infect Innovat Med Unit, Waltham, MA USA; [Allen, Eleanor K. H.; Daryaee, Fereidoon; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Johnstone, Michele] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	AstraZeneca; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Walkup, GK (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	peter.tonge@stonybrook.edu; stewfisher@slfisherconsulting.com	Tonge, Peter J/A-7443-2009	Tonge, Peter J/0000-0003-1606-3471	US National Institutes of Health [GM102864]; AstraZeneca; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102864] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P.J.T. acknowledges this research was partially funded by the US National Institutes of Health (GM102864) and through a sponsored research agreement with AstraZeneca. We thank J. Kotz and R.A. Copeland for advice in preparation of the manuscript. We also acknowledge contributions from P. Hill, A. Li, T. Grebe and C. Joubran as well as S. Kuppusamy and the chemists at Syngene for chemical synthesis and analytical support; B. de Jonge for guidance on microbiological assessments; and K. Kapilashrami and A. Chang for helpful discussions.	Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BUNDTZEN RW, 1981, REV INFECT DIS, V3, P28; Caughlan RE, 2012, ANTIMICROB AGENTS CH, V56, P17, DOI 10.1128/AAC.05417-11; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2011, ANAL BIOCHEM, V416, P206, DOI 10.1016/j.ab.2011.05.029; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Czock D, 2007, J PHARMACOKINET PHAR, V34, P727, DOI 10.1007/s10928-007-9069-x; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; de Jonge BLM, 2013, ANTIMICROB AGENTS CH, V57, P6005, DOI 10.1128/AAC.01661-13; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Drusano GL, 2004, NAT REV MICROBIOL, V2, P289, DOI 10.1038/nrmicro862; Fung-Tomc JC, 2000, ANTIMICROB AGENTS CH, V44, P1377, DOI 10.1128/AAC.44.5.1377-1380.2000; Gao N, 2014, PROTEIN EXPRES PURIF, V104, P57, DOI 10.1016/j.pep.2014.09.006; Gennadios HA, 2006, BIOCHEMISTRY-US, V45, P7940, DOI 10.1021/bi060823m; Gennadios HA, 2006, BIOCHEMISTRY-US, V45, P15216, DOI 10.1021/bi0619021; GERBER AU, 1983, J INFECT DIS, V147, P910, DOI 10.1093/infdis/147.5.910; GUDMUNDSSON S, 1986, J ANTIMICROB CHEMOTH, V18, P67, DOI 10.1093/jac/18.Supplement_E.67; Hale MR, 2013, BIOORG MED CHEM LETT, V23, P2362, DOI 10.1016/j.bmcl.2013.02.055; Hickey E, 2007, CURR OPIN DRUG DISC, V10, P49; Kariv I, 2001, J PHARM SCI, V90, P580, DOI 10.1002/1520-6017(200105)90:5<580::AID-JPS1014>3.0.CO;2-4; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Mager DE, 2006, BIOCHEM PHARMACOL, V72, P1, DOI 10.1016/j.bcp.2005.12.041; Mager DE, 2003, DRUG METAB DISPOS, V31, P510, DOI 10.1124/dmd.31.5.510; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; McKenzie C, 2011, J ANTIMICROB CHEMOTH, V66, pII25, DOI 10.1093/jac/dkq516; Mdluli KE, 2006, ANTIMICROB AGENTS CH, V50, P2178, DOI 10.1128/AAC.00140-06; Millan DS, 2011, J MED CHEM, V54, P7797, DOI 10.1021/jm200677b; Montgomery JI, 2012, J MED CHEM, V55, P1662, DOI 10.1021/jm2014875; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; NIKAIDO H, 1993, ANTIMICROB AGENTS CH, V37, P1393, DOI 10.1128/AAC.37.7.1393; Nikolaou M, 2007, ANN BIOMED ENG, V35, P1458, DOI 10.1007/s10439-007-9306-x; PARKER RF, 1946, J BACTERIOL, V51, P181, DOI 10.1128/JB.51.2.181-186.1946; Schwarzbich MA, 2014, RECENT RESULTS CANC, V201, P259, DOI 10.1007/978-3-642-54490-3_17; SMITH H, 1990, J GEN MICROBIOL, V136, P377, DOI 10.1099/00221287-136-3-377; Spangler SK, 2000, ANTIMICROB AGENTS CH, V44, P186, DOI 10.1128/AAC.44.1.186-189.2000; Swinney DC, 2006, CURR TOP MED CHEM, V6, P461, DOI 10.2174/156802606776743093; Swinney DC, 2009, CURR OPIN DRUG DISC, V12, P31; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Takashima H., 2008, PCT Int. Appl., Patent No. [WO2008105515A1, 2008105515]; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vauquelin G, 2010, EXPERT OPIN DRUG DIS, V5, P927, DOI 10.1517/17460441.2010.512037; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Williams J W, 1979, Methods Enzymol, V63, P437; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yan XY, 2010, J PHARMACOKINET PHAR, V37, P25, DOI 10.1007/s10928-009-9142-8; Zhang Rumin, 2013, Methods Mol Biol, V1030, P59, DOI 10.1007/978-1-62703-484-5_6	58	93	96	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					416	+		10.1038/nchembio.1796	http://dx.doi.org/10.1038/nchembio.1796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25894085	Green Accepted			2022-12-25	WOS:000354539400012
J	Wong, VK; Baker, S; Pickard, DJ; Parkhill, J; Page, AJ; Feasey, NA; Kingsley, RA; Thomson, NR; Keanel, JA; Weill, FX; Edwards, DJ; Hawkey, J; Harris, SR; Mather, AE; Cain, AK; Hadfield, J; Hart, PJ; Thieu, NTV; Klemm, EJ; Glinos, DA; Breiman, RF; Watson, CH; Kariuki, S; Gordon, MA; Heyderman, RS; Okoro, C; Jacobs, J; Lunguya, O; Edmunds, WJ; Msefula, C; Chabalgoity, JA; Kama, M; Jenkins, K; Dutta, S; Marks, F; Campos, J; Thompson, C; Obaro, S; MacLennan, CA; Dolecek, C; Keddy, KH; Smith, AM; Parry, CM; Karkey, A; Mulholland, EK; Campbell, JI; Dongol, S; Basnyat, B; Dufour, M; Bandaranayake, D; Naseri, TT; Singh, SP; Hatta, M; Newton, P; Onsare, RS; Isaia, L; Dance, D; Davong, V; Thwaites, G; Wijedoru, L; Crump, JA; De Pinna, E; Nair, S; Nilles, EJ; Thanh, DP; Turner, P; Soeng, S; Valcanis, M; Powling, J; Dimovski, K; Hogg, G; Farrar, J; Holt, KE; Dougan, G				Wong, Vanessa K.; Baker, Stephen; Pickard, Derek J.; Parkhill, Julian; Page, Andrew J.; Feasey, Nicholas A.; Kingsley, Robert A.; Thomson, Nicholas R.; Keanel, Jacqueline A.; Weill, Francois-Xavier; Edwards, David J.; Hawkey, Jane; Harris, Simon R.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Hart, Peter J.; Nga Tran Vu Thieu; Klemm, Elizabeth J.; Glinos, Dafni A.; Breiman, Robert F.; Watson, Conall H.; Kariuki, Samuel; Gordon, Melita A.; Heyderman, Robert S.; Okoro, Chinyere; Jacobs, Jan; Lunguya, Octavie; Edmunds, W. John; Msefula, Chisorno; Chabalgoity, Jose A.; Kama, Mike; Jenkins, Kylie; Dutta, Shanta; Marks, Florian; Campos, Josefina; Thompson, Corinne; Obaro, Stephen; MacLennan, Calman A.; Dolecek, Christiane; Keddy, Karen H.; Smith, Anthony M.; Parry, Christopher M.; Karkey, Abhilasha; Mulholland, E. Kim; Campbell, James I.; Dongol, Sabina; Basnyat, Buddha; Dufour, Muriel; Bandaranayake, Don; Naseri, Take Toleafoa; Singh, Shalini Pravin; Hatta, Mochammad; Newton, Paul; Onsare, Robert S.; Isaia, Lupeoletalalei; Dance, David; Davong, Viengmon; Thwaites, Guy; Wijedoru, Lalith; Crump, John A.; De Pinna, Elizabeth; Nair, Satheesh; Nilles, Eric J.; Duy Pham Thanh; Turner, Paul; Soeng, Sona; Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff; Farrar, Jeremy; Holt, Kathryn E.; Dougan, Gordon			Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events	NATURE GENETICS			English	Article							ENTERICA SEROVAR TYPHI; ANTIBIOTIC-RESISTANCE; INTERACTIVE TREE; INCHI1 PLASMIDS; FEVER; MUTATIONS; EVOLUTION; ANNOTATION; POPULATION; PARATYPHI	The emergence of multidrug-resistant (MDR) typhoid is a major global health threat affecting many countries where the disease is endemic. Here whole-genome sequence analysis of 1,832 Salmonella enterica serovar Typhi (S. Typhi) identifies a single dominant MDR lineage, H58, that has emerged and spread throughout Asia and Africa over the last 30 years. Our analysis identifies numerous transmissions of H58, including multiple transfers from Asia to Africa and an ongoing, unrecognized MDR epidemic within Africa itself. Notably, our analysis indicates that H58 lineages are displacing antibiotic-sensitive isolates, transforming the global population structure of this pathogen. H58 isolates can harbor a complex MDR element residing either on transmissible IncHI1 plasmids or within multiple chromosomal integration sites. We also identify new mutations that define the H58 lineage. This phylogeographical analysis provides a framework to facilitate global management of MDR typhoid and is applicable to similar MDR lineages emerging in other bacterial species.	[Wong, Vanessa K.; Pickard, Derek J.; Page, Andrew J.; Kingsley, Robert A.; Keanel, Jacqueline A.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Klemm, Elizabeth J.; Glinos, Dafni A.; Okoro, Chinyere; MacLennan, Calman A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Wong, Vanessa K.] Univ Cambridge, Hosp Natl Hlth Serv NHS Fdn Trust, Addenbrookes Hosp, Dept Microbiol, Cambridge, England; [Baker, Stephen; Nga Tran Vu Thieu; Thompson, Corinne; Thwaites, Guy] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen; Thompson, Corinne; Dolecek, Christiane; Newton, Paul; Dance, David; Thwaites, Guy; Turner, Paul; Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen; Thomson, Nicholas R.; Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Feasey, Nicholas A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kingsley, Robert A.] Inst Food Res, Norwich, Norfolk, England; [Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Edwards, David J.; Hawkey, Jane] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Hawkey, Jane] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia; [MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England; [Breiman, Robert F.; Kariuki, Samuel] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Breiman, Robert F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Breiman, Robert F.] Emory Global Hlth Inst, Atlanta, GA USA; [Watson, Conall H.; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Ctr Math Modelling Infect Dis, London WC1, England; [Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Katholieke Univ KU Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lunguya, Octavie] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Lunguya, Octavie] Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Msefula, Chisorno] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Chabalgoity, Jose A.] Inst Higiene, Facultad Medicina, Dept Desarrollo Biotecnol, Montevideo, Uruguay; [Kama, Mike] Minist Hlth, Suva, Fiji; [Jenkins, Kylie] Fiji Hlth Sector Support Program, Suva, Fiji; [Dutta, Shanta] Natl Inst Cholera & Enter Dis, Kolkata, India; [Marks, Florian] Int Vaccine Inst, Dept Epidemiol, Seoul, South Korea; [Campos, Josefina] Carlos G Malbran Inst, ANLIS, Enteropathogen Div, Buenos Aires, DF, Argentina; [Obaro, Stephen] Univ Nebraska, Med Ctr, Div Pediat Infect Dis, Omaha, NE 68182 USA; [Obaro, Stephen] Univ Abuja, Teaching Hosp, Abuja, Nigeria; [Obaro, Stephen] Bingham Univ, Karu, Nigeria; [MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Ctr Enter Dis, Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Parry, Christopher M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Parry, Christopher M.] Nagasaki Univ, Grad Sch Trop Med & Global Hlth, Nagasaki 852, Japan; [Dongol, Sabina; Basnyat, Buddha] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Patan Acad Hlth Sci, Kathmandu, Nepal; [Mulholland, E. Kim] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dufour, Muriel] Inst Environm Sci & Res Ltd ESR, Enter & Leptospira Reference Lab, Porirua, New Zealand; [Bandaranayake, Don] Inst Environm Sci & Res, Natl Ctr Biosecur & Infect Dis, Porirua, New Zealand; [Singh, Shalini Pravin] WHO, Ctr Communicable Dis Control, Natl Influenza Ctr, Suva, Fiji; [Hatta, Mochammad] Hasanuddin Univ, Dept Microbiol, Makassar, Indonesia; [Newton, Paul; Dance, David; Davong, Viengmon] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Wellcome Trust Res Unit, Viangchan, Laos; [Wijedoru, Lalith; Turner, Paul] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Wijedoru, Lalith] Chelsea & Westminster Hosp, Paediat Emergency Med, London, England; [Crump, John A.] Univ Otago, Ctr Int Hlth & Otago Int Hlth Res Network, Dunedin Sch Med, Dunedin, New Zealand; [De Pinna, Elizabeth; Nair, Satheesh] Publ Hlth England, Salmonella Reference Serv, London, England; [Nilles, Eric J.] WHO, Div Pacific Tech Support, Emerging Dis Surveillance & Response, Suva, Fiji; [Turner, Paul; Soeng, Sona] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff] Univ Melbourne, Microbiol Diagnost Unit, Dept Microbiol & Immunol, Doherty Inst Infect & Immun,Publ Hlth Lab, Melbourne, Vic, Australia	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Melbourne; University of Melbourne; University of Birmingham; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; University of Malawi; Institute of Tropical Medicine (ITM); KU Leuven; Institute Nacional de Recherche Biomedical; University of Malawi; Universidad de la Republica, Uruguay; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); International Vaccine Institute; University of Nebraska System; University of Nebraska Medical Center; Novartis; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University; University of Oxford; Murdoch Children's Research Institute; Institute of Environmental Science & Research (ESR) - New Zealand; Institute of Environmental Science & Research (ESR) - New Zealand; World Health Organization; Universitas Hasanuddin; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Imperial College London; University of Otago; Public Health England; World Health Organization; University of Melbourne	Wong, VK (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	vw1@sanger.ac.uk	MacLennan, Calman A/L-9343-2014; Keddy, Karen Helena/AAZ-2189-2020; Jacobs, Jan/GRX-7316-2022; Hawkey, Jane/AAE-3443-2021; Pham, Thanh Duy/AAX-3845-2020; Thwaites, Guy E/R-4993-2019; Crump, John A./AAZ-6289-2020; Holt, Kathryn E/A-8108-2012; Parkhill, Julian/G-4703-2011; Nilles, Eric/ABA-4757-2021; Farrar, Jeremy J./HGA-7610-2022; Crump, John A./AAZ-6412-2020; Thomson, Nicholas R/P-5988-2014; HATTA, MOCHAMMAD/D-3742-2019; Msefula, Chisomo/AAY-9107-2020; Gordon, Melita/F-5563-2012	MacLennan, Calman A/0000-0001-9694-0846; Keddy, Karen Helena/0000-0001-8640-2235; Hawkey, Jane/0000-0001-9661-5293; Pham, Thanh Duy/0000-0001-7029-9210; Thwaites, Guy E/0000-0002-2858-2087; Crump, John A./0000-0002-4529-102X; Holt, Kathryn E/0000-0003-3949-2471; Parkhill, Julian/0000-0002-7069-5958; Nilles, Eric/0000-0001-7044-5257; Crump, John A./0000-0002-4529-102X; Thomson, Nicholas R/0000-0002-4432-8505; HATTA, MOCHAMMAD/0000-0002-8456-4203; Dufour, Muriel/0000-0003-3638-4918; Baker, Stephen/0000-0003-1308-5755; Newton, Paul/0000-0002-4608-6431; Gordon, Melita/0000-0002-0629-0884; Weill, Francois-Xavier/0000-0001-9941-5799; Glinos, Dafni/0000-0001-5556-0222; Kingsley, Robert/0000-0002-0194-6485; Farrar, Jeremy/0000-0002-2700-623X; Turner, Paul/0000-0002-1013-7815; Page, Andrew/0000-0001-6919-6062; Feasey, Nicholas/0000-0003-4041-1405; Nair, Satheesh/0000-0002-7297-1485; Campos, Josefina/0000-0003-1409-0441; Msefula, Chisomo/0000-0003-2304-886X; Keane, Jacqueline A./0000-0003-0739-6848; Watson, Conall/0000-0002-2469-791X; Okoro, Chinyere/0000-0002-2466-304X; Marks, Florian/0000-0002-6043-7170; Cain, Amy/0000-0002-4230-6572; Heyderman, Robert/0000-0003-4573-449X; Dance, David/0000-0001-9189-7244	Wellcome Trust; Wellcome Trust award [098051]; Wellcome Trust research fellowship [WT092152MA]; Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme [101113/Z/13/Z]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme; Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant); European Society for Paediatric Infectious Diseases; University of Oxford-Li Ka Shing Global Health Foundation; Wellcome Trust [089275/H/091Z]; National Health and Medical Research Council of Australia [1061409]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0082]; Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council PhD studentship; Institut Pasteur; Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence) [ANR-10-LABX-62-IBEID]; UK Medical Research Council [MR/J003999/1, G1100100/1]; Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in the Democratic Republic of the Congo; Belgian Directorate General of Development Cooperation [2.01]; Institute of Tropical Medicine (Antwerp, Belgium) [2.01]; Bill and Melinda Gates Foundation; US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program [R01 TW009237]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J010367/1]; UK BBSRC Zoonoses in Emerging Livestock Systems awards [BB/L017679, BB/L018926, BB/L018845]; US National Institutes of Health grant [R01 AI099525-02]; Royal Society [100087/Z/12/Z]; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R01 AI097493]; FOGARTY INTERNATIONAL CENTER [R01TW009237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099525, R01AI097493, U01AI062563] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1330800] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/L018926/1, BB/L018845/1, BB/J010367/1] Funding Source: researchfish; Medical Research Council [G1100100, G9818340, 1263989] Funding Source: researchfish; BBSRC [BB/L018926/1, BB/L018845/1, BB/J010367/1] Funding Source: UKRI; MRC [G9818340] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Wellcome Trust award(Wellcome Trust); Wellcome Trust research fellowship(Wellcome Trust); Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme(Wellcome Trust); Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant)(Wellcome Trust); European Society for Paediatric Infectious Diseases; University of Oxford-Li Ka Shing Global Health Foundation; Wellcome Trust(Wellcome Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative (VLSCI); Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut Pasteur(European Commission); Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence)(French National Research Agency (ANR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in the Democratic Republic of the Congo; Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine (Antwerp, Belgium); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK BBSRC Zoonoses in Emerging Livestock Systems awards(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust. We would like to thank the members of the Pathogen Informatics Team and the core sequencing teams at the Wellcome Trust Sanger Institute (Cambridge, UK). We are grateful to D. Harris for his superb work in managing the sequence data. We also thank L. Fabre for her excellent technical assistance.; This work was supported by a number of organizations. The authors affiliated with the Wellcome Trust Sanger Institute were funded by Wellcome Trust award 098051; N.A.F. was supported by Wellcome Trust research fellowship WT092152MA. N.A.F., R.S.H. and this work were supported by a strategic award from the Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme (101113/Z/13/Z). C.M.P. was funded by the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant), the European Society for Paediatric Infectious Diseases and the University of Oxford-Li Ka Shing Global Health Foundation. D.D., P.N. and V.D. were supported by the Wellcome Trust (core grant 089275/H/091Z). K.E.H. was supported by the National Health and Medical Research Council of Australia (fellowship 1061409) and the Victorian Life Sciences Computation Initiative (VLSCI; grant VR0082). C.A.M. was supported by a Clinical Research Fellowship from GlaxoSmithKline, and P.J.H. was supported by a UK Medical Research Council PhD studentship. This work forms part of a European Union Framework Programme 7 Marie Curie Actions Industry Academia Partnerships and Pathways (LAPP) Consortium Programme, entitled GENDRIVAX (Genome-Driven Vaccine Development for Bacterial Infections), involving the Wellcome Trust Sanger Institute, KEMRI Nairobi and the Novartis Vaccines Institute for Global Health. The authors affiliated with the Institut Pasteur were funded by the Institut Pasteur, the Institut de Veille Sanitaire and the French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, grant ANR-10-LABX-62-IBEID). C.H.W. was supported by the UK Medical Research Council (MR/J003999/1). CO. was supported by Society in Science and the Branco Weiss Fellowship, administered by ETH Zurich. A.K.C. was supported by the UK Medical Research Council (G1100100/1). J.J. was supported by the antibiotic resistance surveillance project in the Democratic Republic of the Congo, funded by project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine (Antwerp, Belgium). F.M. was supported by a research grant from the Bill and Melinda Gates Foundation. The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill and Melinda Gates Foundation. J.A. Crump was supported by the joint US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program (R01 TW009237), the UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/J010367/1) and UK BBSRC Zoonoses in Emerging Livestock Systems awards BB/L017679, BB/L018926 and BB/L018845. S.K. was supported by US National Institutes of Health grant R01 AI099525-02. S.B. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). S.O. was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R01 AI097493). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. C.D.; was supported by the University of Oxford-Li Ka Shing Global Health Foundation.	ANDERSON ES, 1975, J HYG-CAMBRIDGE, V74, P289, DOI 10.1017/S0022172400024360; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Baker S, 2013, ELIFE, V2, DOI 10.7554/eLife.01229; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Baucheron S, 2005, ANTIMICROB AGENTS CH, V49, P862, DOI 10.1128/AAC.49.2.862-863.2005; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Bwakura-Dangarembizi M, 2014, NEW ENGL J MED, V370, P41, DOI 10.1056/NEJMoa1214901; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Chiou CS, 2014, ANTIMICROB AGENTS CH, V58, P6501, DOI 10.1128/AAC.03608-14; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Gomes C, 2013, MICROB DRUG RESIST, V19, P88, DOI 10.1089/mdr.2012.0036; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Haanpera M, 2005, ANTIMICROB AGENTS CH, V49, P457, DOI 10.1128/AAC.49.1.457-460.2005; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Keddy KH, 2010, EMERG INFECT DIS, V16, P879, DOI 10.3201/eid1605.091917; Khan MI, 2010, EXPERT REV VACCINES, V9, P485, DOI 10.1586/ERV.10.43; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Marvig RL, 2012, ANTIMICROB AGENTS CH, V56, P4519, DOI 10.1128/AAC.00630-12; Menezes GA, 2012, CLIN MICROBIOL INFEC, V18, P239, DOI 10.1111/j.1469-0691.2011.03546.x; Mirza SH, 1996, J MED MICROBIOL, V44, P317, DOI 10.1099/00222615-44-5-317; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; OLARTE J, 1973, ANTIMICROB AGENTS CH, V4, P597, DOI 10.1128/AAC.4.6.597; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Phoba MF, 2012, EMERG INFECT DIS, V18, P1692, DOI 10.3201/eid1810.120525; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Song YJ, 2010, J ANTIMICROB CHEMOTH, V65, P1631, DOI 10.1093/jac/dkq175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	73	274	279	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					632	639		10.1038/ng.3281	http://dx.doi.org/10.1038/ng.3281			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25961941	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000355386500014
J	Wei, S; Kozono, S; Kats, L; Nechama, M; Li, WZ; Guarnerio, J; Luo, ML; You, MH; Yao, YD; Kondo, A; Hu, H; Bozkurt, G; Moerke, NJ; Cao, SG; Reschke, M; Chen, CH; Rego, EM; Lo-Coco, F; Cantley, LC; Lee, TH; Wu, H; Zhang, Y; Pandolfi, PP; Zhou, XZ; Lu, KP				Wei, Shuo; Kozono, Shingo; Kats, Lev; Nechama, Morris; Li, Wenzong; Guarnerio, Jlenia; Luo, Manli; You, Mi-Hyeon; Yao, Yandan; Kondo, Asami; Hu, Hai; Bozkurt, Gunes; Moerke, Nathan J.; Cao, Shugeng; Reschke, Markus; Chen, Chun-Hau; Rego, Eduardo M.; Lo-Coco, Francesco; Cantley, Lewis C.; Lee, Tae Ho; Wu, Hao; Zhang, Yan; Pandolfi, Pier Paolo; Zhou, Xiao Zhen; Lu, Kun Ping			Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer	NATURE MEDICINE			English	Article							PROLYL-ISOMERASE PIN1; ALPHA; PHOSPHORYLATION; ISOMERIZATION; CELLS; TRIAL; DEGRADATION; PREVENTION; INHIBITORS; APL	A common key regulator of oncogenic signaling pathways in multiple tumor types is the unique isomerase Pin1. However, available Pin1 inhibitors lack the required specificity and potency for inhibiting Pin1 function in vivo. By using mechanism-based screening, here we find that all-trans retinoic acid (ATRA)-a therapy for acute promyelocytic leukemia (APL) that is considered the first example of targeted therapy in cancer, but whose drug target remains elusive-inhibits and degrades active Pin1 selectively in cancer cells by directly binding to the substrate phosphate-and proline-binding pockets in the Pin1 active site. ATRA-induced Pin1 ablation degrades the protein encoded by the fusion oncogene PML-RARA and treats APL in APL cell and animal models as well as in human patients. ATRA-induced Pin1 ablation also potently inhibits triple-negative breast cancer cell growth in human cells and in animal models by acting on many Pin1 substrate oncogenes and tumor suppressors. Thus, ATRA simultaneously blocks multiple Pin1-regulated cancer-driving pathways, an attractive property for treating aggressive and drug-resistant tumors.	[Wei, Shuo; Kozono, Shingo; Nechama, Morris; Luo, Manli; Yao, Yandan; Kondo, Asami; Chen, Chun-Hau; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Translat Therapeut,Dept Med, Boston, MA 02215 USA; [Wei, Shuo; Kozono, Shingo; Kats, Lev; Nechama, Morris; Guarnerio, Jlenia; Luo, Manli; Yao, Yandan; Kondo, Asami; Hu, Hai; Reschke, Markus; Chen, Chun-Hau; Cantley, Lewis C.; Pandolfi, Pier Paolo; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Wei, Shuo; Kozono, Shingo; Kats, Lev; Nechama, Morris; Guarnerio, Jlenia; Luo, Manli; Yao, Yandan; Kondo, Asami; Hu, Hai; Reschke, Markus; Chen, Chun-Hau; Cantley, Lewis C.; Pandolfi, Pier Paolo; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Res Inst, Boston, MA 02215 USA; [Kats, Lev; Guarnerio, Jlenia; Reschke, Markus; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Li, Wenzong; Zhang, Yan] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [You, Mi-Hyeon; Lee, Tae Ho] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gerontol, Boston, MA 02215 USA; [Bozkurt, Gunes; Cao, Shugeng; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Moerke, Nathan J.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Rego, Eduardo M.] Univ Sao Paulo, Dept Internal Med, BR-14049 Ribeirao Preto, Brazil; [Lo-Coco, Francesco] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Lo-Coco, Francesco] Santa Lucia Fdn, Rome, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; University of Texas Austin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Universidade de Sao Paulo; University of Rome Tor Vergata; IRCCS Santa Lucia	Lu, KP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Translat Therapeut,Dept Med, Boston, MA 02215 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	Rego, Eduardo M./Y-5572-2019; Kats, Lev/AAW-3252-2021; Lee, Tae Ho/AAT-1721-2020; Luo, Man/GWQ-4789-2022; Rego, Eduardo M/A-1058-2012; Cantley, Lewis C/D-1800-2014; luo, man/HGC-7868-2022; Rego, Eduardo/AFS-7973-2022; You, Mi-Hyeon/AGC-8865-2022; Bozkurt, Gunes/I-6453-2019; CTC USP, CEPID 13 18/J-8951-2014	Rego, Eduardo M./0000-0003-1567-4086; Kats, Lev/0000-0001-8742-8138; Rego, Eduardo M/0000-0003-1567-4086; Cantley, Lewis C/0000-0002-1298-7653; Rego, Eduardo/0000-0003-1567-4086; Bozkurt, Gunes/0000-0002-6025-3582; CTC USP, CEPID 13 18/0000-0002-7123-9524; Pandolfi, Pier Paolo/0000-0002-5352-5295	Susan G. Komen for the Cure postdoctoral fellowship [KG111233]; US National Institutes of Health [R01CA167677, R03DA031663, R01HL111430]; NATIONAL CANCER INSTITUTE [R01CA167677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA031663] Funding Source: NIH RePORTER	Susan G. Komen for the Cure postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank W. G. Kaelin Jr., N. Gray, J. Clardy and A. Chakraborty for constructive advice; and H. de The (INSERM) for RAR-alpha, RAR-beta, and RAR-gamma triple-KO MEFs originally generated by P.A. Chambon (Universite de Strasbourg); C. Ng for assistance with immunostaining and T. Garvey for editing the manuscript. S.W. is a recipient of a Susan G. Komen for the Cure postdoctoral fellowship (KG111233). The work is supported by grants from the US National Institutes of Health (R01CA167677, R03DA031663 and R01HL111430 to K.P.L.).	Ablain J, 2013, J EXP MED, V210, P647, DOI 10.1084/jem.20122337; Arrieta O, 2010, J CLIN ONCOL, V28, P3463, DOI 10.1200/JCO.2009.26.6452; Auld D. S., 2004, ASSAY GUIDANCE MANUA; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERNSTEIN PS, 1995, P NATL ACAD SCI USA, V92, P654, DOI 10.1073/pnas.92.3.654; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Brondani V, 2005, BIOCHEM BIOPH RES CO, V328, P6, DOI 10.1016/j.bbrc.2004.12.130; Budd GT, 1998, CLIN CANCER RES, V4, P635; Chen H, 1998, BIOCHEM J, V336, P223, DOI 10.1042/bj3360223; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connolly RM, 2013, CLIN CANCER RES, V19, P1651, DOI 10.1158/1078-0432.CCR-12-3175; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Decensi A, 2009, J CLIN ONCOL, V27, P3749, DOI 10.1200/JCO.2008.19.3797; dos Santos GAS, 2012, LEUKEMIA, V26, P451, DOI 10.1038/leu.2011.216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gausdal G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.39; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Jain Preetesh, 2014, Clin Lymphoma Myeloma Leuk, V14, pe47, DOI 10.1016/j.clml.2013.08.004; Kogan SC, 2000, BLOOD, V95, P1541, DOI 10.1182/blood.V95.5.1541.005k28_1541_1550; Lam PB, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-91; Langenfeld J, 1997, P NATL ACAD SCI USA, V94, P12070, DOI 10.1073/pnas.94.22.12070; LANOTTE M, 1991, BLOOD, V77, P1080; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee TH, 2011, MOL CELL, V42, P147, DOI 10.1016/j.molcel.2011.03.005; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068148; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu ZM, 2014, CELL RES, V24, P1033, DOI 10.1038/cr.2014.109; Luo M.L., 2015, CELL REPORT IN PRESS; Luo ML, 2014, CANCER RES, V74, P3603, DOI 10.1158/0008-5472.CAN-13-2785; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; MOON RC, 1979, CANCER RES, V39, P1339; Moore JD, 2013, BIOORG MED CHEM LETT, V23, P4283, DOI 10.1016/j.bmcl.2013.05.088; MUINDI J, 1992, BLOOD, V79, P299; MUINDI JRF, 1992, CANCER RES, V52, P2138; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Ramlau R, 2008, J CLIN ONCOL, V26, P1886, DOI 10.1200/JCO.2007.12.2614; Rego EM, 2013, BLOOD, V121, P1935, DOI 10.1182/blood-2012-08-449918; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Tsai YC, 2008, INFLAMMATION, V31, P428, DOI 10.1007/s10753-008-9095-x; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044	73	166	178	2	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					457	U230		10.1038/nm.3839	http://dx.doi.org/10.1038/nm.3839			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25849135	Green Submitted, Green Accepted			2022-12-25	WOS:000354068800012
J	Chen, JH; Perry, CJ; Tsui, YC; Staron, MM; Parish, IA; Dominguez, CX; Rosenberg, DW; Kaech, SM				Chen, Jonathan H.; Perry, Curtis J.; Tsui, Yao-Chen; Staron, Matthew M.; Parish, Ian A.; Dominguez, Claudia X.; Rosenberg, Daniel W.; Kaech, Susan M.			Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection	NATURE MEDICINE			English	Article							CD8(+) T-CELLS; APOPTOTIC PROTEIN BIM; CAMP/PROTEIN-KINASE; IMMUNE-RESPONSES; I ANTAGONIST; MICE LACKING; EXHAUSTION; PERSISTENCE; EXPRESSION; PD-1	More than 10% of the world's population is chronically infected with HIV, hepatitis C virus (HCV) or hepatitis B virus (HBV), all of which can cause severe disease and death. These viruses persist in part because continuous antigenic stimulation causes the deterioration of virus-specific cytotoxic T lymphocyte (CTL) function and survival. Additionally, antiviral CTLs autonomously suppress their responses to limit immunopathology by upregulating inhibitory receptors such as programmed cell death 1 (PD-1). Identification and blockade of the pathways that induce CTL dysfunction may facilitate the clearance of chronic viral infections. We found that the prostaglandin E2 (PGE(2)) receptors EP2 and EP4 were upregulated on virus-specific CTLs during chronic lymphocytic choriomeningitis virus (LCMV) infection and suppressed CTL survival and function. We show that the combined blockade of PGE(2) and PD-1 signaling was therapeutic in terms of improving viral control and augmenting the numbers of functional virus-specific CTLs. Thus, PGE(2) inhibition is both an independent candidate therapeutic target and a promising adjunct therapy to PD-1 blockade for the treatment of HIV and other chronic viral infections.	[Chen, Jonathan H.; Perry, Curtis J.; Tsui, Yao-Chen; Staron, Matthew M.; Parish, Ian A.; Dominguez, Claudia X.; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Rosenberg, Daniel W.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; University of Connecticut; Howard Hughes Medical Institute	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	susan.kaech@yale.edu		Parish, Ian/0000-0003-3528-478X	Yale Medical Scientist Training Program [T32GM07205]; Howard Hughes Medical Institute;  [RO1AI074699]; NATIONAL CANCER INSTITUTE [R01CA038350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066232, R01AI074699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Yale Medical Scientist Training Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge C. Hao (Vanderbilt University, Nashville, Tennessee, USA) and E. Wherry (University of Pennsylvania, Philadelphia, Pennsylvania, USA) for generously providing EP2-and EP4-deficient mice and K<SUP>b</SUP>GP34 tetramers, respectively. This work was supported by RO1AI074699 (S.M.K.), the Yale Medical Scientist Training Program (T32GM07205 to J.H.C.) and the Howard Hughes Medical Institute (S.M.K.).	Aandahl EM, 1999, AIDS, V13, pF109; Aandahl EM, 1998, FASEB J, V12, P855, DOI 10.1096/fasebj.12.10.855; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brudvik KW, 2012, BRIT J PHARMACOL, V166, P411, DOI 10.1111/j.1476-5381.2011.01800.x; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Demeure CE, 1997, EUR J IMMUNOL, V27, P3526, DOI 10.1002/eji.1830271254; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jin HT, 2011, CURR TOP MICROBIOL, V350, P17, DOI 10.1007/82_2010_116; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Johansson CC, 2004, AIDS, V18, P951, DOI 10.1097/00002030-200404090-00015; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalinski P., J IMMUNOL, V188; Kennedy CRJ, 1999, NAT MED, V5, P217, DOI 10.1038/5583; KHAN MM, 1990, IMMUNOPHARMACOLOGY, V19, P151, DOI 10.1016/0162-3109(90)90064-L; Kvale D, 2006, AIDS, V20, P813, DOI 10.1097/01.aids.0000218544.54586.f1; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; LINNEMEYER PA, 1993, J IMMUNOL, V150, P3747; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Moujalled D, 2011, EMBO REP, V12, P77, DOI 10.1038/embor.2010.190; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Rahmouni S, 2004, BIOCHEM J, V384, P469, DOI 10.1042/BJ20031859; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schneider A, 2004, GENESIS, V40, P7, DOI 10.1002/gene.20048; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; Su YY, 2011, CANCER IMMUNOL IMMUN, V60, P111, DOI 10.1007/s00262-010-0924-z; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zambon AC, 2011, J BIOL CHEM, V286, P33260, DOI 10.1074/jbc.M111.268979; Zhang LZ, 2008, J BIOL CHEM, V283, P4304, DOI 10.1074/jbc.M708673200; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	63	96	105	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					327	+		10.1038/nm.3831	http://dx.doi.org/10.1038/nm.3831			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25799228	Green Accepted			2022-12-25	WOS:000352493600014
J	Kim, H; Verhaak, RGW				Kim, Hoon; Verhaak, Roel G. W.			Transcriptional mimicry by tumor-associated stroma	NATURE GENETICS			English	News Item							POOR-PROGNOSIS; CANCER; MACROPHAGE		[Kim, Hoon; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kim, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	rverhaak@mdanderson.org	Kim, Hoon/AAL-9283-2020; Verhaak, Roel/ABE-7058-2020	Kim, Hoon/0000-0003-4244-6126; 	NCI NIH HHS [P01 CA085878, P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA085878] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Busuttil RA, 2014, CLIN CANCER RES, V20, P2761, DOI 10.1158/1078-0432.CCR-13-3049; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Martinez E, 2015, ONCOGENE, V34, P2732, DOI 10.1038/onc.2014.216; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	14	12	12	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					307	309		10.1038/ng.3255	http://dx.doi.org/10.1038/ng.3255			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25814306				2022-12-25	WOS:000351922900003
J	Blancquaert, D; Van Daele, J; Strobbe, S; Kiekens, F; Storozhenko, S; De Steur, H; Gellynck, X; Lambert, W; Stove, C; Van Der Straeten, D				Blancquaert, Dieter; Van Daele, Jeroen; Strobbe, Simon; Kiekens, Filip; Storozhenko, Sergei; De Steur, Hans; Gellynck, Xavier; Lambert, Willy; Stove, Christophe; Van Der Straeten, Dominique			Improving folate (vitamin B-9) stability in biofortified rice through metabolic engineering	NATURE BIOTECHNOLOGY			English	Article							TIME QUANTITATIVE PCR; FOLIC-ACID; EXPRESSION; HEALTH; IMPACT; GENES; ENHANCEMENT; FRAMEWORK; SEQUENCE; CHINA	Biofortification of staple crops could help to alleviate micronutrient deficiencies in humans. We show that folates in stored rice grains are unstable, which reduces the potential benefits of folate biofortification. We obtain folate concentrations that are up to 150 fold higher than those of wild-type rice by complexing folate to folate-binding proteins to improve folate stability, thereby enabling long-term storage of biofortified high-folate rice grains.	[Blancquaert, Dieter; Strobbe, Simon; Storozhenko, Sergei; Van Der Straeten, Dominique] Univ Ghent, Dept Physiol, Lab Funct Plant Biol, B-9000 Ghent, Belgium; [Van Daele, Jeroen; Kiekens, Filip; Lambert, Willy; Stove, Christophe] Univ Ghent, Dept Bioanal, Lab Toxicol, B-9000 Ghent, Belgium; [De Steur, Hans; Gellynck, Xavier] Univ Ghent, Dept Agr Econ, Div Agrifood Mkt & Chain Management, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Van Der Straeten, D (corresponding author), Univ Ghent, Dept Physiol, Lab Funct Plant Biol, B-9000 Ghent, Belgium.	dominique.vanderstraeten@ugent.be	Strobbe, Simon/ABB-6163-2020; Van Der Straeten, Dominique/E-7385-2016; Stove, Christophe/B-6057-2008	Strobbe, Simon/0000-0003-0583-9406; Van Der Straeten, Dominique/0000-0002-7755-1420; Stove, Christophe/0000-0001-7126-348X; De Steur, Hans/0000-0003-1340-0882	Ghent University, Belgium, (Bijzonder Onderzoeksfonds) [BOF2004GOA012, BOF2009G0A004]; Research Foundation-Flanders (FWO) [3G012609, 35963]; Agency for Innovation by Science AMP; Technology (IWT); F.W.O	Ghent University, Belgium, (Bijzonder Onderzoeksfonds); Research Foundation-Flanders (FWO)(FWO); Agency for Innovation by Science AMP; Technology (IWT); F.W.O(FWO)	The authors thank O. Saracutu for excellent rice transformation work. D.V.D.S. and W.L. gratefully acknowledge financial support from Ghent University, Belgium, (Bijzonder Onderzoeksfonds, BOF2004GOA012 and BOF2009G0A004), and the Research Foundation-Flanders (FWO, projects 3G012609 and 35963). D.B. is indebted to F.W.O. for a postdoctoral fellowship. Simon Strobbe is supported by a PhD fellowship from the Agency for Innovation by Science & Technology (IWT).	Blancquaert D, 2014, J EXP BOT, V65, P895, DOI 10.1093/jxb/ert483; Blancquaert D, 2013, PLANT MOL BIOL, V83, P329, DOI 10.1007/s11103-013-0091-7; Blancquaert D, 2010, CRIT REV PLANT SCI, V29, P14, DOI 10.1080/07352680903436283; Counce PA, 2000, CROP SCI, V40, P436, DOI 10.2135/cropsci2000.402436x; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; De Brouwer V, 2010, J CHROMATOGR B, V878, P509, DOI 10.1016/j.jchromb.2009.12.032; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; De Steur H, 2014, TRENDS FOOD SCI TECH, V39, P116, DOI 10.1016/j.tifs.2014.06.010; De Steur H, 2012, NEW BIOTECHNOL, V29, P432, DOI 10.1016/j.nbt.2011.11.012; De Steur H, 2010, NAT BIOTECHNOL, V28, P554, DOI 10.1038/nbt0610-554; Fitzpatrick TB, 2012, PLANT CELL, V24, P395, DOI 10.1105/tpc.111.093120; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Iyer R, 2009, J FOOD SCI, V74, pR114, DOI 10.1111/j.1750-3841.2009.01359.x; Kiekens F, 2015, MOL NUTR FOOD RES, V59, P490, DOI 10.1002/mnfr.201400590; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakase M, 1996, GENE, V170, P223, DOI 10.1016/0378-1119(95)00887-X; Orsomando G, 2005, J BIOL CHEM, V280, P28877, DOI 10.1074/jbc.M504306200; RUEB S, 1994, PLANT CELL TISS ORG, V36, P259, DOI 10.1007/BF00037729; SAUBERLICH HE, 1987, AM J CLIN NUTR, V46, P1016, DOI 10.1093/ajcn/46.6.1016; Scarpella E, 2000, DEVELOPMENT, V127, P3655; Scott J, 2000, J SCI FOOD AGR, V80, P795, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;795::AID-JSFA599&gt;3.0.CO;2-K, 10.1002/(SICI)1097-0010(20000515)80:7<795::AID-JSFA599>3.0.CO;2-K]; Storozhenko S, 2007, NAT BIOTECHNOL, V25, P1277, DOI 10.1038/nbt1351; TAKAIWA F, 1991, PLANT MOL BIOL, V17, P875, DOI 10.1007/BF00037068; Van Daele J, 2014, J AGR FOOD CHEM, V62, P3092, DOI 10.1021/jf500753v; Yang LJ, 2007, PLANT BIOTECHNOL J, V5, P815, DOI 10.1111/j.1467-7652.2007.00287.x	25	92	97	6	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1076	+		10.1038/nbt.3358	http://dx.doi.org/10.1038/nbt.3358			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26389575				2022-12-25	WOS:000362555700027
J	Govindan, JA; Jayamani, E; Zhang, XR; Breen, P; Larkins-Ford, J; Mylonakis, E; Ruvkun, G				Govindan, J. Amaranath; Jayamani, Elamparithi; Zhang, Xinrui; Breen, Peter; Larkins-Ford, Jonah; Mylonakis, Eleftherios; Ruvkun, Gary			Lipid signalling couples translational surveillance to systemic detoxification in Caenorhabditis elegans	NATURE CELL BIOLOGY			English	Article							C. ELEGANS; MAPK PHOSPHATASE; BACTERIA; PROLIFERATION; ASSOCIATION; INFECTIONS; RESISTANCE; INHIBITION; IMMUNITY; PATHWAYS	Translation in eukaryotes is followed to detect toxins and virulence factors and coupled to the induction of defence pathways. Caenorhabditis elegans germline-specific mutations in translation components are detected by this system to induce detoxification and immune responses in distinct somatic cells. An RNA interference screen revealed gene inactivations that act at multiple steps in lipid biosynthetic and kinase pathways upstream of MAP kinase to mediate the systemic communication of translation defects to induce detoxification genes. Mammalian bile acids can rescue the defect in detoxification gene induction caused by C. elegans lipid biosynthetic gene inactivations. Extracts prepared from C. elegans with translation deficits but not from the wild type can also rescue detoxification gene induction in lipid-biosynthesis-defective strains. These eukaryotic antibacterial countermeasures are not ignored by bacteria: particular bacterial species suppress normal C. elegans detoxification responses to mutations in translation factors.	[Govindan, J. Amaranath; Jayamani, Elamparithi; Zhang, Xinrui; Breen, Peter; Larkins-Ford, Jonah; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Govindan, J. Amaranath; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jayamani, Elamparithi; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Larkins-Ford, Jonah/0000-0001-9123-9508; Zhang, Xinrui/0000-0002-7728-6970	NIH Office at Research Infrastructure Programs [P40 OD010440]; Japanese National Bioresources Project; National Institutes it Health [AG043184-16A]; NATIONAL INSTITUTE ON AGING [R01AG043184, R01AG016636] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office at Research Infrastructure Programs; Japanese National Bioresources Project; National Institutes it Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office at Research Infrastructure Programs (P40 OD010440), and S. Mitani of the Japanese National Bioresources Project. This work was supported in part by the National Institutes it Health Grant AG043184-16A (to G.R). Thanks to D. Coil and J. Eisen tor providing Kocuria species.	Autio KJ, 2014, BIOCHEM J, V461, P125, DOI 10.1042/BJ20130915; Azzopardi EA, 2011, J BURN CARE RES, V32, P570, DOI 10.1097/BCR.0b013e31822ac7e6; Becker K, 2008, J CLIN MICROBIOL, V46, P3537, DOI 10.1128/JCM.00823-08; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Enright MR, 2004, MICROB ECOL, V48, P414, DOI 10.1007/s00248-003-0166-0; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Ferdinandusse S, 2006, AM J HUM GENET, V78, P1046, DOI 10.1086/503921; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Hanazawa M, 2004, MECH DEVELOP, V121, P213, DOI 10.1016/j.mod.2004.02.001; Hillion M, 2013, MICROBIOLOGYOPEN, V2, P953, DOI 10.1002/mbo3.138; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Maciejowski J, 2005, GENETICS, V169, P1997, DOI 10.1534/genetics.104.040121; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Mertenskotter A, 2013, CELL STRESS CHAPERON, V18, P293, DOI 10.1007/s12192-012-0382-y; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Moissenet D, 2012, J CLIN MICROBIOL, V50, P1495, DOI 10.1128/JCM.06038-11; Montalvo-Katz S, 2013, INFECT IMMUN, V81, P514, DOI 10.1128/IAI.00653-12; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; PITTENGER RC, 1953, ANTIBIOT CHEMOTHER, V3, P1268; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Son SH, 2009, J APPL MICROBIOL, V107, P524, DOI 10.1111/j.1365-2672.2009.04238.x; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; WAITZ JA, 1974, ANTIMICROB AGENTS CH, V6, P579, DOI 10.1128/AAC.6.5.579; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101; Zhang R., 2013, ISRN MICROBIOL, V2013	37	13	15	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1294	+		10.1038/ncb3229	http://dx.doi.org/10.1038/ncb3229			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26322678	Green Accepted			2022-12-25	WOS:000362213500009
J	Guler, R; Brombacher, F				Guler, Reto; Brombacher, Frank			Host-directed drug therapy for tuberculosis	NATURE CHEMICAL BIOLOGY			English	Editorial Material							IMMUNE-RESPONSES; NONCODING RNAS; MACROPHAGES; MYCOBACTERIA; CHROMATIN	Chemical compounds designed to enhance understanding of host-pathogen interaction together with next-generation 'smart drugs' will rationally drive the discovery of promising new host-directed targets against pathogens including Mycobacterium tuberculosis, the causative agent of tuberculosis.	[Guler, Reto; Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Int Ctr Genet Engn & Biotechnol, Cape Town Component, ZA-7925 Cape Town, South Africa; [Guler, Reto; Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Div Immunol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town	Guler, R (corresponding author), Univ Cape Town, Fac Hlth Sci, Int Ctr Genet Engn & Biotechnol, Cape Town Component, ZA-7925 Cape Town, South Africa.	frank.brombacher@icgeb.org						Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Barichievy S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00108; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hawn TR, 2015, IMMUNOL REV, V264, P344, DOI 10.1111/imr.12255; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Iannaccone M, 2014, EXPERT OPIN THER TAR, V18, P491, DOI 10.1517/14728222.2014.897696; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Li J, 2015, J IMMUNOL, V194, P3756, DOI 10.4049/jimmunol.1402679; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550; Parihar SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075490; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Roy S, 2015, NUCLEIC ACIDS RES, V43, P6969, DOI 10.1093/nar/gkv646; Sharma G, 2015, NUCLEIC ACIDS RES, V43, P3922, DOI 10.1093/nar/gkv261; Singhal A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009885; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Wang J, 2015, NAT IMMUNOL, V16, P237, DOI 10.1038/ni.3096; Yi ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043184; Yu AD, 2015, IMMUNOL CELL BIOL, V93, P277, DOI 10.1038/icb.2015.2	23	30	30	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					748	751		10.1038/nchembio.1917	http://dx.doi.org/10.1038/nchembio.1917			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26379013				2022-12-25	WOS:000361536500002
J	Shain, AH; Garrido, M; Botton, T; Talevich, E; Yeh, I; Sanborn, JZ; Chung, J; Wang, NJ; Kakavand, H; Mann, GJ; Thompson, JF; Wiesner, T; Roy, R; Olshen, AB; Gagnon, A; Gray, JW; Huh, N; Hur, JS; Busam, KJ; Scolyer, RA; Cho, RJ; Murali, R; Bastian, BC				Shain, A. Hunter; Garrido, Maria; Botton, Thomas; Talevich, Eric; Yeh, Iwei; Sanborn, J. Zachary; Chung, Jongsuk; Wang, Nicholas J.; Kakavand, Hojabr; Mann, Graham J.; Thompson, John F.; Wiesner, Thomas; Roy, Ritu; Olshen, Adam B.; Gagnon, Alexander; Gray, Joe W.; Huh, Nam; Hur, Joe S.; Busam, Klaus J.; Scolyer, Richard A.; Cho, Raymond J.; Murali, Rajmohan; Bastian, Boris C.			Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway	NATURE GENETICS			English	Article							FACTOR-KAPPA-B; PROGNOSTIC-FACTORS; CANCER; CELLS; KINASE; BRAF; LANDSCAPE	Desmoplastic melanoma is an uncommon variant of melanoma with sarcomatous histology, distinct clinical behavior and unknown pathogenesis1-3. We performed low-coverage genome and high-coverage exome sequencing of 20 desmoplastic melanomas, followed by targeted sequencing of 293 genes in a validation cohort of 42 cases. A high mutation burden (median of 62 mutations/Mb) ranked desmoplastic melanoma among the most highly mutated cancers(4). Mutation patterns strongly implicate ultraviolet radiation as the dominant mutagen(5), indicating a superficially located cell of origin. Newly identified alterations included recurrent promoter mutations of NFKBIE, encoding NF-kappa B inhibitor. (I kappa B epsilon), in 14.5% of samples. Common oncogenic mutations in melanomas, in particular in BRAF (encoding p. Val600Glu) and NRAS (encoding p. Gln61Lys or p. Gln61Arg), were absent. Instead, other genetic alterations known to activate the MAPK and PI3K signaling cascades were identified in 73% of samples, affecting NF1, CBL, ERBB2, MAP2K1, MAP3K1, BRAF, EGFR, PTPN11, MET, RAC1, SOS2, NRAS and PIK3CA, some of which are candidates for targeted therapies.	[Shain, A. Hunter; Garrido, Maria; Botton, Thomas; Talevich, Eric; Yeh, Iwei; Gagnon, Alexander; Bastian, Boris C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Shain, A. Hunter; Garrido, Maria; Botton, Thomas; Talevich, Eric; Yeh, Iwei; Roy, Ritu; Olshen, Adam B.; Gagnon, Alexander; Bastian, Boris C.] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Shain, A. Hunter; Garrido, Maria; Botton, Thomas; Talevich, Eric; Yeh, Iwei; Gagnon, Alexander; Cho, Raymond J.; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Sanborn, J. Zachary] Five3 Genom LLC, Santa Cruz, CA USA; [Chung, Jongsuk; Huh, Nam] Samsung Adv Inst Technol, Seoul, South Korea; [Wang, Nicholas J.; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Wang, Nicholas J.; Gray, Joe W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Kakavand, Hojabr; Mann, Graham J.; Thompson, John F.; Scolyer, Richard A.] Melanoma Inst Australia, Sydney, NSW, Australia; [Kakavand, Hojabr; Mann, Graham J.; Thompson, John F.; Scolyer, Richard A.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Thompson, John F.; Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Wiesner, Thomas] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hur, Joe S.] Samsung Elect Headquarters, Seoul, South Korea; [Busam, Klaus J.; Murali, Rajmohan] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Murali, Rajmohan] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY 10021 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Samsung; Oregon Health & Science University; Oregon Health & Science University; Melanoma Institute Australia; University of Sydney; University of Sydney; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Samsung; Samsung Electronics; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bastian, BC (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	boris.bastian@ucsf.edu	Scolyer, Richard/AAE-8511-2019; Botton, Thomas/AAA-9258-2020; Cho, Raymond/AAO-8125-2020; Gray, Joe/AAX-9549-2020; Murali, Rajmohan/A-7960-2008; Mann, Graham/G-4758-2014	Scolyer, Richard/0000-0002-8991-0013; Botton, Thomas/0000-0001-9079-7014; Cho, Raymond/0000-0001-6090-6603; Wiesner, Thomas/0000-0001-5877-2992; Kakavand, Hojabr/0000-0002-3458-7853; Yeh, Iwei/0000-0002-3941-3561; Thompson, John/0000-0002-2816-2496; Murali, Rajmohan/0000-0001-6988-4295; Talevich, Eric/0000-0002-8106-0720; Mann, Graham/0000-0003-1301-405X; Bastian, Boris/0000-0003-1836-6062	US National Institutes of Health [R01 CA131524, P01 CA025874, P30 CA82103, 5T32 CA17755502, K08 CA169865, U54 CA112970]; American Skin Association; Gerson and Barbara Bakar Distinguished Chair in Cancer Biology; Well Aging Research Center at the Samsung Advanced Institute of Technology under S.C. Park; Dermatology Foundation; Oregon Health and Sciences University Knight Cancer Institute [5P30 CA069533]; Australian National Health and Medical Research Council; Cancer Institute New South Wales; Melanoma Foundation of the University of Sydney; Royal Prince Alfred Hospital; NATIONAL CANCER INSTITUTE [P30CA082103, U54CA112970, R01CA131524, P01CA025874, K08CA169865, T32CA177555, P30CA069533] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Skin Association; Gerson and Barbara Bakar Distinguished Chair in Cancer Biology; Well Aging Research Center at the Samsung Advanced Institute of Technology under S.C. Park(Samsung); Dermatology Foundation; Oregon Health and Sciences University Knight Cancer Institute; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; Melanoma Foundation of the University of Sydney(University of Sydney); Royal Prince Alfred Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes of Health grants R01 CA131524 (B.C.B.), P01 CA025874 (B.C.B.), P30 CA82103 (A.B.O.) and 5T32 CA17755502 (A.H.S.), the American Skin Association (B.C.B.), the Gerson and Barbara Bakar Distinguished Chair in Cancer Biology (B.C.B.), the Well Aging Research Center at the Samsung Advanced Institute of Technology under the auspices of S.C. Park, the Dermatology Foundation and US National Institutes of Health grants K08 CA169865 (R.J.C.), U54 CA112970 (J.W.G.) and the Oregon Health and Sciences University Knight Cancer Institute 5P30 CA069533 (J.W.G.). The authors acknowledge support from the Australian National Health and Medical Research Council, Cancer Institute New South Wales, the Melanoma Foundation of the University of Sydney and the staff of Melanoma Institute Australia and Royal Prince Alfred Hospital. Finally, we would like to thank A. Ribas (UCLA Jonsson Comprehensive Cancer Center) and G. Long (Melanoma Institute Australia) for providing samples used in this study.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Aydin IT, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju107; Bastian BC, 2014, ANNU REV PATHOL-MECH, V9, P239, DOI 10.1146/annurev-pathol-012513-104658; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Busam KJ, 2004, AM J SURG PATHOL, V28, P1518, DOI 10.1097/01.pas.0000141391.91677.a4; Chen LL, 2013, J AM ACAD DERMATOL, V68, P825, DOI 10.1016/j.jaad.2012.10.041; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davison JM, 2005, CANCER-AM CANCER SOC, V103, P788, DOI 10.1002/cncr.20861; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Karandikar M, 2000, J BIOL CHEM, V275, P40120, DOI 10.1074/jbc.M005926200; Kim J, 2012, J CUTAN PATHOL, V39, P821, DOI 10.1111/j.1600-0560.2012.01950.x; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; McNulty SE, 2001, PIGM CELL RES, V14, P456, DOI 10.1034/j.1600-0749.2001.140606.x; Meyskens FL, 1999, CLIN CANCER RES, V5, P1197; Murali R, 2010, CANCER-AM CANCER SOC, V116, P4130, DOI 10.1002/cncr.25148; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ni TK, 2013, P NATL ACAD SCI USA, V110, pE3640, DOI 10.1073/pnas.1314435110; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Quinn MJ, 1998, CANCER-AM CANCER SOC, V83, P1128, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1128::AID-CNCR11>3.3.CO;2-Y; Shain AH, 2012, PIGM CELL MELANOMA R, V25, P708, DOI 10.1111/pcmr.12012; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Talevich E, 2014, BIORXIV, DOI [10.1101/010876, DOI 10.1101/010876]; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wasif N, 2011, J SURG ONCOL, V103, P158, DOI 10.1002/jso.21778; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yang JM, 2001, CANCER RES, V61, P4901	42	158	159	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1194	+		10.1038/ng.3382	http://dx.doi.org/10.1038/ng.3382			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26343386	Green Accepted, Green Submitted			2022-12-25	WOS:000361969900015
J	Grande, MT; Sanchez-Laorden, B; Lopez-Blau, C; De Frutos, CA; Boutet, A; Arevalo, M; Rowe, RG; Weiss, SJ; Lopez-Novoa, JM; Nieto, MA				Teresa Grande, M.; Sanchez-Laorden, Berta; Lopez-Blau, Cristina; De Frutos, Cristina A.; Boutet, Agnes; Arevalo, Miguel; Grant Rowe, R.; Weiss, Stephen J.; Lopez-Novoa, Jose M.; Angela Nieto, M.			Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease	NATURE MEDICINE			English	Article							UNILATERAL URETERAL OBSTRUCTION; NF-KAPPA-B; KIDNEY FIBROSIS; TUBULOINTERSTITIAL FIBROSIS; MOLECULAR-MECHANISMS; SNAIL; CANCER; INFLAMMATION; INJURY; CELLS	Progressive kidney fibrosis contributes greatly to end-stage renal failure, and no specific treatment is available to preserve organ function. During renal fibrosis, myofibroblasts accumulate in the interstitium of the kidney, leading to massive deposition of extracellular matrix and organ dysfunction. The origin of myofibroblasts is manifold, but the contribution of an epithelial-to-mesenchymal transition (EMT) undergone by renal epithelial cells during kidney fibrosis is still debated. We show that the reactivation of Snai1 (encoding snail family zinc finger 1, known as Snail1) in mouse renal epithelial cells is required for the development of fibrosis in the kidney. Damage-mediated Snail1 reactivation induces a partial EMT in tubular epithelial cells that, without directly contributing to the myofibroblast population, relays signals to the interstitium to promote myofibroblast differentiation and fibrogenesis and to sustain inflammation. We also show that Snail1-induced fibrosis can be reversed in vivo and that obstructive nephropathy can be therapeutically ameliorated in mice by targeting Snail1 expression. These results reconcile conflicting data on the role of the EMT in renal fibrosis and provide avenues for the design of novel anti-fibrotic therapies.	[Teresa Grande, M.; Sanchez-Laorden, Berta; Lopez-Blau, Cristina; De Frutos, Cristina A.; Boutet, Agnes; Angela Nieto, M.] CSIC, Inst Neurociencias, Alacant, Spain; [Arevalo, Miguel; Lopez-Novoa, Jose M.] Univ Salamanca, E-37008 Salamanca, Spain; [Arevalo, Miguel; Lopez-Novoa, Jose M.] Biomed Res Inst Salamanca IBSAL, Salamanca, Spain; [Grant Rowe, R.; Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Inst Life Sci, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Salamanca; University of Michigan System; University of Michigan	Nieto, MA (corresponding author), CSIC, Inst Neurociencias, Alacant, Spain.	anieto@umh.es	Grande, M Teresa/L-2205-2014; Nieto, M. Angela/A-6531-2008; Lopez-Novoa, Jose M/A-3672-2008; Sanchez-Laorden, Berta/T-2177-2017	Grande, M Teresa/0000-0001-7447-328X; Nieto, M. Angela/0000-0002-3538-840X; Sanchez-Laorden, Berta/0000-0002-6499-6332; Lopez-Blau, Cristina/0000-0002-2445-5697	Spanish Ministry of Economy and Competitiveness [BFU2008-01042, CSD2007-00023, CDS2007-00017]; Generalitat Valenciana [Prometeo 2008/049, PROMETEOII/2013/002]; European Research Council [ERC AdG 322694]; Junta de Ampliacion de Estudios program at the Consejo Superior de Investigaciones Cientificas European Social Fund	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Research Council(European Research Council (ERC)European Commission); Junta de Ampliacion de Estudios program at the Consejo Superior de Investigaciones Cientificas European Social Fund	We thank members of A. Nieto's laboratory for their helpful discussions and comments throughout the years. We also thank S. Canals for his advice on statistical analysis, and C. Villena and S. Ingham for the design of Supplementary Figure 10. We are very grateful to P. Igarashi (University of Minnesota Medical School) for providing the Ksp1.3-Cre mice. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2008-01042 and CONSOLIDER-INGENIO 2010 CSD2007-00023 and CDS2007-00017), the Generalitat Valenciana (Prometeo 2008/049 and PROMETEOII/2013/002) and the European Research Council (ERC AdG 322694) to M.A.N. The Instituto de Neurociencias is a Centre of Excellence Severo Ochoa. M.T.G. was a recipient of a contract from the Junta de Ampliacion de Estudios program at the Consejo Superior de Investigaciones Cientificas European Social Fund.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Costa MZD, 2006, APPL IMMUNOHISTO M M, V14, P348; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Dressler GR, 2002, TRENDS CELL BIOL, V12, P390, DOI 10.1016/S0962-8924(02)02334-6; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Lyons JG, 2008, CANCER RES, V68, P4525, DOI 10.1158/1078-0432.CCR-07-6735; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Miyajima A, 2003, J UROLOGY, V169, P1559, DOI 10.1097/01.ju.0000045686.21766.c1; Morizane R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04578; National Institute of Diabetes and Digestive and Kidney Diseases, KIDN DIS STAT US; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Rodriguez-Lopez AM, 1998, KIDNEY INT, V54, pS36, DOI 10.1046/j.1523-1755.1998.06810.x; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	46	447	471	8	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					989	+		10.1038/nm.3901	http://dx.doi.org/10.1038/nm.3901			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26236989	Green Submitted			2022-12-25	WOS:000360961300010
J	Hanafusa, H; Kedashiro, S; Tezuka, M; Funatsu, M; Usami, S; Toyoshima, F; Matsumoto, K				Hanafusa, Hiroshi; Kedashiro, Shin; Tezuka, Motohiro; Funatsu, Motoki; Usami, Satoshi; Toyoshima, Fumiko; Matsumoto, Kunihiro			PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; POLO-LIKE KINASE-1; ASYMMETRIC CELL-DIVISION; TUBULIN RING COMPLEX; GAMMA-TUBULIN; MICROTUBULE NUCLEATION; ENDOSOMAL TRAFFICKING; MITOTIC PROGRESSION; ADHERENT CELLS; BOX DOMAIN	Correct formation of the cell division axis requires the initial precise orientation of the mitotic spindle. Proper spindle orientation depends on centrosome maturation, and Polo-like kinase 1 (PLK1) is known to play a crucial role in this process. However, the molecular mechanisms that function downstream of PLK1 are not well understood. Here we show that LRRK1 is a PLK1 substrate that is phosphorylated on Ser 1790. PLK1 phosphorylation is required for CDK1-mediated activation of LRRK1 at the centrosomes, and this in turn regulates mitotic spindle orientation by nucleating the growth of astral microtubules from the centrosomes. Interestingly, LRRK1 in turn phosphorylates CDK5RAP2(Cep215), a human homologue of Drosophila Centrosomin (Cnn), in its gamma-tubulin-binding motif, thus promoting the interaction of CDK5RAP2 with gamma-tubulin. LRRK1 phosphorylation of CDK5RAP2 Ser 140 is necessary for CDK5RAP2-dependent microtubule nucleation. Thus, our findings provide evidence that LRRK1 regulates mitotic spindle orientation downstream of PLK1 through CDK5RAP2-dependent centrosome maturation.	[Hanafusa, Hiroshi; Kedashiro, Shin; Tezuka, Motohiro; Funatsu, Motoki; Usami, Satoshi; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Toyoshima, Fumiko] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan	Nagoya University; Kyoto University	Hanafusa, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	q47371a@nucc.cc.nagoya-u.ac.jp; g44177a@nucc.cc.nagoya-u.ac.jp		Toyoshima, Fumiko/0000-0002-3698-0034	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research [26112706] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Hisamoto for helpful discussion, K. Ishikawa for virus infections and G. Goshima for U2OS cells. This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.M. and H.H.), as well as from the Takeda Science Foundation and the Daiichi Sankyo Foundation of Life Science (to H.H.).	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Conduit PT, 2014, DEV CELL, V28, P659, DOI 10.1016/j.devcel.2014.02.013; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Hanafusa H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1161; Ishikawa K, 2012, MOL BIOL CELL, V23, P1294, DOI 10.1091/mbc.E11-09-0780; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kedashiro S, 2015, J CELL SCI, V128, P385, DOI 10.1242/jcs.161547; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Matsumura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1634; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Yang YH, 2010, P NATL ACAD SCI USA, V107, P3499, DOI 10.1073/pnas.0914307107; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhu M, 2013, J CELL BIOL, V200, P773, DOI 10.1083/jcb.201207050; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	42	43	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1024	U360		10.1038/ncb3204	http://dx.doi.org/10.1038/ncb3204			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26192437				2022-12-25	WOS:000358847700010
J	Kelemen, LE; Lawrenson, K; Tyrer, J; Li, Q; Lee, JM; Seo, JH; Phelan, CM; Beesley, J; Chen, XQ; Spindler, TJ; Aben, KKH; Anton-Culver, H; Antonenkova, N; Baker, H; Bandera, EV; Bean, Y; Beckmann, MW; Bisogna, M; Bjorge, L; Bogdanova, N; Brinton, LA; Brooks-Wilson, A; Bruinsma, F; Butzow, R; Campbell, IG; Carty, K; Chang-Claude, J; Chen, YA; Chen, ZH; Cook, LS; Cramer, DW; Cunningham, JM; Cybulski, C; Dansonka-Mieszkowska, A; Dennis, J; Dicks, E; Doherty, JA; Dicks, E; Doherty, JA; Dork, T; du Bois, A; Durst, M; Eccles, D; Easton, DT; Edwards, RP; Eilber, U; Ekici, AB; Engelholm, SA; Fasching, PA; Fridley, BL; Gao, YT; Gentry-Maharaj, A; Giles, GG; Glasspool, R; Goode, EL; Goodman, MT; Grownwald, J; Harrington, P; Harter, P; Hasmad, HN; Hein, A; Heitz, F; Hildebrandt, MAT; Hillemanns, P; Hogdall, E; Hogdall, C; Hosono, S; Iversen, ES; Jakubowska, A; Jensen, A; Ji, BT; Karlan, BY; Kellar, M; Kelley, JL; Kiemeney, LA; Krakstad, C; Kjaer, SK; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, AW; Lele, S; Leminen, A; Lester, J; Levine, DA; Liang, D; Lissowska, J; Lu, KR; Lubinski, J; Lundvall, L; Massuger, LFAG; Matsuo, K; McGuire, V; McLaughlin, JR; McNeish, I; Menon, U; Modugno, F; Moes-Sosnowska, J; Moysich, KB; Narod, SA; Nedergaard, L; Ness, RB; Nevanlinna, H; Adenan, NAM; Odunsi, K; Olson, SH; Orlow, I; Orsulic, S; Weber, RP; Paul, J; Pearce, CL; Pejovic, T; Pelttari, LM; Permuth-Wey, J; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rosen, B; Rossing, MA; Rothstein, JH; Rudolph, A; Runnebaum, IB; Rzepecka, IK; Salvesen, HB; Schildkraut, JM; Schwaab, I; Shu, XO; Shvetsov, YB; Siddiqui, N; Sieh, W; Song, HL; Southey, MC; Sucheston, L; Tangen, IL; Teo, SH; Terry, KL; Thompson, PJ; Tworoger, SS; van Altena, AM; Van Nieuwenhuysen, E; Vergote, I; Vierkant, RA; Wang-Gohrke, S; Walsh, C; Wentzensen, N; Whittemore, AS; Wicklund, KG; Wilkens, LR; Sawicki, W; Woo, YL; Wu, XF; Wu, AH; Yang, H; Zheng, W; Ziogas, A; Sellers, TA; Freedman, ML; Chenevix-Trench, G; Pharoah, PDP; Gayther, SA; Berchuck, A				Kelemen, Linda E.; Lawrenson, Kate; Tyrer, Jonathan; Li, Qiyuan; Lee, Janet M.; Seo, Ji-Heui; Phelan, Catherine M.; Beesley, Jonathan; Chen, Xiaoqing; Spindler, Tassja J.; Aben, Katja K. H.; Anton-Culver, Hoda; Antonenkova, Natalia; Baker, Helen; Bandera, Elisa V.; Bean, Yukie; Beckmann, Matthias W.; Bisogna, Maria; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise A.; Brooks-Wilson, Angela; Bruinsma, Fiona; Butzow, Ralf; Campbell, Ian G.; Carty, Karen; Chang-Claude, Jenny; Chen, Y. Ann; Chen, Zhihua; Cook, Linda S.; Cramer, Daniel W.; Cunningham, Julie M.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Dennis, Joe; Dicks, Ed; Doherty, Jennifer A.; Dicks, Ed; Doherty, Jennifer A.; Doerk, Thilo; du Bois, Andreas; Duerst, Matthias; Eccles, Diana; Easton, Douglas T.; Edwards, Robert P.; Eilber, Ursula; Ekici, Arif B.; Engelholm, Svend Aage; Fasching, Peter A.; Fridley, Brooke L.; Gao, Yu-Tang; Gentry-Maharaj, Aleksandra; Giles, Graham G.; Glasspool, Rosalind; Goode, Ellen L.; Goodman, Marc T.; Grownwald, Jacek; Harrington, Patricia; Harter, Philipp; Hasmad, Hanis Nazihah; Hein, Alexander; Heitz, Florian; Hildebrandt, Michelle A. T.; Hillemanns, Peter; Hogdall, Estrid; Hogdall, Claus; Hosono, Satoyo; Iversen, Edwin S.; Jakubowska, Anna; Jensen, Allan; Ji, Bu-Tian; Karlan, Beth Y.; Kellar, Melissa; Kelley, Joseph L.; Kiemeney, Lambertus A.; Krakstad, Camilla; Kjaer, Susanne K.; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Alice W.; Lele, Shashi; Leminen, Arto; Lester, Jenny; Levine, Douglas A.; Liang, Dong; Lissowska, Jolanta; Lu, Karen; Lubinski, Jan; Lundvall, Lene; Massuger, Leon F. A. G.; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; McNeish, Iain; Menon, Usha; Modugno, Francesmary; Moes-Sosnowska, Joanna; Moysich, Kirsten B.; Narod, Steven A.; Nedergaard, Lotte; Ness, Roberta B.; Nevanlinna, Heli; Adenan, Noor Azmi Mat; Odunsi, Kunle; Olson, Sara H.; Orlow, Irene; Orsulic, Sandra; Weber, Rachel Palmieri; Paul, James; Pearce, Celeste Leigh; Pejovic, Tanja; Pelttari, Liisa M.; Permuth-Wey, Jennifer; Pike, Malcolm C.; Poole, Elizabeth M.; Ramus, Susan J.; Risch, Harvey A.; Rosen, Barry; Rossing, Mary Anne; Rothstein, Joseph H.; Rudolph, Anja; Runnebaum, Ingo B.; Rzepecka, Iwona K.; Salvesen, Helga B.; Schildkraut, Joellen M.; Schwaab, Ira; Shu, Xiao-Ou; Shvetsov, Yurii B.; Siddiqui, Nadeem; Sieh, Weiva; Song, Honglin; Southey, Melissa C.; Sucheston, Lara; Tangen, Ingvild L.; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Tworoger, Shelley S.; van Altena, Anne M.; Van Nieuwenhuysen, Els; Vergote, Ignace; Vierkant, Robert A.; Wang-Gohrke, Shan; Walsh, Christine; Wentzensen, Nicolas; Whittemore, Alice S.; Wicklund, Kristine G.; Wilkens, Lynne R.; Sawicki, Wlodzimierz; Woo, Yin-Ling; Wu, Xifeng; Wu, Anna H.; Yang, Hannah; Zheng, Wei; Ziogas, Argyrios; Sellers, Thomas A.; Freedman, Matthew L.; Chenevix-Trench, Georgia; Pharoah, Paul D. P.; Gayther, Simon A.; Berchuck, Andrew		Australian Canc Study; Australian Ovarian Canc Study Grp; Ovarian Canc Assoc Consortium	Genome-wide significant risk associations for mucinous ovarian carcinoma	NATURE GENETICS			English	Article							CANCER SUSCEPTIBILITY LOCUS; BREAST-CANCER; COLORECTAL-CANCER; ANALYSES REVEAL; FALLOPIAN-TUBE; CELL-TYPE; GENES; EXPRESSION; IDENTIFICATION; HEREDITARY	Genome-wide association studies have identified several risk associations for ovarian carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC cases and 21,693 controls with imputation identified 3 new risk associations: rs752590 at 2q13 (P = 3.3 x 10(-8)), rs711830 at 2q31.1 (P = 7.5 x 10(-12)) and rs688187 at 19q13.2 (P = 6.8 x 10(-13)). We identified significant expression quantitative trait locus (eQTL) associations for HOXD9 at 2q31.1 in ovarian (P = 4.95 x 10(-4), false discovery rate (FDR) = 0.003) and colorectal (P = 0.01, FDR = 0.09) tumors and for PAX8 at 2q13 in colorectal tumors (P = 0.03, FDR = 0.09). Chromosome conformation capture analysis identified interactions between the HOXD9 promoter and risk-associated SNPs at 2q31.1. Overexpressing HOXD9 in MOC cells augmented the neoplastic phenotype. These findings provide the first evidence for MOC susceptibility variants and insights into the underlying biology of the disease.	[Kelemen, Linda E.] Med Univ S Carolina, Coll Med, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Lawrenson, Kate; Lee, Janet M.; Spindler, Tassja J.; Lee, Alice W.; Pearce, Celeste Leigh; Pike, Malcolm C.; Ramus, Susan J.; Wu, Anna H.; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Tyrer, Jonathan; Harrington, Patricia; Song, Honglin; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Li, Qiyuan] Xiamen Univ, Coll Med, Xiamen, Peoples R China; [Li, Qiyuan; Seo, Ji-Heui; Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Med Oncol, Boston, MA 02115 USA; [Phelan, Catherine M.; Permuth-Wey, Jennifer; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Beesley, Jonathan; Chen, Xiaoqing; Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Canc Genet, Brisbane, Qld, Australia; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Genet Epidemiol Res Inst, Dept Epidemiol, Irvine, CA 92717 USA; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, BELARUS; [Baker, Helen; Dennis, Joe; Dicks, Ed; Easton, Douglas T.; Song, Honglin; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Bandera, Elisa V.] Rutgers State Univ, Canc Inst New Jersey, Canc Prevent & Control Program, New Brunswick, NJ 08903 USA; [Bean, Yukie; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Bean, Yukie; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, D-91054 Erlangen, Germany; [Bisogna, Maria; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Brinton, Louise A.; Ji, Bu-Tian; Wentzensen, Nicolas; Yang, Hannah] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Bruinsma, Fiona; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Australia; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Helsinki Univ Hosp, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Campbell, Ian G.] Peter MacCallum Canc Ctr, Div Res, Canc Genet Lab, East Melbourne, Vic, Australia; [Campbell, Ian G.; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Campbell, Ian G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Carty, Karen; Glasspool, Rosalind; Paul, James] Beatson West Scotland Canc Ctr, Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland; [Chang-Claude, Jenny; Eilber, Ursula; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chen, Y. Ann; Chen, Zhihua] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Cramer, Daniel W.; Poole, Elizabeth M.; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.] Brigham & Womens Hosp, Obstetr & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN USA; [Cybulski, Cezary; Grownwald, Jacek; Jakubowska, Anna; Lubinski, Jan] West Pomeranian Univ Technol, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70310 Szczecin, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Moes-Sosnowska, Joanna; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland; [Doherty, Jennifer A.] Geisel Sch Med, Dept Epidemiol, Lebanon, NH USA; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Kliniken Essen Mitte Evang Huyssens Stiftung Knap, Dept Gynecol & Gynecol Oncol, Essen, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [Duerst, Matthias; Runnebaum, Ingo B.] Univ Jena, Jena Univ Hospital, Dept Gynecol, Jena, Germany; [Eccles, Diana] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Edwards, Robert P.; Kelley, Joseph L.; Modugno, Francesmary] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, Pittsburgh, PA USA; [Edwards, Robert P.; Kelley, Joseph L.; Modugno, Francesmary] Univ Pittsburgh, Ovarian Canc Ctr Excellence, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Ctr Comprehens Canc, Inst Human Genet, D-91054 Erlangen, Germany; [Engelholm, Svend Aage] Univ Copenhagen, Rigshosp, Dept Radiat Oncol, DK-2100 Copenhagen, Denmark; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Shanghai, Peoples R China; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Inst Womens Hlth, Gynaecol Canc Res Ctr, Dept Womens Canc, London, England; [Giles, Graham G.] Univ Melbourne, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Giles, Graham G.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Canc Prevent & Control, Los Angeles, CA 90048 USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Community & Populat Hlth Res Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Hasmad, Hanis Nazihah; Teo, Soo-Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hillemanns, Peter] Hannover Med Sch, Clin Obstet & Gynaecol, Hannover, Germany; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Copenhagen, Denmark; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne K.] Danish Canc Soc Res Ctr, Dept Virus Lifestyle & Genes, Copenhagen, Denmark; [Hogdall, Claus; Kjaer, Susanne K.; Lundvall, Lene; Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Gynaecol, DK-2100 Copenhagen, Denmark; [Hosono, Satoyo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Walsh, Christine] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Lambrechts, Sandrina; Van Nieuwenhuysen, Els; Vergote, Ignace] Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Gynecol Oncol, Leuven, Belgium; [Lambrechts, Sandrina; Van Nieuwenhuysen, Els; Vergote, Ignace] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium; [Le, Nhu D.] British Columbia Canc Agcy, Canc Control Res, Vancouver, BC V5Z 4E6, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston, Lara] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Liang, Dong] Texas So Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Massuger, Leon F. A. G.; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands; [Matsuo, Keitaro; Rothstein, Joseph H.] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Nagoya, Aichi, Japan; [McGuire, Valerie; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [McLaughlin, John R.] Publ Hlth Ontario, Toronto, ON, Canada; [McNeish, Iain] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Beatson Inst Canc Res, Inst Canc Sci, Glasgow, Lanark, Scotland; [Modugno, Francesmary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Modugno, Francesmary] Magee Womens Res Inst, Womens Canc Res Program, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Adenan, Noor Azmi Mat; Woo, Yin-Ling] Univ Malaya, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Olson, Sara H.; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Weber, Rachel Palmieri; Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC USA; [Pearce, Celeste Leigh] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Med, Boston, MA USA; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Rosen, Barry] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Rossing, Mary Anne; Wicklund, Kristine G.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Schildkraut, Joellen M.] Duke Canc Inst, Durham, NC USA; [Schwaab, Ira] Praxis Humangenet, Wiesbaden, Germany; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Shvetsov, Yurii B.; Wilkens, Lynne R.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Teo, Soo-Hwang; Woo, Yin-Ling] Univ Malaya, Fac Med, Med Ctr, Canc Res Inst, Kuala Lumpur, Malaysia; [Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, D-89069 Ulm, Germany; [Sawicki, Wlodzimierz] Med Univ Warsaw, Fac Med 2, Dept Obstet Gynecol & Oncol, Warsaw, Poland; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Medical University of South Carolina; University of Southern California; University of Cambridge; Xiamen University; Harvard University; Dana-Farber Cancer Institute; H Lee Moffitt Cancer Center & Research Institute; QIMR Berghofer Medical Research Institute; Radboud University Nijmegen; University of California System; University of California Irvine; University of Cambridge; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Oregon Health & Science University; Oregon Health & Science University; University of Erlangen Nuremberg; Memorial Sloan Kettering Cancer Center; University of Bergen; Haukeland University Hospital; University of Bergen; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); British Columbia Cancer Agency; Simon Fraser University; Cancer Council Victoria; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Beatson Oncology Centre; Helmholtz Association; German Cancer Research Center (DKFZ); H Lee Moffitt Cancer Center & Research Institute; University of New Mexico; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Mayo Clinic; West Pomeranian University of Technology; Maria Sklodowska-Curie National Research Institute of Oncology; Dartmouth College; Kliniken Essen-Mitte; Friedrich Schiller University of Jena; University of Southampton; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Erlangen Nuremberg; Rigshospitalet; University of Copenhagen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kansas; University of Kansas Medical Center; Shanghai Jiao Tong University; University of London; University College London; University of Melbourne; Monash University; Mayo Clinic; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Texas System; UTMD Anderson Cancer Center; Hannover Medical School; University of Copenhagen; Herlev & Gentofte Hospital; Danish Cancer Society; Rigshospitalet; University of Copenhagen; Aichi Cancer Center; Duke University; Cedars Sinai Medical Center; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; British Columbia Cancer Agency; Roswell Park Cancer Institute; Texas Southern University; Maria Sklodowska-Curie National Research Institute of Oncology; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; Kyushu University; Stanford University; Beatson Institute; University of Glasgow; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Universiti Malaya; Roswell Park Cancer Institute; Memorial Sloan Kettering Cancer Center; Duke University; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; University of Toronto; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Duke University; Vanderbilt University; Vanderbilt University; Cancer Research Center of Hawaii; University of Hawaii System; University of Glasgow; Universiti Malaya; Mayo Clinic; Ulm University; Medical University of Warsaw; Duke University	Gayther, SA (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA.	simon.gayther@med.usc.edu	Eccles, Diana/K-6327-2019; Lissowska, Jolanta/AAH-3252-2020; chen, xi/GXH-3653-2022; Krakstad, Camilla/AAB-5138-2020; Ramus, Susan/AAG-8352-2019; Kiemeney, Lambertus A./D-3357-2009; zhang, weihua/GXV-1334-2022; van Altena, Anne M/B-9824-2016; Woo, Yin Ling/GPX-0086-2022; Bjorge, Line/AAD-6179-2021; Matsuo, Keitaro/H-6758-2019; salvesen, Helga B/C-1187-2017; Bowtell, David/H-1007-2016; Vierkant, Robert/AAP-4927-2020; Narod, Steven A/AAA-6112-2022; jones, Rob j/N-9379-2017; chen, xia/GYR-3948-2022; Menon, Usha/C-4716-2008; Gao, Yu/HGE-1937-2022; Massuger, Leon F.A.G./H-8072-2014; Rzepecka, Iwona K/AFO-1670-2022; Zheng, Wei/O-3351-2013; Green, Adele C/P-2736-2014; Pharoah, Paul/V-6658-2019; Ekici, Arif B/C-3971-2013; chen, xia/GXM-5435-2022; Fasching, Peter A/ABH-9912-2020; Modugno, Francesmary/AIB-6722-2022; Wentzensen, Nicolas/AAG-8522-2019; Aben, Katja KH/G-9686-2016; Gao, Y./GWZ-3665-2022; Jakubowska, Anna/O-8050-2014; Lambrechts, Diether/AAJ-3167-2020; Bogdanova, Natalia V./Y-2205-2019; Woo, Yin Ling/B-5198-2010; Teo, Soo-hwang/H-2353-2014; Hein, Alexander/F-6999-2010; Shvetsov, Yurii/ABA-3196-2020; Chenevix-Trench, Georgia/AAV-2014-2020; Bjorge, Line/C-1307-2017; Dörk, Thilo/J-8620-2012; Brooks-Wilson, Angela/E-9399-2012; gao, yi/HCI-8298-2022	Eccles, Diana/0000-0002-9935-3169; Lissowska, Jolanta/0000-0003-2695-5799; Krakstad, Camilla/0000-0002-0174-8139; Ramus, Susan/0000-0003-0005-7798; Kiemeney, Lambertus A./0000-0002-2368-1326; Woo, Yin Ling/0000-0003-1742-1066; Bjorge, Line/0000-0002-0240-2770; Matsuo, Keitaro/0000-0003-1761-6314; salvesen, Helga B/0000-0002-4438-8831; Bowtell, David/0000-0001-9089-7525; Vierkant, Robert/0000-0001-6242-5221; Menon, Usha/0000-0003-3708-1732; Zheng, Wei/0000-0003-1226-070X; Green, Adele C/0000-0002-2753-4841; Pharoah, Paul/0000-0001-8494-732X; Ekici, Arif B/0000-0001-6099-7066; Fasching, Peter A/0000-0003-4885-8471; Aben, Katja KH/0000-0002-0214-2147; Jakubowska, Anna/0000-0002-5650-0501; Lambrechts, Diether/0000-0002-3429-302X; Woo, Yin Ling/0000-0003-1742-1066; Hein, Alexander/0000-0003-2601-3398; Chenevix-Trench, Georgia/0000-0002-1878-2587; Bjorge, Line/0000-0002-0240-2770; Dörk, Thilo/0000-0002-9458-0282; Brooks-Wilson, Angela/0000-0003-1009-6408; Lee, Alice/0000-0001-8756-7066; Beesley, Jonathan/0000-0003-1942-325X; Campbell, Ian/0000-0002-7773-4155; Pelttari, Liisa/0000-0001-8091-9751; Glasspool, Rosalind/0000-0002-5000-1680; Giles, Graham/0000-0003-4946-9099; Rzepecka, Iwona Krystyna/0000-0001-7305-6687; Southey, Melissa/0000-0002-6313-9005; Moes-Sosnowska, Joanna/0000-0003-1706-8290; Kjaer, Susanne/0000-0002-8347-1398; Goodman, Marc/0000-0002-4839-3021; Kupryjanczyk, Jolanta/0000-0001-5820-0214; Lawrenson, Kate/0000-0002-6469-2515; Levine, Douglas/0000-0003-1038-8232; Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Heitz, Florian/0000-0002-2412-0352; Hogdall, Claus/0000-0002-5959-8874; Jensen, Allan/0000-0001-8124-4880; McNeish, Iain/0000-0002-9387-7586; Chen, yian/0000-0003-1468-3490; Orlow, Irene/0000-0001-6234-6961; Olson, Sara/0000-0003-0182-2754; Lubinski, Jan/0000-0003-2931-3003	European Commission [223175-HEALTH-F2-2009-223175]; Ovarian Cancer Research Fund [PPD/RPCI.07]; Genetic Associations and Mechanisms in Oncology (GAME-ON); National Cancer Institute Cancer Post-GWAS Initiative [U19-CA148112]; Wellcome Trust [076113]; Cancer Research UK [16561, 12677] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD071966] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA074850, R01CA112523, R25CA174664, UM1CA186107, R01CA126841, P01CA087969, R01CA058860, R01CA160565, K07CA092044, R03CA173531, K07CA143047, R00CA184415, P50CA159981, R01CA076016, UM1CA182910, K99CA184415, R01CA049449, R03CA115195, P30CA015083, R01CA170546, P30CA016672, ZIACP010126, R01CA087538, P30CA008748, R01CA106414, R01CA063682, K12CA090628, R01CA114343, R37CA070867, R01CA067262, R01CA083918, R01CA122443, R01CA141154, R01CA058598, K07CA095666, UM1CA176726, R01CA080742, K22CA138563, R01CA087696, U19CA148112, R01CA063678, R01CA149429, P30CA071789, R03CA113148, P50CA105009] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071766] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Ovarian Cancer Research Fund; Genetic Associations and Mechanisms in Oncology (GAME-ON); National Cancer Institute Cancer Post-GWAS Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all the individuals who took part in this study and all the researchers, clinicians, and technical and administrative staff who made possible the many studies contributing to this work (a full list is provided in the Supplementary Note). The COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement 223175-HEALTH-F2-2009-223175). The Ovarian Cancer Association Consortium (OCAC) is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). The scientific development and funding for this project were supported in part by Genetic Associations and Mechanisms in Oncology (GAME-ON) and a National Cancer Institute Cancer Post-GWAS Initiative (U19-CA148112). Details of the funding of individual investigators and studies are provided in the Supplementary Note. This study made use of data generated by the Wellcome Trust Case Control Consortium; funding for the project was provided by the Wellcome Trust under award 076113. A full list of the investigators who contributed to the generation of the data is available from the consortium website (see URLs). The results published here are based in part on data generated by The Cancer Genome Atlas (TCGA) Pilot Project established by the National Cancer Institute and National Human Genome Research Institute; information about TCGA and the investigators and institutions who constitute the TCGA research network can be found on the project website (see URLs).	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Boyd J, 1997, GYNECOL ONCOL, V64, P196, DOI 10.1006/gyno.1996.4572; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Chen KX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5682; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Coetzee SG, 2015, HUM MOL GENET, V24, P3595, DOI 10.1093/hmg/ddv101; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cuatrecasas M, 1997, CANCER, V79, P1581, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Di Palma T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-292; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Faber MT, 2013, CANCER CAUSE CONTROL, V24, P989, DOI 10.1007/s10552-013-0174-4; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gilks CB, 2008, HUM PATHOL, V39, P1239, DOI 10.1016/j.humpath.2008.01.003; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hart WR, 2005, INT J GYNECOL PATHOL, V24, P4, DOI 10.1097/01.pgp.0000148335.39146.a7; Heinzelmann-Schwarz VA, 2006, BRIT J CANCER, V94, P904, DOI 10.1038/sj.bjc.6603003; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; ICHIKAWA Y, 1994, CANCER RES, V54, P33; Kelemen LE, 2011, LANCET ONCOL, V12, P1071, DOI 10.1016/S1470-2045(11)70058-4; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; KUNZMANN R, 1987, CANCER GENET CYTOGEN, V28, P201, DOI 10.1016/0165-4608(87)90206-8; Laury AR, 2011, AM J SURG PATHOL, V35, P816, DOI 10.1097/PAS.0b013e318216c112; Laury AR, 2010, AM J SURG PATHOL, V34, P627, DOI 10.1097/PAS.0b013e3181da7687; Lee KR, 2003, AM J SURG PATHOL, V27, P281, DOI 10.1097/00000478-200303000-00001; Li H, 2002, GYNECOL ONCOL, V84, P216, DOI 10.1006/gyno.2001.6498; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Li QY, 2014, HUM MOL GENET, V23, P5294, DOI 10.1093/hmg/ddu228; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; LYNCH HT, 1991, CANCER GENET CYTOGEN, V53, P161, DOI 10.1016/0165-4608(91)90094-B; LYNCH HT, 1985, CANCER, V56, P939, DOI 10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; Ochi H, 2011, J GEN VIROL, V92, P1071, DOI 10.1099/vir.0.029124-0; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; PEJOVIC T, 1995, ANN MED, V27, P73, DOI 10.3109/07853899509031940; Permuth-Wey J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2613; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pieretti M, 2002, CANCER INVEST, V20, P11, DOI 10.1081/CNV-120000361; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Ronnett BM, 2004, HUM PATHOL, V35, P949, DOI 10.1016/j.humpath.2004.03.006; RONNETT BM, 1995, AM J SURG PATHOL, V19, P1390, DOI 10.1097/00000478-199512000-00006; Seidman JD, 2003, AM J SURG PATHOL, V27, P985, DOI 10.1097/00000478-200307000-00014; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Tabuse M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-60; Tavassoulu F.A., 2003, WHO CLASSIFICATION T; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Xing G, 2012, ANN HUM GENET, V76, P168, DOI 10.1111/j.1469-1809.2011.00700.x; Yemelyanova AV, 2008, AM J SURG PATHOL, V32, P128, DOI 10.1097/PAS.0b013e3180690d2d	71	64	66	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					888	897		10.1038/ng.3336	http://dx.doi.org/10.1038/ng.3336			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26075790	Green Accepted, Green Submitted			2022-12-25	WOS:000358674100012
J	Vizoso, M; Ferreira, HJ; Lopez-Serra, P; Carmona, FJ; Martinez-Cardus, A; Girotti, MR; Villanueva, A; Guil, S; Moutinho, C; Liz, J; Portela, A; Heyn, H; Moran, S; Vidal, A; Martinez-Iniesta, M; Manzano, JL; Fernandez-Figueras, MT; Elez, E; Munoz-Couselo, E; Botella-Estrada, R; Berrocal, A; Ponten, F; van den Oord, J; Gallagher, WM; Frederick, DT; Flaherty, KT; McDermott, U; Lorigan, P; Marais, R; Esteller, M				Vizoso, Miguel; Ferreira, Humberto J.; Lopez-Serra, Paula; Javier Carmona, F.; Martinez-Cardus, Anna; Girotti, Maria Romina; Villanueva, Alberto; Guil, Sonia; Moutinho, Catia; Liz, Julia; Portela, Anna; Heyn, Holger; Moran, Sebastian; Vidal, August; Martinez-Iniesta, Maria; Manzano, Jose L.; Teresa Fernandez-Figueras, Maria; Elez, Elena; Munoz-Couselo, Eva; Botella-Estrada, Rafael; Berrocal, Alfonso; Ponten, Fredrik; van den Oord, Joost; Gallagher, William M.; Frederick, Dennie T.; Flaherty, Keith T.; McDermott, Ultan; Lorigan, Paul; Marais, Richard; Esteller, Manel			Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR	NATURE MEDICINE			English	Article							CANCER; RECEPTOR; INHIBITION; RESISTANCE; PROTEIN	Metastasis is responsible for most cancer-related deaths, and, among common tumor types, melanoma is one with great potential to metastasize. Here we study the contribution of epigenetic changes to the dissemination process by analyzing the changes that occur at the DNA methylation level between primary cancer cells and metastases. We found a hypomethylation event that reactivates a cryptic transcript of the Rab GTPase activating protein TBC1D16 (TBC1D16-47 kDa; referred to hereafter as TBC1D16-47KD) to be a characteristic feature of the metastatic cascade. This short isoform of TBC1D16 exacerbates melanoma growth and metastasis both in vitro and in vivo. By combining immunoprecipitation and mass spectrometry, we identified RAB5C as a new TBC1D16 target and showed that it regulates EGFR in melanoma cells. We also found that epigenetic reactivation of TBC1D16-47KD is associated with poor clinical outcome in melanoma, while conferring greater sensitivity to BRAF and MEK inhibitors.	[Vizoso, Miguel; Ferreira, Humberto J.; Lopez-Serra, Paula; Javier Carmona, F.; Martinez-Cardus, Anna; Guil, Sonia; Moutinho, Catia; Liz, Julia; Portela, Anna; Heyn, Holger; Moran, Sebastian] Bellvitge Biomed Res Inst, Canc Epigenet & Biol Program, Barcelona, Catalonia, Spain; [Girotti, Maria Romina; Marais, Richard] Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester, Lancs, England; [Villanueva, Alberto; Martinez-Iniesta, Maria] Bellvitge Biomed Res Inst, Catalan Inst Oncol, Translat Res Lab, Barcelona, Catalonia, Spain; [Vidal, August] Bellvitge Univ Hosp, Bellvitge Biomed Res Inst, Dept Pathol Anat, Barcelona, Catalonia, Spain; [Manzano, Jose L.] Germans Trias & Pujol Univ Hosp, Catalan Inst Oncol, Med Oncol Serv, Badalona, Catalonia, Spain; [Teresa Fernandez-Figueras, Maria] Germans Trias & Pujol Univ Hosp, Dept Pathol, Badalona, Catalonia, Spain; [Elez, Elena; Munoz-Couselo, Eva] Vall dHebron Univ Hosp, Med Oncol Serv, Barcelona, Catalonia, Spain; [Botella-Estrada, Rafael] Univ Valencia, Dermatol Serv, Hosp La Fe, Valencia, Spain; [Berrocal, Alfonso] Gen Hosp, Med Oncol Serv, Valencia, Spain; [Ponten, Fredrik] Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden; [van den Oord, Joost] Katholieke Univ Leuven, Translat Cell & Tissue Pathol, Leuven, Belgium; [Gallagher, William M.] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Frederick, Dennie T.; Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Ctr Melanoma, Boston, MA USA; [McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Lorigan, Paul] Univ Manchester, Christie Natl Hlth Serv Fdn Trust, Manchester, Lancs, England; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain; [Esteller, Manel] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Cancer Research UK; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Hospital Universitari Vall d'Hebron; Hospital Universitari i Politecnic La Fe; University of Valencia; Uppsala University; Uppsala University Hospital; KU Leuven; University College Dublin; Harvard University; Massachusetts General Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Christie NHS Foundation Trust; University of Manchester; University of Barcelona; ICREA	Esteller, M (corresponding author), Bellvitge Biomed Res Inst, Canc Epigenet & Biol Program, Barcelona, Catalonia, Spain.	mesteller@idibell.cat	Lorigan, Paul/J-6898-2015; Martinez, Anna/AAA-4939-2020; Élez, Elena/AAH-2945-2019; Moran, Sebastian/G-5293-2013; Lopez-Serra, Paula/M-6835-2015; Guil, Sonia/M-8036-2015; Esteller, Manel/L-5956-2014; Vidal, August/N-4662-2016	Lorigan, Paul/0000-0002-8875-2164; Moran, Sebastian/0000-0003-4192-8983; Lopez-Serra, Paula/0000-0001-7231-3426; Guil, Sonia/0000-0002-2257-3331; Esteller, Manel/0000-0003-4490-6093; Vidal, August/0000-0001-5727-2099; Heyn, Holger/0000-0002-3276-1889; Martinez Cardus, Anna/0000-0002-3937-8794; Portela, Anna/0000-0003-2184-2584; McDermott, Ultan/0000-0001-9032-4700; Martinez-Iniesta, Maria/0000-0001-6252-6671; Gallagher, William/0000-0002-4307-5999; Ferreira, Humberto/0000-0003-0834-2956; Elez, Elena/0000-0002-4653-6324; Vizoso, Miguel/0000-0002-9992-2851	European Community's Seventh Framework Programme FP7 [PIAPP-GA-2009-230614]; Worldwide Cancer Research grant [15-0354]; European Research Council [268626-EPINORC]; Ministerio de Ciencia e Innovacion [SAF2011-22803, FIS PI13-01339]; CRUK Manchester Institute [C5759/A12328]; Wellcome Trust [100282/Z/12/Z]; Cellex Foundation; Health Department of the Catalan Government Generalitat de Catalunya [2005-SGR00727, 2014-SGR 633]; Science Department of the Catalan Government Generalitat de Catalunya [2005-SGR00727, 2014-SGR 633]; Formacion de Profesorado Universitario fellowship from the Spanish Ministry of Education; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [P01CA163222] Funding Source: NIH RePORTER; Cancer Research UK [19279, 17240] Funding Source: researchfish; Worldwide Cancer Research [15-0354] Funding Source: researchfish	European Community's Seventh Framework Programme FP7(European Commission); Worldwide Cancer Research grant; European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CRUK Manchester Institute; Wellcome Trust(Wellcome Trust); Cellex Foundation(Foundation CELLEX); Health Department of the Catalan Government Generalitat de Catalunya(Generalitat de Catalunya); Science Department of the Catalan Government Generalitat de Catalunya; Formacion de Profesorado Universitario fellowship from the Spanish Ministry of Education(German Research Foundation (DFG)); ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We thank the patients and their families. The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. PIAPP-GA-2009-230614-Target-Melanoma project (F.P., J.O., W.M.G., M.E.), the Worldwide Cancer Research grant reference no. 15-0354 (M.E.), the European Research Council Advanced grant no. 268626-EPINORC project (M.E.), the Ministerio de Ciencia e Innovacion grant numbers SAF2011-22803 (M.E.) and FIS PI13-01339 (A. Villanueva), the CRUK Manchester Institute (C5759/A12328 to R.M.), the Wellcome Trust (100282/Z/12/Z to R.M.), the Cellex Foundation (M.E.) and the Health and Science Departments of the Catalan Government Generalitat de Catalunya 2005-SGR00727 (A. Villanueva) and 2014-SGR 633 (M.E.). M.V. was supported by a Formacion de Profesorado Universitario fellowship from the Spanish Ministry of Education. We thank the staff of the Animal Core Facility of Bellvitge Biomedical Research Institute for mouse care and maintenance. M.E. is an Institucio Catalana de Recerca i Estudis Avancats Research Professor.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Carmona FJ, 2014, CANCER RES, V74, P5608, DOI 10.1158/0008-5472.CAN-13-3659; Catalanotti F, 2013, CLIN CANCER RES, V19, P2257, DOI 10.1158/1078-0432.CCR-12-3476; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cunha S, 2014, CELL REP, V6, P141, DOI 10.1016/j.celrep.2013.12.010; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Goueli BS, 2012, P NATL ACAD SCI USA, V109, P15787, DOI 10.1073/pnas.1204540109; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harbst K, 2010, MELANOMA RES, V20, P381, DOI 10.1097/CMR.0b013e32833b7c7c; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; HOWARDJONES N, 1985, WHO CHRON, V39, P51; Huang ZM, 2012, P NATL ACAD SCI USA, V109, P553, DOI 10.1073/pnas.1118366109; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaufman HL, 2014, LANCET ONCOL, V15, P251, DOI 10.1016/S1470-2045(14)70059-2; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kedlaya R, 2011, ARCH BIOCHEM BIOPHYS, V508, P227, DOI 10.1016/j.abb.2011.01.021; Lopez-Serra P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4608; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Mandala M, 2014, VIRCHOWS ARCH, V464, P265, DOI 10.1007/s00428-013-1526-x; Marzese DM, 2014, HUM MOL GENET, V23, P226, DOI 10.1093/hmg/ddt420; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Moutinho C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt322; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Villanueva M Teresa, 2012, Nat Rev Clin Oncol, V9, P370, DOI 10.1038/nrclinonc.2012.90; WEINREB A, 1984, EUR J CANCER CLIN ON, V20, P673, DOI 10.1016/0277-5379(84)90015-4; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300	43	76	80	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					741	+		10.1038/nm.3863	http://dx.doi.org/10.1038/nm.3863			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26030178	Green Accepted			2022-12-25	WOS:000357604600015
J	Cybulski, C; Carrot-Zhang, F; Kluzniak, W; Rivera, B; Kashyap, A; Wokolorczyk, D; Giroux, S; Nadaf, J; Hamel, N; Zhang, SY; Huzarski, T; Gronwald, J; Byrski, T; Szwiec, M; Jakubowska, A; Rudnicka, H; Lener, M; Masojc, B; Tonin, PN; Rousseau, F; Gorski, B; Debniak, T; Majewski, J; Lubinski, J; Foulkes, WD; Narod, SA; Akbari, MR				Cybulski, Cezary; Carrot-Zhang, Flan; Kluzniak, Wojciech; Rivera, Barbara; Kashyap, Aniruddh; Wokolorczyk, Dominika; Giroux, Sylvie; Nadaf, Javad; Hamel, Nancy; Zhang, Shiyu; Huzarski, Tomasz; Gronwald, Jacek; Byrski, Tomasz; Szwiec, Marek; Jakubowska, Anna; Rudnicka, Helena; Lener, Marcin; Masojc, Bartiomiej; Tonin, Patrica N.; Rousseau, Francois; Gorski, Bohdan; Debniak, Tadeusz; Majewski, Jacek; Lubinski, Jan; Foulkes, William D.; Narod, Steven A.; Akbari, Mohammad R.			Germline RECQL mutations are associated with breast cancer susceptibility	NATURE GENETICS			English	Article							GENE; HELICASE; PROTEIN; CLONING; BRCA1; IDENTIFICATION; PALB2	Several moderate- and high-risk breast cancer susceptibility genes have been discovered, but more are likely to exist. To discover new breast cancer susceptibility genes, we used 2 populations (from Poland and Quebec, Canada) and applied whole-exome sequencing in a discovery phase (n = 195), followed by validation. We identified rare recurrent RECQL mutations in each population. In Quebec, 7 of 1,013 higher-risk breast cancer cases and 1 of 7,136 newborns carried the c.634C>T (p.Arg215*) variant (P = 0.00004). In Poland, 30 of 13,136 unselected breast cancer cases and 2 of 4,702 controls carried the c.1667_1667+3delAGTA (p.K555delinsMYKLIHYSFR) variant (P = 0.008). RECQL is implicated in resolving stalled DNA replication forks to prevent double-stranded DNA (dsDNA) breaks. This function is related to that of other known breast cancer susceptibility genes, many of which are involved in repairing dsDNA breaks. We conclude that RECQL is a breast cancer susceptibility gene.	[Cybulski, Cezary; Kluzniak, Wojciech; Kashyap, Aniruddh; Wokolorczyk, Dominika; Huzarski, Tomasz; Gronwald, Jacek; Byrski, Tomasz; Jakubowska, Anna; Rudnicka, Helena; Lener, Marcin; Masojc, Bartiomiej; Gorski, Bohdan; Debniak, Tadeusz; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Carrot-Zhang, Flan; Rivera, Barbara; Nadaf, Javad; Hamel, Nancy; Tonin, Patrica N.; Majewski, Jacek; Foulkes, William D.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Carrot-Zhang, Flan; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Carrot-Zhang, Flan; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Rivera, Barbara; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Dept Med Genet, Montreal, PQ H3T 1E2, Canada; [Giroux, Sylvie; Rousseau, Francois] Ctr Hosp Univ Quebec, Ctr Rech, Unite Rech Genet Humaine & Mol, Axe Sante Populat & Prat Optim Sante, Quebec City, PQ, Canada; [Hamel, Nancy; Tonin, Patrica N.; Foulkes, William D.] McGill Univ, Dept Med Genet, Montreal, PQ, Canada; [Hamel, Nancy; Tonin, Patrica N.; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Zhang, Shiyu; Narod, Steven A.; Akbari, Mohammad R.] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Szwiec, Marek] Adeusz Koszarowski Reg Oncol Ctr, Opole, Poland; [Rousseau, Francois] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada; [Foulkes, William D.] McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Narod, Steven A.; Akbari, Mohammad R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Pomeranian Medical University; McGill University; McGill University; Lady Davis Institute; McGill University; Laval University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Laval University; McGill University; University of Toronto	Akbari, MR (corresponding author), Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	mohammad.akban@utoronto.ca	Hamel, Nancy/L-5122-2016; Gronwald, Jacek/A-4576-2017; Narod, Steven A/AAA-6112-2022; Pinheiro, Maísa/E-7424-2012; Jakubowska, Anna/O-8050-2014; BYRSKI, Tomasz/I-2844-2014; Rivera, Barbara/AFM-6892-2022; Carrot-Zhang, Jian/K-8618-2019; Huzarski, Tomasz/AAQ-2161-2021; Kashyap, Aniruddh/AAE-5053-2022; Rivera, Barbara/AAI-8047-2020; Szwiec, Marek/ABD-8838-2021; Foulkes, William D./AAR-9586-2021	Hamel, Nancy/0000-0001-8971-0428; Gronwald, Jacek/0000-0002-3643-2871; Jakubowska, Anna/0000-0002-5650-0501; BYRSKI, Tomasz/0000-0001-9181-5026; Rivera, Barbara/0000-0001-9434-6288; Huzarski, Tomasz/0000-0003-3857-4854; Rivera, Barbara/0000-0001-9434-6288; Foulkes, William D./0000-0001-7427-4651; Kashyap, Aniruddh/0000-0001-7374-7912; Lubinski, Jan/0000-0003-2931-3003	Polish National Science Centre [DEC-2011/03/N/NZ2/01510]; Women's College Research Institute's internal fund; Susan G. Komen; Cancer Research Society/Quebec Breast Cancer Foundation; Fundacion Alfonso Martin Escudero; Cedars Cancer Institute; Canadian Institutes of Health Research (CIHR); Cancer Research Society; Quebec Breast Cancer Foundation; Fonds de Recherche du Quebec-Sante; Canadian Cancer Society Research Institute; Canadian Breast Cancer Foundation	Polish National Science Centre; Women's College Research Institute's internal fund; Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Cancer Research Society/Quebec Breast Cancer Foundation; Fundacion Alfonso Martin Escudero; Cedars Cancer Institute; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Quebec Breast Cancer Foundation; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This paper is dedicated to the memory of Parviz Ghadirian. The whole-exome sequencing and part of the Sanger sequencing for these projects were carried out by the McGill University and Genome Quebec Innovation Centre. The study was funded in part by the Polish National Science Centre on the basis of decision number DEC-2011/03/N/NZ2/01510 and by the Women's College Research Institute's internal fund. W.D.F. was funded by Susan G. Komen and the Cancer Research Society/Quebec Breast Cancer Foundation. B.R. was funded by Fundacion Alfonso Martin Escudero and a fellowship from the Cedars Cancer Institute. J.C.-Z. was funded by the Canadian Institutes of Health Research (CIHR). P.N.T. was funded by the Cancer Research Society, the Quebec Breast Cancer Foundation and the Fonds de Recherche du Quebec-Sante. M.R.A. is funded by the Canadian Cancer Society Research Institute and the Canadian Breast Cancer Foundation.	Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Cybulski C, 2015, CLIN GENET, V88, P366, DOI 10.1111/cge.12524; Cybulski C, 2007, BREAST CANCER RES TR, V102, P119, DOI 10.1007/s10549-006-9320-y; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Futami K, 2008, CANCER SCI, V99, P71, DOI 10.1111/j.1349-7006.2007.00647.x; Gorski B, 2000, AM J HUM GENET, V66, P1963, DOI 10.1086/302922; Grepmeier U, 2005, INT J ONCOL, V27, P481; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Parvathaneni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062481; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Popuri V, 2014, NUCLEIC ACIDS RES, V42, P5671, DOI 10.1093/nar/gku200; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Steffen J, 2006, INT J CANCER, V119, P472, DOI 10.1002/ijc.21853; Tonin PN, 1998, AM J HUM GENET, V63, P1341, DOI 10.1086/302099; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	29	131	137	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					643	646		10.1038/ng.3284	http://dx.doi.org/10.1038/ng.3284			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915596				2022-12-25	WOS:000355386500016
J	Rock, JM; Lang, UF; Chase, MR; Ford, CB; Gerrick, ER; Gawande, R; Coscolla, M; Gagneux, S; Fortune, SM; Lamers, MH				Rock, Jeremy M.; Lang, Ulla F.; Chase, Michael R.; Ford, Christopher B.; Gerrick, Elias R.; Gawande, Richa; Coscolla, Mireia; Gagneux, Sebastien; Fortune, Sarah M.; Lamers, Meindert H.			DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader	NATURE GENETICS			English	Article							POLYMERASE-III; ESCHERICHIA-COLI; IDENTIFICATION; EVOLUTION; REPAIR; MOTIF	The DNA replication machinery is an important target for antibiotic development in increasingly drug-resistant bacteria, including Mycobacterium tuberculosis(1). Although blocking DNA replication leads to cell death, disrupting the processes used to ensure replication fidelity can accelerate mutation and the evolution of drug resistance. In Escherichia coli, the proofreading subunit of the replisome, the epsilon exonuclease, is essential for high-fidelity DNA replication(2); however, we find that the corresponding subunit is completely dispensable in M. tuberculosis. Rather, the mycobacterial replicative polymerase DnaE1 itself encodes an editing function that proofreads DNA replication, mediated by an intrinsic 3'-5' exonuclease activity within its PHP domain. Inactivation of the DnaE1 PHP domain increases the mutation rate by more than 3,000-fold. Moreover, phylogenetic analysis of DNA replication proofreading in the bacterial kingdom suggests that Escherichia coli is a phylogenetic outlier and that PHP domain-mediated proofreading is widely conserved and indeed may be the ancestral prokaryotic proofreader.	[Rock, Jeremy M.; Chase, Michael R.; Ford, Christopher B.; Gerrick, Elias R.; Gawande, Richa; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lang, Ulla F.; Lamers, Meindert H.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Ford, Christopher B.; Fortune, Sarah M.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Coscolla, Mireia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Coscolla, Mireia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Fortune, Sarah M.] Massachusetts Gen Hosp, Harvard & Massachusetts Inst Technol, Ragon Inst Massachusetts, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; MRC Laboratory Molecular Biology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Ragon Institute	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu; mlamers@mrc-lmb.cam.ac.uk	Coscolla, Mireia/ABD-7942-2021; Gagneux, Sebastien/ABE-7909-2020; Lamers, Meindert/AGG-8911-2022	Lamers, Meindert/0000-0002-4205-1338; Rock, Jeremy/0000-0002-9310-951X; Fortune, Sarah/0000-0001-7565-9975; Gagneux, Sebastien/0000-0001-7783-9048; Coscolla, Mireia/0000-0003-0752-0538; , Richa/0000-0002-1831-0977	Helen Hay Whitney fellowship; US National Institutes of Health Director's New Innovator Award [1DP20D001378]; National Institute of Allergy and Infectious Diseases (NIAID) [U19AI076217, AI109755-01]; Doris Duke Charitable Foundation [2010054]; UK Medical Research Council grant [MC_U105197143]; Medical Research Council [MC_U105197143] Funding Source: researchfish; MRC [MC_U105197143] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076217, U19AI109755] Funding Source: NIH RePORTER	Helen Hay Whitney fellowship; US National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); UK Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Rubin, B. Bloom, D. Boyd, J. McKenzie, D. Warner and B. Javid for comments, B. Jacobs (Albert Einstein College of Medicine) and M. Wilmans (European Molecular Biology Laboratory) for bacterial strains, and T. Baker (University of Auckland) for plasmids. This work was supported by a Helen Hay Whitney fellowship to J.M.R., US National Institutes of Health Director's New Innovator Award 1DP20D001378, subcontracts from National Institute of Allergy and Infectious Diseases (NIAID) U19AI076217 and AI109755-01, the Doris Duke Charitable Foundation under grant 2010054 to S.M.F. and a UK Medical Research Council grant to M.H.L. (MC_U105197143).	Barros T, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-8; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Long MC, 2008, BIOCHEM PHARMACOL, V75, P1588, DOI 10.1016/j.bcp.2008.01.007; Malshetty VS, 2010, MICROBIOL-SGM, V156, P940, DOI 10.1099/mic.0.034363-0; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Robinson A, 2012, CURR DRUG TARGETS, V13, P352, DOI 10.2174/138945012799424598; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Timinskas K, 2014, NUCLEIC ACIDS RES, V42, P1393, DOI 10.1093/nar/gkt900; Wing RA, 2008, J MOL BIOL, V382, P859, DOI 10.1016/j.jmb.2008.07.058	21	44	44	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					677	681		10.1038/ng.3269	http://dx.doi.org/10.1038/ng.3269			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25894501	Green Submitted, Green Accepted			2022-12-25	WOS:000355386500022
J	Helgason, A; Einarsson, AW; Gudmundsdottir, VB; Sigurdsson, A; Gunnarsdottir, ED; Jagadeesan, A; Ebenesersdottir, SS; Kong, A; Stefansson, K				Helgason, Agnar; Einarsson, Axel W.; Gudmundsdottir, Valdis B.; Sigurdsson, Asgeir; Gunnarsdottir, Ellen D.; Jagadeesan, Anuradha; Ebenesersdottir, S. Sunna; Kong, Augustine; Stefansson, Kari			The Y-chromosome point mutation rate in humans	NATURE GENETICS			English	Article							GENE CONVERSION; PHYLOGENETIC TREE; MITOCHONDRIAL-DNA; COMMON ANCESTOR; HUMAN-EVOLUTION; ROOT; AFRICA; ORIGIN; TIME	Mutations are the fundamental source of biological variation, and their rate is a crucial parameter for evolutionary and medical studies. Here we used whole-genome sequence data from 753 Icelandic males, grouped into 274 patrilines, to estimate the point mutation rate for 21.3 Mb of male-specific Y chromosome (MSY) sequence, on the basis of 1,365 meioses (47,123 years). The combined mutation rate for 15.2 Mb of X-degenerate (XDG), X-transposed (XTR) and ampliconic excluding palindromes (rAMP) sequence was 8.71 x 10(-10) mutations per position per year (PPPY). We observed a lower rate (P = 0.04) of 7.37 x 10(-10) PPPY for 6.1 Mb of sequence from palindromes (PAL), which was not statistically different from the rate of 7.2 x 10(-10) PPPY for paternally transmitted autosomes1. We postulate that the difference between PAL and the other MSY regions may provide an indication of the rate at which nascent autosomal and PAL de novo mutations are repaired as a result of gene conversion.	[Helgason, Agnar; Einarsson, Axel W.; Gudmundsdottir, Valdis B.; Sigurdsson, Asgeir; Gunnarsdottir, Ellen D.; Jagadeesan, Anuradha; Ebenesersdottir, S. Sunna; Kong, Augustine; Stefansson, Kari] Amgen Inc, DeCODE Genet, Reykjavik, Iceland; [Helgason, Agnar; Einarsson, Axel W.; Jagadeesan, Anuradha; Ebenesersdottir, S. Sunna] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Iceland; University of Iceland	Helgason, A (corresponding author), Amgen Inc, DeCODE Genet, Reykjavik, Iceland.	agnar@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Kong, Augustine/0000-0001-8193-5438; Einarsson, Axel Wilhelm/0000-0001-7468-4247; Jagadeesan, Anuradha/0000-0002-7579-9713; Helgason, Agnar/0000-0002-8545-3767	Rannis, Icelandic Student Research Fund [1103340061]; EUROTAST Marie Curie Framework Programme 7 Initial Training Network [290344]	Rannis, Icelandic Student Research Fund; EUROTAST Marie Curie Framework Programme 7 Initial Training Network	We thank E. Haraldsdottir for help with processing some of the whole-genome sequencing data and K.S.H. Moore for help with calling SNP microarray genotypes. A.W.E. was funded by a grant from Rannis, Icelandic Student Research Fund (1103340061). A.J. was funded by the EUROTAST Marie Curie Framework Programme 7 Initial Training Network (290344).	Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Elhaik E, 2014, EUR J HUM GENET, V22, P1111, DOI 10.1038/ejhg.2013.303; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Gudbjartsson DF, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.11; Hallast P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003666; Harris R.S., 2007, THESIS PENN STATE U; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Martin ER, 2010, BIOINFORMATICS, V26, P2803, DOI 10.1093/bioinformatics/btq526; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosser ZH, 2009, AM J HUM GENET, V85, P130, DOI 10.1016/j.ajhg.2009.06.009; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Scozzari R, 2014, GENOME RES, V24, P535, DOI 10.1101/gr.160788.113; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Trombetta B, 2014, MOL BIOL EVOL, V31, P2108, DOI 10.1093/molbev/msu155; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Walsh B, 2001, GENETICS, V158, P897; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	31	57	59	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					453	U38		10.1038/ng.3171	http://dx.doi.org/10.1038/ng.3171			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25807285				2022-12-25	WOS:000353635800007
J	Li, FG; Fan, GY; Lu, CR; Xiao, GH; Zou, CS; Kohel, RJ; Ma, ZY; Shang, HH; Ma, XF; Wu, JY; Liang, XM; Huang, G; Percy, RG; Liu, K; Yang, WH; Chen, WB; Du, XM; Shi, CC; Yuan, YL; Ye, WW; Liu, X; Zhang, XY; Liu, WQ; Wei, HL; Wei, SJ; Huang, GD; Zhang, XL; Zhu, SJ; Zhang, H; Sun, FM; Wang, XF; Liang, J; Wang, JH; He, Q; Huang, LH; Wang, J; Cui, JJ; Song, GL; Wang, KB; Xu, X; Yu, JZ; Zhu, YX; Yu, SX				Li, Fuguang; Fan, Guangyi; Lu, Cairui; Xiao, Guanghui; Zou, Changsong; Kohel, Russell J.; Ma, Zhiying; Shang, Haihong; Ma, Xiongfeng; Wu, Jianyong; Liang, Xinming; Huang, Gai; Percy, Richard G.; Liu, Kun; Yang, Weihua; Chen, Wenbin; Du, Xiongming; Shi, Chengcheng; Yuan, Youlu; Ye, Wuwei; Liu, Xin; Zhang, Xueyan; Liu, Weiqing; Wei, Hengling; Wei, Shoujun; Huang, Guodong; Zhang, Xianlong; Zhu, Shuijin; Zhang, He; Sun, Fengming; Wang, Xingfen; Liang, Jie; Wang, Jiahao; He, Qiang; Huang, Leihuan; Wang, Jun; Cui, Jinjie; Song, Guoli; Wang, Kunbo; Xu, Xun; Yu, John Z.; Zhu, Yuxian; Yu, Shuxun			Genome sequence of cultivated Upland cotton (Gossypium hirsutum TM-1) provides insights into genome evolution	NATURE BIOTECHNOLOGY			English	Article							TRANSPOSABLE ELEMENTS; FIBER; PREDICTION; ETHYLENE; SUGGESTS; PROGRAM; FINDER; MAP	Gossypium hirsutum has proven difficult to sequence owing to its complex allotetraploid (A(t)D(t)) genome. Here we produce a draft genome using 181-fold paired-end sequences assisted by fivefold BAC-to-BAC sequences and a high-resolution genetic map. In our assembly 88.5% of the 2,173-Mb scaffolds, which cover 89.6%similar to 96.7% of the A(t)D(t) genome, are anchored and oriented to 26 pseudochromosomes. Comparison of this Gossypium hirsutum A(t)D(t) genome with the already sequenced diploid Gossypium arboreum (AA) and Gossypium raimondii (DD) genomes revealed conserved gene order. Repeated sequences account for 67.2% of the AtDt genome, and transposable elements (TEs) originating from D-t seem more active than from A(t). Reduction in the A(t)D(t) genome size occurred after allopolyploidization. The A or A(t) genome may have undergone positive selection for fiber traits. Concerted evolution of different regulatory mechanisms for Cellulose synthase (CesA) and 1-Aminocyclopropane-1-carboxylic acid oxidase1 and 3 (ACO1,3) may be important for enhanced fiber production in Gossypium hirsutum.	[Li, Fuguang; Lu, Cairui; Zou, Changsong; Shang, Haihong; Ma, Xiongfeng; Wu, Jianyong; Liu, Kun; Yang, Weihua; Du, Xiongming; Yuan, Youlu; Ye, Wuwei; Zhang, Xueyan; Wei, Hengling; Wei, Shoujun; Cui, Jinjie; Song, Guoli; Wang, Kunbo; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Fan, Guangyi; Liang, Xinming; Chen, Wenbin; Shi, Chengcheng; Liu, Xin; Liu, Weiqing; Huang, Guodong; Zhang, He; Sun, Fengming; Liang, Jie; Wang, Jiahao; He, Qiang; Huang, Leihuan; Wang, Jun; Xu, Xun] BGI Shenzhen, Shenzhen, Peoples R China; [Xiao, Guanghui; Huang, Gai; Zhu, Yuxian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Xiao, Guanghui; Huang, Gai; Zhu, Yuxian] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Peoples R China; [Xiao, Guanghui; Huang, Gai; Zhu, Yuxian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Kohel, Russell J.; Percy, Richard G.] USDA ARS, Crop Germplasm Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA; [Ma, Zhiying; Wang, Xingfen] Agr Univ Hebei, Key Lab Crop Germplasm Resources Hebei, Baoding, Peoples R China; [Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhu, Shuijin] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Beijing Genomics Institute (BGI); Peking University; Wuhan University; Wuhan University; United States Department of Agriculture (USDA); Hebei Agricultural University; Huazhong Agricultural University; Zhejiang University	Zhu, YX (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	John.Yu@ars.usda.gov; zhuyx@whu.edu.cn; Yu@cricaas.com.cn	Du, Xiongming/AAI-9999-2020; Xu, Xun/AAI-6763-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Xu, Xun/0000-0002-5338-5173; Huang, Gai/0000-0003-0426-9691; zou, changsong/0000-0001-6805-3545; Zhang, He/0000-0001-9294-1403; Zhu, Yuxian/0000-0003-2371-5933; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Wu, Jianyong/0000-0003-1392-4790; yu, shuxun/0000-0002-9715-3462; Liu, Xin/0000-0003-3256-2940; SHI, Chengcheng/0000-0003-2154-5491	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China [U1303282]; National Natural Science Foundation of China [90717009]; 863 National High-Tech Research Development Program in China [2013AA102601]; United States Department of Agriculture, Agricultural Research Service (USDA-ARS project) [3091-21000-038-01]	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 National High-Tech Research Development Program in China(National High Technology Research and Development Program of China); United States Department of Agriculture, Agricultural Research Service (USDA-ARS project)	We are grateful to Q. Li for his assistance with data analysis and with the early phase of manuscript preparation. This work was supported by the Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China (grant U1303282), the National Natural Science Foundation of China (grant 90717009) and the 863 National High-Tech Research Development Program in China (grant 2013AA102601), and United States Department of Agriculture, Agricultural Research Service (USDA-ARS project 3091-21000-038-01).	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bennetzen JL, 2014, ANNU REV PLANT BIOL, V65, P505, DOI 10.1146/annurev-arplant-050213-035811; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KOHEL R. J., 1970, J. Crop Science, V10, P670, DOI 10.2135/cropsci1970.0011183X001000060019x; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Oliver KR, 2013, GENOME BIOL EVOL, V5, P1886, DOI 10.1093/gbe/evt141; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Small RL, 2002, MOL BIOL EVOL, V19, P597, DOI 10.1093/oxfordjournals.molbev.a004119; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Wright RJ, 1998, GENETICS, V149, P1987; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Zhang H, 2008, LECT NOTES ENG COMP, P1, DOI 10.1155/2008/742304; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	59	681	795	11	295	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					524	U242		10.1038/nbt.3208	http://dx.doi.org/10.1038/nbt.3208			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25893780	hybrid			2022-12-25	WOS:000354314500034
J	Onengut-Gumuscu, S; Chen, WM; Burren, O; Cooper, NJ; Quinlan, AR; Mychaleckyj, JC; Farber, E; Bonnie, JK; Szpak, M; Schofield, E; Achuthan, P; Guo, H; Fortune, MD; Stevens, H; Walker, NM; Ward, LD; Kundaje, A; Kellis, M; Daly, MJ; Barrett, JC; Cooper, JD; Deloukas, P; Todd, JA; Wallace, C; Concannon, P; Rich, SS				Onengut-Gumuscu, Suna; Chen, Wei-Min; Burren, Oliver; Cooper, Nick J.; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Farber, Emily; Bonnie, Jessica K.; Szpak, Michal; Schofield, Ellen; Achuthan, Premanand; Guo, Hui; Fortune, Mary D.; Stevens, Helen; Walker, Neil M.; Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis; Daly, Mark J.; Barrett, Jeffrey C.; Cooper, Jason D.; Deloukas, Panos; Todd, John A.; Wallace, Chris; Concannon, Patrick; Rich, Stephen S.		Type 1 Diabet Genetics Consortium	Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; EXPRESSION; RISK; RESOURCE; LINKAGE	Genetic studies of type 1 diabetes (T1D) have identified 50 susceptibility regions(1,2), finding major pathways contributing to risk(3), with some loci shared across immune disorders(4-6). To make genetic comparisons across autoimmune disorders as informative as possible, a dense genotyping array, the Immunochip, was developed, from which we identified four new T1D-associated regions (P < 5 x 10(-8)). A comparative analysis with 15 immune diseases showed that T1D is more similar genetically to other autoantibody-positive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least similar to ulcerative colitis, and provided support for three additional new T1D risk loci. Using a Bayesian approach, we defined credible sets for the T1D-associated SNPs. The associated SNPs localized to enhancer sequences active in thymus, T and B cells, and CD34(+) stem cells. Enhancer-promoter interactions can now be analyzed in these cell types to identify which particular genes and regulatory sequences are causal.	[Onengut-Gumuscu, Suna; Chen, Wei-Min; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Farber, Emily; Bonnie, Jessica K.; Szpak, Michal; Concannon, Patrick; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Onengut-Gumuscu, Suna] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA USA; [Chen, Wei-Min; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Burren, Oliver; Cooper, Nick J.; Schofield, Ellen; Achuthan, Premanand; Guo, Hui; Fortune, Mary D.; Stevens, Helen; Walker, Neil M.; Cooper, Jason D.; Todd, John A.; Wallace, Chris] Univ Cambridge, Natl Inst Hlth Res,Dept Med Genet, Biomed Res Ctr,Wellcome Trust Diabet & Inflammat, Cambridge Inst Med Res,Juvenile Diabet Res Fdn, Cambridge, England; [Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Kundaje, Anshul] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kundaje, Anshul; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Barrett, Jeffrey C.; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Wallace, Chris] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Virginia; University of Virginia; University of Virginia; University of Cambridge; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute; MRC Biostatistics Unit; University of Cambridge	Rich, SS (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	ssr4n@virginia.edu	Todd, John A/A-3542-2010; Kundaje, Anshul/Y-2739-2019; Ludvigsson, Johnny/AAI-2051-2020; Deloukas, Panos/B-2922-2013; Paterson, Andrew D/A-4088-2011; Kellis, Manolis/ABE-7385-2020; Briggs, Farren/Q-2164-2019; de Bakker, Paul IW/B-8730-2009; Kundaje, Anshul/Y-2598-2019; Vázquez, Federico/AAF-9825-2021; Cameron, Fergus J/N-9535-2015; Paterson, Andrew/AAQ-7511-2020; Tillmann, Vallo/G-8118-2012; Daly, Mark J/B-2453-2017; Boehm, Bernhard Otto/F-8750-2015; Roep, Bart/AAD-7609-2021; Skrha, Jan/C-3095-2017; Argente, Jesus/L-2928-2013; Kretowski, Adam/U-6299-2018; Doria, Alessandro/H-9157-2018; Urbanavicius, Vaidotas/D-4907-2016	Todd, John A/0000-0003-2740-8148; Kundaje, Anshul/0000-0003-3084-2287; Ludvigsson, Johnny/0000-0003-1695-5234; Deloukas, Panos/0000-0001-9251-070X; Paterson, Andrew D/0000-0002-9169-118X; Kellis, Manolis/0000-0001-7113-9630; Briggs, Farren/0000-0003-0903-1359; de Bakker, Paul IW/0000-0001-7735-7858; Kundaje, Anshul/0000-0003-3084-2287; Vázquez, Federico/0000-0001-6493-2374; Paterson, Andrew/0000-0002-9169-118X; Tillmann, Vallo/0000-0002-5279-4493; Daly, Mark J/0000-0002-0949-8752; Skrha, Jan/0000-0001-8012-8802; Castano, Luis/0000-0003-0437-9401; Burren, Oliver/0000-0002-3388-5760; Pociot, Flemming/0000-0003-3274-5448; CUCCA, Francesco/0000-0002-7414-1995; Quinlan, Aaron/0000-0003-1756-0859; Concannon, Patrick/0000-0002-5801-1859; Ward, Lucas/0000-0002-8017-809X; Sumnik, Zdenek/0000-0002-6462-6462; McIndoe, Richard/0000-0002-3040-3631; Knip, Mikael/0000-0003-0474-0033; Argente, Jesus/0000-0001-5826-0276; Willi, Steven/0000-0002-4910-2425; Dunger, Professor David/0000-0002-2566-9304; Ampudia Blasco, Francisco Javier/0000-0003-0221-0901; Metzger, Daniel/0000-0002-1715-4319; Abdul Ghani, Rohana/0000-0002-3520-8472; Schofield, Ellen/0000-0003-0648-1418; Pirags, Valdis/0000-0002-3650-7394; vandiedonck, claire/0000-0002-6669-6923; Couper, Jennifer/0000-0003-4448-8629; Rich, Stephen/0000-0003-3872-7793; Van der Auwera, Bart/0000-0003-4133-2565; Guo, Hui/0000-0003-0282-6933; Colman, Peter/0000-0001-8718-6175; Wallace, Chris/0000-0001-9755-1703; Walker, Neil/0000-0001-9796-7688; Barrett, Jeffrey/0000-0002-1152-370X; McLaren, William/0000-0001-6218-1116; Kretowski, Adam/0000-0002-4522-4978; Li, Xiaoying/0000-0002-9383-5757; Achuthan, Premanand/0000-0002-1119-6892; Avbelj Stefanija, Magdalena/0000-0002-0836-5114; Wagner, Ana M/0000-0002-7663-9308; Doria, Alessandro/0000-0002-3830-4304; Hall, Mark A./0000-0001-6277-144X; Johannesen, Jesper/0000-0003-2772-2567; Urbanavicius, Vaidotas/0000-0002-8601-4563; Szpak, Michal/0000-0002-9096-852X; Plagnol, Vincent/0000-0002-5597-9215	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); US National Institutes of Health [U01 DK062418]; NIDDK [DK046635, DK085678]; joint JDRF; Wellcome Trust [WT061858/09115, 089989]; NIHR Cambridge Biomedical Research Centre; Eli Lilly and Company; Wellcome Trust Strategic Award [100140]; UK Medical Research Council; Wellcome Trust award [076113]; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046635, DP3DK085678, U01DK062418, R01DK096926] Funding Source: NIH RePORTER; Medical Research Council [G1001799, MR/N01104X/1, 1508956, MC_U105261167] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10274, NF-SI-0508-10275, NF-SI-0513-10143, NF-SI-0513-10012] Funding Source: researchfish; MRC [MC_U105261167, MR/N01104X/1, G1001799] Funding Source: UKRI	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); joint JDRF; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Eli Lilly and Company(Eli Lilly); Wellcome Trust Strategic Award(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust award(Wellcome Trust); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHD) and JDRF and supported by grant U01 DK062418 from the US National Institutes of Health. Further support was provided by grants from the NIDDK (DK046635 and DK085678) to P.C. and by a joint JDRF and Wellcome Trust grant (WT061858/09115) to the Diabetes and Inflammation Laboratory at Cambridge University, which also received support from the NIHR Cambridge Biomedical Research Centre. ImmunoBase receives support from Eli Lilly and Company. C.W. and H.G. are funded by the Wellcome Trust (089989). The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (100140).; We gratefully acknowledge the following groups and individuals who provided biological samples or data for this study. We obtained DNA samples from the British 1958 Birth Cohort collection, funded by the UK Medical Research Council and the Wellcome Trust. We acknowledge use of DNA samples from the NIHR Cambridge BioResource. We thank volunteers for their support and participation in the Cambridge BioResource and members of the Cambridge BioResource Scientific Advisory Board (SAB) and Management Committee for their support of our study. We acknowledge the NIHR Cambridge Biomedical Research Centre for funding. Access to Cambridge BioResource volunteers and to their data and samples are governed by the Cambridge BioResource SAB. Documents describing access arrangements and contact details are available at http://www.cambridgebioresource.org.uk/. We thank the Avon Longitudinal Study of Parents and Children laboratory in Bristol, UK, and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton, for preparing and providing the control DNA samples. This study makes use of data generated by the Wellcome Trust Case Control Consortium, funded by Wellcome Trust award 076113; a full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; [Anonymous], 2012, SNPSTATS SNPMATRIX X; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; Concannon P, 2009, DIABETES, V58, P1018, DOI 10.2337/db08-1551; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Genuth S, 2003, DIABETES CARE, V26, P3160; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hilner JE, 2010, CLIN TRIALS, V7, pS5, DOI 10.1177/1740774510373497; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wallace C., 2013, WGSEA WILCOXON BASED; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zaykin DV, 2010, GENET EPIDEMIOL, V34, P725, DOI 10.1002/gepi.20536; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	48	384	386	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					381	U199		10.1038/ng.3245	http://dx.doi.org/10.1038/ng.3245			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25751624	Green Accepted, Green Submitted			2022-12-25	WOS:000351922900014
J	Wachsmuth, M; Conrad, C; Bulkescher, J; Koch, B; Mahen, R; Isokane, M; Pepperkok, R; Ellenberg, J				Wachsmuth, Malte; Conrad, Christian; Bulkescher, Jutta; Koch, Birgit; Mahen, Robert; Isokane, Mayumi; Pepperkok, Rainer; Ellenberg, Jan			High-throughput fluorescence correlation spectroscopy enables analysis of proteome dynamics in living cells	NATURE BIOTECHNOLOGY			English	Article							CROSS-CORRELATION SPECTROSCOPY; CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; SYSTEMS BIOLOGY; PROTEINS; LOCALIZATION; MICROSCOPY; DIFFUSION; MOBILITY; MITOSIS	To understand the function of cellular protein networks, spatial and temporal context is essential. Fluorescence correlation spectroscopy (FCS) is a single-molecule method to study the abundance, mobility and interactions of fluorescence-labeled biomolecules in living cells. However, manual acquisition and analysis procedures have restricted live-cell FCS to short-term experiments of a few proteins. Here, we present high-throughput (HT)-FCS, which automates screening and time-lapse acquisition of FCS data at specific subcellular locations and subsequent data analysis(1,2). We demonstrate its utility by studying the dynamics of 53 nuclear proteins(3,4). We made 60,000 measurements in 10,000 living human cells, to obtain biophysical parameters that allowed us to classify proteins according to their chromatin binding and complex formation. We also analyzed the cell-cycle-dependent dynamics of the mitotic kinase complex Aurora B/INCENP5 and showed how a rise in Aurora concentration triggers two-step complex formation. We expect that throughput and robustness will make HT-FCS a broadly applicable technology for characterizing protein network dynamics in cells.	[Wachsmuth, Malte; Koch, Birgit; Mahen, Robert; Isokane, Mayumi; Pepperkok, Rainer; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Conrad, Christian; Bulkescher, Jutta; Pepperkok, Rainer] European Mol Biol Lab, Adv Light Microscopy Facil, Heidelberg, Germany; [Conrad, Christian] German Canc Res Ctr BioQuant, Theoret Bioinformat, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Ellenberg, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	rainer.pepperkok@embl.de; jan.ellenberg@embl.de	Ellenberg, Jan/I-4688-2014	Ellenberg, Jan/0000-0001-5909-701X; Mahen, Robert/0000-0002-4748-3690; Koch, Birgit/0000-0003-4683-3115	EMBL; MitoSys; European Commission [FP7/2007-2013-241548, FP7/2007-2013-258068]	EMBL; MitoSys; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank F. Sieckmann and W. Knebel of Leica Microsystems for providing microscope hardware and for implementing FCS functionality in the HCS-A module of the LASAF software. We also thank the mechanical and the electronics workshop of EMBL for custom hardware and the Advanced Light Microscopy Facility of EMBL for microscopy support. We gratefully acknowledge S. Trautmann and M. Knop for fruitful discussions, J.-K. Heriche for advice on data analysis, Y. Cai for critically reading the manuscript and B. Kramer of PicoQuant for help with FCS acquisition hardware and software. We thank K. Rippe and D. Boeke for comments on and testing of software and J. Braumann for technical help. We are grateful for support from EMBL and from the MitoSys and the Systems Microscopy projects funded by the European Commission (FP7/2007-2013-241548 and FP7/2007-2013-258068). HeLa Kyoto cells stably expressing the chromatin-targeted FRET biosensor were provided by D. Gerlich (IMBA, Vienna, Austria).	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Baum M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5494; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Conrad C, 2011, NAT METHODS, V8, P246, DOI 10.1038/NMETH.1558; Digman MA, 2011, ANNU REV PHYS CHEM, V62, P645, DOI 10.1146/annurev-physchem-032210-103424; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Guo SM, 2012, ANAL CHEM, V84, P3880, DOI 10.1021/ac2034375; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kaur G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2657; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Ma Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003721; Mahen R, 2014, MOL BIOL CELL, V25, P3610, DOI 10.1091/mbc.E14-06-1091; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Muller KP, 2009, BIOPHYS J, V97, P2876, DOI 10.1016/j.bpj.2009.08.057; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Regard JB, 2004, J NEUROSCI, V24, P4092, DOI 10.1523/JNEUROSCI.4252-03.2004; Ries J, 2010, OPT EXPRESS, V18, P11073, DOI 10.1364/OE.18.011073; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sankaran J, 2010, OPT EXPRESS, V18, P25468, DOI 10.1364/OE.18.025468; Schmidt U, 2009, RNA, V15, P862, DOI 10.1261/rna.1387009; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Schwille P, 2000, P NATL ACAD SCI USA, V97, P151, DOI 10.1073/pnas.97.1.151; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Simpson JC, 2001, HISTOCHEM CELL BIOL, V115, P23, DOI 10.1007/s004180000236; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; van der Waal MS, 2012, EMBO REP, V13, P847, DOI 10.1038/embor.2012.93; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; Weidemann T, 2013, METHOD ENZYMOL, V518, P43, DOI 10.1016/B978-0-12-388422-0.00003-0; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Wood C, 2011, PROC SPIE, V7905, DOI 10.1117/12.873947; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Xu ZJ, 2009, J CELL BIOL, V187, P637, DOI 10.1083/jcb.200906053; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	49	102	103	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					384	U91		10.1038/nbt.3146	http://dx.doi.org/10.1038/nbt.3146			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25774713				2022-12-25	WOS:000352348500024
J	Guimier, A; Gabriel, GC; Bajolle, F; Tsang, M; Liu, H; Noll, A; Schwartz, M; El Malti, R; Smith, LD; Klena, NT; Jimenez, G; Miller, NA; Oufadem, M; de Bellaing, AM; Yagi, H; Saunders, CJ; Baker, CN; Di Filippo, S; Peterson, KA; Thiffault, I; Bole-Feysot, C; Cooley, LD; Farrow, EG; Masson, C; Schoen, P; Deleuze, JF; Nitschke, P; Lyonnet, S; de Pontual, L; Murray, SA; Bonnet, D; Kingsmore, SF; Amiel, J; Bouvagnet, P; Lo, CW; Gordon, CT				Guimier, Anne; Gabriel, George C.; Bajolle, Fanny; Tsang, Michael; Liu, Hui; Noll, Aaron; Schwartz, Molly; El Malti, Rajae; Smith, Laurie D.; Klena, Nikolai T.; Jimenez, Gina; Miller, Neil A.; Oufadem, Myriam; de Bellaing, Anne Moreau; Yagi, Hisato; Saunders, Carol J.; Baker, Candice N.; Di Filippo, Sylvie; Peterson, Kevin A.; Thiffault, Isabelle; Bole-Feysot, Christine; Cooley, Linda D.; Farrow, Emily G.; Masson, Cecile; Schoen, Patric; Deleuze, Jean-Francois; Nitschke, Patrick; Lyonnet, Stanislas; de Pontual, Loic; Murray, Stephen A.; Bonnet, Damien; Kingsmore, Stephen F.; Amiel, Jeanne; Bouvagnet, Patrice; Lo, Cecilia W.; Gordon, Christopher T.			MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates	NATURE GENETICS			English	Article							MATRIX METALLOPROTEINASE-21; SNP CHIP; GENE; CILIA; BETA	Heterotaxy results from a failure to establish normal left-right asymmetry early in embryonic development. By whole-exome sequencing, whole-genome sequencing and high-throughput cohort resequencing, we identified recessive mutations in MMP21 (encoding matrix metallopeptidase 21) in nine index cases with heterotaxy. In addition, Mmp21-mutant mice and mmp21-morphant zebrafish displayed heterotaxy and abnormal cardiac looping, respectively, suggesting a new role for extracellular matrix remodeling in the establishment of laterality in vertebrates.	[Guimier, Anne; Oufadem, Myriam; Bole-Feysot, Christine; Masson, Cecile; Nitschke, Patrick; Lyonnet, Stanislas; de Pontual, Loic; Amiel, Jeanne; Gordon, Christopher T.] INSERM, Lab Embryol & Genet Congenital Malformat, U1163, Inst Imagine, Paris, France; [Guimier, Anne; Oufadem, Myriam; Bole-Feysot, Christine; Masson, Cecile; Nitschke, Patrick; Lyonnet, Stanislas; de Pontual, Loic; Bonnet, Damien; Amiel, Jeanne; Gordon, Christopher T.] Paris Descartes Sorbonne Paris Cite Univ, Inst Imagine, Paris, France; [Gabriel, George C.; Tsang, Michael; Schwartz, Molly; Klena, Nikolai T.; Yagi, Hisato; Lyonnet, Stanislas; Lo, Cecilia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Bajolle, Fanny; Bonnet, Damien] Hop Necker Enfants Malad, AP HP, Ctr Reference Malformat Cardiaques Congenitales C, Unite Medicochirurg Cardiol Congenitale & Pediat, Paris, France; [Liu, Hui; El Malti, Rajae; Jimenez, Gina; de Bellaing, Anne Moreau; Bouvagnet, Patrice] Hosp Civils Lyon, Lab Cardiogenet, Bron, France; [Liu, Hui; El Malti, Rajae; Jimenez, Gina; de Bellaing, Anne Moreau; Bouvagnet, Patrice] Univ Lyon 1, EA 4173, F-69365 Lyon, France; [Liu, Hui; El Malti, Rajae; Jimenez, Gina; de Bellaing, Anne Moreau; Bouvagnet, Patrice] Hop Nord Ouest, Lyon, France; [Noll, Aaron; Smith, Laurie D.; Miller, Neil A.; Saunders, Carol J.; Thiffault, Isabelle; Cooley, Linda D.; Farrow, Emily G.; Kingsmore, Stephen F.] Childrens Mercy Kansas City, Dept Pediat & Pathol, Ctr Pediat Genom Med, Kansas City, MO USA; [Noll, Aaron; Smith, Laurie D.; Miller, Neil A.; Saunders, Carol J.; Thiffault, Isabelle; Cooley, Linda D.; Farrow, Emily G.; Kingsmore, Stephen F.] Univ Missouri, Kansas City Sch Med, Kansas City, MO 64110 USA; [Baker, Candice N.; Peterson, Kevin A.; Murray, Stephen A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Di Filippo, Sylvie] Hosp Civils Lyon, Serv Cardiol Pediat, Lyon, France; [Schoen, Patric] Tech Univ Munich, Deutsch Herzzentrum Munchen, Dept Pediat Cardiol & Congenital Heart Dis, D-80290 Munich, Germany; [Deleuze, Jean-Francois] Commissariat Energie Atom & Energies Alternat CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Amiel, Jeanne] Hop Necker Enfants Malad, AP HP, Serv Genet, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Jackson Laboratory; CHU Lyon; German Heart Centre Munich; Technical University of Munich; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Gordon, CT (corresponding author), INSERM, Lab Embryol & Genet Congenital Malformat, U1163, Inst Imagine, Paris, France.	patrice.bouvagnet@univ-lyon1.fr; cel36@pitt.edu; chris.gordon@inserm.fr	amiel, jeanne/H-3501-2017; Gordon, Chris/F-1267-2017; Di+Filippo, Sylvie/AAH-8191-2021; Tsang, Michael/AAG-9338-2020; Di Filippo, Sylvie/AAM-2016-2020; Carmen, Team3/Y-7384-2019; COOLEY, LINDA/R-6086-2019; Tsang, Michael W/I-9305-2014; amiel, jeanne/AGX-1124-2022; Tsang, Michael/ABV-0504-2022; Lyonnet, Stanislas/H-5483-2017	amiel, jeanne/0000-0001-5973-4728; Gordon, Chris/0000-0002-9300-8399; Carmen, Team3/0000-0002-3614-0924; Tsang, Michael W/0000-0001-7123-0063; Tsang, Michael/0000-0001-7123-0063; Lyonnet, Stanislas/0000-0001-5426-9417; Klena, Nikolai/0000-0002-2631-2294; Yagi, Hisato/0000-0003-1460-4043; DE PONTUAL, LOIC/0000-0002-3123-0453; Guimier, Anne/0000-0002-4759-0621; Gabriel, George/0000-0003-3250-2518; Kingsmore, Stephen/0000-0001-7180-2527; Lab, Carmen/0000-0002-5935-3236	Fondation pour la Recherche Medicale (HeartGenomics); Agence Nationale de la Recherche [ANR-10-IAHU-01]; Programme Hospitalier de Recherche Clinique (PHRC); Fondation Renaud Febvre; National Institute of Child Health and Human Development (NICHD); National Human Genome Research Institute (NHGRI) [U19HD077693]; National Center for Advancing Translational Sciences (NCATS; CTSA grant) [TL1TR000120]; National Heart, Lung, and Blood Institute (NHLBI) [U01HL098180, U01HL098188]; National Institute of General Medical Sciences (NIGMS) [R01GM104412]; US National Institutes of Health [S10RR029439]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098180, U01HL098188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104412] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010340] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale (HeartGenomics)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Programme Hospitalier de Recherche Clinique (PHRC); Fondation Renaud Febvre; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences (NCATS; CTSA grant); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Federation Francaise de Cardiologie, the Societe Francaise de Cardiologie, the Centre de Ressources Biologiques (CRB-ADN; BB-033-00065) at Institut Imagine, the zebrafish core facility of the Cardiovascular Development Consortium (CvDC), the Divisions of Clinical Genetics and Neonatology at Children's Mercy-Kansas City, the families for their participation, V. Salle, C. Ollagnier and B. Aime for excellent technical assistance, X. Liu and W. Devine for diagnosis of CHDs in mutant mouse embryos, and H. Roest Crollius and M. Delous for discussions. This work was supported by grants from the Fondation pour la Recherche Medicale (HeartGenomics), the Agence Nationale de la Recherche (ANR-10-IAHU-01), the Programme Hospitalier de Recherche Clinique (PHRC; 2008), the Fondation Renaud Febvre, the National Institute of Child Health and Human Development (NICHD) and the National Human Genome Research Institute (NHGRI) (U19HD077693), the National Center for Advancing Translational Sciences (NCATS; CTSA grant TL1TR000120), the National Heart, Lung, and Blood Institute (NHLBI; U01HL098180 and U01HL098188), the National Institute of General Medical Sciences (NIGMS; R01GM104412) and the US National Institutes of Health (S10RR029439).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahokas K, 2002, GENE, V301, P31, DOI 10.1016/S0378-1119(02)01088-0; Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Collins MM, 2014, GENESIS, V52, P488, DOI 10.1002/dvg.22774; Fan Xian, 2014, Curr Protoc Bioinformatics, V45, DOI 10.1002/0471250953.bi1506s45; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Gazal S, 2014, BIOINFORMATICS, V30, P1940, DOI 10.1093/bioinformatics/btu149; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Jacobs JP, 2007, CARDIOL YOUNG, V17, P1, DOI 10.1017/S1047951107000182; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Lin AE, 2014, AM J MED GENET A, V164, P2581, DOI 10.1002/ajmg.a.36695; Marchenko GN, 2003, BIOCHEM J, V372, P503, DOI 10.1042/BJ20030174; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Smith KR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r85; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Yu Q, 2000, GENE DEV, V14, P163	23	52	57	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1260	+		10.1038/ng.3376	http://dx.doi.org/10.1038/ng.3376			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26437028	Green Accepted			2022-12-25	WOS:000363988200009
J	Chang, CJ				Chang, Christopher J.			Searching for harmony in transition-metal signaling	NATURE CHEMICAL BIOLOGY			English	Editorial Material							CELL-DEATH; ZINC; COPPER; CHELATORS	The recent emergence of signaling roles for transition metals presages a broader contribution of these elements beyond their traditional functions as metabolic cofactors. New chemical approaches to identify the sources, targets and physiologies of transition-metal signaling can help expand understanding of the periodic table in a biological context.	[Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Chang, Christopher J.] ShanghaiTech Univ, Div Mat Biol, Shanghai, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; ShanghaiTech University	Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Chem, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	chrischang@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM 79465] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts B, 2008, MOL BIOL CELL; Anderson CT, 2015, P NATL ACAD SCI USA, V112, pE2705, DOI 10.1073/pnas.1503348112; Aron A.T., 2015, J ACC CHEM RES, V18, P2434; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Burdette SC, 2003, P NATL ACAD SCI USA, V100, P3605, DOI 10.1073/pnas.0637711100; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Carter KP, 2014, CHEM REV, V114, P4564, DOI 10.1021/cr400546e; Chan J, 2012, NAT CHEM, V4, P973, DOI [10.1038/nchem.1500, 10.1038/NCHEM.1500]; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; Franz KJ, 2013, CURR OPIN CHEM BIOL, V17, P143, DOI 10.1016/j.cbpa.2012.12.021; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Kawabata E, 2005, J AM CHEM SOC, V127, P818, DOI 10.1021/ja044697q; Kim AM, 2011, ACS CHEM BIOL, V6, P716, DOI 10.1021/cb200084y; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Lippard S. J., 1994, PRINCIPLES BIOINORGA; MASKE H, 1955, NATURWISSENSCHAFTEN, V42, P424, DOI 10.1007/BF00601955; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Que EL, 2015, NAT CHEM, V7, P130, DOI [10.1038/NCHEM.2133, 10.1038/nchem.2133]; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	25	96	98	3	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					744	747		10.1038/nchembio.1913	http://dx.doi.org/10.1038/nchembio.1913			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26379012	Green Published			2022-12-25	WOS:000361536500001
J	Jacques, IB; Moutiez, M; Witwinowski, J; Darbon, E; Martel, C; Seguin, J; Favry, E; Thai, R; Lecoq, A; Dubois, S; Pernodet, JL; Gondry, M; Belin, P				Jacques, Isabelle B.; Moutiez, Mireille; Witwinowski, Jerzy; Darbon, Emmanuelle; Martel, Cecile; Seguin, Jerome; Favry, Emmanuel; Thai, Robert; Lecoq, Alain; Dubois, Steven; Pernodet, Jean-Luc; Gondry, Muriel; Belin, Pascal			Analysis of 51 cyclodipeptide synthases reveals the basis for substrate specificity	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE-SYNTHESIS; COLLISION-INDUCED DISSOCIATION; TANDEM MASS-SPECTROMETRY; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCES-NOURSEI; ADENYLATION DOMAINS; SEQUENCE ALIGNMENT; CYCLIC DIPEPTIDES; INTERACTIVE TREE; STRUCTURAL BASIS	Cyclodipeptide synthases (CDPSs) constitute a family of peptide bond- forming enzymes that use aminoacyl-tRNAs for the synthesis of cyclodipeptides. Here, we describe the activity of 41 new CDPSs. We also show that CDPSs can be classified into two main phylogenetically distinct subfamilies characterized by specific functional subsequence signatures, named NYH and XYP. All 11 previously characterized CDPSs belong to the NYH subfamily, suggesting that further special features may be yet to be discovered in the other subfamily. CDPSs synthesize a large diversity of cyclodipeptides made up of 17 proteinogenic amino acids. The identification of several CDPSs having the same specificity led us to determine specificity sequence motifs that, in combination with the phylogenetic distribution of CDPSs, provide a first step toward being able to predict the cyclodipeptides synthesized by newly discovered CDPSs. The determination of the activity of ten more CDPSs with predicted functions constitutes a first experimental validation of this predictive approach.	[Jacques, Isabelle B.; Moutiez, Mireille; Seguin, Jerome; Favry, Emmanuel; Thai, Robert; Lecoq, Alain; Dubois, Steven; Gondry, Muriel; Belin, Pascal] Commissariat Energie Atom & Energies Alternat CEA, Inst Biol & Technol Saclay iBiTec S, Serv Ingn Mol Prot, Gif Sur Yvette, France; [Witwinowski, Jerzy; Darbon, Emmanuelle; Martel, Cecile; Pernodet, Jean-Luc] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Belin, P (corresponding author), CEA, iBiTec S, Serv Biol Integrat & Genet Mol, UMR 9198, Gif Sur Yvette, France.	muriel.gondry@cea.fr; pascal.belin@cea.fr	Moutiez, Mireille/T-7788-2019; Pernodet, Jean-Luc/A-4074-2015	Moutiez, Mireille/0000-0002-0064-8291; Pernodet, Jean-Luc/0000-0002-6129-7093; Witwinowski, Jerzy/0000-0002-7167-741X; Thai, Robert/0000-0001-9438-4225; Gondry, Muriel/0000-0003-0398-3404	CEA; CNRS; Paris-Sud University; French National Research Agency [ANR 2010/Blan 1501 01]	CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Paris-Sud University; French National Research Agency(French National Research Agency (ANR))	This work was supported by the CEA, the CNRS, the Paris-Sud University and a grant from the French National Research Agency (ANR 2010/Blan 1501 01) to M.G. and J.-L.P. I.B.J. was supported by a doctoral fellowship from the CEA. The Service d'Ingenierie Moleculaire des Proteines is member of the Laboratory of Excellence LERMIT. We warmly thank V. Dive, head of the Service d'Ingenierie Moleculaire des Proteines, for his continuous support and encouragement throughout this work. We thank O. Lespinet for advice about the building of phylogenetic trees, D. Vallenet, M. Stam and M. Sorokina for helpful discussion on bioinformatics, and A. Ponties for technical assistance in cloning experiments. We are indebted to L. Beuvier for skillful assistance in mass data analysis. We thank F. Fenaille for kindly performing the experiments using the Orbitrap mass spectrophotometer. We thank P. Kessler and O. Lequin for skillful assistance in NMR experiments.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-48; Armirotti A, 2007, J AM SOC MASS SPECTR, V18, P57, DOI 10.1016/j.jasms.2006.08.011; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Belin P, 2012, NAT PROD REP, V29, P961, DOI 10.1039/c2np20010d; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bonnefond L, 2011, P NATL ACAD SCI USA, V108, P3912, DOI 10.1073/pnas.1019480108; Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen YH, 2004, EUR FOOD RES TECHNOL, V218, P589, DOI 10.1007/s00217-004-0901-x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cryle MJ, 2010, BIOCHEMISTRY-US, V49, P7282, DOI 10.1021/bi100910y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FALICK AM, 1993, J AM SOC MASS SPECTR, V4, P882, DOI 10.1016/1044-0305(93)87006-X; FUKUSHIMA K, 1973, J ANTIBIOT, V26, P175, DOI 10.7164/antibiotics.26.175; Giessen TW, 2014, INT J MOL SCI, V15, P14610, DOI 10.3390/ijms150814610; Giessen TW, 2013, CHEM BIOL, V20, P828, DOI 10.1016/j.chembiol.2013.04.017; Giessen TW, 2013, BIOCHEMISTRY-US, V52, P4274, DOI 10.1021/bi4004827; Gondry M, 2001, EUR J BIOCHEM, V268, P1712, DOI 10.1046/j.1432-1033.2001.02038.x; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gu BB, 2013, APPL MICROBIOL BIOT, V97, P8439, DOI 10.1007/s00253-013-5175-4; Jeedigunta S, 2000, TETRAHEDRON, V56, P3303, DOI 10.1016/S0040-4020(00)00249-0; JOHNSON RS, 1987, ANAL CHEM, V59, P2621, DOI 10.1021/ac00148a019; Lautru S, 2002, CHEM BIOL, V9, P1355, DOI 10.1016/S1074-5521(02)00285-5; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Moutiez M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6141; Moutiez M, 2014, NUCLEIC ACIDS RES, V42, P7247, DOI 10.1093/nar/gku348; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sambrook J, 2001, MOL CLONING LAB MANU; Sauguet L, 2011, NUCLEIC ACIDS RES, V39, P4475, DOI 10.1093/nar/gkr027; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seguin J, 2011, CHEM BIOL, V18, P1362, DOI 10.1016/j.chembiol.2011.09.010; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stark T, 2005, J AGR FOOD CHEM, V53, P7222, DOI 10.1021/jf051313m; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang M. R., 2006, IND BIOTECHNOLOGY, V2, P66, DOI DOI 10.1089/IND.2006.2.66; Vetting MW, 2010, NAT CHEM BIOL, V6, P797, DOI 10.1038/NCHEMBIO.440	42	46	46	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					721	+		10.1038/NCHEMBIO.1868	http://dx.doi.org/10.1038/NCHEMBIO.1868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26236937				2022-12-25	WOS:000359954700017
J	Patel, PH; Dutta, D; Edgar, BA				Patel, Parthive H.; Dutta, Devanjali; Edgar, Bruce A.			Niche appropriation by Drosophila intestinal stem cell tumours	NATURE CELL BIOLOGY			English	Article							CONTROLS SELF-RENEWAL; PROLIFERATION; JAK/STAT; MIDGUT; NOTCH; DIFFERENTIATION; REGENERATION; WINGLESS; DIVISION; EGFR	Mutations that inhibit differentiation in stem cell lineages are a common early step in cancer development, but precisely how a loss of differentiation initiates tumorigenesis is unclear. We investigated Drosophila intestinal stem cell (ISC) tumours generated by suppressing Notch (N) signalling, which blocks differentiation. Notch-defective ISCs require stress-induced divisions for tumour initiation and an autocrine EGFR ligand, Spitz, during early tumour growth. On achieving a critical mass these tumours displace surrounding enterocytes, competing with them for basement membrane space and causing their detachment, extrusion and apoptosis. This loss of epithelial integrity induces JNK and Yki/YAP activity in enterocytes and, consequently, their expression of stress-dependent cytokines (Upd2, Upd3). These paracrine signals, normally used within the stem cell niche to trigger regeneration, propel tumour growth without the need for secondary mutations in growth signalling pathways. The appropriation of niche signalling by differentiation-defective stem cells may be a common mechanism of early tumorigenesis.	[Patel, Parthive H.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Patel, Parthive H.; Dutta, Devanjali; Edgar, Bruce A.] Univ Heidelberg Alliance, Ctr Mol Biol, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany	Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Patel, PH (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North, Seattle, WA 98109 USA.	p.patel@zmbh.uni-heidelberg.de; b.edgar@dkfz.de	Patel, Parthive H./ABC-8505-2021	Patel, Parthive/0000-0002-9288-8056; Dutta, Devanjali/0000-0002-4993-9639	American Cancer Society Postdoctoral Fellowship [PF-08-040-01-DDC]; NIH [R01 GM051186]; DKFZ [A220]; DFG [SFB 873]; ERC Advanced Grant [268515]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051186] Funding Source: NIH RePORTER	American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DKFZ(Helmholtz Association); DFG(German Research Foundation (DFG)); ERC Advanced Grant(European Research Council (ERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Center (VDRC), National Institute of Genetics (Japan), Developmental Studies Hybridoma Bank, H. Bellen, S. Eaton, G. Halder, S. Hou, Y. N. Jan, H. Jasper, B. Lemaitre, D. McEwen, A. Page-McCaw, N. Perrimon, T. Xu and X. Yang for fly stocks and antibodies. We thank B. Schneider and J. Bousman (FHCRC Electron Microscopy Resource), M. Langlotz (ZMBH Flow Cytometry), D. Ibberson (Deep Sequencing Core Facility, U. Heidelberg), J. Delrow (FHCRC Sequencing Shared Resource) and C. Glaser (ZMBH, Bioinformatics). Financially supported by American Cancer Society Postdoctoral Fellowship (PF-08-040-01-DDC) to P.H.P. and NIH R01 GM051186, DKFZ A220, DFG SFB 873 and ERC Advanced Grant 268515 to B.A.E.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Bond D, 2012, J BIOL CHEM, V287, P27359, DOI 10.1074/jbc.M112.378018; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108; Cordero JB, 2012, DEVELOPMENT, V139, P4524, DOI 10.1242/dev.078261; Cordero JB, 2012, EMBO J, V31, P3901, DOI 10.1038/emboj.2012.248; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Dutta Devanjali, 2013, Curr Protoc Stem Cell Biol, V27, DOI 10.1002/9780470151808.sc02f02s27; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kohlmaier A, 2015, ONCOGENE, V34, P2371, DOI 10.1038/onc.2014.163; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lin GN, 2013, DEV BIOL, V377, P177, DOI 10.1016/j.ydbio.2013.01.032; Lin GN, 2010, J MOL CELL BIOL, V2, P37, DOI 10.1093/jmcb/mjp028; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maeda K, 2008, GENES CELLS, V13, P1219, DOI 10.1111/j.1365-2443.2008.01239.x; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Okumura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089387; Patel PH, 2014, SEMIN CELL DEV BIOL, V28, P86, DOI 10.1016/j.semcdb.2014.03.012; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; You J, 2014, STEM CELL REP, V2, P761, DOI 10.1016/j.stemcr.2014.04.007; Zhou J, 2015, DEV BIOL, V399, P189, DOI 10.1016/j.ydbio.2014.12.017	44	98	98	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1182	+		10.1038/ncb3214	http://dx.doi.org/10.1038/ncb3214			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26237646	Green Accepted			2022-12-25	WOS:000361113700012
J	Yuan, L; Lv, YR; Li, HC; Gao, HD; Song, SS; Zhang, Y; Xing, GC; Kong, XZ; Wang, LJ; Li, Y; Zhou, T; Gao, DM; Xiao, ZX; Yin, YX; Wei, WY; He, FC; Zhang, LQ				Yuan, Lin; Lv, Yanrong; Li, Hongchang; Gao, Haidong; Song, Shanshan; Zhang, Yuan; Xing, Guichun; Kong, Xiangzhen; Wang, Lijing; Li, Yang; Zhou, Tao; Gao, Daming; Xiao, Zhi-Xiong; Yin, Yuxin; Wei, Wenyi; He, Fuchu; Zhang, Lingqiang			Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; GERMLINE MUTATIONS; BREAST-CANCER; PROTEIN STABILITY; NUCLEAR PTEN; C-TERMINUS; GENE; PTEN/MMAC1; UBIQUITINATION; EXPRESSION	PTEN is one of the most frequently mutated tumour suppressors and reduction in PTEN protein stability also plays a role in tumorigenesis. Although several ubiquitin ligases for PTEN have been identified, the deubiquitylase for de-polyubiquitylation and stabilization of PTEN is less defined. Here, we report OTUD3 as a deubiquitylase of PTEN. OTUD3 interacts with, de-polyubiquitylates and stabilizes PTEN. Depletion of OTUD3 leads to the activation of Akt signalling, induction of cellular transformation and cancer metastasis. OTUD3 transgenic mice exhibit higher levels of the PTEN protein and are less prone to tumorigenesis. Reduction of OTUD3 expression, concomitant with decreased PTEN abundance, correlates with human breast cancer progression. Furthermore, we identified loss-of-function OTUD3 mutations in human cancers, which either abolish OTUD3 catalytic activity or attenuate the interaction with PTEN. These findings demonstrate that OTUD3 is an essential regulator of PTEN and that the OTUD3-PTEN signalling axis plays a critical role in tumour suppression.	[Yuan, Lin; Li, Hongchang; Song, Shanshan; Zhang, Yuan; Xing, Guichun; Kong, Xiangzhen; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Collaborat Innovat Ctr Canc Med, Beijing Proteome Res Ctr, State Key Lab Proteom, Beijing 100850, Peoples R China; [Yuan, Lin; Zhang, Lingqiang] Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Liaoning Provin, Peoples R China; [Lv, Yanrong; Gao, Haidong] Shandong Univ, QiLu Hosp, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China; [Wang, Lijing] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou 510006, Guangdong, Peoples R China; [Li, Yang] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing 100850, Peoples R China; [Zhou, Tao] China Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China; [Gao, Daming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol,Innovat Ctr Cell Signaling Netw, Shanghai 200031, Peoples R China; [Xiao, Zhi-Xiong] Sichuan Univ, Sch Life Sci, Chengdu 610065, Sichuan Provinc, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Ctr Syst Biol & Med Aging, Inst Syst Biomed, Beijing 100191, Peoples R China; [Wei, Wenyi] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA	Academy of Military Medical Sciences - China; Dalian Medical University; Shandong University; Guangdong Pharmaceutical University; Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Sichuan University; Peking University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zhang, LQ (corresponding author), Beijing Inst Radiat Med, Collaborat Innovat Ctr Canc Med, Beijing Proteome Res Ctr, State Key Lab Proteom, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn		YUAN, LIN/0000-0001-5449-3435; Zhang, Lingqiang/0000-0002-9795-2141; Gao, Daming/0000-0003-4374-1055	Chinese National Basic Research Programs [2012CB910702, 2011CB910602, 2012CB919304]; Program of International ST Cooperation [2014DFB30020]; Chinese National Natural Science Foundation Projects [31330021, 31125010, 812210041]; Beijing Natural Science Foundation Project [5142020]	Chinese National Basic Research Programs(National Basic Research Program of China); Program of International ST Cooperation; Chinese National Natural Science Foundation Projects(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Project(Beijing Natural Science Foundation)	We thank Q. Ye (Beijing Institute of Biotechnology, Beijing, China), Z. Liu (Chinese Academy of Medical Sciences and Peking Union Medical College, Beijiing, China) and S. Maddika (Centre for DNA Fingerprinting and Diagnostics, Nampally Hyderabad, India) for kindly providing materials and H. Li, R Xie, Y. Chen, S. Wang, J. Feng. M. Lai and Zhao for technical assistance. This work was supported Chinese National Basic Research Programs (2012CB910702, 2011CB910602, 2012CB919304), the Program of International S&T Cooperation (2014DFB30020), Chinese National Natural Science Foundation Projects (31330021, 31125010, 812210041 and Beijing Natural Science Foundation Project (5142020).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Climent J, 2010, J CLIN ONCOL, V28, P3770, DOI 10.1200/JCO.2009.27.0215; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Feilotter HE, 1999, BRIT J CANCER, V79, P718, DOI 10.1038/sj.bjc.6690115; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; FitzGerald MG, 1998, ONCOGENE, V17, P727, DOI 10.1038/sj.onc.1201984; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Georgescu MM, 2000, CANCER RES, V60, P7033; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee JT, 2013, CELL RES, V23, P552, DOI 10.1038/cr.2013.27; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maglione JE, 2001, CANCER RES, V61, P8298; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rhei E, 1997, CANCER RES, V57, P3657; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Sacco JJ, 2014, ONCOGENE, V33, P4265, DOI 10.1038/onc.2013.512; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874	53	92	97	5	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1169	+		10.1038/ncb3218	http://dx.doi.org/10.1038/ncb3218			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26280536				2022-12-25	WOS:000361113700010
J	Gentles, AJ; Newman, AM; Liu, CL; Bratman, SV; Feng, WG; Kim, D; Nair, VS; Xu, Y; Khuong, A; Hoang, CD; Diehn, M; West, RB; Plevritis, SK; Alizadeh, AA				Gentles, Andrew J.; Newman, Aaron M.; Liu, Chih Long; Bratman, Scott V.; Feng, Weiguo; Kim, Dongkyoon; Nair, Viswam S.; Xu, Yue; Khuong, Amanda; Hoang, Chuong D.; Diehn, Maximilian; West, Robert B.; Plevritis, Sylvia K.; Alizadeh, Ash A.			The prognostic landscape of genes and infiltrating immune cells across human cancers	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; CHRONIC INFLAMMATION; TUMOR; EXPRESSION; NEUTROPHILS; SURVIVAL; MACROPHAGES; RECURRENCE; MICROARRAY; SIGNATURES	Molecular profiles of tumors and tumor-associated cells hold great promise as biomarkers of clinical outcomes. However, existing data sets are fragmented and difficult to analyze systematically. Here we present a pan-cancer resource and meta-analysis of expression signatures from similar to 18,000 human tumors with overall survival outcomes across 39 malignancies. By using this resource, we identified a forkhead box MI (FOXM1) regulatory network as a major predictor of adverse outcomes, and we found that expression of favorably prognostic genes, including KLRB1 (encoding CD161), largely reflect tumor-associated leukocytes. By applying CIBERSORT, a computational approach for inferring leukocyte representation in bulk tumor transcriptomes, we identified complex associations between 22 distinct leukocyte subsets and cancer survival. For example, tumor-associated neutrophil and plasma cell signatures emerged as significant but opposite predictors of survival for diverse solid tumors, including breast and lung adenocarcinomas. This resource and associated analytical tools (http://precog.stanford.edu) may help delineate prognostic genes and leukocyte subsets within and across cancers, shed light on the impact of tumor heterogeneity on cancer outcomes, and facilitate the discovery of biomarkers and therapeutic targets.	[Gentles, Andrew J.; Plevritis, Sylvia K.; Alizadeh, Ash A.] Stanford Univ, CCSB, Stanford, CA 94305 USA; [Gentles, Andrew J.; Plevritis, Sylvia K.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Newman, Aaron M.; Liu, Chih Long; Bratman, Scott V.; Feng, Weiguo; Kim, Dongkyoon; Diehn, Maximilian; Alizadeh, Ash A.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Newman, Aaron M.; Liu, Chih Long; Alizadeh, Ash A.] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Inst, Stanford, CA 94305 USA; [Bratman, Scott V.; Feng, Weiguo; Diehn, Maximilian] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Nair, Viswam S.] Stanford Univ, Dept Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Xu, Yue; Khuong, Amanda; Hoang, Chuong D.] Stanford Univ, Dept Cardiothorac Surg, Div Thorac Surg, Stanford, CA 94305 USA; [Diehn, Maximilian; Alizadeh, Ash A.] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA; [West, Robert B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Dept Med, Div Hematol, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Alizadeh, AA (corresponding author), Stanford Univ, CCSB, Stanford, CA 94305 USA.	arasha@stanford.edu	Alizadeh, Ash A/C-5594-2009; Newman, Aaron M/ABE-1620-2021; wang, edwin/G-5372-2010; Teh, Muy-Teck/B-9284-2016	Alizadeh, Ash A/0000-0002-5153-5625; Newman, Aaron M/0000-0002-1857-8172; Teh, Muy-Teck/0000-0002-7725-8355; West, Robert/0000-0002-8330-8283; Bratman, Scott/0000-0001-8610-4908	Doris Duke Charitable Foundation; Damon Runyon Cancer Research Foundation; V-Foundation; US Public Health Service/National Institutes of Health [U01 CA194389, R01 CA188298, U54 CA149145, U01CA154969, 5T32 CA09302-35]; Bent & Janet Cardan Oncology Research Fund; Ludwig Institute for Cancer Research; Department of Defense [W81XWH-12-1-0498]; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE [U01CA194389, U01CA154969, U54CA149145, R01CA188298, T32CA009302] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Damon Runyon Cancer Research Foundation; V-Foundation; US Public Health Service/National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Bent & Janet Cardan Oncology Research Fund; Ludwig Institute for Cancer Research; Department of Defense(United States Department of Defense); Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank S Galli, I. Weissman, P. Brown, R. Levy and H. Kohrt for critically reading the manuscript, and members of the Center for Cancer Systems Biology and the Plevritis, Diehn, Levy, and Alizadeh laboratories for valuable guidance and suggestions. This work was supported by grants from the Doris Duke Charitable Foundation (A.A.A.), Damon Runyon Cancer Research Foundation (A.A.A.), V-Foundation (A.A.A.); by the US Public Health Service/National Institutes of Health U01 CA194389 (A.A.A.), R01 CA188298 (M.D. and A.A.A.), U54 CA149145 (S.K.P.), U01CA154969 (S.K.P.), and 5T32 CA09302-35 (A.M.N.); by the Bent & Janet Cardan Oncology Research Fund (A.A.A.); by the Ludwig Institute for Cancer Research (A.A.A.); by a Department of Defense grant W81XWH-12-1-0498 (A.M.N.); and by a grant from the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation (A.M.N.).	Alizadeh AA, 2011, BLOOD, V118, P1350, DOI 10.1182/blood-2011-03-345272; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Chen XT, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0021-z; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hebestreit K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039148; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Minarik I, 2013, IMMUNOL LETT, V152, P144, DOI 10.1016/j.imlet.2013.05.010; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Varmus H, 2010, NEW ENGL J MED, V362, P2028, DOI 10.1056/NEJMe0911933; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yuan Y, 2014, NAT BIOTECHNOL, V32, P644, DOI 10.1038/nbt.2940; Zeuner A, 2014, CELL STEM CELL, V15, P692, DOI 10.1016/j.stem.2014.11.012; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	55	1657	1691	12	227	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					938	945		10.1038/nm.3909	http://dx.doi.org/10.1038/nm.3909			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26193342	Green Accepted			2022-12-25	WOS:000359181000022
J	Huston, A; Arrowsmith, CH; Knapp, S; Schapira, M				Huston, Andrea; Arrowsmith, Cheryl H.; Knapp, Stefan; Schapira, Matthieu			Probing the epigenome	NATURE CHEMICAL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; METHYLTRANSFERASE ACTIVITY; CHEMICAL PROBE; BREAST-CANCER; IN-VIVO; INHIBITION; LEUKEMIA; BROMODOMAINS; EXPRESSION; INDUCTION	Epigenetic chemical probes are having a strong impact in biological discovery and target validation. Systematic coverage of emerging epigenetic target classes with these potent, selective, cell-active chemical tools will profoundly influence understanding of the human biology and pathology of chromatin-templated mechanisms.	[Huston, Andrea; Arrowsmith, Cheryl H.; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Knapp, Stefan] Univ Oxford, Target Discovery Inst, Oxford, England; [Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford, England; [Knapp, Stefan] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60054 Frankfurt, Germany; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Oxford; University of Oxford; University of Oxford; Goethe University Frankfurt; University of Toronto	Huston, A (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	knapp@pharmchem.uni-frankfurt.de; matthieu.schapira@utoronto.ca	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Arrowsmith, Cheryl/0000-0002-4971-3250	Wellcome Trust [106169] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Borkin D, 2015, CANCER CELL, V27, P589, DOI 10.1016/j.ccell.2015.02.016; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Copeland RA, 2013, CLIN CANCER RES, V19, P6344, DOI 10.1158/1078-0432.CCR-13-0223; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gibaja V, 2016, ONCOGENE, V35, P558, DOI 10.1038/onc.2015.114; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Malik R, 2015, NAT MED, V21, P344, DOI 10.1038/nm.3830; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Schones DE, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-23; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Yu H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.28	30	35	35	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					542	545		10.1038/nchembio.1871	http://dx.doi.org/10.1038/nchembio.1871			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26196765				2022-12-25	WOS:000358255300004
J	MacPherson, CR; Scherf, A				MacPherson, Cameron Ross; Scherf, Artur			Flexible guide-RNA design for CRISPR applications using Protospacer Workbench	NATURE BIOTECHNOLOGY			English	Letter									Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; CNRS, ERL 9195, Paris, France; INSERM, U1201, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)		cameron.crm@gmail.com; artur.scherf@pasteur.fr		Scherf, Artur/0000-0003-2411-3328; MacPherson, Cameron/0000-0002-8945-9736				Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448	7	56	59	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					805	806		10.1038/nbt.3291	http://dx.doi.org/10.1038/nbt.3291			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26121414				2022-12-25	WOS:000359274900010
J	Johnson-Buck, A; Su, X; Giraldez, MD; Zhao, MP; Tewari, M; Walter, NG				Johnson-Buck, Alexander; Su, Xin; Giraldez, Maria D.; Zhao, Meiping; Tewari, Muneesh; Walter, Nils G.			Kinetic fingerprinting to identify and count single nucleic acids	NATURE BIOTECHNOLOGY			English	Article							INTERNAL-REFLECTION FLUORESCENCE; MOLECULE DETECTION; MICRORNA; HYBRIDIZATION; SPECIFICITY; EXPRESSION; MICROSCOPY; ASSAY	MicroRNAs (miRNAs) have emerged as promising diagnostic biomarkers. We introduce a kinetic fingerprinting approach called single-molecule recognition through equilibrium Poisson sampling (SiMREPS) for the amplification-free counting of single unlabeled miRNA molecules, which circumvents thermodynamic limits of specificity and virtually eliminates false positives. We demonstrate high-confidence, single-molecule detection of synthetic and endogenous miRNAs in both buffer and minimally treated biofluids, as well as >500-fold discrimination between single nucleotide polymorphisms.	[Johnson-Buck, Alexander; Walter, Nils G.] Univ Michigan, Dept Chem, Single Mol Anal Grp, Ann Arbor, MI 48109 USA; [Su, Xin; Zhao, Meiping] Peking Univ, Coll Chem & Mol Engn, MOE Key Lab Bioorgan Chem & Mol Engn, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Giraldez, Maria D.; Tewari, Muneesh] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Chinese Academy of Sciences; Peking University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Walter, NG (corresponding author), Univ Michigan, Dept Chem, Single Mol Anal Grp, Ann Arbor, MI 48109 USA.	nwalter@umich.edu	Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016; Giraldez, Maria D/E-7395-2018	Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275; Giraldez, Maria D/0000-0001-6829-7603; Johnson-Buck, Alexander/0000-0003-3748-6000	Department of Defense MURI Award [W911NF-12-1-0420]; US National Institutes of Health [R0IDK085714]; China Scholarship Council; Rio Hortega Fellowship; Martin Escudero Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085714] Funding Source: NIH RePORTER	Department of Defense MURI Award(MURIUnited States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Rio Hortega Fellowship; Martin Escudero Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the Department of Defense MURI Award W911NF-12-1-0420 (to N.G.W.) and US National Institutes of Health Transformative R01 grant R0IDK085714 (to M.T.). X.S. acknowledges support from the China Scholarship Council. M.D.G. acknowledges initial support from a Rio Hortega Fellowship and later from a Martin Escudero Fellowship. The authors thank A.M. Chinnaiyan, M. Bitzer, A. Sahu, S. Pitchiaya, L.A. Heinicke and M.L. Kahlscheuer for helpful discussions. The authors acknowledge J.D. Hoff and the Single-Molecule Analysis in Real-Time (SMART) Center for instrumentation and assistance in TIRF microscopy measurements.	AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Baaske MD, 2014, NAT NANOTECHNOL, V9, P933, DOI [10.1038/NNANO.2014.180, 10.1038/nnano.2014.180]; Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294; Dupuis NF, 2013, BIOPHYS J, V105, P756, DOI 10.1016/j.bpj.2013.05.061; Garcia-Schwarz G, 2013, ANGEW CHEM INT EDIT, V52, P11534, DOI 10.1002/anie.201305875; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gunnarsson A, 2008, NANO LETT, V8, P183, DOI 10.1021/nl072401j; Ho SL, 2014, ANAL CHEM, V86, P9880, DOI 10.1021/ac5025182; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Li L, 2011, ANAL CHIM ACTA, V685, P52, DOI 10.1016/j.aca.2010.11.012; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sorgenfrei S, 2011, NAT NANOTECHNOL, V6, P125, DOI 10.1038/nnano.2010.275; Walter NG, 2008, NAT METHODS, V5, P475, DOI 10.1038/nmeth.1215; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]	18	93	97	7	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					730	732		10.1038/nbt.3246	http://dx.doi.org/10.1038/nbt.3246			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098451	Green Accepted			2022-12-25	WOS:000358396100027
J	Wieczorek, M; Bechstedt, S; Chaaban, S; Brouhard, GJ				Wieczorek, Michal; Bechstedt, Susanne; Chaaban, Sami; Brouhard, Gary J.			Microtubule-associated proteins control the kinetics of microtubule nucleation	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; SELF-ASSEMBLY KINETICS; TUBULIN RING COMPLEX; GAMMA-TUBULIN; DYNAMIC INSTABILITY; IN-VITRO; PLUS-END; SPINDLE FORMATION; IMPORTIN-ALPHA; TPX2	Microtubules are born and reborn continuously, even during quiescence. These polymers are nucleated from templates, namely gamma-tubulin ring complexes (gamma-TuRCs) and severed microtubule ends. Using single-molecule biophysics, we show that nucleation from gamma-TuRCs, axonemes and seed microtubules requires tubulin concentrations that lie well above the critical concentration. We measured considerable time lags between the arrival of tubulin and the onset of steady-state elongation. Microtubule-associated proteins (MAPs) alter these time lags. Catastrophe factors (MCAK and EB1) inhibited nucleation, whereas a polymerase (XMAP215) and an anti-catastrophe factor (TPX2) promoted nucleation. We observed similar phenomena in cells. We conclude that GTP hydrolysis inhibits microtubule nucleation by destabilizing the nascent plus ends required for persistent elongation. Our results explain how MAPs establish the spatial and temporal profile of microtubule nucleation.	[Wieczorek, Michal; Bechstedt, Susanne; Chaaban, Sami; Brouhard, Gary J.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Brouhard, GJ (corresponding author), McGill Univ, Dept Biol, 1205 Ave Doctor Penfield, Montreal, PQ H3A 1B1, Canada.	gary.brouhard@mcgill.ca	Brouhard, Gary/AAZ-7789-2021	Wieczorek, Michal/0000-0003-3067-7314	Canadian Institutes of Health Research (CIHR) [MOP-111265]; Natural Sciences and Engineering Research Council of Canada (NSERC) [372593-09]; McGill University; NSERC CGS-D award; Fonds de Recherche du Quebec-Nature et Technologie Bourse de Doctorat en Recherche; NSERC CREATE training program in the Cellular Dynamics of Macromolecular Complexes; NSERC CGS-D	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McGill University; NSERC CGS-D award; Fonds de Recherche du Quebec-Nature et Technologie Bourse de Doctorat en Recherche; NSERC CREATE training program in the Cellular Dynamics of Macromolecular Complexes; NSERC CGS-D(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank H. Higgs for suggesting the hysteresis experiment (Fig. 2) during the question period of an American Society for Cell Biology mini-symposium. We thank L. Cassimeris (Lehigh University, USA) for providing the LLCPK1:EB1-GFP cell line, A. Bird (Max Planck Institute of Molecular Physiology, Germany) for providing the U2OS:EB3-mCherry cell line, and R. Ohi (Vanderbilt University, USA) for providing the LLCPK1:GFP-tubulin cell line. We thank the Cell Imaging and Analysis Network for microscopy support. We thank C. Rocha for help with immunoblot sample preparation. We thank A. Bird, C. Friel, J. Howard, L. Rice and M. Zanic for comments on the manuscript. This work was supported by the Canadian Institutes of Health Research (CIHR, MOP-111265 to G.J.B.), by the Natural Sciences and Engineering Research Council of Canada (NSERC, no. 372593-09 to G.J.B.), and by McGill University. KW. is supported by an NSERC CGS-D award and a Fonds de Recherche du Quebec-Nature et Technologie Bourse de Doctorat en Recherche. S.C. is supported by the NSERC CREATE training program in the Cellular Dynamics of Macromolecular Complexes and an NSERC CGS-D. G. Brouhard is a CIHR New Investigator.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; BAAS PW, 1992, J CELL BIOL, V116, P1231, DOI 10.1083/jcb.116.5.1231; Bechstedt S, 2014, CURR BIOL, V24, P2366, DOI 10.1016/j.cub.2014.08.039; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gardner MK, 2011, CELL, V147, P1092, DOI 10.1016/j.cell.2011.10.037; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HEAD J, 1985, J BIOL CHEM, V260, P1060; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2015, NAT STRUCT MOL BIOL, V22, P132, DOI 10.1038/nsmb.2953; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Meurer-Grob P, 2001, BIOCHEMISTRY-US, V40, P8000, DOI 10.1021/bi010343p; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Oosawa F., 1975, THERMODYNAMICS POLYM, V20; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Popov AV, 2002, CURR BIOL, V12, P1326, DOI 10.1016/S0960-9822(02)01033-3; Reber SB, 2013, NAT CELL BIOL, V15, P1116, DOI 10.1038/ncb2834; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Ringhoff DN, 2009, MOL BIOL CELL, V20, P3451, DOI 10.1091/mbc.E09-02-0140; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; VOTER WA, 1984, J BIOL CHEM, V259, P430; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	60	130	131	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					907	916		10.1038/ncb3188	http://dx.doi.org/10.1038/ncb3188			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26098575				2022-12-25	WOS:000357353400011
J	Kiser, PD; Zhang, JY; Badiee, M; Li, QJ; Shi, WX; Sui, XW; Golczak, M; Tochtrop, GP; Palczewski, K				Kiser, Philip D.; Zhang, Jianye; Badiee, Mohsen; Li, Qingjiang; Shi, Wuxian; Sui, Xuewu; Golczak, Marcin; Tochtrop, Gregory P.; Palczewski, Krzysztof			Catalytic mechanism of a retinoid isomerase essential for vertebrate vision	NATURE CHEMICAL BIOLOGY			English	Article							PIGMENT EPITHELIAL-CELLS; CRYSTAL-STRUCTURE; VISUAL CYCLE; KEY RESIDUES; VITAMIN-A; RPE65; ISOMERIZATION; SPECIFICITY; ISOMEROHYDROLASE; IDENTIFICATION	Visual function in vertebrates is dependent on the membrane-bound retinoid isomerase RPE65, an essential component of the retinoid cycle pathway that regenerates 11-cis-retinal for rod and cone opsins. The mechanism by which RPE65 catalyzes stereoselective retinoid isomerization has remained elusive because of uncertainty about how retinoids bind to its active site. Here we present crystal structures of RPE65 in complex with retinoid-mimetic compounds, one of which is in clinical trials for the treatment of age-related macular degeneration. The structures reveal the active site retinoid-binding cavity located near the membrane-interacting surface of the enzyme as well as an Fe-bound palmitate ligand positioned in an adjacent pocket. With the geometry of the RPE65-substrate complex clarified, we delineate a mechanism of catalysis that reconciles the extensive biochemical and structural research on this enzyme. These data provide molecular foundations for understanding a key process in vision and pharmacological inhibition of RPE65 with small molecules.	[Kiser, Philip D.; Zhang, Jianye; Sui, Xuewu; Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Dept Pharmacol, Cleveland, OH 44106 USA; [Badiee, Mohsen; Li, Qingjiang; Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Shi, Wuxian] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Shi, Wuxian] Case Western Reserve Univ, Sch Med, Case Ctr Synchrotron Biosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; Case Western Reserve University	Kiser, PD (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Dept Pharmacol, Cleveland, OH 44106 USA.	kxp65@case.edu		Badiee, Mohsen/0000-0003-3722-4609	US National Institutes of Health [EY023948, EY009339, EY021126, CA157735]; Department of Veterans Affairs [IK2BX002683]; National Science Foundation [MCB-084480]; Office of Biological and Environmental Research of US Department of Energy (DOE); National Center for Research Resources [P41RR012408]; National Institute of General Medical Sciences of National Institutes of Health [P41GM103473]; National Institute of Biomedical Imaging and Bioengineering [P30-EB-09998]; National Institute of General Medical Sciences [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; Office of Basic Energy Sciences of US Department of Energy (DOE); NATIONAL CANCER INSTITUTE [R01CA157735] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY021126, R01EY009339, R01EY023948, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research of US Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences of US Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L.T. Webster Jr. for helpful comments on this manuscript. This work was supported by funding from US National Institutes of Health grants EY023948 (M.G.), EY009339 (K.P.), EY021126 (K.P.) and CA157735 (G.P.T.), Department of Veterans Affairs IK2BX002683 (P.D.K.) and National Science Foundation MCB-084480 (G.P.T.). Data for this study were measured at beamline X29 of the National Synchrotron Light Source. Financial support came principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy (DOE) and from the National Center for Research Resources (P41RR012408), the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health and the National Institute of Biomedical Imaging and Bioengineering (P30-EB-09998). We thank the staff at the Advanced Photon Source Northeastern Collaborative Access Team beamlines, supported by a grant from the National Institute of General Medical Sciences (P41 GM103403), for assistance with collection of preliminary diffraction data. This research used resources of the Advanced Photon Source, a US DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. K.P. is John H. Hord Professor of Pharmacology.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhat S, 2006, PROTEINS, V62, P244, DOI 10.1002/prot.20682; Blatz P. E., 1968, CHEM COMMUN, V176; BLATZ PE, 1968, J AM CHEM SOC, V90, P1296, DOI 10.1021/ja01007a033; Caspi DD, 2004, ADV SYNTH CATAL, V346, P185, DOI 10.1002/adsc.200303188; Chander P, 2012, J BIOL CHEM, V287, P30552, DOI 10.1074/jbc.M112.364596; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crombie BS, 2001, J CHEM SOC PERK T 1, P206, DOI 10.1039/b005617k; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Jang GF, 2000, J BIOL CHEM, V275, P28128; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirby AJ., 1972, COMPR CHEM KINETICS, V10, P57, DOI 10.1016/s0069-8040(08)70344-3; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kubota R, 2014, RETINA-J RET VIT DIS, V34, P603, DOI 10.1097/01.iae.0000434565.80060.f8; LAW WC, 1988, BIOCHEMISTRY-US, V27, P4147, DOI 10.1021/bi00411a037; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pakhomova S, 2001, NAT STRUCT BIOL, V8, P447, DOI 10.1038/87617; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Scott I. L., 2010, WO Patent, Patent No. 2010048332; Scott I. L., 2009, WO Patent, Patent No. 2009045479; Smith M. B., 2001, MARCHS ADV ORGANIC C, V5th, P389; SRIKRISHNA A, 1993, J CHEM SOC PERK T 1, P667, DOI 10.1039/p19930000667; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Sui XW, 2014, J BIOL CHEM, V289, P12286, DOI 10.1074/jbc.M114.552836; Takahashi Y, 2012, BIOCHEMISTRY-US, V51, P4217, DOI 10.1021/bi300144n; Tickle IJ, 2012, ACTA CRYSTALLOGR D, V68, P454, DOI 10.1107/S0907444911035918; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	50	51	51	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					409	+		10.1038/NCHEMBIO.1799	http://dx.doi.org/10.1038/NCHEMBIO.1799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25894083	Green Accepted, Green Submitted			2022-12-25	WOS:000354539400011
J	Long, AH; Haso, WM; Shern, JF; Wanhainen, KM; Murgai, M; Ingaramo, M; Smith, JP; Walker, AJ; Kohler, ME; Venkateshwara, VR; Kaplan, RN; Patterson, GH; Fry, TJ; Orentas, RJ; Mackall, CL				Long, Adrienne H.; Haso, Waleed M.; Shern, Jack F.; Wanhainen, Kelsey M.; Murgai, Meera; Ingaramo, Maria; Smith, Jillian P.; Walker, Alec J.; Kohler, M. Eric; Venkateshwara, Vikas R.; Kaplan, Rosandra N.; Patterson, George H.; Fry, Terry J.; Orentas, Rimas J.; Mackall, Crystal L.			4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors	NATURE MEDICINE			English	Article							SINGLE-CHAIN FV; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; ENHANCED SURVIVAL; CLINICAL-TRIAL; CD28; PERSISTENCE; ANTIBODY; MEMORY; DOMAIN	Chimeric antigen receptors (CARs) targeting CD19 have mediated dramatic antitumor responses in hematologic malignancies, but tumor regression has rarely occurred using CARs targeting other antigens. It remains unknown whether the impressive effects of CD19 CARs relate to greater susceptibility of hematologic malignancies to CAR therapies, or superior functionality of the CD19 CAR itself. We show that tonic CAR CD3-zeta, phosphorylation, triggered by antigen-independent clustering of CAR single-chain variable fragments, can induce early exhaustion of CAR T cells that limits antitumor efficacy. Such activation is present to varying degrees in all CARs studied, except the highly effective CD19 CAR. We further determine that CD28 costimulation augments, whereas 4-1BB costimulation reduces, exhaustion induced by persistent CAR signaling. Our results provide biological explanations for the antitumor effects of CD19 CARs and for the observations that CD19 CAR T cells incorporating the 4-1BB costimulatory domain are more persistent than those incorporating CD28 in clinical trials.	[Long, Adrienne H.; Haso, Waleed M.; Shern, Jack F.; Wanhainen, Kelsey M.; Murgai, Meera; Smith, Jillian P.; Walker, Alec J.; Kohler, M. Eric; Venkateshwara, Vikas R.; Kaplan, Rosandra N.; Fry, Terry J.; Orentas, Rimas J.; Mackall, Crystal L.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Long, Adrienne H.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Wanhainen, Kelsey M.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Ingaramo, Maria; Patterson, George H.] Natl Inst Biomed Imaging & Bioengn, Sect Biophoton, NIH, Bethesda, MD USA; [Kohler, M. Eric] Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine; Colgate University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Johns Hopkins University; Johns Hopkins Medicine	Mackall, CL (corresponding author), NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mackallc@mail.nih.gov	Shern, Jack/V-4002-2019; Murgai, Meera/AAW-1114-2021; Patterson, George/ABI-4751-2020	Kohler, Mark/0000-0002-1181-0418; Long, Adrienne/0000-0002-1523-9095; Wanhainen, Kelsey/0000-0001-8666-0584; Murgai, Meera/0000-0001-5015-839X	NIH, NCI; NIH, National Institute of Biomedical Imaging and Bioengineering (NIBIB) [ZIA BC 011073, ZIA BC 011565, ZIA BC 011332, ZIA EB 000071-06]; Stand Up To Cancer - St. Baldrick's - NCI Pediatric Dream Team Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE [ZIABC011073, T32CA060441, ZIABC011565, ZIABC011332, ZIABC011734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000071] Funding Source: NIH RePORTER	NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Stand Up To Cancer - St. Baldrick's - NCI Pediatric Dream Team Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We kindly thank S. Gottschalk (Texas Children's Hospital) for providing sequences for the 14g2a scFv and IgG<INF>1</INF> CH<INF>2</INF>CH<INF>3</INF>; J. Kochenderfer (National Cancer Institute, NCI, US National Institutes of Health, NIH) for the H3 MSGV-FMC63-28z retroviral vector producer line; S. Grupp (Children's Hospital of Philadelphia) for the NALM6-GL cell line; R. Morgan (BlueBird Bio, previously NCI, NIH) for the MSGV-139-28z and MSGV-4D5-28BBz vectors; and C. June (University of Pennsylvania) for sequences to the 4-1BB CAR endodomain. We also thank L. Cooper (M.D. Anderson) for providing the 136.20.1, FMC63 anti-idiotype antibody; the Biological Research Branch of NCI for providing the 1A7, 14g2a anti-idiotype antibody; the Clinical Support Laboratory of the Frederick National Laboratory for Cancer Research (FNLCR) for assisting in MesoScale cytokine release assays; and the Laboratory of Molecular Technology (LMT) Microarray Group of FNLCR for assisting in microarray assays. We thank N. Restifo and M. Roederer for careful review of this manuscript. This work was supported by the Intramural Research Program of the NIH, including the NCI and the National Institute of Biomedical Imaging and Bioengineering (NIBIB): ZIA BC 011073 (A.H.L., K.M.W., J.P.S., A.J.W., M.E.K., V.R.V., R.J.O. and C.L.M); ZIA BC 011565 (W.M.H. and T.J.F.); ZIA BC 011332 (M.M. and R.N.K.); and ZIA EB 000071-06 (M.I. and G.H.P.) This research was also supported by a Stand Up To Cancer - St. Baldrick's - NCI Pediatric Dream Team Translational Cancer Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Dittus C, 2013, BLOOD, V122, P4162, DOI 10.1182/blood-2013-08-519306; Dodson LF, 2009, MOL CELL BIOL, V29, P3710, DOI 10.1128/MCB.01869-08; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dolezal O, 2003, PROTEIN ENG, V16, P47, DOI 10.1093/proeng/gzg006; Friend LD, 2006, J EXP MED, V203, P2121, DOI 10.1084/jem.20052230; Frigault M.J., 2015, CANC IMMUNOL RES; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guest RD, 2005, J IMMUNOTHER, V28, P203, DOI 10.1097/01.cji.0000161397.96582.59; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; James ST, 2008, J IMMUNOL, V180, P7028, DOI 10.4049/jimmunol.180.10.7028; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2012, CLIN CANCER RES, V18, P2780, DOI 10.1158/1078-0432.CCR-11-1920; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Nieba L, 1997, PROTEIN ENG, V10, P435, DOI 10.1093/protein/10.4.435; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rossig C, 2001, INT J CANCER, V94, P228, DOI 10.1002/ijc.1457; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vezys V, 2011, J IMMUNOL, V187, P1634, DOI 10.4049/jimmunol.1100077; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang C, 2007, J IMMUNOL, V179, P8252, DOI 10.4049/jimmunol.179.12.8252; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WHITLOW M, 1994, PROTEIN ENG, V7, P1017, DOI 10.1093/protein/7.8.1017; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425	56	888	969	5	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					581	590		10.1038/nm.3838	http://dx.doi.org/10.1038/nm.3838			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25939063	Green Accepted			2022-12-25	WOS:000355778300014
J	Chimen, M; McGettrick, HM; Apta, B; Kuravi, SJ; Yates, CM; Kennedy, A; Odedra, A; Alassiri, M; Harrison, M; Martin, A; Barone, F; Nayar, S; Hitchcock, JR; Cunningham, AF; Raza, K; Filer, A; Copland, DA; Dick, AD; Robinson, J; Kalia, N; Walker, LSK; Buckley, CD; Nash, GB; Narendran, P; Rainger, GE				Chimen, Myriam; McGettrick, Helen M.; Apta, Bonita; Kuravi, Sahithi J.; Yates, Clara M.; Kennedy, Amy; Odedra, Arjun; Alassiri, Mohammed; Harrison, Matthew; Martin, Ashley; Barone, Francesca; Nayar, Saba; Hitchcock, Jessica R.; Cunningham, Adam F.; Raza, Karim; Filer, Andrew; Copland, David A.; Dick, Andrew D.; Robinson, Joseph; Kalia, Neena; Walker, Lucy S. K.; Buckley, Christopher D.; Nash, Gerard B.; Narendran, Parth; Rainger, G. Ed			Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease	NATURE MEDICINE			English	Article							SPHINGOSINE-1-PHOSPHATE TRANSPORTER SPNS2; ENDOTHELIAL-CELLS; LYMPHOCYTE TRAFFICKING; VASCULAR ENDOTHELIUM; SPHINGOSINE 1-PHOSPHATE; ADIPONECTIN RECEPTORS; RHEUMATOID-ARTHRITIS; ADHESION CASCADE; 14-3-3 PROTEINS; RECRUITMENT	During an inflammatory response, lymphocyte recruitment into tissue must be tightly controlled because dysregulated trafficking contributes to the pathogenesis of chronic disease. Here we show that during inflammation and in response to adiponectin, B cells tonically inhibit T cell trafficking by secreting a peptide (PEPITEM) proteolytically derived from 14.3.3 zeta delta (14.3.3. zeta delta) protein. PEPITEM binds cadherin-15 on endothelial cells, promoting synthesis and release of sphingosine-1 phosphate, which inhibits trafficking of T cells without affecting recruitment of other leukocytes. Expression of adiponectin receptors on B cells and adiponectin-induced PEPITEM secretion wanes with age, implying immune senescence of the pathway. Additionally, these changes are evident in individuals with type 1 diabetes or rheumatoid arthritis, and circulating PEPITEM in patient serum is reduced compared to that of healthy age-matched donors. In both diseases, tonic inhibition of T cell trafficking across inflamed endothelium is lost. Control of patient T cell trafficking is re-established by treatment with exogenous PEPITEM. Moreover, in animal models of peritonitis, hepatic ischemia-reperfusion injury, Salmonella infection, uveitis and Sjogren's syndrome, PEPITEM reduced T cell recruitment into inflamed tissues.	[Chimen, Myriam; Apta, Bonita; Kuravi, Sahithi J.; Yates, Clara M.; Kennedy, Amy; Odedra, Arjun; Alassiri, Mohammed; Harrison, Matthew; Robinson, Joseph; Kalia, Neena; Nash, Gerard B.; Narendran, Parth; Rainger, G. Ed] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [McGettrick, Helen M.; Barone, Francesca; Nayar, Saba; Raza, Karim; Filer, Andrew; Buckley, Christopher D.] Univ Birmingham, Coll Med & Dent Sci, Arthrit Res UK Ctr Excellence Pathogenesis Rheuma, Rheumatol Res Grp,Sch Immun & Infect, Birmingham, W Midlands, England; [Kennedy, Amy; Narendran, Parth] Univ Hosp Birmingham NHS Fdn Trust, Dept Diabet, Birmingham, W Midlands, England; [Martin, Ashley] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Barone, Francesca; Raza, Karim; Buckley, Christopher D.] Sandwell & West Birmingham Hosp Natl Hlth Serv NH, Dept Rheumatol, Birmingham, W Midlands, England; [Hitchcock, Jessica R.; Cunningham, Adam F.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England; [Filer, Andrew] Univ Hosp Birmingham NHS Fdn Trust, Dept Rheumatol, Birmingham, W Midlands, England; [Copland, David A.; Dick, Andrew D.] Univ Bristol, Sch Clin Sci, Acad Unit Ophthalmol, Bristol, Avon, England; [Dick, Andrew D.] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, Bristol, Avon, England; [Dick, Andrew D.] UCL, Inst Ophthalmol, London, England; [Dick, Andrew D.] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England; [Dick, Andrew D.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Walker, Lucy S. K.] UCL, Sch Med, Inst Immun & Transplantat, London W1N 8AA, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Bristol; University of Bristol; University of London; University College London; UCL Medical School	Rainger, GE (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England.	p.narendran@bham.ac.uk; g.e.rainger@bham.ac.uk	Filer, Andrew/AAP-9179-2021; Buckley, Christopher/AAN-6378-2021; Copland, David/AAE-5334-2020; Raza, Karim/AAN-3089-2021; Nash, Gerard B/E-4182-2010; McGettrick, Helen M/H-3442-2011; Chimen, Myriam/D-6344-2015; Alassiri, Mohammed/GRO-0324-2022; Copland, David/AAG-2368-2019	Filer, Andrew/0000-0001-8164-6249; Buckley, Christopher/0000-0001-6924-6402; Copland, David/0000-0002-2257-4270; Raza, Karim/0000-0003-1570-1232; Nash, Gerard B/0000-0002-5935-2831; McGettrick, Helen M/0000-0002-5950-8840; Chimen, Myriam/0000-0002-3567-1731; KALIA, NEENA/0000-0003-2960-7829; Narendran, Parth/0000-0002-4583-8793; Cunningham, Adam/0000-0003-0248-964X; Barone, Francesca/0000-0002-5287-9614; Dick, Andrew/0000-0002-0742-3159; NAYAR, SABA/0000-0002-4350-110X; Walker, Lucy/0000-0001-5986-5015	Diabetes UK [097825/Z/11/A]; Wellcome Trust [ISSF 12/13-097825/Z/11/A]; Society for Endocrinology; Medical Research Council [CIC 12011, G0802382]; Juvenile Diabetes Research Foundation [5-2013-207]; British Heart Foundation [PG/11/49/28983, RG/12/7/29693]; Arthritis Research UK [19899, 18547]; National Institute for Health Research [PB-PG-0609-19093]; Wellcome Trust; National Institute for Health Research/Wellcome Trust;  [FP7-HEALTH-F2-2012-305549]; BBSRC [BB/L009986/1] Funding Source: UKRI; MRC [G0802382, MC_PC_12011, MR/K00414X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L009986/1] Funding Source: researchfish; Medical Research Council [MR/K00414X/1, MC_PC_12011] Funding Source: researchfish; Versus Arthritis [19791, 19899, 20088] Funding Source: researchfish	Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome Trust); Society for Endocrinology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); British Heart Foundation(British Heart Foundation); Arthritis Research UK(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); National Institute for Health Research/Wellcome Trust; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	The authors thank A. Sams and S. Tullin from Novo Nordisk for providing high-molecular-weight recombinant adiponectin. We are grateful to N. Shimwell and D. Ward for assistance with mass spectrometry, and to G. Pui Choy for her help with animal experiments (all from the University of Birmingham, UK). Thanks also to N. Hogg (Cancer Research UK, London Research Institute, UK) for the activation epitope-sensitive anti-LFA-1 antibody, KIM127. We also thank C. McDonnel (GE Healthcare) for her help with the Biacore experiments and R. A. Kingsley for the Salmonella Typhimurium strain SL3261 (Wellcome Trust Sanger Institute, Cambridge, UK). We also thank D. Hardie for helping with the automated cell sorting (University of Birmingham, UK) and the University of Bristol Flow Cytometry Facility. We thank P. Nightingale (University Hospitals Birmingham NHS Trust) for advice on statistical analysis. This work was supported by grants from Diabetes UK (P.N., G.E.R.) (097825/Z/11/A), the Wellcome Trust (P.N., G. E. R.; ISSF 12/13-097825/Z/11/A), an Early Career Award from the Society for Endocrinology (M. C.), the Medical Research Council (CIC 12011) a senior fellowship for L. S. K. W. (G0802382) and the Juvenile Diabetes Research Foundation (P. N., G. E. R.; 5-2013-207). Work in the laboratories of G. E. R. is supported by the British Heart Foundation at Project grant (PG/11/49/28983) and Programme grant (RG/12/7/29693) level. H. M. M. was supported by an Arthritis Research UK Career Development Fellowship (19899). A. K. was supported by a National Institute for Health Research, Research for Patient Benefit (PB-PG-0609-19093). F. B. is supported by a Wellcome Trust Clinician Scientist Fellowship. A. F. was supported by an Arthritis Research UK Clinician Scientist Fellowship (18547). The research leading to the rheumatoid arthritis subject data was funded within the FP7 HEALTH programme under the grant agreement FP7-HEALTH-F2-2012-305549. This report is independent research which was partly supported by the National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Ahmed SR, 2011, J IMMUNOL, V187, P1432, DOI 10.4049/jimmunol.1100299; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andrew DP, 1998, EUR J IMMUNOL, V28, P1959, DOI 10.1002/(SICI)1521-4141(199806)28:06<1959::AID-IMMU1959>3.0.CO;2-4; Bombardieri M, 2012, J IMMUNOL, V189, P3767, DOI 10.4049/jimmunol.1201216; BREZINSCHEK RI, 1995, J IMMUNOL, V154, P3062; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Butler LM, 2005, EXP CELL RES, V310, P22, DOI 10.1016/j.yexcr.2005.07.001; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; De Vita S, 2002, ARTHRITIS RHEUM, V46, P2029, DOI 10.1002/art.10467; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Eidhammer I., 2012, COMPUTATIONAL STAT M; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Finnegan A, 2012, AUTOIMMUNITY, V45, P353, DOI 10.3109/08916934.2012.665526; Flores-Langarica A, 2012, J IMMUNOL, V189, P5745, DOI 10.4049/jimmunol.1202283; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Garcia-Guzman M, 1999, J BIOL CHEM, V274, P5762, DOI 10.1074/jbc.274.9.5762; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Han DC, 2001, ONCOGENE, V20, P346, DOI 10.1038/sj.onc.1204068; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Johansson C, 2006, MICROB PATHOGENESIS, V41, P49, DOI 10.1016/j.micpath.2006.03.004; JONES DA, 1994, J CLIN INVEST, V94, P2443, DOI 10.1172/JCI117612; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kerr EC, 2008, J AUTOIMMUN, V31, P354, DOI 10.1016/j.jaut.2008.08.006; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lodygin D, 2005, CELL RES, V15, P237, DOI 10.1038/sj.cr.7290292; LUSCINSKAS FW, 1995, J EXP MED, V181, P1179, DOI 10.1084/jem.181.3.1179; Ma L, 2012, J IMMUNOL, V189, P4104, DOI 10.4049/jimmunol.1201739; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGettrick HM, 2009, J LEUKOCYTE BIOL, V85, P98, DOI 10.1189/jlb.0508301; Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P710, DOI 10.1016/j.biocel.2006.02.004; Pang TTL, 2008, ANN NY ACAD SCI, V1150, P143, DOI 10.1196/annals.1447.021; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Piali L, 1998, EUR J IMMUNOL, V28, P961, DOI 10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4; POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001; Rainger GE, 2001, J IMMUNOL METHODS, V255, P73, DOI 10.1016/S0022-1759(01)00427-6; Rajakariarl R, 2008, BLOOD, V111, P4184, DOI 10.1182/blood-2007-08-108936; Rodriguez LG, 2005, J CELL PHYSIOL, V202, P285, DOI 10.1002/jcp.20122; Roviezzo F, 2011, J PHARMACOL EXP THER, V337, P830, DOI 10.1124/jpet.111.179168; Sattler K, 2009, CARDIOVASC RES, V82, P201, DOI 10.1093/cvr/cvp070; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; YAGO T, 1995, J IMMUNOL, V154, P1216; Yuan YH, 2009, CIRC RES, V105, P1177, DOI 10.1161/CIRCRESAHA.109.204669	67	70	75	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					467	U244		10.1038/nm.3842	http://dx.doi.org/10.1038/nm.3842			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25894827	Green Accepted, Green Submitted			2022-12-25	WOS:000354068800013
J	Lorchner, H; Poling, J; Gajawada, P; Hou, YL; Polyakova, V; Kostin, S; Adrian-Segarra, JM; Boettger, T; Wietelmann, A; Warnecke, H; Richter, M; Kubin, T; Braun, T				Loerchner, Holger; Poeling, Jochen; Gajawada, Praveen; Hou, Yunlong; Polyakova, Viktoria; Kostin, Sawa; Adrian-Segarra, Juan M.; Boettger, Thomas; Wietelmann, Astrid; Warnecke, Henning; Richter, Manfred; Kubin, Thomas; Braun, Thomas			Myocardial healing requires Reg3 beta-dependent accumulation of macrophages in the ischemic heart	NATURE MEDICINE			English	Article							PANCREATITIS-ASSOCIATED PROTEIN; SMOOTH-MUSCLE-CELLS; ONCOSTATIN-M; INFLAMMATORY RESPONSE; CARDIAC REPAIR; STEADY-STATE; INFARCTION; EXPRESSION; GROWTH; INTERLEUKIN-6	Cardiac healing after myocardial ischemia depends on the recruitment and local expansion of myeloid cells, particularly macrophages. Here we identify Reg3 beta as an essential regulator of macrophage trafficking to the damaged heart. Using mass spectrometry-based secretome analysis, we found that dedifferentiating cardiomyocytes release Reg3 beta in response to the cytokine OSM, which signals through Jak1 and Stat3. Loss of Reg3 beta led to a large decrease in the number of macrophages in the ischemic heart, accompanied by increased ventricular dilatation and insufficient removal of neutrophils. This defect in neutrophil removal in turn caused enhanced matrix degradation, delayed collagen deposition and increased susceptibility to cardiac rupture. Our data indicate that OSM, acting through distinct intracellular pathways, regulates both cardiomyocyte dedifferentiation and cardiomyocyte-dependent regulation of macrophage trafficking. Release of OSM from infiltrating neutrophils and macrophages initiates a positive feedback loop in which OSM-induced production of Reg3 beta in cardiomyocytes attracts additional OSM-secreting macrophages. The activity of the feedback loop controls the degree of macrophage accumulation in the heart, which is instrumental in myocardial healing.	[Loerchner, Holger; Poeling, Jochen; Gajawada, Praveen; Hou, Yunlong; Polyakova, Viktoria; Kostin, Sawa; Adrian-Segarra, Juan M.; Boettger, Thomas; Wietelmann, Astrid; Kubin, Thomas; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany; [Poeling, Jochen; Warnecke, Henning] Schuchtermann Clin, Dept Cardiac Surg, Bad Rothenfelde, Germany; [Richter, Manfred] Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, Dept Cardiac Surg, Bad Nauheim, Germany	Max Planck Society; Kerckhoff Clinic; Max Planck Society	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany.	jochen.poeling@mpi-bn.mpg.de; thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Boettger, Thomas/E-3406-2012	Boettger, Thomas/0000-0003-4280-8449; Adrian-Segarra, Juan M./0000-0002-3712-0554; Braun, Thomas/0000-0002-6165-4804	Foundation Leducq; Excellence Initiative "Cardiopulmonary System,"; Cell and Gene Therapy Center (CGT); German Center for Cardiovascular Research	Foundation Leducq(Leducq Foundation); Excellence Initiative "Cardiopulmonary System,"; Cell and Gene Therapy Center (CGT); German Center for Cardiovascular Research	We thank J. Wetzel, K. Richter, B. Matzke, U. Hofmann and S. Thomas for excellent technical assistance. We are indebted to A. Miyajima (University of Tokyo, Tokyo, Japan) and S. Hunt (University College London, London, UK) for the generous gifts of OSMR-deficient and Reg3 beta-deficient mice, respectively. This work was supported by the Foundation Leducq, the Excellence Initiative "Cardiopulmonary System," the Cell and Gene Therapy Center (CGT) and the German Center for Cardiovascular Research (DZHK).	Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Benigni F, 1996, BLOOD, V87, P1851, DOI 10.1182/blood.V87.5.1851.bloodjournal8751851; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Closa D, 2007, WORLD J GASTROENTERO, V13, P170, DOI 10.3748/wjg.v13.i2.170; COX G, 1995, AM J RESP CELL MOL, V12, P232, DOI 10.1165/ajrcmb.12.2.7865221; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dobaczewski M, 2008, FUTUR CARDIOL, V4, P347, DOI 10.2217/14796678.4.4.347; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Elsasser A, 2000, MOL CELL BIOCHEM, V213, P17, DOI 10.1023/A:1007182617215; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045; Frangogiannis NG, 2004, INFLAMM RES, V53, P585, DOI 10.1007/s00011-004-1298-5; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Frangogiannis NG, 2004, CURR VASC PHARMACOL, V2, P163, DOI 10.2174/1570161043476375; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; Grenier A, 1999, BLOOD, V93, P1413, DOI 10.1182/blood.V93.4.1413.404k06_1413_1421; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hintzen C, 2008, J IMMUNOL, V181, P7341, DOI 10.4049/jimmunol.181.10.7341; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; Irwin MW, 1999, CIRCULATION, V99, P1492, DOI 10.1161/01.CIR.99.11.1492; Iversen PO, 2001, AM J PHYSIOL-HEART C, V281, pH2211, DOI 10.1152/ajpheart.2001.281.5.H2211; Jiang BB, 2010, J CARDIOVASC TRANSL, V3, P410, DOI 10.1007/s12265-010-9193-7; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Kiji T, 2005, AM J PHYSIOL-HEART C, V289, pH277, DOI 10.1152/ajpheart.01206.2004; Kosmala W, 2005, INT J CARDIOL, V101, P449, DOI 10.1016/j.ijcard.2004.03.067; Kubin T, 2003, MOL CELL BIOCHEM, V242, P39, DOI 10.1023/A:1021177326151; Kubin T, 1999, AM J PHYSIOL-HEART C, V276, pH2179, DOI 10.1152/ajpheart.1999.276.6.H2179; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lieu HT, 2006, HEPATOLOGY, V44, P1452, DOI 10.1002/hep.21434; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Mortier A, 2012, IMMUNOL LETT, V145, P2, DOI 10.1016/j.imlet.2012.04.015; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Namikawa K, 2006, J NEUROSCI, V26, P7460, DOI 10.1523/JNEUROSCI.0023-06.2006; Neuhaus P, 2003, MOL CELL BIOL, V23, P6037, DOI 10.1128/MCB.23.17.6037-6048.2003; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; RADKA SF, 1993, J IMMUNOL, V150, P5195; Stross C, 2006, J BIOL CHEM, V281, P8458, DOI 10.1074/jbc.M511212200; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tofaris GK, 2002, J NEUROSCI, V22, P6696; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Virag JAI, 2011, JOVE-J VIS EXP, DOI 10.3791/2581; Watanabe R, 2008, TRANSL RES, V152, P119, DOI 10.1016/j.trsl.2008.07.006; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Wilkinson P. C., 1996, Methods (Orlando), V10, P74, DOI 10.1006/meth.1996.0081; Zamilpa R, 2011, AM J PHYSIOL-HEART C, V300, pH1418, DOI 10.1152/ajpheart.01002.2010; Zidar N, 2005, CARDIOVASC PATHOL, V14, P247, DOI 10.1016/j.carpath.2005.04.002	60	115	118	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					353	+		10.1038/nm.3816	http://dx.doi.org/10.1038/nm.3816			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25751817				2022-12-25	WOS:000352493600017
J	Gonzales, PR; Pesesky, MW; Bouley, R; Ballard, A; Biddy, BA; Suckow, MA; Wolter, WR; Schroeder, VA; Burnham, CAD; Mobashery, S; Chang, M; Dantas, G				Gonzales, Patrick R.; Pesesky, Mitchell W.; Bouley, Renee; Ballard, Anna; Biddy, Brent A.; Suckow, Mark A.; Wolter, William R.; Schroeder, Valerie A.; Burnham, Carey-Ann D.; Mobashery, Shahriar; Chang, Mayland; Dantas, Gautam			Synergistic, collaterally sensitive beta-lactam combinations suppress resistance in MRSA	NATURE CHEMICAL BIOLOGY			English	Article							PENICILLIN-BINDING PROTEINS; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL AGENTS; ANTIBIOTICS; MEROPENEM; 2A; PHARMACOKINETICS; EXPRESSION; MECHANISM; EVOLUTION	Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most prevalent multidrug-resistant pathogens worldwide, exhibiting increasing resistance to the latest antibiotic therapies. Here we show that the triple beta-lactam combination meropenem-piperacillin-tazobactam (ME/PI/TZ) acts synergistically and is bactericidal against MRSA subspecies N315 and 72 other clinical MRSA isolates in vitro and clears MRSA N315 infection in a mouse model. ME/PI/TZ suppresses evolution of resistance in MRSA via reciprocal collateral sensitivity of its constituents. We demonstrate that these activities also extend to other carbapenem-penicillin-beta-lactamase inhibitor combinations. ME/PI/TZ circumvents the tight regulation of the mec and bla operons in MRSA, the basis for inducible resistance to beta-lactam antibiotics. Furthermore, ME/PI/TZ subverts the function of penicillin-binding protein-2a (PBP2a) via allostery, which we propose as the mechanism for both synergy and collateral sensitivity. Showing in vivo activity similar to that of linezolid, ME/PI/TZ demonstrates that combinations of older beta-lactam antibiotics could be effective against MRSA infections in humans.	[Gonzales, Patrick R.; Pesesky, Mitchell W.; Ballard, Anna; Biddy, Brent A.; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Bouley, Renee; Mobashery, Shahriar; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Suckow, Mark A.; Wolter, William R.; Schroeder, Valerie A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Suckow, Mark A.; Wolter, William R.; Schroeder, Valerie A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Burnham, Carey-Ann D.; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Burnham, Carey-Ann D.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); University of Notre Dame; University of Notre Dame; University of Notre Dame; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gonzales, PR (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA.	dantas@wustl.edu	Bouley, Renee/AAG-7186-2019; Gonzales, Patrick Rolland/ABC-3669-2021	Bouley, Renee/0000-0002-1358-0994; Dantas, Gautam/0000-0003-0455-8370; Biddy, Brent/0000-0003-1554-6340; Suckow, Mark/0000-0001-7317-697X; Gonzales, Patrick/0000-0003-1594-0233	NIH; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [DP2DK098089, R01GM099538]; National Institute of Allergy and Infectious Diseases of the NIH [AI90818, AI104987]; NIGMS Cell and Molecular Biology Training Grant [GM007067]; NIH [T32 GM075762, F31 AI115851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090818, F31AI115851, R01AI104987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK098089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762, T32GM007067, R01GM099538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS Cell and Molecular Biology Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Mitra for discussions about SNP calling and NGS data analysis; M. Wallace for MRSA SCCmec typing; B. Wang for technical advice on genomic preparations and sequencing; C. Munck, M. Sommer and J. Lehar regarding prior discussions of 23 antibiotics chosen for combinatorial screening; J. Marasa for screening optimization; J. Fries for optimization of plate reader assays; K. Forsberg for discussions on mechanisms of reciprocal collateral sensitivity; T. Crofts for antibiotic structures in figures; and members of G.D.'s lab for helpful general discussion of the project and manuscript. We thank T. Roemer of Merck Research Laboratories for the kind gift of the antisense strains. This work was supported in part by the NIH Director's New Innovator Award, the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of General Medical Sciences of the National Institutes of Health (NIH) under award numbers DP2DK098089 and R01GM099538 to G.D. It is also supported in part by the National Institute of Allergy and Infectious Diseases of the NIH under award numbers AI90818 to M.C. and S.M. and AI104987 to S.M. M.W.P. was supported by the NIGMS Cell and Molecular Biology Training Grant (GM007067). R.B. was supported by T32 GM075762 and by an individual Ruth L. Kirschstein National Research Service Award F31 AI115851 from the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Ankomah P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003300; Arede P, 2013, ANTIMICROB AGENTS CH, V57, P3037, DOI 10.1128/AAC.02621-12; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Barry A.L., 1999, METHODS DETERMINING, V19; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Bhusal Y, 2005, INT J ANTIMICROB AG, V26, P292, DOI 10.1016/j.ijantimicag.2005.05.005; Blazquez B, 2014, BIOCHEMISTRY-US, V53, P1548, DOI 10.1021/bi500074w; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bouley R, 2015, J AM CHEM SOC, V137, P1738, DOI 10.1021/jacs.5b00056; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Campbell EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086971; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Craig WA, 1997, CLIN INFECT DIS, V24, pS266, DOI 10.1093/clinids/24.Supplement_2.S266; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DeRyke CA, 2007, ANTIMICROB AGENTS CH, V51, P1481, DOI 10.1128/AAC.00752-06; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fishovitz J, 2014, J AM CHEM SOC, V136, P9814, DOI 10.1021/ja5030657; Ford CW, 1996, ANTIMICROB AGENTS CH, V40, P1508, DOI 10.1128/AAC.40.6.1508; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Goldstein F, 2007, ANTIMICROB AGENTS CH, V51, P2514, DOI 10.1128/AAC.00040-07; Gu B, 2013, J ANTIMICROB CHEMOTH, V68, P4, DOI 10.1093/jac/dks354; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; KINZIG M, 1992, ANTIMICROB AGENTS CH, V36, P1997, DOI 10.1128/AAC.36.9.1997; Koga T, 2009, ANTIMICROB AGENTS CH, V53, P1238, DOI 10.1128/AAC.01433-08; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; Lee SH, 2011, CHEM BIOL, V18, P1379, DOI 10.1016/j.chembiol.2011.08.015; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Long SW, 2014, ANTIMICROB AGENTS CH, V58, P6668, DOI 10.1128/AAC.03622-14; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; MALOUIN F, 1986, ANTIMICROB AGENTS CH, V30, P1; Munck C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009940; Otero LH, 2013, P NATL ACAD SCI USA, V110, P16808, DOI 10.1073/pnas.1300118110; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Saiman L, 2007, PAEDIATR RESPIR REV, V8, P249, DOI 10.1016/j.prrv.2007.04.006; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; SOMANI P, 1988, ANTIMICROB AGENTS CH, V32, P530, DOI 10.1128/AAC.32.4.530; SONSTEIN SA, 1972, J BACTERIOL, V109, P262, DOI 10.1128/JB.109.1.262-265.1972; STUTMAN HR, 1984, ANTIMICROB AGENTS CH, V25, P212, DOI 10.1128/AAC.25.2.212; Tupin A, 2010, INT J ANTIMICROB AG, V35, P519, DOI 10.1016/j.ijantimicag.2009.12.017; van Hal SJ, 2011, EUR J CLIN MICROBIOL, V30, P603, DOI 10.1007/s10096-010-1128-3; Villegas-Estrada A, 2008, J AM CHEM SOC, V130, P9212, DOI 10.1021/ja8029448; Walsh T.R., 2011, LANCET INFECT DIS; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; YANG YJ, 1995, J ANTIMICROB CHEMOTH, V35, P75, DOI 10.1093/jac/35.1.75; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	54	90	92	0	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					855	U71		10.1038/nchembio.1911	http://dx.doi.org/10.1038/nchembio.1911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26368589	Green Accepted			2022-12-25	WOS:000363272100011
J	Spisak, S; Lawrenson, K; Fu, YF; Csabai, I; Cottman, RT; Seo, JH; Haiman, C; Han, Y; Lenci, R; Li, QY; Tisza, V; Szallasi, Z; Herbert, ZT; Chabot, M; Pomerantz, M; Solymosi, N; Gayther, SA; Joung, JK; Freedman, ML				Spisak, Sandor; Lawrenson, Kate; Fu, Yanfang; Csabai, Istvan; Cottman, Rebecca T.; Seo, Ji-Heui; Haiman, Christopher; Han, Ying; Lenci, Romina; Li, Qiyuan; Tisza, Viktoria; Szallasi, Zoltan; Herbert, Zachery T.; Chabot, Matthew; Pomerantz, Mark; Solymosi, Norbert; Gayther, Simon A.; Joung, J. Keith; Freedman, Matthew L.		GAME-ON ELLIPSE Consortium	CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants	NATURE MEDICINE			English	Article							OFF-TARGET CLEAVAGE; PROSTATE-CANCER; ENGINEERED NUCLEASES; WIDE ASSOCIATION; GENE-EXPRESSION; DISEASE; TALENS; DNA; CRISPR-CAS9; TRAITS	The vast majority of disease-associated single-nucleotide polymorphisms (SNPs) mapped by genome-wide association studies (GWASs) are located in the non-protein-coding genome, but establishing the functional and mechanistic roles of these sequence variants has proven challenging. Here we describe a general pipeline in which candidate functional SNPs are first evaluated by fine mapping, epigenomic profiling, and epigenome editing, and then interrogated for causal function by using genome editing to create isogenic cell lines followed by phenotypic characterization. To validate this approach, we analyzed the 6q22.1 prostate cancer risk locus and identified rs339331 as the top-scoring SNP. Epigenome editing confirmed that the rs339331 region possessed regulatory potential. By using transcription activator-like effector nuclease (TALEN)-mediated genome editing, we created a panel of isogenic 22Rv1 prostate cancer cell lines representing all three genotypes (TT, TC, CC) at rs339331. Introduction of the 'T' risk allele increased transcription of the regulatory factor 6 (RFX6) gene, increased homeobox B13 (HOXB13) binding at the rs339331 region, and increased deposition of the enhancer-associated H3K4me2 histone mark at the rs339331 region compared to lines homozygous for the 'C' protective allele. The cell lines also differed in cellular morphology and adhesion, and pathway analysis of differentially expressed genes suggested an influence of androgens. In summary, we have developed and validated a widely accessible approach that can be used to establish functional causality for noncoding sequence variants identified by GWASs.	[Spisak, Sandor; Seo, Ji-Heui; Lenci, Romina; Li, Qiyuan; Tisza, Viktoria; Chabot, Matthew; Pomerantz, Mark; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Spisak, Sandor; Seo, Ji-Heui; Lenci, Romina; Li, Qiyuan; Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Lawrenson, Kate; Haiman, Christopher; Han, Ying; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Fu, Yanfang; Cottman, Rebecca T.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Fu, Yanfang; Cottman, Rebecca T.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Fu, Yanfang; Cottman, Rebecca T.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Fu, Yanfang; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Csabai, Istvan] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Cottman, Rebecca T.; Joung, J. Keith] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Haiman, Christopher] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Li, Qiyuan] Xiamen Univ, Coll Med, Xiamen, Peoples R China; [Tisza, Viktoria; Szallasi, Zoltan] Boston Childrens Hosp, CHIP, Boston, MA USA; [Szallasi, Zoltan] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Szallasi, Zoltan] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Herbert, Zachery T.] Dana Farber Canc Inst, Mol Biol Core Facil, Boston, MA 02115 USA; [Solymosi, Norbert] Szent Istvan Univ, Dept Anim Hyg, Budapest, Hungary; [Gayther, Simon A.] Cedars Sinai Med Ctr, Ctr Canc Prevent & Translat Genom, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Freedman, Matthew L.] Eli & Edythe L Broad Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Southern California; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Eotvos Lorand University; Harvard University; Harvard Medical School; University of Southern California; Xiamen University; Harvard University; Boston Children's Hospital; Technical University of Denmark; Semmelweis University; Harvard University; Dana-Farber Cancer Institute; Hungarian University of Agriculture & Life Sciences; Cedars Sinai Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gayther, SA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	simon.gayther@cshs.org; jjoung@mgh.harvard.edu; freedman@broadinstitute.org	Solymosi, Norbert/B-5428-2012; Csabai, Istvan/F-6045-2011	Csabai, Istvan/0000-0001-9232-9898; Lenci, Romina/0000-0002-0025-3134; Lawrenson, Kate/0000-0002-6469-2515; Solymosi, Norbert/0000-0003-1783-2041; Szallasi, Zoltan/0000-0001-5395-7509; /0000-0003-4914-1157	US National Institutes of Health (NIH) [R01 GM107427]; NIH [DP1 GM105378]; Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; Prostate Cancer Foundation; US NIH [R01CA193910]; H.L. Snyder Medical Foundation; US National Cancer Institute GAME-ON Post-GWAS Initiative [U19CA148112, U19CA148537]; National Cancer Institute [1K99CA184415-01]; Hungarian National Research, Development and Innovation Office [KMR-12-1-2012-0216]; Hungarian National Research Fund [OTKA103244]; Breast Cancer Research Foundation; Szechenyi Progam, Hungary [KTIA_NAP_13-2014-0021]; Program Project Development Grant from the Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [K99CA184415, U19CA148112, R01CA193910, R00CA184415, U19CA148537, P50CA090381, R01CA129435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107427, DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; Prostate Cancer Foundation; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); H.L. Snyder Medical Foundation; US National Cancer Institute GAME-ON Post-GWAS Initiative; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Breast Cancer Research Foundation; Szechenyi Progam, Hungary; Program Project Development Grant from the Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M.L.F. and J.K.J. were supported by US National Institutes of Health (NIH) grant no. R01 GM107427; J.K.J. was supported by a NIH Director's Pioneer Award (DP1 GM105378) and The Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; M.L.F. is supported by the Prostate Cancer Foundation (Challenge Award), the US NIH grant no. R01CA193910, and the H.L. Snyder Medical Foundation. The scientific development and funding for this project were in part supported by the US National Cancer Institute GAME-ON Post-GWAS Initiative (U19CA148112 and U19CA148537). K.L. is supported by a K99/R00 grant from the National Cancer Institute (grant no. 1K99CA184415-01). I.C. is supported by grants from the Hungarian National Research, Development and Innovation Office (KMR-12-1-2012-0216) and the Hungarian National Research Fund (OTKA103244). Z.S. is supported by the Breast Cancer Research Foundation and the Szechenyi Progam, Hungary (KTIA_NAP_13-2014-0021). This project was also supported by a Program Project Development Grant from the Ovarian Cancer Research Fund (K.L. and SAG). We thank the Dana-Farber Cancer Institute Molecular Biology Core Facility for Sanger sequencing and Illumina high-throughput sequencing. We thank C. Nicolet at the University of Southern California Epigenome Center Core for RNA-seq services and M. Li at the University of Southern California Norris Medical Library Bioinformatics Center, who provided assistance with the analysis of RNA-seq data.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Han Y, 2015, HUM MOL GENET, V24, P5603, DOI 10.1093/hmg/ddv269; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Joung JK, 2015, NATURE, V523, P158, DOI 10.1038/523158a; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Knight JC, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0092-4; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ochiai H, 2014, P NATL ACAD SCI USA, V111, P1461, DOI 10.1073/pnas.1317008111; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127	25	65	66	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1357	1363		10.1038/nm.3975	http://dx.doi.org/10.1038/nm.3975			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26398868	Green Accepted, Green Submitted			2022-12-25	WOS:000364621200022
J	Li, YH; Zhou, QL; Sun, WJ; Chandrasekharan, P; Cheng, HS; Ying, Z; Lakshmanan, M; Raju, A; Tenen, DG; Cheng, SY; Chuang, KH; Li, J; Prabhakar, S; Li, MF; Tergaonkar, V				Li, Yinghui; Zhou, Qi-Ling; Sun, Wenjie; Chandrasekharan, Prashant; Cheng, Hui Shan; Ying, Zhe; Lakshmanan, Manikandan; Raju, Anandhkumar; Tenen, Daniel G.; Cheng, Shi-Yuan; Chuang, Kai-Hsiang; Li, Jun; Prabhakar, Shyam; Li, Mengfeng; Tergaonkar, Vinay			Non-canonical NF-kappa B signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation	NATURE CELL BIOLOGY			English	Article							TELOMERASE COMPONENTS; GENOMIC LANDSCAPE; DENDRITIC CELLS; WEAK INDUCER; KINASE NIK; STEM-CELLS; TRANSCRIPTION; MUTATIONS; CANCER; EXPRESSION	Transcriptional reactivation of TERT, the catalytic subunit of telomerase, is necessary for cancer progression in about 90% of human cancers. The recent discovery of two prevalent somatic mutations-C250T and C228T-in the TERT promoter in various cancers has provided insight into a plausible mechanism of TERT reactivation. Although the two hotspot mutations create a similar binding motif for E-twenty-six (ETS) transcription factors, we show that they are functionally distinct, in that the C250T unlike the C228T TERT promoter is driven by non-canonical NF-kappa B signalling. We demonstrate that binding of ETS to the mutant TERT promoter is insufficient in driving its transcription but this process requires non-canonical NF-kappa B signalling for stimulus responsiveness, sustained telomerase activity and hence cancer progression. Our findings highlight a previously unrecognized role of non-canonical NF-kappa B signalling in tumorigenesis and elucidate a fundamental mechanism for TERT reactivation in cancers, which if targeted could have immense therapeutic implications.	[Li, Yinghui; Zhou, Qi-Ling; Cheng, Hui Shan; Lakshmanan, Manikandan; Raju, Anandhkumar; Tergaonkar, Vinay] ASTAR, IMCB, Singapore 138673, Singapore; [Zhou, Qi-Ling; Tenen, Daniel G.] Canc Sci Inst Singapore, Singapore 117599, Singapore; [Sun, Wenjie; Prabhakar, Shyam] Genome Inst Singapore, Computat & Syst Biol, Singapore 138672, Singapore; [Chandrasekharan, Prashant; Chuang, Kai-Hsiang] Agcy Sci Technol & Res Singapore, Singapore Bioimaging Consortium, Lab Mol Imaging, Singapore 138667, Singapore; [Ying, Zhe; Li, Jun; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510080, Guangdong, Peoples R China; [Ying, Zhe; Li, Jun; Li, Mengfeng] Sun Yat Sen Univ, Chinese Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Cheng, Shi-Yuan] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Dept Neurol,Northwestern Brain Tumor Inst, Chicago, IL 60611 USA; [Cheng, Shi-Yuan] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Sun Yat Sen University; Sun Yat Sen University; Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Tergaonkar, V (corresponding author), ASTAR, IMCB, Singapore 138673, Singapore.	vinayt@imcb.a-star.edu.sg	meng, li/GVT-2063-2022; Li, Yinghui/K-8253-2018; Chandrasekharan, Prashant/I-2196-2019; Zhou, Qiling/AAB-2493-2021; Chandrasekharan, Prashant/C-5174-2011; Chuang, Kai-Hsiang/C-4224-2017	Chandrasekharan, Prashant/0000-0002-6139-1979; Li, Yinghui/0000-0002-9023-9466; Chuang, Kai-Hsiang/0000-0002-8356-0657	Agency for Science Technology and Research, Singapore (A*STAR); IMCB; A*STAR; IMCB Early Career Researcher (ECR) grant; NATIONAL CANCER INSTITUTE [R01CA159811, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093843, R01NS095634] Funding Source: NIH RePORTER	Agency for Science Technology and Research, Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); IMCB; A*STAR(Agency for Science Technology & Research (A*STAR)); IMCB Early Career Researcher (ECR) grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Agency for Science Technology and Research, Singapore (A*STAR) and IMCB for their financial support of this work. We are grateful to K. C. Low from IMCB for purification of recombinant proteins and cloning of shRNA and TERT promoter constructs. We thank H. C. Tay from SBIC for performing the surgery of mice and the Advanced Molecular Pathology Laboratory (AMPL) of IMCB for the histology work. Y.L. is supported by an A*STAR fellowship and an IMCB Early Career Researcher (ECR) grant.	Akincilar SC, 2015, FEBS LETT, V589, P974, DOI 10.1016/j.febslet.2015.02.035; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Bassuk AG, 1997, J VIROL, V71, P3563, DOI 10.1128/JVI.71.5.3563-3573.1997; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cherry EM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0273-1; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Counter CM, 1996, MUTAT RES-REV GENET, V366, P45, DOI 10.1016/S0165-1110(96)90006-8; Dey A., 2008, CELL CYCLE, V7, P3759; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greider CW, 2012, SCIENCE, V336, P1519, DOI 10.1126/science.1223785; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heidenreich B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4401; Heusch M, 1999, ONCOGENE, V18, P6201, DOI 10.1038/sj.onc.1203022; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jankowski A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-208; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kar A, 2013, CRIT REV BIOCHEM MOL, V48, P522, DOI 10.3109/10409238.2013.838202; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Koh CM, 2015, J CLIN INVEST, V125, P2109, DOI 10.1172/JCI79134; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Lee DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057489; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Lind EF, 2008, J IMMUNOL, V181, P354, DOI 10.4049/jimmunol.181.1.354; Longoni N, 2013, CANCER RES, V73, P4533, DOI 10.1158/0008-5472.CAN-12-4537; Low KC, 2013, TRENDS BIOCHEM SCI, V38, P426, DOI 10.1016/j.tibs.2013.07.001; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Newman JA, 2015, J BIOL CHEM, V290, P8539, DOI 10.1074/jbc.M114.619270; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Salzmann S, 2013, J BIOL CHEM, V288, P13455, DOI 10.1074/jbc.M112.435917; Sampl S, 2012, TRANSL ONCOL, V5, P56, DOI 10.1593/tlo.11202; Shin EM, 2014, J CLIN INVEST, V124, P3807, DOI 10.1172/JCI73451; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sun WJ, 2013, NUCLEIC ACIDS RES, V41, P5555, DOI 10.1093/nar/gkt250; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Thu YM, 2012, ONCOGENE, V31, P2580, DOI 10.1038/onc.2011.427; Tong L, 2014, BIOSCIENCE REP, V34, P283, DOI 10.1042/BSR20140021; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Yin L, 2000, J BIOL CHEM, V275, P36671, DOI 10.1074/jbc.M007378200; Zhang WZ, 2013, CANCER CELL, V23, P647, DOI 10.1016/j.ccr.2013.03.012; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037	67	130	132	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1327	+		10.1038/ncb3240	http://dx.doi.org/10.1038/ncb3240			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26389665	Green Accepted			2022-12-25	WOS:000362213500013
J	Deshaies, RJ				Deshaies, Raymond J.			Prime time for PROTACs	NATURE CHEMICAL BIOLOGY			English	News Item							E3 UBIQUITIN LIGASE; DEGRADATION; COMPLEX; TARGET; LENALIDOMIDE; THALIDOMIDE; MODULATION; PROTEINS; CEREBLON; IKAROS		[Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Deshaies, Raymond J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	deshaies@its.caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM065997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Buckley DL, 2015, ACS CHEM BIOL, V10, P1831, DOI 10.1021/acschembio.5b00442; Buckley DL, 2014, ANGEW CHEM INT EDIT, V53, P2312, DOI 10.1002/anie.201307761; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216	13	94	101	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					634	635		10.1038/nchembio.1887	http://dx.doi.org/10.1038/nchembio.1887			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26284668				2022-12-25	WOS:000359954700004
J	Mi, N; Chen, Y; Wang, S; Chen, MR; Zhao, MK; Yang, G; Ma, MS; Su, Q; Luo, S; Shi, JW; Xu, J; Guo, Q; Gao, N; Sun, YJ; Chen, ZC; Yu, L				Mi, Na; Chen, Yang; Wang, Shuai; Chen, Mengran; Zhao, Mingkun; Yang, Guang; Ma, Meisheng; Su, Qian; Luo, Sai; Shi, Jingwen; Xu, Jia; Guo, Qiang; Gao, Ning; Sun, Yujie; Chen, Zhucheng; Yu, Li			CapZ regulates autophagosomal membrane shaping by promoting actin assembly inside the isolation membrane	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; DEPOLYMERIZING FACTOR; CAPPING PROTEIN; F-ACTIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; DYNAMICS; COFILIN; PATHWAY	A fundamental question regarding autophagosome formation is how the shape of the double-membrane autophagosomal vesicle is generated. Here we show that in mammalian cells assembly of an actin scaffold inside the isolation membrane (the autophagosomal precursor) is essential for autophagosomal membrane shaping. Actin filaments are depolymerized shortly after starvation and actin is assembled into a network within the isolation membrane. When formation of actin puncta is disrupted by an actin polymerization inhibitor or by knocking down the actin-capping protein CapZ beta, isolation membranes and omegasomes collapse into mixed-membrane bundles. Formation of actin puncta is PtdIns(3) P dependent, and inhibition of PtdIns(3)P formation by treating cells with the PI(3)K inhibitor 3-MA, or by knocking down Beclin-1, abolishes the formation of actin puncta. Binding of CapZ to PtdIns(3)P, which is enriched in omegasomes, stimulates actin polymerization. Our findings illuminate the mechanism underlying autophagosomal membrane shaping and provide key insights into how autophagosomes are formed.	[Mi, Na; Chen, Yang; Zhao, Mingkun; Yang, Guang; Ma, Meisheng; Luo, Sai; Shi, Jingwen; Xu, Jia; Yu, Li] Tsinghua Univ, Sch Life Sci, Tsinghua Univ Peking Univ Joint Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Wang, Shuai; Chen, Mengran; Chen, Zhucheng] Tsinghua Univ, Struct Biol Ctr, Beijing 100084, Peoples R China; [Su, Qian; Sun, Yujie] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Guo, Qiang; Gao, Ning] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Tsinghua University	Mi, N (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Univ Peking Univ Joint Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	mina@mail.tsinghua.edu.cn; zhucheng_chen@mail.tsinghua.edu.cn; liyulab@mail.tsinghua.edu.cn	Gao, Ning/AAK-2214-2020; Guo, Qiang/J-7542-2019; Su, Qian Peter/AAO-7623-2021; Gao, Ning/J-9623-2012	Gao, Ning/0000-0003-3067-9993; Su, Qian Peter/0000-0001-7364-3945; Gao, Ning/0000-0003-3067-9993; Guo, Qiang/0000-0003-3520-5439; Mi, Na/0000-0003-3090-197X; Wang, Shuai/0000-0002-8920-969X; Shi, Jingwen/0000-0002-4802-0727	National Science Foundation [31125018, 31030043, 31321003]; 973 Program [2010CB833704, 2011CB910100]; Tsinghua University Grant [2010THZ0, 2009THZ03071]	National Science Foundation(National Science Foundation (NSF)); 973 Program(National Basic Research Program of China); Tsinghua University Grant	We are gratutul to Nikon instruments (Shanghai) and the Tsinghua Cell Biology Core Facility for providing technical support, and to Y. Li and L Huang for assistance with confocal microscopy, TEM, and image processing. GFP-DFCP1 was a gift from N. T. Ktistakis. This research was supported by National Science Foundation Grants 31125018, 31030043 and 31321003, 973 Program 2010CB833704, 2011CB910100, and Tsinghua University Grants 2010THZ0 and 2009THZ03071 to L.Y.	APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; BARAK LS, 1981, J CELL BIOL, V89, P368, DOI 10.1083/jcb.89.2.368; Baskaran S, 2012, AUTOPHAGY, V8, P1851, DOI 10.4161/auto.22077; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Chen R, 2014, J CELL BIOL, V206, P173, DOI 10.1083/jcb.201403009; Cheung PCF, 2001, BIOCHEM J, V355, P113, DOI 10.1042/bj3550113; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Derubeis AR, 2000, GENE, V255, P195, DOI 10.1016/S0378-1119(00)00303-6; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; HUG C, 1992, J CELL BIOL, V116, P923, DOI 10.1083/jcb.116.4.923; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kast DJ, 2015, CURR BIOL, V25, P1791, DOI 10.1016/j.cub.2015.05.042; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Aguilera MO, 2012, AUTOPHAGY, V8, P1590, DOI 10.4161/auto.21459; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Proikas-Cezanne T, 2015, J CELL SCI, V128, P207, DOI 10.1242/jcs.146258; Ridley SH, 2001, J CELL SCI, V114, P3991; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roberts R, 2013, ESSAYS BIOCHEM, V55, P17, DOI [10.1042/BSE0550017, 10.1042/bse0550017]; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Seglen P O, 1990, Semin Cell Biol, V1, P441; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Small JV, 2008, J MICROSC-OXFORD, V231, P479, DOI 10.1111/j.1365-2818.2008.02060.x; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	55	84	88	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1112	+		10.1038/ncb3215	http://dx.doi.org/10.1038/ncb3215			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26237647				2022-12-25	WOS:000361113700005
J	Rodic, N; Steranka, JP; Makohon-Moore, A; Moyer, A; Shen, P; Sharma, R; Kohutek, ZA; Huang, CR; Ahn, D; Mita, P; Taylor, MS; Barker, NJ; Hruban, RH; Iacobuzio-Donahue, CA; Boeke, JD; Burns, KH				Rodic, Nemanja; Steranka, Jared P.; Makohon-Moore, Alvin; Moyer, Allison; Shen, Peilin; Sharma, Reema; Kohutek, Zachary A.; Huang, Cheng Ran; Ahn, Daniel; Mita, Paolo; Taylor, Martin S.; Barker, Norman J.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Boeke, Jef D.; Burns, Kathleen H.			Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma	NATURE MEDICINE			English	Article							L1 RETROTRANSPOSITION; SOMATIC RETROTRANSPOSITION; HUMAN GENOMES; HUMAN CANCERS; GENE; MUTATION; METASTASIS; EXPRESSION; CARCINOMA; SEQUENCES	Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed after the disease has metastasized; it is among the most lethal forms of cancer. We recently described aberrant expression of an open reading frame 1 protein, ORF1p, encoded by long interspersed element-1 (LINE-1; L1) retrotransposon, in PDAC(1). To test whether LINE-1 expression leads to somatic insertions of this mobile DNA, we used a targeted method to sequence LINE-1 insertion sites in matched PDAC and normal samples. We found evidence of 465 somatic LINE-1 insertions in 20 PDAC genomes, which were absent from corresponding normal samples. In cases in which matched normal tissue, primary PDAC and metastatic disease sites were available, insertions were found in primary and metastatic tissues in differing proportions. Two adenocarcinomas secondarily involving the pancreas, but originating in the stomach and duodenum, acquired insertions with a similar discordance between primary and metastatic sites. Together, our findings show that LINE-1 contributes to the genetic evolution of PDAC and suggest that somatic insertions are acquired discontinuously in gastrointestinal neoplasms.	[Rodic, Nemanja; Steranka, Jared P.; Makohon-Moore, Alvin; Moyer, Allison; Shen, Peilin; Sharma, Reema; Ahn, Daniel; Barker, Norman J.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Makohon-Moore, Alvin; Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Kohutek, Zachary A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Huang, Cheng Ran; Boeke, Jef D.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Mita, Paolo; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Mita, Paolo; Taylor, Martin S.; Boeke, Jef D.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, High Throughput HiT Biol Ctr, Baltimore, MD USA; [Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Boeke, Jef D.; Burns, Kathleen H.] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Sol Goldman Ctr Pancreat Canc Res, Baltimore, MD 21205 USA; [Boeke, Jef D.] NYU, Langone Sch Med, Inst Syst Genet, New York, NY USA	Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; New York University; NYU Langone Medical Center	Burns, KH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	kburns@jhmi.edu	Makohon-Moore, Alvin/ABH-1764-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Makohon-Moore, Alvin/0000-0002-4781-3565; Burns, Kathleen/0000-0003-1620-3761; Taylor, Martin/0000-0001-5824-142X; Kohutek, Zachary/0000-0002-2472-9977	Sol Goldman Pancreatic Cancer Research Center; Fred and Janet Sanfilippo Fund in the Department of Pathology at the Johns Hopkins University School of Medicine; Burroughs Wellcome Fund Career Award for Biomedical Scientists Program; US National Institutes of Health [F31CA180682, R01CA163705, R01GM103999, P50CA62924, R01CA179991]; National Institute of General Medical Sciences Center for Systems Biology of Retrotransposition [P50GM107632]; National Science Foundation [DBI-0959894]; NATIONAL CANCER INSTITUTE [F31CA180682, R01CA179991, R01CA163705, P50CA062924, R01CA161210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103999, P50GM107632] Funding Source: NIH RePORTER	Sol Goldman Pancreatic Cancer Research Center; Fred and Janet Sanfilippo Fund in the Department of Pathology at the Johns Hopkins University School of Medicine; Burroughs Wellcome Fund Career Award for Biomedical Scientists Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Center for Systems Biology of Retrotransposition; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was started by funding from the Sol Goldman Pancreatic Cancer Research Center (K.H.B. and N.R.) and supported also by the Fred and Janet Sanfilippo Fund in the Department of Pathology at the Johns Hopkins University School of Medicine (N.R.); a Burroughs Wellcome Fund Career Award for Biomedical Scientists Program (K.H.B.); and US National Institutes of Health awards F31CA180682 (A.M.-M.), R01CA163705 (K.H.B.), R01GM103999 (K.H.B.), P50CA62924 (R.H.H. and C.A.I.-D.), R01CA179991 (C.A.I.-D.), as well as the National Institute of General Medical Sciences Center for Systems Biology of Retrotransposition P50GM107632 (K.H.B. and J.D.B.). Computational resources were provided through the National Science Foundation-funded MRI-R2 project #DBI-0959894. The authors would like to thank H. Kazazian, S. Solyom and A. Ewing for their helpful discussion. This work is dedicated to Dr. Frank Kretzer.	AMIKURA K, 1995, INT J PANCREATOL, V17, P139; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy KM, 2002, CANCER RES, V62, P3789; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Rodic N, 2014, AM J PATHOL, V184, P1280, DOI 10.1016/j.ajpath.2014.01.007; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WHELAN AJ, 1995, NEW ENGL J MED, V333, P975, DOI 10.1056/NEJM199510123331505; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	30	84	86	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1060	+		10.1038/nm.3919	http://dx.doi.org/10.1038/nm.3919			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26259033	Green Accepted			2022-12-25	WOS:000360961300019
J	Yassine, HM; Boyington, JC; McTamney, PM; Wei, CJ; Kanekiyo, M; Kong, WP; Gallagher, JR; Wang, LS; Zhang, Y; Joyce, MG; Lingwood, D; Moin, SM; Andersen, H; Okuno, Y; Rao, SS; Harris, AK; Kwong, PD; Mascola, JR; Nabel, GJ; Graham, BS				Yassine, Hadi M.; Boyington, Jeffrey C.; McTamney, Patrick M.; Wei, Chih-Jen; Kanekiyo, Masaru; Kong, Wing-Pui; Gallagher, John R.; Wang, Lingshu; Zhang, Yi; Joyce, M. Gordon; Lingwood, Daniel; Moin, Syed M.; Andersen, Hanne; Okuno, Yoshinobu; Rao, Srinivas S.; Harris, Audray K.; Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.			Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection	NATURE MEDICINE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; MONOCLONAL-ANTIBODIES; VIRUS; DESIGN; IMMUNOGEN; IMMUNITY; COMPLEX; DOMAIN; CELLS; MICE	The antibody response to influenza is primarily focused on the head region of the hemagglutinin (HA) glycoprotein, which in turn undergoes antigenic drift, thus necessitating annual updates of influenza vaccines. In contrast, the immunogenically subdominant stem region of HA is highly conserved and recognized by antibodies capable of binding multiple HA subtypes(1-6). Here we report the structure-based development of an H1 HA stem-only immunogen that confers heterosubtypic protection in mice and ferrets. Six iterative cycles of structure-based design (Gen1-Gen6) yielded successive H1 HA stabilized-stem (HA-SS) immunogens that lack the immunodominant head domain. Antigenic characterization, determination of two HA-SS crystal structures in complex with stem-specific monoclonal antibodies and cryo-electron microscopy analysis of HA-SS on ferritin nanoparticles (H1-SS-np) confirmed the preservation of key structural elements. Vaccination of mice and ferrets with H1-SS-np elicited broadly cross-reactive antibodies that completely protected mice and partially protected ferrets against lethal heterosubtypic H5N1 influenza virus challenge despite the absence of detectable H5N1 neutralizing activity in vitro. Passive transfer of immunoglobulin from H1-SS-np-immunized mice to naive mice conferred protection against H5N1 challenge, indicating that vaccine-elicited HA stem-specific antibodies can protect against diverse group 1 influenza strains.	[Yassine, Hadi M.; Boyington, Jeffrey C.; McTamney, Patrick M.; Wei, Chih-Jen; Kanekiyo, Masaru; Kong, Wing-Pui; Wang, Lingshu; Zhang, Yi; Joyce, M. Gordon; Lingwood, Daniel; Moin, Syed M.; Rao, Srinivas S.; Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Gallagher, John R.; Harris, Audray K.] NIAID, Struct Informat Unit, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Andersen, Hanne] BIOQUAL Inc, Rockville, MD USA; [Okuno, Yoshinobu] Osaka Univ, Res Fdn Microbial Dis, Kanonji Inst, Kanonji, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); BIOQUAL Inc.; Osaka University	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gary.nabel@sanofi.com; bgraham@nih.gov	Wei, Chih/GVT-5734-2022; Kanekiyo, Masaru/Y-9820-2018; Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019; YASSINE, HADI M./AAW-6475-2020	Kanekiyo, Masaru/0000-0001-5767-1532; Graham, Barney S./0000-0001-8112-0853; YASSINE, HADI M./0000-0001-7592-2788; Moin, Syed/0000-0001-8789-9167; Elyard, Hanne/0000-0003-1103-9608; Wang, Lingshu/0000-0002-8404-4910; Gallagher, John/0000-0002-1954-8872	Vaccine Research Center; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001180, ZIAAI005003, ZIAAI005024] Funding Source: NIH RePORTER	Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Taylor, H. Bao, J.P. Todd and C. Chiedi for help with the animal studies, U. Baxa for EM studies, K. Dai and X. Chen for technical support and B. Hartman for manuscript preparation. We thank M.C. Nason for excellent statistical advice and support. We also thank K. Modjarrad and laboratory members for helpful discussions. This work was supported by the Intramural Research Program of the Vaccine Research Center and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health. X-ray data were collected at the SER-CAT 22-BM beamline at the Advanced Photon Source (APS), Argonne National Laboratory. Use of APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science under contract no. W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bommakanti G, 2012, J VIROL, V86, P13434, DOI 10.1128/JVI.01429-12; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jegaskanda S, 2014, J IMMUNOL, V193, P469, DOI 10.4049/jimmunol.1400432; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Krammer F, 2014, J VIROL, V88, P3432, DOI 10.1128/JVI.03004-13; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.03183-13, 10.1128/JVI.00641-13]; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Lu Y, 2014, P NATL ACAD SCI USA, V111, P125, DOI 10.1073/pnas.1308701110; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/erv.12.140, 10.1586/ERV.12.140]; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sagawa H, 1996, J GEN VIROL, V77, P1483, DOI 10.1099/0022-1317-77-7-1483; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wei CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004273; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865	48	420	446	3	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1065	+		10.1038/nm.3927	http://dx.doi.org/10.1038/nm.3927			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26301691				2022-12-25	WOS:000360961300020
J	Abrams, AJ; Hufnagel, RB; Rebelo, A; Zanna, C; Patel, N; Gonzalez, MA; Campeanu, IJ; Griffin, LB; Groenewald, S; Strickland, AV; Tao, FF; Speziani, F; Abreu, L; Schule, R; Caporali, L; La Morgia, C; Maresca, A; Liguori, R; Lodi, R; Ahmed, ZM; Sund, KL; Wang, XJ; Krueger, LA; Peng, YY; Prada, CE; Prows, CA; Schorry, EK; Antonellis, A; Zimmerman, HH; Abdul-Rahman, OA; Yang, YP; Downes, SM; Prince, J; Fontanesi, F; Barrientos, A; Nemeth, AH; Carelli, V; Huang, TS; Zuchner, S; Dallman, JE				Abrams, Alexander J.; Hufnagel, Robert B.; Rebelo, Adriana; Zanna, Claudia; Patel, Neville; Gonzalez, Michael A.; Campeanu, Ion J.; Griffin, Laurie B.; Groenewald, Saskia; Strickland, Alleene V.; Tao, Feifei; Speziani, Fiorella; Abreu, Lisa; Schuele, Rebecca; Caporali, Leonardo; La Morgia, Chiara; Maresca, Alessandra; Liguori, Rocco; Lodi, Raffaele; Ahmed, Zubair M.; Sund, Kristen L.; Wang, Xinjian; Krueger, Laura A.; Peng, Yanyan; Prada, Carlos E.; Prows, Cynthia A.; Schorry, Elizabeth K.; Antonellis, Anthony; Zimmerman, Holly H.; Abdul-Rahman, Omar A.; Yang, Yaping; Downes, Susan M.; Prince, Jeffery; Fontanesi, Flavia; Barrientos, Antonio; Nemeth, Andrea H.; Carelli, Valerio; Huang, Taosheng; Zuchner, Stephan; Dallman, Julia E.			Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder	NATURE GENETICS			English	Article							MITOCHONDRIAL DYNAMICS; OPA1; FUSION; OUTER; RECRUITMENT; NEUROPATHY; ZEBRAFISH; GTPASE; UGO1P; CELLS	Dominant optic atrophy (DOA)(1,2) and axonal peripheral neuropathy (Charcot-Marie-Tooth type 2, or CMT2)(3) are hereditary neurodegenerative disorders most commonly caused by mutations in the canonical mitochondrial fusion genes OPA1 and MFN2, respectively(4). In yeast, homologs of OPA1 (Mgm1) and MFN2 (Fzo1)(5,6) work in concert with Ugo1, for which no human equivalent has been identified thus far(7). By whole-exome sequencing of patients with optic atrophy and CMT2, we identified four families with recessive mutations in SLC25A46. We demonstrate that SLC25A46, like Ugo1, is a modified carrier protein that has been recruited to the outer mitochondrial membrane and interacts with the inner membrane remodeling protein mitofilin (Fcj1). Loss of function in cultured cells and in zebrafish unexpectedly leads to increased mitochondrial connectivity, while severely affecting the development and maintenance of neurons in the fish. The discovery of SLC25A46 strengthens the genetic overlap between optic atrophy and CMT2 while exemplifying a new class of modified solute transporters linked to mitochondrial dynamics.	[Abrams, Alexander J.; Rebelo, Adriana; Gonzalez, Michael A.; Strickland, Alleene V.; Tao, Feifei; Speziani, Fiorella; Abreu, Lisa; Schuele, Rebecca; Zuchner, Stephan] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, John P Hussman Inst Human Gen, Miami, FL 33124 USA; [Abrams, Alexander J.; Rebelo, Adriana; Gonzalez, Michael A.; Strickland, Alleene V.; Tao, Feifei; Speziani, Fiorella; Abreu, Lisa; Schuele, Rebecca; Zuchner, Stephan] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL USA; [Abrams, Alexander J.; Patel, Neville; Campeanu, Ion J.; Groenewald, Saskia; Prince, Jeffery; Dallman, Julia E.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Hufnagel, Robert B.; Sund, Kristen L.; Wang, Xinjian; Krueger, Laura A.; Peng, Yanyan; Prada, Carlos E.; Prows, Cynthia A.; Schorry, Elizabeth K.; Huang, Taosheng] Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH USA; [Zanna, Claudia; Caporali, Leonardo; La Morgia, Chiara; Maresca, Alessandra; Liguori, Rocco; Carelli, Valerio] Osped Bellaria, Ist Sci Neurol Bologna, IRCCS, Bologna, Italy; [Zanna, Claudia; La Morgia, Chiara; Maresca, Alessandra; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Neurol Unit, Bologna, Italy; [Griffin, Laurie B.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Griffin, Laurie B.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Schuele, Rebecca] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Schuele, Rebecca] German Res Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Lodi, Raffaele] Univ Bologna, Policlin S Orsola Malpighi Dept Biomed & Neuromot, Bologna, Italy; [Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Antonellis, Anthony] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Antonellis, Anthony] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Zimmerman, Holly H.; Abdul-Rahman, Omar A.] Univ Mississippi, Med Ctr, Dept Pediat, Div Med Genet, Jackson, MS 39216 USA; [Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Downes, Susan M.; Nemeth, Andrea H.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Downes, Susan M.] Oxford Eye Hosp Natl Hlth Serv NHS Trust, Oxford, England; [Fontanesi, Flavia; Barrientos, Antonio] Univ Miami, Dept Biochem & Mol Biol, Miami, FL USA; [Barrientos, Antonio] Univ Miami, Dept Neurol, Miami, FL USA; [Nemeth, Andrea H.] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford, England	University of Miami; University of Miami; University of Miami; Cincinnati Children's Hospital Medical Center; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bologna; University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Mississippi; University of Mississippi Medical Center; Baylor College of Medicine; University of Oxford; University of Miami; University of Miami; Oxford University Hospitals NHS Foundation Trust	Zuchner, S (corresponding author), Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, John P Hussman Inst Human Gen, Miami, FL 33124 USA.	taosheng.huang@cchmc.org; szuchner@med.miami.edu	Peng, Yanyan/I-1515-2019; Liguori, Rocco/AAB-7860-2020; Schüle, Rebecca/B-5763-2019; La Morgia, Chiara/H-6765-2012; Dallman, Julia/I-1414-2019; Caporali, Leonardo/J-7398-2016; Lodi, Raffaele/K-4984-2016; Zanna, Claudia/GVT-1932-2022; Griffin, Laurie/ABE-4525-2021; Tao, Feifei/AAI-6256-2021; Maresca, Alessandra/J-7393-2016; Dallman, Julia/AGG-3507-2022	Peng, Yanyan/0000-0002-1176-4837; Schüle, Rebecca/0000-0002-7781-2766; Caporali, Leonardo/0000-0002-0666-4380; Tao, Feifei/0000-0003-4477-2304; Maresca, Alessandra/0000-0002-8959-8832; Dallman, Julia/0000-0002-5839-807X; Fontanesi, Flavia/0000-0003-0509-3835; Lodi, Raffaele/0000-0003-3878-304X; Huang, Taosheng/0000-0001-6601-6687; CARELLI, VALERIO/0000-0003-4923-6404; LA MORGIA, Chiara/0000-0002-4639-8929; Nemeth, Andrea/0000-0002-2941-7657; Liguori, Rocco/0000-0002-1815-1013; Hufnagel, Robert/0000-0003-3015-3545; Prada, Carlos/0000-0003-3348-3531	US National Institutes of Health (NIH) [R01NS075764, 5R01NS072248, U54NS065712]; CMT Association; Muscular Dystrophy Association; Lois Pope Life Foundation; Cincinnati Children's Hospital Medical Center (CCHMC) Research Foundation; Division of Human Genetics; US NIH [R01DC012564, T32GM007315, T32GM07863, F30 NRSA NS092238, RO1GM071775, GM105781, GM112179]; ERMION, the E-RARE European consortium; UK Oxford Partnership Comprehensive Biomedical Research Centre; UK Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; European Union [01GM1408B, PIOF-GA-2012-326681]; Interdisciplinary Center for Clinical Research (IZKF) Tubingen [1970-0-0]; National Institute of Neurological Disorders and Stroke; American Heart Association; Action Medical Research [2063] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775, R01GM105781, T32GM007315, R01GM112179, T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248, U54NS065712, F30NS092238, R01NS075764, R01NS073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012564] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CMT Association; Muscular Dystrophy Association(Muscular Dystrophy Association); Lois Pope Life Foundation; Cincinnati Children's Hospital Medical Center (CCHMC) Research Foundation; Division of Human Genetics; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERMION, the E-RARE European consortium; UK Oxford Partnership Comprehensive Biomedical Research Centre; UK Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; European Union(European Commission); Interdisciplinary Center for Clinical Research (IZKF) Tubingen; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); Action Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank all families for participating in this study. We thank A. Torroni and A. Olivieri for their kind help with the control population samples from Sardinia. From the University of Miami, we are thankful to R. Cepeda for his excellent care and maintenance of the zebrafish facility, the transmission electron microscopy class of J. Prince, and to R. Duncan, W. Browne and P. Tsouflas for advice concerning phylogenic analysis. We are thankful to F. Poulain from the University of Utah for providing the Islet2-b fish and B. Schmid from the German Center for Neurodegenerative Diseases (DZNE) for donating the mitofish construct. This study was supported by US National Institutes of Health (NIH) grants R01NS075764, 5R01NS072248 and U54NS065712 (to S.Z.) and by the CMT Association and the Muscular Dystrophy Association. A.J.A. received additional support from the Lois Pope Life Foundation development award. This study was partially supported by the Cincinnati Children's Hospital Medical Center (CCHMC) Research Foundation and the Division of Human Genetics (to T.H.), US NIH grant R01DC012564 (to Z.M.A.) and ERMION, the E-RARE European consortium on optic atrophies (to V.C.). A.H.N. and S.M.D. were funded by the UK Oxford Partnership Comprehensive Biomedical Research Centre with funding from the UK Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme. R.S. was funded by the European Union (E-RARE JTC grants 'NEUROLIPID' 01GM1408B and 'HSP/CMT genetics' PIOF-GA-2012-326681) and the Interdisciplinary Center for Clinical Research (IZKF) Tubingen (grant 1970-0-0). A.A. is supported by the National Institute of Neurological Disorders and Stroke, and L.B.G. is supported by US NIH Cellular and Molecular Biology Training Grant T32GM007315, US NIH Medical Scientist Training Grant T32GM07863 and US NIH grant F30 NRSA NS092238. A.B. is supported by US NIH grants RO1GM071775, GM105781 and GM112179. F.F. is supported by a Development grant from the American Heart Association.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Braathen GJ, 2012, ACTA NEUROL SCAND, V126, DOI 10.1111/ane.12013; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chan DC, 2006, DEV CELL, V11, P592, DOI 10.1016/j.devcel.2006.10.009; Coonrod EM, 2007, TRAFFIC, V8, P500, DOI 10.1111/j.1600-0854.2007.00550.x; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hoppins S, 2009, J CELL BIOL, V184, P569, DOI 10.1083/jcb.200809099; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kucenas S, 2008, NEURON GLIA BIOL, V4, P71, DOI 10.1017/S1740925X09990123; Lamarca V, 2007, AM J PHYSIOL-CELL PH, V293, pC1347, DOI 10.1152/ajpcell.00431.2006; Li YC, 2004, BRAIN RES, V1026, P235, DOI 10.1016/j.brainres.2004.08.016; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Narendra DP, 2012, NATURE, V483, P418, DOI 10.1038/nature10952; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Plucinska G, 2012, J NEUROSCI, V32, P16203, DOI 10.1523/JNEUROSCI.1327-12.2012; Polyakov VY, 2003, BIOCHEMISTRY-MOSCOW+, V68, P838, DOI 10.1023/A:1025738712958; Poulain FE, 2013, NEURON, V78, P49, DOI 10.1016/j.neuron.2013.02.005; Prince J, 1998, J EXP BIOL, V201, P1595; Rebelo AP, 2009, NUCLEIC ACIDS RES, V37, P6701, DOI 10.1093/nar/gkp727; Robinson AJ, 2012, EXP CELL RES, V318, P1316, DOI 10.1016/j.yexcr.2012.01.026; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Shamas-Din A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.234; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797; Zuchner S, 2005, J MOL MED-JMM, V83, P935, DOI 10.1007/s00109-005-0694-9	40	124	128	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					926	+		10.1038/ng.3354	http://dx.doi.org/10.1038/ng.3354			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26168012	Green Accepted			2022-12-25	WOS:000358674100019
J	Guan, JC; Koch, KE				Guan, Jiahn-Chou; Koch, Karen E.			A time and a place for sugar in your ears	NATURE BIOTECHNOLOGY			English	Editorial Material							SUCROSE METABOLISM; EXPRESSION; DROUGHT; MECHANISMS		[Guan, Jiahn-Chou; Koch, Karen E.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Guan, JC (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	kekoch@ufl.edu			Division Of Integrative Organismal Systems [1116561] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Andersen MN, 2002, PLANT PHYSIOL, V130, P591, DOI 10.1104/pp.005637; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Nuccio ML, 2015, NAT BIOTECHNOL, V33, P862, DOI 10.1038/nbt.3277; Wobus U, 1999, BIOL CHEM, V380, P937, DOI 10.1515/BC.1999.116; Xu J, 1996, PLANT CELL, V8, P1209, DOI 10.1105/tpc.8.7.1209; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457	10	7	7	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					827	828		10.1038/nbt.3315	http://dx.doi.org/10.1038/nbt.3315			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252140				2022-12-25	WOS:000359274900018
J	Li, XY; Zhu, P; Ma, SQ; Song, JH; Bai, JY; Sun, FF; Yi, CQ				Li, Xiaoyu; Zhu, Ping; Ma, Shiqing; Song, Jinghui; Bai, Jinyi; Sun, Fangfang; Yi, Chengqi			Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA; NUCLEOTIDE RESOLUTION; RIBOSOMAL-RNA; HUMAN-CELLS; SYNTHASE; YEAST; METHYLATION; RESIDUES; GENE; IDENTIFICATION	Pseudouridine (psi) is the most abundant post-transcriptional RNA modification, yet little is known about its prevalence, mechanism and function in mRNA. Here, we performed quantitative MS analysis and show that psi is much more prevalent (psi/U ratio similar to 0.2-0.6%) in mammalian mRNA than previously believed. We developed N-3-CMC-enriched pseudouridine sequencing (CeU-Seq), a selective chemical labeling and pulldown method, to identify 2,084 psi sites within 1,929 human transcripts, of which four (in ribosomal RNA and EEF1A1 mRNA) are biochemically verified. We show that hPUS1, a known psi synthase, acts on human mRNA; under stress, CeU-Seq demonstrates inducible and stress-specific mRNA pseudouridylation. Applying CeU-Seq to the mouse transcriptome revealed conserved and tissue-specific pseudouridylation. Collectively, our approaches allow comprehensive analysis of transcriptome-wide pseudouridylation and provide tools for functional studies of psi-mediated epigenetic regulation.	[Li, Xiaoyu; Ma, Shiqing; Song, Jinghui; Bai, Jinyi; Sun, Fangfang; Yi, Chengqi] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing 100871, Peoples R China; [Li, Xiaoyu; Ma, Shiqing; Song, Jinghui; Bai, Jinyi; Sun, Fangfang; Yi, Chengqi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhu, Ping] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Ma, Shiqing; Bai, Jinyi] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Univ, Coll Chem & Mol Engn, Dept Biol Chem, Synthet & Funct Biomol Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Li, XY (corresponding author), Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing 100871, Peoples R China.	chengqi.yi@pku.edu.cn		Zhu, Ping/0000-0002-4521-7524; Yi, Chengqi/0000-0003-2540-9729	National Basic Research Foundation of China [2014CB964900]; National Natural Science Foundation of China [21472009, 31270838]	National Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors would like to thank R. Meng and S. Huang for technical assistance and N. Liu, X. Wang and X. Liu for discussion. This work was supported by the National Basic Research Foundation of China (no. 2014CB964900) and the National Natural Science Foundation of China (nos. 21472009 and 31270838).	BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Bakin AV, 1998, METH MOL B, V77, P297; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Basak A, 2014, CELL REP, V8, P966, DOI 10.1016/j.celrep.2014.07.004; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Charette M, 2000, IUBMB LIFE, V49, P341; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtes FC, 2014, J BIOTECHNOL, V174, P16, DOI 10.1016/j.jbiotec.2014.01.024; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Fernandez IS, 2013, NATURE, V500, P107, DOI 10.1038/nature12302; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HO NWY, 1967, BIOCHEMISTRY-US, V6, P3632, DOI 10.1021/bi00864a002; HUGHES DG, 1978, BIOCHEM J, V171, P781, DOI 10.1042/bj1710781; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huttenhofer A, 2002, CURR OPIN CHEM BIOL, V6, P835, DOI 10.1016/S1367-5931(02)00397-6; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Lovejoy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110799; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Sibert BS, 2012, NUCLEIC ACIDS RES, V40, P2107, DOI 10.1093/nar/gkr1017; Tremml G., 2008, CURR PROTOC STEM CEL, V5, p1C4; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yu AT, 2011, PROTEIN CELL, V2, P712, DOI 10.1007/s13238-011-1087-1; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	49	297	315	13	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					592	U93		10.1038/NCHEMBIO.1836	http://dx.doi.org/10.1038/NCHEMBIO.1836			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26075521				2022-12-25	WOS:000358255300016
J	Link, AJ				Link, A. James			BIOSYNTHESIS Leading the way to RiPPs	NATURE CHEMICAL BIOLOGY			English	News Item							PEPTIDES		[Link, A. James] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Link, A. James] Princeton Univ, Dept Biol Engn, Princeton, NJ 08544 USA; [Link, A. James] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Link, AJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	ajlink@princeton.edu		Link, A. James/0000-0001-5066-9691	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107036] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM107036] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Koehnke J, 2015, NAT CHEM BIOL, V11, P558, DOI 10.1038/nchembio.1841; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146	8	13	13	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					551	552		10.1038/nchembio.1862	http://dx.doi.org/10.1038/nchembio.1862			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26196773	Green Accepted			2022-12-25	WOS:000358255300006
J	Liu, HY; Tang, X; Srivastava, A; Pecot, T; Daniel, P; Hemmelgarn, B; Reyes, S; Fackler, N; Bajwa, A; Kladney, R; Koivisto, C; Chen, Z; Wang, QB; Huang, K; Machiraju, R; Saenz-Robles, MT; Cantalupo, P; Pipas, JM; Leone, G				Liu, Huayang; Tang, Xing; Srivastava, Arunima; Pecot, Thierry; Daniel, Piotr; Hemmelgarn, Benjamin; Reyes, Stephan; Fackler, Nicholas; Bajwa, Amneet; Kladney, Raleigh; Koivisto, Christopher; Chen, Zhong; Wang, Qianben; Huang, Kun; Machiraju, Raghu; Saenz-Robles, Maria Teresa; Cantalupo, Paul; Pipas, James M.; Leone, Gustavo			Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles	NATURE CELL BIOLOGY			English	Article							RNA-POLYMERASE-I; C-MYC; TRANSCRIPTIONAL NETWORK; CONDITIONAL DELETION; MURINE DEVELOPMENT; INTESTINAL CRYPTS; DNA-REPLICATION; GENE-EXPRESSION; RIBOSOMAL DNA; BETA-CATENIN	Robust mechanisms to control cell proliferation have evolved to maintain the integrity of organ architecture. Here, we investigated how two critical proliferative pathways, Myc and E2f, are integrated to control cell cycles in normal and Rb-deficient cells using a murine intestinal model. We show that Myc and E2f1-3 have little impact on normal G(1)-S transitions. Instead, they synergistically control an S-G(2) transcriptional program required for normal cell divisions and maintaining crypt-villus integrity. Surprisingly, Rb deficiency results in the Myc-dependent accumulation of E2f3 protein and chromatin repositioning of both Myc and E2f3, leading to the 'super activation' of a G(1)-S transcriptional program, ectopic S phase entry and rampant cell proliferation. These findings reveal that Rb-deficient cells hijack and redeploy Myc and E2f3 from an S-G(2) program essential for normal cell cycles to a G(1)-S program that re-engages ectopic cell cycles, exposing an unanticipated addiction of Rb-null cells on Myc.	[Liu, Huayang; Tang, Xing; Srivastava, Arunima; Pecot, Thierry; Daniel, Piotr; Hemmelgarn, Benjamin; Reyes, Stephan; Fackler, Nicholas; Bajwa, Amneet; Kladney, Raleigh; Koivisto, Christopher; Chen, Zhong; Wang, Qianben; Leone, Gustavo] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Liu, Huayang; Tang, Xing; Srivastava, Arunima; Pecot, Thierry; Daniel, Piotr; Hemmelgarn, Benjamin; Reyes, Stephan; Fackler, Nicholas; Bajwa, Amneet; Kladney, Raleigh; Koivisto, Christopher; Leone, Gustavo] Ohio State Univ, Coll Biol Sci, Dept Mol Genet, Columbus, OH 43210 USA; [Liu, Huayang; Tang, Xing; Srivastava, Arunima; Pecot, Thierry; Daniel, Piotr; Hemmelgarn, Benjamin; Reyes, Stephan; Fackler, Nicholas; Bajwa, Amneet; Kladney, Raleigh; Koivisto, Christopher; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Machiraju, Raghu] Ohio State Univ, Dept Comp Sci & Engn, Columbus, OH 43210 USA; [Saenz-Robles, Maria Teresa; Cantalupo, Paul; Pipas, James M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Leone, G (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	gustavo.Leone@osumc.edu	Wang, Qianben/E-4267-2011; Chen, Zhong/E-2776-2018	Chen, Zhong/0000-0002-9644-1737; Pecot, Thierry/0000-0003-0772-9753; Fackler, Nick/0000-0003-3291-7617	Microarray, Nucleic Acid and Analytical Cytometry Core Shawl Resources at Ohio State University; NIH [R01CA121275, R01HD047470, R01CA098956]; Graduate Pelotonia Fellowship; Postdoctoral Pelotonia Fellowship; Undergraduate Pelotonia Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA121275, R01CA098956] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Microarray, Nucleic Acid and Analytical Cytometry Core Shawl Resources at Ohio State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Pelotonia Fellowship; Postdoctoral Pelotonia Fellowship; Undergraduate Pelotonia Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank M. L. Rawahneh, N. Lovett and I. Moffitt for assistance with histology. We also acknowledge assistance from C. Martin for reviewing histological slides, S. Bae tor advice on sequencing library construction, and V. Jin, Z. Ye and J. McElroy for suggestions on the analysis of sequencing data. This work was supported the Microarray, Nucleic Acid and Analytical Cytometry Core Shawl Resources at Ohio State University. We are grateful to SI Gopalan and A. Simcox for critical suggestions. This is was financially supported by NIH grants to GL. (R01CA121275 and R01HD047470) and an NIH grant to J MP (R01CA098956). H.L., T.P. and B.H. were recipients at Graduate, Postdoctoral and Undergraduate Pelotonia Fellowships, respectively.	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; GOODRICH DW, 1992, NATURE, V360, P177, DOI 10.1038/360177a0; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heinen CD, 2002, GASTROENTEROLOGY, V123, P751, DOI 10.1053/gast.2002.35382; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Li F, 2006, CANCER RES, V66, P5608, DOI 10.1158/0008-5472.CAN-05-4242; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Malynn BA, 2000, GENE DEV, V14, P1390; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Petrella LN, 2011, DEVELOPMENT, V138, P1069, DOI 10.1242/dev.059501; Phesse TJ, 2014, CELL DEATH DIFFER, V21, P956, DOI 10.1038/cdd.2014.15; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Saenz-Robles MT, 2007, J VIROL, V81, P13191, DOI 10.1128/JVI.01658-07; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Serandour AA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r147; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Siddiqui H, 2007, J CELL PHYSIOL, V211, P131, DOI 10.1002/jcp.20913; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wenzel PL, 2011, DEV BIOL, V351, P35, DOI 10.1016/j.ydbio.2010.12.025; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	69	46	47	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1036	U384		10.1038/ncb3210	http://dx.doi.org/10.1038/ncb3210			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26192440	Green Accepted			2022-12-25	WOS:000358847700011
J	Sheridan, C				Sheridan, Cormac			New class PCSK9 blockers stride into cholesterol market	NATURE BIOTECHNOLOGY			English	News Item							STATIN THERAPY											2015, EUR HEART J, V36, P1012; 2012, NAT BIOTECHNOL, V30, P302; 2015, NEW ENGL J MED, V372, P2387; 2012, J AMER HEART ASSOC, V1, P1800	4	5	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					785	786		10.1038/nbt0815-785	http://dx.doi.org/10.1038/nbt0815-785			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252118				2022-12-25	WOS:000359274900003
J	Zenaro, E; Pietronigro, E; Della Bianca, V; Piacentino, G; Marongiu, L; Budui, S; Turano, E; Rossi, B; Angiari, S; Dusi, S; Montresor, A; Carlucci, T; Nani, S; Tosadori, G; Calciano, L; Catalucci, D; Berton, G; Bonetti, B; Constantin, G				Zenaro, Elena; Pietronigro, Enrica; Della Bianca, Vittorina; Piacentino, Gennj; Marongiu, Laura; Budui, Simona; Turano, Ermanna; Rossi, Barbara; Angiari, Stefano; Dusi, Silvia; Montresor, Alessio; Carlucci, Tommaso; Nani, Sara; Tosadori, Gabriele; Calciano, Lucia; Catalucci, Daniele; Berton, Giorgio; Bonetti, Bruno; Constantin, Gabriela			Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin	NATURE MEDICINE			English	Article							BLOOD-BRAIN-BARRIER; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRIPLE-TRANSGENIC MODEL; TAU PATHOLOGY; A-BETA; INFLAMMATION; NEURODEGENERATION; NEUROTOXICITY; MICROGLIA; PLAQUES	Inflammation is a pathological hallmark of Alzheimer's disease, and innate immune cells have been shown to contribute to disease pathogenesis. In two transgenic models of Alzheimer's disease (5xFAD and 3xTg-AD mice), neutrophils extravasated and were present in areas with amyloid-beta (A beta) deposits, where they released neutrophil extracellular traps (NETs) and IL-17. A beta(42) peptide triggered the LFA-1 integrin high-affinity state and rapid neutrophil adhesion to integrin ligands. In vivo, LFA-1 integrin controlled neutrophil extravasation into the CNS and intraparenchymal motility. In transgenic Alzheimer's disease models, neutrophil depletion or inhibition of neutrophil trafficking via LFA-1 blockade reduced Alzheimer's disease like neuropathology and improved memory in mice already showing cognitive dysfunction. Temporary depletion of neutrophils for 1 month at early stages of disease led to sustained improvements in memory. Transgenic Alzheimer's disease model mice lacking LFA-1 were protected from cognitive decline and had reduced gliosis. In humans with Alzheimer's disease, neutrophils adhered to and spread inside brain venules and were present in the parenchyma, along with NETs. Our results demonstrate that neutrophils contribute to Alzheimer's disease pathogenesis and cognitive impairment and suggest that the inhibition of neutrophil trafficking may be beneficial in Alzheimer's disease.	[Zenaro, Elena; Pietronigro, Enrica; Della Bianca, Vittorina; Piacentino, Gennj; Marongiu, Laura; Budui, Simona; Rossi, Barbara; Angiari, Stefano; Dusi, Silvia; Montresor, Alessio; Carlucci, Tommaso; Nani, Sara; Tosadori, Gabriele; Berton, Giorgio; Constantin, Gabriela] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Turano, Ermanna; Bonetti, Bruno] Univ Verona, Dept Neurol & Movement Sci, Neurol Sect, I-37100 Verona, Italy; [Montresor, Alessio; Tosadori, Gabriele; Constantin, Gabriela] Univ Verona, Ctr Biomed Comp CBMC, I-37100 Verona, Italy; [Calciano, Lucia] Univ Verona, Dept Publ Hlth & Community Med, I-37100 Verona, Italy; [Catalucci, Daniele] Natl Res Council CNR, Inst Genet & Biomed Res IRGB, Milan, Italy; [Catalucci, Daniele] Humanitas Res Hosp, Milan, Italy	University of Verona; University of Verona; University of Verona; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Constantin, G (corresponding author), Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy.	gabriela.constantin@univr.it	tosadori, gabriele/ABB-7383-2021; Catalucci, Daniele/B-6745-2015; Bonetti, Bruno/F-1431-2013; tosadori, gabriele/GXH-6684-2022	tosadori, gabriele/0000-0001-5971-4815; Catalucci, Daniele/0000-0001-7041-6114; tosadori, gabriele/0000-0001-5971-4815; BONETTI, Bruno/0000-0002-3944-4165; Carlucci, Tommaso/0000-0003-3459-361X; Turano, Ermanna/0000-0002-0760-1787; DUSI, SILVIA/0000-0002-5241-9394; Constantin, Gabriela/0000-0001-8978-3539; Angiari, Stefano/0000-0003-4434-2224; Calciano, Lucia/0000-0001-9801-5080; Pietronigro, Enrica Caterina/0000-0001-7661-2247; ROSSI, Barbara/0000-0003-4711-1528; Zenaro, Elena/0000-0003-3928-6272	European Research Council [261079-NEUROTRAFFICKING]; Fondazione Cariverona; European Community FP7 grant [282095-TARKINAID]; Fondazione Italiana Sclerosi Multipla, Genoa, Italy	European Research Council(European Research Council (ERC)European Commission); Fondazione Cariverona(Fondazione Cariverona); European Community FP7 grant; Fondazione Italiana Sclerosi Multipla, Genoa, Italy	We thank C. Laudanna (University of Verona) for providing the reagents to measure LFA-1 integrin affinity in human neutrophils. This work was supported by funding under the European Research Council grant 261079-NEUROTRAFFICKING (G.C.), Fondazione Cariverona (G.C.) and the European Community FP7 grant 282095-TARKINAID (G.B.). S.D. received a fellowship from the Fondazione Italiana Sclerosi Multipla, Genoa, Italy.	Allen C, 2012, J IMMUNOL, V189, P381, DOI 10.4049/jimmunol.1200409; Baik SH, 2014, NEUROBIOL AGING, V35, P1286, DOI 10.1016/j.neurobiolaging.2014.01.003; Baldwin KJ, 2013, CURR OPIN NEUROL, V26, P318, DOI 10.1097/WCO.0b013e328360279f; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kalaria RN, 1999, ANN NY ACAD SCI, V893, P113, DOI 10.1111/j.1749-6632.1999.tb07821.x; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Prokop Stefan, 2013, Acta Neuropathol, V126, P461; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Ryu JK, 2009, J CELL MOL MED, V13, P2911, DOI 10.1111/j.1582-4934.2008.00434.x; SAVAGE MJ, 1994, NEUROSCIENCE, V60, P607, DOI 10.1016/0306-4522(94)90490-1; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Subramanian S, 2010, J ALZHEIMERS DIS, V22, P619, DOI 10.3233/JAD-2010-100852; Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	45	372	381	11	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					880	886		10.1038/nm.3913	http://dx.doi.org/10.1038/nm.3913			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26214837				2022-12-25	WOS:000359181000014
J	Zhang, X; Zhang, DY; Jia, HJ; Feng, Q; Wang, DH; Liang, D; Wu, XN; Li, JH; Tang, LQ; Li, Y; Lan, Z; Chen, B; Li, YL; Zhong, HZ; Xie, HL; Jie, ZY; Chen, WN; Tang, SM; Xu, XQ; Wang, XK; Cai, XH; Liu, S; Xia, Y; Li, JY; Qiao, XY; Al-Aama, JY; Chen, H; Wang, L; Wu, QJ; Zhang, FC; Zheng, WJ; Li, YZ; Zhang, MR; Luo, GW; Xue, WB; Xiao, L; Li, J; Chen, WT; Xu, X; Yin, Y; Yang, HM; Wang, J; Kristiansen, K; Liu, L; Li, T; Huang, QC; Li, YR; Wang, J				Zhang, Xuan; Zhang, Dongya; Jia, Huijue; Feng, Qiang; Wang, Donghui; Liang, Di; Wu, Xiangni; Li, Junhua; Tang, Longqing; Li, Yin; Lan, Zhou; Chen, Bing; Li, Yanli; Zhong, Huanzi; Xie, Hailiang; Jie, Zhuye; Chen, Weineng; Tang, Shanmei; Xu, Xiaoqiang; Wang, Xiaokai; Cai, Xianghang; Liu, Sheng; Xia, Yan; Li, Jiyang; Qiao, Xingye; Al-Aama, Jumana Yousuf; Chen, Hua; Wang, Li; Wu, Qing-jun; Zhang, Fengchun; Zheng, Wenjie; Li, Yongzhe; Zhang, Mingrong; Luo, Guangwen; Xue, Wenbin; Xiao, Liang; Li, Jun; Chen, Wanting; Xu, Xun; Yin, Ye; Yang, Huanming; Wang, Jian; Kristiansen, Karsten; Liu, Liang; Li, Ting; Huang, Qingchun; Li, Yingrui; Wang, Jun			The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment	NATURE MEDICINE			English	Article							WILFORDII HOOK-F; CROSS-REACTIVITY; IMPACT; IDENTIFICATION; PATHOGENESIS; ASSOCIATION; DISEASE; HEALTH	We carried out metagenomic shotgun sequencing and a metagenome-wide association study (MGWAS) of fecal, dental and salivary samples from a cohort of individuals with rheumatoid arthritis (RA) and healthy controls. Concordance was observed between the gut and oral microbiomes, suggesting overlap in the abundance and function of species at different body sites. Dysbiosis was detected in the gut and oral microbiomes of RA patients, but it was partially resolved after RA treatment. Alterations in the gut, dental or saliva microbiome distinguished individuals with RA from healthy controls, were correlated with clinical measures and could be used to stratify individuals on the basis of their response to therapy. In particular, Haemophilus spp. were depleted in individuals with RA at all three sites and negatively correlated with levels of serum autoantibodies, whereas Lactobacillus salivarius was over-represented in individuals with RA at all three sites and was present in increased amounts in cases of very active RA. Functionally, the redox environment, transport and metabolism of iron, sulfur, zinc and arginine were altered in the microbiota of individuals with RA. Molecular mimicry of human antigens related to RA was also detectable. Our results establish specific alterations in the gut and oral microbiomes in individuals with RA and suggest potential ways of using microbiome composition for prognosis and diagnosis.	[Zhang, Xuan; Liang, Di; Wu, Xiangni; Chen, Hua; Wang, Li; Wu, Qing-jun; Zhang, Fengchun; Zheng, Wenjie; Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Zhang, Xuan; Liang, Di; Wu, Xiangni; Chen, Hua; Wang, Li; Wu, Qing-jun; Zhang, Fengchun; Zheng, Wenjie; Li, Yongzhe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Dongya; Jia, Huijue; Feng, Qiang; Wang, Donghui; Li, Junhua; Tang, Longqing; Li, Yin; Lan, Zhou; Chen, Bing; Li, Yanli; Zhong, Huanzi; Xie, Hailiang; Jie, Zhuye; Chen, Weineng; Tang, Shanmei; Xu, Xiaoqiang; Wang, Xiaokai; Cai, Xianghang; Liu, Sheng; Xia, Yan; Li, Jiyang; Al-Aama, Jumana Yousuf; Zhang, Mingrong; Luo, Guangwen; Xue, Wenbin; Xiao, Liang; Li, Jun; Chen, Wanting; Xu, Xun; Yin, Ye; Yang, Huanming; Wang, Jian; Kristiansen, Karsten; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Dongya; Jia, Huijue; Li, Junhua; Xiao, Liang] BGI Shenzhen, Shenzhen Key Lab Human Commensal Microorganisms &, Shenzhen, Peoples R China; [Feng, Qiang] BGI Shenzhen, Shenzhen Engn Lab Detect & Intervent Human Intest, Shenzhen, Peoples R China; [Feng, Qiang; Wang, Donghui; Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Xu, Xiaoqiang; Wang, Xiaokai; Liu, Sheng; Xia, Yan] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen, Peoples R China; [Li, Jiyang] Qingdao Univ, Qingdao Univ BGI Joint Innovat Coll, Qingdao 266071, Peoples R China; [Qiao, Xingye] SUNY Binghamton, Dept Math Sci, Binghamton, NY 13901 USA; [Al-Aama, Jumana Yousuf] King Abdulaziz Univ, Fac Med, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia; [Liu, Liang; Li, Ting; Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Huang, Qingchun] Guangdong Hosp Tradit Chinese Med, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); University of Copenhagen; South China University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; King Abdulaziz University; Macau University of Science & Technology; Guangzhou University of Chinese Medicine	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	zxpumch2003@sina.com; liyr@bgitechsolutions.com; wangj@genomics.org.cn	Ho, Igor Osorio/AAG-8616-2020; Al-aama, Jumana/AAA-8653-2021; Jia, Huijue/M-3991-2015; zhang, xuan/GQO-8953-2022; Li, Yingrui/K-1064-2015; Qiao, Xingye/P-6321-2019; Kristiansen, Karsten/J-5148-2014; zhang, xuan/AAN-9914-2020; Xu, Xun/AAI-6763-2020; zhang, xu/GRX-9733-2022; Li, Junhua/AAG-3919-2019; chen, want/GRX-0662-2022; wang, edwin/G-5372-2010; Xiao, Liang/L-5614-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jia, Huijue/0000-0002-3592-126X; zhang, xuan/0000-0001-8775-1699; Qiao, Xingye/0000-0003-0937-9822; Kristiansen, Karsten/0000-0002-6024-0917; zhang, xuan/0000-0001-8775-1699; Xu, Xun/0000-0002-5338-5173; Li, Junhua/0000-0001-6784-1873; Xiao, Liang/0000-0003-0836-4397; Li, Jiyang/0000-0003-3553-8006; wang, xiaokai/0000-0002-6055-0325; Luo, Guangwen/0000-0002-3141-8704; Wang, Jun/0000-0002-8540-8931; Liu, Sheng/0000-0001-5119-0324; Wang, Jun/0000-0002-2113-5874	Natural Science Foundation of China [30890032, 30725008, 81325019]; Shenzhen Municipal Government of China [BGI20100001, JSGG20140702161403250, DRC-SZ[2015]162]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Fund for Science and Technology Development (FDCT) from Macao [077/2014/A2]; Research Special Fund for Public Welfare Industry of Health [2013202017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Fund for Science and Technology Development (FDCT) from Macao; Research Special Fund for Public Welfare Industry of Health	This research was supported by the Natural Science Foundation of China (grants 30890032 and 30725008 to Jun Wang and 81325019 to X.Z.), the Shenzhen Municipal Government of China (grant BGI20100001 to Jun Wang and grants JSGG20140702161403250 and DRC-SZ[2015]162 to Q.E.), the Danish Strategic Research Council (grant 2106-07-0021 to J.W.), an Ole Romer grant from the Danish Natural Science Research Council and the Solexa project (272-07-0196 to J.W.), the Fund for Science and Technology Development (FDCT) from Macao (grant 077/2014/A2 to J.W.) and the Research Special Fund for Public Welfare Industry of Health (grant 2013202017 to X.Z.). The authors are very grateful to colleagues at BGI-Shenzhen for DNA extraction, library construction, sequencing and discussions.	Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Colombo APV, 2012, J PERIODONTOL, V83, P1279, DOI 10.1902/jop.2012.110566; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Deane KD, 2014, NAT REV RHEUMATOL, V10, P212, DOI 10.1038/nrrheum.2014.6; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Goldbach-Mansky R, 2009, ANN INTERN MED, V151, P229, DOI 10.7326/0003-4819-151-4-200908180-00005; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Konig MF, 2015, ANN RHEUM DIS, V74, P2054, DOI 10.1136/annrheumdis-2014-205385; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu XF, 2013, CURR MICROBIOL, V67, P170, DOI 10.1007/s00284-013-0338-1; Lv QW, 2015, ANN RHEUM DIS, V74, P1078, DOI 10.1136/annrheumdis-2013-204807; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Michels F, 2007, ACTA ORTHOP BELG, V73, P263; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Park HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109479; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rashid T, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/539282; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Tao XL, 2002, ARTHRITIS RHEUM, V46, P1735, DOI 10.1002/art.10411; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; van der Helm-van Mil AHM, 2014, NAT REV RHEUMATOL, V10, P171, DOI 10.1038/nrrheum.2013.215; van Heemst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7681; Verrall AJ, 2010, J CLIN MICROBIOL, V48, P2648, DOI 10.1128/JCM.02217-09; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269	40	856	928	31	383	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					895	905		10.1038/nm.3914	http://dx.doi.org/10.1038/nm.3914			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26214836				2022-12-25	WOS:000359181000016
J	Chen, YC; Auer-Grumbach, M; Matsukawa, S; Zitzelsberger, M; Themistocleous, AC; Strom, TM; Samara, C; Moore, AW; Cho, LTY; Young, GT; Weiss, C; Schabhuttl, M; Stucka, R; Schmid, AB; Parman, Y; Graul-Neumann, L; Heinritz, W; Passarge, E; Watson, RM; Hertz, JM; Moog, U; Baumgartner, M; Valente, EM; Pereira, D; Restrepo, CM; Katona, I; Dusl, M; Stendel, C; Wieland, T; Stafford, F; Reimann, F; Von Au, K; Finke, C; Willems, PJ; Nahorski, MS; Shaikh, SS; Carvalho, OP; Nicholas, AK; Karbani, G; McAleer, MA; Cilio, MR; McHugh, JC; Murphy, SM; Irvine, AD; Jensen, UB; Windhager, R; Weis, J; Bergmann, C; Rautenstrauss, B; Baets-, J; De Jonghe, P; Reilly, MM; Kropatsch, R; Kurth, I; Chrast, R; Michiue, T; Bennett, DLH; Woods, CG; Senderek, J				Chen, Ya-Chun; Auer-Grumbach, Michaela; Matsukawa, Shinya; Zitzelsberger, Manuela; Themistocleous, Andreas C.; Strom, Tim M.; Samara, Chrysanthi; Moore, Adrian W.; Cho, Lily Ting-Yin; Young, Gareth T.; Weiss, Caecilia; Schabhuettl, Maria; Stucka, Rolf; Schmid, Annina B.; Parman, Yesim; Graul-Neumann, Luitgard; Heinritz, Wolfram; Passarge, Eberhard; Watson, Rosemarie M.; Hertz, Jens Michael; Moog, Ute; Baumgartner, Manuela; Valente, Enza Maria; Pereira, Diego; Restrepo, Carlos M.; Katona, Istvan; Dusl, Marina; Stendel, Claudia; Wieland, Thomas; Stafford, Fay; Reimann, Frank; Von Au, Katja; Finke, Christian; Willems, Patrick J.; Nahorski, Michael S.; Shaikh, Samiha S.; Carvalho, Ofelia P.; Nicholas, Adeline K.; Karbani, Gulshan; McAleer, Maeve A.; Cilio, Maria Roberta; McHugh, John C.; Murphy, Sinead M.; Irvine, Alan D.; Jensen, Uffe Birk; Windhager, Reinhard; Weis, Joachim; Bergmann, Carsten; Rautenstrauss, Bernd; Baets, Jonathan; De Jonghe, Peter; Reilly, Mary M.; Kropatsch, Regina; Kurth, Ingo; Chrast, Roman; Michiue, Tatsuo; Bennett, David L. H.; Woods, C. Geoffrey; Senderek, Jan			Transcriptional regulator PRDM12 is essential for human pain perception	NATURE GENETICS			English	Article							STEM-CELLS; SET DOMAIN; EPIGENETIC CONTROL; NEURAL CREST; PROTEIN; MUTATIONS; NEUROGENESIS; EXPRESSION; GENE; NEUROPATHY	Pain perception has evolved as a warning mechanism to alert organisms to tissue damage and dangerous environments(1,2). In humans, however, undesirable, excessive or chronic pain is a common and major societal burden for which available medical treatments are currently suboptimal(3,4). New therapeutic options have recently been derived from studies of individuals with congenital insensitivity to pain (CIP)(5,6). Here we identified 10 different homozygous mutations in PRDM12 (encoding PRDI-BF1 and RIZ homology domain-containing protein 12) in subjects with CIP from 11 families. Prdm proteins are a family of epigenetic regulators that control neural specification and neurogenesis(7,8). We determined that Prdm12 is expressed in nociceptors and their progenitors and participates in the development of sensory neurons in Xenopus embryos. Moreover, CIP-associated mutants abrogate the histone-modifying potential associated with wild-type Prdm12. Prdm12 emerges as a key factor in the orchestration of sensory neurogenesis and may hold promise as a target for new pain therapeutics(9,10).	[Chen, Ya-Chun; Stafford, Fay; Nahorski, Michael S.; Shaikh, Samiha S.; Carvalho, Ofelia P.; Woods, C. Geoffrey] Univ Cambridge, Dept Med Genet, Cambridge, England; [Chen, Ya-Chun; Stafford, Fay; Nahorski, Michael S.; Shaikh, Samiha S.; Carvalho, Ofelia P.; Nicholas, Adeline K.; Woods, C. Geoffrey] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Auer-Grumbach, Michaela; Schabhuettl, Maria; Cilio, Maria Roberta; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed, Vienna, Austria; [Matsukawa, Shinya; Baets, Jonathan; Michiue, Tatsuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Zitzelsberger, Manuela; Weiss, Caecilia; Stucka, Rolf; Dusl, Marina; Stendel, Claudia; Rautenstrauss, Bernd; Senderek, Jan] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Themistocleous, Andreas C.; Schmid, Annina B.; Bennett, David L. H.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Themistocleous, Andreas C.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa; [Strom, Tim M.; Wieland, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Strom, Tim M.; Chrast, Roman] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Samara, Chrysanthi] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; RIKEN Brain Sci Inst, Dis Mech Res Core, Saitama, Japan; [Cho, Lily Ting-Yin; Young, Gareth T.] Pfizer, Neusentis Res Unit, Cambridge, England; [Schmid, Annina B.] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Parman, Yesim] Istanbul Univ, Dept Neurol, Istanbul, Turkey; [Graul-Neumann, Luitgard] Univ Med Berlin, Ambulantes Gesundheitszentrum Charite Campus Virc, Berlin, Germany; [Heinritz, Wolfram] Praxis Humangenetik Cottbus, Cottbus, Germany; [Heinritz, Wolfram; Passarge, Eberhard] Univ Leipzig, Inst Humangenet, D-04109 Leipzig, Germany; [Passarge, Eberhard] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Watson, Rosemarie M.; McAleer, Maeve A.; Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Dermatol, Dublin, Ireland; [Hertz, Jens Michael] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Moog, Ute] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Baumgartner, Manuela] Krankenhaus Barmherzigen Schwestern Linz, Neuropadiatr Ambulanz, Linz, Austria; [Valente, Enza Maria] Casa Sollievo Sofferenza, Neurogenet Unit, San Giovanni Rotondo, Italy; [Pereira, Diego] Univ San Jose Bogota, Hosp Infantil, Dept Cirugia Plast, Bogota, Colombia; [Restrepo, Carlos M.] Univ Rosario, Unidad Genet, Bogota, Colombia; [Katona, Istvan; Weis, Joachim] Uniklin RWTH Aachen, Inst Neuropathol, Aachen, Germany; [Stendel, Claudia] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Reimann, Frank] Univ Cambridge, Dept Clin Biochem, Cambridge, England; [Von Au, Katja] Uni Med Berlin, SP7 Neuropadiat Charite, Berlin, Germany; [Finke, Christian] Uni Med Berlin, Arbeitsbereich Kinderzahnmed, ChariteCentrum Zahn Mund & Kieferheilkunde, Berlin, Germany; [Willems, Patrick J.] GENDIA, GENet DIAgnost Network, Antwerp, Belgium; [Karbani, Gulshan] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Cilio, Maria Roberta] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Cilio, Maria Roberta] Bambino Gesu Pediat Hosp, Dept Neurosci, Rome, Italy; [Cilio, Maria Roberta] Res Inst, Rome, Italy; [McHugh, John C.] Our Ladys Childrens Hosp, Dept Neurol & Neurophysiol, Dublin, Ireland; [Murphy, Sinead M.] Adelaide & Meath Hosp, Dept Neurol, Dublin, Ireland; [Murphy, Sinead M.] Trin Coll, Acad Unit Neurol, Dublin, Ireland; [Irvine, Alan D.] Trin Coll, Clin Med, Dublin, Ireland; [Jensen, Uffe Birk] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Bergmann, Carsten] Ctr Human Genet, Bioscientia, Ingelheim, Germany; [Bergmann, Carsten] Univ Freiburg, Med Ctr, Div Renal, Dept Med, D-79106 Freiburg, Germany; [Bergmann, Carsten] Univ Freiburg, Med Ctr, Clin Res Ctr, D-79106 Freiburg, Germany; [Rautenstrauss, Bernd] Med Genet Zentrum, Munich, Germany; [De Jonghe, Peter] Univ Antwerp, VIB Dept Mol Genet, Neurogenet Grp, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Reilly, Mary M.] Natl Hosp Neurol, UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England; [Kropatsch, Regina] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Kurth, Ingo] Jena Univ Hosp, Inst Human Genet, Jena, Germany; [Chrast, Roman] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Chrast, Roman] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	University of Cambridge; University of Cambridge; Medical University of Vienna; University of Tokyo; University of Munich; University of Oxford; University of Witwatersrand; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Lausanne; RIKEN; Pfizer; University of Queensland; Istanbul University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; University of Duisburg Essen; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Southern Denmark; Odense University Hospital; Ruprecht Karls University Heidelberg; Konventhospital Der Barmherzigen Bruder; IRCCS Casa Sollievo Della Sofferenza; Fundacion Universitaria de Ciencias de la Salud (FUCS); Universidad del Rosario; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cambridge; Chapel Allerton Hospital; University of California System; University of California San Francisco; IRCCS Bambino Gesu; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Aarhus University; University of Freiburg; University of Freiburg; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Antwerp; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Ruhr University Bochum; Friedrich Schiller University of Jena; Karolinska Institutet; Karolinska Institutet	Woods, CG (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge, England.	cw347@cam.ac.uk; jan.senderek@med.uni-muenchen.de	Weis, Joachim/G-1984-2014; Senderek, Jan/F-8405-2015; bennett, david/ABG-1184-2020; Cilio, Maria Roberta/AAY-6197-2021; Jensen, Uffe Birk/ABA-8306-2021; Hertz, Jens Michael/H-6269-2014; Katona, Istvan/I-6704-2016; Irvine, Alan D/A-3982-2008; Moore, Adrian W/A-3339-2013; Moore, Adrian Walton/AAN-5656-2021; Jensen, Uffe Birk/E-6066-2017; Valente, Enza Maria/G-2942-2017; Restrepo, Carlos M/K-2830-2016; Schmid, Annina B/F-3070-2010; Vieira Pinto de Carvalho, Ofelia Maria/L-2780-2014	Weis, Joachim/0000-0003-3280-6773; Senderek, Jan/0000-0002-8263-1783; Cilio, Maria Roberta/0000-0003-2481-8053; Jensen, Uffe Birk/0000-0002-6205-6355; Hertz, Jens Michael/0000-0003-0087-4739; Katona, Istvan/0000-0002-0955-8911; Irvine, Alan D/0000-0002-9048-2044; Moore, Adrian W/0000-0002-8242-301X; Moore, Adrian Walton/0000-0002-8242-301X; Jensen, Uffe Birk/0000-0002-6205-6355; Valente, Enza Maria/0000-0002-0600-6820; Restrepo, Carlos M/0000-0001-6410-0084; Schmid, Annina B/0000-0001-7759-0211; Bennett, David/0000-0002-7996-2696; Windhager, Reinhard/0000-0002-6321-1804; Nahorski, Mike/0000-0003-2681-9041; Reilly, Mary/0000-0003-0686-905X; Kurth, Ingo/0000-0002-5642-8378; Murphy, Sinead/0000-0002-7277-414X; Themistocleous, Andreas/0000-0002-1089-1543; Chrast, Roman/0000-0003-4189-3514; Vieira Pinto de Carvalho, Ofelia Maria/0000-0002-7450-9980; Reimann, Frank/0000-0001-9399-6377; Nicholas, Adeline/0000-0002-7124-629X	Cambridge NIHR Biomedical Research Centre; Austrian Science Fond [P23223-B19]; UK Medical Research Council; Association Belge contre les Maladies Neuromusculaires; EU [2012-305121]; Deutsche Forschungsgemeinschaft [CRC/SFB 1140, KU1587/4-1]; Gebert-Ruf Stiftung [GRS-046/09]; Friedrich-Baur Stiftung; MRC [MC_UU_12012/3, MR/K000608/1, MR/J012742/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 23223] Funding Source: researchfish; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Austrian Science Fond(Austrian Science Fund (FWF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association Belge contre les Maladies Neuromusculaires; EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gebert-Ruf Stiftung; Friedrich-Baur Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful for the participation of the patients and their families in this study. The help of all contributing medical, technical and administrative staff is greatly appreciated. We thank S. Malik for her invaluable work with family A, J.R.P. Madrid and F. Axelrod for advice and discussion and M.F. Passarge for helpful suggestions on the text. D.L.H.B. is a senior Wellcome Clinical Scientist (ref. no. 095698z/11/z). This work was supported by Cambridge NIHR Biomedical Research Centre (Y.-C.C., F.S. and C.G.W.), Austrian Science Fond (P23223-B19 to M.A.-G.), the UK Medical Research Council (M.S.N. and S.S.S.), Association Belge contre les Maladies Neuromusculaires and EU FP7/2007-2013 (grant 2012-305121 (NEUROMICS) to J.B. and P.D.J.), Deutsche Forschungsgemeinschaft (CRC/SFB 1140 to C.B. and KU1587/4-1 to I. Kurth), Gebert-Ruf Stiftung (GRS-046/09 to R.C. and J.S.), and Friedrich-Baur Stiftung (J.S.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arnaud E, 2009, P NATL ACAD SCI USA, V106, P17528, DOI 10.1073/pnas.0905523106; Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Boshnjaku V, 2011, EPIGENETICS-US, V6, P1207, DOI 10.4161/epi.6.10.17592; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chittka A, 2012, J BIOL CHEM, V287, P42995, DOI 10.1074/jbc.M112.392746; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Crow M, 2013, GENOME MED, V5, DOI 10.1186/gm416; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Doppler K, 2013, J PERIPHER NERV SYST, V18, P168, DOI 10.1111/jns5.12023; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Endo K, 2012, NAT NEUROSCI, V15, P224, DOI 10.1038/nn.2998; Goldberg YP, 2012, CLIN GENET, V82, P367, DOI 10.1111/j.1399-0004.2012.01942.x; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Holmes D, 2012, NAT REV DRUG DISCOV, V11, P337, DOI [10.1038/nrd3733, 10.1038/nrd3732]; Hu XL, 2012, PROTEIN CELL, V3, P278, DOI 10.1007/s13238-012-2916-6; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Hughes J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003290; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jobe EM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00059; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Leipold E, 2013, NAT GENET, V45, P1399, DOI 10.1038/ng.2767; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; MERSKEY H, 1979, PAIN, V7, P271, DOI 10.1016/0304-3959(79)90084-8; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OCHOA J, 1969, ACTA NEUROPATHOL, V13, P197, DOI 10.1007/BF00690642; Rossi CC, 2009, DEV DYNAM, V238, P931, DOI 10.1002/dvdy.21915; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Stendel C, 2010, BRAIN, V133, P2462, DOI 10.1093/brain/awq168; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Tan SL, 2012, DEVELOPMENT, V139, P3806, DOI 10.1242/dev.082198; Wong KC, 2014, BIOINFORMATICS, V30, P1112, DOI 10.1093/bioinformatics/btt769; Yang CM, 2013, CELL STRUCT FUNCT, V38, P195, DOI 10.1247/csf.13010; Young GT, 2014, MOL THER, V22, P1530, DOI 10.1038/mt.2014.86; Zannino DA, 2014, DEV BIOL, V390, P247, DOI 10.1016/j.ydbio.2014.02.025	56	95	102	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					803	+		10.1038/ng.3308	http://dx.doi.org/10.1038/ng.3308			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005867	Green Accepted, Green Submitted			2022-12-25	WOS:000357090300019
J	Chick, JM; Kolippakkam, D; Nusinow, DP; Zhai, B; Rad, R; Huttlin, EL; Gygi, SP				Chick, Joel M.; Kolippakkam, Deepak; Nusinow, David P.; Zhai, Bo; Rad, Ramin; Huttlin, Edward L.; Gygi, Steven P.			A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides	NATURE BIOTECHNOLOGY			English	Article							N-TERMINAL ACETYLTRANSFERASES; PROTEIN IDENTIFICATION; POSTTRANSLATIONAL MODIFICATIONS; SEQUENCE DATABASES; DYNAMIC-RANGE; SPECTROMETRY; ACCURACY; HYBRID; PHOSPHORYLATION; ACETYLATION	Fewer than half of all tandem mass spectrometry (MS/MS) spectra acquired in shotgun proteomics experiments are typically matched to a peptide with high confidence. Here we determine the identity of unassigned peptides using an ultra-tolerant Sequest database search that allows peptide matching even with modifications of unknown masses up to +/- 500 Da. In a proteome-wide data set on HEK293 cells (9,513 proteins and 396,736 peptides), this approach matched an additional 184,000 modified peptides, which were linked to biological and chemical modifications representing 523 distinct mass bins, including phosphorylation, glycosylation and methylation. We localized all unknown modification masses to specific regions within a peptide. Known modifications were assigned to the correct amino acids with frequencies >90%. We conclude that at least one-third of unassigned spectra arise from peptides with substoichiometric modifications.	[Chick, Joel M.; Kolippakkam, Deepak; Nusinow, David P.; Zhai, Bo; Rad, Ramin; Huttlin, Edward L.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu	Nusinow, David/AAJ-4284-2020	Nusinow, David/0000-0002-7819-5261; Huttlin, Edward/0000-0002-1822-1173	US National Institutes of Health [HG3456, GM67945]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of S.P.G.'s lab for fruitful discussions about this work. This work was funded in part by US National Institutes of Health grants HG3456 and GM67945 to S.P.G.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bern M, 2007, ANAL CHEM, V79, P1393, DOI 10.1021/ac0617013; Boyne MT, 2009, J PROTEOME RES, V8, P374, DOI 10.1021/pr800635m; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Dasari S, 2010, J PROTEOME RES, V9, P1716, DOI 10.1021/pr900850m; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim S, 2009, MOL CELL PROTEOMICS, V8, P53, DOI 10.1074/mcp.M800103-MCP200; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Li J, 2010, HUM MUTAT, V31, P219, DOI 10.1002/humu.21176; Liu C, 2006, BIOINFORMATICS, V22, pE307, DOI 10.1093/bioinformatics/btl226; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nielsen ML, 2006, MOL CELL PROTEOMICS, V5, P2384, DOI 10.1074/mcp.M600248-MCP200; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Renard BY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014167; Savitski MM, 2006, MOL CELL PROTEOMICS, V5, P935, DOI 10.1074/mcp.T500034-MCP200; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sunyaev S, 2003, ANAL CHEM, V75, P1307, DOI 10.1021/ac026199a; Tabb DL, 2003, ANAL CHEM, V75, P6415, DOI 10.1021/ac0347462; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Tsur D, 2005, NAT BIOTECHNOL, V23, P1562, DOI 10.1038/nbt1168; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	43	250	259	7	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					743	749		10.1038/nbt.3267	http://dx.doi.org/10.1038/nbt.3267			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26076430	Green Accepted, Green Submitted			2022-12-25	WOS:000358396100030
J	Fan, D; Coughlin, LA; Neubauer, MM; Kim, J; Kim, MS; Zhan, XW; Simms-Waldrip, TR; Xie, Y; Hooper, LV; Koh, AY				Fan, Di; Coughlin, Laura A.; Neubauer, Megan M.; Kim, Jiwoong; Kim, Min Soo; Zhan, Xiaowei; Simms-Waldrip, Tiffany R.; Xie, Yang; Hooper, Lora V.; Koh, Andrew Y.			Activation of HIF-1 alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization	NATURE MEDICINE			English	Article							CHAIN FATTY-ACIDS; GASTROINTESTINAL-TRACT; MICROBIOTA; ANTIBIOTICS; EXPRESSION; CAPACITY; MICE; SKIN	Candida albicans colonization is required for invasive disease(1-3). Unlike humans, adult mice with mature intact gut microbiota are resistant to C. albicans gastrointestinal (GI) colonization(2,4), but the factors that promote C. albicans colonization resistance are unknown. Here we demonstrate that commensal anaerobic bacteria-specifically clostridial Firmicutes (clusters IV and XIVa) and Bacteroidetes-are critical for maintaining C. albicans colonization resistance in mice. Using Bacteroides thetaiotamicron as a model organism, we find that hypoxia-inducible factor-1 alpha (HIF-1 alpha), a transcription factor important for activating innate immune effectors, and the antimicrobial peptide LL-37 (CRAMP in mice) are key determinants of C. albicans colonization resistance. Although antibiotic treatment enables C. albicans colonization, pharmacologic activation of colonic Hif1a induces CRAMP expression and results in a significant reduction of C. albicans GI colonization and a 50% decrease in mortality from invasive disease. In the setting of antibiotics, Hif1a and Camp (which encodes CRAMP) are required for B. thetaiotamicron-induced protection against C. albicans colonization of the gut. Thus, modulating C. albicans GI colonization by activation of gut mucosal immune effectors may represent a novel therapeutic approach for preventing invasive fungal disease in humans.	[Fan, Di; Coughlin, Laura A.; Neubauer, Megan M.; Simms-Waldrip, Tiffany R.; Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Kim, Jiwoong; Kim, Min Soo; Zhan, Xiaowei; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Zhan, Xiaowei; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Xie, Yang; Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hooper, Lora V.; Koh, Andrew Y.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Koh, AY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	andrew.koh@utsouthwestern.edu	Koh, Andrew/R-6837-2019	Koh, Andrew/0000-0003-2172-5126; Kim, Min Soo/0000-0001-7035-9092	Roberta I. and Norman L. Pollock Fund; Global Probiotics Council Young Investigator Grant for Probiotics; US National Institutes of Health (NIH) [R01 DK060855]; Howard Hughes Medical Institute; NIH [P30CA142543]; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	Roberta I. and Norman L. Pollock Fund; Global Probiotics Council Young Investigator Grant for Probiotics; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank K. Nickerson (University of Nebraska, Lincoln, Nebraska), J. Patton-Vogt (Duquesne University, Pittsburgh, Pennsylvania), R. Wheeler (University of Maine, Orono, Maine) and M. Lorenz (University of Texas Health Science Center, Houston, Texas) for providing the C. albicans strains SN152 (from K. Nickerson), BWP17 (from J. Patton-Vogt), Can098 (from R. Wheeler), WO-1 (from M. Lorenz), 3153A (from M. Lorenz); C. Doern (Children's Medical Center Dallas, Dallas, Texas) for the C. glabrata, C. parapsilosis and C. tropicalis strains; and Y. Iwakura (Institute of Medical Science, Tokyo University, Tokyo, Japan) and J. Kolls (Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania) for the IL-17A-knockout mice. We would like to thank S. Skapek, J. Amatruda, R. DeBerardinis and D. Greenberg for providing helpful comments on the manuscript. This study was supported by the Roberta I. and Norman L. Pollock Fund (A. Y. K.), the Global Probiotics Council Young Investigator Grant for Probiotics (A. Y. K.), US National Institutes of Health (NIH) grant R01 DK060855 (L.V.H.), the Howard Hughes Medical Institute (L.V.H.) and NIH grant P30CA142543 (Y.X.).	Angebault C, 2013, J INFECT DIS, V208, P1705, DOI 10.1093/infdis/jit389; Argimon S, 2011, EUKARYOT CELL, V10, P272, DOI 10.1128/EC.00133-10; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Beaugerie L, 2004, BEST PRACT RES CL GA, V18, P337, DOI 10.1016/j.bpg.2003.10.002; BERG RD, 1981, INFECT IMMUN, V33, P854, DOI 10.1128/IAI.33.3.854-861.1981; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; GARROD LP, 1960, BRIT MED J, V2, P1695, DOI 10.1136/bmj.2.5214.1695; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hatakka K, 2007, J DENT RES, V86, P125, DOI 10.1177/154405910708600204; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lopez-Garcia B, 2005, J INVEST DERMATOL, V125, P108, DOI 10.1111/j.0022-202X.2005.23713.x; Manzoni P, 2006, CLIN INFECT DIS, V42, P1735, DOI 10.1086/504324; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nucci M, 2001, CLIN INFECT DIS, V33, P1959, DOI 10.1086/323759; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Pizzo PA., 2011, PRINCIPLES PRACTICE, P1531; Ringel-Kulka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064315; SAMONIS G, 1993, ANTIMICROB AGENTS CH, V37, P51, DOI 10.1128/AAC.37.1.51; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; VANDERWAAIJ D, 1982, J ANTIMICROB CHEMOTH, V10, P263; Vedantam G, 2003, CURR OPIN MICROBIOL, V6, P457, DOI 10.1016/j.mib.2003.09.006; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Xu JP, 2003, CLIN INFECT DIS, V36, P221, DOI 10.1086/345672; Zarember KA, 2005, J CLIN INVEST, V115, P1702, DOI 10.1172/JCI25740; Zinkernagel AS, 2008, J INFECT DIS, V197, P214, DOI 10.1086/524843; Zwolinska-Wcislo M, 2006, J PHYSIOL PHARMACOL, V57, P35	46	224	237	3	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					808	+		10.1038/nm.3871	http://dx.doi.org/10.1038/nm.3871			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26053625	Green Accepted			2022-12-25	WOS:000357604600024
J	Lemos, DR; Babaeijandaghi, F; Low, M; Chang, CK; Lee, ST; Fiore, D; Zhang, RH; Natarajan, A; Nedospasov, SA; Rossi, FMV				Lemos, Dario R.; Babaeijandaghi, Farshad; Low, Marcela; Chang, Chih-Kai; Lee, Sunny T.; Fiore, Daniela; Zhang, Regan-Heng; Natarajan, Anuradha; Nedospasov, Sergei A.; Rossi, Fabio M. V.			Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; SKELETAL-MUSCLE; DYSTROPHIC MUSCLE; FACTOR-ALPHA; IFN-GAMMA; MACROPHAGES; MDX; INFLAMMATION; REGENERATION; EXPRESSION	Depending on the inflammatory milieu, injury can result either in a tissue's complete regeneration or in its degeneration and fibrosis, the latter of which could potentially lead to permanent organ failure. Yet how inflammatory cells regulate matrix-producing cells involved in the reparative process is unknown. Here we show that in acutely damaged skeletal muscle, sequential interactions between multipotent mesenchymal progenitors and infiltrating inflammatory cells determine the outcome of the reparative process. We found that infiltrating inflammatory macrophages, through their expression of tumor necrosis factor (TNF), directly induce apoptosis of fibro/adipogenic progenitors (FAPs). In states of chronic damage, however, such as those in mdx mice, macrophages express high levels of transforming growth factor beta 1 (TGF-beta 1), which prevents the apoptosis of FAPs and induces their differentiation into matrix-producing cells. Treatment with nilotinib, a kinase inhibitor with proposed anti-fibrotic activity, can block the effect of TGF-beta 1 and reduce muscle fibrosis in mdx mice. Our findings reveal an unexpected anti-fibrotic role of TNF and suggest that disruption of the precisely timed progression from a TNF-rich to a TGF-beta-rich environment favors fibrotic degeneration of the muscle during chronic injury.	[Lemos, Dario R.; Babaeijandaghi, Farshad; Low, Marcela; Chang, Chih-Kai; Lee, Sunny T.; Zhang, Regan-Heng; Natarajan, Anuradha; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Lemos, Dario R.; Babaeijandaghi, Farshad; Low, Marcela; Chang, Chih-Kai; Zhang, Regan-Heng; Natarajan, Anuradha; Rossi, Fabio M. V.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Fiore, Daniela] Univ Roma La Sapienza, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, I-00185 Rome, Italy; [Nedospasov, Sergei A.] VA Engelhardt Mol Biol Inst, Moscow 117984, Russia; [Nedospasov, Sergei A.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Nedospasov, Sergei A.] German Rheumatism Res Ctr, Berlin, Germany	University of British Columbia; University of British Columbia; Sapienza University Rome; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; Deutsches Rheuma-Forschungszentrum (DRFZ)	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Nedospasov, Sergei/C-3043-2018; Nedospasov, Sergei/Q-7319-2016; Nedospasov, Sergei/L-1990-2015; FIORE, DANIELA/K-7576-2016; Rossi, Fabio/B-5587-2013	FIORE, DANIELA/0000-0002-0111-2034; Rossi, Fabio/0000-0002-0368-2620	Heart and Stroke Foundation of Canada; Canadian Institute for Health Research [MOP 97856]; Russian Science Foundation [14-50-00029]; Four-Year Doctoral Fellowship (4YF) by the University of British Columbia; Chilean government	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Russian Science Foundation(Russian Science Foundation (RSF)); Four-Year Doctoral Fellowship (4YF) by the University of British Columbia; Chilean government	We thank the Biomedical Research Centre Animal Facility and core staff as well as the University of British Columbia flow cytometry facility staff for their technical assistance. We are very grateful to Claudia Hopkins for schematic presented in Supplementary Figure 10. The Col1a1<SUP>star</SUP>3.6-eGFP mice were a gift from D.W. Rowe (Center for Regenerative Medicine and Skeletal Development, University of Connecticut Health Center). This work was supported by a grant from the Heart and Stroke Foundation of Canada, the Canadian Institute for Health Research grant MOP 97856 (both to F.M.V.R.), and a Russian Science Foundation grant #14-50-00029 (to S.A.N.). F.B. was supported by a Four-Year Doctoral Fellowship (4YF) by the University of British Columbia, and M.L. was supported by a fellowship from the Chilean government.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bergmann MW, 2001, J MOL CELL CARDIOL, V33, P1223, DOI 10.1006/jmcc.2001.1385; BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brigitte M, 2010, ARTHRITIS RHEUM-US, V62, P268, DOI 10.1002/art.27183; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb; Chen KM, 2007, J LEUKOCYTE BIOL, V81, P306, DOI 10.1189/jlb.0606402; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dadgar S, 2014, J CELL BIOL, V207, P139, DOI 10.1083/jcb.201402079; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Desguerre I, 2012, MUSCLE NERVE, V45, P803, DOI 10.1002/mus.23341; Distler JHW, 2008, ARTHRITIS RHEUM, V58, P2228, DOI 10.1002/art.23645; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Huggett MT, 2006, RHEUMATOLOGY, V45, P1312, DOI 10.1093/rheumatology/kel220; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Kruglov AA, 2012, J IMMUNOL, V188, P4, DOI 10.4049/jimmunol.1190080; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Lemos DR, 2012, STEM CELLS, V30, P1152, DOI 10.1002/stem.1082; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Liu YQ, 2011, J HEPATOL, V55, P612, DOI 10.1016/j.jhep.2010.11.035; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mann PB, 2004, INFECT IMMUN, V72, P6650, DOI 10.1128/IAI.72.11.6650-6658.2004; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ostor AJK, 2004, BRIT MED J, V329, P1266, DOI 10.1136/bmj.329.7477.1266; Peng F, 2011, BIOCHEM BIOPH RES CO, V406, P601, DOI 10.1016/j.bbrc.2011.02.100; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rhee CK, 2011, RESPIRATION, V82, P273, DOI 10.1159/000327719; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Taki H, 2009, RHEUMATOL INT, V30, P275, DOI 10.1007/s00296-009-0931-6; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Warren GL, 2004, FASEB J, V18, P413, DOI 10.1096/fj.04-2421fje; Zhang K, 1997, J IMMUNOL, V158, P954	53	365	372	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					786	+		10.1038/nm.3869	http://dx.doi.org/10.1038/nm.3869			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26053624				2022-12-25	WOS:000357604600020
J	Maza, I; Caspi, I; Zviran, A; Chomsky, E; Rais, Y; Viukov, S; Geula, S; Buenrostro, JD; Weinberger, L; Krupalnik, V; Hanna, S; Zerbib, M; Dutton, JR; Greenleaf, WJ; Massarwa, R; Novershtern, N; Hanna, JH				Maza, Itay; Caspi, Inbal; Zviran, Asaf; Chomsky, Elad; Rais, Yoach; Viukov, Sergey; Geula, Shay; Buenrostro, Jason D.; Weinberger, Leehee; Krupalnik, Vladislav; Hanna, Suhair; Zerbib, Mirie; Dutton, James R.; Greenleaf, William J.; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H.			Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors	NATURE BIOTECHNOLOGY			English	Article							MOUSE FIBROBLASTS; DIRECT CONVERSION; NANOG; HEPATOCYTES; ACTIVATION	Somatic cells can be transdifferentiated to other cell types without passing through a pluripotent state by ectopic expression of appropriate transcription factors(1,2). Recent reports have proposed an alternative transdifferentiation method in which fibroblasts are directly converted to various mature somatic cell types by brief expression of the induced pluripotent stem cell (iPSC) reprogramming factors Oct4, Sox2, Klf4 and c-Myc (OSKM) followed by cell expansion in media that promote lineage differentiation(3-6). Here we test this method using genetic lineage tracing for expression of endogenous Nanog and Oct4 and for X chromosome reactivation, as these events mark acquisition of pluripotency. We show that the vast majority of reprogrammed cardiomyocytes or neural stem cells obtained from mouse fibroblasts by OSKM-induced 'transdifferentiation' pass through a transient pluripotent state, and that their derivation is molecularly coupled to iPSC formation mechanisms. Our findings underscore the importance of defining trajectories during cell reprogramming by various methods.	[Maza, Itay; Caspi, Inbal; Zviran, Asaf; Chomsky, Elad; Rais, Yoach; Viukov, Sergey; Geula, Shay; Weinberger, Leehee; Krupalnik, Vladislav; Hanna, Suhair; Zerbib, Mirie; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Maza, Itay] Rambam Hlth Care Campus, Dept Gastroenterol, Haifa, Israel; [Maza, Itay; Hanna, Suhair] Technion Israel Inst Technol, Bruce Rappaport Sch Med, Haifa, Israel; [Buenrostro, Jason D.; Greenleaf, William J.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Hanna, Suhair] Rambam Hlth Care Campus, Dept Pediat, Haifa, Israel; [Hanna, Suhair] Rambam Hlth Care Campus, Pediat Immunol Unit, Haifa, Israel; [Dutton, James R.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	Weizmann Institute of Science; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Stanford University; Rambam Health Care Campus; Rambam Health Care Campus; University of Minnesota System; University of Minnesota Twin Cities	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rada.massarwa@weizmann.ac.il; noa.novershtern@weizmann.ac.il; jacob.hanna@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Geula, Shay Yosef/Z-3789-2019	Hanna, Jacob/0000-0003-2042-9974; Geula, Shay Yosef/0000-0001-8111-4410; Maza, Itay/0000-0003-3877-6501; Novershtern, Noa/0000-0002-2244-6877	New York Stem Cell Foundation (NYSCF); FAMRI; Kimmel Innovator Research Award; ERC [StG-2011-281906]; Leona M. and Harry B. Helmsley Charitable Trust; Morass Cancer Institute; Israel Science Foundation Regular research program; ICRF Foundation; Helen and Martin Kimmel Institute for Stem Cell research (HMKISCR); Benoziyo Endowment fund; HFSPO research grant; Weizmann Institute management; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	New York Stem Cell Foundation (NYSCF); FAMRI; Kimmel Innovator Research Award; ERC(European Research Council (ERC)European Commission); Leona M. and Harry B. Helmsley Charitable Trust; Morass Cancer Institute; Israel Science Foundation Regular research program; ICRF Foundation; Helen and Martin Kimmel Institute for Stem Cell research (HMKISCR); Benoziyo Endowment fund; HFSPO research grant; Weizmann Institute management; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.H.H. is supported by a generous gift from I. and P. Mantoux; the New York Stem Cell Foundation (NYSCF), FAMRI, the Kimmel Innovator Research Award, the ERC (StG-2011-281906), the Leona M. and Harry B. Helmsley Charitable Trust, Morass Cancer Institute, the Israel Science Foundation Regular research program, the ICRF Foundation, Helen and Martin Kimmel Institute for Stem Cell research (HMKISCR), the Benoziyo Endowment fund. J.H.H. and W.G. are supported by an HFSPO research grant. J.H.H. is a New York Stem Cell Foundation - Robertson Investigator. We thank K. Hochedlinger for mutual exchange of results and discussions before publication. We thank Weizmann Institute management for providing critical financial and infrastructural support.	Bar-Nur O, 2015, NAT BIOTECHNOL, V33, P761, DOI 10.1038/nbt.3247; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carter AC, 2014, STEM CELL REP, V2, P119, DOI 10.1016/j.stemcr.2013.12.010; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Greder LV, 2012, STEM CELLS, V30, P2596, DOI 10.1002/stem.1216; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Ko K, 2010, NAT PROTOC, V5, P921, DOI 10.1038/nprot.2010.44; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Rodriguez-Ubreva J, 2012, NUCLEIC ACIDS RES, V40, P1954, DOI 10.1093/nar/gkr1015; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	31	99	99	3	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					769	774		10.1038/nbt.3270	http://dx.doi.org/10.1038/nbt.3270			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098448	Green Accepted, Green Submitted			2022-12-25	WOS:000358396100034
J	Nussinovitch, U; Gepstein, L				Nussinovitch, Udi; Gepstein, Lior			Optogenetics for in vivo cardiac pacing and resynchronization therapies	NATURE BIOTECHNOLOGY			English	Article							MESENCHYMAL STEM-CELLS; IMPLANTABLE DEFIBRILLATOR; OPTICAL CONTROL; MUSCLE	Abnormalities in the specialized cardiac conduction system may result in slow heart rate or mechanical dyssynchrony. Here we apply optogenetics, widely used to modulate neuronal excitability(1-4), for cardiac pacing and resynchronization. We used adeno-associated virus (AAV) 9 to express the Channelrhodopsin-2 (ChR2) transgene at one or more ventricular sites in rats. This allowed optogenetic pacing of the hearts at different beating frequencies with blue-light illumination both in vivo and in isolated perfused hearts. Optical mapping confirmed that the source of the new pacemaker activity was the site of ChR2 transgene delivery. Notably, diffuse illumination of hearts where the ChR2 transgene was delivered to several ventricular sites resulted in electrical synchronization and significant shortening of ventricular activation times. These findings highlight the unique potential of optogenetics for cardiac pacing and resynchronization therapies.	[Nussinovitch, Udi; Gepstein, Lior] Technion Israel Inst Technol, Rappaport Fac Med, Sohnis Lab Cardiac Electrophysiol & Regenerat Med, Haifa, Israel; [Nussinovitch, Udi; Gepstein, Lior] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Nussinovitch, Udi; Gepstein, Lior] Rambam Hlth Care Campus, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus	Gepstein, L (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Sohnis Lab Cardiac Electrophysiol & Regenerat Med, Haifa, Israel.	mdlior@tx.technion.ac.il	Core, Vector/CAF-4832-2022		NOFAR project from the Office of the Chief Scientist (OCS) in the Israel Ministry of Economy; Israel Science Foundation [1609/14]; Nancy & Stephen Grand Philanthropic Fund	NOFAR project from the Office of the Chief Scientist (OCS) in the Israel Ministry of Economy; Israel Science Foundation(Israel Science Foundation); Nancy & Stephen Grand Philanthropic Fund	This study was supported in part by the NOFAR project from the Office of the Chief Scientist (OCS) in the Israel Ministry of Economy, by the Israel Science Foundation (1609/14) and by the Nancy & Stephen Grand Philanthropic Fund. We thank C. Giridish for his technical help with the light sources. Also, we wish to thank I. Huber (from the Rappaport Faculty of Medicine, Technion), E. Suss-Toby, M. Holdengreber Shahar and L. Leiba (Imaging center at the Faculty of Medicine, Technion) and S. Ben Eliezer (Pathology Department, Rambam Health Center, Haifa, Israel) for their help with histological slide processing and their assistance with results analysis.	Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Boyle PM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3370; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jia ZH, 2011, CIRC-ARRHYTHMIA ELEC, V4, P753, DOI 10.1161/CIRCEP.111.964247; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kravitz AV, 2011, CURR OPIN NEUROBIOL, V21, P433, DOI 10.1016/j.conb.2011.02.010; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nussinovitch U, 2014, CARDIOVASC RES, V102, P176, DOI 10.1093/cvr/cvu037; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; Plotnikov AN, 2004, CIRCULATION, V109, P506, DOI 10.1161/01.CIR.0000114527.10764.CC; Potapova I, 2004, CIRC RES, V94, P952, DOI 10.1161/01.RES.0000123827.60210.72; Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115	22	131	135	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					750	754		10.1038/nbt.3268	http://dx.doi.org/10.1038/nbt.3268			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098449				2022-12-25	WOS:000358396100031
J	Siravegna, G; Mussolin, B; Buscarino, M; Corti, G; Cassingena, A; Crisafulli, G; Ponzetti, A; Cremolini, C; Amatu, A; Lauricella, C; Lamba, S; Hobor, S; Avallone, A; Valtorta, E; Rospo, G; Medico, E; Motta, V; Antoniotti, C; Tatangelo, F; Bellosillo, B; Veronese, S; Budillon, A; Montagut, C; Racca, P; Marsoni, S; Falcone, A; Corcoran, RB; Di Nicolantonio, F; Loupakis, F; Siena, S; Sartore-Bianchi, A; Bardelli, A				Siravegna, Giulia; Mussolin, Benedetta; Buscarino, Michela; Corti, Giorgio; Cassingena, Andrea; Crisafulli, Giovanni; Ponzetti, Agostino; Cremolini, Chiara; Amatu, Alessio; Lauricella, Calogero; Lamba, Simona; Hobor, Sebastijan; Avallone, Antonio; Valtorta, Emanuele; Rospo, Giuseppe; Medico, Enzo; Motta, Valentina; Antoniotti, Carlotta; Tatangelo, Fabiana; Bellosillo, Beatriz; Veronese, Silvio; Budillon, Alfredo; Montagut, Clara; Racca, Patrizia; Marsoni, Silvia; Falcone, Alfredo; Corcoran, Ryan B.; Di Nicolantonio, Federica; Loupakis, Fotios; Siena, Salvatore; Sartore-Bianchi, Andrea; Bardelli, Alberto			Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients	NATURE MEDICINE			English	Article							DROPLET DIGITAL PCR; FREE TUMOR DNA; KRAS MUTATIONS; ACQUIRED-RESISTANCE; SENSITIVE DETECTION; DRUG-RESISTANCE; NUCLEIC-ACIDS; HETEROGENEITY; MELANOMA; THERAPY	Colorectal cancers (CRCs) evolve by a reiterative process of genetic diversification and clonal evolution. The molecular profile of CRC is routinely assessed in surgical or bioptic samples(1). Genotyping of CRC tissue has inherent limitations; a tissue sample represents a single snapshot in time, and it is subjected to spatial selection bias owing to tumor heterogeneity. Repeated tissue samples are difficult to obtain and cannot be used for dynamic monitoring of disease progression and response to therapy. We exploited circulating tumor DNA (ctDNA) to genotype colorectal tumors and track clonal evolution during treatment with the epidermal growth factor receptor (EGFR)specific antibodies cetuximab or panitumumab. We identified alterations in ctDNA of patients with primary or acquired resistance to EGFR blockade in the following genes: KRAS, NRAS, MET, ERBB2, FLT3, EGFR and MAP2K1. Mutated KRAS clones, which emerge in blood during EGFR blockade, decline upon withdrawal of EGFR-specific antibodies, indicating that clonal evolution continues beyond clinical progression. Pharmacogenomic analysis of CRC cells that had acquired resistance to cetuximab reveals that upon antibody withdrawal KRAS clones decay, whereas the population regains drug sensitivity. ctDNA profiles of individuals who benefit from multiple challenges with anti-EGFR antibodies exhibit pulsatile levels of mutant KRAS. These results indicate that the CRC genome adapts dynamically to intermittent drug schedules and provide a molecular explanation for the efficacy of rechallenge therapies based on EGFR blockade.	[Siravegna, Giulia; Medico, Enzo; Di Nicolantonio, Federica; Bardelli, Alberto] Univ Turin, Dept Oncol, Turin, Italy; [Siravegna, Giulia; Mussolin, Benedetta; Buscarino, Michela; Corti, Giorgio; Crisafulli, Giovanni; Lamba, Simona; Hobor, Sebastijan; Rospo, Giuseppe; Medico, Enzo; Marsoni, Silvia; Di Nicolantonio, Federica; Bardelli, Alberto] Fdn Piemontese Oncol, Candiolo Canc Inst, IRCCS, Turin, Italy; [Siravegna, Giulia] Fdn Italiana Ric Canc, Inst Mol Oncol IFOM, Turin, Italy; [Cassingena, Andrea; Amatu, Alessio; Lauricella, Calogero; Valtorta, Emanuele; Motta, Valentina; Veronese, Silvio; Siena, Salvatore; Sartore-Bianchi, Andrea] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy; [Ponzetti, Agostino; Racca, Patrizia] San Giovanni Battista Hosp, Colorectal Canc Unit, Div Med Oncol 1, AOU Citta Salute & Sci, Turin, Italy; [Cremolini, Chiara; Antoniotti, Carlotta; Falcone, Alfredo; Loupakis, Fotios] Azienda Osped Univ Pisana, Pisa, Italy; [Cremolini, Chiara; Antoniotti, Carlotta; Falcone, Alfredo; Loupakis, Fotios] Univ Pisa, Pisa, Italy; [Avallone, Antonio; Tatangelo, Fabiana; Budillon, Alfredo] Ist Nazl Tumori Fdn G Pascale IRCCS, Naples, Italy; [Bellosillo, Beatriz; Montagut, Clara] Inst Hosp Mar Invest Med IMIM, Barcelona, Spain; [Corcoran, Ryan B.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IFOM - FIRC Institute of Molecular Oncology; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; IRCCS Fondazione Pascale; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Harvard University; Massachusetts General Hospital	Sartore-Bianchi, A (corresponding author), Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy.	andrea.sartorebianchi@ospedaleniguarda.it; alberto.bardelli@unito.it	SIENA, SALVATORE/AAC-5806-2019; Budillon, Alfredo/K-4763-2016; Crisafulli, Giovanni/AAB-6256-2019; Rospo, Giuseppe/AAC-4523-2020; Siravegna, Giulia/Z-2826-2019; Amatu, Alessio/AAB-3878-2019; Di Nicolantonio, Federica/A-2503-2011; Cremolini, Chiara/AAC-1889-2019; Avallone, Antonio/K-4662-2016; Sartore-Bianchi, Andrea/AAB-9848-2019; Cassingena, Andrea/AGD-7137-2022; Loupakis, Fotios/I-7243-2012; Tatangelo, Fabiana/AAA-8413-2020; Falcone, Alfredo/G-5217-2013; Amatu, Alessio/K-2669-2018; Medico, Enzo/AAC-3185-2021; BARDELLI, Alberto/J-9721-2018	SIENA, SALVATORE/0000-0002-2681-2846; Budillon, Alfredo/0000-0002-6330-6053; Crisafulli, Giovanni/0000-0002-5511-1555; Rospo, Giuseppe/0000-0002-1757-9085; Siravegna, Giulia/0000-0002-7132-6484; Amatu, Alessio/0000-0001-5396-3378; Di Nicolantonio, Federica/0000-0001-9618-2010; Avallone, Antonio/0000-0001-6188-5664; Sartore-Bianchi, Andrea/0000-0003-0780-0409; Cassingena, Andrea/0000-0003-4116-3992; Loupakis, Fotios/0000-0001-9651-0395; Tatangelo, Fabiana/0000-0002-9943-6079; Medico, Enzo/0000-0002-3917-2438; VALTORTA, EMANUELE/0000-0002-5087-6233; MUSSOLIN, BENEDETTA/0000-0001-5723-5685; CREMOLINI, CHIARA/0000-0002-0520-4841; Marsoni, Silvia/0000-0002-5361-7122; Veronese, Silvio Marco/0000-0002-5280-3740; Falcone, Alfredo/0000-0001-5840-2529; Lamba, Simona Elena/0000-0003-3207-1594; BARDELLI, Alberto/0000-0003-1647-5070; Corti, Giorgio/0000-0001-6379-4117	EU Seventh Framework Programme [259015 COLTHERES]; Associazione Italiana per la Ricerca sul Cancro (AIRC), IG [12812]; AIRC, MFAG [11349]; Fondazione Piemontese per la Ricerca sul Cancro ONLUS (FPRC), Italian Ministry of Education, Universities and Research (MIUR); AIRC [9970]; FPRC, Italian Ministry of Health; MIUR, grant PRIN; Italian Ministry of Health [RF2009-1539464]; Xarxa de Banc de Tumors de Catalunya; Fondazione Oncologia Niguarda Ca' Granda Onlus; Azioni, Ricerche e Cure in Oncologia (ARCO);  [RD12/0036/0051];  [PI12/00989];  [PI12/00680];  [PT13/0010/0005];  [2014 SGR 740]; NATIONAL CANCER INSTITUTE [K08CA166510] Funding Source: NIH RePORTER	EU Seventh Framework Programme; Associazione Italiana per la Ricerca sul Cancro (AIRC), IG(Fondazione AIRC per la ricerca sul cancro); AIRC, MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro ONLUS (FPRC), Italian Ministry of Education, Universities and Research (MIUR); AIRC(Fondazione AIRC per la ricerca sul cancro); FPRC, Italian Ministry of Health; MIUR, grant PRIN(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Xarxa de Banc de Tumors de Catalunya; Fondazione Oncologia Niguarda Ca' Granda Onlus; Azioni, Ricerche e Cure in Oncologia (ARCO); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank all the patients that participated in the study and their families. We are grateful to the members of the Laboratory of Molecular Genetics at Candiolo Cancer Institute for critical reading and editing of this manuscript. We thank S. Destefanis for administrative support. We thank S. Lonardi and F. Bergamo (Istituto Oncologico Veneto) for clinical data collection. This work was supported by The EU Seventh Framework Programme under grant agreement no. 259015 COLTHERES (A. Bardelli); Associazione Italiana per la Ricerca sul Cancro (AIRC), IG grant no. 12812 (A. Bardelli); AIRC, MFAG grant no. 11349 (F.D.N.); Fondazione Piemontese per la Ricerca sul Cancro ONLUS (FPRC), 5 per mille 2009 Italian Ministry of Education, Universities and Research (MIUR) grant Farmacogenomica (F.D.N.); AIRC, 2010 Special Program Molecular Clinical Oncology 5 per mille, project no. 9970 (A. Bardelli); FPRC, 5 per mille 2010 and 2011 Italian Ministry of Health (A. Bardelli); and MIUR, grant PRIN (A. Bardelli). This work was partially supported by a grant to A. Avallone from the Italian Ministry of Health (RF2009-1539464). This work was supported by RD12/0036/0051, PI12/00989, PI12/00680, PT13/0010/0005 and 2014 SGR 740 grants and by the Xarxa de Banc de Tumors de Catalunya (C.M.). Investigators at Niguarda Cancer Center are supported by grant Terapia Molecolare Tumori by Fondazione Oncologia Niguarda Ca' Granda Onlus (A.S.-B. and S.S.). This work was also partially supported by Azioni, Ricerche e Cure in Oncologia (ARCO) (C.C., C.A., F.L., A.F.)	Arena S, 2015, CLIN CANC RES; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Beaver JA, 2014, CLIN CANC RES; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Forbes SA, 2014, NUCL ACIDS RES; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hata Akito, 2013, J Gastrointest Cancer, V44, P456, DOI 10.1007/s12029-012-9453-7; Hata A, 2013, J THORAC ONCOL, V8, pE27, DOI 10.1097/JTO.0b013e318282e047; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ma ESK, 2009, J CLIN PATHOL, V62, P886, DOI 10.1136/jcp.2008.063677; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mohan S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004271; Montagut C., 2014, ASCO; Morelli M. P., 2015, ANN ONCOL; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura T, 2012, J THORAC ONCOL, V7, P1369, DOI 10.1097/JTO.0b013e31825f2821; Overman MJ, 2013, J CLIN ONCOL, V31, P17, DOI 10.1200/JCO.2012.43.1718; Palacio-Rua KA, 2014, REV GASTROENTEROL ME, V79, P79, DOI 10.1016/j.rgmx.2014.05.001; Reinert T, 2015, GUT; Sanmamed MF, 2015, CLIN CHEM, V61, P297, DOI 10.1373/clinchem.2014.230235; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Siravegna G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0449-4; Sundstrom M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-660; Tiacci E, 2012, BLOOD, V119, P192, DOI 10.1182/blood-2011-08-371179; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wong NACS, 2014, J CLIN PATHOL, V67, P751, DOI 10.1136/jclinpath-2014-202467; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442	49	610	629	1	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					795	+		10.1038/nm.3870	http://dx.doi.org/10.1038/nm.3870			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26030179	Green Accepted, Green Submitted			2022-12-25	WOS:000357604600021
J	Tilgner, H; Jahanbani, F; Blauwkamp, T; Moshrefi, A; Jaeger, E; Chen, F; Harel, I; Bustamante, CD; Rasmussen, M; Snyder, MP				Tilgner, Hagen; Jahanbani, Fereshteh; Blauwkamp, Tim; Moshrefi, Ali; Jaeger, Erich; Chen, Feng; Harel, Itamar; Bustamante, Carlos D.; Rasmussen, Morten; Snyder, Michael P.			Comprehensive transcriptome analysis using synthetic long-read sequencing reveals molecular co-association of distant splicing events	NATURE BIOTECHNOLOGY			English	Article							MESSENGER-RNA; HUMAN GENOME; GENE; SEQ; LANDSCAPE; GENCODE	Alternative splicing shapes mammalian transcriptomes, with many RNA molecules undergoing multiple distant alternative splicing events. Comprehensive transcriptome analysis, including analysis of exon co-association in the same molecule, requires deep, long-read sequencing. Here we introduce an RNA sequencing method, synthetic long-read RNA sequencing (SLR-RNA-seq), in which small pools (<= 1,000 molecules/pool, <= 1 molecule/gene for most genes) of full-length cDNAs are amplified, fragmented and short-read-sequenced. We demonstrate that these RNA sequences reconstructed from the short reads from each of the pools are mostly close to full length and contain few insertion and deletion errors. We report many previously undescribed isoforms (human brain: similar to 13,800 affected genes, 14.5% of molecules; mouse brain similar to 8,600 genes, 18% of molecules) and up to 165 human distant molecularly associated exon pairs (dMAPs) and distant molecularly and mutually exclusive pairs (dMEPs). Of 16 associated pairs detected in the mouse brain, 9 are conserved in human. Our results indicate conserved mechanisms that can produce distant but phased features on transcript and proteome isoforms.	[Tilgner, Hagen; Jahanbani, Fereshteh; Harel, Itamar; Bustamante, Carlos D.; Rasmussen, Morten; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Blauwkamp, Tim; Moshrefi, Ali; Jaeger, Erich; Chen, Feng] Illumina Inc, San Francisco, CA USA	Stanford University; Illumina	Snyder, MP (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu		Harel, Itamar/0000-0001-9749-8279; Bustamante, Carlos D./0000-0002-4187-7920; Snyder, Michael/0000-0003-0784-7987	Danish Council for Independent Research [12-131829];  [5U01HL10739304];  [1P50HG007735-01];  [5P01GM09913004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, U54HG006996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Spies and F.A. Bava for a thorough reading of this manuscript and valuable comments and S. Shringarpure, V. Kuleshov, CS. Foo and H. Tang for valuable comments on statistics. We thank A. Brunet for providing mice and S. Munro for valuable comments on this manuscript. We also thank the Genetics Bioinformatics Service Center at Stanford for providing a well-working computing cluster. M.R. is paid by grant 12-131829 from the Danish Council for Independent Research. This work was supported by grant 5U01HL10739304 (to M.S. as co-PI), 1P50HG007735-01 (to M.S. as co-PI) and 5P01GM09913004 (to M.S.).	Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Chen JK, 2014, INT J STRUCT STAB DY, V14, DOI 10.1142/S0219455413500715; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Cho HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108095; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dujardin G, 2013, BBA-GENE REGUL MECH, V1829, P134, DOI 10.1016/j.bbagrm.2012.08.005; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Tilgner H, 2013, G3-GENES GENOM GENET, V3, P387, DOI 10.1534/g3.112.004812; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	49	120	125	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					736	742		10.1038/nbt.3242	http://dx.doi.org/10.1038/nbt.3242			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	25985263	Green Accepted			2022-12-25	WOS:000358396100029
J	Xue, RD; Lynes, MD; Dreyfuss, JM; Shamsi, F; Schulz, TJ; Zhang, HB; Huang, TL; Townsend, KL; Li, YM; Takahashi, H; Weiner, LS; White, AP; Lynes, MS; Rubin, LL; Goodyear, LJ; Cypess, AM; Tseng, YH				Xue, Ruidan; Lynes, Matthew D.; Dreyfuss, Jonathan M.; Shamsi, Farnaz; Schulz, Tim J.; Zhang, Hongbin; Huang, Tian Lian; Townsend, Kristy L.; Li, Yiming; Takahashi, Hirokazu; Weiner, Lauren S.; White, Andrew P.; Lynes, Maureen S.; Rubin, Lee L.; Goodyear, Laurie J.; Cypess, Aaron M.; Tseng, Yu-Hua			Clonal analyses and gene profiling identify genetic biomarkers of the thermogenic potential of human brown and white preadipocytes	NATURE MEDICINE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADIPOSE-TISSUE; FUNCTIONAL-CHARACTERIZATION; COLD-EXPOSURE; FAT; IDENTIFICATION; ADIPOCYTES; CELL; ACTIVATION; DISTINCT	Targeting brown adipose tissue (BAT) content or activity has therapeutic potential for treating obesity and the metabolic syndrome by increasing energy expenditure. However, both inter-and intra-individual differences contribute to heterogeneity in human BAT and potentially to differential thermogenic capacity in human populations. Here we generated clones of brown and white preadipocytes from human neck fat and characterized their adipogenic and thermogenic differentiation. We combined an uncoupling protein 1 (UCP1) reporter system and expression profiling to define novel sets of gene signatures in human preadipocytes that could predict the thermogenic potential of the cells once they were maturated. Knocking out the positive UCP1 regulators, PREX1 and EDNRB, in brown preadipocytes using CRISPR-Cas9 markedly abolished the high level of UCP1 in brown adipocytes differentiated from the preadipocytes. Finally, we were able to prospectively isolate adipose progenitors with great thermogenic potential using the cell surface marker CD29. These data provide new insights into the cellular heterogeneity in human fat and offer potential biomarkers for identifying thermogenically competent preadipocytes.	[Xue, Ruidan; Lynes, Matthew D.; Shamsi, Farnaz; Schulz, Tim J.; Zhang, Hongbin; Huang, Tian Lian; Townsend, Kristy L.; Takahashi, Hirokazu; Weiner, Lauren S.; Goodyear, Laurie J.; Cypess, Aaron M.; Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab,Res Div, Boston, MA 02115 USA; [Xue, Ruidan; Li, Yiming] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Div Endocrinol & Metab, Shanghai 200433, Peoples R China; [Dreyfuss, Jonathan M.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Bioinformat Core, Boston, MA 02115 USA; [Dreyfuss, Jonathan M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [White, Andrew P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Orthoped Surg, Boston, MA 02215 USA; [Lynes, Maureen S.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lynes, Maureen S.; Rubin, Lee L.; Tseng, Yu-Hua] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Cypess, Aaron M.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Fudan University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Tseng, YH (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab,Res Div, Boston, MA 02115 USA.	yu-hua.tseng@joslin.harvard.edu	Tseng, Yu-Hua/AAE-6471-2021; Schulz, Tim/F-4842-2013	Tseng, Yu-Hua/0000-0003-2053-9559; Schulz, Tim/0000-0002-8413-3972; Lynes, Matthew/0000-0003-0746-0854; Dreyfuss, Jonathan/0000-0001-7242-3991; Rubin, Lee/0000-0002-8658-841X	US National Institutes of Health (NIH) [R01DK077097, R01DK099511, K23DK081604, P30DK036836]; National Institute of Diabetes and Digestive and Kidney Diseases; Chugai Pharmaceutical Co.; American Diabetes Association [ADA 7-12-BS-191]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Harvard Stem Cell Institute; NIH [T32DK007260, F32DK102320]; Novo Nordisk Fonden [NNF14OC0009897] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075115, F32DK102320, T32DK007260, R01DK099511, K23DK081604, R01DK077097, P30DK036836, ZIADK075112] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chugai Pharmaceutical Co.; American Diabetes Association(American Diabetes Association); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US National Institutes of Health (NIH) grants R01DK077097 (to Y.-H.T.), R01DK099511 (to L.J.G.), K23DK081604 (to A.M.C.) and P30DK036836 (to Joslin Diabetes Center's Diabetes Research Center, DRC) from the National Institute of Diabetes and Digestive and Kidney Diseases, a sponsored research grant from Chugai Pharmaceutical Co. (to Y.-H.T. and A.M.C.), a research grant from the American Diabetes Association (ADA 7-12-BS-191, to Y.-H.T.), the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and by funding from the Harvard Stem Cell Institute (to Y.-H.T.). M.D.L. was supported by NIH fellowships (T32DK007260 and F32DK102320). We thank M.-E. Patti and K. Hughes of the Advanced Genomics and Genetics Core of Joslin's DRC for advice and expert technical assistance. The authors thank Stryker Regenerative Medicine (Hopkinton, Massachusetts) for the generous gift of recombinant BMP7.	Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen TY, 2013, DRUG DES DEV THER, V7, P545, DOI 10.2147/DDDT.S45263; Cheung J, 2001, GENOMICS, V78, P7, DOI 10.1006/geno.2001.6651; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Farnier C, 2002, ANN NY ACAD SCI, V973, P594, DOI 10.1111/j.1749-6632.2002.tb04706.x; Garciafigueroa DY, 2013, TOXICOL SCI, V134, P335, DOI 10.1093/toxsci/kft108; Gierloff M, 2014, J PLAST RECONSTR AES, V67, P1427, DOI 10.1016/j.bjps.2014.05.042; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Juan CC, 2006, OBESITY, V14, P398, DOI 10.1038/oby.2006.53; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kikkawa T, 2013, GENES CELLS, V18, P636, DOI 10.1111/gtc.12061; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lewis JP, 2010, GENOMICS, V96, P211, DOI 10.1016/j.ygeno.2010.07.006; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu-Wong JSR, 2002, CLIN SCI, V103, p418S, DOI 10.1042/CS103S418S; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	51	162	163	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					760	+		10.1038/nm.3881	http://dx.doi.org/10.1038/nm.3881			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26076036	Green Accepted, Green Submitted			2022-12-25	WOS:000357604600017
J	Greene, CS; Krishnan, A; Wong, AK; Ricciotti, E; Zelaya, RA; Himmelstein, DS; Zhang, R; Hartmann, BM; Zaslavsky, E; Sealfon, SC; Chasman, DI; FitzGerald, GA; Dolinski, K; Grosser, T; Troyanskaya, OG				Greene, Casey S.; Krishnan, Arjun; Wong, Aaron K.; Ricciotti, Emanuela; Zelaya, Rene A.; Himmelstein, Daniel S.; Zhang, Ran; Hartmann, Boris M.; Zaslavsky, Elena; Sealfon, Stuart C.; Chasman, Daniel I.; FitzGerald, Garret A.; Dolinski, Kara; Grosser, Tilo; Troyanskaya, Olga G.			Understanding multicellular function and disease with human tissue-specific networks	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ENHANCER-BINDING; GENE-FUNCTION; EXPRESSION; LEF-1; GENOME; CELLS; PREDICTION; RESOURCE; AIRWAY	Tissue and cell-type identity lie at the core of human physiology and disease. Understanding the genetic underpinnings of complex tissues and individual cell lineages is crucial for developing improved diagnostics and therapeutics. We present genome-wide functional interaction networks for 144 human tissues and cell types developed using a data-driven Bayesian methodology that integrates thousands of diverse experiments spanning tissue and disease states. Tissue-specific networks predict lineage-specific responses to perturbation, identify the changing functional roles of genes across tissues and illuminate relationships among diseases. We introduce NetWAS, which combines genes with nominally significant genome-wide association study (GWAS) P values and tissue-specific networks to identify disease-gene associations more accurately than GWAS alone. Our webserver, GIANT, provides an interface to human tissue networks through multi-gene queries, network visualization, analysis tools including NetWAS and downloadable networks. GIANT enables systematic exploration of the landscape of interacting genes that shape specialized cellular functions across more than a hundred human tissues and cell types.	[Greene, Casey S.; Zelaya, Rene A.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA; [Greene, Casey S.] Dartmouth Hitchcock Norris Cotton Canc Ctr, Lebanon, NH USA; [Greene, Casey S.] Dartmouth Coll, Inst Quantitat Biomed Sci, Hanover, NH 03755 USA; [Krishnan, Arjun; Dolinski, Kara; Troyanskaya, Olga G.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wong, Aaron K.; Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Ricciotti, Emanuela; FitzGerald, Garret A.; Grosser, Tilo] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Ricciotti, Emanuela; FitzGerald, Garret A.; Grosser, Tilo] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Himmelstein, Daniel S.] Univ Calif San Francisco, Biol & Med Informat, San Francisco, CA 94143 USA; [Zhang, Ran] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Hartmann, Boris M.; Zaslavsky, Elena; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Chasman, Daniel I.] Harvard Univ, Sch Med, Boston, MA USA; [Troyanskaya, Olga G.] Simons Fdn, Simons Ctr Data Anal, New York, NY USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Princeton University; Princeton University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; Princeton University; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Troyanskaya, OG (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ogt@genomics.princeton.edu	Hartmann, Boris M./A-6121-2010; Himmelstein, Daniel S/J-8986-2013; Greene, Casey/L-2057-2015; Grosser, Tilo/A-1057-2007; Ricciotti, Emanuela/AAH-2729-2019; Dolinski, Kara/GPP-4026-2022	Hartmann, Boris M./0000-0002-5649-6776; Himmelstein, Daniel S/0000-0002-3012-7446; Greene, Casey/0000-0001-8713-9213; Grosser, Tilo/0000-0001-8569-8396; Dolinski, Kara/0000-0002-7010-0264; Zelaya, Rene/0000-0003-1037-309X; Troyanskaya, Olga/0000-0002-5676-5737; Krishnan, Arjun/0000-0002-7980-4110; Wong, Aaron/0000-0002-7294-0646; Zaslavsky, Elena/0000-0002-4828-7771; SEALFON, Stuart/0000-0001-5791-1217; Zhang, Ran/0000-0002-7630-1251	US National Institutes of Health (NIH) [R01 GM071966, R01 HG005998, U54 HL117798]; US NIH [T32 CA009528, P20 GM 103534, T32 HG003284, P50 GM071508, HHSN272201000054C]; NATIONAL CANCER INSTITUTE [T32CA009528] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284, R01HG005998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM071966, P20GM103534] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011194] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was primarily supported by US National Institutes of Health (NIH) grants R01 GM071966 and R01 HG005998 to O.G.T. and U54 HL117798 to G.A.F. C.S.G. was supported in part by US NIH grants T32 CA009528 and P20 GM 103534. A.K.W. was supported in part by US NIH grant T32 HG003284. This work was supported in part by US NIH grant P50 GM071508 and by US NIH contract HHSN272201000054C. O.G.T. is a senior fellow of the Genetic Networks program of the Canadian Institute for Advanced Research (CIFAR).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cohen MM, 2013, J CRANIOFAC SURG, V24, P130, DOI 10.1097/SCS.0b013e3182636b7e; D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Driskell RR, 2004, AM J PHYSIOL-LUNG C, V287, pL752, DOI 10.1152/ajplung.00026.2004; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; Duan DS, 1999, DEVELOPMENT, V126, P4441; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erdfelder F, 2010, HEMATOL REP, V2, P24, DOI 10.4081/hr.2010.e3; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hibbs MA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000322; Ho JE, 2011, J HYPERTENS, V29, P62, DOI 10.1097/HJH.0b013e3283406927; Hoeppner LH, 2009, J CELL PHYSIOL, V221, P480, DOI 10.1002/jcp.21879; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Hwang S, 2011, NAT PROTOC, V6, P1429, DOI 10.1038/nprot.2011.372; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kofler S, 2005, CLIN SCI, V108, P205, DOI 10.1042/CS20040174; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Myers CL, 2007, BIOINFORMATICS, V23, P2322, DOI 10.1093/bioinformatics/btm332; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; OLDHAM PD, 1960, LANCET, V1, P1085; Pandey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088889; Park CY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002957; Park SK, 2011, MOL CELLS, V32, P67, DOI 10.1007/s10059-011-1031-5; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qin C, 2014, NUCLEIC ACIDS RES, V42, pD1118, DOI 10.1093/nar/gkt1129; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Thorn Caroline F, 2013, Methods Mol Biol, V1015, P311, DOI 10.1007/978-1-62703-435-7_20; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Wang X, 2009, ZEBRAFISH, V6, P49, DOI 10.1089/zeb.2008.0570; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	64	455	463	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					569	576		10.1038/ng.3259	http://dx.doi.org/10.1038/ng.3259			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915600	Green Accepted, Green Submitted			2022-12-25	WOS:000355386500005
J	Wirth, T				Wirth, Thierry			Massive lineage replacements and cryptic outbreaks of Salmonella Typhi in eastern and southern Africa	NATURE GENETICS			English	Editorial Material							RESISTANT TUBERCULOSIS; EVOLUTIONARY HISTORY		[Wirth, Thierry] Univ Paris 06, Museum Natl Hist Nat, Inst Systemat Evolut Biodiversite ISYEB, UMR 7205,CNRS, Paris, France; [Wirth, Thierry] Univ Paris 04, EPHE, Paris Sci & Lettres, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Wirth, T (corresponding author), Univ Paris 06, Museum Natl Hist Nat, Inst Systemat Evolut Biodiversite ISYEB, UMR 7205,CNRS, Paris, France.	wirth@mnhn.fr	Wirth, Thierry/B-4915-2008	Wirth, Thierry/0000-0002-7371-0172				Bernard C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.33.20555; Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Safi H, 2013, NAT GENET, V45, P1190, DOI 10.1038/ng.2743; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Stegger M, 2014, MBIO, V5, DOI 10.1128/mBio.01044-14; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281	14	16	16	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					565	567		10.1038/ng.3318	http://dx.doi.org/10.1038/ng.3318			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	26018894				2022-12-25	WOS:000355386500004
J	Yang, ST; Kiessling, V; Simmons, JA; White, JM; Tamm, LK				Yang, Sung-Tae; Kiessling, Volker; Simmons, James A.; White, Judith M.; Tamm, Lukas K.			HIV gp41-mediated membrane fusion occurs at edges of cholesterol-rich lipid domains	NATURE CHEMICAL BIOLOGY			English	Article							MODEL MEMBRANES; BIOLOGICAL-MEMBRANES; CELL-MEMBRANES; LINE TENSION; RAFTS; BILAYERS; FLUID; PROTEINS; PLANAR; ENTRY	Lipid rafts in plasma membranes have emerged as possible platforms for the entry of HIV and other viruses into cells. However, little is known about how lipid phase heterogeneity contributes to viral entry because of the fine-grained and still poorly understood complexity of biological membranes. We used model systems mimicking HIV envelopes and T cell membranes and found that raft-like liquid-ordered (L-o-phase) lipid domains were necessary and sufficient for efficient membrane targeting and fusion. Interestingly, membrane binding and fusion were low in homogeneous liquid-disordered (L-d-phase) and L-o-phase membranes, indicating that lipid phase heterogeneity is essential. The HIV fusion peptide preferentially targeted to L-o-L-d boundary regions and promoted full fusion at the interface between ordered and disordered lipids. L-d-phase vesicles proceeded only to hemifusion. Thus, we propose that edges but not areas of raft-like ordered lipid domains are vital for HIV entry and membrane fusion.	[Yang, Sung-Tae; Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA; [Yang, Sung-Tae; Kiessling, Volker; Simmons, James A.; White, Judith M.; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA USA; [Simmons, James A.; White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Yang, ST (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA.	Lkt2e@virginia.edu			NIH [R01 AI30577, R21 AI103601]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055925, R01AI030557] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI30577 (to L.K.T.) and R21 AI103601 ( to J.M.W.). We thank E. Nelson for technical help with the production of pseudoviruses.	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Feigenson GW, 2006, NAT CHEM BIOL, V2, P560, DOI 10.1038/nchembio1106-560; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Honerkamp-Smith AR, 2008, BIOPHYS J, V95, P236, DOI 10.1529/biophysj.107.128421; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jensen MH, 2007, LANGMUIR, V23, P8135, DOI 10.1021/la700647v; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Kiessling V, 2013, BIOPHYS J, V104, P1950, DOI 10.1016/j.bpj.2013.03.038; Kiessling V, 2009, BBA-BIOMEMBRANES, V1788, P64, DOI 10.1016/j.bbamem.2008.09.003; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lai AL, 2012, J MOL BIOL, V418, P3, DOI 10.1016/j.jmb.2012.02.010; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; LIPOWSKY R, 1993, BIOPHYS J, V64, P1133, DOI 10.1016/S0006-3495(93)81479-6; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; Moissoglu K, 2014, J CELL SCI, V127, P2565, DOI 10.1242/jcs.149088; Mukai A, 2009, EXP CELL RES, V315, P3052, DOI 10.1016/j.yexcr.2009.07.010; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Qiang W, 2009, BIOCHEMISTRY-US, V48, P289, DOI 10.1021/bi8015668; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tamm L. K., 2007, INFLUENZA VIRUSES, P48; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Tamm LK, 2014, STRUCTURE, V22, P1225, DOI 10.1016/j.str.2014.08.010; Tayebi L, 2012, NAT MATER, V11, P1074, DOI [10.1038/nmat3451, 10.1038/NMAT3451]; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Zhao J, 2013, BIOPHYS J, V104, P825, DOI 10.1016/j.bpj.2012.12.047	54	119	120	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					424	+		10.1038/NCHEMBIO.1800	http://dx.doi.org/10.1038/NCHEMBIO.1800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25915200	Green Accepted			2022-12-25	WOS:000354539400013
J	Akizu, N; Cantagrel, V; Zaki, MS; Al-Gazali, L; Wang, X; Rosti, RO; Dikoglu, E; Gelot, AB; Rosti, B; Vaux, KK; Scott, EM; Silhavy, JL; Schroth, J; Copeland, B; Schaffer, AE; Gordts, PLSM; Esko, JD; Buschman, MD; Field, SJ; Napolitano, G; Abdel-Salam, GM; Ozgul, RK; Sagiroglu, MS; Azam, M; Ismail, S; Aglan, M; Selim, L; Mahmoud, IG; Abdel-Hadi, S; El Badawy, A; Sadek, AA; Mojahedi, F; Kayserili, H; Masri, A; Bastaki, L; Temtamy, S; Muller, U; Desguerre, I; Casanova, JL; Dursun, A; Gunel, M; Gabriel, SB; de Lonlay, P; Gleeson, JG				Akizu, Naiara; Cantagrel, Vincent; Zaki, Maha S.; Al-Gazali, Lihadh; Wang, Xin; Rosti, Rasim Ozgur; Dikoglu, Esra; Gelot, Antoinette Bernabe; Rosti, Basak; Vaux, Keith K.; Scott, Eric M.; Silhavy, Jennifer L.; Schroth, Jana; Copeland, Brett; Schaffer, Ashleigh E.; Gordts, Philip L. S. M.; Esko, Jeffrey D.; Buschman, Matthew D.; Field, Seth J.; Napolitano, Gennaro; Abdel-Salam, Ghada M.; Ozgul, R. Koksal; Sagiroglu, Mahmut Samil; Azam, Matloob; Ismail, Samira; Aglan, Mona; Selim, Laila; Mahmoud, Iman G.; Abdel-Hadi, Sawsan; El Badawy, Amera; Sadek, Abdelrahim A.; Mojahedi, Faezeh; Kayserili, Hulya; Masri, Amira; Bastaki, Laila; Temtamy, Samia; Mueller, Ulrich; Desguerre, Isabelle; Casanova, Jean-Laurent; Dursun, Ali; Gunel, Murat; Gabriel, Stacey B.; de Lonlay, Pascale; Gleeson, Joseph G.			Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction	NATURE GENETICS			English	Article							NEURODEGENERATIVE DISEASE; INTELLECTUAL DISABILITY; ATAXIA; SUPPRESSION; DISCOVERY; DEATH; MODEL	Pediatric-onset ataxias often present clinically as developmental delay and intellectual disability, with prominent cerebellar atrophy as a key neuroradiographic finding. Here we describe a new clinically distinguishable recessive syndrome in 12 families with cerebellar atrophy together with ataxia, coarsened facial features and intellectual disability, due to truncating mutations in the sorting nexin gene SNX14, encoding a ubiquitously expressed modular PX domain-containing sorting factor. We found SNX14 localized to lysosomes and associated with phosphatidylinositol (3,5)-bisphosphate, a key component of late endosomes/lysosomes. Patient-derived cells showed engorged lysosomes and a slower autophagosome clearance rate upon autophagy induction by starvation. Zebrafish morphants for snx14 showed dramatic loss of cerebellar parenchyma, accumulation of autophagosomes and activation of apoptosis. Our results characterize a unique ataxia syndrome due to biallelic SNX14 mutations leading to lysosome-autophagosome dysfunction.	[Akizu, Naiara; Wang, Xin; Rosti, Rasim Ozgur; Dikoglu, Esra; Rosti, Basak; Vaux, Keith K.; Scott, Eric M.; Silhavy, Jennifer L.; Schroth, Jana; Copeland, Brett; Schaffer, Ashleigh E.; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10021 USA; [Akizu, Naiara; Wang, Xin; Rosti, Rasim Ozgur; Dikoglu, Esra; Rosti, Basak; Vaux, Keith K.; Scott, Eric M.; Silhavy, Jennifer L.; Schroth, Jana; Copeland, Brett; Schaffer, Ashleigh E.; Casanova, Jean-Laurent; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Akizu, Naiara; Mueller, Ulrich] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Cantagrel, Vincent] Hop Necker Enfants Malad, INSERM, Inst Imagine, U1163, Paris, France; [Zaki, Maha S.; Abdel-Salam, Ghada M.; Ismail, Samira; Aglan, Mona; Temtamy, Samia] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo, Egypt; [Al-Gazali, Lihadh] United Arab Emirates Univ, Dept Pediat, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates; [Gelot, Antoinette Bernabe] Hop Armand Trousseau, Assistance Publ Hop Paris, UF Genet Dev, Dept Genet,Neuropathol, Paris, France; [Gelot, Antoinette Bernabe] INSERM, Inst Neurobiol Mediterranee INMED, U901, F-13258 Marseille, France; [Gordts, Philip L. S. M.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Buschman, Matthew D.; Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Napolitano, Gennaro] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ozgul, R. Koksal] Hacettepe Univ, Inst Child Hlth, Pediat Metab, Ankara, Turkey; [Sagiroglu, Mahmut Samil] Tubitak Bilgem Uekae, Gebze, Turkey; [Azam, Matloob] Wah Med Coll, Wah, Pakistan; [Selim, Laila; Mahmoud, Iman G.; Abdel-Hadi, Sawsan; El Badawy, Amera] Cairo Univ, Childrens Hosp, Dept Pediat Neurol, Cairo, Egypt; [Sadek, Abdelrahim A.] Sohag Univ, Fac Med, Pediat Neurol Dept, Sohag, Egypt; [Mojahedi, Faezeh] Mashhad Med Genet Counseling Ctr, Mashhad, Iran; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Med Genet Dept, Istanbul, Turkey; [Masri, Amira] Univ Jordan, Dept Pediat, Div Child Neurol, Amman, Jordan; [Bastaki, Laila] Matern Hosp, Kuwait Med Genet Ctr, Safat, Kuwait; [Desguerre, Isabelle] Paris Descartes Univ, Necker Enfants Malad Hosp, Dept Pediat Neurol, Paris, France; [Casanova, Jean-Laurent] Univ Paris 05, Inst Imagine, Genet Humaine Malad Infect, INSERM,U1163, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Dursun, Ali] Hacettepe Univ, Fac Med, Pediat Metab, TR-06100 Ankara, Turkey; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gabriel, Stacey B.] Broad Inst MIT & Harvard, Cambridge, MA USA; [de Lonlay, Pascale] Paris Descartes Univ, Necker Enfants Malades Hosp, Assistance Publ Hop Paris, Reference Ctr Inherited Metab Dis, Paris, France; [Gleeson, Joseph G.] New York Genome Ctr, New York, NY USA	Rockefeller University; Howard Hughes Medical Institute; Scripps Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); United Arab Emirates University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Hacettepe University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Sohag University; Istanbul University; University of Jordan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Hacettepe University; Yale University; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, 1230 York Ave, New York, NY 10021 USA.	jogleeson@rockefeller.edu	Casanova, Jean-Laurent/I-3418-2017; Napolitano, Gennaro/O-5377-2016; Wang, Guilin/G-8794-2018; Mahmoud, Iman Gamal El Din/Y-6497-2019; Vincent, Cantagrel/H-8698-2017; Kayserili, Hülya/M-3791-2015; masri, amira/C-4570-2015; Wang, Xin/A-8119-2017; Kayserili, Hülya/AAA-5593-2021; OZGUL, RIZA KOKSAL/J-1569-2013; Zaki, Maha S/B-9361-2013; Abdel-Salam, Ghada/W-1718-2017; Vaux, Keith/R-2716-2019; Dursun, Ali/AAA-1586-2020	Mahmoud, Iman Gamal El Din/0000-0003-4853-1874; Vincent, Cantagrel/0000-0002-5180-4848; masri, amira/0000-0001-6103-8713; Kayserili, Hülya/0000-0003-0376-499X; Abdel-Salam, Ghada/0000-0003-2893-8802; Vaux, Keith/0000-0001-8738-5940; Dursun, Ali/0000-0003-1104-9902; Selim, laila/0000-0002-6548-6545; temtamy, samia/0000-0002-6452-823X; Casanova, Jean-Laurent/0000-0002-7782-4169; Ozgul, Riza Koksal/0000-0002-0283-635X; Field, Seth/0000-0002-8893-4806; Copeland, Brett/0000-0003-2933-6061; Zaki, Maha/0000-0001-7840-0002; Napolitano, Gennaro/0000-0002-8615-4654; Gordts, Philip/0000-0001-7224-4328; Buschman, Matthew/0000-0002-2949-5815; Schaffer, Ashleigh/0000-0002-1164-697X; aglan, mona/0000-0002-0908-0639; ismail, samira/0000-0002-0406-8251; Gelot, Antoinette/0000-0002-3032-014X	US National Institutes of Health [P01HD070494, R01NS048453]; Howard Hughes Medical Institute; US National Institutes of Health grant [K99NS089859-01]; Broad Institute grant [U54HG003067]; Yale Center for Mendelian Disorders grant [U54HG006504]; INSERM; Paris Descartes University; Giles Foundation; Candidoser Association; Scientific and Technology Research Council of Turkey (TUBITAK-SBAG) [111S217]; Turkey Republic Ministry of Development [TRMOD, 108S420]; Scientific and Technology Research Council of Turkey (TUBITAK-BILGEM-UEKAE) [K030-T439]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455, K99NS089859] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute grant; Yale Center for Mendelian Disorders grant; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; Giles Foundation; Candidoser Association; Scientific and Technology Research Council of Turkey (TUBITAK-SBAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkey Republic Ministry of Development(Turkiye Cumhuriyeti Kalkinma Bakanligi); Scientific and Technology Research Council of Turkey (TUBITAK-BILGEM-UEKAE)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Itan and B. Boisson for sequencing, T. Meerloo and A. Schmitt for electron microscopy support, the Sanford Burnham Institute for iPSC reprogramming, and A.M. Cuervo and M. Farquhar for comments and suggestions. Analysis was performed by the University of California San Diego Glycotechnology Core and the University of California San Diego Microscopy Imaging Core. This work was supported by US National Institutes of Health grants P01HD070494 and R01NS048453 and the Howard Hughes Medical Institute (to J.G.G.), US National Institutes of Health grant K99NS089859-01 (to N.A.), Broad Institute grant U54HG003067, Yale Center for Mendelian Disorders grant U54HG006504 (to M.G.), INSERM, Paris Descartes University, the St. Giles Foundation, and the Candidoser Association and Howard Hughes Medical Institute (to J.-L.C.), the Scientific and Technology Research Council of Turkey (grant TUBITAK-SBAG, 111S217, grant TUBITAK-BILGEM-UEKAE, K030-T439) and the Turkey Republic Ministry of Development (grant TRMOD, 108S420) (to A.D.).	Aker M, 2012, J MED GENET, V49, P221, DOI 10.1136/jmedgenet-2011-100520; Bargal R, 2002, NEUROPEDIATRICS, V33, P199, DOI 10.1055/s-2002-34496; Batlevi Y, 2011, NEUROBIOL DIS, V43, P46, DOI 10.1016/j.nbd.2010.09.009; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Clements P.R., 2012, CURR PROTOC HUM GENE, V10; Coutinho P, 2013, JAMA NEUROL, V70, P746, DOI 10.1001/jamaneurol.2013.1707; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Deik A, 2014, MUSCLE NERVE, V49, P768, DOI 10.1002/mus.24146; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Gordts PLSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038330; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hegarty JM, 2013, DEVELOPMENT, V140, P1713, DOI 10.1242/dev.093112; Heiseke A, 2008, TRAFFIC, V9, P1116, DOI 10.1111/j.1600-0854.2008.00750.x; Huang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098383; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lin JW, 2004, DEV BIOL, V270, P474, DOI 10.1016/j.ydbio.2004.02.023; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Paton L, 2014, J BIOL CHEM, V289, P26709, DOI 10.1074/jbc.M114.586156; Raben N, 2010, AUTOPHAGY, V6, P1078, DOI 10.4161/auto.6.8.13378; Roda RH, 2014, J CLIN NEUROSCI, V21, P1627, DOI 10.1016/j.jocn.2013.11.048; Sousa SB, 2014, AM J MED GENET A, V164, P10, DOI 10.1002/ajmg.a.36235; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Thomas AC, 2014, AM J HUM GENET, V95, P611, DOI 10.1016/j.ajhg.2014.10.007; Wang X, 2013, NAT MED, V19, P473, DOI 10.1038/nm.3117; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Zhao YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-30	38	80	84	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					528	U137		10.1038/ng.3256	http://dx.doi.org/10.1038/ng.3256			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25848753	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000353635800017
J	Chakradhar, S				Chakradhar, Shraddha			Buzzkill: Regulatory uncertainty plagues rollout of genetically modified mosquitoes	NATURE MEDICINE			English	News Item																		1973, B WHO, V48, P49; 2015, SCI TRANSL MED, V7; 2015, CELL REPORTS, V11, P51	3	7	7	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					416	418		10.1038/nm0515-416	http://dx.doi.org/10.1038/nm0515-416			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25951523				2022-12-25	WOS:000354068800002
J	Etchegaray, JP; Chavez, L; Huang, Y; Ross, KN; Choi, J; Martinez-Pastor, B; Walsh, RM; Sommer, CA; Lienhard, M; Gladden, A; Kugel, S; Silberman, DM; Ramaswamy, S; Mostoslavsky, G; Hochedlinger, K; Goren, A; Rao, A; Mostoslavsky, R				Etchegaray, Jean-Pierre; Chavez, Lukas; Huang, Yun; Ross, Kenneth N.; Choi, Jiho; Martinez-Pastor, Barbara; Walsh, Ryan M.; Sommer, Cesar A.; Lienhard, Matthias; Gladden, Adrianne; Kugel, Sita; Silberman, Dafne M.; Ramaswamy, Sridhar; Mostoslavsky, Gustavo; Hochedlinger, Konrad; Goren, Alon; Rao, Anjana; Mostoslavsky, Raul			The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine	NATURE CELL BIOLOGY			English	Article							GENOMIC INSTABILITY; DNA; 5-METHYLCYTOSINE; METHYLATION; CONVERSION; REVEALS; HYDROXYLATION; PROTEINS; ROLES; OCT4	How embryonic stem cells (ESCs) commit to specific cell lineages and yield all cell types of a fully formed organism remains a major question. ESC differentiation is accompanied by large-scale histone and DNA modifications, but the relations between these epigenetic categories are not understood. Here we demonstrate the interplay between the histone deacetylase sirtuin 6 (SIRT6) and the ten-eleven translocation enzymes (TETs). SIRT6 targets acetylated histone H3 at Lys 9 and 56 (H3K9ac and H3K56ac), while TETs convert 5-methylcytosine into 5-hydroxymethylcytosine (5hmC). ESCs derived from Sirt6 knockout (S6KO) mice are skewed towards neuroectoderm development. This phenotype involves derepression of OCT4, SOX2 and NANOG, which causes an upregulation of TET-dependent production of 5hmC. Genome-wide analysis revealed neural genes marked with 5hmC in S6KO ESCs, thereby implicating TET enzymes in the neuroectoderm-skewed differentiation phenotype. We demonstrate that SIRT6 functions as a chromatin regulator safeguarding the balance between pluripotency and differentiation through Tet-mediated production of 5hmC.	[Etchegaray, Jean-Pierre; Ross, Kenneth N.; Choi, Jiho; Martinez-Pastor, Barbara; Walsh, Ryan M.; Kugel, Sita; Ramaswamy, Sridhar; Hochedlinger, Konrad; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Etchegaray, Jean-Pierre; Ross, Kenneth N.; Choi, Jiho; Martinez-Pastor, Barbara; Walsh, Ryan M.; Kugel, Sita; Ramaswamy, Sridhar; Hochedlinger, Konrad; Mostoslavsky, Raul] Harvard Univ, Sch Med, MGH Ctr Regenerat Med, Boston, MA 02114 USA; [Chavez, Lukas; Huang, Yun; Lienhard, Matthias; Rao, Anjana] UCSD Moores Canc Ctr, UCSD Dept Pharmacol, La Jolla Inst Allergy & Immunol, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Boston Med Ctr, CReM, Boston, MA 02118 USA; [Gladden, Adrianne; Goren, Alon] Broad Inst Harvard & MIT, BTL, Cambridge, MA 02142 USA; [Silberman, Dafne M.] UBA, CONICET, CEFyBO, Dept Human Biochem,Med Sch, RA-1121 Buenos Aires, DF, Argentina; [Hochedlinger, Konrad] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; La Jolla Institute for Immunology; Boston Medical Center; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Howard Hughes Medical Institute	Etchegaray, JP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA.	etchegaray.jean-pierre@mgh.harvard.edu; agoren@broadinstitute.org; rmostoslavsky@mgh.harvard.edu		Goren, Alon/0000-0001-5669-9357; Huang, Yun/0000-0001-5950-9168; Chavez, Lukas/0000-0002-8718-8848; Choi, Jiho/0000-0001-8839-4056	NIH [GM 093072-01, DK088190-01A1, 5R01HD058013-05, HD065812, CA151535]; Alexander von Humboldt Foundation; Leukemia and Lymphoma Society; Broad Institute SPARC (Scientific Projects to Accelerate Research and Collaboration) program; Evans Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812, R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Broad Institute SPARC (Scientific Projects to Accelerate Research and Collaboration) program; Evans Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants GM 093072-01, DK088190-01A1 (R.M.), 5R01HD058013-05 (to K.H.) and HD065812, CA151535 (to A.R.). R.M. is the Kristine and Bob Higgins MGH Research Scholar, the Warshaw Institute Fellow, and a Howard Goodman Awardee. L.C. was the recipient of a Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation. Y.H. was supported by a postdoctoral fellowship from the Leukemia and Lymphoma Society. C.A.S. is the recipient of the Evans Center Fellow Award A. Gladden and A. Goren were the recipient of the Broad Institute SPARC (Scientific Projects to Accelerate Research and Collaboration) program. We thank O. Bar-Nur and S.Cheloufi for advice on there programming of neural progenitor cells, and E. Kelliher for setting up the automation of the ChIP-Seq experiments.	Bocker MT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1826; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gomes I. C., 2010, J VIS EXP, V46; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lodato MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003288; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu YY, 2013, MOL BIOL REP, V40, P2897, DOI 10.1007/s11033-012-2305-5; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	56	107	113	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2015	17	5					545	U50		10.1038/ncb3147	http://dx.doi.org/10.1038/ncb3147			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH1HG	25915124	Green Accepted, Green Published			2022-12-25	WOS:000353771500004
J	Faridani, OR; Sandberg, R				Faridani, Omid R.; Sandberg, Rickard			Putting cells in their place	NATURE BIOTECHNOLOGY			English	Editorial Material							IN-SITU; TISSUE		[Faridani, Omid R.] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet	Faridani, OR (corresponding author), Ludwig Inst Canc Res, S-10401 Stockholm, Sweden.	omid.faridani@licr.ki.se; rickard.sandberg@ki.se		Faridani, Omid/0000-0001-9330-887X; Sandberg, Rickard/0000-0001-6473-1740				Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192	10	3	3	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					490	491		10.1038/nbt.3219	http://dx.doi.org/10.1038/nbt.3219			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965757				2022-12-25	WOS:000354314500027
J	Hilton, IB; D'Ippolito, AM; Vockley, CM; Thakore, PI; Crawford, GE; Reddy, TE; Gersbach, CA				Hilton, Isaac B.; D'Ippolito, Anthony M.; Vockley, Christopher M.; Thakore, Pratiksha I.; Crawford, Gregory E.; Reddy, Timothy E.; Gersbach, Charles A.			Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers	NATURE BIOTECHNOLOGY			English	Article							FINGER TRANSCRIPTION FACTORS; ENDOGENOUS GENES; IN-VIVO; TARGETING ENHANCERS; CHROMATIN; CRISPR; CAS9; EXPRESSION; SYSTEM; CELLS	Technologies that enable targeted manipulation of epigenetic marks could be used to precisely control cell phenotype or interrogate the relationship between the epigenome and transcriptional control. Here we describe a programmable, CRISPR-Cas9-based acetyltransferase consisting of the nuclease-null dCas9 protein fused to the catalytic core of the human acetyltransferase p300. The fusion protein catalyzes acetylation of histone H3 lysine 27 at its target sites, leading to robust transcriptional activation of target genes from promoters and both proximal and distal enhancers. Gene activation by the targeted acetyltransferase was highly specific across the genome. In contrast to previous dCas9-based activators, the acetyltransferase activates genes from enhancer regions and with an individual guide RNA. We also show that the core p300 domain can be fused to other programmable DNA-binding proteins. These results support targeted acetylation as a causal mechanism of transactivation and provide a robust tool for manipulating gene regulation.	[Hilton, Isaac B.; Thakore, Pratiksha I.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Hilton, Isaac B.; D'Ippolito, Anthony M.; Vockley, Christopher M.; Thakore, Pratiksha I.; Crawford, Gregory E.; Reddy, Timothy E.; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [D'Ippolito, Anthony M.] Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC USA; [Vockley, Christopher M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Crawford, Gregory E.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Reddy, Timothy E.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Gersbach, Charles A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Reddy, TE (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.	tim.reddy@duke.edu; charles.gersbach@duke.edu	Gersbach, Charles/Y-3412-2019; Thakore, Pratiksha I./HDM-5197-2022	Hilton, Isaac/0000-0002-3064-8532	US National Institutes of Health (NIH) grant [R01DA036865, U01HG007900]; NIH Director's New Innovator Award [DP2OD008586]; National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award [CBET-1151035]; NIH [P30AR066527]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036865] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008586] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	P. Perez-Pinera, D. Kocak, D. Ousterout and D. Lim provided assistance with gRNA design, plasmid cloning, PCR primer validation, and/or RNA isolations. The gene encoding the ICAM1-targeted zinc finger protein was provided by C. Barbas, III. This work was supported by a US National Institutes of Health (NIH) grants to G.E.C., C.A.G. and T.E.R. (R01DA036865 and U01HG007900), a NIH Director's New Innovator Award (DP2OD008586) and National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award (CBET-1151035) to C.A.G. and NIH grant P30AR066527.	Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Ji QZ, 2014, NUCLEIC ACIDS RES, V42, P6158, DOI 10.1093/nar/gku243; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Kim YW, 2013, BBA-GENE REGUL MECH, V1829, P963, DOI 10.1016/j.bbagrm.2013.04.006; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Magnenat L, 2004, J MOL BIOL, V341, P635, DOI 10.1016/j.jmb.2004.06.030; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Memedula S, 2003, CURR BIOL, V13, P241, DOI 10.1016/S0960-9822(03)00048-4; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	58	1063	1142	13	436	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					510	U225		10.1038/nbt.3199	http://dx.doi.org/10.1038/nbt.3199			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25849900	Green Accepted			2022-12-25	WOS:000354314500032
J	Ilkow, CS; Marguerie, M; Batenchuk, C; Mayer, J; Ben Neriah, D; Cousineau, S; Falls, T; Jennings, VA; Boileau, M; Bellamy, D; Bastin, D; de Souza, CT; Alkayyal, A; Zhang, JQ; Le Boeuf, F; Arulanandam, R; Stubbert, L; Sampath, P; Thorne, SH; Paramanthan, P; Chatterjee, A; Strieter, RM; Burdick, M; Addison, CL; Stojdl, DF; Atkins, HL; Auer, RC; Diallo, JS; Lichty, BD; Bell, JC				Ilkow, Carolina S.; Marguerie, Monique; Batenchuk, Cory; Mayer, Justin; Ben Neriah, Daniela; Cousineau, Sophie; Falls, Theresa; Jennings, Victoria A.; Boileau, Meaghan; Bellamy, David; Bastin, Donald; de Souza, Christiano Tanese; Alkayyal, Almohanad; Zhang, Jiqing; Le Boeuf, Fabrice; Arulanandam, Rozanne; Stubbert, Lawton; Sampath, Padma; Thorne, Steve H.; Paramanthan, Piriya; Chatterjee, Avijit; Strieter, Robert M.; Burdick, Marie; Addison, Christina L.; Stojdl, David F.; Atkins, Harold L.; Auer, Rebecca C.; Diallo, Jean-Simon; Lichty, Brian D.; Bell, John C.			Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity	NATURE MEDICINE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; RIG-I; TRANSFORMING GROWTH-FACTOR-BETA-1; INNATE IMMUNITY; RESISTANCE; THERAPY; STROMA; EXPRESSION; GROWTH; INDUCTION	Tumors are complex ecosystems composed of networks of interacting 'normal' and malignant cells. It is well recognized that cytokine-mediated cross-talk between normal stromal cells, including cancer-associated fibroblasts (CAFs), vascular endothelial cells, immune cells, and cancer cells, influences all aspects of tumor biology(1). Here we demonstrate that the cross-talk between CAFs and cancer cells leads to enhanced growth of oncolytic virus (OV)-based therapeutics. Transforming growth factor-beta (TGF-beta) produced by tumor cells reprogrammed CAFs, dampened their steady-state level of antiviral transcripts and rendered them sensitive to virus infection. In turn, CAFs produced high levels of fibroblast growth factor 2 (FGF2), initiating a signaling cascade in cancer cells that reduced retinoic acid-inducible gene I (RIG-I) expression and impeded the ability of malignant cells to detect and respond to virus. In xenografts derived from individuals with pancreatic cancer, the expression of FGF2 correlated with the susceptibility of the cancer cells to OV infection, and local application of FGF2 to resistant tumor samples sensitized them to virotherapy both in vitro and in vivo. An OV engineered to express FGF2 was safe in tumor-bearing mice, showed improved therapeutic efficacy compared to parental virus and merits consideration for clinical testing.	[Ilkow, Carolina S.; Marguerie, Monique; Batenchuk, Cory; Mayer, Justin; Ben Neriah, Daniela; Cousineau, Sophie; Falls, Theresa; Jennings, Victoria A.; Boileau, Meaghan; Bellamy, David; Bastin, Donald; de Souza, Christiano Tanese; Alkayyal, Almohanad; Zhang, Jiqing; Le Boeuf, Fabrice; Arulanandam, Rozanne; Stubbert, Lawton; Addison, Christina L.; Atkins, Harold L.; Auer, Rebecca C.; Diallo, Jean-Simon; Bell, John C.] Ottawa Hosp Res Inst, Ctr Innovat Canc Therapeut, Ottawa, ON, Canada; [Ilkow, Carolina S.; Marguerie, Monique; Batenchuk, Cory; Le Boeuf, Fabrice; Arulanandam, Rozanne; Stubbert, Lawton; Addison, Christina L.; Stojdl, David F.; Bell, John C.] Univ Ottawa, Dept Biochem Immunol & Microbiol, Ottawa, ON, Canada; [Alkayyal, Almohanad] Univ Tabuk, Fac Appl Med Sci, Dept Med Lab Technol, Tabuk, Saudi Arabia; [Zhang, Jiqing] Shandong Univ, Dept Neurosurg, Hosp 2, Jinan 250100, Shandong, Peoples R China; [Sampath, Padma; Thorne, Steve H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Sampath, Padma; Thorne, Steve H.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Sampath, Padma; Thorne, Steve H.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Paramanthan, Piriya; Chatterjee, Avijit] Ottawa Hosp, Div Gastroenterol, Ottawa, ON, Canada; [Strieter, Robert M.] Novartis Inst BioMed Res, Global Translat Med, Cambridge, MA USA; [Burdick, Marie] Univ Virginia, Dept Med Pulm & Crit Care, Charlottesville, VA USA; [Stojdl, David F.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Lichty, Brian D.] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Tabuk; Shandong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Ottawa; Ottawa Hospital Research Institute; Novartis; University of Virginia; University of Ottawa; Children's Hospital of Eastern Ontario; McMaster University	Bell, JC (corresponding author), Ottawa Hosp Res Inst, Ctr Innovat Canc Therapeut, Ottawa, ON, Canada.	jbell@ohri.ca	Alkayyal, almohanad/GZK-4462-2022; Falls, Theresa/GWZ-9829-2022; Diallo, Jean-Simon/G-4465-2017	Alkayyal, almohanad/0000-0001-7042-5985; Falls, Theresa/0000-0001-5995-9118; Bastin, Donald/0000-0003-1645-8262; Cousineau, Sophie/0000-0003-3757-1176; Marguerie, Monique/0000-0002-8540-3823; Sampath, Padmavathi/0000-0003-4788-4096; Bellamy, David/0000-0002-6878-0803; Diallo, Jean-Simon/0000-0002-4862-2795; Auer, Rebecca/0000-0002-3617-0015; Ilkow, Carolina/0000-0003-3488-4062; Ben Neriah, Daniela/0000-0003-4871-0098	Terry Fox Research Foundation [201201TFF-271514-TFF-AYDP-29782]; Canadian Institutes of Health Research [314043]; Alberta Innovative Health Solutions; Ontario Institute for Cancer Research; Ottawa Regional Cancer Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Terry Fox Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovative Health Solutions; Ontario Institute for Cancer Research; Ottawa Regional Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by grants from the Terry Fox Research Foundation (201201TFF-271514-TFF-AYDP-29782) and the Canadian Institutes of Health Research (314043) to J.C.B., J.-S.D., D.F.S., B.D.L. and R.C.A. C.S.I. is the recipient of a Fellowship award from the Alberta Innovative Health Solutions. J.C.B., D.F.S. and B.D.L. are supported by the Ontario Institute for Cancer Research and the Ottawa Regional Cancer Foundation. M.M. is funded by the Canadian Institutes of Health Research Frederick Banting and Charles Best Master's Award. C.B. is funded by the Natural Sciences and Engineering Research Council of Canada. We thank C. Cemeus and D. Vaillant for their exceptional technical support as well as members of the Bell, Auer, Atkins and Diallo laboratories for feedback on this project. pWPI-spbFGF plasmid was a gift from J. Kiss and P. Salmon (University of Geneva Medical School). HSV-1 N212 expressing GFP<SUP>14,36</SUP> was a gift from K. Mossman (McMaster University). Reovirus was a gift from P. Lee (Dalhousie University). Rabbit anti-reovirus T3 antibody was a gift from E. Brown (University of Ottawa).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Altomonte J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00085; AZZARONE B, 1984, INT J CANCER, V33, P759, DOI 10.1002/ijc.2910330608; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Breitbach CJ, 2011, MOL THER, V19, P886, DOI 10.1038/mt.2011.26; BROUTYBOYE D, 1991, INT J CANCER, V47, P697, DOI 10.1002/ijc.2910470512; Brun J, 2010, MOL THER, V18, P1440, DOI 10.1038/mt.2010.103; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Cirri P, 2011, AM J CANCER RES, V1, P482; Dayer AG, 2007, BRAIN, V130, P2962, DOI 10.1093/brain/awm200; Dell Ralph B, 2002, ILAR J, V43, P207; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Erkan M, 2012, CURR MOL MED, V12, P288, DOI 10.2174/156652412799218921; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim JH, 2006, MOL THER, V14, P361, DOI 10.1016/j.ymthe.2006.05.008; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Kurozumi K, 2007, JNCI-J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Lichty BD, 2014, NAT REV CANCER, V14, P559, DOI 10.1038/nrc3770; Lisanti MP, 2013, CELL CYCLE, V12, P2723, DOI 10.4161/cc.25695; Lohr M, 2001, CANCER RES, V61, P550; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sanfilippo CM, 2006, J VIROL, V80, P6810, DOI 10.1128/JVI.00334-06; SCHOR SL, 1988, J CELL SCI, V90, P401; Sobol PT, 2011, MOL THER, V19, P335, DOI 10.1038/mt.2010.264; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	46	103	103	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					530	U168		10.1038/nm.3848	http://dx.doi.org/10.1038/nm.3848			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25894825				2022-12-25	WOS:000354068800023
J	Perkins, MD; Kessel, M				Perkins, Mark D.; Kessel, Mark			What Ebola tells us about outbreak diagnostic readiness	NATURE BIOTECHNOLOGY			English	Article							HEMORRHAGIC-FEVER; IMMUNOSORBENT-ASSAY; VIRUS; ANTIBODIES; CONGO; IGG; PCR		[Perkins, Mark D.; Kessel, Mark] FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics	Perkins, MD (corresponding author), FIND, Geneva, Switzerland.	mark.perkins@finddx.org						Becquart P., PLOS ONE, V5, pe9126; Bitar D, 2009, EUROSURVEILLANCE, V14; Bolkan H.A., 2014, J PLOS CURR, V6, DOI [10.1371/currents.dis.8b3c24217d80f3975618fc9d9228a144., DOI 10.1371/CURRENTS.DIS.8B3C24217D80F3975618FC9D9228A144]; Cho KS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014004; Fink S., 2015, THE NEW YORK TIMES; Formenty P, 2006, CLIN INFECT DIS, V42, P1521, DOI 10.1086/503836; Heffernan RT, 2005, J INFECT DIS, V191, P964, DOI 10.1086/427994; Kim J.Y., 2014, THE NEW YORK TIMES; KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Kuan MM, 2010, INT J INFECT DIS, V14, pE693, DOI 10.1016/j.ijid.2009.12.010; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2000, J MED VIROL, V60, P463, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;463::AID-JMV15&gt;3.0.CO;2-M; McBride WJH, 2010, AUST NZ J PUBL HEAL, V34, P5, DOI 10.1111/j.1753-6405.2010.00466.x; Priest PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014490; Saijo M, 2005, J MED VIROL, V76, P111, DOI 10.1002/jmv.20332; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; WHO, 2013, WORLD MALARIA REPORT 2013, P1	20	29	32	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					464	469		10.1038/nbt.3215	http://dx.doi.org/10.1038/nbt.3215			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965752	Bronze			2022-12-25	WOS:000354314500023
J	Bazellieres, E; Conte, V; Elosegui-Artola, A; Serra-Picamal, X; Bintanel-Morcillo, M; Roca-Cusachs, P; Munoz, JJ; Sales-Pardo, M; Guimera, R; Trepat, X				Bazellieres, Elsa; Conte, Vito; Elosegui-Artola, Alberto; Serra-Picamal, Xavier; Bintanel-Morcillo, Maria; Roca-Cusachs, Pere; Munoz, Jose J.; Sales-Pardo, Marta; Guimera, Roger; Trepat, Xavier			Control of cell-cell forces and collective cell dynamics by the intercellular adhesome	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; P-CADHERIN; ALPHA-CATENIN; INTERMEDIATE-FILAMENTS; ADHESION; COMPLEX; TENSION; MORPHOGENESIS	Dynamics of epithelial tissues determine key processes in development, tissue healing and cancer invasion. These processes are critically influenced by cell-cell adhesion forces. However, the identity of the proteins that resist and transmit forces at cell-cell junctions remains unclear, and how these proteins control tissue dynamics is largely unknown. Here we provide a systematic study of the interplay between cell-cell adhesion proteins, intercellular forces and epithelial tissue dynamics. We show that collective cellular responses to selective perturbations of the intercellular adhesome conform to three mechanical phenotypes. These phenotypes are controlled by different molecular modules and characterized by distinct relationships between cellular kinematics and intercellular forces. We show that these forces and their rates can be predicted by the concentrations of cadherins and catenins. Unexpectedly, we identified different mechanical roles for P-cadherin and E-cadherin; whereas P-cadherin predicts levels of intercellular force, E-cadherin predicts the rate at which intercellular force builds up.	[Bazellieres, Elsa; Conte, Vito; Elosegui-Artola, Alberto; Serra-Picamal, Xavier; Bintanel-Morcillo, Maria; Roca-Cusachs, Pere; Trepat, Xavier] Inst Bioengn Catalonia, Barcelona 08028, Spain; [Roca-Cusachs, Pere; Trepat, Xavier] Univ Barcelona, Unitat Biofis & Bioengn, Fac Med, E-08036 Barcelona, Spain; [Roca-Cusachs, Pere; Trepat, Xavier] CIBERES, Barcelona 08036, Spain; [Munoz, Jose J.] Univ Politecn Cataluna, Dept Appl Math 3, Lab Calcul Numer, Barcelona 08036, Spain; [Sales-Pardo, Marta; Guimera, Roger] Univ Rovira & Virgili, Dept Engn Quim, E-43007 Tarragona, Catalonia, Spain; [Guimera, Roger; Trepat, Xavier] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Politecnica de Catalunya; Universitat Rovira i Virgili; ICREA	Trepat, X (corresponding author), Inst Bioengn Catalonia, Barcelona 08028, Spain.	xtrepat@ibecbarcelona.eu	Guimera, Roger/M-9808-2019; Guimera, Roger/C-1727-2008; Sales-Pardo, Marta/O-9797-2019; Sales-Pardo, Marta/C-1725-2008; Trepat, Xavier/I-3912-2015; Roca-Cusachs, Pere/D-4309-2009; Elosegui-Artola, Alberto/G-2691-2016; Conte, Vito/I-1194-2015; Munoz, Jose J/B-2475-2009	Guimera, Roger/0000-0002-3597-4310; Guimera, Roger/0000-0002-3597-4310; Sales-Pardo, Marta/0000-0002-8140-6525; Sales-Pardo, Marta/0000-0002-8140-6525; Trepat, Xavier/0000-0002-7621-5214; Roca-Cusachs, Pere/0000-0001-6947-961X; Elosegui-Artola, Alberto/0000-0003-0644-3294; Conte, Vito/0000-0002-7439-2866; Munoz, Jose J/0000-0002-0083-3673; Bazellieres, Elsa/0000-0002-2234-7537	European Research Council [StG-242993, CoG-616480]; 7th European Community Framework Programme [PCIG10-GA-2011-303848, PIRG-GA-2010-277166, PIRG-GA-2010-268342]; FET [317532]; Spanish Ministerio de Economia y Comptetitividad [BFU2012-38146, DPI2013-43727-R, FIS2010-18639, FIS2013-47532-C3, BFU2011-23111]; Juan de la Cierva Fellowship [JCI-2012-15123]; National Institutes of Health [R01HL107561]; Fundacio La Caixa, Fundacio la Marato de TV3 [20133330]; James S. McDonnell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107561] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); 7th European Community Framework Programme(European Commission); FET; Spanish Ministerio de Economia y Comptetitividad; Juan de la Cierva Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacio La Caixa, Fundacio la Marato de TV3; James S. McDonnell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ICREA(ICREA)	We thank F. Supek, B. Lehner, A. Brugus and R. Vincent for discussions, R. Zaidel-Bar for sharing unpublished data, and E. Sahai for contributing reagents. This research was supported by the European Research Council (StG-242993 and CoG-616480 to X.T.), the 7th European Community Framework Programme (PCIG10-GA-2011-303848 to P.R-C., PIRG-GA-2010-277166 to R.G., PIRG-GA-2010-268342 to M.S-P., FET Grant 317532 to M.S-P. and R.G.), the Spanish Ministerio de Economia y Comptetitividad (BFU2012-38146 to X.T., DPI2013-43727-R to J.J.M., FIS2010-18639 and FIS2013-47532-C3 to M.S-P. and R.G., BFU2011-23111 to P.R-C., Juan de la Cierva Fellowship JCI-2012-15123 to V.C.), the National Institutes of Health (R01HL107561 to X.T.), Fundacio La Caixa, Fundacio la Marato de TV3 (20133330 to P.R-C.), and the James S. McDonnell Foundation (R.G. and M.S-P.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Albergaria A, 2011, INT J DEV BIOL, V55, P811, DOI 10.1387/ijdb.113382aa; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Bechhoefer J, 2005, REV MOD PHYS, V77, P783, DOI 10.1103/RevModPhys.77.783; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Brugues A, 2014, NAT PHYS, V10, P684, DOI [10.1038/nphys3040, 10.1038/NPHYS3040]; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Budnar Srikanth, 2013, F1000Prime Rep, V5, P35, DOI 10.12703/P5-35; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Campinho P, 2013, NAT CELL BIOL, V15, P1405, DOI 10.1038/ncb2869; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cloutier M, 2010, J R SOC INTERFACE, V7, P651, DOI 10.1098/rsif.2009.0371; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Harris AR, 2012, P NATL ACAD SCI USA, V109, P16449, DOI 10.1073/pnas.1213301109; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Hur SS, 2012, P NATL ACAD SCI USA, V109, P11110, DOI 10.1073/pnas.1207326109; Jacobs K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-255; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leckband DE, 2011, CURR OPIN CELL BIOL, V23, P523, DOI 10.1016/j.ceb.2011.08.003; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Maitre JL, 2013, CURR BIOL, V23, pR626, DOI 10.1016/j.cub.2013.06.019; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Ng MR, 2014, ELIFE, V3, DOI 10.7554/eLife.03282; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Ribeiro AS, 2010, ONCOGENE, V29, P392, DOI 10.1038/onc.2009.338; Ribeiro AS, 2013, J PATHOL, V229, P705, DOI 10.1002/path.4143; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Runkle EA, 2013, CANCER LETT, V337, P41, DOI 10.1016/j.canlet.2013.05.038; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Simon R., 2007, FUNDAMENTALS DATA MI, P177; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tabdili H, 2012, J CELL SCI, V125, P4362, DOI 10.1242/jcs.105775; Tambe DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055172; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trepat X, 2011, TRENDS CELL BIOL, V21, P638, DOI 10.1016/j.tcb.2011.06.006; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Van Marck V, 2005, CANCER RES, V65, P8774, DOI 10.1158/0008-5472.CAN-04-4414; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zaidel-Bar R, 2013, J CELL SCI, V126, P373, DOI 10.1242/jcs.111559	72	185	186	2	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					409	+		10.1038/ncb3135	http://dx.doi.org/10.1038/ncb3135			38	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25812522	Green Accepted, Green Published			2022-12-25	WOS:000351920500011
J	Chen, CW; Koche, RP; Sinha, AU; Deshpande, AJ; Zhu, N; Eng, R; Doench, JG; Xu, HM; Chu, SH; Qi, J; Wang, X; Delaney, C; Bernt, KM; Root, DE; Hahn, WC; Bradner, JE; Armstrong, SA				Chen, Chun-Wei; Koche, Richard P.; Sinha, Amit U.; Deshpande, Aniruddha J.; Zhu, Nan; Eng, Rowena; Doench, John G.; Xu, Haiming; Chu, Scott H.; Qi, Jun; Wang, Xi; Delaney, Christopher; Bernt, Kathrin M.; Root, David E.; Hahn, William C.; Bradner, James E.; Armstrong, Scott A.			DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia	NATURE MEDICINE			English	Article							H3K79 METHYLATION; HISTONE H3; TRANSCRIPTIONAL ELONGATION; METHYLTRANSFERASE; SIRT1; CHROMATIN; YEAST; STEM; PROMOTES; HETEROCHROMATIN	Rearrangements of MLL (encoding lysine-specific methyltransferase 2A and officially known as KMT2A; herein referred to as MLL to denote the gene associated with mixed-lineage leukemia) generate MLL fusion proteins that bind DNA and drive leukemogenic gene expression. This gene expression program is dependent on the disruptor of telomeric silencing 1-like histone 3 lysine 79 (H3K79) methyltransferase DOT1L, and small-molecule DOT1L inhibitors show promise as therapeutics for these leukemias. However, the mechanisms underlying this dependency are unclear. We conducted a genome-scale RNAi screen and found that the histone deacetylase SIRT1 is required for the establishment of a heterochromatin-like state around MLL fusion target genes after DOT1L inhibition. DOT1L inhibits chromatin localization of a repressive complex composed of SIRT1 and the H3K9 methyltransferase SUV39H1, thereby maintaining an open chromatin state with elevated H3K9 acetylation and minimal H3K9 methylation at MLL fusion target genes. Furthermore, the combination of SIRT1 activators and DOT1L inhibitors shows enhanced antiproliferative activity against MLL-rearranged leukemia cells. These results indicate that the dynamic interplay between chromatin regulators controlling the activation and repression of gene expression could provide novel opportunities for combination therapy.	[Chen, Chun-Wei; Koche, Richard P.; Sinha, Amit U.; Deshpande, Aniruddha J.; Zhu, Nan; Eng, Rowena; Xu, Haiming; Chu, Scott H.; Wang, Xi; Delaney, Christopher; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Doench, John G.; Root, David E.; Hahn, William C.; Bradner, James E.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Qi, Jun; Hahn, William C.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bernt, Kathrin M.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA	Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Armstrong, SA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	Armstros@mskcc.org	Doench, John G/HCI-9570-2022; Bernt, Kathrin/L-1826-2016; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Bernt, Kathrin/0000-0002-5400-0482; Doench, John/0000-0002-3707-9889; Wang, Xi/0000-0002-7936-9366; Delaney, Christopher/0000-0002-4549-6869; Bernt, Kathrin/0000-0002-0691-356X; Koche, Richard/0000-0002-6820-5083; Chu, S. Haihua/0000-0002-8333-5409; Chen, Chun-Wei/0000-0002-8737-6830	Leukemia and Lymphoma Society; Gabrielle's Angel Research Foundation; US National Institutes of Health [CA66996, CA140575, CA176745]; NATIONAL CANCER INSTITUTE [R01CA176745, P01CA066996, P30CA008748, R01CA140575] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Gabrielle's Angel Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank J. Bradner for providing EPZ4777, and J. Brady and Z. Feng for administrative assistance. This work was supported by the Leukemia and Lymphoma Society, by Gabrielle's Angel Research Foundation and by US National Institutes of Health grant nos. CA66996, CA140575 and CA176745 (to S.A.A.).	Anglin JL, 2012, J MED CHEM, V55, P8066, DOI 10.1021/jm300917h; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Basavapathruni A, 2014, BIOPHARM DRUG DISPOS, V35, P237, DOI 10.1002/bdd.1889; Bernt KM, 2011, EPIGENOMICS-UK, V3, P667, DOI [10.2217/EPI.11.98, 10.2217/epi.11.98]; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buske C, 2000, INT J HEMATOL, V71, P301; Cen Y, 2010, BBA-PROTEINS PROTEOM, V1804, P1635, DOI 10.1016/j.bbapap.2009.11.010; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Chen L, 2013, LEUKEMIA, V27, P813, DOI 10.1038/leu.2012.327; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Deshpande AJ, 2014, CANCER CELL, V26, P896, DOI 10.1016/j.ccell.2014.10.009; Deshpande AJ, 2013, BLOOD, V121, P2533, DOI 10.1182/blood-2012-11-465120; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Kim S, 2012, IEEE INT SYMP INTELL, P1, DOI 10.1109/ISIC.2012.6398245; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Klaus CR, 2014, J PHARMACOL EXP THER, V350, P646, DOI 10.1124/jpet.114.214577; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mishra BP, 2014, CELL REP, V7, P1239, DOI 10.1016/j.celrep.2014.04.015; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Park G, 2010, PROTEIN J, V29, P213, DOI 10.1007/s10930-010-9242-8; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sasca D, 2014, BLOOD, V124, P121, DOI 10.1182/blood-2013-11-538819; Shen CX, 2013, J BIOL CHEM, V288, P30585, DOI 10.1074/jbc.M113.457135; Singer MS, 1998, GENETICS, V150, P613; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Sinha AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031690; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Stein EM, 2014, BLOOD, V124, P387; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi YH, 2011, MOL CELL, V42, P118, DOI 10.1016/j.molcel.2011.03.006; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Yu WY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2304; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	63	148	151	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					335	+		10.1038/nm.3832	http://dx.doi.org/10.1038/nm.3832			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25822366	Green Accepted			2022-12-25	WOS:000352493600015
J	Scholz, C; Weinert, BT; Wagner, SA; Beli, P; Miyake, Y; Qi, J; Jensen, LJ; Streicher, W; McCarthy, AR; Westwood, NJ; Lain, S; Cox, J; Matthias, P; Mann, M; Bradner, JE; Choudhary, C				Scholz, Christian; Weinert, Brian T.; Wagner, Sebastian A.; Beli, Petra; Miyake, Yasuyuki; Qi, Jun; Jensen, Lars J.; Streicher, Werner; McCarthy, Anna R.; Westwood, Nicholas J.; Lain, Sonia; Cox, Juergen; Matthias, Patrick; Mann, Matthias; Bradner, James E.; Choudhary, Chunaram			Acetylation site specificities of lysine deacetylase inhibitors in human cells	NATURE BIOTECHNOLOGY			English	Article							CYTOSCAPE PLUG-IN; HISTONE DEACETYLASE; COHESIN ACETYLATION; HDAC INHIBITORS; GENE ONTOLOGY; PROTEIN; MECHANISMS; ESTABLISHMENT; PHYSIOLOGY; REGULATOR	Lysine deacetylases inhibitors (KDACIs) are used in basic research, and many are being investigated in clinical trials for treatment of cancer and other diseases. However, their specificities in cells are incompletely characterized. Here we used quantitative mass spectrometry (MS) to obtain acetylation signatures for 19 different KDACIs, covering all 18 human lysine deacetylases. Most KDACIs increased acetylation of a small, specific subset of the acetylome, including sites on histones and other chromatin-associated proteins. Inhibitor treatment combined with genetic deletion showed that the effects of the pan-sirtuin inhibitor nicotinamide are primarily mediated by SIRT1 inhibition. Furthermore, we confirmed that the effects of tubacin and bufexamac on cytoplasmic proteins result from inhibition of HDAC6. Bufexamac also triggered an HDAC6-independent, hypoxia-like response by stabilizing HIF1-alpha, providing a possible mechanistic explanation of its adverse, pro-inflammatory effects. Our results offer a systems view of KDACI specificities, providing a framework for studying function of acetylation and deacetylases.	[Scholz, Christian; Weinert, Brian T.; Wagner, Sebastian A.; Beli, Petra; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth & Med Sci, Dept Prote, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark; [Miyake, Yasuyuki; Matthias, Patrick] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Qi, Jun; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jensen, Lars J.] Univ Copenhagen, Fac Hlth Sci, Dept Prot Sci & Technol, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark; [Streicher, Werner] Univ Copenhagen, Fac Hlth Sci, Dept Dis Syst Biol, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark; [McCarthy, Anna R.; Lain, Sonia] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Westwood, Nicholas J.] Univ St Andrews, EaStCHEM, Sch Chem, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] Univ St Andrews, EaStCHEM, St Andrews, Fife, Scotland; [Cox, Juergen; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Novo Nordisk Foundation; University of Copenhagen; Friedrich Miescher Institute for Biomedical Research; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Karolinska Institutet; University of St Andrews; University of St Andrews; Max Planck Society	Choudhary, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Prote, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark.	chuna.choudhary@cpr.ku.dk	Jensen, Lars Juhl/C-6492-2008; Schölz, Christian/K-2855-2014; Miyake, Yasuyuki/AAS-1504-2021; Lain, Sonia/B-6980-2014; Cox, Jurgen/B-9481-2008; choudhary, chunaram/ABE-6634-2020	Jensen, Lars Juhl/0000-0001-7885-715X; Schölz, Christian/0000-0002-1633-2072; Miyake, Yasuyuki/0000-0001-6250-0260; Lain, Sonia/0000-0001-9693-5246; Cox, Jurgen/0000-0001-8597-205X; choudhary, chunaram/0000-0002-9863-433X; Beli, Petra/0000-0001-9507-9820; Streicher, Werner/0000-0002-2425-5839; Weinert, Brian/0000-0002-1335-9915; Westwood, Nicholas/0000-0003-0630-0138	Novo Nordisk Foundation [NNF14CC0001]; Danish Research Council [FSS: 10-085134, FSS: 12-12610]; EMBO Young Investigator program; Doris Duke Charitable Foundation; Novo Nordisk Fonden [NNF14OC0008541, NNF15SA0018240] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Matthias Mann, PI Chunaram Choudhary] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council(Det Frie Forskningsrad (DFF)); EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research	We thank the members of the department of proteomics at CPR for their helpful discussions. We thank T. Narita for providing help with bioinformatic analyses. We thank R. Lavallee, D. Bekker-Jensen, H.C. Grell and B. Smith for their technical support. We gratefully acknowledge M. W. McBurney for providing SIRT1 knockout MEFs, D. Reinberg for providing SIRT2 knockout MEFs, and R. Mostoslavsky for providing SIRT6 knockout MEFs. This work was supported by the Hallas Moller Investigator grant from the Novo Nordisk Foundation to C.C. S.A.W. and P.B. were supported by individual postdoctoral grants from the Danish Research Council (FSS: 10-085134, FSS: 12-12610). C.C. is supported by the EMBO Young Investigator program. The Center for Protein Research is supported by a generous grant from the Novo Nordisk Foundation (grant no. NNF14CC0001). J.E.B. is supported by a grant from the Doris Duke Charitable Foundation. We thank the PRIDE team for their support with data storage.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Buggy JJ, 2006, MOL CANCER THER, V5, P1309, DOI 10.1158/1535-7163.MCT-05-0442; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Dell'Aversana C, 2012, EXP CELL RES, V318, P1229, DOI 10.1016/j.yexcr.2012.01.025; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Drogaris P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00220; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fukuda H, 2012, J DERMATOL, V39, P405, DOI 10.1111/j.1346-8138.2011.01261.x; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Grabiec AM, 2011, CRIT REV IMMUNOL, V31, P233, DOI 10.1615/CritRevImmunol.v31.i3.40; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Iyer A, 2012, IMMUNOL CELL BIOL, V90, P39, DOI 10.1038/icb.2011.99; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Uter W, 2011, CONTACT DERMATITIS, V64, P235, DOI 10.1111/j.1600-0536.2011.01883.x; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waanders LF, 2008, MOL CELL PROTEOMICS, V7, P1452, DOI 10.1074/mcp.M800141-MCP200; Wagner Gregory R, 2011, J Aging Res, V2011, P234875, DOI 10.4061/2011/234875; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Weinert Brian T, 2009, Cancer Immun, V9, P9; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	65	186	191	2	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					415	U136		10.1038/nbt.3130	http://dx.doi.org/10.1038/nbt.3130			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25751058	Green Accepted			2022-12-25	WOS:000352348500029
J	Bergstralh, DT; Lovegrove, HE; St Johnston, D				Bergstralh, Dan T.; Lovegrove, Holly E.; St Johnston, Daniel			Lateral adhesion drives reintegration of misplaced cells into epithelial monolayers	NATURE CELL BIOLOGY			English	Article							REGULATES SPINDLE ORIENTATION; DROSOPHILA-OOGENESIS; FOLLICULAR-EPITHELIUM; POLARITY; DIVISION; MORPHOGENESIS; JUNCTIONS; TISSUE; ORGANIZATION; MOLECULE	Cells in simple epithelia orient their mitotic spindles in the plane of the epithelium so that both daughter cells are born within the epithelial sheet. This is assumed to be important to maintain epithelial integrity and prevent hyperplasia, because misaligned divisions give rise to cells outside the epithelium(1,2). Here we test this assumption in three types of Drosophila epithelium; the cuboidal follicle epithelium, the columnar early embryonic ectoderm, and the pseudostratified neuroepithelium. Ectopic expression of Inscuteable in these tissues reorients mitotic spindles, resulting in one daughter cell being born outside the epithelial layer. Live imaging reveals that these misplaced cells reintegrate into the tissue. Reducing the levels of the lateral homophilic adhesion molecules Neuroglian or Fasciclin 2 disrupts reintegration, giving rise to extra-epithelial cells, whereas disruption of adherens junctions has no effect. Thus, the reinsertion of misplaced cells seems to be driven by lateral adhesion, which pulls cells born outside the epithelial layer back into it. Our findings reveal a robust mechanism that protects epithelia against the consequences of misoriented divisions.	[Bergstralh, Dan T.; Lovegrove, Holly E.; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Bergstralh, Dan T.; Lovegrove, Holly E.; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.	d.stjohnston@gurdon.cam.ac.uk		St Johnston, Daniel/0000-0001-5582-3301; Bergstralh, Dan/0000-0003-1689-3715	Wellcome Trust Principal Fellowship [080007]; Wellcome Trust [092096]; Cancer Research UK [A14492]; Marie Curie Fellowship; Wellcome Trust; Herchel Smith Studentship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	Wellcome Trust Principal Fellowship(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Marie Curie Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Studentship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to R. Nieuwburg, the St Johnston group, and other Gurdon Institute members for suggestions. We thank the Bloomington Stock Center, J. Knoblich, and the TRIP at Harvard Medical School (NIH/NIGMS R01-GM084947) for fly stocks. We thank N. Lowe for technical assistance. This work was supported by a Wellcome Trust Principal Fellowship to D.St.J. (080007), and by core support from the Wellcome Trust (092096) and Cancer Research UK (A14492). D.T.B. was supported by a Marie Curie Fellowship and the Wellcome Trust. H.E.L. was supported by a Herchel Smith Studentship.	Bergstralh DT, 2013, CURR BIOL, V23, P1707, DOI 10.1016/j.cub.2013.07.017; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Guilgur LG, 2012, DEVELOPMENT, V139, P503, DOI 10.1242/dev.071027; Herszterg S, 2013, DEV CELL, V24, P256, DOI 10.1016/j.devcel.2012.11.019; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; Morais-de-Sa E, 2013, EMBO REP, V14, P696, DOI 10.1038/embor.2013.85; Nakajima Y, 2013, NATURE, V500, P359, DOI 10.1038/nature12335; Packard A, 2013, DEV CELL, V27, P319, DOI 10.1016/j.devcel.2013.09.001; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Rujano MA, 2013, NAT CELL BIOL, V15, P1294, DOI 10.1038/ncb2858; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Szafranski P, 2004, DEVELOPMENT, V131, P2023, DOI 10.1242/dev.01097; Szafranski P, 2007, DEV DYNAM, V236, P364, DOI 10.1002/dvdy.21020; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Wei J, 2004, DEV DYNAM, V230, P800, DOI 10.1002/dvdy.20108; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	26	38	38	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1497	1503		10.1038/ncb3248	http://dx.doi.org/10.1038/ncb3248			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26414404	Green Accepted			2022-12-25	WOS:000364270500014
J	Banci, L; Ciofi-Baffoni, S; Gajda, K; Muzzioli, R; Peruzzini, R; Winkelmann, J				Banci, Lucia; Ciofi-Baffoni, Simone; Gajda, Karolina; Muzzioli, Riccardo; Peruzzini, Riccardo; Winkelmann, Julia			N-terminal domains mediate [2Fe-2S] cluster transfer from glutaredoxin-3 to anamorsin	NATURE CHEMICAL BIOLOGY			English	Article							IRON-SULFUR PROTEIN; SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXINS; NMR-SPECTROSCOPY; 3 PICOT; YEAST; BIOGENESIS; HEMATOPOIESIS; TRAFFICKING; METABOLISM	In eukaryotes, cytosolic monothiol glutaredoxins are proteins implicated in intracellular iron trafficking and sensing via their bound [2Fe-2S] clusters. We define a new role of human cytosolic monothiol glutaredoxin-3 (GRX3) in transferring its [2Fe-2S] clusters to human anamorsin, a physical and functional protein partner of GRX3 in the cytosol, whose [2Fe-2S] cluster-bound form is involved in the biogenesis of cytosolic and nuclear Fe-S proteins. Specific protein recognition between the N-terminal domains of the two proteins is the mandatory requisite to promote the [2Fe-2S] cluster transfer from GRX3 to anamorsin.	[Banci, Lucia; Ciofi-Baffoni, Simone; Gajda, Karolina; Muzzioli, Riccardo; Peruzzini, Riccardo; Winkelmann, Julia] Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy; [Banci, Lucia; Ciofi-Baffoni, Simone; Muzzioli, Riccardo] Univ Florence, Dept Chem, Florence, Italy	University of Florence; University of Florence	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy.	banci@cerm.unifi.it; ciofi@cerm.unifi.it	Ciofi-Baffoni, Simone/AAH-9778-2021	Ciofi Baffoni, Simone/0000-0002-2376-3321; Muzzioli, Riccardo/0000-0003-3726-3480; BANCI, LUCIA/0000-0003-0562-5774	Ente Cassa di Risparmio [2013/7101]; Ministero dell'Istruzione, dell'Universita e della Ricerca [CTN01_00177_962865]; European Integrated Structural Biology Infrastructure (INSTRUCT), European Strategy Forum on Research Infrastructures	Ente Cassa di Risparmio; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Integrated Structural Biology Infrastructure (INSTRUCT), European Strategy Forum on Research Infrastructures	We thank A. Gallo (CERM) for assistance in recording the EPR spectra. This work was supported by Ente Cassa di Risparmio (Grant ID no. 2013/7101); the Ministero dell'Istruzione, dell'Universita e della Ricerca (Grant ID number: CTN01_00177_962865); the European Integrated Structural Biology Infrastructure (INSTRUCT), which is part of the European Strategy Forum on Research Infrastructures; and national member subscriptions.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Banci L, 2014, P NATL ACAD SCI USA, V111, P6203, DOI 10.1073/pnas.1400102111; Banci L, 2013, J BIOL INORG CHEM, V18, P883, DOI 10.1007/s00775-013-1033-1; Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Ciofi-Baffoni S, 2014, J BIOMOL NMR, V58, P123, DOI 10.1007/s10858-013-9810-2; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Philpott CC, 2012, J BIOL CHEM, V287, P13518, DOI 10.1074/jbc.R111.326876; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Shakamuri P, 2012, J AM CHEM SOC, V134, P15213, DOI 10.1021/ja306061x; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; Tanimura A, 2014, EXP HEMATOL, V42, P410, DOI 10.1016/j.exphem.2014.01.002; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uzarska MA, 2013, MOL BIOL CELL, V24, P1830, DOI 10.1091/mbc.E12-09-0644; Wassenaar TA, 2012, J GRID COMPUT, V10, P743, DOI 10.1007/s10723-012-9246-z; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Zhang Y, 2014, P NATL ACAD SCI USA, V111, pE1695, DOI 10.1073/pnas.1405204111; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	39	51	52	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					772	+		10.1038/NCHEMBIO.1892	http://dx.doi.org/10.1038/NCHEMBIO.1892			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26302480	Green Submitted			2022-12-25	WOS:000361536500009
J	Miller, MA; Ganesan, APV; Luckashenak, N; Mendonca, M; Eisenlohr, LC				Miller, Michael A.; Ganesan, Asha Purnima V.; Luckashenak, Nancy; Mendonca, Mark; Eisenlohr, Laurence C.			Endogenous antigen processing drives the primary CD4(+) T cell response to influenza	NATURE MEDICINE			English	Article							COMPLEX CLASS-II; A VIRUS; PROTEASOME; PEPTIDE; REPLICATION; BINDING; REQUIREMENTS; RECOGNITION; INDUCTION; INFECTION	By convention, CD4(+) T lymphocytes recognize foreign and self peptides derived from internalized antigens in combination with major histocompatibility complex class II molecules. Alternative pathways of epitope production have been identified, but their contributions to host defense have not been established. We show here in a mouse infection model that the CD4(+) T cell response to influenza, critical for durable protection from the virus, is driven principally by unconventional processing of antigen synthesized within the infected antigen-presenting cell, not by classical processing of endocytosed virions or material from infected cells. Investigation of the cellular components involved, including the H2-M molecular chaperone, the proteasome and g-interferon-inducible lysosomal thiol reductase revealed considerable heterogeneity in the generation of individual epitopes, an arrangement that ensures peptide diversity and broad CD4(+) T cell engagement. These results could fundamentally revise strategies for rational vaccine design and may lead to key insights into the induction of autoimmune and anti-tumor responses.	[Miller, Michael A.; Ganesan, Asha Purnima V.; Luckashenak, Nancy; Mendonca, Mark; Eisenlohr, Laurence C.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Eisenlohr, LC (corresponding author), Childrens Hosp Philadelphia, Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	EisenlohrL@email.chop.edu			US National Institutes of Health (NIH) [AI036331, AI101134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036331, R01AI113286, R56AI101134] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Kinnarney for logistical support, S. Hensley (Wistar Institute) for technical advice on virus inactivation, and J. Comber for assistance with some of the ELISpot assays. We also thank the Flow Cytometry Facility and Division of Biostatistics (in particular, B. Leiby and S. Keith) at Thomas Jefferson University. Mouse-adapted PR8 was provided by C. Lopez (University of Pennsylvania School of Veterinary Medicine). The H2-DMa<SUP>-/-</SUP> mice were provided by P. Roche (National Institute of Health/National Cancer Institute). Ifi30<SUP>-/-</SUP> mice were provided by K. Hastings (University of Arizona College of Medicine). Cd74<SUP>-/-</SUP> mice were provided by G. Shi at Brigham and Women's Hospital (Harvard University). We thank C. Norbury, P. Roche, B. DeHaven and E. Wold for critical reading of this manuscript and P. Cresswell, S. Hensley and R. Langlois for helpful discussions. This study was funded by US National Institutes of Health (NIH) grants AI036331 and AI101134.	Baz M, 2013, J VIROL, V87, P6901, DOI 10.1128/JVI.03520-12; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Bikoff EK, 2001, J IMMUNOL, V166, P5087, DOI 10.4049/jimmunol.166.8.5087; Boyden AW, 2014, IMMUNOL RES, V59, P73, DOI 10.1007/s12026-014-8541-0; Brooke CB, 2013, J VIROL, V87, P3155, DOI 10.1128/JVI.02284-12; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Comber JD, 2011, J VIROL, V85, P6453, DOI 10.1128/JVI.02122-10; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Gannage M, 2009, CURR TOP MICROBIOL, V335, P123, DOI 10.1007/978-3-642-00302-8_6; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; GOLDSTEI.MA, 1970, APPL MICROBIOL, V19, P290, DOI 10.1128/AEM.19.2.290-294.1970; HOSAKA Y, 1988, J IMMUNOL, V140, P606; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; JOHNSON PR, 1985, J MED VIROL, V17, P325, DOI 10.1002/jmv.1890170405; Lamb R.A., 1983, GENETICS INFLUENZA V, P21; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Lay M, 2009, VACCINE, V27, P3811, DOI 10.1016/j.vaccine.2009.04.054; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Nair P, 2011, TRAFFIC, V12, P1669, DOI 10.1111/j.1600-0854.2011.01251.x; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Roederer M, 2003, J IMMUNOL METHODS, V274, P221, DOI 10.1016/S0022-1759(02)00423-4; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; SIlverstein AM., 1989, HIST IMMUNOLOGY; Sinnathamby G, 2003, J IMMUNOL, V170, P3504, DOI 10.4049/jimmunol.170.7.3504; Spencer CT, 2013, EUR J IMMUNOL, V43, P1162, DOI 10.1002/eji.201243087; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Testa JS, 2010, J IMMUNOL, V185, P6608, DOI 10.4049/jimmunol.1001768; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zhou Y, 2012, J EXP MED, V209, P1481, DOI 10.1084/jem.20111906	40	55	56	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1216	+		10.1038/nm.3958	http://dx.doi.org/10.1038/nm.3958			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26413780	Green Accepted			2022-12-25	WOS:000362355400024
J	Moffitt, RA; Marayati, R; Flate, EL; Volmar, KE; Loeza, SGH; Hoadley, KA; Rashid, NU; Williams, LA; Eaton, SC; Chung, AH; Smyla, JK; Anderson, JM; Kim, HJ; Bentrem, DJ; Talamonti, MS; Iacobuzio-Donahue, CA; Hollingsworth, MA; Yeh, JJ				Moffitt, Richard A.; Marayati, Raoud; Flate, Elizabeth L.; Volmar, Keith E.; Loeza, S. Gabriela Herrera; Hoadley, Katherine A.; Rashid, Naim U.; Williams, Lindsay A.; Eaton, Samuel C.; Chung, Alexander H.; Smyla, Jadwiga K.; Anderson, Judy M.; Kim, Hong Jin; Bentrem, David J.; Talamonti, Mark S.; Iacobuzio-Donahue, Christine A.; Hollingsworth, Michael A.; Yeh, Jen Jen			Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma	NATURE GENETICS			English	Article							GENE-EXPRESSION; MUTATIONAL PROCESSES; CANCER TYPES; PATTERNS; FIBROBLASTS; SIGNATURES; ENRICHMENT; LANDSCAPE; INSIGHTS; PATHWAYS	Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival rate of 4%. A key hallmark of PDAC is extensive stromal involvement, which makes capturing precise tumor-specific molecular information difficult. Here we have overcome this problem by applying blind source separation to a diverse collection of PDAC gene expression microarray data, including data from primary tumor, metastatic and normal samples. By digitally separating tumor, stromal and normal gene expression, we have identified and validated two tumor subtypes, including a 'basal-like' subtype that has worse outcome and is molecularly similar to basal tumors in bladder and breast cancers. Furthermore, we define 'normal' and 'activated' stromal subtypes, which are independently prognostic. Our results provide new insights into the molecular composition of PDAC, which may be used to tailor therapies or provide decision support in a clinical setting where the choice and timing of therapies are critical.	[Moffitt, Richard A.; Marayati, Raoud; Flate, Elizabeth L.; Loeza, S. Gabriela Herrera; Hoadley, Katherine A.; Rashid, Naim U.; Williams, Lindsay A.; Smyla, Jadwiga K.; Kim, Hong Jin; Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Volmar, Keith E.] Univ N Carolina, Rex Healthcare, Chapel Hill, NC USA; [Hoadley, Katherine A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Williams, Lindsay A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Eaton, Samuel C.; Chung, Alexander H.; Yeh, Jen Jen] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Anderson, Judy M.; Hollingsworth, Michael A.] Univ Nebraska, Eppley Canc Inst, Lincoln, NE USA; [Kim, Hong Jin; Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Bentrem, David J.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Bentrem, David J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Talamonti, Mark S.] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, David Rubenstein Ctr Pancreat Canc Res, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Nebraska System; University of Nebraska Lincoln; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; NorthShore University Health System; Memorial Sloan Kettering Cancer Center	Yeh, JJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jen_jen_yeh@med.unc.edu	Iacobuzio-Donahue, Christine/ABF-1295-2020; , Pathology Services Core/CEZ-2246-2022	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Hoadley, Katherine/0000-0002-1216-477X; Williams, Lindsay/0000-0003-3842-4629; Moffitt, Richard/0000-0003-2723-5902	NIH [P30-DK034897]; US National Institutes of Health (NIH) [R01-CA140424]; Kimmel Foundation; American College of Surgeons; University Cancer Research Fund; UNC Lineberger Comprehensive Cancer Center Postdoctoral Training Grant from the US NIH [T32-CA009156]; NATIONAL CANCER INSTITUTE [T32CA009156, P30CA060553, R01CA140424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Foundation; American College of Surgeons; University Cancer Research Fund; UNC Lineberger Comprehensive Cancer Center Postdoctoral Training Grant from the US NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the University of North Carolina (UNC) Tissue Procurement, Translational Pathology Laboratory, Animal Studies, Animal Histopathology, and Center for Gastrointestinal Biology and Disease Histopathology core facilities (NIH grant P30-DK034897), the PDX Program and Department of Pharmacology for tremendous technical support. We thank the patients and their families who generously donated their samples to research and in particular to the University of Nebraska Medical Center Rapid Autopsy Pancreatic Program and the Johns Hopkins Gastrointestinal Cancer Rapid Medical Donation Program. This work was partially supported by grant R01-CA140424 from the US National Institutes of Health (NIH) (J.J.Y.), the Kimmel Foundation (J.J.Y.), the American College of Surgeons (J.J.Y.), the University Cancer Research Fund (J.J.Y.) and UNC Lineberger Comprehensive Cancer Center Postdoctoral Training Grant T32-CA009156 from the US NIH (R.A.M.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Biton A, 2014, CELL REP, V9, P1235, DOI 10.1016/j.celrep.2014.10.035; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dal Molin M, 2015, CLIN CANCER RES, V21, P1944, DOI 10.1158/1078-0432.CCR-14-2600; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Haeger SM, 2016, ONCOGENE, V35, P577, DOI 10.1038/onc.2015.112; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JJ, 2014, P NATL ACAD SCI USA, V111, pE3091, DOI 10.1073/pnas.1411679111; Logsdon CD, 2003, CANCER RES, V63, P2649; McConkey D, 2015, EUR UROL, V67, pE76, DOI 10.1016/j.eururo.2014.08.064; Neel NF, 2014, MOL CANCER THER, V13, P122, DOI 10.1158/1535-7163.MCT-12-1232; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Nones K, 2014, INT J CANCER, V135, P1110, DOI 10.1002/ijc.28765; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Stolze B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08535; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wamunyokoli FW, 2006, CLIN CANCER RES, V12, P690, DOI 10.1158/1078-0432.CCR-05-1110; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	61	940	964	4	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1168	+		10.1038/ng.3398	http://dx.doi.org/10.1038/ng.3398			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26343385	Green Accepted, Green Submitted			2022-12-25	WOS:000361969900012
J	Nault, JC; Datta, S; Imbeaud, S; Franconi, A; Mallet, M; Couchy, G; Letouze, E; Pilati, C; Verret, B; Blanc, JF; Balabaud, C; Calderaro, J; Laurent, A; Letexier, M; Bioulac-Sage, P; Calvo, F; Zucman-Rossi, J				Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Verret, Benjamin; Blanc, Jean-Frederic; Balabaud, Charles; Calderaro, Julien; Laurent, Alexis; Letexier, Melanie; Bioulac-Sage, Paulette; Calvo, Fabien; Zucman-Rossi, Jessica			Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas	NATURE GENETICS			English	Article							ADENOASSOCIATED VIRUS AAV; NEUTRALIZING ANTIBODIES; SOMATIC MUTATIONS; DEFECTIVE VIRUS; LIVER CANCERS; GENE-THERAPY; INTEGRATION; MECHANISMS; EXPRESSION; ALIGNMENT	Hepatocellular carcinomas (HCCs) are liver tumors related to various etiologies, including alcohol intake and infection with hepatitis B (HBV) or C (HCV) virus. Additional risk factors remain to be identified, particularly in patients who develop HCC without cirrhosis. We found clonal integration of adeno-associated virus type 2 (AAV2) in 11 of 193 HCCs. These AAV2 integrations occurred in known cancer driver genes, namely CCNA2 (cyclin A2; four cases), TERT (telomerase reverse transcriptase; one case), CCNE1 (cyclin E1; three cases), TNFSF10 (tumor necrosis factor superfamily member 10; two cases) and KMT2B (lysine-specific methyltransferase 2B; one case), leading to overexpression of the target genes. Tumors with viral integration mainly developed in non-cirrhotic liver (9 of 11 cases) and without known risk factors (6 of 11 cases), suggesting a pathogenic role for AAV2 in these patients. In conclusion, AAV2 is a DNA virus associated with oncogenic insertional mutagenesis in human HCC.	[Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Verret, Benjamin; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] INSERM, UMR 1162, Genom Fonct Tumeurs Solides, Equipe Labellisee Ligue Canc, Paris, France; [Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] Univ Paris 05, Labex Immunooncol, Sorbonne Paris Cite, Paris, France; [Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] Univ Paris 13, Sorbonne Paris Cite, UFR, SMHB, Bobigny, France; [Nault, Jean-Charles; Datta, Shalini; Imbeaud, Sandrine; Franconi, Andrea; Mallet, Maxime; Couchy, Gabrielle; Letouze, Eric; Pilati, Camilla; Verret, Benjamin; Calderaro, Julien; Calvo, Fabien; Zucman-Rossi, Jessica] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Nault, Jean-Charles] Hop Univ Paris Seine St Denis, AP HP, Pole Act Cancerol Specialisee, Serv Hepatol, Bondy, France; [Blanc, Jean-Frederic] Hop St Andre, Dept Hepatol, CHU Bordeaux, Bordeaux, France; [Blanc, Jean-Frederic; Balabaud, Charles; Bioulac-Sage, Paulette] INSERM, UMR 1053, Bordeaux, France; [Blanc, Jean-Frederic; Balabaud, Charles; Bioulac-Sage, Paulette] Univ Bordeaux, Bordeaux, France; [Calderaro, Julien] CHU Henri Mondor, AP HP, Dept Pathol, F-94010 Creteil, France; [Laurent, Alexis] CHU Henri Mondor, AP HP, Dept Digest & Hepatobiliary Surg, F-94010 Creteil, France; [Laurent, Alexis] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Letexier, Melanie] IntegraGen, Evry, France; [Bioulac-Sage, Paulette] CHU Bordeaux, Pellegrin Hosp, Dept Pathol, Bordeaux, France; [Calvo, Fabien] Inst Gustave Roussy, Core Europe, Villejuif, France; [Zucman-Rossi, Jessica] Hop Europeen Georges Pompidou, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zucman-Rossi, J (corresponding author), INSERM, UMR 1162, Genom Fonct Tumeurs Solides, Equipe Labellisee Ligue Canc, Paris, France.	jessica.zucman-rossi@inserm.fr	zucman-rossi, Jessica/B-5098-2009; j, zucman-rossi/AAV-3594-2021; Laurent, Alexis/O-3657-2016; Datta, Shalini/B-3408-2010; Letouzé, Eric/AAP-9924-2020; Imbeaud, Sandrine/P-8780-2017	zucman-rossi, Jessica/0000-0002-5687-0334; j, zucman-rossi/0000-0002-5687-0334; Laurent, Alexis/0000-0003-1372-0843; Letouzé, Eric/0000-0002-6369-2839; nault, jean charles/0000-0002-4875-9353; Pilati, Camilla/0000-0002-1781-5180; calvo, fabien/0000-0002-0298-7633; Imbeaud, Sandrine/0000-0001-8439-6732	Institut Nationale du Cancer (INCa); International Cancer Genome Consortium (ICGC); PAIR-CHC project NoFLIC (Association pour la Recherche sur le Cancer (ARC)); Ligue Nationale contre le Cancer; INCa; AERIO-Boehringer-Ingelheim; ARC	Institut Nationale du Cancer (INCa)(Institut National du Cancer (INCA) France); International Cancer Genome Consortium (ICGC); PAIR-CHC project NoFLIC (Association pour la Recherche sur le Cancer (ARC)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); AERIO-Boehringer-Ingelheim; ARC(Australian Research Council)	We warmly thank L. Yost, E. Chevet and A. de Reynies for critical review of the manuscript and helpful discussion. We thank all the clinician surgeons and pathologists who have participated in this work: J. Saric, C. Laurent, L. Chiche, B. Le Bail and C. Castain (CHU Bordeaux) and Y. Allory, K. Leroy and D. Azoulay (CHU Henri Mondor). We also thank the Reseau National Centre de Ressources Biologiques (CRB) Foie and the tumor banks of CHU Bordeaux and CHU Henri Mondor for contributing to the tissue collection. This work was supported by Institut Nationale du Cancer (INCa) with the International Cancer Genome Consortium (ICGC) and the PAIR-CHC project NoFLIC (also funded by Association pour la Recherche sur le Cancer (ARC)). The group is supported by the Ligue Nationale contre le Cancer. J.-C.N., M.M., C.P. and A.F. were supported by fellowships from INCa, AERIO-Boehringer-Ingelheim, ARC and the Ligue Nationale contre le Cancer, respectively.	ATCHISON RW, 1965, SCIENCE, V149, P754, DOI 10.1126/science.149.3685.754; Baudard M, 1996, HUM GENE THER, V7, P1309, DOI 10.1089/hum.1996.7.11-1309; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Berasain C, 1998, ONCOGENE, V16, P1277, DOI 10.1038/sj.onc.1201893; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Flotte TR, 2005, HUM GENE THER, V16, P401, DOI 10.1089/hum.2005.16.401; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; McAlister VJ, 2007, J VIROL, V81, P9718, DOI 10.1128/JVI.00746-07; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nault JC, 2014, HEPATOLOGY, V60, P1983, DOI 10.1002/hep.27372; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rosas LE, 2012, MOL THER, V20, P2098, DOI 10.1038/mt.2012.197; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; Wang PR, 2012, P NATL ACAD SCI USA, V109, P11264, DOI 10.1073/pnas.1117032109	49	299	310	0	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1187	+		10.1038/ng.3389	http://dx.doi.org/10.1038/ng.3389			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26301494				2022-12-25	WOS:000361969900014
J	Chal, J; Oginuma, M; Al Tanoury, Z; Gobert, B; Sumara, O; Hick, A; Bousson, F; Zidouni, Y; Mursch, C; Moncuquet, P; Tassy, O; Vincent, S; Miyanari, A; Bera, A; Garnier, JM; Guevara, G; Hestin, M; Kennedy, L; Hayashi, S; Drayton, B; Cherrier, T; Gayraud-Morel, B; Gussoni, E; Relaix, F; Tajbakhsh, S; Pourquie, O				Chal, Jerome; Oginuma, Masayuki; Al Tanoury, Ziad; Gobert, Benedicte; Sumara, Olga; Hick, Aurore; Bousson, Fanny; Zidouni, Yasmine; Mursch, Caroline; Moncuquet, Philippe; Tassy, Olivier; Vincent, Stephane; Miyanari, Ayako; Bera, Agata; Garnier, Jean-Marie; Guevara, Getzabel; Hestin, Marie; Kennedy, Leif; Hayashi, Shinichiro; Drayton, Bernadette; Cherrier, Thomas; Gayraud-Morel, Barbara; Gussoni, Emanuela; Relaix, Frederic; Tajbakhsh, Shahragim; Pourquie, Olivier			Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy	NATURE BIOTECHNOLOGY			English	Article							MOUSE; DERIVATION; PROGENITORS; GENERATION; GENES; EXPRESSION; MYOGENESIS; MESODERM; ES; HETEROGENEITY	During embryonic development, skeletal muscles arise from somites, which derive from the presomitic mesoderm (PSM). Using PSM development as a guide, we establish conditions for the differentiation of monolayer cultures of mouse embryonic stem (ES) cells into PSM-like cells without the introduction of transgenes or cell sorting. We show that primary and secondary skeletal myogenesis can be recapitulated in vitro from the PSM-like cells, providing an efficient, serum-free protocol for the generation of striated, contractile fibers from mouse and human pluripotent cells. The mouse ES cells also differentiate into Pax7(+) cells with satellite cell characteristics, including the ability to form dystrophin(+) fibers when grafted into muscles of dystrophin-deficient mdx mice, a model of Duchenne muscular dystrophy (DMD). Fibers derived from ES cells of mdx mice exhibit an abnormal branched phenotype resembling that described in vivo, thus providing an attractive model to study the origin of the pathological defects associated with DMD.	[Chal, Jerome; Oginuma, Masayuki; Al Tanoury, Ziad; Gobert, Benedicte; Sumara, Olga; Zidouni, Yasmine; Mursch, Caroline; Moncuquet, Philippe; Tassy, Olivier; Vincent, Stephane; Miyanari, Ayako; Bera, Agata; Garnier, Jean-Marie; Kennedy, Leif; Cherrier, Thomas; Pourquie, Olivier] Univ Strasbourg, Inserm U964, CNRS UMR 7104, IGBMC, Illkirch Graffenstaden, France; [Chal, Jerome; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO USA; [Chal, Jerome; Guevara, Getzabel; Hestin, Marie] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chal, Jerome; Guevara, Getzabel; Hestin, Marie; Pourquie, Olivier] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Chal, Jerome; Guevara, Getzabel; Hestin, Marie; Pourquie, Olivier] Harvard Stem Cell Inst, Boston, MA USA; [Hick, Aurore; Bousson, Fanny] Anagenesis Biotechnol, Illkirch Graffenstaden, France; [Hayashi, Shinichiro; Drayton, Bernadette; Relaix, Frederic] Univ Paris 06, INSERM, Avenir Team, Paris, France; [Hayashi, Shinichiro; Drayton, Bernadette; Relaix, Frederic] Inst Myol, Paris, France; [Gayraud-Morel, Barbara; Tajbakhsh, Shahragim] Inst Pasteur, CNRS URA 2578, Paris, France; [Gussoni, Emanuela] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Stowers Institute for Medical Research; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Pourquie, O (corresponding author), Univ Strasbourg, Inserm U964, CNRS UMR 7104, IGBMC, Illkirch Graffenstaden, France.	pourquie@genetics.med.harvard.edu	Pourquié, Olivier/CAJ-5443-2022; Gussoni, Emanuela/AAL-6150-2021; Vincent, Stéphane D/M-2046-2013; CHERRIER, Thomas/F-8727-2018	Pourquié, Olivier/0000-0001-5189-1227; Gussoni, Emanuela/0000-0002-9915-3677; Vincent, Stéphane D/0000-0003-1638-9615; Hayashi, Shinichiro/0000-0001-5553-7698; Chal, Jerome/0000-0002-0468-7677; CHERRIER, Thomas/0000-0002-0707-9204; Relaix, Frederic/0000-0003-1270-1472; Sumara, Olga/0000-0002-0845-3720; Gayraud-Morel, Barbara/0000-0002-1168-8504	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abujarour R, 2014, STEM CELL TRANSL MED, V3, P149, DOI 10.5966/sctm.2013-0095; Albini S, 2013, CELL REP, V3, P661, DOI 10.1016/j.celrep.2013.02.012; Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BRAUN T, 1994, DEV BIOL, V164, P24, DOI 10.1006/dbio.1994.1177; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Chan S, 2011, EXP PHYSIOL, V96, P564, DOI 10.1113/expphysiol.2010.056713; Chang H, 2009, FASEB J, V23, P1907, DOI 10.1096/fj.08-123661; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Friedrich O, 2010, BIOPHYS J, V98, P606, DOI 10.1016/j.bpj.2009.11.005; Goodall MH, 2012, AM J PHYSIOL-CELL PH, V303, pC224, DOI 10.1152/ajpcell.00136.2012; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Hwang YS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072023, 10.1371/annotation/b02313dc-840f-4f03-91a2-77cb55a3a4c9]; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Li WW, 2011, FAMILY ENTERPRISE IN THE ASIA PACIFIC: EXPLORING TRANSGENERATIONAL ENTREPRENEURSHIP IN FAMILY FIRMS, P76; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Merrick D, 2009, DIS MODEL MECH, V2, P374, DOI 10.1242/dmm.001008; Messina G, 2010, CELL, V140, P554, DOI 10.1016/j.cell.2010.01.027; Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mouly V, 2005, Acta Myol, V24, P128; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Ozbudak EM, 2010, P NATL ACAD SCI USA, V107, P4224, DOI 10.1073/pnas.0909375107; Pavlath GK, 2010, CELL ADHES MIGR, V4, P502, DOI 10.4161/cam.4.4.12291; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Rinaldi F, 2014, TRANSL RES, V163, P409, DOI 10.1016/j.trsl.2013.11.006; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sakurai H, 2008, STEM CELLS, V26, P1865, DOI 10.1634/stemcells.2008-0173; Sakurai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047078; Sakurai H, 2009, STEM CELL RES, V3, P157, DOI 10.1016/j.scr.2009.08.002; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Sambasivan R, 2007, SEMIN CELL DEV BIOL, V18, P870, DOI 10.1016/j.semcdb.2007.09.013; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; Tan JY, 2013, STEM CELLS DEV, V22, P1893, DOI 10.1089/scd.2012.0590; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Tanaka M, 2009, STEM CELL RES, V3, P126, DOI 10.1016/j.scr.2009.07.001; Tassy O, 2014, NUCLEIC ACIDS RES, V42, pD882, DOI 10.1093/nar/gkt807; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonegawa A, 1997, DEVELOPMENT, V124, P1975; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	69	231	241	7	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					962	U207		10.1038/nbt.3297	http://dx.doi.org/10.1038/nbt.3297			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26237517	Green Submitted			2022-12-25	WOS:000360990900024
J	Kim, IK; Kim, BS; Koh, CH; Seok, JW; Park, JS; Shin, KS; Bae, EA; Lee, GE; Jeon, H; Cho, J; Jung, YJ; Han, D; Kwon, BS; Lee, HY; Chung, Y; Kang, CY				Kim, Il-Kyu; Kim, Byung-Seok; Koh, Choong-Hyun; Seok, Jae-Won; Park, Jun-Seok; Shin, Kwang-Soo; Bae, Eun-Ah; Lee, Ga-Eun; Jeon, Hyewon; Cho, Jaebeom; Jung, Yujin; Han, Daehee; Kwon, Byoung S.; Lee, Ho-Young; Chung, Yeonseok; Kang, Chang-Yuil			Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells	NATURE MEDICINE			English	Article							ANTI-GITR MAB; TNFR FAMILY; T-HELPER-2 CELLS; TGF-BETA; KAPPA-B; IMMUNITY; CANCER; ACTIVATION; DIFFERENTIATION; EXPRESSION	T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear. Here we demonstrate a crucial role for interleukin (IL)-9 in antitumor immunity generated by the GITR agonistic antibody DTA-1. IL-4 receptor knockout (Il4ra(-/-)) mice, which have reduced expression of IL-9, were resistant to tumor growth inhibition by DTA-1. Notably, neutralization of IL-9 considerably impaired tumor rejection induced by DTA-1. In particular, DTA-1-induced IL-9 promoted tumor-specific cytotoxic T lymphocyte (CTL) responses by enhancing the function of dendritic cells in vivo. Furthermore, GITR signaling enhanced the differentiation of IL-9-producing CD4(+) T-helper (T(H)9) cells in a TNFR-associated factor 6 (TRAF6)- and NF-kappa B-dependent manner and inhibited the generation of induced regulatory T cells in vitro. Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting T(H)9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.	[Kim, Il-Kyu; Kim, Byung-Seok; Koh, Choong-Hyun; Shin, Kwang-Soo; Lee, Ga-Eun; Chung, Yeonseok; Kang, Chang-Yuil] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Lab Immunol, Seoul, South Korea; [Seok, Jae-Won; Park, Jun-Seok; Bae, Eun-Ah; Jeon, Hyewon; Kang, Chang-Yuil] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Cho, Jaebeom; Jung, Yujin; Lee, Ho-Young] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Lab Pathophysiol, Seoul, South Korea; [Han, Daehee] Inst for Basic Sci Korea, Acad Immunol & Microbiol, Pohang, South Korea; [Kwon, Byoung S.] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea; [Chung, Yeonseok] Univ Texas Med Sch Houston, Inst Mol Med, Ctr Immunol & Autoimmune Dis, Houston, TX USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Institute for Basic Science - Korea (IBS); National Cancer Center - Korea (NCC); University of Texas System; University of Texas Health Science Center Houston	Kang, CY (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Lab Immunol, Seoul, South Korea.	cykang@snu.ac.kr	kang, chang-yuil/G-4688-2017	Bae, Eunah/0000-0003-2670-4578; Kim, Il-Kyu/0000-0002-4661-0133; Chung, Yeonseok/0000-0001-5780-4841; Lee, Ho-Young/0000-0001-7556-9312	Public Welfare & Safety Research Program [20100020843]; National R&D Program for Cancer Control, Ministry of Health and Welfare [0720500]	Public Welfare & Safety Research Program; National R&D Program for Cancer Control, Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	We thank J.-O. Kim (International Vaccine Institute) for CD45.1 congenic mice, D.H. Chung (Seoul National University College of Medicine) for IL-4-deficient mice, Y.-K. Kim (Ewha Institute of Convergence Medicine) for IL-4Ra-deficient mice, T.H. Watts (University of Toronto) and P.P. Pandolfi (Harvard Medical School) for GITR-deficient mice, C.D. Surh (Pohang University of Science and Technology) and T.A. Chatila (Harvard Medical School) for Foxp3GFP reporter mice, Y. Choi (University of Pennsylvania School of Medicine) for Traf6<SUP>fl/fl</SUP> mice, G. Lozano (MD Anderson Cancer Center) for K-Ras transgenic mice, S. Sakaguchi (Osaka University) for the antibody to GITR (DTA-1), J.v. Snick (Ludwig Institute) for the antibody to IL-9 (MM9C1), S.-I. Nishikawa (RIKEN Center for Developmental Biology) for the antibody to c-kit (ACK2), H.-W. Yum (Seoul National University) and D.-H. Kim (Seoul National University) for assistance in setting up a colorectal cancer model, and members of the Kang laboratory for technical support. This work was supported by grants from the Public Welfare & Safety Research Program (20100020843; C.-Y.K.) and the National R&D Program for Cancer Control, Ministry of Health and Welfare (no. 0720500; C.-Y.K.).	Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cohen AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010436; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Elyaman W, 2012, IMMUNITY, V36, P623, DOI 10.1016/j.immuni.2012.01.020; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hong SY, 2008, CANCER RES, V68, P8456, DOI 10.1158/0008-5472.CAN-08-2213; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Jash A, 2012, J BIOL CHEM, V287, P15445, DOI 10.1074/jbc.M112.340356; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kim WJ, 2006, IMMUNOLOGY, V119, P421, DOI 10.1111/j.1365-2567.2006.02453.x; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kitajima M, 2011, CANCER RES, V71, P4790, DOI 10.1158/0008-5472.CAN-10-1572; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Lin GHY, 2013, J IMMUNOL, V190, P4627, DOI 10.4049/jimmunol.1201854; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Maio M, 2013, CURR OPIN ONCOL, V25, P166, DOI 10.1097/CCO.0b013e32835dae4f; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Motta AC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-93; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nishikawa H, 2008, CANCER RES, V68, P5948, DOI 10.1158/0008-5472.CAN-07-5839; Patel M, 2005, EUR J IMMUNOL, V35, P3581, DOI 10.1002/eji.200535421; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Schaer DA, 2012, CURR OPIN IMMUNOL, V24, P217, DOI 10.1016/j.coi.2011.12.011; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Takami M, 2012, J IMMUNOL, V188, P4369, DOI 10.4049/jimmunol.1102698; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; van der Werf N, 2011, J IMMUNOL, V187, P1411, DOI 10.4049/jimmunol.1100834; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yao WG, 2013, IMMUNITY, V38, P360, DOI 10.1016/j.immuni.2013.01.007; Zhou PF, 2007, J IMMUNOL, V179, P7365, DOI 10.4049/jimmunol.179.11.7365; Zhou P, 2010, J IMMUNOTHER, V33, P789, DOI 10.1097/CJI.0b013e3181ee6ba9; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	53	105	122	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1010	+		10.1038/nm.3922	http://dx.doi.org/10.1038/nm.3922			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26280119				2022-12-25	WOS:000360961300013
J	Westhof, E				Westhof, Eric			RNA structure from deep sequencing	NATURE BIOTECHNOLOGY			English	Editorial Material							SECONDARY STRUCTURE		Univ Strasbourg, CNRS, Inst Mol & Cellular Biol, Architecture & React RNA, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Westhof, E (corresponding author), Univ Strasbourg, CNRS, Inst Mol & Cellular Biol, Architecture & React RNA, Strasbourg, France.	e.westhof@ibmc-cnrs.unistra.fr						Ares Manuel Jr, 2014, Cold Spring Harb Protoc, V2014, P1139, DOI 10.1101/pdb.top083352; Ding YL, 2015, NAT PROTOC, V10, P1050, DOI 10.1038/nprot.2015.064; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Ramani V, 2015, NAT BIOTECHNOL, V33, P980, DOI 10.1038/nbt.3289; Rice GM, 2014, RNA, V20, P846, DOI 10.1261/rna.043323.113	6	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					928	929		10.1038/nbt.3338	http://dx.doi.org/10.1038/nbt.3338			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348961				2022-12-25	WOS:000360990900018
J	Grebien, F; Vedadi, M; Getlik, M; Giambruno, R; Grover, A; Avellino, R; Skucha, A; Vittori, S; Kuznetsova, E; Smil, D; Barsyte-Lovejoy, D; Li, FL; Poda, G; Schapira, M; Wu, H; Dong, AP; Senisterra, G; Stukalov, A; Huber, KVM; Schonegger, A; Marcellus, R; Bilban, M; Bock, C; Brown, PJ; Zuber, J; Bennett, KL; Al-Awar, R; Delwel, R; Nerlov, C; Arrowsmith, CH; Superti-Furga, G				Grebien, Florian; Vedadi, Masoud; Getlik, Matthaeus; Giambruno, Roberto; Grover, Amit; Avellino, Roberto; Skucha, Anna; Vittori, Sarah; Kuznetsova, Ekaterina; Smil, David; Barsyte-Lovejoy, Dalia; Li, Fengling; Poda, Gennadiy; Schapira, Matthieu; Wu, Hong; Dong, Aiping; Senisterra, Guillermo; Stukalov, Alexey; Huber, Kilian V. M.; Schoenegger, Andreas; Marcellus, Richard; Bilban, Martin; Bock, Christoph; Brown, Peter J.; Zuber, Johannes; Bennett, Keiryn L.; Al-Awar, Rima; Delwel, Ruud; Nerlov, Claus; Arrowsmith, Cheryl H.; Superti-Furga, Giulio			Pharmacological targeting of the Wdr5-MLL interaction in C/EBP alpha N-terminal leukemia	NATURE CHEMICAL BIOLOGY			English	Article							MIXED-LINEAGE LEUKEMIA; H3K4 METHYLTRANSFERASE ACTIVITY; HISTONE H3; PROTEOMIC IDENTIFICATION; MYELOID DIFFERENTIATION; SELF-RENEWAL; DNA-BINDING; IN-VIVO; PROTEIN; EXPRESSION	The CEBPA gene is mutated in 9% of patients with acute myeloid leukemia (AML). Selective expression of a short (30-kDa) CCAAT-enhancer binding protein-alpha (C/EBP alpha) translational isoform, termed p30, represents the most common type of CEBPA mutation in AML. The molecular mechanisms underlying p30-mediated transformation remain incompletely understood. We show that C/EBP alpha p30, but not the normal p42 isoform, preferentially interacts with Wdr5, a key component of SET/MLL (SET-domain/mixed-lineage leukemia) histone-methyltransferase complexes. Accordingly, p30-bound genomic regions were enriched for MLL-dependent H3K4me3 marks. The p30-dependent increase in self-renewal and inhibition of myeloid differentiation required Wdr5, as downregulation of the latter inhibited proliferation and restored differentiation in p30-dependent AML models. OICR-9429 is a new small-molecule antagonist of the Wdr5-MLL interaction. This compound selectively inhibited proliferation and induced differentiation in p30-expressing human AML cells. Our data reveal the mechanism of p30-dependent transformation and establish the essential p30 cofactor Wdr5 as a therapeutic target in CEBPA-mutant AML.	[Grebien, Florian; Giambruno, Roberto; Skucha, Anna; Vittori, Sarah; Stukalov, Alexey; Huber, Kilian V. M.; Schoenegger, Andreas; Bock, Christoph; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Grebien, Florian] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Vedadi, Masoud; Kuznetsova, Ekaterina; Smil, David; Barsyte-Lovejoy, Dalia; Li, Fengling; Schapira, Matthieu; Wu, Hong; Dong, Aiping; Senisterra, Guillermo; Brown, Peter J.] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Vedadi, Masoud; Schapira, Matthieu; Al-Awar, Rima] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Getlik, Matthaeus; Poda, Gennadiy; Marcellus, Richard; Al-Awar, Rima] Ontario Inst Canc Res, Drug Discovery Program, Toronto, ON, Canada; [Grover, Amit; Nerlov, Claus] Weatherall Inst Mol Med, MRC Mol Hematol Unit, Oxford, England; [Avellino, Roberto; Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Poda, Gennadiy] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Core Facil, Core Facil Genom, Vienna, Austria; [Zuber, Johannes] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Arrowsmith, Cheryl H.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Ludwig Boltzmann Institute; University of Toronto; Structural Genomics Consortium; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Oxford; Erasmus University Rotterdam; Erasmus MC; University of Toronto; Medical University of Vienna; Medical University of Vienna; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Medical University of Vienna	Grebien, F (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	florian.grebien@lbicr.lbg.ac.at; gsuperti@cemm.oeaw.ac.at	Zuber, Johannes/E-7517-2011; Giambruno, Roberto/W-4868-2017; Giambruno, Roberto/AAI-6717-2021; Stukalov, Alexey/AAS-3208-2021; Bock, Christoph/AAE-7618-2019; Huber, Kilian V. M./L-6921-2015; Superti-Furga, Giulio/AAE-5681-2019; Grebien, Florian/H-9234-2019	Zuber, Johannes/0000-0001-8810-6835; Giambruno, Roberto/0000-0002-4566-261X; Giambruno, Roberto/0000-0002-4566-261X; Stukalov, Alexey/0000-0002-4981-8124; Bock, Christoph/0000-0001-6091-3088; Huber, Kilian V. M./0000-0002-1103-5300; Grebien, Florian/0000-0003-4289-2281; Bennett, Keiryn L./0000-0001-9356-7708; Brown, Peter/0000-0002-8454-0367; Bilban, Martin/0000-0001-7043-7142; Smil, David/0000-0002-6232-6087	Austrian Science Fund (FWF) [P22282-B11]; FP7-PEOPLE-ITN Project HemID [289611]; Austrian Academy of Sciences; European Research Council (ERC) [ERC-2009-AdG-250179-i-FIVE]; AbbVie [1097737]; Bayer; Boehringer Ingelheim; Genome Canada through the Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Government of Ontario; Leukemia and Lymphoma Society of Canada; Austrian Science Fund (FWF) [P 22282] Funding Source: researchfish; Medical Research Council [G0900892, MC_UU_12009/7, G0701761] Funding Source: researchfish; Worldwide Cancer Research [11-0724] Funding Source: researchfish; MRC [G0900892, G0701761, MC_UU_12009/7] Funding Source: UKRI	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FP7-PEOPLE-ITN Project HemID; Austrian Academy of Sciences; European Research Council (ERC)(European Research Council (ERC)European Commission); AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Government of Ontario; Leukemia and Lymphoma Society of Canada; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Gridling, M. Planyavsky, D. Printz and A. Spittler for experimental help and K. Kandasamy and M. Schuster for bioinformatic help. Next-generation sequencing was performed at the Campus Science Support Facilities Next-Generation Sequencing Unit (http://www.csf.ac.at/). F.G. and R.G. were funded by the Austrian Science Fund (FWF grant P22282-B11). A. Skucha is supported by FP7-PEOPLE-2011-ITN Project HemID (289611). The Superti-Furga laboratory is supported by the Austrian Academy of Sciences and by European Research Council (ERC) grant ERC-2009-AdG-250179-i-FIVE. The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, Genome Canada through the Ontario Genomics Institute (OGI-055), GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z). The Ontario Institute for Cancer Research is funded by the Government of Ontario. Funding was also provided by the Leukemia and Lymphoma Society of Canada.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Bilban M, 2006, LEUKEMIA, V20, P1080, DOI 10.1038/sj.leu.2404220; Bolshan Y, 2013, ACS MED CHEM LETT, V4, P353, DOI 10.1021/ml300467n; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Cleaves R, 2004, ONCOGENE, V23, P716, DOI 10.1038/sj.onc.1207172; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; D'Alo F, 2003, BLOOD, V102, P3163, DOI 10.1182/blood-2003-02-0479; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dias J, 2014, GENE DEV, V28, P929, DOI 10.1101/gad.240200.114; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fasan A, 2014, LEUKEMIA, V28, P794, DOI 10.1038/leu.2013.273; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Koleva RI, 2012, BLOOD, V119, P4878, DOI 10.1182/blood-2011-10-383083; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavallee-Adam M, 2011, J PROTEOME RES, V10, P886, DOI 10.1021/pr100795z; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Senisterra G, 2013, BIOCHEM J, V449, P151, DOI 10.1042/BJ20121280; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siarheyeva A, 2012, STRUCTURE, V20, P1425, DOI 10.1016/j.str.2012.06.001; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wang QF, 2003, ONCOGENE, V22, P2548, DOI 10.1038/sj.onc.1206360; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zada AA, 2006, LEUKEMIA, V20, P2137, DOI 10.1038/sj.leu.2404438; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou HL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3096; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	59	159	168	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					571	578		10.1038/NCHEMBIO.1859	http://dx.doi.org/10.1038/NCHEMBIO.1859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26167872	Green Accepted			2022-12-25	WOS:000358255300011
J	Yao, LX; Li, Y; Ghosh, S; Evans, JA; Rzhetsky, A				Yao, Lixia; Li, Ying; Ghosh, Soumitra; Evans, James A.; Rzhetsky, Andrey			Health ROI as a measure of misalignment of biomedical needs and resources	NATURE BIOTECHNOLOGY			English	Letter							DISEASES; BURDEN		[Yao, Lixia] Univ N Carolina, Dept Software & Informat Syst, Charlotte, NC 28223 USA; [Li, Ying] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Ghosh, Soumitra] GlaxoSmithKline R&D, Dept Genet, King Of Prussia, PA USA; [Evans, James A.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Evans, James A.; Rzhetsky, Andrey] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Rzhetsky, Andrey] Univ Chicago, Dept Med, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Rzhetsky, Andrey] Univ Chicago, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA	University of North Carolina; University of North Carolina Charlotte; Columbia University; GlaxoSmithKline; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Yao, LX (corresponding author), Univ N Carolina, Dept Software & Informat Syst, Charlotte, NC 28223 USA.	L.Yao@uncc.edu; arzhetsky@uchicago.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405	NHLBI NIH HHS [U01HL108634-01, R01 HL122712, K12 HL119995, U01 HL108634] Funding Source: Medline; NIGMS NIH HHS [R01 GM061372] Funding Source: Medline; NIMH NIH HHS [P50 MH094267, R01 MH110905, T32 MH020065, 1P50MH094267] Funding Source: Medline; NLM NIH HHS [R01 LM010132] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108634, R01HL122712, K12HL119995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110905, T32MH020065, P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010132] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1158803] Funding Source: National Science Foundation	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Evans JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090147; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Kleinbaum D., 2013, APPL REGRESSION ANAL; MERTON RC, 1973, BELL J ECON, V4, P141, DOI 10.2307/3003143; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Reiss J., 2010, THEORIA-SPAIN, V24, P263; Sampat BN, 2013, MILBANK Q, V91, P163, DOI 10.1111/milq.12005; Vanderelst D, 2013, J INFORMETR, V7, P240, DOI 10.1016/j.joi.2012.10.004; Vanderelst D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000576	11	16	16	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					807	811		10.1038/nbt.3276	http://dx.doi.org/10.1038/nbt.3276			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252133	Green Accepted			2022-12-25	WOS:000359274900011
J	[Anonymous]				[Anonymous]			BGI goes head-to-head with Illumina	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					792	792		10.1038/nbt0815-792b	http://dx.doi.org/10.1038/nbt0815-792b			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252125				2022-12-25	WOS:000359274900038
J	Li, XM; Chao, DY; Wu, Y; Huang, XH; Chen, K; Cui, LG; Su, L; Ye, WW; Chen, H; Chen, HC; Dong, NQ; Guo, T; Shi, M; Feng, Q; Zhang, P; Han, B; Shan, JX; Gao, JP; Lin, HX				Li, Xin-Min; Chao, Dai-Yin; Wu, Yuan; Huang, Xuehui; Chen, Ke; Cui, Long-Gang; Su, Lei; Ye, Wang-Wei; Chen, Hao; Chen, Hua-Chang; Dong, Nai-Qian; Guo, Tao; Shi, Min; Feng, Qi; Zhang, Peng; Han, Bin; Shan, Jun-Xiang; Gao, Ji-Ping; Lin, Hong-Xuan			Natural alleles of a proteasome alpha 2 subunit gene contribute to thermotolerance and adaptation of African rice	NATURE GENETICS			English	Article							ARABIDOPSIS 26S PROTEASOME; 19S REGULATORY PARTICLE; QUANTITATIVE TRAIT LOCI; ORYZA-GLABERRIMA; HEAT-STRESS; SPOROPHYTE DEVELOPMENT; GENOME; IDENTIFICATION; TRANSFORMATION; AGROBACTERIUM	Global warming threatens many aspects of human life(1,2), for example, by reducing crop yields(3-5). Breeding heat-tolerant crops using genes conferring thermotolerance is a fundamental way to help deal with this challenge(4-9). Here we identify a major quantitative trait locus (QTL) for thermotolerance in African rice (Oryza glaberrima), Thermo-tolerance 1 (TT1), which encodes an alpha 2 subunit of the 26S proteasome involved in the degradation of ubiquitinated proteins. Ubiquitylome analysis indicated that OgTT1 protects cells from heat stress through more efficient elimination of cytotoxic denatured proteins and more effective maintenance of heat-response processes than achieved with OsTT1. Variation in TT1 has been selected for on the basis of climatic temperature and has had an important role in local adaptation during rice evolution. In addition, we found that overexpression of OgTT1 was associated with markedly enhanced thermotolerance in rice, Arabidopsis and Festuca elata. This discovery may lead to an increase in crop security in the face of the ongoing threat of global warming.	[Li, Xin-Min; Chao, Dai-Yin; Wu, Yuan; Chen, Ke; Cui, Long-Gang; Su, Lei; Ye, Wang-Wei; Chen, Hao; Chen, Hua-Chang; Dong, Nai-Qian; Guo, Tao; Shi, Min; Zhang, Peng; Shan, Jun-Xiang; Gao, Ji-Ping; Lin, Hong-Xuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Huang, Xuehui; Feng, Qi; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai, Peoples R China; [Han, Bin; Lin, Hong-Xuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	jxshan@sibs.ac.cn; jpgao@sibs.ac.cn; hxlin@sibs.ac.cn	Chao, Dai-Yin/GYV-5944-2022; Dong, Nai-Qian/X-2857-2019; Lin, Hong-Xuan/AEQ-6607-2022	Dong, Nai-Qian/0000-0001-7804-1417; Lin, Hong-Xuan/0000-0002-2818-023X; Gao, Ji-Ping/0000-0002-8968-4423; zhang, peng/0000-0003-0408-2923; ?, ??/0000-0003-2832-4800	Ministry of Science and Technology of China [2012AA10A302, 2012CB944800]; National Natural Science Foundation of China [31421093, 31101128]; CAS-Croucher Funding Scheme for Joint Laboratories; China Postdoctoral Science Foundation; Research Grants Council of Hong Kong [CUHK2/CRF/11G, AoE/M-05/12]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS-Croucher Funding Scheme for Joint Laboratories; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	We thank G.Q. Zhang and the National Mid-term Genebank for Rice of China National Rice Research Institute for kindly providing O. glaberrima and O. sativa from Africa, respectively. We thank Y. Li for help with bioinformatics analysis. This work was supported by grants from the Ministry of Science and Technology of China (2012AA10A302, 2012CB944800), the National Natural Science Foundation of China (31421093, 31101128), the CAS-Croucher Funding Scheme for Joint Laboratories, the China Postdoctoral Science Foundation, and the Research Grants Council of Hong Kong (CUHK2/CRF/11G and AoE/M-05/12).	Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Bohra-Mishra P, 2014, P NATL ACAD SCI USA, V111, P9780, DOI 10.1073/pnas.1317166111; Book AJ, 2009, PLANT CELL, V21, P460, DOI 10.1105/tpc.108.064444; Brukhin V, 2005, PLANT CELL, V17, P2723, DOI 10.1105/tpc.105.034975; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; Gallois JL, 2009, PLANT CELL, V21, P442, DOI 10.1105/tpc.108.062372; Gao CX, 2009, PLANT CELL REP, V28, P1431, DOI 10.1007/s00299-009-0743-x; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hao Wei, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P354; Hao W, 2009, J INTEGR PLANT BIOL, V51, P500, DOI 10.1111/j.1744-7909.2009.00822.x; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang WH, 2006, PLANT CELL, V18, P2479, DOI 10.1105/tpc.106.045013; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Lee KH, 2011, PLANT CELL, V23, P4298, DOI 10.1105/tpc.111.089482; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Luo JJ, 2008, MOL PLANT, V1, P830, DOI 10.1093/mp/ssn045; Lyman NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072157; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mba C., 2012, AGR FOOD SECURITY, V1, P7, DOI DOI 10.1186/2048-7010-1-7; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nishizawa-Yokoi A, 2010, PLANT CELL PHYSIOL, V51, P486, DOI 10.1093/pcp/pcq015; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Peng ZH, 2001, MOL BIOL CELL, V12, P383, DOI 10.1091/mbc.12.2.383; Ruschak AM, 2010, NATURE, V467, P868, DOI 10.1038/nature09444; Sakai H, 2011, PLANT J, V66, P796, DOI 10.1111/j.1365-313X.2011.04539.x; Sarla N, 2005, CURR SCI INDIA, V89, P955; Semenov MA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00066; Shibahara T, 2002, EUR J BIOCHEM, V269, P1474, DOI 10.1046/j.1432-1033.2002.02792.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SY, 2009, NAT CELL BIOL, V11, P845, DOI 10.1038/ncb1892; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Trnka M, 2014, NAT CLIM CHANGE, V4, P637, DOI [10.1038/nclimate2242, 10.1038/NCLIMATE2242]; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Ueda M, 2004, DEVELOPMENT, V131, P2101, DOI 10.1242/dev.01096; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wang SH, 2009, PLANT CELL PHYSIOL, V50, P1721, DOI 10.1093/pcp/pcp105; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Wei H, 2013, J HERED, V104, P287, DOI 10.1093/jhered/ess103; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yanagawa Y, 1999, PLANT SCI, V149, P33, DOI 10.1016/S0168-9452(99)00140-5; Zhu ChangLan, 2005, Rice Science, V12, P33	54	158	188	20	196	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					827	+		10.1038/ng.3305	http://dx.doi.org/10.1038/ng.3305			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	25985140				2022-12-25	WOS:000357090300024
J	Rosenthal, RG; Vogeli, B; Quade, N; Capitani, G; Kiefer, P; Vorholt, JA; Ebert, MO; Erb, TJ				Rosenthal, Raoul G.; Voegeli, Bastian; Quade, Nick; Capitani, Guido; Kiefer, Patrick; Vorholt, Julia A.; Ebert, Marc-Olivier; Erb, Tobias J.			The use of ene adducts to study and engineer enoyl-thioester reductases	NATURE CHEMICAL BIOLOGY			English	Article							CROTONYL-COA CARBOXYLASE/REDUCTASE; COMPUTATIONAL DESIGN; PATHWAY; STEREOCHEMISTRY; MUTAGENESIS; INSIGHTS; FEATURES; MODEL	An improved understanding of enzymes' catalytic proficiency and stereoselectivity would further enable applications in chemistry, biocatalysis and industrial biotechnology. We use a chemical probe to dissect individual catalytic steps of enoyl-thioester reductases (Etrs), validating an active site tyrosine as the cryptic proton donor and explaining how it had eluded definitive identification. This information enabled the rational redesign of Etr, yielding mutants that create products with inverted stereochemistry at wild type-like frequency.	[Rosenthal, Raoul G.; Kiefer, Patrick; Vorholt, Julia A.; Erb, Tobias J.] Swiss Fed Inst Technol, ETH, Inst Microbiol, Zurich, Switzerland; [Voegeli, Bastian; Erb, Tobias J.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Quade, Nick] ETH, Inst Mol Biol & Biophys, Zurich, Switzerland; [Capitani, Guido] Paul Scherrer Inst, Villigen, Switzerland; [Ebert, Marc-Olivier] ETH, Organ Chem Lab, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rosenthal, RG (corresponding author), Swiss Fed Inst Technol, ETH, Inst Microbiol, Zurich, Switzerland.	toerb@mpi-marburg.mpg.de	Ebert, Marc-Olivier/L-6197-2017; Vorholt, Julia/K-3514-2016; Erb, Tobias/J-5214-2013	Ebert, Marc-Olivier/0000-0003-1507-219X; Vorholt, Julia/0000-0002-6011-4910; Erb, Tobias/0000-0003-3685-0894; Vogeli, Bastian/0000-0001-7870-7311	Swiss National Science Foundation (SNF-Ambizione program) [PZ00P3_136828/1]	Swiss National Science Foundation (SNF-Ambizione program)	This work was supported by the Swiss National Science Foundation (SNF-Ambizione program PZ00P3_136828/1; granted to T.J.E.).	Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Hamilton G., 1971, PROGRESS BIOORGANIC, V1, P83; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Kwan DH, 2010, ACS CHEM BIOL, V5, P829, DOI 10.1021/cb100175a; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Libby RD, 2012, BIOORG CHEM, V40, P57, DOI 10.1016/j.bioorg.2011.10.002; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesa J, 2015, CHEM-BIOL INTERACT, V234, P105, DOI 10.1016/j.cbi.2015.01.021; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Rosenthal RG, 2014, NAT CHEM BIOL, V10, P50, DOI [10.1038/NCHEMBIO.1385, 10.1038/nchembio.1385]; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Toogood HS, 2014, CURR OPIN CHEM BIOL, V19, P107, DOI 10.1016/j.cbpa.2014.01.019; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; Wu YH, 2008, STRUCTURE, V16, P1714, DOI 10.1016/j.str.2008.09.007; Zheng JT, 2013, ACS CHEM BIOL, V8, P1964, DOI 10.1021/cb400161g; Zheng JT, 2012, NAT CHEM BIOL, V8, P615, DOI [10.1038/nchembio.964, 10.1038/NCHEMBIO.964]	34	20	21	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					398	+		10.1038/nchembio.1794	http://dx.doi.org/10.1038/nchembio.1794			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25867044				2022-12-25	WOS:000354539400009
J	Malik, R; Khan, AP; Asangani, IA; Cieslik, M; Prensner, JR; Wang, XJ; Iyer, MK; Jiang, X; Borkin, D; Escara-Wilke, J; Stender, R; Wu, YM; Niknafs, YS; Jing, XJ; Qiao, YY; Palanisamy, N; Kunju, LP; Krishnamurthy, PM; Yocum, AK; Mellacheruvu, D; Nesvizhskii, AI; Cao, XH; Dhanasekaran, SM; Feng, FY; Grembecka, J; Cierpicki, T; Chinnaiyan, AM				Malik, Rohit; Khan, Amjad P.; Asangani, Irfan A.; Cieslik, Marcin; Prensner, John R.; Wang, Xiaoju; Iyer, Matthew K.; Jiang, Xia; Borkin, Dmitry; Escara-Wilke, June; Stender, Rachell; Wu, Yi-Mi; Niknafs, Yashar S.; Jing, Xiaojun; Qiao, Yuanyuan; Palanisamy, Nallasivam; Kunju, Lakshmi P.; Krishnamurthy, Pranathi M.; Yocum, Anastasia K.; Mellacheruvu, Dattatreya; Nesvizhskii, Alexey I.; Cao, Xuhong; Dhanasekaran, Saravana M.; Feng, Felix Y.; Grembecka, Jolanta; Cierpicki, Tomasz; Chinnaiyan, Arul M.			Targeting the MLL complex in castration-resistant prostate cancer	NATURE MEDICINE			English	Article							ANDROGEN-RECEPTOR; INCREASED SURVIVAL; MENIN; GENE; EXPRESSION; PROTEINS; ANTIANDROGEN; CELLS	Resistance to androgen deprivation therapies and increased androgen receptor (AR) activity are major drivers of castrationresistant prostate cancer (CRPC). Although prior work has focused on targeting AR directly, co-activators of AR signaling, which may represent new therapeutic targets, are relatively underexplored. Here we demonstrate that the mixed-lineage leukemia protein (MLL) complex, a well-known driver of MLL fusion-positive leukemia, acts as a co-activator of AR signaling. AR directly interacts with the MLL complex via the menin-MLL subunit. Menin expression is higher in CRPC than in both hormone-naive prostate cancer and benign prostate tissue, and high menin expression correlates with poor overall survival of individuals diagnosed with prostate cancer. Treatment with a small-molecule inhibitor of menin-MLL interaction blocks AR signaling and inhibits the growth of castration-resistant tumors in vivo in mice. Taken together, this work identifies the MLL complex as a crucial co-activator of AR and a potential therapeutic target in advanced prostate cancer.	[Malik, Rohit; Khan, Amjad P.; Asangani, Irfan A.; Cieslik, Marcin; Prensner, John R.; Wang, Xiaoju; Iyer, Matthew K.; Jiang, Xia; Escara-Wilke, June; Stender, Rachell; Wu, Yi-Mi; Niknafs, Yashar S.; Jing, Xiaojun; Qiao, Yuanyuan; Palanisamy, Nallasivam; Kunju, Lakshmi P.; Krishnamurthy, Pranathi M.; Yocum, Anastasia K.; Nesvizhskii, Alexey I.; Cao, Xuhong; Dhanasekaran, Saravana M.; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Malik, Rohit; Khan, Amjad P.; Asangani, Irfan A.; Cieslik, Marcin; Prensner, John R.; Wang, Xiaoju; Iyer, Matthew K.; Jiang, Xia; Borkin, Dmitry; Escara-Wilke, June; Stender, Rachell; Wu, Yi-Mi; Jing, Xiaojun; Qiao, Yuanyuan; Palanisamy, Nallasivam; Kunju, Lakshmi P.; Mellacheruvu, Dattatreya; Nesvizhskii, Alexey I.; Dhanasekaran, Saravana M.; Grembecka, Jolanta; Cierpicki, Tomasz; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Palanisamy, Nallasivam] Henry Ford Hlth Syst, Dept Urol, Detroit, MI USA; [Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Mellacheruvu, Dattatreya; Nesvizhskii, Alexey I.; Chinnaiyan, Arul M.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Feng, Felix Y.] Univ Michigan, Radiat Oncol, Ann Arbor, MI 48109 USA; [Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Nesvizhskii, Alexey/A-5410-2012; Mellacheruvu, Dattatreya/H-8985-2019; Palanisamy, Nallasivam/ABC-8844-2020; meda, Pranathi/J-7637-2019	Nesvizhskii, Alexey/0000-0002-2806-7819; Mellacheruvu, Dattatreya/0000-0001-8221-7673; Palanisamy, Nallasivam/0000-0002-0633-9772; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Prensner, John/0000-0002-7024-636X; asangani, irfan/0000-0001-5381-1702; Qiao, Yuanyuan/0000-0002-1178-3480	US National Institutes of Health (NIH) Prostate Specialized Program of Research Excellence [P50CA186786]; Early Detection Research Network [UO1 CA111275]; Prostate Cancer Foundation; Howard Hughes Medical Institute; NIH R01 grant [1R01CA160467]; Leukemia & Lymphoma Society Translational Research Program grant [6116-12]; American Cancer Society Research Scholar grant [RSG-11-082-01-DMC]; NIH [R01-GM-094231]; Department of Defense postdoctoral award [W81XWH-13-1-0284]; Prostate Cancer Foundation Young Investigator award; NATIONAL CANCER INSTITUTE [R01CA160467, P50CA186786, U01CA111275, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, R01GM094231, T32GM007315] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Prostate Specialized Program of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; Prostate Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society Translational Research Program grant; American Cancer Society Research Scholar grant(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense postdoctoral award; Prostate Cancer Foundation Young Investigator award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Poliakov, J. Siddiqui and S. Shukla for helpful discussions; B. Malik, S. Subramanian, K. Wilder-Romans, S. Yazdani and V.L. Dommeti for technical assistance; K. Giles and C. Betts for critically looking over the manuscript and the submission of documents; the University of Michigan Viral Vector Core for generating the lentiviral constructs and Microscopy and Image-analysis Laboratory (MIL) for help with immunofluorescence microscopy. We thank C. Sawyers (Memorial Sloan-Kettering Cancer Center) for the LNCaP-AR cell line. This work was supported in part by the US National Institutes of Health (NIH) Prostate Specialized Program of Research Excellence grant (P50CA186786) and the Early Detection Research Network grant (UO1 CA111275) to A.M.C. A.M.C. is supported by the Prostate Cancer Foundation and the Howard Hughes Medical Institute. A.M.C. is an American Cancer Society Research Professor and a Taubman Scholar of the University of Michigan. J.G. is supported by the NIH R01 grant (1R01CA160467) and The Leukemia & Lymphoma Society Translational Research Program grant (6116-12). T.C. is supported by the American Cancer Society Research Scholar grant (RSG-11-082-01-DMC). A.N. is supported by US NIH grant R01-GM-094231. R.M is supported by a Department of Defense postdoctoral award (W81XWH-13-1-0284). R.M., I.A.A. and M.C. are supported by a Prostate Cancer Foundation Young Investigator award.	Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Borkin D., CANC CELL IN PRESS; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/NCHEMBIO.773, 10.1038/nchembio.773]; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Imachi H, 2010, BREAST CANCER RES TR, V122, P395, DOI 10.1007/s10549-009-0581-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Korenchuk S, 2001, IN VIVO, V15, P163; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Smith MR, 2011, CANCER-AM CANCER SOC, V117, P2077, DOI 10.1002/cncr.25762; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Xu B, 2013, P NATL ACAD SCI USA, V110, P17480, DOI 10.1073/pnas.1312022110; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou HB, 2013, J MED CHEM, V56, P1113, DOI 10.1021/jm3015298	53	128	135	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					344	+		10.1038/nm.3830	http://dx.doi.org/10.1038/nm.3830			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25822367	Green Accepted			2022-12-25	WOS:000352493600016
J	Jung-, H; Lee, D; Lee, J; Park, D; Kim, YJ; Park, WY; Hong, D; Park, PJ; Lee, E				Jung-, Hyunchul; Lee, Donghoon; Lee, Jongkeun; Park, Donghyun; Kim, Yeon Jeong; Park, Woong-Yang; Hong, Dongwan; Park, Peter J.; Lee, Eunjung			Intron retention is a widespread mechanism of tumor-suppressor inactivation	NATURE GENETICS			English	Article							MESSENGER-RNA; HUMAN CANCER; MUTATIONS; IDENTIFICATION; GENOME; DISCOVERY; TRANSCRIPTOME; ALIGNMENT; NONSENSE; ELEMENTS	A substantial fraction of disease-causing mutations are pathogenic through aberrant splicing. Although genome profiling studies have identified somatic single-nucleotide variants (SNVs) in cancer, the extent to which these variants trigger abnormal splicing has not been systematically examined. Here we analyzed RNA sequencing and exome data from 1,812 patients with cancer and identified similar to 900 somatic exonic SNVs that disrupt splicing. At least 163 SNVs, including 31 synonymous ones, were shown to cause intron retention or exon skipping in an allele-specific manner, with similar to 70% of the SNVs occurring on the last base of exons. Notably, SNVs causing intron retention were enriched in tumor suppressors, and 97% of these SNVs generated a premature termination codon, leading to loss of function through nonsense-mediated decay or truncated protein. We also characterized the genomic features predictive of such splicing defects. Overall, this work demonstrates that intron retention is a common mechanism of tumor-suppressor inactivation.	[Jung-, Hyunchul; Lee, Donghoon; Lee, Jongkeun; Hong, Dongwan] Natl Canc Ctr, Res Inst, Gyeonggi Do, South Korea; [Jung-, Hyunchul; Park, Donghyun; Kim, Yeon Jeong; Park, Woong-Yang] Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Jung-, Hyunchul] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Lee, Donghoon] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Lee, Jongkeun; Hong, Dongwan] Natl Canc Ctr, Div Canc Biol, Canc Immunol Branch, Gyeonggi Do, South Korea; [Park, Donghyun; Kim, Yeon Jeong] Samsung Elect Co Ltd, Samsung Adv Inst Technol, Samsung Biomed Res Inst, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea; [Park, Peter J.; Lee, Eunjung] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Park, Peter J.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA USA	National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center; University of California System; University of California San Diego; Yale University; National Cancer Center - Korea (NCC); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, E (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	dwhong@ncc.re.kr; peter_park@hms.harvard.edu; elee20@partners.org	Lee, Donghoon/I-9967-2017; Park, Donghyun/I-5849-2019; Lee, Donghoon/AAQ-9786-2021; Lee, Donghoon/AAH-2252-2020	Lee, Donghoon/0000-0003-0453-6059; Park, Donghyun/0000-0002-7946-6924; Lee, Donghoon/0000-0003-0453-6059; Jung, Hyunchul/0000-0003-0450-2190; Park, Woong-Yang/0000-0003-4234-0380; Hong, Dongwan/0000-0002-7816-1299; Kim, Yeon Jeong/0000-0003-3297-9463; Park, Peter/0000-0001-9378-960X	National Cancer Center, Korea [NCC-1310190, NCC-1410675]; Harvard Medical School Eleanor and Miles Shore fellowship; William Randolph Hearst Fund; NATIONAL INSTITUTE ON AGING [K01AG051791] Funding Source: NIH RePORTER	National Cancer Center, Korea; Harvard Medical School Eleanor and Miles Shore fellowship; William Randolph Hearst Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S.J. Elledge, H. Schaa, A. Han, N. Gehlenborg and N. Smedemark-Margulies for insightful discussion on tumor-suppressor inactivation, providing a script to determine H-bond scores, advice on minigene experimental validation, comments on visualization, and critical reading and editing of the manuscript, respectively. This study was supported by a grant from the National Cancer Center, Korea (NCC-1310190 and NCC-1410675 to D.H.). E.L. was supported by the Harvard Medical School Eleanor and Miles Shore fellowship and William Randolph Hearst Fund.	Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Bader HL, 2012, FEBS LETT, V586, P1562, DOI 10.1016/j.febslet.2012.04.032; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Burge C.B., 1993, RNA WORLD NATURE MOD, V37, P525; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danan-Gotthold M, 2015, NUCLEIC ACIDS RES, V43, P5130, DOI 10.1093/nar/gkv210; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Freund M, 2003, NUCLEIC ACIDS RES, V31, P6963, DOI 10.1093/nar/gkg901; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang LL, 2012, WIRES RNA, V3, P807, DOI 10.1002/wrna.1137; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Nguyen LS, 2014, NEUROSCI BIOBEHAV R, V46, P175, DOI 10.1016/j.neubiorev.2013.10.016; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; MAQUAT L, 2006, NONSENSE MEDIATED MR; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Spinelli R, 2013, MOL GENET GENOM MED, V1, P246, DOI 10.1002/mgg3.23; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Van Laar RK, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-30; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yoshida K., 2014, WILEY INTERDISCIP RE; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	64	204	212	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1242	+		10.1038/ng.3414	http://dx.doi.org/10.1038/ng.3414			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26437032				2022-12-25	WOS:000363988200007
J	Sidore, C; Busonero, F; Maschio, A; Porcu, E; Naitza, S; Zoledziewska, M; Mulas, A; Pistis, G; Steri, M; Danjou, F; Kwong, A; del Vecchyo, VDO; Chiang, CWK; Bragg-Gresham, J; Pitzalis, M; Nagaraja, R; Tarrier, B; Brennan, C; Uzzau, S; Fuchsberger, C; Atzeni, R; Reinier, F; Berutti, R; Huang, J; Timpson, NJ; Toniolo, D; Gasparini, P; Malerba, G; Dedoussis, G; Zeggini, E; Soranzo, N; Jones, C; Lyons, R; Angius, A; Kang, HM; Novembre, J; Sanna, S; Schlessinger, D; Cucca, F; Abecasis, GR				Sidore, Carlo; Busonero, Fabio; Maschio, Andrea; Porcu, Eleonora; Naitza, Silvia; Zoledziewska, Magdalena; Mulas, Antonella; Pistis, Giorgio; Steri, Maristella; Danjou, Fabrice; Kwong, Alan; del Vecchyo, Vicente Diego Ortega; Chiang, Charleston W. K.; Bragg-Gresham, Jennifer; Pitzalis, Maristella; Nagaraja, Ramaiah; Tarrier, Brendan; Brennan, Christine; Uzzau, Sergio; Fuchsberger, Christian; Atzeni, Rossano; Reinier, Frederic; Berutti, Riccardo; Huang, Jie; Timpson, Nicholas J.; Toniolo, Daniela; Gasparini, Paolo; Malerba, Giovanni; Dedoussis, George; Zeggini, Eleftheria; Soranzo, Nicole; Jones, Chris; Lyons, Robert; Angius, Andrea; Kang, Hyun M.; Novembre, John; Sanna, Serena; Schlessinger, David; Cucca, Francesco; Abecasis, Goncalo R.			Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers	NATURE GENETICS			English	Article							C-REACTIVE PROTEIN; WIDE ASSOCIATION; GENOTYPE IMPUTATION; COMPLEX TRAITS; HEART-DISEASE; VARIANTS; POPULATION; MULTIPLE; RISK; HERITABILITY	We report similar to 17.6 million genetic variants from whole-genome sequencing of 2,120 Sardinians; 22% are absent from previous sequencing-based compilations and are enriched for predicted functional consequences. Furthermore, similar to 76,000 variants common in our sample (frequency >5%) are rare elsewhere (<0.5% in the 1000 Genomes Project). We assessed the impact of these variants on circulating lipid levels and five inflammatory biomarkers. We observe 14 signals, including 2 major new loci, for lipid levels and 19 signals, including 2 new loci, for inflammatory markers. The new associations would have been missed in analyses based on 1000 Genomes Project data, underlining the advantages of large-scale sequencing in this founder population.	[Sidore, Carlo; Busonero, Fabio; Maschio, Andrea; Porcu, Eleonora; Naitza, Silvia; Zoledziewska, Magdalena; Mulas, Antonella; Pistis, Giorgio; Steri, Maristella; Danjou, Fabrice; Pitzalis, Maristella; Angius, Andrea; Sanna, Serena; Cucca, Francesco] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Sidore, Carlo; Busonero, Fabio; Maschio, Andrea; Porcu, Eleonora; Pistis, Giorgio; Kwong, Alan; Bragg-Gresham, Jennifer; Fuchsberger, Christian; Kang, Hyun M.; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sidore, Carlo; Porcu, Eleonora; Mulas, Antonella; Pistis, Giorgio; Berutti, Riccardo; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Busonero, Fabio; Maschio, Andrea; Tarrier, Brendan; Brennan, Christine; Lyons, Robert] Univ Michigan, DNA Sequencing Core, Ann Arbor, MI 48109 USA; [del Vecchyo, Vicente Diego Ortega] Univ Calif Los Angeles, Interdept Program Bioinformat, Los Angeles, CA USA; [Chiang, Charleston W. K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Nagaraja, Ramaiah; Schlessinger, David] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; [Uzzau, Sergio] Porto Conte Ric, Tramariglio, Alghero, Italy; [Atzeni, Rossano; Reinier, Frederic; Berutti, Riccardo; Jones, Chris; Angius, Andrea] Parco Sci & Tecnol Sardegna, Res & Dev Sardinia CRS4, Ctr Adv Studies, Pula, Italy; [Huang, Jie; Zeggini, Eleftheria; Soranzo, Nicole] Wellcome Trust Sanger Inst, Human Genet, Hinxton, England; [Timpson, Nicholas J.] Univ Bristol, Integrat Epidemiol Unit, MRC, Bristol, Avon, England; [Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Gasparini, Paolo] Univ Trieste, Dipartimento Salute Mentale, Trieste, Italy; [Gasparini, Paolo] Burlo Garofolo Children Hosp, Ist Ricovero & Cura Carattere Sci, Trieste, Italy; [Gasparini, Paolo] Sidra, Expt Genet Div, Doha, Qatar; [Malerba, Giovanni] Univ Verona, Dept Life & Reprod Sci, I-37100 Verona, Italy; [Dedoussis, George] Harokopio Univ Athens, Dept Nutr & Dietet, Athens, Greece; [Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge, England; [Novembre, John] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Michigan System; University of Michigan; University of Sassari; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Porto Conte Ricerche; Wellcome Trust Sanger Institute; University of Bristol; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Trieste; IRCCS Burlo Garofolo; Sidra Medical & Research Center; University of Verona; Harokopio University Athens; University of Cambridge; University of Chicago	Cucca, F (corresponding author), CNR, Ist Ric Genet & Biomed, Cagliari, Italy.	fcucca@uniss.it; goncalo@umich.edu	Uzzau, Sergio/F-3233-2015; Danjou, Fabrice/D-1563-2014; Fuchsberger, Christian/ABD-7127-2021; Chiang, Charleston W. K./H-3169-2019; Dedoussis, George/AAN-7252-2021; Angius, Andrea/P-9549-2015; Vecchyo, Diego Ortega-Del/AAB-8246-2019; Maschio, Andrea/AAX-8185-2020; Attrill, Lauren/V-1688-2018; Timpson, Nicholas John/O-7548-2015; Sidore, Carlo/AAV-7967-2020; Malerba, Giovanni/T-3278-2019; Steri, Maristella/AAX-8760-2020; NAITZA, SILVIA/AAB-8775-2022; sanna, serena/H-3009-2019; Mulas, Antonella/B-4231-2015; Naitza, Silvia/D-5620-2017; Fox, Laura J/C-6249-2016; Gasparini, Paolo/B-6173-2014; Toniolo, Daniela/AAE-2969-2019	Uzzau, Sergio/0000-0001-6246-2794; Danjou, Fabrice/0000-0002-4976-2327; Fuchsberger, Christian/0000-0002-5918-8947; Chiang, Charleston W. K./0000-0002-0668-7865; Dedoussis, George/0000-0002-7798-6221; Angius, Andrea/0000-0003-2596-6461; Vecchyo, Diego Ortega-Del/0000-0003-4054-3766; Timpson, Nicholas John/0000-0002-7141-9189; Sidore, Carlo/0000-0001-7504-7477; Steri, Maristella/0000-0001-5869-3872; NAITZA, SILVIA/0000-0002-0108-757X; sanna, serena/0000-0002-3768-1749; Toniolo, Daniela/0000-0001-9545-6032; Mulas, Antonella/0000-0002-6856-1483; maschio, andrea/0000-0002-4238-9144; CUCCA, Francesco/0000-0002-7414-1995; Atzeni, Rossano/0000-0003-0020-0013; Pitzalis, Maristella/0000-0003-4975-6987; Soranzo, Nicole/0000-0003-1095-3852; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Zeggini, Eleftheria/0000-0003-4238-659X; Zoledziewska, Magdalena/0000-0002-3033-6133; Gasparini, Paolo/0000-0002-0859-0856; Malerba, Giovanni/0000-0001-8705-8560	National Human Genome Research Institute [HG005581, HG005552, HG006513, HG007022, HG007089]; National Heart, Lung, and Blood Institute [HL117626]; US National Institutes of Health, National Institute on Aging [N01-AG-1-2109, HHSN271201100005C]; Sardinian Autonomous Region [cRP3-154]; InterOmics MIUR Flagship Project [PB05]; FaReBio 'Farmaci e Reti Biotecnologiche di Qualita'; US National Institutes of Health National Research Service Award (NRSA) [F32GM106656]; UC MEXUS/CONOCYT fellowship; Wellcome Trust [WT091310, WT098051, 098051, WT091310/C/10/Z]; European Union [257082, HEALTH-F5-2011-282510]; National Institute for Health Research (NIHR) British Research Council (BRC); Ministero della Salute-Ricerca Finalizzata [PE-2011-02347500]; Fondazione Cariplo (Italy); Ministry of Health; Public Health Genomics Project; European Research Council [ERC-2011-StG 280559-SEPI]; Ricerca Finalizzata (Italy); MRC [MC_UU_12013/3] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626, U01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513, R01HG007022, R01HG007089, RC2HG005581, RC2HG005552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12013/3] Funding Source: researchfish	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Sardinian Autonomous Region(Regione Sardegna); InterOmics MIUR Flagship Project; FaReBio 'Farmaci e Reti Biotecnologiche di Qualita'; US National Institutes of Health National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC MEXUS/CONOCYT fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Institute for Health Research (NIHR) British Research Council (BRC); Ministero della Salute-Ricerca Finalizzata(Ministry of Health, Italy); Fondazione Cariplo (Italy)(Fondazione Cariplo); Ministry of Health; Public Health Genomics Project; European Research Council(European Research Council (ERC)European Commission); Ricerca Finalizzata (Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the volunteers who generously participated in this study and made this research possible. This research was supported by National Human Genome Research Institute grants HG005581, HG005552, HG006513, HG007022 and HG007089; by National Heart, Lung, and Blood Institute grant HL117626; by the Intramural Research Program of the US National Institutes of Health, National Institute on Aging, contracts N01-AG-1-2109 and HHSN271201100005C; by Sardinian Autonomous Region (L.R. 7/2009) grant cRP3-154; by the PB05 InterOmics MIUR Flagship Project; by grant FaReBio2011 'Farmaci e Reti Biotecnologiche di Qualita'; by a US National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship (F32GM106656) to C.W.K.C.; and by the UC MEXUS/CONOCYT fellowship to V.D.O.d.V. The replication cohorts acknowledge the use of data generated by the UK10K Consortium, supported by Wellcome Trust award WT091310. The UK10K research was specifically funded by a Wellcome Trust award, '10,000 UK Genome Sequences: Accessing the Role of Rare Genetic Variants in Health and Disease' (WT091310/C/10/Z). The research of N.S. is supported by the Wellcome Trust (grants WT098051 and WT091310), the European Union's Seventh Framework Programme (EPIGENESYS grant 257082 and BLUEPRINT grant HEALTH-F5-2011-282510) and the National Institute for Health Research (NIHR) British Research Council (BRC). The ING-FVG cohort was supported by grant Ministero della Salute-Ricerca Finalizzata PE-2011-02347500 (to P.G.); the ING-VB study thanks the inhabitants of Val Borbera for participating in the study, M. Traglia, C. Sala and C. Masciullo for data management, and the funding sources Fondazione Cariplo (Italy), the Ministry of Health, Ricerca Finalizzata (Italy) 2008, 2011-2012, and the Public Health Genomics Project 2010. The HELIC cohorts are thankful to the residents of the Pomak villages and the Mylopotamos villages for participating and to their funding sources, including the Wellcome Trust (098051) and the European Research Council (ERC-2011-StG 280559-SEPI).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Chen W, 2013, GENOME RES, V23, P142, DOI 10.1101/gr.142455.112; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Esko T, 2013, EUR J HUM GENET, V21, P659, DOI 10.1038/ejhg.2012.229; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Golledge J, 2010, ATHEROSCLEROSIS, V209, P487, DOI 10.1016/j.atherosclerosis.2009.09.027; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hou SP, 2013, HUM MUTAT, V34, P74, DOI 10.1002/humu.22208; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jun G, 2015, GENOME RES, V25, P918, DOI 10.1101/gr.176552.114; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Kullo IJ, 2011, AM J HUM GENET, V89, P131, DOI 10.1016/j.ajhg.2011.05.019; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/865181; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Maioli M, 1997, ATHEROSCLEROSIS, V131, P127, DOI 10.1016/S0021-9150(97)06095-4; MAIOLI M, 1989, ATHEROSCLEROSIS, V75, P245, DOI 10.1016/0021-9150(89)90182-2; Mathieson I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004528; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pistis G, 2015, EUR J HUM GENET, V23, P975, DOI 10.1038/ejhg.2014.216; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schick UM, 2015, HUM MOL GENET, V24, P559, DOI 10.1093/hmg/ddu450; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi XF, 2002, J MOL MODEL, V8, P217, DOI 10.1007/s00894-002-0089-6; Taylor PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6681; Tournamille C, 1998, BLOOD, V92, P2147, DOI 10.1182/blood.V92.6.2147.418k04_2147_2156; Traglia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007554; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winkelmann BR, 2001, PHARMACOGENOMICS, V2, pS7; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Xu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S12; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84; Zoledziewska M, 2015, NAT GENET, V47, P1352, DOI 10.1038/ng.3403; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	76	116	116	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1272	+		10.1038/ng.3368	http://dx.doi.org/10.1038/ng.3368			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26366554	Green Accepted, Green Submitted			2022-12-25	WOS:000363988200011
J	Derrington, IM; Craig, JM; Stava, E; Laszlo, AH; Ross, BC; Brinkerhoff, H; Nova, IC; Doering, K; Tickman, BI; Ronaghi, M; Mandell, JG; Gunderson, KL; Gundlach, JH				Derrington, Ian M.; Craig, Jonathan M.; Stava, Eric; Laszlo, Andrew H.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Ronaghi, Mostafa; Mandell, Jeffrey G.; Gunderson, Kevin L.; Gundlach, Jens H.			Subangstrom single-molecule measurements of motor proteins using a nanopore	NATURE BIOTECHNOLOGY			English	Article							STRANDED-DNA; MSPA; POLYMERASE; HELICASE	Techniques for measuring the motion of single motor proteins, such as FRET and optical tweezers, are limited to a resolution of similar to 300 pm. We use ion current modulation through the protein nanopore MspA to observe translocation of helicase Hel308 on DNA with up to similar to 40 pm sensitivity. This approach should be applicable to any protein that translocates on DNA or RNA, including helicases, polymerases, recombinases and DNA repair enzymes.	[Derrington, Ian M.; Craig, Jonathan M.; Laszlo, Andrew H.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Stava, Eric; Ronaghi, Mostafa; Mandell, Jeffrey G.; Gunderson, Kevin L.] Illumina Inc, San Diego, CA USA	University of Washington; University of Washington Seattle; Illumina	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu		Brinkerhoff, Henry/0000-0003-2735-8048; Laszlo, Andrew/0000-0002-7853-0533; Craig, Jonathan M/0000-0003-4791-5112; Gundlach, Jens Horst/0000-0002-0773-8038	National Institutes of Health National Human Genome Research Institute (NHGRI) grant [R01HG005115]; Illumina; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115] Funding Source: NIH RePORTER	National Institutes of Health National Human Genome Research Institute (NHGRI) grant; Illumina; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported at the University of Washington by the National Institutes of Health National Human Genome Research Institute (NHGRI) grant R01HG005115 and at Illumina through internal funding. We thank J.J. Bartlett, S. Klebanoff, M.T. Svet and M.T. Noakes for assisting in the data collection and C.-Y. Chen, A. Nikoomanzar and W. Chang for making Hel308 and testing its activity. M. Hopper, N. Sam-Soon and S. Marx performed the initial experiments that revealed Hel308's fractional steps and their ATP dependence.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Bosco A, 2014, NUCLEIC ACIDS RES, V42, P2064, DOI 10.1093/nar/gkt1089; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Henrickson SE, 2000, PHYS REV LETT, V85, P3057, DOI 10.1103/PhysRevLett.85.3057; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kim H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016601; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Woodman IL, 2011, BIOCHEM SOC T, V39, P140, DOI 10.1042/BST0390140	19	82	84	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1073	+		10.1038/nbt.3357	http://dx.doi.org/10.1038/nbt.3357			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26414351	Green Accepted			2022-12-25	WOS:000362555700026
J	Dina, C; Bouatia-Naji, N; Tucker, N; Delling, FN; Toomer, K; Durst, R; Perrocheau, M; Fernandez-Friera, L; Solis, J; Le Tourneau, T; Chen, MH; Probst, V; Bosse, Y; Pibarot, P; Zelenika, D; Lathrop, M; Hercberg, S; Roussel, R; Benjamin, EJ; Bonnet, F; Lo, SH; Dolmatova, E; Simonet, F; Lecointe, S; Kyndt, F; Redon, R; Le Marec, H; Froguel, P; Ellinor, PT; Vasan, RS; Bruneval, P; Markwald, RR; Norris, RA; Milan, DJ; Slaugenhaupt, SA; Levine, RA; Schott, JJ; Hagege, AA; Jeunemaitre, X				Dina, Christian; Bouatia-Naji, Nabila; Tucker, Nathan; Delling, Francesca N.; Toomer, Katelynn; Durst, Ronen; Perrocheau, Maelle; Fernandez-Friera, Leticia; Solis, Jorge; Le Tourneau, Thierry; Chen, Ming-Huei; Probst, Vincent; Bosse, Yohan; Pibarot, Philippe; Zelenika, Diana; Lathrop, Mark; Hercberg, Serge; Roussel, Ronan; Benjamin, Emelia J.; Bonnet, Fabrice; Lo, Su Hao; Dolmatova, Elena; Simonet, Floriane; Lecointe, Simon; Kyndt, Florence; Redon, Richard; Le Marec, Herve; Froguel, Philippe; Ellinor, Patrick T.; Vasan, Ramachandran S.; Bruneval, Patrick; Markwald, Roger R.; Norris, Russell A.; Milan, David J.; Slaugenhaupt, Susan A.; Levine, Robert A.; Schott, Jean-Jacques; Hagege, Albert A.; Jeunemaitre, Xavier		PROMESA Investigators; MVP-France; Leducq Transatlantic MITRAL Networ	Genetic association analyses highlight biological pathways underlying mitral valve prolapse	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CARDIAC VALVULAR DYSTROPHY; FILAMIN-A; NATURAL-HISTORY; MARFAN-SYNDROME; CELL-MIGRATION; EXPRESSION; LOCUS; PATHOGENESIS; METAANALYSIS	Nonsyndromic mitral valve prolapse (MVP) is a common degenerative cardiac valvulopathy of unknown etiology that predisposes to mitral regurgitation, heart failure and sudden death(1). Previous family and pathophysiological studies suggest a complex pattern of inheritance(2-5). We performed a meta-analysis of 2 genome-wide association studies in 1,412 MVP cases and 2,439 controls. We identified 6 loci, which we replicated in 1,422 cases and 6,779 controls, and provide functional evidence for candidate genes. We highlight LMCD1 (LIM and cysteine-rich domains 1), which encodes a transcription factor(6) and for which morpholino knockdown of the ortholog in zebrafish resulted in atrioventricular valve regurgitation. A similar zebrafish phenotype was obtained with knockdown of the ortholog of TNS1, which encodes tensin 1, a focal adhesion protein involved in cytoskeleton organization. We also showed expression of tensin 1 during valve morphogenesis and describe enlarged posterior mitral leaflets in Tns(1-/-) mice. This study identifies the first risk loci for MVP and suggests new mechanisms involved in mitral valve regurgitation, the most common indication for mitral valve repair(7).	[Dina, Christian; Le Tourneau, Thierry; Probst, Vincent; Simonet, Floriane; Lecointe, Simon; Kyndt, Florence; Redon, Richard; Le Marec, Herve; Schott, Jean-Jacques] CNRS, INSERM, Inst Thorax, UMR 1087,UMR 6291, Nantes, France; [Dina, Christian; Le Tourneau, Thierry; Probst, Vincent; Lecointe, Simon; Kyndt, Florence; Redon, Richard; Le Marec, Herve; Schott, Jean-Jacques] Univ Nantes, CHU Nantes, Nantes, France; [Bouatia-Naji, Nabila; Perrocheau, Maelle; Bruneval, Patrick; Hagege, Albert A.; Jeunemaitre, Xavier] Paris Cardiovasc Res Ctr, INSERM, UMR 970, Paris, France; [Bouatia-Naji, Nabila; Perrocheau, Maelle; Hercberg, Serge; Bruneval, Patrick; Jeunemaitre, Xavier] Paris Descartes Univ, Paris Sorbonne Cite, Paris, France; [Tucker, Nathan; Dolmatova, Elena; Ellinor, Patrick T.; Milan, David J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Delling, Francesca N.; Chen, Ming-Huei; Benjamin, Emelia J.; Vasan, Ramachandran S.] NHLBI, Framingham Heart Study, Populat Sci Branch, Div Intramural Res,US Natl Inst Hlth, Framingham, MA USA; [Delling, Francesca N.; Benjamin, Emelia J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02215 USA; [Toomer, Katelynn; Markwald, Roger R.; Norris, Russell A.] Med Univ S Carolina, Childrens Res Inst, Cardiovasc Dev Biol Ctr, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Durst, Ronen] Hadassah Hebrew Univ Med Ctr, Dept Cardiol, Jerusalem, Israel; [Fernandez-Friera, Leticia; Solis, Jorge] Univ Ctr Estudios Univ CEU, Hosp Univ Monteprincipe, Madrid, Spain; [Fernandez-Friera, Leticia; Solis, Jorge; Leducq Transatlantic MITRAL Networ] Carlos III CNIC, Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Bosse, Yohan; Pibarot, Philippe] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Lathrop, Mark] Genome Quebec, Montreal, PQ, Canada; [Hercberg, Serge] Univ Paris 13, Sorbonne Paris Cite, Bobigny, France; [Hercberg, Serge] INRA, INSERM, U1153, U1125,Nutr Epidemiol Res Unit,Epidemiol & Biostat, Bobigny, France; [Hercberg, Serge] Avicenne Hosp, AP HP, Dept Publ Hlth, Bobigny, France; [Hercberg, Serge; Roussel, Ronan] Paris Diderot Univ, Paris, France; [Roussel, Ronan] Ctr Rech Cordeliers, INSERM, UMRS 1138, Paris, France; [Roussel, Ronan] Hop Xavier Bichat, AP HP, Fibrosis Inflammat Remodeling Cardiovasc Resp & R, Dept Endocrinol Diabet & Nutr, Paris, France; [Bonnet, Fabrice] Univ Hosp Pontchaillou, INSERM, CIC 0203, Rennes, France; [Bonnet, Fabrice] Univ Hosp, Dept Endocrinol, Rennes, France; [Lo, Su Hao] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Froguel, Philippe] Univ Lille 2, CNRS, Lille Pasteur Inst, UMR 8199,EGID, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Ellinor, Patrick T.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Bruneval, Patrick] Hop Europeen Georges Pompidou, AP HP, Dept Pathol, Paris, France; [Slaugenhaupt, Susan A.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Slaugenhaupt, Susan A.; Levine, Robert A.] Harvard Univ, Sch Med, Boston, MA USA; [Levine, Robert A.] Massachusetts Gen Hosp, Cardiac Ultrasound Lab, Boston, MA 02114 USA; [Hagege, Albert A.] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, Paris, France; [Jeunemaitre, Xavier] Hop Europeen Georges Pompidou, AP HP, Dept Genet, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Medical University of South Carolina; Hebrew University of Jerusalem; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Boston University; Laval University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite Paris 13; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Dina, C (corresponding author), CNRS, INSERM, Inst Thorax, UMR 1087,UMR 6291, Nantes, France.	christian.dina@univ-nantes.fr; nabila.bouatia-naji@inserm.fr; xavier.jeunemaitre@inserm.fr	Bouatia-Naji, Nabila/AGF-1400-2022; HERCBERG, Serge/B-4429-2008; Le Tourneau, Thierry/D-5428-2015; Redon, Richard/F-3303-2014; Le Marec, Hervé/D-2718-2015; Bonnet, Fabrice/G-4255-2017; Schott, jean-Jacques/F-8842-2013; Ramachandran, Vasan/Y-2527-2019; FROGUEL, Philippe/O-6799-2017; Pibarot, Philippe/ABD-5300-2021; JEUNEMAITRE, Xavier/AAQ-4853-2021; Serge, Hercberg/F-3038-2017; KYNDT, Florence/D-6370-2015; probst, vincent/D-4996-2015; Dina, Christian R/D-3535-2015; Benjamin, Emelia/E-7103-2011; BOUATIA-NAJI, NABILA/D-5863-2013; solis, jorge/E-2709-2018; Fernandez Friera, Leticia/E-9931-2015	Bouatia-Naji, Nabila/0000-0001-5424-2134; HERCBERG, Serge/0000-0002-3168-1350; Redon, Richard/0000-0001-7751-2280; Le Marec, Hervé/0000-0002-8288-8693; Bonnet, Fabrice/0000-0001-9255-8228; Schott, jean-Jacques/0000-0002-9578-9475; Ramachandran, Vasan/0000-0001-7357-5970; FROGUEL, Philippe/0000-0003-2972-0784; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Serge, Hercberg/0000-0002-3168-1350; KYNDT, Florence/0000-0001-6651-1696; probst, vincent/0000-0002-5492-8619; Dina, Christian R/0000-0002-7722-7348; Benjamin, Emelia/0000-0003-4076-2336; Ellinor, Patrick/0000-0002-2067-0533; HAGEGE, Albert/0000-0003-4685-6077; Simonet, Floriane/0000-0002-6366-7211; Lo, Su Hao/0000-0002-2675-9387; solis, jorge/0000-0002-4227-7062; Fernandez Friera, Leticia/0000-0002-4237-2166; Durst, Ronen/0000-0003-3559-1050; Tucker, Nathan/0000-0002-5071-4218; Chen, Ming-Huei/0000-0003-3551-8726	Nantes Hospital (CHU Nantes); US National Institutes of Health (NIH) [K24 HL67434, R01 HL72265, HL109506]; French young investigator fund [ANR-13-ISV1-0006-0]; Hassenfeld Scholar Program; NIH [HL092577, HL104156, K24HL105780, HL065962]; American Heart Association [13EIA14220013, 15GRNT25080052]; Fondation Leducq [14CVD01]; Canadian Institutes of Health Research (CIHR) [MOP-102737, MOP-114997, MOP-126072]; Fonds de recherche Quebec-Sante (FRQS); CIHR [MOP-102481, MOP-137058]; Spanish Society of Cardiology; fund for medical discovery of the Massachusetts General Hospital; European Commission; US National Institutes of Health [C06 RR018823]; Extramural Research Facilities Program of the Heart, Lung, and Blood Institute [R01-HL33756, COBRE 1P30 GM103342, 8P20 GM103444-07, R01-HL127692]; INSERM; French Society of Cardiology; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092577, R01HL128099, U19HL065962, R01HL072265, R01HL109004, T32HL007208, K24HL067434, U01HL065962, K24HL105780, R01HL109506, K23HL116652, R01HL127692, R01HL033756, R01HL104156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342, P20GM103444] Funding Source: NIH RePORTER	Nantes Hospital (CHU Nantes); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French young investigator fund; Hassenfeld Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondation Leducq(Leducq Foundation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche Quebec-Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); Spanish Society of Cardiology; fund for medical discovery of the Massachusetts General Hospital; European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extramural Research Facilities Program of the Heart, Lung, and Blood Institute; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Society of Cardiology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the major contribution of the Leducq Foundation, Paris for supporting a transatlantic consortium investigating the physiopathology of mitral valve disease, for which this genome-wide association study was a major project (coordinators: R.A.L. and A.A.H.). We thank J. Leyton-Mange, X.-X. Nguyen and M. McLellan for help with the zebrafish experiments and P. Mathieu as one of the main investigators of the PROGRAM (Determinants of the Progression and Outcomes of Organic Mitral Regurgitation) study, from which was ascertained the Canadian MVP case control study. C.D., T.L.T. and J.-J.S. acknowledge a translational research grant on genetics of mitral valve funded by the Nantes Hospital (CHU Nantes). R.A.L. acknowledges grant support from the US National Institutes of Health (NIH; grants K24 HL67434, R01 HL72265 and HL109506). N.B.-N. is recipient of a French young investigator fund (ANR-13-ISV1-0006-0). D.J.M. acknowledges the support of the Hassenfeld Scholar Program and a gift from Michael Zak. P.T.E. is supported by grants from the NIH (HL092577, HL104156, K24HL105780, HL065962), an Established Investigator Award from the American Heart Association (13EIA14220013) and support from the Fondation Leducq (14CVD01). P.P. holds the Canada Research Chair in Valvular Heart Diseases and is supported by grants from the Canadian Institutes of Health Research (CIHR; grants MOP-102737, MOP-114997 and MOP-126072). Y.B. is the recipient of a Junior 2 Research Scholar award from the Fonds de recherche Quebec-Sante (FRQS) and is supported by the CIHR (MOP-102481 and MOP-137058). L.F.-F. and J.S. received financial support from the Spanish Society of Cardiology. R.D. was supported by fellowships from the fund for medical discovery of the Massachusetts General Hospital and by a Marie Curie reintegration award from the European Commission R.R.M. and R.A.N. performed their work in a facility constructed with support from the US National Institutes of Health, grant C06 RR018823, from the Extramural Research Facilities Program of the Heart, Lung, and Blood Institute: R01-HL33756 (R.R.M.), COBRE 1P30 GM103342 (R.R.M. and R.A.N.), 8P20 GM103444-07 (R.R.M. and R.A.N.), R01-HL127692 (D.J.M., S.A.S. and R.A.N.) and American Heart Association 15GRNT25080052 (R.A.N.). A.A.H., N.B.-N. and X.J. acknowledge funds from INSERM and the French Society of Cardiology.	Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Chang CY, 2012, ONCOGENE, V31, P2640, DOI 10.1038/onc.2011.440; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Delling FN, 2014, J AM SOC ECHOCARDIOG, V27, P17, DOI 10.1016/j.echo.2013.09.015; DEVEREUX RB, 1982, ANN INTERN MED, V97, P826, DOI 10.7326/0003-4819-97-6-826; Disse S, 1999, AM J HUM GENET, V65, P1242, DOI 10.1086/302624; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Freed LA, 2003, AM J HUM GENET, V72, P1551, DOI 10.1086/375452; Freed LA, 2002, J AM COLL CARDIOL, V40, P1298, DOI 10.1016/S0735-1097(02)02161-7; GLESBY MJ, 1989, JAMA-J AM MED ASSOC, V262, P523, DOI 10.1001/jama.262.4.523; Hagege AA, 2011, J CARDIOVASC TRANSL, V4, P757, DOI 10.1007/s12265-011-9319-6; Hall EH, 2009, J BIOL CHEM, V284, P34713, DOI 10.1074/jbc.M109.059592; Jensen MO, 2013, CIRCULATION, V127, P766, DOI 10.1161/CIRCULATIONAHA.112.000628; Kyndt F, 1998, AM J HUM GENET, V62, P627, DOI 10.1086/301747; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Lee APW, 2013, CIRCULATION, V127, P832, DOI 10.1161/CIRCULATIONAHA.112.118083; LEVINE RA, 1989, CIRCULATION, V80, P589, DOI 10.1161/01.CIR.80.3.589; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lockhart MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057073; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Nesta F, 2005, CIRCULATION, V112, P2022, DOI 10.1161/CIRCULATIONAHA.104.516930; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Norris RA, 2010, DEV DYNAM, V239, P2118, DOI 10.1002/dvdy.22346; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; PYERITZ RE, 1983, AM J MED, V74, P797, DOI 10.1016/0002-9343(83)91070-7; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Sauls K, 2012, CARDIOVASC RES, V96, P109, DOI 10.1093/cvr/cvs238; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Stouffer SA, 1949, AM SOLDIER ADJUSTMEN, V1; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	38	70	70	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1206	+		10.1038/ng.3383	http://dx.doi.org/10.1038/ng.3383			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26301497	Green Accepted, Green Submitted			2022-12-25	WOS:000361969900017
J	Nakashige, TG; Zhang, B; Krebs, C; Nolan, EM				Nakashige, Toshiki G.; Zhang, Bo; Krebs, Carsten; Nolan, Elizabeth M.			Human calprotectin is an iron-sequestering host-defense protein	NATURE CHEMICAL BIOLOGY			English	Article							INNATE IMMUNE-RESPONSE; FERROUS IRON; NUTRITIONAL IMMUNITY; CRYSTAL-STRUCTURES; MANGANESE; ZINC; SEQUESTRATION; PATHOGEN; AFFINITY; INFECTION	Human calprotectin (CP) is a metal-chelating antimicrobial protein of the innate immune response. The current working model states that CP sequesters manganese and zinc from pathogens. We report the discovery that CP chelates iron and deprives bacteria of this essential nutrient. Elemental analysis of CP-treated growth medium establishes that CP reduces the concentrations of manganese, iron and zinc. Microbial growth studies reveal that iron depletion by CP contributes to the growth inhibition of bacterial pathogens. Biochemical investigations demonstrate that CP coordinates Fe(II) at an unusual hexahistidine motif, and the Mossbauer spectrum of Fe-57(II)-bound CP is consistent with coordination of high-spin Fe(II) at this site (delta = 1.20 mm/s, Delta E-Q = 1.78 mm/s). In the presence of Ca(II), CP turns on its iron-sequestering function and exhibits subpicomolar affinity for Fe(II). Our findings expand the biological coordination chemistry of iron and support a previously unappreciated role for CP in mammalian iron homeostasis.	[Nakashige, Toshiki G.; Nolan, Elizabeth M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Zhang, Bo; Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Nakashige, TG (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lnolan@mit.edu	Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	MIT Center for Environmental Health Sciences [NIH P30-ES002109]; Sloan Foundation; Kinship Foundation; NSF Graduate Research Fellowship; NIH NIAID grant [HHSN272200700055C]; Office of the Director of the US National Institutes of Health (NIH) [1DP2OD007045]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007045] Funding Source: NIH RePORTER	MIT Center for Environmental Health Sciences; Sloan Foundation(Alfred P. Sloan Foundation); Kinship Foundation; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH NIAID grant(CGIAR); Office of the Director of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research on Fe(II)-CP in the Nolan Laboratory was supported by the Office of the Director of the US National Institutes of Health (NIH grant 1DP2OD007045, E.M.N.), the MIT Center for Environmental Health Sciences (NIH P30-ES002109, E.M.N.), the Sloan Foundation and the Kinship Foundation (Searle Scholar Award, E.M.N.). T.G.N. is a recipient of the NSF Graduate Research Fellowship. Any opinion, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF. We thank R. Laufhutte for performing the ICP-MS and ICP-OES analyses, A.J. Wommack for synthesizing ZP1 and J. Stubbe and members of her laboratory for guidance on the <SUP>55</SUP>Fe experiments and for providing the facilities to work with radioactivity. We acknowledge the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for providing the S. aureus USA300 JE2 parent strain of the Nebraska Transposon Mutant Library (NTML) that is supported by NIH NIAID grant HHSN272200700055C.	Aguirre JD, 2013, J BIOL CHEM, V288, P8468, DOI 10.1074/jbc.M112.433540; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Asch L, 1970, CHEM PHYS LETT, V5, P105, DOI 10.1016/0009-2614(70)80014-8; Bertini I., 2007, BIOL INORGANIC CHEM; Bossek U, 1997, INORG CHEM, V36, P2834, DOI 10.1021/ic970119h; Brodersen DE, 1999, BIOCHEMISTRY-US, V38, P1695, DOI 10.1021/bi982483d; Brophy MB, 2015, ACS CHEM BIOL, V10, P641, DOI 10.1021/cb500792b; Brophy MB, 2013, J AM CHEM SOC, V135, P17804, DOI 10.1021/ja407147d; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Carver G, 2003, INORG CHEM, V42, P5771, DOI 10.1021/ic034110t; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cotruvo JA, 2012, METALLOMICS, V4, P1020, DOI 10.1039/c2mt20142a; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Diaz-Ochoa VE, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00002; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Frey PA, 2012, ACS CHEM BIOL, V7, P1477, DOI 10.1021/cb300323q; Gagnon DM, 2015, J AM CHEM SOC, V137, P3004, DOI 10.1021/ja512204s; GIBBS CR, 1976, ANAL CHEM, V48, P1197, DOI 10.1021/ac50002a034; Greenwood N. N., 1971, MOSSBAUER SPECTROSCO; Hayden JA, 2013, J AM CHEM SOC, V135, P775, DOI 10.1021/ja3096416; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Konigsberger LC, 2000, J INORG BIOCHEM, V78, P175, DOI 10.1016/S0162-0134(99)00222-6; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Munck E., 2000, PHYS METHODS BIOINOR, P287; Nistor A, 2011, ACTA CRYSTALLOGR E, V67, pM1600, DOI 10.1107/S1600536811043169; Ostendorp T, 2011, BBA-MOL CELL RES, V1813, P1083, DOI 10.1016/j.bbamcr.2010.10.006; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; SOHNLE PG, 1991, J INFECT DIS, V164, P137, DOI 10.1093/infdis/164.1.137; STOJILJKOVIC I, 1993, FEMS MICROBIOL LETT, V108, P111; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Walkup GK, 2000, J AM CHEM SOC, V122, P5644, DOI 10.1021/ja000868p; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Zaharik ML, 2004, FRONT BIOSCI-LANDMRK, V9, P1035, DOI 10.2741/1317	48	168	169	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					765	+		10.1038/NCHEMBIO.1891	http://dx.doi.org/10.1038/NCHEMBIO.1891			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26302479	Green Submitted, Green Accepted			2022-12-25	WOS:000361536500008
J	Prideaux, B; Via, LE; Zimmerman, MD; Eum, S; Sarathy, J; O'Brien, P; Chen, C; Kaya, F; Weiner, DM; Chen, PY; Song, T; Lee, M; Shim, TS; Cho, JS; Kim, W; Cho, SN; Olivier, KN; Barry, CE; Dartois, V				Prideaux, Brendan; Via, Laura E.; Zimmerman, Matthew D.; Eum, Seokyong; Sarathy, Jansy; O'Brien, Paul; Chen, Chao; Kaya, Firat; Weiner, Danielle M.; Chen, Pei-Yu; Song, Taeksun; Lee, Myungsun; Shim, Tae Sun; Cho, Jeong Su; Kim, Wooshik; Cho, Sang Nae; Olivier, Kenneth N.; Barry, Clifton E., III; Dartois, Veronique			The association between sterilizing activity and drug distribution into tuberculosis lesions	NATURE MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; PULMONARY TUBERCULOSIS; MURINE TUBERCULOSIS; COMPUTED-TOMOGRAPHY; MOXIFLOXACIN; CHEMOTHERAPY; GRANULOMAS; RESISTANCE; MODEL	Finding new treatment-shortening antibiotics to improve cure rates and curb the alarming emergence of drug resistance is the major objective of tuberculosis (TB) drug development. Using a matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging suite in a biosafety containment facility, we show that the key sterilizing drugs rifampicin and pyrazinamide efficiently penetrate the sites of TB infection in lung lesions. Rifampicin even accumulates in necrotic caseum, a critical lesion site where persisting tubercle bacilli reside1. In contrast, moxifloxacin, which is active in vitro against a subpopulation of Mycobacterium tuberculosis that persists in specific niches under drug pressure and has achieved treatment shortening in mice2, does not diffuse well in caseum, concordant with its failure to shorten therapy in recent clinical trials. We suggest that such differential spatial distribution and kinetics of accumulation in lesions may create temporal and spatial windows of monotherapy in specific niches, allowing the gradual development of multidrug-resistant TB. We propose an alternative working model to prioritize new antibiotic regimens based on quantitative and spatial distribution of TB drugs in the major lesion types found in human lungs. The finding that lesion penetration may contribute to treatment outcome has wide implications for TB.	[Prideaux, Brendan; Zimmerman, Matthew D.; Sarathy, Jansy; O'Brien, Paul; Chen, Chao; Kaya, Firat; Chen, Pei-Yu; Dartois, Veronique] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Via, Laura E.; Weiner, Danielle M.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Eum, Seokyong; Song, Taeksun; Lee, Myungsun] Int TB Res Ctr, Chang Won, South Korea; [Shim, Tae Sun] Asan Med Ctr, Seoul, South Korea; [Cho, Jeong Su] Pusan Natl Univ Hosp, Pusan, South Korea; [Kim, Wooshik] Natl Med Ctr, Seoul, South Korea; [Cho, Sang Nae] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Cho, Sang Nae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Olivier, Kenneth N.] NHLBI, Pulm Clin Med, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA; [Barry, Clifton E., III] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pusan National University; Pusan National University Hospital; National Medical Center - Korea; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Cape Town	Barry, CE (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@niaid.nih.gov; veronique.dartois@rutgers.edu	Via, Laura/AAD-3917-2021; Barry, Clifton E/ABE-7992-2020; Chen, Chao/J-7879-2015; Barry, III, Clifton/H-3839-2012	Via, Laura/0000-0001-6074-9521; Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X; Sarathy, Jansy/0000-0002-1532-146X	US National Institutes of Health (NIH) [1R01AI106398-01, OPP1066499]; Bill and Melinda Gates Foundation; NIH National Institute of Allergy and Infectious Diseases; National Heart, Lung and Blood Institute; Korean Centers for Disease Control of the Korean Ministry of Health and Welfare; Grand Challenge for Global Health (GCGH 11) consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000734, R01AI106398, ZIAAI001067, R01AI111967] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018072] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Korean Centers for Disease Control of the Korean Ministry of Health and Welfare; Grand Challenge for Global Health (GCGH 11) consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Young and the funders of the Grand Challenge for Global Health (GCGH 11) consortium for their faith and support. We are grateful to the subjects who enrolled in the study; Y. Kim, M.S. Kong, Y. Cai, J. Gonzales and L. Goldfeder; and the clinical teams at the three Korean centers (Asan Medical Centre, Pusan National University Hospital, and the National Medical Center) for their efforts in making the study a success. We thank S. Dorman, D. Alland and H. Boshoff for sharing clinical MIC and in vitro MAC data sets, M. Stoeckli and D. Staab for providing access to the MALDI imaging platform at the Novartis Institutes for Biomedical Research, E. Eugenin, J. Flynn and J. Mattila for sharing images of M. tuberculosis in nonhuman primate lesions, and T. Dick for discussions and advice. This work was carried out with funding from US National Institutes of Health (NIH) grant 1R01AI106398-01 (V.D.), grant OPP1066499 (V.D.) from the Bill and Melinda Gates Foundation, the Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases (C.E.B.) and the National Heart, Lung and Blood Institute (K.N.O.), as well as funding from the Korean Centers for Disease Control of the Korean Ministry of Health and Welfare to the International Tuberculosis Research Center.	Aber V R, 1978, Bull Int Union Tuberc, V53, P276; Baik J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047494; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Canetti G., 1955, TUBERCLE BACILLUS PU; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Dartois V, 2014, NAT REV MICROBIOL, V12, P159, DOI 10.1038/nrmicro3200; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Hoff DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017550; Irwin SM, 2014, ANTIMICROB AGENTS CH, V58, P4026, DOI 10.1128/AAC.02565-14; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Kell DB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00231; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Lakshminarayana SB, 2015, J ANTIMICROB CHEMOTH, V70, P857, DOI 10.1093/jac/dku457; Lee J, 2014, ANTIMICROB AGENTS CH, V58, P11, DOI 10.1128/AAC.01209-13; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Li SY, 2015, ANTIMICROB AGENTS CH, V59, P4026, DOI 10.1128/AAC.00105-15; MacCarrick MJ, 2010, LUNG, V188, P235, DOI 10.1007/s00408-009-9211-1; Merker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082551; Michot JM, 2005, ANTIMICROB AGENTS CH, V49, P2429, DOI 10.1128/AAC.49.6.2429-2437.2005; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Nathan C, 2015, IMMUNOL REV, V264, P308, DOI 10.1111/imr.12275; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; O'Connell ML, 2012, CHEST, V141, P1203, DOI 10.1378/chest.11-0425; Okumura M, 2008, INTERNAL MED, V47, P1465, DOI 10.2169/internalmedicine.47.1114; Pichugin AV, 2009, AM J PATHOL, V174, P2190, DOI 10.2353/ajpath.2009.081075; Prideaux B, 2012, J PROTEOMICS, V75, P4999, DOI 10.1016/j.jprot.2012.07.028; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; RASTOGI N, 1992, EUR J CLIN MICROBIOL, V11, P901, DOI 10.1007/BF01962370; Reyzer ML, 2007, CURR OPIN CHEM BIOL, V11, P29, DOI 10.1016/j.cbpa.2006.11.035; Robichaud G, 2013, J AM SOC MASS SPECTR, V24, P718, DOI 10.1007/s13361-013-0607-z; Subbian S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110016; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Via LE, 2015, ACS INFECT DIS, V1, P203, DOI 10.1021/id500028m; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Wagner C, 2006, PHARMACOLOGY, V78, P1, DOI 10.1159/000094668; Waters NJ, 2008, J PHARM SCI-US, V97, P4586, DOI 10.1002/jps.21317; Yuan MK, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-65; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999	42	285	291	5	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1223	+		10.1038/nm.3937	http://dx.doi.org/10.1038/nm.3937			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26343800	Green Accepted			2022-12-25	WOS:000362355400025
J	Tanaka, S; Takahashi, T; Koide, A; Ishihara, S; Koikeda, S; Koide, S				Tanaka, Shun-ichi; Takahashi, Tetsuya; Koide, Akiko; Ishihara, Satoru; Koikeda, Satoshi; Koide, Shohei			Monobody-mediated alteration of enzyme specificity	NATURE CHEMICAL BIOLOGY			English	Article							CYCLODEXTRIN GLYCOSYLTRANSFERASE; BINDING-PROTEINS; III DOMAIN; GALACTOSIDASE; OLIGOSACCHARIDES; INHIBITORS; EVOLUTION; AFFINITY; SCAFFOLD; MUTANTS	Current methods for engineering enzymes modify enzymes themselves and require a detailed mechanistic understanding or a high-throughput assay. Here, we describe a new approach where catalytic properties are modulated with synthetic binding proteins, termed monobodies, directed to an unmodified enzyme. Using the example of a beta-galactosidase from Bacillus circulans, we efficiently identified monobodies that restricted its substrates for its transgalactosylation reaction and selectively enhanced the production of small oligosaccharide prebiotics.	[Tanaka, Shun-ichi; Koide, Akiko; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Tanaka, Shun-ichi; Takahashi, Tetsuya; Ishihara, Satoru; Koikeda, Satoshi] Amano Enzyme Inc, Gifu R&D Ctr, Frontier Res Dept, Gifu, Japan	University of Chicago	Tanaka, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	skoide@uchicago.edu		Koide, Shohei/0000-0001-5473-4358	US National Institutes of Health grant [P30CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the use of the University of Chicago Genomics Core, which is supported by US National Institutes of Health grant P30CA014599 to the University of Chicago Comprehensive Cancer Center.	Albayrak N, 2002, BIOTECHNOL BIOENG, V77, P8, DOI 10.1002/bit.1195; Barile D, 2013, CURR OPIN BIOTECH, V24, P214, DOI 10.1016/j.copbio.2013.01.008; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bultema JB, 2014, FEBS OPEN BIO, V4, P1015, DOI 10.1016/j.fob.2014.11.002; CHEN KQ, 1991, BIO-TECHNOL, V9, P1073, DOI 10.1038/nbt1191-1073; Chen-Goodspeed M, 2001, BIOCHEMISTRY-US, V40, P1332, DOI 10.1021/bi001549d; Davids T, 2013, CURR OPIN CHEM BIOL, V17, P215, DOI 10.1016/j.cbpa.2013.02.022; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Gilbreth RN, 2011, P NATL ACAD SCI USA, V108, P7751, DOI 10.1073/pnas.1102294108; Goldsmith M, 2012, CURR OPIN STRUC BIOL, V22, P406, DOI 10.1016/j.sbi.2012.03.010; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Ishikawa K, 2015, FEBS J, V282, P2540, DOI 10.1111/febs.13298; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XM, 2012, COMPUT STRUCT BIOTEC, V2, DOI 10.5936/csbj.201209007; Mak WS, 2014, CURR OPIN STRUC BIOL, V27, P87, DOI 10.1016/j.sbi.2014.05.010; Nishikori S, 2012, J MOL BIOL, V424, P391, DOI 10.1016/j.jmb.2012.09.022; Schmitt J, 2002, PROTEIN ENG, V15, P595, DOI 10.1093/protein/15.7.595; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Song JY, 2011, BIOSCI BIOTECH BIOCH, V75, P1194, DOI 10.1271/bbb.110014; Song JY, 2011, BIOSCI BIOTECH BIOCH, V75, P268, DOI 10.1271/bbb.100574; STROKOPYTOV B, 1995, BIOCHEMISTRY-US, V34, P2234, DOI 10.1021/bi00007a018; van der Veen BA, 2000, J MOL BIOL, V296, P1027, DOI 10.1006/jmbi.2000.3528; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793	30	21	21	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					762	+		10.1038/NCHEMBIO.1896	http://dx.doi.org/10.1038/NCHEMBIO.1896			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26322825	Green Accepted			2022-12-25	WOS:000361536500007
J	[Anonymous]				[Anonymous]			BEAM to fight antimicrobial resistance	NATURE BIOTECHNOLOGY			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					889	889						1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VB8EQ	26348940				2022-12-25	WOS:000418257000002
J	Bachman, M; Uribe-Lewis, S; Yang, XP; Burgess, HE; Iurlaro, M; Reik, W; Murrell, A; Balasubramanian, S				Bachman, Martin; Uribe-Lewis, Santiago; Yang, Xiaoping; Burgess, Heather E.; Iurlaro, Mario; Reik, Wolf; Murrell, Adele; Balasubramanian, Shankar			5-Formylcytosine can be a stable DNA modification in mammals	NATURE CHEMICAL BIOLOGY			English	Article							SINGLE-BASE RESOLUTION; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; TET; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; GENOME; METHYLATION; DEAMINATION; PROTEINS	5-Formylcytosine (5fC) is a rare base found in mammalian DNA and thought to be involved in active DNA demethylation. Here, we show that developmental dynamics of 5fC levels in mouse DNA differ from those of 5-hydroxymethylcytosine (5hmC), and using stable isotope labeling in vivo, we show that 5fC can be a stable DNA modification. These results suggest that 5fC has functional roles in DNA that go beyond being a demethylation intermediate.	[Bachman, Martin; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Bachman, Martin; Uribe-Lewis, Santiago; Yang, Xiaoping; Murrell, Adele; Balasubramanian, Shankar] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Burgess, Heather E.; Iurlaro, Mario; Reik, Wolf] Babraham Inst, Babraham, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Hinxton, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute	Bachman, M (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sb10031@cam.ac.uk	Iurlaro, Mario/ABB-4283-2020; Balasubramanian, Shankar/C-1671-2009; Reik, Wolf/I-6794-2012; Bachman, Martin/V-4902-2019	Iurlaro, Mario/0000-0003-3919-9689; Balasubramanian, Shankar/0000-0002-0281-5815; Murrell, adele/0000-0003-2647-3511; Burgess, Heather/0000-0002-9596-2039; Bachman, Martin/0000-0003-3903-6492	Cancer Research UK [C14303/A17197]; Wellcome Trust [WT099232, WT095645/Z/11/Z]; Biotechnology and Biological Sciences Research Council UK [BB/K010867/1]; BBSRC [BBS/E/B/0000H112, BBS/E/B/000C0402] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0402, BBS/E/B/0000H112] Funding Source: researchfish; Cancer Research UK [12488, 6934] Funding Source: researchfish; Wellcome Trust [099232/Z/12/Z] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C. d'Santos and D. Oxley for their support with mass spectrometry and G. Xu for kindly providing TET-TKO mES cells. This work was supported by Cancer Research UK (C14303/A17197, S.B.), The Wellcome Trust (WT099232, S.B.; WT095645/Z/11/Z, W.R.) and the Biotechnology and Biological Sciences Research Council UK (BB/K010867/1, W.R.).	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Booth MJ, 2014, NAT CHEM, V6, P435, DOI [10.1038/NCHEM.1893, 10.1038/nchem.1893]; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Kraus TFJ, 2015, J NEURAL TRANSM, V122, P1035, DOI 10.1007/s00702-014-1346-4; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lu XY, 2015, CELL RES, V25, P386, DOI 10.1038/cr.2015.5; Neri F, 2015, CELL REP, V10, P674, DOI 10.1016/j.celrep.2015.01.008; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Raiber EA, 2015, NAT STRUCT MOL BIOL, V22, P44, DOI 10.1038/nsmb.2936; Schiesser S, 2013, J AM CHEM SOC, V135, P14593, DOI 10.1021/ja403229y; Song CX, 2013, TRENDS BIOCHEM SCI, V38, P480, DOI 10.1016/j.tibs.2013.07.003; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	24	169	174	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					555	U40		10.1038/nchembio.1848	http://dx.doi.org/10.1038/nchembio.1848			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26098680	Green Accepted			2022-12-25	WOS:000358255300008
J	Nassar, D; Latil, M; Boeckx, B; Lambrechts, D; Blanpain, C				Nassar, Dany; Latil, Mathilde; Boeckx, Bram; Lambrechts, Diether; Blanpain, Cedric			Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma	NATURE MEDICINE			English	Article							TUMOR-SUPPRESSOR; MUTATIONAL LANDSCAPE; POINT MUTATIONS; HA-RAS; GENE; PROGRESSION; CANCER; ACTIVATION; INITIATION; REVEALS	Mouse models of cancers are routinely used to study cancer biology. However, it remains unclear whether carcinogenesis in mice is driven by the same spectrum of genomic alterations found in humans. Here we conducted a comprehensive genomic analysis of 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced skin cancer, the most commonly used skin cancer model, which appears as benign papillomas that progress into squamous cell carcinomas (SCCs). We also studied genetically induced SCCs that expressed G12D mutant Kras (Kras G12D) but were deficient for p53. Using whole-exome sequencing, we uncovered a characteristic mutational signature of DMBA-induced SCCs. We found that the vast majority of DMBA-induced SCCs presented recurrent mutations in Hras, Kras or Rras2 and mutations in several additional putative oncogenes and tumor-suppressor genes. Similar genes were recurrently mutated in mouse and human SCCs that were from different organs or had been exposed to different carcinogens. Invasive SCCs, but not papillomas, presented substantial chromosomal aberrations, especially in DMBA-induced and genetically induced Trp53-mutated SCCs. Metastasis occurred through sequential spreading, with relatively few additional genetic events. This study provides a framework for future functional cancer genomic studies in mice.	[Nassar, Dany; Latil, Mathilde; Blanpain, Cedric] ULB, IRIBHM, Brussels, Belgium; [Boeckx, Bram; Lambrechts, Diether] Vlaams Inst Biotechnol VIB, Vesalius Res Ctr, Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Blanpain, Cedric] WELBIO, Brussels, Belgium	Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); KU Leuven; WELBIO	Blanpain, C (corresponding author), ULB, IRIBHM, Brussels, Belgium.	Diether.Lambrechts@vib-kuleuven.be; Cedric.Blanpain@ulb.ac.be	Latil, Mathilde/E-2011-2017; Lambrechts, Diether/AAJ-3167-2020; Blanpain, Cedric/ABD-8392-2021	Lambrechts, Diether/0000-0002-3429-302X; Nassar, Dany/0000-0001-6780-0721	Televie; EMBO long-term fellowship; Hercules Foundation; Flemish Government, Department of Economy, Science and Innovation (EWI); Fonds de la Recherche Scientifique (FNRS); Interuniversity Attraction Program (PAT); Fondation Contre le Cancer/Stichting tegen Kanker; Fondation ULB; Fond Yvonne Boel; Fond Gaston Ithier; Baillet Latour Foundation; European Research Council (ERC)	Televie; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Hercules Foundation; Flemish Government, Department of Economy, Science and Innovation (EWI); Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Program (PAT); Fondation Contre le Cancer/Stichting tegen Kanker; Fondation ULB; Fond Yvonne Boel; Fond Gaston Ithier; Baillet Latour Foundation; European Research Council (ERC)(European Research Council (ERC))	C.B. is an investigator at Walloon Excellence in Life Sciences and Biotechnology (WELBIO). D.N. and M.L. are supported by Televie and an EMBO long-term fellowship, respectively. The computational resources and services used in this work were provided by the Flemish Supercomputer Center (VSC), funded by the Hercules Foundation and the Flemish Government, Department of Economy, Science and Innovation (EWI). This work was supported by Fonds de la Recherche Scientifique (FNRS), Televie, the Interuniversity Attraction Program (PAT), a research grant and an infrastructure grant from Fondation Contre le Cancer/Stichting tegen Kanker, Fondation ULB, Fond Yvonne Boel, Fond Gaston Ithier, the the Baillet Latour Foundation and the European Research Council (ERC).	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Al Bashir S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-21; ALDAZ CM, 1989, MOL CARCINOGEN, V2, P22, DOI 10.1002/mc.2940020104; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; BOS JL, 1989, CANCER RES, V49, P4682; Cai YQ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/174252; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cohen-Dvashi H, 2015, EMBO MOL MED, V7, P299, DOI 10.15252/emmm.201404134; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; DIPPLE A, 1983, CANCER RES, V43, P4132; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hase K, 2013, GASTROENTEROLOGY, V145, P625, DOI 10.1053/j.gastro.2013.05.013; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Laczmanska I, 2014, PATHOL RES PRACT, V210, P893, DOI 10.1016/j.prp.2014.07.010; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee CS, 2014, NAT GENET, V46, P1060, DOI 10.1038/ng.3091; Li YY, 2015, CLIN CANCER RES, V21, P1447, DOI 10.1158/1078-0432.CCR-14-1773; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Poirier MC, 2004, NAT REV CANCER, V4, P630, DOI 10.1038/nrc1410; Provost E, 2014, ZEBRAFISH, V11, P551, DOI 10.1089/zeb.2014.1024; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; Quintana RM, 2013, J INVEST DERMATOL, V133, P239, DOI 10.1038/jid.2012.245; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; RUGGERI B, 1991, CANCER RES, V51, P6615; SAEZ R, 1994, ONCOGENE, V9, P2977; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Toll A, 2009, BRIT J DERMATOL, V161, P1112, DOI 10.1111/j.1365-2133.2009.09351.x; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Yu J., DEV CELL, V18, P288	49	125	127	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					946	954		10.1038/nm.3878	http://dx.doi.org/10.1038/nm.3878			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26168291				2022-12-25	WOS:000359181000023
J	Betsholtz, C				Betsholtz, Christer			Lipid transport and human brain development	NATURE GENETICS			English	Editorial Material							DOCOSAHEXAENOIC ACID; LYSOPHOSPHATIDYLCHOLINE; BARRIER; MFSD2A	How the human brain rapidly builds up its lipid content during brain growth and maintains its lipids in adulthood has remained elusive. Two new studies show that inactivating mutations in MFSD2A, known to be expressed specifically at the blood-brain barrier, lead to microcephaly, thereby offering a simple and surprising solution to an old enigma.	[Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Vasc Biol Program, Uppsala, Sweden; [Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Betsholtz, C (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Vasc Biol Program, Uppsala, Sweden.	christer.betsholtz@igp.uu.se						Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Edmond J, 2001, J MOL NEUROSCI, V16, P181, DOI 10.1385/JMN:16:2-3:181; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; ILLINGWORTH DR, 1972, BIOCHEM J, V130, P557, DOI 10.1042/bj1300557; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Mitchell RW, 2011, PROSTAG LEUKOTR ESS, V85, P293, DOI 10.1016/j.plefa.2011.04.007; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	9	24	24	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					699	701		10.1038/ng.3348	http://dx.doi.org/10.1038/ng.3348			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26111510				2022-12-25	WOS:000357090300005
J	Taylor, JC; Martin, HC; Lise, S; Broxholme, J; Cazier, JB; Rimmer, A; Kanapin, A; Lunter, G; Fiddy, S; Allan, C; Aricescu, AR; Attar, M; Babbs, C; Becq, J; Beeson, D; Bento, C; Bignell, P; Blair, E; Buckle, VJ; Bull, K; Cais, O; Cario, H; Chapel, H; Copley, RR; Cornall, R; Dahan, JCK; Dahan, K; Davenport, EE; Dendrou, C; Devuyst, O; Fenwick, AL; Flint, J; Fugger, L; Gilbert, RD; Goriely, A; Green, A; Greger, IH; Grocock, R; Gruszczyk, AV; Hastings, R; Hatton, E; Higgs, D; Hill, A; Holmes, C; Howard, M; Hughes, L; Humburg, P; Johnson, D; Karpe, F; Kingsbury, Z; Kini, U; Knight, JC; Krohn, J; Lamble, S; Langman, C; Lonie, L; Luck, J; McCarthy, D; McGowan, SJ; McMullin, MF; Miller, KA; Murray, L; Nemeth, AH; Nesbit, MA; Nutt, D; Ormondroyd, E; Oturai, AB; Pagnamenta, A; Patel, SY; Percy, M; Petousi, N; Piazza, P; Piret, SE; Polanco-Echeverry, G; Popitsch, N; Powrie, F; Pugh, C; Quek, L; Robbins, PA; Robson, K; Russo, A; Sahgal, N; van Schouwenburg, PA; Schuh, A; Silverman, E; Simmons, A; Sorensen, PS; Sweeney, E; Taylor, J; Thakker, RV; Tomlinson, I; Trebes, A; Twigg, SRF; Uhlig, HH; Vyas, P; Vyse, T; Wall, SA; Watkins, H; Whyte, MP; Witty, L; Wright, B; Yau, C; Buck, D; Humphray, S; Ratcliffe, PJ; Bell, JI; Wilkie, AOM; Bentley, D; Donnelly, P; McVean, G				Taylor, Jenny C.; Martin, Hilary C.; Lise, Stefano; Broxholme, John; Cazier, Jean-Baptiste; Rimmer, Andy; Kanapin, Alexander; Lunter, Gerton; Fiddy, Simon; Allan, Chris; Aricescu, A. Radu; Attar, Moustafa; Babbs, Christian; Becq, Jennifer; Beeson, David; Bento, Celeste; Bignell, Patricia; Blair, Edward; Buckle, Veronica J.; Bull, Katherine; Cais, Ondrej; Cario, Holger; Chapel, Helen; Copley, Richard R.; Cornall, Richard; Craft, Jude; Dahan, Karin; Davenport, Emma E.; Dendrou, Calliope; Devuyst, Olivier; Fenwick, Aimee L.; Flint, Jonathan; Fugger, Lars; Gilbert, Rodney D.; Goriely, Anne; Green, Angie; Greger, Ingo H.; Grocock, Russell; Gruszczyk, Anja V.; Hastings, Robert; Hatton, Edouard; Higgs, Doug; Hill, Adrian; Holmes, Chris; Howard, Malcolm; Hughes, Linda; Humburg, Peter; Johnson, David; Karpe, Fredrik; Kingsbury, Zoya; Kini, Usha; Knight, Julian C.; Krohn, Jonathan; Lamble, Sarah; Langman, Craig; Lonie, Lorne; Luck, Joshua; McCarthy, Davis; McGowan, Simon J.; McMullin, Mary Frances; Miller, Kerry A.; Murray, Lisa; Nemeth, Andrea H.; Nesbit, M. Andrew; Nutt, David; Ormondroyd, Elizabeth; Oturai, Annette Bang; Pagnamenta, Alistair; Patel, Smita Y.; Percy, Melanie; Petousi, Nayia; Piazza, Paolo; Piret, Sian E.; Polanco-Echeverry, Guadalupe; Popitsch, Niko; Powrie, Fiona; Pugh, Chris; Quek, Lynn; Robbins, Peter A.; Robson, Kathryn; Russo, Alexandra; Sahgal, Natasha; van Schouwenburg, Pauline A.; Schuh, Anna; Silverman, Earl; Simmons, Alison; Sorensen, Per Soelberg; Sweeney, Elizabeth; Taylor, John; Thakker, Rajesh V.; Tomlinson, Ian; Trebes, Amy; Twigg, Stephen R. F.; Uhlig, Holm H.; Vyas, Paresh; Vyse, Tim; Wall, Steven A.; Watkins, Hugh; Whyte, Michael P.; Witty, Lorna; Wright, Ben; Yau, Chris; Buck, David; Humphray, Sean; Ratcliffe, Peter J.; Bell, John I.; Wilkie, Andrew O. M.; Bentley, David; Donnelly, Peter; McVean, Gilean			Factors influencing success of clinical genome sequencing across a broad spectrum of disorders	NATURE GENETICS			English	Article							LONG-QT SYNDROME; JUVENILE MYELOMONOCYTIC LEUKEMIA; SEVERE INTELLECTUAL DISABILITY; DISEASE GENE-DISCOVERY; OVARIAN-CANCER; GERMLINE MUTATIONS; BREAST-CANCER; HEREDITARY BREAST; CANDIDATE GENES; EXOME	To assess factors influencing the success of whole-genome sequencing for mainstream clinical diagnosis, we sequenced 217 individuals from 156 independent cases or families across a broad spectrum of disorders in whom previous screening had identified no pathogenic variants. We quantified the number of candidate variants identified using different strategies for variant calling, filtering, annotation and prioritization. We found that jointly calling variants across samples, filtering against both local and external databases, deploying multiple annotation tools and using familial transmission above biological plausibility contributed to accuracy. Overall, we identified disease-causing variants in 21% of cases, with the proportion increasing to 34% (23/68) for mendelian disorders and 57% (8/14) in family trios. We also discovered 32 potentially clinically actionable variants in 18 genes unrelated to the referral disorder, although only 4 were ultimately considered reportable. Our results demonstrate the value of genome sequencing for routine clinical diagnosis but also highlight many outstanding challenges.	[Taylor, Jenny C.; Copley, Richard R.; Craft, Jude; Howard, Malcolm; Pagnamenta, Alistair; Popitsch, Niko; Schuh, Anna; Taylor, John; Tomlinson, Ian] Comprehens Biomed Res Ctr, NIHR, Oxford, England; [Taylor, Jenny C.; Martin, Hilary C.; Lise, Stefano; Broxholme, John; Rimmer, Andy; Kanapin, Alexander; Lunter, Gerton; Fiddy, Simon; Allan, Chris; Aricescu, A. Radu; Attar, Moustafa; Bull, Katherine; Copley, Richard R.; Craft, Jude; Davenport, Emma E.; Flint, Jonathan; Green, Angie; Hatton, Edouard; Hill, Adrian; Holmes, Chris; Howard, Malcolm; Hughes, Linda; Humburg, Peter; Knight, Julian C.; Krohn, Jonathan; Lamble, Sarah; Lonie, Lorne; McCarthy, Davis; Pagnamenta, Alistair; Piazza, Paolo; Polanco-Echeverry, Guadalupe; Popitsch, Niko; Sahgal, Natasha; Tomlinson, Ian; Trebes, Amy; Witty, Lorna; Wright, Ben; Yau, Chris; Buck, David; Donnelly, Peter; McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Cazier, Jean-Baptiste] Univ Birmingham, Ctr Computat Biol, Edgbaston, England; [Babbs, Christian; Buckle, Veronica J.; Higgs, Doug; Quek, Lynn; Robson, Kathryn; Vyas, Paresh] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, MRC, Oxford, England; [Becq, Jennifer; Grocock, Russell; Kingsbury, Zoya; Murray, Lisa; Humphray, Sean; Bentley, David] Illumina Cambridge Ltd, Saffron Walden, Essex, England; [Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Neurosci Grp, Oxford, England; [Bento, Celeste] Ctr Hosp, Dept Hematol, Coimbra, Portugal; [Bento, Celeste] Univ Coimbra, Coimbra, Portugal; [Bignell, Patricia] Oxford Univ Hosp, Natl Hlth Serv, Mol Haematol Dept, Oxford, England; [Blair, Edward; Kini, Usha] Univ Oxford, Hosp NHS Trust, Dept Clin Genet, Oxford, England; [Bull, Katherine; Cornall, Richard] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford, England; [Cais, Ondrej; Greger, Ingo H.] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England; [Cario, Holger] Univ Med Ctr, Dept Pediat & Adolescent Med, Ulm, Germany; [Chapel, Helen; Patel, Smita Y.; van Schouwenburg, Pauline A.] Univ Oxford, Nuffield Dept Med, Primary Immunodeficiency Unit, Oxford, England; [Dahan, Karin] Ctr Genet Humaine, Inst Genet & Pathol, Gosselies, Belgium; [Dahan, Karin] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium; [Dendrou, Calliope; Devuyst, Olivier; Fugger, Lars; Simmons, Alison] Univ Oxford, MRC, Weatherall Inst Mol Med, Human Immunol Unit, Oxford, England; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Fenwick, Aimee L.; Goriely, Anne; Gruszczyk, Anja V.; Luck, Joshua; McGowan, Simon J.; Miller, Kerry A.; Twigg, Stephen R. F.; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford, England; [Gilbert, Rodney D.] Univ Southampton, Southampton Univ Hosp, NHS Fdn Trust, Southampton, Hants, England; [Hastings, Robert; Ormondroyd, Elizabeth; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Hill, Adrian] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England; [Holmes, Chris; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Johnson, David; Wall, Steven A.] Univ Oxford, Hosp NHS Trust, Dept Plast & Reconstruct Surg, Craniofacial Unit, Oxford OX1 3TG, England; [Karpe, Fredrik] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford Lab Integrat Physiol, Oxford OX1 3TG, England; [Langman, Craig] Northwestern Univ, Feinberg Sch Med, Kidney Dis, Chicago, IL 60611 USA; [Langman, Craig] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [McMullin, Mary Frances] Queens Univ, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Nemeth, Andrea H.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Nesbit, M. Andrew; Piret, Sian E.; Thakker, Rajesh V.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Acad Endocrine Unit, Oxford, England; [Nutt, David] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Ctr Neuropsychopharmacol, London, England; [Oturai, Annette Bang; Sorensen, Per Soelberg] Copenhagen Univ Hosp, Dept Neurol, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Percy, Melanie] Belfast City Hosp, Dept Haematol, Belfast BT9 7AD, Antrim, North Ireland; [Petousi, Nayia; Pugh, Chris; Uhlig, Holm H.; Ratcliffe, Peter J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Powrie, Fiona; Simmons, Alison] Univ Oxford, Translat Gastroenterol Unit, Oxford, England; [Robbins, Peter A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Russo, Alexandra] Univ Hosp, Dept Pediat, Mainz, Germany; [Schuh, Anna] Univ Oxford, Dept Oncol, Oxford, England; [Silverman, Earl] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada; [Sweeney, Elizabeth] Liverpool Womens NHS Fdn Trust, Dept Clin Genet, Liverpool, Merseyside, England; [Taylor, John] Univ Oxford, Hosp NHS Trust, Oxford NHS Reg Mol Genet Lab, Oxford, England; [Vyse, Tim] Kings Coll London, Guys Hosp, Div Genet, London, England; [Whyte, Michael P.] Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO USA; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Birmingham; University of Oxford; Illumina; University of Oxford; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; NHS Blood & Transplant (NHSBT); Oxford University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; MRC Laboratory Molecular Biology; Ulm University; University of Oxford; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Oxford; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Oxford; University of Southampton; University of Oxford; University of Oxford; Jenner Institute; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Queens University Belfast; University of Oxford; University of Oxford; Imperial College London; University of Copenhagen; Belfast City Hospital; University of Oxford; University of Oxford; University of Oxford; University Hospital Mainz; University of Oxford; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Oxford University Hospitals NHS Foundation Trust; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford	McVean, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mcvean@well.ox.ac.uk	Vyas, Paresh/B-5708-2009; Cazier, Jean-Baptiste/GLR-2949-2022; Cazier, Jean-Baptiste/F-2369-2010; Kanapin, Alexander A/Q-7590-2016; Yau, Christopher/G-2896-2012; Twigg, Stephen/AAU-1135-2021; Babbs, Christian/AAA-5917-2022; Cario, Holger/AAH-6713-2019; Goriely, Anne/AAR-1133-2020; Wilkie, Andrew/AAC-3820-2020; Knight, Julian Charles/W-2399-2019; McCarthy, Davis James/B-5332-2018; McMullin, Mary Frances/AAG-6078-2021; wei, wei/HHR-8613-2022; Humburg, Peter/A-4191-2009; Lunter, Gerton/H-4939-2016; McMullin, Mary F/AAF-6472-2020; Bull, Katherine/AAC-2411-2019; Robbins, Peter/C-7846-2016	Vyas, Paresh/0000-0003-3931-0914; Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Kanapin, Alexander A/0000-0001-9802-5297; Yau, Christopher/0000-0001-7615-8523; Twigg, Stephen/0000-0001-5024-049X; Babbs, Christian/0000-0002-1898-5878; Wilkie, Andrew/0000-0002-2972-5481; Knight, Julian Charles/0000-0002-0377-5536; McCarthy, Davis James/0000-0002-2218-6833; McMullin, Mary Frances/0000-0002-0773-0204; Humburg, Peter/0000-0002-3331-6496; Bull, Katherine/0000-0003-0656-0917; van Schouwenburg, Pauline/0000-0003-2779-1415; Lise, Stefano/0000-0003-4472-6893; Devuyst, Olivier/0000-0003-3744-4767; Cario, Holger/0000-0002-6923-488X; Ratcliffe, Peter/0000-0002-2853-806X; McGowan, Simon/0000-0001-9720-1914; Davenport, Emma Elisabeth/0000-0002-8768-346X; Bento, Celeste/0000-0003-1080-411X; Watkins, Hugh/0000-0002-5287-9016; Aricescu, Alexandru ARadu/0000-0003-3783-1388; Simmons, Alison/0000-0003-3454-0710; Gilbert, Rodney/0000-0001-7426-0188; Ormondroyd, Elizabeth/0000-0002-9116-4064; Jones, Aimee/0000-0003-0279-1814; Goriely, Anne/0000-0001-9229-7216; Pugh, Chris/0000-0002-5170-1662; Higgs, Douglas/0000-0003-3579-8705; Lunter, Gerton/0000-0002-3798-2058; Nemeth, Andrea/0000-0002-2941-7657; Taylor, Jenny/0000-0003-3602-5704; Anna, schuh/0000-0002-3938-8490; Flint, Jonathan/0000-0002-9427-4429; Piret, Sian/0000-0002-3586-7654; Robbins, Peter/0000-0002-4975-0609; Uhlig, Holm/0000-0002-6111-7355; Piazza, Paolo/0000-0002-3736-1841; Karpe, Fredrik/0000-0002-2751-1770; Dendrou, Calliope/0000-0003-1179-4021; Patel, Smita/0000-0002-6207-2208; Petousi, Nayia/0000-0002-5524-020X	Wellcome Trust [090532/Z/09/Z, 093329, 091182, 102731, 100308]; Medical Research Council [G0900747 91070]; NIHR Biomedical Research Centre Oxford; UK Department of Health's NIHR Biomedical Research Centres funding scheme; Illumina; Biotechnology and Biological Science Research Council (BBSRC) [BB/I02593X/1]; Newlife Foundation for Disabled Children [10-11/04]; AtaxiaUK; Haemochromatosis Society; European Research Council [281824, 305608]; Jeffrey Modell Foundation NYC; Baxter Healthcare; Action de Recherche Concertee [ARC10/15-029]; Fonds de la Recherche Scientifique (FNRS); Fonds de la Recherche Scientifique Medicale (FRSM); Inter-University Attraction Pole (IUAP; Belgium federal government); Swiss National Centre of Competence in Research Kidney Control of Homeostasis Program; Gebert Ruf Stiftung [GRS-038/12]; Swiss National Science Foundation [310030-146490]; Shriners Hospitals for Children [15958]; UK Medical Research Council [G9825289, G1000467, L009609, G1000801, MC_UC_12010/3]; Academy of Medical Sciences (AMS) [AMS-SGCL11-Petousi] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/I02593X/1] Funding Source: researchfish; British Heart Foundation [RG/12/16/29939] Funding Source: researchfish; Cancer Research UK [16459] Funding Source: researchfish; Medical Research Council [MC_UU_12009/11, MC_UU_12010/6, MC_U137961145, G1000801j, MC_UU_12010/7, G1000801b, MR/L009609/1, MC_UU_12009/1, MR/M006824/1, G1000467, MC_UU_12010/3, MC_UP_1502/3, G1000801, G9825289, G1000801c, MC_U105174197, G0900747, MR/L001411/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026, NF-SI-0508-10235, NF-SI-0514-10091, CL-2013-13-003] Funding Source: researchfish; Wellcome Trust [102731/Z/13/Z] Funding Source: researchfish; Action Medical Research [2063] Funding Source: researchfish; BBSRC [BB/I02593X/1] Funding Source: UKRI; MRC [MC_UU_12009/11, G0900747, MC_U137961145, MC_UU_12009/1, MC_UP_1502/3, MR/L009609/1, MR/M006824/1, MC_UU_12010/7, G1000801, MC_U105174197, MC_UU_12010/3, G1000467, MR/L001411/1, G9825289] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre Oxford(National Institute for Health Research (NIHR)); UK Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Illumina; Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newlife Foundation for Disabled Children; AtaxiaUK; Haemochromatosis Society; European Research Council(European Research Council (ERC)European Commission); Jeffrey Modell Foundation NYC; Baxter Healthcare; Action de Recherche Concertee; Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Inter-University Attraction Pole (IUAP; Belgium federal government); Swiss National Centre of Competence in Research Kidney Control of Homeostasis Program; Gebert Ruf Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Shriners Hospitals for Children; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Core Award (090532/Z/09/Z) and a Medical Research Council Hub grant (G0900747 91070) to P.D., the NIHR Biomedical Research Centre Oxford, the UK Department of Health's NIHR Biomedical Research Centres funding scheme and Illumina. Additional support is acknowledged from the Biotechnology and Biological Science Research Council (BBSRC) (BB/I02593X/1) to G.L. and G.M.; Wellcome Trust grants 093329, 091182 and 102731 to A.O.M.W. and 100308 to L.F.; the Newlife Foundation for Disabled Children (10-11/04) to A.O.M.W.; AtaxiaUK to A.H.N.; the Haemochromatosis Society to K.R.; European Research Council (FP7/2007-2013) grant agreements 281824 to J.C.K. and 305608 to O.D.; the Jeffrey Modell Foundation NYC and Baxter Healthcare to S.Y.P. and H. Chapel; Action de Recherche Concertee (ARC10/15-029, Communaute Francaise de Belgique) to O.D.; Fonds de la Recherche Scientifique (FNRS), Fonds de la Recherche Scientifique Medicale (FRSM) and Inter-University Attraction Pole (IUAP; Belgium federal government) to O.D.; the Swiss National Centre of Competence in Research Kidney Control of Homeostasis Program to O.D.; the Gebert Ruf Stiftung (project GRS-038/12) to O.D.; Swiss National Science Foundation grant 310030-146490 to O.D.; the Shriners Hospitals for Children (grant 15958) to M.P.W.; and UK Medical Research Council grants G9825289 and G1000467 to R.V.T., L009609 to A.R.A., G1000801 to D.H. and MC_UC_12010/3 to L.F. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Babbs C, 2013, HAEMATOLOGICA, V98, P1383, DOI 10.3324/haematol.2013.089490; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Borg A, 2010, HUM MUTAT, V31, pE1200, DOI 10.1002/humu.21202; Bowl MR, 2005, J CLIN INVEST, V115, P2822, DOI 10.1172/JCI24156; Brohet RM, 2014, J MED GENET, V51, P98, DOI 10.1136/jmedgenet-2013-101974; Caputo S, 2012, NUCLEIC ACIDS RES, V40, pD992, DOI 10.1093/nar/gkr1160; Castera L, 2014, EUR J HUM GENET, V22, P1305, DOI 10.1038/ejhg.2014.16; Cazier JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4756; Choi G, 2004, CIRCULATION, V110, P2119, DOI 10.1161/01.CIR.0000144471.98080.CA; Chong HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097408; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cossins J, 2013, BRAIN, V136, P944, DOI 10.1093/brain/awt010; Crotti L, 2013, JAMA-J AM MED ASSOC, V309, P1473, DOI 10.1001/jama.2013.3219; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Denayer E, 2007, EUR J PEDIATR, V166, P1091, DOI 10.1007/s00431-007-0535-7; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hakansson S, 1997, AM J HUM GENET, V60, P1068; Isrie M, 2013, EUR J MED GENET, V56, P379, DOI 10.1016/j.ejmg.2013.05.005; Jacob HJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006468; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kapplinger JD, 2011, J AM COLL CARDIOL, V57, P2317, DOI 10.1016/j.jacc.2010.12.036; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Lamble S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2013, P NATL ACAD SCI USA, V110, P18922, DOI 10.1073/pnas.1315649110; Lise S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003074; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Martinelli S, 2010, AM J HUM GENET, V87, P250, DOI 10.1016/j.ajhg.2010.06.015; McCarthy DJ, 2014, GENOME MED, V6, DOI 10.1186/gm543; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McMullin MF, 2008, INT J LAB HEMATOL, V30, P447, DOI 10.1111/j.1751-553X.2008.01102.x; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Metcalfe K, 2010, JNCI-J NATL CANCER I, V102, P1874, DOI 10.1093/jnci/djq443; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Moutsianas L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005165; Nava C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.102; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pagnamenta AT, 2012, J HUM GENET, V57, P70, DOI 10.1038/jhg.2011.128; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Perez B, 2010, J MED GENET, V47, P686, DOI 10.1136/jmg.2010.076836; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Sharma VP, 2013, NAT GENET, V45, P304, DOI 10.1038/ng.2531; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vukcevic M, 2010, ANESTH ANALG, V111, P185, DOI 10.1213/ANE.0b013e3181cbd815; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yau C, 2013, BIOINFORMATICS, V29, P2482, DOI 10.1093/bioinformatics/btt416; Zajac JD, 2008, CURR OPIN NEPHROL HY, V17, P353, DOI 10.1097/MNH.0b013e328304651c; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	72	227	231	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					717	+		10.1038/ng.3304	http://dx.doi.org/10.1038/ng.3304			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	25985138	Green Submitted, Green Accepted			2022-12-25	WOS:000357090300008
J	Yates, LR; Gerstung, M; Knappskog, S; Desmedt, C; Gundem, G; Van Loo, P; Aas, T; Alexandrov, LB; Larsimont, D; Davies, H; Li, YL; Ju, YS; Ramakrishna, M; Haugland, HK; Lilleng, PK; Nik-Zainal, S; McLaren, S; Butler, A; Martin, S; Glodzik, D; Menzies, A; Raine, K; Hinton, J; Jones, D; Mudie, LJ; Jiang, B; Vincent, D; Greene-Colozzi, A; Adnet, PY; Fatima, A; Maetens, M; Ignatiadis, M; Stratton, MR; Sotiriou, C; Richardson, AL; Lonning, PE; Wedge, DC; Campbell, PJ				Yates, Lucy R.; Gerstung, Moritz; Knappskog, Stian; Desmedt, Christine; Gundem, Gunes; Van Loo, Peter; Aas, Turid; Alexandrov, Ludmil B.; Larsimont, Denis; Davies, Helen; Li, Yilong; Ju, Young Seok; Ramakrishna, Manasa; Haugland, Hans Kristian; Lilleng, Peer Kaare; Nik-Zainal, Serena; McLaren, Stuart; Butler, Adam; Martin, Sancha; Glodzik, Dominic; Menzies, Andrew; Raine, Keiran; Hinton, Jonathan; Jones, David; Mudie, Laura J.; Jiang, Bing; Vincent, Delphine; Greene-Colozzi, April; Adnet, Pierre-Yves; Fatima, Aquila; Maetens, Marion; Ignatiadis, Michail; Stratton, Michael R.; Sotiriou, Christos; Richardson, Andrea L.; Lonning, Per Eystein; Wedge, David C.; Campbell, Peter J.			Subclonal diversification of primary breast cancer revealed by multiregion sequencing	NATURE MEDICINE			English	Article							INTRATUMOR HETEROGENEITY; MUTATIONAL PROCESSES; DRIVER MUTATIONS; TUMOR EVOLUTION; CHEMOTHERAPY; METASTASIS; LANDSCAPE; DIVERSITY; PATTERNS; HISTORY	The sequencing of cancer genomes may enable tailoring of therapeutics to the underlying biological abnormalities driving a particular patient's tumor. However, sequencing-based strategies rely heavily on representative sampling of tumors. To understand the subclonal structure of primary breast cancer, we applied whole-genome and targeted sequencing to multiple samples from each of 50 patients' tumors (303 samples in total). The extent of subclonal diversification varied among cases and followed spatial patterns. No strict temporal order was evident, with point mutations and rearrangements affecting the most common breast cancer genes, including PIK3CA, TP53, PTEN, BRCA2 and MYC, occurring early in some tumors and late in others. In 13 out of 50 cancers, potentially targetable mutations were subclonal. Landmarks of disease progression, such as resistance to chemotherapy and the acquisition of invasive or metastatic potential, arose within detectable subclones of antecedent lesions. These findings highlight the importance of including analyses of subclonal structure and tumor evolution in clinical trials of primary breast cancer.	[Gerstung, Moritz; Gundem, Gunes; Van Loo, Peter; Alexandrov, Ludmil B.; Davies, Helen; Li, Yilong; Ju, Young Seok; Ramakrishna, Manasa; Nik-Zainal, Serena; McLaren, Stuart; Butler, Adam; Martin, Sancha; Glodzik, Dominic; Menzies, Andrew; Raine, Keiran; Hinton, Jonathan; Jones, David; Mudie, Laura J.; Stratton, Michael R.; Wedge, David C.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Yates, Lucy R.] Univ Cambridge, Dept Oncol, Cambridge, England; [Knappskog, Stian; Lonning, Per Eystein] Univ Bergen, Sect Oncol, Dept Clin Sci, Bergen, Norway; [Knappskog, Stian; Lonning, Per Eystein] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Desmedt, Christine; Larsimont, Denis; Vincent, Delphine; Adnet, Pierre-Yves; Maetens, Marion; Ignatiadis, Michail; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium; [Van Loo, Peter] Univ Leuven, Dept Human Genet, Leuven, Belgium; [Aas, Turid] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Haugland, Hans Kristian; Lilleng, Peer Kaare] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Lilleng, Peer Kaare] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Jiang, Bing; Greene-Colozzi, April; Fatima, Aquila; Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Richardson, Andrea L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; University of Cambridge; University of Bergen; University of Bergen; Haukeland University Hospital; Institut Jules Bordet; Universite Libre de Bruxelles; KU Leuven; University of Bergen; Haukeland University Hospital; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England.	pc8@sanger.ac.uk	Desmedt, Christine/P-7438-2017; Wedge, David/AAC-4977-2021; Nik-Zainal, Serena/ABD-4437-2020; Alexandrov, Ludmil/AAS-1454-2021; Ju, Young Seok/E-1324-2012	Desmedt, Christine/0000-0002-5223-5579; Alexandrov, Ludmil/0000-0003-3596-4515; Ju, Young Seok/0000-0002-5514-4189; Martin, Sancha/0000-0001-6213-5259; Yates, Lucy/0000-0003-4519-7794; Lonning, Per Eystein/0000-0002-8890-6303; Glodzik, Dominik/0000-0001-8112-9073; Wedge, David/0000-0002-7572-3196; Gerstung, Moritz/0000-0001-6709-963X; Raine, Keiran/0000-0002-5634-1539; Van Loo, Peter/0000-0003-0292-1949; Knappskog, Stian/0000-0002-4153-1655	Wellcome Trust [077012/Z/05/Z]; Wellcome Trust Intermediate Clinical Research Fellowship [WT100183MA]; Belgian Cancer Plan-Ministry of Health; Breast Cancer Research Foundation; Brussels Region; Norwegian Cancer Society; Norwegian Health Region West; Bergen Research Foundation; European Community's Seventh Framework Programme (FP7) [242006]; Institut National du Cancer (INCa); National Nuclear Security Administration of the US Department of Energy; The Francis Crick Institute [10202] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Intermediate Clinical Research Fellowship(Wellcome Trust); Belgian Cancer Plan-Ministry of Health; Breast Cancer Research Foundation; Brussels Region; Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Health Region West; Bergen Research Foundation; European Community's Seventh Framework Programme (FP7)(European Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); National Nuclear Security Administration of the US Department of Energy(National Nuclear Security Administration); The Francis Crick Institute	This work is supported by the Wellcome Trust. P.J.C. is a Wellcome Trust Senior Clinical Fellow (103858/Z/14/Z). L.R.Y., Y.L. and L.B.A. are funded by Wellcome Trust PhD fellowships. S.N.-Z. is funded by a Wellcome Trust Intermediate Clinical Research Fellowship (WT100183MA). P.V.L. is a postdoctoral researcher at the Research Foundation Flanders (FWO). Work within the project is supported by the Belgian Cancer Plan-Ministry of Health, the Breast Cancer Research Foundation, the Brussels Region, the Norwegian Cancer Society, the Norwegian Health Region West and the Bergen Research Foundation. Some samples referenced in this publication will be included in the Breast Cancer Genome Analyses for the International Cancer Genome Consortium (ICGC) Working Group led by the Wellcome Trust Sanger Institute. BASIS is a part of the ICGC working group and is funded by the European Community's Seventh Framework Programme (FP7/2010-2014) under grant agreement number 242006. This working group also encompasses a triple-negative breast cancer project funded by the Wellcome Trust (grant 077012/Z/05/Z) and a HER2<SUP>+</SUP> breast cancer project funded by Institut National du Cancer (INCa). We thank B. Leirvaag, D. Ekse, N.K. Duong and C. Eriksen for technical assistance. Research performed at Los Alamos National Laboratory was carried out under the auspices of the National Nuclear Security Administration of the US Department of Energy.	Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Ali HR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0431-1; Almendro V, 2014, CANCER RES, V74, P1338, DOI 10.1158/0008-5472.CAN-13-2357-T; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Meric-Bernstam F, 2014, MOL CANCER THER, V13, P1382, DOI 10.1158/1535-7163.MCT-13-0482; Moskaluk CA, 1997, CANCER RES, V57, P2140; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rakha EA, 2014, NAT REV CLIN ONCOL, V11, P8, DOI 10.1038/nrclinonc.2013.230; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Seol H, 2012, MODERN PATHOL, V25, P938, DOI 10.1038/modpathol.2012.36; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Sleijfer S, 2013, J CLIN ONCOL, V31, P1834, DOI 10.1200/JCO.2012.45.3639; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yuan Y, 2014, NAT BIOTECHNOL, V32, P644, DOI 10.1038/nbt.2940; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	52	506	516	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					751	+		10.1038/nm.3886	http://dx.doi.org/10.1038/nm.3886			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26099045	Green Accepted, Green Submitted			2022-12-25	WOS:000357604600016
J	Grasso, CS; Tang, YJ; Truffaux, N; Berlow, NE; Liu, LN; Debily, MA; Quist, MJ; Davis, LE; Huang, EC; Woo, PJ; Ponnuswami, A; Chen, S; Johung, TB; Sun, WC; Kogiso, M; Dui, YC; Qi, L; Huang, YL; Hutt-Cabezas, M; Warrenm, KE; Le Dret, L; Meltzerm, PS; Mao, H; Quezado, M; van Vuurden, DG; Abraham, J; Fouladi, M; Svalina, MN; Wang, N; Hawkins, C; Nazarian, J; Alonso, MM; Raabe, EH; Hulleman, E; Spellman, PT; Li, XN; Keller, C; Pal, R; Grill, J; Monje, M				Grasso, Catherine S.; Tang, Yujie; Truffaux, Nathalene; Berlow, Noah E.; Liu, Lining; Debily, Marie-Anne; Quist, Michael J.; Davis, Lara E.; Huang, Elaine C.; Woo, Pamelyn J.; Ponnuswami, Anitha; Chen, Spenser; Johung, Tessa B.; Sun, Wenchao; Kogiso, Mari; Dui, Yuchen; Qi, Lin; Huang, Yulun; Huett-Cabezas, Marianne; Warrenm, Katherine E.; Le Dret, Ludivine; Meltzerm, Paul S.; Mao, Hua; Quezado, Martha; van Vuurden, Dannis G.; Abraham, Jinu; Fouladi, Maryam; Svalina, Matthew N.; Wang, Nicholas; Hawkins, Cynthia; Nazarian, Javad; Alonso, Marta M.; Raabe, Eric H.; Hulleman, Esther; Spellman, Paul T.; Li, Xiao-Nan; Keller, Charles; Pal, Ranadip; Grill, Jacques; Monje, Michelle			Functionally defined therapeutic targets in diffuse intrinsic pontine glioma	NATURE MEDICINE			English	Article							HISTONE H3.3; MUTATIONS; INHIBITION; SUBGROUPS; CELL	Diffuse intrinsic pontine glioma (DIPG) is a fatal childhood cancer. We performed a chemical screen in patient-derived DIPG cultures along with RNA-seq analyses and integrated computational modeling to identify potentially effective therapeutic strategies. The multi histone deacetylase inhibitor panobinostat demonstrated therapeutic efficacy both in vitro and in DIPG orthotopic xenograft models. Combination testing of panobinostat and the histone demethylase inhibitor GSK-J4 revealed that the two had synergistic effects. Together, these data suggest a promising therapeutic strategy for DIPG.	[Grasso, Catherine S.; Quist, Michael J.; Wang, Nicholas; Spellman, Paul T.] Oregon Hlth & Sci Univ, Ctr Spatial Syst Biomed, Dept Mol & Med Genet, Portland, OR 97201 USA; [Grasso, Catherine S.; Tang, Yujie; Liu, Lining; Woo, Pamelyn J.; Ponnuswami, Anitha; Chen, Spenser; Johung, Tessa B.; Sun, Wenchao; Monje, Michelle] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Tang, Yujie; Liu, Lining; Woo, Pamelyn J.; Ponnuswami, Anitha; Chen, Spenser; Johung, Tessa B.; Monje, Michelle] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Tang, Yujie; Liu, Lining; Woo, Pamelyn J.; Ponnuswami, Anitha; Chen, Spenser; Johung, Tessa B.; Monje, Michelle] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Tang, Yujie; Liu, Lining; Woo, Pamelyn J.; Ponnuswami, Anitha; Chen, Spenser; Johung, Tessa B.; Monje, Michelle] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Truffaux, Nathalene; Le Dret, Ludivine; Grill, Jacques] Univ Paris Sud, CNRS, Gustave Roussy, UMR 8203, Villejuif, France; [Berlow, Noah E.; Pal, Ranadip] Texas Tech Univ, Elect & Comp Engn, Lubbock, TX 79409 USA; [Debily, Marie-Anne; Davis, Lara E.] Univ Evry Val dEssone, Dept Biol, Evry, France; [Huang, Elaine C.; Abraham, Jinu; Keller, Charles] Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, Pediat Canc Biol Program, Portland, OR 97201 USA; [Kogiso, Mari; Dui, Yuchen; Qi, Lin; Mao, Hua; Li, Xiao-Nan] Baylor Coll Med, Texas Childrens Canc Ctr, Mol Neurooncol Lab, Houston, TX 77030 USA; [Huett-Cabezas, Marianne; Raabe, Eric H.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Huett-Cabezas, Marianne; Warrenm, Katherine E.; Quezado, Martha; Raabe, Eric H.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Meltzerm, Paul S.] NCI, Bethesda, MD 20892 USA; [van Vuurden, Dannis G.; Hulleman, Esther] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Oncol & Hematol, Amsterdam, Netherlands; [van Vuurden, Dannis G.; Hulleman, Esther] Vrije Univ Amsterdam, Med Ctr, Neuroncol Res Grp Canc Ctr Amsterdam, Amsterdam, Netherlands; [Fouladi, Maryam] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Svalina, Matthew N.; Keller, Charles] Childrens Canc Therapy Dev Inst, Ft Collins, CO USA; [Hawkins, Cynthia] Univ Toronto, Dept Pediat Lab Med, Toronto, ON, Canada; [Hawkins, Cynthia] Univ Toronto, Hosp Sick Children, Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Nazarian, Javad] Childrens Natl Hlth Syst, Ctr Res Inst, Washington, DC USA; [Alonso, Marta M.] Univ Hosp Navarra, Dept Oncol, Pamplona, Spain; [Grill, Jacques] Univ Paris Sud, Inst Gustave Roussy, Dept Cancerol Enfant & Adolescent, Villejuif, France; [Grill, Jacques] Parke Davis Res Unit, Inst Gustave Roussy, Dept Cancerol Enfant & Adolescent, Villejuif, France	Oregon Health & Science University; Stanford University; Stanford University; Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Texas Tech University System; Texas Tech University; UDICE-French Research Universities; Universite Paris Saclay; Oregon Health & Science University; Baylor College of Medicine; Texas Children's Cancer Center; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Cincinnati Children's Hospital Medical Center; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's National Health System; Servicio Navarro de Salud - Osasunbidea; University of Navarra; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Monje, M (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.	charles@cc-TDI.org; mmonje@stanford.edu	van Vuurden, Dannis/ACA-6952-2022; Hawkins, Cynthia/M-2571-2019; Alonso, Marta M/AAI-9457-2020; Sun, Wenchao/H-7738-2017; Debily, Marie-Anne/X-7697-2018; liu, lining/GXM-5412-2022; Grill, Jacques/R-8093-2019; Pal, Ranadip/F-3905-2012; Hulleman, Esther/AAD-7073-2021	Alonso, Marta M/0000-0002-7520-7351; Sun, Wenchao/0000-0003-4306-2896; Debily, Marie-Anne/0000-0002-8509-6165; Nazarian, Javad/0000-0002-1951-9828; Davis, Lara/0000-0002-6480-1611; Van Vuurden, Dannis/0000-0002-1364-9007; Hulleman, Esther/0000-0001-9256-947X; Keller, Charles/0000-0003-2505-7487; Chen, Spenser/0000-0003-2741-9058; Pal, Ranadip/0000-0002-9311-5901	Lyla Nsouli Foundation; Children's Oncology Group (COG) Central Nervous System Committee; DIPG Collaborative (The Cure Starts Now Foundation); DIPG Collaborative (Reflections of Grace Foundation); DIPG Collaborative (Smiles for Sophie Foundation); DIPG Collaborative (Cancer-Free Kids Foundation); DIPG Collaborative (Carly's Crusade Foundation); DIPG Collaborative (Jeffrey Thomas Hayden Foundation); DIPG Collaborative (Soar with Grace Foundation); Accelerate Brain Cancer Cures Foundation (ABC2); CureSearch for Childhood Cancer; Team Julian Foundation; COG Chair's Grant [5UOCA098543]; US National Institutes of Health [K08NS070926]; Alex's Lemonade Stand Foundation; McKenna Claire Foundation; Connor Johnson Memorial Fund; Dylan Jewett Memorial Fund; Elizabeth Stein Memorial Fund; Dylan Frick Memorial Fund; Abigail Jensen Memorial Fund; Zoey Ganesh Memorial Fund; Wayland Villars DIPG Foundation; Jennifer Kranz Memorial Fund; Unravel Pediatric Cancer; Virginia & D.K. Ludwig Fund for Cancer Research; Price Family Charitable Fund; Matthew Larson Foundation; Godfrey Family Fund in Memory of Fiona Penelope; Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; Etoile de Martin; Fondation Lemos; Le Defi de Fortunee; Scott Carter Foundation; Semmy Foundation; US Department of Defense; National Science Foundation [CCF0953366]; Marie Curie grant [IRG270459]; Spanish Ministry of Health [PI13/0125]; St. Baldrick's Foundation; Iron Matt Foundation; Division of Computing and Communication Foundations [0953366] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [ZIABC011514, P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	Lyla Nsouli Foundation; Children's Oncology Group (COG) Central Nervous System Committee; DIPG Collaborative (The Cure Starts Now Foundation); DIPG Collaborative (Reflections of Grace Foundation); DIPG Collaborative (Smiles for Sophie Foundation); DIPG Collaborative (Cancer-Free Kids Foundation); DIPG Collaborative (Carly's Crusade Foundation); DIPG Collaborative (Jeffrey Thomas Hayden Foundation); DIPG Collaborative (Soar with Grace Foundation); Accelerate Brain Cancer Cures Foundation (ABC2); CureSearch for Childhood Cancer; Team Julian Foundation; COG Chair's Grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; McKenna Claire Foundation; Connor Johnson Memorial Fund; Dylan Jewett Memorial Fund; Elizabeth Stein Memorial Fund; Dylan Frick Memorial Fund; Abigail Jensen Memorial Fund; Zoey Ganesh Memorial Fund; Wayland Villars DIPG Foundation; Jennifer Kranz Memorial Fund; Unravel Pediatric Cancer; Virginia & D.K. Ludwig Fund for Cancer Research; Price Family Charitable Fund; Matthew Larson Foundation; Godfrey Family Fund in Memory of Fiona Penelope; Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; Etoile de Martin; Fondation Lemos; Le Defi de Fortunee; Scott Carter Foundation; Semmy Foundation; US Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); Marie Curie grant(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); St. Baldrick's Foundation; Iron Matt Foundation; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the many children and families who selflessly contributed to this study through tissue donations obtained from surgery or autopsy, and A. Gajjar for his guidance and vision throughout this study. We also thank D. Hargrave, J. Olson and S. Leary for selection of V.2 chemical screen agents. We are grateful for the critical questions and comments by S. Cheetham and N. Nsouli. We also acknowledge important comments by another DIPG Preclinical Consortium member, O. Becher. We thank G. Grant for assistance in developing rodent CED techniques. We thank R. Hashizume and C.D. James (Northwestern University) for use of the SF7761 DIPG cell line. Short-read sequencing was performed by the OHSU Massively Parallel Sequencing Shared Resource. This research is supported by the Lyla Nsouli Foundation, the Children's Oncology Group (COG) Central Nervous System Committee, the DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer-Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation), the Accelerate Brain Cancer Cures Foundation (ABC<SUP>2</SUP>), CureSearch for Childhood Cancer, the Team Julian Foundation and the COG Chair's Grant (5UOCA098543). Additional funding support was provided by US National Institutes of Health grant K08NS070926 (to M.M.), Alex's Lemonade Stand Foundation (to M.M. and Y.T.), the McKenna Claire Foundation, the Connor Johnson Memorial Fund, the Dylan Jewett Memorial Fund, the Elizabeth Stein Memorial Fund, the Dylan Frick Memorial Fund, the Abigail Jensen Memorial Fund, the Zoey Ganesh Memorial Fund, the Wayland Villars DIPG Foundation, the Jennifer Kranz Memorial Fund, Unravel Pediatric Cancer, the Virginia & D.K. Ludwig Fund for Cancer Research, the Price Family Charitable Fund, the Matthew Larson Foundation, the Godfrey Family Fund in Memory of Fiona Penelope, the Child Health Research Institute at Stanford, the Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases (all to M.M.), Etoile de Martin (to J.G. and N.T.), Fondation Lemos and Le Defi de Fortunee (to J.G.), the Scott Carter Foundation (to N.E.B.), the Semmy Foundation (to D.G.v.V. and E.H.), the US Department of Defense (to X.-N.L.), National Science Foundation grant CCF0953366 (to R.P.), Marie Curie grant IRG270459 (to M.M.A.); the Spanish Ministry of Health grant PI13/0125 (to M.M.A.), and the St. Baldrick's Foundation and Iron Matt Foundation (both to E.R. and M.H.-C.).	Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Berlow N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-239; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Brown ZZ, 2014, J AM CHEM SOC, V136, P13498, DOI 10.1021/ja5060934; Caretti V, 2014, ACTA NEUROPATHOL, V127, P897, DOI 10.1007/s00401-014-1272-4; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hashizume R, 2012, J NEURO-ONCOL, V110, P305, DOI 10.1007/s11060-012-0973-6; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Pal R, 2012, BIOCOMPUT-PAC SYM, P351; Sandberg DI, 2002, J NEUROSURG, V96, P885, DOI 10.3171/jns.2002.96.5.0885; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; Veringa SJE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061512; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102	19	311	327	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					555	559		10.1038/nm.3855	http://dx.doi.org/10.1038/nm.3855			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25939062	Green Accepted			2022-12-25	WOS:000355778300010
J	Maass, PG; Aydin, A; Luft, FC; Schachterle, C; Weise, A; Stricker, S; Lindschau, C; Vaegler, M; Qadri, F; Toka, HR; Schulz, H; Krawitz, PM; Parkhomchuk, D; Hecht, J; Hollfinger, I; Wefeld-Neuenfeld, Y; Bartels-Klein, E; Muhl, A; Kann, M; Schuster, H; Chitayat, D; Bialer, MG; Wienker, TF; Ott, J; Rittscher, K; Liehr, T; Jordan, J; Plessis, G; Tank, J; Mai, K; Naraghi, R; Hodge, R; Hopp, M; Hattenbach, LO; Busjahn, A; Rauch, A; Vandeput, F; Gong, ML; Ruschendorf, F; Hubner, N; Haller, H; Mundlos, S; Bilginturan, N; Movsesian, MA; Klussmann, E; Toka, O; Bahring, S				Maass, Philipp G.; Aydin, Atakan; Luft, Friedrich C.; Schaechterle, Carolin; Weise, Anja; Stricker, Sigmar; Lindschau, Carsten; Vaegler, Martin; Qadri, Fatimunnisa; Toka, Hakan R.; Schulz, Herbert; Krawitz, Peter M.; Parkhomchuk, Dmitri; Hecht, Jochen; Hollfinger, Irene; Wefeld-Neuenfeld, Yvette; Bartels-Klein, Eireen; Muehl, Astrid; Kann, Martin; Schuster, Herbert; Chitayat, David; Bialer, Martin G.; Wienker, Thomas F.; Ott, Juerg; Rittscher, Katharina; Liehr, Thomas; Jordan, Jens; Plessis, Ghislaine; Tank, Jens; Mai, Knut; Naraghi, Ramin; Hodge, Russell; Hopp, Maxwell; Hattenbach, Lars O.; Busjahn, Andreas; Rauch, Anita; Vandeput, Fabrice; Gong, Maolian; Rueschendorf, Franz; Huebner, Norbert; Haller, Hermann; Mundlos, Stefan; Bilginturan, Nihat; Movsesian, Matthew A.; Klussmann, Enno; Toka, Okan; Baehring, Sylvia			PDE3A mutations cause autosomal dominant hypertension with brachydactyly	NATURE GENETICS			English	Article							NUCLEOTIDE PHOSPHODIESTERASE PDE3A; SMOOTH-MUSCLE-CELLS; IDENTIFIES PDE4D MUTATIONS; ACTIVATED PROTEIN-KINASE; SARCOPLASMIC-RETICULUM; CHROMOSOME 12P; CAMP LEVELS; 3A PDE3A; PHOSPHORYLATION; ACRODYSOSTOSIS	Cardiovascular disease is the most common cause of death worldwide, and hypertension is the major risk factor(1). Mendelian hypertension elucidates mechanisms of blood pressure regulation. Here we report six missense mutations in PDE3A (encoding phosphodiesterase 3A) in six unrelated families with mendelian hypertension and brachydactyly type E (HTNB)(2). The syndrome features brachydactyly type E (BDE), severe salt-independent but age-dependent hypertension, an increased fibroblast growth rate, neurovascular contact at the rostral-ventrolateral medulla, altered baroreflex blood pressure regulation and death from stroke before age 50 years when untreated(3,4). In vitro analyses of mesenchymal stem cell-derived vascular smooth muscle cells (VSMCs) and chondrocytes provided insights into molecular pathogenesis. The mutations increased protein kinase A-mediated PDE3A phosphorylation and resulted in gain of function, with increased cAMP-hydrolytic activity and enhanced cell proliferation. Levels of phosphorylated VASP were diminished, and PTHrP levels were dysregulated. We suggest that the identified PDE3A mutations cause the syndrome. VSMC-expressed PDE3A deserves scrutiny as a therapeutic target for the treatment of hypertension.	[Maass, Philipp G.; Aydin, Atakan; Luft, Friedrich C.; Vaegler, Martin; Qadri, Fatimunnisa; Toka, Hakan R.; Mai, Knut; Gong, Maolian; Baehring, Sylvia] Joint Cooperat Charite Med Fac, ECRC, Berlin, Germany; [Maass, Philipp G.; Aydin, Atakan; Luft, Friedrich C.; Schaechterle, Carolin; Vaegler, Martin; Qadri, Fatimunnisa; Schulz, Herbert; Hollfinger, Irene; Wefeld-Neuenfeld, Yvette; Bartels-Klein, Eireen; Muehl, Astrid; Mai, Knut; Gong, Maolian; Huebner, Norbert; Klussmann, Enno; Baehring, Sylvia] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Berlin, Germany; [Luft, Friedrich C.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Weise, Anja; Rittscher, Katharina; Liehr, Thomas] Univ Jena, Jena Univ Hosp, Inst Human Genet, Jena, Germany; [Stricker, Sigmar; Krawitz, Peter M.; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stricker, Sigmar] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Lindschau, Carsten; Haller, Hermann] Leibniz Univ Hannover, Sch Med, Dept Nephrol, D-30167 Hannover, Germany; [Lindschau, Carsten] Staatl Technikerschule Berlin, Berlin, Germany; [Vaegler, Martin] Univ Tubingen, Dept Urol, Lab Tissue Engn, Tubingen, Germany; [Toka, Hakan R.] Eastern Virginia Med Sch, Div Nephrol & Hypertens, Norfolk, VA 23501 USA; [Toka, Hakan R.] Brigham & Womens Hosp, Div Nephrol, Boston, MA 02115 USA; [Schulz, Herbert] Univ Cologne, CCG, D-50931 Cologne, Germany; [Krawitz, Peter M.; Parkhomchuk, Dmitri; Mundlos, Stefan] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Krawitz, Peter M.; Parkhomchuk, Dmitri; Hecht, Jochen; Mundlos, Stefan] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Kann, Martin] Univ Cologne, Dept Med 2, D-50931 Cologne, Germany; [Kann, Martin] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Schuster, Herbert] INFOGEN, Berlin, Germany; [Chitayat, David] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Chitayat, David] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Bialer, Martin G.] North Shore LIJ Hlth Syst, Div Med Genet, Manhasset, NY USA; [Bialer, Martin G.] North Shore LIJ Hlth Syst, Dept Pediat, Manhasset, NY USA; [Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Ott, Juerg] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Ott, Juerg] Rockefeller Univ, Stat Genet, New York, NY 10021 USA; [Jordan, Jens; Tank, Jens] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Plessis, Ghislaine] CHU Caen, Cytogenet Postnatale & Genet Clin, F-14000 Caen, France; [Naraghi, Ramin] Bundeswehrkrankenhaus Ulm, Dept Neurosurg, Ulm, Germany; [Hopp, Maxwell] Griffith Base Hosp, Dept Pediat, Griffith, NSW, Australia; [Hattenbach, Lars O.] Hosp Ludwigshafen, Dept Ophthalmol, Ludwigshafen, Germany; [Busjahn, Andreas] HealthTwist, Berlin, Germany; [Rauch, Anita] Univ Zurich, Inst Med Genet, Zurich, Switzerland; [Vandeput, Fabrice; Movsesian, Matthew A.] Vet Affairs Salt Lake City Hlth Care Syst, Cardiol Sect, Salt Lake City, UT USA; [Vandeput, Fabrice; Movsesian, Matthew A.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Vandeput, Fabrice; Movsesian, Matthew A.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Klussmann, Enno] DZHK German Ctr Cardiovasc Res, Berlin, Germany; [Huebner, Norbert] Charite, D-13353 Berlin, Germany; [Bilginturan, Nihat] Hacettepe Univ, Dept Pediat Oncol, Ankara, Turkey; [Toka, Okan] Univ Erlangen Nurnberg, Childrens Hosp, Dept Pediat Cardiol, D-91054 Erlangen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Vanderbilt University; Friedrich Schiller University of Jena; Max Planck Society; Free University of Berlin; Leibniz University Hannover; Eberhard Karls University of Tubingen; Eastern Virginia Medical School; Harvard University; Brigham & Women's Hospital; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Cologne; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Northwell Health; Northwell Health; University of Bonn; Chinese Academy of Sciences; Institute of Psychology, CAS; Rockefeller University; Hannover Medical School; CHU de Caen NORMANDIE; Universite de Caen Normandie; Ulm University; Military Hospital Ulm; Ludwigshafen Hospital; University of Zurich; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hacettepe University; University of Erlangen Nuremberg	Luft, FC (corresponding author), Joint Cooperat Charite Med Fac, ECRC, Berlin, Germany.	friedrich.luft@charite.de	Hattenbach, Lars-Olof/AAC-5621-2020; Bader, Michael/K-2124-2013; Weise, Anja/H-6669-2019; Rauch, Anita/C-5568-2014; Stricker, Sigmar/B-9169-2009; Mundlos, Stefan/ABH-9585-2020; Lindschau, Carsten/AAE-6721-2020; Krawitz, Peter M/F-3142-2012; Mai, Knut/W-9904-2019; Busjahn, Andreas/P-5023-2019; Toka, Hakan/AAQ-2162-2021; Liehr, Thomas/H-2852-2019	Hattenbach, Lars-Olof/0000-0002-5275-8118; Weise, Anja/0000-0003-3988-8919; Rauch, Anita/0000-0003-2930-3163; Stricker, Sigmar/0000-0002-7174-5363; Krawitz, Peter M/0000-0002-3194-8625; Mai, Knut/0000-0003-0126-3155; Busjahn, Andreas/0000-0001-9650-6919; Liehr, Thomas/0000-0003-1672-3054; Mundlos, Stefan/0000-0002-9788-3166; Naraghi, Ramin/0000-0003-3643-791X; Tank, Jens/0000-0002-5672-1187; Maass, Philipp/0000-0002-2742-8301	Deutsche Forschungsgemeinschaft (DFG) [BA1773/4-1, BA1773/4-2, MA5028/1-2, MA5028/1-3]; German Hypertension Society (Deutsche Hochdruckliga, DHL); German Heart Research Foundation [F/24/13]; DFG [KL1415/4-2]; Else Kroner-Fresenius-Stiftung [2013_A145]; German-Israeli Foundation [I-1210-286.13/2012]; Lingen-Stiftung; US Department of Veterans Affairs [CARA-029-09F]; American Heart Association [10034439]; University of Utah Research Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Hypertension Society (Deutsche Hochdruckliga, DHL); German Heart Research Foundation; DFG(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Lingen-Stiftung; US Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); University of Utah Research Foundation	We thank all family members for their cooperation. We thank M.-B. Kohler and M. Toliat for technical assistance. P.G.M., F.C.L., O.T. and S.B. received support from the Deutsche Forschungsgemeinschaft (DFG; BA1773/4-1, BA1773/4-2, MA5028/1-2 and MA5028/1-3) and grants-in-aid from the German Hypertension Society (Deutsche Hochdruckliga, DHL) and from the German Heart Research Foundation (F/24/13). E.K. was supported by the DFG (KL1415/4-2), the Else Kroner-Fresenius-Stiftung (2013_A145) and the German-Israeli Foundation (I-1210-286.13/2012). F.C.L. received support from the Lingen-Stiftung. F.V. and M.A.M. were supported by the US Department of Veterans Affairs (CARA-029-09F), the American Heart Association (10034439) and the University of Utah Research Foundation. James C. Melby referred one of the families. Dr. Melby died on 19 August 2007.	Ahmad F, 2015, J BIOL CHEM, V290, P6763, DOI 10.1074/jbc.M115.638585; Bahring S, 2008, HYPERTENSION, V51, P426, DOI 10.1161/HYPERTENSIONAHA.107.101774; Bahring S, 2004, HYPERTENSION, V43, P471, DOI 10.1161/01.HYP.0000111808.08715.ec; Bassler D, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007802.pub2; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Beca S, 2013, CIRC RES, V112, P289, DOI 10.1161/CIRCRESAHA.111.300003; Begum N, 2011, J BIOL CHEM, V286, P26238, DOI 10.1074/jbc.M110.214155; BILGINTURAN N, 1973, J MED GENET, V10, P253, DOI 10.1136/jmg.10.3.253; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chilco PJ, 1998, MOL CELL ENDOCRINOL, V138, P173, DOI 10.1016/S0303-7207(97)00239-6; Choi YH, 2001, BIOCHEM J, V353, P41, DOI 10.1042/0264-6021:3530041; Cone J, 1999, J CARDIOVASC PHARM, V34, P497, DOI 10.1097/00005344-199910000-00004; Dunkerley HA, 2002, MOL PHARMACOL, V61, P1033, DOI 10.1124/mol.61.5.1033; Gong ML, 2003, HUM MOL GENET, V12, P1273, DOI 10.1093/hmg/ddg135; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; INSEL PA, 1982, J BIOL CHEM, V257, P7485; Klopocki E, 2010, AM J HUM GENET, V86, P434, DOI 10.1016/j.ajhg.2010.01.023; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Lifton Richard P, 2004, Harvey Lect, V100, P71; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Michot C, 2012, AM J HUM GENET, V90, P740, DOI 10.1016/j.ajhg.2012.03.003; Naraghi R, 1997, STROKE, V28, P1749, DOI 10.1161/01.STR.28.9.1749; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; Schuster H, 1996, HYPERTENSION, V28, P1085, DOI 10.1161/01.HYP.28.6.1085; Schuster H, 1998, KIDNEY INT, V53, P167, DOI 10.1046/j.1523-1755.1998.00732.x; Song GJ, 2009, MOL ENDOCRINOL, V23, P1681, DOI 10.1210/me.2009-0098; Toka O, 2010, HYPERTENSION, V56, P988, DOI 10.1161/HYPERTENSIONAHA.110.156620; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Wakabayashi S, 2002, J BONE MINER RES, V17, P249, DOI 10.1359/jbmr.2002.17.2.249; Wechsler J, 2002, J BIOL CHEM, V277, P38072, DOI 10.1074/jbc.M203647200; Zhao H, 2008, EUR J PHARMACOL, V590, P29, DOI 10.1016/j.ejphar.2008.05.016	41	104	110	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					647	653		10.1038/ng.3302	http://dx.doi.org/10.1038/ng.3302			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25961942	Green Accepted, Green Published			2022-12-25	WOS:000355386500017
J	Tsujita, K; Takenawa, T; Itoh, T				Tsujita, Kazuya; Takenawa, Tadaomi; Itoh, Toshiki			Feedback regulation between plasma membrane tension and membrane-bending proteins organizes cell polarity during leading edge formation	NATURE CELL BIOLOGY			English	Article							ACTIN CYTOSKELETON; BAR-DOMAIN; INVAGINATION; PROTRUSIONS; TUBULATION; DYNAMIN; SHAPE	Tension applied to the plasma membrane (PM) is a global mechanical parameter involved in cell migration. However, how membrane tension regulates actin assembly is unknown. Here, we demonstrate that FBP17, a membrane-bending protein and an activator of WASP/N-WASP-dependent actin nucleation, is a PM tension sensor involved in leading edge formation. In migrating cells, FBP17 localizes to short membrane invaginations at the leading edge, while diminishing from the cell rear in response to PM tension increase. Conversely, following reduced PM tension, FBP17 dots randomly distribute throughout the cell, correlating with loss of polarized actin assembly on PM tension reduction. Actin protrusive force is required for the polarized accumulation, indicating a role for FBP17-mediated activation of WASP/N-WASP in PM tension generation. In vitro experiments show that FBP17 membrane-bending activity depends on liposomal membrane tension. Thus, FBP17 is the local activator of actin polymerization that is inhibited by PM tension in the feedback loop that regulates cell migration.	[Tsujita, Kazuya; Itoh, Toshiki] Kobe Univ, Org Adv Sci & Technol, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Itoh, Toshiki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University	Itoh, T (corresponding author), Kobe Univ, Org Adv Sci & Technol, Biosignal Res Ctr, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	titoh@people.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS; Uehara a Memorial Foundation; Grants-in-Aid for Scientific Research [25440085] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara a Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank T. Inoue for discussions, M. Ichikawa for technical assistance and H. Yamamoto for help with plasmid constructions. This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) to K.T. and T.I., a Grant-in-Aid for Scientific Research (S) from JSPS to T.T amd a Uehara a Memorial Foundation grant K.T.	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Chander H, 2013, ONCOGENE, V32, P3080, DOI 10.1038/onc.2012.317; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Graziano BR, 2014, CURR OPIN CELL BIOL, V30, P60, DOI 10.1016/j.ceb.2014.06.007; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Malet-Engra G, 2013, CANCER RES, V73, P3412, DOI 10.1158/0008-5472.CAN-12-3564; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rolland Y, 2014, DEV CELL, V30, P553, DOI 10.1016/j.devcel.2014.08.006; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Truesdell P, 2014, ONCOGENE; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Tsujita K, 2013, J CELL SCI, V126, P2267, DOI 10.1242/jcs.122515; Ueno T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002033; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Veltman DM, 2012, J CELL BIOL, V198, P501, DOI 10.1083/jcb.201205058; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yamazaki D, 2013, MOL BIOL CELL, V24, P3393, DOI 10.1091/mbc.E13-04-0178	48	88	88	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					749	+		10.1038/ncb3162	http://dx.doi.org/10.1038/ncb3162			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25938814				2022-12-25	WOS:000355277500007
J	Cebola, I; Rodriguez-Segui, SA; Cho, CHH; Bessa, J; Rovira, M; Luengo, M; Chhatriwala, M; Berry, A; Ponsa-Cobas, J; Maestro, MA; Jennings, RE; Pasquali, L; Moran, I; Castro, N; Hanley, NA; Gomez-Skarmeta, JL; Vallier, L; Ferrer, J				Cebola, Ines; Rodriguez-Segui, Santiago A.; Cho, Candy H-H.; Bessa, Jose; Rovira, Meritxell; Luengo, Mario; Chhatriwala, Mariya; Berry, Andrew; Ponsa-Cobas, Joan; Angel Maestro, Miguel; Jennings, Rachel E.; Pasquali, Lorenzo; Moran, Ignasi; Castro, Natalia; Hanley, Neil A.; Luis Gomez-Skarmeta, Jose; Vallier, Ludovic; Ferrer, Jorge			TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors	NATURE CELL BIOLOGY			English	Article							BETA-CELL DIFFERENTIATION; STEM-CELLS; TRANSCRIPTOME ANALYSIS; DUCTAL ADENOCARCINOMA; IN-VIVO; ZEBRAFISH; ORGANOGENESIS; EXPRESSION; AGENESIS; SOX9	The genomic regulatory programmes that underlie human organogenesis are poorly understood. Pancreas development, in particular, has pivotal implications for pancreatic regeneration, cancer and diabetes. We have now characterized the regulatory landscape of embryonic multipotent progenitor cells that give rise to all pancreatic epithelial lineages. Using human embryonic pancreas and embryonic-stem-cell-derived progenitors we identify stage-specific transcripts and associated enhancers, many of which are co-occupied by transcription factors that are essential for pancreas development. We further show that TEAD1, a Hippo signalling effector, is an integral component of the transcription factor combinatorial code of pancreatic progenitor enhancers. TEAD and its coactivator YAP activate key pancreatic signalling mediators and transcription factors, and regulate the expansion of pancreatic progenitors. This work therefore uncovers a central role for TEAD and YAP as signal-responsive regulators of multipotent pancreatic progenitors, and provides a resource for the study of embryonic development of the human pancreas.	[Cebola, Ines; Ponsa-Cobas, Joan; Moran, Ignasi; Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England; [Rodriguez-Segui, Santiago A.; Rovira, Meritxell; Angel Maestro, Miguel; Pasquali, Lorenzo; Castro, Natalia; Ferrer, Jorge] Inst Invest August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona 08035, Spain; [Rodriguez-Segui, Santiago A.; Rovira, Meritxell; Angel Maestro, Miguel; Pasquali, Lorenzo; Castro, Natalia; Ferrer, Jorge] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona 08036, Spain; [Rodriguez-Segui, Santiago A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Fisiol & Biol Mol,IFIBYNE,CONICET, Buenos Aires, DF, Argentina; [Cho, Candy H-H.; Vallier, Ludovic] Univ Cambridge, Wellcome Trust, Cambridge CB2 0SZ, England; [Cho, Candy H-H.; Vallier, Ludovic] Univ Cambridge, MRC Stem Cells Ctr, Anne McLaren Lab Regenerat Med, Dept Surg, Cambridge CB2 0SZ, England; [Cho, Candy H-H.; Vallier, Ludovic] Univ Cambridge, Wellcome Trust, MRC, Cambridge Stem Cell Inst, Cambridge CB2 0SZ, England; [Bessa, Jose] IBMC, P-4150180 Oporto, Portugal; [Bessa, Jose] Univ Porto, Inst Invest & Inovacao Saude, P-4200135 Oporto, Portugal; [Luengo, Mario; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Chhatriwala, Mariya; Vallier, Ludovic] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Berry, Andrew; Jennings, Rachel E.; Hanley, Neil A.] Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester Acad Hlth Sci Ctr,Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Hanley, Neil A.] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Endocrinol, Manchester M13 9WU, Lancs, England	Imperial College London; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Wellcome Trust Sanger Institute; University of Manchester; University of Manchester	Hanley, NA (corresponding author), Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester Acad Hlth Sci Ctr,Fac Med & Human Sci, Manchester M13 9PT, Lancs, England.	Neil.Hanley@manchester.ac.uk; jlgomska@upo.es; lv225@cam.ac.uk; j.ferrer@imperial.ac.uk	Cebola, Inês/AAG-9652-2020; Rovira, Meritxell/AGZ-1200-2022; Pasquali, Lorenzo/B-6239-2008; Moran, Ignasi/AAA-6417-2020; Ferrer, Jorge/A-3176-2012; Gomez-Skarmeta, Jose Luis/B-5268-2014; Rovira, Meritxell/Y-6241-2019; Bessa, Jose/I-8084-2013	Cebola, Inês/0000-0003-3528-4982; Rovira, Meritxell/0000-0002-0538-4846; Pasquali, Lorenzo/0000-0003-2423-1826; Moran, Ignasi/0000-0002-3307-7106; Ferrer, Jorge/0000-0002-5959-5729; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Vallier, Ludovic/0000-0002-3848-2602; Hanley, Neil/0000-0003-3234-4038; Rodriguez-Segui, Santiago A./0000-0003-2952-8485; Jennings, Rachel/0000-0003-1492-600X; Bessa, Jose/0000-0002-8591-7138	National institute for Health Research (NIHR) Imperial Biomedical Research Centre; Ministerio de Econotnia y Competitividad [CB07/08/0021, SAF2011-27085, PLF2009-0162, BFU2013-41322-P]; Wellcome Trust [WT997820, WT1111033]; Manchester Biomedical Research Centre; ERC; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Medical Research Council [G1100420, G0800784, MR/L02036X/1, G0701448] Funding Source: researchfish; National Institute for Health Research [CL-2014-06-002] Funding Source: researchfish; MRC [G0701448, G1100420, MR/L02036X/1, G0800784] Funding Source: UKRI	National institute for Health Research (NIHR) Imperial Biomedical Research Centre; Ministerio de Econotnia y Competitividad; Wellcome Trust(Wellcome TrustEuropean Commission); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); ERC(European Research Council (ERC)European Commission); Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by the National institute for Health Research (NIHR) Imperial Biomedical Research Centre. Work was funded by grants from the Ministerio de Econotnia y Competitividad (CB07/08/0021, SAF2011-27085, PLF2009-0162 to J.F., BFU2013-41322-P to J.L.G.S.), the Wellcome Trust WT997820 to N.A.H., WT1111033 to J.F.), the Manchester Biomedical Research Centre, ERC advanced starting grant IMDs (C.H-H.C. and L.V.) and the Cambridge Hospitals National Institute for Health Research Biomedical Research Centre (L.V). R.E.J. is a Medical Research Council clinical training fellow The authors are grateful to C. Wright (Vanderbilt University) for zebrafish Pdx1 antiserum, J. Postlethwait (Purdue University) for a Sox9b clone, FL Sasaki (Kumamoto University) for a TEAD-EnR clone, C. Vinod and L. Abi for research nurse assistance, and clinical colleagues at Central Manchester University Hospitals NHS Foundation Trust. The authors thank L Garcia-Hurtado for technical assistance (IDIBAPS).	Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; Bardeesy N., 2013, GASTROENTEROLOGY, V144; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Binot AC, 2010, DEV BIOL, V340, P397, DOI 10.1016/j.ydbio.2010.01.025; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Carrasco M, 2012, J CLIN INVEST, V122, P3504, DOI 10.1172/JCI63240; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Cortijo C, 2012, CELL REP, V2, P1593, DOI 10.1016/j.celrep.2012.10.016; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Elghazi L, 2002, P NATL ACAD SCI USA, V99, P3884, DOI 10.1073/pnas.062321799; Esni F, 2005, METH MOLEC MED, V103, P259; Fang H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-108; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; George NM, 2012, MOL CELL BIOL, V32, P5116, DOI 10.1128/MCB.01034-12; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Luco RF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000079; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Offield MF, 1996, DEVELOPMENT, V122, P983; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; ORAHILLY R, 1987, AM J ANAT, V180, P69, DOI 10.1002/aja.1001800106; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Petzold KM, 2012, JOVE-J VIS EXP, DOI 10.3791/3979; Piper K, 2002, MECH DEVELOP, V116, P223, DOI 10.1016/S0925-4773(02)00145-4; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rodriguez-Seguel E., 2013, GENE DEV, V27, P1932; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sawada A, 2005, DEVELOPMENT, V132, P4719, DOI 10.1242/dev.02059; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	68	138	142	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2015	17	5					615	U183		10.1038/ncb3160	http://dx.doi.org/10.1038/ncb3160			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH1HG	25915126	Green Accepted, Green Submitted			2022-12-25	WOS:000353771500010
J	Mann, MB; Black, MA; Jones, DJ; Ward, JM; Yew, CCK; Newberg, JY; Dupuy, AJ; Rust, AG; Bosenberg, MW; McMahon, M; Print, CG; Copeland, NG; Jenkins, NA				Mann, Michael B.; Black, Michael A.; Jones, Devin J.; Ward, Jerrold M.; Yew, Christopher Chin Kuan; Newberg, Justin Y.; Dupuy, Adam J.; Rust, Alistair G.; Bosenberg, Marcus W.; McMahon, Martin; Print, Cristin G.; Copeland, Neal G.; Jenkins, Nancy A.			Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LONG NONCODING RNAS; SUSCEPTIBILITY LOCUS; MOUSE MODEL; CANCER; MUTATIONS; KINASE; PTEN; LANDSCAPE; DISCOVERY	Although nearly half of human melanomas harbor oncogenic BRAF(V600E) mutations, the genetic events that cooperate with these mutations to drive melanogenesis are still largely unknown. Here we show that Sleeping Beauty (SB) transposon-mediated mutagenesis drives melanoma progression in Braf(V600E) mutant mice and identify 1,232 recurrently mutated candidate cancer genes (CCGs) from 70 SB-driven melanomas. CCGs are enriched in Wnt, PI3K, MAPK and netrin signaling pathway components and are more highly connected to one another than predicted by chance, indicating that SB targets cooperative genetic networks in melanoma. Human orthologs of >500 CCGs are enriched for mutations in human melanoma or showed statistically significant clinical associations between RNA abundance and survival of patients with metastatic melanoma. We also functionally validate CEP350 as a new tumor-suppressor gene in human melanoma. SB mutagenesis has thus helped to catalog the cooperative molecular mechanisms driving BRAF(V600E) melanoma and discover new genes with potential clinical importance in human melanoma.	[Mann, Michael B.; Jones, Devin J.; Newberg, Justin Y.; Copeland, Neal G.; Jenkins, Nancy A.] Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA; [Mann, Michael B.; Ward, Jerrold M.; Yew, Christopher Chin Kuan; Copeland, Neal G.; Jenkins, Nancy A.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Dupuy, Adam J.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Rust, Alistair G.] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton, Cambs, England; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [McMahon, Martin] Univ Calif San Francisco, Dept Cell & Mol Pharmacol, San Francisco, CA 94143 USA; [Print, Cristin G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, New Zealand Bioinformat Inst, Auckland 1, New Zealand	The Methodist Hospital System; The Methodist Hospital - Houston; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Otago; University of Iowa; Wellcome Trust Sanger Institute; Yale University; Yale University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Auckland; University of Auckland	Jenkins, NA (corresponding author), Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA.	njenkins2@houstonmethodist.org	Mann, Michael Bruce/M-4674-2019	Mann, Michael Bruce/0000-0002-7515-6515; Dupuy, Adam/0000-0002-8561-4911; Black, Michael/0000-0003-1174-6054; Rust, Alistair/0000-0001-7287-192X; Print, Cristin/0000-0001-8345-7812	Biomedical Research Council; A*STAR, Singapore; Cancer Prevention Research Institute of Texas; Health Research Council of New Zealand; University of Auckland; New Zealand Maurice Wilkins Centre; National Cancer Institute; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA176839] Funding Source: NIH RePORTER	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Prevention Research Institute of Texas; Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland; New Zealand Maurice Wilkins Centre; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank K. Mann for helpful discussions and for critical reading and editing of the manuscript; M. Eccles (Otago) and the Copeland and Jenkins laboratories in Singapore and Houston for helpful discussions; V. Hearing (National Cancer Institute) for PEP antibodies and L. Chin (Dana-Farber Cancer Institute) for Tyr-cre<SUP>ERT2</SUP> mice; D. Adams (Sanger Institute), T. Whipp, R. Rance and the Wellcome Trust Sanger Institute sequencing and informatics teams for 454 sequencing and bioinformatics support; K. Rogers, S. Rogers and the Institute for Molecular and Cell Biology Histopathology Core; P. Cheok, N. Lim, D. Chen and C. Wee (Singapore) and H. Lee and E. Freiter (Houston) for assistance with tumor monitoring and animal husbandry; and A. Trevarton (Auckland) for assistance with molecular pathway analysis. Histology work was performed by the Advanced Molecular Pathology Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore. This work was supported in part by the Biomedical Research Council, A*STAR, Singapore (to N.G.C. and N. A.J.), the Cancer Prevention Research Institute of Texas (to N.G.C. and N.A.J.), the Health Research Council of New Zealand, the University of Auckland and the New Zealand Maurice Wilkins Centre (to C.G.P.), the National Cancer Institute (to M.M. and M.W.B.) and the Melanoma Research Alliance (to M.M.). N.G.C. and N.A.J. are also Cancer Prevention Research Institute of Texas Scholars in Cancer Research.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Araki H, 2012, FEBS OPEN BIO, V2, P76, DOI 10.1016/j.fob.2012.04.003; Azmi AS, 2010, MOL CANCER THER, V9, P3137, DOI 10.1158/1535-7163.MCT-10-0642; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Flaherty KT, 2011, NAT REV DRUG DISCOV, V10, P811, DOI 10.1038/nrd3579; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Henare K, 2012, BRIT J CANCER, V106, P1134, DOI 10.1038/bjc.2012.63; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Howell PM, 2009, CANCER CONTROL, V16, P200, DOI 10.1177/107327480901600302; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Le Clech M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003855; Lelievre H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-30; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nan HM, 2011, HUM MOL GENET, V20, P2673, DOI 10.1093/hmg/ddr154; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ni TK, 2013, P NATL ACAD SCI USA, V110, pE3640, DOI 10.1073/pnas.1314435110; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Patel H, 2005, J CELL SCI, V118, P175, DOI 10.1242/jcs.01600; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Sabatino M, 2008, CANCER RES, V68, P122, DOI 10.1158/0008-5472.CAN-07-1939; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Sigalotti L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-56; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stites EC, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003354; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Teerlink C, 2012, HUM GENET, V131, P77, DOI 10.1007/s00439-011-1048-z; Tran SL, 2012, J INVEST DERMATOL, V132, P2226, DOI 10.1038/jid.2012.126; Trigueros-Motos L, 2014, CLIN GENET, V86, P217, DOI 10.1111/cge.12416; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wilmott JS, 2013, BRIT J CANCER, V108, P924, DOI 10.1038/bjc.2013.29; Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630	96	44	44	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					486	U86		10.1038/ng.3275	http://dx.doi.org/10.1038/ng.3275			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25848750	Green Accepted			2022-12-25	WOS:000353635800011
J	Cook, CN; Murray, ME; Petrucelli, L				Cook, Casey N.; Murray, Melissa E.; Petrucelli, Leonard			Novel approaches to detecting tau pathology	NATURE MEDICINE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; IN-VIVO; ALZHEIMERS-DISEASE; PET; RADIOLIGAND	Tau pathology is commonly analyzed by positron emission tomography (PET) imaging. However, recently developed cell-based techniques for analyzing tau pathogenicity may also be used to measure an early biomarker in tauopathies.	[Cook, Casey N.; Murray, Melissa E.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Cook, CN (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu	Murray, Melissa E/C-2763-2015	Murray, Melissa E/0000-0001-7379-2545				BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Villemagne VL, 2014, EUR J NUCL MED MOL I, V41, P816, DOI 10.1007/s00259-013-2681-7; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046	14	14	14	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					219	220		10.1038/nm.3809	http://dx.doi.org/10.1038/nm.3809			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25742457				2022-12-25	WOS:000350362000013
J	Cleary, B; Brito, IL; Huang, K; Gevers, D; Shea, T; Young, S; Alm, EJ				Cleary, Brian; Brito, Ilana Lauren; Huang, Katherine; Gevers, Dirk; Shea, Terrance; Young, Sarah; Alm, Eric J.			Detection of low-abundance bacterial strains in metagenomic datasets by eigengenome partitioning	NATURE BIOTECHNOLOGY			English	Article							DIVERSITY; ASSEMBLER; ACCURATE; COVERAGE; GENOMES; REVEAL; VELVET	Analyses of metagenomic datasets that are sequenced to a depth of billions or trillions of bases can uncover hundreds of microbial genomes, but naive assembly of these data is computationally intensive, requiring hundreds of gigabytes to terabytes of RAM. We present latent strain analysis (LSA), a scalable, de novo pre-assembly method that separates reads into biologically informed partitions and thereby enables assembly of individual genomes. LSA is implemented with a streaming calculation of unobserved variables that we call eigengenomes. Eigengenomes reflect covariance in the abundance of short, fixed-length sequences, or k-mers. As the abundance of each genome in a sample is reflected in the abundance of each k-mer in that genome, eigengenome analysis can be used to partition reads from different genomes. This partitioning can be done in fixed memory using tens of gigabytes of RAM, which makes assembly and downstream analyses of terabytes of data feasible on commodity hardware. Using LSA, we assemble partial and near-complete genomes of bacterial taxa present at relative abundances as low as 0.00001%. We also show that LSA is sensitive enough to separate reads from several strains of the same species.	[Cleary, Brian] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Cleary, Brian; Brito, Ilana Lauren; Huang, Katherine; Gevers, Dirk; Shea, Terrance; Young, Sarah; Alm, Eric J.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Brito, Ilana Lauren; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Brito, Ilana Lauren; Alm, Eric J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Alm, EJ (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	ejalm@mit.edu	Gevers, Dirk/C-1451-2009; Brito, Ilana/W-1827-2017	Brito, Ilana/0000-0002-2250-3480	Rasmussen Family Foundation; National Human Genome Research Institute [U54HG003067]; Center for Environmental Health Sciences at MIT; Fijian Ministry of Health; Earth Institute at Columbia University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM087237] Funding Source: NIH RePORTER	Rasmussen Family Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for Environmental Health Sciences at MIT; Fijian Ministry of Health; Earth Institute at Columbia University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Rasmussen Family Foundation. The Fiji Community Microbiome Project was supported by the National Human Genome Research Institute, grant number U54HG003067 to the Broad Institute; the Center for Environmental Health Sciences at MIT; and the Fijian Ministry of Health. I.L.B. was supported in part by the Earth Institute at Columbia University. We would like to thank S. Jupiter and W. Naisilisili at the Wildlife Conservation Society's Fiji Islands site office, and A. Jenkins at the Edith Cowan University.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/nmeth.3103, 10.1038/NMETH.3103]; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gionis A, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P518; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Kulis B, 2009, IEEE I CONF COMP VIS, P2130, DOI 10.1109/ICCV.2009.5459466; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rehurek R, 2010, P LREC 2010 WORKSH N, P46; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; TREANGEN T. J., 2011, GENOME BIOL, P25, DOI DOI 10.1186/gb-2011-12-s1-p25; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	80	83	6	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1053	+		10.1038/nbt.3329	http://dx.doi.org/10.1038/nbt.3329			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26368049	Bronze, Green Submitted, Green Accepted			2022-12-25	WOS:000362555700024
J	Chan, K; Roberts, SA; Klimczak, LJ; Sterling, JF; Saini, N; Malc, EP; Kim, J; Kwiatkowski, DJ; Fargo, DC; Mieczkowski, PA; Getz, G; Gordenin, DA				Chan, Kin; Roberts, Steven A.; Klimczak, Leszek J.; Sterling, Joan F.; Saini, Natalie; Malc, Ewa P.; Kim, Jaegil; Kwiatkowski, David J.; Fargo, David C.; Mieczkowski, Piotr A.; Getz, Gad; Gordenin, Dmitry A.			An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers	NATURE GENETICS			English	Article							DNA-POLYMERASE-ZETA; BREAST-CANCER; DELETION POLYMORPHISM; MUTATIONAL PROCESSES; CYTIDINE DEAMINASES; GENE-EXPRESSION; CARCINOMA; YEAST; GENOMES; DAMAGE	Elucidation of mutagenic processes shaping cancer genomes is a fundamental problem whose solution promises insights into new treatment, diagnostic and prevention strategies(1). Single-strand DNA-specific APOBEC cytidine deaminase(s) are major source(s) of mutation in several cancer types(2-4). Previous indirect evidence implicated APOBEC3B as the more likely major mutator deaminase, whereas the role of APOBEC3A is not established(5,6). Using yeast models enabling the controlled generation of long single-strand genomic DNA substrates(7), we show that the mutation signatures of APOBEC3A and APOBEC3B are statistically distinguishable. We then apply three complementary approaches to identify cancer samples with mutation signatures resembling either APOBEC. Strikingly, APOBEC3A-like samples have over tenfold more APOBEC-signature mutations than APOBEC3B-like samples. We propose that APOBEC3A-mediated mutagenesis is much more frequent because APOBEC3A itself is highly proficient at generating DNA breaks(8-10), whose repair can trigger the formation of single-strand hypermutation substrates.	[Chan, Kin; Roberts, Steven A.; Sterling, Joan F.; Saini, Natalie; Gordenin, Dmitry A.] NIEHS, Genome Integr & Struct Biol Lab, US NIH, Res Triangle Pk, NC 27709 USA; [Roberts, Steven A.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Klimczak, Leszek J.; Fargo, David C.] NIEHS, Integrat Bioinformat Support Grp, US NIH, Res Triangle Pk, NC 27709 USA; [Malc, Ewa P.; Mieczkowski, Piotr A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Kim, Jaegil; Kwiatkowski, David J.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Kwiatkowski, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Getz, Gad] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gordenin, DA (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, US NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	gordenin@niehs.nih.gov	Saini, Natalie/J-4044-2019; Dmitry, Gordenin/C-3907-2018	Saini, Natalie/0000-0002-1668-5417; Dmitry, Gordenin/0000-0002-8399-1836; Chan, Kin/0000-0002-5827-3154; Mieczkowski, Piotr/0000-0003-2418-0096; Malc, Ewa/0000-0002-4596-1142	US National Institutes of Health Intramural Research Program [Z1AES103266]; US National Institutes of Health [U24CA143845, R01GM052319, 1P01CA120964, R00ES022633, K99ES024424]; NATIONAL CANCER INSTITUTE [P01CA120964, U24CA143845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103266, R00ES022633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052319] Funding Source: NIH RePORTER	US National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T.A. Kunkel, S.A. Lujan and D.V. Zaykin for critical reading of the manuscript. This work was supported by US National Institutes of Health Intramural Research Program Project Z1AES103266 to D.A.G. and US National Institutes of Health grants U24CA143845 to G.G., R01GM052319 to P.A.M., 1P01CA120964 to D.J.K., R00ES022633 to S.A.R. and K99ES024424 to K.C.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Broad Institute TCGA Genome Data Analysis Center, 2014, AN MUT APOBEC CYT DE; Burns MB, 2015, BIOMED J, V38, P102, DOI 10.4103/2319-4170.148904; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Casey RG, 2015, EUR UROL, V67, P876, DOI 10.1016/j.eururo.2014.10.040; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; Caval V, 2014, MOL BIOL EVOL, V31, P330, DOI 10.1093/molbev/mst195; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chan K, 2013, DNA REPAIR, V12, P878, DOI 10.1016/j.dnarep.2013.07.008; Chan K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003149; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Degtyareva NP, 2013, NUCLEIC ACIDS RES, V41, P8995, DOI 10.1093/nar/gkt671; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; HALDANE JBS, 1945, BIOMETRIKA, V33, P222, DOI 10.1093/biomet/33.3.222; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Poon SL, 2014, GENOME MED, V6, DOI 10.1186/gm541; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sakamoto AN, 2007, DNA REPAIR, V6, P1829, DOI 10.1016/j.dnarep.2007.07.002; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Sasaki H, 2014, BIOMED REP, V2, P392, DOI 10.3892/br.2014.256; Shee C, 2013, ELIFE, V2, DOI 10.7554/eLife.01222; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Waters CE, 2015, ONCOTARGET, V6, P3409, DOI 10.18632/oncotarget.2636; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200	55	230	233	3	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1067	+		10.1038/ng.3378	http://dx.doi.org/10.1038/ng.3378			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26258849	Green Accepted, Green Submitted			2022-12-25	WOS:000360394100018
J	Geva-Zatorsky, N; Alvarez, D; Hudak, JE; Reading, NC; Erturk-Hasdemir, D; Dasgupta, S; von Andrian, UH; Kasper, DL				Geva-Zatorsky, Naama; Alvarez, David; Hudak, Jason E.; Reading, Nicola C.; Erturk-Hasdemir, Deniz; Dasgupta, Suryasarathi; von Andrian, Ulrich H.; Kasper, Dennis L.			In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria	NATURE MEDICINE			English	Article							BACTEROIDES-FRAGILIS; IMMUNE-SYSTEM; DENDRITIC CELLS; T-CELLS; POLYSACCHARIDE; DISEASE; MACROPHAGES; HOMEOSTASIS; INDUCTION; DIVERSITY	The intestine is densely populated by anaerobic commensal bacteria. These microorganisms shape immune system development, but understanding of host-commensal interactions is hampered by a lack of tools for studying the anaerobic intestinal environment. We applied metabolic oligosaccharide engineering and bioorthogonal click chemistry to label various commensal anaerobes, including Bacteroides fragilis, a common and immunologically important commensal. We studied the dissemination of B. fragilis after acute peritonitis and characterized the interactions of the intact microbe and its polysaccharide components in myeloid and B cell lineages. We were able to assess the distribution and colonization of labeled B. fragilis along the intestine, as well as niche competition after coadministration of multiple species of the microbiota. We also fluorescently labeled nine additional commensals (eight anaerobic and one microaerophilic) from three phyla common in the gut-Bacteroidetes, Firmicutes and Proteobacteria-as well as one aerobic pathogen (Staphylococcus aureus). This strategy permits visualization of the anaerobic microbial niche by various methods, including intravital two-photon microscopy and non-invasive whole-body imaging, and can be used to study microbial colonization and host-microbe interactions in real time.	[Geva-Zatorsky, Naama; Alvarez, David; Hudak, Jason E.; Reading, Nicola C.; Erturk-Hasdemir, Deniz; Dasgupta, Suryasarathi; von Andrian, Ulrich H.; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02163 USA; [von Andrian, Ulrich H.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Kasper, DL (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02163 USA.	dennis_kasper@hms.harvard.edu	Geva-Zatorsky, Naama/AAP-9176-2021	Geva-Zatorsky, Naama/0000-0002-7303-854X	Neurobiology Imaging Facility; Neural Imaging Center as part of NINDS P30 Core Center grant [NS072030]; NIH [1 S10 OD016401]; BCH/PCMM; US National Institutes of Health [PO1 AI1112521, RO1 AI111595, 5T32 HL066987]; Ragon Institute at MGH; EMBO Long-Term Fellowship [ALTF 251-2011]; Human Frontiers Science Program [LT000079/2012]; UNESCO L'Oreal National and International Women in Science Award; Fulbright Award; Weizmann Institute of Science-National Postdoctoral Award Program for Advancing Women in Science; Cancer Research Institute Irvington Fellowship Program; departmental Kirschstein-NRSA training grant; Ragon Institute at MIT; Ragon Institute at Harvard;  [U19AI095261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095261, R01AI111595, P01AI112521, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016401] Funding Source: NIH RePORTER	Neurobiology Imaging Facility; Neural Imaging Center as part of NINDS P30 Core Center grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCH/PCMM; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute at MGH; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); UNESCO L'Oreal National and International Women in Science Award; Fulbright Award; Weizmann Institute of Science-National Postdoctoral Award Program for Advancing Women in Science; Cancer Research Institute Irvington Fellowship Program; departmental Kirschstein-NRSA training grant; Ragon Institute at MIT; Ragon Institute at Harvard; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Neurobiology Imaging Facility for consultation and instrument availability that supported this work. This facility is supported in part by the Neural Imaging Center as part of NINDS P30 Core Center grant NS072030. We also thank N. Barteneva of the Flow and Imaging Cytometry Resource for help in whole-body imaging on the IVIS Spectrum (funded by grants NIH 1 S10 OD016401 and BCH/PCMM); J. Czupryna and M. Guerra from PerkinElmer for consultation and expert advice; C. Araneo (Division of Immunology Flow Cytometry Core Facility, HMS) and L. Comstock for helpful discussions, comments and reagents; and members of the Kasper and von Andrian labs for helpful discussions.; This work was also partly supported by the US National Institutes of Health (grants PO1 AI1112521, RO1 AI111595 (to U.H.v.A.) and 5T32 HL066987 (to D.A.)). Additional support to U.H.v.A. was provided by U19AI095261 and the Ragon Institute at MGH, MIT and Harvard. N.G.-Z. was supported by an EMBO Long-Term Fellowship (ALTF 251-2011), the Human Frontiers Science Program (LT000079/2012), a UNESCO L'Oreal National and International Women in Science Award, a Fulbright Award and the Weizmann Institute of Science-National Postdoctoral Award Program for Advancing Women in Science. J.E.H. was supported by the Cancer Research Institute Irvington Fellowship Program. N.C.R. was supported by a departmental Kirschstein-NRSA training grant.	Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Boyce M, 2011, NAT METHODS, V8, P638, DOI 10.1038/nmeth.1657; Cobb BA, 2008, GLYCOBIOLOGY, V18, P707, DOI 10.1093/glycob/cwn050; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Craggs TD, 2009, CHEM SOC REV, V38, P2865, DOI 10.1039/b903641p; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; Dasgupta S, 2013, INFLAMM BOWEL DIS, V19, P2478, DOI 10.1097/MIB.0b013e318297d884; Dehnert KW, 2011, ACS CHEM BIOL, V6, P547, DOI 10.1021/cb100284d; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dumont A, 2012, ANGEW CHEM INT EDIT, V51, P3143, DOI 10.1002/anie.201108127; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaewsapsak P, 2013, CHEMBIOCHEM, V14, P721, DOI 10.1002/cbic.201300006; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Millet YA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004405; NORD CE, 1990, CLIN THER, V12, P9; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Surana NK, 2012, IMMUNOL REV, V245, P13, DOI 10.1111/j.1600-065X.2011.01075.x; Troy EB, 2010, J BACTERIOL, V192, P5832, DOI 10.1128/JB.00555-10; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Yurkovetskiy LA, 2015, CELL HOST MICROBE, V17, P548, DOI 10.1016/j.chom.2015.04.010	37	138	142	5	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1091	+		10.1038/nm.3929	http://dx.doi.org/10.1038/nm.3929			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26280120	Green Accepted			2022-12-25	WOS:000360961300024
J	Hrustanovic, G; Olivas, V; Pazarentzos, E; Tulpule, A; Asthana, S; Blakely, CM; Okimoto, RA; Lin, LP; Neel, DS; Sabnis, A; Flanagan, J; Chan, E; Varella-Garcia, M; Aisner, DL; Vaishnavi, A; Ou, SHI; Collisson, EA; Ichihara, E; Mack, PC; Lovly, CM; Karachaliou, N; Rosell, R; Riess, JW; Doebele, RC; Bivona, TG				Hrustanovic, Gorjan; Olivas, Victor; Pazarentzos, Evangelos; Tulpule, Asmin; Asthana, Saurabh; Blakely, Collin M.; Okimoto, Ross A.; Lin, Luping; Neel, Dana S.; Sabnis, Amit; Flanagan, Jennifer; Chan, Elton; Varella-Garcia, Marileila; Aisner, Dara L.; Vaishnavi, Aria; Ou, Sai-Hong I.; Collisson, Eric A.; Ichihara, Eiki; Mack, Philip C.; Lovly, Christine M.; Karachaliou, Niki; Rosell, Rafael; Riess, Jonathan W.; Doebele, Robert C.; Bivona, Trever G.			RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer	NATURE MEDICINE			English	Article							MEK INHIBITION; COMBINED BRAF; ALK; RESISTANCE; MELANOMA; GENE; EML4-ALK; IDENTIFICATION; CHEMOTHERAPY; DABRAFENIB	One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in models of lung adenocarcinoma harboring the oncogenic fusion of ALK and EML4 that the GTPase RAS-mitogen-activated protein kinase (MAPK) pathway, but not other known ALK effectors, is required for tumor-cell survival. EML4-ALK activated RAS-MAPK signaling by engaging all three major RAS isoforms through the HELP domain of EML4. Reactivation of the MAPK pathway via either a gain in the number of copies of the gene encoding wild-type K-RAS (KRAS(WT)) or decreased expression of the MAPK phosphatase DUSP6 promoted resistance to ALK inhibitors in vitro, and each was associated with resistance to ALK inhibitors in individuals with EML4-ALK-positive lung adenocarcinoma. Upfront inhibition of both ALK and the kinase MEK enhanced both the magnitude and duration of the initial response in preclinical models of EML4-ALK lung adenocarcinoma. Our findings identify RAS-MAPK dependence as a hallmark of EML4-ALK lung adenocarcinoma and provide a rationale for the upfront inhibition of both ALK and MEK to forestall resistance and improve patient outcomes.	[Hrustanovic, Gorjan; Olivas, Victor; Pazarentzos, Evangelos; Tulpule, Asmin; Asthana, Saurabh; Blakely, Collin M.; Okimoto, Ross A.; Lin, Luping; Neel, Dana S.; Sabnis, Amit; Flanagan, Jennifer; Chan, Elton; Collisson, Eric A.; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Hrustanovic, Gorjan; Olivas, Victor; Pazarentzos, Evangelos; Tulpule, Asmin; Asthana, Saurabh; Blakely, Collin M.; Okimoto, Ross A.; Lin, Luping; Neel, Dana S.; Sabnis, Amit; Flanagan, Jennifer; Chan, Elton; Collisson, Eric A.; Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Varella-Garcia, Marileila; Vaishnavi, Aria; Doebele, Robert C.] Univ Colorado Anschutz Med Campus, Dept Med, Denver, CO USA; [Varella-Garcia, Marileila; Aisner, Dara L.] Univ Colorado Anschutz Med Campus, Dept Pathol, Denver, CO USA; [Ou, Sai-Hong I.] Univ Calif Irvine, Sch Med, Div Hematol Oncol, Orange, CA 92668 USA; [Ou, Sai-Hong I.] Univ Calif Irvine, Sch Med, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA; [Ichihara, Eiki; Lovly, Christine M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Mack, Philip C.; Riess, Jonathan W.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Mack, Philip C.; Riess, Jonathan W.] Ctr Comprehens Canc, Sacramento, CA USA; [Karachaliou, Niki; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Canc Biol & Precis Med Program, Barcelona, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University of California System; University of California Irvine; Vanderbilt University; University of California System; University of California Davis; Catalan Institute of Oncology; Hospital Germans Trias i Pujol	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Trever.Bivona@ucsf.edu	Ou, Sai-Hong/AAA-3389-2020; Doebele, Robert C./I-8230-2019	Doebele, Robert C./0000-0001-6728-6857; Pazarentzos, Evangelos/0000-0002-5453-1646; Sabnis, Amit/0000-0002-2061-5139; Lovly, Christine/0000-0002-3641-6361	US National Institute of Health (NIH) Director's New Innovator Award; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; American Lung Association; National Lung Cancer Partnership; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; UCSF Clinical and Translational Science Institute; National Cancer Institute (NCI) of the NIH [R01CA121210, P01CA129243]; Damon Runyon Clinical Investigator Award; LUNGevity Career Development Award; NIH [NCI5K12CA086913, NCI-P30CA046934]; NIH Paul Calabresi Cancer Development Award in Clinical Oncology [K12CA138464]; Lung Cancer SPORE [NCI-P50CA058187]; La Caixa Foundation; Redes Tematicas de Investigacion en Cancer [RD12/0036/0072]; NATIONAL CANCER INSTITUTE [P50CA058187, P01CA129243, R01CA121210, DP2CA174497, P30CA046934, K12CA138464, R01CA211052, K08CA154787, T32CA128583, K12CA086913, R01CA169338] Funding Source: NIH RePORTER	US National Institute of Health (NIH) Director's New Innovator Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Lung Association; National Lung Cancer Partnership; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; UCSF Clinical and Translational Science Institute; National Cancer Institute (NCI) of the NIH; Damon Runyon Clinical Investigator Award; LUNGevity Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Paul Calabresi Cancer Development Award in Clinical Oncology; Lung Cancer SPORE; La Caixa Foundation(La Caixa Foundation); Redes Tematicas de Investigacion en Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. McMahon, F. McCormick, K. Shannon and M. Von Zastrow (UCSF) for advice and discussions, and H. Mano (University of Tokyo) for EML4-ALK cDNA constructs and for advice. We acknowledge funding support from the following sources: a US National Institute of Health (NIH) Director's New Innovator Award, the Howard Hughes Medical Institute, the Doris Duke Charitable Foundation, the American Lung Association, the National Lung Cancer Partnership, the Sidney Kimmel Foundation for Cancer Research and the Searle Scholars Program (T.G.B.); the UCSF Clinical and Translational Science Institute (G.H.); the National Cancer Institute (NCI) of the NIH (R01CA121210 and P01CA129243), a Damon Runyon Clinical Investigator Award and a LUNGevity Career Development Award (C.M.L.); the NIH (NCI5K12CA086913) (R.C.D.); an NIH Paul Calabresi Cancer Development Award in Clinical Oncology (K12CA138464) (J.W.R.); the NIH (NCI-P30CA046934) and Lung Cancer SPORE (NCI-P50CA058187) (M.V.G.); and the La Caixa Foundation and Redes Tematicas de Investigacion en Cancer (RD12/0036/0072) (R.R.).	Alessandrini A, 1996, J BIOL CHEM, V271, P31612, DOI 10.1074/jbc.271.49.31612; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chapman PB, 2014, CANCER CELL, V26, P603, DOI 10.1016/j.ccell.2014.10.017; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Esfahani K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00174; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Graham JM, 2009, AM J MED GENET A, V149A, P2122, DOI 10.1002/ajmg.a.32992; Hainsworth JD, 2010, J THORAC ONCOL, V5, P1630, DOI 10.1097/JTO.0b013e3181e8b3a3; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin LP, 2014, P NATL ACAD SCI USA, V111, pE748, DOI 10.1073/pnas.1320956111; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Nissan M.H., 2014, CANCER RES, V74, P430; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Pollmann M, 2006, EXP CELL RES, V312, P3241, DOI 10.1016/j.yexcr.2006.06.035; Richards MW, 2014, P NATL ACAD SCI USA, V111, P5195, DOI 10.1073/pnas.1322892111; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Takezawa K, 2011, CLIN CANCER RES, V17, P2140, DOI 10.1158/1078-0432.CCR-10-2798; Tanizaki J, 2012, BRIT J CANCER, V106, P763, DOI 10.1038/bjc.2011.586; Wilson FH, 2015, CANCER CELL, V27, P397, DOI 10.1016/j.ccell.2015.02.005; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	42	180	183	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1038	+		10.1038/nm.3930	http://dx.doi.org/10.1038/nm.3930			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26301689	Green Accepted			2022-12-25	WOS:000360961300016
J	Magidson, V; Paul, R; Yang, NC; Ault, JG; O'Connell, CB; Tikhonenko, I; McEwen, BF; Mogilner, A; Khodjakov, A				Magidson, Valentin; Paul, Raja; Yang, Nachen; Ault, Jeffrey G.; O'Connell, Christopher B.; Tikhonenko, Irina; McEwen, Bruce F.; Mogilner, Alex; Khodjakov, Alexey			Adaptive changes in the kinetochore architecture facilitate proper spindle assembly	NATURE CELL BIOLOGY			English	Article							MAMMALIAN TISSUE-CELLS; NEWT LUNG-CELLS; MITOTIC-SPINDLE; MICROTUBULE ATTACHMENT; CENP-E; CHROMOSOME SEGREGATION; OUTER PLATE; DROSOPHILA-MELANOGASTER; ELECTRON-MICROSCOPY; CANCER-CELLS	Mitotic spindle formation relies on the stochastic capture of microtubules at kinetochores. Kinetochore architecture affects the efficiency and fidelity of this process with large kinetochores expected to accelerate assembly at the expense of accuracy, and smaller kinetochores to suppress errors at the expense of efficiency. We demonstrate that on mitotic entry, kinetochores in cultured human cells form large crescents that subsequently compact into discrete structures on opposite sides of the centromere. This compaction occurs only after the formation of end-on microtubule attachments. Live-cell microscopy reveals that centromere rotation mediated by lateral kinetochore-microtubule interactions precedes the formation of end-on attachments and kinetochore compaction. Computational analyses of kinetochore expansion-compaction in the context of lateral interactions correctly predict experimentally observed spindle assembly times with reasonable error rates. The computational model suggests that larger kinetochores reduce both errors and assembly times, which can explain the robustness of spindle assembly and the functional significance of enlarged kinetochores.	[Magidson, Valentin; Yang, Nachen; Ault, Jeffrey G.; O'Connell, Christopher B.; Tikhonenko, Irina; McEwen, Bruce F.; Khodjakov, Alexey] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Paul, Raja] Indian Assoc Cultivat Sci, Kolkata 700032, India; [Paul, Raja; Mogilner, Alex] NYU, Courant Inst, New York, NY 10012 USA; [Paul, Raja; Mogilner, Alex] NYU, Dept Biol, New York, NY 10012 USA; [Khodjakov, Alexey] Rensselaer Polytech Inst, Troy, NY 12180 USA	State University of New York (SUNY) System; Wadsworth Center; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; New York University; New York University; Rensselaer Polytechnic Institute	Mogilner, A (corresponding author), NYU, Courant Inst, New York, NY 10012 USA.	mogilner@cims.nyu.edu; alexey.khodjakov@health.ny.gov		Magidson, Valentin/0000-0002-0780-9123	NIH [GM059363]; NSF [DMS-1118206]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM059363 to A.K. and NSF grant DMS-1118206 to A.M. The Electron Microscopy was enabled by the use of the Wadsworth Center's Electron Microscopy Core Facility. We thank J .Pines (University of Cambridge, UK) for his generous donation of Mad2-Venus cells and S. Li (Air Worldwide, USA) for assistance with the intensity quantifications.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; CHURCH K, 1985, CHROMOSOMA, V92, P273, DOI 10.1007/BF00329810; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Jones JT, 2004, NAT BIOTECHNOL, V22, P306, DOI 10.1038/nbt941; Kalinina I, 2013, NAT CELL BIOL, V15, P82, DOI 10.1038/ncb2640; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kleylein-Sohn J, 2012, J CELL SCI, V125, P5391, DOI 10.1242/jcs.107474; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; McEwen BF, 1998, CHROMOSOME RES, V6, P123, DOI 10.1023/A:1009239013215; MCEWEN BF, 1993, J CELL BIOL, V120, P301, DOI 10.1083/jcb.120.2.301; McIntosh JR, 2012, Q REV BIOPHYS, V45, P147, DOI 10.1017/S0033583512000017; MERDES A, 1990, EUR J CELL BIOL, V53, P313; Nicholson JM, 2011, ADV CANCER RES, V112, P43, DOI 10.1016/B978-0-12-387688-1.00003-X; O'Connell CB, 2009, J CELL BIOL, V187, P43, DOI 10.1083/jcb.200903076; Paul R, 2009, P NATL ACAD SCI USA, V106, P15708, DOI 10.1073/pnas.0908261106; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; ROOS UP, 1973, CHROMOSOMA, V41, P195, DOI 10.1007/BF00319696; Shrestha RL, 2013, CURR BIOL, V23, P1514, DOI 10.1016/j.cub.2013.06.040; Sikirzhytski V, 2014, J CELL BIOL, V206, P231, DOI 10.1083/jcb.201401090; Silkworth WT, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-19; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Thrower DA, 1996, CELL MOTIL CYTOSKEL, V35, P121, DOI 10.1002/(SICI)1097-0169(1996)35:2<121::AID-CM5>3.0.CO;2-D; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107	50	85	85	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1134	+		10.1038/ncb3223	http://dx.doi.org/10.1038/ncb3223			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26258631	Green Accepted			2022-12-25	WOS:000361113700007
J	Neu, A; Neu, U; Fuchs, AL; Schlager, B; Sprangers, R				Neu, Ancilla; Neu, Ursula; Fuchs, Anna-Lisa; Schlager, Benjamin; Sprangers, Remco			An excess of catalytically required motions inhibits the scavenger decapping enzyme	NATURE CHEMICAL BIOLOGY			English	Article							NMR-SPECTROSCOPY; DCPS; MECHANISM; DYNAMICS; ELIMINATION; CATALYSIS; INSIGHTS; EXOSOME; SYSTEM; MOUSE	The scavenger decapping enzyme hydrolyzes the protective 5' cap structure on short mRNA fragments that are generated from the exosomal degradation of mRNAs. From static crystal structures and NMR data, it is apparent that the dimeric enzyme has to undergo large structural changes to bind its substrate in a catalytically competent conformation. Here we studied the yeast enzyme and showed that the associated opening and closing motions can be orders of magnitude faster than the catalytic turnover rate. This excess of motion is induced by the binding of a second ligand to the enzyme, which occurs at high substrate concentrations. We designed a mutant that disrupted the allosteric pathway that links the second binding event to the dynamics and showed that this mutant enzyme is hyperactive. Our data reveal a unique mechanism of substrate inhibition in which motions that are required for catalytic activity also inhibit efficient turnover when they are present in excess.	[Neu, Ancilla; Fuchs, Anna-Lisa; Schlager, Benjamin; Sprangers, Remco] Max Planck Inst Dev Biol, Tubingen, Germany; [Neu, Ursula] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Sprangers, R (corresponding author), Max Planck Inst Dev Biol, Tubingen, Germany.	remco.sprangers@tuebingen.mpg.de		Neu, Ursula/0000-0001-6852-0879	Max Planck Society; European Research Council under the EU's Seventh Framework Programme (FP7), ERC grant [616052]	Max Planck Society(Max Planck Society); European Research Council under the EU's Seventh Framework Programme (FP7), ERC grant	We acknowledge J. Peters for excellent technical support, S. Wiesner for discussions, G. Zocher for assistance in recording diffraction data, T. Stehle for support and L. Kay for valuable comments on the manuscript. This work has received funding from the Max Planck Society and the European Research Council under the EU's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement no. 616052.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Amero C, 2011, J BIOMOL NMR, V50, P229, DOI 10.1007/s10858-011-9513-5; Audin MJC, 2013, ANGEW CHEM INT EDIT, V52, P8312, DOI 10.1002/anie.201302811; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Chen N, 2005, J MOL BIOL, V347, P707, DOI 10.1016/j.jmb.2005.01.062; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gogliotti RG, 2013, HUM MOL GENET, V22, P4084, DOI 10.1093/hmg/ddt258; Gu MG, 2004, MOL CELL, V14, P67, DOI 10.1016/S1097-2765(04)00180-7; HAMMES GG, 1964, NATURE, V204, P342, DOI 10.1038/204342a0; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Han GW, 2005, PROTEINS, V60, P797, DOI 10.1002/prot.20467; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Liu SW, 2008, J BIOL CHEM, V283, P16427, DOI 10.1074/jbc.M800341200; Liu SW, 2004, RNA, V10, P1412, DOI 10.1261/rna.7660804; Malys N, 2006, J MOL BIOL, V363, P370, DOI 10.1016/j.jmb.2006.08.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeagh JD, 2011, BBA-PROTEINS PROTEOM, V1814, P1077, DOI 10.1016/j.bbapap.2010.12.002; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pentikainen U, 2008, PROTEINS, V70, P498, DOI 10.1002/prot.21540; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Rosenzweig R, 2014, ANNU REV BIOCHEM, V83, P291, DOI 10.1146/annurev-biochem-060713-035829; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Seraphin B., 1992, DNA Sequence, V3, P177, DOI 10.3109/10425179209034013; Singh J, 2008, ACS CHEM BIOL, V3, P711, DOI 10.1021/cb800120t; Sinturel F, 2012, P NATL ACAD SCI USA, V109, P8264, DOI 10.1073/pnas.1120090109; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Taverniti V, 2015, NUCLEIC ACIDS RES, V43, P482, DOI 10.1093/nar/gku1251; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; van den Bedem H, 2015, NAT METHODS, V12, P307, DOI 10.1038/nmeth.3324; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Wypijewska A, 2012, BIOCHEMISTRY-US, V51, P8003, DOI 10.1021/bi300781g; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	46	20	20	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					697	+		10.1038/NCHEMBIO.1866	http://dx.doi.org/10.1038/NCHEMBIO.1866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26258763	Green Accepted			2022-12-25	WOS:000359954700014
J	Jefferson, DJ; Graff, GD; Chi-Ham, CL; Bennett, AB				Jefferson, David J.; Graff, Gregory D.; Chi-Ham, Cecilia L.; Bennett, Alan B.			The emergence of agbiogenerics	NATURE BIOTECHNOLOGY			English	Editorial Material							BIOTECHNOLOGY; CROPS		[Jefferson, David J.; Chi-Ham, Cecilia L.; Bennett, Alan B.] Univ Calif Davis, Dept Plant Sci, PIPRA Publ Sect Intellectual Property Resource Ag, Davis, CA 95616 USA; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA	University of California System; University of California Davis; Colorado State University	Jefferson, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, PIPRA Publ Sect Intellectual Property Resource Ag, Davis, CA 95616 USA.	djjefferson@ucdavis.edu		Graff, Gregory/0000-0002-9140-0901; Jefferson, David/0000-0001-5156-3469				Allred J. S., 2013, SOC SCI RES NETWORK; American Seed Trade Association & Biotechnology Industry Organization, 2012, AC GEN EV MARK ACC A; [Anonymous], 2014, SEED QUEST; [Anonymous], 2015, AUTH CORR N MCKINNEY; [Anonymous], 2015, SOYA BEAN GMO COMPAS; Barry GF, 2006, Patent No. [US RE039247, 039247]; Biotechnology Industry Organization & American Seed Trade Association, 2013, ACC GEN EV MARK ACC, VFirst; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Brants IO, 2000, US Patent, Patent No. 6083878; Chi-Ham CL, 2012, PLANT BIOTECHNOL J, V10, P501, DOI 10.1111/j.1467-7652.2011.00674.x; Coggio BD, 2002, FOOD DRUG LAW J, V57, P161; Comai L., 2000, US patent, Patent No. [6,051,753, 6051753]; Feng P. C. C., 2012, MODERN CROP PROTECTI, V1, P415; Graff G. D., INNOVATION AGR GENOM; Grushkin D, 2013, NAT BIOTECHNOL, V31, P10, DOI 10.1038/nbt0113-10c; Herrera-Estrella L., 1998, US patent, Patent No. [5,728,925, 5728925]; Herrera-Estrella L., 1998, US patent, Patent No. [5,717,084, 5717084]; Krieb R., 2007, US patent, Patent No. [7,306,909, 7306909]; Krieb R., 2010, US patent, Patent No. [7,718,373, 7718373, US 7,718,373 B2]; Lema M. A., 2008, BIORES, V2, P3; Monsanto, 2015, ROUND READ SOYB PAT; Rabesandratana T, 2014, SCIENCE, V346, P1280, DOI 10.1126/science.346.6215.1280; Redick T., 2010, AGR LAW UPDATE, V27, P2; Redick T. P., 2013, BIOTECH N AM SPEC CR, V226, P221; Schonenberg B.M, 2014, MARQUETTE LAW REV, V97, P1039; USDA, 2014, REC TRENDS GE AD	26	12	14	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					819	823		10.1038/nbt.3306	http://dx.doi.org/10.1038/nbt.3306			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252137	Bronze			2022-12-25	WOS:000359274900016
J	Shintomi, K; Takahashi, TS; Hirano, T				Shintomi, Keishi; Takahashi, Tatsuro S.; Hirano, Tatsuya			Reconstitution of mitotic chromatids with a minimum set of purified factors	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; NUCLEOSOME ASSEMBLY PROTEIN-1; CHROMOSOME CONDENSATION; TOPOISOMERASE-II; CRYSTAL-STRUCTURE; 13S CONDENSIN; IN-VITRO; AURORA-B; HISTONE; DNA	The assembly of mitotic chromosomes, each composed of a pair of rod-shaped chromatids, is an essential prerequisite for accurate transmission of the genome during cell division. It remains poorly understood, however, how this fundamental process might be achieved and regulated in the cell. Here we report an in vitro system in which mitotic chromatids can be reconstituted by mixing a simple substrate with only six purified factors: core histones, three histone chaperones (nucleoplasmin, Nap1 and FACT), topoisomerase II (topo II) and condensin I. We find that octameric nucleosomes containing the embryonic variant H2A.X-F are highly susceptible to FACT and function as the most productive substrate for subsequent actions of topo II and condensin I. Cdk1 phosphorylation of condensin I is the sole mitosis-specific modification required for chromatid reconstitution. This experimental system will enhance our understanding of the mechanisms of action of individual factors and their cooperation during this process.	[Shintomi, Keishi; Hirano, Tatsuya] RIKEN, Chromosome Dynam Lab, Wako, Saitama 3510198, Japan; [Takahashi, Tatsuro S.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	RIKEN; Osaka University	Hirano, T (corresponding author), RIKEN, Chromosome Dynam Lab, Wako, Saitama 3510198, Japan.	hiranot@riken.jp	Hirano, Tatsuya/F-6008-2011; Takahashi, Tatsuro/AAD-9936-2020; Takahashi, Tatsuro/F-4669-2016; Shintomi, Keishi/C-3629-2017	Hirano, Tatsuya/0000-0002-4219-6473; Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Shintomi, Keishi/0000-0003-0484-9901	Grants-in-Aid for Scientific Research [26116525] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Flemming, 1882, ZELLSUBSTANTZ KERN Z; Formosa Tim, 2013, Biochim Biophys Acta, V1819, P247; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Hancock R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036045; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirano T, 2014, TRENDS CELL BIOL, V24, P727, DOI 10.1016/j.tcb.2014.06.007; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Isaacs RJ, 1998, BBA-GENE STRUCT EXPR, V1400, P121, DOI 10.1016/S0167-4781(98)00131-6; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Lindsley JE, 1999, METH MOL B, V94, P187; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacCallum DE, 2002, MOL BIOL CELL, V13, P25, DOI 10.1091/mbc.01-09-0441; Maeshima K, 2010, COLD SH Q B, V75, P439, DOI 10.1101/sqb.2010.75.034; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; OHSUMI K, 1991, DEV BIOL, V148, P295, DOI 10.1016/0012-1606(91)90338-4; OHSUMI K, 1993, SCIENCE, V262, P2033, DOI 10.1126/science.8266099; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Okumura E, 1996, J CELL BIOL, V132, P125, DOI 10.1083/jcb.132.1.125; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pepenella S, 2014, CHROMOSOMA, V123, P3, DOI 10.1007/s00412-013-0435-8; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Shintomi K, 2005, P NATL ACAD SCI USA, V102, P8210, DOI 10.1073/pnas.0500822102; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Wang WL, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-22; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236	49	106	106	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1014	U336		10.1038/ncb3187	http://dx.doi.org/10.1038/ncb3187			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26075356				2022-12-25	WOS:000358847700009
J	Ding, J; Chen, JH; Wang, YQ; Kataoka, M; Ma, LX; Zhou, PZ; Hu, XY; Lin, ZQ; Nie, M; Deng, ZL; Pu, WT; Wang, DZ				Ding, Jian; Chen, Jinghai; Wang, Yanqun; Kataoka, Masaharu; Ma, Lixin; Zhou, Pingzhu; Hu, Xiaoyun; Lin, Zhiqiang; Nie, Mao; Deng, Zhong-Liang; Pu, William T.; Wang, Da-Zhi			Trbp regulates heart function through microRNA-mediated Sox6 repression	NATURE GENETICS			English	Article							RNA-BINDING-PROTEIN; GENE-EXPRESSION; CARDIOMYOCYTE PROLIFERATION; CARDIAC-HYPERTROPHY; MUTATION; DICER; COEXISTENCE; ACTIVATION; CONDUCTION; MYOPATHY	Cardiomyopathy is associated with altered expression of genes encoding contractile proteins. Here we show that Trbp (Tarbp2), an RNA-binding protein, is required for normal heart function. Cardiac-specific inactivation in mice of Trbp (Trbp(cKO)) caused progressive cardiomyopathy and lethal heart failure. Loss of Trbp function resulted in upregulation of Sox6, repression of genes encoding normal cardiac slow-twitch myofiber proteins and pathologically increased expression of genes encoding skeletal fast-twitch myofiber proteins. Remarkably, knockdown of Sox6 fully rescued the Trbp-mutant phenotype, whereas mice overexpressing Sox6 phenocopied Trbp(cKO) mice. Trbp inactivation was mechanistically linked to Sox6 upregulation through altered processing of miR-208a, which is a direct inhibitor of Sox6. Transgenic overexpression of Mir208a sufficiently repressed Sox6, restored the balance in gene expression for fast-and slow-twitch myofiber proteins, and rescued cardiac function in Trbp(cKO) mice. Together, our studies identify a new Trbp-mediated microRNA-processing mechanism in the regulation of a linear genetic cascade essential for normal heart function.	[Ding, Jian; Chen, Jinghai; Kataoka, Masaharu; Ma, Lixin; Zhou, Pingzhu; Hu, Xiaoyun; Lin, Zhiqiang; Nie, Mao; Pu, William T.; Wang, Da-Zhi] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02139 USA; [Wang, Yanqun] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kataoka, Masaharu] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Ma, Lixin] Hubei Univ, Coll Life Sci, Wuhan, Peoples R China; [Nie, Mao; Deng, Zhong-Liang] Chongqing Med Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Chongqing, Peoples R China; [Pu, William T.; Wang, Da-Zhi] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Keio University; Hubei University; Chongqing Medical University; Harvard University	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02139 USA.	dwang@enders.tch.harvard.edu	Ding, Jian/F-6996-2015; Nie, Mao/GZM-0399-2022; Pu, William/AAJ-8301-2020	Ding, Jian/0000-0002-5578-5410; Pu, William/0000-0002-4551-8079; Lin, zhiqiang/0000-0002-2034-2492	March of Dimes Foundation; Muscular Dystrophy Association; US National Institutes of Health [HL085635, HL116919]; Banyu Life Science Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085635, R01HL125925, R01HL116919] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Muscular Dystrophy Association(Muscular Dystrophy Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banyu Life Science Foundation International(Banyu Life Science Foundation International); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Clapham and members of the Wang laboratory for advice and support. We thank R. Espinoza-Lewis, G. Wang and F. Gu for technical support. We thank F.F. Wang for careful reading of the manuscript. Work in the Wang laboratory is supported by the March of Dimes Foundation, the Muscular Dystrophy Association and the US National Institutes of Health (HL085635 and HL116919). M.K. was supported by Banyu Life Science Foundation International.	An CI, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-59; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Creemers EE, 2011, NAT REV GENET, V12, P357, DOI 10.1038/nrg2983; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; Feng HZ, 2010, AM J PHYSIOL-HEART C, V299, pH97, DOI 10.1152/ajpheart.01105.2009; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Jiang JM, 2013, SCIENCE, V342, P111, DOI 10.1126/science.1236921; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Kim Y, 2014, CELL REP, V9, P1061, DOI 10.1016/j.celrep.2014.09.039; Kimber E, 2006, NEUROLOGY, V67, P597, DOI 10.1212/01.wnl.0000230168.05328.f4; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lin ZQ, 2014, CIRC RES, V115, P354, DOI 10.1161/CIRCRESAHA.115.303632; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Matkovich SJ, 2013, CIRC RES, V113, P62, DOI 10.1161/CIRCRESAHA.113.300975; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Olson TM, 2002, CIRCULATION, V105, P2337, DOI 10.1161/01.CIR.0000018444.47798.94; Petchey LK, 2014, P NATL ACAD SCI USA, V111, P9515, DOI 10.1073/pnas.1406191111; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Tajsharghi H, 2007, ARCH NEUROL-CHICAGO, V64, P1334, DOI 10.1001/archneur.64.9.1334; Trivedi CM, 2011, J MOL CELL CARDIOL, V50, P1056, DOI 10.1016/j.yjmcc.2011.02.015; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; VANBILSEN M, 1993, CARDIOVASC RES, V27, P1140; Yu ZB, 2012, AM J PHYSIOL-CELL PH, V303, pC24, DOI 10.1152/ajpcell.00026.2012; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	50	41	41	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					776	+		10.1038/ng.3324	http://dx.doi.org/10.1038/ng.3324			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029872	Green Accepted, Green Submitted			2022-12-25	WOS:000357090300015
J	Gaidatzis, D; Burger, L; Florescu, M; Stadler, MB				Gaidatzis, Dimos; Burger, Lukas; Florescu, Maria; Stadler, Michael B.			Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; EMBRYONIC STEM-CELLS; PRE-MESSENGER-RNA; GENE-EXPRESSION; MAMMALIAN MICRORNAS; CELLULAR CONTEXTS; REVEALS; RECONSTRUCTION; LANDSCAPE; PRECISION	RNA-seq experiments generate reads derived not only from mature RNA transcripts but also from pre-mRNA. Here we present a computational approach called exon-intron split analysis (EISA) that measures changes in mature RNA and pre-mRNA reads across different experimental conditions to quantify transcriptional and post-transcriptional regulation of gene expression. We apply EISA to 17 diverse data sets to show that most intronic reads arise from nuclear RNA and changes in intronic read counts accurately predict changes in transcriptional activity. Furthermore, changes in post-transcriptional regulation can be predicted from differences between exonic and intronic changes. EISA reveals both transcriptional and post-transcriptional contributions to expression changes, increasing the amount of information that can be gained from RNA-seq data sets.	[Gaidatzis, Dimos; Burger, Lukas; Florescu, Maria; Stadler, Michael B.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Gaidatzis, Dimos; Burger, Lukas; Florescu, Maria; Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland; [Florescu, Maria] Univ Basel, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; University of Basel	Gaidatzis, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	d.gaidatzis@fmi.ch; lukas.burger@fmi.ch; michael.stadler@fmi.ch		Florescu, Maria/0000-0002-0564-5663	Novartis Research Foundation	Novartis Research Foundation	We thank D. Schubeler, A. Krebs, R. Ivanek and T.C. Roloff for feedback on the manuscript. We gratefully acknowledge funding from the Novartis Research Foundation.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Zaghlool A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-99; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62	50	143	144	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					722	729		10.1038/nbt.3269	http://dx.doi.org/10.1038/nbt.3269			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098447	Bronze			2022-12-25	WOS:000358396100026
J	Long, L; Ormiston, ML; Yang, XD; Southwood, M; Graf, S; Machado, RD; Mueller, M; Kinzel, B; Yung, LM; Wilkinson, JM; Moore, SD; Drake, KM; Aldred, MA; Yu, PB; Upton, PD; Morrell, NW				Long, Lu; Ormiston, Mark L.; Yang, Xudong; Southwood, Mark; Graef, Stefan; Machado, Rajiv D.; Mueller, Matthias; Kinzel, Bernd; Yung, Lai Ming; Wilkinson, Janine M.; Moore, Stephen D.; Drake, Kylie M.; Aldred, Micheala A.; Yu, Paul B.; Upton, Paul D.; Morrell, Nicholas W.			Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension	NATURE MEDICINE			English	Article							BONE MORPHOGENETIC PROTEIN; HEREDITARY HEMORRHAGIC TELANGIECTASIA; SMOOTH-MUSCLE-CELLS; RECEPTOR-II; INCREASED SUSCEPTIBILITY; GERMLINE MUTATIONS; GENETIC ABLATION; BARRIER FUNCTION; IN-VITRO; MICE	Genetic evidence implicates the loss of bone morphogenetic protein type II receptor (BMPR-II) signaling in the endothelium as an initiating factor in pulmonary arterial hypertension (PAH). However, selective targeting of this signaling pathway using BMP ligands has not yet been explored as a therapeutic strategy. Here, we identify BMP9 as the preferred ligand for preventing apoptosis and enhancing monolayer integrity in both pulmonary arterial endothelial cells and blood outgrowth endothelial cells from subjects with PAH who bear mutations in the gene encoding BMPR-II, BMPR2. Mice bearing a heterozygous knock-in allele of a human BMPR2 mutation, R899X, which we generated as an animal model of PAH caused by BMPR-II deficiency, spontaneously developed PAH. Administration of BMP9 reversed established PAH in these mice, as well as in two other experimental PAH models, in which PAH develops in response to either monocrotaline or VEGF receptor inhibition combined with chronic hypoxia. These results demonstrate the promise of direct enhancement of endothelial BMP signaling as a new therapeutic strategy for PAH.	[Long, Lu; Ormiston, Mark L.; Yang, Xudong; Graef, Stefan; Wilkinson, Janine M.; Moore, Stephen D.; Upton, Paul D.; Morrell, Nicholas W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Southwood, Mark] Papworth Hosp, Dept Pathol, Cambridge CB3 8RE, England; [Machado, Rajiv D.] Lincoln Univ, Sch Life Sci, Lincoln, New Zealand; [Mueller, Matthias; Kinzel, Bernd] Novartis Inst Biomed Res, Basel, Switzerland; [Yung, Lai Ming; Yu, Paul B.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Yung, Lai Ming; Yu, Paul B.] Harvard Univ, Sch Med, Boston, MA USA; [Drake, Kylie M.; Aldred, Micheala A.] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; Lincoln University - New Zealand; Novartis; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cleveland Clinic Foundation	Morrell, NW (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	nwm23@cam.ac.uk	Yu, Paul B./J-7540-2019; wei, wei/HHR-8613-2022; Machado, Rajiv D./AAD-7813-2019	Yu, Paul B./0000-0003-2145-4944; Machado, Rajiv D./0000-0001-9247-0744; Ormiston, Mark/0000-0003-0907-1940; Morrell, Nicholas/0000-0001-5700-9792; southwood, mark/0000-0002-3493-9599; Wilkinson, Janine/0000-0003-4901-131X	British Heart Foundation [RG/13/4/30107, CH/09/001/25945, PG/11/10/28724, FS/12/39/29653]; Fondation Leducq Transatlantic Network of Excellence Award; US National Institutes of Health [5R01-AR057374, 5K08-HL079943, R01-HL098199]; Howard Hughes Medical Institute Early Career Physician Scientist Award; UK National Institute for Health Research Healthcare Science Fellowship; MRC [MR/K020919/1, G1000847, G0800784] Funding Source: UKRI; British Heart Foundation [PG/12/54/29734, PG/10/35/28339] Funding Source: researchfish; Medical Research Council [G0800784, MR/K020919/1, G1000847] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10086] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, R01HL098199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057374] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Fondation Leducq Transatlantic Network of Excellence Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Early Career Physician Scientist Award; UK National Institute for Health Research Healthcare Science Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the British Heart Foundation RG/13/4/30107 (N.W.M.), CH/09/001/25945 (N.W.M.), PG/11/10/28724 (P.D.U. and N.W.M.) and FS/12/39/29653 (M.L.O.); a Fondation Leducq Transatlantic Network of Excellence Award (N.W.M. and P.B.Y.); US National Institutes of Health grants 5R01-AR057374 (P.B.Y.), 5K08-HL079943 (P.B.Y.) and R01-HL098199 (M.A.A.); a Howard Hughes Medical Institute Early Career Physician Scientist Award (P.B.Y.) and a UK National Institute for Health Research Healthcare Science Fellowship (M.S.). The UK National Institute for Health Research Cambridge Biomedical Research Centre and Cell Phenotyping Hub provided infrastructure support.	Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Ciumas M, 2013, ARTERIOSCL THROM VAS, V33, P2577, DOI 10.1161/ATVBAHA.113.301976; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Frump AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080319; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Geti I, 2012, STEM CELL TRANSL MED, V1, P855, DOI 10.5966/sctm.2012-0093; Gonzalez-Nunez M, 2013, BBA-MOL BASIS DIS, V1832, P1492, DOI 10.1016/j.bbadis.2013.05.016; Han C, 2013, HYPERTENSION, V61, P1044, DOI 10.1161/HYPERTENSIONAHA.111.199158; Harrington EO, 2003, AM J RESP CELL MOL, V28, P626, DOI 10.1165/rcmb.2002-0085OC; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kim CW, 2013, ARTERIOSCL THROM VAS, V33, P1350, DOI 10.1161/ATVBAHA.112.300287; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nasim MT, 2011, HUM MUTAT, V32, P1385, DOI 10.1002/humu.21605; Prewitt AR, 2015, J BIOL CHEM, V290, P960, DOI 10.1074/jbc.M114.591057; Reynolds AM, 2012, EUR RESPIR J, V39, P329, DOI 10.1183/09031936.00187310; Reynolds AM, 2007, AM J PHYSIOL-LUNG C, V292, pL1182, DOI 10.1152/ajplung.00020.2006; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Slowik MR, 1997, LAB INVEST, V77, P257; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Waters JP, 2013, J VASC RES, V50, P324, DOI 10.1159/000353303; WILSON DW, 1992, CRIT REV TOXICOL, V22, P307, DOI 10.3109/10408449209146311; Yang J, 2008, CIRC RES, V102, P1212, DOI 10.1161/CIRCRESAHA.108.173567; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yeager ME, 2001, CIRC RES, V88, pE2	52	296	315	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					777	+		10.1038/nm.3877	http://dx.doi.org/10.1038/nm.3877			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26076038	Green Submitted, Green Accepted			2022-12-25	WOS:000357604600019
J	Dilthey, A; Cox, C; Iqbal, Z; Nelson, MR; McVean, G				Dilthey, Alexander; Cox, Charles; Iqbal, Zamin; Nelson, Matthew R.; McVean, Gil			Improved genome inference in the MHC using a population reference graph	NATURE GENETICS			English	Article							READ ALIGNMENT; HAPLOTYPES; INVERSION; SEQUENCES; DIVERSITY; SNP	Although much is known about human genetic variation, such information is typically ignored in assembling new genomes. Instead, reads are mapped to a single reference, which can lead to poor characterization of regions of high sequence or structural diversity. We introduce a population reference graph, which combines multiple reference sequences and catalogs of variation. The genomes of new samples are reconstructed as paths through the graph using an efficient hidden Markov model, allowing for recombination between different haplotypes and additional variants. By applying the method to the 4.5-Mb extended MHC region on human chromosome 6, combining 8 assembled haplotypes, the sequences of known classical HLA alleles and 87,640 SNP variants from the 1000 Genomes Project, we demonstrate using simulations, SNP genotyping, and short-read and long-read data how the method improves the accuracy of genome inference and identified regions where the current set of reference sequences is substantially incomplete.	[Dilthey, Alexander; Iqbal, Zamin; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Cox, Charles] GlaxoSmithKline, Dept Quantitat Sci, Stevenage, Herts, England; [Nelson, Matthew R.] GlaxoSmithKline, Dept Quantitat Sci, Res Triangle Pk, NC USA	University of Oxford; Wellcome Centre for Human Genetics; GlaxoSmithKline; GlaxoSmithKline	Dilthey, A (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	dilthey@well.ox.ac.uk; mcvean@well.ox.ac.uk		Iqbal, Zamin/0000-0001-8466-7547	GlaxoSmithKline; Wellcome Trust [100956/Z/13/Z, 102541/Z/13/Z]; Nuffield Department of Medicine Fellowship; Royal Society [102541/Z/13/Z]	GlaxoSmithKline(GlaxoSmithKline); Wellcome Trust(Wellcome Trust); Nuffield Department of Medicine Fellowship; Royal Society(Royal Society of London)	We thank M. Eberle and colleagues at Illumina for early access to the Moleculo data. The study was funded by grants from GlaxoSmithKline and grant 100956/Z/13/Z from the Wellcome Trust to G.M., a Nuffield Department of Medicine Fellowship to Z.I. and a Sir Henry Dale Fellowship jointly awarded by the Wellcome Trust and the Royal Society to Z.I. (102541/Z/13/Z).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Garrison E, 2012, HAPLOTYPE BASED VARI; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Huang L, 2013, BIOINFORMATICS, V29, P361, DOI 10.1093/bioinformatics/btt215; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Paten B., 2014, MAPPING REFERENCE GE; Paten B, 2011, J COMPUT BIOL, V18, P469, DOI 10.1089/cmb.2010.0252; Raphael B, 2004, GENOME RES, V14, P2336, DOI 10.1101/gr.2657504; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Weisenfeld NI, 2014, NAT GENET, V46, P1350, DOI 10.1038/ng.3121; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	30	107	111	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					682	688		10.1038/ng.3257	http://dx.doi.org/10.1038/ng.3257			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915597	Green Submitted, Green Accepted			2022-12-25	WOS:000355386500023
J	Possas, C; Antunes, AMD; Mendes, FML; Schumacher, SDR; Martins, RM; Homma, A				Possas, Cristina; de Souza Antunes, Adelaide Maria; Lins Mendes, Flavia Maria; Rodrigues Schumacher, Suzanne de Oliveira; Martins, Reinaldo Menezes; Homma, Akira			Access to new technologies in multipatented vaccines: challenges for Brazil	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY; DEVELOPING-COUNTRIES; HEALTH; INDIA		[Possas, Cristina; Martins, Reinaldo Menezes; Homma, Akira] Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil; [de Souza Antunes, Adelaide Maria; Lins Mendes, Flavia Maria; Rodrigues Schumacher, Suzanne de Oliveira] Univ Fed Rio de Janeiro, Sch Chem, Rio De Janeiro, Brazil; [Possas, Cristina] Fiocruz MS, Evandro Chagas Natl Inst Infectol, BR-21045900 Rio De Janeiro, Brazil; [de Souza Antunes, Adelaide Maria] Natl Inst Ind Property, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Instituto Nacional da Propriedade Industrial (INPI)	Possas, C (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil.	cristina.possas@bio.fiocruz.br	Possas, Cristina/AAJ-3840-2020; Martins, Reinaldo/I-3413-2015; Antunes, Adelaide M S/C-6328-2017	Martins, Reinaldo/0000-0002-0667-532X; Antunes, Adelaide/0000-0002-2245-7517				[Anonymous], 2013, REV PAT LAW INN SUPP; Basso M., 2006, International Journal of Intellectual Property Management, V1, P54, DOI 10.1504/IJIPM.2006.011022; Block F., 2011, STATE INNOVATION US; Brazilian National Confederation of Industry, 2014, INT PROP CHANG IND N; Geradin D., 2011, SANT CLAR U COMP HIG; Greenwood B, 2011, PHILOS T R SOC B, V366, P2733, DOI 10.1098/rstb.2011.0076; Homma A, 2013, VACCINE, V31, pB54, DOI 10.1016/j.vaccine.2012.11.084; Homma A, 2009, BIOLOGICALS, V37, P173, DOI 10.1016/j.biologicals.2009.02.011; Mahoney RT, 2004, VACCINE, V22, P786, DOI 10.1016/j.vaccine.2003.04.001; Mazzucato M, 2006, KNOWLEDGE ACCUMULATION AND INDUSTRY EVOLUTION: THE CASE OF PHARMA-BIOTECH, P1, DOI 10.2277/ 0521858224; Mazzucato M., 2013, ENTREPRENEURIAL STAT; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Milstien JB, 2007, VACCINE, V25, P7610, DOI 10.1016/j.vaccine.2007.09.007; Oliveira M.H., 2015, FACTO ABIFINA, V43, P18; Padmanabhan S, 2010, NAT BIOTECHNOL, V28, P671, DOI 10.1038/nbt0710-671; Rezaie R, 2008, NAT BIOTECHNOL, V26, P627, DOI 10.1038/nbt0608-627; Santos P.R., 2014, INTEL PROP RIGHTS, V2, P119; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; US Patent and Trademark Office, 2015, ALL TECHN REP PAT TE	19	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					599	604		10.1038/nbt.3244	http://dx.doi.org/10.1038/nbt.3244			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057975	Bronze			2022-12-25	WOS:000356019700016
J	Surakka, I; Horikoshi, M; Magi, R; Sarin, AP; Mahajan, A; Lagou, V; Marullo, L; Ferreira, T; Miraglio, B; Timonen, S; Kettunen, J; Pirinen, M; Karjalainen, J; Thorleifsson, G; Hagg, S; Hottenga, JJ; Isaacs, A; Ladenvall, C; Beekman, M; Esko, T; Ried, JS; Nelson, CP; Willenborg, C; Gustafsson, S; Westra, HJ; Blades, M; de Craen, AJM; de Geus, EJ; Deelen, J; Grallert, H; Hamsten, A; Havulinna, AS; Hengstenberg, C; Houwing-Duistermaat, JJ; Hypponen, E; Karssen, LC; Lehtimaki, T; Lyssenko, V; Magnusson, PKE; Mihailov, E; Muller-Nurasyid, M; Mpindi, JP; Pedersen, NL; Penninx, BWJH; Perola, M; Pers, TH; Peters, A; Rung, J; Smit, JH; Steinthorsdottir, V; Tobin, MD; Tsernikova, N; van Leeuwen, EM; Viikari, JS; Willems, SM; Willemsen, G; Schunkert, H; Erdmann, J; Samani, NJ; Kaprio, J; Lind, L; Gieger, C; Metspalu, A; Slagboom, PE; Groop, L; van Duijn, CM; Eriksson, JG; Jula, A; Salomaa, V; Boomsma, DI; Power, C; Raitakari, OT; Ingelsson, E; Jarvelin, MR; Thorsteinsdottir, U; Franke, L; Ikonen, E; Kallioniemi, O; Pietiainen, V; Lindgren, CM; Stefansson, K; Palotie, A; McCarthy, MI; Morris, AP; Prokopenko, I; Ripatti, S				Surakka, Ida; Horikoshi, Momoko; Magi, Reedik; Sarin, Antti-Pekka; Mahajan, Anubha; Lagou, Vasiliki; Marullo, Letizia; Ferreira, Teresa; Miraglio, Benjamin; Timonen, Sanna; Kettunen, Johannes; Pirinen, Matti; Karjalainen, Julia; Thorleifsson, Gudmar; Hagg, Sara; Hottenga, Jouke-Jan; Isaacs, Aaron; Ladenvall, Claes; Beekman, Marian; Esko, Tonu; Ried, Janina S.; Nelson, Christopher P.; Willenborg, Christina; Gustafsson, Stefan; Westra, Harm-Jan; Blades, Matthew; de Craen, Anton J. M.; de Geus, Eco J.; Deelen, Joris; Grallert, Harald; Hamsten, Anders; Havulinna, Aki S.; Hengstenberg, Christian; Houwing-Duistermaat, Jeanine J.; Hypponen, Elina; Karssen, Lennart C.; Lehtimaki, Terho; Lyssenko, Valeriya; Magnusson, Patrik K. E.; Mihailov, Evelin; Muller-Nurasyid, Martina; Mpindi, John-Patrick; Pedersen, Nancy L.; Penninx, Brenda W. J. H.; Perola, Markus; Pers, Tune H.; Peters, Annette; Rung, Johan; Smit, Johannes H.; Steinthorsdottir, Valgerdur; Tobin, Martin D.; Tsernikova, Natalia; van Leeuwen, Elisabeth M.; Viikari, Jorma S.; Willems, Sara M.; Willemsen, Gonneke; Schunkert, Heribert; Erdmann, Jeanette; Samani, Nilesh J.; Kaprio, Jaakko; Lind, Lars; Gieger, Christian; Metspalu, Andres; Slagboom, P. Eline; Groop, Leif; van Duijn, Cornelia M.; Eriksson, Johan G.; Jula, Antti; Salomaa, Veikko; Boomsma, Dorret I.; Power, Christine; Raitakari, Olli T.; Ingelsson, Erik; Jarvelin, Marjo-Riitta; Thorsteinsdottir, Unnur; Franke, Lude; Ikonen, Elina; Kallioniemi, Olli; Pietiainen, Vilja; Lindgren, Cecilia M.; Stefansson, Kari; Palotie, Aarno; McCarthy, Mark I.; Morris, Andrew P.; Prokopenko, Inga; Ripatti, Samuli		ENGAGE Consortium	The impact of low-frequency and rare variants on lipid levels	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HETEROGENEITY; EXPRESSION; SIALOMUCIN; SEQUENCE; GLUCOSE; GENES; CD300; LOCI	Using a genome-wide screen of 9.6 million genetic variants achieved through 1000 Genomes Project imputation in 62,166 samples, we identify association to lipid traits in 93 loci, including 79 previously identified loci with new lead SNPs and 10 new loci, 15 loci with a low-frequency lead SNP and 10 loci with a missense lead SNP, and 2 loci with an accumulation of rare variants. In six loci, SNPs with established function in lipid genetics (CELSR2, GCKR, LIPC and APOE) or candidate missense mutations with predicted damaging function (CD300LG and TM6SF2) explained the locus associations. The low-frequency variants increased the proportion of variance explained, particularly for low-density lipoprotein cholesterol and total cholesterol. Altogether, our results highlight the impact of low-frequency variants in complex traits and show that imputation offers a cost-effective alternative to resequencing.	[Surakka, Ida; Sarin, Antti-Pekka; Miraglio, Benjamin; Timonen, Sanna; Kettunen, Johannes; Pirinen, Matti; Isaacs, Aaron; Mpindi, John-Patrick; Perola, Markus; Kaprio, Jaakko; Groop, Leif; Kallioniemi, Olli; Pietiainen, Vilja; Palotie, Aarno; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Surakka, Ida; Sarin, Antti-Pekka; Kettunen, Johannes; Havulinna, Aki S.; Perola, Markus; Kaprio, Jaakko; Eriksson, Johan G.; Jula, Antti; Salomaa, Veikko; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Helsinki, Finland; [Horikoshi, Momoko; Mahajan, Anubha; Lagou, Vasiliki; Ferreira, Teresa; Ingelsson, Erik; Lindgren, Cecilia M.; McCarthy, Mark I.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Horikoshi, Momoko; Lagou, Vasiliki; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Magi, Reedik; Esko, Tonu; Mihailov, Evelin; Perola, Markus; Tsernikova, Natalia; Metspalu, Andres; Morris, Andrew P.] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Marullo, Letizia] Univ Ferrara, Genet Sect, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Karjalainen, Julia; Westra, Harm-Jan; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Hagg, Sara; Gustafsson, Stefan; Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hagg, Sara; Gustafsson, Stefan; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol, Uppsala, Sweden; [Hagg, Sara; Gustafsson, Stefan; Ingelsson, Erik] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Hottenga, Jouke-Jan; de Geus, Eco J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Biol Psychol, Amsterdam, Netherlands; [Hottenga, Jouke-Jan; de Geus, Eco J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Isaacs, Aaron; Karssen, Lennart C.; van Leeuwen, Elisabeth M.; Willems, Sara M.; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Isaacs, Aaron] Ctr Med Syst Biol, Leiden, Netherlands; [Ladenvall, Claes; Lyssenko, Valeriya; Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, Skane Univ Hosp, Malmo, Sweden; [Beekman, Marian; de Craen, Anton J. M.; Deelen, Joris; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Beekman, Marian; Deelen, Joris; Slagboom, P. Eline] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Esko, Tonu; Pers, Tune H.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Esko, Tonu; Pers, Tune H.] Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Esko, Tonu; Pers, Tune H.; Lindgren, Cecilia M.; Palotie, Aarno] Broad Inst & MIT Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Ried, Janina S.; Muller-Nurasyid, Martina; Gieger, Christian] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Genet Epidemiol, Neuherberg, Germany; [Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Hosp, Leicester Cardiovasc Dis Biomed Res Unit, NIHR, Leicester, Leics, England; [Erdmann, Jeanette] Univ Lubeck, Inst Integrat & Experimentelle Genom, Lubeck, Germany; [Willenborg, Christina; Erdmann, Jeanette] Deutsches Zentrum Herz Kreislauf Forsch DZHK, Lubeck, Germany; [Willenborg, Christina; Erdmann, Jeanette] Deutsches Zentrum Herz Kreislauf Forsch DZHK, Kiel, Germany; [Blades, Matthew] Univ Leicester, BBASH, Leicester, Leics, England; [de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Grallert, Harald; Peters, Annette; Gieger, Christian] Helmholtz Zentrum Munchen German Res Ctr Environm, Res Unit Mol Epidemiol, Neuherberg, Germany; [Grallert, Harald] German Ctr Diabet Res DZD, Neuherberg, Germany; [Grallert, Harald; Peters, Annette; Gieger, Christian] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany; [Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Cardiovasc Genet & Genom Grp, Stockholm, Sweden; [Hengstenberg, Christian; Peters, Annette; Schunkert, Heribert] Tech Univ Munich, Deutsches Herzzentrum Munchen, D-80290 Munich, Germany; [Hengstenberg, Christian; Muller-Nurasyid, Martina; Schunkert, Heribert] Munich Heart Alliance, Deutsches Zentrum Herz Kreislauf Forsch DZHK, Munich, Germany; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Hypponen, Elina; Power, Christine] UCL, Inst Child Hlth, Populat Policy & Practice, London, England; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Hypponen, Elina] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Hypponen, Elina] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Fimlab Labs, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Lyssenko, Valeriya] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Muller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Muller-Nurasyid, Martina] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Munich, Germany; [Penninx, Brenda W. J. H.; Smit, Johannes H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Perola, Markus] Univ Helsinki, Diabet & Obes Res Program, Helsinki, Finland; [Rung, Johan] European Bioinformat Inst, Hinxton, England; [Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England; [Viikari, Jorma S.] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma S.] Turku Univ Hosp, Div Med, FIN-20520 Turku, Finland; [Kaprio, Jaakko; Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Lind, Lars] Uppsala Univ, Akad Sjukhuset, Dept Med Sci, Uppsala, Sweden; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Unit Primary Hlth Care, Helsinki, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol & Nucl Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC,HPA,Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Ikonen, Elina] Univ Helsinki, Inst Biomed, Anat, Helsinki, Finland; [Ikonen, Elina] Minerva Fdn, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Prokopenko, Inga] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Hinxton, England	University of Helsinki; Finland National Institute for Health & Welfare; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Tartu; University of Ferrara; University of Groningen; Karolinska Institutet; Uppsala University; Uppsala University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Lund University; Skane University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Lubeck; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research; University of Leicester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; South Australian Health & Medical Research Institute (SAHMRI); University of South Australia; University of South Australia; Tampere University; Tampere University; Steno Diabetes Center; University of Munich; University of Munich; Vrije Universiteit Amsterdam; University of Helsinki; European Molecular Biology Laboratory (EMBL); University of Leicester; University of Turku; University of Turku; University of Helsinki; Uppsala University; Uppsala University Hospital; University of Tartu; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; Health Protection Agency; Imperial College London; University of Oulu; University of Oulu; University of Oulu; University of Iceland; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Oxford; University of Liverpool; Imperial College London; Wellcome Trust Sanger Institute	Ripatti, S (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	samuli.ripatti@fimm.fi	Beekman, Marian/L-3004-2019; van Leeuwen, Elisabeth/G-3382-2017; Grallert, Harald/B-3424-2013; Peters, Annette/A-6117-2011; Hypponen, Elina/B-2596-2014; Lehtimäki, Terho/AAD-1094-2022; Deelen, Joris/H-3201-2019; Franke, Lude/P-7036-2016; Karjalainen, Juha/P-8624-2016; Horikoshi, Momoko/AAF-9034-2019; Ripatti, Samuli/H-9446-2014; Boomsma, Dorret I/AAX-4470-2020; Willenborg, Christina/D-2668-2012; Slagboom, P. Eline/R-4790-2016; Erdmann, Jeanette/A-4417-2009; Kaprio, Jaakko/A-1820-2008; Stefansson, Kari/AAE-7187-2019; Raitakari, Olli/AAQ-7389-2021; Mägi, Reedik/AAJ-9679-2021; Erdmann, Jeanette/P-7513-2014; Magnusson, Patrik KE/C-4458-2017; Houwing-Duistermaat, Jeanne/V-9048-2018; Hengstenberg, Christian/U-5485-2019; Kallioniemi, Olli P/H-5111-2011; Prokopenko, Inga/AAU-9895-2020; Prokopenko, Inga/H-3241-2014; Penninx, Brenda WJH/S-7627-2017; Havulinna, Aki/AAM-4769-2021; de Geus, Eco J.C./M-9318-2015; Müller-Nurasyid, Martina/I-8735-2018; McCarthy, Mark/M-3763-2015	Beekman, Marian/0000-0003-0585-6206; Peters, Annette/0000-0001-6645-0985; Hypponen, Elina/0000-0003-3670-9399; Lehtimäki, Terho/0000-0002-2555-4427; Deelen, Joris/0000-0003-4483-3701; Franke, Lude/0000-0002-5159-8802; Ripatti, Samuli/0000-0002-0504-1202; Willenborg, Christina/0000-0001-5217-6882; Slagboom, P. Eline/0000-0002-2875-4723; Kaprio, Jaakko/0000-0002-3716-2455; Erdmann, Jeanette/0000-0002-4486-6231; Magnusson, Patrik KE/0000-0002-7315-7899; Kallioniemi, Olli P/0000-0002-3231-0332; Prokopenko, Inga/0000-0003-1624-7457; Penninx, Brenda WJH/0000-0001-7779-9672; de Geus, Eco J.C./0000-0001-6022-2666; Müller-Nurasyid, Martina/0000-0003-3793-5910; Timonen, Sanna/0000-0002-8139-5950; Eriksson, Johan/0000-0002-2516-2060; Willemsen, Gonneke/0000-0003-3755-0236; Esko, Tonu/0000-0003-1982-6569; McCarthy, Mark/0000-0002-4393-0510; Hagg, Sara/0000-0002-2452-1500; Magi, Reedik/0000-0002-2964-6011; Lindgren, Cecilia/0000-0002-4903-9374; Tobin, Martin/0000-0002-3596-7874; Palotie, Aarno/0000-0002-2527-5874; Mahajan, Anubha/0000-0001-5585-3420; Van Duijn, Cornelia/0000-0002-2374-9204; Gieger, Christian/0000-0001-6986-9554; Pietiainen, Vilja/0000-0003-3125-2406; Karssen, Lennart C./0000-0002-1959-342X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Ikonen, Elina/0000-0001-8382-1135; Rung, Johan/0000-0001-5875-8429; Pirinen, Matti/0000-0002-1664-1350; Nelson, Christopher/0000-0001-8025-2897; Surakka, Ida/0000-0002-6669-5541; Pers, Tune/0000-0003-0207-4831; Lagou, Vasiliki/0000-0003-3165-8940	European Union's Seventh Framework Programme (FP7), ENGAGE Consortium [HEALTH-F4-2007-201413]; Helsinki University Doctoral Programme in Biomedicine (DPBM); Manpei Suzuki Diabetes Foundation; Wellcome Trust [WT098017, WT090532, WT064890]; European Union's Seventh Framework Programme (FP7), ENGAGE project [HEALTH-F4-2007-201413]; ENGAGE Exchange and Mobility Program; UK Medical Research Council Senior Clinical Fellowship [G0902313]; Sigrid Juselius Foundation; RFBR (Russian Foundation for Basic Research)-Helmholtz Joint Research Group [12-04-91322]; European Union's Seventh Framework Programme (FP7-Health-F5) [305280]; European Union's Seventh Framework Programme [305280, 313010, 261433]; Finnish Academy [269517, 139635]; Yrjo Jahnsson Foundation; Juho Vainio Foundation; British Heart Foundation (BHF); BHF; NIHR Leicester Cardiovascular Biomedical Research Unit; Finnish Foundation for Cardiovascular Research; Academy of Finland Centre of Excellence in Biomembrane Research [272130]; Academy of Finland [263841, 251217, 255847]; University of Helsinki Postdoctoral Researcher grant; Magnus Ehrnrooth Foundation; Kymenlaakso Cultural Foundation; European Union's Seventh Framework Programme (FP7) [258068]; EU-FP7-Systems Microscopy Network of Excellence; Center of Excellence in Complex Disease Genetics; European Union's Seventh Framework Programme project ENGAGE [201413]; European Union's Seventh Framework Programme project BioSHaRE [261433]; Biocentrum Helsinki; MRC [G0902313] Funding Source: UKRI; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [G0902313] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099, NF-SI-0611-10170] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016416, NNF12OC1016467] Funding Source: researchfish	European Union's Seventh Framework Programme (FP7), ENGAGE Consortium; Helsinki University Doctoral Programme in Biomedicine (DPBM); Manpei Suzuki Diabetes Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); European Union's Seventh Framework Programme (FP7), ENGAGE project; ENGAGE Exchange and Mobility Program; UK Medical Research Council Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); RFBR (Russian Foundation for Basic Research)-Helmholtz Joint Research Group; European Union's Seventh Framework Programme (FP7-Health-F5); European Union's Seventh Framework Programme(European Commission); Finnish Academy(Academy of Finland); Yrjo Jahnsson Foundation; Juho Vainio Foundation; British Heart Foundation (BHF)(British Heart Foundation); BHF(British Heart Foundation); NIHR Leicester Cardiovascular Biomedical Research Unit; Finnish Foundation for Cardiovascular Research; Academy of Finland Centre of Excellence in Biomembrane Research; Academy of Finland(Academy of Finland); University of Helsinki Postdoctoral Researcher grant; Magnus Ehrnrooth Foundation; Kymenlaakso Cultural Foundation; European Union's Seventh Framework Programme (FP7); EU-FP7-Systems Microscopy Network of Excellence; Center of Excellence in Complex Disease Genetics(Academy of Finland); European Union's Seventh Framework Programme project ENGAGE; European Union's Seventh Framework Programme project BioSHaRE; Biocentrum Helsinki; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	We acknowledge CSC (IT Center for Science) and the Technology Centre of the Institute for Molecular Medicine for computational services. The High-Throughput Biomedicine Unit of the Institute for Molecular Medicine Finland, R. Kovanen and A. Uro are acknowledged for technical expertise. M. Jauhiainen is acknowledged for sharing his expertise in the manuscript writing process. This research was supported through funds from the European Union's Seventh Framework Programme (FP7/2007-2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. LS. was partly funded by the Helsinki University Doctoral Programme in Biomedicine (DPBM). M.H. was funded by a Manpei Suzuki Diabetes Foundation Grant-in-Aid for young scientists working abroad. A.P.M. and A. Mahajan acknowledge funding from the Wellcome Trust under awards WT098017, WT090532 and WT064890. V. Lagou, L.M., S.H. and I.P. were funded in part through the European Union's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. L.M. was in part sponsored by '5 per mile' contribution assigned to the University of Ferrara, income tax return year 2009, and in part by the ENGAGE Exchange and Mobility Program for ENGAGE training funds. M.D.T. holds a UK Medical Research Council Senior Clinical Fellowship (G0902313). S.T. is supported by the Sigrid Juselius Foundation. J.S.R. and C.G. have received funding from a grant from the RFBR (Russian Foundation for Basic Research)-Helmholtz Joint Research Group (12-04-91322). C.G. received funding from the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement 305280 (MIMOmics). M. Perola has been supported by the European Union's Seventh Framework Programme (grant agreements 313010; BBMRI-LPC, 305280; MIMOmics, and 261433; BioSHaRE-BU), Finnish Academy grant 269517, the Yrjo Jahnsson Foundation and the Juho Vainio Foundation. N.J.S. holds a chair funded by the British Heart Foundation (BHF) and is an NIHR Senior Investigator. C.P.N. is funded by the BHF and was preciously funded by the NIHR Leicester Cardiovascular Biomedical Research Unit. V. Salomaa was supported by the Finnish Foundation for Cardiovascular Research and the Finnish Academy (grant 139635). E. Ikonen was supported by the Academy of Finland Centre of Excellence in Biomembrane Research (272130), the Academy of Finland (263841) and the Sigrid Juselius Foundation. V.P. was supported by a University of Helsinki Postdoctoral Researcher grant, the Magnus Ehrnrooth Foundation and the Kymenlaakso Cultural Foundation. O.K., J.-P.M. and V.P. have received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 258068; EU-FP7-Systems Microscopy Network of Excellence. S.R. was supported by the Academy of Finland (251217 and 255847), the Center of Excellence in Complex Disease Genetics, the European Union's Seventh Framework Programme projects ENGAGE (201413) and BioSHaRE (261433), the Finnish Foundation for Cardiovascular Research, Biocentrum Helsinki and the Sigrid Juselius Foundation. Cohort-specific acknowledgments are provided in the Supplementary Note.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Blattmann P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003338; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Carim-Todd L, 2000, CYTOGENET CELL GENET, V90, P255, DOI 10.1159/000056784; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Deeb SS, 2000, J LIPID RES, V41, P155; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURSTENFELD A, 1994, ARTERIOSCLER THROMB, V14, P381, DOI 10.1161/01.ATV.14.3.381; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Ghebranious N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni155; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jin S, 2008, FEBS LETT, V582, P3018, DOI 10.1016/j.febslet.2008.07.041; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Magi R, 2012, GENET EPIDEMIOL, V36, P785, DOI 10.1002/gepi.21675; Mahdessian H, 2014, P NATL ACAD SCI USA, V111, P8913, DOI 10.1073/pnas.1323785111; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1983, J CLIN INVEST, V71, P1023, DOI 10.1172/JCI110829; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Service SK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004147; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	34	219	221	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					589	597		10.1038/ng.3300	http://dx.doi.org/10.1038/ng.3300			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25961943	Green Accepted, Green Submitted			2022-12-25	WOS:000355386500009
J	Weren, RDA; Ligtenberg, MJL; Kets, CM; de Voer, RM; Verwiell, ETP; Spruijt, L; van Zelst-Stams, WAG; Jongmans, MC; Gilissen, C; Hehir-Kwa, JY; Hoischen, A; Shendure, J; Boyle, EA; Kamping, EJ; Nagtegaal, ID; Tops, BBJ; Nagengast, FM; van Kessel, AG; van Krieken, JHJM; Kuiper, RP; Hoogerbrugge, N				Weren, Robbert D. A.; Ligtenberg, Marjolijn J. L.; Kets, C. Marleen; de Voer, Richarda M.; Verwiel, Eugene T. P.; Spruijt, Liesbeth; van Zelst-Stams, Wendy A. G.; Jongmans, Marjolijn C.; Gilissen, Christian; Hehir-Kwa, Jayne Y.; Hoischen, Alexander; Shendure, Jay; Boyle, Evan A.; Kamping, Eveline J.; Nagtegaal, Iris D.; Tops, Bastiaan B. J.; Nagengast, Fokko M.; van Kessel, Ad Geurts; van Krieken, J. Han J. M.; Kuiper, Roland P.; Hoogerbrugge, Nicoline			A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer	NATURE GENETICS			English	Article							OXIDATIVE DNA-DAMAGE; PREDISPOSITION; CARCINOMAS; MUTYH; NEIL1; OGG1	The genetic cause underlying the development of multiple colonic adenomas, the premalignant precursors of colorectal cancer (CRC), frequently remains unresolved in patients with adenomatous polyposis. Here we applied whole-exome sequencing to 51 individuals with multiple colonic adenomas from 48 families. In seven affected individuals from three unrelated families, we identified a homozygous germline nonsense mutation in the base-excision repair (BER) gene NTHL1. This mutation was exclusively found in a heterozygous state in controls (minor allele frequency of 0.0036; n = 2,329). All three families showed recessive inheritance of the adenomatous polyposis phenotype and progression to CRC in at least one member. All three affected women developed an endometrial malignancy or premalignancy. Genetic analysis of three carcinomas and five adenomas from different affected individuals showed a non-hypermutated profile enriched for cytosine-to-thymine transitions. We conclude that a homozygous loss-of-function germline mutation in the NTHL1 gene predisposes to a new subtype of BIER-associated adenomatous polyposis and CRC.	[Weren, Robbert D. A.; Ligtenberg, Marjolijn J. L.; Kets, C. Marleen; de Voer, Richarda M.; Verwiel, Eugene T. P.; Spruijt, Liesbeth; van Zelst-Stams, Wendy A. G.; Jongmans, Marjolijn C.; Gilissen, Christian; Hehir-Kwa, Jayne Y.; Hoischen, Alexander; Kamping, Eveline J.; van Kessel, Ad Geurts; Kuiper, Roland P.; Hoogerbrugge, Nicoline] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Ligtenberg, Marjolijn J. L.; Nagtegaal, Iris D.; Tops, Bastiaan B. J.; van Krieken, J. Han J. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Shendure, Jay; Boyle, Evan A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Nagengast, Fokko M.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Washington; University of Washington Seattle; Radboud University Nijmegen	Kuiper, RP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	roland.kuiper@radboudumc.nl	Gilissen, Christian/E-5246-2012; Zelst-Stams, W.A.G./L-4775-2015; Spruijt, L./L-4664-2015; Kamping, Eveline J/E-9530-2016; de Voer, Richarda/P-5728-2015; van Kessel, Ad Geurts/A-2810-2010; Hoischen, Alexander/AGF-7293-2022; Hehir, g. J.Y./L-4358-2015; Weren, Robbert/D-9618-2016; Kets, M./L-4429-2015; Ligtenberg, Marjolijn/N-9666-2013; Kuiper, Roland/A-9646-2014; Nagtegaal, Iris D/A-2448-2014; Hoogerbrugge, Nicoline/O-1016-2013; Shendure, Jay/AAU-3684-2021; van Krieken, Joannes H J M/D-4138-2009; de Voer, Richarda M/ABD-1525-2021; de Voer, Richarda M/GSD-6097-2022; Hoischen, Alexander/D-1282-2013; Tops, Bastiaan/L-4697-2015	Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Ligtenberg, Marjolijn/0000-0003-1290-1474; Nagtegaal, Iris D/0000-0003-0887-4127; Hoogerbrugge, Nicoline/0000-0003-2393-8141; van Krieken, Joannes H J M/0000-0001-6544-1040; de Voer, Richarda M/0000-0002-8222-0343; Hoischen, Alexander/0000-0002-8072-4476; Hehir-Kwa, Jayne/0000-0003-0837-304X; Verwiel, Eugene/0000-0001-9663-6780; van Krieken, Joannes/0000-0002-8105-0450; Tops, Bastiaan/0000-0002-1699-8210; Boyle, Evan/0000-0003-4494-9771; tops, funnel/0000-0003-3116-4203	Dutch Cancer Society (KWF) [2009-4335]; Netherlands Organization for Scientific Research (NWO) [917-10-358]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank N. Arts, A. van Raaij, S. van Vliet, M. van de Vorst and M. Kwint for technical assistance, and R. Derks and M. Nelen for targeted tumor sequencing and data analysis. We thank H. Brunner for critical reading of the manuscript. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. This work was supported by research grants from the Dutch Cancer Society (KWF; grant 2009-4335), and the Netherlands Organization for Scientific Research (NWO; grant 917-10-358).	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Briggs S, 2013, J PATHOL, V230, P148, DOI 10.1002/path.4185; Broderick P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-243; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Corral R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071211; Dallosso AR, 2008, GUT, V57, P1252, DOI 10.1136/gut.2007.145748; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Lipton L, 2003, CANCER RES, V63, P7595; Mongin C, 2012, CLIN GENET, V81, P38, DOI 10.1111/j.1399-0004.2011.01676.x; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nielsen M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-184; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Smith CG, 2013, JNCI-J NATL CANCER I, V105, P1249, DOI 10.1093/jnci/djt183	15	235	241	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					668	671		10.1038/ng.3287	http://dx.doi.org/10.1038/ng.3287			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25938944				2022-12-25	WOS:000355386500020
J	Yao, Z; Petschnigg, J; Ketteler, R; Stagljar, I				Yao, Zhong; Petschnigg, Julia; Ketteler, Robin; Stagljar, Igor			Application guide for omics approaches to cell signaling	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CHEMICAL-GENETIC SCREEN; CHRONIC MYELOID-LEUKEMIA; MASS-SPECTROMETRY; PROXIMITY LIGATION; MAMMALIAN-CELLS; IN-VIVO; SMALL MOLECULES; BREAST-CANCER; SH2 DOMAIN	Research in signal transduction aims to identify the functions of different signaling pathways in physiological and pathological states. Traditional techniques using biochemical, genetic or cell biological approaches have made important contributions to our understanding of cellular signaling. However, the single-gene approach does not take into account the full complexity of cell signaling. With the availability of omics techniques, great progress has been made in understanding signaling networks. Omics approaches can be classified into two categories: 'molecular profiling', including genomic, proteomic, post-translational modification and interactome profiling; and 'molecular perturbation', including genetic and functional perturbations.	[Yao, Zhong; Stagljar, Igor] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Petschnigg, Julia; Ketteler, Robin] UCL, MRC Lab Mol Cell Biol, London, England; [Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Stagljar, Igor] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; MRC Laboratory Molecular Biology; University of London; University College London; University of Toronto; University of Toronto	Yao, Z (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.	igor.stagljar@utoronto.ca		Ketteler, Robin/0000-0002-2786-7291	CQDM/OCE Explore Program; Ontario Genomics Institute; Canadian Cystic Fibrosis Foundation; Canadian Cancer Society; Pancreatic Cancer Canada; University Health Network; UK Medical Research Council [MC_EX_G0800785]; Biotechnology and Biological Sciences Research Council New Investigator Award [BB/JO/5581/1]; EC-Marie Curie International Incoming Fellowship (FP7-PEOPLE-IIF); BBSRC [BB/J015881/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015881/1] Funding Source: researchfish; Medical Research Council [MC_EX_G0800785] Funding Source: researchfish	CQDM/OCE Explore Program; Ontario Genomics Institute; Canadian Cystic Fibrosis Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Pancreatic Cancer Canada; University Health Network; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council New Investigator Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC-Marie Curie International Incoming Fellowship (FP7-PEOPLE-IIF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Riley and J. Snider for valuable comments on this manuscript. Work in the Stagljar laboratory is supported by grants from the CQDM/OCE Explore Program, Ontario Genomics Institute, Canadian Cystic Fibrosis Foundation, Canadian Cancer Society, Pancreatic Cancer Canada and University Health Network. R.K. is supported by UK Medical Research Council core funding to the MRC-UCL University Unit (Ref. MC_EX_G0800785) and a Biotechnology and Biological Sciences Research Council New Investigator Award (BB/JO/5581/1). J.P. is supported by an EC-Marie Curie International Incoming Fellowship (FP7-PEOPLE-2013-IIF).	Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Berger B, 2013, NAT REV GENET, V14, P333, DOI 10.1038/nrg3433; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Campbell SJ, 2003, PROTEIN ENG, V16, P217, DOI 10.1093/proeng/gzg025; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/NMETH.2703, 10.1038/nmeth.2703]; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Gu GJ, 2013, NEW BIOTECHNOL, V30, P144, DOI 10.1016/j.nbt.2012.05.005; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Heintze Jacob, 2013, Frontiers in Genetics, V4, P193, DOI 10.3389/fgene.2013.00193; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jabbour E, 2010, LEUKEMIA, V24, P6, DOI 10.1038/leu.2009.193; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kasap C, 2014, NAT CHEM BIOL, V10, P626, DOI 10.1038/nchembio.1551; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Ketteler Robin, 2012, Frontiers in Genetics, V3, P242, DOI 10.3389/fgene.2012.00242; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Kristensen VN, 2014, NAT REV CANCER, V14, P299, DOI 10.1038/nrc3721; Lambert JP, 2013, NAT METHODS, V10, P1239, DOI [10.1038/NMETH.2702, 10.1038/nmeth.2702]; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lemmens I, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng075; Lemmens I, 2006, NAT PROTOC, V1, P92, DOI 10.1038/nprot.2006.14; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leuchowius KJ, 2013, MOL CELL PROTEOMICS, V12, P1563, DOI 10.1074/mcp.O112.023374; Lievens S, 2014, MOL CELL PROTEOMICS, V13, P3332, DOI 10.1074/mcp.M114.041087; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marine S, 2012, J BIOMOL SCREEN, V17, P692, DOI 10.1177/1087057112439233; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pawson T, 2000, GENE DEV, V14, P1027; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Petschnigg J, 2014, NAT METHODS, V11, P585, DOI [10.1038/NMETH.2895, 10.1038/nmeth.2895]; Petschnigg J, 2011, CURR OPIN BIOTECH, V22, P50, DOI 10.1016/j.copbio.2010.09.001; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; SEED B, 1995, CURR OPIN BIOTECH, V6, P567, DOI 10.1016/0958-1669(95)80094-8; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Smith MA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005906; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tchekanda E, 2014, NAT METHODS, V11, P641, DOI [10.1038/nmeth.2934, 10.1038/NMETH.2934]; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Tiede C, 2014, PROTEIN ENG DES SEL, V27, P145, DOI 10.1093/protein/gzu007; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Wutz A, 2014, DEVELOPMENT, V141, P1423, DOI 10.1242/dev.102202; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308; Zuzuarregui A, 2012, NAT METHODS, V9, P594, DOI [10.1038/NMETH.2017, 10.1038/nmeth.2017]	100	51	52	4	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					387	397		10.1038/nchembio.1809	http://dx.doi.org/10.1038/nchembio.1809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25978996	Green Submitted			2022-12-25	WOS:000354539400008
J	Bhang, HEC; Ruddy, DA; Radhakrishna, VK; Caushi, JX; Zhao, R; Hims, MM; Singh, AP; Kao, I; Rakiec, D; Shaw, P; Balak, M; Raza, A; Ackley, E; Keen, N; Schlabach, MR; Palmer, M; Leary, RJ; Chiang, DY; Sellers, WR; Michor, F; Cooke, VG; Korn, JM; Stegmeier, F				Bhang, Hyo-eun C.; Ruddy, David A.; Radhakrishna, Viveksagar Krishnamurthy; Caushi, Justina X.; Zhao, Rui; Hims, Matthew M.; Singh, Angad P.; Kao, Iris; Rakiec, Daniel; Shaw, Pamela; Balak, Marissa; Raza, Alina; Ackley, Elizabeth; Keen, Nicholas; Schlabach, Michael R.; Palmer, Michael; Leary, Rebecca J.; Chiang, Derek Y.; Sellers, William R.; Michor, Franziska; Cooke, Vesselina G.; Korn, Joshua M.; Stegmeier, Frank			Studying clonal dynamics in response to cancer therapy using high-complexity barcoding	NATURE MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL KINASE DOMAIN; BCR-ABL; ACQUIRED-RESISTANCE; LUNG-CANCER; MET AMPLIFICATION; EGFR INHIBITORS; DRUG-SENSITIVITY; RARE MUTATIONS; GENE-MUTATIONS	Resistance to cancer therapies presents a significant clinical challenge. Recent studies have revealed intratumoral heterogeneity as a source of therapeutic resistance. However, it is unclear whether resistance is driven predominantly by pre-existing or de novo alterations, in part because of the resolution limits of next-generation sequencing. To address this, we developed a high-complexity barcode library, ClonTracer, which enables the high-resolution tracking of more than 1 million cancer cells under drug treatment. In two clinically relevant models, ClonTracer studies showed that the majority of resistant clones were part of small, pre-existing subpopulations that selectively escaped under therapeutic challenge. Moreover, the ClonTracer approach enabled quantitative assessment of the ability of combination treatments to suppress resistant clones. These findings suggest that resistant clones are present before treatment, which would make up-front therapeutic combinations that target non-overlapping resistance a preferred approach. Thus, ClonTracer barcoding may be a valuable tool for optimizing therapeutic regimens with the goal of curative combination therapies for cancer.	[Bhang, Hyo-eun C.; Radhakrishna, Viveksagar Krishnamurthy; Caushi, Justina X.; Hims, Matthew M.; Singh, Angad P.; Raza, Alina; Keen, Nicholas; Schlabach, Michael R.; Leary, Rebecca J.; Chiang, Derek Y.; Sellers, William R.; Cooke, Vesselina G.; Korn, Joshua M.; Stegmeier, Frank] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA; [Ruddy, David A.; Kao, Iris; Rakiec, Daniel; Shaw, Pamela; Balak, Marissa; Ackley, Elizabeth; Palmer, Michael] Novartis Inst Biomed Res, Translat Clin Oncol, Cambridge, MA USA; [Zhao, Rui; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Zhao, Rui; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Novartis; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Stegmeier, F (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA.	frank.stegmeier@novartis.com	Chiang, Derek/L-6452-2019	Chiang, Derek/0000-0002-1131-6065	Dana-Farber Cancer Institute Physical Sciences-Oncology Center [U54CA143798]; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Physical Sciences-Oncology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Wylie, J. Donovan, S. Zhu, E. R. McDonald, Z. Jagani and B. Firestone for helpful discussion. We also thank J. Brugge, K. Polyak, J. Williams and J. Kuiken for critical reading of the manuscript and K. Yu for technical assistance. R.Z. and F.M. gratefully acknowledge support from the Dana-Farber Cancer Institute Physical Sciences-Oncology Center (U54CA143798).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Amann J, 2005, CANCER RES, V65, P226; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Costa DB, 2010, J THORAC ONCOL, V5, P1311, DOI 10.1097/JTO.0b013e3181edf55c; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Iwasa Y, 2003, P ROY SOC B-BIOL SCI, V270, P2573, DOI 10.1098/rspb.2003.2539; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lange T, 2013, HAEMATOLOGICA, V98, P714, DOI 10.3324/haematol.2012.068890; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Morrison CD, 2014, P NATL ACAD SCI USA, V111, pE672, DOI 10.1073/pnas.1313580111; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Ohashi K, 2013, J CLIN ONCOL, V31, P1070, DOI 10.1200/JCO.2012.43.3912; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rahal R, 2014, NAT MED, V20, P87, DOI 10.1038/nm.3435; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Soverini S, 2013, BLOOD, V122, P1634, DOI 10.1182/blood-2013-03-487728; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhong Q, 2011, LAB CHIP, V11, P2167, DOI 10.1039/c1lc20126c	57	264	271	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					440	U207		10.1038/nm.3841	http://dx.doi.org/10.1038/nm.3841			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25849130				2022-12-25	WOS:000354068800010
J	Maruyama, T; Dougan, SK; Truttmann, MC; Bilate, AM; Ingram, JR; Ploegh, HL				Maruyama, Takeshi; Dougan, Stephanie K.; Truttmann, Matthias C.; Bilate, Angelina M.; Ingram, Jessica R.; Ploegh, Hidde L.			Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining	NATURE BIOTECHNOLOGY			English	Article							ONE-STEP GENERATION; DNA-LIGASE-IV; CELLS; MICE; RECOMBINATION; DEFICIENT; ABSENCE; REPAIR; KU70	Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by nonhomologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for all four genes examined, up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like effector nucleases, and to nonmammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.	[Maruyama, Takeshi; Dougan, Stephanie K.; Truttmann, Matthias C.; Bilate, Angelina M.; Ingram, Jessica R.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	truttmann, matthias/ABC-2727-2021; Maruyama, Takeshi/T-7568-2019	truttmann, matthias/0000-0002-0536-7923; Maruyama, Takeshi/0000-0003-0331-4702	National Institutes of Health (RO1 grant) [AI087879-01]; Japan Society for the Promotion of Science; Japan Heart Foundation; AACR-Pancreatic Cancer Action Network; SNSF Early Postdoc Mobility fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087879] Funding Source: NIH RePORTER	National Institutes of Health (RO1 grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Heart Foundation; AACR-Pancreatic Cancer Action Network; SNSF Early Postdoc Mobility fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Ploegh laboratory, especially N. Pishesha and F. Tafesse, for critical reading of the manuscript; P.A. Koenig, L.K. Swee, C.S. Shivalila, H. Wang, H. Yang and R. Jaenisch for discussions; T. Wang and D.M. Sabatini for pCW-Cas9; P. Thiru and G. Bell of BARC (WIBR) for assistance with statistical analysis; and F. Zhang (Addgene) for pX330. This work was supported by the National Institutes of Health (RO1 grant AI087879-01 to H.L.P.), Japan Society for the Promotion of Science (to T.M.), Japan Heart Foundation (to T.M.), AACR-Pancreatic Cancer Action Network (to S.K.D. and H.L.P.) and an SNSF Early Postdoc Mobility fellowship (to M.C.T.).	Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanyal S, 2013, CELL HOST MICROBE, V14, P510, DOI 10.1016/j.chom.2013.10.011; Shi JH, 2014, P NATL ACAD SCI USA, V111, P10131, DOI 10.1073/pnas.1409861111; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; Song L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0509-9; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	32	710	810	6	259	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					538	U260		10.1038/nbt.3190	http://dx.doi.org/10.1038/nbt.3190			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25798939	Green Submitted, Green Accepted			2022-12-25	WOS:000354314500036
J	Paterson, AH; Wendel, JF				Paterson, Andrew H.; Wendel, Jonathan F.			Unraveling the fabric of polyploidy	NATURE BIOTECHNOLOGY			English	Editorial Material							GENOME SEQUENCE; COTTON; EVOLUTION		[Paterson, Andrew H.] Univ Georgia, Athens, GA 30602 USA; [Wendel, Jonathan F.] Iowa State Univ, Ames, IA USA	University System of Georgia; University of Georgia; Iowa State University	Paterson, AH (corresponding author), Univ Georgia, Athens, GA 30602 USA.	paterson@uga.edu						Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carvalho MR, 2011, AM J BOT, V98, P1337, DOI 10.3732/ajb.1000539; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Guo H, 2014, GENETICS, V197, P1153, DOI 10.1534/genetics.114.166124; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Rong J, 2012, HEREDITY, V108, P500, DOI 10.1038/hdy.2011.111; STEPHENS SG, 1949, GENETICS, V34, P627; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	15	13	13	1	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					491	493		10.1038/nbt.3217	http://dx.doi.org/10.1038/nbt.3217			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965758				2022-12-25	WOS:000354314500028
J	Ross, JB; Huh, D; Noble, LB; Tavazoie, SF				Ross, Jason B.; Huh, Doowon; Noble, Lisa B.; Tavazoie, Sohail F.			Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; EXTRACELLULAR-MATRIX; IN-SITU; EXPRESSION; GENE; PROGRESSION; CARCINOMAS; LAMININ-8; ADHESION; DISSEMINATION	Through in vivo selection of multiple ER-negative human breast cancer populations for enhanced tumour-forming capacity, we have derived subpopulations that generate tumours more efficiently than their parental populations at low cell numbers. Tumorigenic-enriched subpopulations exhibited increased expression of LAMA4, FOXQ1 and NAP1L3-genes that are also expressed at greater levels by independently derived metastatic subpopulations. These genes promote metastatic efficiency. FOXQ1 promotes LAMA4 expression, and LAMA4 enhances clonal expansion following substratum detachment in vitro, tumour re-initiation in multiple organs, and disseminated metastatic cell proliferation and colonization. The promotion of cancer cell proliferation and tumour re-initiation by LAMA4 requires fil-integrin. Increased LAMA4 expression marks the transition of human pre-malignant breast lesions to malignant carcinomas, and tumoral LAMA4 overexpression predicts reduced relapse-free survival in ER-negative patients. Our findings reveal common features that govern primary and metastatic tumour re-initiation and identify a key molecular determinant of these processes.	[Ross, Jason B.; Huh, Doowon; Noble, Lisa B.; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, Box 16,1230 York Ave, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu		Noble, Lisa/0000-0002-2735-2650; Huh, Doowon/0000-0003-2722-0217	MSTP [GM077.39]; Head of the Elizabeth and Vincent Meyer Laboratory of Systems Cancer Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	MSTP; Head of the Elizabeth and Vincent Meyer Laboratory of Systems Cancer Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of our laboratory for insightful discussion and C. Alarcon, N. Halberg, N. Pencheva and A. Nguyen for providing comments on is versions of this manuscript. We thank C. Blobel, S. Simon and J. Friedman intellectual input and helpful suggestions. We thank A. Nguyen and J. M. Loo assistance with splenic injections. We thank N. Halberg for assistance a with Ads. We thank H. Goodarzi for assistance with statistical analysis. We thank P. Furlow for cloning assistance. We thank C. Zhao of the Rockefeller Genomics Resource Center for assistance with transcriptomic profiling. We thank S. Mazel and members of the Rockefeller Flow Cytometry Resource Center for FACS sorting. J.B.R., D.H. and L.B.N. are members of the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program supported by MSTP grant GM077.39. S.F.T. is a DOD Era of Hope Scholar and Collaborative Scholars and Innovators Award recipient and Head of the Elizabeth and Vincent Meyer Laboratory of Systems Cancer Biology.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Attia M, 2011, J MOL BIOL, V407, P647, DOI 10.1016/j.jmb.2011.02.016; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Buchstaller J, 2012, CANCER CELL, V21, P240, DOI 10.1016/j.ccr.2011.12.027; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Diehn M, 2010, CELL STEM CELL, V6, P502, DOI 10.1016/j.stem.2010.05.001; Espina V, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc2950-c2; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fujita M, 2005, BREAST CANCER RES, V7, pR411, DOI 10.1186/bcr1011; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Geberhiwot T, 2001, J CELL SCI, V114, P423; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Goering W, 2008, CYTOGENET GENOME RES, V121, P88, DOI 10.1159/000125833; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Grassian AR, 2011, COLD SH Q B, V76, P313, DOI 10.1101/sqb.2011.76.010967; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; HARPER JW, 1993, CELL, V75, P805; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hickson J, 2010, CELL DEATH DIFFER, V17, P1003, DOI 10.1038/cdd.2009.205; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Kusuma N, 2012, INT J CANCER, V130, P555, DOI 10.1002/ijc.26018; Lee S, 2012, CANCER RES, V72, P4574, DOI 10.1158/0008-5472.CAN-12-0636; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Putti TC, 2005, MODERN PATHOL, V18, P26, DOI 10.1038/modpathol.3800255; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vainionpaa N, 2007, LAB INVEST, V87, P780, DOI 10.1038/labinvest.3700592; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Williams SA, 2013, LAB INVEST, V93, P970, DOI 10.1038/labinvest.2013.92; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	70	50	54	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2015	17	5					651	U258		10.1038/ncb3148	http://dx.doi.org/10.1038/ncb3148			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH1HG	25866923	Green Accepted			2022-12-25	WOS:000353771500013
J	Willyard, C				Willyard, Cassandra			An unknown enemy: Drugs sought against EV-68 as paralysis link is explored	NATURE MEDICINE			English	News Item																		Ayscue P, 2014, MMWR-MORBID MORTAL W, V63, P903; Greninger, 2015, LANCET INFECT DIS, DOI [10.1016/S1473-3099(15)70093-9, DOI 10.1016/S1473-3099(15)70093-9]; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Liu Y, 2015, SCIENCE, V347, P71, DOI 10.1126/science.1261962; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798	6	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					419	421		10.1038/nm.3846	http://dx.doi.org/10.1038/nm.3846			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25822590				2022-12-25	WOS:000354068800003
J	Zhang, TZ; Hu, Y; Jiang, WK; Fang, L; Guan, XY; Chen, JD; Zhang, JB; Saski, CA; Scheffler, BE; Stelly, DM; Hulse-Kemp, AM; Wan, Q; Liu, BL; Liu, CX; Wang, S; Pan, MQ; Wang, YK; Wang, DW; Ye, WX; Chang, LJ; Zhang, WP; Song, QX; Kirkbride, RC; Chen, XY; Dennis, E; Llewellyn, DJ; Peterson, DG; Thaxton, P; Jones, DC; Wang, Q; Xu, XY; Zhang, H; Wu, HT; Zhou, L; Mei, GF; Chen, SQ; Tian, Y; Xiang, D; Li, XH; Ding, J; Zuo, QY; Tao, LN; Liu, YC; Li, J; Lin, Y; Hui, YY; Cao, ZS; Cai, CP; Zhu, XF; Jiang, Z; Zhou, BL; Guo, WZ; Li, RQ; Chen, ZJ				Zhang, Tianzhen; Hu, Yan; Jiang, Wenkai; Fang, Lei; Guan, Xueying; Chen, Jiedan; Zhang, Jinbo; Saski, Christopher A.; Scheffler, Brian E.; Stelly, David M.; Hulse-Kemp, Amanda M.; Wan, Qun; Liu, Bingliang; Liu, Chunxiao; Wang, Sen; Pan, Mengqiao; Wang, Yangkun; Wang, Dawei; Ye, Wenxue; Chang, Lijing; Zhang, Wenpan; Song, Qingxin; Kirkbride, Ryan C.; Chen, Xiaoya; Dennis, Elizabeth; Llewellyn, Danny J.; Peterson, Daniel G.; Thaxton, Peggy; Jones, Don C.; Wang, Qiong; Xu, Xiaoyang; Zhang, Hua; Wu, Huaitong; Zhou, Lei; Mei, Gaofu; Chen, Shuqi; Tian, Yue; Xiang, Dan; Li, Xinghe; Ding, Jian; Zuo, Qiyang; Tao, Linna; Liu, Yunchao; Li, Ji; Lin, Yu; Hui, Yuanyuan; Cao, Zhisheng; Cai, Caiping; Zhu, Xiefei; Jiang, Zhi; Zhou, Baoliang; Guo, Wangzhen; Li, Ruiqiang; Chen, Z. Jeffrey			Sequencing of allotetraploid cotton (Gossypium hirsutum L. acc. TM-1) provides a resource for fiber improvement	NATURE BIOTECHNOLOGY			English	Article							GENOME SEQUENCE; GENE-EXPRESSION; BRASSICA-NAPUS; CELL-WALL; EVOLUTION; ARABIDOPSIS; PREDICTION; REVEALS; TOOL; ANNOTATION	Upland cotton is a model for polyploid crop domestication and transgenic improvement. Here we sequenced the allotetraploid Gossypium hirsutum L. acc. TM-1 genome by integrating whole-genome shotgun reads, bacterial artificial chromosome (BAC)-end sequences and genotype-by-sequencing genetic maps. We assembled and annotated 32,032 A-subgenome genes and 34,402 D-subgenome genes. Structural rearrangements, gene loss, disrupted genes and sequence divergence were more common in the A subgenome than in the D subgenome, suggesting asymmetric evolution. However, no genome-wide expression dominance was found between the subgenomes. Genomic signatures of selection and domestication are associated with positively selected genes (PSGs) for fiber improvement in the A subgenome and for stress tolerance in the D subgenome. This draft genome sequence provides a resource for engineering superior cotton lines.	[Zhang, Tianzhen; Hu, Yan; Fang, Lei; Guan, Xueying; Chen, Jiedan; Wan, Qun; Liu, Bingliang; Liu, Chunxiao; Wang, Sen; Pan, Mengqiao; Wang, Yangkun; Ye, Wenxue; Chang, Lijing; Zhang, Wenpan; Wang, Qiong; Xu, Xiaoyang; Zhang, Hua; Wu, Huaitong; Zhou, Lei; Mei, Gaofu; Chen, Shuqi; Tian, Yue; Xiang, Dan; Li, Xinghe; Ding, Jian; Cai, Caiping; Zhu, Xiefei; Zhou, Baoliang; Guo, Wangzhen; Chen, Z. Jeffrey] Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Minist Educ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Jiang, Wenkai; Zhang, Jinbo; Wang, Dawei; Zuo, Qiyang; Tao, Linna; Liu, Yunchao; Li, Ji; Lin, Yu; Hui, Yuanyuan; Cao, Zhisheng; Jiang, Zhi; Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Fang, Lei; Song, Qingxin; Kirkbride, Ryan C.; Chen, Z. Jeffrey] Univ Texas Austin, Dept Mol Biosci, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Fang, Lei; Guan, Xueying; Song, Qingxin; Kirkbride, Ryan C.; Chen, Z. Jeffrey] Univ Texas Austin, Dept Mol Biosci, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Saski, Christopher A.] Clemson Univ, Genom Inst, Clemson, SC USA; [Scheffler, Brian E.] ARS, USDA, MSA, Genom Lab, Stoneville, MS USA; [Stelly, David M.; Hulse-Kemp, Amanda M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Chen, Xiaoya] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Natl Plant Gene Res Ctr, Inst Plant Physiol & Ecol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Dennis, Elizabeth; Llewellyn, Danny J.] Commonwealth Sci & Ind Res Org, Plant Ind, Black Mt, Australia; [Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Starkville, MS USA; [Thaxton, Peggy] Mississippi State Univ, Delta Res & Extens Ctr, Stoneville, MS USA; [Jones, Don C.] Cotton Inc, Cary, NC USA	Nanjing Agricultural University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Clemson University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Mississippi State University; Mississippi State University; Cotton Incorporated	Zhang, TZ (corresponding author), Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Minist Educ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn; moelab@njau.edu.cn; lirq@novogene.cn; zjchen@austin.utexas.edu	Song, Qingxin/AAB-2101-2021; Llewellyn, Danny J/D-5230-2009; zhang, jin/GXV-9154-2022; Stelly, David/ABC-7400-2020; Mei, Gaofu/AAG-7632-2020; Dennis, Elizabeth S/A-6074-2008	Song, Qingxin/0000-0001-7081-3339; Llewellyn, Danny J/0000-0001-9535-8707; Stelly, David/0000-0002-3468-4119; Dennis, Elizabeth S/0000-0002-7850-591X; ye, wenxue/0000-0001-9917-2176; Hulse-Kemp, Amanda/0000-0001-9670-9433; Scheffler, Brian/0000-0003-1968-8952; Peterson, Daniel/0000-0002-0274-5968; Chen, Xiaoya/0000-0002-2909-8414; Chen, Jiedan/0000-0002-5223-8243; Wang, Qiong/0000-0001-8843-7060	Major State Basic Research Development Program of China (973 Program) [2011CB109300]; National Natural Science Foundation of China [3133058, 31290213]; NSF [ISO1025947]; Fundamental Research Funds by the Central Universities [KYZ201201]; Cotton Incorporated [07-161, 14-371]; Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program; Direct For Biological Sciences [1444552] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1025947] Funding Source: National Science Foundation; ARS [ARS-0425248] Funding Source: Federal RePORTER	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); Fundamental Research Funds by the Central Universities; Cotton Incorporated(Cotton R&D Corp); Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program(Ministry of Education, China - 111 Project); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was financially supported in part by grants from the Major State Basic Research Development Program of China (973 Program) (2011CB109300), National Natural Science Foundation of China (No. 3133058; No. 31290213), NSF (ISO1025947), The Fundamental Research Funds by the Central Universities (KYZ201201), Cotton Incorporated (07-161, 14-371), the Priority Academic Program Development of Jiangsu Higher Education Institutions and the 111 program.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Feldman M, 1997, GENETICS, V147, P1381; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Guan XY, 2014, TRENDS PLANT SCI, V19, P516, DOI 10.1016/j.tplants.2014.04.007; Guigo R, 1998, J COMPUT BIOL, V5, P681, DOI 10.1089/cmb.1998.5.681; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kagale S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4706; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; KOHEL R J, 1970, Crop Science, V10, P670; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Leach LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-276; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Motamayor JC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r53; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Ooijen J.W., 2001, PLANT RES INT; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TURCOTTE EL, 1969, CROP SCI, V9, P653, DOI 10.2135/cropsci1969.0011183X000900050045x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang K, 2012, THEOR APPL GENET, V124, P1173, DOI 10.1007/s00122-011-1777-3; Wang K, 2010, CHROMOSOMA, V119, P255, DOI 10.1007/s00412-009-0254-0; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoo MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004073; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008	83	1032	1163	23	359	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					531	U252		10.1038/nbt.3207	http://dx.doi.org/10.1038/nbt.3207			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25893781	hybrid			2022-12-25	WOS:000354314500035
J	Generoso, SF; Giustiniano, M; La Regina, G; Bottone, S; Passacantilli, S; Di Maro, S; Cassese, H; Bruno, A; Mallardo, M; Dentice, M; Silvestri, R; Marinelli, L; Sarnataro, D; Bonatti, S; Novellino, E; Stornaiuolo, M				Generoso, Serena F.; Giustiniano, Mariateresa; La Regina, Giuseppe; Bottone, Sara; Passacantilli, Sara; Di Maro, Salvatore; Cassese, Hilde; Bruno, Agostino; Mallardo, Massimo; Dentice, Monica; Silvestri, Romano; Marinelli, Luciana; Sarnataro, Daniela; Bonatti, Stefano; Novellino, Ettore; Stornaiuolo, Mariano			Pharmacological folding chaperones act as allosteric ligands of Frizzled4	NATURE CHEMICAL BIOLOGY			English	Article							CELL-SURFACE EXPRESSION; DISHEVELLED DEP DOMAIN; ENDOPLASMIC-RETICULUM; STRUCTURAL BASIS; RECEPTOR; ACTIVATION; CATENIN; PATHWAY; BINDING; RESCUE	Upon binding, ligands can chaperone their protein targets by preventing them from misfolding and aggregating. Thus, an organic molecule that works as folding chaperone for a protein might be its specific ligand, and, similarly, the chaperone potential could represent an alternative readout in a molecular screening campaign toward the identification of new hits. Here we show that small molecules selected for acting as pharmacological chaperones on a misfolded mutant of the Frizzled4 (Fz4) receptor bind and modulate wild-type Fz4, representing what are to our knowledge the first organic ligands of this until-now-undruggable GPCR. The novelty and the advantages of the screening platform, the allosteric binding site addressed by these new ligands and the mechanism they use to modulate Fz4 suggest new avenues for development of inhibitors of the Wnt-beta-catenin pathway and for drug discovery.	[Generoso, Serena F.; Mallardo, Massimo; Sarnataro, Daniela; Bonatti, Stefano] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Giustiniano, Mariateresa; Bottone, Sara; Di Maro, Salvatore; Cassese, Hilde; Bruno, Agostino; Marinelli, Luciana; Novellino, Ettore; Stornaiuolo, Mariano] Univ Naples Federico II, Dept Pharm, Naples, Italy; [La Regina, Giuseppe; Passacantilli, Sara; Silvestri, Romano] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy; [Dentice, Monica] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Sarnataro, Daniela] CEINGE Biotecnol Avanzate Scarl, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Stornaiuolo, M (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	mariano.stornaiuolo@gmail.com	Sarnataro, Daniela/X-5629-2019; Marinelli, Luciana/AHE-5969-2022; Bruno, Agostino/F-3929-2014; Stornaiuolo, Mariano/J-6557-2016; Generoso, Serena Francesca/K-9149-2015; La Regina, Giuseppe/I-2161-2012; Stornaiuolo, Mariano/AAY-6072-2021	Sarnataro, Daniela/0000-0002-6094-8384; Bruno, Agostino/0000-0002-2731-980X; La Regina, Giuseppe/0000-0003-3252-1161; Stornaiuolo, Mariano/0000-0003-2200-5083; Di Maro, Salvatore/0000-0002-9286-4433; Bottone, Sara/0000-0002-4049-2332; Marinelli, Luciana/0000-0002-4084-8044; Novellino, Ettore/0000-0002-2181-2142; Passacantilli, Sara/0000-0001-9781-0621; Silvestri, Romano/0000-0003-2489-0178; MALLARDO, Massimo/0000-0002-4001-3856; GENEROSO, SERENA FRANCESCA/0000-0002-2733-1710	Progetti di Rilevante Interesse Nazionale (PRIN) [2012C5YJSK_003, 2010W7YRLZ_001]; Bando Futuro in Ricerca [RBFR10ZJQT]; Fondazione Telethon [GGP14002]	Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Bando Futuro in Ricerca; Fondazione Telethon(Fondazione TelethonEuropean Commission)	We thank R. Polishchuk (Telethon Institute of Genetics and Medicine) and B.A. Stanton (Dartmouth Center for the Environmental Health Sciences) for sharing ATP-7B and CFTR expression constructs. We thank J. Hausmann for the fruitful discussions. We thank R. Carmelo for the technical help and A. Ciogli and A. Sansone for MS spectral analyses. This work was financed by Progetti di Rilevante Interesse Nazionale (PRIN) 2012-2015 (grant no. 2012C5YJSK_003) to L.M., PRIN2010-2011 (grant no. 2010W7YRLZ_001) to R.S., Bando Futuro in Ricerca 2010 (grant no. RBFR10ZJQT) to G.L.R. and Fondazione Telethon (grant no. GGP14002) to S.B.	Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Chatel G, 2007, INT J CANCER, V121, P2622, DOI 10.1002/ijc.22998; D'Agostino M, 2014, J MEMBRANE BIOL, V247, P1149, DOI 10.1007/s00232-014-9710-8; D'Agostino M, 2013, J CELL SCI, V126, P4160, DOI 10.1242/jcs.125443; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; Eshaq RS, 2010, BRAIN RES, V1346, P1, DOI 10.1016/j.brainres.2010.05.030; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Halaban R, 2001, J BIOL CHEM, V276, P11933, DOI 10.1074/jbc.M008703200; Hartl FU, 2011, NAT MED, V17, P1206, DOI 10.1038/nm.2467; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jin X, 2011, CANCER RES, V71, P3066, DOI 10.1158/0008-5472.CAN-10-1495; Jones KH, 1996, GENETICS, V142, P205; Jung H, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.28; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Ke JY, 2013, GENE DEV, V27, P2305, DOI 10.1101/gad.228544.113; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Lemma V, 2013, SCI REP-UK, V3, DOI 10.1038/srep02659; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Maya-Nunez Guadalupe, 2012, Subcell Biochem, V63, P263, DOI 10.1007/978-94-007-4765-4_14; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Radner S, 2012, J STRUCT BIOL, V179, P46, DOI 10.1016/j.jsb.2012.04.013; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Stornaiuolo M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2900; Strutt D, 2012, GENETICS, V192, P1295, DOI 10.1534/genetics.112.144592; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Ulloa-Aguirre A, 2011, RECENT PATENTS ENDOC, V5, P13, DOI 10.2174/187221411794351851; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Zimmerman ZF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008086	55	29	30	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2015	11	4					280	U65		10.1038/NCHEMBIO.1770	http://dx.doi.org/10.1038/NCHEMBIO.1770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2SG	25751279				2022-12-25	WOS:000351666500011
J	Wu, Y; Song, P; Zhang, WC; Liu, JH; Dai, XY; Liu, ZY; Lu, QL; Ouyang, CH; Xie, ZL; Zhao, ZX; Zhuo, XZ; Viollet, B; Foretz, M; Wu, JL; Yuan, ZY; Zou, MH				Wu, Yue; Song, Ping; Zhang, Wencheng; Liu, Junhui; Dai, Xiaoyan; Liu, Zhaoyu; Lu, Qiulun; Ouyang, Changhan; Xie, Zhonglin; Zhao, Zhengxing; Zhuo, Xiaozhen; Viollet, Benoit; Foretz, Marc; Wu, Jiliang; Yuan, Zuyi; Zou, Ming-Hui			Activation of AMPK alpha 2 in adipocytes is essential for nicotine-induced insulin resistance in vivo	NATURE MEDICINE			English	Article							MAP KINASE PHOSPHATASE-1; DIET-INDUCED OBESITY; PROTEIN-KINASE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; CARDIOVASCULAR-DISEASE; SMOKING-CESSATION; HEPATIC STEATOSIS; CIGARETTE-SMOKING; UP-REGULATION	Cigarette smoking promotes body weight reduction in humans while paradoxically also promoting insulin resistance (IR) and hyperinsulinemia. However, the mechanisms behind these effects are unclear. Here we show that nicotine, a major constituent of cigarette smoke, selectively activates AMP-activated protein kinase alpha 2 (AMPK alpha 2) in adipocytes, which in turn phosphorylates MAP kinase phosphatase-1 (MKP1) at serine 334, initiating its proteasome-dependent degradation. The nicotine-dependent reduction of MKP1 induces the aberrant activation of both p38 mitogen-activated protein kinase and c-Jun N-terminal kinase, leading to increased phosphorylation of insulin receptor substrate 1 (IRS1) at serine 307. Phosphorylation of IRS1 leads to its degradation, protein kinase B inhibition, and the loss of insulin-mediated inhibition of lipolysis. Consequently, nicotine increases lipolysis, which results in body weight reduction, but this increase also elevates the levels of circulating free fatty acids and thus causes IR in insulin-sensitive tissues. These results establish AMPKa2 as an essential mediator of nicotine-induced whole-body IR in spite of reductions in adiposity.	[Wu, Yue; Song, Ping; Zhang, Wencheng; Dai, Xiaoyan; Liu, Zhaoyu; Lu, Qiulun; Ouyang, Changhan; Xie, Zhonglin; Zhao, Zhengxing; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK USA; [Wu, Yue; Liu, Junhui; Zhuo, Xiaozhen; Yuan, Zuyi] Xi An Jiao Tong Univ, Dept Cardiol, Cardiovasc Res Ctr, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China; [Ouyang, Changhan; Wu, Jiliang; Zou, Ming-Hui] Hubei Univ Sci & Technol, Key Lab Hubei Prov Cardiocerebral Dis, Xianning, Hubei, Peoples R China; [Viollet, Benoit; Foretz, Marc] INSERM, Inst Cochin, U1016, Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, Paris, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; Xi'an Jiaotong University; Hubei University of Science & Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zou, MH (corresponding author), Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA 30303 USA.	zuyiyuan@mail.xjtu.edu.cn; mzou@gsu.edu	liu, zhao/GXV-6141-2022; Viollet, Benoit/O-6927-2017; Lu, Qiulun/A-7073-2018; Viollet, Benoit/N-2397-2019; Song, Ping/N-8456-2018; FORETZ, Marc/O-7334-2017; Zhang, Wencheng/AAO-8445-2020	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Song, Ping/0000-0002-6143-4270; FORETZ, Marc/0000-0001-7017-9032; Yuan, Zuyi/0000-0002-4141-0298	US National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, AG047776, HL128014]; National Natural Science Foundation of China [81100209, 81025002, 91339116, 81270355]; Scientist Development Grant of American Heart Association [11SDG5560036]; Oklahoma Center for the Advancement of Science and Technology [HR12-061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110488, R01HL079584, R01HL074399, R01HL105157, R01HL096032, R01HL089920, R01HL080499, R01HL128014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientist Development Grant of American Heart Association(American Heart Association); Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Yu for helpful discussions and D. Wang and Y. Du for technical support. Prkaa1<SUP>flox/flox</SUP> and Prkaa2<SUP>flox/flox</SUP> mice were provided by B. Viollet (INSERM, U1016, Institut Cochin, Paris, France). This study was supported by grants from the US National Institutes of Health (HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, and AG047776 to M.-H.Z.) and (HL128014 to Z.X.). This study was also supported in part by grants from the National Natural Science Foundation of China (81100209, 81025002 and 91339116 to Z.Y. and 81270355 to J.W.), the Scientist Development Grant of American Heart Association (11SDG5560036 to P.S.), and the Oklahoma Center for the Advancement of Science and Technology (HR12-061 to P.S.).	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; Bolinder J, 1996, DIABETOLOGIA, V39, P845, DOI 10.1007/s001250050519; Bourron O, 2010, DIABETOLOGIA, V53, P768, DOI 10.1007/s00125-009-1639-6; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dorfman K, 1996, ONCOGENE, V13, P925; Dube JJ, 2011, DIABETOLOGIA, V54, P1147, DOI 10.1007/s00125-011-2065-0; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Fernandez-Galilea M, 2012, J LIPID RES, V53, P2296, DOI 10.1194/jlr.M027086; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Friedman TC, 2012, ENDOCRINOLOGY, V153, P5809, DOI 10.1210/en.2012-1750; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; GABRIELSSON J, 1987, J PHARMACOKINET BIOP, V15, P583, DOI 10.1007/BF01068414; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Guo W, 2009, ARTERIOSCL THROM VAS, V29, P2028, DOI 10.1161/ATVBAHA.109.191304; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heusch WL, 1998, CARCINOGENESIS, V19, P551, DOI 10.1093/carcin/19.4.551; Hiratani K, 2005, BIOCHEM BIOPH RES CO, V335, P836, DOI 10.1016/j.bbrc.2005.07.152; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hogg RC, 2004, SCIENCE, V306, P983, DOI 10.1126/science.1106030; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Jocken JWE, 2013, DIABETOLOGIA, V56, P2255, DOI 10.1007/s00125-013-2995-9; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Li JM, 2004, ARTERIOSCL THROM VAS, V24, P80, DOI 10.1161/01.ATV.0000104007.17365.1c; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Lin LG, 2012, AM J PHYSIOL-ENDOC M, V302, pE1550, DOI 10.1152/ajpendo.00462.2011; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Nakamura S, 2010, MED MOL MORPHOL, V43, P204, DOI 10.1007/s00795-010-0493-4; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; Schnoll RA, 2013, ADDICTION, V108, P1989, DOI 10.1111/add.12285; Seoane-Collazo P, 2014, ENDOCRINOLOGY, V155, P1679, DOI 10.1210/en.2013-1839; Siri P, 2001, J BIOL CHEM, V276, P46064, DOI 10.1074/jbc.M108909200; Song P, 2013, ARTERIOSCL THROM VAS, V33, P2800, DOI 10.1161/ATVBAHA.113.301869; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Targher G, 1997, J CLIN ENDOCR METAB, V82, P3619, DOI 10.1210/jc.82.11.3619; Tundulawessa Yongyuth, 2010, Journal of the Medical Association of Thailand, V93, P574; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; WACK JT, 1982, AM J CLIN NUTR, V35, P366, DOI 10.1093/ajcn/35.2.366; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; WOLFFENBUTTEL BHR, 1989, DIABETIC MED, V6, P520, DOI 10.1111/j.1464-5491.1989.tb01220.x; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xu TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051217; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Zhang WC, 2013, DIABETES, V62, P2347, DOI 10.2337/db12-1229; Zhong CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082719	66	112	115	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					373	+		10.1038/nm.3826	http://dx.doi.org/10.1038/nm.3826			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25799226	Green Accepted			2022-12-25	WOS:000352493600019
J	Gonzalez, AJ; Setty, M; Leslie, CS				Gonzalez, Alvaro J.; Setty, Manu; Leslie, Christina S.			Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; CHROMATIN STATE DYNAMICS; GENE-EXPRESSION; SUPER-ENHANCERS; IDENTITY GENES; R PACKAGE; LANDSCAPE; GENOME; PROMOTER; ELEMENTS	We carried out an integrative analysis of enhancer landscape and gene expression dynamics during hematopoietic differentiation using DNase-seq, histone mark ChIP-seq and RNA sequencing to model how the early establishment of enhancers and regulatory locus complexity govern gene expression changes at cell state transitions. We found that high-complexity genes-those with a large total number of DNase-mapped enhancers across the lineage-differ architecturally and functionally from low-complexity genes, achieve larger expression changes and are enriched for both cell type-specific and transition enhancers, which are established in hematopoietic stem and progenitor cells and maintained in one differentiated cell fate but lost in others. We then developed a quantitative model to accurately predict gene expression changes from the DNA sequence content and lineage history of active enhancers. Our method suggests a new mechanistic role for PU.1 at transition peaks during B cell specification and can be used to correct assignments of enhancers to genes.	[Gonzalez, Alvaro J.; Setty, Manu; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.	cleslie@cbio.mskcc.org		Setty, Manu/0000-0002-0344-2627	US National Institutes of Health [R01-HG006798, U01-HG007893, U01-HG007033]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893, U01HG007033, R01HG006798] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank A. Kundaje for extensive advice on the processing of Roadmap Epigenomics data sets, and we thank A. Arvey for helpful discussions at early stages in the project. This work was supported by US National Institutes of Health grants R01-HG006798, U01-HG007893 and U01-HG007033.	Anderson E, 2014, CURR OPIN GENET DEV, V27, P54, DOI 10.1016/j.gde.2014.03.011; Benaglia T, 2009, J STAT SOFTW, V32, P1; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mairal J, 2010, J MACH LEARN RES, V11, P19; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; Malin J, 2013, NUCLEIC ACIDS RES, V41, P6828, DOI 10.1093/nar/gkt374; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothenberg EV, 2014, TRENDS IMMUNOL, V35, P195, DOI 10.1016/j.it.2014.03.001; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Setty M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004271; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smale ST, 2010, CURR OPIN GENET DEV, V20, P519, DOI 10.1016/j.gde.2010.06.010; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wickrema A, 2009, MOL BASIS HEMATOPOIE; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Yoshida T, 2013, BLOOD, V122, P3149, DOI 10.1182/blood-2013-01-474916; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	52	54	54	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1249	+		10.1038/ng.3402	http://dx.doi.org/10.1038/ng.3402			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26390058	Green Accepted			2022-12-25	WOS:000363988200008
J	Collinet, C; Rauzi, M; Lenne, PF; Lecuit, T				Collinet, Claudio; Rauzi, Matteo; Lenne, Pierre-Francois; Lecuit, Thomas			Local and tissue-scale forces drive oriented junction growth during tissue extension	NATURE CELL BIOLOGY			English	Article							EPITHELIAL TISSUE; CELL INTERCALATION; E-CADHERIN; CONVERGENT EXTENSION; ADHERENS JUNCTIONS; SURFACE MECHANICS; PLANAR POLARITY; IN-VIVO; DROSOPHILA; MORPHOGENESIS	Convergence-extension is a widespread morphogenetic process driven by polarized cell intercalation. In the Drosophila germ band, epithelial intercalation comprises loss of junctions between anterior-posterior neighbours followed by growth of new junctions between dorsal-ventral neighbours. Much is known about how active stresses drive polarized junction shrinkage. However, it is unclear how tissue convergence-extension emerges from local junction remodelling and what the specific role, if any, of junction growth is. Here we report that tissue convergence and extension correlate mostly with new junction growth. Simulations and in vivo mechanical perturbations reveal that junction growth is due to local polarized stresses driven by medial actomyosin contractions. Moreover, we find that tissue-scale pulling forces at the boundary with the invaginating posterior midgut actively participate in tissue extension by orienting junction growth. Thus, tissue extension is akin to a polarized fluid flow that requires parallel and concerted local and tissue-scale forces to drive junction growth and cell-cell displacement.	[Collinet, Claudio; Lenne, Pierre-Francois; Lecuit, Thomas] Aix Marseille Univ, CNRS, IBDM, UMR7288, F-13009 Marseille, France; [Rauzi, Matteo] EMBL Heidelberg, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; European Molecular Biology Laboratory (EMBL)	Collinet, C (corresponding author), Aix Marseille Univ, CNRS, IBDM, UMR7288, F-13009 Marseille, France.	claudio.collinet@univ-amu.fr; thomas.leccuit@univ-amu.fr		Lenne, Pierre-Francois/0000-0003-1066-7506; Collinet, Claudio/0000-0002-8532-2601; Rauzi, Matteo/0000-0002-6313-0668	ANR Archiplast; ERC [323027]; FRM (Fondation Recherche Medicale, Equipe Labelisee); Human Frontier Science Program Long-Term Fellowship; FRM; Agence Nationale de la Recherche [ANR-10-INSB-04-01]; Region PACA; EMBO-Marie Curie; Human Frontier Science Program Long-Term fellowships; Amplitudes Systemes	ANR Archiplast(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); FRM (Fondation Recherche Medicale, Equipe Labelisee); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); FRM(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Region PACA(Region Provence-Alpes-Cote d'Azur); EMBO-Marie Curie; Human Frontier Science Program Long-Term fellowships; Amplitudes Systemes	We thank J.-M. Philippe (IBDM, France) for designing and preparing the dsRNA probes used in this study and C. Chardes for development and assistance with the ablation set up. We thank R. Levayer, M. Rao and members of the Lecuit and Lenne groups for stimulating and useful discussions during the course of this project. We thank B. Aigouy for help with cell segmentation and tracking. This work was supported by the ANR Archiplast, the ERC (Biomecamorph no. 323027) and by the FRM (Fondation Recherche Medicale, Equipe Labelisee). C.C. was supported by a Human Frontier Science Program Long-Term Fellowship and by a post-doctoral fellowship from the FRM. We acknowledge the France-BioImaging infrastructure supported by the Agence Nationale de la Recherche (ANR-10-INSB-04-01, call 'Investissements d'Avenir'). M. R. was supported by a PhD fellowship by the Region PACA and Amplitudes Systemes at the time when he first discovered the infrared laser-based cell cauterization process and then by the cofunded EMBO-Marie Curie and by the Human Frontier Science Program Long-Term fellowships when he further developed the technique.	Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Bambardekar K, 2015, P NATL ACAD SCI USA, V112, P1416, DOI 10.1073/pnas.1418732112; Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Campinho P, 2013, NAT CELL BIOL, V15, P1405, DOI 10.1038/ncb2869; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey Matthieu, 2008, V420, P219, DOI 10.1007/978-1-59745-583-1_13; Cox B. T., 2007, INTRO LASER TISSUE I; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Founounou N, 2013, DEV CELL, V24, P242, DOI 10.1016/j.devcel.2013.01.008; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Guillot C, 2013, DEV CELL, V24, P227, DOI 10.1016/j.devcel.2013.01.010; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Herszterg S, 2013, DEV CELL, V24, P256, DOI 10.1016/j.devcel.2012.11.019; Hilgenfeldt S, 2008, P NATL ACAD SCI USA, V105, P907, DOI 10.1073/pnas.0711077105; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Niemz MH, 2007, LASER TISSUE INTERAC; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Sawyer JK, 2011, MOL BIOL CELL, V22, P2491, DOI 10.1091/mbc.E11-05-0411; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHUPBACH T, 1986, ROUX ARCH DEV BIOL, V195, P302, DOI 10.1007/BF00376063; SHIH J, 1992, DEVELOPMENT, V116, P901; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Sommer C, 2011, 8 IEEE INT S BIOM IM; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Wu Y, 2015, DEV CELL, V32, P139, DOI 10.1016/j.devcel.2014.12.003; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	46	169	170	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1247	+		10.1038/ncb3226	http://dx.doi.org/10.1038/ncb3226			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26389664				2022-12-25	WOS:000362213500005
J	Gilja, V; Pandarinath, C; Blabe, CH; Nuyujukian, P; Simeral, JD; Sarma, AA; Sorice, BL; Perge, JA; Jarosiewicz, B; Hochberg, LR; Shenoy, KV; Henderson, JM				Gilja, Vikash; Pandarinath, Chethan; Blabe, Christine H.; Nuyujukian, Paul; Simeral, John D.; Sarma, Anish A.; Sorice, Brittany L.; Perge, Janos A.; Jarosiewicz, Beata; Hochberg, Leigh R.; Shenoy, Krishna V.; Henderson, Jaimie M.			Clinical translation of a high-performance neural prosthesis	NATURE MEDICINE			English	Article							POSTERIOR PARIETAL CORTEX; CORTICAL CONTROL; MOVEMENT SIGNAL; TETRAPLEGIA; INTERFACE; HUMANS; FEEDBACK; DEVICES; ARM	Neural prostheses have the potential to improve the quality of life of individuals with paralysis by directly mapping neural activity to limb- and computer-control signals. We translated a neural prosthetic system previously developed in animal model studies for use by two individuals with amyotrophic lateral sclerosis who had intracortical microelectrode arrays placed in motor cortex. Measured more than 1 year after implant, the neural cursor-control system showed the highest published performance achieved by a person to date, more than double that of previous pilot clinical trial participants.	[Gilja, Vikash; Pandarinath, Chethan; Blabe, Christine H.; Nuyujukian, Paul; Henderson, Jaimie M.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Gilja, Vikash; Pandarinath, Chethan; Nuyujukian, Paul; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Gilja, Vikash; Simeral, John D.; Sarma, Anish A.; Perge, Janos A.; Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Gilja, Vikash] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Pandarinath, Chethan; Nuyujukian, Paul; Shenoy, Krishna V.; Henderson, Jaimie M.] Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Simeral, John D.; Sarma, Anish A.; Perge, Janos A.; Jarosiewicz, Beata; Hochberg, Leigh R.] Dept Vet Affairs Med Ctr, Rehabil R&D Serv, Ctr Neurorestorat & Neurotechnol, Providence, RI USA; [Simeral, John D.; Sarma, Anish A.; Perge, Janos A.; Jarosiewicz, Beata; Hochberg, Leigh R.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Simeral, John D.; Sarma, Anish A.; Sorice, Brittany L.; Hochberg, Leigh R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Jarosiewicz, Beata] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Hochberg, Leigh R.] Harvard Univ, Sch Med, Neurol, Boston, MA USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Brown University; University of California System; University of California San Diego; Stanford University; Brown University; Harvard University; Massachusetts General Hospital; Brown University; Harvard University; Harvard Medical School; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Henderson, JM (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.	henderj@stanford.edu	Hochberg, Leigh/R-6872-2019; Jarosiewicz, Beata/AAT-8548-2021; Simeral, John/CCI-2624-2022	Hochberg, Leigh/0000-0003-0261-2273; Henderson, Jaimie/0000-0002-3276-2267; Pandarinath, Chethan/0000-0003-1241-1432; Nuyujukian, Paul/0000-0001-7778-5473; Blabe, Christine/0000-0003-4623-4251	Stanford Institute for Neuro-Innovation and Translational Neuroscience; Stanford BioX-NeuroVentures; Stanford Office of Postdoctoral Affairs; Garlick Foundation; Craig H. Neilsen Foundation; US National Institutes of Health: the National Institute on Deafness and Other Communication Disorders (NIDCD) [R01DC009899, R01DC014034]; US National Institutes of Health: National Institute of Neurological Disorders and Stroke (NINDS) [RO1NS066311-S1]; US National Institutes of Health: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-National Center for Medical Rehabilitation Research (NCMRR) [N01HD53403, N01HD10018]; Rehabilitation Research and Development Service, Department of Veterans Affairs [B6453R, B6310N]; Massachusetts General Hospital (MGH)-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014034, R01DC009899] Funding Source: NIH RePORTER	Stanford Institute for Neuro-Innovation and Translational Neuroscience; Stanford BioX-NeuroVentures; Stanford Office of Postdoctoral Affairs; Garlick Foundation; Craig H. Neilsen Foundation; US National Institutes of Health: the National Institute on Deafness and Other Communication Disorders (NIDCD); US National Institutes of Health: National Institute of Neurological Disorders and Stroke (NINDS); US National Institutes of Health: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-National Center for Medical Rehabilitation Research (NCMRR); Rehabilitation Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); Massachusetts General Hospital (MGH)-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to thank participants T6, T7, S3 and their families; E.N. Eskandar for participant T7's implantation surgery; B. Davis, B. Pedrick, M. Coburn, B. Travers and D. Rosler for administrative support; S.I. Ryu for surgical assistance; L. Barefoot, P. Gigante, A. Sachs, S. Cash, J. Menon and S. Mernoff for clinical assistance; K. Newell for data collection assistance; J. Saab and N. Schmansky for technical assistance; and J.P. Donoghue for helpful scientific discussions. This work was supported by the Stanford Institute for Neuro-Innovation and Translational Neuroscience; Stanford BioX-NeuroVentures; the Stanford Office of Postdoctoral Affairs; the Garlick Foundation; the Craig H. Neilsen Foundation; The US National Institutes of Health: the National Institute on Deafness and Other Communication Disorders (NIDCD) (R01DC009899, principal investigator (PI): L.R.H.; R01DC014034, PI: J.M.H.), the National Institute of Neurological Disorders and Stroke (NINDS) (RO1NS066311-S1, PI: K.V.S.), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-National Center for Medical Rehabilitation Research (NCMRR) (N01HD53403 and N01HD10018, Sub-award PI: L.R.H.); the Rehabilitation Research and Development Service, Department of Veterans Affairs (B6453R and B6310N, PI: L.R.H.); and the Massachusetts General Hospital (MGH)-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health, the Department of Veterans Affairs or the United States Government.	Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Bacher D, 2015, NEUROREHAB NEURAL RE, V29, P462, DOI 10.1177/1545968314554624; Bensmaia SJ, 2014, NAT REV NEUROSCI, V15, P313, DOI 10.1038/nrn3724; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chestek CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026002; Christie BP, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016009; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Cunningham JP, 2011, J NEUROPHYSIOL, V105, P1932, DOI 10.1152/jn.00503.2010; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jarosiewicz B, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046012; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Masse NY, 2014, J NEUROSCI METH, V236, P58, DOI 10.1016/j.jneumeth.2014.08.004; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perge JA, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046007; Quiroga RQ, 2009, J NEUROSCI METH, V177, P194, DOI 10.1016/j.jneumeth.2008.09.033; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Sussillo D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026027; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Ward DJ, 2002, NATURE, V418, P838, DOI 10.1038/418838a; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	31	176	178	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1142	+		10.1038/nm.3953	http://dx.doi.org/10.1038/nm.3953			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26413781	Green Accepted			2022-12-25	WOS:000362355400015
J	Penchala, SC; Miller, MR; Pal, A; Dong, J; Madadi, NR; Xie, JH; Joo, H; Tsai, J; Batoon, P; Samoshin, V; Franz, A; Cox, T; Miles, J; Chan, WK; Park, MS; Alhamadsheh, MM				Penchala, Sravan C.; Miller, Mark R.; Pal, Arindom; Dong, Jin; Madadi, Nikhil R.; Xie, Jinghang; Joo, Hyun; Tsai, Jerry; Batoon, Patrick; Samoshin, Vyacheslav; Franz, Andreas; Cox, Trever; Miles, Jesse; Chan, William K.; Park, Miki S.; Alhamadsheh, Mamoun M.			A biomimetic approach for enhancing the in vivo half-life of peptides	NATURE CHEMICAL BIOLOGY			English	Article							RETINOL-BINDING-PROTEIN; ALBUMIN-BINDING; TRANSTHYRETIN; RATS; NEUROTENSIN; PREALBUMIN; RECEPTORS; STRATEGY; AFFINITY; ANALOGS	The tremendous therapeutic potential of peptides has not yet been realized, mainly owing to their short in vivo half-life. Although conjugation to macromolecules has been a mainstay approach for enhancing protein half-life, the steric hindrance of macro-molecules often harms the binding of peptides to target receptors, compromising the in vivo efficacy. Here we report a new strategy for enhancing the in vivo half-life of peptides without compromising their potency. Our approach involves endowing peptides with a small molecule that binds reversibly to the serum protein transthyretin. Although there are a few molecules that bind albumin reversibly, we are unaware of designed small molecules that reversibly bind other serum proteins and are used for half-life extension in vivo. We show here that our strategy was effective in enhancing the half-life of an agonist for GnRH receptor while maintaining its binding affinity, which was translated into superior in vivo efficacy.	[Penchala, Sravan C.; Miller, Mark R.; Pal, Arindom; Dong, Jin; Madadi, Nikhil R.; Xie, Jinghang; Cox, Trever; Miles, Jesse; Chan, William K.; Park, Miki S.; Alhamadsheh, Mamoun M.] Univ Pacific, Thomas J Long Sch Pharm & Hlth Sci, Dept Pharmaceut & Med Chem, Stockton, CA 95211 USA; [Joo, Hyun; Tsai, Jerry; Batoon, Patrick; Samoshin, Vyacheslav; Franz, Andreas] Univ Pacific, Dept Chem, Stockton, CA 95211 USA	University of the Pacific; University of the Pacific	Penchala, SC (corresponding author), Univ Pacific, Thomas J Long Sch Pharm & Hlth Sci, Dept Pharmaceut & Med Chem, Stockton, CA 95211 USA.	malhamadsheh@pacific.edu	Madadi, Nikhil/M-9702-2015; madadi, nikhil/A-2518-2016; Joo, Hyun/M-7622-2015; Franz, Andreas/ABD-1098-2021	Madadi, Nikhil/0000-0002-5852-9041; Joo, Hyun/0000-0002-2298-5475; , Jin/0000-0002-3317-0386; Franz, Andreas/0000-0002-3016-516X; Xie, Jinghang/0000-0003-0894-5765	New Investigator Award from the American Association of Colleges of Pharmacy; US National Institutes of Health [1R15GM110677-01]; National Science Foundation Instrumentation grant [NSF-MRI-0722654]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110677] Funding Source: NIH RePORTER	New Investigator Award from the American Association of Colleges of Pharmacy; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Instrumentation grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a New Investigator Award from the American Association of Colleges of Pharmacy and the US National Institutes of Health grant 1R15GM110677-01 (M.M.A.). The support by a National Science Foundation Instrumentation grant (NSF-MRI-0722654) is gratefully acknowledged.	Ahlskog JKJ, 2009, BIOORG MED CHEM LETT, V19, P4851, DOI 10.1016/j.bmcl.2009.06.022; Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a; Alhamadsheh MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002473; Anderes KL, 2003, J PHARMACOL EXP THER, V305, P688, DOI 10.1124/jpet.102.046656; BARELLI H, 1994, BRIT J PHARMACOL, V112, P127, DOI 10.1111/j.1476-5381.1994.tb13041.x; Bendele A, 1998, TOXICOL SCI, V42, P152, DOI 10.1093/toxsci/42.2.152; Boohaker RJ, 2012, CURR MED CHEM, V19, P3794; Choi S, 2011, BIOORGAN MED CHEM, V19, P1505, DOI 10.1016/j.bmc.2010.12.050; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; DICKSON PW, 1982, EUR J BIOCHEM, V129, P289, DOI 10.1111/j.1432-1033.1982.tb07051.x; Engstrom T, 1998, EUR J PHARMACOL, V355, P203, DOI 10.1016/S0014-2999(98)00513-5; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gaberc-Porekar V, 2008, CURR OPIN DRUG DISC, V11, P242; Halmos G, 1996, P NATL ACAD SCI USA, V93, P2398, DOI 10.1073/pnas.93.6.2398; Hayden C, 2008, EUR J ENDOCRINOL, V159, pS17, DOI 10.1530/EJE-08-0354; Hopp J, 2010, PROTEIN ENG DES SEL, V23, P827, DOI 10.1093/protein/gzq058; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; Kontermann R, 2012, THERAPEUTIC PROTEINS; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Levy OE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087704; Lubberink M, 2002, J NUCL MED, V43, P1391; Mager DE, 2001, J PHARMACOKINET PHAR, V28, P507, DOI 10.1023/A:1014414520282; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; MOCK EJ, 1978, ENDOCRINOLOGY, V103, P1111, DOI 10.1210/endo-103-4-1111; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Morgat C, 2014, J NUCL MED, V55, P1650, DOI 10.2967/jnumed.114.142000; Nagy A, 2005, BIOL REPROD, V73, P851, DOI 10.1095/biolreprod.105.043489; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; SUNDELIN J, 1985, J BIOL CHEM, V260, P6481; Trussel S, 2009, BIOCONJUGATE CHEM, V20, P2286, DOI 10.1021/bc9002772; Tweedle MF, 2009, ACCOUNTS CHEM RES, V42, P958, DOI 10.1021/ar800215p; VICKERY BH, 1986, ENDOCR REV, V7, P115, DOI 10.1210/edrv-7-1-115; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Zobel K, 2003, BIOORG MED CHEM LETT, V13, P1513, DOI 10.1016/S0960-894X(03)00209-9	40	79	85	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					793	+		10.1038/NCHEMBIO.1907	http://dx.doi.org/10.1038/NCHEMBIO.1907			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26344696	Green Accepted			2022-12-25	WOS:000361536500012
J	Szalay, T; Golovchenko, JA				Szalay, Tamas; Golovchenko, Jene A.			De novo sequencing and variant calling with nanopores using PoreSeq	NATURE BIOTECHNOLOGY			English	Article							INDIVIDUAL DNA STRANDS; SINGLE; POLYMERASE; ALGORITHM; MOLECULES; READS	The accuracy of sequencing single DNA molecules with nanopores is continually improving, but de novo genome sequencing and assembly using only nanopore data remain challenging. Here we describe PoreSeq, an algorithm that identifies and corrects errors in nanopore sequencing data and improves the accuracy of de novo genome assembly with increasing coverage depth. The approach relies on modeling the possible sources of uncertainty that occur as DNA transits through the nanopore and finds the sequence that best explains multiple reads of the same region. PoreSeq increases nanopore sequencing read accuracy of M13 bacteriophage DNA from 85% to 99% at 100x coverage. We also use the algorithm to assemble Escherichia coli with 30x coverage and the lambda genome at a range of coverages from 3x to 50x. Additionally, we classify sequence variants at an order of magnitude lower coverage than is possible with existing methods.	[Szalay, Tamas; Golovchenko, Jene A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Golovchenko, Jene A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Golovchenko, JA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	golovchenko@physics.harvard.edu		Szalay, Tamas/0000-0002-6539-7497	National Institutes of Health [R01HG003703]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank E. Brandin for molecule preparation, D. Branton for obtaining MinION sequencers, S. Fleming for helpful algorithmic discussions and Figure 1a, and A. Kuan and M. Burns for feedback on this manuscript. The computations in this paper were run on the Odyssey cluster supported by the Faculty of Arts and Sciences Division of Science, Research Computing Group at Harvard University, and the work was supported by the National Institutes of Health Award no. R01HG003703 to J.A. Golovchenko and D. Branton.	Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Bayley H, 2015, CLIN CHEM, V61, P25, DOI 10.1373/clinchem.2014.223016; Bellman R., 1957, DYNAMIC PROGRAMMING; Brudno M, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P138, DOI 10.1109/CSB.2002.1039337; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Gollnick B, 2015, SMALL, V11, P1273, DOI 10.1002/smll.201402686; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schreiber J, 2013, P NATL ACAD SCI USA, V110, P18910, DOI 10.1073/pnas.1310615110; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Timp W, 2012, BIOPHYS J, V102, pL37, DOI 10.1016/j.bpj.2012.04.009; Vintsyuk T. K, 1972, CYBERNETICS, V4, P52; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wescoe ZL, 2014, J AM CHEM SOC, V136, P16582, DOI 10.1021/ja508527b	28	60	62	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1087	+		10.1038/nbt.3360	http://dx.doi.org/10.1038/nbt.3360			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26352647	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000362555700029
J	Zhang, JW; Tripathi, DN; Jing, J; Alexander, A; Kim, J; Powell, RT; Dere, R; Tait-Mulder, J; Lee, JH; Paull, TT; Pandita, RK; Charaka, VK; Pandita, TK; Kastan, MB; Walker, CL				Zhang, Jiangwei; Tripathi, Durga Nand; Jing, Ji; Alexander, Angela; Kim, Jinhee; Powell, Reid T.; Dere, Ruhee; Tait-Mulder, Jacqueline; Lee, Ji-Hoon; Paull, Tanya T.; Pandita, Raj K.; Charaka, Vijaya K.; Pandita, Tej K.; Kastan, Michael B.; Walker, Cheryl Lyn			ATM functions at the peroxisome to induce pexophagy in response to ROS	NATURE CELL BIOLOGY			English	Article							AUTOPHAGIC MACHINERY; SELECTIVE AUTOPHAGY; REGULATE AUTOPHAGY; RECEPTOR; PHOSPHORYLATION; PROTEIN; IMPORT; UBIQUITINATION; MATRIX; DEGRADATION	Peroxisomes are highly metabolic, autonomously replicating organelles that generate reactive oxygen species (ROS) as a by-product of fatty acid beta-oxidation. Consequently, cells must maintain peroxisome homeostasis, or risk pathologies associated with too few peroxisomes, such as peroxisome biogenesis disorders, or too many peroxisomes, inducing oxidative damage and promoting diseases such as cancer. We report that the PEX5 peroxisome import receptor binds ataxia-telangiectasia mutated (ATM) and localizes this kinase to the peroxisome. In response to ROS, ATM signalling activates ULK1 and inhibits mTORC1 to induce autophagy. Specificity for autophagy of peroxisomes (pexophagy) is provided by ATM phosphorylation of PEX5 at Ser 141, which promotes PEX5 monoubiquitylation at Lys 209, and recognition of ubiquitylated PEX5 by the autophagy adaptor protein p62, directing the autophagosome to peroxisomes to induce pexophagy. These data reveal an important new role for ATM in metabolism as a sensor of ROS that regulates pexophagy.	[Zhang, Jiangwei; Tripathi, Durga Nand; Jing, Ji; Powell, Reid T.; Dere, Ruhee; Walker, Cheryl Lyn] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA; [Alexander, Angela] UT MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Kim, Jinhee] Korea Inst Oriental Med, Dajeon 305811, South Korea; [Tait-Mulder, Jacqueline; Kastan, Michael B.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Lee, Ji-Hoon; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Pandita, Raj K.; Charaka, Vijaya K.; Pandita, Tej K.] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX 77030 USA; [Kastan, Michael B.] Duke Univ, Med Ctr, Pharmacol & Canc Biol, Durham, NC 27710 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Korea Institute of Oriental Medicine (KIOM); St Jude Children's Research Hospital; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; The Methodist Hospital System; The Methodist Hospital - Houston; Duke University	Walker, CL (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA.	cwalker@ibt.tamhsc.edu	Lee, Jihoon/AAK-3497-2021; Tripathi, Durga Nand/H-3247-2019; Pandita, Tej K/AAM-9188-2020; 高, 雨莉/HGU-8187-2022	Lee, Jihoon/0000-0001-7387-935X; Tripathi, Durga Nand/0000-0001-8736-4808; Paull, Tanya/0000-0002-2991-651X; Alexander, Angela/0000-0002-6649-7991; Powell, Reid T./0000-0002-6242-8315	National Institutes of Health (NIH) [R01 CA143811]; Robert A. Welch Endowed Chair in Chemistry [BE-0023]; NIH [CA129537, CA154320, GM109768]; China Scholarship Council (CSC); NATIONAL CANCER INSTITUTE [R01CA154320, R01CA143811, R01CA129537, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109768] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Endowed Chair in Chemistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Subramani (University of California, San Diego, California) for critical advice and providing the mRFP-EGFP-SKL plasmids, and M. Mancini (Baylor College of Medicine, Houston, Texas for providing the DsRed-SKL plasmid. We are also grateful for the assistance of K. Dunner (U.T.M.D. Cancer Center, Houston, Texas) and D. Townley (Baylor College of Medicine, Houston, Texas) in electron microscopy image acquisition. This work was supported by National Institutes of Health (NIH) Grant R01 CA143811 to C.L.W., a Robert A. Welch Endowed Chair in Chemistry (BE-0023) to C.L.W., and NIH grants CA129537, CA154320 and GM109768 to T.K.P.J.J. was a recipient of the China Scholarship Council (CSC).	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Apanasets O, 2014, TRAFFIC, V15, P94, DOI 10.1111/tra.12129; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Benjamin D, 2013, NAT CELL BIOL, V15, P1135, DOI 10.1038/ncb2849; Brown AI, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003426; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Dhar S, 2000, MOL CELL BIOL, V20, P7764, DOI 10.1128/MCB.20.20.7764-7772.2000; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Dunn WA, 2005, AUTOPHAGY, V1, P75; Farre JC, 2004, TRENDS CELL BIOL, V14, P515, DOI 10.1016/j.tcb.2004.07.014; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Gammoh N, 2013, NAT STRUCT MOL BIOL, V20, P144, DOI 10.1038/nsmb.2475; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Gupta A, 2014, CELL REP, V8, P177, DOI 10.1016/j.celrep.2014.05.044; Hara-Kuge S, 2008, EXP CELL RES, V314, P3531, DOI 10.1016/j.yexcr.2008.09.015; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hunt CR, 2007, CANCER RES, V67, P3010, DOI 10.1158/0008-5472.CAN-06-4328; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nazarko TY, 2014, J CELL BIOL, V204, P541, DOI 10.1083/jcb.201307050; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Singh I, 2009, J CHILD NEUROL, V24, P1147, DOI 10.1177/0883073809338327; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Thoms S, 2006, BBA-MOL CELL RES, V1763, P1620, DOI 10.1016/j.bbamcr.2006.08.046; Till Andreas, 2012, Int J Cell Biol, V2012, P512721, DOI 10.1155/2012/512721; Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	61	259	262	4	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1259	+		10.1038/ncb3230	http://dx.doi.org/10.1038/ncb3230			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26344566	Green Accepted			2022-12-25	WOS:000362213500006
J	Birket, MJ; Ribeiro, MC; Verkerk, AO; Ward, D; Leitoguinho, AR; den Hartogh, SC; Orlova, VV; Devalla, HD; Schwach, V; Bellin, M; Passier, R; Mummery, CL				Birket, Matthew J.; Ribeiro, Marcelo C.; Verkerk, Arie O.; Ward, Dorien; Leitoguinho, Ana Rita; den Hartogh, Sabine C.; Orlova, Valeria V.; Devalla, Harsha D.; Schwach, Verena; Bellin, Milena; Passier, Robert; Mummery, Christine L.			Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							SECONDARY HEART FIELD; SMOOTH-MUSCLE; CARDIAC DIFFERENTIATION; ZEBRAFISH HEART; BMP; CARDIOMYOCYTE; INDUCTION; MOUSE; POPULATION; LINEAGES	The inability of multipotent cardiovascular progenitor cells (CPCs) to undergo multiple divisions in culture has precluded stable expansion of precursors of cardiomyocytes and vascular cells. This contrasts with neural progenitors, which can be expanded robustly and are a renewable source of their derivatives. Here we use human pluripotent stem cells bearing a cardiac lineage reporter to show that regulated MYC expression enables robust expansion of CPCs with insulin-like growth factor-1 (IGF-1) and a hedgehog pathway agonist. The CPCs can be patterned with morphogens, recreating features of heart field assignment, and controllably differentiated to relatively pure populations of pacemaker-like or ventricular-like cardiomyocytes. The cells are clonogenic and can be expanded for >40 population doublings while retaining the ability to differentiate into cardiomyocytes and vascular cells. Access to CPCs will allow precise recreation of elements of heart development in vitro and facilitate investigation of the molecular basis of cardiac fate determination. This technology is applicable for cardiac disease modeling, toxicology studies and tissue engineering.	[Birket, Matthew J.; Ribeiro, Marcelo C.; Ward, Dorien; Leitoguinho, Ana Rita; den Hartogh, Sabine C.; Orlova, Valeria V.; Devalla, Harsha D.; Schwach, Verena; Bellin, Milena; Passier, Robert; Mummery, Christine L.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Verkerk, Arie O.] Amsterdam Med Ctr, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Mummery, CL (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	c.l.mummery@lumc.nl	Bellin, Milena/M-2311-2014; Devalla, Harsha D./GRF-0685-2022; Orlova, Valeria V/C-6065-2014; Birket, Matthew/P-1704-2017	Bellin, Milena/0000-0001-5380-6743; Devalla, Harsha D./0000-0001-5343-1021; Orlova, Valeria V/0000-0002-1169-2802; Verkerk, Arie/0000-0003-2140-834X; Birket, Matthew/0000-0002-5985-6626; Mummery, Christine/0000-0002-4549-6535; Catarino Ribeiro, Marcelo/0000-0003-0583-7443	Cardiovascular Research Netherlands (CVON HUSTCARE); Netherlands Institute of Regenerative Medicine (NIRM); European Research Council (ERCAdG) [323182]; Netherlands Organization for Scientific Research (NWO-FOM FOM) [09MMC02]; etherlands Organization for Scientific Research [ZonMW-TOP 40-00812-98-12086, ZonMW-MKMD 40-42600-98-036]; Rembrandt Institute of Cardiovascular Science; European Community [602423]; National Centre for the Replacement [NC/C013202/1, NC/C013105/1] Funding Source: researchfish	Cardiovascular Research Netherlands (CVON HUSTCARE); Netherlands Institute of Regenerative Medicine (NIRM); European Research Council (ERCAdG)(European Research Council (ERC)); Netherlands Organization for Scientific Research (NWO-FOM FOM); etherlands Organization for Scientific Research; Rembrandt Institute of Cardiovascular Science; European Community(European Commission); National Centre for the Replacement	We acknowledge the contributions of I. Marcuccio and S. Casini. Work in C.L.M.'s lab is supported by Cardiovascular Research Netherlands (CVON HUSTCARE), The Netherlands Institute of Regenerative Medicine (NIRM), the European Research Council (ERCAdG 323182 STEMCARDIOVASC) and The Netherlands Organization for Scientific Research (NWO-FOM FOM 09MMC02). Work in R.P.'s lab is supported by the Netherlands Organization for Scientific Research (ZonMW-TOP 40-00812-98-12086 and ZonMW-MKMD 40-42600-98-036) and the Rembrandt Institute of Cardiovascular Science. V.V.O. was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) grant agreement 602423.	Ardehali R, 2013, P NATL ACAD SCI USA, V110, P3405, DOI 10.1073/pnas.1220832110; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Bellin M, 2013, EMBO J, V32, P3161, DOI 10.1038/emboj.2013.240; Bhave M, 2014, ONCOLOGY-NY, V28, P482; Birket MJ, 2015, DEV BIOL, V400, P169, DOI 10.1016/j.ydbio.2015.01.012; Birket MJ, 2013, STEM CELL REP, V1, P560, DOI 10.1016/j.stemcr.2013.11.008; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cai WQ, 2013, GENE DEV, V27, P2332, DOI 10.1101/gad.225144.113; de Pater E, 2012, CIRC RES, V110, P578, DOI 10.1161/CIRCRESAHA.111.261172; Den Hartogh SC, 2015, STEM CELLS, V33, P56, DOI 10.1002/stem.1842; Devalla HD, 2015, EMBO MOL MED, V7, P394, DOI 10.15252/emmm.201404757; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Drawnel FM, 2014, CELL REP, V9, P810, DOI 10.1016/j.celrep.2014.09.055; Dyer LA, 2010, DEV BIOL, V348, P167, DOI 10.1016/j.ydbio.2010.09.021; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Groot ACGD, 2007, ANAT REC, V290, P115, DOI 10.1002/ar.20406; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JACKSON T, 1990, MOL CELL BIOL, V10, P3709, DOI 10.1128/MCB.10.7.3709; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Keren-Politansky A, 2009, DEV BIOL, V335, P374, DOI 10.1016/j.ydbio.2009.09.012; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Liang XQ, 2013, CIRC RES, V113, P399, DOI 10.1161/CIRCRESAHA.113.301588; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lundy Scott D, 2014, Curr Treat Options Cardiovasc Med, V16, P319, DOI 10.1007/s11936-014-0319-0; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marques SR, 2008, DEV BIOL, V321, P397, DOI 10.1016/j.ydbio.2008.06.033; Matsa E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008921; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Milgrom-Hoffman M, 2011, DEVELOPMENT, V138, P4777, DOI 10.1242/dev.061192; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Reifers F, 2000, DEVELOPMENT, V127, P225; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Verkerk AO, 2009, INT J CARDIOL, V132, P318, DOI 10.1016/j.ijcard.2008.12.196; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xi JY, 2010, FASEB J, V24, P2739, DOI 10.1096/fj.09-145177; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163	57	133	142	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					970	U219		10.1038/nbt.3271	http://dx.doi.org/10.1038/nbt.3271			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26192318				2022-12-25	WOS:000360990900025
J	Gupta, PK; Choudhary, B; Gheysen, G				Gupta, Pushpendra Kumar; Choudhary, Bhagirath; Gheysen, Godelieve			Removing Bt eggplant from the face of Indian regulators	NATURE BIOTECHNOLOGY			English	Letter							CROPS		[Gupta, Pushpendra Kumar] Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Choudhary, Bhagirath; Gheysen, Godelieve] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Choudhary, Bhagirath; Gheysen, Godelieve] Univ Ghent, Inst Plant Biotechnol Outreach, B-9000 Ghent, Belgium	Chaudhary Charan Singh University; Ghent University; Ghent University	Gupta, PK (corresponding author), Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.	b.choudhary@cgiar.org						Alberts B, 2013, SCIENCE, V341, P1320, DOI 10.1126/science.1245017; [Anonymous], 2014, INDIAN EXPRESS; [Anonymous], 2010, HINDU; [Anonymous], BUSINESS STANDA 0811; Bagla P, 2012, SCIENCE, V337, P789, DOI 10.1126/science.337.6096.789; Bagla P, 2010, SCIENCE, V327, P767, DOI 10.1126/science.327.5967.767; Barik S., 2010, HINDU; Choudhary B, 2014, PLANT BIOTECHNOL J, V12, P135, DOI 10.1111/pbi.12155; Genetic Engineering Approval Committee, 2009, 97 M GEN ENG APPR CO; Indian Academy of Sciences, 2010, INT REP GM CROPS; Kumar S, 2015, NATURE, V521, P138, DOI 10.1038/521138a; Kurmanath K. V., 2013, HINDU BUSINESS  0606; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Ministry of Environment and Forests, 2011, CIT CLIENTS CHART 20; Ministry of Environment and Forests, 2006, 1533 GOV IND MIN ENV; Ministry of Environment and Forests, 2010, DEC COMM BT BRINJ; Seralini GE, 2012, FOOD CHEM TOXICOL, V50, P4221, DOI 10.1016/j.fct.2012.08.005; Shantharam S, 2010, CURR SCI INDIA, V98, P996; Shetty P., 2010, NATURE NEWS BLOG; Shiva Vandana, 2006, SEEDS SUICIDE ECOLOG	20	6	6	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					904	907		10.1038/nbt.3331	http://dx.doi.org/10.1038/nbt.3331			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348953				2022-12-25	WOS:000360990900011
J	Tagliabue, G				Tagliabue, Giovanni			The nonsensical GMO pseudo-category and a precautionary rabbit hole	NATURE BIOTECHNOLOGY			English	Letter												giovanni.tagliabue@uniedi.com		Molteni Tagliabue, Giovanni/0000-0001-7115-0936				Convention on Biological Diversity, 2000, CONV BIOL DIV MONTR; European Commission, 2000, COMMUNICATION; Taleb NN, 2014, PRECAUTIONARY PRINCI; UN, 1992, UN C ENV DEV ANN 1 R	4	13	13	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					907	908		10.1038/nbt.3333	http://dx.doi.org/10.1038/nbt.3333			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348954				2022-12-25	WOS:000360990900012
J	Williams, LK; Zhang, XH; Caner, S; Tysoe, C; Nguyen, NT; Wicki, J; Williams, DE; Coleman, J; McNeill, JH; Yuen, V; Andersen, RJ; Withers, SG; Brayer, GD				Williams, Leslie K.; Zhang, Xiaohua; Caner, Sami; Tysoe, Christina; Nguyen, Nham T.; Wicki, Jacqueline; Williams, David E.; Coleman, John; McNeill, John H.; Yuen, Violet; Andersen, Raymond J.; Withers, Stephen G.; Brayer, Gary D.			The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif	NATURE CHEMICAL BIOLOGY			English	Article							PANCREATIC ALPHA-AMYLASE; MALTASE-GLUCOAMYLASE; STRUCTURAL-ANALYSIS; MUTAGENESIS; GLUCOSIDASE; MECHANISMS; FLAVONOIDS; MYRICETIN; ACARBOSE; MODEL	The complex plant flavonol glycoside montbretin A is a potent (K-i = 8 nM) and specific inhibitor of human pancreatic alpha-amylase with potential as a therapeutic for diabetes and obesity. Controlled degradation studies on montbretin A, coupled with inhibition analyses, identified an essential high-affinity core structure comprising the myricetin and caffeic acid moieties linked via a disaccharide. X-ray structural analyses of the montbretin A-human alpha-amylase complex confirmed the importance of this core structure and revealed a novel mode of glycosidase inhibition wherein internal pi-stacking interactions between the myricetin and caffeic acid organize their ring hydroxyls for optimal hydrogen bonding to the alpha-amylase catalytic residues D197 and E233. This novel inhibitory motif can be reproduced in a greatly simplified analog, offering potential for new strategies for glycosidase inhibition and therapeutic development.	[Williams, Leslie K.; Caner, Sami; Nguyen, Nham T.; Withers, Stephen G.; Brayer, Gary D.] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Zhang, Xiaohua; Wicki, Jacqueline; Williams, David E.; Andersen, Raymond J.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Fac Sci, Vancouver, BC, Canada; [Tysoe, Christina] Univ British Columbia, Genome Sci & Technol Grad Programme, Vancouver, BC V5Z 1M9, Canada; [Williams, David E.; Andersen, Raymond J.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Coleman, John] Univ British Columbia, Ctr Drug Res & Dev, Vancouver, BC V5Z 1M9, Canada; [McNeill, John H.; Yuen, Violet] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	withers@chem.ubc.ca			Canadian Institutes of Health Research (CIHR) [(FRN) 111082, 200704PPP]; Natural Sciences and Engineering Research Council (NSERC) of Canada; Alexander Graham Bell Canada Graduate Scholarship (NSERC); Tier 1 Canada Research Chair; US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS) [P41GM103393]; CDRD-Pfizer Innovation Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alexander Graham Bell Canada Graduate Scholarship (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tier 1 Canada Research Chair(Canada Research Chairs); US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CDRD-Pfizer Innovation Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Maurus for helpful discussions regarding structural analyses and E. Goddard-Borger for advice on synthesis. We thank E. Kwan for preparation of HPA, T. Hill for isolation of human gut bacterial amylases, C. Hii, P. Lincez and K. Liu for additional technical assistance, H. Flint for providing clones of the human gut bacterial amylases and D.R. Rose (University of Waterloo) for supplies of ntMGAM, ctMGAM and ctSI. This work was supported by Operating and Proof of Principle grants from the Canadian Institutes of Health Research (CIHR; ref. nos. (FRN) 111082, 200704PPP (to G.D.B. and S.G.W.)), by an operating grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada to R.J.A. and through the CDRD-Pfizer Innovation Fund. L.K.W. was supported by an Alexander Graham Bell Canada Graduate Scholarship (NSERC). S.G.W. is supported by a Tier 1 Canada Research Chair. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, which is supported by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. The graphics program PyMOL (ref. 21) was used in part to generate figures.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASADA Y, 1988, PHYTOCHEMISTRY, V27, P1497, DOI 10.1016/0031-9422(88)80223-1; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; BRAYER GD, 1995, PROTEIN SCI, V4, P1730, DOI 10.1002/pro.5560040908; CHIASSON JL, 1994, ANN INTERN MED, V121, P928, DOI 10.7326/0003-4819-121-12-199412150-00004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; Lo Piparo E, 2008, J MED CHEM, V51, P3555, DOI 10.1021/jm800115x; Manaharan T, 2012, FOOD CHEM, V132, P1802, DOI 10.1016/j.foodchem.2011.11.147; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mhlongo NN, 2014, PROTEINS, V82, P1747, DOI 10.1002/prot.24528; Mooradian AD, 1999, DRUGS, V57, P19, DOI 10.2165/00003495-199957010-00003; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Numao S, 2002, BIOCHEMISTRY-US, V41, P215, DOI 10.1021/bi0115636; Ong KC, 2000, LIFE SCI, V67, P1695, DOI 10.1016/S0024-3205(00)00758-X; Rydberg EH, 1999, PROTEIN SCI, V8, P635; Rydberg EH, 2002, BIOCHEMISTRY-US, V41, P4492, DOI 10.1021/bi011821z; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott LJ, 2000, DRUGS, V59, P521, DOI 10.2165/00003495-200059030-00012; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Tarling CA, 2008, CHEMBIOCHEM, V9, P433, DOI 10.1002/cbic.200700470; WANG QP, 1994, J AM CHEM SOC, V116, P11594, DOI 10.1021/ja00104a060; Williams LK, 2012, J MED CHEM, V55, P10177, DOI 10.1021/jm301273u; Woods K.B, 2010, THESIS U BRIT COLUMB; Yoshida K, 2008, J AGR FOOD CHEM, V56, P4367, DOI 10.1021/jf8007579	31	78	79	2	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					691	+		10.1038/NCHEMBIO.1865	http://dx.doi.org/10.1038/NCHEMBIO.1865			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26214255				2022-12-25	WOS:000359954700013
J	Brower, V				Brower, Vicki			NCI-MATCH pairs tumor mutations with matching drugs	NATURE BIOTECHNOLOGY			English	News Item							MEDICINE											2014, NAT REV DRUG DISC, V13, P407; 2014, NAT BIOTECHNOL, V32, P116; 2015, NAT BIOTECHNOL, V33, P325; 2014, NAT BIOTECHNOL, V32, P117	4	29	30	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					790	791		10.1038/nbt0815-790	http://dx.doi.org/10.1038/nbt0815-790			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252121				2022-12-25	WOS:000359274900006
J	Lee, D; Gorkin, DU; Baker, M; Strober, BJ; Asoni, AL; McCallion, AS; Beer, MA				Lee, Dongwon; Gorkin, David U.; Baker, Maggie; Strober, Benjamin J.; Asoni, Alessandro L.; McCallion, Andrew S.; Beer, Michael A.			A method to predict the impact of regulatory variants from DNA sequence	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE SUSCEPTIBILITY; PRIMARY BILIARY-CIRRHOSIS; GENE-EXPRESSION; MAMMALIAN ENHANCERS; MULTIPLE COMMON; CELIAC-DISEASE; CHIP-SEQ; LOCI; METAANALYSIS	Most variants implicated in common human disease by genome-wide association studies (GWAS) lie in noncoding sequence intervals. Despite the suggestion that regulatory element disruption represents a common theme, identifying causal risk variants within implicated genomic regions remains a major challenge. Here we present a new sequence-based computational method to predict the effect of regulatory variation, using a classifier (gkm-SVM) that encodes cell type-specific regulatory sequence vocabularies. The induced change in the gkm-SVM score, deltaSVM, quantifies the effect of variants. We show that deltaSVM accurately predicts the impact of SNPs on DNase I sensitivity in their native genomic contexts and accurately predicts the results of dense mutagenesis of several enhancers in reporter assays. Previously validated GWAS SNPs yield large deltaSVM scores, and we predict new risk-conferring SNPs for several autoimmune diseases. Thus, deltaSVM provides a powerful computational approach to systematically identify functional regulatory variants.	[Lee, Dongwon; Gorkin, David U.; Baker, Maggie; McCallion, Andrew S.; Beer, Michael A.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Strober, Benjamin J.; Asoni, Alessandro L.; Beer, Michael A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Beer, MA (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	andy@jhmi.edu; mbeer@jhu.edu	Beer, Michael/AFV-4282-2022	Beer, Michael A/0000-0001-9955-3809; Lee, Dongwon/0000-0002-1568-2249; Gorkin, David/0000-0003-4944-4107	US National Institutes of Health [R01 NS62972, R01 HG007348]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by US National Institutes of Health grant R01 NS62972 to A.S.M. and by grant R01 HG007348 to M.A.B.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Ghandi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003711; Ghandi M, 2014, J MATH BIOL, V69, P469, DOI 10.1007/s00285-013-0705-3; Gorkin DU, 2012, GENOME RES, V22, P2290, DOI 10.1101/gr.139360.112; Gourraud PA, 2013, BRAIN, V136, P1012, DOI 10.1093/brain/aws363; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee D, 2014, GENOME ANALYSIS: CURRENT PROCEDURES AND APPLICATIONS, P101; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Murisier F, 2007, PIGM CELL RES, V20, P173, DOI 10.1111/j.1600-0749.2007.00368.x; Murisier F, 2006, DEV BIOL, V298, P644, DOI 10.1016/j.ydbio.2006.05.011; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	251	257	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					955	+		10.1038/ng.3331	http://dx.doi.org/10.1038/ng.3331			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26075791	Green Accepted			2022-12-25	WOS:000358674100024
J	Boutros, PC; Fraser, M; Harding, NJ; de Borja, R; Trudel, D; Lalonde, E; Meng, A; Hennings-Yeomans, PH; McPherson, A; Sabelnykova, VY; Zia, AM; Fox, NS; Livingstone, J; Shiah, YJ; Wang, JX; Beck, TA; Have, CL; Chong, T; Sam, M; Johns, J; Timms, L; Buchner, N; Wong, A; Watson, JD; Simmons, TT; P'ng, C; Zafarana, G; Nguyen, F; Luo, XM; Chu, KC; Prokopec, SD; Sykes, J; Dal Pra, A; Berlin, A; Brown, A; Chan-Seng-Yue, MA; Yousif, F; Denroche, RE; Chong, LC; Chen, GM; Jung, E; Fung, C; Starmans, MHW; Chen, H; Govind, SK; Hawley, J; D'Costa, A; Pintilie, M; Waggott, D; Hach, F; Lambin, P; Muthuswamy, LB; Cooper, C; Eeles, R; Neal, D; Tetu, B; Sahinalp, C; Stein, LD; Fleshner, N; Shah, SP; Collins, CC; Hudson, TJ; McPherson, JD; van der Kwast, T; Bristow, RG				Boutros, Paul C.; Fraser, Michael; Harding, Nicholas J.; de Borja, Richard; Trudel, Dominique; Lalonde, Emilie; Meng, Alice; Hennings-Yeomans, Pablo H.; McPherson, Andrew; Sabelnykova, Veronica Y.; Zia, Amin; Fox, Natalie S.; Livingstone, Julie; Shiah, Yu-Jia; Wang, Jianxin; Beck, Timothy A.; Have, Cherry L.; Chong, Taryne; Sam, Michelle; Johns, Jeremy; Timms, Lee; Buchner, Nicholas; Wong, Ada; Watson, John D.; Simmons, Trent T.; P'ng, Christine; Zafarana, Gaetano; Nguyen, Francis; Luo, Xuemei; Chu, Kenneth C.; Prokopec, Stephenie D.; Sykes, Jenna; Dal Pra, Alan; Berlin, Alejandro; Brown, Andrew; Chan-Seng-Yue, Michelle A.; Yousif, Fouad; Denroche, Robert E.; Chong, Lauren C.; Chen, Gregory M.; Jung, Esther; Fung, Clement; Starmans, Maud H. W.; Chen, Hanbo; Govind, Shaylan K.; Hawley, James; D'Costa, Alister; Pintilie, Melania; Waggott, Daryl; Hach, Faraz; Lambin, Philippe; Muthuswamy, Lakshmi B.; Cooper, Colin; Eeles, Rosalind; Neal, David; Tetu, Bernard; Sahinalp, Cenk; Stein, Lincoln D.; Fleshner, Neil; Shah, Sohrab P.; Collins, Colin C.; Hudson, Thomas J.; McPherson, John D.; van der Kwast, Theodorus; Bristow, Robert G.			Spatial genomic heterogeneity within localized, multifocal prostate cancer	NATURE GENETICS			English	Article							COPY-NUMBER ALTERATION; C-MYC; GENE; MUTATIONS; LANDSCAPE; GENERATION; EXPRESSION; RELAPSE; RECURRENCE; DISCOVERY	Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized, multifocal prostate cancer to delineate new oncogenes or tumor suppressors. We initially determined the copy number aberration (CNA) profiles of 74 patients with index tumors of Gleason score 7. Of these, 5 patients were subjected to whole-genome sequencing using DNA quantities achievable in diagnostic biopsies, with detailed spatial sampling of 23 distinct tumor regions to assess intraprostatic heterogeneity in focal genomics. Multifocal tumors are highly heterogeneous for single-nucleotide variants (SNVs), CNAs and genomic rearrangements. We identified and validated a new recurrent amplification of MYCL, which is associated with TP53 deletion and unique profiles of DNA damage and transcriptional dysregulation. Moreover, we demonstrate divergent tumor evolution in multifocal cancer and, in some cases, tumors of independent clonal origin. These data represent the first systematic relation of intraprostatic genomic heterogeneity to predicted clinical outcome and inform the development of novel biomarkers that reflect individual prognosis.	[Boutros, Paul C.; Harding, Nicholas J.; de Borja, Richard; Lalonde, Emilie; Hennings-Yeomans, Pablo H.; Sabelnykova, Veronica Y.; Zia, Amin; Fox, Natalie S.; Livingstone, Julie; Shiah, Yu-Jia; Wang, Jianxin; Beck, Timothy A.; Chong, Taryne; Sam, Michelle; Johns, Jeremy; Timms, Lee; Buchner, Nicholas; Wong, Ada; Watson, John D.; Simmons, Trent T.; P'ng, Christine; Nguyen, Francis; Luo, Xuemei; Chu, Kenneth C.; Prokopec, Stephenie D.; Brown, Andrew; Chan-Seng-Yue, Michelle A.; Yousif, Fouad; Denroche, Robert E.; Chong, Lauren C.; Chen, Gregory M.; Jung, Esther; Fung, Clement; Starmans, Maud H. W.; Chen, Hanbo; Govind, Shaylan K.; Hawley, James; D'Costa, Alister; Waggott, Daryl; Muthuswamy, Lakshmi B.; Stein, Lincoln D.; Hudson, Thomas J.; McPherson, John D.] Ontario Inst Canc Res, Toronto, ON, Canada; [Boutros, Paul C.; Lalonde, Emilie; Fox, Natalie S.; Bristow, Robert G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.; Meng, Alice] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Fraser, Michael; Zafarana, Gaetano; Bristow, Robert G.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada; [Trudel, Dominique; Have, Cherry L.; van der Kwast, Theodorus] Univ Hlth Network, Toronto Gen Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada; [McPherson, Andrew; Hach, Faraz; Sahinalp, Cenk] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Sykes, Jenna; Pintilie, Melania] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada; [Dal Pra, Alan; Berlin, Alejandro; Bristow, Robert G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Lambin, Philippe] Maastricht Univ, Dept Radiotherapy, NL-6200 MD Maastricht, Netherlands; [Cooper, Colin; Eeles, Rosalind] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Cooper, Colin] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cooper, Colin] Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Eeles, Rosalind] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, England; [Neal, David] Canc Res UK Cambridge Res Inst, Urol Res Lab, Cambridge, England; [Neal, David] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 2QQ, England; [Tetu, Bernard] Univ Laval, Dept Pathol, Quebec City, PQ, Canada; [Fleshner, Neil] Univ Hlth Network, Princess Margaret Canc Ctr, Div Urol, Toronto, ON, Canada; [Shah, Sohrab P.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Shah, Sohrab P.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V5Z 1M9, Canada; [Shah, Sohrab P.] British Columbia Canc Agcy Res Ctr, Vancouver, BC, Canada; [Collins, Colin C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Collins, Colin C.] Vancouver Prostate Ctr, Lab Adv Genome Anal, Vancouver, BC, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Simon Fraser University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Maastricht University; University of London; Institute of Cancer Research - UK; University of East Anglia; University of East Anglia; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Laval University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Boutros, PC (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	paul.boutros@oicr.on.ca; rob.bristow@rmp.uhn.on.ca	Sahinalp, Suleyman Cenk/X-7843-2018; McPherson, Andrew W/J-6552-2015; Dal Pra, Alan/AAM-9352-2021; wang, edwin/G-5372-2010; McPherson, John D/D-2633-2017; Hawley, James/E-6220-2017; Dal Pra, Alan/AAN-9511-2020; Trudel, Dominique/AAS-4455-2020	Sahinalp, Suleyman Cenk/0000-0002-5050-0682; McPherson, Andrew W/0000-0002-5654-5101; Dal Pra, Alan/0000-0002-1648-6557; McPherson, John D/0000-0001-8049-9347; Hawley, James/0000-0003-4744-5552; Harding, Nicholas/0000-0001-5907-0773; Lambin, Philippe/0000-0001-7961-0191; Boutros, Paul/0000-0003-0553-7520; Chan-Seng-Yue, Michelle/0000-0003-3773-9354; Beck, Timothy/0000-0003-0145-3557; de Borja, Richard/0000-0002-8181-6348; Eeles, Rosalind/0000-0002-3698-6241; Nguyen, Francis/0000-0003-2521-450X; Berlin, Alejandro/0000-0002-1880-6905; Van der Kwast, Theodorus/0000-0001-8640-5786; Bristow, Robert/0000-0002-8553-9544; Lalonde, Emilie/0000-0002-8573-1966; Trudel, Dominique/0000-0001-9820-1772; Hach, Faraz/0000-0003-1143-0172; Livingstone, Julie/0000-0002-8424-3768	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; government of Ontario; Ontario Institute for Cancer Research through government of Ontario; Canadian Institutes of Health Research (CIHR); Princess Margaret Cancer Centre Foundation; Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation [RS2014-01]; Terry Fox Research Institute New Investigator Award; Genome Canada through a Large-Scale Applied Project; Cancer Research UK [17528, 15007] Funding Source: researchfish	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; government of Ontario; Ontario Institute for Cancer Research through government of Ontario; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Princess Margaret Cancer Centre Foundation(University of Toronto); Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation; Terry Fox Research Institute New Investigator Award; Genome Canada through a Large-Scale Applied Project(Genome Canada); Cancer Research UK(Cancer Research UK)	The authors thank all members of the Boutros and Bristow laboratories for helpful suggestions. This study was conducted with the support of Movember funds through Prostate Cancer Canada and with the additional support of the Ontario Institute for Cancer Research, funded by the government of Ontario. This study was conducted with the support of the Ontario Institute for Cancer Research to P.C.B. through funding provided by the government of Ontario. This work has been funded by a Doctoral Fellowship from the Canadian Institutes of Health Research (CIHR) to E.L. The authors gratefully thank the Princess Margaret Cancer Centre Foundation and the Radiation Medicine Program Academic Enrichment Fund for support (to R.G.B.). R.G.B. is a recipient of a Canadian Cancer Society Research Scientist Award. This work was supported by Prostate Cancer Canada and is proudly funded by the Movember Foundation, grant RS2014-01. P.C.B. was supported by a Terry Fox Research Institute New Investigator Award and a CIHR New Investigator Award. This project was supported by Genome Canada through a Large-Scale Applied Project contract to P.C.B., S.P.S. and R. Morin.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Buyyounouski MK, 2012, J CLIN ONCOL, V30, P1857, DOI 10.1200/JCO.2011.35.1924; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Cortese R, 2012, HUM MOL GENET, V21, P3619, DOI 10.1093/hmg/dds192; D'Amico AV, 2003, J CLIN ONCOL, V21, P2163, DOI 10.1200/JCO.2003.01.075; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Djulbegovic M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4543; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishkanian AS, 2009, PROSTATE, V69, P1091, DOI 10.1002/pros.20959; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Locke JA, 2012, PROSTATE, V72, P1295, DOI 10.1002/pros.22478; Locke JA, 2012, CLIN CANCER RES, V18, P308, DOI 10.1158/1078-0432.CCR-11-2147; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Nichol AM, 2005, CANCER-AM CANCER SOC, V104, P891, DOI 10.1002/cncr.21257; O'Connor BD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S2; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Ruijter ET, 1996, J PATHOL, V180, P295; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VILLERS A, 1992, CANCER, V70, P2313, DOI 10.1002/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Zafarana G, 2012, CANCER-AM CANCER SOC, V118, P4053, DOI 10.1002/cncr.26729; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	65	308	313	2	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					736	+		10.1038/ng.3315	http://dx.doi.org/10.1038/ng.3315			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005866	Green Published			2022-12-25	WOS:000357090300010
J	Palacino, J; Swalley, SE; Song, C; Cheung, AK; Shu, L; Zhang, XL; Van Hoosear, M; Shin, Y; Chin, DN; Keller, CG; Beibel, M; Renaud, NA; Smith, TM; Salcius, M; Shi, XY; Hild, M; Servais, R; Jain, M; Deng, L; Bullock, C; McLellan, M; Schuierer, S; Murphy, L; Blommers, MJJ; Blaustein, C; Berenshteyn, F; Lacoste, A; Thomas, JR; Roma, G; Michaud, GA; Tseng, BS; Porter, JA; Myer, VE; Tallarico, JA; Hamann, LG; Curtis, D; Fishman, MC; Dietrich, WF; Dales, NA; Sivasankaran, R				Palacino, James; Swalley, Susanne E.; Song, Cheng; Cheung, Atwood K.; Shu, Lei; Zhang, Xiaolu; Van Hoosear, Mailin; Shin, Youngah; Chin, Donovan N.; Keller, Caroline Gubser; Beibel, Martin; Renaud, Nicole A.; Smith, Thomas M.; Salcius, Michael; Shi, Xiaoying; Hild, Marc; Servais, Rebecca; Jain, Monish; Deng, Lin; Bullock, Caroline; McLellan, Michael; Schuierer, Sven; Murphy, Leo; Blommers, Marcel J. J.; Blaustein, Cecile; Berenshteyn, Frada; Lacoste, Arnaud; Thomas, Jason R.; Roma, Guglielmo; Michaud, Gregory A.; Tseng, Brian S.; Porter, Jeffery A.; Myer, Vic E.; Tallarico, John A.; Hamann, Lawrence G.; Curtis, Daniel; Fishman, Mark C.; Dietrich, William F.; Dales, Natalie A.; Sivasankaran, Rajeev			SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice	NATURE CHEMICAL BIOLOGY			English	Article							SPINAL MUSCULAR-ATROPHY; SINGLE NUCLEOTIDE; MESSENGER-RNA; GENE; SURVIVAL; EXPRESSION; BINDING; PROTEIN; SYSTEM; IDENTIFICATION	Spinal muscular atrophy (SMA), which results from the loss of expression of the survival of motor neuron-1 (SMN1) gene, represents the most common genetic cause of pediatric mortality. A duplicate copy (SMN2) is inefficiently spliced, producing a truncated and unstable protein. We describe herein a potent, orally active, small-molecule enhancer of SMN2 splicing that elevates full-length SMN protein and extends survival in a severe SMA mouse model. We demonstrate that the molecular mechanism of action is via stabilization of the transient double-strand RNA structure formed by the SMN2 pre-mRNA and U1 small nuclear ribonucleic protein (snRNP) complex. The binding affinity of U1 snRNP to the 5' splice site is increased in a sequence-selective manner, discrete from constitutive recognition. This new mechanism demonstrates the feasibility of small molecule-mediated, sequence-selective splice modulation and the potential for leveraging this strategy in other splicing diseases.	[Palacino, James; Swalley, Susanne E.; Song, Cheng; Cheung, Atwood K.; Shu, Lei; Zhang, Xiaolu; Van Hoosear, Mailin; Shin, Youngah; Chin, Donovan N.; Renaud, Nicole A.; Smith, Thomas M.; Salcius, Michael; Shi, Xiaoying; Hild, Marc; Servais, Rebecca; Jain, Monish; Deng, Lin; Bullock, Caroline; McLellan, Michael; Murphy, Leo; Blaustein, Cecile; Berenshteyn, Frada; Lacoste, Arnaud; Thomas, Jason R.; Michaud, Gregory A.; Tseng, Brian S.; Porter, Jeffery A.; Myer, Vic E.; Tallarico, John A.; Hamann, Lawrence G.; Curtis, Daniel; Fishman, Mark C.; Dietrich, William F.; Dales, Natalie A.; Sivasankaran, Rajeev] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Keller, Caroline Gubser; Beibel, Martin; Schuierer, Sven; Blommers, Marcel J. J.; Roma, Guglielmo] Novartis Inst Biomed Res, Forum 1, Basel, Switzerland	Novartis; Novartis	Swalley, SE (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	susanne.swalley@novartis.com; rajeev.sivasankaran@novartis.com		MCLELLAN, MICHAEL/0000-0002-2703-8784; Gubser Keller, Caroline/0000-0001-9459-6076				ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Akerman M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r30; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheung A.K., 2014, United States Patent, Patent No. [8,729,263, 8729263]; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Frostell-Karlsson A, 2000, J MED CHEM, V43, P1986, DOI 10.1021/jm991174y; Gavrilov DK, 1998, NAT GENET, V20, P230, DOI 10.1038/3030; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Kariya S, 2014, J CLIN INVEST, V124, P785, DOI 10.1172/JCI72017; Kastner B, 1999, METH MOL B, V118, P289; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; KRAINER AR, 1988, NUCLEIC ACIDS RES, V16, P9415, DOI 10.1093/nar/16.20.9415; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lara-Pezzi E, 2013, J CARDIOVASC TRANSL, V6, P945, DOI 10.1007/s12265-013-9482-z; Le TT, 2011, HUM MOL GENET, V20, P3578, DOI 10.1093/hmg/ddr275; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewandowska MA, 2013, INT J CLIN EXP PATHO, V6, P2675; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Osborne M, 2012, HUM MOL GENET, V21, P4431, DOI 10.1093/hmg/dds285; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Rueda M, 2012, J CHEM INF MODEL, V52, P2705, DOI [10.1021/ci3001088, 10.1021/ci30010881]; Salcius M, 2014, J BIOMOL SCREEN, V19, P917, DOI 10.1177/1087057114522691; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vitali T, 1999, HUM MOL GENET, V8, P2525, DOI 10.1093/hmg/8.13.2525; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang J, 2012, NUCLEIC ACIDS RES, V40, pD1055, DOI 10.1093/nar/gkr1171; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550; Zhou JH, 2012, MOL CELLS, V33, P223, DOI 10.1007/s10059-012-0005-6	54	255	268	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					511	+		10.1038/NCHEMBIO.1837	http://dx.doi.org/10.1038/NCHEMBIO.1837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26030728				2022-12-25	WOS:000356334600016
J	Pang, BX; de Jong, J; Qiao, XH; Wessels, LFA; Neefjes, J				Pang, Baoxu; de Jong, Johann; Qiao, Xiaohang; Wessels, Lodewyk F. A.; Neefjes, Jacques			Chemical profiling of the genome with anti-cancer drugs defines target specificities	NATURE CHEMICAL BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; DNA TOPOISOMERASE-II; EMBRYONIC STEM-CELLS; HISTONE H3; OPEN CHROMATIN; CANCER; EXPRESSION; MONOMETHYLATION; ARCHITECTURE; DOXORUBICIN	Many anticancer drugs induce DNA breaks to eliminate tumor cells. The anthracycline topoisomerase II inhibitors additionally cause histone eviction. Here, we performed genome-wide high-resolution mapping of chemotherapeutic effects of various topoisomerase I and II (TopoI and II) inhibitors and integrated this mapping with established maps of genomic or epigenomic features to show their activities in different genomic regions. The TopoI inhibitor topotecan and the TopoII inhibitor etoposide are similar in inducing DNA damage at transcriptionally active genomic regions. The anthracycline daunorubicin induces DNA breaks and evicts histones from active chromatin, thus quenching local DNA damage responses. Another anthracycline, aclarubicin, has a different genomic specificity and evicts histones from H3K27me3-marked heterochromatin, with consequences for diffuse large B-cell lymphoma cells with elevated levels of H3K27me3. Modifying anthracycline structures may yield compounds with selectivity for different genomic regions and activity for different tumor types.	[Pang, Baoxu; Qiao, Xiaohang; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [de Jong, Johann; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Neefjes, Jacques] Inst Chem Immunol, Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Pang, BX (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	b.pang@nki.nl; l.wessels@nki.nl; j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017; Pang, Baoxu/ABG-2378-2020	Neefjes, Jacques J.C./0000-0001-6763-2211; Pang, Baoxu/0000-0003-0779-0730; de Jong, Johann/0000-0002-2097-0915	European Research Council grant	European Research Council grant(European Research Council (ERC))	We thank R. Kerkhoven, M. Nieuwland and A. Velds of the Netherlands Cancer Institute Genomic Core Facility; L. Janssen for support in cloning; and W. Akhtar, J. Gruber, B. van Steensel and P. Borst for their critical reading of the manuscript. This work was supported by a European Research Council grant to J.N. J.N. is a member of the Institute of Chemical Immunology.	Arcamone FM, 2009, CHEM-EUR J, V15, P7774, DOI 10.1002/chem.200900292; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; de Jong J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004250; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FREDERICK CA, 1990, BIOCHEMISTRY-US, V29, P2538, DOI 10.1021/bi00462a016; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gupta J, 2012, BIOCHIMIE, V94, P2656, DOI 10.1016/j.biochi.2012.08.011; He LR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-461; Holm K, 2012, MOL ONCOL, V6, P494, DOI 10.1016/j.molonc.2012.06.002; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Jin J, 2013, LANCET ONCOL, V14, P599, DOI 10.1016/S1470-2045(13)70152-9; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Pang BX, 2009, J IMMUNOL, V183, P1083, DOI 10.4049/jimmunol.0900861; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sehn LH, 2010, BLOOD, V116, P2000, DOI 10.1182/blood-2010-07-293407; Sehouli J, 2008, J CLIN ONCOL, V26, P3176, DOI 10.1200/JCO.2007.15.1258; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Thakurela S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3478; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Vey N, 1999, INVEST NEW DRUG, V17, P89, DOI 10.1023/A:1006271618635; Yang F, 2013, CURR BIOL, V23, P782, DOI 10.1016/j.cub.2013.03.043	42	40	43	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					472	+		10.1038/NCHEMBIO.1811	http://dx.doi.org/10.1038/NCHEMBIO.1811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	25961671				2022-12-25	WOS:000356334600011
J	Wong, SL; Demers, M; Martinod, K; Gallant, M; Wang, YM; Goldfine, AB; Kahn, CR; Wagner, DD				Wong, Siu Ling; Demers, Melanie; Martinod, Kimberly; Gallant, Maureen; Wang, Yanming; Goldfine, Allison B.; Kahn, C. Ronald; Wagner, Denisa D.			Diabetes primes neutrophils to undergo NETosis, which impairs wound healing	NATURE MEDICINE			English	Article							EXTRACELLULAR TRAP FORMATION; DNASE-I GENE; POLYMORPHONUCLEAR LEUKOCYTES; MICE; THROMBOSIS; MELLITUS; RELEASE; PAD4; SUSCEPTIBILITY; ASSOCIATION	Wound healing is impaired in diabetes, resulting in significant morbidity and mortality. Neutrophils are the main leukocytes involved in the early phase of healing. As part of their antimicrobial defense, neutrophils form extracellular traps (NETs) by releasing decondensed chromatin lined with cytotoxic proteins(1). NETs, however, can also induce tissue damage. Here we show that neutrophils isolated from type 1 and type 2 diabetic humans and mice were primed to produce NETs (a process termed NETosis). Expression of peptidylarginine deiminase 4 (PAD4, encoded by Padi4 in mice), an enzyme important in chromatin decondensation, was elevated in neutrophils from individuals with diabetes. When subjected to excisional skin wounds, wild-type (WT) mice produced large quantities of NETs in wounds, but this was not observed in Padi4(-/-) ice. In diabetic mice, higher levels of citrullinated histone H3 (H3Cit, a NET marker) were found in their wounds than in normoglycemic mice and healing was delayed. Wound healing was accelerated in Padi4(-/-) ice as compared to WT mice, and it was not compromised by diabetes. DNase 1, which disrupts NETs, accelerated wound healing in diabetic and normoglycemic WT mice. Thus, NETs impair wound healing, particularly in diabetes, in which neutrophils are more susceptible to NETosis. Inhibiting NETosis or cleaving NETs may improve wound healing and reduce NET-driven chronic inflammation in diabetes.	[Wong, Siu Ling; Demers, Melanie; Martinod, Kimberly; Gallant, Maureen; Wagner, Denisa D.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wong, Siu Ling; Demers, Melanie; Martinod, Kimberly; Wagner, Denisa D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wang, Yanming] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Clin Res, Boston, MA 02115 USA; [Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02115 USA; [Wagner, Denisa D.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital	Wagner, DD (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	Denisa.Wagner@childrens.harvard.edu	Wong, Siu Ling Christine/A-9895-2019; Martinod, Kimberly/K-4742-2019; Kahn, Ronald/AAY-2435-2021	Martinod, Kimberly/0000-0002-1026-6107; Kahn, Ronald/0000-0002-7583-9228; Wang, Yanming/0000-0002-0710-043X; Wong, Siu Ling/0000-0002-2294-3187	Harvard Clinical and Translational Science Center, US National Institutes of Health (NIH) [UL1 TR001102]; American Diabetes Association [7-13-IN-44]; National Heart, Lung, and Blood Institute of the NIH [R01HL102101]; National Cancer Institute [R01CA136856]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK031036]; GlaxoSmithKline/Immune Disease Institute Alliance Fellowship; NATIONAL CANCER INSTITUTE [R01CA136856] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102101, T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK033201, R01DK031036] Funding Source: NIH RePORTER	Harvard Clinical and Translational Science Center, US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); GlaxoSmithKline/Immune Disease Institute Alliance Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Ferris for advice on diabetes protocols; L. DeVita for selection of diabetic patients; P. Forbes (The Harvard Clinical and Translational Science Center, US National Institutes of Health (NIH) Award UL1 TR001102) for statistical advice; J.E. Cabral and S. Cifuni for valuable technical support; and L. Cowan for manuscript preparation assistance. This study was supported by the American Diabetes Association (Innovation Award 7-13-IN-44 to D.D.W.), the National Heart, Lung, and Blood Institute of the NIH (R01HL102101 to D.D.W.), the National Cancer Institute (R01CA136856 to Y.W.), the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK031036 to C.R.K.) and a GlaxoSmithKline/Immune Disease Institute Alliance Fellowship (S.L.W.).	Alexandraki KI, 2008, J CLIN IMMUNOL, V28, P314, DOI 10.1007/s10875-007-9164-1; ALEXIEWICZ JM, 1995, ANN INTERN MED, V123, P919, DOI 10.7326/0003-4819-123-12-199512150-00004; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bodano A, 2007, ANN RHEUM DIS, V66, P560, DOI 10.1136/ard.2006.067140; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Coudane F, 2011, EUR J DERMATOL, V21, P376, DOI 10.1684/ejd.2011.1394; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Gupta AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097088; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hanses F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023633; Herrick S, 1997, LAB INVEST, V77, P281; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Karima M, 2005, J LEUKOCYTE BIOL, V78, P862, DOI 10.1189/jlb.1004583; Kumamoto T, 2006, EUR HEART J, V27, P2081, DOI 10.1093/eurheartj/ehl177; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Martinod K, 2015, BLOOD, V125, P1948, DOI 10.1182/blood-2014-07-587709; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Menegazzo L., 2014, ACTA DIABET IN PRESS; Morel O, 2013, SEMIN THROMB HEMOST, V39, P477, DOI 10.1055/s-0033-1343888; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Rebecchi IMM, 2000, CELL BIOCHEM FUNCT, V18, P127, DOI 10.1002/(SICI)1099-0844(200006)18:2<127::AID-CBF865>3.3.CO;2-M; Riyapa D, 2012, INFECT IMMUN, V80, P3921, DOI 10.1128/IAI.00806-12; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Subramaniam M, 1997, AM J PATHOL, V150, P1701; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671	40	562	589	26	224	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					815	+		10.1038/nm.3887	http://dx.doi.org/10.1038/nm.3887			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26076037	Green Accepted			2022-12-25	WOS:000357604600025
J	Belgardt, BF; Ahmed, K; Spranger, M; Latreille, M; Denzler, R; Kondratiuk, N; von Meyenn, F; Villena, FN; Herrmanns, K; Bosco, D; Kerr-Conte, J; Pattou, F; Rulicke, T; Stoffel, M				Belgardt, Bengt-Frederik; Ahmed, Kashan; Spranger, Martina; Latreille, Mathieu; Denzler, Remy; Kondratiuk, Nadiia; von Meyenn, Ferdinand; Villena, Felipe Nunez; Herrmanns, Karolin; Bosco, Domenico; Kerr-Conte, Julie; Pattou, Francois; Ruelicke, Thomas; Stoffel, Markus			The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes	NATURE MEDICINE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; THIOREDOXIN-INTERACTING PROTEIN; GENOME-WIDE ASSOCIATION; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; APOPTOSIS; ISLETS; ZEB1; MICE; GENE	Pancreatic beta cell death is a hallmark of type 1 (T1D) and type 2 (T2D) diabetes, but the molecular mechanisms underlying this aspect of diabetic pathology are poorly understood. Here we report that expression of the microRNA (miR)-200 family is strongly induced in islets of diabetic mice and that beta cell specific overexpression of miR-200 in mice is sufficient to induce beta cell apoptosis and lethal T2D. Conversely, mir-200 ablation in mice reduces beta cell apoptosis and ameliorates T2D. We show that miR-200 negatively regulates a conserved anti-apoptotic and stress-resistance network that includes the essential beta cell chaperone Dnajc3 (also known as p58IPK) and the caspase inhibitor Xiap. We also observed that mir-200 dosage positively controls activation of the tumor suppressor Trp53 and thereby creates a pro-apoptotic gene-expression signature found in islets of diabetic mice. Consequently, miR-200 induced T2D is suppressed by interfering with the signaling of Trp53 and Bax, a proapoptotic member of the B cell lymphoma 2 protein family. Our results reveal a crucial role for the miR-200 family in beta cell survival and the pathophysiology of diabetes.	[Belgardt, Bengt-Frederik; Ahmed, Kashan; Spranger, Martina; Latreille, Mathieu; Denzler, Remy; Kondratiuk, Nadiia; von Meyenn, Ferdinand; Villena, Felipe Nunez; Herrmanns, Karolin; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland; [Belgardt, Bengt-Frederik; Ahmed, Kashan; Spranger, Martina; Latreille, Mathieu; Denzler, Remy; Kondratiuk, Nadiia; von Meyenn, Ferdinand; Villena, Felipe Nunez; Herrmanns, Karolin; Stoffel, Markus] Swiss Fed Inst Technol, Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland; [Bosco, Domenico] Univ Hosp Geneva, Cell Isolat & Transplantat Ctr, Dept Surg, Geneva, Switzerland; [Bosco, Domenico] Univ Geneva, Geneva, Switzerland; [Kerr-Conte, Julie; Pattou, Francois] Univ Lille 2, INSERM, European Genom Inst Diabet, Lille, France; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of Veterinary Medicine Vienna	Stoffel, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland.	stoffel@biol.ethz.ch	von Meyenn, Ferdinand/O-4517-2017; Pattou, Francois/O-6151-2017	von Meyenn, Ferdinand/0000-0001-9920-3075; Pattou, Francois/0000-0001-8388-3766; Stoffel, Markus/0000-0003-1304-5817; Bosco, Domenico/0000-0003-3453-9613; Belgardt, Bengt-Frederik/0000-0003-4537-9002; Latreille, Mathieu/0000-0001-8542-749X	Functional Genomics Center Zurich; Light Microscopy and Screening Center Zurich; European Molecular Biology Organization; Austrian Genome Research Programme GEN-AU II and III (Austromouse); European Genomic Institute for Diabetes [ANR-10-LABX-46]; Juvenile Diabetes Research Foundation (JDRF); European Research Council; Starr Foundation International; Swiss National Science Foundation; National Center of Competence in Research on RNA Biology and Disease; JDRF [31-2012-783]	Functional Genomics Center Zurich; Light Microscopy and Screening Center Zurich; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Austrian Genome Research Programme GEN-AU II and III (Austromouse); European Genomic Institute for Diabetes; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); European Research Council(European Research Council (ERC)European Commission); Starr Foundation International; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research on RNA Biology and Disease; JDRF(Juvenile Diabetes Research Foundation)	We wish to thank B. Kaps and R. Kubsch for excellent technical and animal husbandry assistance. We thank the Functional Genomics Center Zurich and the Light Microscopy and Screening Center Zurich for support, and N. Danial (Dana Farber Cancer Institute, Boston, USA), D. Hanahan (Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland) and P. Herrera (University of Geneva, Switzerland) for sharing Bad<SUP>-/-</SUP>, Rip-Tag2 and Rip-Cre mice, respectively. This work was supported by European Molecular Biology Organization Long-Term Fellowships (to B.-F.B. and K.A.), the Austrian Genome Research Programme GEN-AU II and III (Austromouse) (to T.R.) and the European Genomic Institute for Diabetes (ANR-10-LABX-46 to F.P.) and in part sponsored by a Juvenile Diabetes Research Foundation (JDRF) Scholar award, European Research Council grant 'Metabolomirs', the Starr Foundation International and the Swiss National Science Foundation, and the National Center of Competence in Research on RNA Biology and Disease (all to M.S.). Human islets for research were provided thanks to the European Consortium for Islet Transplantation funded by the JDRF (31-2012-783 to F.P.).	Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482; Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610; Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Couch FJ, 2010, CANCER EPIDEM BIOMAR, V19, P251, DOI 10.1158/1055-9965.EPI-09-0629; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Emamaullee JA, 2005, DIABETES, V54, P2541, DOI 10.2337/diabetes.54.9.2541; Filios SR, 2014, J BIOL CHEM, V289, P36275, DOI 10.1074/jbc.M114.592360; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kim YK, 2013, NAT STRUCT MOL BIOL, V20, P1458, DOI 10.1038/nsmb.2701; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Mandelbaum A.D., 2012, EXP DIABETES RES, V2012; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Ohki R, 2014, P NATL ACAD SCI USA, V111, pE2404, DOI 10.1073/pnas.1319962111; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Puff R, 2011, HORM METAB RES, V43, P306, DOI 10.1055/s-0031-1271817; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Shang X, 2010, ONCOGENE, V29, P4938, DOI 10.1038/onc.2010.244; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tonne JM, 2013, DIS MODEL MECH, V6, P1236, DOI 10.1242/dmm.012591; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Volchuk A, 2010, DIABETES OBES METAB, V12, P48, DOI 10.1111/j.1463-1326.2010.01271.x; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x	58	186	192	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					619	627		10.1038/nm.3862	http://dx.doi.org/10.1038/nm.3862			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25985365	Green Published			2022-12-25	WOS:000355778300018
J	Watkin, LB; Jessen, B; Wiszniewski, W; Vecel, TJ; Jan, M; Sha, YB; Thamsen, M; Santos-Cortez, RLP; Lee, K; Gambint, T; Forbes, LR; Law, CS; Stray-Pedersenzt, A; Cheng, MH; Mace, EM; Anderson, MS; Liu, DF; Tang, LF; Nicholas, SK; Nahmod, K; Makedonas, G; Canter, DL; Kwok, PY; Hicks, J; Jones, KD; Penney, S; Jhangiani, SN; Rosenblum, MD; Dell, SD; Waterfield, MR; Papa, FR; Muzny, DM; Zaitlen, N; Leal, SM; Gonzaga-Jaureguit, C; Boerwinkle, E; Eissa, NT; Gibbs, RA; Lupski, JR; Orange, JS; Shum, AK				Watkin, Levi B.; Jessen, Birthe; Wiszniewski, Wojciech; Vecel, Timothy J.; Jan, Max; Sha, Youbao; Thamsen, Maike; Santos-Cortez, Regie L. P.; Lee, Kwanghyuk; Gambint, Tomasz; Forbes, Lisa R.; Law, Christopher S.; Stray-Pedersenzt, Asbjorg; Cheng, Mickie H.; Mace, Emily M.; Anderson, Mark S.; Liu, Dongfang; Tang, Ling Fung; Nicholas, Sarah K.; Nahmod, Karen; Makedonas, George; Canter, Debra L.; Kwok, Pui-Yan; Hicks, John; Jones, Kirk D.; Penney, Samantha; Jhangiani, Shalini N.; Rosenblum, Michael D.; Dell, Sharon D.; Waterfield, Michael R.; Papa, Feroz R.; Muzny, Donna M.; Zaitlen, Noah; Leal, Suzanne M.; Gonzaga-Jaureguit, Claudia; Boerwinkle, Eric; Eissa, N. Tony; Gibbs, Richard A.; Lupski, James R.; Orange, Jordan S.; Shum, Anthony K.		Baylor-Hopkins Ctr Mendelian Genom	COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; TH17 CELLS; COATOMER; AUTOPHAGY; PATHOGENESIS; SIGNALS; ANTIGEN; GENES; ARF	Unbiased genetic studies have uncovered surprising molecular mechanisms in human cellular immunity and autoimmunity(1). We performed whole-exome sequencing and targeted sequencing in five families with an apparent mendelian syndrome of autoimmunity characterized by high-titer autoantibodies, inflammatory arthritis and interstitial lung disease. We identified four unique deleterious variants in the COPA gene (encoding coatomer subunit alpha) affecting the same functional domain. Hypothesizing that mutant COPA leads to defective intracellular transport via coat protein complex I (COPI)(2-4), we show that COPA variants impair binding to proteins targeted for retrograde Golgi-to-ER transport. Additionally, expression of mutant COPA results in ER stress and the upregulation of cytokines priming for a T helper type 17 (T(H)17) response. Patient-derived CD4(+)T cells also demonstrate significant skewing toward a T(H)17 phenotype that is implicated in autoimmunity(5,6). Our findings uncover an unexpected molecular link between a vesicular transport protein and a syndrome of autoimmunity manifested by lung and joint disease.	[Watkin, Levi B.; Vecel, Timothy J.; Forbes, Lisa R.; Mace, Emily M.; Liu, Dongfang; Nicholas, Sarah K.; Nahmod, Karen; Makedonas, George; Canter, Debra L.; Lupski, James R.; Orange, Jordan S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Watkin, Levi B.; Forbes, Lisa R.; Mace, Emily M.; Liu, Dongfang; Nicholas, Sarah K.; Nahmod, Karen; Makedonas, George; Canter, Debra L.; Orange, Jordan S.] Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Jessen, Birthe; Jan, Max; Thamsen, Maike; Law, Christopher S.; Cheng, Mickie H.; Anderson, Mark S.; Papa, Feroz R.; Zaitlen, Noah; Shum, Anthony K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA; [Wiszniewski, Wojciech; Gambint, Tomasz; Stray-Pedersenzt, Asbjorg; Penney, Samantha; Gonzaga-Jaureguit, Claudia; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sha, Youbao] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Santos-Cortez, Regie L. P.; Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Ctr Stat Genet, Houston, TX 77030 USA; [Tang, Ling Fung; Kwok, Pui-Yan; Shum, Anthony K.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kwok, Pui-Yan; Rosenblum, Michael D.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Hicks, John] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Jones, Kirk D.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Jhangiani, Shalini N.; Muzny, Donna M.; Boerwinkle, Eric; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Dell, Sharon D.] Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Waterfield, Michael R.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Baylor College of Medicine; University of California System; University of California San Francisco; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Shum, AK (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA.	orange@bcm.edu; anthony.shum@ucsf.edu	Gambin, Tomasz/HDN-5840-2022; Gonzaga-Jauregui, Claudia/H-4752-2019	Gambin, Tomasz/0000-0002-0941-4571; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Dell, Sharon/0000-0003-2169-9407; Watkin, Levi/0000-0003-0404-4548; Lee, Kwanghyuk/0000-0003-1389-1220; Vece, Timothy/0000-0002-0645-8923; Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Papa, Feroz/0000-0002-3684-9108; Mace, Emily/0000-0003-0226-7393; Liu, Dongfang/0000-0002-7295-8088; orange, jordan/0000-0001-7117-7725	US National Institutes of Health (NIH) grant [R01AI067946]; Jeffrey Modell Foundation; US NIH grant [K08HL095659, K23NS078056, AI053831]; Foundation of the American Thoracic Society; Pulmonary Fibrosis Foundation; Nina Ireland Lung Disease Program; US NIH (National Human Genome Research Institute/National Heart, Lung, and Blood Institute) grant [U54HG006542]; (National Institute of Neurological Disorders and Stroke) grant [2RO1NS058529]; US NIH (National Human Genome Research Institute) grant [U54HG003273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL121295, R21HL125018, R01HL122533, K08HL095659] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067946, R21AI124769, T32AI053831, R56AI130197, R21AI129594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR062064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, K23NS078056] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jeffrey Modell Foundation; US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of the American Thoracic Society; Pulmonary Fibrosis Foundation; Nina Ireland Lung Disease Program; US NIH (National Human Genome Research Institute/National Heart, Lung, and Blood Institute) grant; (National Institute of Neurological Disorders and Stroke) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US NIH (National Human Genome Research Institute) grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and their families for their involvement in these studies. The group at the University of California San Francisco thanks R. Schekman for useful comments, S. McClymont, O. Estrada, R. Wadia and M. Newasker for assistance with subject recruitment and the University of California San Francisco Genomics Core. Funding was provided by US National Institutes of Health (NIH) grant R01AI067946 (J.S.O.), the Jeffrey Modell Foundation (J.S.O.), US NIH grant K08HL095659 (A.K.S.), the Foundation of the American Thoracic Society (A.K.S.), the Pulmonary Fibrosis Foundation (A.K.S.), the Nina Ireland Lung Disease Program (A.K.S.), US NIH (National Human Genome Research Institute/National Heart, Lung, and Blood Institute) grant U54HG006542 and (National Institute of Neurological Disorders and Stroke) grant 2RO1NS058529 (J.R.L.), US NIH (National Human Genome Research Institute) grant U54HG003273 (R.A.G.), US NIH grant K23NS078056 (W.W.) and US NIH grant AI053831 (L.B.W.).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470; Benham H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4317; Bhattacharya A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00088; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Cheng MH, 2012, ANNU REV IMMUNOL, V30, P393, DOI 10.1146/annurev-immunol-020711-074953; Claerhout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039400; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Gissen P, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050294; Glatigny S, 2012, ARTHRITIS RHEUM-US, V64, P110, DOI 10.1002/art.33321; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Olewicz-Gawlik A, 2014, INT J RHEUM DIS, V17, P664, DOI 10.1111/1756-185X.12290; Palmer MT, 2010, NAT IMMUNOL, V11, P36, DOI 10.1038/ni.1802; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rieux-Laucat F, 2014, SCIENCE, V345, P1560, DOI 10.1126/science.1260791; Russo R, 2013, AM J HEMATOL, V88, P135, DOI 10.1002/ajh.23292; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Schroder-Kohne S, 1998, J CELL SCI, V111, P3459; Strange C, 2004, CLIN CHEST MED, V25, P549, DOI 10.1016/j.ccm.2004.05.009; Tanjore H, 2012, AM J PHYSIOL-LUNG C, V302, pL721, DOI 10.1152/ajplung.00410.2011; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Weber CK, 2010, RHEUMATOLOGY, V49, P2255, DOI 10.1093/rheumatology/keq272; Wheeler MC, 2008, J IMMUNOL, V181, P256, DOI 10.4049/jimmunol.181.1.256; Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003	39	179	188	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					654	660		10.1038/ng.3279	http://dx.doi.org/10.1038/ng.3279			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25894502	Green Accepted			2022-12-25	WOS:000355386500018
J	Suzuki, H; Aoki, K; Chiba, K; Sato, Y; Shiozawa, Y; Shiraishi, Y; Shimamura, T; Niida, A; Motomura, K; Ohka, F; Yamamoto, T; Tanahashi, K; Ranjit, M; Wakabayashi, T; Yoshizato, T; Kataoka, K; Yoshida, K; Nagata, Y; Sato-Otsubo, A; Tanaka, H; Sanada, M; Kondo, Y; Nakamura, H; Mizoguchi, M; Abe, T; Muragaki, Y; Watanabe, R; Ito, I; Miyano, S; Natsume, A; Ogawa, S				Suzuki, Hiromichi; Aoki, Kosuke; Chiba, Kenichi; Sato, Yusuke; Shiozawa, Yusuke; Shiraishi, Yuichi; Shimamura, Teppei; Niida, Atsushi; Motomura, Kazuya; Ohka, Fumiharu; Yamamoto, Takashi; Tanahashi, Kuniaki; Ranjit, Melissa; Wakabayashi, Toshihiko; Yoshizato, Tetsuichi; Kataoka, Keisuke; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Tanaka, Hiroko; Sanada, Masashi; Kondo, Yutaka; Nakamura, Hideo; Mizoguchi, Masahiro; Abe, Tatsuya; Muragaki, Yoshihiro; Watanabe, Reiko; Ito, Ichiro; Miyano, Satoru; Natsume, Atsushi; Ogawa, Seishi			Mutational landscape and clonal architecture in grade II and III gliomas	NATURE GENETICS			English	Article							IDH2 MUTATIONS; INTRATUMOR HETEROGENEITY; ADJUVANT TEMOZOLOMIDE; GENETIC ALTERATIONS; ASTROCYTIC TUMORS; MALIGNANT GLIOMAS; SURVIVAL RATES; FREQUENT ATRX; EVOLUTION; CANCER	Grade II and III gliomas are generally slowly progressing brain cancers, many of which eventually transform into more aggressive tumors. Despite recent findings of frequent mutations in IDH1 and other genes, knowledge about their pathogenesis is still incomplete. Here, combining two large sets of high-throughput sequencing data, we delineate the entire picture of genetic alterations and affected pathways in these glioma types, with sensitive detection of driver genes. Grade II and III gliomas comprise three distinct subtypes characterized by discrete sets of mutations and distinct clinical behaviors. Mutations showed significant positive and negative correlations and a chronological hierarchy, as inferred from different allelic burdens among coexisting mutations, suggesting that there is functional interplay between the mutations that drive clonal selection. Extensive serial and multi-regional sampling analyses further supported this finding and also identified a high degree of temporal and spatial heterogeneity generated during tumor expansion and relapse, which is likely shaped by the complex but ordered processes of multiple clonal selection and evolutionary events.	[Suzuki, Hiromichi; Aoki, Kosuke; Motomura, Kazuya; Ohka, Fumiharu; Yamamoto, Takashi; Tanahashi, Kuniaki; Ranjit, Melissa; Wakabayashi, Toshihiko; Natsume, Atsushi] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; [Suzuki, Hiromichi; Aoki, Kosuke; Sato, Yusuke; Shiozawa, Yusuke; Yoshizato, Tetsuichi; Kataoka, Keisuke; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan; [Chiba, Kenichi; Shiraishi, Yuichi; Niida, Atsushi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Tokyo, Japan; [Shimamura, Teppei] Nagoya Univ, Sch Med, Div Syst Biol, Nagoya, Aichi 466, Japan; [Ohka, Fumiharu; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi, Japan; [Nakamura, Hideo] Kumamoto Univ, Dept Neurosurg, Kumamoto, Japan; [Mizoguchi, Masahiro] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan; [Abe, Tatsuya] Oita Univ, Dept Neurosurg, Oita 87011, Japan; [Muragaki, Yoshihiro] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan; [Watanabe, Reiko; Ito, Ichiro] Shizuoka Canc Ctr, Div Clin Pathol, Shizuoka, Japan	Nagoya University; Kyoto University; University of Tokyo; Nagoya University; Nagoya City University; Kumamoto University; Kyushu University; Oita University; Tokyo Women's Medical University; Shizuoka Cancer Center	Ogawa, S (corresponding author), Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan.	anatsume@med.nagoya-u.ac.jp; sogawa-tky@umin.ac.jp	Suzuki, Hiromichi/AAO-4664-2021; Natsume, Atsushi/I-7364-2014; Yoshizato, Tetsuichi/AAD-7308-2019; MURAGAKI, YOSHIHIRO/AAZ-9863-2021; Wakabayashi, Toshihiko/I-3526-2012; Ohka, Fumiharu/A-3420-2016; Ito, Ichiro/AAK-1080-2020; Ogawa, Seishi/AAE-7088-2019; Motomura, Kazuya/AAF-8776-2021; Kataoka, Keisuke/AAS-2546-2020	Suzuki, Hiromichi/0000-0002-8858-0294; Natsume, Atsushi/0000-0002-9113-0470; Yoshizato, Tetsuichi/0000-0003-4283-2983; Wakabayashi, Toshihiko/0000-0001-5254-2088; Motomura, Kazuya/0000-0002-4376-1104; Kataoka, Keisuke/0000-0002-8263-9902; Ohka, Fumiharu/0000-0002-5569-5626; Yoshida, Kenichi/0000-0003-4612-2778; Miyano, Satoru/0000-0002-1753-6616; Shimamura, Teppei/0000-0003-2994-872X	Funding Program for World-Leading Innovative Research and Development on Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [23107010]; Japan Neurosurgical Society [FY2012-2014];  [22134006]; Grants-in-Aid for Scientific Research [15K19964] Funding Source: KAKEN	Funding Program for World-Leading Innovative Research and Development on Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Neurosurgical Society; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Mori, M. Nakamura and H. Higashi for their technical assistance. We gratefully acknowledge the TCGA Consortium and all its members for making their invaluable data publically available. We are grateful to all patients who generously agreed to participate in this study. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (S.O.; 22134006) and the Funding Program for World-Leading Innovative Research and Development on Science and Technology (S.O.) and by a Grant-in Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (A. Natsume; 23107010) and funding from the Japan Neurosurgical Society (A. Natsume; Basic Project Plan FY2012-2014).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Bauman G, 2009, INT J RADIAT ONCOL, V75, P1401, DOI 10.1016/j.ijrobp.2009.01.010; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kannan K, 2012, ONCOTARGET, V3, P1194; Katagiri T, 2011, BLOOD, V118, P6601, DOI 10.1182/blood-2011-07-365189; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; LANCASTER JF, 1983, BIOMETRICS, V39, P245, DOI 10.2307/2530824; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mantha S, 2007, LEUKEMIA RES, V31, P321, DOI 10.1016/j.leukres.2006.06.009; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Niida A, 2012, BIOINFORMATICS, V28, pI115, DOI 10.1093/bioinformatics/bts203; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom Quinn T, 2013, Neuro Oncol, V15 Suppl 2, pii1, DOI 10.1093/neuonc/not151; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Purdom PW, 2000, BIOINFORMATICS, V16, P140, DOI 10.1093/bioinformatics/16.2.140; Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Vogazianou AP, 2010, NEURO-ONCOLOGY, V12, P664, DOI 10.1093/neuonc/nop075; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wiestler B, 2014, ACTA NEUROPATHOL, V128, P561, DOI 10.1007/s00401-014-1315-x; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	65	520	531	1	69	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					458	U52		10.1038/ng.3273	http://dx.doi.org/10.1038/ng.3273			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25848751				2022-12-25	WOS:000353635800008
J	Garber, K				Garber, Ken			Drugging the gut microbiome	NATURE BIOTECHNOLOGY			English	Editorial Material							METABOLISM; DISEASE											Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	9	37	41	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					228	231		10.1038/nbt.3161	http://dx.doi.org/10.1038/nbt.3161			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748907				2022-12-25	WOS:000350766900012
J	Kulis, M; Merkel, A; Heath, S; Queiros, AC; Schuyler, RP; Castellano, G; Beekman, R; Raineri, E; Esteve, A; Clot, G; Verdaguer-Dot, N; Duran-Ferrer, M; Russinol, N; Vilarrasa-Blasi, R; Ecker, S; Pancaldi, V; Rico, D; Agueda, L; Blanc, J; Richardson, D; Clarke, L; Datta, A; Pascual, M; Agirre, X; Prosper, F; Alignani, D; Paiva, B; Caron, G; Fest, T; Muench, MO; Fomin, ME; Lee, ST; Wiemels, JL; Valencia, A; Gut, M; Flicek, P; Stunnenberg, HG; Siebert, R; Kuppers, R; Gut, IG; Campo, E; Martin-Subero, JI				Kulis, Marta; Merkel, Angelika; Heath, Simon; Queiros, Ana C.; Schuyler, Ronald P.; Castellano, Giancarlo; Beekman, Renee; Raineri, Emanuele; Esteve, Anna; Clot, Guillem; Verdaguer-Dot, Nuria; Duran-Ferrer, Marti; Russinol, Nuria; Vilarrasa-Blasi, Roser; Ecker, Simone; Pancaldi, Vera; Rico, Daniel; Agueda, Lidia; Blanc, Julie; Richardson, David; Clarke, Laura; Datta, Avik; Pascual, Marien; Agirre, Xabier; Prosper, Felipe; Alignani, Diego; Paiva, Bruno; Caron, Gersende; Fest, Thierry; Muench, Marcus O.; Fomin, Marina E.; Lee, Seung-Tae; Wiemels, Joseph L.; Valencia, Alfonso; Gut, Marta; Flicek, Paul; Stunnenberg, Hendrik G.; Siebert, Reiner; Kueppers, Ralf; Gut, Ivo G.; Campo, Elias; Martin-Subero, Jose I.			Whole-genome fingerprint of the DNA methylome during human B cell differentiation	NATURE GENETICS			English	Article							REGULATORY ELEMENTS; METHYLATION CHANGES; EPIGENOMIC ANALYSIS; PLASMA-CELLS; CHROMATIN; DYNAMICS; HYPERMETHYLATION; DEMETHYLATION; REVEALS; WIDESPREAD	We analyzed the DNA methylome of ten subpopulations spanning the entire B cell differentiation program by whole-genome bisulfite sequencing and high-density microarrays. We observed that non-CpG methylation disappeared upon B cell commitment, whereas CpG methylation changed extensively during B cell maturation, showing an accumulative pattern and affecting around 30% of all measured CpG sites. Early differentiation stages mainly displayed enhancer demethylation, which was associated with upregulation of key B cell transcription factors and affected multiple genes involved in B cell biology. Late differentiation stages, in contrast, showed extensive demethylation of heterochromatin and methylation gain at Polycomb-repressed areas, and genes with apparent functional impact in B cells were not affected. This signature, which has previously been linked to aging and cancer, was particularly widespread in mature cells with an extended lifespan. Comparing B cell neoplasms with their normal counterparts, we determined that they frequently acquire methylation changes in regions already undergoing dynamic methylation during normal B cell differentiation.	[Kulis, Marta; Queiros, Ana C.; Castellano, Giancarlo; Beekman, Renee; Clot, Guillem; Verdaguer-Dot, Nuria; Duran-Ferrer, Marti; Russinol, Nuria; Vilarrasa-Blasi, Roser; Campo, Elias; Martin-Subero, Jose I.] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, IDIBAPS, Barcelona, Spain; [Merkel, Angelika; Heath, Simon; Schuyler, Ronald P.; Raineri, Emanuele; Esteve, Anna; Duran-Ferrer, Marti; Agueda, Lidia; Blanc, Julie; Gut, Marta; Gut, Ivo G.] Parc Cient Barcelona, CNAG, Barcelona, Spain; [Ecker, Simone; Pancaldi, Vera; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Program, Madrid, Spain; [Richardson, David; Clarke, Laura; Datta, Avik; Flicek, Paul] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Hinxton, England; [Pascual, Marien; Agirre, Xabier; Prosper, Felipe] Univ Navarra, CIMA, Area Oncol, E-31080 Pamplona, Spain; [Prosper, Felipe; Paiva, Bruno] Clin Univ Navarra, Serv Hematol, Pamplona, Spain; [Alignani, Diego; Paiva, Bruno] Univ Navarra, CIMA, Flow Cytometry Core, E-31080 Pamplona, Spain; [Caron, Gersende; Fest, Thierry] Univ Rennes 1, Univ Hosp Rennes, INSERM, Hematol Lab,U917, Rennes, France; [Muench, Marcus O.; Fomin, Marina E.] Blood Syst Res Inst, San Francisco, CA USA; [Muench, Marcus O.; Fomin, Marina E.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lee, Seung-Tae] Yonsei Univ, Coll Med, Dept Lab Med, Seoul 120749, South Korea; [Wiemels, Joseph L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Fac Sci & Med, NCMLS, Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Kueppers, Ralf] Univ Duisburg Essen, Sch Med, Inst Cell Biol Canc Res, Essen, Germany	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro Nacional de Investigaciones Oncologicas (CNIO); European Molecular Biology Laboratory (EMBL); University of Navarra; University of Navarra; University of Navarra; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Yonsei University; Yonsei University Health System; University of California System; University of California San Francisco; Radboud University Nijmegen; University of Kiel; University of Duisburg Essen	Martin-Subero, JI (corresponding author), Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, IDIBAPS, Barcelona, Spain.	imartins@clinic.ub.es	Beekman, Renée/AAF-2088-2020; Agirre, Xabier/ABE-4110-2020; Esteve-Codina, Anna/M-9614-2015; Siebert, Reiner/A-8049-2010; Prosper, Felipe/H-6859-2017; Gut, Ivo/ABF-3188-2020; Valencia, Alfonso/AAN-9230-2020; Ecker, Simone/W-8200-2019; Paiva, Bruno/AAB-8881-2021; Campo, elias/O-7192-2016; Valencia, Alfonso/I-3127-2015; Clot, Guillem/AAD-9087-2020; Raineri, Emanuele/AAX-7874-2020; Heath, Simon C/J-4138-2012; Pascual, Marién/F-6661-2013; Pancaldi, Vera/I-2555-2015; Stunnenberg, Hendrik G./D-6875-2012; Muench, Marcus O./C-5025-2009; Campo, Elias/AAC-5593-2019; Rico, Daniel/I-2049-2013	Beekman, Renée/0000-0001-7081-7874; Esteve-Codina, Anna/0000-0003-0361-2873; Prosper, Felipe/0000-0001-6115-8790; Gut, Ivo/0000-0001-7219-632X; Valencia, Alfonso/0000-0002-8937-6789; Ecker, Simone/0000-0001-5648-1710; Paiva, Bruno/0000-0003-1977-3815; Campo, elias/0000-0001-9850-9793; Valencia, Alfonso/0000-0002-8937-6789; Clot, Guillem/0000-0003-2588-7413; Heath, Simon C/0000-0002-9550-0897; Pascual, Marién/0000-0002-1678-1054; Pancaldi, Vera/0000-0002-7433-624X; Stunnenberg, Hendrik G./0000-0002-0066-1576; Muench, Marcus O./0000-0001-8946-6605; Campo, Elias/0000-0001-9850-9793; Kulis, Marta/0000-0001-8104-9620; fest, thierry/0000-0002-6437-4189; Duran-Ferrer, Marti/0000-0003-1666-5819; Rico, Daniel/0000-0002-6561-2310; Richardson, David/0000-0003-0247-9118; Vilarrasa-Blasi, Roser/0000-0002-3384-0693; Castellano, Giancarlo/0000-0002-5715-7733; Clarke, Laura/0000-0002-5989-6898; Merkel, Angelika/0000-0001-5164-6803; Flicek, Paul/0000-0002-3897-7955; Lee, Seung-Tae/0000-0003-1047-1415; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Kuppers, Ralf/0000-0002-6691-7191; Queiros, Ana/0000-0001-8585-4803; Verdaguer, Nuria/0000-0002-6523-3038; Datta, Avik/0000-0002-1411-8638	European Union's Seventh Framework Programme through the Blueprint Consortium [282510]; Spanish Ministry of Economy and Competitivity (MINECO) [SAF2009-08663]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Generalitat de Catalunya)	European Union's Seventh Framework Programme through the Blueprint Consortium; Spanish Ministry of Economy and Competitivity (MINECO); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	We thank C. Lopez-Otin for critical reading of this manuscript, M. Dabad Castella for his assistance with the WGBS data analysis and M. A. Peinado (Institute of Predictive and Personalized Medicine of Cancer, Barcelona) for providing RNA from HCT116 DKO cells. This work was funded by the European Union's Seventh Framework Programme through the Blueprint Consortium (grant agreement 282510) and the Spanish Ministry of Economy and Competitivity (MINECO; project SAF2009-08663). Methylation microarrays were outsourced to the Spanish Centro Nacional de Genotipado (CEGEN-ISCIII). We are indebted to the Genomics core facility of the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) for technical help. This work was partially developed at the Centro Esther Koplowitz (CEK; Barcelona, Spain). M.K. is supported by Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Generalitat de Catalunya), E.C. is an Academia Researcher of the Institucio Catalana de Recerca i Estudis Avancats and J.I.M.-S. is a Ramon y Cajal researcher of MINECO.	Agirre X, 2015, GENOME RES, V25, P478, DOI 10.1101/gr.180240.114; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bastian M., 2009, INT AAAI C WEBL SOC, P361; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Busche S, 2013, CANCER RES, V73, P4323, DOI 10.1158/0008-5472.CAN-12-4367; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cruickshanks HA, 2013, NAT CELL BIOL, V15, P1495, DOI 10.1038/ncb2879; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Mammana A, 2013, BIOINFORMATICS, V29, P2547, DOI 10.1093/bioinformatics/btt449; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Schlesinger F, 2013, GENOME RES, V23, P1601, DOI 10.1101/gr.157271.113; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Tagoh H, 2004, BLOOD, V103, P2950, DOI 10.1182/blood-2003-09-3323; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tooze RM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00460; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	71	207	210	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					746	+		10.1038/ng.3291	http://dx.doi.org/10.1038/ng.3291			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053498	Green Submitted, Green Accepted			2022-12-25	WOS:000357090300011
J	Okada, Y; Momozawa, Y; Ashikawa, K; Kanai, M; Matsuda, K; Kamatani, Y; Takahashi, A; Kubo, M				Okada, Yukinori; Momozawa, Yukihide; Ashikawa, Kyota; Kanai, Masahiro; Matsuda, Koichi; Kamatani, Yoichiro; Takahashi, Atsushi; Kubo, Michiaki			Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SEROPOSITIVE RHEUMATOID-ARTHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; HAPLOTYPE BLOCKS; LOCI; MHC; ALLELES; SUSCEPTIBILITY; IDENTIFICATION; HLA-DRB1	To fine map association signals of human leukocyte antigen (HLA) variants in the major histocompatibility complex (MHC) region, we constructed a Japanese population-specific reference panel (n = 908). We conducted trans-ancestry comparisons of linkage disequilibrium (LD) and haplotype structure for HLA variants using an entropy-based LD measurement,., and a visualization tool to capture high-dimensional variables. Our Japanese reference panel exhibited stronger LD between HLA genes than European or other East Asian populations, characterized by one population-specific common long-range HLA haplotype. We applied HLA imputation to genome-wide association study (GWAS) data for Graves' disease in Japanese (n = 9,003) and found that amino acid polymorphisms of multiple class I and class II HLA genes independently contribute to disease risk (HLA-DPB1, HLA-A, HLA-B and HLA-DRB1; P < 2.3 x 10(-6)), with the strongest impact at HLA-DPB1 (P = 1.6 x 10(-42)). Our study illustrates the value of population-specific HLA reference panels.	[Okada, Yukinori; Kanai, Masahiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori; Kamatani, Yoichiro; Takahashi, Atsushi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Momozawa, Yukihide; Ashikawa, Kyota] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Matsuda, Koichi] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Mol Med Lab, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; RIKEN; University of Tokyo	Okada, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan.	yokada.brc@tmd.ac.jp; michiaki.kubo@riken.jp	Momozawa, Yukihide/N-6453-2015; Kubo, Michiaki/N-7947-2015; Kamatani, Yoichiro/N-5513-2015; Kanai, Masahiro/AAD-6726-2021; Matsuda, Koichi/D-4597-2011	Kanai, Masahiro/0000-0001-5165-4408; Matsuda, Koichi/0000-0001-7292-2686	Japan Science and Technology Agency (JST); Japan Society of the Promotion of Science (JSPS); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; Grants-in-Aid for Scientific Research [15K14429] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society of the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation(Japan Rheumatism Foundation); Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Kumasaka who originally developed the Disentangler software. We acknowledge T. Aoi and C. Inai for technical assistance and the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International for supporting our study. Y.O. was supported by the Japan Science and Technology Agency (JST), the Japan Society of the Promotion of Science (JSPS), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Takeda Science Foundation, the Gout Research Foundation, the Tokyo Biochemical Research Foundation and the Japan Rheumatism Foundation. The BioBank Japan Project was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Jin H, 2014, P NATL ACAD SCI USA, V111, P3787, DOI 10.1073/pnas.1401105111; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046806; Kumasaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010207; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Nakabayashi K, 2011, J HUM GENET, V56, P772, DOI 10.1038/jhg.2011.99; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nothnagel M, 2005, AM J HUM GENET, V77, P988, DOI 10.1086/498175; Nothnagel M, 2002, HUM HERED, V54, P186, DOI 10.1159/000070664; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Okada Y, 2010, ANN RHEUM DIS, V69, P1569, DOI 10.1136/ard.2009.118018; Okada Y, 2009, ARTHRITIS RHEUM-US, V60, P3582, DOI 10.1002/art.24939; ONUMA H, 1994, HUM IMMUNOL, V39, P195, DOI 10.1016/0198-8859(94)90260-7; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Ueda S, 2014, J CLIN ENDOCR METAB, V99, pE379, DOI 10.1210/jc.2013-2841; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Zhao SX, 2013, HUM MOL GENET, V22, P3347, DOI 10.1093/hmg/ddt183	34	87	88	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					798	+		10.1038/ng.3310	http://dx.doi.org/10.1038/ng.3310			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029868				2022-12-25	WOS:000357090300018
J	Cho, J				Cho, Judy			The heritable immune system	NATURE BIOTECHNOLOGY			English	Editorial Material									Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Cho, J (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	judy.cho@mssm.edu						Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Hedl M, 2014, IMMUNITY, V40, P734, DOI 10.1016/j.immuni.2014.04.011; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046	7	5	5	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					608	609		10.1038/nbt.3256	http://dx.doi.org/10.1038/nbt.3256			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057979				2022-12-25	WOS:000356019700019
J	Shankman, LS; Gomez, D; Cherepanova, OA; Salmon, M; Alencar, GF; Haskins, RM; Swiatlowska, P; Newman, AAC; Greene, ES; Straub, AC; Isakson, B; Randolph, GJ; Owens, GK				Shankman, Laura S.; Gomez, Delphine; Cherepanova, Olga A.; Salmon, Morgan; Alencar, Gabriel F.; Haskins, Ryan M.; Swiatlowska, Pamela; Newman, Alexandra A. C.; Greene, Elizabeth S.; Straub, Adam C.; Isakson, Brant; Randolph, Gwendalyn J.; Owens, Gary K.			KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis	NATURE MEDICINE			English	Article							STEM-CELLS; DIFFERENTIATION MARKERS; SM22-ALPHA PROMOTER; FACTOR KLF4; EXPRESSION; MECHANISMS; PROLIFERATION; TRANSCRIPTION; INFLAMMATION; INDUCTION	Previous studies investigating the role of smooth muscle cells (SMCs) and macrophages in the pathogenesis of atherosclerosis have provided controversial results owing to the use of unreliable methods for clearly identifying each of these cell types. Here, using Myh11-CreER(T2) ROSA floxed STOP eYFP Apoe(-/-) mice to perform SMC lineage tracing, we find that traditional methods for detecting SMCs based on immunostaining for SMC markers fail to detect >80% of SMC-derived cells within advanced atherosclerotic lesions. These unidentified SMC-derived cells exhibit phenotypes of other cell lineages, including macrophages and mesenchymal stem cells (MSCs). SMC-specific conditional knockout of Kruppel-like factor 4 (Klf4) resulted in reduced numbers of SMC-derived MSC- and macrophage-like cells, a marked reduction in lesion size, and increases in multiple indices of plaque stability, including an increase in fibrous cap thickness as compared to wild-type controls. On the basis of in vivo KLF4 chromatin immunoprecipitation-sequencing (ChIP-seq) analyses and studies of cholesterol-treated cultured SMCs, we identified >800 KLF4 target genes, including many that regulate pro-inflammatory responses of SMCs. Our findings indicate that the contribution of SMCs to atherosclerotic plaques has been greatly underestimated, and that KLF4-dependent transitions in SMC phenotype are critical in lesion pathogenesis.	[Shankman, Laura S.; Gomez, Delphine; Cherepanova, Olga A.; Alencar, Gabriel F.; Haskins, Ryan M.; Swiatlowska, Pamela; Newman, Alexandra A. C.; Greene, Elizabeth S.; Isakson, Brant; Owens, Gary K.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22904 USA; [Shankman, Laura S.; Isakson, Brant; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA; [Salmon, Morgan] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Alencar, Gabriel F.; Newman, Alexandra A. C.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Haskins, Ryan M.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Swiatlowska, Pamela] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80952 Gdansk, Poland; [Straub, Adam C.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Randolph, Gwendalyn J.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Fahrenheit Universities; University of Gdansk; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Owens, GK (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22904 USA.	gko@virginia.edu	Cherepanova, Olga E./K-1277-2015; Gomez, Delphine/J-6349-2019	Cherepanova, Olga E./0000-0001-7775-6488; Gomez, Delphine/0000-0002-3880-6961; Straub, Adam/0000-0003-0542-9466	US National Institutes of Health [HL057353, HL098538, HL087867, HL112904]; AstraZeneca as part of a University of Virginia-AstraZeneca Research Alliance; Mid-Atlantic American Heart Association [11PRE7170008, 13POST17080043]; NATIONAL CANCER INSTITUTE [T32CA009109, P30CA044579] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087867, R01HL121008, T32HL007284, K99HL112904, R01HL057353, R01HL088554, R01HL098538, R00HL112904] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca as part of a University of Virginia-AstraZeneca Research Alliance; Mid-Atlantic American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to acknowledge the valuable contributions of technicians M. McCanna and M. Bevard for their assistance in histological cutting and staining; R. Tripathi for assistance with cell culture work; J. Lannigan and M. Solga from the Flow Cytometry Core at the University of Virginia for their help designing flow cytometry panels and help running the cytometers; S. Guilot at the Advanced Microscopy Facility at University of Virginia for her help running the transmission electron microscope; J. Roithmayr, N. Hendley, M. Quetsch and M. Goodwin for their assistance in immunofluorescence image analysis; Y. Babiy for designing the cartoon in Supplementary Figure 6, and W. Evans for assistance in processing statistical analyses. We would also like to thank N. McGinn from the Department of Pathology, University of Virginia Hospital for the de-identified coronary arteries specimens; C. Murray from the University of Washington for the coronary artery heart transplant specimen; S. Offermanns from the Max Planck Institute for the Myh11-CreER<SUP>T2</SUP> mice; K. Kaestner for the Klf4<SUP>fl/fl</SUP> mice; G. Randolph for the LysM<SUP>Cre/Cre</SUP> mice; and A. Berns from the Netherlands Cancer Institute, Amsterdam, Netherlands, for the transgenic tamoxifen-inducible Cre (ER<SUP>T</SUP>-Cre) recombinase mice. This work was supported by US National Institutes of Health R01 grants HL057353, HL098538 and HL087867 to G.K.O., HL112904 to A.C.S., as well as a pilot grant from AstraZeneca as part of a University of Virginia-AstraZeneca Research Alliance to G.K.O.; and Mid-Atlantic American Heart Association fellowship grants 11PRE7170008 and 13POST17080043 to L.S.S. and D.G., respectively.	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Iwata H, 2010, CIRCULATION, V122, P2048, DOI 10.1161/CIRCULATIONAHA.110.965202; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Klein D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02178; Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Martin K, 2009, CIRC RES, V105, P214, DOI 10.1161/CIRCRESAHA.109.199984; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Nguyen AT, 2013, CIRC RES, V112, P17, DOI 10.1161/CIRCRESAHA.112.281048; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saffitz J E, 1987, Cardiol Clin, V5, P21; Salmon M, 2012, CIRC RES, V111, P685, DOI 10.1161/CIRCRESAHA.112.269811; Sharma N, 2012, ARTERIOSCL THROM VAS, V32, P2836, DOI 10.1161/ATVBAHA.112.300471; Swirski FK, 2014, CIRC RES, V115, P605, DOI 10.1161/CIRCRESAHA.114.304925; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Thomas JA, 2009, AM J PHYSIOL-HEART C, V296, pH442, DOI 10.1152/ajpheart.00165.2008; Vengrenyuk Y, 2015, ARTERIOSCL THROM VAS, V35, P535, DOI 10.1161/ATVBAHA.114.304029; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Vladykovskaya E, 2011, J LIPID RES, V52, P2209, DOI 10.1194/jlr.M013854; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	53	615	627	12	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					628	637		10.1038/nm.3866	http://dx.doi.org/10.1038/nm.3866			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25985364	Green Accepted			2022-12-25	WOS:000355778300019
J	Bosley, KS; Botchan, M; Bredenoord, AL; Carroll, D; Charo, RA; Charpentier, E; Cohen, R; Corn, J; Doudna, J; Feng, GP; Greely, HT; Isasi, R; Ji, WZ; Kim, JS; Knoppers, B; Lanphier, E; Li, JS; Lovell-Badge, R; Martin, GS; Moreno, J; Naldini, L; Pera, M; Perry, ACF; Venter, JC; Zhang, F; Zhou, Q				Bosley, Katrine S.; Botchan, Michael; Bredenoord, Annelien L.; Carroll, Dana; Charo, R. Alta; Charpentier, Emmanuelle; Cohen, Ron; Corn, Jacob; Doudna, Jennifer; Feng, Guoping; Greely, Henry T.; Isasi, Rosario; Ji, Weihzi; Kim, Jin-Soo; Knoppers, Bartha; Lanphier, Edward; Li, Jinsong; Lovell-Badge, Robin; Martin, G. Steven; Moreno, Jonathan; Naldini, Luigi; Pera, Martin; Perry, Anthony C. F.; Venter, J. Craig; Zhang, Feng; Zhou, Qi			CRISPR germline engineering-the community speaks	NATURE BIOTECHNOLOGY			English	Article									[Bosley, Katrine S.] Editas Med, Cambridge, MA 02142 USA; [Botchan, Michael; Martin, G. Steven] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bredenoord, Annelien L.] Univ Med Ctr, Dept Med Humanities, Utrecht, Netherlands; [Carroll, Dana] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI USA; [Charo, R. Alta] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Hist & Bioeth, Madison, WI USA; [Charpentier, Emmanuelle] Helmholtz Ctr Infect Res, Dept Regulat Infect Biol, Braunschweig, Germany; [Cohen, Ron] Acorda Therapeut, Ardsley, NY USA; [Corn, Jacob] Innovat Genom Initiat, Berkeley, CA USA; [Doudna, Jennifer] Univ Calif Berkeley, Dept Mol & Cell Biol & Chem, Berkeley, CA 94720 USA; [Feng, Guoping] MIT, Broad Inst, Stanley Ctr Psychiat Res, Dept Brain & Cognit Sci, Cambridge, MA USA; [Feng, Guoping] Harvard Univ, Cambridge, MA 02138 USA; [Greely, Henry T.] Stanford Law Sch, Stanford, CA USA; [Isasi, Rosario] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ji, Weihzi] Kunming Biomed Int & Natl Engn Res Ctr Biomed & A, Kunming, Peoples R China; [Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Knoppers, Bartha] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Lanphier, Edward] Sangamo Biosci, Richmond, CA USA; [Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Lovell-Badge, Robin] Francis Crick Inst, London, England; [Moreno, Jonathan] Univ Penn, Philadelphia, PA 19104 USA; [Naldini, Luigi] San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Pera, Martin] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Perry, Anthony C. F.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Venter, J. Craig] J Craig Venter Inst, La Jolla, CA USA; [Zhang, Feng] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	University of California System; University of California Berkeley; Utrecht University; Utrecht University Medical Center; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Helmholtz Association; Helmholtz-Center for Infection Research; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; McGill University; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); McGill University; Sangamo Therapeutics, Inc.; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Francis Crick Institute; University of Pennsylvania; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Melbourne; University of Bath; J. Craig Venter Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Chinese Academy of Sciences; Institute of Zoology, CAS	Bosley, KS (corresponding author), Editas Med, Cambridge, MA 02142 USA.		Feng, Guoping/Y-2827-2019; KIM, Jin-Soo/M-6918-2013; PERA, MARTIN/A-9812-2012	KIM, Jin-Soo/0000-0003-4847-1306; PERA, MARTIN/0000-0001-6239-0428; Perry, Tony/0000-0003-3136-5355; Corn, Jacob/0000-0002-7798-5309; Lovell-Badge, Robin/0000-0001-9364-4179; NALDINI, Luigi/0000-0002-7835-527X; Charo, Robin Alta/0000-0003-3710-1043; li, jin song/0000-0003-3456-662X	MRC [G1000839, MC_U117562207] Funding Source: UKRI; The Francis Crick Institute [10107] Funding Source: researchfish; Medical Research Council [MC_U117562207, G1000839] Funding Source: Medline; NIGMS NIH HHS [R01 GM078571] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	96	98	25	200	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					478	486		10.1038/nbt.3227	http://dx.doi.org/10.1038/nbt.3227			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965754	Green Published			2022-12-25	WOS:000354314500025
J	Caruana, I; Savoldo, B; Hoyos, V; Weber, G; Liu, H; Kim, ES; Ittmann, MM; Marchetti, D; Dotti, G				Caruana, Ignazio; Savoldo, Barbara; Hoyos, Valentina; Weber, Gerrit; Liu, Hao; Kim, Eugene S.; Ittmann, Michael M.; Marchetti, Dario; Dotti, Gianpietro			Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes	NATURE MEDICINE			English	Article							METASTATIC BREAST-CANCER; ANTIGEN RECEPTOR; GENE-EXPRESSION; SULFATE; CELLS; GROWTH; MATRIX; ENDOGLYCOSIDASE; PROTEOGLYCANS; TRANSCRIPTION	Adoptive transfer of chimeric antigen receptor (CAR)-redirected T lymphocytes (CAR-T cells) has had less striking therapeutic effects in solid tumors(1-3) than in lymphoid malignancies(4,5). Although active tumor-mediated immunosuppression may have a role in limiting the efficacy of CAR-T cells(6), functional changes in T lymphocytes after their ex vivo manipulation may also account for the reduced ability of cultured CAR-T cells to penetrate stroma-rich solid tumors compared with lymphoid tissues. We therefore studied the capacity of human in vitro-cultured CAR-T cells to degrade components of the extracellular matrix (ECM). In contrast to freshly isolated T lymphocytes, we found that in vitro-cultured T lymphocytes lack expression of the enzyme heparanase (HPSE), which degrades heparan sulfate proteoglycans, the main components of ECM. We found that HPSE mRNA is downregulated in in vitro-expanded T cells, which may be a consequence of p53 (officially known as TP53, encoding tumor protein 53) binding to the HPSE gene promoter. We therefore engineered CAR-T cells to express HPSE and showed their improved capacity to degrade the ECM, which promoted tumor T cell infiltration and antitumor activity. The use of this strategy may enhance the activity of CAR-T cells in individuals with stroma-rich solid tumors.	[Caruana, Ignazio; Savoldo, Barbara; Hoyos, Valentina; Weber, Gerrit; Dotti, Gianpietro] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Caruana, Ignazio; Savoldo, Barbara; Hoyos, Valentina; Weber, Gerrit; Dotti, Gianpietro] Houston Methodist Hosp, Houston, TX USA; [Savoldo, Barbara] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Liu, Hao] Baylor Coll Med, Biostat Shared Resource, Houston, TX 77030 USA; [Kim, Eugene S.] Texas Childrens Hosp, Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Ittmann, Michael M.; Marchetti, Dario; Dotti, Gianpietro] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ittmann, Michael M.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Ittmann, Michael M.] Michael E DeBakey Dept Vet Affairs Med Ctr, Dan L Duncan Canc Ctr, Houston, TX USA; [Dotti, Gianpietro] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine	Dotti, G (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	gdotti@bcm.edu	Caruana, Ignazio/AAW-7904-2020; Weber, Gerrit/J-5055-2018	Caruana, Ignazio/0000-0002-9250-0605; Weber, Gerrit/0000-0001-7240-0300; Kim, Eugene/0000-0001-7959-5614	US National Institutes of Health-National Cancer Institute [R01 CA142636]; Department of Defense; Technology and Therapeutic Development Award [W81XWH-10-10425]; NATIONAL CANCER INSTITUTE [P01CA094237, R01CA142636, P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER	US National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Technology and Therapeutic Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank I. Vlodavsky and M. Brenner for the critical review of the manuscript and C. Gillespie for editing. This work was supported in part by the US National Institutes of Health-National Cancer Institute (G.D., no. R01 CA142636) and by a Department of Defense and Technology and Therapeutic Development Award (G.D., no. W81XWH-10-10425). L. Metelitsa kindly provided the CHLA-255 human NB cell line.	Arvatz G, 2010, FASEB J, V24, P4969, DOI 10.1096/fj.10-156372; Baraz L, 2006, ONCOGENE, V25, P3939, DOI 10.1038/sj.onc.1209425; BARTLETT MR, 1995, IMMUNOL CELL BIOL, V73, P113, DOI 10.1038/icb.1995.19; Bawley V.S., 2012, CANCER RES, V72, P3500; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; de Mestre AM, 2007, J LEUKOCYTE BIOL, V82, P1289, DOI 10.1189/jlb.0507315; FRIDMAN R, 1987, J CELL PHYSIOL, V130, P85, DOI 10.1002/jcp.1041300113; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Geldres C, 2014, CLIN CANCER RES, V20, P962, DOI 10.1158/1078-0432.CCR-13-2218; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Lu WC, 2003, ONCOGENE, V22, P919, DOI 10.1038/sj.onc.1206201; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; NAKAJIMA M, 1984, J BIOL CHEM, V259, P2283; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Patterson D. M., 2011, CURR PROTOC PHARM, V52; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Roy M, 2005, NEOPLASIA, V7, P253, DOI 10.1593/neo.04493; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Smith C A, 1995, J Hematother, V4, P73, DOI 10.1089/scd.1.1995.4.73; Vera J, 2006, BLOOD, V108, P3890, DOI 10.1182/blood-2006-04-017061; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Wilson TJ, 2008, BBA-REV CANCER, V1785, P85, DOI 10.1016/j.bbcan.2007.11.001; Yadav R, 2003, THROMB HAEMOSTASIS, V90, P598, DOI 10.1160/TH03-04-0220; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Yvon E, 2009, CLIN CANCER RES, V15, P5852, DOI 10.1158/1078-0432.CCR-08-3163; Zhang LX, 2015, NEOPLASIA, V17, P101, DOI 10.1016/j.neo.2014.11.007; Zhang LX, 2010, MOL CANCER RES, V8, P278, DOI 10.1158/1541-7786.MCR-09-0375; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	37	414	438	10	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					524	U158		10.1038/nm.3833	http://dx.doi.org/10.1038/nm.3833			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25849134	Green Submitted, Green Accepted			2022-12-25	WOS:000354068800022
J	MacDonald, JI; Munch, HK; Moore, T; Francis, MB				MacDonald, James I.; Munch, Henrik K.; Moore, Troy; Francis, Matthew B.			One-step site-specific modification of native proteins with 2-pyridinecarboxyaldehydes	NATURE CHEMICAL BIOLOGY			English	Article							FUNCTIONALIZED POLY(ETHYLENE GLYCOL); N-TERMINAL MODIFICATION; CHEMICAL-MODIFICATION; IN-VIVO; PEPTIDES; IDENTIFICATION; REACTIVITY; OXIDATION; ANALOGS	The chemical modification of proteins is an enabling technology for many scientific fields, including chemical biology, biophysics, bioengineering and materials science. These methods allow the attachment of strategically selected detection probes, polymers, drug molecules and analysis platforms. However, organic reactions that can proceed under conditions mild enough to maintain biomolecular function are limited. Even more rare are chemical strategies that can target a single site, leading to products with uniform properties and optimal function. We present a versatile method for the selective modification of protein N termini that does not require any genetic engineering of the protein target. This reaction is demonstrated for 12 different proteins, including the soluble domain of the human estrogen receptor. The function of this protein was confirmed through the binding of a fluorescent estrogen mimic, and the modified protein was explored as a prototype for the detection of endocrine-disrupting chemicals in water.	[MacDonald, James I.; Munch, Henrik K.; Moore, Troy; Francis, Matthew B.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Francis, Matthew B.] Lawrence Berkeley Natl Labs, Mol Foundry, Div Mat Sci, Berkeley, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Francis, MB (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	mbfrancis@berkeley.edu		Munch, Henrik Fischer/0000-0002-3464-677X	Berkeley Chemical Biology Graduate Program (National Research Service) [1 T32 GMO66698]; Villum Kann Rasmussens Foundation; Laboratory Directed Research and Development Program at Lawrence Berkeley National Labs; Direct For Mathematical & Physical Scien [1413666] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	Berkeley Chemical Biology Graduate Program (National Research Service); Villum Kann Rasmussens Foundation; Laboratory Directed Research and Development Program at Lawrence Berkeley National Labs; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The development of this reaction was supported by the Energy Biosciences Institute at the University of California-Berkeley. The application of the reaction to the human estrogen receptor was supported by the US National Science Foundation (CHE-1059083 and CHE-1413666). J.I.M. was supported by the Berkeley Chemical Biology Graduate Program (National Research Service Award Training grant 1 T32 GMO66698). H.K.M. was supported by the Villum Kann Rasmussens Foundation as well as the Laboratory Directed Research and Development Program at Lawrence Berkeley National Labs. We would like to acknowledge M. Dedeo for the tobacco mosaic virus coat protein, L. Witus for the GFP and A. Obermeyer for X-ADSWAG peptides (all at the University of California-Berkeley).	ANDERSON PJ, 1970, BIOCHEM J, V117, P291, DOI 10.1042/bj1170291; Baker DP, 2006, BIOCONJUGATE CHEM, V17, P179, DOI 10.1021/bc050237q; BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Banerjee D, 2010, CHEMBIOCHEM, V11, P1273, DOI 10.1002/cbic.201000125; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chan AOY, 2012, J AM CHEM SOC, V134, P2589, DOI 10.1021/ja208009r; Cornish VW, 1996, J AM CHEM SOC, V118, P8150, DOI 10.1021/ja961216x; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Deiters A, 2003, J AM CHEM SOC, V125, P11782, DOI 10.1021/ja0370037; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dixon H B, 1972, Methods Enzymol, V25, P409, DOI 10.1016/S0076-6879(72)25036-4; DIXON HBF, 1984, J PROTEIN CHEM, V3, P99, DOI 10.1007/BF01024840; FRAENKELCONRAT H, 1948, J BIOL CHEM, V174, P827; Gaertner HF, 1996, BIOCONJUGATE CHEM, V7, P38, DOI 10.1021/bc950074d; Gangloff M, 2001, J BIOL CHEM, V276, P15059, DOI 10.1074/jbc.M009870200; GEOGHEGAN KF, 1992, BIOCONJUGATE CHEM, V3, P138, DOI 10.1021/bc00014a008; Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368; GLAZER AN, 1970, ANNU REV BIOCHEM, V39, P101, DOI 10.1146/annurev.bi.39.070170.000533; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gryder BE, 2013, J MED CHEM, V56, P5782, DOI 10.1021/jm400467w; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ; Himo F, 2005, J AM CHEM SOC, V127, P210, DOI 10.1021/ja0471525; Join B, 2011, ADV SYNTH CATAL, V353, P3023, DOI 10.1002/adsc.201100210; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XF, 2000, TETRAHEDRON LETT, V41, P4069, DOI 10.1016/S0040-4039(00)00592-X; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Ning XH, 2010, ANGEW CHEM INT EDIT, V49, P3065, DOI 10.1002/anie.201000408; Obermeyer AC, 2014, J AM CHEM SOC, V136, P9572, DOI 10.1021/ja500728c; PETER W, 1992, PROTEIN ENG, V5, P351, DOI 10.1093/protein/5.4.351; Rao JH, 2007, CURR OPIN BIOTECH, V18, P17, DOI 10.1016/j.copbio.2007.01.003; SANGEORGE RC, 1986, J BIOL CHEM, V261, P6811; Singudas R, 2015, CHEM COMMUN, V51, P473, DOI 10.1039/c4cc08503e; Stephanopoulos N, 2010, ACS NANO, V4, P6014, DOI 10.1021/nn1014769; Storr T, 2005, EUR J INORG CHEM, P2685, DOI 10.1002/ejic.200500018; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tam JP, 1999, BIOPOLYMERS, V51, P311, DOI 10.1002/(SICI)1097-0282(1999)51:5<311::AID-BIP2>3.0.CO;2-A; Ternes TA, 2003, WATER RES, V37, P1976, DOI 10.1016/S0043-1354(02)00570-5; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; VANGOMPEL J, 1987, J ORG CHEM, V52, P1465, DOI 10.1021/jo00384a015; Wang HM, 2011, CHEM COMMUN, V47, P4439, DOI 10.1039/c1cc10506j; Wiita AP, 2014, P NATL ACAD SCI USA, V111, P7594, DOI 10.1073/pnas.1405987111; Witus LS, 2013, J AM CHEM SOC, V135, P17223, DOI 10.1021/ja408868a; Witus LS, 2011, ACCOUNTS CHEM RES, V44, P774, DOI 10.1021/ar2001292; Witus LS, 2010, J AM CHEM SOC, V132, P16812, DOI 10.1021/ja105429n; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002	50	179	183	5	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2015	11	5					326	U114		10.1038/NCHEMBIO.1792	http://dx.doi.org/10.1038/NCHEMBIO.1792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG3FD	25822913				2022-12-25	WOS:000353162600008
J	Zhao, Z; Chen, CC; Rillahan, CD; Shen, RL; Kitzing, T; McNerney, ME; Diaz-Flores, E; Zuber, J; Shannon, K; Le Beau, MM; Spector, MS; Kogan, SC; Lowe, SW				Zhao, Zhen; Chen, Chi-Chao; Rillahan, Cory D.; Shen, Ronglai; Kitzing, Thomas; McNerney, Megan E.; Diaz-Flores, Ernesto; Zuber, Johannes; Shannon, Kevin; Le Beau, Michelle M.; Spector, Mona S.; Kogan, Scott C.; Lowe, Scott W.			Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; CANCER GENOMICS; P53 RESTORATION; ONCOGENIC KRAS; IN-VIVO; LEUKEMIA; HAPLOINSUFFICIENCY; SENESCENCE; DELETIONS; DEL(5Q)	RAS network activation is common in human cancers, and in acute myeloid leukemia (AML) this activation is achieved mainly through gain-of-function mutations in KRAS, NRAS or the receptor tyrosine kinase FLT3. We show that in mice, premalignant myeloid cells harboring a Kras(G12D) allele retained low levels of Ras signaling owing to negative feedback involving Spry4 that prevented transformation. In humans, SPRY4 is located on chromosome 5q, a region affected by large heterozygous deletions that are associated with aggressive disease in which gain-of-function mutations in the RAS pathway are rare. These 5q deletions often co-occur with chromosome 17 alterations involving the deletion of NF1 (another RAS negative regulator) and TP53. Accordingly, combined suppression of Spry4, Nf1 and p53 produces high levels of Ras signaling and drives AML in mice. Thus, SPRY4 is a tumor suppressor at 5q whose disruption contributes to a lethal AML subtype that appears to acquire RAS pathway activation through a loss of negative regulators.	[Zhao, Zhen; Chen, Chi-Chao; Rillahan, Cory D.; Kitzing, Thomas; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Chen, Chi-Chao] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [McNerney, Megan E.] Univ Chicago, Dept Pathol, Dept Pediat, Sect Hematol Oncol, Chicago, IL 60637 USA; [Diaz-Flores, Ernesto; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Zuber, Johannes] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Le Beau, Michelle M.] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Spector, Mona S.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kogan, Scott C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; University of Chicago; University of California System; University of California San Francisco; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Chicago; Cold Spring Harbor Laboratory; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	lowes@mskcc.org	Zuber, Johannes/E-7517-2011; Paulson, James/AAG-3565-2019	Zuber, Johannes/0000-0001-8810-6835; McNerney, Megan/0000-0002-8260-3598; Kogan, Scott/0000-0002-2395-8479; Zhao, Zhen/0000-0001-5271-4759	Specialized Center of Research (SCOR) grant from the Leukemia & Lymphoma Society (LLS); Starr Cancer Consortium grant; Don Monti Memorial Research Foundation; Geoffrey Beene Center for Cancer Research; LLS Research Fellow Award [5428-15]; Ministry of Education of Taiwan; NATIONAL CANCER INSTITUTE [K08CA181254, P30CA008748, P01CA087497, P01CA013106, R37CA072614] Funding Source: NIH RePORTER	Specialized Center of Research (SCOR) grant from the Leukemia & Lymphoma Society (LLS); Starr Cancer Consortium grant; Don Monti Memorial Research Foundation; Geoffrey Beene Center for Cancer Research; LLS Research Fellow Award; Ministry of Education of Taiwan(Ministry of Education, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge A. Chicas, O. Aksoy, C.-H. Huang, C. He and C. Chen for their expert technical assistance, advice and supportive data, as well as members of the Lowe laboratory for helpful comments. The authors also thank C. Sherr and S. Mayack for editorial comments on the manuscript. This study was supported by a Specialized Center of Research (SCOR) grant from the Leukemia & Lymphoma Society (LLS), a Starr Cancer Consortium grant, the Don Monti Memorial Research Foundation, the Geoffrey Beene Center for Cancer Research, an Award from the Ministry of Education of Taiwan to C.-C. C. and an LLS Research Fellow Award to C.D.R. (5428-15). S.W.L. is an investigator in the Howard Hughes Medical Institute.	Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Cutts BA, 2009, BLOOD, V114, P3629, DOI 10.1182/blood-2009-02-205146; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Douet-Guilbert N, 2012, LEUKEMIA, V26, P1695, DOI 10.1038/leu.2012.9; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jerez A, 2012, J CLIN ONCOL, V30, P1343, DOI 10.1200/JCO.2011.36.1824; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kadia TM, 2012, CANCER-AM CANCER SOC, V118, P5550, DOI 10.1002/cncr.27596; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Wang JH, 2010, BLOOD, V115, P3481, DOI 10.1182/blood-2009-11-251835; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262; Zhao ND, 1997, P NATL ACAD SCI USA, V94, P6948, DOI 10.1073/pnas.94.13.6948; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	43	25	26	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					539	U150		10.1038/ng.3251	http://dx.doi.org/10.1038/ng.3251			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25822087	Green Accepted			2022-12-25	WOS:000353635800019
J	Blom, T; Li, SQ; Dichlberger, A; Back, N; Kim, YA; Loizides-Mangold, U; Riezman, H; Bittman, R; Ikonen, E				Blom, Tomas; Li, Shiqian; Dichlberger, Andrea; Back, Nils; Kim, Young Ah; Loizides-Mangold, Ursula; Riezman, Howard; Bittman, Robert; Ikonen, Elina			LAPTM4B facilitates late endosomal ceramide export to control cell death pathways	NATURE CHEMICAL BIOLOGY			English	Article							DISEASE TYPE C1; ACID SPHINGOMYELINASE; MULTIDRUG-RESISTANCE; SPHINGOLIPID METABOLISM; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; SACCHAROMYCES-CEREVISIAE; LYSOSOMAL CALCIUM; MEMBRANE-PROTEIN; CHEMOTHERAPY	Lysosome-associated protein transmembrane-4b (LAPTM4B) associates with poor prognosis in several cancers, but its physiological function is not well understood. Here we use novel ceramide probes to provide evidence that LAPTM4B interacts with ceramide and facilitates its removal from late endosomal organelles (LEs). This lowers LE ceramide in parallel with and independent of acid ceramidase-dependent catabolism. In LAPTM4B-silenced cells, LE sphingolipid accumulation is accompanied by lysosomal membrane destabilization. However, these cells resist ceramide-driven caspase-3 activation and apoptosis induced by chemotherapeutic agents or gene silencing. Conversely, LAPTM4B overexpression reduces LE ceramide and stabilizes lysosomes but sensitizes to drug-induced caspase-3 activation. Together, these data uncover a cellular ceramide export route from LEs and identify LAPTM4B as its regulator. By compartmentalizing ceramide, LAPTM4B controls key sphingolipid-mediated cell death mechanisms and emerges as a candidate for sphingolipid-targeting cancer therapies.	[Blom, Tomas; Li, Shiqian; Dichlberger, Andrea; Back, Nils; Ikonen, Elina] Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland; [Blom, Tomas; Li, Shiqian; Dichlberger, Andrea; Ikonen, Elina] Minerva Fdn, Inst Med Res, Helsinki, Finland; [Kim, Young Ah; Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY USA; [Loizides-Mangold, Ursula; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland	University of Helsinki; City University of New York (CUNY) System; Queens College NY (CUNY); University of Geneva	Blom, T (corresponding author), Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland.	tomas.blom@helsinki.fi; elina.ikonen@helsinki.fi	Li, Shiqian/ABH-2154-2021; Loizides-Mangold, Ursula/I-9061-2014	Loizides-Mangold, Ursula/0000-0001-9233-2974; Back, Nils/0000-0001-9992-3726; Ikonen, Elina/0000-0001-8382-1135; li, shiqian/0000-0003-1663-0704; Blom, Tomas/0000-0001-9711-8387; Dichlberger, Andrea/0000-0002-2083-3283; Riezman, Howard/0000-0003-4680-9422	Academy of Finland [273533, 266092, 131489, 263841, 272130]; Liv och Halsa Foundation; University of Helsinki Research Fund Grant; Ruth and Nils-Erik Stenback Foundation; Finnish Medical Foundation; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Perklen Foundation; Swiss National Science Foundation; NCCR Chemical Biology; SystemsX.ch	Academy of Finland(Academy of Finland); Liv och Halsa Foundation; University of Helsinki Research Fund Grant; Ruth and Nils-Erik Stenback Foundation; Finnish Medical Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Perklen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Chemical Biology(Swiss National Science Foundation (SNSF)); SystemsX.ch	The authors thank K. Sandhoff for helpful comments on the manuscript; A. Uro and D.J. Baek for technical support; S. Hautaniemi, R. Louhimo and S. Karinen for help with bioinformatics and the Biomedicum imaging unit for help with microscopy. This study was supported by Academy of Finland grants 273533 and 266092 (T.B.), 131489, 263841 and 272130 (E.I.), the Liv och Halsa Foundation (T.B. and N.B.), the University of Helsinki Research Fund Grant (T.B.), the Ruth and Nils-Erik Stenback Foundation (T.B.), the Finnish Medical Foundation (E.I. and R.B.), the Sigrid Juselius Foundation (E.I.), the Magnus Ehrnrooth Foundation (N.B.), the Perklen Foundation (N.B.), the Swiss National Science Foundation (H.R.), the NCCR Chemical Biology (H.R.) and SystemsX.ch (H.R.).	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Bandhuvula P, 2009, BIOCHEM BIOPH RES CO, V380, P366, DOI 10.1016/j.bbrc.2009.01.106; Bedia C, 2011, J BIOL CHEM, V286, P28200, DOI 10.1074/jbc.M110.216382; Bjorkholm P, 2014, BBA-BIOMEMBRANES, V1838, P2066, DOI 10.1016/j.bbamem.2014.04.026; Blom T, 2012, TRAFFIC, V13, P1234, DOI 10.1111/j.1600-0854.2012.01379.x; Cabrita MA, 1999, CANCER RES, V59, P4890; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; de Ronde JJ, 2013, BREAST CANCER RES TR, V137, P213, DOI 10.1007/s10549-012-2340-x; Ellegaard AM, 2013, MOL CANCER THER, V12, P2018, DOI 10.1158/1535-7163.MCT-13-0084; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Henry B, 2013, CANCER LETT, V332, P286, DOI 10.1016/j.canlet.2011.07.010; Hogue DL, 1996, J BIOL CHEM, V271, P9801, DOI 10.1074/jbc.271.16.9801; Hogue DL, 1999, J BIOL CHEM, V274, P12877, DOI 10.1074/jbc.274.18.12877; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lee AJX, 2012, J PATHOL, V226, P482, DOI 10.1002/path.2998; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loizides-Mangold U, 2012, J LIPID RES, V53, P1522, DOI 10.1194/jlr.M025692; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Sandhoff K, 2012, P JPN ACAD B-PHYS, V88, P554, DOI 10.2183/pjab.88.554; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Speak AO, 2014, BLOOD, V123, P51, DOI 10.1182/blood-2013-03-488692; Sullards M.C., 2001, SCI STKE, V2001; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tafesse FG, 2014, J CELL SCI, V127, P445, DOI 10.1242/jcs.138933; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Truman JP, 2014, BBA-MOL CELL BIOL L, V1841, P1174, DOI 10.1016/j.bbalip.2013.12.013; Ullio C, 2012, J LIPID RES, V53, P1134, DOI 10.1194/jlr.M022384; Vergarajauregui S, 2011, J CELL SCI, V124, P459, DOI 10.1242/jcs.076240; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006	51	37	39	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					799	+		10.1038/NCHEMBIO.1889	http://dx.doi.org/10.1038/NCHEMBIO.1889			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26280656				2022-12-25	WOS:000361536500013
J	Chen, KF; Chen, Z; Wu, DY; Zhang, LL; Lin, XQ; Su, JZ; Rodriguez, B; Xi, YX; Xia, Z; Chen, X; Shi, XB; Wang, QB; Li, W				Chen, Kaifu; Chen, Zhong; Wu, Dayong; Zhang, Lili; Lin, Xueqiu; Su, Jianzhong; Rodriguez, Benjamin; Xi, Yuanxin; Xia, Zheng; Chen, Xi; Shi, Xiaobing; Wang, Qianben; Li, Wei			Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; SUPER-ENHANCERS; CANCER GENOME; C-MYC; ANDROGEN RECEPTOR; PROSTATE-CANCER; CHROMATIN; IDENTITY	Tumor suppressors are mostly defined by inactivating mutations in tumors, yet little is known about their epigenetic features in normal cells. Through integrative analysis of 1,134 genome-wide epigenetic profiles, mutations from >8,200 tumor-normal pairs and our experimental data from clinical samples, we discovered broad peaks for trimethylation of histone H3 at lysine 4 (H3K4me3; wider than 4 kb) as the first epigenetic signature for tumor suppressors in normal cells. Broad H3K4me3 is associated with increased transcription elongation and enhancer activity, which together lead to exceptionally high gene expression, and is distinct from other broad epigenetic features, such as super-enhancers. Genes with broad H3K4me3 peaks conserved across normal cells may represent pan-cancer tumor suppressors, such as TP53 and PTEN, whereas genes with cell type-specific broad H3K4me3 peaks may represent cell identity genes and cell type-specific tumor suppressors. Furthermore, widespread shortening of broad H3K4me3 peaks in cancers is associated with repression of tumor suppressors. Thus, the broad H3K4me3 epigenetic signature provides mutation-independent information for the discovery and characterization of new tumor suppressors.	[Chen, Kaifu; Lin, Xueqiu; Su, Jianzhong; Rodriguez, Benjamin; Xi, Yuanxin; Xia, Zheng; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Chen, Kaifu; Lin, Xueqiu; Su, Jianzhong; Rodriguez, Benjamin; Xi, Yuanxin; Xia, Zheng; Chen, Xi; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Chen, Kaifu] Methodist Hosp, Res Inst, Inst Acad Med, Houston, TX 77030 USA; [Chen, Kaifu] Methodist Hosp, Res Inst, Ctr Cardiovasc Regenerat, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Chen, Kaifu] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Chen, Zhong; Wu, Dayong; Wang, Qianben] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Chen, Zhong; Wu, Dayong; Wang, Qianben] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Zhang, Lili] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Lin, Xueqiu] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Houston, TX 77030 USA; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Baylor College of Medicine; Tongji University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, QB (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA.	qianben.wang@osumc.edu; wl1@bcm.edu	Wang, Qianben/E-4267-2011; Chen, Zhong/E-2776-2018; lin, xueqiu/AGI-7531-2022; Xia, Zheng/AAC-5360-2022	Chen, Zhong/0000-0002-9644-1737; Xia, Zheng/0000-0003-3364-8324; Su, Jianzhong/0000-0002-1172-7411; Shi, Xiaobing/0000-0001-5242-8189; Chen, Xi/0000-0002-7995-6202	US National Institutes of Health (NIH) [R01HG007538, R01CA193466]; Cancer Prevention Research Institute of Texas (CPRIT) grant [RP110471, RP150292]; US NIH grant [R01CA151979, U54CA113001]; US Department of Defense grant [W81XWH-12-1-0615]; NATIONAL CANCER INSTITUTE [R01CA151979, R01CA193466, U54CA113001, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT) grant; US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to M. Luo, M. Goodell, L. Donehower, T. Westbrook and A. Brunet for helpful discussions. This work was supported by the US National Institutes of Health (NIH) grants R01HG007538 and R01CA193466, Cancer Prevention Research Institute of Texas (CPRIT) grants RP110471 and RP150292 (W.L.), and US NIH grant R01CA151979, US Department of Defense grant W81XWH-12-1-0615 and US NIH grant U54CA113001 (Q.W.). X.S. is an inaugural MD Anderson Cancer Center R. Lee Clark Fellow.	Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Chen Z, 2015, EMBO J, V34, P502, DOI 10.15252/embj.201490306; Coley HM, 2012, ONCOTARGET, V3, P78; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Matthew EM, 2009, CELL CYCLE, V8, P4168, DOI 10.4161/cc.8.24.10800; Mendes RD, 2014, BLOOD, V124, P567, DOI 10.1182/blood-2014-03-562751; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rincon-Arano H, 2012, CELL, V151, P1214, DOI 10.1016/j.cell.2012.11.009; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shulha HP, 2012, ARCH GEN PSYCHIAT, V69, P314, DOI 10.1001/archgenpsychiatry.2011.151; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith P, 2006, CELL CYCLE, V5, P1262, DOI 10.4161/cc.5.12.2813; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Virely C, 2010, LEUKEMIA, V24, P1200, DOI 10.1038/leu.2010.63; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yasuo K., 1990, INT J BIOCHEM, V22, P219; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	47	176	178	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1149	+		10.1038/ng.3385	http://dx.doi.org/10.1038/ng.3385			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26301496	Green Accepted			2022-12-25	WOS:000361969900010
J	Sun, HS; Damez-Werno, DM; Scobie, KN; Shao, NY; Dias, C; Rabkin, J; Koo, JW; Korb, E; Bagot, RC; Ahn, FH; Cahill, ME; Labonte, B; Mouzon, E; Heller, EA; Cates, H; Golden, SA; Gleason, K; Russo, SJ; Andrews, S; Neve, R; Kennedy, PJ; Maze, I; Dietz, DM; Allis, CD; Turecki, G; Varga-Weisz, P; Tamminga, C; Shen, L; Nestler, EJ				Sun, HaoSheng; Damez-Werno, Diane M.; Scobie, Kimberly N.; Shao, Ning-Yi; Dias, Caroline; Rabkin, Jacqui; Koo, Ja Wook; Korb, Erica; Bagot, Rosemary C.; Ahn, Francisca H.; Cahill, Michael E.; Labonte, Benoit; Mouzon, Ezekiell; Heller, Elizabeth A.; Cates, Hannah; Golden, Sam A.; Gleason, Kelly; Russo, Scott J.; Andrews, Simon; Neve, Rachael; Kennedy, Pamela J.; Maze, Ian; Dietz, David M.; Allis, C. David; Turecki, Gustavo; Varga-Weisz, Patrick; Tamminga, Carol; Shen, Li; Nestler, Eric J.			ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior	NATURE MEDICINE			English	Article							HISTONE METHYLATION; SOCIAL DEFEAT; MAJOR DEPRESSION; IN-VIVO; ISWI; ACETYLATION; DISORDERS; SUBUNIT; TRANSCRIPTION; COMORBIDITY	Improved treatment for major depressive disorder (MDD) remains elusive because of the limited understanding of its underlying biological mechanisms. It is likely that stress-induced maladaptive transcriptional regulation in limbic neural circuits contributes to the development of MDD, possibly through epigenetic factors that regulate chromatin structure. We establish that persistent upregulation of the ACF (ATP-utilizing chromatin assembly and remodeling factor) ATP-dependent chromatin-remodeling complex, occurring in the nucleus accumbens of stress-susceptible mice and depressed humans, is necessary for stress-induced depressive-like behaviors. We found that altered ACF binding after chronic stress was correlated with altered nucleosome positioning, particularly around the transcription start sites of affected genes. These alterations in ACF binding and nucleosome positioning were associated with repressed expression of genes implicated in susceptibility to stress. Together, our findings identify the ACF chromatin-remodeling complex as a critical component in the development of susceptibility to depression and in regulating stress-related behaviors.	[Sun, HaoSheng; Damez-Werno, Diane M.; Scobie, Kimberly N.; Shao, Ning-Yi; Dias, Caroline; Rabkin, Jacqui; Koo, Ja Wook; Bagot, Rosemary C.; Ahn, Francisca H.; Cahill, Michael E.; Labonte, Benoit; Mouzon, Ezekiell; Heller, Elizabeth A.; Cates, Hannah; Golden, Sam A.; Russo, Scott J.; Maze, Ian; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Sun, HaoSheng; Damez-Werno, Diane M.; Scobie, Kimberly N.; Shao, Ning-Yi; Dias, Caroline; Rabkin, Jacqui; Koo, Ja Wook; Bagot, Rosemary C.; Ahn, Francisca H.; Cahill, Michael E.; Labonte, Benoit; Mouzon, Ezekiell; Heller, Elizabeth A.; Cates, Hannah; Golden, Sam A.; Russo, Scott J.; Maze, Ian; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Korb, Erica; Maze, Ian; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Gleason, Kelly; Tamminga, Carol] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Andrews, Simon; Varga-Weisz, Patrick] Babraham Inst, Cambridge, England; [Neve, Rachael] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Kennedy, Pamela J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Maze, Ian] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Dietz, David M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Dietz, David M.] SUNY Buffalo, Inst Addict, Buffalo, NY 14260 USA; [Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; McGill University	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Dietz, David/J-9458-2015; Bagot, Rosemary/V-4325-2019; Dietz, David/AAW-4574-2021; Labonte, Benoit/GPF-5629-2022; SHAO, Ning-Yi/N-4947-2015; Russo, Scott/R-7107-2019; Heller, Elizabeth A/W-4653-2019; Maze, Ian/P-8077-2018	Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Labonte, Benoit/0000-0002-1251-5605; SHAO, Ning-Yi/0000-0003-4231-828X; Russo, Scott/0000-0002-6470-1805; Heller, Elizabeth A/0000-0002-2984-8705; Sun, Haosheng/0000-0003-3919-559X; Cahill, Michael/0000-0003-0574-2655; Turecki, Gustavo/0000-0003-4075-2736; Golden, Sam/0000-0002-2104-2272; Cates, Hannah/0000-0002-9413-0847; Varga-Weisz, Patrick/0000-0001-7409-8686; Korb, Erica/0000-0002-7064-8123	National Institute of Mental Health [P50 MH096890, R01 MH51399]; Hope for Depression Research Foundation; Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F020236/1, BBS/E/B/000C0404] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020236/1, BBS/E/B/0000H125, BBS/E/B/000C0404] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037257] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the patients and their families for their contribution to the brain banks. This work was supported by the National Institute of Mental Health (grants P50 MH096890 and R01 MH51399) and the Hope for Depression Research Foundation. S.A. and P.V.-W. are funded by the Biotechnology and Biological Sciences Research Council (BBSRC).	Abe N, 2011, J PSYCHIATR RES, V45, P1106, DOI 10.1016/j.jpsychires.2011.01.016; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Caldji C, 2011, FEBS LETT, V585, P2049, DOI 10.1016/j.febslet.2011.03.032; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ewing AK, 2007, MOL ENDOCRINOL, V21, P1791, DOI 10.1210/me.2007-0095; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gorwood P, 2004, EUR PSYCHIAT, V19, P27, DOI 10.1016/j.eurpsy.2003.10.002; Gudsnuk K, 2012, ILAR J, V53, P279, DOI 10.1093/ilar.53.3-4.279; Hobara T, 2010, J PSYCHIATR RES, V44, P263, DOI 10.1016/j.jpsychires.2009.08.015; Hollis F, 2011, HORM BEHAV, V59, P331, DOI 10.1016/j.yhbeh.2010.09.005; Hunter RG, 2009, P NATL ACAD SCI USA, V106, P20912, DOI 10.1073/pnas.0911143106; Jiang Y, 2010, J NEUROSCI, V30, P7152, DOI 10.1523/JNEUROSCI.1314-10.2010; Kendler KS, 1998, PHARMACOPSYCHIATRY, V31, P5, DOI 10.1055/s-2007-979287; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu YI, 2008, DEV BIOL, V323, P41, DOI 10.1016/j.ydbio.2008.08.011; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Sala A, 2011, EMBO J, V30, P1766, DOI 10.1038/emboj.2011.98; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sun HS, 2013, NEUROPSYCHOPHARMACOL, V38, P124, DOI 10.1038/npp.2012.73; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036	45	57	59	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1146	+		10.1038/nm.3939	http://dx.doi.org/10.1038/nm.3939			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26390241	Green Accepted			2022-12-25	WOS:000362355400016
J	Schmidt, C				Schmidt, Charlie			Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug	NATURE BIOTECHNOLOGY			English	News Item																		2014, J APPL BIOPHARM PHAR, V2, P50; 2010, ARCH DERMATOLOGY, V146, P891	2	18	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					894	895		10.1038/nbt0915-894b	http://dx.doi.org/10.1038/nbt0915-894b			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348946				2022-12-25	WOS:000360990900005
J	Hanssen, MJW; Hoeks, J; Brans, B; van der Lans, AAJJ; Schaart, G; van den Driessche, JJ; Jorgensen, JA; Boekschoten, MV; Hesselink, MKC; Havekes, B; Kersten, S; Mottaghy, FM; Lichtenbelt, WDV; Schrauwen, P				Hanssen, Mark J. W.; Hoeks, Joris; Brans, Boudewijn; van der Lans, Anouk A. J. J.; Schaart, Gert; van den Driessche, Jose J.; Jorgensen, Johanna A.; Boekschoten, Mark V.; Hesselink, Matthijs K. C.; Havekes, Bas; Kersten, Sander; Mottaghy, Felix M.; Lichtenbelt, Wouter D. van Marken; Schrauwen, Patrick			Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; MITOCHONDRIAL-FUNCTION; ENERGY-EXPENDITURE; GLUCOSE-UPTAKE; FAT; THERMOGENESIS; HOMEOSTASIS	Cold exposure may be a potential therapy for diabetes by increasing brown adipose tissue (BAT) mass and activity. Here we report that 10 d of cold acclimation (14-15 degrees C) increased peripheral insulin sensitivity by similar to 43% in eight type 2 diabetes subjects. Basal skeletal muscle GLUT4 translocation markedly increased, without effects on insulin signaling or AMP-activated protein kinase (AMPK) activation and only a minor increase in BAT glucose uptake.	[Hanssen, Mark J. W.; Hoeks, Joris; van der Lans, Anouk A. J. J.; van den Driessche, Jose J.; Jorgensen, Johanna A.; Lichtenbelt, Wouter D. van Marken; Schrauwen, Patrick] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands; [Brans, Boudewijn; Mottaghy, Felix M.] Maastricht Univ, Med Ctr, Dept Nucl Med, Maastricht, Netherlands; [Schaart, Gert; Hesselink, Matthijs K. C.] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab, Dept Human Movement Sci, Maastricht, Netherlands; [Boekschoten, Mark V.; Kersten, Sander] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands; [Havekes, Bas] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab, Dept Internal Med,Div Endocrinol & Metab, Maastricht, Netherlands; [Mottaghy, Felix M.] Univ Hosp Rhein Westfal Tech Hsch RWTH Aachen, Dept Nucl Med, Aachen, Germany	Maastricht University; Maastricht University; Maastricht University; Wageningen University & Research; Maastricht University	Schrauwen, P (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands.	p.schrauwen@maastrichtuniversity.nl	Mottaghy, Felix/AAU-2673-2020; Kersten, Sander/A-1116-2011; Boekschoten, Mark/AAS-4597-2021	Mottaghy, Felix/0000-0002-7212-6521; Kersten, Sander/0000-0003-4488-7734; Boekschoten, Mark/0000-0002-2139-0795; Hoeks, Joris/0000-0002-0265-0870; schrauwen, patrick/0000-0002-0973-847X	EU FP7 project DIABAT [HEALTH-F2-2011-278373]; Netherlands Organization for Scientific Research (NWO) [TOP 91209037]; NWO [917.14.358]	EU FP7 project DIABAT; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	We thank K. Jardon, E. Broeders, D. Van Moorsel, K. Jansen, M. Visser, R. Hensgens and R. Wierts (Maastricht University Medical Center) for assistance during the experiments and H. Aydeniz, E. Kornips, J. Stegen, W Sluijsmans, L. Donselaar (Maastricht University Medical Center), W Wickenhagen (VU University Medical Center Amsterdam) and M. Ackermans (Academic Medical Center Amsterdam) for assistance with the biochemical analyses. The technical support of P. Schoffelen, L. Wouters and M. Souren (Maastricht University Medical Center) is highly appreciated. This work was supported by the EU FP7 project DIABAT (HEALTH-F2-2011-278373 to W.D.v.M.L.) and by the Netherlands Organization for Scientific Research (NWO) (TOP 91209037 to W.D.v.M.L). J.H. is supported by an NWO Vidi grant for innovative research (grant 917.14.358).	Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Blondin DP, 2014, J CLIN ENDOCR METAB, V99, pE438, DOI 10.1210/jc.2013-3901; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gaigani J. E., 2008, DIABETES, V57, P841; Hanssen MJW, 2015, DIABETOLOGIA, V58, P586, DOI 10.1007/s00125-014-3465-8; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sato M, 2014, DIABETES, V63, P4115, DOI 10.2337/db13-1860; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang GX, 2014, NAT MED, V20, P1436, DOI 10.1038/nm.3713; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105	20	344	350	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					863	865		10.1038/nm.3891	http://dx.doi.org/10.1038/nm.3891			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26147760	Green Published			2022-12-25	WOS:000359181000011
J	Lu, WY; Bird, TG; Boulter, L; Tsuchiya, A; Cole, AM; Hay, T; Guest, RV; Wojtacha, D; Man, TY; Mackinnon, A; Ridgway, RA; Kendall, T; Williams, MJ; Jamieson, T; Raven, A; Hay, DC; Iredale, JP; Clarke, AR; Sansom, OJ; Forbes, SJ				Lu, Wei-Yu; Bird, Thomas G.; Boulter, Luke; Tsuchiya, Atsunori; Cole, Alicia M.; Hay, Trevor; Guest, Rachel V.; Wojtacha, Davina; Man, Tak Yung; Mackinnon, Alison; Ridgway, Rachel A.; Kendall, Timothy; Williams, Michael J.; Jamieson, Thomas; Raven, Alex; Hay, David C.; Iredale, John P.; Clarke, Alan R.; Sansom, Owen J.; Forbes, Stuart J.			Hepatic progenitor cells of biliary origin with liver repopulation capacity	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; DUCTULAR REACTIONS; CHOLINE-DEFICIENT; MOUSE-LIVER; ADULT LIVER; OVAL CELLS; HEPATOCYTES; DIFFERENTIATION; SENESCENCE; EXPANSION	Hepatocytes and cholangiocytes self-renew following liver injury. Following severe injury hepatocytes are increasingly senescent, but whether hepatic progenitor cells (HPCs) then contribute to liver regeneration is unclear. Here, we describe a mouse model where the E3 ubiquitin ligase Mdm2 is inducibly deleted in more than 98% of hepatocytes, causing apoptosis, necrosis and senescence with nearly all hepatocytes expressing p21. This results in florid HPC activation, which is necessary for survival, followed by complete, functional liver reconstitution. HPCs isolated from genetically normal mice, using cell surface markers, were highly expandable and phenotypically stable in vitro. These HPCs were transplanted into adult mouse livers where hepatocyte Mdm2 was repeatedly deleted, creating a non-competitive repopulation assay. Transplanted HPCs contributed significantly to restoration of liver parenchyma, regenerating hepatocytes and biliary epithelia, highlighting their in vivo lineage potency. HPCs are therefore a potential future alternative to hepatocyte or liver transplantation for liver disease.	[Lu, Wei-Yu; Bird, Thomas G.; Guest, Rachel V.; Wojtacha, Davina; Man, Tak Yung; Mackinnon, Alison; Williams, Michael J.; Raven, Alex; Hay, David C.; Forbes, Stuart J.] MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Boulter, Luke; Kendall, Timothy] MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Tsuchiya, Atsunori] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata 9518510, Japan; [Cole, Alicia M.; Ridgway, Rachel A.; Jamieson, Thomas; Sansom, Owen J.] CRUK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Hay, Trevor; Clarke, Alan R.] European Canc Stem Cell Res Inst, Cardiff Sch Biosci, London CF24 4HQ, England; [Iredale, John P.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh; Niigata University; Beatson Institute; University of Edinburgh	Forbes, SJ (corresponding author), MRC, Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	stuart.forbes@ed.ac.uk	Kendall, Tim/H-2698-2019; Lu, Wei-Yu/N-5884-2019; Bird, Tom/H-3840-2019	Kendall, Tim/0000-0002-4174-2786; Lu, Wei-Yu/0000-0002-0419-0257; Bird, Tom/0000-0002-6120-1581; Sansom, Owen J./0000-0001-9540-3010; Iredale, John/0000-0003-2174-5127; Forbes, Stuart/0000-0003-3715-2561; Raven, Alexander/0000-0003-4409-9543; Clarke, Alan/0000-0002-4281-426X	Wellcome Trust; Academy of Medical Sciences; University of Edinburgh; Charles Darwin Scholarship; Edinburgh Overseas Research Scholarship; UK Regenerative Medicine Platform; MRC; Cancer Research UK; European Research Council; Sir Jules Thorn Charitable Trust; Medical Research Council; MRC [MR/L012766/1, G0600033, G0900446, G1000868, MR/L022974/1, MR/K026666/1, G0901697] Funding Source: UKRI; Medical Research Council [G1000868, MR/L012766/1, MR/K026666/1, G0600033, MR/L022974/1, G0900446, G0901697] Funding Source: researchfish; Versus Arthritis [21139] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [07JTA] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K08990] Funding Source: KAKEN	Wellcome Trust(Wellcome Trust); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); University of Edinburgh; Charles Darwin Scholarship; Edinburgh Overseas Research Scholarship; UK Regenerative Medicine Platform; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Sir Jules Thorn Charitable Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); The Sir Jules Thorn Charitable Trust; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to thank Biogen Idec for supplying the Fn14<SUP>KO</SUP> mouse line. We would also like to thank V. Factor for kindly supplying the A6 antibody, and M. Alison for proofreading the manuscript. We would like to thank F. Rossi, C. Cryer, O. Rodrigues and S. Monard for assistance with flow cytometry. T.G.B. is financially supported by the Wellcome Trust and the Academy of Medical Sciences. W.Y.L. was supported by the University of Edinburgh, Charles Darwin Scholarship, Edinburgh Overseas Research Scholarship, and the UK Regenerative Medicine Platform. J.P.I is supported by the MRC. O.J.S. is financially supported by Cancer Research UK and the European Research Council. S.J.F. is supported by the Sir Jules Thorn Charitable Trust, the Medical Research Council, and the UK Regenerative Medicine Platform.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Dorrell C, 2008, HEPATOLOGY, V48, P1282, DOI 10.1002/hep.22468; Eischen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046148; Erker L, 2010, GASTROENTEROLOGY, V139, P1019, DOI 10.1053/j.gastro.2010.05.082; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Fickert P, 2010, LAB INVEST, V90, P844, DOI 10.1038/labinvest.2010.61; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GOLDING M, 1995, HEPATOLOGY, V22, P1243, DOI 10.1002/hep.1840220433; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Grier JD, 2002, GENESIS, V32, P145, DOI 10.1002/gene.10066; Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hay DC, 2010, GASTROENTEROLOGY, V139, P729, DOI 10.1053/j.gastro.2010.07.013; Horslen SP, 2004, TRANSPLANTATION, V77, P1481, DOI 10.1097/01.TP.0000113809.53415.C2; Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jors S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585; Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345; Lu W. Y., 2015, PROTOC EXCH; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Overturf K, 1997, AM J PATHOL, V151, P1273; Qiu Q, 2011, STEM CELLS DEV, V20, P2177, DOI 10.1089/scd.2010.0352; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Tsuchiya A, 2005, GASTROENTEROLOGY, V128, P2089, DOI 10.1053/j.gastro.2005.03.030; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060	54	284	294	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					971	U43		10.1038/ncb3203	http://dx.doi.org/10.1038/ncb3203			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26192438	Green Submitted, Green Accepted			2022-12-25	WOS:000358847700005
J	Noguchi, TK; Ninomiya, N; Sekine, M; Komazaki, S; Wang, PC; Asashima, M; Kurisaki, A				Noguchi, Taka-aki K.; Ninomiya, Naoto; Sekine, Mari; Komazaki, Shinji; Wang, Pi-Chao; Asashima, Makoto; Kurisaki, Akira			Generation of stomach tissue from mouse embryonic stem cells	NATURE CELL BIOLOGY			English	Article							GROUND-STATE; DISEASE; NAIVE; DIFFERENTIATION; EXPRESSION; DERIVATION; EXPANSION; ENDODERM; GENES	Successful pluripotent stem cell differentiation methods have been developed for several endoderm-derived cells, including hepatocytes, beta-cells and intestinal cells. However, stomach lineage commitment from pluripotent stem cells has remained a challenge, and only antrum specification has been demonstrated. We established a method for stomach differentiation from embryonic stem cells by inducing mesenchymal Barx1, an essential gene for in vivo stomach specification from gut endoderm. Barx1-inducing culture conditions generated stomach primordium-like spheroids, which differentiated into mature stomach tissue cells in both the corpus and antrum by three-dimensional culture. This embryonic stem cell-derived stomach tissue (e-ST) shared a similar gene expression profile with adult stomach, and secreted pepsinogen as well as gastric acid. Furthermore, TGFA overexpression in e-ST caused hypertrophic mucus and gastric anacidity, which mimicked Menetrier disease in vitro. Thus, in vitro stomach tissue derived from pluripotent stem cells mimics in vivo development and can be used for stomach disease models.	[Noguchi, Taka-aki K.; Sekine, Mari; Wang, Pi-Chao; Kurisaki, Akira] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058577, Japan; [Ninomiya, Naoto; Asashima, Makoto; Kurisaki, Akira] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Ibaraki 3058562, Japan; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan; [Asashima, Makoto] Univ Tsukuba, Life Sci Ctr Tsukuba Adv Res Alliance, Ibaraki 3058577, Japan	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Saitama Medical University; University of Tsukuba	Noguchi, TK (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058577, Japan.	taka.noguchi@aist.go.jp; a-kurisaki@aist.go.jp	Asashima, Makoto/O-8389-2018	Asashima, Makoto/0000-0002-0012-026X	Japan Society for the Promotion of Science (JSPS) [21241048]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank E. Kobayashi for kindly providing technical help with electron microscopy. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS; No. 21241048, M.A. and A.K.) and for JSPS Fellows (T.-a.K.N.).	Antherieu S, 2014, TOXICOL APPL PHARM, V276, P63, DOI 10.1016/j.taap.2014.01.019; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Brafman DA, 2013, STEM CELL REP, V1, P464, DOI 10.1016/j.stemcr.2013.09.005; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Coffey RJ, 2007, J CLIN INVEST, V117, P70, DOI 10.1172/JCI30491; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Fukuda K, 2005, DEV GROWTH DIFFER, V47, P375; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; HAYASHI K, 1988, DEVELOPMENT, V103, P725; Hoffmann W, 2008, CURR MED CHEM, V15, P3133, DOI 10.2174/092986708786848587; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kearns NA, 2013, STEM CELL RES, V11, P1003, DOI 10.1016/j.scr.2013.06.007; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunisato A, 2010, STEM CELLS DEV, V19, P229, DOI 10.1089/scd.2009.0149; LAWSON HH, 1977, S AFR J SURG, V15, P179; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ninomiya N, 2013, IN VITRO CELL DEV-AN, V49, P230, DOI 10.1007/s11626-013-9589-1; Nishimura Y, 2010, BIOCHEM BIOPH RES CO, V401, P1, DOI 10.1016/j.bbrc.2010.08.099; Noguchi T. K., 2015, NAT PROTOC EXCH; Noguchi TK, 2012, GENE EXPR PATTERNS, V12, P154, DOI 10.1016/j.gep.2012.01.001; Ochi Y, 2005, LIFE SCI, V77, P2040, DOI 10.1016/j.lfs.2005.04.006; Piazuelo MB, 2013, COLOMB MEDICA, V44, P192; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Speer AL, 2011, J SURG RES, V171, P6, DOI 10.1016/j.jss.2011.03.062; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Stringer EJ, 2008, FEBS LETT, V582, P2555, DOI 10.1016/j.febslet.2008.06.024; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; TAKAGI H, 1992, J CLIN INVEST, V90, P1161, DOI 10.1172/JCI115936; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; TAKIGUCHI K, 1986, ROUX ARCH DEV BIOL, V195, P475, DOI 10.1007/BF00375887; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Torihashi S, 2006, STEM CELLS, V24, P2618, DOI 10.1634/stemcells.2006-0148; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Udager A, 2010, PROG MOL BIOL TRANSL, V96, P35, DOI 10.1016/S1877-1173(10)96002-X; Verzi MP, 2009, GASTROENTEROLOGY, V136, P1701, DOI 10.1053/j.gastro.2009.01.009; Vivas Y, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-86; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	49	69	75	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					984	U62		10.1038/ncb3200	http://dx.doi.org/10.1038/ncb3200			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26192439				2022-12-25	WOS:000358847700006
J	Sampaziotis, F; de Brito, MC; Madrigal, P; Bertero, A; Saeb-Parsy, K; Soares, FAC; Schrumpf, E; Melum, E; Karlsen, TH; Bradley, JA; Gelson, WTH; Davies, S; Baker, A; Kaser, A; Alexander, GJ; Hannan, NRF; Vallier, L				Sampaziotis, Fotios; de Brito, Miguel Cardoso; Madrigal, Pedro; Bertero, Alessandro; Saeb-Parsy, Kourosh; Soares, Filipa A. C.; Schrumpf, Elisabeth; Melum, Espen; Karlsen, Tom H.; Bradley, J. Andrew; Gelson, William T. H.; Davies, Susan; Baker, Alastair; Kaser, Arthur; Alexander, Graeme J.; Hannan, Nicholas R. F.; Vallier, Ludovic			Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation	NATURE BIOTECHNOLOGY			English	Article							POLYCYSTIC LIVER-DISEASE; CYSTIC-FIBROSIS; PROGENITOR CELLS; RAT; PATHOPHYSIOLOGY; MECHANISMS; GENERATION; DISORDERS; DEVELOP	The study of biliary disease has been constrained by a lack of primary human cholangiocytes. Here we present an efficient, serum-free protocol for directed differentiation of human induced pluripotent stem cells into cholangiocyte-like cells (CLCs). CLCs show functional characteristics of cholangiocytes, including bile acids transfer, alkaline phosphatase activity,. gamma-glutamyl-transpeptidase activity and physiological responses to secretin, somatostatin and vascular endothelial growth factor. We use CLCs to model in vitro key features of Alagille syndrome, polycystic liver disease and cystic fibrosis (CF)-associated cholangiopathy. Furthermore, we use CLCs generated from healthy individuals and patients with polycystic liver disease to reproduce the effects of the drugs verapamil and octreotide, and we show that the experimental CF drug VX809 rescues the disease phenotype of CF cholangiopathy in vitro. Our differentiation protocol will facilitate the study of biological mechanisms controlling biliary development, as well as disease modeling and drug screening.	[Sampaziotis, Fotios; de Brito, Miguel Cardoso; Madrigal, Pedro; Bertero, Alessandro; Soares, Filipa A. C.; Hannan, Nicholas R. F.; Vallier, Ludovic] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Dept Surg, Cambridge, England; [Sampaziotis, Fotios; Saeb-Parsy, Kourosh; Bradley, J. Andrew] Univ Cambridge, Dept Surg, Cambridge, England; [Sampaziotis, Fotios; Saeb-Parsy, Kourosh; Bradley, J. Andrew] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Madrigal, Pedro; Vallier, Ludovic] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Schrumpf, Elisabeth; Melum, Espen; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Div Canc Surg & Transplant, N-0027 Oslo, Norway; [Schrumpf, Elisabeth; Melum, Espen; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, KG Jebsen Inflammat Res Ctr,Res Inst Internal Med, N-0027 Oslo, Norway; [Schrumpf, Elisabeth; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sampaziotis, Fotios; Gelson, William T. H.] Cambridge Univ Hosp NHS Fdn Trust, Dept Hepatol, Cambridge, England; [Davies, Susan] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Baker, Alastair] Kings Hlth Partners, Child Hlth Clin Acad Grouping, London, England; [Kaser, Arthur] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England; [Alexander, Graeme J.] Univ Cambridge, Dept Med, Sch Clin Med, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Cambridge; University of Cambridge; University of London; King's College London; University of Cambridge; University of Cambridge	Vallier, L (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Dept Surg, Cambridge, England.	lv225@cam.ac.uk	Hannan, Nicholas/ABG-6497-2020; Bertero, Alessandro/AAC-7409-2021; Madrigal, Pedro/AAG-8543-2019	Vallier, Ludovic/0000-0002-3848-2602; Bertero, Alessandro/0000-0002-4919-9087; Madrigal, Pedro/0000-0003-1959-8199; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Hannan, Nicholas/0000-0002-9843-1559	European Research Council; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Evelyn Trust; European Union; Wellcome Trust; UK Medical Research Council; Addenbrooke's Charitable Trust Clinical Research Training Fellowship; UK Medical Research Council-Sparks Clinical Research Training Fellowship; Medical Research Council [G0800784, G1000847, MR/L016761/1] Funding Source: researchfish; Sparks Charity [14CAM01] Funding Source: researchfish; MRC [MR/L016761/1, G1000847, G0800784] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Evelyn Trust; European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Addenbrooke's Charitable Trust Clinical Research Training Fellowship; UK Medical Research Council-Sparks Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Sparks Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank the Cambridge BRC hiPSCs core facility for the derivation of the cystic fibrosis hiPSC line, P.-A. Tsagkaraki for her help with the generation of the manuscript figures and statistical analyses, J. Skepper, L. Carter and the University of Cambridge Advanced Imaging Centre for their help with electron microscopy, C. McGee and the Wellcome Trust Sanger Institute for their help with microarray data processing and analysis, B. McLeod for IT support and S. Brown for technical support and advice. This work was funded by European Research Council starting grant Relieve IMDs (L.V., N.H.), the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L.V., N.H., F.S.), the Evelyn Trust (N.H.), the European Union FP7 grant TissuGEN (M.C.d.B.) and core support grant from the Wellcome Trust and UK Medical Research Council to the Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute. F.S. has been supported by an Addenbrooke's Charitable Trust Clinical Research Training Fellowship and a joint UK Medical Research Council-Sparks Clinical Research Training Fellowship.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Caperna TJ, 2011, IN VITRO CELL DEV-AN, V47, P218, DOI 10.1007/s11626-010-9382-3; Caroli A, 2010, CLIN J AM SOC NEPHRO, V5, P783, DOI 10.2215/CJN.05380709; Chandok N, 2012, ANN HEPATOL, V11, P819, DOI 10.1016/S1665-2681(19)31406-1; Cizkova D, 2005, PHYSIOL RES, V54, P419, DOI 10.33549/physiolres.930674; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Gigliozzi A, 2000, GASTROENTEROLOGY, V119, P1113, DOI 10.1053/gast.2000.18156; Gong AY, 2003, AM J PHYSIOL-CELL PH, V284, pC1205, DOI 10.1152/ajpcell.00313.2002; Haack A, 2013, WORLD J GASTROENTERO, V19, P8552, DOI 10.3748/wjg.v19.i46.8552; Hannan NRF, 2015, STEM CELLS DEV, V24, P1680, DOI 10.1089/scd.2014.0512; Hannan NRF, 2013, STEM CELL REP, V1, P293, DOI 10.1016/j.stemcr.2013.09.003; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Kanno N, 2000, HEPATOLOGY, V31, P555, DOI 10.1002/hep.510310302; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Minagawa N, 2006, WORLD J GASTROENTERO, V12, P3466, DOI 10.3748/wjg.v12.i22.3466; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; Pollheimer MJ, 2011, CLIN RES HEPATOL GAS, V35, P792, DOI 10.1016/j.clinre.2011.04.014; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Raynaud P, 2011, HEPATOLOGY, V53, P1959, DOI 10.1002/hep.24292; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sampaziotis F, 2015, HEPATOLOGY, V62, P303, DOI 10.1002/hep.27651; Saravanamuthu SS, 2009, DEV BIOL, V332, P166, DOI 10.1016/j.ydbio.2009.05.566; Shenoy A, 2011, PEDIATR RES, V70, P447, DOI 10.1203/PDR.0b013e31822f2448; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Staufer K, 2014, INT J MOL SCI, V15, P13529, DOI 10.3390/ijms150813529; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Temmerman F, 2011, ALIMENT PHARM THER, V34, P702, DOI 10.1111/j.1365-2036.2011.04783.x; Turnpenny PD, 2012, EUR J HUM GENET, V20, P251, DOI 10.1038/ejhg.2011.181; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; WARD CL, 1994, J BIOL CHEM, V269, P25710; Xia XF, 2006, WORLD J GASTROENTERO, V12, P3553, DOI 10.3748/wjg.v12.i22.3553; Yanai M, 2008, DEV DYNAM, V237, P1268, DOI 10.1002/dvdy.21520; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	48	227	233	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					845	+		10.1038/nbt.3275	http://dx.doi.org/10.1038/nbt.3275			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26167629	Green Accepted, Green Published			2022-12-25	WOS:000359274900024
J	Wilson, JE; Petrucelli, AS; Chen, L; Koblansky, AA; Truax, AD; Oyama, Y; Rogers, AB; Brickey, WJ; Wang, YL; Schneider, M; Muhlbauer, M; Chou, WC; Barker, BR; Jobin, C; Allbritton, NL; Ramsden, DA; Davis, BK; Ting, JPY				Wilson, Justin E.; Petrucelli, Alex S.; Chen, Liang; Koblansky, A. Alicia; Truax, Agnieszka D.; Oyama, Yoshitaka; Rogers, Arlin B.; Brickey, W. June; Wang, Yuli; Schneider, Monika; Muehlbauer, Marcus; Chou, Wei-Chun; Barker, Brianne R.; Jobin, Christian; Allbritton, Nancy L.; Ramsden, Dale A.; Davis, Beckley K.; Ting, Jenny P. Y.			Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt	NATURE MEDICINE			English	Article							DEPENDENT PROTEIN-KINASE; MELANOMA 2 AIM2; COLORECTAL-CANCER; IN-VITRO; INTESTINAL INFLAMMATION; STEM-CELLS; ABSENT; GENE; CARCINOGENESIS; ACTIVATION	The inflammasome activates caspase-1 and the release of interleukin-1 beta (IL-1 beta) and IL-18, and several inflammasomes protect against intestinal inflammation and colitis-associated colon cancer (CAC) in animal models. The absent in melanoma 2 (AIM2) inflammasome is activated by double-stranded DNA, and AIM2 expression is reduced in several types of cancer, but the mechanism by which AIM2 restricts tumor growth remains unclear. We found that Aim2-deficient mice had greater tumor load than Asc-deficient mice in the azoxymethane/dextran sodium sulfate (AOM/DSS) model of colorectal cancer. Tumor burden was also higher in Aim2(-/-)/Apc(Min/+) than in APC(Min/+) mice. The effects of AIM2 on CAC were independent of inflammasome activation and IL-1 beta and were primarily mediated by a non bone marrow source of AIM2. In resting cells, AIM2 physically interacted with and limited activation of DNA-dependent protein kinase (DNA-PK), a PI3K-related family member that promotes Akt phosphorylation, whereas loss of AIM2 promoted DNA-PK mediated Akt activation. AIM2 reduced Akt activation and tumor burden in colorectal cancer models, while an Akt inhibitor reduced tumor load in Aim2(-/-) mice. These findings suggest that Akt inhibitors could be used to treat AIM2-deficient human cancers.	[Wilson, Justin E.; Petrucelli, Alex S.; Chen, Liang; Koblansky, A. Alicia; Truax, Agnieszka D.; Oyama, Yoshitaka; Brickey, W. June; Chou, Wei-Chun; Ramsden, Dale A.; Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilson, Justin E.; Petrucelli, Alex S.; Chen, Liang; Koblansky, A. Alicia; Truax, Agnieszka D.; Oyama, Yoshitaka; Brickey, W. June; Chou, Wei-Chun; Ting, Jenny P. Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Wilson, Justin E.; Petrucelli, Alex S.; Chen, Liang; Koblansky, A. Alicia; Truax, Agnieszka D.; Oyama, Yoshitaka; Brickey, W. June; Chou, Wei-Chun; Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Rogers, Arlin B.] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA USA; [Wang, Yuli; Allbritton, Nancy L.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Schneider, Monika] Amer Assoc Immunologists, Bethesda, MD USA; [Muehlbauer, Marcus; Jobin, Christian] Univ Florida, Coll Med, Dept Med, Div Gastroenterol, Gainesville, FL USA; [Muehlbauer, Marcus; Jobin, Christian] Univ Florida, Coll Med, Dept Infect Dis & Pathol, Gainesville, FL USA; [Barker, Brianne R.] Drew Univ, Dept Biol, Madison, NJ 07940 USA; [Ramsden, Dale A.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Ramsden, Dale A.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Davis, Beckley K.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Drew University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Franklin & Marshall College	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Barker, Brianne/AAW-2583-2020; Wang, Yuli/C-6297-2011; Chen, Liang/J-4277-2017	Barker, Brianne/0000-0001-6932-479X; Ramsden, Dale/0000-0003-1575-4748; Chen, Liang/0000-0002-3605-8883	National Institute of Health (NIH) [RO1-CA156330, U19-AI067798, R37-AI029564, P01 DK094779]; NIH [F32-K088417-01, R01 EY024556, R15 DK098754]; American Cancer Society [PF-13-401-01-TBE]; NATIONAL CANCER INSTITUTE [T32CA009156, R01CA156330, R01CA084442] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088417, P01DK094779, P30DK034987, R15DK098754, F32DK098916] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E.H. Guthrie for technical assistance and I.C. Allen from the Department of Biomedical Sciences and Pathobiology at Virginia Tech for technical advice regarding the CAC model. P.K. Lund and S. Ding from the Department of Cell Biology and Physiology at UNC for their helpful discussions and technical advice pertaining to the Apc<SUP>Min/+</SUP> model of spontaneous intestinal cancer; the Center for Gastrointestinal Biology and Disease (CGIBD) at UNC for providing core and technical support; and the Department of Microbiology and Immunology Flow Cytometry Core Facility at UNC for providing core and technical support. This work was supported by National Institute of Health (NIH) grants RO1-CA156330 (National Cancer Institute), U19-AI067798 (National Institute of Allergy and Infectious Disease (NIAID)), R37-AI029564 (NIAID) and P01 DK094779 (National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)) (J.P.-Y.T.). J.E.W. was supported in part by the NIH postdoctoral fellowship F32-K088417-01 (NIDDK) and in part by the American Cancer Society, PF-13-401-01-TBE. This work was also supported by the NIH grants R01 EY024556 (National Eye Institute) (N.L.A. and Y.W.) and R15 DK098754 (NIDDK) (B.K.D.).	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; An J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-32; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Chen IF, 2006, MOL CANCER THER, V5, P1, DOI 10.1158/1535-7163.MCT-05-0310; Choubey D, 2000, FEBS LETT, V474, P38, DOI 10.1016/S0014-5793(00)01571-4; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dihlmann S, 2014, INT J CANCER, V135, P2387, DOI 10.1002/ijc.28891; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hosoi Y, 2004, INT J ONCOL, V25, P461; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Lee J, 2012, ONCOGENE, V31, P1242, DOI 10.1038/onc.2011.320; Li YK, 2013, J BIOL CHEM, V288, P13215, DOI 10.1074/jbc.M113.463679; Li Z, 2013, INT J COLORECTAL DIS, V28, P1107, DOI 10.1007/s00384-013-1678-9; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Patsos G, 2010, INT J CANCER, V126, P1838, DOI 10.1002/ijc.24905; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Wang Y, 2013, LAB CHIP, V13, P4625, DOI 10.1039/c3lc50813g; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Woerner SM, 2005, ONCOGENE, V24, P2525, DOI 10.1038/sj.onc.1208456; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046	48	183	192	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					906	913		10.1038/nm.3908	http://dx.doi.org/10.1038/nm.3908			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26107252	Green Accepted, Green Submitted			2022-12-25	WOS:000359181000017
J	DeLoache, WC; Russ, ZN; Narcross, L; Gonzales, AM; Martin, VJJ; Dueber, JE				DeLoache, William C.; Russ, Zachary N.; Narcross, Lauren; Gonzales, Andrew M.; Martin, Vincent J. J.; Dueber, John E.			An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose	NATURE CHEMICAL BIOLOGY			English	Article							BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; NATURAL-PRODUCTS; ESCHERICHIA-COLI; TYROSINASE; PATHWAY; METABOLITES; DISCOVERY; BETALAINS; MECHANISM	Benzylisoquinoline alkaloids (BIAs) are a diverse family of plant-specialized metabolites that include the pharmaceuticals codeine and morphine and their derivatives. Microbial synthesis of BIAs holds promise as an alternative to traditional crop-based manufacturing. Here we demonstrate the production of the key BIA intermediate (S)-reticuline from glucose in Saccharomyces cerevisiae. To aid in this effort, we developed an enzyme-coupled biosensor for the upstream intermediate L-3,4-dihydroxyphenylalanine (L-DOPA). Using this sensor, we identified an active tyrosine hydroxylase and improved its L-DOPA yields by 2.8-fold via PCR mutagenesis. Coexpression of DOPA decarboxylase enabled what is to our knowledge the first demonstration of dopamine production from glucose in yeast, with a 7.4-fold improvement in titer obtained for our best mutant enzyme. We extended this pathway to fully reconstitute the seven-enzyme pathway from L-tyrosine to (S)-reticuline. Future work to improve titers and connect these steps with downstream pathway branches, already demonstrated in S. cerevisiae, will enable low-cost production of many high-value BIAs.	[DeLoache, William C.; Russ, Zachary N.; Gonzales, Andrew M.; Dueber, John E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Narcross, Lauren; Martin, Vincent J. J.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Narcross, Lauren; Martin, Vincent J. J.] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	University of California System; University of California Berkeley; Concordia University - Canada; Concordia University - Canada	Dueber, JE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	jdueber@berkeley.edu		Russ, Zachary/0000-0002-0571-8252	US Department of Energy Office of Science Early Career Research Program (Office of Biological and Environmental Research) [DE-SC0008084]; US National Science Foundation; US Department of Defense; Genome Canada; Genome Quebec; Canada Research Chair	US Department of Energy Office of Science Early Career Research Program (Office of Biological and Environmental Research)(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); US Department of Defense(United States Department of Defense); Genome Canada(Genome Canada); Genome Quebec; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank H. Lee for assistance with preliminary experiments; S. Bauer for LC/MS training; members of the Martin and Dueber Labs, in particular M. Lee, for valuable feedback throughout the project and in the preparation of the manuscript; and L. Bourgeois and J. Scrivens for their contribution in identifying NCS enzymes active in yeast. The work on engineering an enzyme-coupled biosensor was supported by the US Department of Energy Office of Science Early Career Research Program (Office of Biological and Environmental Research) under award number DE-SC0008084 (grant to J.E.D.), the US National Science Foundation (fellowship to W.C.D.) and the US Department of Defense (fellowship to Z.N.R.). Research in the Martin lab was financially supported by Genome Canada, Genome Quebec and a Canada Research Chair (V.J.J.M.)	Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Beaudoin GAW, 2014, PLANTA, V240, P19, DOI 10.1007/s00425-014-2056-8; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Fossati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124459; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gandia-Herrero F, 2005, J CHROMATOGR A, V1078, P83, DOI 10.1016/j.chroma.2005.05.013; Gandia-Herrero F, 2007, J AGR FOOD CHEM, V55, P1546, DOI 10.1021/jf062858z; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Gandia-Herrero F, 2012, PLANTA, V236, P91, DOI 10.1007/s00425-012-1593-2; Glenn WS, 2013, CURR OPIN BIOTECH, V24, P354, DOI 10.1016/j.copbio.2012.08.003; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Halaouli S, 2006, J APPL MICROBIOL, V100, P219, DOI 10.1111/j.1365-2672.2006.02866.x; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Hernandez-Romero D, 2006, FEBS J, V273, P257, DOI 10.1111/j.1742-4658.2005.05038.x; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Koyanagi T, 2012, MICROBIOL-SGM, V158, P2965, DOI 10.1099/mic.0.062463-0; Leonard E, 2009, NAT CHEM BIOL, V5, P292, DOI 10.1038/nchembio.160; Lezzi C, 2012, J IND MICROBIOL BIOT, V39, P1875, DOI 10.1007/s10295-012-1192-z; Lichman BR, 2015, FEBS J, V282, P1137, DOI 10.1111/febs.13208; Luttik MAH, 2008, METAB ENG, V10, P141, DOI 10.1016/j.ymben.2008.02.002; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Minami H, 2007, J BIOL CHEM, V282, P6274, DOI 10.1074/jbc.M608933200; Mora-Pale M, 2014, CURR OPIN BIOTECH, V25, P86, DOI 10.1016/j.copbio.2013.09.009; Nakagawa A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06695; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; Santos CNS, 2008, APPL ENVIRON MICROB, V74, P1190, DOI 10.1128/AEM.02448-07; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; SENTHESHANMUGANATHAN S, 1958, BIOCHEM J, V69, P210, DOI 10.1042/bj0690210; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou K, 2015, NAT BIOTECHNOL, V33, P377, DOI 10.1038/nbt.3095	46	219	248	13	284	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					465	+		10.1038/nchembio.1816	http://dx.doi.org/10.1038/nchembio.1816			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	25984720				2022-12-25	WOS:000356334600010
J	Martinez, J; Malireddi, RKS; Lu, Q; Cunha, LD; Pelletier, S; Gingras, S; Orchard, R; Guan, JL; Tan, HY; Peng, JM; Kanneganti, TD; Virgin, HW; Green, DR				Martinez, Jennifer; Malireddi, R. K. Subbarao; Lu, Qun; Cunha, Larissa Dias; Pelletier, Stephane; Gingras, Sebastien; Orchard, Robert; Guan, Jun-Lin; Tan, Haiyan; Peng, Junmin; Kanneganti, Thirumala-Devi; Virgin, Herbert W.; Green, Douglas R.			Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins	NATURE CELL BIOLOGY			English	Article							NADPH OXIDASE ACTIVATION; GENOME-WIDE ASSOCIATION; NONCANONICAL AUTOPHAGY; REGULATE AUTOPHAGY; CROHN-DISEASE; CELL-DEATH; MICE; INFLAMMATION; GENERATION; MATURATION	LC3-associated phagocytosis (LAP) is a process wherein elements of autophagy conjugate LC3 to phagosomal membranes. We characterize the molecular requirements for LAP, and identify Rubicon as being required for LAP but not autophagy. Rubicon is recruited to LAPosomes and is required for the activity of a Class III PI(3)K complex containing UVRAG but lacking ATG14 and Ambra1. This allows for the sustained localization of PtdIns(3)P, which is critical for recruitment of downstream autophagic proteins and stabilization of the NOX2 complex to produce reactive oxygen species. Both PtdIns(3)P and reactive oxygen species are required for conjugation of LC3 to LAPosomes and subsequent association with LAMP1(+) lysosomes. LAP is induced by engulfment of Aspergillus fumigatus, a fungal pathogen that commonly afflicts immunocompromised hosts, and is required for its optimal clearance in vivo. Therefore, we have identified molecules that distinguish LAP from canonical autophagy, thereby elucidating the importance of LAP in response to A. fumigatus infection.	[Martinez, Jennifer; Malireddi, R. K. Subbarao; Cunha, Larissa Dias; Pelletier, Stephane; Gingras, Sebastien; Kanneganti, Thirumala-Devi; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Lu, Qun; Orchard, Robert; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Pelletier, Stephane; Gingras, Sebastien] St Jude Childrens Res Hosp, Embryon Stem Cell Lab, Memphis, TN 38105 USA; [Guan, Jun-Lin] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA; [Tan, Haiyan; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Washington University (WUSTL); St Jude Children's Research Hospital; University System of Ohio; University of Cincinnati; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Green, Douglas R/N-8083-2018; Peng, Junmin/N-2614-2018; Martinez, Jennifer/C-3740-2019; Malireddi, RKSubbarao/C-5804-2013; Cunha, Larissa D/I-4204-2012; Lu, Qun/O-2978-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Green, Douglas R/0000-0002-7332-1417; Peng, Junmin/0000-0003-0472-7648; Martinez, Jennifer/0000-0002-3060-2518; Malireddi, RKSubbarao/0000-0001-8855-9447; Pelletier, Stephane/0000-0002-1127-0212; Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health; Lupus Research Institute; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725, R01AI040646, T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the veterinary pathology core lab (VPCL) at St Jude for their work in processing of H&E and Gomori slides. We also thank C. Guy in the Department of Immunology for his help with confocal microscopy. We thank M. Yang for assistance with maintenance of the mouse colony. This work was supported by research grants from the National Institutes of Health, the Lupus Research Institute, and ALSAC.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Cadwell K, 2009, CURR TOP MICROBIOL, V335, P141, DOI 10.1007/978-3-642-00302-8_7; Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Debeurme F, 2010, J BIOL CHEM, V285, P33197, DOI 10.1074/jbc.M110.151555; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jo EK, 2012, MICROBES INFECT, V14, P119, DOI 10.1016/j.micinf.2011.08.014; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mamishi Setareh, 2005, Ann Clin Microbiol Antimicrob, V4, P4, DOI 10.1186/1476-0711-4-4; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Poison H.E., 2010, AUTOPHAGY, V6, P506, DOI DOI 10.4161/AUT0.6.4.11863; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Smith WL, 2008, J BIOL CHEM, V283, P15513, DOI 10.1074/jbc.R800006200; Song ZP, 2014, CARDIOVASC RES, V101, P48, DOI 10.1093/cvr/cvt223; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Sun QM, 2011, J BIOL CHEM, V286, P185, DOI 10.1074/jbc.M110.126425; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Ueyama T, 2011, J BIOL CHEM, V286, P40693, DOI 10.1074/jbc.M111.237289; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang CS, 2012, CELL HOST MICROBE, V11, P264, DOI 10.1016/j.chom.2012.01.018; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	54	514	544	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					893	906		10.1038/ncb3192	http://dx.doi.org/10.1038/ncb3192			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26098576	Green Accepted			2022-12-25	WOS:000357353400010
J	Gutierrez-Achury, J; Zhernakova, A; Pulit, SL; Trynka, G; Hunt, KA; Romanos, J; Raychaudhuri, S; van Heel, DA; Wijmenga, C; de Balcker, PIW				Gutierrez-Achury, Javier; Zhernakova, Alexandra; Pulit, Sara L.; Trynka, Gosia; Hunt, Karen A.; Romanos, Jihane; Raychaudhuri, Soumya; van Heel, David A.; Wijmenga, Cisca; de Balcker, Paul I. W.			Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease	NATURE GENETICS			English	Article							HERITABILITY; HLA; ASSOCIATION; HAPLOTYPE; VARIANTS	Although dietary gluten is the trigger for celiac disease, risk is strongly influenced by genetic variation in the major histocompatibility complex (MHC) region. We fine mapped the MHC association signal to identify additional risk factors independent of the HLA-DQA1 and HLA-DQB1 alleles and observed five new associations that account for 18% of the genetic risk. Taking these new loci together with the 57 known non-MHC loci, genetic variation can now explain up to 48% of celiac disease heritability.	[Gutierrez-Achury, Javier; Zhernakova, Alexandra; Romanos, Jihane; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Pulit, Sara L.; de Balcker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Trynka, Gosia] Wellcome Trust Sanger Inst, Cambridge, England; [Hunt, Karen A.; van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Inst Inflammat & Repair, Ctr Musculoskeletal Res, Arthritis Res UK Epidemiol Unit, Manchester, Lancs, England; [de Balcker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University Medical Center; Wellcome Trust Sanger Institute; University of London; Queen Mary University London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; Utrecht University; Utrecht University Medical Center	Wijmenga, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	c.wijmenga@umcg.nl	Zhernakova, Alexandra/ABA-9372-2020; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614; Zhernakova, Alexandra/0000-0002-4574-0841; Gutierrez-Achury, Javier/0000-0002-4971-1474; Pulit, Sara/0000-0002-2502-3669; Trynka, Gosia/0000-0002-6955-9529; Raychaudhuri, Soumya/0000-0002-1901-8265; van Heel, David/0000-0002-0637-2265	Celiac Disease Consortium; European Research Council advanced grant (FP)/ERC [2012-322698]; Dutch Reumafonds [11-1-101]; Rosalind Franldin Fellowship from the University of Groningen; US National Institutes of Health [1R01AR062886]; VIDI award from the Netherlands Organization for Scientific Research (NWO) [016.126.354]; Doris Duke Clinical Scientist Development Award; MRC [G1001158] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, R01AR063759, R01AR062886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	Celiac Disease Consortium; European Research Council advanced grant (FP)/ERC; Dutch Reumafonds; Rosalind Franldin Fellowship from the University of Groningen; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIDI award from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Senior for carefully reading the manuscript and C. Gonzalez-Arevalo for the graphics. This study was funded by a grant from the Celiac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative (to C.W.), a European Research Council advanced grant (FP/2007-2013/ERC grant 2012-322698) (to C.W.), a grant from the Dutch Reumafonds (11-1-101) (to A.Z.) and a Rosalind Franldin Fellowship from the University of Groningen (to A.Z.). S.R. and P.I.W.d.B. received support from the US National Institutes of Health (1R01AR062886). P.I.W.d.B. holds a VIDI award from the Netherlands Organization for Scientific Research (NWO project 016.126.354). S.R. is also supported by a Doris Duke Clinical Scientist Development Award.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	15	93	98	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					577	578		10.1038/ng.3268	http://dx.doi.org/10.1038/ng.3268			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25894500	Green Accepted, Green Submitted			2022-12-25	WOS:000355386500006
J	Moriarity, BS; Otto, GM; Rahrmann, EP; Rathe, SK; Wolf, NK; Weg, MT; Manlove, LA; Larue, RS; Temiz, NA; Molyneux, SD; Choi, K; Holly, KJ; Sarver, AL; Scott, MC; Forster, CL; Modiano, JF; Khanna, C; Hewitt, SM; Khokha, R; Yang, Y; Gorlick, R; Dyer, MA; Largaespada, DA				Moriarity, Branden S.; Otto, George M.; Rahrmann, Eric P.; Rathe, Susan K.; Wolf, Natalie K.; Weg, Madison T.; Manlove, Luke A.; LaRue, Rebecca S.; Temiz, Nuri A.; Molyneux, Sam D.; Choi, Kwangmin; Holly, Kevin J.; Sarver, Aaron L.; Scott, Milcah C.; Forster, Colleen L.; Modiano, Jaime F.; Khanna, Chand; Hewitt, Stephen M.; Khokha, Rama; Yang, Yi; Gorlick, Richard; Dyer, Michael A.; Largaespada, David A.			A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis	NATURE GENETICS			English	Article							POOR-PROGNOSIS; CELL-PROLIFERATION; OSTEOGENIC-SARCOMA; TUMOR PROGRESSION; COPY NUMBER; EXPRESSION; CANCER; PROTEIN; SURVIVAL; PTEN	Osteosarcomas are sarcomas of the bone, derived from osteoblasts or their precursors, with a high propensity to metastasize. Osteosarcoma is associated with massive genomic instability, making it problematic to identify driver genes using human tumors or prototypical mouse models, many of which involve loss of Trp53 function. To identify the genes driving osteosarcoma development and metastasis, we performed a Sleeping Beauty (SB) transposon-based forward genetic screen in mice with and without somatic loss of Trp53. Common insertion site (CIS) analysis of 119 primary tumors and 134 metastatic nodules identified 232 sites associated with osteosarcoma development and 43 sites associated with metastasis, respectively. Analysis of CIS-associated genes identified numerous known and new osteosarcoma-associated genes enriched in the ErbB, PI3K-AKT-mTOR and MAPK signaling pathways. Lastly, we identified several oncogenes involved in axon guidance, including Sema4d and Sema6d, which we functionally validated as oncogenes in human osteosarcoma.	[Moriarity, Branden S.; Otto, George M.; Rahrmann, Eric P.; Largaespada, David A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Moriarity, Branden S.; Otto, George M.; Rahrmann, Eric P.; Largaespada, David A.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA; [Moriarity, Branden S.; Otto, George M.; Rahrmann, Eric P.; Largaespada, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Otto, George M.; Rahrmann, Eric P.; Wolf, Natalie K.; Weg, Madison T.; Manlove, Luke A.; Holly, Kevin J.; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [LaRue, Rebecca S.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Molyneux, Sam D.; Khokha, Rama] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Choi, Kwangmin] Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Scott, Milcah C.; Modiano, Jaime F.] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Forster, Colleen L.] Univ Minnesota, Acad Hlth Ctr, BioNet, Minneapolis, MN USA; [Modiano, Jaime F.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Khanna, Chand] NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Hewitt, Stephen M.] NCI, TARP, Pathol Lab, Bethesda, MD 20892 USA; [Yang, Yi] Peking Univ, Peoples Hosp, Musculoskeletal Tumor Ctr, Dept Orthoped Surg, Beijing 100871, Peoples R China; [Gorlick, Richard] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Gorlick, Richard] Childrens Hosp Montefiore, Bronx, NY USA; [Gorlick, Richard] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Peking University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; St Jude Children's Research Hospital	Largaespada, DA (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	larga002@umn.edu	Dyer, Michael/N-8134-2018; MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648; Khokha, Rama/0000-0002-6028-1524; GORLICK, RICHARD/0000-0001-8995-2929; Hewitt, Stephen/0000-0001-8283-1788	US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases Musculoskeletal Training Grant [AR050938]; Sobiech Osteosarcoma Fund Award; Children's Cancer Research Fund; American Cancer Center Research Professor Grant [123939]; National Cancer Institute grant [R01 CA113636]; comprehensive Masonic Cancer Center (US National Institutes of Health grant) [P30 CA077598]; NATIONAL CANCER INSTITUTE [R01CA113636, P30CA077598, P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases Musculoskeletal Training Grant; Sobiech Osteosarcoma Fund Award; Children's Cancer Research Fund; American Cancer Center Research Professor Grant; National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); comprehensive Masonic Cancer Center (US National Institutes of Health grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	B.S.M. was funded by US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases Musculoskeletal Training Grant AR050938. This research was funded by the Sobiech Osteosarcoma Fund Award, the Children's Cancer Research Fund, an American Cancer Center Research Professor Grant (123939) and National Cancer Institute grant R01 CA113636 (to D.A.L.). We extend our thanks to the University of Minnesota resources involved in our project. The University of Minnesota Genomics Center provided services for RNA sequencing, oligonudeotide preparation and Sanger sequencing. The Minnesota Supercomputing Institute maintains the Galaxy software platform, as well as provides data management services and training. The cytogenetic analyses were performed in the Cytogenomics Shared Resource at the University of Minnesota with support from the comprehensive Masonic Cancer Center (US National Institutes of Health grant P30 CA077598).	Akatsuka T, 2002, CANCER-AM CANCER SOC, V94, P1397, DOI 10.1002/cncr.10360; Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Toledo SRC, 2010, J ORTHOP RES, V28, P1142, DOI 10.1002/jor.21120; Catalano A, 2009, CANCER RES, V69, P1485, DOI 10.1158/0008-5472.CAN-08-3659; Chen L, 2013, FEBS LETT, V587, P1366, DOI 10.1016/j.febslet.2013.03.007; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chowdhry M, 2009, J BONE JOINT SURG BR, V91B, P1223, DOI 10.1302/0301-620X.91B9.22299; Chueh FS, 2014, ENVIRON TOXICOL, V29, P21, DOI 10.1002/tox.20769; Cinamon U, 2002, EUR ARCH OTO-RHINO-L, V259, P540, DOI 10.1007/s00405-002-0497-3; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; de Nigris F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-472; Dobson J. M., 2013, ISRN VET SCI, V2013, DOI DOI 10.1155/2013/941275); Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Ferrari Andrea, 2007, Paediatr Drugs, V9, P239, DOI 10.2165/00148581-200709040-00005; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Gao Y, 2014, BIOCHEM BIOPH RES CO, V444, P230, DOI 10.1016/j.bbrc.2014.01.061; Geryk-Hall M, 2009, CURR ONCOL REP, V11, P446, DOI 10.1007/s11912-009-0061-z; Guo W, 1999, CLIN ORTHOP RELAT R, P175; Han K, 2014, INT J ONCOL, V45, P1437, DOI 10.3892/ijo.2014.2571; Jaffe Norman, 2013, Sarcoma, V2013, P203531, DOI 10.1155/2013/203531; Jiang L, 2014, ONCOTARGET, V5, P7663, DOI 10.18632/oncotarget.2288; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Jones Kevin B., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/694136; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kim KO, 2014, J ORTHOP RES, V32, P848, DOI 10.1002/jor.22598; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Kusama T, 2006, CANCER SCI, V97, P848, DOI 10.1111/j.1349-7006.2006.00242.x; Law Janice Wai Sze, 2012, J Signal Transduct, V2012, P902854, DOI 10.1155/2012/902854; Li D, 2014, ONCOL REP, V32, P1578, DOI 10.3892/or.2014.3360; Li X, 2014, GASTROENTEROLOGY, V146, P1301, DOI 10.1053/j.gastro.2014.02.003; Liu YD, 2013, ACTA BIOCH BIOPH SIN, V45, P259, DOI 10.1093/abbs/gmt002; Loh AHP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00093; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Nakajima Go, 2008, Cancer Genomics & Proteomics, V5, P37; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Osborne TS, 2011, J PEDIAT HEMATOL ONC, V33, P524, DOI 10.1097/MPH.0b013e318223d0c1; Overholtzer M, 2003, P NATL ACAD SCI USA, V100, P11547, DOI 10.1073/pnas.1934852100; Patane S, 2006, CANCER RES, V66, P4750, DOI 10.1158/0008-5472.CAN-05-4422; Patino-Garcia A, 2009, J PEDIATR-US, V154, P688, DOI 10.1016/j.jpeds.2008.11.030; Rahrmann EP, 2013, NAT GENET, V45, P756, DOI 10.1038/ng.2641; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sabile AA, 2013, BBA-MOL BASIS DIS, V1832, P1173, DOI 10.1016/j.bbadis.2013.03.014; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; SATO H, 1995, BIOCHEM BIOPH RES CO, V214, P468, DOI 10.1006/bbrc.1995.2310; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Song CY, 2013, TUMOR BIOL, V34, P1925, DOI 10.1007/s13277-013-0737-8; Song QC, 2014, ONCOL REP, V31, P1263, DOI 10.3892/or.2014.2989; Srivastava A, 2006, CLIN CANCER RES, V12, P4237, DOI 10.1158/1078-0432.CCR-05-2307; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stemmer-Rachamimov AO, 1998, NEUROGENETICS, V2, P73, DOI 10.1007/s100480050054; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Tesser-Gamba F, 2012, HUM PATHOL, V43, P994, DOI 10.1016/j.humpath.2011.08.003; Tsuchiya H, 2002, J CLIN ONCOL, V20, P3470, DOI 10.1200/JCO.2002.11.028; Wang K, 2014, EXP THER MED, V7, P1691, DOI 10.3892/etm.2014.1644; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Williams KC, 2014, J CELL SCI, V127, P1712, DOI 10.1242/jcs.134734; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Xiao A, 2005, CANCER RES, V65, P5172, DOI 10.1158/0008-5472.CAN-04-3902; Xu HD, 2014, CELL BIOCHEM BIOPHYS, V69, P319, DOI 10.1007/s12013-013-9801-7; Yuan DT, 2013, J SURG ONCOL, V108, P157, DOI 10.1002/jso.23368; Yue B., 2014, J CLIN EXP PATHOL, V4, P2640; Zhang GY, 2011, INT J MOL SCI, V12, P2994, DOI 10.3390/ijms12052994; Zhang PY, 2008, CLIN CANCER RES, V14, P2962, DOI 10.1158/1078-0432.CCR-07-1992; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zhao R, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-9; Zhou CX, 2007, ONCOL REP, V17, P73; Zhou H, 2012, ANGIOGENESIS, V15, P391, DOI 10.1007/s10456-012-9268-y; Zhu YL, 2014, MOL MED REP, V10, P737, DOI 10.3892/mmr.2014.2314	80	161	165	0	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					615	624		10.1038/ng.3293	http://dx.doi.org/10.1038/ng.3293			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25961939	Green Accepted			2022-12-25	WOS:000355386500012
J	Liao, J; Karnik, R; Gu, HC; Ziller, MJ; Clement, K; Tsankov, AM; Akopian, V; Gifford, CA; Donaghey, J; Galonska, C; Pop, R; Reyon, D; Tsai, SQ; Mallard, W; Joung, JK; Rinn, JL; Gnirke, A; Meissner, A				Liao, Jing; Karnik, Rahul; Gu, Hongcang; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Reyon, Deepak; Tsai, Shengdar Q.; Mallard, William; Joung, J. Keith; Rinn, John L.; Gnirke, Andreas; Meissner, Alexander			Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells	NATURE GENETICS			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; SELF-RENEWAL; HUMAN ES; PLURIPOTENT; EXPRESSION; MAINTENANCE; MUTATIONS; INDUCTION; CPG	DNA methylation is a key epigenetic modification involved in regulating gene expression and maintaining genomic integrity. Here we inactivated all three catalytically active DNA methyltransferases (DNMTs) in human embryonic stem cells (ESCs) using CRISPR/Cas9 genome editing to further investigate the roles and genomic targets of these enzymes. Disruption of DNMT3A or DNMT3B individually as well as of both enzymes in tandem results in viable, pluripotent cell lines with distinct effects on the DNA methylation landscape, as assessed by whole-genome bisulfite sequencing. Surprisingly, in contrast to findings in mouse, deletion of DNMT1 resulted in rapid cell death in human ESCs. To overcome this immediate lethality, we generated a doxycycline-responsive tTA-DNMT1* rescue line and readily obtained homozygous DNMT1-mutant lines. However, doxycycline-mediated repression of exogenous DNMT1* initiates rapid, global loss of DNA methylation, followed by extensive cell death. Our data provide a comprehensive characterization of DNMT-mutant ESCs, including single-base genome-wide maps of the targets of these enzymes.	[Liao, Jing; Karnik, Rahul; Gu, Hongcang; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Liao, Jing; Karnik, Rahul; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA USA; [Liao, Jing; Karnik, Rahul; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Joung, J. Keith] Massachusetts Gen Hosp, Dept Pathol, Mol Pathol Unit, Charlestown, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Reyon, Deepak/HCH-3183-2022; Clement, Kendell/AAZ-6854-2021; Tsai, Shengdar Q./G-4600-2012	Tsai, Shengdar Q./0000-0001-9161-3993; Rinn, John/0000-0002-7231-7539; Gu, Hongcang/0000-0002-1439-7606; Gifford, Casey/0000-0002-7757-573X; Galonska, Christina/0000-0002-6920-5608; Karnik, Rahul/0000-0002-0400-635X	Human Frontiers Science Program; US NIH Director's Pioneer Award [DP1 GM105378]; US NIH (National Institute of General Medical Sciences) [P01GM099117]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378, P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036898] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); US NIH Director's Pioneer Award; US NIH (National Institute of General Medical Sciences); New York Stem Cell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the Meissner laboratory, in particular C. Sindhu for helpful discussion and Z.D. Smith for critical feedback on the manuscript. We thank K. Musunuru (Harvard University) for providing the CRIPSR/Cas9 plasmids and thank Q. Ding from the Musunuru laboratory for technical support. J.L. was supported by a postdoctoral fellowship from the Human Frontiers Science Program. J.K.J. is supported by US NIH Director's Pioneer Award DP1 GM105378. A.M. is a New York Stem Cell Foundation Robertson Investigator. The work was funded by a US NIH (National Institute of General Medical Sciences) grant (P01GM099117) and the New York Stem Cell Foundation.	Barra V, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Giaimo R, 2005, GENE, V351, P73, DOI 10.1016/j.gene.2005.02.015; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gordon CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069486; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Hsiao EC, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt52; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li L, 2010, BIOPHYS J, V98, P2442, DOI 10.1016/j.bpj.2010.02.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Rao LJ, 2012, STEM CELL REV REP, V8, P1109, DOI 10.1007/s12015-012-9413-4; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	66	288	303	2	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					469	U64		10.1038/ng.3258	http://dx.doi.org/10.1038/ng.3258			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25822089	Green Accepted, Green Submitted			2022-12-25	WOS:000353635800009
J	Satija, R; Farrell, JA; Gennert, D; Schier, AF; Regev, A				Satija, Rahul; Farrell, Jeffrey A.; Gennert, David; Schier, Alexander F.; Regev, Aviv			Spatial reconstruction of single-cell gene expression data	NATURE BIOTECHNOLOGY			English	Article							IN-SITU HYBRIDIZATION; RNA-SEQ; ZEBRAFISH EMBRYO; GENOME; FATE; TRANSCRIPTOMICS; AMPLIFICATION; GASTRULATION; LINEAGE; MODELS	Spatial localization is a key determinant of cellular fate and behavior, but methods for spatially resolved, transcriptome-wide gene expression profiling across complex tissues are lacking. RNA staining methods assay only a small number of transcripts, whereas single-cell RNA-seq, which measures global gene expression, separates cells from their native spatial context. Here we present Seurat, a computational strategy to infer cellular localization by integrating single-cell RNA-seq data with in situ RNA patterns. We applied Seurat to spatially map 851 single cells from dissociated zebrafish (Danio rerio) embryos and generated a transcriptome-wide map of spatial patterning. We confirmed Seurat's accuracy using several experimental approaches, then used the strategy to identify a set of archetypal expression patterns and spatial markers. Seurat correctly localizes rare subpopulations, accurately mapping both spatially restricted and scattered groups. Seurat will be applicable to mapping cellular localization within complex patterned tissues in diverse systems.	[Satija, Rahul; Gennert, David; Schier, Alexander F.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Farrell, Jeffrey A.; Schier, Alexander F.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Schier, AF (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	schier@fas.harvard.edu; aregev@broad.mit.edu	Horwitz, Marshall/AAE-8376-2021; Satija, Rahul/AAF-9564-2019; huang, dezhi/ABC-6566-2021	Farrell, Jeffrey/0000-0003-4774-1562; Schier, Alexander Franz/0000-0001-7645-5325	Jane Coffin Childs Memorial Fund for Medical Research; NIH; National Human Genome Research Institute; Center of Excellence in Genome Science [1P50HG006193]; Klarman Cell Observatory; Howard Hughes Medical Institute;  [F32 HD075541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105960] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center of Excellence in Genome Science; Klarman Cell Observatory; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Regev and Schier laboratories for helpful discussion, O. Wurtzel for assistance with the R markdown scripts, A. Pauli for sharing the aplnrb plasmid, K. Rogers for donating superior, unpublished in situ hybridizations. This work was supported by F32 HD075541 (R.S.), the Jane Coffin Childs Memorial Fund for Medical Research (J.A.F.), the NIH (A.F.S.), National Human Genome Research Institute, Center of Excellence in Genome Science 1P50HG006193, the Klarman Cell Observatory and Howard Hughes Medical Institute (A.R.).	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Chung NC, 2015, BIOINFORMATICS, V31, P545, DOI 10.1093/bioinformatics/btu674; Clay H, 2005, ZEBRAFISH, V2, P105, DOI 10.1089/zeb.2005.2.105; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Fodor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070053; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; HO RK, 1993, SCIENCE, V261, P109, DOI 10.1126/science.8316841; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Kawahara A, 2000, P NATL ACAD SCI USA, V97, P12121, DOI 10.1073/pnas.97.22.12121; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Roussigne M, 2012, DEV NEUROBIOL, V72, P269, DOI 10.1002/dneu.20885; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2013, NATURE, V496, P443, DOI 10.1038/nature12094; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Soumillon M., 2014, PREPRINT; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thisse B, 2004, METHOD CELL BIOL, V77, P505; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Yoon C, 1997, DEVELOPMENT, V124, P3157	50	1874	1923	37	246	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					495	U206		10.1038/nbt.3192	http://dx.doi.org/10.1038/nbt.3192			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25867923	Green Submitted, Green Accepted, Bronze			2022-12-25	WOS:000354314500030
J	Lim, JS; Kim, WI; Kang, HC; Kim, SH; Park, AH; Park, EK; Cho, YW; Kim, S; Kim, HM; Kim, JA; Kim, J; Rhee, H; Kang, SG; Kim, HD; Kim, D; Kim, DS; Lee, JH				Lim, Jae Seok; Kim, Woo-il; Kang, Hoon-Chul; Kim, Se Hoon; Park, Ah Hyung; Park, Eun Kyung; Cho, Young-Wook; Kim, Sangwoo; Kim, Ho Min; Kim, Jeong A.; Kim, Junho; Rhee, Hwanseok; Kang, Seok-Gu; Kim, Heung Dong; Kim, Daesoo; Kim, Dong-Seok; Lee, Jeong Ho			Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy	NATURE MEDICINE			English	Article							TUBEROUS SCLEROSIS COMPLEX; POINT MUTATIONS; MALFORMATIONS; ACTIVATION; SPECTRUM; FEATURES; SUBTYPES; PATHWAY; AKT3	Focal cortical dysplasia type II (FCDII) is a sporadic developmental malformation of the cerebral cortex characterized by dysmorphic neurons, dyslamination and medically refractory epilepsy(1,2). It has been hypothesized that FCD is caused by somatic mutations in affected regions(3,4). Here, we used deep whole-exome sequencing (read depth, 412-668x) validated by site-specific amplicon sequencing (100-347,499x) in paired brain-blood DNA from four subjects with FCDII and uncovered a de novo brain somatic mutation, mechanistic target of rapamycin (MTOR) c. 7280T>C (p.Leu2427Pro) in two subjects. Deep sequencing of the MTOR gene in an additional 73 subjects with FCDII using hybrid capture and PCR amplicon sequencing identified eight different somatic missense mutations found in multiple brain tissue samples of ten subjects. The identified mutations accounted for 15.6% of all subjects with FCDII studied (12 of 77). The identified mutations induced the hyperactivation of mTOR kinase. Focal cortical expression of mutant MTOR by in utero electroporation in mice was sufficient to disrupt neuronal migration and cause spontaneous seizures and cytomegalic neurons. Inhibition of mTOR with rapamycin suppressed cytomegalic neurons and epileptic seizures. This study provides, to our knowledge, the first evidence that brain somatic activating mutations in MTOR cause FCD and identifies mTOR as a treatment target for intractable epilepsy in FCD.	[Lim, Jae Seok; Kim, Woo-il; Kim, Ho Min; Lee, Jeong Ho] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Kang, Hoon-Chul; Kim, Jeong A.; Kim, Heung Dong] Severance Childrens Hosp, Pediat Epilepsy Clin, Dept Pediat, Div Pediat Neurol, Seoul, South Korea; [Kang, Hoon-Chul; Park, Eun Kyung; Kim, Jeong A.; Kang, Seok-Gu; Kim, Heung Dong; Kim, Dong-Seok] Yonsei Univ, Coll Med, Epilepsy Res Inst, Seoul, South Korea; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Brain Korea Project Med Sci 21, Seoul, South Korea; [Park, Ah Hyung; Kim, Daesoo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Eun Kyung; Kang, Seok-Gu; Kim, Dong-Seok] Yonsei Univ, Coll Med, Severance Childrens Hosp,Dept Neurosurg, Pediat Epilepsy Clin,Brain Korea Project Med Sci, Seoul, South Korea; [Cho, Young-Wook] Korea Basic Sci Inst, Chuncheon Ctr, Chuncheon Si, Gangwon Do, South Korea; [Kim, Sangwoo; Kim, Junho] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Rhee, Hwanseok] Macrogen, Macrogen Bioinformat Ctr, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Korea Basic Science Institute (KBSI); Yonsei University; Yonsei University Health System; Macrogen, Inc.	Lee, JH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea.	dskim33@yuhs.ac; jhlee4246@kaist.ac.kr	Lee, Jeong Ho/G-7361-2012; Kim, Daesoo/C-1625-2011; Kim, Ho Min/G-2712-2011	Kim, Daesoo/0000-0001-9915-1463; Kim, Sangwoo/0000-0001-5356-0827; Kim, Se Hoon/0000-0001-7516-7372; Kang, Seok-Gu/0000-0001-5676-2037	Ministry of Health & Welfare, Republic of Korea [A121070, HI13C0208]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology (ICT) & Future Planning [2013M3C7A1056564]; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning; Korean Health Technology Research and Development (RD) Project	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology (ICT) & Future Planning; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning; Korean Health Technology Research and Development (RD) Project	We thank E.J. Kim, J. Kim and S. Kim at KAIST for stimulating discussion and critical reading of the manuscript, S.M. Park at KAIST for coordinating clinical information, M.H. Kim at KAIST for analyzing behavioral seizures, J.S. Lee at Yonsei University Health System (YUHS) for providing clinical information, and K.L. Guan at the University of California-San Diego for kindly providing Flag-mTOR construct. This work was supported by a grant of the Korean Health Technology Research and Development (R&D) Project, Ministry of Health & Welfare, Republic of Korea (A121070 to J.H. Lee; HI13C0208 to J.H. Lee and D.S. Kim), the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communication Technology (ICT) & Future Planning (2013M3C7A1056564 to J. H. Lee), and the KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning ( to H.M. Kim, D. Kim and J.H. Lee).	Aronica E, 2012, BRAIN PATHOL, V22, P380, DOI 10.1111/j.1750-3639.2012.00581.x; Bast T, 2006, ACTA NEUROL SCAND, V113, P72, DOI 10.1111/j.1600-0404.2005.00555.x; Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Becker AJ, 2002, ANN NEUROL, V52, P29, DOI 10.1002/ana.10251; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Chen J, 2012, ANN NEUROL, V72, P881, DOI 10.1002/ana.23795; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Colombo N, 2012, NEURORADIOLOGY, V54, P1065, DOI 10.1007/s00234-012-1049-1; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Crino PB, 2009, EPILEPSIA, V50, P3, DOI 10.1111/j.1528-1167.2009.02289.x; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Kim S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r90; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; Krsek P, 2008, ANN NEUROL, V63, P758, DOI 10.1002/ana.21398; Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Liu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-71; Miyata H, 2004, ANN NEUROL, V56, P510, DOI 10.1002/ana.20234; Navarro-Quiroga I, 2007, J NEUROSCI, V27, P5007, DOI 10.1523/JNEUROSCI.0867-07.2007; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Scheffer IE, 2014, ANN NEUROL, V75, P782, DOI 10.1002/ana.24126; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Sisodiyo SM, 2009, LANCET NEUROL, V8, P830, DOI 10.1016/S1474-4422(09)70201-7; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yasin SA, 2013, ACTA NEUROPATHOL, V126, P207, DOI 10.1007/s00401-013-1135-4; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331	38	292	304	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					395	+		10.1038/nm.3824	http://dx.doi.org/10.1038/nm.3824			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25799227				2022-12-25	WOS:000352493600022
J	Janiszewska, M; Liu, L; Almendro, V; Kuang, Y; Paweletz, C; Sakr, RA; Weigelt, B; Hanker, AB; Chandarlapaty, S; King, TA; Reis, JS; Arteaga, CL; Park, SY; Michor, F; Polyak, K				Janiszewska, Michalina; Liu, Lin; Almendro, Vanessa; Kuang, Yanan; Paweletz, Cloud; Sakr, Rita A.; Weigelt, Britta; Hanker, Ariella B.; Chandarlapaty, Sarat; King, Tari A.; Reis-Filho, Jorge S.; Arteaga, Carlos L.; Park, So Yeon; Michor, Franziska; Polyak, Kornelia			In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer	NATURE GENETICS			English	Article							PRACTICE GUIDELINE UPDATE; PI3K PATHWAY ACTIVATION; INTRATUMORAL HETEROGENEITY; CLINICAL ONCOLOGY/COLLEGE; GENE AMPLIFICATION; AMERICAN SOCIETY; TRASTUZUMAB RESISTANCE; PCR-AMPLIFICATION; TUMOR EVOLUTION; DIGITAL PCR	Detection of minor, genetically distinct subpopulations within tumors is a key challenge in cancer genomics. Here we report STAR-FISH (specific-to-allele PCR-FISH), a novel method for the combined detection of single-nucleotide and copy number alterations in single cells in intact archived tissues. Using this method, we assessed the clinical impact of changes in the frequency and topology of PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant therapy. We found that these two genetic events are not always present in the same cells. Chemotherapy selects for PIK3CA-mutant cells, a minor subpopulation in nearly all treatment-naive samples, and modulates genetic diversity within tumors. Treatment-associated changes in the spatial distribution of cellular genetic diversity correlated with poor long-term outcome following adjuvant therapy with trastuzumab. Our findings support the use of in situ single cell-based methods in cancer genomics and imply that chemotherapy before HER2-targeted therapy may promote treatment resistance.	[Janiszewska, Michalina; Almendro, Vanessa; Kuang, Yanan; Paweletz, Cloud; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Janiszewska, Michalina; Almendro, Vanessa; Polyak, Kornelia] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Janiszewska, Michalina; Almendro, Vanessa; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Liu, Lin; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Lin; Michor, Franziska] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kuang, Yanan; Paweletz, Cloud] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA; [Sakr, Rita A.; King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA; [Weigelt, Britta; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Hanker, Ariella B.; Arteaga, Carlos L.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Chandarlapaty, Sarat; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Arteaga, Carlos L.] Vanderbilt Univ, Dept Med, Breast Canc Res Program, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Park, So Yeon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Polyak, Kornelia] Broad Inst, Cambridge, MA USA; [Polyak, Kornelia] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Seoul National University (SNU); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Polyak, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	michor@jimmy.harvard.edu; kornelia_polyak@dfci.harvard.edu	Hanker, Ariella/M-7136-2019; Liu, Lin/AAG-2129-2021	Hanker, Ariella/0000-0002-8655-8341; Liu, Lin/0000-0002-9883-7962; Park, So Yeon/0000-0002-0299-7268	Dana-Farber Cancer Institute Physical Sciences-Oncology Center [U54CA143798]; European Molecular Biology Organization (EMBO); Swiss National Science Foundation; American Cancer Society [CRP-07-234-06-COUN]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [K12CA090625, P30CA008748, U54CA143798] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Physical Sciences-Oncology Center; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); American Cancer Society(American Cancer Society); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Winer, I. Krop, B. Vogelstein and members of the Polyak and Michor laboratories for their critical reading of the manuscript and useful discussions. We thank A. Marusyk and D. Tabassum for their help with the xenograft assays, R. Witwicki for help with data processing, L. Cameron in the Dana-Farber Cancer Institute Confocal Microscopy center for her technical support, A. Richardson (Dana-Farber Cancer Institute) for providing slides from a human breast tumor with known status for the PIK3CA mutation encoding p.His1047Arg, and H. Russness and I. Rye (Oslo University Hospital) for providing the BAC probe for HER2. This work was supported by the Dana-Farber Cancer Institute Physical Sciences-Oncology Center (U54CA143798 to F.M.), the European Molecular Biology Organization (EMBO; M.J.), the Swiss National Science Foundation (M.J.), the American Cancer Society (CRP-07-234-06-COUN to C.L.A.) and the Breast Cancer Research Foundation (K.P.).	Almendro V, 2014, CANCER RES, V74, P1338, DOI 10.1158/0008-5472.CAN-13-2357-T; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Andersson J, 2004, APPL IMMUNOHISTO M M, V12, P14; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bagasra O, 2007, NAT PROTOC, V2, P2782, DOI 10.1038/nprot.2007.395; Bartlett AI, 2011, AM J CLIN PATHOL, V136, P266, DOI 10.1309/AJCP0EN6AQMWETZZ; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brunelli M, 2009, AM J CLIN PATHOL, V131, P678, DOI 10.1309/AJCP09VUTZWZXBMJ; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cizkova M, 2013, BRIT J CANCER, V108, P1807, DOI 10.1038/bjc.2013.164; Cizkova M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3113; Cottu PH, 2008, ANN ONCOL, V19, P596, DOI 10.1093/annonc/mdn021; Deng G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-456; Duprez R, 2012, J PATHOL, V226, P427, DOI 10.1002/path.3032; Ebina M, 2001, ONCOGENE, V20, P2579, DOI 10.1038/sj.onc.1204351; Efron B., 1994, INTRO BOOTSTRAP; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Glockner S, 2002, LAB INVEST, V82, P1419, DOI 10.1097/01.LAB.0000032371.16521.40; Grundberg I, 2013, ONCOTARGET, V4, P2407, DOI 10.18632/oncotarget.1527; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Hanna W, 2007, BREAST J, V13, P122, DOI 10.1111/j.1524-4741.2007.00396.x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Ikeda S, 2007, PATHOL INT, V57, P594, DOI 10.1111/j.1440-1827.2007.02144.x; Jensen JD, 2011, CLIN CANCER RES, V17, P667, DOI 10.1158/1078-0432.CCR-10-1133; Jurinke C, 2001, Methods Mol Biol, V170, P103; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lewis JT, 2005, AM J CLIN PATHOL, V124, P273, DOI 10.1309/J9VXABUGKC4Y07DL; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin NE, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0452-9; Ng CKY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0657-6; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Rexer BN, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3601; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Sakr RA, 2014, CLIN CANCER RES, V20, P2326, DOI 10.1158/1078-0432.CCR-13-2267; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Seol H, 2012, MODERN PATHOL, V25, P938, DOI 10.1038/modpathol.2012.36; Shin SJ, 2006, INT J SURG PATHOL, V14, P279, DOI 10.1177/1066896906293055; Striebel JM, 2008, AM J CLIN PATHOL, V129, P383, DOI 10.1309/KFKDNK8CENVN24VU; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang YH, 2013, CURR MED RES OPIN, V29, P633, DOI 10.1185/03007995.2013.794775; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854	55	117	119	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1212	+		10.1038/ng.3391	http://dx.doi.org/10.1038/ng.3391			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26301495	Green Accepted, Green Submitted			2022-12-25	WOS:000361969900018
J	Zhang, JY; Dominguez-Sola, D; Hussein, S; Lee, JE; Holmes, AB; Bansal, M; Vlasevska, S; Mo, TW; Tang, HY; Basso, K; Ge, K; Dalla-Favera, R; Pasqualucci, L				Zhang, Jiyuan; Dominguez-Sola, David; Hussein, Shafinaz; Lee, Ji-Eun; Holmes, Antony B.; Bansal, Mukesh; Vlasevska, Sofija; Mo, Tongwei; Tang, Hongyan; Basso, Katia; Ge, Kai; Dalla-Favera, Riccardo; Pasqualucci, Laura			Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis	NATURE MEDICINE			English	Article							SOMATIC MUTATIONS; COMPASS FAMILY; SELECTION; METHYLATION; DISCOVERY; CHROMATIN; GENES; EZH2; SET1; DNA	Mutations in the gene encoding the KMT2D (or MLL2) methyltransferase are highly recurrent and occur early during tumorigenesis in diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL). However, the functional consequences of these mutations and their role in lymphomagenesis are unknown. Here we show that FL-and DLBCL-associated KMT2D mutations impair KMT2D enzymatic activity, leading to diminished global H3K4 methylation in germinal-center (GC) B cells and DLBCL cells. Conditional deletion of Kmt2d early during B cell development, but not after initiation of the GC reaction, results in an increase in GC B cells and enhances B cell proliferation in mice. Moreover, genetic ablation of Kmt2d in mice overexpressing Bcl2 increases the incidence of GC-derived lymphomas resembling human tumors. These findings suggest that KMT2D acts as a tumor suppressor gene whose early loss facilitates lymphomagenesis by remodeling the epigenetic landscape of the cancer precursor cells. Eradication of KMT2D-deficient cells may thus represent a rational therapeutic approach for targeting early tumorigenic events.	[Zhang, Jiyuan; Dominguez-Sola, David; Hussein, Shafinaz; Holmes, Antony B.; Vlasevska, Sofija; Mo, Tongwei; Tang, Hongyan; Basso, Katia; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Lee, Ji-Eun; Ge, Kai] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Bansal, Mukesh] Columbia Univ, Dept Syst Biol, New York, NY USA; [Basso, Katia; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA; [Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	lp171@columbia.edu	Ge, Kai/H-2810-2019; Lee, Ji-Eun/F-7891-2011	Ge, Kai/0000-0002-7442-5138; Lee, Ji-Eun/0000-0002-3768-7016; Dominguez-Sola, David/0000-0001-9569-8402; Pasqualucci, Laura/0000-0001-6819-7370	US National Institutes of Health [RO1-CA172492, RO1-CA37295]; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA164152, R37CA037295, R01CA172492, R01CA037295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075017, ZIADK075003] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank U. Klein and S. Zha for discussions, S. Nataraj, L. Belver, C. Scuoppo and N. De Silva for help and suggestions on various experimental procedures, E. McIntush (Bethyl Laboratories, Inc.) for help in generating several antibodies to KMT2D, the Flow Cytometry Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University for assistance with cell-sorting procedures, the Molecular Pathology lab for the preparation of mouse FFPE tissue samples and the Genomic Technologies Shared Resource for sequencing the ChIP-DNA libraries. We also thank S. Cory (Walter and Eliza Hall Institute of Medical Research, Parkville, Australia) for the VavP-Bcl2 mice and K. Rajewsky (Max Delbruck Center for Molecular Medicine, Berlin, Germany) for the CD19-Cre and C gamma 1-Cre mice. The indicated DLBCL cell lines in Supplementary Table 5 were a kind gift of L. Staudt, M.A. Shipp and T. Gilmore. This work was supported by US National Institutes of Health grants RO1-CA172492 (L.P.) and RO1-CA37295 (R.D.-F.), and J.Z. is supported by a Lymphoma Research Foundation postdoctoral fellowship. L.P. is on leave from the University of Perugia.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Guo CC, 2013, ONCOTARGET, V4, P2144, DOI 10.18632/oncotarget.1555; Guo CC, 2012, P NATL ACAD SCI USA, V109, P17603, DOI 10.1073/pnas.1208807109; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pasqualucci L, 2013, CURR OPIN HEMATOL, V20, P336, DOI 10.1097/MOH.0b013e3283623d7f; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	75	257	265	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1190	+		10.1038/nm.3940	http://dx.doi.org/10.1038/nm.3940			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26366712	Green Accepted			2022-12-25	WOS:000362355400021
J	Lovisa, S; LeBleu, VS; Tampe, B; Sugimoto, H; Vadnagara, K; Carstens, JL; Wu, CC; Hagos, Y; Burckhardt, BC; Pentcheva-Hoang, T; Nischal, H; Allison, JP; Zeisberg, M; Kalluri, R				Lovisa, Sara; LeBleu, Valerie S.; Tampe, Bjorn; Sugimoto, Hikaru; Vadnagara, Komal; Carstens, Julienne L.; Wu, Chia-Chin; Hagos, Yohannes; Burckhardt, Birgitta C.; Pentcheva-Hoang, Tsvetelina; Nischal, Hersharan; Allison, James P.; Zeisberg, Michael; Kalluri, Raghu			Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis	NATURE MEDICINE			English	Article							KIDNEY FIBROSIS; MOLECULAR-MECHANISMS; POSTISCHEMIC KIDNEY; FIBROBLASTS; ACTIVATION; FIBROGENESIS; ANTIGEN; CANCER; EMERGE; TWIST	Kidney fibrosis is marked by an epithelial-to-mesenchymal transition (EMT) of tubular epithelial cells (TECs). Here we find that, during renal fibrosis, TECs acquire a partial EMT program during which they remain associated with their basement membrane and express markers of both epithelial and mesenchymal cells. The functional consequence of the EMT program during fibrotic injury is an arrest in the G2 phase of the cell cycle and lower expression of several solute and solvent transporters in TECs. We also found that transgenic expression of either Twist1 (encoding twist family bHLH transcription factor 1, known as Twist) or Snai1 (encoding snail family zinc finger 1, known as Snail) expression is sufficient to promote prolonged TGF-beta 1-induced G2 arrest of TECs, limiting the cells' potential for repair and regeneration. In mouse models of experimentally induced renal fibrosis, conditional deletion of Twist1 or Snai1 in proximal TECs resulted in inhibition of the EMT program and the maintenance of TEC integrity, while also restoring cell proliferation, dedifferentiation-associated repair and regeneration of the kidney parenchyma and attenuating interstitial fibrosis. Thus, inhibition of the EMT program in TECs during chronic renal injury represents a potential anti-fibrosis therapy.	[Lovisa, Sara; LeBleu, Valerie S.; Sugimoto, Hikaru; Vadnagara, Komal; Carstens, Julienne L.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Tampe, Bjorn; Zeisberg, Michael] Univ Gottingen, Med Ctr, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany; [Wu, Chia-Chin] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Hagos, Yohannes; Burckhardt, Birgitta C.] Univ Gottingen, Med Ctr, Inst Syst Physiol & Pathophysiol, D-37073 Gottingen, Germany; [Pentcheva-Hoang, Tsvetelina; Nischal, Hersharan; Allison, James P.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Gottingen; University of Texas System; UTMD Anderson Cancer Center; University of Gottingen; University of Texas System; UTMD Anderson Cancer Center	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA.	rkalluri@mdanderson.org	Wu, Chia-Chin/ABD-5516-2021; Lovisa, Sara/AAB-1141-2020; Tampe, Björn/ABA-6091-2021; Kalluri, Raghu/E-2677-2015	Wu, Chia-Chin/0000-0002-5208-6016; Lovisa, Sara/0000-0001-7776-2896; Tampe, Björn/0000-0002-4357-9863; Allison, James/0000-0001-8980-5697; Carstens, Julienne/0000-0001-9914-0430; Kalluri, Raghu/0000-0002-2190-547X	University of Texas M.D. Anderson Cancer Center (UT MDACC); Cancer Prevention and Research Institute of Texas; University of Texas System Science and Technology Acquisition and Retention (STARS) awards; US National Institutes of Health (NIH) [CA-155370, CA-151925, DK-081576, DK-55001]; Metastasis Research Center at the M.D. Anderson Cancer Center [P30CA016672]; NIH [P30CA016672]; Khalifa Bin Zayed Al Nahya Foundation; NIH through MDACC Support grant [CA-016672]; Deutsche Forschungsgemeinschaft [INST1525/16-1 FUGG]; NATIONAL CANCER INSTITUTE [U01CA151925, P30CA016672, R01CA155370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081576, R01DK055001, P30DK081943] Funding Source: NIH RePORTER	University of Texas M.D. Anderson Cancer Center (UT MDACC); Cancer Prevention and Research Institute of Texas; University of Texas System Science and Technology Acquisition and Retention (STARS) awards; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metastasis Research Center at the M.D. Anderson Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Khalifa Bin Zayed Al Nahya Foundation; NIH through MDACC Support grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was primarily supported with funds from the University of Texas M.D. Anderson Cancer Center (UT MDACC), partially supported by the Cancer Prevention and Research Institute of Texas and funding from the University of Texas System Science and Technology Acquisition and Retention (STARS) awards to RK and VSL. The research in R.K. laboratory is also supported by the US National Institutes of Health (NIH) (grants CA-155370, CA-151925, DK-081576, DK-55001) and the Metastasis Research Center at the M.D. Anderson Cancer Center (P30CA016672). V.S.L. is supported by the NIH under award number P30CA016672 and the Khalifa Bin Zayed Al Nahya Foundation. This research was performed in the Flow Cytometry & Cellular Imaging Facility at UT MDACC, which is supported in part by the NIH through MDACC Support grant CA-016672. This work was in part supported by the Deutsche Forschungsgemeinschaft (equipment grant INST1525/16-1 FUGG). Snail<SUP>loxP/loxP</SUP> mice were kindly provided by S.J. Weiss, University of Michigan, and Twist1<SUP>loxP/loxP</SUP> mice were kindly provided by R.R. Behringer, UT MDACC via the Mutant Mouse Regional Resource Center (MMRRC) repository. pcDNA3-Twist plasmid was kindly provided by R. Maestro, Centro di Riferimento Oncologico National Cancer Institute, Italy. Nephrotoxic serum was a kind gift from D.J. Salant, Boston University. MCT cells were a gift from E.G. Neilson, Northwestern University School of Medicine. We thank E. Lawson for technical help with immunostaining, E. Chang for help with digital microscopy scanning of tissue histology slides and L. Gibson for help with breeding and genotyping mice.	Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Hertig A, 2008, J AM SOC NEPHROL, V19, P1584, DOI 10.1681/ASN.2007101160; Hills CE, 2010, MOL ENDOCRINOL, V24, P822, DOI 10.1210/me.2009-0391; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kida Y, 2007, J HISTOCHEM CYTOCHEM, V55, P661, DOI 10.1369/jhc.6A7157.2007; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Liu T, 2012, TOXICOL APPL PHARM, V264, P423, DOI 10.1016/j.taap.2012.08.019; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Maeda T, 2007, DRUG METAB DISPOS, V35, P394, DOI 10.1124/dmd.106.012112; Martini S, 2014, J AM SOC NEPHROL, V25, P2559, DOI 10.1681/ASN.2013080906; Megyesi J, 1999, P NATL ACAD SCI USA, V96, P10830, DOI 10.1073/pnas.96.19.10830; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Rastaldi MP, 2006, J NEPHROL, V19, P407; Reich HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013451; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2010, NAT MED, V16, P523, DOI 10.1038/nm0510-523; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zeisberg M, 2002, AM J PATHOL, V160, P2001, DOI 10.1016/S0002-9440(10)61150-9; Zeisberg M, 2008, FRONT BIOSCI, V13, P6991; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616	55	558	594	11	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					998	+		10.1038/nm.3902	http://dx.doi.org/10.1038/nm.3902			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26236991	Green Accepted			2022-12-25	WOS:000360961300012
J	Procopio, MG; Laszlo, C; Al Labban, D; Kim, DE; Bordignon, P; Jo, SH; Goruppi, S; Menietti, E; Ostano, P; Ala, U; Provero, P; Hoetzenecker, W; Neel, V; Kilarski, WW; Swartz, MA; Brisken, C; Lefort, K; Dotto, GP				Procopio, Maria-Giuseppina; Laszlo, Csaba; Al Labban, Dania; Kim, Dong Eun; Bordignon, Pino; Jo, Seung-Hee; Goruppi, Sandro; Menietti, Elena; Ostano, Paola; Ala, Ugo; Provero, Paolo; Hoetzenecker, Wolfram; Neel, Victor; Kilarski, Witold W.; Swartz, Melody A.; Brisken, Cathrin; Lefort, Karine; Dotto, G. Paolo			Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation	NATURE CELL BIOLOGY			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; MULTIFOCAL EPITHELIAL TUMORS; FIELD CANCERIZATION; CELLULAR SENESCENCE; NOTCH; TRANSCRIPTION; EXPRESSION; CELLS; GENE; SUPPRESSOR	Stromal fibroblast senescence has been linked to ageing-associated cancer risk. However, density and proliferation of cancer-associated fibroblasts (CAFs) are frequently increased. Loss or downmodulation of the Notch effector CSL (also known as RBP-J kappa) in dermal fibroblasts is sufficient for CAF activation and ensuing keratinocyte-derived tumours. We report that CSL silencing induces senescence of primary fibroblasts from dermis, oral mucosa, breast and lung. CSL functions in these cells as a direct repressor of multiple senescence-and CAF-effector genes. It also physically interacts with p53, repressing its activity. CSL is downmodulated in stromal fibroblasts of premalignant skin actinic keratosis lesions and squamous cell carcinomas, whereas p53 expression and function are downmodulated only in the latter, with paracrine FGF signalling as the probable culprit. Concomitant loss of CSL and p53 overcomes fibroblast senescence, enhances expression of CAF effectors and promotes stromal and cancer cell expansion. The findings support a CAF activation-stromal co-evolution model under convergent CSL-p53 control.	[Procopio, Maria-Giuseppina; Laszlo, Csaba; Al Labban, Dania; Kim, Dong Eun; Bordignon, Pino; Menietti, Elena; Lefort, Karine; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Jo, Seung-Hee; Goruppi, Sandro; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; [Ostano, Paola] Edo & Elvo Tempia Valenta Fdn, Canc Genom Lab, I-13900 Biella, Italy; [Ala, Ugo; Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Life Sci, I-10126 Turin, Italy; [Hoetzenecker, Wolfram] Univ Zurich, Dept Dermatol, CH-8091 Zurich, Switzerland; [Neel, Victor] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Kilarski, Witold W.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Brisken, Cathrin] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Lefort, Karine] Univ Hosp CHUV, Sect Dermatol, Dept Med, CH-1011 Lausanne, Switzerland	University of Lausanne; Harvard University; Massachusetts General Hospital; University of Turin; University of Zurich; Harvard University; Massachusetts General Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Dotto, GP (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Paolo.Dotta@unil.ch	Kilarski, Witold W./G-8673-2012; Kilarski, Witold/AAA-1843-2019; Ostano, Paola/K-1979-2018; Swartz, Melody A./F-9563-2011; Provero, Paolo/AAC-1930-2019; Ala, Ugo/K-2029-2016; Kim, Dong-Eun/D-8304-2011	Kilarski, Witold W./0000-0003-0734-4749; Ostano, Paola/0000-0002-4000-2954; Ala, Ugo/0000-0001-5408-6397; Kim, Dong-Eun/0000-0001-6545-8387; Bordignon, Pino/0000-0002-3157-8695; Brisken, Cathrin/0000-0002-6857-3230	Swiss National Science Foundation [310030_156191/1]; National Institutes of Health [R01AR039190, R01AR064786]; European Research Council [26075083]; OncoSuisse [OCS-2922-02-2012, KFS-3301-08-2013]; Lauretana S.P.A.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039190, R01AR064786] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); OncoSuisse; Lauretana S.P.A.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Bernards, R. Agami, W. Raffoul, J. P. Rival, J. M. Joseph, U. Just, F. Martinon and T. Petrova for vectors or cells, F. De Sousa e Melo and B. Hu for early contributions, K. Harshman for RNA-Seq and ChIP-Seq analysis and C. Pasche and T. Proust for technical help. The work was supported by grants from the Swiss National Science Foundation (310030_156191/1), National Institutes of Health (R01AR039190; R01AR064786; the content not necessarily representing the offcial views of NIH), European Research Council (26075083) and OncoSuisse (OCS-2922-02-2012 and KFS-3301-08-2013). P. Ostano was supported by a grant from Lauretana S.P.A.	Bar J, 2010, SEMIN CELL DEV BIOL, V21, P47, DOI 10.1016/j.semcdb.2009.11.006; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Boggs K, 2007, J BIOL CHEM, V282, P7982, DOI 10.1074/jbc.M611675200; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Chene P, 2004, MOL CANCER RES, V2, P20; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dotto G. P., 2000, BIOCHIM BIOPHYS ACTA, V87483, P1; Dotto GP, 2014, J CLIN INVEST, V124, P1446, DOI 10.1172/JCI72589; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Gatenby R, 2012, NATURE, V491, pS55, DOI 10.1038/491S55a; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; Hosein AN, 2010, CANCER RES, V70, P5770, DOI 10.1158/0008-5472.CAN-10-0673; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783; Johnson JE, 2011, CURR TOP DEV BIOL, V97, P55, DOI 10.1016/B978-0-12-385975-4.00009-7; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kilarski WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057135; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Lefort K, 2013, EMBO J, V32, P2248, DOI 10.1038/emboj.2013.156; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Reisman D, 1998, SEMIN CANCER BIOL, V8, P317, DOI 10.1006/scbi.1998.0094; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Salem AF, 2013, CELL CYCLE, V12, P818, DOI 10.4161/cc.23722; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Sun YB, 2004, J CELL BIOCHEM, V92, P258, DOI 10.1002/jcb.20044; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weinberg RA, 2008, NAT GENET, V40, P494, DOI 10.1038/ng0508-494; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996; Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	68	140	144	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1193	+		10.1038/ncb3228	http://dx.doi.org/10.1038/ncb3228			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26302407	Green Accepted, Green Submitted			2022-12-25	WOS:000361113700013
J	Ueoka, R; Uria, AR; Reiter, S; Mori, T; Karbaum, P; Peters, EE; Helfrich, EJN; Morinaka, BI; Gugger, M; Takeyama, H; Matsunaga, S; Piel, J				Ueoka, Reiko; Uria, Agustinus R.; Reiter, Silke; Mori, Tetsushi; Karbaum, Petra; Peters, Eike E.; Helfrich, Eric J. N.; Morinaka, Brandon I.; Gugger, Muriel; Takeyama, Haruko; Matsunaga, Shigeki; Piel, Joern			Metabolic and evolutionary origin of actin-binding polyketides from diverse organisms	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCT DISCOVERY; SPONGE THEONELLA-SWINHOEI; IN-SITU HYBRIDIZATION; GENE-CLUSTER; CYTOTOXIC MACROLIDES; ANTIFUNGAL MACROLIDE; BACTERIAL SYMBIONT; SYNTHASES; IDENTIFICATION; CYANOBACTERIA	Actin-targeting macrolides comprise a large, structurally diverse group of cytotoxins isolated from remarkably dissimilar micro- and macroorganisms. In spite of their disparate origins and structures, many of these compounds bind actin at the same site and exhibit structural relationships reminiscent of modular, combinatorial drug libraries. Here we investigate biosynthesis and evolution of three compound groups: misakinolides, scytophycin-type compounds and luminaolides. For misakinolides from the sponge Theonella swinhoei WA, our data suggest production by an uncultivated 'Entotheonella' symbiont, further supporting the relevance of these bacteria as sources of bioactive polyketides and peptides in sponges. Insights into misakinolide biosynthesis permitted targeted genome mining for other members, providing a cyanobacterial luminaolide producer as the first cultivated source for this dimeric compound family. The data indicate that this polyketide family is bacteria-derived and that the unusual macrolide diversity is the result of combinatorial pathway modularity for some compounds and of convergent evolution for others.	[Ueoka, Reiko; Uria, Agustinus R.; Reiter, Silke; Karbaum, Petra; Peters, Eike E.; Helfrich, Eric J. N.; Morinaka, Brandon I.; Piel, Joern] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Mori, Tetsushi; Takeyama, Haruko] Waseda Univ, Ctr Adv Biomed Sci, Fac Sci & Engn, Tokyo, Japan; [Karbaum, Petra] Kekule Inst Organ Chem & Biochem, Bonn, Germany; [Gugger, Muriel] Inst Pasteur, Collect Cyanobacteries, Paris, France; [Matsunaga, Shigeki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Tokyo, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; Waseda University; University of Bonn; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Tokyo	Piel, J (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	jpiel@ethz.ch	Mori, Tetsushi/C-1973-2017; Mori, Tetsushi/AAN-5656-2020; Ueoka, Reiko/N-8468-2019	Mori, Tetsushi/0000-0001-7096-4161; Morinaka, Brandon/0000-0001-8239-619X; Helfrich, Eric Jan Nikolaus/0000-0001-8751-3279; Uria, Agustinus R./0000-0002-9223-7464; Gugger, Muriel/0000-0001-6728-1976	SNF [IZLSZ3_149025]; EU (BlueGenics); EU (BluePharmTrain); Institut Pasteur; Alexander von Humboldt Research Fellowship; DAAD fellowship	SNF; EU (BlueGenics); EU (BluePharmTrain); Institut Pasteur(European Commission); Alexander von Humboldt Research Fellowship(Alexander von Humboldt Foundation); DAAD fellowship(Deutscher Akademischer Austausch Dienst (DAAD))	We thank T. Wakimoto and K. Takada for providing sponge samples, D. Uemura for a generous sample of luminaolide, M. Wilson for sequence analysis and naming of 'Entotheonella serta', C. Maufrais and A. Criscuolo from the Bioinformatic Plateform of the Institut Pasteur for help in ANI calculation, and J. Pernthaler for helpful discussion and for providing material for CARD-FISH experiments. We are also grateful to Y.I. Park and J.-F. Humbert for the use of cyanobacterial genomes. This work was funded by grants of the SNF (IZLSZ3_149025), and the EU (BlueGenics and BluePharmTrain) to J.P., by the Institut Pasteur to M.G., by an Alexander von Humboldt Research Fellowship to R.U. and by a DAAD fellowship to A.R.U.	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Andrianasolo EH, 2005, ORG LETT, V7, P1375, DOI 10.1021/ol050188x; Berkhan G, 2014, ANGEW CHEM INT EDIT, V53, P14240, DOI 10.1002/anie.201407979; Bewley CA, 1996, EXPERIENTIA, V52, P716, DOI 10.1007/BF01925581; Bewley CA, 1998, ANGEW CHEM INT EDIT, V37, P2163, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2162::AID-ANIE2162>3.0.CO;2-2; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; CARMELI S, 1990, J NAT PROD, V53, P1533, DOI 10.1021/np50072a021; DAURIA MV, 1994, TETRAHEDRON, V50, P4829, DOI 10.1016/S0040-4020(01)85019-5; Donia MS, 2011, P NATL ACAD SCI USA, V108, pE1423, DOI 10.1073/pnas.1111712108; Elshahawi SI, 2013, P NATL ACAD SCI USA, V110, pE295, DOI 10.1073/pnas.1213892110; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Gaget V, 2015, SYST APPL MICROBIOL, V38, P141, DOI 10.1016/j.syapm.2015.02.004; GARCIAPICHEL F, 1991, J PHYCOL, V27, P395, DOI 10.1111/j.0022-3646.1991.00395.x; GUELLA G, 1989, HELV CHIM ACTA, V72, P237, DOI 10.1002/hlca.19890720207; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Irschik H, 2010, CHEMBIOCHEM, V11, P1840, DOI 10.1002/cbic.201000313; ISHIBASHI M, 1986, J ORG CHEM, V51, P5300, DOI 10.1021/jo00376a047; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jenner M, 2015, ANGEW CHEM INT EDIT, V54, P1817, DOI 10.1002/anie.201410219; Jenner M, 2013, ANGEW CHEM INT EDIT, V52, P1143, DOI 10.1002/anie.201207690; Kampa A, 2013, P NATL ACAD SCI USA, V110, pE3129, DOI 10.1073/pnas.1305867110; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; KERNAN MR, 1987, TETRAHEDRON LETT, V28, P2809, DOI 10.1016/S0040-4039(00)96215-4; Kitamura M, 2009, TETRAHEDRON LETT, V50, P6606, DOI 10.1016/j.tetlet.2009.09.065; Kohlhaas C, 2013, CHEM SCI, V4, P3212, DOI 10.1039/c3sc50540e; Kubanek J, 2003, P NATL ACAD SCI USA, V100, P6916, DOI 10.1073/pnas.1131855100; MATSUNAGA S, 1986, J AM CHEM SOC, V108, P847, DOI 10.1021/ja00264a053; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; O'Brien RV, 2014, J ANTIBIOT, V67, P89, DOI 10.1038/ja.2013.125; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Perrins RD, 2008, CHEM BIOL, V15, P287, DOI 10.1016/j.chembiol.2008.01.010; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Pistorius D, 2012, CHEMBIOCHEM, V13, P416, DOI 10.1002/cbic.201100575; Poplau P, 2013, ANGEW CHEM INT EDIT, V52, P13215, DOI 10.1002/anie.201307406; RASHID MA, 1995, J NAT PRODUCTS, V58, P1120, DOI 10.1021/np50121a025; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SAKAI R, 1986, CHEM LETT, P1499, DOI 10.1246/cl.1986.1499; SASSE F, 1993, J ANTIBIOT, V46, P741, DOI 10.7164/antibiotics.46.741; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schramm A, 2002, ENVIRON MICROBIOL, V4, P713, DOI 10.1046/j.1462-2920.2002.00364.x; SPIEGEL M, 1972, EXP CELL RES, V70, P423, DOI 10.1016/0014-4827(72)90155-3; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Teta R, 2010, CHEMBIOCHEM, V11, P2506, DOI 10.1002/cbic.201000542; Wakimoto T, 2014, NAT CHEM BIOL, V10, P648, DOI [10.1038/NCHEMBIO.1573, 10.1038/nchembio.1573]; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; YAMADA K, 1993, J AM CHEM SOC, V115, P11020, DOI 10.1021/ja00076a082; Yang JY, 2012, J BACTERIOL, V194, P6023, DOI 10.1128/JB.00823-12; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10	59	74	76	0	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					705	+		10.1038/NCHEMBIO.1870	http://dx.doi.org/10.1038/NCHEMBIO.1870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26236936	Green Accepted			2022-12-25	WOS:000359954700015
J	Burkhart, BJ; Hudson, GA; Dunbar, KL; Mitchell, DA				Burkhart, Brandon J.; Hudson, Graham A.; Dunbar, Kyle L.; Mitchell, Douglas A.			A prevalent peptide-binding domain guides ribosomal natural product biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN HOMOLOGY DETECTION; POSTTRANSLATIONAL MODIFICATION; ANTIBIOTICS; PLANTAZOLICIN; DISCOVERY; SEQUENCE; PATHWAY; CYCLODEHYDRATASE; TRIFOLITOXIN; RESISTANCE	Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a rapidly growing class of natural products. RiPP precursor peptides can undergo extensive enzymatic tailoring to yield structurally and functionally diverse products, and their biosynthetic logic makes them attractive bioengineering targets. Recent work suggests that unrelated RiPP-modifying enzymes contain structurally similar precursor peptide-binding domains. Using profile hidden Markov model comparisons, we discovered related and previously unrecognized peptide-binding domains in proteins spanning the majority of known prokaryotic RiPP classes, and we named this conserved domain the RiPP precursor peptide recognition element (RRE). Through binding studies we verified RRE's roles for three distinct RiPP classes: linear azole-containing peptides, thiopeptides and lasso peptides. Because numerous RiPP biosynthetic enzymes act on peptide substrates, our findings have powerful predictive value as to which protein(s) drive substrate binding, thereby laying a foundation for further characterization of RiPP biosynthetic pathways and the rational engineering of new peptide-binding activities.	[Burkhart, Brandon J.; Hudson, Graham A.; Dunbar, Kyle L.; Mitchell, Douglas A.] Univ Illinois, Dept Chem, Urbana, IL 61820 USA; [Burkhart, Brandon J.; Hudson, Graham A.; Dunbar, Kyle L.; Mitchell, Douglas A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Mitchell, Douglas A.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Mitchell, DA (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61820 USA.	douglasm@illinois.edu		Mitchell, Douglas/0000-0002-9564-0953; Dunbar, Kyle L./0000-0002-7410-5169	US National Institutes of Health (NIH) [1R01 GM097142, 2T32 GM070421]; University of Illinois at Urbana-Champaign Department of Chemistry; National Science Foundation [DGE-1144245]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421, R01GM097142] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Urbana-Champaign Department of Chemistry; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Maniak and R. Dowen for cloning several of the TOMM biosynthetic proteins and to C. Cox for bioinformatics consultation. We also thank C. Deane for critical review of this manuscript. This work was supported by the US National Institutes of Health (NIH) (1R01 GM097142 to D.A.M. and 2T32 GM070421 to B.J.B. and K.L.D.). Additional financial support came from the University of Illinois at Urbana-Champaign Department of Chemistry (Robert C. and Carolyn J. Springborn Endowment to B.J.B. and Harold R. Snyder Fellowship to K.L.D. and G.A.H.). B.J.B. was also funded by a National Science Foundation Graduate Research Fellowship (DGE-1144245).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Bantysh O, 2014, MBIO, V5, DOI 10.1128/mBio.01059-14; Bindman NA, 2013, J AM CHEM SOC, V135, P10362, DOI 10.1021/ja4010706; Breil BT, 1996, J BACTERIOL, V178, P4150, DOI 10.1128/jb.178.14.4150-4156.1996; BREIL BT, 1993, J BACTERIOL, V175, P3693, DOI 10.1128/JB.175.12.3693-3702.1993; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Carlson EE, 2010, ACS CHEM BIOL, V5, P639, DOI 10.1021/cb100105c; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Deane CD, 2013, ACS CHEM BIOL, V8, P1998, DOI 10.1021/cb4003392; Dunbar K. L., 2015, J AM CHEM SOC; Dunbar KL, 2014, NAT CHEM BIOL, V10, P823, DOI [10.1038/NCHEMBIO.1608, 10.1038/nchembio.1608]; Dunbar KL, 2012, NAT CHEM BIOL, V8, P569, DOI [10.1038/NCHEMBIO.944, 10.1038/nchembio.944]; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Goto Y, 2014, CHEM BIOL, V21, P766, DOI 10.1016/j.chembiol.2014.04.008; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Haft DH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-15; Hegemann JD, 2013, BIOPOLYMERS, V100, P527, DOI 10.1002/bip.22326; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Lee J, 2013, P NATL ACAD SCI USA, V110, P12954, DOI 10.1073/pnas.1306101110; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li Y., 2015, LASSO PEPTIDES, P81; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McIntosh JA, 2013, ACS CHEM BIOL, V8, P877, DOI 10.1021/cb300614c; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; Melby JO, 2012, J AM CHEM SOC, V134, P5309, DOI 10.1021/ja211675n; Melby JO, 2011, CURR OPIN CHEM BIOL, V15, P369, DOI 10.1016/j.cbpa.2011.02.027; Metelev M, 2015, CHEM BIOL, V22, P241, DOI 10.1016/j.chembiol.2014.11.017; Mitchell DA, 2009, J BIOL CHEM, V284, P13004, DOI 10.1074/jbc.M900802200; Molohon KJ, 2011, ACS CHEM BIOL, V6, P1307, DOI 10.1021/cb200339d; Morinaka BI, 2014, ANGEW CHEM INT EDIT, V53, P8503, DOI 10.1002/anie.201400478; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Ruffner DE, 2015, ACS SYNTH BIOL, V4, P482, DOI 10.1021/sb500267d; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tsai TY, 2009, PROTEINS, V76, P1042, DOI 10.1002/prot.22461; Wecksler SR, 2010, CHEM COMMUN, V46, P7031, DOI 10.1039/c0cc00968g; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275	56	194	196	2	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					564	U56		10.1038/nchembio.1856	http://dx.doi.org/10.1038/nchembio.1856			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26167873	Green Accepted			2022-12-25	WOS:000358255300010
J	Liu, QZ; Huang, XZ; Zhang, H; Tian, XY; He, LJ; Yang, R; Yan, Y; Wang, QD; Gillich, A; Zhou, B				Liu, Qiaozhen; Huang, Xiuzhen; Zhang, Hui; Tian, Xueying; He, Lingjuan; Yang, Rui; Yan, Yan; Wang, Qing-Dong; Gillich, Astrid; Zhou, Bin			c-kit(+) cells adopt vascular endothelial but not epithelial cell fates during lung maintenance and repair	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; REGENERATION; ALVEOLAR; AIRWAY	Unraveling the fate specification of resident stem cells during lung regeneration is of clinical importance. It has been reported that c-kit(+) progenitor cells resident in the human lung regenerate epithelial lineages upon transplantation into injured mouse lung. Here we test the lineage potential of c-kit(+) cells by inducible genetic lineage tracing. We find that c-kit(+) cells do not contribute to lung epithelium during homeostasis and repair, and instead maintain a vascular endothelial cell fate. These findings call attention to the clinical application of c-kit(+) stem cells as lung epithelial progenitors for the treatment of pulmonary disease.	[Liu, Qiaozhen; Huang, Xiuzhen; Zhang, Hui; Tian, Xueying; He, Lingjuan; Yang, Rui; Zhou, Bin] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Yan, Yan] Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200433, Peoples R China; [Wang, Qing-Dong] AstraZeneca, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden; [Gillich, Astrid] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Excellence Brain Sci, Shanghai, Peoples R China; [Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; AstraZeneca; Stanford University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhou, B (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.	zhoubin@sibs.ac.cn		Wang, Qing-Dong/0000-0001-9570-4411; Zhou, Bin/0000-0001-5278-5522	National Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Ministry of Science and Technology [2012CB945102, 2013CB945302]; Bajian Talent Project; Shanghai Basic Research Key Project [14JC1407400]; Shanghai Institutes for Biological Sciences (SIBS) President Fund; Sanofi-SIBS Fellowship; AstraZeneca; Shanghai Yangfan Project grant [15YF1414000]; Qimingxing Project grant [15QA1404300]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Bajian Talent Project; Shanghai Basic Research Key Project; Shanghai Institutes for Biological Sciences (SIBS) President Fund; Sanofi-SIBS Fellowship; AstraZeneca(AstraZeneca); Shanghai Yangfan Project grant; Qimingxing Project grant	We thank H Zeng from the Allen Institute for Brain Science for providing Ai9 and Ai47 mouse lines. We thank Shanghai Biomodel Organism Co., Ltd. for generating Kit-CreER mouse line. This work was supported by the National Science Foundation of China (91339104, 31271552, 31222038 to B.Z.; 31301188 to X.T.), the Ministry of Science and Technology (2012CB945102, 2013CB945302 to B.Z.), the Bajian Talent Project (B.Z.), the Shanghai Basic Research Key Project (14JC1407400 to B.Z.), the Shanghai Institutes for Biological Sciences (SIBS) President Fund (B.Z.), a Sanofi-SIBS Fellowship (X.T.), AstraZeneca, Shanghai Yangfan Project grant (15YF1414000 to H.Z.) and by a Qimingxing Project grant (15QA1404300 to X.T.).	Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Geller GB, 2011, NAT MED, V17, P788, DOI 10.1038/nm0711-788; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; Suzuki T, 2014, AM J PHYSIOL-LUNG C, V306, pL855, DOI 10.1152/ajplung.00211.2013; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309	15	48	51	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					866	868		10.1038/nm.3888	http://dx.doi.org/10.1038/nm.3888			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26168292				2022-12-25	WOS:000359181000012
J	Hu, B; Wang, W; Ou, SJ; Tang, JY; Li, H; Che, RH; Zhang, ZH; Chai, XY; Wang, HR; Wang, YQ; Liang, CZ; Liu, LC; Piao, ZZ; Deng, QY; Deng, K; Xu, C; Liang, Y; Zhang, LH; Li, LG; Chu, CC				Hu, Bin; Wang, Wei; Ou, Shujun; Tang, Jiuyou; Li, Hua; Che, Ronghui; Zhang, Zhihua; Chai, Xuyang; Wang, Hongru; Wang, Yiqin; Liang, Chengzhen; Liu, Linchuan; Piao, Zhongze; Deng, Qiyun; Deng, Kun; Xu, Chi; Liang, Yan; Zhang, Lianhe; Li, Legong; Chu, Chengcai			Variation in NRT1.1B contributes to nitrate-use divergence between rice subspecies	NATURE GENETICS			English	Article							CHLORATE-RESISTANT MUTANTS; ARABIDOPSIS-THALIANA; JAPONICA RICE; TRANSPORTER; AMMONIUM; INDICA; CHL1; SEQUENCE; REVEALS; PLANTS	Asian cultivated rice (Oryza sativa L.) consists of two main subspecies, indica and japonica. Indica has higher nitrate-absorption activity than japonica, but the molecular mechanisms underlying that activity remain elusive. Here we show that variation in a nitrate-transporter gene, NRT1.1B (OsNPF6.5), may contribute to this divergence in nitrate use. Phylogenetic analysis revealed that NRT1.1B diverges between indica and japonica. NRT1.1B-indica variation was associated with enhanced nitrate uptake and root-to-shoot transport and upregulated expression of nitrate-responsive genes. The selection signature of NRT1.1B-indica suggests that nitrate-use divergence occurred during rice domestication. Notably, field tests with near-isogenic and transgenic lines confirmed that the japonica variety carrying the NRT1.1B-indica allele had significantly improved grain yield and nitrogen-use efficiency (NUE) compared to the variety without that allele. Our results show that variation in NRT1.1B largely explains nitrate-use divergence between indica and japonica and that NRT1.1Bindica can potentially improve the NUE of japonica.	[Hu, Bin; Wang, Wei; Ou, Shujun; Tang, Jiuyou; Li, Hua; Che, Ronghui; Zhang, Zhihua; Wang, Hongru; Wang, Yiqin; Liang, Chengzhen; Xu, Chi; Liang, Yan; Chu, Chengcai] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, State Key Lab Plant Gen, Beijing, Peoples R China; [Wang, Wei; Li, Hua; Zhang, Zhihua; Wang, Hongru; Liang, Yan] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Ou, Shujun] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Chai, Xuyang] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Liu, Linchuan] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Piao, Zhongze] Shanghai Acad Agr Sci, Crop Breeding & Cultivat Res Inst, Shanghai, Peoples R China; [Deng, Qiyun] China Natl Hybrid Rice Res, Changsha, Peoples R China; [Deng, Qiyun] Dev Ctr, Changsha, Peoples R China; [Deng, Kun; Zhang, Lianhe] Henan Univ Sci & Technol, Sch Agr, Luoyang, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Michigan State University; Capital Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Academy of Agricultural Sciences; Henan University of Science & Technology	Chu, CC (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, State Key Lab Plant Gen, Beijing, Peoples R China.	ccchu@genetics.ac.cn	Hu, Bin/HCI-1705-2022; Zhang, Zhihua/AAJ-4229-2021; Wang, Yiqin/AAJ-8144-2020; Chu, Chengcai/AAF-6083-2019; Tang, Jiuyou/J-7224-2015; Zhang, Zhihua/GQZ-1360-2022; Ou, Shujun/N-5263-2019	Hu, Bin/0000-0002-2696-4348; Chu, Chengcai/0000-0001-8097-6115; Tang, Jiuyou/0000-0002-9059-2139; Ou, Shujun/0000-0001-5938-7180; Wang, Hongru/0000-0001-8305-5231; Liu, Linchuan/0000-0002-8669-7202	Ministry of Science and Technology of China [2014AA10A602-5, 2015CB755702]; Chinese Academy of Sciences [XDA08010400]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank H. Xue (Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China) for providing the nrt1.1b mutant and M. Schlqappi (Marquette University, Milwaukee, Wisconsin, USA) and X. Wang (China Agricultural University, Beijing, China) for language editing. This work was supported by grants from the Ministry of Science and Technology of China (2014AA10A602-5, 2015CB755702) and the Chinese Academy of Sciences (XDA08010400).	Alachiotis N, 2012, BIOINFORMATICS, V28, P2274, DOI 10.1093/bioinformatics/bts419; Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Ho CH, 2010, CURR OPIN PLANT BIOL, V13, P604, DOI 10.1016/j.pbi.2010.08.005; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Koutroubas SD, 2003, FIELD CROP RES, V83, P251, DOI 10.1016/S0378-4290(03)00067-4; Kronzucker HJ, 2000, NEW PHYTOL, V145, P471, DOI 10.1046/j.1469-8137.2000.00606.x; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Mandal A, 2012, BIOCHEM J, V445, P313, DOI 10.1042/BJ20120190; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; MOLL RH, 1987, CROP SCI, V27, P181, DOI 10.2135/cropsci1987.0011183X002700020007x; Monden I, 2001, BIOL CHEM, V382, P1551, DOI 10.1515/BC.2001.189; Oka H.I., 1983, ORIGIN CULTIVATED RI; OOSTINDI.FJ, 1973, MUTAT RES, V19, P175, DOI 10.1016/0027-5107(73)90076-6; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; SCHOLTEN HJ, 1986, J PLANT PHYSIOL, V123, P45, DOI 10.1016/S0176-1617(86)80065-7; TA TC, 1981, SOIL SCI PLANT NUTR, V27, P347, DOI 10.1080/00380768.1981.10431289; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teng S, 2006, EUPHYTICA, V152, P141, DOI 10.1007/s10681-006-9189-1; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; WANG XM, 1986, THEOR APPL GENET, V72, P328, DOI 10.1007/BF00288569; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhao Y, 2014, STRUCTURE, V22, P1152, DOI 10.1016/j.str.2014.06.008	34	346	426	39	446	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					834	+		10.1038/ng.3337	http://dx.doi.org/10.1038/ng.3337			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053497				2022-12-25	WOS:000357090300025
J	Kohl, S; Zobor, D; Chiang, WC; Weisschuh, N; Staller, J; Menendez, IG; Chang, S; Beck, SC; Garrido, MG; Sothilingam, V; Seeliger, MW; Stanzial, F; Benedicenti, F; Inzana, F; Heon, E; Vincent, A; Beis, J; Strom, TM; Rudolph, G; Roosing, S; den Hollander, AI; Cremers, FPM; Lopez, I; Ren, H; Moore, AT; Webster, AR; Michaelides, M; Koenekoop, RK; Zrenner, E; Kaufman, RJ; Tsang, SH; Wissinger, B; Lin, JH				Kohl, Susanne; Zobor, Ditta; Chiang, Wei-Chieh; Weisschuh, Nicole; Staller, Jennifer; Menendez, Irene Gonzalez; Chang, Stanley; Beck, Susanne C.; Garrido, Marina Garcia; Sothilingam, Vithiyanjali; Seeliger, Mathias W.; Stanzial, Franco; Benedicenti, Francesco; Inzana, Francesca; Heon, Elise; Vincent, Ajoy; Beis, Jill; Strom, Tim M.; Rudolph, Guenther; Roosing, Susanne; den Hollander, Anneke I.; Cremers, Frans P. M.; Lopez, Irma; Ren, Huanan; Moore, Anthony T.; Webster, Andrew R.; Michaelides, Michel; Koenekoop, Robert K.; Zrenner, Eberhart; Kaufman, Randal J.; Tsang, Stephen H.; Wissinger, Bernd; Lin, Jonathan H.			Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; OPTICAL COHERENCE TOMOGRAPHY; TRANSCRIPTION FACTOR; RETINAL STRUCTURE; ALPHA-SUBUNIT; GENE-THERAPY; MOUSE MODEL; CONGENITAL ACHROMATOPSIA; TOTAL COLOURBLINDNESS; LONG-TERM	Achromatopsia (ACHM) is an autosomal recessive disorder characterized by color blindness, photophobia, nystagmus and severely reduced visual acuity. Using homozygosity mapping and whole-exome and candidate gene sequencing, we identified ten families carrying six homozygous and two compound-heterozygous mutations in the ATF6 gene (encoding activating transcription factor 6A), a key regulator of the unfolded protein response (UPR) and cellular endoplasmic reticulum (ER) homeostasis. Patients had evidence of foveal hypoplasia and disruption of the cone photoreceptor layer. The ACHM-associated ATF6 mutations attenuate ATF6 transcriptional activity in response to ER stress. Atf6(-/-) mice have normal retinal morphology and function at a young age but develop rod and cone dysfunction with increasing age. This new ACHM-related gene suggests a crucial and unexpected role for ATF6A in human foveal development and cone function and adds to the list of genes that, despite ubiquitous expression, when mutated can result in an isolated retinal photoreceptor phenotype.	[Kohl, Susanne; Zobor, Ditta; Weisschuh, Nicole; Staller, Jennifer; Menendez, Irene Gonzalez; Beck, Susanne C.; Garrido, Marina Garcia; Sothilingam, Vithiyanjali; Seeliger, Mathias W.; Zrenner, Eberhart; Wissinger, Bernd] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Chiang, Wei-Chieh; Lin, Jonathan H.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Chang, Stanley; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Chang, Stanley] New York Presbyterian Hosp, Edward Harkness Eye Inst, New York, NY USA; [Stanzial, Franco; Benedicenti, Francesco; Inzana, Francesca] Reg Hosp Bozen, Clin Genet Serv, Bolzano, Italy; [Heon, Elise; Vincent, Ajoy] Univ Toronto, Hosp Sick Children, Dept Ophthalmol & Vis Sci, Programme Genet & Genom, Toronto, ON M5G 1X8, Canada; [Beis, Jill] IWK Hlth Ctr, Med Genet, Halifax, NS, Canada; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Rudolph, Guenther] Univ Munich, Univ Eye Hosp, Munich, Germany; [Roosing, Susanne; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Lopez, Irma; Ren, Huanan; Koenekoop, Robert K.] McGill Univ, Ctr Hlth, McGill Ocular Genet Ctr, Montreal, PQ, Canada; [Moore, Anthony T.; Webster, Andrew R.; Michaelides, Michel] UCL, Inst Ophthalmol, London, England; [Moore, Anthony T.; Webster, Andrew R.; Michaelides, Michel] Moorfields Eye Hosp, London, England; [Moore, Anthony T.] Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; [Zrenner, Eberhart] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, Degenerat Dis Program, La Jolla, CA USA; [Tsang, Stephen H.] Columbia Univ, Jonas Lab Stem Cell & Regenerat Med, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Brown Glaucoma Lab, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Tsang, Stephen H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Lin, Jonathan H.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California San Diego; Columbia University; NewYork-Presbyterian Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Dalhousie University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Radboud University Nijmegen; Radboud University Nijmegen; McGill University; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Sanford Burnham Prebys Medical Discovery Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California San Diego	Kohl, S (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	susanne.kohl@uni-tuebingen.de; jlin@ucsd.edu	Roosing, Susanne/F-1616-2018; Roosing, Susanne/ABF-9604-2021; Vincent, Ajoy/D-1149-2018; Cremers, Frans/A-5625-2014; Chang, Stanley/AAL-2741-2021; Roosing, Susanne/AAK-3454-2020; Hollander, Anneke den/N-4911-2014; Koenekoop, Robert/AAT-6676-2021	Roosing, Susanne/0000-0001-9038-0067; Roosing, Susanne/0000-0001-9038-0067; Vincent, Ajoy/0000-0001-6446-3846; Cremers, Frans/0000-0002-4954-5592; Roosing, Susanne/0000-0001-9038-0067; Benedicenti, Francesco/0000-0002-9458-0688; Lin, Jonathan/0000-0002-7438-6941; Kohl, Susanne/0000-0002-6438-6331; Chiang, Wei-Chieh/0000-0002-1268-3019	Bundesministerium fur Bildung und Forschung (BMBF) grant [01GM1108A]; US National Institutes of Health [EY001919, EY020846, DK042394, DK088227, HL052173, 5P30EY019007]; post-doctoral Foundation Fighting Blindness fellowship; National Institute for Health Research, Biomedical Research Centre at Moorfields Eye Hospital, National Health Service (NHS) Foundation Trust; University College London Institute of Ophthalmology, Fight For Sight, Moorfields Eye Hospital Special Trustees, Retinitis Pigmentosa Fighting Blindness; Foundation Fighting Blindness (US); Wellcome Trust [099173/Z/12/Z]; Foundation Fighting Blindness Career Development Award; Mira Godard Research fund; Cannon; National Cancer Institute [5P30CA013696]; Research to Prevent Blindness (RPB); Columbia University; New York RPB Physician-Scientist Award; Schneeweiss Stem Cell Fund, New York State [N09G-302, N13G-275]; Gebroe Family Foundation [R01EY018213]; Foundation Fighting Blindness (US) [BR-GE-0510-0489-RAD, C-GE-0811-0545-RAD01]; Prof. Dr. H.J. Flieringa Foundation Stichting Wetenschappelijk Onderzoek het Oogziekenhuis (SWOO); Rotterdam Eye Hospital; Center for Integrative Neuroscience-DFG Center of Excellence, University of Tubingen, Germany [EXC 307]; Foundation Fighting Blindness (Canada); CIHR (Canadian Institutes for Health Research); National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish; Fight for Sight [24RP131, 1317/18] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY001919, P30EY019007, R01EY020846, R01EY018213, R37EY001919] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK042394, R01DK088227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088485] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002284] Funding Source: NIH RePORTER	Bundesministerium fur Bildung und Forschung (BMBF) grant(Federal Ministry of Education & Research (BMBF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); post-doctoral Foundation Fighting Blindness fellowship; National Institute for Health Research, Biomedical Research Centre at Moorfields Eye Hospital, National Health Service (NHS) Foundation Trust; University College London Institute of Ophthalmology, Fight For Sight, Moorfields Eye Hospital Special Trustees, Retinitis Pigmentosa Fighting Blindness; Foundation Fighting Blindness (US); Wellcome Trust(Wellcome Trust); Foundation Fighting Blindness Career Development Award; Mira Godard Research fund; Cannon; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Columbia University; New York RPB Physician-Scientist Award; Schneeweiss Stem Cell Fund, New York State; Gebroe Family Foundation; Foundation Fighting Blindness (US); Prof. Dr. H.J. Flieringa Foundation Stichting Wetenschappelijk Onderzoek het Oogziekenhuis (SWOO); Rotterdam Eye Hospital; Center for Integrative Neuroscience-DFG Center of Excellence, University of Tubingen, Germany; Foundation Fighting Blindness (Canada); CIHR (Canadian Institutes for Health Research)(Canadian Institutes of Health Research (CIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We want to thank C.W. Seok for data analysis. These studies were supported by various grants to the different authors and institutions: Bundesministerium fur Bildung und Forschung (BMBF) grant 01GM1108A to B.W. and S.K.; US National Institutes of Health grants EY001919 and EY020846 to J.H.L. and DK042394, DK088227 and HL052173 to R.J.K. and a post-doctoral Foundation Fighting Blindness fellowship to W.-C.C.; National Institute for Health Research, Biomedical Research Centre at Moorfields Eye Hospital, National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology, Fight For Sight, Moorfields Eye Hospital Special Trustees, Retinitis Pigmentosa Fighting Blindness and the Foundation Fighting Blindness (US) all to A.T.M., M.M. and A.R.W.; and the Wellcome Trust (099173/Z/12/Z) to M.M. and A.R.W.M.M. is supported by a Foundation Fighting Blindness Career Development Award; Mira Godard Research fund to E.H.; the imaging facilities at the Barbara and Donald Jonas Laboratory of Stem Cells and Regenerative Medicine and the Bernard and Shirlee Brown Glaucoma Laboratory are supported by Cannon, US National Institutes of Health Core grant 5P30EY019007, National Cancer Institute Core grant 5P30CA013696 and unrestricted funds from Research to Prevent Blindness (RPB), a Columbia University, New York RPB Physician-Scientist Award, the Schneeweiss Stem Cell Fund, New York State (N09G-302 and N13G-275) and the Gebroe Family Foundation, grant R01EY018213 to S.H.T.; Foundation Fighting Blindness (US) grants BR-GE-0510-0489-RAD to A.I.d.H. and C-GE-0811-0545-RAD01 to F.P.M.C., the Prof. Dr. H.J. Flieringa Foundation Stichting Wetenschappelijk Onderzoek het Oogziekenhuis (SWOO) and the Rotterdam Eye Hospital to F.P.M.C. and A.I.d.H.E.Z. is supported by Center for Integrative Neuroscience-DFG Center of Excellence EXC 307, University of Tubingen, Germany. R.K.K. is supported by the Foundation Fighting Blindness (Canada) and the CIHR (Canadian Institutes for Health Research).	Aboshiha J, 2014, INVEST OPHTH VIS SCI, V55, P5733, DOI 10.1167/iovs.14-14937; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Aligianis IA, 2002, J MED GENET, V39, P656, DOI 10.1136/jmg.39.9.656; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P188, DOI 10.3389/fgene.2013.00188; Carvalho LS, 2011, HUM MOL GENET, V20, P3161, DOI 10.1093/hmg/ddr218; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Hong IH, 2014, OSLI RETINA, V45, P74, DOI 10.3928/23258160-20131220-12; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Park SP, 2014, OSLI RETINA, V45, P469, DOI 10.3928/23258160-20140908-01; Park SP, 2013, EUR J HUM GENET, V21, P1240, DOI 10.1038/ejhg.2013.21; Park SP, 2013, GRAEF ARCH CLIN EXP, V251, P2299, DOI 10.1007/s00417-013-2296-5; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sundaram V, 2014, OPHTHALMOLOGY, V121, P234, DOI 10.1016/j.ophtha.2013.08.017; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Thomas MG, 2011, OPHTHALMOLOGY, V118, P1653, DOI 10.1016/j.ophtha.2011.01.028; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Thuerauf DJ, 2007, J BIOL CHEM, V282, P22865, DOI 10.1074/jbc.M701213200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	48	125	131	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					757	+		10.1038/ng.3319	http://dx.doi.org/10.1038/ng.3319			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029869	Green Accepted			2022-12-25	WOS:000357090300012
J	Meador, CB; Lovly, CM				Meador, Catherine B.; Lovly, Christine M.			Liquid biopsies reveal the dynamic nature of resistance mechanisms in solid tumors	NATURE MEDICINE			English	Editorial Material							ANTI-EGFR THERAPY; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; AZD9291; HETEROGENEITY; EVOLUTION	Two new studies demonstrate that so-called 'liquid biopsies' may reveal important genomic information needed to monitor treatment responses, forecast tumor recurrences, and provide a rationale for novel therapeutic strategies in patients with lung cancer and colon cancer.	[Meador, Catherine B.; Lovly, Christine M.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Meador, Catherine B.; Lovly, Christine M.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Lovly, Christine M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Meador, CB (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	christine.lovly@vanderbilt.edu	Meador, Catherine/AAU-1379-2021	Meador, Catherine/0000-0001-5006-3569; Lovly, Christine/0000-0002-3641-6361	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yu HA, 2014, CLIN CANCER RES, V20, P5898, DOI 10.1158/1078-0432.CCR-13-2437	12	12	13	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					663	665		10.1038/nm.3899	http://dx.doi.org/10.1038/nm.3899			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26151324				2022-12-25	WOS:000357604600004
J	Potts, MB; McMillan, EA; Rosales, TI; Kim, HS; Ou, YH; Toombs, JE; Brekken, RA; Minden, MD; MacMillan, JB; White, MA				Potts, Malia B.; McMillan, Elizabeth A.; Rosales, Tracy I.; Kim, Hyun Seok; Ou, Yi-Hung; Toombs, Jason E.; Brekken, Rolf A.; Minden, Mark D.; MacMillan, John B.; White, Michael A.			Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B	NATURE CHEMICAL BIOLOGY			English	Article							ANTIPROLIFERATIVE AGENT DIDEMNIN; NEURONAL CEROID-LIPOFUSCINOSIS; CELL-LINES; MYELOID-LEUKEMIA; KINASE; BREAST; ACTIVATION; INHIBITION; MECHANISM; PATHWAY	Modern cancer treatment employs many effective chemotherapeutic agents originally discovered from natural sources. The cyclic depsipeptide didemnin B has demonstrated impressive anticancer activity in preclinical models. Clinical use has been approved but is limited by sparse patient responses combined with toxicity risk and an unclear mechanism of action. From a broad-scale effort to match antineoplastic natural products to their cellular activities, we found that didemnin B selectively induces rapid and wholesale apoptosis through dual inhibition of PPT1 and EEF1A1. Furthermore, empirical discovery of a small panel of exceptional responders to didemnin B allowed the generation of a regularized regression model to extract a sparse-feature genetic biomarker capable of predicting sensitivity to didemnin B. This may facilitate patient selection in a fashion that could enhance and expand the therapeutic application of didemnin B against neoplastic disease.	[Potts, Malia B.; McMillan, Elizabeth A.; Rosales, Tracy I.; Kim, Hyun Seok; Ou, Yi-Hung; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Toombs, Jason E.; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Surg, Hamon Ctr Therapeut Oncol Res, Div Surg Oncol, Dallas, TX 75390 USA; [Minden, Mark D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Minden, Mark D.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Minden, Mark D.] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [MacMillan, John B.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; University of Texas Southwestern Medical Center Dallas	Potts, MB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Potts, Malia B/N-8130-2018	Potts, Malia B/0000-0002-8308-1963; MacMillan, John/0000-0003-1430-1077; Ou, Yi-Hung/0000-0002-9909-7791; Kim, Hyun Seok/0000-0003-4498-8690	Welch Foundation [I-1414, I-1689]; US National Cancer Institute [CA071443, CA176284, CA149833]; Cancer Prevention and Research Institute of Texas [RP120718, RP110708]; Komen; US National Institutes of Health [2T32GM008203]; Cancer Interventions and Discoveries Program [RP101496]; NATIONAL CANCER INSTITUTE [R01CA149833, R01CA071443, R35CA197717, U01CA176284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas; Komen(Susan G. Komen Breast Cancer Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Interventions and Discoveries Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Molinski for providing additional Trididemnum solidum material; D. Sabatini and N. Gray for the Torin1; J. Willson and S. Markowitz for the Vaco colon cancer cell lines; K. Huffman, M. Peyton, A. Gazdar and J. Minna for the lung and breast cancer cell lines; J. Shay for the human colonic epithelial cells; X. Wang for the U2OS GFP-LC3 cells; J. Brugarolas for the REDD1-knockout MEFs; F. Grinnell for the BR5 fibroblasts; R. Potts for the U2OS cells and J. Mendell for the P493 cells. We also thank N. Williams for formulating didemnin B for animal delivery. This study was supported by the Welch Foundation (I-1414, I-1689), the US National Cancer Institute (CA071443, CA176284, CA149833) and the Cancer Prevention and Research Institute of Texas (RP120718, RP110708). M.B.P. was supported by a Komen for the Cure Postdoctoral Fellowship. E.A.M. was supported in part by the US National Institutes of Health (2T32GM008203). Y.-H.O. and H.S.K. were supported by fellowships from the Cancer Interventions and Discoveries Program (RP101496).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; BLENIS J, 1991, CELL GROWTH DIFFER, V2, P279; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; COLLINS S, 1982, NATURE, V298, P679, DOI 10.1038/298679a0; Creevey L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-23; Crews CM, 1996, P NATL ACAD SCI USA, V93, P4316, DOI 10.1073/pnas.93.9.4316; CREWS CM, 1994, J BIOL CHEM, V269, P15411; Das AK, 2000, J BIOL CHEM, V275, P23847, DOI 10.1074/jbc.M002758200; Fritz RD, 2010, ONCOGENE, V29, P3575, DOI 10.1038/onc.2010.104; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gong JN, 2014, CELL DEATH DIFFER, V21, P100, DOI 10.1038/cdd.2013.133; GRUBB DR, 1995, BIOCHEM BIOPH RES CO, V215, P1130, DOI 10.1006/bbrc.1995.2580; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; He ZW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0557-0; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hu YC, 2013, J AM CHEM SOC, V135, P13387, DOI 10.1021/ja403412y; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Le Tourneau C, 2007, CURR PHARM DESIGN, V13, P3427; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee J, 2012, NAT PROD REP, V29, P404, DOI 10.1039/c2np00065b; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Li ZY, 2011, MOL BIOSYST, V7, P871, DOI 10.1039/c0mb00230e; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Mamo A, 2012, MOL CELL BIOL, V32, P1855, DOI 10.1128/MCB.06726-11; Meng LH, 1998, BIOCHEMISTRY-US, V37, P10488, DOI 10.1021/bi9804479; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Potts MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004657; Ribrag V, 2013, HAEMATOLOGICA, V98, P357, DOI 10.3324/haematol.2012.069757; RINEHART KL, 1981, SCIENCE, V212, P933, DOI 10.1126/science.7233187; RINEHART KL, 1981, J AM CHEM SOC, V103, P1857, DOI 10.1021/ja00397a055; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SIRDESHPANDE BV, 1995, BIOCHEMISTRY-US, V34, P9177, DOI 10.1021/bi00028a030; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soares DC, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-29; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Suryani S, 2014, CLIN CANCER RES, V20, P4520, DOI 10.1158/1078-0432.CCR-14-0259; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Tsukimoto M, 2011, J NAT PROD, V74, P2329, DOI 10.1021/np200543z; Vera MD, 2002, MED RES REV, V22, P102, DOI 10.1002/med.10003; Voznyi YV, 1999, J MED GENET, V36, P471; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	54	37	37	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					401	+		10.1038/nchembio.1797	http://dx.doi.org/10.1038/nchembio.1797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25867045	Green Accepted			2022-12-25	WOS:000354539400010
J	Vicuna, L; Strochlic, DE; Latremoliere, A; Bali, KK; Simonetti, M; Husainie, D; Prokosch, S; Riva, P; Griffin, RS; Njoo, C; Gehrig, S; Mall, MA; Arnold, B; Devor, M; Woolf, CJ; Liberles, SD; Costigan, M; Kuner, R				Vicuna, Lucas; Strochlic, David E.; Latremoliere, Alban; Bali, Kiran Kumar; Simonetti, Manuela; Husainie, Dewi; Prokosch, Sandra; Riva, Priscilla; Griffin, Robert S.; Njoo, Christian; Gehrig, Stefanie; Mall, Marcus A.; Arnold, Bernd; Devor, Marshall; Woolf, Clifford J.; Liberles, Stephen D.; Costigan, Michael; Kuner, Rohini			The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase	NATURE MEDICINE			English	Article							HUMAN NEUTROPHIL ELASTASE; ACUTE LUNG INJURY; NERVE INJURY; SPINAL-CORD; IN-VIVO; IMMUNE-RESPONSES; MODEL; ACTIVATION; GENE; HYPERSENSITIVITY	Neuropathic pain is a major, intractable clinical problem and its pathophysiology is not well understood. Although recent gene expression profiling studies have enabled the identification of novel targets for pain therapy(1-4), classical study designs provide unclear results owing to the differential expression of hundreds of genes across sham and nerve-injured groups, which can be difficult to validate, particularly with respect to the specificity of pain modulation(5). To circumvent this, we used two outbred lines of rats(6), which are genetically similar except for being genetically segregated as a result of selective breeding for differences in neuropathic pain hypersensitivity(7). SerpinA3N, a serine protease inhibitor, was upregulated in the dorsal root ganglia (DRG) after nerve injury, which was further validated for its mouse homolog. Mice lacking SerpinA3N developed more neuropathic mechanical allodynia than wild-type (WT) mice, and exogenous delivery of SerpinA3N attenuated mechanical allodynia in WT mice. T lymphocytes infiltrate the DRG after nerve injury and release leukocyte elastase (LE), which was inhibited by SerpinA3N derived from DRG neurons. Genetic loss of LE or exogenous application of a LE inhibitor (Sivelastat) in WT mice attenuated neuropathic mechanical allodynia. Overall, we reveal a novel and clinically relevant role for a member of the serpin superfamily and a leukocyte elastase and crosstalk between neurons and T cells in the modulation of neuropathic pain.	[Vicuna, Lucas; Bali, Kiran Kumar; Simonetti, Manuela; Husainie, Dewi; Njoo, Christian; Kuner, Rohini] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [Strochlic, David E.; Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Latremoliere, Alban; Riva, Priscilla; Woolf, Clifford J.; Costigan, Michael] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [Latremoliere, Alban; Woolf, Clifford J.; Costigan, Michael] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Prokosch, Sandra; Arnold, Bernd] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany; [Griffin, Robert S.] Hosp Special Surg, Dept Anesthesiol Pain Management, New York, NY 10021 USA; [Gehrig, Stefanie; Mall, Marcus A.] Heidelberg Univ, Translat Lung Res Ctr Heidelberg, Dept Translat Pulmonol, Heidelberg, Germany; [Devor, Marshall] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; [Devor, Marshall] Hebrew Univ Jerusalem, Ctr Res Pain, Jerusalem, Israel; [Costigan, Michael] Boston Childrens Hosp, Dept Anesthesia, Boston, MA USA	Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Boston Children's Hospital	Kuner, R (corresponding author), Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany.	rohini.kuner@pharma.uni-heidelberg.de	Mall, Marcus A./AAA-1498-2022; Kuner, Rohini/AGU-0204-2022; Vicuña, Lucas/AAR-2636-2020; Vicuña, Lucas/AAD-5889-2019; Bali, Kiran/F-6828-2013; Vicuña, Lucas/O-3075-2015; Woolf, Clifford/A-9784-2010	Mall, Marcus A./0000-0002-4057-2199; Vicuña, Lucas/0000-0002-0901-0032; Bali, Kiran/0000-0002-9503-1402; Latremoliere, Alban/0000-0002-9212-1007; Husainie, Dewi/0000-0001-5200-0545; Liberles, Stephen/0000-0002-2177-9741	European Research Council (ERC) [294293]; Deutsche Forschungsgemeinschaft (DFG) [MA 2081/4-1, SFB 938]; US National Institutes of Health [5 R01 NS038253, 2R37NS039518, R01 NS074430, RO1DE022912]; Israel Science Foundation; CellNetworks; Hartmut-Hoffmann Berling International Graduate School for Cellular and Molecular Biology; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R03NS052623, R01NS074430, R37NS039518] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); CellNetworks; Hartmut-Hoffmann Berling International Graduate School for Cellular and Molecular Biology; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to R. LeFaucheur for secretarial assistance and to D. Baumgartl-Ahlert for technical assistance. We acknowledge support from the Interdisciplinary Neurobehavioral Core, Heidelberg, for the behavioral experiments performed here. We are grateful to M. Meister for his help in the analysis of FACS data. This work was supported by a European Research Council (ERC) Advanced Investigator Grant (PAINPLASTICITY; project no. 294293) to R.K., by grants from the Deutsche Forschungsgemeinschaft (DFG; MA 2081/4-1) to M.A.M., by grants from the Deutsche Forschungsgemeinschaft (SFB 938) to B.A., by grants from the US National Institutes of Health (5 R01 NS038253 and 2R37NS039518 to C.W., and R01 NS074430 to M.C.), and by a grant from the Israel Science Foundation to M.D. M.A.M. and R.K. are members of the Molecular Medicine Partnership Unit, Heidelberg. R.K. is a principal investigator in the Excellence Cluster 'CellNetworks' of Heidelberg University. M. A. M. is a member of the German Center for Lung Research. L.V. was partially supported by a PhD fellowship from CellNetworks and by the Hartmut-Hoffmann Berling International Graduate School for Cellular and Molecular Biology. M.S. was partially supported by a post-doctoral fellowship from CellNetworks. A.L. was partially supported by the RO1DE022912 grant from the US National Institutes of Health.	Alam SR, 2012, BIOCHEM PHARMACOL, V83, P695, DOI 10.1016/j.bcp.2011.11.003; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Chiang HS, 2014, NAT IMMUNOL, V15, P63, DOI 10.1038/ni.2766; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DEVOR M, 1990, PAIN, V42, P51, DOI 10.1016/0304-3959(90)91092-W; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; Ferry G, 1997, FEBS LETT, V402, P111, DOI 10.1016/S0014-5793(96)01508-6; Gangadharan V, 2013, PAIN, V154, P2801, DOI 10.1016/j.pain.2013.08.019; Garcia PS, 2010, THROMB HAEMOSTASIS, V103, P1145, DOI 10.1160/TH09-12-0848; Gehrig S, 2012, ANGEW CHEM INT EDIT, V51, P6258, DOI 10.1002/anie.201109226; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Hirota Y, 2012, STEM CELLS, V30, P1726, DOI 10.1002/stem.1137; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jackson PL, 2010, MOL MED, V16, P159, DOI 10.2119/molmed.2009.00109; Jiang P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3196; KAWABATA K, 1991, BIOCHEM BIOPH RES CO, V177, P814, DOI 10.1016/0006-291X(91)91862-7; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Lu JN, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-233; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nissenbaum J, 2010, GENOME RES, V20, P1180, DOI 10.1101/gr.104976.110; Papatriantafyllou M, 2012, P NATL ACAD SCI USA, V109, P1631, DOI 10.1073/pnas.1115980109; Persson AK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-7; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Reardon C, 2011, IMMUNITY, V35, P223, DOI 10.1016/j.immuni.2011.05.015; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Sipione S, 2006, J IMMUNOL, V177, P5051, DOI 10.4049/jimmunol.177.8.5051; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Wang Zhuo, 2011, Dev Growth Differ, V53, P357, DOI 10.1111/j.1440-169X.2010.01235.x; Xu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032581; Ziv-Sefer S, 2009, PAIN, V146, P148, DOI 10.1016/j.pain.2009.07.020	53	122	125	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					518	U298		10.1038/nm.3852	http://dx.doi.org/10.1038/nm.3852			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25915831	Green Accepted, Green Submitted			2022-12-25	WOS:000354068800021
J	Shinoda, K; Luijten, IHN; Hasegawa, Y; Hong, H; Sonne, SB; Kim, M; Xue, R; Chondronikola, M; Cypess, AM; Tseng, YH; Nedergaard, J; Sidossis, LS; Kajimura, S				Shinoda, Kosaku; Luijten, Ineke H. N.; Hasegawa, Yutaka; Hong, Haemin; Sonne, Si B.; Kim, Miae; Xue, Ruidan; Chondronikola, Maria; Cypess, Aaron M.; Tseng, Yu-Hua; Nedergaard, Jan; Sidossis, Labros S.; Kajimura, Shingo			Genetic and functional characterization of clonally derived adult human brown adipocytes	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; INSULIN SENSITIVITY; FAT DEVELOPMENT; EXPRESSION; NECK; CELL; STIMULATION; TEMPERATURE; BRITE; INDEX	Brown adipose tissue (BAT) acts in mammals as a natural defense system against hypothermia, and its activation to a state of increased energy expenditure is believed to protect against the development of obesity. Even though the existence of BAT in adult humans has been widely appreciated(1-8), its cellular origin and molecular identity remain elusive largely because of high cellular heterogeneity within various adipose tissue depots. To understand the nature of adult human brown adipocytes at single cell resolution, we isolated clonally derived adipocytes from stromal vascular fractions of adult human BAT from two individuals and globally analyzed their molecular signatures. We used RNA sequencing followed by unbiased genome-wide expression analyses and found that a population of uncoupling protein 1 (UCP1)-positive human adipocytes possessed molecular signatures resembling those of a recruitable form of thermogenic adipocytes (that is, beige adipocytes). In addition, we identified molecular markers that were highly enriched in UCP1-positive human adipocytes, a set that included potassium channel K3 (KCNK3) and mitochondrial tumor suppressor 1 (MTUS1). Further, we functionally characterized these two markers using a loss-of-function approach and found that KCNK3 and MTUS1 were required for beige adipocyte differentiation and thermogenic function. The results of this study present new opportunities for human BAT research, such as facilitating cell-based disease modeling and unbiased screens for thermogenic regulators.	[Shinoda, Kosaku; Luijten, Ineke H. N.; Hasegawa, Yutaka; Hong, Haemin; Sonne, Si B.; Kim, Miae; Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Shinoda, Kosaku; Luijten, Ineke H. N.; Hasegawa, Yutaka; Hong, Haemin; Sonne, Si B.; Kim, Miae; Kajimura, Shingo] UCSF, Dept Cell & Tissue Biol, San Francisco, CA USA; [Shinoda, Kosaku; Luijten, Ineke H. N.; Hasegawa, Yutaka; Hong, Haemin; Sonne, Si B.; Kim, Miae; Kajimura, Shingo] UCSF, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Luijten, Ineke H. N.; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Xue, Ruidan; Cypess, Aaron M.; Tseng, Yu-Hua] Joslin Diabet Ctr, Boston, MA 02215 USA; [Xue, Ruidan; Cypess, Aaron M.; Tseng, Yu-Hua] Harvard Univ, Sch Med, Boston, MA USA; [Chondronikola, Maria; Sidossis, Labros S.] Shriners Hosp Children, Metab Unit, Galveston, TX 77550 USA; [Chondronikola, Maria; Sidossis, Labros S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Chondronikola, Maria; Sidossis, Labros S.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Chondronikola, Maria; Sidossis, Labros S.] Univ Texas Med Branch, Dept Nutr & Metab, Galveston, TX 77555 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stockholm University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kajimura, S (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	skajimura@diabetes.ucsf.edu	Kajimura, Shingo/AAC-5090-2019; Sonne, Si Brask/A-4851-2012; Chondronikola, Maria/ABH-6994-2020; Sidossis, Labros/AAN-9546-2021; Shinoda, Kosaku/V-1698-2019; Nedergaard, Jan/A-1706-2010; Nedergaard, Jan/Q-8286-2019; Tseng, Yu-Hua/AAE-6471-2021	Kajimura, Shingo/0000-0003-0672-5910; Sonne, Si Brask/0000-0003-3194-3805; Sidossis, Labros/0000-0001-8313-7966; Shinoda, Kosaku/0000-0002-1928-0749; Tseng, Yu-Hua/0000-0003-2053-9559; Nedergaard, Jan/0000-0003-2070-1587	National Institutes of Health (NIH) [DK087853, DK097441]; UCSF Diabetes Research Center grant [DK63720]; UCSF Program for Breakthrough Biomedical Research program; Pew Charitable Trust; Japan Science and Technology Agency; NIH [P50-GM60338]; American Dental Association [1-14-TS-35]; Japan Society for the Promotion of Science; Manpei Suzuki Diabetes Foundation; Dutch Heart Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075112, R01DK097441, P30DK036836, ZIADK075115, R00DK087853, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Diabetes Research Center grant; UCSF Program for Breakthrough Biomedical Research program; Pew Charitable Trust; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Dental Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Manpei Suzuki Diabetes Foundation; Dutch Heart Foundation(Netherlands Heart Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the National Institutes of Health (NIH) (DK087853 and DK097441), the UCSF Diabetes Research Center grant (DK63720), the UCSF Program for Breakthrough Biomedical Research program, the Pew Charitable Trust, and the Japan Science and Technology Agency (all to S.K.); and from the NIH (P50-GM60338) and the American Dental Association (1-14-TS-35) (both to L.S.S.). K.S. is supported by a fellowship from the Japan Society for the Promotion of Science. Y.H. is supported by the Manpei Suzuki Diabetes Foundation. I.H.N.L. is supported by the Dutch Heart Foundation.	Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue M, 2008, J NEUROCHEM, V106, P1804, DOI 10.1111/j.1471-4159.2008.05521.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nouet S, 2004, J BIOL CHEM, V279, P28989, DOI 10.1074/jbc.M403880200; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Sondergaard E, 2015, DIABETIC MED, V32, pE4, DOI 10.1111/dme.12595; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Tews D, 2014, MOL CELL ENDOCRINOL, V395, P41, DOI 10.1016/j.mce.2014.07.011; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125	41	293	300	0	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					389	+		10.1038/nm.3819	http://dx.doi.org/10.1038/nm.3819			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25774848	Green Accepted, Green Published			2022-12-25	WOS:000352493600021
J	Waltz, E				Waltz, Emily			Engineers of scent	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	7	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					329	332		10.1038/nbt.3191	http://dx.doi.org/10.1038/nbt.3191			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25850048				2022-12-25	WOS:000352348500011
J	Kato, N; Loh, M; Takeuchi, F; Verweij, N; Wang, X; Zhang, WH; Kelly, TN; Saleheen, D; Lehne, B; Leach, IM; Drong, AW; Abbott, J; Wahl, S; Tan, ST; Scott, WR; Campanella, G; Chadeau-Hyam, M; Afzal, U; Ahluwalia, TS; Bonder, MJ; Chen, P; Dehghan, A; Edwards, TL; Esko, T; Go, MJ; Harris, SE; Hartiala, J; Kasela, S; Kasturiratne, A; Khor, CC; Kleber, ME; Li, HX; Mok, ZY; Nakatochi, M; Sapari, NS; Saxena, R; Stewart, AFR; Stolk, L; Tabara, Y; Teh, AL; Wu, Y; Wu, JY; Zhang, Y; Aits, I; Alves, ADC; Das, S; Dorajoo, R; Hopewell, JC; Kim, YK; Koivula, RW; Luan, J; Lyytikainen, LP; Nguyen, QN; Pereira, MA; Postmus, I; Raitakari, OT; Bryan, MS; Scott, RA; Sorice, R; Tragante, V; Traglia, M; White, J; Yamamoto, K; Zhang, YH; Adair, LS; Ahmed, A; Akiyama, K; Asif, R; Aung, T; Barroso, I; Bjonnes, A; Braun, TR; Cai, H; Chang, LC; Chen, CH; Cheng, CY; Chong, YS; Collins, R; Courtney, R; Davies, G; Delgado, G; Do, LD; Doevendans, PA; Gansevoort, RT; Gao, YT; Grammer, TB; Grarup, N; Grewal, J; Gu, DF; Wander, GS; Hartikainen, AL; Hazen, SL; He, J; Heng, CK; Hixson, JE; Hofman, A; Hsu, C; Huang, W; Husemoen, LLN; Hwang, JY; Ichihara, S; Igase, M; Isono, M; Justesen, JM; Katsuy, T; Kibriya, MG; Kim, YJ; Kishimoto, M; Koh, WP; Kohara, K; Kumari, M; Kwek, K; Lee, NR; Lee, J; Liao, JM; Lieb, W; Liewald, DCM; Matsubara, T; Matsushita, Y; Meitinger, T; Mihailov, E; Milani, L; Mills, R; Mononen, N; Muller-Nurasyid, M; Nabika, T; Nakashima, E; Ng, HK; Nikus, K; Nutile, T; Ohkubo, T; Ohnaka, K; Parish, S; Paternoster, L; Peng, H; Peters, A; Pham, ST; Pinidiyapathirage, MJ; Rahman, M; Rakugi, H; Rolandsson, O; Rozario, MA; Ruggiero, D; Sala, CF; Sarju, R; Shimokawa, K; Snieder, H; Sparso, T; Spiering, W; Starr, JM; Stott, DJ; Stram, DO; Sugiyama, T; Szymczak, S; Tang, WHW; Tong, L; Trompet, S; Turjanmaa, V; Ueshima, H; Uitterlinden, AG; Umemura, S; Vaarasmaki, M; van Dam, RM; van Gilst, WH; van Veldhuisen, DJ; Viikari, JS; Waldenberger, M; Wang, YQ; Wang, AL; Wilson, R; Wong, TY; Xiang, YB; Yamaguchi, S; Ye, XW; Young, RD; Young, TL; Yuan, JM; Zhou, XY; Asselbergs, FW; Ciullo, M; Clarke, R; Deloukas, P; Franke, A; Franks, PW; Franks, S; Friedlander, Y; Gross, MD; Guo, ZR; Hansen, T; Jarvelin, MR; Jorgensen, T; Jukema, JW; Kahonen, M; Kajio, H; Kivimaki, M; Lee, JY; Lehtimaki, T; Linneberg, A; Miki, T; Pedersen, O; Samani, NJ; Sorensen, TIA; Takayanagi, R; Toniolo, D; Ahsan, H; Allayee, H; Chen, YT; Danesh, J; Deary, IJ; Franco, OH; Franke, L; Heijman, BT; Holbrook, JD; Isaacs, A; Kim, BJ; Lin, X; Liu, JJ; Marz, W; Metspalu, A; Mohlke, KL; Sanghera, DK; Shu, XO; van Meurs, JBJ; Vithana, E; Wickremasinghe, AR; Wijmenga, C; Wolffenbuttel, BHW; Yokota, M; Zheng, W; Zhu, DL; Vineis, P; Kyrtopoulos, SA; Kleinjans, JCS; McCarthy, MI; Soong, R; Gieger, C; Scott, J; Teo, YY; He, J; Elliott, P; Tai, ES; van der Harst, P; Kooner, JS; Chambers, JC				Kato, Norihiro; Loh, Marie; Takeuchi, Fumihiko; Verweij, Niek; Wang, Xu; Zhang, Weihua; Kelly, Tanika N.; Saleheen, Danish; Lehne, Benjamin; Leach, Irene Mateo; Drong, Alexander W.; Abbott, James; Wahl, Simone; Tan, Sian-Tsung; Scott, William R.; Campanella, Gianluca; Chadeau-Hyam, Marc; Afzal, Uzma; Ahluwalia, Tarunveer S.; Bonder, Marc Jan; Chen, Peng; Dehghan, Abbas; Edwards, Todd L.; Esko, Tonu; Go, Min Jin; Harris, Sarah E.; Hartiala, Jaana; Kasela, Silva; Kasturiratne, Anuradhani; Khor, Chiea-Chuen; Kleber, Marcus E.; Li, Huaixing; Mok, Zuan Yu; Nakatochi, Masahiro; Sapari, Nur Sabrina; Saxena, Richa; Stewart, Alexandre F. R.; Stolk, Lisette; Tabara, Yasuharu; Teh, Ai Ling; Wu, Ying; Wu, Jer-Yuarn; Zhang, Yi; Aits, Imke; Alves, Alexessander Da Silva Couto; Das, Shikta; Dorajoo, Rajkumar; Hopewell, Jemma C.; Kim, Yun Kyoung; Koivula, Robert W.; Luan, Jian'an; Lyytikainen, Leo-Pekka; Nguyen, Quang N.; Pereira, Mark A.; Postmus, Iris; Raitakari, Olli T.; Bryan, Molly Scannell; Scott, Robert A.; Sorice, Rossella; Tragante, Vinicius; Traglia, Michela; White, Jon; Yamamoto, Ken; Zhang, Yonghong; Adair, Linda S.; Ahmed, Alauddin; Akiyama, Koichi; Asif, Rasheed; Aung, Tin; Barroso, Ines; Bjonnes, Andrew; Braun, Timothy R.; Cai, Hui; Chang, Li-Ching; Chen, Chien-Hsiun; Cheng, Ching-Yu; Chong, Yap-Seng; Collins, Rory; Courtney, Regina; Davies, Gail; Delgado, Graciela; Do, Loi D.; Doevendans, Pieter A.; Gansevoort, Ron T.; Gao, Yu-Tang; Grammer, Tanja B.; Grarup, Niels; Grewal, Jagvir; Gu, Dongfeng; Wander, Gurpreet S.; Hartikainen, Anna-Liisa; Hazen, Stanley L.; He, Jing; Heng, Chew-Kiat; Hixson, James E.; Hofman, Albert; Hsu, Chris; Huang, Wei; Husemoen, Lise L. N.; Hwang, Joo-Yeon; Ichihara, Sahoko; Igase, Michiya; Isono, Masato; Justesen, Johanne M.; Katsuy, Tomohiro; Kibriya, Muhammad G.; Kim, Young Jin; Kishimoto, Miyako; Koh, Woon-Puay; Kohara, Katsuhiko; Kumari, Meena; Kwek, Kenneth; Lee, Nanette R.; Lee, Jeannette; Liao, Jiemin; Lieb, Wolfgang; Liewald, David C. M.; Matsubara, Tatsuaki; Matsushita, Yumi; Meitinger, Thomas; Mihailov, Evelin; Milani, Lili; Mills, Rebecca; Mononen, Nina; Mueller-Nurasyid, Martina; Nabika, Toru; Nakashima, Eitaro; Ng, Hong Kiat; Nikus, Kjell; Nutile, Teresa; Ohkubo, Takayoshi; Ohnaka, Keizo; Parish, Sarah; Paternoster, Lavinia; Peng, Hao; Peters, Annette; Pham, Son T.; Pinidiyapathirage, Mohitha J.; Rahman, Mahfuzar; Rakugi, Hiromi; Rolandsson, Olov; Rozario, Michelle Ann; Ruggiero, Daniela; Sala, Cinzia F.; Sarju, Ralhan; Shimokawa, Kazuro; Snieder, Harold; Sparso, Thomas; Spiering, Wilko; Starr, John M.; Stott, David J.; Stram, Daniel O.; Sugiyama, Takao; Szymczak, Silke; Tang, W. H. Wilson; Tong, Lin; Trompet, Stella; Turjanmaa, Vaino; Ueshima, Hirotsugu; Uitterlinden, Andre G.; Umemura, Satoshi; Vaarasmaki, Marja; van Dam, Rob M.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.; Viikari, Jorma S.; Waldenberger, Melanie; Wang, Yiqin; Wang, Aili; Wilson, Rory; Wong, Tien-Yin; Xiang, Yong-Bing; Yamaguchi, Shuhei; Ye, Xingwang; Young, Robin D.; Young, Terri L.; Yuan, Jian-Min; Zhou, Xueya; Asselbergs, Folkert W.; Ciullo, Marina; Clarke, Robert; Deloukas, Panos; Franke, Andre; Franks, Paul W.; Franks, Steve; Friedlander, Yechiel; Gross, Myron D.; Guo, Zhirong; Hansen, Torben; Jarvelin, Marjo-Riitta; Jorgensen, Torben; Jukema, J. Wouter; Kahonen, Mika; Kajio, Hiroshi; Kivimaki, Mika; Lee, Jong-Young; Lehtimaki, Terho; Linneberg, Allan; Miki, Tetsuro; Pedersen, Oluf; Samani, Nilesh J.; Sorensen, Thorkild I. A.; Takayanagi, Ryoichi; Toniolo, Daniela; Ahsan, Habibul; Allayee, Hooman; Chen, Yuan-Tsong; Danesh, John; Deary, Ian J.; Franco, Oscar H.; Franke, Lude; Heijman, Bastiaan T.; Holbrook, Joanna D.; Isaacs, Aaron; Kim, Bong-Jo; Lin, Xu; Liu, Jianjun; Maerz, Winfried; Metspalu, Andres; Mohlke, Karen L.; Sanghera, Dharambir K.; Shu, Xiao-Ou; van Meurs, Joyce B. J.; Vithana, Eranga; Wickremasinghe, Ananda R.; Wijmenga, Cisca; Wolffenbuttel, Bruce H. W.; Yokota, Mitsuhiro; Zheng, Wei; Zhu, Dingliang; Vineis, Paolo; Kyrtopoulos, Soterios A.; Kleinjans, Jos C. S.; McCarthy, Mark I.; Soong, Richie; Gieger, Christian; Scott, James; Teo, Yik-Ying; He, Jiang; Elliott, Paul; Tai, E. Shyong; van der Harst, Pim; Kooner, Jaspal S.; Chambers, John C.		BIOS-consortium; CARDIo GRAMplusCD; LifeLines Cohort Study; InterAct Consortium	Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation	NATURE GENETICS			English	Article							RISK-FACTORS; REGIONS; DISEASE; KIDNEY; METAANALYSIS; INDIVIDUALS; PERFORMANCE; POPULATION; EXPRESSION; VARIANTS	We carried out a trans-ancestry genome-wide association and replication study of blood pressure phenotypes among up to 320,251 individuals of East Asian, European and South Asian ancestry. We find genetic variants at 12 new loci to be associated with blood pressure (P = 3.9 x 10(-11) to 5.0 x 10(-21)). The sentinel blood pressure SNPs are enriched for association with DNA methylation at multiple nearby CpG sites, suggesting that, at some of the loci identified, DNA methylation may lie on the regulatory pathway linking sequence variation to blood pressure. The sentinel SNPs at the 12 new loci point to genes involved in vascular smooth muscle (IGFBP3, KCNK3, PDE3A and PRDM6) and renal (ARHGAP24, OSR1, SLC22A7 and TBX2) function. The new and known genetic variants predict increased left ventricular mass, circulating levels of NT-proBNP, and cardiovascular and all-cause mortality (P = 0.04 to 8.6 x 10(-6)). Our results provide new evidence for the role of DNA methylation in blood pressure regulation.	[Kato, Norihiro; Takeuchi, Fumihiko; Akiyama, Koichi; Isono, Masato; Shimokawa, Kazuro] Natl Ctr Global Hlth & Med, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo, Japan; [Loh, Marie; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Loh, Marie; Zhang, Weihua; Lehne, Benjamin; Scott, William R.; Campanella, Gianluca; Chadeau-Hyam, Marc; Afzal, Uzma; Grewal, Jagvir; Vineis, Paolo; Elliott, Paul; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Loh, Marie] ASTAR, Translat Lab Genet Med, Singapore, Singapore; [Verweij, Niek; Leach, Irene Mateo; van Gilst, Wiek H.; van Veldhuisen, Dirk J.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Wang, Xu; Chen, Peng; Khor, Chiea-Chuen; Cheng, Ching-Yu; Koh, Woon-Puay; Lee, Jeannette; van Dam, Rob M.; Liu, Jianjun; Teo, Yik-Ying; Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wang, Xu; Chen, Peng; Khor, Chiea-Chuen; Cheng, Ching-Yu; Koh, Woon-Puay; Lee, Jeannette; van Dam, Rob M.; Liu, Jianjun; Teo, Yik-Ying; Tai, E. Shyong] Natl Univ Hlth Syst, Singapore, Singapore; [Zhang, Weihua; Tan, Sian-Tsung; Afzal, Uzma; Grewal, Jagvir; Mills, Rebecca; Kooner, Jaspal S.; Chambers, John C.] Ealing Hosp Natl Hlth Serv NHS Trust, Southall, Middx, England; [Kelly, Tanika N.; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Saleheen, Danish; Asif, Rasheed] Ctr Non Communicable Dis, Karachi, Pakistan; [Saleheen, Danish; Young, Robin D.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Saleheen, Danish] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Drong, Alexander W.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Abbott, James] Univ London Imperial Coll Sci Technol & Med, Bioinformat Support Serv, London, England; [Wahl, Simone; Waldenberger, Melanie; Wilson, Rory; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Wahl, Simone; Peters, Annette; Waldenberger, Melanie; Wilson, Rory; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Wahl, Simone] German Ctr Diabet Res DZD, Neuherberg, Germany; [Tan, Sian-Tsung; Scott, William R.; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Ahluwalia, Tarunveer S.; Grarup, Niels; Justesen, Johanne M.; Sparso, Thomas; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood COSP, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Bonder, Marc Jan; Franke, Lude; Wijmenga, Cisca; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Dehghan, Abbas; Hofman, Albert; Uitterlinden, Andre G.; Franco, Oscar H.; Isaacs, Aaron] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Edwards, Todd L.] Vanderbilt Univ, Dept Med, Div Epidemiol, Vanderbilt Epidemiol Ctr,Ctr Human Genet Res, Nashville, TN USA; [Esko, Tonu; Kasela, Silva; Mihailov, Evelin; Milani, Lili; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Go, Min Jin; Kim, Yun Kyoung; Hwang, Joo-Yeon; Kim, Young Jin; Kim, Bong-Jo] Natl Inst Hlth, Ctr Genome Sci, Chungcheongbuk Do, South Korea; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.] Western Gen Hosp, Inst Genet & Mol Med, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Harris, Sarah E.; Davies, Gail; Liewald, David C. M.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Aging & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Kasturiratne, Anuradhani; Pinidiyapathirage, Mohitha J.; Wickremasinghe, Ananda R.] Univ Kelaniya, Fac Med, Dept Publ Hlth, Ragama, Sri Lanka; [Khor, Chiea-Chuen; Dorajoo, Rajkumar; Liu, Jianjun; Teo, Yik-Ying] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Khor, Chiea-Chuen; Cheng, Ching-Yu; Liao, Jiemin; Wong, Tien-Yin; Vithana, Eranga] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Khor, Chiea-Chuen] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Kleber, Marcus E.; Delgado, Graciela; Grammer, Tanja B.; Maerz, Winfried] Heidelberg Univ, Mannheim Med Fac, Med Clin V, Mannheim, Germany; [Li, Huaixing; Wang, Yiqin; Ye, Xingwang; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Mok, Zuan Yu; Sapari, Nur Sabrina; Ng, Hong Kiat; Rozario, Michelle Ann; Soong, Richie] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Nakatochi, Masahiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Saxena, Richa; Bjonnes, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Stewart, Alexandre F. R.] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada; [Stewart, Alexandre F. R.] Ruddy Canadian Cardiovasc Genet Ctr, Ottawa, ON, Canada; [Stolk, Lisette; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Tabara, Yasuharu] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Teh, Ai Ling; Chong, Yap-Seng; Holbrook, Joanna D.] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Wu, Jer-Yuarn; Chang, Li-Ching; Chen, Chien-Hsiun; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Wu, Jer-Yuarn; Chen, Chien-Hsiun] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Zhang, Yi; Zhu, Dingliang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, State Key Lab Med Genet, Shanghai 200030, Peoples R China; [Zhang, Yi; Zhu, Dingliang] Shanghai Res Inst Hypertens, Shanghai, Peoples R China; [Aits, Imke; Lieb, Wolfgang] Univ Kiel, Inst Epidemiol & Biobank Popgen, Kiel, Germany; [Alves, Alexessander Da Silva Couto; Das, Shikta; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC,Hlth Protect Agcy PHE,Ctr Environm & Hlth, London, England; [Hopewell, Jemma C.; Collins, Rory; Parish, Sarah; Clarke, Robert] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trials Support Unit, Oxford, England; [Koivula, Robert W.; Franks, Paul W.] Skane Univ, Hosp Malmo, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Luan, Jian'an; Scott, Robert A.] Univ Cambridge, Epidemiol Unit, MRC, Inst Metab Sci, Cambridge, England; [Lyytikainen, Leo-Pekka; Mononen, Nina; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lyytikainen, Leo-Pekka; Mononen, Nina; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland; [Nguyen, Quang N.; Do, Loi D.; Pham, Son T.] Bach Mai Hosp, Vietnam Natl Heart Inst, Hanoi, Vietnam; [Pereira, Mark A.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Postmus, Iris] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Postmus, Iris] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Bryan, Molly Scannell; Kibriya, Muhammad G.; Tong, Lin; Ahsan, Habibul] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Sorice, Rossella; Nutile, Teresa; Ruggiero, Daniela; Ciullo, Marina] CNR, Inst Genet & Biophys Buzzati Traverso, I-80125 Naples, Italy; [Tragante, Vinicius; Doevendans, Pieter A.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Traglia, Michela; Sala, Cinzia F.; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Traglia, Michela] Ist Ricovero & Cura Carattere Sci IRCCS Burlo Gar, Inst Maternal & Child Hlth, Trieste, Italy; [White, Jon] UCL, Genet Inst, Dept Genet Environm & Evolut, London, England; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Div Genom, Fukuoka 812, Japan; [Zhang, Yonghong; Peng, Hao; Wang, Aili; Guo, Zhirong] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Ahmed, Alauddin; Rahman, Mahfuzar] UChicago Res Bangladesh, Dhaka, Bangladesh; [Aung, Tin; Cheng, Ching-Yu; Liao, Jiemin; Wong, Tien-Yin; Vithana, Eranga; Teo, Yik-Ying] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Barroso, Ines] Wellcome Trust Sanger Inst, Metabol Dis Grp, Cambridge, England; [Barroso, Ines] Addenbrookes Hosp, Inst Metab Sci, Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge, England; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Braun, Timothy R.; Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Cai, Hui; Courtney, Regina; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Dept Med, Div Epidemiol, Vanderbilt Epidemiol Ctr,Vanderbilt Genet Inst, Nashville, TN USA; [Cai, Hui; Courtney, Regina; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Dept Med, Div Epidemiol, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Cheng, Ching-Yu] Duke Natl Univ Singapore, Grad Sch Med, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore; [Chong, Yap-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Davies, Gail; Liewald, David C. M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wander, Gurpreet S.; Sarju, Ralhan] Hero DMC Heart Inst, Dayanand Med Coll & Hosp Unit, Ludhiana, Punjab, India; [Hartikainen, Anna-Liisa; Vaarasmaki, Marja] Oulu Univ Hosp, Dept Obstet & Gynecol, Oulu, Finland; [Hartikainen, Anna-Liisa; Vaarasmaki, Marja] Univ Oulu, Med Res Ctr, Oulu, Finland; [Hartikainen, Anna-Liisa; Vaarasmaki, Marja; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Hazen, Stanley L.; Tang, W. H. Wilson] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [He, Jing] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Heng, Chew-Kiat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore; [Hixson, James E.] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Hsu, Chris; Stram, Daniel O.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Huang, Wei] Chinese Natl Human Genom Ctr, Dept Genet, Shanghai, Peoples R China; [Husemoen, Lise L. N.; Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Ichihara, Sahoko] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie 514, Japan; [Igase, Michiya; Kohara, Katsuhiko; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon, Ehime, Japan; [Katsuy, Tomohiro; Tai, E. Shyong] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Katsuy, Tomohiro; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Kishimoto, Miyako; Matsushita, Yumi; Kajio, Hiroshi] Natl Ctr Global Hlth & Med, Toyama, Japan; [Koh, Woon-Puay] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Kumari, Meena; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kwek, Kenneth] KK Womens & Childrens Hosp, Singapore, Singapore; [Lee, Nanette R.] Univ San Carlos, Off Populat Studies Fdn, Cebu, Philippines; [Lee, Nanette R.] Univ San Carlos, Dept Anthropol Sociol & Hist, Cebu, Philippines; [Matsubara, Tatsuaki] Aichi Gakuin Univ, Sch Dent, Dept Internal Med, Nagoya, Aichi 464, Japan; [Meitinger, Thomas] Helmholtz Zenntrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Mueller-Nurasyid, Martina] Helmholtz Zenntrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina; Peters, Annette] German Ctr Cardiovasc Res DZHK, Munich, Germany; [Nabika, Toru] Shimane Univ, Fac Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Nakashima, Eitaro] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Nakashima, Eitaro] Chubu Rosai Hosp, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Nikus, Kjell] Tampere Univ Hosp, Dept Cardiol, Ctr Heart, Tampere, Finland; [Nikus, Kjell] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Ohnaka, Keizo] Kyushu Univ, Grad Sch Med Sci, Dept Geriatr Med, Fukuoka, Japan; [Paternoster, Lavinia; Sorensen, Thorkild I. A.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Rahman, Mahfuzar] Bangladesh Rehabil Assistance Comm, Res & Evaluat Div, Dhaka, Bangladesh; [Rolandsson, Olov; Franks, Paul W.] Umea Univ, Sect Family Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Stott, David J.] Univ Glasgow, Fac Med, Inst Cardiovasc & Med Sci, Acad Sect Geriatr Med, Glasgow, Lanark, Scotland; [Sugiyama, Takao] Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan; [Szymczak, Silke; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Tang, W. H. Wilson] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Turjanmaa, Vaino; Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Turjanmaa, Vaino; Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 52021, Japan; [Ueshima, Hirotsugu] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan; [Viikari, Jorma S.] Turku Univ Hosp, Div Med, FIN-20520 Turku, Finland; [Viikari, Jorma S.] Univ Turku, Dept Med, Turku, Finland; [Yamaguchi, Shuhei] Shimane Univ, Fac Med, Dept Internal Med 3, Izumo, Shimane, Japan; [Young, Terri L.; Vithana, Eranga] Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders NBD Program, Singapore, Singapore; [Young, Terri L.] Duke Univ, Med Ctr, Duke Eye Ctr, Durham, NC USA; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Canc Control & Populat Sci, Pittsburgh, PA USA; [Zhou, Xueya] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Dept Automat, Bioinformat Div,Minist Educ,Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhou, Xueya] Tsinghua Univ, Dept Automat, Ctr Synthet & Syst Biol, TNLIST,Minist Educ,Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhou, Xueya] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Asselbergs, Folkert W.; Jukema, J. Wouter; van der Harst, Pim] Netherlands Heart Inst, Interuniv Cardiol Inst Netherlands, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England; [Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Deloukas, Panos] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Franks, Steve] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London, England; [Friedlander, Yechiel] Hebrew Univ Jerusalem, Sch Publ Hlth, Jerusalem, Israel; [Gross, Myron D.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Epidemiol, Oulu, Finland; [Jukema, J. Wouter] ICIN, Utrecht, Netherlands; [Lee, Jong-Young] Minist Hlth & Welf, Seoul, South Korea; [Lee, Jong-Young] THERAGEN ETEX Bio Inst, Suwon, South Korea; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, DK-2100 Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Kyushu, Japan; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Danesh, John] Wellcome Trust Sanger Inst, Hinxton, England; [Heijman, Bastiaan T.] Leiden Univ, Med Ctr, Mol Epidemiol, Leiden, Netherlands; [Maerz, Winfried] Med Univ Graz, Inst Clin Med, Graz, Austria; [Maerz, Winfried] Med Univ Graz, Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Synlab Acad, Synlab Serv, Mannheim, Germany; [Wolffenbuttel, Bruce H. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Kyrtopoulos, Soterios A.] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, GR-11635 Athens, Greece; [Kleinjans, Jos C. S.] Maastricht Univ, Dept Toxicogenom, Maastricht, Netherlands; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Soong, Richie] Natl Univ Singapore, Dept Pathol, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London, England	National Center for Global Health & Medicine - Japan; University of Oulu; Imperial College London; Agency for Science Technology & Research (A*STAR); University of Groningen; National University of Singapore; National University of Singapore; Tulane University; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Vanderbilt University; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Southern California; University of Southern California; University Kelaniya; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Ruprecht Karls University Heidelberg; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National University of Singapore; Nagoya University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Ottawa; University of Ottawa Heart Institute; Erasmus University Rotterdam; Erasmus MC; Kyoto University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of North Carolina; University of North Carolina Chapel Hill; Academia Sinica - Taiwan; China Medical University Taiwan; Shanghai Jiao Tong University; University of Kiel; Imperial College London; University of Oxford; Lund University; Skane University Hospital; University of Cambridge; Tampere University; University of Minnesota System; University of Minnesota Twin Cities; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turku; University of Turku; University of Chicago; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Utrecht University; Utrecht University Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Burlo Garofolo; University of London; University College London; Kyushu University; Soochow University - China; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore; Singapore National Eye Center; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oklahoma System; University of Oklahoma Health Sciences Center; Vanderbilt University; Vanderbilt University; National University of Singapore; National University of Singapore; University of Edinburgh; University of Groningen; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Dayanand Medical College & Hospital; University of Oulu; University of Oulu; University of Oulu; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Vanderbilt University; National University of Singapore; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Southern California; University of Copenhagen; Mie University; Ehime University; Osaka University; Osaka University; National Center for Global Health & Medicine - Japan; National University of Singapore; University of London; University College London; KK Women's & Children's Hospital; University of San Carlos; University of San Carlos; Aichi Gakuin University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; German Centre for Cardiovascular Research; Shimane University; Nagoya University; Tampere University; Tampere University Hospital; Tampere University; Teikyo University; Kyushu University; University of Bristol; Bangladesh Rural Advancement Committee BRAC; Umea University; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Edinburgh; University of Glasgow; Asahi Life Foundation; University of Kiel; Cleveland Clinic Foundation; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tampere University; Tampere University Hospital; Tampere University; Shiga University of Medical Science; Shiga University of Medical Science; Yokohama City University; University of Turku; University of Turku; Shimane University; National University of Singapore; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; Tsinghua University; University of Hong Kong; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of London; University College London; University of London; Queen Mary University London; King Abdulaziz University; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; Hebrew University of Jerusalem; University of Minnesota System; University of Minnesota Twin Cities; University of Oulu; University of Oulu; Rigshospitalet; University of Copenhagen; University of Copenhagen; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Copenhagen; Bispebjerg Hospital; Kyushu University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Wellcome Trust Sanger Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Medical University of Graz; Medical University of Graz; SYNLAB Group; University of Groningen; Aichi Gakuin University; National Hellenic Research Foundation; Maastricht University; University of Oxford; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England.	nokato@ri.ncgm.go.jp; jhe@tulane.edu; p.elliott@ic.ac.uk; e_shyong_tai@nuhs.edu.sg; p.van.der.harst@umcg.nl; j.kooner@ic.ac.uk; john.chambers@ic.ac.uk	Pedersen, Oluf/AAG-8015-2020; Franke, Lude/P-7036-2016; Verweij, Niek/ABC-6249-2021; Szymczak, Silke/HGT-8202-2022; Lee, Jong-Young/M-6319-2013; van Gilst, Wiek/R-1806-2019; Meitinger, Thomas/O-1318-2015; Asselbergs, Folkert W./ABD-6752-2021; Chen, Chien Hsiun/Q-3826-2018; Lyytikäinen, Leo-Pekka/C-8544-2016; Kyrtopoulos, Soterios/AAI-6426-2020; Grarup, Niels/K-2807-2015; Justesen, Johanne Marie/AAY-4210-2021; Milani, Lili/N-1097-2019; Wong, Tien Yin/AAC-9724-2020; Gao, Yu/HGE-1937-2022; Zheng, Wei/O-3351-2013; Hartiala, Jaana A/GLR-1825-2022; Kim, Young-jin/GSD-3168-2022; Cheng, Ching-Yu/Y-2229-2019; Toniolo, Daniela/AAE-2969-2019; peng, hao/I-7707-2018; Pinidiyapathirage, Janani/AAR-8074-2021; Drong, Alexander/AAG-1115-2020; He, Jiang/AAF-5303-2020; Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; Wu, Jer-Yuarn/S-7010-2018; Ahluwalia, Tarunveer Singh/C-5549-2009; Raitakari, Olli/AAQ-7389-2021; Pedersen, Oluf/Z-1731-2019; Nakatochi, Masahiro/Q-1247-2015; Wijmenga, Cisca/AAE-7719-2019; Franke, Andre/B-2151-2010; Jørgensen, Torben/Z-1335-2018; Müller-Nurasyid, Martina/I-8735-2018; zhang, weihua/GXV-1334-2022; Traglia, Michela/AAX-5816-2020; Liu, Jianjun/AAK-4989-2020; Verweij, Niek/A-4499-2017; Tang, Wai Hong Wilson/I-1238-2013; Dehghan, Abbas/ABE-7377-2020; Lehtimäki, Terho/AAD-1094-2022; Franco, Óscar H/ABE-2305-2020; Saxena, Richa/AAG-7279-2020; Ciullo, Marina/AAE-3041-2020; Szymczak, Silke/C-6625-2013; Deary, Ian J/C-6297-2009; Kivimaki, Mika/B-3607-2012; Waldenberger, Melanie/B-5355-2014; Franks, Paul/AAA-3300-2020; Peng, Hao/AAB-4759-2022; Sala, Cinzia Felicita/AAN-1900-2020; Justesen, Johanne Marie/L-6023-2015; Lieb, Wolfgang/AAC-7650-2022; Chadeau, Marc/AAN-7586-2021; Stewart, Alexandre F.R./A-5677-2011; Zheng, Wei/GQQ-8951-2022; Hazen, Stanley L/ABD-5845-2021; Deloukas, Panos/B-2922-2013; Peters, Annette/A-6117-2011; ruggiero, daniela/K-5638-2016; Nikus, Kjell/K-7813-2019; van Dam, Rob M/F-9674-2010; Jukema, J. Wouter/ABD-6503-2021; Heng, Chew-Kiat/A-5530-2009; Wijmenga, Cisca/D-2173-2009; Campanella, Gianluca/G-2617-2010; Dehghan, Abbas/B-9896-2008; Peng, Hao/I-1134-2014; McCarthy, Mark/M-3763-2015; Paternoster, Lavinia/C-1292-2015	Franke, Lude/0000-0002-5159-8802; Verweij, Niek/0000-0002-4303-7685; Lee, Jong-Young/0000-0002-0092-9958; van Gilst, Wiek/0000-0003-2968-8585; Asselbergs, Folkert W./0000-0002-1692-8669; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Grarup, Niels/0000-0001-5526-1070; Justesen, Johanne Marie/0000-0002-0484-8522; Milani, Lili/0000-0002-5323-3102; Wong, Tien Yin/0000-0002-8448-1264; Zheng, Wei/0000-0003-1226-070X; Hartiala, Jaana A/0000-0003-4883-9318; Cheng, Ching-Yu/0000-0003-0655-885X; Toniolo, Daniela/0000-0001-9545-6032; Pinidiyapathirage, Janani/0000-0003-2947-3015; He, Jiang/0000-0002-8286-9652; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Pedersen, Oluf/0000-0002-3321-3972; Nakatochi, Masahiro/0000-0002-1838-4837; Wijmenga, Cisca/0000-0002-5635-1614; Franke, Andre/0000-0003-1530-5811; Müller-Nurasyid, Martina/0000-0003-3793-5910; Liu, Jianjun/0000-0002-3255-3019; Lehtimäki, Terho/0000-0002-2555-4427; Franco, Óscar H/0000-0002-4606-4929; Ciullo, Marina/0000-0002-9621-9984; Deary, Ian J/0000-0002-1733-263X; Kivimaki, Mika/0000-0002-4699-5627; Waldenberger, Melanie/0000-0003-0583-5093; Justesen, Johanne Marie/0000-0002-0484-8522; Chadeau, Marc/0000-0001-8341-5436; Deloukas, Panos/0000-0001-9251-070X; Peters, Annette/0000-0001-6645-0985; ruggiero, daniela/0000-0003-3898-7827; van Dam, Rob M/0000-0002-7354-8734; Jukema, J. Wouter/0000-0002-3246-8359; Heng, Chew-Kiat/0000-0002-7309-9473; Kasela, Silva/0000-0003-4362-0034; Campanella, Gianluca/0000-0002-5411-6338; van Meurs, Joyce/0000-0001-6245-2123; Pereira, Mark/0000-0002-6704-5276; Dehghan, Abbas/0000-0001-6403-016X; Rakugi, Hiromi/0000-0001-6508-4338; Wang, Yiqin/0000-0003-4714-774X; Holbrook, Joanna/0000-0003-1791-6894; NUTILE, TERESA/0000-0001-7062-8352; s, hema/0000-0002-3440-9475; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; Takeuchi, Fumihiko/0000-0003-3185-5661; Elliott, Paul/0000-0002-7511-5684; Peng, Hao/0000-0001-6277-662X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Nikus, Kjell/0000-0002-9345-9851; Szymczak, Silke/0000-0002-8897-9035; McCarthy, Mark/0000-0002-4393-0510; Linneberg, Allan/0000-0002-0994-0184; Kyrtopoulos, Soterios/0000-0002-6821-6532; Bonder, Marc Jan/0000-0002-8431-3180; Dorajoo, Rajkumar/0000-0001-6608-2051; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hansen, Torben/0000-0001-8748-3831; Khor, Chiea Chuen/0000-0002-1128-4729; Tang, W. H. Wilson/0000-0002-8335-735X; Franks, Paul/0000-0002-0520-7604; Zhou, Xueya/0000-0003-2350-081X; Ohkubo, Takayoshi/0000-0002-3283-8196; Stewart, Alexandre/0000-0003-2673-9164; Hughes, Rebecca/0000-0003-2110-5234; Paternoster, Lavinia/0000-0003-2514-0889; Tai, E Shyong/0000-0003-2929-8966; Meitinger, Thomas/0000-0002-8838-8403; Saxena, Richa/0000-0003-2233-1065; Jorgensen, Torben/0000-0001-9453-2830; Kahonen, Mika/0000-0002-4510-7341; Chong, Yap Seng/0000-0002-7232-8473; Loh, Marie/0000-0003-3626-8466; Vaarasmaki, Marja/0000-0002-8234-4434; Matsubara, Tatsuaki/0000-0002-0647-5475; Gieger, Christian/0000-0001-6986-9554; Couto Alves, Alex/0000-0001-8519-7356; Abbott, James/0000-0001-7701-4249; Scannell Bryan, Molly/0000-0003-1030-3155; Kumari, Meena/0000-0001-9716-1035; Kleber, Marcus/0000-0003-0663-7275; Scott, William/0000-0001-5467-114X	Grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan [24390084, 21390099, 20390185, 22390186, 24591060, 25253059, 25461127]; Science and Technology Incubation Program in Advanced Regions, Japanese Science and Technology Agency; Japanese Atherosclerosis Prevention Fund; Takeda Medical Research Foundation; National Cardiovascular Research Grants; US National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082766]; National Human Genome Research Institute [NOT-HG-11-009]; VPR bridge grant from the University of Oklahoma Health Sciences Center; BBMRI-NL; Netherlands Organization for Scientific Research (NWO project) [184.021.007]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Society for the Promotion of Science; grants for Core Research for Evolutional Science and Technology (CREST) from the Japanese Science and Technology Agency; Program for the Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation Organization (NIBIO); KAKENHI on Priority Area 'Applied Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Center for Global Health and Medicine; Okinaga Scholarship; Grants for International Health Research from the Ministry of Health, Labour and Welfare of Japan [17C-1, 20S-6]; National Center for Global Health and Medicine [22S-10, 25S-1]; Manpei Suzuki Diabetes Foundation; Italian Ministry of Universities (Interomics Flag project) [FIRB-RBNE08NKH7]; Assessorato Ricerca Regione Campania; Fondazione con il SUD [2011-PDR-13]; Fondazione Banco di Napoli; National Institutes of Health [DK078150, TW05596, HL085144, TW008288]; Novo Nordisk; Swedish Research Council; Pahlssons Foundation; Swedish Heart Lung Foundation; Skane Regional Health Authority; Estonian government [SF0180142s08]; Center of Excellence in Genomics (EXCEGEN); University of Tartu [SP1GVARENG]; Competitive Research Funding from Tampere University Hospital [9M048, 9N035]; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation, Finland; Tampere Tuberculosis Foundation; US NIH [R01CA107431, P42ES10349, 2R01LM010098, NCI RO1CA55069, R35CA53890, R01CA80205, R01CA144034, RO1CA82729, UM1CA173640, R37CA70867]; National Heart, Lung, and Blood Institute [P01HL098055, P01HL076491, R01HL103866, P20HL113452, R01HL103931]; National Institute of Environmental Health Sciences [R01ES021801]; National Heart, Lung, and Blood Institute, US NIH [U01HL072507, R01HL087263, R01HL090682]; Velux Foundation; Danish Medical Research Council; Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello (Horsholm, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories Denmark; Research Centre for Prevention and Health; Capital Region of Denmark; Lundbeck Foundation; Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp); Novo Nordisk Foundation; Korean Centers for Disease Control and Prevention [4845-301, 4851-302, 4851-307]; Korean National Institute of Health, Republic of Korea [2012-N73002-00]; UK Medical Research Council; British Heart Foundation; Merck Co.; Roche Vitamins, Ltd.; University of Oxford; Centre National de Genotypage from Merck Co.; Oxford British Heart Foundation Centre of Research Excellence; British Heart Foundation [FS/14/55/30806, RG/07/008/23674]; GENDINOB project; Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme [NMRC/TCR/012-NUHS/2014]; Singapore Institute for Clinical Sciences, A*STAR, Singapore; Compagnia di San Paolo (Torino, Italy); Fondazione Cariplo, Italy; Ministry of Health, Ricerca Finalizzata; CCM; Telethon, Italy; Danish Research Council; Danish Centre for Health Technology Assessment; Research Foundation of Copenhagen County; Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Danish Diabetes Association; European Union (Sixth Framework Programme of the European Community) [LSHM-CT-2006-037197]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21390099, 20390185, 19659163, 16790336, 12204008, 15790293, 16590433, 17790381, 18390192, 18590265, 18590587, 18590811, 19590929, 19650188, 19790423, 17390186, 20390184, 21390223]; Ministry of Health, Labor and Welfare of Japan [H15-Longevity-005, H17-Longevity-003, H16-Kenko-001, H18-Longevity(kokusai), H11-Longevity-020, H17-Kenkou-007, H17-Pharmaco-common-003, H18-Junkankitou[Seishuu]-Ippan-012, H20-Junkankitou[Seishuu]-Ippan-009, 013]; Health and Labor Sciences Research Grants, Japan; Science and Technology Incubation Program in Advanced Regions; Japanese Science and Technology Agency; Japanese Society for the Promotion of Science [16.54041, 18.54042, 19.7152, 20.7198, 20.7477, 20.54043]; Health Science Research Grants and Medical Technology Evaluation Research Grants from the Ministry of Health, Labour and Welfare of Japan; Uehara Memorial Foundation; Biomedical Innovation Grants; Japanese Research Foundation for Clinical Pharmacology; Helmholtz Zentrum Munchen-German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); Federal Ministry of Health; Munich Center of Health Sciences (MC Health), LMUinnovativ; German-Israeli Foundation for Scientific Research and Development; European Union [305280, 279143, 201668, 305739, LSHM-CT-2004-503485]; Helmholtz-Russia Joint Research Group (HRJRG) [310]; German Center for Diabetes Research (DZD); EU [602936]; BMBF e:Med project e:AtheroSysMed-Systems Medicine of Myocardial Infarction and Stroke; UK Biotechnology and Biological Sciences Research Council (BBSRC); Royal Society; Chief Scientist Office of the Scottish government; BBSRC; Age UK (The Disconnected Mind project); Netherlands Organization for Scientific Research (NWO) [175.010.2007.006, 184021007]; Economic Structure-Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); province of Groningen, University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; Medical Research Council, UK [G0601966, G0700931, G0500539, G0600331, G0902037]; Wellcome Trust [084723/Z/08/Z]; NIHR [RP-PG-0407-10371]; Action on Hearing Loss [G51]; INTERREG IV Oberrhein Program (Genetic Mechanisms of Cardiovascular Diseases) [A28]; European Regional Development Fund (ERDF); Wissenschaftsoffensive TMO; Academy of Finland (Center of Excellence in Complex Disease Genetics) [104781, 120315, 129269]; University Hospital Oulu, Biocenter; University of Oulu, Finland [75617]; European Commission [QLG1-CT-2000-01643, 223004]; National Heart, Lung, and Blood Institute through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; US NIH/National Institute of Mental Health [5R01MH63706:02]; ENGAGE project; Academy of Finland [286284, 134309, 126925, 121584, 124282, 129378, 117787, 41071]; Biocentrum Helsinki; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); Ministry of Science, Commerce and Transportation of the state of Schleswig-Holstein; German Ministry of Education and Research [01EY1103]; Dutch Kidney Foundation [E033]; European Union project grant GENECURE [FP-6 LSHM CT 2006 037697]; Netherlands Organization for Health Research and Development (NWO-Groot grant) [175.010.2007.006]; Netherlands Organization for Health Research and Development (NWO VENI grant) [916.761.70]; Netherlands Organization for Health Research and Development (ZonMw grant) [90.700.441]; Dutch Interuniversity Cardiology Institute Netherlands (ICIN); Pfizer; Bristol-Myers-Squibb; Netherlands Heart Foundation [2001 D 032]; Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging grant) [050-060-810]; Erasmus Medical Center; Erasmus University; Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); European Commission (DG XII); municipality of Rotterdam; Genetic Laboratory of the Department of Internal Medicine, Erasmus Medical Center; Biomedical Research Council of Singapore [08/1/35/19/550, 09/1/35/19/616]; NMRC, Singapore [STaR/0003/2008, CG/SERI/2010, NMRC/1270/2010, 0796/2003, IRG07nov013, IRG09nov014]; Genetic and Environmental Determinants of Type 2 Diabetes in Chinese Singaporeans, grant from the US NIH [R01DK080720]; NMRC of Singapore; Genome Institute of Singapore; A*STAR, Singapore; US NIH/National Cancer Institute [R35CA53890, R01CA80205, R01CA144034, RO1CA55069]; NUS-HUJ CREATE Programme of the National Research Foundation, Singapore [370062002]; Biomedical Research Council of Singapore (A*STAR, Singapore); Dutch government [NWO 184.021.007]; National Natural Science Foundation of China [81172761]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions; Yong Loo Lin School of Medicine; National University Health System; Life Sciences Institute of the National University of Singapore; National Research Foundation of Singapore [NRF-RF-2010-05]; Biomedical Research Council of Singapore (under the individual research grants scheme); Chinese National Key Program for Basic Research (973) [2004CB518603, 2006CB503804, 2009CB521905]; Chinese National High-Tech Program (863) [2009AA022703, 2006AA022179]; Ministry of Science and Technology, National Natural Science Foundation of China [30871361]; Academia Sinica Genomic Medicine Multicenter Study, Taiwan [40-05-GMM]; Stroke Association; National Institute on Aging [5RO1AG13196]; Agency for Health Care Policy Research [HS06516]; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-Economic Status and Health; Social Insurance Institution of Finland; Kuopio, Tampere and Turku University Hospital Medical Funds [X51001]; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation;  [RR20649];  [ES10126];  [DK56350];  [HEALTH-F4-2007-201413]; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MC_UU_12015/1, MR/K002414/1, G0700931, G0802782, MR/L003120/1, G0600331, MR/L01341X/1, MR/K013351/1, G0601966, G0800270, MC_UU_12013/1, G0902037] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; British Heart Foundation [RG/13/2/30098, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0902037, G0700931, MC_UU_12013/1, G0600331, MR/K002414/1, MR/L003120/1, G0601966, 1241993, G0800270, MC_U106179471, MR/K013351/1, MC_UU_12015/1, G0802782, MR/K026992/1, MR/L01341X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136, NF-SI-0611-10170, NF-SI-0512-10165] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish; RNID [G51] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW008288, R01TW005596] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA173640, R35CA053890, R01CA080205, UM1CA182910, R37CA070867, R01CA055069, R01CA144034, R01CA082729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020649] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679, R01HL090682, R01HL085144, U01HL072507, P01HL076491, P20HL113452, R21HL121429, R01HL103931, R01HL087263, R01HL103866, P01HL098055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK078150, R01DK082766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES021801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	Grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Science and Technology Incubation Program in Advanced Regions, Japanese Science and Technology Agency; Japanese Atherosclerosis Prevention Fund; Takeda Medical Research Foundation; National Cardiovascular Research Grants; US National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); VPR bridge grant from the University of Oklahoma Health Sciences Center; BBMRI-NL; Netherlands Organization for Scientific Research (NWO project)(Netherlands Organization for Scientific Research (NWO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); grants for Core Research for Evolutional Science and Technology (CREST) from the Japanese Science and Technology Agency; Program for the Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation Organization (NIBIO); KAKENHI on Priority Area 'Applied Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Okinaga Scholarship; Grants for International Health Research from the Ministry of Health, Labour and Welfare of Japan; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Manpei Suzuki Diabetes Foundation; Italian Ministry of Universities (Interomics Flag project); Assessorato Ricerca Regione Campania(Regione Campania); Fondazione con il SUD; Fondazione Banco di Napoli; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk(Novo Nordisk); Swedish Research Council(Swedish Research CouncilEuropean Commission); Pahlssons Foundation; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Skane Regional Health Authority; Estonian government; Center of Excellence in Genomics (EXCEGEN); University of Tartu; Competitive Research Funding from Tampere University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation, Finland; Tampere Tuberculosis Foundation; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute, US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Velux Foundation(Velux Fonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello (Horsholm, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories Denmark; Research Centre for Prevention and Health; Capital Region of Denmark; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Korean Centers for Disease Control and Prevention; Korean National Institute of Health, Republic of Korea; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Merck Co.(Merck & Company); Roche Vitamins, Ltd.; University of Oxford; Centre National de Genotypage from Merck Co.; Oxford British Heart Foundation Centre of Research Excellence; British Heart Foundation(British Heart Foundation); GENDINOB project; Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); Singapore Institute for Clinical Sciences, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Compagnia di San Paolo (Torino, Italy)(Compagnia di San Paolo); Fondazione Cariplo, Italy(Fondazione Cariplo); Ministry of Health, Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); CCM; Telethon, Italy(Fondazione Telethon); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Centre for Health Technology Assessment; Research Foundation of Copenhagen County; Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Danish Diabetes Association; European Union (Sixth Framework Programme of the European Community); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences Research Grants, Japan; Science and Technology Incubation Program in Advanced Regions; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Science Research Grants and Medical Technology Evaluation Research Grants from the Ministry of Health, Labour and Welfare of Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Biomedical Innovation Grants(Biomedical Innovation Grants); Japanese Research Foundation for Clinical Pharmacology; Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Health; Munich Center of Health Sciences (MC Health), LMUinnovativ; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); European Union(European Commission); Helmholtz-Russia Joint Research Group (HRJRG); German Center for Diabetes Research (DZD); EU(European Commission); BMBF e:Med project e:AtheroSysMed-Systems Medicine of Myocardial Infarction and Stroke(Federal Ministry of Education & Research (BMBF)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Chief Scientist Office of the Scottish government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Age UK (The Disconnected Mind project); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Economic Structure-Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); province of Groningen, University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIHR(National Institute for Health Research (NIHR)); Action on Hearing Loss; INTERREG IV Oberrhein Program (Genetic Mechanisms of Cardiovascular Diseases); European Regional Development Fund (ERDF)(European Commission); Wissenschaftsoffensive TMO; Academy of Finland (Center of Excellence in Complex Disease Genetics)(Academy of Finland); University Hospital Oulu, Biocenter; University of Oulu, Finland; European Commission(European CommissionEuropean Commission Joint Research Centre); National Heart, Lung, and Blood Institute through the STAMPEED program; US NIH/National Institute of Mental Health; ENGAGE project(General Electric); Academy of Finland(Academy of Finland); Biocentrum Helsinki; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Ministry of Science, Commerce and Transportation of the state of Schleswig-Holstein; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Dutch Kidney Foundation; European Union project grant GENECURE; Netherlands Organization for Health Research and Development (NWO-Groot grant); Netherlands Organization for Health Research and Development (NWO VENI grant); Netherlands Organization for Health Research and Development (ZonMw grant); Dutch Interuniversity Cardiology Institute Netherlands (ICIN); Pfizer(Pfizer); Bristol-Myers-Squibb(Bristol-Myers Squibb); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging grant); Erasmus Medical Center; Erasmus University; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); municipality of Rotterdam; Genetic Laboratory of the Department of Internal Medicine, Erasmus Medical Center; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); NMRC, Singapore(National Medical Research Council, Singapore); Genetic and Environmental Determinants of Type 2 Diabetes in Chinese Singaporeans, grant from the US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NMRC of Singapore(National Medical Research Council, Singapore); Genome Institute of Singapore; A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); US NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NUS-HUJ CREATE Programme of the National Research Foundation, Singapore(National University of Singapore); Biomedical Research Council of Singapore (A*STAR, Singapore)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dutch government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions; Yong Loo Lin School of Medicine(National University of Singapore); National University Health System; Life Sciences Institute of the National University of Singapore(National University of Singapore); National Research Foundation of Singapore(National Research Foundation, Singapore); Biomedical Research Council of Singapore (under the individual research grants scheme)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chinese National Key Program for Basic Research (973)(National Basic Research Program of China); Chinese National High-Tech Program (863)(National High Technology Research and Development Program of China); Ministry of Science and Technology, National Natural Science Foundation of China; Academia Sinica Genomic Medicine Multicenter Study, Taiwan(Academia Sinica - Taiwan); Stroke Association; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-Economic Status and Health; Social Insurance Institution of Finland; Kuopio, Tampere and Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; ; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; RNID; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	AASC. This work was supported by Grants for Scientific Research (24390084, 21390099 and 20390185) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Science and Technology Incubation Program in Advanced Regions, Japanese Science and Technology Agency; the Japanese Atherosclerosis Prevention Fund; the Takeda Medical Research Foundation; and National Cardiovascular Research Grants.; AIDHS/SDS. This study was supported by US National Institutes of Health (NIH) grants R01DK082766 (D.K.S.) funded by the National Institute of Diabetes and Digestive and Kidney Diseases and NOT-HG-11-009 (D.K.S.) funded by the National Human Genome Research Institute (D.K.S.) and by a VPR bridge grant (D.K.S.) from the University of Oklahoma Health Sciences Center.; BIOS-consortium. The BIOS-consortium is funded by BBMRI-NL, a research infrastructure financed by the Netherlands Organization for Scientific Research (NWO project 184.021.007).; CAGE-Amagasaki. We acknowledge the outstanding contributions of the employees of the National Center for Global Health and Medicine who provided technical and infrastructural support for this work. Above all, we thank the participants who made this work possible and who gave it value. We also thank T. Ogihara, Y. Yamori, A. Fujioka, C. Makibayashi, S. Katsuya, K. Sugimoto, K. Kamide, R. Morishita and the many physicians of the participating hospitals and medical institutions in the Amagasaki Medical Association for their assistance in collecting the DNA samples and accompanying clinical information. This work was supported by Grants for Scientific Research (22390186, 24591060, 25253059 and 25461127) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; CAGE-Fukuoka. This work was supported by Grants-in-Aid for the 21st Century Center of Excellence Program (Kyushu University) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grants-in-Aid for Scientific Research (category A) from the Japanese Society for the Promotion of Science. We are grateful to all participants of this study. We also especially thank S. Kono for his management of the DNA samples and clinical information.; CAGE_GWAS1. The CAGE Network studies were supported by grants for Core Research for Evolutional Science and Technology (CREST) from the Japanese Science and Technology Agency; the Program for the Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation Organization (NIBIO); KAKENHI (Grant-in-Aid for Scientific Research) on Priority Area 'Applied Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a grant from the National Center for Global Health and Medicine. N.K. is a recipient of the Okinaga Scholarship and thanks S. Okinaga, H. Okinaga and other staff at Teikyo University, Japan, for their considerable support of doctoral work.; CAGE-KING. This study was supported in part by Grants-in-Aid for Scientific Research, including ones from categories A and B and the NEXT program of the Japanese Society for the Promotion of Science and by Grants-in-Aid on Priority Areas 'Comprehensive Genomics' and 'Applied Genomics', from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; CAGE-Vietnam. The CAGE-Vietnam study was supported by Grants for International Health Research (17C-1 and 20S-6) from the Ministry of Health, Labour and Welfare of Japan, grants for the National Center for Global Health and Medicine (22S-10 and 25S-1) and the Manpei Suzuki Diabetes Foundation. We acknowledge the following investigators and institutions for their substantial contribution to the current study: T. Sasazuki, M. Noda, N. Kato, S. Kanagawa, T. Mizoue, H. Ohara and Y. Takahashi (Japanese investigators); T. Quy, N. Lan Viet, P. Thi Hong Hoa, N. Hoa Dieu Van, N. Thi Lam, L. Bach Mai, N. Quang Bay, P. Thi Phuong Thuy and B. Minh Duc (Vietnamese investigators); the National Center for Global Health and Medicine (Japan), Bach Mai Hospital (Vietnam), the Vietnam National Institute of Nutrition and the NCGM-BMH Medical Collaboration Center.; Cilento. We thank the populations of Cilento, Italy, for their participation in the study. This work was supported by grants from the Italian Ministry of Universities (FIRB-RBNE08NKH7, Interomics Flag project), the Assessorato Ricerca Regione Campania, the Fondazione con il SUD (2011-PDR-13) and the Fondazione Banco di Napoli to M.C.; CLHNS. We thank the Office of Population Studies Foundation research and data collection teams for the Cebu Longitudinal Health and Nutrition Survey. This work was supported by National Institutes of Health grants DK078150, TW05596, HL085144 and TW008288 and pilot funds from RR20649, ES10126 and DK56350.; DIABNORD. We are grateful to the study participants who dedicated their time and samples to these studies. We also thank the VHS, the Swedish Diabetes Registry and the Umea Medical Biobank staff for biomedical data and DNA extraction. We also thank M. Sterner, M. Juhas and P. Storm for their expert technical assistance with genotyping and genotype data preparation. The current study was funded by Novo Nordisk, the Swedish Research Council, Pahlssons Foundation, the Swedish Heart Lung Foundation and the Skane Regional Health Authority (all to P.W.F.).; EGCUT. EGCUT received targeted financing from the Estonian government (SF0180142s08), the Center of Excellence in Genomics (EXCEGEN) and the University of Tartu (SP1GVARENG). We acknowledge EGCUT technical personnel, especially V. Soo and S. Smit. Data analyses were carried out in part at the High-Performance Computing Center of the University of Tartu.; FINCAVAS. This work was supported by Competitive Research Funding from Tampere University Hospital (grants 9M048 and 9N035), the Finnish Cultural Foundation, the Finnish Foundation for Cardiovascular Research, the Emil Aaltonen Foundation, Finland, and the Tampere Tuberculosis Foundation. The authors thank the staff of the Department of Clinical Physiology for collecting the exercise test data.; GEMS. This work was partially supported by US NIH grants R01CA107431 and P42ES10349 to H. Ahsan. We would like to thank the study participants, as well as the staff of UChicago Research Bangladesh.; GeneBank. The Cleveland Clinic GeneBank study is supported by National Heart, Lung, and Blood Institute grants P01HL098055, P01HL076491, R01HL103866, P20HL113452 and R01HL103931. H. Allayee was supported by grant R01ES021801 from the National Institute of Environmental Health Sciences.; GenSalt. The Genetic Epidemiology Network of Salt Sensitivity is supported by research grants (U01HL072507, R01HL087263 and R01HL090682) from the National Heart, Lung, and Blood Institute, US NIH.; GLACIER-exome. We are indebted to the study participants who dedicated their time and samples to these studies. We thank J. Hutiainen and A. Agren (Umea Medical Biobank) for data organization and K. Enquist and T. Johansson (Vasterbottens County Council) for technical assistance with DNA extraction. We also thank M. Sterner, M. Juhas and P. Storm for their expert technical assistance with genotyping and genotype data preparation. The current study was funded by Novo Nordisk, the Swedish Research Council, Pahlssons Foundation, the Swedish Heart Lung Foundation and the Skane Regional Health Authority (all to P.W.F.).; GLACIER Metabochip. We are indebted to the study participants who dedicated their time and samples to these studies. We also thank the VIP and Umea Medical Biobank staff for biomedical data collection and preparation. We specifically thank J. Hutiainen, A. Agren and S. Nilsson (Umea Medical Biobank) for data organization, K. Enquist and T. Johansson (Vasterbottens County Council) for expert technical assistance with DNA preparation, and D. Hunter, P. Soule and H. Ranu (Harvard School of Public Health) for expert assistance with planning and undertaking genotyping of GLACIER samples. The current study was funded by Novo Nordisk, the Swedish Research Council, Pahlssons Foundation, the Swedish Heart Lung Foundation and the Skane Regional Health Authority (all to P.W.F.).; Health2006. The Health2006 study was financially supported by grants from the Velux Foundation; the Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; the Aase and Ejner Danielsens Foundation; and ALK-Abello (Horsholm, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories Denmark and Research Centre for Prevention and Health, the Capital Region of Denmark. This project was also funded by the Lundbeck Foundation and produced by the Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp; http://www.lucamp.org/). The Novo Nordisk Foundation Centre for Basic Metabolic Research is an independent Research Centre at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk/).; HEXA. This work was supported by grants from the Korean Centers for Disease Control and Prevention (4845-301, 4851-302 and 4851-307) and an intramural grant from the Korean National Institute of Health (2012-N73002-00), Republic of Korea.; HPS. The Heart Protection Study (ISRCTN48489393) was funded by the UK Medical Research Council, the British Heart Foundation, Merck & Co., and Roche Vitamins, Ltd. Genotyping and analysis were supported by a grant to the University of Oxford and the Centre National de Genotypage from Merck & Co. and the Oxford British Heart Foundation Centre of Research Excellence. J.C.H. acknowledges support from the British Heart Foundation (FS/14/55/30806).; GOYA. This study was conducted as part of the activities of the Gene-Diet Interactions in Obesity project (GENDINOB; http://www.gendinob.dk/) and the Medical Research Council Centre for Causal Analyses in Translational Epidemiology (MRC CAiTE). We thank the staff of the Copenhagen City Heart Study for their skillful examination of the study subjects in the collection of baseline and follow-up data. T.S.A. was also funded by the GENDINOB project and acknowledges the same.; GUSTO. The GUSTO study group includes P. Agarwal, A. Biswas, C. Looi Bong, B.F.P. Broekman, S. Cai, J.K.Y. Chan, Y.H. Chan, C.Y.I. Chee, H.Y.H. Chen, Y.B. Cheung, A. Chia, A. Chinnadurai, C.K. Chng, M.F.-F. Chong, S. C. Chong, M.C. Chua, C.M. Ding, E.A. Finkelstein, D. Fok, M. Fortier, A.E.N. Goh, Y.T.D. Goh, J.J. Gooley, W.M. Han, M. Hanson, C.J. Henry, C.-Y. Hsu, H. Inskip, J. Kapur, K. Kwek, I.Y.-M. Lau, B.W. Lee, N. Lek, S. B. Lim, Y.-L. Low, I. Magiati, L. Mary Daniel, C. Ngo, K. Naiduvaje, W.W. Pang, A. Qiu, B.L. Quah, V.S. Rajadurai, M. Rauff, S. A. Rebello, J.L. Richmond, A. Rifkin-Graboi, L.P.-C. Shek, A. Sheppard, B. Shuter, L. Singh, W. Stunkel, L.L. Su, O.H. Teoh, H.P.S. van Bever, R.M. van Dam, I.B.Y. Wong, P.C. Wong and G.S.H. Yeo. This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore-NMRC/TCR/012-NUHS/2014. Additional funding is provided by the Singapore Institute for Clinical Sciences, A*STAR, Singapore.; INGI-VB. The research was supported by funds from Compagnia di San Paolo (Torino, Italy); Fondazione Cariplo, Italy, and the Ministry of Health, Ricerca Finalizzata 2008 and CCM 2010, and Telethon, Italy, to D.T. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank the inhabitants of Val Borbera who made this study possible, the local administrations, the Tortona and Genova archdioceses, and the ASL-22, Novi Ligure (Al), for support. We also thank C. Camaschella for the supervision of data collection and organization of the clinical data collection, F. Vigano for technical help, and C. Masciullo and M. Cocca for building the analysis platform.; Inter99. Inter99 was initiated by T.J. (principal investigator), K. Borch-Johnsen (co-principal investigator), H. Ibsen and T.F. Thomsen. The steering committee comprises the first two and C. Pisinger. The study was financially supported by research grants from the Danish Research Council, the Danish Centre for Health Technology Assessment, Novo Nordisk, the Research Foundation of Copenhagen County, the Ministry of Internal Affairs and Health, the Danish Heart Foundation, the Danish Pharmaceutical Association, the Augustinus Foundation, the Ib Henriksen Foundation, the Becket Foundation and the Danish Diabetes Association. This project was also funded by the Lundbeck Foundation and produced by LuCamp (http://www.lucamp.org/). The Novo Nordisk Foundation Centre for Basic Metabolic Research is an independent Research Centre at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk/).; InterAct. We are grateful to all participants who gave their time and effort to the study. We are also extremely grateful to all persons who contributed to the data collection across the study sites. This study was supported by funding from the European Union (integrated project LSHM-CT-2006-037197 in the Sixth Framework Programme of the European Community) and the Medical Research Council, UK.; This work was supported by Grants-in-Aid for Scientific Research (Priority Areas 'Medical Genome Science (Millennium Genome Project)' and 'Applied Genomics'), the Leading Project for Personalized Medicine and Scientific Research (20390185, 21390099, 19659163, 16790336, 12204008, 15790293, 16590433, 17790381, 17790381, 18390192, 18590265, 18590587, 18590811, 19590929, 19650188, 19790423, 17390186, 20390184 and 21390223) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid (H15-Longevity-005, H17-Longevity-003, H16-Kenko-001, H18-Longevity(kokusai), H11-Longevity-020, H17-Kenkou-007, H17-Pharmaco-common-003, H18-Junkankitou[Seishuu]-Ippan-012 and H20-Junkankitou[Seishuu]-Ippan-009, 013) from the Ministry of Health, Labor and Welfare of Japan, Health and Labor Sciences Research Grants, Japan; a Science and Technology Incubation Program in Advanced Regions, the Japanese Science and Technology Agency; Grants-in-Aid from Japanese Society for the Promotion of Science fellows (16.54041, 18.54042, 19.7152, 20.7198, 20.7477 and 20.54043); Health Science Research Grants and Medical Technology Evaluation Research Grants from the Ministry of Health, Labour and Welfare of Japan; the Japanese Atherosclerosis Prevention Fund; the Uehara Memorial Foundation; the Takeda Medical Research Foundation; National Cardiovascular Research Grants; Biomedical Innovation Grants; and the Japanese Research Foundation for Clinical Pharmacology.; KARE. This work was supported by grants from the Korean Centers for Disease Control and Prevention (4845-301, 4851-302 and 4851-307) and an intramural grant from the Korean National Institute of Health (2012-N73002-00), Republic of Korea.; KORA. KORA was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health and supported by grants from the German Federal Ministry of Education and Research (BMBF), the Federal Ministry of Health and the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. This research was supported by a grant from the German-Israeli Foundation for Scientific Research and Development, by the European Union's Seventh Framework Programme (FP7-HEALTH-F5-2012) under grant agreement 305280 (MIMOmics), by Helmholtz-Russia Joint Research Group (HRJRG) 310 and by the German Center for Diabetes Research (DZD). We thank all members of the field staff who were involved in the planning and conduct of the MONICA/KORA Augsburg studies. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. C.G. is supported by EU-FP7-HEALTH grant 602936: CARTARDIS-Identification and Validation of Novel Pharmaceutical Drug Targets for Cardiovascular Disease and BMBF e:Med project e:AtheroSysMed-Systems Medicine of Myocardial Infarction and Stroke.; LBC1921. We thank the cohort participants and team members who contributed to these studies. Phenotype collection was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC), the Royal Society and the Chief Scientist Office of the Scottish government. Genotyping was funded by the BBSRC. The work was undertaken by the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross-council Lifelong Health and Wellbeing Initiative (MR/K026992/1). Funding from the BBSRC and Medical Research Council, UK, is gratefully acknowledged.; LBC1936. We thank the cohort participants and team members who contributed to these studies. Phenotype collection was supported by Age UK (The Disconnected Mind project). Genotyping was funded by the BBSRC. The work was undertaken by the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross-council Lifelong Health and Wellbeing Initiative (MR/K026992/1). Funding from the BBSRC and Medical Research Council, UK, is gratefully acknowledged.; LifeLines. The LifeLines Cohort Study and the generation and management of GWAS genotype data for the LifeLines Cohort Study are supported by the Netherlands Organization for Scientific Research (NWO; grant 175.010.2007.006), the Economic Structure-Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the province of Groningen, University Medical Center Groningen, the University of Groningen, the Dutch Kidney Foundation and the Dutch Diabetes Research Foundation. We thank B. Alizadeh, A. Boesjes, M. Bruinenberg, N. Festen, I. Nolte, L. Franke and M. Valimohammadi for their help in creating the GWAS database and R. Bieringa, J. Keers, R. Oostergo, R. Visser and J. Vonk for their work related to data collection and validation. The authors are grateful to the study participants, the staff of the LifeLines Cohort Study and Medical Biobank Northern Netherlands, and the participating general practitioners and pharmacists. LifeLines Scientific Protocol Preparation: R. de Boer, H. Hillege, M. van der Klauw, G. Navis, H. Ormel, D. Postma, J. Rosmalen, J. Slaets, R. Stolk and B. Wolffenbuttel; LifeLines GWAS Working Group: B. Alizadeh, M. Boezen, M. Bruinenberg, N. Festen, L. Franke, P. van der Harst, G. Navis, D. Postma, H. Snieder, C. Wijmenga and B. Wolffenbuttel.; LOLIPOP. The LOLIPOP study is supported by the NIHR Comprehensive Biomedical Research Centre Imperial College Healthcare NHS Trust, the British Heart Foundation (SP/04/002), the Medical Research Council, UK (G0601966 and G0700931), the Wellcome Trust (084723/Z/08/Z), the NIHR (RP-PG-0407-10371), the European Union's Seventh Framework Programme (EpiMigrant, 279143) and Action on Hearing Loss (G51). We thank the participants and research staff who made the study possible.; LURIC. We extend our appreciation to the participants of the LURIC study; without their collaboration, this report would not have been written. We thank the LURIC study team who were either temporarily or permanently involved in patient recruitment as well as sample and data handling, in addition to the laboratory staff at the Ludwigshafen General Hospital, the University of Freiburg and the University of Ulm, Germany. LURIC has received funding from the Sixth Framework Programme (integrated project Bloodomics, grant LSHM-CT-2004-503485) and from the Seventh Framework Programme (Atheroremo, grant agreement 201668 and RiskyCAD, grant agreement 305739) of the European Union as well as from the INTERREG IV Oberrhein Program (project A28, Genetic Mechanisms of Cardiovascular Diseases) with support from the European Regional Development Fund (ERDF) and the Wissenschaftsoffensive TMO.; NFBC86. We thank P. Rantakallio (launch of NFBC1986 and initial data collection), S. Vaara (data collection), T. Ylitalo (administration), M. Koiranen (data management), and O. Tornwall and M. Jussila (DNA biobanking). Financial support was provided by the Academy of Finland (project grants 104781, 120315, 129269 Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Fifth Framework Programme award QLG1-CT-2000-01643), National Heart, Lung, and Blood Institute grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), the US NIH/National Institute of Mental Health (5R01MH63706:02), the ENGAGE project and grant agreement HEALTH-F4-2007-201413 and the Medical Research Council, UK (grants G0500539, G0600331 nad PrevMetSyn). DNA extraction, sample quality control, biobank upkeep and aliquotting were performed at the National Public Health Institute, Biomedicum Helsinki, Finland, and supported financially by the Academy of Finland and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; POPGEN. The POPGEN study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the Ministry of Science, Commerce and Transportation of the state of Schleswig-Holstein. The project has also received infrastructure support through the DFG excellence cluster 'Inflammation at Interfaces'. The POPGEN 2.0 network is supported by a grant from the German Ministry of Education and Research (01EY1103).; PREVEND. PREVEND genetics is supported by the Dutch Kidney Foundation (grant E033), European Union project grant GENECURE (FP-6 LSHM CT 2006 037697), the US NIH (grant 2R01LM010098), the Netherlands Organization for Health Research and Development (NWO-Groot grant 175.010.2007.006, NWO VENI grant 916.761.70 and ZonMw grant 90.700.441) and the Dutch Interuniversity Cardiology Institute Netherlands (ICIN).; PROMIS. Genotyping in PROMIS was supported by the Wellcome Trust and Pfizer. Some core support to PROMIS was provided by the British Heart Foundation. The Cardiovascular Epidemiology Unit at the University of Cambridge is underpinned by the Medical Research Council, UK (G0800270), the British Heart Foundation (SP/09/002), the British Heart Foundation Cambridge Cardiovascular Centre of Excellence and the NIHR Cambridge Biomedical Research Centre.; PROSPER. The PROSPER study was supported by an investigator-initiated grant obtained from Bristol-Myers-Squibb. J.W.J. is an Established Clinical Investigator of the Netherlands Heart Foundation (grant 2001 D 032). Support for genotyping was provided by the Seventh Framework Programme of the European Commission (grant 223004) and by the Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging grant 050-060-810).; RHS. RHS was supported by a grant from the National Center for Global Health and Medicine.; Rotterdam Study. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The generation and management of the Illumina 450K methylation array data (EWAS data) for the Rotterdam Study were executed by the Human Genotyping Facility of the Genetic Laboratory of the Department of Internal Medicine, Erasmus Medical Center, the Netherlands. The EWAS data were funded by the Genetic Laboratory of the Department of Internal Medicine, Erasmus Medical Center, and by the Netherlands Organization for Scientific Research (NWO; project 184021007) and were made available as a Rainbow Project (RP3; BIOS) of BBMRI-NL. We thank M. Verbiest, M. Jhamai, S. Higgins and M. Verkerk for their help in creating the methylation database.; SCES. SCES is funded by the Biomedical Research Council of Singapore (grant 08/1/35/19/550) and the NMRC, Singapore (grants STaR/0003/2008 and CG/SERI/2010). The National University Health System Tissue Repository and the Genome Institute of Singapore (A*STAR, Singapore) provided services for tissue archiving and genotyping, respectively.; SCHS. We would like to thank S.-H. Low of the National University of Singapore for supervising the field work of the Singapore Chinese Health Study and K. Arakawa for development of the cohort study database. The founding, long-standing principal investigator of the Singapore Chinese Health Study is M. C. Yu. Significant contributions to the GWAS substudy of SCHS were made by W.-P. Koh, J.-M. Yuan, R. Wang, Z. Chen, M. Seielstad, A. O. Odegaard, E. S. Tai, Y.-Y. Teo, J. Liu, B. Thyagarajan and R. Koratkar. Funding sources included Genetic and Environmental Determinants of Type 2 Diabetes in Chinese Singaporeans, grant R01DK080720 from the US NIH. Additional support came from the NMRC of Singapore under the individual research grants scheme, from the Genome Institute of Singapore, the NMRC of Singapore under its individual research grants and clinician scientist award scheme, and from A*STAR, Singapore. The Singapore Chinese Health Study primary cohort was supported by US NIH/National Cancer Institute grants RO1CA55069, R35CA53890, R01CA80205 and R01CA144034.; SCHS_MI. SCHS was supported by the US NIH (NCI RO1CA55069, R35CA53890, R01CA80205 and R01CA144034), the NUS-HUJ CREATE Programme of the National Research Foundation, Singapore (project 370062002) and a grant from the NMRC, Singapore (NMRC/1270/2010).; SiMES. SiMES is funded by the NMRC, Singapore (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and CG/SERI/2010) and the Biomedical Research Council of Singapore (grant 09/1/35/19/616). The Singapore Tissue Network and the Genome Institute of Singapore (A*STAR, Singapore) provided services for tissue archiving and genotyping, respectively. SINDI. SINDI is funded by the Biomedical Research Council of Singapore (A*STAR, Singapore) provided services for tissue archiving and genotyping, respectively.; SINDI. SINDI is funded by the Biomedical Research Council of Singapore (grant 08/1/35/19/550) and the NMRC, Singapore (grants STaR/0003/2008 and CG/SERI/2010). The National University Health System Tissue Repository and the Genome Institute of Singapore (A*STAR, Singapore) provided services for tissue archiving and genotyping, respectively.; SMART. This research was financially supported by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007).; SMHS. The study was supported by grants RO1CA82729 and UM1CA173640 from the US NIH. The authors thank the participants and staff members of the SMHS research team for their important contributions.; SMSS. SMSS was supported by the National Natural Science Foundation of China (grant 81172761) and the Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.; SMHS. The study was supported by grants RO1CA82729 and UM1CA173640 from the US NIH. The authors thank the participants and staff members of the SMHS research team for their important contributions.; SMSS. SMSS was supported by the National Natural Science Foundation of China (grant 81172761) and the Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.; SP2. This project acknowledges the support of the Yong Loo Lin School of Medicine, the National University Health System and the Life Sciences Institute of the National University of Singapore. We also acknowledge the support of the National Research Foundation of Singapore (NRF-RF-2010-05), the Biomedical Research Council of Singapore (under the individual research grants scheme) and the NMRC, Singapore, under the individual research grant and the clinician scientist award schemes).; SRS. This work was supported by the Chinese National Key Program for Basic Research (973 grants: 2004CB518603, 2006CB503804 and 2009CB521905), the Chinese National High-Tech Program (863 grants: 2009AA022703 and 2006AA022179) and the Ministry of Science and Technology, National Natural Science Foundation of China (30871361).; SWHS. This research was supported by US NIH research grant R37CA70867. The authors thank the participants and staff members of SWHS for their important contributions.; TWSC. We gratefully acknowledge the members of the Translational Resource Center (TRC) (NSC102-2325-B-001-040) and the National Center for Genome Medicine (NSC102-2319-B-001-001) at Academia Sinica for their support in subject recruitment, genotyping and statistical analysis. The TWSC study was supported by the Academia Sinica Genomic Medicine Multicenter Study, Taiwan (40-05-GMM).; WHII. The WHII study is supported by grants from the Medical Research Council, UK (G0902037), the British Heart Foundation (RG/07/008/23674), the Stroke Association, the National Heart, Lung, and Blood Institute (5RO1HL036310), the National Institute on Aging (5RO1AG13196), the Agency for Health Care Policy Research (HS06516) and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-Economic Status and Health.; YFS. The Young Finns Study has been financially supported by the Academy of Finland through grants 286284 (T.L.), 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi) and 41071 (Skidi); the Social Insurance Institution of Finland; Kuopio, Tampere and Turku University Hospital Medical Funds (grant X51001 for T.L.); the Juho Vainio Foundation; the Paavo Nurmi Foundation; the Finnish Foundation of Cardiovascular Research (T.L.); the Finnish Cultural Foundation; the Tampere Tuberculosis Foundation (T.L.); the Emil Aaltonen Foundation (T.L.); and the Yrjo Jahnsson Foundation (T.L.).	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Teh AL, 2014, GENOME RES, V24, P1064, DOI 10.1101/gr.171439.113; Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Beca S, 2013, CIRC RES, V112, P289, DOI 10.1161/CIRCRESAHA.111.300003; Bellavia A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000212; Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Cheng YF, 2012, DRUG METAB DISPOS, V40, P617, DOI 10.1124/dmd.111.042036; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Flister MJ, 2013, GENOME RES, V23, P1996, DOI 10.1101/gr.160283.113; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Halachev K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r96; Hallmans G, 2003, SCAND J PUBLIC HEALT, V31, P18, DOI 10.1080/14034950310001432; Hebels DGAJ, 2013, ENVIRON HEALTH PERSP, V121, P480, DOI 10.1289/ehp.1205657; Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Imano H, 2009, STROKE, V40, P1571, DOI 10.1161/STROKEAHA.108.538629; Jacoby M, 2012, EPIGENETICS-US, V7, P1421, DOI 10.4161/epi.22845; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lokk K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r54; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mohanraj L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055084; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Pan H, 2012, EPIGENETICS-US, V7, P1173, DOI 10.4161/epi.22102; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Sofer T, 2013, BIOINFORMATICS, V29, P2884, DOI 10.1093/bioinformatics/btt498; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Tomaszewski M, 2010, HYPERTENSION, V56, P1069, DOI 10.1161/HYPERTENSIONAHA.110.155721; Turcot V, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-10; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Woo SK, 2002, CLIN PHARMACOL THER, V71, P246, DOI 10.1067/mcp.2002.122474; Xu XF, 2011, HYPERTENS RES, V34, P981, DOI 10.1038/hr.2011.79; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang Z, 2011, HUM MOL GENET, V20, P4167, DOI 10.1093/hmg/ddr341	50	220	224	4	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1282	+		10.1038/ng.3405	http://dx.doi.org/10.1038/ng.3405			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26390057	Green Submitted, Green Accepted			2022-12-25	WOS:000363988200012
J	Herranz, D; Ambesi-Impiombato, A; Sudderth, J; Sanchez-Martin, M; Belver, L; Tosello, V; Xu, LY; Wendorff, AA; Castillo, M; Haydu, JE; Marquez, J; Mates, JM; Kung, AL; Rayport, S; Cordon-Cardo, C; DeBerardinis, RJ; Ferrando, AA				Herranz, Daniel; Ambesi-Impiombato, Alberto; Sudderth, Jessica; Sanchez-Martin, Marta; Belver, Laura; Tosello, Valeria; Xu, Luyao; Wendorff, Agnieszka A.; Castillo, Mireia; Haydu, J. Erika; Marquez, Javier; Mates, Jose M.; Kung, Andrew L.; Rayport, Stephen; Cordon-Cardo, Carlos; DeBerardinis, Ralph J.; Ferrando, Adolfo A.			Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia	NATURE MEDICINE			English	Article							ATP CITRATE LYASE; NOTCH; INHIBITION; GLUTAMINASE; EXPRESSION; MECHANISM; AUTOPHAGY; PTEN; MYC	Activating mutations in NOTCH1 are common in T cell acute lymphoblastic leukemia (T-ALL). Here we identify glutaminolysis as a critical pathway for leukemia cell growth downstream of NOTCH1 and a key determinant of the response to anti-NOTCH1 therapies in vivo. Mechanistically, inhibition of NOTCH1 signaling in T-ALL induces a metabolic shutdown, with prominent inhibition of glutaminolysis and triggers autophagy as a salvage pathway supporting leukemia cell metabolism. Consequently, inhibition of glutaminolysis and inhibition of autophagy strongly and synergistically enhance the antileukemic effects of anti-NOTCH1 therapy in mice harboring T-ALL. Moreover, we demonstrate that Pten loss upregulates glycolysis and consequently rescues leukemic cell metabolism, thereby abrogating the antileukemic effects of NOTCH1 inhibition. Overall, these results identify glutaminolysis as a major node in cancer metabolism controlled by NOTCH1 and as therapeutic target for the treatment of T-ALL.	[Herranz, Daniel; Ambesi-Impiombato, Alberto; Sanchez-Martin, Marta; Belver, Laura; Tosello, Valeria; Xu, Luyao; Wendorff, Agnieszka A.; Haydu, J. Erika; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Sudderth, Jessica; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Castillo, Mireia; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Marquez, Javier; Mates, Jose M.] Univ Malaga, Inst Invest Biomed Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Kung, Andrew L.; Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Rayport, Stephen] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA	Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Universidad de Malaga; Columbia University; Columbia University; Columbia University	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	af2196@columbia.edu	Kung, Andrew L/AEU-0826-2022; Herranz, Daniel/L-6986-2017; Kung, Andrew/AAL-2384-2020; Castillo-Martin, Mireia/H-6152-2013; Belver, Laura/AAC-1621-2021; marquez, javier/K-3289-2012; Belver, Laura/AAH-2177-2019; Mates, Jose M./L-1350-2014; Tosello, Valeria/N-1010-2016	Kung, Andrew L/0000-0002-9091-488X; Herranz, Daniel/0000-0003-1768-5969; Belver, Laura/0000-0001-7493-7072; marquez, javier/0000-0003-3317-3963; Mates, Jose M./0000-0001-9795-1993; Tosello, Valeria/0000-0001-9560-340X	US National Institutes of Health [R01CA129382, CA120196]; Stand Up To Cancer Innovative Research Award; Swim Across America Foundation; Junta de Andalucia, Spain [CVI-6656]; Leukemia and Lymphoma Society; Rally Foundation; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA129382, R01CA120196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer Innovative Research Award; Swim Across America Foundation; Junta de Andalucia, Spain(Junta de Andalucia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Rally Foundation; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Aster (Brigham and Women's Hospital, Harvard Medical School) for the MigR1-NOTCH1 L1601P Delta PEST vector, D. Vignali (University of Pittsburgh) for the pMSCV-mCherry FP vector, W. Pear (Abramson Family Cancer Research Institute, University of Pennsylvania) for the MigR1 vector, B. Ebert (Dana-Farber Cancer Research Institute) for the pL-CRISPR.EFS.GFP vector, P. Pandolfi (Beth Israel Deaconess Medical Center, Harvard Medical School) for the Pten conditional knockout mouse, T. Ludwig (Columbia University Medical Center) for the Rosa26<SUP>Cre-ERT2/+</SUP> mouse, M. Komatsu (Tokyo Metropolitan Institute of Medical Science) for the Atg7 conditional knockout mouse, S. Indraccolo (Istituto di Ricovero e Cura a Carattere Scientifico) for xenograft T-ALL cells and R. Baer and C. Lopez-Otin for helpful discussions and revision of the manuscript. This work was supported by the US National Institutes of Health grants R01CA129382 and CA120196, the Stand Up To Cancer Innovative Research Award and the Swim Across America Foundation (A.A.F.). J.M. and J.M.M. were supported by CVI-6656 (Junta de Andalucia, Spain). D.H. is supported by the Leukemia and Lymphoma Society. M.S.-M. and A.A.W. are supported by the Rally Foundation. L.B. is supported by the Lymphoma Research Foundation.	Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Campos-Sandoval JA, 2007, INT J BIOCHEM CELL B, V39, P765, DOI 10.1016/j.biocel.2006.12.002; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Homminga I, 2012, HAEMATOL-HEMATOL J, V97, P258, DOI 10.3324/haematol.2011.051722; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Kimbrel EA, 2009, MOL IMAGING, V8, P140, DOI 10.2310/7290.2009.00007; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Medyouf H, 2010, BLOOD, V115, P1175, DOI 10.1182/blood-2009-04-214718; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thompson PK, 2011, SEMIN IMMUNOL, V23, P350, DOI 10.1016/j.smim.2011.08.007; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	34	145	149	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1182	+		10.1038/nm.3955	http://dx.doi.org/10.1038/nm.3955			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26390244	Green Accepted			2022-12-25	WOS:000362355400020
J	Le Loarer, F; Watson, S; Pierron, G; de Montpreville, VT; Ballet, S; Firmin, N; Auguste, A; Pissaloux, D; Boyault, S; Paindavoine, S; Dechelotte, PJ; Besse, B; Vignaud, JM; Brevet, M; Fadel, E; Richer, W; Treilleux, I; Masliah-Planchon, J; Devouassoux-Shisheboran, M; Zalcman, G; Allory, Y; Bourdeaut, F; Thivolet-Bejui, F; Ranchere-Vince, D; Girard, N; Lantuejoul, S; Galateau-Salle, F; Coindre, JM; Leary, A; Delattre, O; Blay, JY; Tirode, F				Le Loarer, Francois; Watson, Sarah; Pierron, Gaelle; de Montpreville, Vincent Thomas; Ballet, Stelly; Firmin, Nelly; Auguste, Aurelie; Pissaloux, Daniel; Boyault, Sandrine; Paindavoine, Sandrine; Dechelotte, Pierre Joseph; Besse, Benjamin; Vignaud, Jean Michel; Brevet, Marie; Fadel, Elie; Richer, Wilfrid; Treilleux, Isabelle; Masliah-Planchon, Julien; Devouassoux-Shisheboran, Mojgan; Zalcman, Gerard; Allory, Yves; Bourdeaut, Franck; Thivolet-Bejui, Francoise; Ranchere-Vince, Dominique; Girard, Nicolas; Lantuejoul, Sylvie; Galateau-Salle, Francoise; Coindre, Jean Michel; Leary, Alexandra; Delattre, Olivier; Blay, Jean Yves; Tirode, Franck			SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas	NATURE GENETICS			English	Article							SMALL-CELL-CARCINOMA; MAMMALIAN SWI/SNF COMPLEXES; CHROMATIN REMODELING FACTOR; TUMOR-SUPPRESSOR GENE; LUNG-CANCER; EPITHELIOID SARCOMA; HYPERCALCEMIC TYPE; RHABDOID TUMORS; EXPRESSION; BRG1	While investigating cohorts of unclassified sarcomas by RNA sequencing, we identified 19 cases with inactivation of SMARCA4, which encodes an ATPase subunit of BAF chromatin-remodeling complexes(1,2). Clinically, the cases were all strikingly similar, presenting as compressive mediastino-pulmonary masses in 30- to 35-year-old adults with a median survival time of 7 months. To help define the nosological relationships of these tumors, we compared their transcriptomic profiles with those of SMARCA4-mutated small-cell carcinomas of the ovary, hypercalcemic type (SCCOHTs)(3-5), SMARCB1-inactivated malignant rhabdoid tumors(6) (MRTs) and lung carcinomas (of which 10% display SMARCA4 mutations(7)). Gene profiling analyses demonstrated that these tumors were distinct from lung carcinomas but related to MRTs and SCCOHTs. Transcriptome analyses, further validated by immunohistochemistry, highlighted strong expression of SOX2, a marker that supports the differential diagnosis of these tumors from SMARCA4-deficient lung carcinomas. The prospective recruitment of cases confirmed this new category of 'SMARCA4-deficient thoracic sarcomas' as readily recognizable in clinical practice, providing opportunities to tailor their therapeutic management.	[Le Loarer, Francois; Blay, Jean Yves] Canc Res Ctr Lyon, INSERM, U1052, Lyon, France; [Le Loarer, Francois; Pissaloux, Daniel; Paindavoine, Sandrine; Treilleux, Isabelle; Ranchere-Vince, Dominique] Ctr Leon Berard, Dept Pathol, F-69373 Lyon, France; [Le Loarer, Francois; Brevet, Marie; Thivolet-Bejui, Francoise; Girard, Nicolas; Blay, Jean Yves] Univ Lyon 1, F-69365 Lyon, France; [Watson, Sarah; Richer, Wilfrid; Delattre, Olivier; Tirode, Franck] Paris Sci & Lettres Res Univ, Inst Curie Res Ctr, Genet & Biol Canc Unit, Paris, France; [Watson, Sarah; Masliah-Planchon, Julien; Delattre, Olivier; Tirode, Franck] Inst Curie Res Ctr, INSERM, U830, Paris, France; [Pierron, Gaelle; Ballet, Stelly; Masliah-Planchon, Julien; Bourdeaut, Franck; Delattre, Olivier] Inst Curie Hosp Grp, Unite Genet Somat, Paris, France; [de Montpreville, Vincent Thomas] Ctr Chirurg Marie Lannelongue, Dept Pathol, Le Plessis Robinson, France; [Firmin, Nelly] Inst Cancerol Montpellier, Dept Oncol, Montpellier, France; [Auguste, Aurelie; Leary, Alexandra] Gustave Roussy, INSERM, U981, Villejuif, France; [Boyault, Sandrine] Ctr Leon Berard, Dept Genet, F-69373 Lyon, France; [Dechelotte, Pierre Joseph] CHU Clermont Ferrand, Dept Pathol, Clermont Ferrand, France; [Besse, Benjamin] Gustave Roussy, Dept Canc Med, Villejuif, France; [Besse, Benjamin; Fadel, Elie] Univ Paris 11, Paris, France; [Vignaud, Jean Michel] CHU Nancy, Dept Pathol, Nancy, France; [Brevet, Marie; Thivolet-Bejui, Francoise] Hosp Civils Lyon, Grp Hosp Est, Dept Pathol, Lyon, France; [Fadel, Elie] Ctr Chirurg Marie Lannelongue, Dept Thorac Surg, Le Plessis Robinson, France; [Richer, Wilfrid] Inst Curie, RTOP, Paris, France; [Devouassoux-Shisheboran, Mojgan] Hop Croix Rousse, Hosp Civils Lyon, Dept Pathol, F-69317 Lyon, France; [Zalcman, Gerard] CHU Caen, Dept Pneumol & Thorac Oncol, F-14000 Caen, France; [Zalcman, Gerard] Univ Caen Basse Normandie, UMR, INSERM, U186, Caen, France; [Allory, Yves; Leary, Alexandra] Hop Univ Henri Mondor, AP HP, Plateforme Ressources Biol, Creteil, France; [Allory, Yves] Univ Paris Est, Creteil, France; [Allory, Yves] Inst Mondor Rech Biomedicale, INSERM, U955, Creteil, France; [Bourdeaut, Franck] Inst Curie, Dept Oncol Pediat, Paris, France; [Girard, Nicolas] Hosp Civils Lyon, Grp Hosp Est, Dept Resp Med, Lyon, France; [Lantuejoul, Sylvie] CHU Grenoble, Dept Pathol, F-38043 Grenoble, France; [Lantuejoul, Sylvie] Univ Grenoble 1, Grenoble, France; [Galateau-Salle, Francoise] CHU Caen, Dept Pathol, F-14000 Caen, France; [Galateau-Salle, Francoise] INSERM, U1086, Caen, France; [Coindre, Jean Michel] Inst Bergonie, Dept Pathol, Bordeaux, France; [Coindre, Jean Michel] Univ Bordeaux 2, F-33076 Bordeaux, France; [Blay, Jean Yves] Ctr Leon Berard, Dept Oncol, F-69373 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Marie Lannelongue; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; CHU Clermont Ferrand; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Hopital Marie Lannelongue; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU Lyon; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Centre Leon Berard	Tirode, F (corresponding author), Paris Sci & Lettres Res Univ, Inst Curie Res Ctr, Genet & Biol Canc Unit, Paris, France.	francois.leloarer@lyon.unicancer.fr; franck.tirode@curie.fr	ZALCMAN, Gerard/M-8113-2019; Girard, Nicolas/ABE-3618-2021; ZALCMAN, Gerard/P-4150-2015; Besse, Benjamin/V-1523-2019; Watson, Sarah/HGB-2661-2022; Watson, Sarah/ABH-2848-2020; ZALCMAN, Gérard/L-7809-2015; lantuejoul, sylvie/N-9315-2017; Blay, Jean-Yves/N-3966-2016; TIRODE, Franck/HHS-7070-2022; Salle, Francoise BJ Galateau/J-1530-2015; , Bourdeaut/AAG-8494-2019; Tirode, Franck/B-4586-2009	Girard, Nicolas/0000-0001-9909-2299; Besse, Benjamin/0000-0001-5090-8189; Watson, Sarah/0000-0003-4534-8783; ZALCMAN, Gérard/0000-0002-0343-9575; lantuejoul, sylvie/0000-0003-4310-6975; Blay, Jean-Yves/0000-0001-7190-120X; Salle, Francoise BJ Galateau/0000-0003-3642-0165; leary, alexandra/0000-0002-2043-2244; Richer, Wilfrid/0000-0003-1802-3529; galateau salle, francoise/0000-0002-2814-1644; PISSALOUX, Daniel/0000-0003-1118-950X; Thomas de Montpreville, Vincent/0000-0001-7490-4000; delattre, olivier/0000-0002-8730-2276; Tirode, Franck/0000-0003-4731-7817; le loarer, francois/0000-0001-8582-9819; BREVET, Marie/0000-0003-2275-691X; Auguste, Aurelie/0000-0001-5115-0218	Institut National de la Sante et de la Recherche Medicale; Institut Curie; Ligue National Contre Le Cancer (Equipe Labellisee); Institut National du Cancer; la Direction Generale de l'Offre de Soins [INCa-DGOS_5716]; European PROVABES project [ERA-649 NET TRANSCAN JTC-2011]; ASSET project [FP7-HEALTH-2010-259348]; Euro Ewing Consortium project [HEALTH-F2-2013-602856]; SiRIC Institut Curie program; Fondation Nuovo-Soldati; Agence Nationale de la Recherche (Investissements d'Avenir) [ANR-10-EQPX-03, ANR-10-INBS-09-08]; Canceropole Ile-de-France; LYRIC [DGOS-INCa 4664]; NetSARC (INCa); RREPS (INCa); LabEx DEvweCAN [ANR-10-LABX-0061]; Eurosarc [FP7-278742]; Ligue de l'Ain Contre le Cancer	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Ligue National Contre Le Cancer (Equipe Labellisee); Institut National du Cancer(Institut National du Cancer (INCA) France); la Direction Generale de l'Offre de Soins; European PROVABES project; ASSET project; Euro Ewing Consortium project; SiRIC Institut Curie program; Fondation Nuovo-Soldati; Agence Nationale de la Recherche (Investissements d'Avenir)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); LYRIC; NetSARC (INCa); RREPS (INCa); LabEx DEvweCAN; Eurosarc; Ligue de l'Ain Contre le Cancer	We thank the following pathologists who provided archival material: C. Bazille, F. Beltjens, P.P. Bringuier, J. Calderaro, L. Chalabreysse, M.C. Charpentier, M.C. Chateau, A. Clemenson, S. Collardeau-Frachon, S. Croce, A. Croue, F. Dauchat, A.V. Decouvelaere, P. Dorfmuller, S. Duquenne, F. Forest, S. Garcia, M.R. Ghigna, I. Goubin Versini, A. Jouvet, E. Longchamp, P. Michenet, F. Mishellany, A. Moreau, H. Perrochia, B. PetitJean, J. M. Picquenot, P. Roger, V. Secques, I. Serre, I. Soubeyran, J.P. Terrier, A. Traverse-Glehen, I. Valo and L. Zemoura. We also thank the following clinicians who provided follow-up information: D. Arpin, F. Barlesi, J.O. Bay, T. Berghmans, P. Cassier, L. Cany, D. Cupissol, L. Diaz, P. Dumont, P. Fevrier, D. Fric, E. Huchot, N. Isambert, S. Labrune, V. Laurence, D. Moro-sibilot, M. Pays, I. Ray Coquard, O. Regnard, C. Rizzo, S. Salas and P.A. Thomas. We are grateful to J. Auclair, M. Carrere, S. Chabaud, A. Colombe, V. Dapremont, V. Haddad, M. Jean-Denis, F. Lorcy, N. Mesli, J.P. Michot, D. Postoly, G. Schummer, A. Shumikhin, V. Velascoa and Q. Wang. INSERM U830 is supported by the Institut National de la Sante et de la Recherche Medicale, the Institut Curie, the Ligue National Contre Le Cancer (Equipe Labellisee), the Institut National du Cancer and la Direction Generale de l'Offre de Soins (INCa-DGOS_5716), the European PROVABES (ERA-649 NET TRANSCAN JTC-2011), ASSET (FP7-HEALTH-2010-259348) and the Euro Ewing Consortium (HEALTH-F2-2013-602856) projects. W.R. is supported by the SiRIC Institut Curie program. U830 is also indebted to the Societe Francaise des Cancers de l'Enfant, Enfants et Sante, Courir pour Mathieu, Dans les Pas du Geant, La Course de l'Espoir du Mont Valerien, Au Nom d'Andrea, Association Abigael, Association Marabout de Ficelle, Les Bagouz a Manon, Les Amis de Claire and Association Adam. S.W. is supported by a grant from the Fondation Nuovo-Soldati. High-throughput sequencing was performed by the next-generation sequencing platform of Institut Curie, supported by grants ANR-10-EQPX-03 and ANR-10-INBS-09-08 from the Agence Nationale de la Recherche (Investissements d'Avenir) and by Canceropole Ile-de-France. INSERM U1052 is supported by grants from LYRIC (DGOS-INCa 4664), NetSARC (INCa), RREPS (INCa), LabEx DEvweCAN (ANR-10-LABX-0061), Eurosarc (FP7-278742) and Ligue de l'Ain Contre le Cancer.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brennan B, 2013, LANCET ONCOL, V14, pE329, DOI 10.1016/S1470-2045(13)70088-3; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Calderaro J, 2012, HISTOPATHOLOGY, V61, P428, DOI 10.1111/j.1365-2559.2012.04228.x; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Foulkes WD, 2014, J PATHOL, V233, P209, DOI 10.1002/path.4362; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Guillou L, 1997, AM J SURG PATHOL, V21, P130, DOI 10.1097/00000478-199702000-00002; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hasselblatt M, 2014, ACTA NEUROPATHOL, V128, P453, DOI 10.1007/s00401-014-1323-x; Hasselblatt M, 2011, AM J SURG PATHOL, V35, P933, DOI 10.1097/PAS.0b013e3182196a39; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jelinic P, 2014, NAT GENET, V46, P424, DOI 10.1038/ng.2922; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kahali B, 2014, ONCOTARGET, V5, P3316, DOI 10.18632/oncotarget.1945; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Le Loarer F, 2014, GENE CHROMOSOME CANC, V53, P475, DOI 10.1002/gcc.22159; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Matsubara D, 2013, CANCER SCI, V104, P266, DOI 10.1111/cas.12065; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Orvis T, 2014, CANCER RES, V74, P6486, DOI 10.1158/0008-5472.CAN-14-0061; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sullivan LM, 2013, MODERN PATHOL, V26, P385, DOI 10.1038/modpathol.2012.175; Torchia J, 2015, LANCET ONCOL, V16, P569, DOI 10.1016/S1470-2045(15)70114-2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Witkowski L, 2013, J PATHOL, V231, P35, DOI 10.1002/path.4225	52	172	173	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1200	+		10.1038/ng.3399	http://dx.doi.org/10.1038/ng.3399			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26343384				2022-12-25	WOS:000361969900016
J	Perez-Lluch, S; Blanco, E; Tilgner, H; Curado, J; Ruiz-Romero, M; Corominas, M; Guigo, R				Perez-Lluch, Slvia; Blanco, Enrique; Tilgner, Hagen; Curado, Joao; Ruiz-Romero, Marina; Corominas, Montserrat; Guigo, Roderic			Absence of canonical marks of active chromatin in developmentally regulated genes	NATURE GENETICS			English	Article							DROSOPHILA GENOME; INTEGRATIVE ANALYSIS; FUNCTIONAL ELEMENTS; HISTONE H3; TRANSCRIPTION; ORGANIZATION; METHYLATION; EXPRESSION; COMPLEX; ASH2	The interplay of active and repressive histone modifications is assumed to have a key role in the regulation of gene expression. In contrast to this generally accepted view, we show that the transcription of genes temporally regulated during fly and worm development occurs in the absence of canonically active histone modifications. Conversely, strong chromatin marking is related to transcriptional and post-transcriptional stability, an association that we also observe in mammals. Our results support a model in which chromatin marking is associated with the stable production of RNA, whereas unmarked chromatin would permit rapid gene activation and deactivation during development. In the latter case, regulation by transcription factors would have a comparatively more important regulatory role than chromatin marks.	[Perez-Lluch, Slvia; Blanco, Enrique; Tilgner, Hagen; Curado, Joao; Guigo, Roderic] Ctr Genom Regulat, Barcelona, Spain; [Perez-Lluch, Slvia; Tilgner, Hagen; Curado, Joao; Guigo, Roderic] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Perez-Lluch, Slvia; Blanco, Enrique; Ruiz-Romero, Marina; Corominas, Montserrat] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Perez-Lluch, Slvia; Blanco, Enrique; Ruiz-Romero, Marina; Corominas, Montserrat] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Curado, Joao] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Barcelona; University of Barcelona; Universidade do Porto	Corominas, M (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	mcorominas@ub.edu; roderic.guigo@crg.cat	Guigo, Roderic/D-1303-2010; Corominas, Montserrat/K-6528-2012; Pérez-Lluch, Sílvia/AAC-5618-2021; Pérez-Lluch, Sílvia/H-5403-2015; Blanco, Enrique/I-5902-2015	Guigo, Roderic/0000-0002-5738-4477; Corominas, Montserrat/0000-0002-0724-8346; Pérez-Lluch, Sílvia/0000-0002-6863-7193; Pérez-Lluch, Sílvia/0000-0002-6863-7193; Blanco, Enrique/0000-0001-6261-7370; Curado, Joao/0000-0003-3916-0936	Spanish Ministry of Economy and Competitiveness [BIO2011-26205, CSD2007-00008, BFU2012-36888]; Centro de Excelencia Severo Ochoa [SEV-2012-0208]; European Research Council/European Community's Seventh Framework Programme [294653 RNA-MAPS]; European Commission [277899]; Portuguese Foundation of Science and Technology [SFRH/BD/33535/2008]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Centro de Excelencia Severo Ochoa; European Research Council/European Community's Seventh Framework Programme; European Commission(European CommissionEuropean Commission Joint Research Centre); Portuguese Foundation of Science and Technology(Portuguese Foundation for Science and Technology)	We thank D. Gonzalez-Knowles, A. Breschi and M. Mele for help with data analysis, F. Serras, M. Morey and A. Kornblihtt for insightful suggestions and G. Cavalli for discussing data before publication, as well as the anonymous reviewers for their critical input. We thank R. Garrido for administrative assistance. We thank the modENCODE project, the ENCODE Project (human and mouse data) and the Roadmap Epigenomics Mapping Consortium for granting open access of these resources to the scientific community. We also thank the Ultrasequencing Unit of the Centre for Genomic Regulation (CRG, Barcelona, Spain) for sample processing and the Confocal Unit of CCiTUB (Centres Cientifics i Tecnologics de la Universitat de Barcelona) (Universitat de Barcelona, Barcelona, Spain). This work was performed under the financial support of the Spanish Ministry of Economy and Competitiveness with grants BIO2011-26205 to R. G., CSD2007-00008 and BFU2012-36888 to M.C., and 'Centro de Excelencia Severo Ochoa 2013-2017', SEV-2012-0208 and the European Research Council/European Community's Seventh Framework Programme with grant 294653 RNA-MAPS to R.G. E.B. is supported by the European Commission's Seventh Framework Programme 4DCellFate grant 277899. This research reflects only the authors' views, and the Community is not liable for any use that may be made of the information contained therein. J.C. is supported by grant SFRH/BD/33535/2008 from the Portuguese Foundation of Science and Technology.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beltran S, 2003, P NATL ACAD SCI USA, V100, P3293, DOI 10.1073/pnas.0538075100; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Ciabrelli F, 2015, J MOL BIOL, V427, P608, DOI 10.1016/j.jmb.2014.09.013; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; Delest A, 2012, CURR OPIN CELL BIOL, V24, P405, DOI 10.1016/j.ceb.2012.01.008; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Espadaa J, 2010, SEMIN CELL DEV BIOL, V21, P238, DOI 10.1016/j.semcdb.2009.10.006; Farley E, 2012, GENE DEV, V26, P873, DOI 10.1101/gad.192583.112; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Froldi F, 2015, GENE DEV, V29, P129, DOI 10.1101/gad.250282.114; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gan QA, 2010, CELL RES, V20, P763, DOI 10.1038/cr.2010.64; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Hodl M, 2012, CURR BIOL, V22, P2253, DOI 10.1016/j.cub.2012.10.008; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luque CM, 2007, DEV BIOL, V301, P327, DOI 10.1016/j.ydbio.2006.07.050; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; NG M, 1995, DEVELOPMENT, V121, P589; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Pennington KL, 2013, P NATL ACAD SCI USA, V110, P7678, DOI 10.1073/pnas.1221712110; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Pineyro D, 2013, BBA-GENE REGUL MECH, V1829, P1056, DOI 10.1016/j.bbagrm.2013.07.002; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rach EA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r73; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; Teves SS, 2013, BIOCHEM CELL BIOL, V91, P42, DOI 10.1139/bcb-2012-0075; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Turkel N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003627; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Weihe U, 2004, DEVELOPMENT, V131, P767, DOI 10.1242/dev.00979; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; XU T, 1993, DEVELOPMENT, V117, P1223; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zeitlinger J, 2010, DEV BIOL, V339, P230, DOI 10.1016/j.ydbio.2009.12.039; Zhang HS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004202; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	67	52	52	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1158	+		10.1038/ng.3381	http://dx.doi.org/10.1038/ng.3381			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26280901	Green Accepted			2022-12-25	WOS:000361969900011
J	Devlin, AS; Fischbach, MA				Devlin, A. Sloan; Fischbach, Michael A.			A biosynthetic pathway for a prominent class of microbiota-derived bile acids	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN INTESTINAL BACTERIA; SP STRAIN VPI-12708; 7-ALPHA-HYDROXYSTEROID DEHYDROGENASE; 7-BETA-HYDROXYSTEROID DEHYDROGENASE; CLOSTRIDIUM-PERFRINGENS; URSODEOXYCHOLIC ACID; EUBACTERIUM-LENTUM; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; COLON CARCINOGENESIS; SODIUM DEOXYCHOLATE	The gut bile acid pool is millimolar in concentration, varies widely in composition among individuals and is linked to metabolic disease and cancer. Although these molecules are derived almost exclusively from the microbiota, remarkably little is known about which bacterial species and genes are responsible for their biosynthesis. Here we report a biosynthetic pathway for the second most abundant class in the gut, 3 beta-hydroxy(iso)-bile acids, whose levels exceed 300 mu M in some humans and are absent in others. We show, for the first time, that iso-bile acids are produced by Ruminococcus gnavus, a far more abundant commensal than previously known producers, and that the iso-bile acid pathway detoxifies deoxycholic acid and thus favors the growth of the keystone genus Bacteroides. By revealing the biosynthetic genes for an abundant class of bile acids, our work sets the stage for predicting and rationally altering the composition of the bile acid pool.	[Devlin, A. Sloan; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Devlin, A. Sloan; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	fischbach@fischbachgroup.org		Fischbach, Michael/0000-0003-3079-8247	Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; Glenn Award for Research in Biological Mechanisms of Aging; Medical Research Program grant from the W.M. Keck Foundation; Fellowship for Science and Engineering from the David and Lucile Packard Foundation; US National Institutes of Health [OD007290, GM081879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; Glenn Award for Research in Biological Mechanisms of Aging; Medical Research Program grant from the W.M. Keck Foundation; Fellowship for Science and Engineering from the David and Lucile Packard Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to P. Turnbaugh (UCSF) for helpful discussions, to A. Hofmann (UCSD) for helpful discussions and for providing an initial sample of isoDCA and to T. Iida (Nihon University) for providing us with an authentic sample of 12-epi-isoDCA. We thank P.O. de Montellano for use of his GC-MS, Y. Varma for background research and experimentation on bile acids, P. Cimermancic for help with the phylogenetic analysis and members of the Fischbach group for helpful discussions. This research was supported by an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund (M.A.F.), a Glenn Award for Research in Biological Mechanisms of Aging (M.A.F.), a Medical Research Program grant from the W.M. Keck Foundation (M.A.F.), a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.) and US National Institutes of Health grants OD007290 and GM081879 (M.A.F.).	AKAO T, 1986, J BIOCHEM-TOKYO, V99, P1425, DOI 10.1093/oxfordjournals.jbchem.a135612; BACHRACH WH, 1982, DIGEST DIS SCI, V27, P737, DOI 10.1007/BF01393771; BARON SF, 1991, J BACTERIOL, V173, P4558, DOI 10.1128/jb.173.15.4558-4569.1991; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bennett MJ, 2003, CURR MICROBIOL, V47, P475, DOI 10.1007/s00284-003-4079-4; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; COLEMAN JP, 1994, J BACTERIOL, V176, P4865, DOI 10.1128/jb.176.16.4865-4874.1994; EDENHARDER R, 1989, BIOCHIM BIOPHYS ACTA, V1004, P230, DOI 10.1016/0005-2760(89)90272-5; EDENHARDER R, 1989, BIOCHIM BIOPHYS ACTA, V1002, P37, DOI 10.1016/0005-2760(89)90061-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hayakawa S, 1973, Adv Lipid Res, V11, P143; HIRANO S, 1981, APPL ENVIRON MICROB, V42, P912, DOI 10.1128/AEM.42.5.912-915.1981; HIRANO S, 1981, APPL ENVIRON MICROB, V42, P394, DOI 10.1128/AEM.42.3.394-399.1981; HOFMANN AF, 1992, J LIPID RES, V33, P599; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483; Kraal L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097279; LAWSON AM, 1988, BILE ACIDS CHEM PHYS, V4, P167; Lee JY, 2013, J LIPID RES, V54, P3062, DOI 10.1194/jlr.M039834; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liu L, 2011, APPL MICROBIOL BIOT, V90, P127, DOI 10.1007/s00253-010-3052-y; MACDONALD IA, 1983, J LIPID RES, V24, P675; MACDONALD IA, 1976, BIOCHIM BIOPHYS ACTA, V450, P142, DOI 10.1016/0005-2760(76)90086-2; MACDONALD IA, 1979, APPL ENVIRON MICROB, V37, P992, DOI 10.1128/AEM.37.5.992-1000.1979; MACDONALD IA, 1983, J STEROID BIOCHEM, V18, P97, DOI 10.1016/0022-4731(83)90336-9; MACDONALD IA, 1977, BIOCHIM BIOPHYS ACTA, V489, P466, DOI 10.1016/0005-2760(77)90167-9; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; MALLONEE DH, 1995, CURR MICROBIOL, V30, P259, DOI 10.1007/BF00295498; Matsuoka K, 2002, BBA-MOL CELL BIOL L, V1580, P189, DOI 10.1016/S1388-1981(01)00203-7; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; NARISAWA T, 1974, JNCI-J NATL CANCER I, V53, P1093, DOI 10.1093/jnci/53.4.1093; NOH DO, 1993, J DAIRY SCI, V76, P1253, DOI 10.3168/jds.S0022-0302(93)77454-8; RAFTER JJ, 1987, AM J CLIN NUTR, V45, P559, DOI 10.1093/ajcn/45.3.559; REDDY BS, 1976, J NATL CANCER I, V56, P441, DOI 10.1093/jnci/56.2.441; REDDY BS, 1975, J NUTR, V105, P878, DOI 10.1093/jn/105.7.878; Ridlon JM, 2010, ANAEROBE, V16, P137, DOI 10.1016/j.anaerobe.2009.05.004; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x; Talukdar S, 2007, J LIPID RES, V48, P2647, DOI 10.1194/jlr.M700189-JLR200; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wells JE, 2000, APPL ENVIRON MICROB, V66, P1107, DOI 10.1128/AEM.66.3.1107-1113.2000; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zavaglia AG, 2002, J APPL MICROBIOL, V93, P794, DOI 10.1046/j.1365-2672.2002.01747.x	46	193	210	6	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					685	+		10.1038/NCHEMBIO.1864	http://dx.doi.org/10.1038/NCHEMBIO.1864			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26192599	Green Accepted, Green Submitted			2022-12-25	WOS:000359954700012
J	Grunewald, TGP; Bernard, V; Gilardi-Hebenstreit, P; Raynal, V; Surdez, D; Aynaud, MM; Mirabeau, O; Cidre-Aranaz, F; Tirode, F; Zaidi, S; Perot, G; Jonker, AH; Lucchesi, C; Le Deley, MC; Oberlin, O; Marec-Berard, P; Veron, AS; Reynaud, S; Lapouble, E; Boeva, V; Frio, TR; Alonso, J; Bhatia, S; Pierron, G; Cancel-Tassin, G; Cussenot, O; Cox, DG; Morton, LM; Machiela, MJ; Chanock, SJ; Charnay, P; Delattre, O				Gruenewald, Thomas G. P.; Bernard, Virginie; Gilardi-Hebenstreit, Pascale; Raynal, Virginie; Surdez, Didier; Aynaud, Marie-Ming; Mirabeau, Olivier; Cidre-Aranaz, Florencia; Tirode, Franck; Zaidi, Sakina; Perot, Gaelle; Jonker, Anneliene H.; Lucchesi, Carlo; Le Deley, Marie-Cecile; Oberlin, Odile; Marec-Berard, Perrine; Veron, Amelie S.; Reynaud, Stephanie; Lapouble, Eve; Boeva, Valentina; Frio, Thomas Rio; Alonso, Javier; Bhatia, Smita; Pierron, Gaelle; Cancel-Tassin, Geraldine; Cussenot, Olivier; Cox, David G.; Morton, Lindsay M.; Machiela, Mitchell J.; Chanock, Stephen J.; Charnay, Patrick; Delattre, Olivier			Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION; EXPRESSION; CHROMATIN; REVEALS; COMMON; KROX20; RISK; VISUALIZATION; GENERATION	Deciphering the ways in which somatic mutations and germline susceptibility variants cooperate to promote cancer is challenging. Ewing sarcoma is characterized by fusions between EWSR1 and members of the ETS gene family, usually EWSR1-FLI1, leading to the generation of oncogenic transcription factors that bind DNA at GGAA motifs(1-3). A recent genome-wide association study(4) identified susceptibility variants near EGR2. Here we found that EGR2 knockdown inhibited proliferation, clonogenicity and spheroidal growth in vitro and induced regression of Ewing sarcoma xenografts. Targeted germline deep sequencing of the EGR2 locus in affected subjects and controls identified 291 Ewing-associated SNPs. At rs79965208, the A risk allele connected adjacent GGAA repeats by converting an interspaced GGAT motif into a GGAA motif, thereby increasing the number of consecutive GGAA motifs and thus the EWSR1-FLI1-dependent enhancer activity of this sequence, with epigenetic characteristics of an active regulatory element. EWSR1-FLI1 preferentially bound to the A risk allele, which increased global and allele-specific EGR2 expression. Collectively, our findings establish cooperation between a dominant oncogene and a susceptibility variant that regulates a major driver of Ewing sarcomagenesis.	[Gruenewald, Thomas G. P.; Raynal, Virginie; Surdez, Didier; Aynaud, Marie-Ming; Mirabeau, Olivier; Tirode, Franck; Zaidi, Sakina; Jonker, Anneliene H.; Lucchesi, Carlo; Delattre, Olivier] PSL Res Univ, Inst Curie, Genet & Biol Canc Unit, Paris, France; [Gruenewald, Thomas G. P.; Raynal, Virginie; Surdez, Didier; Aynaud, Marie-Ming; Mirabeau, Olivier; Tirode, Franck; Zaidi, Sakina; Jonker, Anneliene H.; Lucchesi, Carlo; Delattre, Olivier] Inst Curie, Res Ctr, INSERM, U830, Paris, France; [Bernard, Virginie; Raynal, Virginie; Frio, Thomas Rio; Delattre, Olivier] Inst Curie, Res Ctr, Inst Curie Genom Excellence ICGex Platform, Paris, France; [Gilardi-Hebenstreit, Pascale; Charnay, Patrick] Ecole Normale Super, CNRS, INSERM, Inst Biol ENS IBENS,U1024,UMR8197, Paris, France; [Cidre-Aranaz, Florencia; Alonso, Javier] Inst Salud Carlos III, Inst Invest Enfermedades Raras, Madrid, Spain; [Perot, Gaelle] INSERM, Biol Sarcomas U916, Inst Bergonie, Bordeaux, France; [Le Deley, Marie-Cecile] Inst Gustave Roussy, Dept Epidemiol & Biostat, Villejuif, France; [Oberlin, Odile] Inst Gustave Roussy, Dept Pediat, Villejuif, France; [Marec-Berard, Perrine] Univ Lyon, Leon Berard Canc Ctr, Inst Pediat Hematol & Oncol, Lyon, France; [Veron, Amelie S.; Cox, David G.] Canc Res Ctr Lyon, Leon Berard Canc Ctr, U1052, INSERM, Lyon, France; [Reynaud, Stephanie; Lapouble, Eve; Pierron, Gaelle; Delattre, Olivier] Inst Curie Ctr Hosp, UGS, Paris, France; [Boeva, Valentina] Inst Curie, Res Ctr, INSERM, Bioinformat Biostat Epidemiol & Computat Syst Bio, Paris, France; [Boeva, Valentina] Mines ParisTech, Fontainebleau, France; [Bhatia, Smita] Univ Alabama Birmingham, Sch Med, Inst Canc Outcomes & Survivorship, Birmingham, AL USA; [Cancel-Tassin, Geraldine; Cussenot, Olivier] Univ Paris 06, Hop Tenon, Ctr Rech Pathol Prostat CeRePP, Lab Urol,Res Team 2, Paris, France; [Morton, Lindsay M.; Machiela, Mitchell J.; Chanock, Stephen J.] NCI, DCEG, Bethesda, MD 20892 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; University of Alabama System; University of Alabama Birmingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Delattre, O (corresponding author), PSL Res Univ, Inst Curie, Genet & Biol Canc Unit, Paris, France.	olivier.delattre@curie.fr	TIRODE, Franck/HHS-7070-2022; Boeva, Valentina/C-2855-2017; Machiela, Mitchell J/H-7335-2019; Surdez, Didier/ABG-4565-2020; Pérot, Gaëlle/W-8038-2019; Grünewald, Thomas G. P./O-2317-2013; Jonker, Anneliene/AAW-4326-2020; Morton, Lindsay/AAE-7495-2022; Alonso, Javier/B-6012-2013; Morton, Lindsay M/B-5234-2015; Cox, David G/A-2023-2009; Cox, David/ABA-7454-2020; Tirode, Franck/B-4586-2009	Boeva, Valentina/0000-0002-4382-7185; Machiela, Mitchell J/0000-0001-6538-9705; Grünewald, Thomas G. P./0000-0003-0920-7377; Morton, Lindsay/0000-0001-9767-2310; Alonso, Javier/0000-0002-6287-8391; Morton, Lindsay M/0000-0001-9767-2310; Cox, David G/0000-0002-2152-9259; Cidre Aranaz, Florencia/0000-0002-0246-7179; Tirode, Franck/0000-0003-4731-7817; GILARDI-HEBENSTREIT, Pascale/0000-0003-3134-583X; Lucchesi, Carlo/0000-0001-6657-2341; Charnay, Patrick/0000-0002-3847-6042; cussenot, olivier/0000-0002-9912-0533; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Le Deley, Marie-Cecile/0000-0002-2946-4592; delattre, olivier/0000-0002-8730-2276; Cox, David/0000-0003-2047-4687	German Research Foundation [DFG GR3728/2-1]; Daimler and Benz Foundation; LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative; Mehr LEBEN fur krebskranke Kinder-Bettina-Bruu-Stiftung; Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program; Asociacion Pablo Ugarte; Instituto de Salud Carlos III [RTICC RD12/0036/0027]; InfoSarcomes Association; National Cancer Institute [CA55727]; Intramural Research Program of the National Institutes of Health, National Cancer Institute; Institut Curie; INSERM; Agence Nationale de la Recherche (Investissements d'Avenir) [ANR-10-EQPX-03]; Canceropole Ile-de-France [ANR10-INBS-09-08]; Ligue Nationale Contre le Cancer (Equipe labellisee); Institut National du Cancer [PLBIO14-237]; European PROVABES project [ERA-649 NET TRANSCAN JTC-2011]; ASSET project [FP7-HEALTH-2010-259348]; EEC project [HEALTH-F2-2013-602856]; Societe Francaise des Cancers de l'Enfant; CNRS; Ministere de la Recherche et Technologie; Fondation pour la Recherche Medicale; program "Investissements d'Avenir" [ANR-10-LABX-54 MEMOLIFE, ANR-11-IDEX-0001-02 PSL<SUP>star</SUP>]; NATIONAL CANCER INSTITUTE [U24CA055727] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Daimler and Benz Foundation; LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative; Mehr LEBEN fur krebskranke Kinder-Bettina-Bruu-Stiftung; Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program; Asociacion Pablo Ugarte; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); InfoSarcomes Association; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institut Curie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (Investissements d'Avenir)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); European PROVABES project; ASSET project; EEC project; Societe Francaise des Cancers de l'Enfant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche et Technologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); program "Investissements d'Avenir"(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.G.P.G. is supported by a grant from the German Research Foundation (DFG GR3728/2-1), by the Daimler and Benz Foundation in cooperation with the Reinhard Frank Foundation, by LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative and by the Mehr LEBEN fur krebskranke Kinder-Bettina-Bruu-Stiftung. D.S. is supported by the Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program. F.C.-A. is supported by a grant from the Asociacion Pablo Ugarte and Instituto de Salud Carlos III RTICC RD12/0036/0027. D.G.C. is supported by a grant from the InfoSarcomes Association. The Childhood Cancer Survivor Study is supported by the National Cancer Institute (CA55727, G.T. Armstrong), with funding for genotyping from the Intramural Research Program of the National Institutes of Health, National Cancer Institute. This work was supported by grants from the Institut Curie; INSERM; the Agence Nationale de la Recherche (Investissements d'Avenir) (ANR-10-EQPX-03); the Canceropole Ile-de-France (ANR10-INBS-09-08); the Ligue Nationale Contre le Cancer (Equipe labellisee); the Institut National du Cancer (PLBIO14-237); the European PROVABES (ERA-649 NET TRANSCAN JTC-2011), ASSET (FP7-HEALTH-2010-259348) and EEC (HEALTH-F2-2013-602856) projects; and the Societe Francaise des Cancers de l'Enfant. The following associations supported this work: Courir pour Mathieu, Dans les pas du Geant, Olivier Chape, Les Bagouzamanon, Enfants et Sante, and les Amis de Claire. The Charnay laboratory was financed by INSERM, the CNRS, the Ministere de la Recherche et Technologie, and the Fondation pour la Recherche Medicale. It has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by the ANR, with the references ANR-10-LABX-54 MEMOLIFE and ANR-11-IDEX-0001-02 PSL<SUP>star</SUP> Research University. We thank J. Maris for providing genotype information for the neuroblastoma data set, and we thank L. Liang and W. Cookson for providing access to genotype data on the LCL data set. We thank H. Kovar (Children's Cancer Research Institute Vienna, Vienna, Austria) for providing cell lines STA-ET-1, STA-ET-3 and STA-ET-8, and F. Redini (University of Nantes, Nantes, France) for providing cell line TC-32. Human MSC lines L87 and V54-2 were kindly provided by P. Nelson (University Hospital LMU, Munich, Germany). We also thank the following clinicians and pathologists for providing samples used in this work: I. Aerts, P. Anract, C. Bergeron, L. Boccon-Gibod, F. Boman, F. Bourdeaut, C. Bouvier, R. Bouvier, L. Brugieres, E. Cassagnau, J. Champigneulle, C. Cordonnier, J. M. Coindre, N. Corradini, A. Coulomb-Lhermine, A. De Muret, G. De Pinieux, A.S. Defachelles, A. Deville, F. Dijoud, F. Doz, C. Dufour, K. Fernandez, N. Gaspard, L. Galmiche-Rolland, C. Glorion, A. Gomez-Brouchet, J. M. Guinebretiere, H. Jouan, C. Jeanne-Pasquier, B. Kantelip, F. Labrousse, V. Laithier, F. Larousserie, G. Leverger, C. Linassier, P. Mary, G. Margueritte, E. Mascard, A. Moreau, J. Michon, C. Michot, F. Millot, Y. Musizzano, M. Munzer, B. Narciso, O. Oberlin, D. Orbach, H. Pacquement, Y. Perel, B. Petit, M. Peuchmaur, J. Y. Pierga, C. Piguet, S. Piperno-Neumann, E. Plouvier, D. Ranchere-Vince, J. Rivel, C. Rouleau, H. Rubie, H. Sartelet, G. Schleiermacher, C. Schmitt, N. Sirvent, D. Sommelet, P. Terrier, R. Tichit, J. Vannier, J.M. Vignaud and V. Verkarre. We also thank D. Darmon for technical assistance, S. Grossetete-Lalami for bioinformatic assistance, and V.R. Buchholz and E.; Butt for critical reading of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boeva V, 2012, BIOINFORMATICS, V28, P2517, DOI 10.1093/bioinformatics/bts463; Boeva V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq217; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Clavel-Chapelon F, 1997, EUR J CANCER PREV, V6, P473, DOI 10.1097/00008469-199710000-00007; Conrad C, 2002, EXP HEMATOL, V30, P887, DOI 10.1016/S0301-472X(02)00865-2; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Faye LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003609; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gao C, 2014, BIOINFORMATICS, V30, P369, DOI 10.1093/bioinformatics/btt690; Ghislain J, 2002, DEVELOPMENT, V129, P155; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Labalette C, 2011, DEVELOPMENT, V138, P317, DOI 10.1242/dev.057299; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mackintosh C, 2010, CANCER BIOL THER, V9, P655, DOI 10.4161/cbt.9.9.11511; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melot T, 1997, HYBRIDOMA, V16, P457, DOI 10.1089/hyb.1997.16.457; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Patel M, 2012, GENOME RES, V22, P259, DOI 10.1101/gr.125666.111; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Surdez D, 2012, CANCER RES, V72, P4494, DOI 10.1158/0008-5472.CAN-12-0371; THALMEIER K, 1994, BLOOD, V83, P1799; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wang ZM, 2012, NAT GENET, V44, P6, DOI 10.1038/ng.1044; Weisinger K, 2010, DEV BIOL, V344, P881, DOI 10.1016/j.ydbio.2010.06.001; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Worch J, 2011, CANCER EPIDEM BIOMAR, V20, P449, DOI 10.1158/1055-9965.EPI-10-1170; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	104	107	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1073	+		10.1038/ng.3363	http://dx.doi.org/10.1038/ng.3363			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26214589	Green Submitted, Green Accepted			2022-12-25	WOS:000360394100019
J	Lenz, TL; Deutsch, AJ; Han, B; Hu, XL; Okada, Y; Eyre, S; Knapp, M; Zhernakova, A; Huizinga, TWJ; Abecasis, G; Becker, J; Boeckxstaens, GE; Chen, WM; Franke, A; Gladman, DD; Gockel, I; Gutierrez-Achury, J; Martin, J; Nair, RP; Nothen, MM; Onengut-Gumuscu, S; Rahman, P; Rantapaa-Dahlqvist, S; Stuart, PE; Tsoi, LC; van Heel, DA; Worthington, J; Wouters, MM; Klareskog, L; Elder, JT; Gregersen, PK; Schumacher, J; Rich, SS; Wijmenga, C; Sunyaev, SR; Bakker, PIW; Raychaudhuri, S				Lenz, Tobias L.; Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Eyre, Stephen; Knapp, Michael; Zhernakova, Alexandra; Huizinga, Tom W. J.; Abecasis, Goncalo; Becker, Jessica; Boeckxstaens, Guy E.; Chen, Wei-Min; Franke, Andre; Gladman, Dafna D.; Gockel, Ines; Gutierrez-Achury, Javier; Martin, Javier; Nair, Rajan P.; Noethen, Markus M.; Onengut-Gumuscu, Suna; Rahman, Proton; Rantapaa-Dahlqvist, Solbritt; Stuart, Philip E.; Tsoi, Lam C.; van Heel, David A.; Worthington, Jane; Wouters, Mira M.; Klareskog, Lars; Elder, James T.; Gregersen, Peter K.; Schumacher, Johannes; Rich, Stephen S.; Wijmenga, Cisca; Sunyaev, Shamil R.; de Bakker, Paul I. W.; Raychaudhuri, Soumya			Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SEROPOSITIVE RHEUMATOID-ARTHRITIS; CELIAC-DISEASE; PREFERENTIAL TRANSMISSION; HETEROZYGOTE ADVANTAGE; SHARED EPITOPE; GENETIC RISK; MHC; SUSCEPTIBILITY; ASSOCIATION	Human leukocyte antigen (HLA) genes confer substantial risk for autoimmune diseases on a log-additive scale. Here we speculated that differences in autoantigen-binding repertoires between a heterozygote's two expressed HLA variants might result in additional non-additive risk effects. We tested the non-additive disease contributions of classical HLA alleles in patients and matched controls for five common autoimmune diseases: rheumatoid arthritis (n(cases) = 5,337), type 1 diabetes (T1D; n(cases) = 5,567), psoriasis vulgaris (n(cases) = 3,089), idiopathic achalasia (n(cases) = 727) and celiac disease (ncases = 11,115). In four of the five diseases, we observed highly significant, non-additive dominance effects (rheumatoid arthritis, P = 2.5 x 10(-12); T1D, P = 2.4 x 10(-10); psoriasis, P = 5.9 x 10(-6); celiac disease, P = 1.2 x 10(-87)). In three of these diseases, the non-additive dominance effects were explained by interactions between specific classical HLA alleles (rheumatoid arthritis, P = 1.8 x 10(-3); T1D, P = 8.6 x 10(-27); celiac disease, P = 6.0 x 10(-100)). These interactions generally increased disease risk and explained moderate but significant fractions of phenotypic variance (rheumatoid arthritis, 1.4%; T1D, 4.0%; celiac disease, 4.1%) beyond a simple additive model.	[Lenz, Tobias L.; Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Sunyaev, Shamil R.; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Lenz, Tobias L.; Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Sunyaev, Shamil R.; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Lenz, Tobias L.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Evolutionary Immunogen, Plon, Germany; [Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Deutsch, Aaron J.; Han, Buhm; Hu, Xinli; Okada, Yukinori; Sunyaev, Shamil R.; Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Deutsch, Aaron J.; Hu, Xinli] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Han, Buhm] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Eyre, Stephen; Worthington, Jane; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England; [Eyre, Stephen; Worthington, Jane] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, Natl Inst Hlth Res NIHR Manchester Musculoskeleta, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Zhernakova, Alexandra; Gutierrez-Achury, Javier; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Huizinga, Tom W. J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Abecasis, Goncalo; Tsoi, Lam C.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo; Tsoi, Lam C.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Becker, Jessica; Noethen, Markus M.; Schumacher, Johannes] Univ Bonn, Inst Human Genet, Bonn, Germany; [Becker, Jessica; Noethen, Markus M.; Schumacher, Johannes] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Boeckxstaens, Guy E.; Wouters, Mira M.] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Chen, Wei-Min; Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Gladman, Dafna D.] Univ Toronto, Dept Med, Div Rheumatol, Toronto, ON, Canada; [Gladman, Dafna D.] Univ Toronto, Toronto Western Res Inst, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada; [Gladman, Dafna D.] Univ Toronto, Toronto Western Res Inst, Toronto, ON, Canada; [Gockel, Ines] Univ Hosp Leipzig, Dept Visceral Transplant Thorac & Vasc Surg, Leipzig, Germany; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Nair, Rajan P.; Stuart, Philip E.; Elder, James T.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Rahman, Proton] Mem Univ Newfoundland, Dept Med, St John, NF, Canada; [Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Rheumatol, Umea, Sweden; [van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Klareskog, Lars; Raychaudhuri, Soumya] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars; Raychaudhuri, Soumya] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Ulsan; Asan Medical Center; Tokyo Medical & Dental University (TMDU); RIKEN; University of Manchester; University of Manchester; University of Bonn; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Bonn; University of Bonn; KU Leuven; University of Virginia; University of Kiel; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Leipzig University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Michigan System; University of Michigan; Memorial University Newfoundland; Umea University; Umea University; University of London; Queen Mary University London; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Northwell Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Lenz, TL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	pdebakker@umcutrecht.nl; soumya@broadinstitute.org	Schumacher, Johannes/F-4970-2015; Franke, Andre/B-2151-2010; Wijmenga, Cisca/D-2173-2009; Boeckxstaens, Guy/AAP-2502-2020; Lenz, Tobias L/D-1387-2009; Wijmenga, Cisca/AAE-7719-2019; Han, Buhm/AAQ-9672-2020; Zhernakova, Alexandra/ABA-9372-2020; eyre, stephen/K-3776-2017; Wouters, Mira/K-1371-2013; Martín, Javier/AAV-5209-2021; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022	Schumacher, Johannes/0000-0001-9217-6457; Franke, Andre/0000-0003-1530-5811; Lenz, Tobias L/0000-0002-7203-0044; Wijmenga, Cisca/0000-0002-5635-1614; eyre, stephen/0000-0002-1251-6974; Wouters, Mira/0000-0002-3438-1919; Martin, Javier/0000-0002-2202-0622; Tsoi, Lam Cheung/0000-0003-1627-5722; Rich, Stephen/0000-0003-3872-7793; Deutsch, Aaron/0000-0001-6750-5335; Zhernakova, Alexandra/0000-0002-4574-0841; Nothen, Markus/0000-0002-8770-2464; van Heel, David/0000-0002-0637-2265; Raychaudhuri, Soumya/0000-0002-1901-8265; Gutierrez-Achury, Javier/0000-0002-4971-1474	German Research Foundation (DFG) [LE 2593/1-1, LE 2593/2-1, GO 1795/1-1, KN 378/2-1, SCHU 1596/5-1]; US National Institutes of Health [1R01AR062886, R01AR065183, 1R01AR063759-01A1, 5U01GM092691, 1UH2AR067677-01]; IMI (European Union); Netherlands Organization for Scientific Research (Vernieuwingsimpuls VIDI Award NWO project) [016.126.354]; Instituto de Salud Carlos III [RD12/0009]; Alfried Krupp von Bohlen und Halbach-Stiftung; MRC [G1001158] Funding Source: UKRI; Grants-in-Aid for Scientific Research [15H05670] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062886, R01AR063611, R01AR063759, R01AR065183, R01AR042742, UH2AR067677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; Medical Research Council [G1001158] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMI (European Union); Netherlands Organization for Scientific Research (Vernieuwingsimpuls VIDI Award NWO project)(Netherlands Organization for Scientific Research (NWO)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Alfried Krupp von Bohlen und Halbach-Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by grants from the German Research Foundation (DFG; LE 2593/1-1 and LE 2593/2-1 (T.L.L.), GO 1795/1-1 (I.G.), KN 378/2-1 (M.K.) and SCHU 1596/5-1 (J.S.)), by grants from the US National Institutes of Health (1R01AR062886 (P.I.W.d.B.), R01AR065183 (J.T.E.), 1R01AR063759-01A1 (S.R.), 5U01GM092691 (S.R.) and 1UH2AR067677-01 (S.R.)), by the IMI (European Union)-funded program BTCure (L.K.) and by the Netherlands Organization for Scientific Research (Vernieuwingsimpuls VIDI Award NWO project 016.126.354 (P.I.W.d.B.)). Sample collection for J.M. was supported by a grant from the Instituto de Salud Carlos III (RD12/0009). M.M.N. received support for this work from the Alfried Krupp von Bohlen und Halbach-Stiftung and is a member of the DFG-funded Excellence Cluster ImmunoSensation.	Balding D.J., 2007, HDB STAT GENETICS; Bronson PG, 2009, DIABETES OBES METAB, V11, P74, DOI 10.1111/j.1463-1326.2008.01006.x; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Clop A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071690; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Gjuvsland AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009379; Gockel I, 2014, NAT GENET, V46, P901, DOI 10.1038/ng.3029; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Klareskog L, 2013, ADV IMMUNOL, V118, P129, DOI 10.1016/B978-0-12-407708-9.00003-0; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; Kwan S.H., 2007, STAT GENETICS GENE M, P17; Lenz TL, 2011, EVOLUTION, V65, P2380, DOI 10.1111/j.1558-5646.2011.01288.x; Lipsitch Marc, 2003, BMC Med Genet, V4, P2, DOI 10.1186/1471-2350-4-2; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rich SS, 2006, ANN NY ACAD SCI, V1079, P1, DOI 10.1196/annals.1375.001; Sasaki T, 1999, J HUM GENET, V44, P318, DOI 10.1007/s100380050168; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; VADHEIM CM, 1986, NEW ENGL J MED, V315, P1314, DOI 10.1056/NEJM198611203152103; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131	51	111	113	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1085	+		10.1038/ng.3379	http://dx.doi.org/10.1038/ng.3379			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26258845	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000360394100021
J	Elvidge, S				Elvidge, Suzanne			Blockbuster expectations for hepatitis B therapeutic vaccine	NATURE BIOTECHNOLOGY			English	News Item																		2012, CANC GENE THER, V19, P779; 2014, VACCINE, V32, P4925	2	6	8	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					789	789		10.1038/nbt0815-789	http://dx.doi.org/10.1038/nbt0815-789			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252120				2022-12-25	WOS:000359274900005
J	Wang, YX; Xiong, GS; Hu, J; Jiang, L; Yu, H; Xu, J; Fang, YX; Zeng, LJ; Xu, EB; Xu, J; Ye, WJ; Meng, XB; Liu, RF; Chen, HQ; Jing, YH; Wang, YH; Zhu, XD; Li, JY; Qian, Q				Wang, Yuexing; Xiong, Guosheng; Hu, Jiang; Jiang, Liang; Yu, Hong; Xu, Jie; Fang, Yunxia; Zeng, Longjun; Xu, Erbo; Xu, Jing; Ye, Weijun; Meng, Xiangbing; Liu, Ruifang; Chen, Hongqi; Jing, Yanhui; Wang, Yonghong; Zhu, Xudong; Li, Jiayang; Qian, Qian			Copy number variation at the GL7 locus contributes to grain size diversity in rice	NATURE GENETICS			English	Article							GENE; ENCODES; WEIGHT; LENGTH; YIELD; WIDTH; IMPACT; SHAPE; QTL	Copy number variants (CNVs) are associated with changes in gene expression levels and contribute to various adaptive traits(1,2). Here we show that a CNV at the Grain Length on Chromosome 7 (GL7) locus contributes to grain size diversity in rice (Oryza sativa L.). GL7 encodes a protein homologous to Arabidopsis thaliana LONGIFOLIA proteins, which regulate longitudinal cell elongation. Tandem duplication of a 17.1-kb segment at the GL7 locus leads to upregulation of GL7 and downregulation of its nearby negative regulator, resulting in an increase in grain length and improvement of grain appearance quality. Sequence analysis indicates that allelic variants of GL7 and its negative regulator are associated with grain size diversity and that the CNV at the GL7 locus was selected for and used in breeding. Our work suggests that pyramiding beneficial alleles of GL7 and other yield- and quality-related genes may improve the breeding of elite rice varieties.	[Wang, Yuexing; Hu, Jiang; Xu, Jie; Fang, Yunxia; Xu, Erbo; Xu, Jing; Ye, Weijun; Liu, Ruifang; Chen, Hongqi; Zhu, Xudong; Qian, Qian] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Wang, Yuexing; Xiong, Guosheng; Jiang, Liang; Yu, Hong; Meng, Xiangbing; Jing, Yanhui; Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Wang, Yuexing; Xiong, Guosheng; Jiang, Liang; Yu, Hong; Meng, Xiangbing; Jing, Yanhui; Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China; [Xiong, Guosheng; Zeng, Longjun; Liu, Ruifang; Qian, Qian] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Qian, Q (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	ricezxd@126.com; jyli@genetics.ac.cn; qianqian188@hotmail.com	qian, qian/AAH-8708-2021; Li, Jiayang/AAG-4377-2020; Yu, Hong/H-2770-2012	Yu, Hong/0000-0002-1748-8693; meng, xiangbing/0000-0001-7040-7138	Ministry of Science and Technology of China [2013CBA01400]; National Natural Science Foundation of China [31221004, 31201004, 31201194]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the National Medium Rice Genebank at the China National Rice Research Institute for providing rice accessions. This work was supported by grants from the Ministry of Science and Technology of China (2013CBA01400) and the National Natural Science Foundation of China (31221004, 31201004 and 31201194).	[程俊彪 Cheng Junbiao], 2002, [广东农业科学, Guangdong Agricultural Sciences], V0, P5; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Drevensek S, 2012, PLANT CELL, V24, P178, DOI 10.1105/tpc.111.089748; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Imbe T., 2004, Bulletin of the National Institute of Crop Science, P35; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; McHale LK, 2012, PLANT PHYSIOL, V159, P1295, DOI 10.1104/pp.112.194605; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Yu P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-649; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	27	343	415	16	266	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					944	+		10.1038/ng.3346	http://dx.doi.org/10.1038/ng.3346			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26147619				2022-12-25	WOS:000358674100022
J	Fortune, MD; Guo, H; Burren, O; Schofield, E; Walker, NM; Ban, M; Sawcer, SJ; Bowes, J; Worthington, J; Barton, A; Eyre, S; Todd, JA; Wallace, C				Fortune, Mary D.; Guo, Hui; Burren, Oliver; Schofield, Ellen; Walker, Neil M.; Ban, Maria; Sawcer, Stephen J.; Bowes, John; Worthington, Jane; Barton, Anne; Eyre, Steve; Todd, John A.; Wallace, Chris			Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls	NATURE GENETICS			English	Article							TYPE-2 DIABETES RISK; SUSCEPTIBILITY LOCI; ASSOCIATION SIGNALS; CELIAC-DISEASE; GENOME; ARCHITECTURE; EXPRESSION; INSIGHTS	Determining whether potential causal variants for related diseases are shared can identify overlapping etiologies of multifactorial disorders. Colocalization methods disentangle shared and distinct causal variants. However, existing approaches require independent data sets. Here we extend two colocalization methods to allow for the shared-control design commonly used in comparison of genome-wide association study results across diseases. Our analysis of four autoimmune diseases-type 1 diabetes (T1D), rheumatoid arthritis, celiac disease and multiple sclerosis-identified 90 regions that were associated with at least one disease, 33 (37%) of which were associated with 2 or more disorders. Nevertheless, for 14 of these 33 shared regions, there was evidence that the causal variants differed. We identified new disease associations in 11 regions previously associated with one or more of the other 3 disorders. Four of eight T1D-specific regions contained known type 2 diabetes (T2D) candidate genes (COBL, GLIS3, RNLS and BCAR1), suggesting a shared cellular etiology.	[Fortune, Mary D.; Guo, Hui; Burren, Oliver; Schofield, Ellen; Walker, Neil M.; Todd, John A.; Wallace, Chris] Univ Cambridge, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Dept Med Genet,JDRF Wellcome Trust Diabet & Infla, Cambridge, England; [Guo, Hui] Univ Manchester, Ctr Biostat, Inst Populat Hlth, Manchester, Lancs, England; [Ban, Maria; Sawcer, Stephen J.] Addenbrookes Hosp, Univ Neurol Unit, Cambridge, England; [Bowes, John; Worthington, Jane; Barton, Anne; Eyre, Steve] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthritis Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res,Inst Inflammat & Repair, Manchester, Lancs, England; [Bowes, John; Worthington, Jane; Barton, Anne; Eyre, Steve] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res, Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Wallace, Chris] Cambridge Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Cambridge; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Manchester; University of Manchester; MRC Biostatistics Unit; University of Cambridge	Fortune, MD (corresponding author), Univ Cambridge, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Dept Med Genet,JDRF Wellcome Trust Diabet & Infla, Cambridge, England.	mary.fortune@cimr.cam.ac.uk; chris.wallace@cimr.cam.ac.uk	Todd, John A/A-3542-2010; eyre, stephen/K-3776-2017; Barton, Anne/N-2053-2014	Todd, John A/0000-0003-2740-8148; eyre, stephen/0000-0002-1251-6974; Burren, Oliver/0000-0002-3388-5760; Schofield, Ellen/0000-0003-0648-1418; Sawcer, Stephen/0000-0001-7685-0974; Guo, Hui/0000-0003-0282-6933; Walker, Neil/0000-0001-9796-7688; Barton, Anne/0000-0003-3316-2527; Wallace, Chris/0000-0001-9755-1703; Fortune, Mary/0000-0002-6006-4343	Wellcome Trust [099772, 089989, 091157, 068545/Z/02]; JDRF [9-2011-253]; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Wellcome Trust Strategic Award [100140]; Eli Lilly and Company; UK Medical Research Council (MRC); MRC [G0000934]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); JDRF; NIDDK [U01DK062418]; Arthritis Foundation; US National Institutes of Health; Celiac Disease Consortium; Dutch government [BSIK03009]; Netherlands Organisation for Scientific Research (NWO) [918.66.620]; US National Institutes of Health [1R01CA141743]; Fondo de Investigacion Sanitaria [FIS08/1676, FIS07/0353]; UK Multiple Sclerosis Society; UK MRC; US National Multiple Sclerosis Society; Cambridge NIHR Biomedical Research Centre; DeNDRon; Bibbi and Niels Jensens Foundation; Swedish Brain Foundation; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Foundation for Strategic Research; Stockholm County Council; Karolinska Institutet; INSERM; Fondation d'Aide a la Recherche sur la Sclerose en Plaques; Association Francaise contre les Myopathies; Infrastructures en Biologie Sante et Agronomie (GIS-IBISA); German Ministry for Education and Research; German Competence Network Multiple Sclerosis; Deutsche Forschungsgemeinschaft; Munich Biotec Cluster M4; Fidelity Biosciences Research Initiative; Research Foundation Flanders; Research Fund KU Leuven; Belgian charcot Foundation; gemeinnutzige Hertie Stiftung; University Zurich; Danish Multiple Sclerosis Society; Danish Council for Strategic Research; Academy of Finland; Sigrid Juselius Foundation; Helsinki University; Italian Multiple Sclerosis Foundation; Fondazione Cariplo; Italian Ministry of University and Research; Torino Savings Bank Foundation; Italian Ministry of Health; Italian Institute of Experimental Neurology; Multiple Sclerosis Association of Oslo; Norwegian Research Council; South-Eastern Norwegian Health Authorities; Australian National Health and Medical Research Council; Dutch Multiple Sclerosis Foundation; Kaiser Permanente; Medical Research Council [G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275, NF-SI-0513-10143] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA141743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); JDRF(Juvenile Diabetes Research Foundation); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust Strategic Award(Wellcome Trust); Eli Lilly and Company(Eli Lilly); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); JDRF(Juvenile Diabetes Research Foundation); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Arthritis Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celiac Disease Consortium; Dutch government; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); UK Multiple Sclerosis Society; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Multiple Sclerosis Society(National Multiple Sclerosis Society); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); DeNDRon; Bibbi and Niels Jensens Foundation; Swedish Brain Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Foundation for Strategic Research; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation d'Aide a la Recherche sur la Sclerose en Plaques; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Infrastructures en Biologie Sante et Agronomie (GIS-IBISA); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Competence Network Multiple Sclerosis; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Munich Biotec Cluster M4; Fidelity Biosciences Research Initiative; Research Foundation Flanders(FWO); Research Fund KU Leuven(KU Leuven); Belgian charcot Foundation; gemeinnutzige Hertie Stiftung; University Zurich; Danish Multiple Sclerosis Society; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University; Italian Multiple Sclerosis Foundation; Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Torino Savings Bank Foundation; Italian Ministry of Health(Ministry of Health, Italy); Italian Institute of Experimental Neurology; Multiple Sclerosis Association of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norwegian Health Authorities; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dutch Multiple Sclerosis Foundation; Kaiser Permanente; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.D.F. is funded by the Wellcome Trust (099772). C.W. and H.G. are funded by the Wellcome Trust (089989).; This work was funded by the JDRF (9-2011-253), the Wellcome Trust (091157) and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (100140). ImmunoBase is supported by Eli Lilly and Company.; We thank the UK Medical Research Council (MRC) and Wellcome Trust for funding the collection of DNA for the British 1958 Birth Cohort (MRC grant G0000934 and Wellcome Trust grant 068545/Z/02). Control DNA samples were prepared and provided by S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton.; This research uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHD) and the JDRF and supported by grant U01DK062418 from the NIDDK.; Collection of the rheumatoid arthritis data was funded by the Arthritis Foundation and the US National Institutes of Health.; We are grateful to G. Trynka and D. van Heel for use of the celiac disease data. Funding was provided by the Wellcome Trust, by grants from the Celiac Disease Consortium and an Innovative Cluster approved by the Netherlands Genomics Initiative, by the Dutch government (BSIK03009 to C.W.) and the Netherlands Organisation for Scientific Research (NWO; grant 918.66.620), and by US National Institutes of Health grant 1R01CA141743 and Fondo de Investigacion Sanitaria grants FIS08/1676 and FIS07/0353.; Multiple sclerosis data were provided by S. Sawcer and the International Multiple Sclerosis Genetics Consortium. Funding was provided by the US National Institutes of Health, the Wellcome Trust, the UK Multiple Sclerosis Society, the UK MRC, the US National Multiple Sclerosis Society, the Cambridge NIHR Biomedical Research Centre, DeNDRon, the Bibbi and Niels Jensens Foundation, the Swedish Brain Foundation, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the Foundation for Strategic Research, the Stockholm County Council, Karolinska Institutet, INSERM, Fondation d'Aide a la Recherche sur la Sclerose en Plaques, Association Francaise contre les Myopathies, Infrastructures en Biologie Sante et Agronomie (GIS-IBISA), the German Ministry for Education and Research, the German Competence Network Multiple Sclerosis, Deutsche Forschungsgemeinschaft, Munich Biotec Cluster M4, the Fidelity Biosciences Research Initiative, Research Foundation Flanders, Research Fund KU Leuven, the, Belgian charcot Foundation, gemeinnutzige Hertie Stiftung, University Zurich, the Danish Multiple Sclerosis Society, the Danish Council for Strategic Research, the Academy of Finland, the Sigrid Juselius Foundation, Helsinki University, the Italian Multiple Sclerosis Foundation, Fondazione Cariplo, the Italian Ministry of University and Research, the Torino Savings Bank Foundation, the Italian Ministry of Health, the Italian Institute of Experimental Neurology, the Multiple Sclerosis Association of Oslo, the Norwegian Research Council, the South-Eastern Norwegian Health Authorities, the Australian National Health and Medical Research Council, the Dutch Multiple Sclerosis Foundation and Kaiser Permanente.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Evangelou M, 2014, GENET EPIDEMIOL, V38, P661, DOI 10.1002/gepi.21853; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Harder MN, 2013, J CLIN ENDOCR METAB, V98, pE801, DOI 10.1210/jc.2012-4169; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mero IL, 2010, EUR J HUM GENET, V18, P502, DOI 10.1038/ejhg.2009.195; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Scott R.A., 2014, GENOME WIDE ASS STUD; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Swafford ADE, 2011, DIABETES, V60, P1041, DOI 10.2337/db10-0446; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wallace C, 2013, GENET EPIDEMIOL, V37, P802, DOI 10.1002/gepi.21765; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098	32	87	87	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					839	+		10.1038/ng.3330	http://dx.doi.org/10.1038/ng.3330			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053495	Green Submitted, Green Accepted			2022-12-25	WOS:000357090300026
J	Monaghan, RM; Barnes, RG; Fisher, K; Andreou, T; Rooney, N; Poulin, GB; Whitmarsh, AJ				Monaghan, Richard M.; Barnes, Robert G.; Fisher, Kate; Andreou, Tereza; Rooney, Nicholas; Poulin, Gino B.; Whitmarsh, Alan J.			A nuclear role for the respiratory enzyme CLK-1 in regulating mitochondrial stress responses and longevity	NATURE CELL BIOLOGY			English	Article							ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; COENZYME-Q; PROTEIN; METABOLISM; CONSERVATION; UBIQUINONE; BEHAVIOR; IMPORT	The coordinated regulation of mitochondrial and nuclear activities is essential for cellular respiration and its disruption leads to mitochondrial dysfunction, a hallmark of ageing. Mitochondria communicate with nuclei through retrograde signalling pathways that modulate nuclear gene expression to maintain mitochondrial homeostasis. The monooxygenase CLK-1 (human homologue COQ7) was previously reported to be mitochondrial, with a role in respiration and longevity. We have uncovered a distinct nuclear form of CLK-1 that independently regulates lifespan. Nuclear CLK-1 mediates a retrograde signalling pathway that is conserved from Caenorhabditis elegans to humans and is responsive to mitochondrial reactive oxygen species, thus acting as a barometer of oxidative metabolism. We show that, through modulation of gene expression, the pathway regulates both mitochondrial reactive oxygen species metabolism and the mitochondrial unfolded protein response. Our results demonstrate that a respiratory enzyme acts in the nucleus to control mitochondrial stress responses and longevity.	[Monaghan, Richard M.; Barnes, Robert G.; Fisher, Kate; Andreou, Tereza; Rooney, Nicholas; Poulin, Gino B.; Whitmarsh, Alan J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Poulin, GB (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	gino.poulin@manchester.ac.uk; alan.j.whitmarsh@manchester.ac.uk	Monaghan, Richard/AAD-8526-2022	Andreou, Tereza/0000-0001-9143-8646; Monaghan, Richard/0000-0002-3323-1337; Whitmarsh, Alan/0000-0003-1184-6610; Poulin, Gino/0000-0003-1016-348X	Biotechnology and Biological Sciences Research Council [BB/J014834/1]; Wellcome Trust [093176/Z/10/Z, 097820/Z/11/Z]; NIH Office of Research Infrastructure Programs [P40 OD010440]; BBSRC [BB/J014834/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1065459] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank I. Donaldson and A. Hayes of the Bioinformatics and Genomic Technologies Core Facilities at the University of Manchester for providing support with regard to ChIP-chip tiling arrays. We thank M. Howard for assistance with RP-HPLC. This work was supported by the Biotechnology and Biological Sciences Research Council (BB/J014834/1 to A.J.W. and G.B.P.) and the Wellcome Trust (093176/Z/10/Z to A.J.W. and 097820/Z/11/Z to A.J.W. and G.B.P.). Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank A. Sharrocks, P. Shore, S. H. Yang and A. Gilmore for helpful comments on the manuscript.	Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Aparicio O., 2005, CURR PROTOC MOL BIOL; BarPeled M, 1996, ANAL BIOCHEM, V241, P140, DOI 10.1006/abio.1996.0390; BRENNER S, 1974, GENETICS, V77, P71; Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34; Chueh FY, 2011, CELL SIGNAL, V23, P1170, DOI 10.1016/j.cellsig.2011.03.004; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Itoh K, 2015, J CLIN BIOCHEM NUTR, V56, P91, DOI 10.3164/jcbn.14-134; Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006; Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kotiadis VN, 2014, BBA-GEN SUBJECTS, V1840, P1254, DOI 10.1016/j.bbagen.2013.10.041; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Mates JM, 2009, INT J BIOCHEM CELL B, V41, P2051, DOI 10.1016/j.biocel.2009.03.003; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Miyadera H, 2002, FEBS LETT, V512, P33, DOI 10.1016/S0014-5793(02)02282-2; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; O'Keefe LV, 2011, HUM MOL GENET, V20, P497, DOI 10.1093/hmg/ddq495; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Riera CE, 2015, NAT CELL BIOL, V17, P196, DOI 10.1038/ncb3107; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Van Raamsdonk JM, 2010, GENETICS, V185, P559, DOI 10.1534/genetics.110.115378; Wang Y, 2009, J BIOL CHEM, V284, P314, DOI 10.1074/jbc.M807579200; Whelan SP, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/351613; Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319; WONG A, 1995, GENETICS, V139, P1247; Wright G, 2001, EXP CELL RES, V263, P107, DOI 10.1006/excr.2000.5096; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zeiser E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020082	53	55	59	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					782	+		10.1038/ncb3170	http://dx.doi.org/10.1038/ncb3170			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25961505	Green Submitted, Green Accepted			2022-12-25	WOS:000355277500010
J	Thress, KS; Paweletz, CP; Felip, E; Cho, BC; Stetsonl, D; Dougherty, B; Lai, ZW; Markovets, A; Vivancos, A; Kuang, Y; Ercan, D; Matthews, SE; Cantarini, M; Barrett, JC; Janne, PA; Oxnard, GR				Thress, Kenneth S.; Paweletz, Cloud P.; Felip, Enriqueta; Cho, Byoung Chul; Stetsonl, Daniel; Dougherty, Brian; Lai, Zhongwu; Markovets, Aleksandra; Vivancos, Ana; Kuang, Yanan; Ercan, Dalia; Matthews, Sarah E.; Cantarini, Mireille; Barrett, J. Carl; Jaenne, Pasi A.; Oxnard, Geoffrey R.			Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M	NATURE MEDICINE			English	Article							FACTOR RECEPTOR EGFR; KINASE INHIBITORS; MUTANT	Here we studied cell-free plasma DNA (cfDNA) collected from subjects with advanced lung cancer whose tumors had developed resistance to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) AZD9291. We first performed next-generation sequencing of cfDNA from seven subjects and detected an acquired EGFR C797S mutation in one; expression of this mutant EGFR construct in a cell line rendered it resistant to AZD9291. We then performed droplet digital PCR on serial cfDNA specimens collected from 15 AZD9291-treated subjects. All were positive for the T790M mutation before treatment, but upon developing AZD9291 resistance three molecular subtypes emerged: six cases acquired the C797S mutation, five cases maintained the T790M mutation but did not acquire the C797S mutation and four cases lost the T790M mutation despite the presence of the underlying EGFR activating mutation. Our findings provide insight into the diversity of mechanisms through which tumors acquire resistance to AZD9291 and highlight the need for therapies that are able to overcome resistance mediated by the EGFR C797S mutation.	[Thress, Kenneth S.; Stetsonl, Daniel; Dougherty, Brian; Lai, Zhongwu; Markovets, Aleksandra; Barrett, J. Carl] AstraZeneca, Waltham, MA USA; [Paweletz, Cloud P.; Kuang, Yanan; Ercan, Dalia; Matthews, Sarah E.; Jaenne, Pasi A.; Oxnard, Geoffrey R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Paweletz, Cloud P.; Kuang, Yanan; Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Felip, Enriqueta; Vivancos, Ana] Vall dHebron Inst Oncol, Barcelona, Spain; [Felip, Enriqueta] Vall dHebron Univ Hosp, Barcelona, Spain; [Cho, Byoung Chul] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea; [Cantarini, Mireille] AstraZeneca, Macclesfield, Cheshire, England	AstraZeneca; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; Yonsei University; Yonsei University Health System; AstraZeneca	Oxnard, GR (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	geoffrey_oxnard@DFCI.Harvard.edu	Vivancos, Ana/AAG-8331-2019; FELIP, ENRIQUETA/AAG-6316-2019; Oxnard, Geoffrey R./HCH-4397-2022	Vivancos, Ana/0000-0003-2888-6512; Balmana, Judith/0000-0002-0762-6415; FELIP, ENRIQUETA/0000-0002-7620-0098; Cho, Byoung Chul/0000-0002-5562-270X	National Cancer Institute of the National Institutes of Health [R01CA135257, R01CA114465, P01CA154303]; AstraZeneca; Conquer Cancer Foundation of ASCO; Stading-Younger Cancer Research Foundation; Department of Medical Oncology at Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA114465, P01CA129243, P01CA154303, R01CA135257] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AstraZeneca(AstraZeneca); Conquer Cancer Foundation of ASCO; Stading-Younger Cancer Research Foundation; Department of Medical Oncology at Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Cancer Institute of the National Institutes of Health (R01CA135257 (P.A.J.), R01CA114465 (P.A.J.) and P01CA154303 (P.A.J.)), AstraZeneca, the Conquer Cancer Foundation of ASCO (G.R.O.), the Stading-Younger Cancer Research Foundation (G.R.O.), and the Department of Medical Oncology at Dana-Farber Cancer Institute. We would like to thank the numerous lung cancer patients and clinical investigators that contributed to this scientific effort.	Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Avizienyte E, 2008, BIOCHEM J, V415, P197, DOI 10.1042/BJ20080728; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Janne PA, 2015, N ENGL J MED; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sequist L.V., 2015, N ENGL J ME IN PRESS; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Ward RA, 2013, J MED CHEM, V56, P7025, DOI 10.1021/jm400822z; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Yu Z, 2007, CANCER RES, V67, P10417, DOI 10.1158/0008-5472.CAN-07-1248; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	14	1045	1124	11	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					560	562		10.1038/nm.3854	http://dx.doi.org/10.1038/nm.3854			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25939061	Green Accepted			2022-12-25	WOS:000355778300011
J	Gould, SE; Junttila, MR; de Sauvage, FJ				Gould, Stephen E.; Junttila, Melissa R.; de Sauvage, Frederic J.			Translational value of mouse models in oncology drug development	NATURE MEDICINE			English	Article							BREAST-CANCER METASTASIS; TUMOR-MODELS; ANTITUMOR-ACTIVITY; P53 RESTORATION; CELL-LINES; IN-VITRO; HETEROGENEITY; GROWTH; MEDULLOBLASTOMA; XENOGRAFT	Much has been written about the advantages and disadvantages of various oncology model systems, with the overall finding that these models lack the predictive power required to translate preclinical efficacy into clinical activity. Despite assertions that some preclinical model systems are superior to others, no single model can suffice to inform preclinical target validation and molecule selection. This perspective provides a balanced albeit critical view of these claims of superiority and outlines a framework for the proper use of existing preclinical models for drug testing and discovery. We also highlight gaps in oncology mouse models and discuss general and pervasive model-independent shortcomings in preclinical oncology work, and we propose ways to address these issues.	[Gould, Stephen E.; Junttila, Melissa R.; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	desauvage.fred@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Couzin-Frankel J, 2014, SCIENCE, V346, P28, DOI 10.1126/science.346.6205.28; Das Thakur M, 2014, CLIN CANCER RES, V20, P1074, DOI 10.1158/1078-0432.CCR-13-0103; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Enquist IB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4530; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gajjar A, 2013, CLIN CANCER RES, V19, P6305, DOI 10.1158/1078-0432.CCR-13-1425; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gersbach CA, 2014, NAT METHODS, V11, P1009, DOI 10.1038/nmeth.3113; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hegde GV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004438; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Huijbers IJ, 2014, EMBO MOL MED, V6, P212, DOI 10.1002/emmm.201303297; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Junttila TT, 2014, CANCER RES, V74, P5561, DOI 10.1158/0008-5472.CAN-13-3622-T; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lodhia KA, 2015, BBA-REV CANCER, V1855, P223, DOI 10.1016/j.bbcan.2015.03.002; Martin ES, 2013, CLIN CANCER RES, V19, P2929, DOI 10.1158/1078-0432.CCR-12-2307; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Platzer B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00140; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Saxena M, 2013, MOL ONCOL, V7, P283, DOI 10.1016/j.molonc.2013.02.009; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Singh M, 2012, CANCER RES, V72, P2695, DOI 10.1158/0008-5472.CAN-11-2786; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Utama FE, 2009, ENDOCRINOLOGY, V150, P1782, DOI 10.1210/en.2008-1057; Vatakis DN, 2011, P NATL ACAD SCI USA, V108, pE1408, DOI 10.1073/pnas.1115050108; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Walrath J. C., 2010, ADV CANCER RES; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wong H, 2012, CLIN CANCER RES, V18, P3846, DOI 10.1158/1078-0432.CCR-12-0738; Wong H, 2012, CLIN CANCER RES, V18, P3090, DOI 10.1158/1078-0432.CCR-12-0445; Wong H, 2011, CLIN CANCER RES, V17, P4682, DOI 10.1158/1078-0432.CCR-11-0975; Wong H, 2009, J PHARMACOL EXP THER, V329, P360, DOI 10.1124/jpet.108.148189; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	87	181	187	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					431	439		10.1038/nm.3853	http://dx.doi.org/10.1038/nm.3853			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25951530				2022-12-25	WOS:000354068800009
J	Chu, VT; Weber, T; Wefers, B; Wurst, W; Sander, S; Rajewsky, K; Kuhn, R				Van Trung Chu; Weber, Timm; Wefers, Benedikt; Wurst, Wolfgang; Sander, Sandrine; Rajewsky, Klaus; Kuehn, Ralf			Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells	NATURE BIOTECHNOLOGY			English	Article							DAMAGE RESPONSE; BREAK REPAIR; DNA; RECEPTOR; PROTEIN; KINASE; KU70	The insertion of precise genetic modifications by genome editing tools such as CRISPR-Cas9 is limited by the relatively low efficiency of homology-directed repair (HDR) compared with the higher efficiency of the nonhomologous end-joining (NHEJ) pathway. To enhance HDR, enabling the insertion of precise genetic modifications, we suppressed the NHEJ key molecules KU70, KU80 or DNA ligase IV by gene silencing, the ligase IV inhibitor SCR7 or the coexpression of adenovirus 4 E1B55K and E4orf6 proteins in a 'traffic light' and other reporter systems. Suppression of KU70 and DNA ligase IV promotes the efficiency of HDR 4-5-fold. When co-expressed with the Cas9 system, E1B55K and E4orf6 improved the efficiency of HDR up to eightfold and essentially abolished NHEJ activity in both human and mouse cell lines. Our findings provide useful tools to improve the frequency of precise gene modifications in mammalian cells.	[Van Trung Chu; Weber, Timm; Sander, Sandrine; Rajewsky, Klaus; Kuehn, Ralf] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wefers, Benedikt; Wurst, Wolfgang; Kuehn, Ralf] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Neuherberg, Germany; [Wefers, Benedikt; Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV, Munich, Germany; [Wurst, Wolfgang] Univ Munich, Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Kuehn, Ralf] Berlin Inst Hlth, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Berlin Institute of Health	Kuhn, R (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	klaus.rajewsky@mdc-berlin.de; ralf.kuehn@mdc-berlin.de	Kühn, Ralf/U-1278-2017	Kühn, Ralf/0000-0003-1694-9803; Chu, Van Trung/0000-0003-1327-8696; Rajewsky, Klaus/0000-0002-6633-6370; Wurst, Wolfgang/0000-0003-4422-7410; Sander, Sandrine/0000-0003-4645-3366	European Research Council (ERC advanced grant) [ERC-AG-LS6]; German Ministry of Education and Research within the VIP program [TAL-CUT 03V0261]; European Union within the EUCOMMTOOLS project [FP7-HEALTH-F4-2010-261492]	European Research Council (ERC advanced grant)(European Research Council (ERC)); German Ministry of Education and Research within the VIP program; European Union within the EUCOMMTOOLS project	We thank K. Petsch and H.P. Rahn from the FACS core facility for excellent technical support. This work was supported by the European Research Council (ERC advanced grant ERC-AG-LS6, to K.R.), the German Ministry of Education and Research within the VIP program (TAL-CUT 03V0261, to W.W. and R.K.) and the European Union within the EUCOMMTOOLS project (FP7-HEALTH-F4-2010-261492, to W.W.). The plasmids MSCV-IRES-mCherry and MSCV-IRES-BFP were kind gifts of F. Rosenbauer and M. Janz (Charite, Berlin). We are grateful to H. Ploegh for communicating to us unpublished results and support in coordinating publication.	Adam S, 2014, EXP CELL RES, V329, P148, DOI 10.1016/j.yexcr.2014.07.017; Benkx M, 2005, VIRUS TAXONOMY; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Cheng CY, 2011, J VIROL, V85, P765, DOI 10.1128/JVI.01890-10; Com E, 2007, MOL CELL PROTEOMICS, V6, P1842, DOI 10.1074/mcp.M700119-MCP200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forrester NA, 2011, J VIROL, V85, P2201, DOI 10.1128/JVI.01748-10; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Li BM, 2011, AGING-US, V3, P395, DOI 10.18632/aging.100308; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Munakata Y, 2005, BLOOD, V106, P3449, DOI 10.1182/blood-2005-02-0536; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120; Zhu QZ, 2010, J CELL PHYSIOL, V223, P283, DOI 10.1002/jcp.22060	29	750	854	10	296	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					543	U160		10.1038/nbt.3198	http://dx.doi.org/10.1038/nbt.3198			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25803306	Green Accepted			2022-12-25	WOS:000354314500038
J	He, QY; Johnston, J; Zeitlinger, J				He, Qiye; Johnston, Jeff; Zeitlinger, Julia			ChIP-nexus enables improved detection of in vivo transcription factor binding footprints	NATURE BIOTECHNOLOGY			English	Article							DROSOPHILA-EMBRYO; DNA-BINDING; NUCLEOTIDE RESOLUTION; INITIATION-COMPLEXES; C-MYC; GENOME; MAX; PROTEIN; EXPRESSION; FEATURES	Understanding how eukaryotic enhancers are bound and regulated by specific combinations of transcription factors is still a major challenge. To better map transcription factor binding genome-wide at nucleotide resolution in vivo, we have developed a robust ChIP-exo protocol called ChIP-nexus (chromatin immunoprecipitation experiments with nucleotide resolution through exonuclease, unique barcode and single ligation), which utilizes an efficient DNA self-circularization step during library preparation. Application of ChIP-nexus to four proteins-human TBP and Drosophila NFkB, Twist and Max-shows that it outperforms existing ChIP protocols in resolution and specificity, pinpoints relevant binding sites within enhancers containing multiple binding motifs, and allows for the analysis of in vivo binding specificities. Notably, we show that Max frequently interacts with DNA sequences next to its motif, and that this binding pattern correlates with local DNA-sequence features such as DNA shape. ChIP-nexus will be broadly applicable to the study of in vivo transcription factor binding specificity and its relationship to cis-regulatory changes in humans and model organisms.	[He, Qiye; Johnston, Jeff; Zeitlinger, Julia] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Zeitlinger, Julia] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Zeitlinger, J (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jbz@stowers.org		Johnston, Jeff/0000-0002-8962-6186	US National Institutes of Health (New Innovator Award) [1DP2 OD004561]; Stowers Institute for Medical Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004561] Funding Source: NIH RePORTER	US National Institutes of Health (New Innovator Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Blanchette and A. Stark for discussions and R. Krumlauf and R. Mohan for critical comments on the manuscript. This work was funded by the US National Institutes of Health (New Innovator Award 1DP2 OD004561 to J.Z.) and the Stowers Institute for Medical Research.	Bardet AF, 2013, BIOINFORMATICS, V29, P2705, DOI 10.1093/bioinformatics/btt470; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Casbon JA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr217; Fakhouri WD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.97; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HUANG JD, 1993, GENE DEV, V7, P694, DOI 10.1101/gad.7.4.694; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Ozdemir A, 2011, GENOME RES, V21, P566, DOI 10.1101/gr.104018.109; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Serandour AA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r147; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; SZYMANSKI P, 1995, EMBO J, V14, P2229, DOI 10.1002/j.1460-2075.1995.tb07217.x; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Walhout AJM, 1997, NUCLEIC ACIDS RES, V25, P1493, DOI 10.1093/nar/25.8.1493; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	40	136	142	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					395	U108		10.1038/nbt.3121	http://dx.doi.org/10.1038/nbt.3121			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25751057	Green Accepted			2022-12-25	WOS:000352348500026
J	Kretzmer, H; Bernhart, SH; Wang, W; Haake, A; Weniger, MA; Bergmann, AK; Betts, MJ; Carrillo-de-Santa-Pau, E; Doose, G; Gutwein, J; Richter, J; Hovestadt, V; Huang, BD; Rico, D; Juhling, F; Kolarova, J; Lu, QH; Otto, C; Wagener, R; Arnolds, J; Burkhardt, B; Claviez, A; Drexler, HG; Eberth, S; Eils, R; Flicek, P; Haas, S; Hummel, M; Karsch, D; Kerstens, HHD; Klapper, W; Kreuz, M; Lawerenz, C; Lenze, D; Loeffler, M; Lopez, C; MacLeod, RAF; Martens, JHA; Kulis, M; Martin-Subero, JI; Moller, P; Nagel, I; Picelli, S; Vater, I; Rohde, M; Rosenstiel, P; Rosolowski, M; Russell, RB; Schilhabel, M; Schlesner, M; Stadler, PF; Szczepanowski, M; Trumper, L; Stunnenberg, HG; Kuppers, R; Stunnenberg, HG; Lichter, P; Siebert, R; Hoffmann, S; Radlwimmer, B				Kretzmer, Helene; Bernhart, Stephan H.; Wang, Wei; Haake, Andrea; Weniger, Marc A.; Bergmann, Anke K.; Betts, Matthew J.; Carrillo-de-Santa-Pau, Enrique; Doose, Gero; Gutwein, Jana; Richter, Julia; Hovestadt, Volker; Huang, Bingding; Rico, Daniel; Juehling, Frank; Kolarova, Julia; Lu, Qianhao; Otto, Christian; Wagener, Rabea; Arnolds, Judith; Burkhardt, Birgit; Claviez, Alexander; Drexler, Hans G.; Eberth, Sonja; Eils, Roland; Flicek, Paul; Haas, Siegfried; Hummel, Michael; Karsch, Dennis; Kerstens, Hinrik H. D.; Klapper, Wolfram; Kreuz, Markus; Lawerenz, Chris; Lenze, Dido; Loeffler, Markus; Lopez, Cristina; MacLeod, Roderick A. F.; Martens, Joost H. A.; Kulis, Marta; Ignacio Martin-Subero, Jose; Moeller, Peter; Nagel, Inga; Picelli, Simone; Vater, Inga; Rohde, Marius; Rosenstiel, Philip; Rosolowski, Maciej; Russell, Robert B.; Schilhabel, Markus; Schlesner, Matthias; Stadler, Peter F.; Szczepanowski, Monika; Truemper, Lorenz; Stunnenberg, Hendrik G.; Kueppers, Ralf; Ammerpohl, Ole; Lichter, Peter; Siebert, Reiner; Hoffmann, Steve; Radlwimmer, Bernhard		ICGC MMML-Seq Project; BLUEPRINT Project	DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control	NATURE GENETICS			English	Article							GENOME; LANDSCAPE; GENES; ACTIVATION; MECHANISMS; DIAGNOSIS; REVEALS; CELLS	Although Burkitt lymphomas and follicular lymphomas both have features of germinal center B cells, they are biologically and clinically quite distinct. Here we performed whole-genome bisulfite, genome and transcriptome sequencing in 13 IG-MYC translocation-positive Burkitt lymphoma, nine BCL2 translocation-positive follicular lymphoma and four normal germinal center B cell samples. Comparison of Burkitt and follicular lymphoma samples showed differential methylation of intragenic regions that strongly correlated with expression of associated genes, for example, genes active in germinal center dark-zone and light-zone B cells. Integrative pathway analyses of regions differentially methylated in Burkitt and follicular lymphomas implicated DNA methylation as cooperating with somatic mutation of sphingosine phosphate signaling, as well as the TCF3-ID3 and SWI/SNF complexes, in a large fraction of Burkitt lymphomas. Taken together, our results demonstrate a tight connection between somatic mutation, DNA methylation and transcriptional control in key B cell pathways deregulated differentially in Burkitt lymphoma and other germinal center B cell lymphomas.	[Kretzmer, Helene; Bernhart, Stephan H.; Doose, Gero; Juehling, Frank; Otto, Christian; Stadler, Peter F.; Hoffmann, Steve] Univ Leipzig, Res Ctr Civilizat Dis LIFE, Transcriptome Bioinformat, D-04109 Leipzig, Germany; [Kretzmer, Helene; Bernhart, Stephan H.; Doose, Gero; Juehling, Frank; Otto, Christian; Stadler, Peter F.; Hoffmann, Steve] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Kretzmer, Helene; Bernhart, Stephan H.; Doose, Gero; Hovestadt, Volker; Juehling, Frank; Otto, Christian; Stadler, Peter F.; Hoffmann, Steve] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Wang, Wei; Hovestadt, Volker; Picelli, Simone; Lichter, Peter; Radlwimmer, Bernhard] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Haake, Andrea; Bergmann, Anke K.; Gutwein, Jana; Richter, Julia; Kolarova, Julia; Lu, Qianhao; Wagener, Rabea; Nagel, Inga; Vater, Inga; Ammerpohl, Ole; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Weniger, Marc A.; Kueppers, Ralf] Univ Duisburg Essen, Inst Cell Biol Canc Res, Kiel, Germany; [Bergmann, Anke K.; Claviez, Alexander] Univ Hosp Schleswig Holstein, Dept Pediat, Kiel, Germany; [Betts, Matthew J.; Russell, Robert B.] Heidelberg Univ, Bioquant, Cell Networks, Heidelberg, Germany; [Carrillo-de-Santa-Pau, Enrique; Rico, Daniel] Spanish Natl Canc Res Ctr CNIO, Struct Biol & BioComputing Programme, Madrid, Spain; [Huang, Bingding; Eils, Roland; Lawerenz, Chris; Schlesner, Matthias] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Arnolds, Judith] Univ Duisburg Essen, Dept Otorhinolaryngol, Essen, Germany; [Burkhardt, Birgit] Univ Hosp Munster, Pediat Hematol & Oncol, Munster, Germany; [Drexler, Hans G.; Eberth, Sonja; MacLeod, Roderick A. F.] German Collect Microorganisms & Cell Cultures DSM, Leibniz Inst, Braunschweig, Germany; [Eberth, Sonja; Truemper, Lorenz] Univ Gottingen, Dept Hematol & Oncol, D-37073 Gottingen, Germany; [Eils, Roland] Heidelberg Univ, Bioquant, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Flicek, Paul] European Mol Biol Lab, European Bioinformat Inst, Hinxton, England; [Haas, Siegfried] Friedrich Ebert Hosp Neumunster, Clin Haematol, Neumunster, Germany; [Haas, Siegfried] Friedrich Ebert Hosp Neumunster, Clin Oncol & Nephrol, Neumunster, Germany; [Hummel, Michael; Lenze, Dido] Charite, Inst Pathol, D-13353 Berlin, Germany; [Karsch, Dennis] Univ Med Ctr, Dept Internal Med 2, Hematol & Oncol, Kiel, Germany; [Kerstens, Hinrik H. D.; Martens, Joost H. A.; Kulis, Marta; Szczepanowski, Monika; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Klapper, Wolfram] Univ Kiel, Hematopathol Sect, Kiel, Germany; [Kreuz, Markus; Loeffler, Markus; Rosolowski, Maciej] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Ignacio Martin-Subero, Jose] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain; [Moeller, Peter] Univ Ulm, Inst Pathol, Fac Med, D-89069 Ulm, Germany; [Rohde, Marius] Univ Hosp Giessen, Pediat Hematol & Oncol, Giessen, Germany; [Rosenstiel, Philip; Schilhabel, Markus] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol IZI, RNomics Grp, Leipzig, Germany; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Kiel; University of Duisburg Essen; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; Centro Nacional de Investigaciones Oncologicas (CNIO); Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Munster; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Gottingen; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; Radboud University Nijmegen; University of Kiel; Leipzig University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Ulm University; University Hospital of Giessen & Marburg; University of Kiel; Fraunhofer Gesellschaft; The Santa Fe Institute; Max Planck Society	Siebert, R (corresponding author), Univ Kiel, Inst Human Genet, Kiel, Germany.	rsiebert@medgen.uni-kiel.de; steve@bioinf.uni-leipzig.de; b.radlwimmer@dkfz.de	Hoffmann, Steve/E-1438-2013; Bergmann, Anke/AAT-2509-2020; López, Cristina/ABB-3519-2020; Stunnenberg, Hendrik G./D-6875-2012; Rosenstiel, Philip/A-5137-2009; de Santa Pau, Enrique Carrillo/AAV-7544-2021; Klapper, Wolfram/S-6314-2016; Ammerpohl, Ole/G-2691-2010; Kretzmer, Helene/GSJ-2664-2022; Russell, Rob/AAH-9145-2019; Burkhardt, Birgit/AAS-9678-2021; Russell, Robert/GWU-6389-2022; Siebert, Reiner/A-8049-2010; Langenberger, David/AAF-3313-2020; Eils, Roland/B-6121-2009; Martens, Joost/D-4966-2012; Radlwimmer, Bernhard F/I-3229-2013; Stadler, Peter F. F/L-7857-2015; López, Cristina/W-4621-2017; Schlesner, Matthias/I-4030-2013; Rico, Daniel/I-2049-2013	López, Cristina/0000-0001-6644-1659; Stunnenberg, Hendrik G./0000-0002-0066-1576; Rosenstiel, Philip/0000-0002-9692-8828; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; Kretzmer, Helene/0000-0002-0723-4980; Russell, Rob/0000-0002-1905-4717; Burkhardt, Birgit/0000-0002-1151-829X; Russell, Robert/0000-0002-7213-1398; Eils, Roland/0000-0002-0034-4036; Martens, Joost/0000-0003-2008-6537; Radlwimmer, Bernhard F/0000-0002-4553-7800; Stadler, Peter F. F/0000-0002-5016-5191; López, Cristina/0000-0001-6644-1659; Kreuz, Markus/0000-0002-0520-8391; Otto, Christian/0000-0001-6231-9648; Hovestadt, Volker/0000-0002-3480-6649; Flicek, Paul/0000-0002-3897-7955; Kuppers, Ralf/0000-0002-6691-7191; , Stephan/0000-0002-5928-9449; Betts, Matthew/0000-0003-4583-9814; Claviez, Alexander/0000-0002-1561-5185; Schlesner, Matthias/0000-0002-5896-4086; Hummel, Michael/0000-0001-6717-605X; Rico, Daniel/0000-0002-6561-2310; Kulis, Marta/0000-0001-8104-9620	German Ministry of Science and Education (BMBF) [01KU1002A-J, 036166B]; European Union [HEALTH-F5-2011-282510]; KinderKrebsInitiative Buchholz/Holm-Seppensen; LIFE (Leipzig Research Center for Civilization Diseases), Leipzig University; European Union; European Regional Development Fund (ERDF); European Social Fund (ESF); Free State of Saxony; NGFNplus (BMBF) [01GS0883]; DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dr. Werner Jackstadt Foundation [S134-10.100]; MMML by the Deutsche Krebshilfe	German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); KinderKrebsInitiative Buchholz/Holm-Seppensen; LIFE (Leipzig Research Center for Civilization Diseases), Leipzig University; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); European Social Fund (ESF)(European Social Fund (ESF)); Free State of Saxony; NGFNplus (BMBF)(Federal Ministry of Education & Research (BMBF)); DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dr. Werner Jackstadt Foundation; MMML by the Deutsche Krebshilfe	This study has been supported by the German Ministry of Science and Education (BMBF) in the framework of the ICGC MMML-Seq project (01KU1002A-J) and the MMML-MYC-SYS project (036166B), the European Union in the framework of the BLUEPRINT Project (HEALTH-F5-2011-282510) and the KinderKrebsInitiative Buchholz/Holm-Seppensen and LIFE (Leipzig Research Center for Civilization Diseases), Leipzig University. LIFE is funded by the European Union, the European Regional Development Fund (ERDF), the European Social Fund (ESF) and the Free State of Saxony. WGBS was additionally supported by NGFNplus (BMBF, 01GS0883) and the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO). Former grant support of MMML by the Deutsche Krebshilfe (2003-2011) is gratefully acknowledged. J.R. is supported by the Dr. Werner Jackstadt Foundation in the framework of a Junior Excellence Research Group on 'Mechanisms of B-Cell Lymphomagenesis in the Senium as Basic Principle for the Development of Age-Adjusted Therapy Regimes' (S134-10.100).	Abraham BJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-193; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Bentink S, 2008, LEUKEMIA, V22, P1746, DOI 10.1038/leu.2008.166; Betts MJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1094; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Hahn MA, 2014, CANCER RES, V74, P3617, DOI 10.1158/0008-5472.CAN-13-3147; Hasselblatt M, 2014, ACTA NEUROPATHOL, V128, P453, DOI 10.1007/s00401-014-1323-x; Hasselblatt M, 2011, AM J SURG PATHOL, V35, P933, DOI 10.1097/PAS.0b013e3182196a39; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loeffler M, 2015, LEUKEMIA, V29, P456, DOI 10.1038/leu.2014.209; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Otto C, 2012, BIOINFORMATICS, V28, P1698, DOI 10.1093/bioinformatics/bts254; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Rohde M, 2014, GENE CHROMOSOME CANC, V53, P911, DOI 10.1002/gcc.22202; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Takuwa N, 2011, AM J CANCER RES, V1, P460; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Zhang NR, 2012, STAT SINICA, V22, P1507, DOI 10.5705/ss.2010.257	55	90	91	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1316	+		10.1038/ng.3413	http://dx.doi.org/10.1038/ng.3413			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26437030	Green Published, Green Accepted			2022-12-25	WOS:000363988200015
J	Frantz, LAF; Schraiber, JG; Madsen, O; Megens, HJ; Cagan, A; Bosse, M; Paudel, Y; Crooijmans, RPMA; Larson, G; Groenen, MAM				Frantz, Laurent A. F.; Schraiber, Joshua G.; Madsen, Ole; Megens, Hendrik-Jan; Cagan, Alex; Bosse, Mirte; Paudel, Yogesh; Crooijmans, Richard P. M. A.; Larson, Greger; Groenen, Martien A. M.			Evidence of long-term gene flow and selection during domestication from analyses of Eurasian wild and domestic pig genomes	NATURE GENETICS			English	Article							BAYESIAN COMPUTATION; ANALYSIS REVEALS; ANCIENT DNA; ORIGINS; SPECIATION; EXPRESSION; EVOLUTION; BEHAVIOR; GROWTH; MODEL	Traditionally, the process of domestication is assumed to be initiated by humans, involve few individuals and rely on reproductive isolation between wild and domestic forms. We analyzed pig domestication using over 100 genome sequences and tested whether pig domestication followed a traditional linear model or a more complex, reticulate model. We found that the assumptions of traditional models, such as reproductive isolation and strong domestication bottlenecks, are incompatible with the genetic data. In addition, our results show that, despite gene flow, the genomes of domestic pigs have strong signatures of selection at loci that affect behavior and morphology. We argue that recurrent selection for domestic traits likely counteracted the homogenizing effect of gene flow from wild boars and created 'islands of domestication' in the genome. Our results have major ramifications for the understanding of animal domestication and suggest that future studies should employ models that do not assume reproductive isolation.	[Frantz, Laurent A. F.; Madsen, Ole; Megens, Hendrik-Jan; Bosse, Mirte; Paudel, Yogesh; Crooijmans, Richard P. M. A.; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Grp, NL-6700 AP Wageningen, Netherlands; [Frantz, Laurent A. F.; Larson, Greger] Univ Oxford, Res Lab Archaeol & Hist Art, Palaeogen & Bioarchaeol Res Network, Oxford, England; [Schraiber, Joshua G.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Schraiber, Joshua G.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Cagan, Alex] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Wageningen University & Research; University of Oxford; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Max Planck Society	Frantz, LAF (corresponding author), Wageningen Univ, Anim Breeding & Genom Grp, NL-6700 AP Wageningen, Netherlands.	laurent.frantz@arch.ox.ac.uk	Crooijmans, Richard PMA/E-2492-2012; Groenen, Martien/D-8408-2012; Megens, Hendrik-Jan/E-9676-2010; Megens, Hendrik-Jan/M-5300-2019; Madsen, Ole/E-3730-2012	Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Megens, Hendrik-Jan/0000-0002-3619-7533; Madsen, Ole/0000-0001-8082-7881; Frantz, Laurent/0000-0001-8030-3885; Cagan, Alex/0000-0002-7857-4771; Bosse, Mirte/0000-0003-2433-2483	European Research Council under the European Community's 256 Seventh Framework Programme (FP7)/ERC (SelSweep) [249894, ERC-2013-StG 337574-UNDEAD]; US National Institutes of Health [R01-GM40282]; National Science Foundation [DBI-1402120]; Natural Environment Research Council [NE/K005243/2, NE/H005552/1, NE/F003382/2, NE/K003259/1, NE/K005243/1, NE/H005269/1, NE/F003382/1] Funding Source: researchfish; NERC [NE/H005552/1, NE/F003382/1, NE/F003382/2, NE/K005243/1, NE/K005243/2, NE/K003259/1, NE/H005269/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	European Research Council under the European Community's 256 Seventh Framework Programme (FP7)/ERC (SelSweep); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Peter for his help and guidance during the model-fitting step of the analysis as well as for kindly sharing his code. We are also indebted to D. Wegmann for providing us with the latest version of ABCtoolbox. We also thank K. Lohse for his insights during the conception of the project and D. Caspani for his help with the figures. We thank B. Dibbits for his help during the laboratory work. This project is financially supported by the European Research Council under the European Community's 256 Seventh Framework Programme (FP7/2007-2013)/ERC (SelSweep), grant agreements 249894 and ERC-2013-StG 337574-UNDEAD. J.G.S. was supported by US National Institutes of Health grant R01-GM40282 and National Science Foundation postdoctoral fellowship DBI-1402120.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Ai HS, 2015, NAT GENET, V47, P217, DOI 10.1038/ng.3199; Albarella U., 2011, ETHNOZOOARCHAEOLOGY, P143, DOI DOI 10.2307/J.CTVH1DWVG.19; Albarella Umberto, 2005, Anthropozoologica, V40, P27; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andersson-Eklund L, 1998, J ANIM SCI, V76, P694; Bhoiwala DL, 2013, NEUROL RES, V35, P79, DOI 10.1179/1743132812Y.0000000117; Bosse M, 2014, MOL ECOL, V23, P4089, DOI 10.1111/mec.12807; Bosse M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5392; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Brown CB, 2001, DEVELOPMENT, V128, P3071; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Childe V.G., 1968, DAWN EUROPEAN CIVILI; Cucchi T, 2011, J ARCHAEOL SCI, V38, P11, DOI 10.1016/j.jas.2010.07.024; Darwin Ch., 1868, P411; Dierssen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017010; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Ervynck A., 2002, Paleorient, V27, P47; Evin A, 2013, J ARCHAEOL SCI, V40, P735, DOI 10.1016/j.jas.2012.08.005; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Frantz LAF, 2015, NAT GENET, V47, P188, DOI 10.1038/ng.3197; Frantz LAF, 2014, MOL ECOL, V23, P5566, DOI 10.1111/mec.12958; Frantz LAF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r107; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Garud NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005004; Gonthier B, 2007, CEREB CORTEX, V17, P1712, DOI 10.1093/cercor/bhl082; Grayton HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067114; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Huber CD, 2014, MOL BIOL EVOL, V31, P3026, DOI 10.1093/molbev/msu247; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kim KS, 2000, MAMM GENOME, V11, P131, DOI 10.1007/s003350010025; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2014, ANNU REV ECOL EVOL S, V45, P115, DOI 10.1146/annurev-ecolsys-110512-135813; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; Ludwig A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0386; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacNeish R.S., 1992, ORIGINS AGR SETTLED; Marshall FB, 2014, P NATL ACAD SCI USA, V111, P6153, DOI 10.1073/pnas.1312984110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; O'Connor TP, 2007, INT J OSTEOARCHAEOL, V17, P581, DOI 10.1002/oa.913; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Oschipok LW, 2008, NEUROSCI LETT, V434, P113, DOI 10.1016/j.neulet.2008.01.048; Ottoni C, 2013, MOL BIOL EVOL, V30, P824, DOI 10.1093/molbev/mss261; Owen J, 2014, J ARCHAEOL SCI, V43, P159, DOI 10.1016/j.jas.2013.12.010; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasterkamp RJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-98; Pavlidis P, 2013, MOL BIOL EVOL, V30, P2224, DOI 10.1093/molbev/mst112; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Pickrell JK, 2014, TRENDS GENET, V30, P377, DOI 10.1016/j.tig.2014.07.007; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Porter V., 1993, PIGS HDB BREEDS WORL; Price E. O., 2002, Animal domestication and behavior, DOI 10.1079/9780851995977.0000; Quartu M, 2005, BRAIN RES, V1041, P157, DOI 10.1016/j.brainres.2005.02.007; Rowley-Conwy P, 2012, J WORLD PREHIST, V25, P1, DOI 10.1007/s10963-012-9055-0; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Ruediger T, 2013, CEREB CORTEX, V23, P604, DOI 10.1093/cercor/bhs044; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Simanainen U, 2013, J ENDOCRINOL, V218, P151, DOI 10.1530/JOE-13-0056; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Valette M, 2013, INT J OBESITY, V37, P1027, DOI 10.1038/ijo.2012.169; Vigne JD, 2011, CR BIOL, V334, P171, DOI 10.1016/j.crvi.2010.12.009; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143; Wojcik SM, 2013, MOL MED, V19, P135, DOI 10.2119/molmed.2013.00033; Xu P, 2013, P NATL ACAD SCI USA, V110, P10759, DOI 10.1073/pnas.1308195110; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P227	86	160	170	9	125	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1141	+		10.1038/ng.3394	http://dx.doi.org/10.1038/ng.3394			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26323058				2022-12-25	WOS:000361969900009
J	Liu, XJ; Pu, Y; Cron, K; Deng, LF; Kline, J; Frazier, WA; Xu, HR; Peng, H; Fu, YX; Xu, MM				Liu, Xiaojuan; Pu, Yang; Cron, Kyle; Deng, Liufu; Kline, Justin; Frazier, William A.; Xu, Hairong; Peng, Hua; Fu, Yang-Xin; Xu, Meng Michelle			CD47 blockade triggers T cell-mediated destruction of immunogenic tumors	NATURE MEDICINE			English	Article							ALPHA SIRP-ALPHA; CYCLIC GMP-AMP; I INTERFERON; STEM-CELLS; INNATE; ANTIBODY; CANCER; CALRETICULIN; CLEARANCE; IMMUNITY	Macrophage phagocytosis of tumor cells mediated by CD47-specific blocking antibodies has been proposed to be the major effector mechanism in xenograft models. Here, using syngeneic immunocompetent mouse tumor models, we reveal that the therapeutic effects of CD47 blockade depend on dendritic cell but not macrophage cross-priming of T cell responses. The therapeutic effects of anti-CD47 antibody therapy were abrogated in T cell-deficient mice. In addition, the antitumor effects of CD47 blockade required expression of the cytosolic DNA sensor STING, but neither MyD88 nor TRIF, in CD11c(+) cells, suggesting that cytosolic sensing of DNA from tumor cells is enhanced by anti-CD47 treatment, further bridging the innate and adaptive responses. Notably, the timing of administration of standard chemotherapy markedly impacted the induction of antitumor T cell responses by CD47 blockade. Together, our findings indicate that CD47 blockade drives T cell-mediated elimination of immunogenic tumors.	[Liu, Xiaojuan; Xu, Hairong; Peng, Hua; Fu, Yang-Xin] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Inst Biophys & Univ Chicago Joint Grp Immunothera, Beijing 100080, Peoples R China; [Liu, Xiaojuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Pu, Yang; Cron, Kyle; Deng, Liufu; Fu, Yang-Xin; Xu, Meng Michelle] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Pu, Yang; Cron, Kyle; Deng, Liufu; Kline, Justin; Fu, Yang-Xin; Xu, Meng Michelle] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Kline, Justin] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Frazier, William A.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Chicago; University of Chicago; University of Chicago; Washington University (WUSTL)	Fu, YX (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Inst Biophys & Univ Chicago Joint Grp Immunothera, Beijing 100080, Peoples R China.	yfu@uchicago.edu	Deng, Liufu/AAG-7244-2021	Deng, Liufu/0000-0002-1164-6777	US National Institutes of Health [CA141975, C134563]; National 12.5 major project of China [2012ZX10001006002004]; Chinese Academy of Sciences [XDA09030303, 2012CB910203]; Washington University; NATIONAL CANCER INSTITUTE [R01CA134563, R01CA141975, R01CA166770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National 12.5 major project of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Schreiber (Washington University, St. Louis) for providing us with anti-IFNAR antibody. Ifnar1<SUP>fl/fl</SUP> mice were kindly provided by U. Kalinke from the Institute for Experimental Infection Research. Anti-IFN-gamma neutralizing mAb (clone R46A2) was provided by Z. Qin (the Institute of Biophysics, CAS). Some anti-CD47 antibody (clone MIAP301) was provided by W. Frazier (Washington University, St. Louis). This research was in part supported by US National Institutes of Health grants CA141975 and C134563 to Y.-X.F., the National 12.5 major project of China (No. 2012ZX10001006002004) to Y.-X.F. and H.P., Chinese Academy of Sciences grant XDA09030303 and 2012CB910203 to Y.-X.F. and a Dean's Award from Washington University to W.A.F.	Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Chan KS, 2010, CURR OPIN UROL, V20, P393, DOI 10.1097/MOU.0b013e32833cc9df; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2011, BLOOD, V118, P4890, DOI 10.1182/blood-2011-02-338020; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Danielsen JMR, 2007, BRIT J HAEMATOL, V138, P756, DOI 10.1111/j.1365-2141.2007.06729.x; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Ma YT, 2014, CANCER RES, V74, P436, DOI 10.1158/0008-5472.CAN-13-1265; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; POELS LG, 1986, JNCI-J NATL CANCER I, V76, P781; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Soto-Pantoja DR, 2014, CANCER RES, V74, P6771, DOI 10.1158/0008-5472.CAN-14-0037-T; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004	50	423	449	6	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1209	+		10.1038/nm.3931	http://dx.doi.org/10.1038/nm.3931			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26322579	Green Accepted			2022-12-25	WOS:000362355400023
J	Priya, R; Gomez, GA; Budnar, S; Verma, S; Cox, HL; Hamilton, NA; Yap, AS				Priya, Rashmi; Gomez, Guillermo A.; Budnar, Srikanth; Verma, Suzie; Cox, Hayley L.; Hamilton, Nicholas A.; Yap, Alpha S.			Feedback regulation through myosin II confers robustness on RhoA signalling at E-cadherin junctions	NATURE CELL BIOLOGY			English	Article							EPITHELIAL ZONULA ADHERENS; CELL-CELL JUNCTIONS; BIOLOGICAL PATTERN-FORMATION; G-PROTEINS; GTPASE; ACTIVATION; ACTIN; CONTRACTILITY; MIGRATION; ADHESION	Actomyosin at the epithelial zonula adherens (ZA) generates junctional tension for tissue integrity and morphogenesis. This requires the RhoA GTPase, which establishes a strikingly stable active zone at the ZA. Mechanisms must then exist to confer robustness on junctional RhoA signalling at the population level. We now identify a feedback network that generates a stable mesoscopic RhoA zone out of dynamic elements. The key is scaffolding of ROCK1 to the ZA by myosin II. ROCK1 protects junctional RhoA by phosphorylating Rnd3 to prevent the cortical recruitment of the Rho suppressor, p190B RhoGAP. Combining predictive modelling and experimentation, we show that this network constitutes a bistable dynamical system that is realized at the population level of the ZA. Thus, stability of the RhoA zone is an emergent consequence of the network of interactions that allow myosin II to feedback to RhoA.	[Priya, Rashmi; Gomez, Guillermo A.; Budnar, Srikanth; Verma, Suzie; Cox, Hayley L.; Hamilton, Nicholas A.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Div Cell Biol & Mol Med, Brisbane, Qld 4072, Australia	University of Queensland	Gomez, GA (corresponding author), Univ Queensland, Inst Mol Biosci, Div Cell Biol & Mol Med, Brisbane, Qld 4072, Australia.	g.gomez@uq.edu.au; a.yap@uq.edu.au	Yap, Alpha S./J-1554-2014; Hamilton, Nicholas A/A-6033-2010; Gomez, Guillermo/J-2993-2014; Budnar, Srikanth/J-1827-2014	Yap, Alpha S./0000-0002-1038-8956; Hamilton, Nicholas A/0000-0003-0331-3427; Priya, Rashmi/0000-0002-0510-7515; Gomez, Guillermo/0000-0002-0494-2404; Budnar, Srikanth/0000-0002-8951-9081	National Health and Medical Research Council of Australia [1044041, 1037320, 1067405]; Kids Cancer Project of the Oncology Research Foundation; EMPathy National Collaborative Research Program of the National Breast Cancer Foundation (Australia) [CG-10-04]; University of Queensland Early Career Research Grant [2012003354]; ANZ Trustees PhD Scholarship in Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Kids Cancer Project of the Oncology Research Foundation; EMPathy National Collaborative Research Program of the National Breast Cancer Foundation (Australia); University of Queensland Early Career Research Grant; ANZ Trustees PhD Scholarship in Medical Research	We thank our laboratory colleagues for their unstinting support and advice during the course of this project, and our colleagues elsewhere for their kind gifts of reagents. We also thank M. Zerial and L. Tucker-Kellogg for thought-provoking discussions, M. Naghibosadat for her help with cloning and E. Moussa for his help in nano-ablation analysis. This work was supported by the National Health and Medical Research Council of Australia (1044041, 1037320, 1067405), The Kids Cancer Project of the Oncology Research Foundation, the EMPathy National Collaborative Research Program (CG-10-04) of the National Breast Cancer Foundation (Australia), a University of Queensland Early Career Research Grant to G.A.G. (2012003354) and an ANZ Trustees PhD Scholarship in Medical Research to R.P.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Beach JR, 2009, J BIOL CHEM, V284, P27377, DOI 10.1074/jbc.M109.028316; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Elbediwy A, 2012, J CELL BIOL, V198, P677, DOI 10.1083/jcb.201202094; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lee CS, 2010, J CELL BIOL, V190, P663, DOI 10.1083/jcb.201003057; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Liu ZM, 2009, J BIOL CHEM, V284, P15771, DOI 10.1074/jbc.M901853200; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; McLachlan RW, 2011, CYTOSKELETON, V68, P32, DOI 10.1002/cm.20492; Moore T, 2014, BIOPHYS J, V107, P2652, DOI 10.1016/j.bpj.2014.10.045; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Omelchenko T, 2012, CURR BIOL, V22, P278, DOI 10.1016/j.cub.2012.01.014; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Priya R., 2013, BIOPROTOCOL, V3, pe937; Priya R, 2013, DIFFERENTIATION, V86, P133, DOI 10.1016/j.diff.2013.01.002; Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Simoes SD, 2014, J CELL BIOL, V204, P575, DOI 10.1083/jcb.201307070; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Smutny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022458; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Sun LF, 2015, DEV CELL, V33, P413, DOI 10.1016/j.devcel.2015.03.003; Tse YC, 2012, MOL BIOL CELL, V23, P4020, DOI 10.1091/mbc.E12-04-0268; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu MH, 2014, ONCOGENE, V33, P5109, DOI 10.1038/onc.2014.125; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhang BL, 1998, BIOCHEMISTRY-US, V37, P5249, DOI 10.1021/bi9718447	56	86	86	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1282	+		10.1038/ncb3239	http://dx.doi.org/10.1038/ncb3239			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26368311				2022-12-25	WOS:000362213500008
J	Papathanasiou, S; Rickelt, S; Soriano, ME; Schips, TG; Maier, HJ; Davos, CH; Varela, A; Kaklamanis, L; Mann, DL; Capetanaki, Y				Papathanasiou, Stamatis; Rickelt, Steffen; Soriano, Maria Eugenia; Schips, Tobias G.; Maier, Harald J.; Davos, Constantinos H.; Varela, Aimilia; Kaklamanis, Loukas; Mann, Douglas L.; Capetanaki, Yassemi			Tumor necrosis factor-alpha confers cardioprotection through ectopic expression of keratins K8 and K18	NATURE MEDICINE			English	Article							ELEVATED CIRCULATING LEVELS; HEART-FAILURE; KAPPA-B; DESMIN CYTOSKELETON; ADHERING JUNCTIONS; CAUSES SKELETAL; GENOME BROWSER; TNF-ALPHA; MUSCLE; MICE	Tumor necrosis factor-alpha (TNF-alpha), one of the major stress-induced proinflammatory cytokines, is upregulated in the heart after tissue injury(1,2), and its sustained expression can contribute to the development of heart failure(1,3,4). Whether TNF-alpha also exerts cytoprotective effects in heart failure is not known. Here we provide evidence for a cardioprotective function of TNF-alpha in a genetic heart failure model, desmin-deficient mice. The cardioprotective effects of TNF-alpha are a consequence of nuclear factor-kappa B (NF-kappa B)-mediated ectopic expression in cardiomyocytes of keratin 8 (K8) and keratin 18 (K18), two epithelial-specific intermediate filament proteins(5,6). In cardiomyocytes, K8 and K18 (K8/K18) formed an alternative cytoskeletal network that localized mainly at intercalated discs (IDs) and conferred cardioprotection by maintaining normal ID structure and mitochondrial integrity and function. Ectopic induction of K8/K18 expression in cardiomyocytes also occurred in other genetic and experimental models of heart failure. Loss of the K8/K18 network resulted in a maladaptive cardiac phenotype following transverse aortic constriction. In human failing myocardium, where TNF-alpha expression is upregulated(2), K8/K18 were also ectopically expressed and localized primarily at IDs, which did not contain detectable amounts of desmin. Thus, TNF-alpha- and NF-kappa B-mediated formation of an alternative, stress-induced intermediate filament cytoskeleton has cardioprotective function in mice and potentially in humans.	[Papathanasiou, Stamatis; Capetanaki, Yassemi] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Athens, Greece; [Rickelt, Steffen] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany; [Soriano, Maria Eugenia] Univ Padua, Dept Biol, Padua, Italy; [Schips, Tobias G.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Maier, Harald J.] Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany; [Davos, Constantinos H.; Varela, Aimilia] Acad Athens, Biomed Res Fdn, Clin Expt Surg & Translat Res Ctr, Athens, Greece; [Kaklamanis, Loukas] Onassis Cardiac Surg Ctr, Dept Pathol, Athens, Greece; [Mann, Douglas L.] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA	Academy of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); University of Padua; Cincinnati Children's Hospital Medical Center; Ulm University; Academy of Athens; Onassis Cardiac Surgery Center; Washington University (WUSTL)	Capetanaki, Y (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Basic Res, Athens, Greece.	ycapetanaki@bioacademy.gr	Davos, Constantinos H./AAR-9392-2020; Mann, Douglas Lowell/AAQ-3524-2021; Davos, Constantinos/AAR-3259-2021	Davos, Constantinos/0000-0002-0321-7569; Papathanasiou, Stamatis/0000-0001-6969-044X; Rickelt, Steffen/0000-0002-5224-7764; Soriano, Maria Eugenia/0000-0002-7971-2961	Greek Secretariat of Research and Development [PENED 01ED371, PEP-ATT-39, ESPA SYNERGASIA 09SYN-21-965]; grant of "Excellence II" [5342]; US National Institutes of Health [R01 HL 111094]; European Union; Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111094, R01HL089543, R01HL058081] Funding Source: NIH RePORTER	Greek Secretariat of Research and Development; grant of "Excellence II"; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank W. Franke and Y. Dorflinger (Helmholtz Group for Cell Biology, German Cancer Research Center, Heidelberg) for extensive technical support with EM and immunogold labeling, for providing EM-related materials, antibodies and human tissue samples, and for very valuable comments. We especially thank L. Scorrano (University of Padova) for his help and support on the study of mitochondrial function and for providing the consumables for mitochondrial function experiments for these experiments. We thank L. Staloch, C. Weinheimer and A. Kovachs for the TAC surgeries and echocarardiographic measurements of the TACed mice. We also thank W.K. Jones (Department of Pharmacology and Cell Biophysics, University of Cincinnati) for kindly providing the I kappa B alpha-3M mice, M. Gerstenlauer for technical assistance with IKK<SUP>MyHC</SUP> mice experiments and J. D. Molkentin (Howard Hughes Medical Institute and Cincinnati Children's Hospital Medical Center) for providing samples of MHC-Cn and Csrp3<SUP>-/-</SUP> mice and mice subjected to TAC or MI. We also thank P. Politis and N. Athanassiadis (Biomedical Research Foundation, Academy of Athens) for providing materials related to the luciferase reporter assays and human samples, respectively. Our sincere thanks to I. Kostavasili for her long-term technical assistance throughout this project. This work was supported by the Greek Secretariat of Research and Development grants (PENED 01ED371, PEP-ATT-39, ESPA SYNERGASIA 09SYN-21-965) and grant of "Excellence II" 5342 to Y. C., a US National Institutes of Health R01 HL 111094 grant to D. L. M. and a fellowship (Heracleitus II) by the European Union and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework to S.P.	Antonaki A, 2011, J BIOL CHEM, V286, P38768, DOI 10.1074/jbc.M111.234161; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Brown M, 2005, AM J PHYSIOL-HEART C, V289, pH466, DOI 10.1152/ajpheart.00170.2004; Burchfield JS, 2010, CIRC-HEART FAIL, V3, P157, DOI 10.1161/CIRCHEARTFAILURE.109.899732; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Capetanaki Y, 2015, CURR OPIN CELL BIOL, V32, P113, DOI 10.1016/j.ceb.2015.01.004; Duan S, 2009, CELL DEATH DIFFER, V16, P826, DOI 10.1038/cdd.2009.12; Duran WN, 2008, AM J PHYSIOL-HEART C, V295, pH2221, DOI 10.1152/ajpheart.01050.2008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feldman AM, 2003, MED CLIN N AM, V87, P419, DOI 10.1016/S0025-7125(02)00189-X; Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Garcia-Nogales P, 1999, J NEUROCHEM, V72, P1750, DOI 10.1046/j.1471-4159.1999.721750.x; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; GOWN AM, 1984, AM J PATHOL, V114, P309; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kapadia SR, 2000, J AM COLL CARDIOL, V36, P208, DOI 10.1016/S0735-1097(00)00721-X; Kaplan SR, 2004, CARDIOVASC PATHOL, V13, P26, DOI 10.1016/S1054-8807(03)00107-8; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; KURUC N, 1988, DIFFERENTIATION, V38, P177, DOI 10.1111/j.1432-0436.1988.tb00212.x; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li X, 2000, CIRCULATION, V102, P1690, DOI 10.1161/01.CIR.102.14.1690; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; Mann DL, 2003, ANNU REV PHYSIOL, V65, P81, DOI 10.1146/annurev.physiol.65.092101.142249; Mavroidis M, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0485-6; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakamichi I, 2005, J CELL BIOL, V171, P931, DOI 10.1083/jcb.200507093; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; PAGANI FD, 1992, J CLIN INVEST, V90, P389, DOI 10.1172/JCI115873; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Panagopoulou P, 2008, J CELL BIOL, V181, P761, DOI 10.1083/jcb.200710049; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Psarras S, 2012, EUR HEART J, V33, P1954, DOI 10.1093/eurheartj/ehr119; Rickelt S, 2011, CELL TISSUE RES, V346, P65, DOI 10.1007/s00441-011-1260-0; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Ursitti JA, 2004, J BIOL CHEM, V279, P41830, DOI 10.1074/jbc.M400128200; van den Boogaard M, 2013, Methods Mol Biol, V977, P53, DOI 10.1007/978-1-62703-284-1_5	55	62	64	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1076	+		10.1038/nm.3925	http://dx.doi.org/10.1038/nm.3925			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26280121	Green Accepted			2022-12-25	WOS:000360961300022
J	Ungewickell, A; Bhaduri, A; Rios, E; Reuter, J; Lee, CS; Mah, A; Zehnder, A; Ohgami, R; Kulkarni, S; Armstrong, R; Weng, WK; Gratzinger, D; Tavallaee, M; Rook, A; Snyder, M; Kim, Y; Khavari, PA				Ungewickell, Alexander; Bhaduri, Aparna; Rios, Eon; Reuter, Jason; Lee, Carolyn S.; Mah, Angela; Zehnder, Ashley; Ohgami, Robert; Kulkarni, Shashikant; Armstrong, Randall; Weng, Wen-Kai; Gratzinger, Dita; Tavallaee, Mahkam; Rook, Alain; Snyder, Michael; Kim, Youn; Khavari, Paul A.			Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2	NATURE GENETICS			English	Article							T-CELL LYMPHOMAS; SEQUENCING DATA; GENE; RECEPTORS; DISCOVERY; ALIGNMENT; THERAPY	Mycosis fungoides and Sezary syndrome comprise the majority of cutaneous T cell lymphomas (CTCLs), disorders notable for their clinical heterogeneity that can present in skin or peripheral blood. Effective treatment options for CTCL are limited, and the genetic basis of these T cell lymphomas remains incompletely characterized(1). Here we report recurrent point mutations and genomic gains of TNFRSF1B, encoding the tumor necrosis factor receptor TNFR2, in 18% of patients with mycosis fungoides and Sezary syndrome. Expression of the recurrent TNFR2 Thr377Ile mutant in T cells leads to enhanced non-canonical NF-kappa B signaling that is sensitive to the proteasome inhibitor bortezomib. Using an integrative genomic approach, we additionally discovered a recurrent CTLA4-CD28 fusion, as well as mutations in downstream signaling mediators of these receptors.	[Ungewickell, Alexander; Bhaduri, Aparna; Rios, Eon; Lee, Carolyn S.; Mah, Angela; Zehnder, Ashley; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Ungewickell, Alexander] Stanford Univ, Div Hematol, Stanford, CA 94305 USA; [Reuter, Jason; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ohgami, Robert; Gratzinger, Dita] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Kulkarni, Shashikant] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kulkarni, Shashikant] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Kulkarni, Shashikant] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Armstrong, Randall; Weng, Wen-Kai] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Tavallaee, Mahkam; Kim, Youn] Stanford Univ, Multidisciplinary Cutaneous Lymphoma Program, Stanford, CA 94305 USA; [Rook, Alain] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu	Ohgami, R/AAE-1448-2019	Snyder, Michael/0000-0003-0784-7987; Gratzinger, Dita/0000-0002-9182-8123; Lee, Carolyn/0000-0002-6511-3757	Office of Research and Development of the US Department of Veterans Affairs; US National Institutes of Health (NIH) [R01CA142635]; US NIH [F32CA168091, F310CA180408]; American Society of Hematology Research Training Award; Dermatology Foundation; Haas Family Foundation; Drs. Martin and Dorothy Spatz Charitable Foundation; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635] Funding Source: NIH RePORTER	Office of Research and Development of the US Department of Veterans Affairs; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Research Training Award; Dermatology Foundation; Haas Family Foundation; Drs. Martin and Dorothy Spatz Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Alizadeh, H. Chang, S. Artandi, L. Boxer, D. Webster and J. Kovalski for presubmission review of the manuscript. We thank all the patients who generously participated in this study. This work was supported by the Office of Research and Development of the US Department of Veterans Affairs and by US National Institutes of Health (NIH) grant R01CA142635 awarded to P.A.K. A.U. was supported by US NIH grant F32CA168091 and by the American Society of Hematology Research Training Award for Fellows. A.B. received support from US NIH grant F310CA180408. E.R. received support from the Dermatology Foundation. The studies were generously supported by the Haas Family Foundation and the Drs. Martin and Dorothy Spatz Charitable Foundation.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng XT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-267; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Heemann C, 2012, CLIN CANCER RES, V18, P3637, DOI 10.1158/1078-0432.CCR-11-3299; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lee CS, 2012, BLOOD, V120, P3288, DOI 10.1182/blood-2012-04-423061; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin WM, 2012, J INVEST DERMATOL, V132, P188, DOI 10.1038/jid.2011.254; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; MIGLIAZZA A, 1994, BLOOD, V84, P3850, DOI 10.1182/blood.V84.11.3850.bloodjournal84113850; Newman AM, 2014, BIOINFORMATICS, V30, P3390, DOI 10.1093/bioinformatics/btu549; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Rodriguez M, 2011, J BIOL CHEM, V286, P22814, DOI 10.1074/jbc.M111.225631; Sekulic A, 2015, MOL GENET GENOM MED, V3, P130, DOI 10.1002/mgg3.121; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Shin JH, 2012, BLOOD, V119, P5678, DOI 10.1182/blood-2011-09-380519; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; van Doorn R, 2009, BLOOD, V113, P127, DOI 10.1182/blood-2008-04-153031; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Vasmatzis G, 2012, BLOOD, V120, P2280, DOI 10.1182/blood-2012-03-419937; Wong HK, 2011, BRIT J HAEMATOL, V155, P150, DOI 10.1111/j.1365-2141.2011.08852.x; ZHANG JD, 1994, ONCOGENE, V9, P1931; Zinzani PL, 2007, J CLIN ONCOL, V25, P4293, DOI 10.1200/JCO.2007.11.4207	30	182	187	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1056	+		10.1038/ng.3370	http://dx.doi.org/10.1038/ng.3370			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26258847	Green Accepted			2022-12-25	WOS:000360394100016
J	Hobbs, RP; DePianto, DJ; Jacob, JT; Han, MC; Chung, BM; Batazzi, AS; Poll, BG; Guo, YJ; Han, JN; Ong, SF; Zheng, WX; Taube, JM; Cihakova, D; Wan, FY; Coulombe, PA				Hobbs, Ryan P.; DePianto, Daryle J.; Jacob, Justin T.; Han, Minerva C.; Chung, Byung-Min; Batazzi, Adriana S.; Poll, Brian G.; Guo, Yajuan; Han, Jingnan; Ong, SuFey; Zheng, Wenxin; Taube, Janis M.; Cihakova, Daniela; Wan, Fengyi; Coulombe, Pierre A.			Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes	NATURE GENETICS			English	Article							NF-KAPPA-B; AUTOIMMUNE REGULATOR; HNRNP K; PROTEIN; CANCER; RNA	Expression of the intermediate filament protein keratin 17 (K17) is robustly upregulated in inflammatory skin diseases and in many tumors originating in stratified and pseudostratified epithelia(1-3). We report that autoimmune regulator (Aire), a transcriptional regulator, is inducibly expressed in human and mouse tumor keratinocytes in a K17-dependent manner and is required for timely onset of Gli2-induced skin tumorigenesis in mice. The induction of Aire mRNA in keratinocytes depends on a functional interaction between K17 and the heterogeneous nuclear ribonucleoprotein hnRNP K-4. Further, K17 colocalizes with Aire protein in the nucleus of tumor-prone keratinocytes, and each factor is bound to a specific promoter region featuring an NF-kappa B consensus sequence in a relevant subset of K17-and Aire-dependent proinflammatory genes. These findings provide radically new insight into keratin intermediate filament and Aire function, along with a molecular basis for the K17-dependent amplification of inflammatory and immune responses in diseased epithelia.	[Hobbs, Ryan P.; DePianto, Daryle J.; Jacob, Justin T.; Han, Minerva C.; Chung, Byung-Min; Batazzi, Adriana S.; Poll, Brian G.; Guo, Yajuan; Han, Jingnan; Zheng, Wenxin; Wan, Fengyi; Coulombe, Pierre A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Ong, SuFey; Cihakova, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Taube, Janis M.; Cihakova, Daniela] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Taube, Janis M.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Wan, Fengyi; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Wan, Fengyi; Coulombe, Pierre A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	coulombe@jhu.edu	Chung, Byung Min/H-6219-2019; Poll, Brian/GQH-9509-2022; Cihakova, Daniela/A-9821-2017	Chung, Byung Min/0000-0003-1262-5107; Poll, Brian/0000-0001-7523-626X; Cihakova, Daniela/0000-0002-8713-2860; Guo, Yajuan/0000-0002-6344-5248	US National Institutes of Health [CA160255, AR044232, GM111682, CA009110]; NATIONAL CANCER INSTITUTE [T32CA009110, R01CA160255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111682] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Coulombe laboratory for support, P. Peterson (Aire constructs; Tartu University), R. Foisner (subcellular fractionation), M. Vladut-Talor (central tolerance study) and J. Folmer (electron microscopy) for advice and assistance. These studies were supported by research grants CA160255 and AR044232 (to P.A.C.) and GM111682 (to F.W.) and by training grant CA009110 (to R.P.H.), all from the US National Institutes of Health.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Adamson KA, 2004, J PATHOL, V202, P180, DOI 10.1002/path.1493; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Barboro P, 2014, CANCER LETT, V352, P152, DOI 10.1016/j.canlet.2014.06.019; Chen RY, 2014, ONCOTARGET, V5, P4406, DOI 10.18632/oncotarget.2030; Chung BM, 2015, J CELL BIOL, V208, P613, DOI 10.1083/jcb.201408026; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Fu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2916; Gaetani M, 2012, NUCLEIC ACIDS RES, V40, P11756, DOI 10.1093/nar/gks933; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Jin L, 2014, MED RES REV, V34, P438, DOI 10.1002/med.21291; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kisand K, 2011, ANN NY ACAD SCI, V1246, P77, DOI 10.1111/j.1749-6632.2011.06308.x; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kumar V, 2011, AM J PATHOL, V178, P983, DOI 10.1016/j.ajpath.2010.12.007; Kumeta M, 2013, EXP CELL RES, V319, P3226, DOI 10.1016/j.yexcr.2013.07.021; Laan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00326; Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; LIAO J, 1995, J BIOL CHEM, V270, P915, DOI 10.1074/jbc.270.2.915; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reichelt J, 2010, METHODS MOL BIOL, V585, P59, DOI 10.1007/978-1-60761-380-0_5; Sankar S, 2013, MOL CELL BIOL, V33, P4448, DOI 10.1128/MCB.00241-13; Sillanpaa N, 2004, MOL IMMUNOL, V41, P1185, DOI 10.1016/j.molimm.2004.06.004; Tong XM, 2004, J INVEST DERMATOL, V122, P965, DOI 10.1111/j.0022-202X.2004.22422.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Woodworth CD, 2004, CARCINOGENESIS, V25, P1771, DOI 10.1093/carcin/bgh170	42	76	76	1	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					933	U135		10.1038/ng.3355	http://dx.doi.org/10.1038/ng.3355			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26168014	Green Accepted			2022-12-25	WOS:000358674100020
J	Rapoport, AP; Stadtmauer, EA; Binder-Scholl, GK; Goloubeva, O; Vogl, DT; Lacey, SF; Badros, AZ; Garfall, A; Weiss, B; Finklestein, J; Kulikovskaya, I; Sinha, SK; Kronsberg, S; Gupta, M; Bond, S; Melchiori, L; Brewer, JE; Bennett, AD; Gerry, AB; Pumphrey, NJ; Williams, D; Tayton-Martin, HK; Ribeiro, L; Holdich, T; Yanovich, S; Hardy, N; Yared, J; Kerr, N; Philip, S; Westphal, S; Siegel, DL; Levine, BL; Jakobsen, BK; Kalos, M; June, CH				Rapoport, Aaron P.; Stadtmauer, Edward A.; Binder-Scholl, Gwendolyn K.; Goloubeva, Olga; Vogl, Dan T.; Lacey, Simon F.; Badros, Ashraf Z.; Garfall, Alfred; Weiss, Brendan; Finklestein, Jeffrey; Kulikovskaya, Irina; Sinha, Sanjoy K.; Kronsberg, Shari; Gupta, Minnal; Bond, Sarah; Melchiori, Luca; Brewer, Joanna E.; Bennett, Alan D.; Gerry, Andrew B.; Pumphrey, Nicholas J.; Williams, Daniel; Tayton-Martin, Helen K.; Ribeiro, Lilliam; Holdich, Tom; Yanovich, Saul; Hardy, Nancy; Yared, Jean; Kerr, Naseem; Philip, Sunita; Westphal, Sandra; Siegel, Don L.; Levine, Bruce L.; Jakobsen, Bent K.; Kalos, Michael; June, Carl H.			NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma	NATURE MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; CANCER-TESTIS ANTIGENS; VERSUS-HOST-DISEASE; MULTIPLE-MYELOMA; COMBINATION IMMUNOTHERAPY; METASTATIC MELANOMA; ADOPTIVE TRANSFER; GENE-THERAPY; RECEPTORS; CHEMOTHERAPY	Despite recent therapeutic advances, multiple myeloma (MM) remains largely incurable. Here we report results of a phase I/II trial to evaluate the safety and activity of autologous T cells engineered to express an affinity-enhanced T cell receptor (TCR) recognizing a naturally processed peptide shared by the cancer-testis antigens NY-ESO-1 and LAGE-1. Twenty patients with antigen-positive MM received an average 2.4 x 10(9) engineered T cells 2 d after autologous stem cell transplant. Infusions were well tolerated without clinically apparent cytokine-release syndrome, despite high IL-6 levels. Engineered T cells expanded, persisted, trafficked to marrow and exhibited a cytotoxic phenotype. Persistence of engineered T cells in blood was inversely associated with NY-ESO-1 levels in the marrow. Disease progression was associated with loss of T cell persistence or antigen escape, in accordance with the expected mechanism of action of the transferred T cells. Encouraging clinical responses were observed in 16 of 20 patients (80%) with advanced disease, with a median progression-free survival of 19.1 months. NY-ESO-1-LAGE-1 TCR-engineered T cells were safe, trafficked to marrow and showed extended persistence that correlated with clinical activity against antigen-positive myeloma.	[Rapoport, Aaron P.; Goloubeva, Olga; Badros, Ashraf Z.; Kronsberg, Shari; Yanovich, Saul; Hardy, Nancy; Yared, Jean; Philip, Sunita; Westphal, Sandra] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Stadtmauer, Edward A.; Vogl, Dan T.; Lacey, Simon F.; Garfall, Alfred; Weiss, Brendan; Kulikovskaya, Irina; Gupta, Minnal; Siegel, Don L.; Levine, Bruce L.; Kalos, Michael; June, Carl H.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Binder-Scholl, Gwendolyn K.; Melchiori, Luca; Brewer, Joanna E.; Bennett, Alan D.; Gerry, Andrew B.; Pumphrey, Nicholas J.; Williams, Daniel; Tayton-Martin, Helen K.; Ribeiro, Lilliam; Holdich, Tom; Jakobsen, Bent K.] Adaptimmune Ltd, Oxford, England; [Goloubeva, Olga; Finklestein, Jeffrey; Kronsberg, Shari] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Lacey, Simon F.; Finklestein, Jeffrey; Kulikovskaya, Irina; Gupta, Minnal; Kerr, Naseem; Siegel, Don L.; Levine, Bruce L.; Kalos, Michael; June, Carl H.] Univ Penn, Dept Pathol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sinha, Sanjoy K.] Carleton Univ, Sch Math & Stat, Ottawa, ON K1S 5B6, Canada; [Bond, Sarah] Cambridge Biomed, Cambridge, MA USA	University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; Pennsylvania Medicine; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; Pennsylvania Medicine; Carleton University	June, CH (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu		Vogl, Dan/0000-0002-2935-2566; Garfall, Alfred/0000-0003-2791-5748	US National Institutes of Health [R01-CA166961]; Multiple Myeloma Research Foundation (MMRF); Adaptimmune; NATIONAL CANCER INSTITUTE [R01CA166961, P30CA016520, K12CA076931] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL069286] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation (MMRF); Adaptimmune; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the staff of the Clinical Cell and Vaccine Production Facility and the Translational and Correlative Sciences Laboratory at the University of Pennsylvania, apheresis centers and nurses of the BMT programs of the University of Maryland Greenebaum Cancer Center and the Abramson Cancer Center for outstanding clinical care provide to our patients. We also thank the courageous and visionary patients who agreed to participate in this study. This work was supported in part by a grant from the US National Institutes of Health to A.P.R. and M.K. (R01-CA166961), a Senior Investigator Award to A.P.R. from the Multiple Myeloma Research Foundation (MMRF) and a sponsored research grant from Adaptimmune to M.K. and C.H.J.	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Alyea E, 2001, BLOOD, V98, P934, DOI 10.1182/blood.V98.4.934; Armand P, 2013, J CLIN ONCOL, V31, P4199, DOI 10.1200/JCO.2012.48.3685; Atanackovic D, 2007, BLOOD, V109, P1103, DOI 10.1182/blood-2006-04-014480; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Barlogie B, 1997, BLOOD, V89, P789, DOI 10.1182/blood.V89.3.789; Barrett DM, 2014, CURR OPIN PEDIATR, V26, P43, DOI 10.1097/MOP.0000000000000043; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Burns WR, 2009, BLOOD, V114, P2888, DOI 10.1182/blood-2009-01-199216; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Condomines M, 2007, J IMMUNOL, V178, P3307, DOI 10.4049/jimmunol.178.5.3307; Corrigan-Curay J, 2014, MOL THER, V22, P1564, DOI 10.1038/mt.2014.148; Davila ML, 2014, INT J HEMATOL, V99, P361, DOI 10.1007/s12185-013-1479-5; Dhodapkar MV, 2002, P NATL ACAD SCI USA, V99, P13009, DOI 10.1073/pnas.202491499; Galustian C, 2009, CANCER IMMUNOL IMMUN, V58, P1033, DOI 10.1007/s00262-008-0620-4; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Levine BL, 1997, J IMMUNOL, V159, P5921; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Lokhorst HM, 2004, BLOOD, V103, P4362, DOI 10.1182/blood-2003-11-3862; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Merchant MS, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.tps3102; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Noonan K, 2005, CANCER RES, V65, P2026, DOI 10.1158/0008-5472.CAN-04-3337; Porrata LF, 2004, CLIN EXP MED, V4, P78, DOI 10.1007/s10238-004-0041-4; Porrata LF, 2001, BLOOD, V98, P579, DOI 10.1182/blood.V98.3.579; Purbhoo MA, 2006, J IMMUNOL, V176, P7308, DOI 10.4049/jimmunol.176.12.7308; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Rapoport AP, 2014, CLIN CANCER RES, V20, P1355, DOI 10.1158/1078-0432.CCR-13-2817; Rapoport AP, 2011, BLOOD, V117, P788, DOI 10.1182/blood-2010-08-299396; Rapoport AP, 2009, CLIN CANCER RES, V15, P4499, DOI 10.1158/1078-0432.CCR-09-0418; Rapoport AP, 2005, NAT MED, V11, P1230, DOI 10.1038/nm1310; Richardson Paul, 2003, Oncology (Williston Park), V17, P1063; Robbins P.F., 2014, CLIN CANC RES; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenblatt J, 2013, CLIN CANCER RES, V19, P3640, DOI 10.1158/1078-0432.CCR-13-0282; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sonneveld P, 2013, J CLIN ONCOL, V31, P3279, DOI 10.1200/JCO.2012.48.4626; Stadtmauer EA, 2011, BLOOD, V117, P63, DOI 10.1182/blood-2010-07-296822; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Tricot G, 1996, BLOOD, V87, P1196, DOI 10.1182/blood.V87.3.1196.bloodjournal8731196; van Baren N, 1999, BLOOD, V94, P1156; van Rhee F, 2005, BLOOD, V105, P3939, DOI 10.1182/blood-2004-09-3707; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	56	549	587	8	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					914	921		10.1038/nm.3910	http://dx.doi.org/10.1038/nm.3910			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26193344	Green Accepted			2022-12-25	WOS:000359181000018
J	Rosen, C; Shezen, E; Aronovich, A; Klionsky, YZ; Yaakov, Y; Assayag, M; Biton, IE; Tal, O; Shakhar, G; Ben-Hur, H; Shneider, D; Vaknin, Z; Sadan, O; Evron, S; Freud, E; Shoseyov, D; Wilschanski, M; Berkman, N; Fibbe, WE; Hagin, D; Hillel-Karniel, C; Krentsis, IM; Bachar-Lustig, E; Reisner, Y				Rosen, Chava; Shezen, Elias; Aronovich, Anna; Klionsky, Yael Zlotnikov; Yaakov, Yasmin; Assayag, Miri; Biton, Inbal Eti; Tal, Orna; Shakhar, Guy; Ben-Hur, Herzel; Shneider, David; Vaknin, Zvi; Sadan, Oscar; Evron, Shmuel; Freud, Enrique; Shoseyov, David; Wilschanski, Michael; Berkman, Neville; Fibbe, Willem E.; Hagin, David; Hillel-Karniel, Carmit; Krentsis, Irit Milman; Bachar-Lustig, Esther; Reisner, Yair			Preconditioning allows engraftmentof mouse and human embryonic lung cells, enabling lung repair in mice	NATURE MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; PIG PANCREATIC TISSUE; PROGENITOR CELLS; ISLET XENOGRAFTS; BONE-MARROW; TRANSPLANTATION; EPITHELIUM; AIRWAY; DISEASES; REGENERATION	Repair of injured lungs represents a longstanding therapeutic challenge. We show that human and mouse embryonic lung tissue from the canalicular stage of development (20-22 weeks of gestation for humans, and embryonic day 15-16 (E15-E16) for mouse) are enriched with progenitors residing in distinct niches. On the basis of the marked analogy to progenitor niches in bone marrow (BM), we attempted strategies similar to BM transplantation, employing sublethal radiation to vacate lung progenitor niches and to reduce stem cell competition. Intravenous infusion of a single cell suspension of canalicular lung tissue from GFP-marked mice or human fetal donors into naphthalene-injured and irradiated syngeneic or SCID mice, respectively, induced marked long-term lung chimerism. Donor type structures or 'patches' contained epithelial, mesenchymal and endothelial cells. Transplantation of differentially labeled E16 mouse lung cells indicated that these patches were probably of clonal origin from the donor. Recipients of the single cell suspension transplant exhibited marked improvement in lung compliance and tissue damping reflecting the energy dissipation in the lung tissues. Our study provides proof of concept for lung reconstitution by canalicular-stage human lung cells after preconditioning of the pulmonary niche.	[Rosen, Chava; Shezen, Elias; Aronovich, Anna; Klionsky, Yael Zlotnikov; Tal, Orna; Shakhar, Guy; Hagin, David; Hillel-Karniel, Carmit; Krentsis, Irit Milman; Bachar-Lustig, Esther; Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Yaakov, Yasmin; Wilschanski, Michael] Hebrew Univ Jerusalem, Hadassah Mt Scopus Med Ctr, Pediat Gastroenterol, Jerusalem, Israel; [Assayag, Miri; Berkman, Neville] Hadassah Hebrew Univ, Med Ctr, Pulm Med, Jerusalem, Israel; [Biton, Inbal Eti] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Ben-Hur, Herzel; Shneider, David; Vaknin, Zvi] Assaf Harofeh Med Ctr, Dept Obstet & Gynecol, IL-70300 Zerifin, Israel; [Ben-Hur, Herzel; Shneider, David; Vaknin, Zvi; Sadan, Oscar; Evron, Shmuel; Freud, Enrique] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Sadan, Oscar] Wolfson Med Ctr, Dept Obstet & Gynecol, Tel Aviv, Israel; [Evron, Shmuel] Wolfson Med Ctr, Dept Anesthesiol, Tel Aviv, Israel; [Freud, Enrique] Schneider Childrens Med Ctr, Dept Pediat Surg, Petah Tiqwa, Israel; [Shoseyov, David] Hebrew Univ Jerusalem, Hadassah Mt Scopus Med Ctr, Pediat Pulmonol, Jerusalem, Israel; [Fibbe, Willem E.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Weizmann Institute of Science; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Reisner, Y (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	Yair.Reisner@weizmann.ac.il	Reisner, Yair/AAA-4772-2019; Hagin, David/GRS-3442-2022	Reisner, Yair/0000-0002-3354-6945	Israel Science Foundation [71035803]; Roberto and Renata Ruhman	Israel Science Foundation(Israel Science Foundation); Roberto and Renata Ruhman	The authors thank Z. Kam (Weizmann Institute) and O. Golani (Weizmann Institute) for excellent assistance with the colocalization analysis and R. Rotkopf (Weizmann Institute) for his critical support with the statistical analyses. This study was supported in part by a grant from the Israel Science Foundation (Legacy Bio-Med, 71035803 to Y.R. and M.W.) and by a research grant from Roberto and Renata Ruhman (Y.R.).	Alanis DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4923; Alphonse RS, 2014, CIRCULATION, V129, P2144, DOI 10.1161/CIRCULATIONAHA.114.009124; Aronovich A, 2006, P NATL ACAD SCI USA, V103, P19075, DOI 10.1073/pnas.0607012103; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; Chabot A, 2015, J CELL PHYSIOL, V230, P170, DOI 10.1002/jcp.24696; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Duchesneau P, 2010, MOL THER, V18, P1830, DOI 10.1038/mt.2010.142; Engelhardt JF, 2001, AM J RESP CELL MOL, V24, P649, DOI 10.1165/ajrcmb.24.6.f206; Eventov-Friedman S, 2005, P NATL ACAD SCI USA, V102, P2928, DOI 10.1073/pnas.0500177102; Eventov-Friedman S, 2006, PLOS MED, V3, P1165, DOI 10.1371/journal.pmed.0030215; Farin AM, 2015, RADIAT RES, V183, P124, DOI 10.1667/RR13878.1; Fujino N, 2011, LAB INVEST, V91, P363, DOI 10.1038/labinvest.2010.187; Hashimoto S, 2012, J CELL SCI, V125, P932, DOI 10.1242/jcs.092734; Hecht G, 2009, P NATL ACAD SCI USA, V106, P8659, DOI 10.1073/pnas.0812253106; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Katchman H, 2008, STEM CELLS, V26, P1347, DOI 10.1634/stemcells.2007-0631; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Koulmanda M, 2004, XENOTRANSPLANTATION, V11, P525, DOI 10.1111/j.1399-3089.2004.00174.x; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mirenda V, 2005, DIABETES, V54, P1048, DOI 10.2337/diabetes.54.4.1048; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; STATTER MB, 1988, J UROLOGY, V139, P204, DOI 10.1016/S0022-5347(17)42354-8; Stripp B. R., 1995, AM J PHYSIOL, V269, P791; Sykes M, 2009, TRANSPLANTATION, V87, P309, DOI 10.1097/TP.0b013e31819535c2; Tchorsh-Yutsis D, 2011, TRANSPLANTATION, V91, P398, DOI 10.1097/TP.0b013e318204be15; Tchorsh-Yutsis D, 2009, DIABETES, V58, P1585, DOI 10.2337/db09-0112; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Weiss DJ, 2013, AM J RESP CRIT CARE, V188, P123, DOI 10.1164/rccm.201302-0351ED; Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	54	62	69	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					869	879		10.1038/nm.3889	http://dx.doi.org/10.1038/nm.3889			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26168294				2022-12-25	WOS:000359181000013
J	Mishanina, AV; Libiad, M; Banerjee, R				Mishanina, Atiana V.; Libiad, Marouane; Banerjee, Ruma			Biogenesis of reactive sulfur species for signaling by hydrogen sulfide oxidation pathways	NATURE CHEMICAL BIOLOGY			English	Article							XANTHINE-OXIDASE; SUPEROXIDE-DISMUTASE; SERINE DEHYDRATASE; ELEMENTAL SULFUR; REDOX; THIOSULFATE; H2S; SULFURTRANSFERASE; BIOSYNTHESIS; PERSULFIDES	The chemical species involved in H2S signaling remain elusive despite the profound and pleiotropic physiological effects elicited by this molecule. The dominant candidate mechanism for sulfide signaling is persulfidation of target proteins. However, the relatively poor reactivity of H2S toward oxidized thiols, such as disulfides, the low concentration of disulfides in the reducing milieu of the cell and the low steady-state concentration of H2S raise questions about the plausibility of persulfide formation via reaction between an oxidized thiol and a sulfide anion or a reduced thiol and oxidized hydrogen disulfide. In contrast, sulfide oxidation pathways, considered to be primarily mechanisms for disposing of excess sulfide, generate a series of reactive sulfur species, including persulfides, polysulfides and thiosulfate, that could modify target proteins. We posit that sulfide oxidation pathways mediate sulfide signaling and that sulfurtransferases ensure target specificity.	[Mishanina, Atiana V.; Libiad, Marouane; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Mishanina, Tatiana/0000-0001-7400-3501; Libiad, Marouane/0000-0003-1717-9206	US National Institutes of Health [GM112455, HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the US National Institutes of Health (GM112455 and HL58984).	Alvarez C, 2012, MOL PLANT, V5, P1217, DOI 10.1093/mp/sss043; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; BAXTER CF, 1958, BIOCHIM BIOPHYS ACTA, V28, P573, DOI 10.1016/0006-3002(58)90521-3; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; BRANZOLI U, 1974, J BIOL CHEM, V249, P4346; Brittain T, 2008, IUBMB LIFE, V60, P135, DOI 10.1002/iub.16; Brondino CD, 2006, CURR OPIN CHEM BIOL, V10, P109, DOI 10.1016/j.cbpa.2006.01.034; Bucci M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053319; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Carballal S, 2011, FREE RADICAL BIO MED, V50, P196, DOI 10.1016/j.freeradbiomed.2010.10.705; CAVALLINI D, 1970, EUR J BIOCHEM, V14, P169, DOI 10.1111/j.1432-1033.1970.tb00275.x; CHATFIELD MJ, 1987, BIOCHEMISTRY-US, V26, P6939, DOI 10.1021/bi00396a013; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; Collman J, 2009, P NATL ACAD SCI USA, V106, P22090, DOI 10.1073/pnas.0904082106; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; Das TN, 1999, J PHYS CHEM A, V103, P5221, DOI 10.1021/jp9907544; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; FINAZZIAGRO A, 1976, BIOCHEM BIOPH RES CO, V68, P553, DOI 10.1016/0006-291X(76)91181-5; Finkel T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002943; Flores JF, 2005, P NATL ACAD SCI USA, V102, P2713, DOI 10.1073/pnas.0407455102; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Gruhlke MCH, 2012, PLANT PHYSIOL BIOCH, V59, P98, DOI 10.1016/j.plaphy.2012.03.016; GUNNISON AF, 1987, CRIT REV TOXICOL, V17, P185, DOI 10.3109/10408448709071208; GUTTERIDGE S, 1978, BIOCHEM J, V175, P887, DOI 10.1042/bj1750887; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KATO A, 1966, J BIOCHEM-TOKYO, V59, P40, DOI 10.1093/oxfordjournals.jbchem.a128256; Keilin D, 1933, P R SOC LOND B-CONTA, V113, P393, DOI 10.1098/rspb.1933.0056; Kimura Y, 2013, FASEB J, V27, P2451, DOI 10.1096/fj.12-226415; King AL, 2014, P NATL ACAD SCI USA, V111, P3182, DOI 10.1073/pnas.1321871111; Klotz MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00241; Koike S, 2013, FEBS LETT, V587, P3548, DOI 10.1016/j.febslet.2013.09.013; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Krussel L, 2014, PLANT PHYSIOL, V165, P92, DOI 10.1104/pp.114.239764; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Li Q, 2013, NITRIC OXIDE-BIOL CH, V35, P21, DOI 10.1016/j.niox.2013.07.001; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Liu LJ, 2014, J BIOL CHEM, V289, P26949, DOI 10.1074/jbc.M114.591669; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Marcia M, 2010, PROTEINS, V78, P1073, DOI 10.1002/prot.22665; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; MASSEY V, 1970, J BIOL CHEM, V245, P6595; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Matthies A, 2005, BIOCHEMISTRY-US, V44, P7912, DOI 10.1021/bi0503448; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; NAKAMURA S, 1984, J BIOL CHEM, V259, P7080; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; NICHOLLS P, 1981, BIOCHIM BIOPHYS ACTA, V637, P312, DOI 10.1016/0005-2728(81)90170-5; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; OBRIEN DJ, 1977, ENVIRON SCI TECHNOL, V11, P1114, DOI 10.1021/es60135a009; Ono K, 2014, FREE RADICAL BIO MED, V77, P82, DOI 10.1016/j.freeradbiomed.2014.09.007; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Palinkas Z, 2015, BRIT J PHARMACOL, V172, P1516, DOI 10.1111/bph.12769; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Pavlik JW, 2010, INORG CHEM, V49, P1017, DOI 10.1021/ic901853p; PESTANA A, 1970, BIOCHEM BIOPH RES CO, V39, P522, DOI 10.1016/0006-291X(70)90609-1; Pietri R, 2009, BIOCHEMISTRY-US, V48, P4881, DOI 10.1021/bi801738j; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Ranguelova K, 2013, FREE RADICAL BIO MED, V60, P98, DOI 10.1016/j.freeradbiomed.2013.01.022; Riahi S, 2014, J AM CHEM SOC, V136, P15111, DOI 10.1021/ja508063s; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Sakaguchi M, 2014, ANESTHESIOLOGY, V121, P1248, DOI 10.1097/ALN.0000000000000456; SEARCY DG, 1995, ARCH BIOCHEM BIOPHYS, V318, P251, DOI 10.1006/abbi.1995.1228; SMITH RP, 1966, TOXICOL APPL PHARM, V8, P159, DOI 10.1016/0041-008X(66)90112-8; Snijder PM, 2015, BRIT J PHARMACOL, V172, P1494, DOI 10.1111/bph.12825; SORBO B, 1958, BIOCHIM BIOPHYS ACTA, V27, P324, DOI 10.1016/0006-3002(58)90339-1; Theissen U, 2008, FEBS J, V275, P1131, DOI 10.1111/j.1742-4658.2008.06273.x; TOGAWA T, 1992, CHEM PHARM BULL, V40, P3000, DOI 10.1248/cpb.40.3000; TOOHEY JI, 1975, P NATL ACAD SCI USA, V72, P73, DOI 10.1073/pnas.72.1.73; VALENTINE WN, 1974, CLIN CHIM ACTA, V51, P205, DOI 10.1016/0009-8981(74)90031-X; VALENTINE WN, 1987, P NATL ACAD SCI USA, V84, P1394, DOI 10.1073/pnas.84.5.1394; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yarmolinsky D, 2013, PLANT PHYSIOL, V161, P725, DOI 10.1104/pp.112.207712; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	99	372	378	8	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					457	464		10.1038/nchembio.1834	http://dx.doi.org/10.1038/nchembio.1834			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26083070	Green Accepted			2022-12-25	WOS:000356334600009
J	Chan-Penebre, E; Kuplast, KG; Majer, CR; Boriack-Sjodin, PA; Wigle, TJ; Johnston, LD; Rioux, N; Munchhof, MJ; Jin, L; Jacques, SL; West, KA; Lingaraj, T; Stickland, K; Ribich, SA; Raimondi, A; Scott, MP; Waters, NJ; Pollock, RM; Smith, JJ; Barbash, O; Pappalardi, M; Ho, TF; Nurse, K; Oza, KP; Gallagher, KT; Kruger, R; Moyer, MP; Copeland, RA; Chesworth, R; Duncan, KW				Chan-Penebre, Elayne; Kuplast, Kristy G.; Majer, Christina R.; Boriack-Sjodin, P. Ann; Wigle, Tim J.; Johnston, L. Danielle; Rioux, Nathalie; Munchhof, Michael J.; Jin, Lei; Jacques, Suzanne L.; West, Kip A.; Lingaraj, Trupti; Stickland, Kimberly; Ribich, Scott A.; Raimondi, Alejandra; Scott, Margaret Porter; Waters, Nigel J.; Pollock, Roy M.; Smith, Jesse J.; Barbash, Olena; Pappalardi, Melissa; Ho, Thau F.; Nurse, Kelvin; Oza, Khyati P.; Gallagher, Kathleen T.; Kruger, Ryan; Moyer, Mikel P.; Copeland, Robert A.; Chesworth, Richard; Duncan, Kenneth W.			A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models	NATURE CHEMICAL BIOLOGY			English	Article							ARGININE METHYLTRANSFERASE 5; LYMPHOMA-CELLS; SM PROTEINS; METHYLATION; COMPLEX; GROWTH; ASSAY; EZH2; EXPRESSION; LEUKEMIA	Protein arginine methyltransferase-5 (PRMT5) is reported to have a role in diverse cellular processes, including tumorigenesis, and its overexpression is observed in cell lines and primary patient samples derived from lymphomas, particularly mantle cell lymphoma (MCL). Here we describe the identification and characterization of a potent and selective inhibitor of PRMT5 with antiproliferative effects in both in vitro and in vivo models of MCL. EPZ015666 (GSK3235025) is an orally available inhibitor of PRMT5 enzymatic activity in biochemical assays with a half-maximal inhibitory concentration (IC50) of 22 nM and broad selectivity against a panel of other histone methyltransferases. Treatment of MCL cell lines with EPZ015666 led to inhibition of SmD3 methylation and cell death, with IC50 values in the nanomolar range. Oral dosing with EPZ015666 demonstrated dosedependent antitumor activity in multiple MCL xenograft models. EPZ015666 represents a validated chemical probe for further study of PRMT5 biology and arginine methylation in cancer and other diseases.	[Chan-Penebre, Elayne; Kuplast, Kristy G.; Boriack-Sjodin, P. Ann; Johnston, L. Danielle; Rioux, Nathalie; Munchhof, Michael J.; Jacques, Suzanne L.; West, Kip A.; Lingaraj, Trupti; Stickland, Kimberly; Ribich, Scott A.; Raimondi, Alejandra; Waters, Nigel J.; Smith, Jesse J.; Copeland, Robert A.; Chesworth, Richard; Duncan, Kenneth W.] Epizyme Inc, Dept Biol, Cambridge, MA 02139 USA; [Chan-Penebre, Elayne; Kuplast, Kristy G.; Boriack-Sjodin, P. Ann; Johnston, L. Danielle; Rioux, Nathalie; Munchhof, Michael J.; Jacques, Suzanne L.; West, Kip A.; Lingaraj, Trupti; Stickland, Kimberly; Ribich, Scott A.; Raimondi, Alejandra; Waters, Nigel J.; Smith, Jesse J.; Copeland, Robert A.; Chesworth, Richard; Duncan, Kenneth W.] Epizyme Inc, Dept Mol Discovery, Cambridge, MA USA; [Majer, Christina R.; Wigle, Tim J.; Pollock, Roy M.] Warp Dr Bio, Cambridge, MA USA; [Jin, Lei] Agile Biostruct Solut, Cambridge, MA USA; [Scott, Margaret Porter] Genentech Inc, San Francisco, CA USA; [Barbash, Olena; Pappalardi, Melissa; Kruger, Ryan] GlaxoSmithKline, Canc Epigenet DPU, Collegeville, PA USA; [Ho, Thau F.; Nurse, Kelvin; Oza, Khyati P.] GlaxoSmithKline, Dept Biol Reagents & Assay Dev, Collegeville, PA USA; [Gallagher, Kathleen T.] GlaxoSmithKline, Discovery Core Technol & Capabil, Collegeville, PA USA; [Moyer, Mikel P.] Raze Therapeut, Cambridge, MA USA	Roche Holding; Genentech; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Chan-Penebre, E (corresponding author), Epizyme Inc, Dept Biol, Cambridge, MA 02139 USA.	kduncan@epizyme.com		Waters, Nigel/0000-0002-5063-295X				Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Cheng DH, 2011, J MED CHEM, V54, P4928, DOI 10.1021/jm200453n; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Chung JH, 2013, J BIOL CHEM, V288, P35534, DOI 10.1074/jbc.M113.510669; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Dowden J, 2011, ORG BIOMOL CHEM, V9, P7814, DOI 10.1039/c1ob06100c; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Huynh T, 2009, BIOORG MED CHEM LETT, V19, P2924, DOI 10.1016/j.bmcl.2009.04.075; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaniskan HU, 2015, ANGEW CHEM INT EDIT, V54, P5166, DOI 10.1002/anie.201412154; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Liu F, 2013, J MED CHEM, V56, P2110, DOI 10.1021/jm3018332; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; MCCURDY A, 1992, J AM CHEM SOC, V114, P10314, DOI 10.1021/ja00052a031; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obianyo O, 2010, CHEMBIOCHEM, V11, P1219, DOI 10.1002/cbic.201000209; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Purandare AV, 2008, BIOORG MED CHEM LETT, V18, P4438, DOI 10.1016/j.bmcl.2008.06.026; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smil D, 2015, ACS MED CHEM LETT, V6, P408, DOI 10.1021/ml500467h; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Therrien E, 2009, BIOORG MED CHEM LETT, V19, P6725, DOI 10.1016/j.bmcl.2009.09.110; Wan HH, 2009, BIOORG MED CHEM LETT, V19, P5063, DOI 10.1016/j.bmcl.2009.07.040; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428	51	331	359	12	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					432	+		10.1038/NCHEMBIO.1810	http://dx.doi.org/10.1038/NCHEMBIO.1810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25915199				2022-12-25	WOS:000354539400014
J	Costa-Silva, B; Aiello, NM; Ocean, AJ; Singh, S; Zhang, HY; Thakur, BK; Becker, A; Hoshino, A; Mark, MT; Molina, H; Xiang, J; Zhang, T; Theilen, TM; Garcia-Santos, G; Williams, C; Ararso, Y; Huang, YJ; Rodrigues, G; Shen, TL; Labori, KJ; Lothe, IMB; Kure, EH; Hernandez, J; Doussot, A; Ebbesen, SH; Grandgenett, PM; Hollingsworth, MA; Jain, M; Mallya, K; Batra, SK; Jarnagin, WR; Schwartz, RE; Matei, I; Peinado, H; Stanger, BZ; Bromberg, J; Lyden, D				Costa-Silva, Bruno; Aiello, Nicole M.; Ocean, Allyson J.; Singh, Swarnima; Zhang, Haiying; Thakur, Basant Kumar; Becker, Annette; Hoshino, Ayuko; Mark, Milica Tesic; Molina, Henrik; Xiang, Jenny; Zhang, Tuo; Theilen, Till-Martin; Garcia-Santos, Guillermo; Williams, Caitlin; Ararso, Yonathan; Huang, Yujie; Rodrigues, Goncalo; Shen, Tang-Long; Labori, Knut Jorgen; Lothe, Inger Marie Bowitz; Kure, Elm H.; Hernandez, Jonathan; Doussot, Alexandre; Ebbesen, Saya H.; Grandgenett, Paul M.; Hollingsworth, Michael A.; Jain, Maneesh; Mallya, Kavita; Batra, Surinder K.; Jarnagin, William R.; Schwartz, Robert E.; Matei, Irina; Peinado, Hector; Stanger, Ben Z.; Bromberg, Jacqueline; Lyden, David			Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; INHIBITORY FACTOR EXPRESSION; TGF-BETA; MESENCHYMAL TRANSITION; EXTRACELLULAR VESICLES; DUCTAL ADENOCARCINOMA; KUPFFER CELLS; MOUSE MODEL; MACROPHAGES; ACTIVATION	Pancreatic ductal adenocarcinomas (PDACs) are highly metastatic with poor prognosis, mainly due to delayed detection. We hypothesized that intercellular communication is critical for metastatic progression. Here, we show that PDAC-derived exosomes induce liver pre-metastatic niche formation in naive mice and consequently increase liver metastatic burden. Uptake of PDAC-derived exosomes by Kupffer cells caused transforming growth factor beta secretion and upregulation of fibronectin production by hepatic stellate cells. This fibrotic microenvironment enhanced recruitment of bone marrow-derived macrophages. We found that macrophage migration inhibitory factor (MIF) was highly expressed in PDAC-derived exosomes, and its blockade prevented liver pre-metastatic niche formation and metastasis. Compared with patients whose pancreatic tumours did not progress, MIF was markedly higher in exosomes from stage I PDAC patients who later developed liver metastasis. These findings suggest that exosomal MIF primes the liver for metastasis and may be a prognostic marker for the development of PDAC liver metastasis.	[Costa-Silva, Bruno; Singh, Swarnima; Zhang, Haiying; Thakur, Basant Kumar; Becker, Annette; Hoshino, Ayuko; Theilen, Till-Martin; Garcia-Santos, Guillermo; Williams, Caitlin; Ararso, Yonathan; Huang, Yujie; Rodrigues, Goncalo; Ebbesen, Saya H.; Matei, Irina; Peinado, Hector; Lyden, David] Weill Cornell Med Coll, Meyer Canc Ctr, Childrens Canc & Blood Fdn Labs, Drukier Inst Childrens Hlth,Dept Pediat, New York, NY 10021 USA; [Costa-Silva, Bruno; Singh, Swarnima; Zhang, Haiying; Thakur, Basant Kumar; Becker, Annette; Hoshino, Ayuko; Theilen, Till-Martin; Garcia-Santos, Guillermo; Williams, Caitlin; Ararso, Yonathan; Huang, Yujie; Rodrigues, Goncalo; Ebbesen, Saya H.; Matei, Irina; Peinado, Hector; Lyden, David] Weill Cornell Med Coll, Meyer Canc Ctr, Childrens Canc & Blood Fdn Labs, Drukier Inst Childrens Hlth,Dept Cell & Dev Biol, New York, NY 10021 USA; [Aiello, Nicole M.; Stanger, Ben Z.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Gastroenterol Div,Dept Med, Philadelphia, PA 19104 USA; [Ocean, Allyson J.] Weill Cornell Med Coll, New York Presbyterian Hosp, Div Hematol & Med Oncol, Dept Med, New York, NY 10021 USA; [Thakur, Basant Kumar] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; [Mark, Milica Tesic; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Xiang, Jenny; Zhang, Tuo] Weill Cornell Med Coll, Genom Resources Core Facil, New York, NY 10021 USA; [Rodrigues, Goncalo] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099003 Oporto, Portugal; [Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10617, Taiwan; [Labori, Knut Jorgen] Oslo Univ Hosp, Dept Hepatopancreatobiliary Surg, N-0424 Oslo, Norway; [Lothe, Inger Marie Bowitz] Oslo Univ Hosp, Dept Pathol, N-0424 Oslo, Norway; [Lothe, Inger Marie Bowitz; Kure, Elm H.] Oslo Univ Hosp, Dept Genet, Inst Canc Res, N-0424 Oslo, Norway; [Hernandez, Jonathan; Doussot, Alexandre; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Grandgenett, Paul M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Jain, Maneesh; Mallya, Kavita; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Schwartz, Robert E.] Weill Cornell Med Coll, Dept Med, Div Gastroenterol & Hepatol, New York, NY 10021 USA; [Peinado, Hector] Spanish Natl Canc Res Ctr CNIO, Dept Mol Oncol, Microenvironm & Metaslasis Lab, Madrid 28029, Spain; [Bromberg, Jacqueline] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Bromberg, Jacqueline] Weill Cornell Med Coll, New York, NY 10065 USA; [Lyden, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA	Cornell University; Cornell University; University of Pennsylvania; Pennsylvania Medicine; Cornell University; NewYork-Presbyterian Hospital; Hannover Medical School; Rockefeller University; Cornell University; Universidade do Porto; National Taiwan University; University of Oslo; University of Oslo; University of Oslo; Memorial Sloan Kettering Cancer Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Cornell University; Centro Nacional de Investigaciones Oncologicas (CNIO); Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Stanger, BZ (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Gastroenterol Div,Dept Med, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu; bromberj@mskcc.org; dcl2001@med.cornell.edu	Hoshino, Ayuko/AHD-6448-2022; Peinado, Hector/A-6417-2013; Schwartz, Robert/AAE-7153-2021; Costa-Silva, Bruno/AAY-2266-2020; Garcia-Santos, Guillermo/ABG-4631-2020; Doussot, Alexandre/Y-9592-2019; Labori, Knut Jørgen/W-5510-2019	Hoshino, Ayuko/0000-0003-4149-5073; Peinado, Hector/0000-0002-4256-3413; Doussot, Alexandre/0000-0003-0543-1793; Costa-Silva, Bruno/0000-0002-5932-6211; Aiello, Nicole/0000-0003-1616-5785; Shen, Tang-Long/0000-0001-6264-3608; Rodrigues, Goncalo/0000-0001-5132-9568; Garcia-Santos, Guillermo/0000-0002-4755-2430; Thakur, Barun Kumar/0000-0002-1713-9186	Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Champalimaud Foundation; Fundacao para a Ciencia e a Tecnologia; Nancy C and Daniel P Paduano Foundation; Mary Kay Foundation; Pediatric Oncology Experimental Therapeutic Investigator Consortium; James Paduano Foundation; Melanoma Research Alliance; Sohn Conference Foundation; Beth Tortolani Foundation; Malcolm Hewitt Weiner Foundation; Jose Carreras Leukemia Foundation; Theodore Rapp Foundation; American Hellenic Educational Progressive Association 5th District Cancer Research Foundation; Charles and Marjorie Holloway Foundation; Sussman Family Fund; Lerner Foundation; Breast Cancer Alliance; Manhasset Women's Coalition Against Breast Cancer; NATIONAL CANCER INSTITUTE [P50CA127297, U54CA163120, P30CA008748, U01CA111294] Funding Source: NIH RePORTER	Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Champalimaud Foundation; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Nancy C and Daniel P Paduano Foundation; Mary Kay Foundation; Pediatric Oncology Experimental Therapeutic Investigator Consortium; James Paduano Foundation; Melanoma Research Alliance; Sohn Conference Foundation; Beth Tortolani Foundation; Malcolm Hewitt Weiner Foundation; Jose Carreras Leukemia Foundation; Theodore Rapp Foundation; American Hellenic Educational Progressive Association 5th District Cancer Research Foundation; Charles and Marjorie Holloway Foundation; Sussman Family Fund; Lerner Foundation; Breast Cancer Alliance; Manhasset Women's Coalition Against Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. L. Bajor (Vonderheide laboratory, University of Pennsylvania) for the gift of the R6560B cells. We thank L. Bojmar for carefully reviewing the paper. We thank S. Rudchenko and M. Barbu-Stevanovic at the Hospital for Special Surgery Fannie E. Rippel Foundation Flow Cytometry Core Facility for expert flow cytometry. We are supported by grants from the Children's Cancer and Blood Foundation (H.P., D. L.), Manning Foundation (D. L.), Hartwell Foundation (D. L.), Champalimaud Foundation (D. L.), Fundacao para a Ciencia e a Tecnologia (D. L.), Nancy C and Daniel P Paduano Foundation (H.P., D. L.), Mary Kay Foundation (D. L.), Pediatric Oncology Experimental Therapeutic Investigator Consortium (D. L.), James Paduano Foundation (D. L., H.P.), Melanoma Research Alliance (H.P.), Sohn Conference Foundation (H.P.), Beth Tortolani Foundation (D. L., J.B.), Malcolm Hewitt Weiner Foundation (D. L.), Jose Carreras Leukemia Foundation (B.K.T.), Theodore Rapp Foundation (D. L.), American Hellenic Educational Progressive Association 5th District Cancer Research Foundation (D. L.), Charles and Marjorie Holloway Foundation (J.B.), Sussman Family Fund (J.B.), Lerner Foundation (J.B.), Breast Cancer Alliance (J.B.), and Manhasset Women's Coalition Against Breast Cancer (J.B.).	Achyut BR, 2011, GASTROENTEROLOGY, V141, P1167, DOI 10.1053/j.gastro.2011.07.048; Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Arscott W Tristram, 2011, Biomark Med, V5, P821, DOI 10.2217/bmm.11.80; Barnes MA, 2013, HEPATOLOGY, V57, P1980, DOI 10.1002/hep.26169; Bayon LG, 1996, HEPATOLOGY, V23, P1224, DOI 10.1002/hep.510230542; Bissell DM, 2011, CLIN RES HEPATOL GAS, V35, P521, DOI 10.1016/j.clinre.2011.03.009; Chan A, 2013, J PROTEOMICS, V81, P126, DOI 10.1016/j.jprot.2012.09.025; Chen PF, 2010, MOL MED, V16, P400, DOI 10.2119/molmed.2009.00128; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Cong M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/158547; CORBETT TH, 1984, CANCER RES, V44, P717; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Ellermeier J, 2013, CANCER RES, V73, P1709, DOI 10.1158/0008-5472.CAN-11-3850; Fesinmeyer MD, 2005, CANCER EPIDEM BIOMAR, V14, P1766, DOI 10.1158/1055-9965.EPI-05-0120; Funamizu N, 2013, INT J CANCER, V132, P785, DOI 10.1002/ijc.27736; Gaspar NJ, 2007, MOL PHARMACOL, V72, P152, DOI 10.1124/mol.106.029025; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Hayashi H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00012; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Javle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085942; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kato R, 2002, CLIN CANCER RES, V8, P2455; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Kobayashi S, 1999, HEPATOLOGY, V29, P1752, DOI 10.1002/hep.510290610; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Kruse J, 2013, INT J COLORECTAL DIS, V28, P1337, DOI 10.1007/s00384-013-1703-z; Lau C, 2013, J BIOL CHEM, V288, P26888, DOI 10.1074/jbc.M113.452458; Little EC, 2012, J SURG RES, V176, P359, DOI 10.1016/j.jss.2011.10.025; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; MORIKAWA K, 1988, CANCER RES, V48, P1943; Nanji AA, 2001, J INTERF CYTOK RES, V21, P1055, DOI 10.1089/107999001317205187; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Porembka MR, 2012, CANCER IMMUNOL IMMUN, V61, P1373, DOI 10.1007/s00262-011-1178-0; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Saif MW, 2011, J PANCREAS, V12, P316; Saito Noboru, 2001, International Journal of Clinical Oncology, V6, P215, DOI 10.1007/PL00012108; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Seubert B, 2015, HEPATOLOGY, V61, P238, DOI 10.1002/hep.27378; Shin HN, 2012, INT J MOL MED, V30, P1537, DOI 10.3892/ijmm.2012.1141; Suemizu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082708; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wen SW, 2013, CANCER BIOL THER, V14, P606, DOI 10.4161/cbt.24593; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Xu GX, 1997, J PATHOL, V183, P90, DOI 10.1002/(SICI)1096-9896(199709)183:1<90::AID-PATH1105>3.0.CO;2-J; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Yamamoto M, 2008, CANCER RES, V68, P9754, DOI 10.1158/0008-5472.CAN-08-1748; Zhang HY, 2005, LIVER INT, V25, P571, DOI 10.1111/j.1478-3231.2005.01047.x; Zhang Y, 2013, CLIN EXP METASTAS, V30, P903, DOI 10.1007/s10585-013-9591-8; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652; Zoller Margot, 2013, World J Gastrointest Pathophysiol, V4, P74, DOI 10.4291/wjgp.v4.i4.74; Zvibel I, 1998, INT J CANCER, V77, P295, DOI 10.1002/(SICI)1097-0215(19980717)77:2<295::AID-IJC20>3.0.CO;2-9	67	1566	1624	22	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					816	+		10.1038/ncb3169	http://dx.doi.org/10.1038/ncb3169			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25985394	Green Accepted			2022-12-25	WOS:000355277500013
J	Mascanfroni, ID; Takenaka, MC; Yeste, A; Patel, B; Wu, Y; Kenison, JE; Siddiqui, S; Basso, AS; Otterbein, LE; Pardoll, DM; Pan, F; Priel, A; Clish, CB; Robson, SC; Quintana, FJ				Mascanfroni, Ivan D.; Takenaka, Maisa C.; Yeste, Ada; Patel, Bonny; Wu, Yan; Kenison, Jessica E.; Siddiqui, Shafiuddin; Basso, Alexandre S.; Otterbein, Leo E.; Pardoll, Drew M.; Pan, Fan; Priel, Avner; Clish, Clary B.; Robson, Simon C.; Quintana, Francisco J.			Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha	NATURE MEDICINE			English	Article							HYPOXIA-INDUCIBLE FACTORS; CENTRAL-NERVOUS-SYSTEM; T(H)17 CELLS; TR1 CELLS; C-MAF; RECEPTOR; MECHANISMS; EXPRESSION; INDUCTION; IL-27	Our understanding of the pathways that regulate lymphocyte metabolism, as well as the effects of metabolism and its products on the immune response, is still limited. We report that a metabolic program controlled by the transcription factors hypoxia inducible factor-1 alpha (HIF1-alpha) and aryl hydrocarbon receptor (AHR) supports the differentiation of type 1 regulatory T cell (Tr1) cells. HIF1-alpha controls the early metabolic reprograming of Tr1 cells. At later time points, AHR promotes HIF1-alpha degradation and takes control of Tr1 cell metabolism. Extracellular ATP (eATP) and hypoxia, linked to inflammation, trigger AHR inactivation by HIF1-alpha and inhibit Tr1 cell differentiation. Conversely, CD39 promotes Tr1 cell differentiation by depleting eATP. CD39 also contributes to Tr1 suppressive activity by generating adenosine in cooperation with CD73 expressed by responder T cells and antigen-presenting cells. These results suggest that HIF1-alpha and AHR integrate immunological, metabolic and environmental signals to regulate the immune response.	[Mascanfroni, Ivan D.; Takenaka, Maisa C.; Yeste, Ada; Patel, Bonny; Kenison, Jessica E.; Siddiqui, Shafiuddin; Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Wu, Yan; Otterbein, Leo E.; Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol Hepatol & Transplantat, Boston, MA 02115 USA; [Basso, Alexandre S.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Pardoll, Drew M.; Pan, Fan] Johns Hopkins Univ, Sch Med, Dept Oncol & Med, Immunol & Hematopoiesis Div, Baltimore, MD USA; [Priel, Avner] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Clish, Clary B.] MIT, Broad Inst, Ctr Prote, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); Johns Hopkins University; University of Alberta; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Clish, Clary B/ABB-9374-2021; Robson, Simon C./AAA-8537-2021; Clish, Clary/AAB-7124-2019; Basso, Alexandre S/K-2281-2012; Quintana, Francisco Javier/AAB-6915-2020	Clish, Clary B/0000-0001-8259-9245; Basso, Alexandre S/0000-0002-3302-4792; Priel, Avner/0000-0002-4620-6376; Kenison, Jessica/0000-0002-5599-3228	US National Institutes of Health [AI093903, NS087867, CA164970]; National Multiple Sclerosis Society [RG4111A1, FG 2036-A1/1]; Questcor [A219074]; Ciencias sem Fronteiras CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [246252/2012-0]; NATIONAL CANCER INSTITUTE [R21CA164970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075285, R00AI075285, R01AI093903, R01AI099300, R56AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087867] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Questcor; Ciencias sem Fronteiras CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Frank (Dana-Farber Cancer Institute) for STAT3C plasmid. This work was supported by grants AI093903 and NS087867 from the US National Institutes of Health and RG4111A1 from the National Multiple Sclerosis Society to F.J.Q., and by grant CA164970 from the US National Institutes of Health to S.C.R. I.D.M. received support from an educational grant from Questcor (A219074) and by a postdoctoral fellowship (FG 2036-A1/1) from the National Multiple Sclerosis Society. M.C.T. is a graduate student in the Ph.D. program of the Federal University of Sao Paulo, and was supported by fellowship 246252/2012-0 from Ciencias sem Fronteiras CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.	Amoroso F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.105; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2014, CURR TOP MICROBIOL, V380, P39, DOI 10.1007/978-3-662-43492-5_3; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun XF, 2013, HEPATOLOGY, V57, P205, DOI 10.1002/hep.25989; Sun XF, 2010, GASTROENTEROLOGY, V139, P1030, DOI 10.1053/j.gastro.2010.05.007; Wang CM, 2014, EMBO J, V33, P1354, DOI 10.15252/embj.201386666; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	47	296	306	6	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					638	646		10.1038/nm.3868	http://dx.doi.org/10.1038/nm.3868			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	26005855	Green Accepted			2022-12-25	WOS:000355778300020
J	Paugh, SW; Bonten, EJ; Savic, D; Ramsey, LB; Thierfelder, WE; Gurung, P; Malireddi, RKS; Actis, M; Mayasundari, A; Min, J; Coss, DR; Laudermilk, LT; Panetta, JC; McCorkle, JR; Fan, YP; Crews, KR; Stocco, G; Wilkinson, MR; Ferreira, AM; Cheng, C; Yang, WJ; Karol, SE; Fernandez, CA; Diouf, B; Smith, C; Hicks, JK; Zanut, A; Giordanengo, A; Crona, D; Bianchi, JJ; Holmfeldt, L; Mullighan, CG; den Boer, ML; Pieters, R; Jeha, S; Dunwell, TL; Latif, F; Bhojwani, D; Carroll, WL; Pui, CH; Myers, RM; Guy, RK; Kanneganti, TD; Relling, MV; Evans, WE				Paugh, Steven W.; Bonten, Erik J.; Savic, Daniel; Ramsey, Laura B.; Thierfelder, William E.; Gurung, Prajwal; Malireddi, R. K. Subbarao; Actis, Marcelo; Mayasundari, Anand; Min, Jaeki; Coss, David R.; Laudermilk, Lucas T.; Panetta, John C.; McCorkle, J. Robert; Fan, Yiping; Crews, Kristine R.; Stocco, Gabriele; Wilkinson, Mark R.; Ferreira, Antonio M.; Cheng, Cheng; Yang, Wenjian; Karol, Seth E.; Fernandez, Christian A.; Diouf, Barthelemy; Smith, Colton; Hicks, J. Kevin; Zanut, Alessandra; Giordanengo, Audrey; Crona, Daniel; Bianchi, Joy J.; Holmfeldt, Linda; Mullighan, Charles G.; den Boer, Monique L.; Pieters, Rob; Jeha, Sima; Dunwell, Thomas L.; Latif, Farida; Bhojwani, Deepa; Carroll, William L.; Pui, Ching-Hon; Myers, Richard M.; Guy, R. Kiplin; Kanneganti, Thirumala-Devi; Relling, Mary V.; Evans, William E.			NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INTERLEUKIN-1-BETA CONVERTING-ENZYME; CELLULAR-DRUG RESISTANCE; GENE; ACTIVATION; INHIBITION; CHROMATIN; MECHANISMS; CHILDREN; STRESS	Glucocorticoids are universally used in the treatment of acute lymphoblastic leukemia (ALL), and resistance to glucocorticoids in leukemia cells confers poor prognosis. To elucidate mechanisms of glucocorticoid resistance, we determined the prednisolone sensitivity of primary leukemia cells from 444 patients newly diagnosed with ALL and found significantly higher expression of CASP1 (encoding caspase 1) and its activator NLRP3 in glucocorticoid-resistant leukemia cells, resulting from significantly lower somatic methylation of the CASP1 and NLRP3 promoters. Overexpression of CASP1 resulted in cleavage of the glucocorticoid receptor, diminished the glucocorticoid-induced transcriptional response and increased glucocorticoid resistance. Knockdown or inhibition of CASP1 significantly increased glucocorticoid receptor levels and mitigated glucocorticoid resistance in CASP1-overexpressing ALL. Our findings establish a new mechanism by which the NLRP3-CASP1 inflammasome modulates cellular levels of the glucocorticoid receptor and diminishes cell sensitivity to glucocorticoids. The broad impact on the glucocorticoid transcriptional response suggests that this mechanism could also modify glucocorticoid effects in other diseases.	[Paugh, Steven W.; Bonten, Erik J.; Ramsey, Laura B.; Thierfelder, William E.; Laudermilk, Lucas T.; McCorkle, J. Robert; Crews, Kristine R.; Stocco, Gabriele; Wilkinson, Mark R.; Yang, Wenjian; Karol, Seth E.; Fernandez, Christian A.; Diouf, Barthelemy; Smith, Colton; Hicks, J. Kevin; Zanut, Alessandra; Giordanengo, Audrey; Crona, Daniel; Bianchi, Joy J.; Holmfeldt, Linda; Mullighan, Charles G.; Jeha, Sima; Bhojwani, Deepa; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Hematol Malignancies Program, Memphis, TN 38105 USA; [Paugh, Steven W.; Bonten, Erik J.; Ramsey, Laura B.; Thierfelder, William E.; Laudermilk, Lucas T.; Panetta, John C.; McCorkle, J. Robert; Crews, Kristine R.; Stocco, Gabriele; Wilkinson, Mark R.; Yang, Wenjian; Karol, Seth E.; Fernandez, Christian A.; Diouf, Barthelemy; Smith, Colton; Hicks, J. Kevin; Zanut, Alessandra; Giordanengo, Audrey; Crona, Daniel; Bianchi, Joy J.; Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Savic, Daniel; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Gurung, Prajwal; Malireddi, R. K. Subbarao] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Actis, Marcelo; Mayasundari, Anand; Min, Jaeki; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Coss, David R.; Ferreira, Antonio M.] St Jude Childrens Res Hosp, High Performance Comp Facil, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Karol, Seth E.; Jeha, Sima; Bhojwani, Deepa; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Holmfeldt, Linda; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [den Boer, Monique L.; Pieters, Rob] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Div Pediat Oncol Hematol, Rotterdam, Netherlands; [Pieters, Rob] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Dunwell, Thomas L.; Latif, Farida] Univ Birmingham, Ctr Rare Dis & Personalized Med, Birmingham, W Midlands, England; [Carroll, William L.] NYU, Langone Med Ctr, Inst Canc, New York, NY USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; HudsonAlpha Institute for Biotechnology; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Birmingham; New York University; NYU Langone Medical Center	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Hematol Malignancies Program, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Stocco, Gabriele/K-3798-2018; Ramsey, Laura/ABD-6113-2020; Relling, Mary/N-5032-2018; Guy, Rodney/J-7107-2013; Kanneganti, Thirumala-Devi/M-9435-2018; Karol, Seth/N-2102-2018; Savic, Daniel/N-5525-2018; Malireddi, RKSubbarao/C-5804-2013; Mullighan, Charles/H-3253-2011; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012; Jeha, Sima C/N-8163-2018; Panetta, John/AAY-3850-2021; Cheng, Cheng/N-8075-2018; McCorkle, Rob/AAH-3759-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Stocco, Gabriele/0000-0003-0964-5879; Ramsey, Laura/0000-0001-6417-3961; Guy, Rodney/0000-0002-9638-2060; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Karol, Seth/0000-0001-8113-8180; Savic, Daniel/0000-0002-6693-0265; Malireddi, RKSubbarao/0000-0001-8855-9447; Mullighan, Charles/0000-0002-1871-1850; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; Panetta, John/0000-0003-1308-7208; McCorkle, Rob/0000-0002-5028-8853; Bianchi, Joy/0000-0003-1268-9637; Holmfeldt, Linda/0000-0003-4140-3423; Gurung, Prajwal/0000-0002-7451-9433; Min, Jaeki/0000-0002-0083-3198; Crona, Daniel/0000-0003-3742-8863; Dunwell, Thomas/0000-0001-9985-3828; Bhojwani, Deepa/0000-0002-7559-7927; Laudermilk, Lucas/0000-0001-6181-0136; den Boer, Monique/0000-0002-5795-2921; Zanut, Alessandra/0000-0001-8917-9825; Crews, Kristine/0000-0002-7558-558X; Ferreira, Antonio/0000-0002-6581-6233	US National Institutes of Health (NIH) National Cancer Institute grant [R37CA36401]; US NIH National Institute of General Medical Sciences Pharmacogenomics Research Network grant [U01GM92666]; US NIH grant [F32CA141762]; American Recovery and Reinvestment Act supplement [3R37CA036401-26S1]; Cancer Center Support Grant from the National Cancer Institute [CA21765]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, R01CA163507, R25CA023944, F32CA141762, R37CA036401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Cancer Institute grant; US NIH National Institute of General Medical Sciences Pharmacogenomics Research Network grant; US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act supplement; Cancer Center Support Grant from the National Cancer Institute; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the patients and their parents who participated in this research. We are appreciative of the expert technical assistance of M. Roberts, Y. Chu, Y. Wang, M.A. Payton, J. Stukenborg, S. Salehy, M. Needham, M. Chung, N. Lenchik, M. Loyd and E. Walker. We thank J. Groff and E. Stevens for figure preparation assistance and C. Simmons for assistance with manuscript preparation. We thank D. Green for his scientific advice and discussion of the manuscript. We thank C. Stewart, G. Neale, J. Morris and K. Rakestraw for their technical advice and expertise. This work was supported in part by US National Institutes of Health (NIH) National Cancer Institute grant R37CA36401 (WEE., M.V.R. and C.-H.P.), US NIH National Institute of General Medical Sciences Pharmacogenomics Research Network grant U01GM92666 (M.V.R. and WEE.), US NIH grant F32CA141762 (S.W.P.) and an American Recovery and Reinvestment Act supplement, 3R37CA036401-26S1 (W.E.E.). This work was also supported by Cancer Center Support Grant CA21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Bachmann PS, 2005, BLOOD, V105, P2519, DOI 10.1182/blood-2004-05-2023; Bialer M, 2013, EPILEPSY RES, V103, P2, DOI 10.1016/j.eplepsyres.2012.10.001; Bouligand J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013563; Boxer M.B., 2010, PROBE REPORTS NIH MO; Charmandari E, 2007, J CLIN ENDOCR METAB, V92, P3986, DOI 10.1210/jc.2006-2830; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Jones CL, 2014, J BIOL CHEM, V289, P20502, DOI 10.1074/jbc.M114.569889; KARL M, 1993, J CLIN ENDOCR METAB, V76, P683, DOI 10.1210/jc.76.3.683; Kaspers GJL, 1997, BLOOD, V90, P2723, DOI 10.1182/blood.V90.7.2723.2723_2723_2729; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Michailidou Z, 2008, FASEB J, V22, P3896, DOI 10.1096/fj.08-111914; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pottier N, 2008, JNCI-J NATL CANCER I, V100, P1792, DOI 10.1093/jnci/djn416; PUI CH, 1984, LEUKEMIA RES, V8, P579, DOI 10.1016/0145-2126(84)90006-7; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Riml S, 2004, CELL DEATH DIFFER, V11, pS65, DOI 10.1038/sj.cdd.4401413; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; TEURICH S, 1995, CHEM SENSES, V20, P251, DOI 10.1093/chemse/20.2.251; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	40	96	102	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					607	614		10.1038/ng.3283	http://dx.doi.org/10.1038/ng.3283			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25938942	Green Submitted, Green Accepted			2022-12-25	WOS:000355386500011
J	Paulsson, K; Lilljebjorn, H; Biloglav, A; Olsson, L; Rissler, M; Castor, A; Barbany, G; Fogelstrand, L; Nordgren, A; Sjogren, H; Fioretos, T; Johansson, B				Paulsson, Kajsa; Lilljebjorn, Henrik; Biloglav, Andrea; Olsson, Linda; Rissler, Marianne; Castor, Anders; Barbany, Gisela; Fogelstrand, Linda; Nordgren, Ann; Sjogren, Helene; Fioretos, Thoas; Johansson, Bertil			The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia	NATURE GENETICS			English	Article							MUTATIONS; GENES; REARRANGEMENT; EXPRESSION; CANCER; RAS; FREQUENT; TWINS; FLT3; KRAS	High hyperdiploid (51-67 chromosomes) acute lymphoblastic leukemia (ALL) is one of the most common childhood malignancies, comprising 30% of all pediatric B cell-precursor ALL. Its characteristic genetic feature is the nonrandom gain of chromosomes X, 4, 6, 10, 14, 17, 18 and 21, with individual trisomies or tetrasomies being seen in over 75% of cases, but the pathogenesis remains poorly understood. We performed whole-genome sequencing (WGS) (n = 16) and/or whole-exome sequencing (WES) (n = 39) of diagnostic and remission samples from 51 cases of high hyperdiploid ALL to further define the genomic landscape of this malignancy. The majority of cases showed involvement of the RTK-RAS pathway and of histone modifiers. No recurrent fusion gene-forming rearrangement was found, and an analysis of mutations on trisomic chromosomes indicated that the chromosomal gains were early events, strengthening the notion that the high hyperdiploid pattern is the main driver event in this common pediatric malignancy.	[Paulsson, Kajsa; Lilljebjorn, Henrik; Biloglav, Andrea; Olsson, Linda; Rissler, Marianne; Fioretos, Thoas; Johansson, Bertil] Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden; [Castor, Anders] Lund Univ, Skane Univ Hosp, Dept Pediat, Lund, Sweden; [Barbany, Gisela; Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Fogelstrand, Linda; Sjogren, Helene] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Fogelstrand, Linda] Sahlgrens Univ Hosp, Clin Chem Lab, Gothenburg, Sweden; [Fioretos, Thoas; Johansson, Bertil] Univ & Reg Labs Reg Skane, Dept Clin Genet, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Karolinska Institutet; University of Gothenburg; Sahlgrenska University Hospital	Paulsson, K (corresponding author), Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden.	kajsa.paulsson@med.lu.se	Nordgren, Ann C/N-4057-2013; Nordgren, Ann/AAQ-9142-2021; , Anders/V-6166-2019	Nordgren, Ann C/0000-0003-3285-4281; Nordgren, Ann/0000-0003-3285-4281; Paulsson, Kajsa/0000-0001-7950-222X; Barbany, Gisela/0000-0003-3185-2962; Fioretos, Thoas/0000-0002-3235-6154; Lilljebjorn, Henrik/0000-0001-8703-1173	Swedish Cancer Society [CAN 2013/545, CAN 2014/357]; Swedish Childhood Cancer Foundation [PROJ12/7050, PROJ12/009]; Swedish Research Council [521-2012-864, 521-2011-4090]	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Swedish Cancer Society (K.P., grant reference CAN 2013/545; B.J., grant reference CAN 2014/357), the Swedish Childhood Cancer Foundation (K.P., grant reference PROJ12/7050; B.J., grant reference PROJ12/009) and the Swedish Research Council (K.P., grant reference 521-2012-864; B.J., grant reference 521-2011-4090).	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Armstrong SA, 2004, BLOOD, V103, P3544, DOI 10.1182/blood-2003-07-2441; Barbaric D, 2006, LEUKEMIA RES, V30, P1355, DOI 10.1016/j.leukres.2006.03.009; Bateman CM, 2015, LEUKEMIA, V29, P58, DOI 10.1038/leu.2014.177; Biggs P. J., 1993, MUTAGENESIS, V8, P275; Collins Andrew R., 1998, Molecular Aspects of Medicine, V19, P359, DOI 10.1016/S0098-2997(99)00003-5; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Gelsi-Boyer V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-299; Gruszka-Westwood AM, 2004, GENE CHROMOSOME CANC, V41, P191, DOI 10.1002/gcc.20085; Inthal A, 2012, LEUKEMIA, V26, P1797, DOI 10.1038/leu.2012.60; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kodani A, 2010, MOL BIOL CELL, V21, P3376, DOI 10.1091/mbc.E10-05-0430; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Maia AT, 2004, GENE CHROMOSOME CANC, V40, P38, DOI 10.1002/gcc.20010; Maia AT, 2003, LEUKEMIA, V17, P2202, DOI 10.1038/sj.leu.2403101; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Paulsson K, 2008, GENE CHROMOSOME CANC, V47, P26, DOI 10.1002/gcc.20502; Paulsson K, 2009, GENE CHROMOSOME CANC, V48, P637, DOI 10.1002/gcc.20671; Perentesis JP, 2004, LEUKEMIA, V18, P685, DOI 10.1038/sj.leu.2403272; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Szczepanski T, 2001, LEUKEMIA, V15, P1415, DOI 10.1038/sj.leu.2402206; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Thomas DDH, 2010, BIOCHEM BIOPH RES CO, V402, P583, DOI 10.1016/j.bbrc.2010.10.041; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	31	107	109	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					672	676		10.1038/ng.3301	http://dx.doi.org/10.1038/ng.3301			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25961940	Green Submitted			2022-12-25	WOS:000355386500021
J	Fjeld, K; Weiss, FU; Lasher, D; Rosendahl, J; Chen, JM; Johansson, BB; Kirsten, H; Ruffert, C; Masson, E; Steine, SJ; Bugert, P; Cnop, M; Grutzmann, R; Mayerle, J; Mossner, J; Ringdal, M; Schulz, HU; Sendler, M; Simon, P; Sztromwasser, P; Torsvik, J; Scholz, M; Tjora, E; Ferec, C; Witt, H; Lerch, MM; Njolstad, PR; Johansson, S; Molven, A				Fjeld, Karianne; Weiss, Frank Ulrich; Lasher, Denise; Rosendahl, Jonas; Chen, Jian-Min; Johansson, Bente B.; Kirsten, Holger; Ruffert, Claudia; Masson, Emmanuelle; Steine, Solrun J.; Bugert, Peter; Cnop, Miriam; Gruetzmann, Robert; Mayerle, Julia; Moessner, Joachim; Ringdal, Monika; Schulz, Hans-Ulrich; Sendler, Matthias; Simon, Peter; Sztromwasser, Pawel; Torsvik, Janniche; Scholz, Markus; Tjora, Erling; Ferec, Claude; Witt, Heiko; Lerch, Markus M.; Njolstad, Pal R.; Johansson, Stefan; Molven, Anders			A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis	NATURE GENETICS			English	Article							CARBOXYL-ESTER LIPASE; SALT-STIMULATED LIPASE; CYSTIC-FIBROSIS GENE; HEREDITARY PANCREATITIS; MUTATIONS; VARIANTS; CTRC; VNTR; GLYCOSYLATION; LOCALIZATION	Carboxyl ester lipase is a digestive pancreatic enzyme encoded by the CEL gene(1). Mutations in CEL cause maturity-onset diabetes of the young as well as pancreatic exocrine dysfunction(2). Here we describe a hybrid allele (CEL-HYB) originating from a crossover between CEL and its neighboring pseudogene, CELP. In a discovery series of familial chronic pancreatitis cases, we observed CEL-HYB in 14.1% (10/71) of cases compared to 1.0% (5/478) of controls (odds ratio (OR) = 15.5; 95% confidence interval (CI) = 5.1-46.9; P = 1.3 x 10(-6) by two-tailed Fisher's exact test). In three replication studies of nonalcoholic chronic pancreatitis, we identified CEL-HYB in a total of 3.7% (42/1,122) cases and 0.7% (30/4,152) controls (OR = 5.2; 95% CI = 3.2-8.5; P = 1.2 x 10(-11); formal meta-analysis). The allele was also enriched in alcoholic chronic pancreatitis. Expression of CEL-HYB in cellular models showed reduced lipolytic activity, impaired secretion, prominent intracellular accumulation and induced autophagy. These findings implicate a new pathway distinct from the protease-antiprotease system of pancreatic acinar cells in chronic pancreatitis.	[Fjeld, Karianne; Johansson, Bente B.; Ringdal, Monika; Sztromwasser, Pawel; Torsvik, Janniche; Tjora, Erling; Njolstad, Pal R.; Johansson, Stefan; Molven, Anders] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Fjeld, Karianne; Johansson, Bente B.; Ringdal, Monika; Sztromwasser, Pawel; Torsvik, Janniche; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Weiss, Frank Ulrich; Mayerle, Julia; Sendler, Matthias; Simon, Peter; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Lasher, Denise; Witt, Heiko] Tech Univ Munich, Pediat Nutr Med, Freising Weihenstephan, Germany; [Lasher, Denise; Moessner, Joachim; Witt, Heiko] TUM, Else Kroner Fresenius Zentrum Ernahrungsmed, Freising Weihenstephan, Germany; [Rosendahl, Jonas; Ruffert, Claudia] Univ Leipzig, Div Gastroenterol, Dept Internal Med Neurol & Dermatol, D-04109 Leipzig, Germany; [Chen, Jian-Min; Masson, Emmanuelle; Ferec, Claude] INSERM, U1078, Brest, France; [Chen, Jian-Min; Ferec, Claude] Etab Francais Sang EFS Bretagne, Brest, France; [Chen, Jian-Min; Ferec, Claude] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Kirsten, Holger] Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany; [Kirsten, Holger; Scholz, Markus] Univ Leipzig, Leipzig Res Ctr Civilizat Dis LIFE Leipzig, D-04109 Leipzig, Germany; [Kirsten, Holger; Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol IMISE, D-04109 Leipzig, Germany; [Ruffert, Claudia] Univ Leipzig, Div Endocrinol, Dept Internal Med Neurol & Dermatol, D-04109 Leipzig, Germany; [Ruffert, Claudia] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Masson, Emmanuelle; Ferec, Claude] Hop Morvan, Ctr Hosp Univ CHU Brest, Lab Genet Mol & Histocompatibilite, Brest, France; [Steine, Solrun J.; Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Bugert, Peter] Heidelberg Univ, German Red Cross Blood Serv Baden Wurttemberg Hes, Med Fac Mannheim, Inst Transfus Med & Immunol, Mannheim, Germany; [Cnop, Miriam] ULB, Ctr Diabet Res, Brussels, Belgium; [Cnop, Miriam] Erasmus Hosp, Div Endocrinol, Brussels, Belgium; [Gruetzmann, Robert] Univ Klinikum Dresden, Dept Surg, Dresden, Germany; [Schulz, Hans-Ulrich] Univ Magdeburg, Dept Surg, D-39106 Magdeburg, Germany; [Sztromwasser, Pawel] Univ Bergen, Dept Informat, Computat Biol Unit, N-5008 Bergen, Norway; [Tjora, Erling; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Greifswald Medical School; Technical University of Munich; Technical University of Munich; Leipzig University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Fraunhofer Gesellschaft; Leipzig University; Leipzig University; Leipzig University; Leipzig University; CHU Brest; Universite de Bretagne Occidentale; University of Bergen; Ruprecht Karls University Heidelberg; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Otto von Guericke University; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Molven, A (corresponding author), Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway.	anders.molven@gades.uib.no	Lerch, Markus M./E-2206-2016; Fjeld, Karianne/Q-7122-2018; Ferec, Claude/ABG-9699-2020; Kirsten, Holger/AAP-7250-2020; Mayerle, Julia/W-7907-2019; Weiss, Frank Ulrich/A-6386-2009; Johansson, Stefan/C-4394-2011; Sendler, Matthias/V-9341-2017; Johansson, Bente Berg/AAE-7666-2022	Lerch, Markus M./0000-0002-9643-8263; Fjeld, Karianne/0000-0003-0441-1475; Ferec, Claude/0000-0002-2325-0710; Kirsten, Holger/0000-0002-3126-7950; Weiss, Frank Ulrich/0000-0003-3369-6369; Johansson, Stefan/0000-0002-2298-7008; Johansson, Bente Berg/0000-0001-8893-1915; MASSON, Emmanuelle/0000-0001-9777-523X; Sendler, Matthias/0000-0003-3554-9426; Chen, Jian-Min/0000-0002-2424-3969; Sztromwasser, Pawel/0000-0002-0661-8800; Mayerle, Julia/0000-0002-3666-6459; Sendler, Matthias/0000-0001-6494-4105; Cnop, Miriam/0000-0002-5112-1692	Translational Fund of Bergen Medical Research Foundation; KG Jebsen Foundation; University of Bergen; Research Council of Norway; European Research Council; German Federal Ministry of Education and Research [BMBF GANI-MED 03152061A, BMBF 0314107]; Europaische Fonds fur regionale Entwicklung; State Ministry of Economics Mecklenburg-Vorpommern [V-630-S-150-2012/132/133]; Deutsche Forschungsgemeinschaft [RO 3929/1-1, RO 3939/2-1-1, Wi 2036/2-3, SFB 1052 C01, SPP 1629, TO 718/2-1]; Colora Stiftung gGmbH; Leipzig Interdisciplinary Research Cluster of Genetic Factors; Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig); INSERM; French Association des Pancreatites Chroniques Hereditaires (APCH); Actions de Recherche Concertee de la Communaute Francaise (ARC); Fonds National de la Recherche Scientifique (FNRS, Belgium); Western Norway Regional Health Authority (Helse Vest); European Union Framework Programme 7 (EPC-TM); European Union Framework Programme 7 (REGPOT-1); European Union Framework Programme 7 (BetaBat)	Translational Fund of Bergen Medical Research Foundation; KG Jebsen Foundation; University of Bergen; Research Council of Norway(Research Council of Norway); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Europaische Fonds fur regionale Entwicklung; State Ministry of Economics Mecklenburg-Vorpommern; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Colora Stiftung gGmbH; Leipzig Interdisciplinary Research Cluster of Genetic Factors; Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Association des Pancreatites Chroniques Hereditaires (APCH); Actions de Recherche Concertee de la Communaute Francaise (ARC); Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Western Norway Regional Health Authority (Helse Vest); European Union Framework Programme 7 (EPC-TM); European Union Framework Programme 7 (REGPOT-1); European Union Framework Programme 7 (BetaBat)	The authors thank all study participants and the members of the Gesellschaft fur Padiatrische Gastroenterologie und Ernahrung (GPGE) for providing clinical data and blood samples. The confocal imaging was performed at the Molecular Imaging Center, Department of Biomedicine, University of Bergen. We are also grateful to G. Bjorkoy for commenting on the manuscript. This work was supported by grants and fellowships to P.R.N. and A.M. from the Translational Fund of Bergen Medical Research Foundation, KG Jebsen Foundation, University of Bergen, Research Council of Norway and Western Norway Regional Health Authority (Helse Vest), and to P.R.N. from the European Research Council. Work performed in the German, French and Belgian laboratories was supported by grants from the German Federal Ministry of Education and Research (BMBF GANI-MED 03152061A and BMBF 0314107), European Union Framework Programme 7 (EPC-TM, REGPOT-2010-1 and BetaBat), Europaische Fonds fur regionale Entwicklung, State Ministry of Economics Mecklenburg-Vorpommern (V-630-S-150-2012/132/133), Deutsche Forschungsgemeinschaft (RO 3929/1-1, RO 3939/2-1-1, Wi 2036/2-3, SFB 1052 C01 and SPP 1629 TO 718/2-1), Colora Stiftung gGmbH, Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig), INSERM, French Association des Pancreatites Chroniques Hereditaires (APCH), Actions de Recherche Concertee de la Communaute Francaise (ARC) and Fonds National de la Recherche Scientifique (FNRS, Belgium). We thank O. Hernell (Umea University, Sweden) for providing antibodies.	Bengtsson-Ellmark SH, 2004, EUR J HUM GENET, V12, P627, DOI 10.1038/sj.ejhg.5201204; Castino R, 2011, TOXICOL SCI, V123, P523, DOI 10.1093/toxsci/kfr179; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Derikx MH, 2015, GUT, V64, P1426, DOI 10.1136/gutjnl-2014-307453; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; Gukovskaya AS, 2012, AM J PHYSIOL-GASTR L, V303, pG993, DOI 10.1152/ajpgi.00122.2012; HANSSON L, 1993, J BIOL CHEM, V268, P26692; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Hou X, 2014, J PROTEOMICS, V96, P82, DOI 10.1016/j.jprot.2013.10.041; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; LIDBERG U, 1992, GENOMICS, V13, P630, DOI 10.1016/0888-7543(92)90134-E; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Madeyski K, 1998, MAMM GENOME, V9, P334, DOI 10.1007/s003359900762; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Masson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073522; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2014, DIABETES, V63, P259, DOI 10.2337/db13-1012; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Rosendahl J, 2013, GUT, V62, P582, DOI 10.1136/gutjnl-2011-300645; Sannerud Ragna, 2008, V457, P253, DOI 10.1007/978-1-59745-261-8_19; Scholz M, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1162; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Torsvik J, 2014, J BIOL CHEM, V289, P29097, DOI 10.1074/jbc.M114.574244; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Weiss FU, 2015, GUT, V64, P646, DOI 10.1136/gutjnl-2014-306930; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730	39	112	116	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					518	U121		10.1038/ng.3249	http://dx.doi.org/10.1038/ng.3249			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25774637	Green Accepted			2022-12-25	WOS:000353635800015
J	Lorach, H; Goetz, G; Smith, R; Lei, X; Mandel, Y; Kamins, T; Mathieson, K; Huie, P; Harris, J; Sher, A; Palanker, D				Lorach, Henri; Goetz, Georges; Smith, Richard; Lei, Xin; Mandel, Yossi; Kamins, Theodore; Mathieson, Keith; Huie, Philip; Harris, James; Sher, Alexander; Palanker, Daniel			Photovoltaic restoration of sight with high visual acuity	NATURE MEDICINE			English	Article							RETINAL GANGLION-CELLS; CONTRAST SENSITIVITY; RAT; FREQUENCY; PROSTHESIS; RESOLUTION; SYSTEM; MODEL	Patients with retinal degeneration lose sight due to the gradual demise of photoreceptors. Electrical stimulation of surviving retinal neurons provides an alternative route for the delivery of visual information. We demonstrate that subretinal implants with 70-mm-wide photovoltaic pixels provide highly localized stimulation of retinal neurons in rats. The electrical receptive fields recorded in retinal ganglion cells were similar in size to the natural visual receptive fields. Similarly to normal vision, the retinal response to prosthetic stimulation exhibited flicker fusion at high frequencies, adaptation to static images and nonlinear spatial summation. In rats with retinal degeneration, these photovoltaic arrays elicited retinal responses with a spatial resolution of 64 +/- 11 mu m, corresponding to half of the normal visual acuity in healthy rats. The ease of implantation of these wireless and modular arrays, combined with their high resolution, opens the door to the functional restoration of sight in patients blinded by retinal degeneration.	[Lorach, Henri; Goetz, Georges; Huie, Philip; Palanker, Daniel] Stanford Univ, Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Lorach, Henri; Huie, Philip; Palanker, Daniel] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA; [Lorach, Henri] INSERM, Inst Vis, UMR S968, Paris, France; [Goetz, Georges; Lei, Xin; Kamins, Theodore; Harris, James] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Smith, Richard; Sher, Alexander] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Mandel, Yossi] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52100 Ramat Gan, Israel; [Mathieson, Keith] Univ Strathclyde, Inst Photon, Glasgow, Lanark, Scotland	Stanford University; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; University of California System; University of California Santa Cruz; Bar Ilan University; University of Strathclyde	Goetz, G (corresponding author), Stanford Univ, Hansen Expt Phys Lab, Stanford, CA 94305 USA.	ggoetz@stanford.edu	Mathieson, Keith/G-6308-2011	Mathieson, Keith/0000-0002-9517-8076; Palanker, Daniel/0000-0002-0480-3025; LORACH, HENRI/0000-0003-4337-2798; Goetz, Georges/0000-0001-5907-0554; Sher, Alexander/0000-0001-6655-6456	US National Institutes of Health [R01-EY-018608]; Department of Defense [W81XWH-15-1-0009]; Stanford Spectrum fund; Burroughs Wellcome Fund; Pew Charitable Trust; SU2P fellowship, RCUK Science Bridges award; Foundation Voir et Entendre (Paris); NATIONAL EYE INSTITUTE [R01EY018608] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Stanford Spectrum fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Pew Charitable Trust; SU2P fellowship, RCUK Science Bridges award; Foundation Voir et Entendre (Paris); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank D. Boinagrov, E. J. Chichilnisky, M. F. Marmor and S. Picaud for stimulating discussions and encouragement. We would also like to thank J. Liao for providing the VEP recording setup, S. Lee for assistance in developing surgical procedures, as well as P. Haeusser, S. Kachiguine, P. Hottowy and A. Litke for providing and supporting the multielectrode array recording setup. Funding was provided by the US National Institutes of Health (grant R01-EY-018608, D. P.), the Department of Defense (grant W81XWH-15-1-0009, D. P.) and the Stanford Spectrum fund (D. P.). A. S. was supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface and a Pew Charitable Trusts Scholarship in the Biomedical Sciences. K. M. was supported by an SU2P fellowship as part of a RCUK Science Bridges award. H. L. was supported by the Foundation Voir et Entendre (Paris) and Pixium Vision.	Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Behrend MR, 2011, IEEE T NEUR SYS REH, V19, P436, DOI 10.1109/TNSRE.2011.2140132; Boinagrov D, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026008; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; DEAN P, 1981, BEHAV BRAIN RES, V3, P239, DOI 10.1016/0166-4328(81)90050-4; Delori FC, 2007, J OPT SOC AM A, V24, P1250, DOI 10.1364/JOSAA.24.001250; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Fransen JW, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046012; Goetz GA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056021; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; HARNOIS C, 1984, EXP BRAIN RES, V57, P1; Heine WF, 2011, VISUAL NEUROSCI, V28, P403, DOI 10.1017/S0952523811000307; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Jensen RJ, 2006, EXP EYE RES, V83, P367, DOI 10.1016/j.exer.2006.01.012; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Joucla S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004828; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Lorach H, 2015, VISION RES, V111, P142, DOI 10.1016/j.visres.2014.09.007; Lorach H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066004; Loudin JD, 2007, J NEURAL ENG, V4, pS72, DOI 10.1088/1741-2560/4/1/S09; Loudin JD, 2011, IEEE T BIOMED CIRC S, V5, P468, DOI 10.1109/TBCAS.2011.2144980; Mandel Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2980; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Mathieson K, 2012, NAT PHOTONICS, V6, P391, DOI [10.1038/NPHOTON.2012.104, 10.1038/nphoton.2012.104]; Nanduri D, 2012, INVEST OPHTH VIS SCI, V53, P205, DOI 10.1167/iovs.11-8401; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Rossi EA, 2010, NAT NEUROSCI, V13, P156, DOI 10.1038/nn.2465; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; SILVEIRA LCL, 1987, VISION RES, V27, P1719, DOI 10.1016/0042-6989(87)90101-5; Stingl K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0077; Strauss O, 1998, ACTA ANAT, V162, P101; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; VICTOR JD, 1977, P NATL ACAD SCI USA, V74, P3068, DOI 10.1073/pnas.74.7.3068; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wang LL, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046014; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Whitley E, 2002, CRIT CARE, V6, P335; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; Zrenner E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007399; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	49	208	211	4	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					476	U254		10.1038/nm.3851	http://dx.doi.org/10.1038/nm.3851			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25915832	Green Accepted, Green Submitted			2022-12-25	WOS:000354068800014
J	Goel, S; Palmkvist, M; Moll, K; Joannin, N; Lara, P; Akhouri, RR; Moradi, N; Ojemalm, K; Westman, M; Angeletti, D; Kjellin, H; Lehtio, J; Blixt, O; Idestrom, L; Gahmberg, CG; Storry, JR; Hult, AK; Olsson, ML; von Heijne, G; Nilsson, I; Wahlgren, M				Goel, Suchi; Palmkvist, Mia; Moll, Kirsten; Joannin, Nicolas; Lara, Patricia; Akhouri, Reetesh R.; Moradi, Nasim; Ojemalm, Karin; Westman, Mattias; Angeletti, Davide; Kjellin, Hanna; Lehtio, Janne; Blixt, Ola; Idestrom, Lars; Gahmberg, Carl G.; Storry, Jill R.; Hult, Annika K.; Olsson, Martin L.; von Heijne, Gunnar; Nilsson, IngMarie; Wahlgren, Mats			RIFINs are adhesins implicated in severe Plasmodium falciparum malaria	NATURE MEDICINE			English	Article							MEMBRANE-PROTEIN; CONSENSUS PREDICTION; TOPOLOGY PREDICTION; VARIANT PROTEINS; ERYTHROCYTE; FAMILY; RELIABILITY; EXPRESSION; PARASITES; SURFACE	Rosetting is a virulent Plasmodium falciparum phenomenon associated with severe malaria. Here we demonstrate that P. falciparum-encoded repetitive interspersed families of polypeptides (RIFINs) are expressed on the surface of infected red blood cells (iRBCs), bind to RBCs-preferentially of blood group A-to form large rosettes and mediate microvascular binding of iRBCs. We suggest that RIFINs have a fundamental role in the development of severe malaria and thereby contribute to the varying global distribution of ABO blood groups in the human population.	[Goel, Suchi; Palmkvist, Mia; Moll, Kirsten; Joannin, Nicolas; Akhouri, Reetesh R.; Westman, Mattias; Angeletti, Davide; Wahlgren, Mats] Karolinska Inst, Ctr Infect Dis Res, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Lara, Patricia; Moradi, Nasim; Ojemalm, Karin; von Heijne, Gunnar; Nilsson, IngMarie] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Kjellin, Hanna; Lehtio, Janne] Karolinska Inst, Dept Oncol, SciLifeLab, Stockholm, Sweden; [Kjellin, Hanna; Lehtio, Janne] Karolinska Inst, Dept Pathol, S-10401 Stockholm, Sweden; [Kjellin, Hanna; Lehtio, Janne] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Kjellin, Hanna; Lehtio, Janne] Karolinska Inst, Dept Surg, Stockholm, Sweden; [Blixt, Ola] Univ Copenhagen, Fac Sci, Dept Chem, Frederiksberg, Denmark; [Idestrom, Lars] Karolinska Univ Hosp, Dept Med Phys, Stockholm, Sweden; [Gahmberg, Carl G.] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, Helsinki, Finland; [Storry, Jill R.; Hult, Annika K.; Olsson, Martin L.] Lund Univ, Dept Lab Med, Hematol & Transfus Med, Lund, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; SciLifeLab; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; Lund University	Wahlgren, M (corresponding author), Karolinska Inst, Ctr Infect Dis Res, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	mats.wahlgren@ki.se	Angeletti, Davide/H-7350-2019; Gahmberg, Carl/AAE-1876-2019; Storry, Jill R/AAF-9130-2019; von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	Angeletti, Davide/0000-0002-5256-1972; Storry, Jill R/0000-0003-2940-2604; von Heijne, Gunnar/0000-0002-4490-8569; Blixt, Ola/0000-0003-4143-6276; Lehtio, Janne/0000-0002-8100-9562; Akhouri, Reetesh/0000-0001-5995-2418; Olsson, Martin L/0000-0003-1647-9610; Gahmberg, Carl/0000-0001-9892-9296	Swedish Strategic Foundation; EU Sixth-and Seventh-Framework Programs [MEST-CT-2004-8475]; Swedish Research Council [VR/2012-2014/521-2011-3377, VR/2011-2018/14251]; Soderberg Foundation; Swedish governmental ALF grants; Karolinska Institutet; Swedish Academy of Sciences, Swedish governmental ALF grants	Swedish Strategic Foundation; EU Sixth-and Seventh-Framework Programs; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Swedish governmental ALF grants; Karolinska Institutet(Karolinska Institutet); Swedish Academy of Sciences, Swedish governmental ALF grants	We thank B. Dobberstein (Ruprecht-Karls-Universitat, Heidelberg) for providing dog pancreas microsomes and O. Puijalon (Pasteur Institute, France) for the gift of mAb D15-50. 3-alpha-N-acetylgalactosaminidase (Azyme) and 3-alpha-galactosidase (Bzyme) were kindly provided by Henrik Clausen (Copenhagen Center for Glycomics). This study was supported by the Swedish Strategic Foundation to I.M.N. and M.W., the EU Sixth-and Seventh-Framework Programs (MEST-CT-2004-8475 and EviMalar Network of Excellence to I.M.N. and M.W.), the Swedish Research Council (VR/2012-2014/521-2011-3377 to M.W., VR/2011-2018/14251 to M.L.O.), the Soderberg Foundation and Swedish Academy of Sciences, Swedish governmental ALF grants to Lund University Healthcare to J.R.S. and M.L.O., and a Distinguished Professor Award from Karolinska Institutet to M.W. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2013, METHODS MALARIA RES; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; GAHMBERG CG, 1976, J BIOL CHEM, V251, P6108; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; JOHANSSON HE, 1993, NUCLEIC ACIDS RES, V21, P2275, DOI 10.1093/nar/21.9.2275; Kall L, 2002, FEBS LETT, V532, P415, DOI 10.1016/S0014-5793(02)03730-4; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mok BW, 2007, MOL BIOCHEM PARASIT, V151, P184, DOI 10.1016/j.molbiopara.2006.11.006; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Pettersson F, 2005, INFECT IMMUN, V73, P7736, DOI 10.1128/IAI.73.11.7736-7746.2005; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781	37	130	133	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					314	+		10.1038/nm.3812	http://dx.doi.org/10.1038/nm.3812			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25751816				2022-12-25	WOS:000352493600012
J	Miyazaki, M; Chiba, M; Eguchi, H; Ohki, T; Ishiwata, S				Miyazaki, Makito; Chiba, Masataka; Eguchi, Hiroki; Ohki, Takashi; Ishiwata, Shin'ichi			Cell-sized spherical confinement induces the spontaneous formation of contractile actomyosin rings in vitro	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENTS; MYOSIN-II; ALPHA-ACTININ; F-ACTIN; THERMAL FLUCTUATIONS; ATP-ACTIN; ADP-ACTIN; CYTOKINESIS; MECHANISM; DIVISION	During cell division, many animal cells transform into a spherical shape and assemble a contractile ring composed of actin filaments and myosin motors at the equator to separate the cell body into two. Although actomyosin regulatory proteins are spatio-temporally controlled during cytokinesis, the direct contribution of cell shape and actomyosin activity to the contractile ring assembly remains unclear. Here, we demonstrated in vitro that actin polymerization inside cell-sized spherical droplets induced the spontaneous formation of single ring-shaped actin bundles in the presence of bundling factors. Despite a lack of spatial regulatory signals, the rings always assembled at the equator to minimize the elastic energy of the bundles. Myosin promoted ring formation by the dynamic remodelling of actin networks, and an increase in the effective concentration of myosin triggered ring contraction. These results will help us understand how animal cells coordinate cell shape and actomyosin activities to direct cytokinesis.	[Miyazaki, Makito; Chiba, Masataka; Eguchi, Hiroki; Ohki, Takashi; Ishiwata, Shin'ichi] Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; [Ishiwata, Shin'ichi] Waseda Biosci Res Inst Singapore WABIOS, Singapore 138667, Singapore	Waseda University	Ishiwata, S (corresponding author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	ishiwata@waseda.jp		Miyazaki, Makito/0000-0002-4603-851X	Japan Science Society; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21000011] Funding Source: KAKEN	Japan Science Society; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kinosita Jr, K. Takiguchi and K. Yoshikawa for helpful discussions, and H. Kubota, K. Sato and S. Ishii for actin preparation. This work was supported in part by a Sasakawa Scientific Research Grant from The Japan Science Society (M.M.), Grants-in-Aid for Young Scientists (B) and Scientific Research on Innovative Areas (M.M.), and Grants-in-Aid for Specially Promoted Research and Scientific Research (S) (S.I.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alvarado J, 2013, NAT PHYS, V9, P591, DOI [10.1038/nphys2715, 10.1038/NPHYS2715]; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Carvalho A, 2009, CELL, V137, P926, DOI 10.1016/j.cell.2009.03.021; Chiba M, 2014, BIOPHYS J, V107, P346, DOI 10.1016/j.bpj.2014.05.039; Claessens MMAE, 2006, NAT PHYS, V2, P186, DOI 10.1038/nphys241; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Falzone TT, 2013, BIOPHYS J, V104, P1709, DOI 10.1016/j.bpj.2013.01.017; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; FUJIME S, 1970, J PHYS SOC JPN, V29, P751, DOI 10.1143/JPSJ.29.751; FUJIME S, 1971, J MOL BIOL, V62, P251, DOI 10.1016/0022-2836(71)90144-6; FUJIWARA K, 1978, J CELL BIOL, V79, P268, DOI 10.1083/jcb.79.1.268; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; HARRIS A, 1973, DEV BIOL, V35, P97, DOI 10.1016/0012-1606(73)90009-2; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Hase M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2174004; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kondo T, 2013, NATURE, V494, P125, DOI 10.1038/nature11792; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Laporte D, 2012, MOL BIOL CELL, V23, P3094, DOI 10.1091/mbc.E12-02-0123; MABUCHI I, 1985, J CELL BIOL, V100, P375, DOI 10.1083/jcb.100.2.375; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MAUPIN P, 1986, J ULTRA MOL STRUCT R, V94, P92, DOI 10.1016/0889-1605(86)90055-8; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Mishra M, 2013, NAT CELL BIOL, V15, P853, DOI 10.1038/ncb2781; Mishra M, 2012, J CELL SCI, V125, P3850, DOI 10.1242/jcs.103788; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Negishi M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051921; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Ohki T, 2012, J MUSCLE RES CELL M, V33, P351, DOI 10.1007/s10974-012-9323-8; Pinto IM, 2013, BIOPHYS J, V105, P547, DOI 10.1016/j.bpj.2013.06.033; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; SANGER JM, 1980, J CELL BIOL, V86, P568, DOI 10.1083/jcb.86.2.568; SANGER JM, 1984, CELL TISSUE RES, V237, P409; SCHROEDER TE, 1972, J CELL BIOL, V53, P419, DOI 10.1083/jcb.53.2.419; Silva MSE, 2011, SOFT MATTER, V7, P10631, DOI 10.1039/c1sm06060k; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520, DOI 10.1093/oxfordjournals.jbchem.a123414; Tanaka-Takiguchi Y, 2004, J MOL BIOL, V341, P467, DOI 10.1016/j.jmb.2004.06.019; Thoresen T, 2013, BIOPHYS J, V104, P655, DOI 10.1016/j.bpj.2012.12.042; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783; Zumdieck A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000696	62	84	84	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					480	+		10.1038/ncb3142	http://dx.doi.org/10.1038/ncb3142			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25799060				2022-12-25	WOS:000351920500018
J	Rozbicki, E; Chuai, M; Karjalainen, AI; Song, FF; Sang, HM; Martin, R; Knolker, HJ; MacDonald, MP; Weijer, CJ				Rozbicki, Emil; Chuai, Manli; Karjalainen, Antti I.; Song, Feifei; Sang, Helen M.; Martin, Rene; Knoelker, Hans-Joachim; MacDonald, Michael P.; Weijer, Cornelis J.			Myosin-II-mediated cell shape changes and cell intercalation contribute to primitive streak formation	NATURE CELL BIOLOGY			English	Article							MULTICELLULAR ROSETTE FORMATION; PLANAR POLARITY; MESENCHYMAL TRANSITION; EMBRYONIC-DEVELOPMENT; CHICK; GASTRULATION; INHIBITORS; MECHANISM; DYNAMICS; PATTERNS	Primitive streak formation in the chick embryo involves large-scale highly coordinated flows of more than 100,000 cells in the epiblast. These large-scale tissue flows and deformations can be correlated with specific anisotropic cell behaviours in the forming mesendoderm through a combination of light-sheet microscopy and computational analysis. Relevant behaviours include apical contraction, elongation along the apical-basal axis followed by ingression, and asynchronous directional cell intercalation of small groups of mesendoderm cells. Cell intercalation is associated with sequential, directional contraction of apical junctions, the onset, localization and direction of which correlate strongly with the appearance of active myosin II cables in aligned apical junctions in neighbouring cells. Use of class specific myosin inhibitors and gene-specific knockdown shows that apical contraction and intercalation are myosin II dependent and also reveal critical roles for myosin I and myosin V family members in the assembly of junctional myosin II cables.	[Rozbicki, Emil; Chuai, Manli; Karjalainen, Antti I.; Weijer, Cornelis J.] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland; [Song, Feifei; Sang, Helen M.] Univ Edinburgh, Royal Dick Sch Vet Sci, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Martin, Rene; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Med, D-01069 Dresden, Germany; [MacDonald, Michael P.] Univ Dundee, Sch Engn Phys & Math, Div Phys, Dundee DD1 4HN, Scotland; [MacDonald, Michael P.] Univ Dundee, Sch Med, Inst Med Sci & Technol, Dundee DD2 1FD, Scotland	University of Dundee; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Technische Universitat Dresden; University of Dundee; University of Dundee	Sang, HM (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Sci, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland.	helen.sang@roslin.ed.ac.uk; m.p.macdonald@dundee.ac.uk; c.j.weijer@dundee.ac.uk	Knölker, Hans-Joachim/I-4954-2019; MacDonald, Michael P/F-5880-2011	Knölker, Hans-Joachim/0000-0002-9631-5239; MacDonald, Michael P/0000-0003-4415-5437; Weijer, Cornelis/0000-0003-2192-8150	BBSRC [BB/E011276/1, BB/G015082/1]; Wellcome Trust [094131/Z/10/Z]; NERC [R8/H10/56]; MRC [MR/K001744/1]; Biotechnology and Biological Sciences Research Council [BB/G015082/1, BB/K00204X/1, BBS/E/D/20320000, BBS/E/R/00001603, 1101416, BBS/E/D/20221658, BBS/E/D/20310000, BB/E011276/1] Funding Source: researchfish; Medical Research Council [G0900740, MR/K001744/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish; BBSRC [BBS/E/D/20320000, BBS/E/R/00001603, BB/K00204X/1, BBS/E/D/20310000, BBS/E/D/20221658] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank E. Stelzer and P. Keller for advice on the construction of LSMs, and A. Sherman, F. Thomson, M. Hutchison and R. Mitchell for support in generation and breeding of the transgenic chick lino and supplying tins fertilized transgenic eggs. This work was supported by BBSRC (BB/E011276/1) to H.M.S. and C.J.W (BB/G015082/1) and to C.J.W. and M.P.M., Institute Grant funding to H.M.S., Wellcome Trust (094131/Z/10/Z) to C.J.W. RNA sequencing was carried out by Edinburgh Genomics, The University of Edinhurgh. Edinburgh Genomics is partly supported through core grants from NERC(R8/H10/56), MRC (MR/K001744/1) and BBSRC (BB/J004243/1).	Alev C, 2013, DEVELOPMENT, V140, P2691, DOI 10.1242/dev.094318; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; Amat F, 2013, BIOINFORMATICS, V29, P373, DOI 10.1093/bioinformatics/bts706; Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Bond LM, 2013, FUTURE MED CHEM, V5, P41, DOI 10.4155/fmc.12.185; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Chinthalapudi K, 2011, J BIOL CHEM, V286, P29700, DOI 10.1074/jbc.M111.239210; Chuai M, 2008, CURR TOP DEV BIOL, V81, P135, DOI 10.1016/S0070-2153(07)81004-0; Chuai ML, 2006, DEV BIOL, V296, P137, DOI 10.1016/j.ydbio.2006.04.451; Chuai M, 2012, CURR GENOMICS, V13, P267, DOI 10.2174/138920212800793357; Cui C, 2005, DEV BIOL, V284, P37, DOI 10.1016/j.ydbio.2005.04.021; Czirok A, 2004, DEV BIOL, V268, P111, DOI 10.1016/j.ydbio.2003.09.040; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; DOWNIE JR, 1976, J EMBRYOL EXP MORPH, V35, P559; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Fedorov R, 2009, NAT STRUCT MOL BIOL, V16, P80, DOI 10.1038/nsmb.1542; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Graeper L., 1929, ROUX ARCH DEV BIOL, V116, P382; Graner F, 2008, EUR PHYS J E, V25, P349, DOI 10.1140/epje/i2007-10298-8; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Heller E, 2014, DEV CELL, V28, P617, DOI 10.1016/j.devcel.2014.02.011; Honda H, 2008, DEV DYNAM, V237, P1826, DOI 10.1002/dvdy.21609; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Manning AJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004427; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Mulchrone KF, 2004, J STRUCT GEOL, V26, P143, DOI 10.1016/S0191-8141(03)00093-2; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Rozbicki E., 2015, NAT PROTOC EXCH; Sandersius SA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045008; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Stern C.D., 2004, GASTRULATION CELLS E; Stern CD, 2012, DEVELOPMENT, V139, P1059, DOI 10.1242/dev.070730; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Thielicke W., 2014, J OPEN RES STW, V2, pe30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Tomer R, 2011, CURR OPIN GENET DEV, V21, P558, DOI 10.1016/j.gde.2011.07.003; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Voiculescu O, 2014, ELIFE, V3, DOI 10.7554/eLife.01817; Wagstaff LJ, 2008, DEV DYNAM, V237, P91, DOI 10.1002/dvdy.21390; Warrington SJ, 2013, DEVELOPMENT, V140, P1045, DOI 10.1242/dev.088724; Wei Y, 2000, DEVELOPMENT, V127, P87; WEINBERGER C, 1982, ROUX ARCH DEV BIOL, V191, P127, DOI 10.1007/BF00848450; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711; Yanagawa N, 2011, DEV GROWTH DIFFER, V53, P366, DOI 10.1111/j.1440-169X.2010.01244.x; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247	70	109	109	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					397	+		10.1038/ncb3138	http://dx.doi.org/10.1038/ncb3138			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25812521	Green Accepted			2022-12-25	WOS:000351920500010
J	Shukla, SA; Rooney, MS; Rajasagi, M; Tiao, G; Dixon, PM; Lawrence, MS; Stevens, J; Lane, WJ; Dellagatta, JL; Steelman, S; Sougnez, C; Cibulskis, K; Kiezun, A; Hacohen, N; Brusic, V; Wu, CJ; Getz, G				Shukla, Sachet A.; Rooney, Michael S.; Rajasagi, Mohini; Tiao, Grace; Dixon, Philip M.; Lawrence, Michael S.; Stevens, Jonathan; Lane, William J.; Dellagatta, Jamie L.; Steelman, Scott; Sougnez, Carrie; Cibulskis, Kristian; Kiezun, Adam; Hacohen, Nir; Brusic, Vladimir; Wu, Catherine J.; Getz, Gad			Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes	NATURE BIOTECHNOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR TYPES; T-CELLS; MOLECULES; DISCOVERY; RNA; IMMUNOTHERAPY; LANDSCAPE; CARCINOMA; ALLELE	Detection of somatic mutations in human leukocyte antigen (HLA) genes using whole-exome sequencing (WES) is hampered by the high polymorphism of the HLA loci, which prevents alignment of sequencing reads to the human reference genome. We describe a computational pipeline that enables accurate inference of germline alleles of class I HLA-A, B and C genes and subsequent detection of mutations in these genes using the inferred alleles as a reference. Analysis of WES data from 7,930 pairs of tumor and healthy tissue from the same patient revealed 298 nonsilent HLA mutations in tumors from 266 patients. These 298 mutations are enriched for likely functional mutations, including putative loss-of-function events. Recurrence of mutations suggested that these 'hotspot' sites were positively selected. Cancers with recurrent somatic HLA mutations were associated with upregulation of signatures of cytolytic activity characteristic of tumor infiltration by effector lymphocytes, supporting immune evasion by altered HLA function as a contributory mechanism in cancer.	[Shukla, Sachet A.; Rajasagi, Mohini; Brusic, Vladimir; Wu, Catherine J.] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Shukla, Sachet A.; Rooney, Michael S.; Tiao, Grace; Lawrence, Michael S.; Steelman, Scott; Sougnez, Carrie; Cibulskis, Kristian; Kiezun, Adam; Hacohen, Nir; Wu, Catherine J.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Shukla, Sachet A.; Dixon, Philip M.] Iowa State Univ, Dept Stat, Ames, IA USA; [Rooney, Michael S.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Rajasagi, Mohini; Brusic, Vladimir; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevens, Jonathan; Lane, William J.; Dellagatta, Jamie L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lane, William J.] Harvard Univ, Sch Med, Boston, MA USA; [Hacohen, Nir; Wu, Catherine J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Getz, Gad] Dept Pathol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Iowa State University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wu, CJ (corresponding author), Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA.	cwu@partners.org; gadgetz@broadinstitute.org	Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019; Dixon, Philip Michael/I-4843-2019; Brusic, Vladimir/B-1478-2008	Dixon, Philip Michael/0000-0002-1778-0686; Brusic, Vladimir/0000-0003-0523-5266; Cibulskis, Kristian/0000-0003-1343-1582	Blavatnik Family Foundation; American Association for Cancer Research (AACR) (SU2C Innovative Research Grant); National Heart, Lung, and Blood Institute (NHLBI) [1RO1HL103532-01]; National Cancer Institute (NCI) [1R01CA155010-01A1]; NATIONAL CANCER INSTITUTE [R01CA155010, U24CA143845] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103532] Funding Source: NIH RePORTER	Blavatnik Family Foundation; American Association for Cancer Research (AACR) (SU2C Innovative Research Grant); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	C.J.W. is a Scholar of the Leukemia and Lymphoma Society and acknowledges support from the Blavatnik Family Foundation, American Association for Cancer Research (AACR) (SU2C Innovative Research Grant), National Heart, Lung, and Blood Institute (NHLBI) (1RO1HL103532-01) and National Cancer Institute (NCI) (1R01CA155010-01A1). This work has made extensive use of data generated by TCGA, a project of the National Cancer Institute and National Human Genome Research Institute. We thank E. Hodis for providing access to the melanoma data. We would also like to thank C. McCowan (Broad Technology Labs), T. Shea (Broad Technology Labs), S. Young (Broad Technology Labs) and M. Weiand (Pacific Biosciences) for their help in setting up, performing and analyzing data using Pacific Biosciences RSII instruments. We are grateful to E. Fritsch for critical reading of the manuscript and providing valuable feedback.	Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-325; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Boegel S, 2012, GENOME MED, V4, DOI 10.1186/gm403; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bubenik J, 2004, INT J ONCOL, V25, P487; Cao HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069388; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Danzer M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-221; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; FAYEN J, 1995, MOL IMMUNOL, V32, P267, DOI 10.1016/0161-5890(94)00149-U; FERNANDEZVINA MA, 1992, HUM IMMUNOL, V33, P163, DOI 10.1016/0198-8859(92)90068-X; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Irimia M, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016071; Jimenez P, 2001, IMMUNOGENETICS, V53, P606, DOI 10.1007/s002510100371; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067885; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lank SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-378; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Norgaard L, 1999, TISSUE ANTIGENS, V54, P370, DOI 10.1034/j.1399-0039.1999.540406.x; Omberg L, 2013, NAT GENET, V45, P1121, DOI 10.1038/ng.2761; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pittet MJ, 2003, J IMMUNOL, V171, P1844, DOI 10.4049/jimmunol.171.4.1844; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; TIERCY JM, 1994, HUM IMMUNOL, V41, P207, DOI 10.1016/0198-8859(94)90038-8; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Warren RL, 2012, GENOME MED, V4, DOI 10.1186/gm396; Welsh K, 1999, Rev Immunogenet, V1, P157; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	47	361	373	5	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1152	U71		10.1038/nbt.3344	http://dx.doi.org/10.1038/nbt.3344			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26372948	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000364916000020
J	Filipczyk, A; Marr, C; Hastreiter, S; Feigelman, J; Schwarzfischee, M; Hoppe, PS; Loeffler, D; Kokkaliaris, KD; Endele, M; Schauberger, B; Hilsenbeck, O; Skylaki, S; Hasenauer, J; Anastassiadis, K; Theis, FJ; Schroeder, T				Filipczyk, Adam; Marr, Carsten; Hastreiter, Simon; Feigelman, Justin; Schwarzfischee, Michael; Hoppe, Philipp S.; Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Endele, Max; Schauberger, Bernhard; Hilsenbeck, Oliver; Skylaki, Stavroula; Hasenauer, Jan; Anastassiadis, Konstantinos; Theis, Fabian J.; Schroeder, Timm			Network plasticity of pluripotency transcription factors in embryonic stem cells	NATURE CELL BIOLOGY			English	Article							SELF-RENEWAL; NANOG AUTOREPRESSION; SIGNALING PATHWAYS; GENE-EXPRESSION; GROUND-STATE; DIFFERENTIATION; PROTEIN; OCT4; FATE; IDENTIFICATION	Transcription factor (TF) networks are thought to regulate embryonic stem cell (ESC) pluripotency. However, TF expression dynamics and regulatory mechanisms are poorly understood. We use reporter mouse ESC lines allowing non-invasive quantification of Nanog or Oct4 protein levels and continuous long-term single-cell tracking and quantification over many generations to reveal diverse TF protein expression dynamics. For cells with low Nanog expression, we identified two distinct colony types: one re-expressed Nanog in a mosaic pattern, and the other did not re-express Nanog over many generations. Although both expressed pluripotency markers, they exhibited differences in their TF protein correlation networks and differentiation propensities. Sister cell analysis revealed that differences in Nanog levels are not necessarily accompanied by differences in the expression of other pluripotency factors. Thus, regulatory interactions of pluripotency TFs are less stringently implemented in individual self-renewing ESCs than assumed at present.	[Filipczyk, Adam; Hastreiter, Simon; Hoppe, Philipp S.; Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Endele, Max; Schauberger, Bernhard; Hilsenbeck, Oliver; Skylaki, Stavroula; Schroeder, Timm] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Stem Cell Dynam, D-85764 Neuherberg, Germany; [Marr, Carsten; Feigelman, Justin; Schwarzfischee, Michael; Schauberger, Bernhard; Hilsenbeck, Oliver; Hasenauer, Jan; Theis, Fabian J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Hastreiter, Simon; Hoppe, Philipp S.; Loeffler, Dirk; Kokkaliaris, Konstantinos D.; Endele, Max; Hilsenbeck, Oliver; Skylaki, Stavroula; Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Hasenauer, Jan; Theis, Fabian J.] Tech Univ Munich, Ctr Math, Chair Math Modelling Biol Syst, D-85748 Garching, Germany; [Anastassiadis, Konstantinos] Tech Univ Dresden, Stem Cell Engn, Inst Biotechnol, D-01307 Dresden, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich; Technische Universitat Dresden	Theis, FJ (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Computat Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	fabian.theis@helmholtz-muenchen.de; timm.schroeder@bsse.ethz.ch	Marr, Carsten/B-3696-2013; Theis, Fabian J/ABD-5212-2021; Kokkaliaris, Konstantinos/GWQ-3400-2022; Anastassiadis, Konstantinos/A-8944-2010; Hasenauer, Jan/B-8853-2013	Marr, Carsten/0000-0003-2154-4552; Theis, Fabian J/0000-0002-2419-1943; Anastassiadis, Konstantinos/0000-0002-9814-0559; Hasenauer, Jan/0000-0002-4935-3312; KOKKALIARIS, KONSTANTINOS/0000-0002-9952-3463; Loeffler, Dirk/0000-0001-9870-0088; Schroeder, Timm/0000-0001-9320-0252; Schauberger, Bernhard/0000-0001-7917-0392	German Federal Ministry of Education and Research (BMBF); European Research Council starting grant; BioSysNet (Bavarian Research Network for Molecular Biosystems); International Human Frontier Science Program Organization; German Research Foundation (DFG) [SPPs 1395, 1356]; SystemsX.ch	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Research Council starting grant(European Research Council (ERC)); BioSysNet (Bavarian Research Network for Molecular Biosystems); International Human Frontier Science Program Organization(Human Frontier Science Program); German Research Foundation (DFG)(German Research Foundation (DFG)); SystemsX.ch	We thank C. Raithel, A. Ziegler, S. Ammersdorfer and B. Vogel for technical support, M. Strasser and F. Buggenthin for helpful discussions and T. Hilger for statistical advice. This work was supported by the German Federal Ministry of Education and Research (BMBF), the European Research Council starting grant (Latent Causes), the BioSysNet (Bavarian Research Network for Molecular Biosystems), the International Human Frontier Science Program Organization, and by the German Research Foundation (DFG) within the SPPs 1395 and 1356. S. S. and O. H. acknowledge financial support for this project from SystemsX.ch.	Abranches E, 2014, DEVELOPMENT, V141, P2770, DOI 10.1242/dev.108910; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Ciotta G, 2011, METHODS, V53, P113, DOI 10.1016/j.ymeth.2010.09.003; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Feigelman J, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-240; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Garcia-Ojalvo J, 2012, CURR OPIN GENET DEV, V22, P619, DOI 10.1016/j.gde.2012.10.004; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Herberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092496; Hofemeister H, 2011, METHODS, V53, P437, DOI 10.1016/j.ymeth.2010.12.026; Hoppe PS, 2014, NAT CELL BIOL, V16, P919, DOI 10.1038/ncb3042; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klein S, 2009, INT J COMPUT VISION, V81, P227, DOI 10.1007/s11263-008-0168-y; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Lauritzen S.L, 1996, GRAPHICAL MODELS; Lauritzen Steffen L., 1996, OXFORD STAT SCI SERI, V17; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Descalzo SM, 2012, STEM CELLS, V30, P2683, DOI 10.1002/stem.1230; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ochiai H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07125; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/NMETH.1577, 10.1038/nmeth.1577]; Schwarzfischer M., 2011, P MICR IM AN APPL BI; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Som A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015165; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Trott J, 2012, MOL BIOSYST, V8, P744, DOI 10.1039/c1mb05398a; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xu HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003777; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	73	86	87	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1235	+		10.1038/ncb3237	http://dx.doi.org/10.1038/ncb3237			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26389663				2022-12-25	WOS:000362213500004
J	Kessel, M				Kessel, Mark			Why microbial diagnostics need more than money	NATURE BIOTECHNOLOGY			English	Letter									FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics	Kessel, M (corresponding author), FIND, Geneva, Switzerland.	mark.kessel@shearman.com						Davies S., 2015, WISH 2015 POLICY BRI; Hwang TJ, 2015, NAT BIOTECHNOL, V33, P589, DOI 10.1038/nbt.3251; International Federation of Pharmaceutical Manufacturers and Associations, 2015, RETH WAY WE FIGHT BA; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1	4	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					898	900		10.1038/nbt.3328	http://dx.doi.org/10.1038/nbt.3328			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348950				2022-12-25	WOS:000360990900008
J	Alizadeh, AA; Aranda, V; Bardelli, A; Blanpain, C; Bock, C; Borowski, C; Caldas, C; Califano, A; Doherty, M; Elsner, M; Esteller, M; Fitzgerald, R; Korbel, JO; Lichter, P; Mason, CE; Navin, N; Pe'er, D; Polyak, K; Roberts, CWM; Siu, L; Snyder, A; Stower, H; Swanton, C; Verhaak, RGW; Zenklusen, JC; Zuber, J; Zucman-Rossi, J				Alizadeh, Ash A.; Aranda, Victoria; Bardelli, Alberto; Blanpain, Cedric; Bock, Christoph; Borowski, Christine; Caldas, Carlos; Califano, Andrea; Doherty, Michael; Elsner, Markus; Esteller, Manel; Fitzgerald, Rebecca; Korbel, Jan O.; Lichter, Peter; Mason, Christopher E.; Navin, Nicholas; Pe'er, Dana; Polyak, Kornelia; Roberts, Charles W. M.; Siu, Lillian; Snyder, Alexandra; Stower, Hannah; Swanton, Charles; Verhaak, Roel G. W.; Zenklusen, Jean C.; Zuber, Johannes; Zucman-Rossi, Jessica			Toward understanding and exploiting tumor heterogeneity	NATURE MEDICINE			English	Article							INTRATUMOR HETEROGENEITY; CELLS; RNA; RESISTANCE; EVOLUTION; PATIENT; PREDICT; GENOME; DNA	The extent of tumor heterogeneity is an emerging theme that researchers are only beginning to understand. How genetic and epigenetic heterogeneity affects tumor evolution and clinical progression is unknown. The precise nature of the environmental factors that influence this heterogeneity is also yet to be characterized. Nature Medicine, Nature Biotechnology and the Volkswagen Foundation organized a meeting focused on identifying the obstacles that need to be overcome to advance translational research in and tumor heterogeneity. Once these key questions were established, the attendees devised potential solutions. Their ideas are presented here.	[Alizadeh, Ash A.] Stanford Univ, Div Oncol, Dept Med, Sch Med, Stanford, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Div Hematol, Dept Med, Sch Med, Stanford, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Inst Canc, Dept Med, Sch Med, Stanford, CA 94305 USA; [Aranda, Victoria; Borowski, Christine] Nat Med, New York, NY 10021 USA; [Bardelli, Alberto] Univ Turin, Dept Oncol, Turin, Italy; [Bardelli, Alberto] IRCCS, Candiolo Canc Inst, FPO, Turin, Italy; [Blanpain, Cedric] ULB, Brussels, Belgium; [Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge, England; [Califano, Andrea; Pe'er, Dana] Columbia Univ, Dept Syst Biol, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Doherty, Michael] Genentech Inc, San Francisco, CA USA; [Elsner, Markus] Nat Biotechnol, New York, NY USA; [Esteller, Manel] Bellvitge Biomed Res Inst, Canc Epigenet & Biol Program, Barcelona, Catalonia, Spain; [Fitzgerald, Rebecca] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge, England; [Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, D-69012 Heidelberg, Germany; [Lichter, Peter] DKFZ, German Canc Res Ctr, Heidelberg, Germany; [Mason, Christopher E.] Weill Cornell Med Coll, New York, NY USA; [Navin, Nicholas] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Navin, Nicholas; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Roberts, Charles W. M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Siu, Lillian] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Snyder, Alexandra] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Swanton, Charles] UCL, Inst Canc, London, England; [Swanton, Charles] Univ Coll London Hosp NHS Fdn Trust, London, England; [Swanton, Charles] Francis Crick Inst, London, England; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Zenklusen, Jean C.] NCI, Canc Genome Atlas Ctr Canc Gen, Bethesda, MD 20892 USA; [Zuber, Johannes] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Zucman-Rossi, Jessica] IUH, Inserm, UMR Genom Fonct Tumeurs Solides 1162, Paris, France	Stanford University; Stanford University; Stanford University; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Universite Libre de Bruxelles; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Cambridge; Columbia University; Columbia University; Columbia University; Roche Holding; Genentech; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Cornell University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Memorial Sloan Kettering Cancer Center; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Francis Crick Institute; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stower, H (corresponding author), Nat Med, New York, NY 10021 USA.	h.stower@us.nature.com	Blanpain, Cedric/ABD-8392-2021; Verhaak, Roel/ABE-7058-2020; Alizadeh, Ash A/C-5594-2009; Bock, Christoph/AAE-7618-2019; Mason, Christopher/HCH-3977-2022; Zuber, Johannes/E-7517-2011; Roberts, Charles/N-2541-2018; j, zucman-rossi/AAV-3594-2021; zucman-rossi, Jessica/B-5098-2009; Esteller, Manel/L-5956-2014; Caldas, Carlos/U-7250-2019; BARDELLI, Alberto/J-9721-2018	Alizadeh, Ash A/0000-0002-5153-5625; Bock, Christoph/0000-0001-6091-3088; Zuber, Johannes/0000-0001-8810-6835; Roberts, Charles/0000-0003-1135-1896; j, zucman-rossi/0000-0002-5687-0334; zucman-rossi, Jessica/0000-0002-5687-0334; Esteller, Manel/0000-0003-4490-6093; Caldas, Carlos/0000-0003-3547-1489; Califano, Andrea/0000-0003-4742-3679; BARDELLI, Alberto/0000-0003-1647-5070; Elsner, Markus/0000-0001-7227-5212; Fitzgerald, Rebecca/0000-0002-3434-3568; Swanton, Charles/0000-0002-4299-3018; Snyder Charen, Alexandra/0000-0002-2606-3523; Pe'er, Dana/0000-0002-9259-8817	NCI NIH HHS [P30 CA016672, U01 CA194389, R01 CA169244] Funding Source: Medline; Cancer Research UK [16942, 17786, 19310] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish; Rosetrees Trust [M179] Funding Source: researchfish; The Francis Crick Institute [10172, 10174, 10359, 10170, 10303, 10169] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA169244] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Bansal M, 2014, NAT BIOTECHNOL, V32, P1213, DOI 10.1038/nbt.3052; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Biasi AR, 2014, CLIN CANCER RES, V20, P5384, DOI 10.1158/1078-0432.CCR-14-1298; Dey SS, 2015, NAT BIOTECHNOL, V33, P285, DOI 10.1038/nbt.3129; Eggermont AMM, 2014, EUR J CANCER, V50, P2745, DOI 10.1016/j.ejca.2014.07.025; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lee JH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.191; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Li S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0472-5; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; Pan XH, 2013, P NATL ACAD SCI USA, V110, P594, DOI 10.1073/pnas.1217322109; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095; Zardavas D, 2015, NAT REV CLIN ONCOL, V12, P381, DOI 10.1038/nrclinonc.2015.73	36	432	444	13	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					846	853		10.1038/nm.3915	http://dx.doi.org/10.1038/nm.3915			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26248267	Green Accepted, Green Submitted			2022-12-25	WOS:000359181000009
J	Bondeson, DP; Mares, A; Smith, IED; Ko, E; Campos, S; Miah, AH; Mulholland, KE; Routly, N; Buckley, DL; Gustafson, JL; Zinn, N; Grandi, P; Shimamura, S; Bergamini, G; Faelth-Savitski, M; Bantscheff, M; Cox, C; Gordon, DA; Willard, RR; Flanagan, JJ; Casillas, LN; Votta, BJ; den Besten, W; Famm, K; Kruidenier, L; Carter, PS; Harling, JD; Churcher, I; Crews, CM				Bondeson, Daniel P.; Mares, Alina; Smith, Ian E. D.; Ko, Eunhwa; Campos, Sebastien; Miah, Afjal H.; Mulholland, Katie E.; Routly, Natasha; Buckley, Dennis L.; Gustafson, Jeffrey L.; Zinn, Nico; Grandi, Paola; Shimamura, Satoko; Bergamini, Giovanna; Faelth-Savitski, Maria; Bantscheff, Marcus; Cox, Carly; Gordon, Deborah A.; Willard, Ryan R.; Flanagan, John J.; Casillas, Linda N.; Votta, Bartholomew J.; den Besten, Willem; Famm, Kristoffer; Kruidenier, Laurens; Carter, Paul S.; Harling, John D.; Churcher, Ian; Crews, Craig M.			Catalytic in vivo protein knockdown by small-molecule PROTACs	NATURE CHEMICAL BIOLOGY			English	Article							ESTROGEN-RECEPTOR-ALPHA; ABSOLUTE QUANTIFICATION; CHEMICAL PROTEOMICS; CHIMERIC MOLECULES; KINASE INHIBITORS; CARD15 MUTATIONS; STRUCTURAL BASIS; LIGASE COMPLEX; BLAU-SYNDROME; CELL-DEATH	The current predominant therapeutic paradigm is based on maximizing drug-receptor occupancy to achieve clinical benefit. This strategy, however, generally requires excessive drug concentrations to ensure sufficient occupancy, often leading to adverse side effects. Here, we describe major improvements to the proteolysis targeting chimeras (PROTACs) method, a chemical knockdown strategy in which a heterobifunctional molecule recruits a specific protein target to an E3 ubiquitin ligase, resulting in the target's ubiquitination and degradation. These compounds behave catalytically in their ability to induce the ubiquitination of super-stoichiometric quantities of proteins, providing efficacy that is not limited by equilibrium occupancy. We present two PROTACs that are capable of specifically reducing protein levels by >90% at nanomolar concentrations. In addition, mouse studies indicate that they provide broad tissue distribution and knockdown of the targeted protein in tumor xenografts. Together, these data demonstrate a protein knockdown system combining many of the favorable properties of small-molecule agents with the potent protein knockdown of RNAi and CRISPR.	[Bondeson, Daniel P.; Ko, Eunhwa; Buckley, Dennis L.; Gustafson, Jeffrey L.; Cox, Carly; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Mares, Alina; Smith, Ian E. D.; Campos, Sebastien; Miah, Afjal H.; Mulholland, Katie E.; Routly, Natasha; Famm, Kristoffer; Kruidenier, Laurens; Carter, Paul S.; Harling, John D.; Churcher, Ian] GSK Med Res Ctr, Stevenage, Herts, England; [Zinn, Nico; Grandi, Paola; Shimamura, Satoko; Bergamini, Giovanna; Faelth-Savitski, Maria; Bantscheff, Marcus] A GSK Co, Cellzome, Heidelberg, Germany; [Gordon, Deborah A.; Willard, Ryan R.; Flanagan, John J.] Arvinas Inc, New Haven, CT USA; [Casillas, Linda N.; Votta, Bartholomew J.] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance, Collegeville, PA USA; [den Besten, Willem] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT USA; [Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT USA	Yale University; GlaxoSmithKline; GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; California Institute of Technology; Yale University; Yale University	Bondeson, DP (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ian.2.churcher@gsk.com; craig.crews@yale.edu	Bantscheff, Marcus/AAQ-2903-2021; Crews, Craig M./ABH-9346-2020; Casillas, Linda/S-5458-2018	Bantscheff, Marcus/0000-0002-8343-8977; Crews, Craig M./0000-0002-8456-2005; Campos, Sebastien/0000-0003-1717-5918; Casillas, Linda/0000-0002-1927-1156; Bergamini, Giovanna/0000-0002-9662-9502	US National Institutes of Health [AI084140, T32GM067543, T32GM007223]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067543, T32GM007223] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Mueller and D. Poeckel for cell culture support; S. Melchert, E. Stonehouse, A. Lachert, J. Cox, M. Leveridge, C. Pancevac and M. Jundt for biochemistry and sample preparation support; M. Boesche, T. Rudi, M. Kloes-Hudak and K. Kammerer for mass spectrometry support; and S. Gade for data analysis support. This research was partially supported by US National Institutes of Health grants AI084140, T32GM067543 and T32GM007223.	Adjei AA, 2006, J CLIN ONCOL, V24, P4054, DOI 10.1200/JCO.2006.07.4658; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Becher I, 2014, ACS CHEM BIOL, V9, P1736, DOI 10.1021/cb500235n; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Bradner JE, 2006, CHEM BIOL, V13, P493, DOI 10.1016/j.chembiol.2006.03.004; Buckley DL, 2014, ANGEW CHEM INT EDIT, V53, P2312, DOI 10.1002/anie.201307761; Buckley DL, 2012, ANGEW CHEM INT EDIT, V51, P11463, DOI 10.1002/anie.201206231; Buckley DL, 2012, J AM CHEM SOC, V134, P4465, DOI 10.1021/ja209924v; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crews C.M., 2013, Patent, Patent No. [PCT/ US2013/ 021141, 2013021141]; Douglass EF, 2013, J AM CHEM SOC, V135, P6092, DOI 10.1021/ja311795d; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; Grossmann J, 2010, J PROTEOMICS, V73, P1740, DOI 10.1016/j.jprot.2010.05.011; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Hines J, 2013, P NATL ACAD SCI USA, V110, P8942, DOI 10.1073/pnas.1217206110; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Humphries F, 2015, CELL DEATH DIFFER, V22, P225, DOI 10.1038/cdd.2014.126; Itoh Y, 2012, BIOORG MED CHEM LETT, V22, P4453, DOI 10.1016/j.bmcl.2012.04.134; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kruse U, 2011, LEUKEMIA, V25, P89, DOI 10.1038/leu.2010.233; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Lee JY, 2010, NAT CHEM BIOL, V6, P258, DOI [10.1038/NCHEMBIO.333, 10.1038/nchembio.333]; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Noblin DJ, 2012, ACS CHEM BIOL, V7, P2055, DOI 10.1021/cb300453k; Okuhira K, 2013, CANCER SCI, V104, P1492, DOI 10.1111/cas.12272; Patch RJ, 2011, J MED CHEM, V54, P788, DOI 10.1021/jm101063h; Puppala D, 2008, MOL PHARMACOL, V73, P1064, DOI 10.1124/mol.107.040840; Rodriguez-Gonzalez A, 2008, ONCOGENE, V27, P7201, DOI 10.1038/onc.2008.320; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Savitski MM, 2010, J AM SOC MASS SPECTR, V21, P1668, DOI 10.1016/j.jasms.2010.01.012; Schneekloth AR, 2008, BIOORG MED CHEM LETT, V18, P5904, DOI 10.1016/j.bmcl.2008.07.114; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sekine K, 2008, J BIOL CHEM, V283, P8961, DOI 10.1074/jbc.M709525200; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spiegel DA, 2013, EXPERT REV CLIN PHAR, V6, P223, DOI 10.1586/ecp.13.10; Tokatlian T, 2010, WIRES NANOMED NANOBI, V2, P305, DOI 10.1002/wnan.81; Werner T, 2014, ANAL CHEM, V86, P3594, DOI 10.1021/ac500140s; Werner T, 2012, ANAL CHEM, V84, P7188, DOI 10.1021/ac301553x; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704	53	597	666	34	425	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					611	U120		10.1038/NCHEMBIO.1858	http://dx.doi.org/10.1038/NCHEMBIO.1858			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26075522	Green Accepted			2022-12-25	WOS:000358255300019
J	Hu, XL; Deutsch, AJ; Lenz, TL; Onengut-Gumuscu, S; Han, B; Chen, WM; Howson, JMM; Todd, JA; De Bakker, PIW; Rich, SS; Raychaudhuri, S				Hu, Xinli; Deutsch, Aaron J.; Lenz, Tobias L.; Onengut-Gumuscu, Suna; Han, Buhm; Chen, Wei-Min; Howson, Joanna M. M.; Todd, John A.; De Bakker, Paul I. W.; Rich, Stephen S.; Raychaudhuri, Soumya			Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk	NATURE GENETICS			English	Article							SEROPOSITIVE RHEUMATOID-ARTHRITIS; CD8 T-CELLS; MHC; SUSCEPTIBILITY; MELLITUS; DECARBOXYLASE; ASSOCIATIONS; VARIANTS; GENOTYPE; DISEASE	Variation in the human leukocyte antigen (HLA) genes accounts for one-half of the genetic risk in type 1 diabetes (T1D). Amino acid changes in the HLA-DR and HLA-DQ molecules mediate most of the risk, but extensive linkage disequilibrium complicates the localization of independent effects. Using 18,832 case-control samples, we localized the signal to 3 amino acid positions in HLA-DQ and HLA-DR. HLA-DQ. 1 position 57 (previously known; P = 1 x 10(-1,355)) by itself explained 15.2% of the total phenotypic variance. Independent effects at HLA-DR. 1 positions 13 (P = 1 x 10(-721)) and 71 (P = 1 x 10(-95)) increased the proportion of variance explained to 26.9%. The three positions together explained 90% of the phenotypic variance in the HLA-DRB1-HLA-DQA1-HLA-DQB1 locus. Additionally, we observed significant interactions for 11 of 21 pairs of common HLA-DRB1-HLA-DQA1-HLA-DQB1 haplotypes (P = 1.6 x 10(-64)). HLA-DR. 1 positions 13 and 71 implicate the P4 pocket in the antigen-binding groove, thus pointing to another critical protein structure for T1D risk, in addition to the HLA-DQ P9 pocket.	[Hu, Xinli; Deutsch, Aaron J.; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hu, Xinli; Deutsch, Aaron J.; Lenz, Tobias L.; Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA; [Hu, Xinli; Deutsch, Aaron J.; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Hu, Xinli; Deutsch, Aaron J.; Han, Buhm; Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Hu, Xinli; Deutsch, Aaron J.] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Hu, Xinli] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Lenz, Tobias L.] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Evolutionary Immunogen, Plon, Germany; [Onengut-Gumuscu, Suna; Chen, Wei-Min] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Han, Buhm] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Howson, Joanna M. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Todd, John A.] Univ Cambridge, Cambridge Biomed Res Ctr, Cambridge Inst Med Res,Dept Med Genet, Juvenile Diabet Res Fdn,NIHR,Wellcome Trust Diabe, Cambridge, England; [De Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [De Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Hlth Sci, Manchester, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Max Planck Society; University of Virginia; University of Ulsan; Asan Medical Center; University of Cambridge; University of Cambridge; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Manchester	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	soumya@broadinstitute.org	Lenz, Tobias L/D-1387-2009; Han, Buhm/AAQ-9672-2020; Todd, John/A-3542-2010	Lenz, Tobias L/0000-0002-7203-0044; Todd, John/0000-0003-2740-8148; Howson, Joanna/0000-0001-7618-0050; Rich, Stephen/0000-0003-3872-7793; Raychaudhuri, Soumya/0000-0002-1901-8265; Deutsch, Aaron/0000-0001-6750-5335	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHHD); Juvenile Diabetes Research Foundation International (JDRFI); NIDDK [U01DK062418]; US National Institutes of Health [5R01AR062886-02, 1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, R01AR065183]; Doris Duke Clinical Scientist Development Award; Wellcome Trust; UK National Institute for Health Research (NIHR); Netherlands Organization for Scientific Research [016.126.354]; German Research Foundation [LE 2593/1-1, LE 2593/2-1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759, UH2AR067677, R01AR062886, R01AR065183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; MRC [MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275, NF-SI-0513-10143, NF-SI-0512-10165] Funding Source: researchfish	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research makes use of resources provided by the Type 1 Diabetes Genetics Consortium (T1DGC), a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHHD) and Juvenile Diabetes Research Foundation International (JDRFI) and supported by grant U01DK062418 (NIDDK). This work is supported in part by funding from the US National Institutes of Health (5R01AR062886-02 (P.I.W.d.B.), 1R01AR063759 (S.R.), 5U01GM092691-05 (S.R.), 1UH2AR067677-01 (S.R.) and R01AR065183 (P.I.W.d.B.)), a Doris Duke Clinical Scientist Development Award (S.R.), the Wellcome Trust (J.A.T.) and the UK National Institute for Health Research (NIHR; J.A.T. and J.M.M.H.) and by a Vernieuwingsimpuls VIDI Award (016.126.354) from the Netherlands Organization for Scientific Research (P.I.W.d.B.). T.L.L. was supported by the German Research Foundation (LE 2593/1-1 and LE 2593/2-1).	Astill TP, 2003, DIABETOLOGIA, V46, P496, DOI 10.1007/s00125-003-1070-3; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Cucca F, 2001, DIABETES, V50, P1200, DOI 10.2337/diabetes.50.5.1200; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; DESCHAMPS I, 1980, DIABETOLOGIA, V19, P189, DOI 10.1007/BF00275267; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Ettinger RA, 1998, J IMMUNOL, V161, P6439; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; KARLSEN AE, 1992, DIABETES, V41, P1355, DOI 10.2337/diabetes.41.10.1355; Knight RR, 2015, CLIN EXP IMMUNOL, V179, P100, DOI 10.1111/cei.12436; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Noble JA, 1996, AM J HUM GENET, V59, P1134; Noble JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007732; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reichstetter S, 1999, TISSUE ANTIGENS, V53, P101, DOI 10.1034/j.1399-0039.1999.530111.x; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sivertsen B, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-83; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; SVEJGAARD A, 1981, ANN HUM GENET, V45, P293, DOI 10.1111/j.1469-1809.1981.tb00340.x; THOMSON G, 1988, AM J HUM GENET, V43, P799; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Trynka G, 2010, TRENDS MOL MED, V16, P537, DOI 10.1016/j.molmed.2010.09.003; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786	37	150	155	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					898	+		10.1038/ng.3353	http://dx.doi.org/10.1038/ng.3353			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26168013	Green Accepted			2022-12-25	WOS:000358674100014
J	Melton, C; Reuter, JA; Spacek, DV; Snyder, M				Melton, Collin; Reuter, Jason A.; Spacek, Damek V.; Snyder, Michael			Recurrent somatic mutations in regulatory regions of human cancer genomes	NATURE GENETICS			English	Article							TERT PROMOTER MUTATIONS; TUMOR TYPES; BINDING; GENES; ANNOTATION; EXPRESSION; DISCOVERY; SEQUENCES; DATABASE; BETA	Aberrant regulation of gene expression in cancer can promote survival and proliferation of cancer cells. Here we integrate whole-genome sequencing data from The Cancer Genome Atlas (TCGA) for 436 patients from 8 cancer subtypes with ENCODE and other regulatory annotations to identify point mutations in regulatory regions. We find evidence for positive selection of mutations in transcription factor binding sites, consistent with these sites regulating important cancer cell functions. Using a new method that adjusts for sample-and genomic locus-specific mutation rates, we identify recurrently mutated sites across individuals with cancer. Mutated regulatory sites include known sites in the TERT promoter and many new sites, including a subset in proximity to cancer-related genes. In reporter assays, two new sites display decreased enhancer activity upon mutation. These data demonstrate that many regulatory regions contain mutations under selective pressure and suggest a greater role for regulatory mutations in cancer than previously appreciated.	[Melton, Collin; Reuter, Jason A.; Spacek, Damek V.; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Melton, Collin] Stanford Univ, Sch Med, Program Biomed Informat, Stanford, CA 94305 USA	Stanford University; Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu		Snyder, Michael/0000-0003-0784-7987	Stanford Biomedical Informatics Training program; US National Institutes of Health (US NIH) [1K99CA191093, 1K99CA191093-01, 5U54HG006996-04]; US NIH/National Human Genome Research Institute [T32HG000044]; Genentech Graduate Fellowship; NATIONAL CANCER INSTITUTE [K99CA191093] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, U54HG006996] Funding Source: NIH RePORTER	Stanford Biomedical Informatics Training program; US National Institutes of Health (US NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH/National Human Genome Research Institute; Genentech Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank members of the Snyder laboratory for critical reading of the manuscript. We would also like to thank A. Boyle for helpful discussion regarding the use of RegulomeDB. Finally, we would like to thank members of the ENCODE Consortium for their helpful scientific feedback during the course of this work. C.M. was supported by the Stanford Biomedical Informatics Training program and funds from the US National Institutes of Health (US NIH; 1K99CA191093). D.V.S. was supported by US NIH/National Human Genome Research Institute grant T32HG000044 and the Genentech Graduate Fellowship. This work was supported by funds to C.M. (US NIH, 1K99CA191093-01) and M.S. (US NIH, 5U54HG006996-04).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hong YL, 2013, COMPUT STAT DATA AN, V59, P41, DOI 10.1016/j.csda.2012.10.006; Howlander N, SEER CANC STAT REV 1; Hoyert DL, 2011, NATL VITAL STAT REP, V61, P1; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Kannan MB, 2012, BBA-MOL CELL RES, V1823, P1841, DOI 10.1016/j.bbamcr.2012.06.012; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miyazawa K, 1998, J BIOL CHEM, V273, P7620, DOI 10.1074/jbc.273.13.7620; Ostrow SL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004239; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	36	173	176	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					710	+		10.1038/ng.3332	http://dx.doi.org/10.1038/ng.3332			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053494	Green Accepted			2022-12-25	WOS:000357090300007
J	Rouault, TA				Rouault, Tracey A.			Iron-sulfur proteins hiding in plain sight	NATURE CHEMICAL BIOLOGY			English	Article							PARAMAGNETIC-RESONANCE; GENOMIC INTEGRITY; DNA METABOLISM; CLUSTERS; DEHYDROGENASE; SPECTROSCOPY; INSIGHTS; ENZYMES		NICHHD, Eunice Kennedy Shriver, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHHD, Eunice Kennedy Shriver, Bethesda, MD 20892 USA.	rouault@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEINERT H, 1989, EUR J BIOCHEM, V186, P5, DOI 10.1111/j.1432-1033.1989.tb15170.x; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BEINERT H, 1960, BIOCHEM BIOPH RES CO, V3, P41, DOI 10.1016/0006-291X(60)90100-5; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bulatov E, 2015, J BIOL CHEM, V290, P4178, DOI 10.1074/jbc.M114.616664; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Grodick MA, 2014, J AM CHEM SOC, V136, P6470, DOI 10.1021/ja501973c; Holmes-Hampton GP, 2014, METHOD ENZYMOL, V547, P275, DOI 10.1016/B978-0-12-801415-8.00015-1; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Karcher A, 2008, J BIOL CHEM, V283, P7962, DOI 10.1074/jbc.M707347200; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; MUNCK E, 1993, METHOD ENZYMOL, V227, P463, DOI 10.1016/0076-6879(93)27019-D; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Petasis D. T., 2014, IRON SULFUR CLUSTERS, P21; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Saikrishnan K, 2012, EMBO J, V31, P1568, DOI 10.1038/emboj.2012.9; SINGER TP, 1985, FEBS LETT, V190, P189, DOI 10.1016/0014-5793(85)81282-5; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; Wu XL, 2005, P NATL ACAD SCI USA, V102, P14058, DOI 10.1073/pnas.0506714102	25	36	37	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					442	445		10.1038/nchembio.1843	http://dx.doi.org/10.1038/nchembio.1843			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26083061				2022-12-25	WOS:000356334600002
J	Ayyaz, A; Li, HJ; Jasper, H				Ayyaz, Arshad; Li, Hongjie; Jasper, Heinrich			Haemocytes control stem cell activity in the Drosophila intestine	NATURE CELL BIOLOGY			English	Article							BMP ACTIVITY GRADIENT; BETA; HOMEOSTASIS; TISSUE; DPP; PROLIFERATION; MIDGUT; MACROPHAGES; SAXOPHONE; RECEPTOR	Coordination of stem cell activity with inflammatory responses is critical for regeneration and homeostasis of barrier epithelia. The temporal sequence of cell interactions during injury-induced regeneration is only beginning to be understood. Here we show that intestinal stem cells (ISCs) are regulated by macrophage-like haemocytes during the early phase of regenerative responses of the Drosophila intestinal epithelium. On tissue damage, haemocytes are recruited to the intestine and secrete the BMP homologue DPP, inducing ISC proliferation by activating the type I receptor Saxophone and the Smad homologue SMOX. Activated ISCs then switch their response to DPP by inducing expression of Thickveins, a second type I receptor that has previously been shown to re-establish ISC quiescence by activating MAD. The interaction between haemocytes and ISCs promotes infection resistance, but also contributes to the development of intestinal dysplasia in ageing flies. We propose that similar interactions influence pathologies such as inflammatory bowel disease and colorectal cancer in humans.	[Ayyaz, Arshad; Li, Hongjie; Jasper, Heinrich] Buck Inst Res Aging, Novato, CA 94945 USA; [Li, Hongjie] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Buck Institute for Research on Aging; University of Rochester	Jasper, H (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	hjasper@buckinstitute.org		Li, hongjie/0000-0002-7332-7122	National Institute on General Medical Sciences [R01 GM100196]; National Eye Institute [R01 EY018177]; NATIONAL EYE INSTITUTE [R01EY018177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER	National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was financially supported by the National Institute on General Medical Sciences (R01 GM100196) and the National Eye Institute (R01 EY018177). We would like to thank J. Karpac for comments.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Bangi E, 2006, DEVELOPMENT, V133, P3295, DOI 10.1242/dev.02513; Bardet PL, 2008, P NATL ACAD SCI USA, V105, P13901, DOI 10.1073/pnas.0806983105; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; Cordero JB, 2012, ACTA PHYSIOL, V204, P137, DOI 10.1111/j.1748-1716.2011.02288.x; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Haerry TE, 2010, MECH DEVELOP, V127, P358, DOI 10.1016/j.mod.2010.04.001; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107443; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Li CY, 2007, DEV BIOL, V309, P70, DOI 10.1016/j.ydbio.2007.06.019; Li HJ, 2013, CELL REP, V4, P10, DOI 10.1016/j.celrep.2013.05.040; Li ZH, 2013, DEV CELL, V24, P133, DOI 10.1016/j.devcel.2012.12.010; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Malvin NP, 2012, MUCOSAL IMMUNOL, V5, P194, DOI 10.1038/mi.2011.65; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Peterson AJ, 2014, METHODS, V68, P183, DOI 10.1016/j.ymeth.2014.03.016; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Skoczek DA, 2014, J IMMUNOL, V193, P439, DOI 10.4049/jimmunol.1301497; Spokony R., 2013, SPOKONY INSERTIONS; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tian AG, 2014, ELIFE, V3, DOI 10.7554/eLife.01857; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Twombly V, 2009, GENETICS, V183, P563, DOI 10.1534/genetics.109.105585; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang GC, 2014, TRANSL MED UNISA, V9, P1; Wang LF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004568; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Zaidman-Remy A, 2012, DEV COMP IMMUNOL, V36, P638, DOI 10.1016/j.dci.2011.10.013; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhou J, 2015, DEV BIOL, V399, P189, DOI 10.1016/j.ydbio.2014.12.017; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	69	95	96	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					736	+		10.1038/ncb3174	http://dx.doi.org/10.1038/ncb3174			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	26005834	Green Accepted			2022-12-25	WOS:000355277500006
J	Tanaka, M; Komi, Y				Tanaka, Motomasa; Komi, Yusuke			Layers of structure and function in protein aggregation	NATURE CHEMICAL BIOLOGY			English	Article							AMYLOID STATE; PRION; OLIGOMERS; SEGREGATION	Protein aggregation is a central hallmark of many neurodegenerative disorders, but the relationship of aggregate structural diversity to the resultant cellular cytotoxicity and phenotypic diversity has remained obscure. Recent advances in understanding the mechanisms of protein aggregation and their physiological consequences have been achieved through chemical biology approaches, such as rationally designed protein modifications and chemical probes, providing crucial mechanistic insights and promise for therapeutic strategies for brain disorders.	[Tanaka, Motomasa; Komi, Yusuke] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	RIKEN	Tanaka, M (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	motomasa@brain.riken.jp	Tanaka, Motomasa/N-5064-2015	Tanaka, Motomasa/0000-0002-2994-7703	Japan Society for the Promotion of Science [LS129]; Ministry of Health, Labour, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [25830025]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the collaborators that have contributed to our work in this research area. In our work, the funding was provided by the Next program (LS129; M.T.) from the Japan Society for the Promotion of Science, Grants-in-Aid from the Ministry of Health, Labour, and Welfare, Japan (the Research Committee of Prion Disease and Slow Virus Infection; M.T.) and from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT; Young Scientist (B) 25830025; Y.K.), Japan.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Jarosz DF, 2014, CELL, V158, P1072, DOI 10.1016/j.cell.2014.07.024; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	27	25	26	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					373	377		10.1038/nchembio.1818	http://dx.doi.org/10.1038/nchembio.1818			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI1XW	25978986				2022-12-25	WOS:000354539400003
J	Wang, YP; Lu, Y; Zhang, Y; Ning, ZM; Li, Y; Zhao, Q; Lu, HY; Huang, R; Xia, XQ; Feng, Q; Liang, XF; Liu, KY; Zhang, L; Lu, TT; Huang, T; Fan, DL; Weng, QJ; Zhu, CR; Lu, YQ; Li, WJ; Wen, ZR; Zhou, CC; Tian, QL; Kang, XJ; Shi, MJ; Zhang, WT; Jang, SH; Du, FK; He, S; Liao, LJ; Li, YM; Gui, B; He, HH; Ning, Z; Yang, C; He, LB; Luo, LF; Yang, R; Luo, Q; Liu, XC; Li, SS; Huang, W; Xiao, L; Lin, HR; Han, B; Zhu, ZY				Wang, Yaping; Lu, Ying; Zhang, Yong; Ning, Zemin; Li, Yan; Zhao, Qiang; Lu, Hengyun; Huang, Rong; Xia, Xiaoqin; Feng, Qi; Liang, Xufang; Liu, Kunyan; Zhang, Lei; Lu, Tingting; Huang, Tao; Fan, Danlin; Weng, Qijun; Zhu, Chuanrang; Lu, Yiqi; Li, Wenjun; Wen, Ziruo; Zhou, Congcong; Tian, Qilin; Kang, Xiaojun; Shi, Mijuan; Zhang, Wanting; Jang, Songhun; Du, Fukuan; He, Shan; Liao, Lanjie; Li, Yongming; Gui, Bin; He, Huihui; Ning, Zhen; Yang, Cheng; He, Libo; Luo, Lifei; Yang, Rui; Luo, Qiong; Liu, Xiaochun; Li, Shuisheng; Huang, Wen; Xiao, Ling; Lin, Haoran; Han, Bin; Zhu, Zuoyan			The draft genome of the grass carp (Ctenopharyngodon idellus) provides insights into its evolution and vegetarian adaptation	NATURE GENETICS			English	Article							MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; ORGAN SIZE; GENE; ZEBRAFISH; IDENTIFICATION; FISH; DUPLICATION; DISCOVERY; SEQUENCE	The grass carp is an important farmed fish, accounting for similar to 16% of global freshwater aquaculture, and has a vegetarian diet. Here we report a 0.9-Gb draft genome of a gynogenetic female adult and a 1.07-Gb genome of a wild male adult. Genome annotation identified 27,263 protein-coding gene models in the female genome. A total of 114 scaffolds consisting of 573 Mb are anchored on 24 linkage groups. Divergence between grass carp and zebrafish is estimated to have occurred 49-54 million years ago. We identify a chromosome fusion in grass carp relative to zebrafish and report frequent crossovers between the grass carp X and Y chromosomes. We find that transcriptional activation of the mevalonate pathway and steroid biosynthesis in liver is associated with the grass carp's adaptation from a carnivorous to an herbivorous diet. We believe that the grass carp genome could serve as an initial platform for breeding better-quality fish using a genomic approach.	[Wang, Yaping; Huang, Rong; Xia, Xiaoqin; Kang, Xiaojun; Shi, Mijuan; Zhang, Wanting; Jang, Songhun; Du, Fukuan; Liao, Lanjie; Li, Yongming; Gui, Bin; He, Huihui; Ning, Zhen; Yang, Cheng; He, Libo; Luo, Lifei; Zhu, Zuoyan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Lu, Ying; Li, Yan; Zhao, Qiang; Lu, Hengyun; Feng, Qi; Liu, Kunyan; Zhang, Lei; Lu, Tingting; Huang, Tao; Fan, Danlin; Weng, Qijun; Zhu, Chuanrang; Lu, Yiqi; Li, Wenjun; Wen, Ziruo; Zhou, Congcong; Tian, Qilin; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai, Peoples R China; [Zhang, Yong; Liu, Xiaochun; Li, Shuisheng; Huang, Wen; Xiao, Ling; Lin, Haoran] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yong; Liu, Xiaochun; Li, Shuisheng; Huang, Wen; Xiao, Ling; Lin, Haoran] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou 510275, Guangdong, Peoples R China; [Ning, Zemin] Wellcome Trust Sanger Inst, Hinxton, England; [Liang, Xufang; He, Shan] Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China; [Liang, Xufang] Huazhong Agr Univ, Coll Fisheries, Freshwater Aquaculture Collaborat Innovat Ctr Hu, Wuhan, Peoples R China; [Kang, Xiaojun; Yang, Cheng] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China; [Jang, Songhun] Kim Illinois Sung Univ, Coll Life Sci, Pyongyang, North Korea; [Yang, Rui; Luo, Qiong] Yunnan Agr Univ, Coll Plant Protect, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Sun Yat Sen University; Sun Yat Sen University; Wellcome Trust Sanger Institute; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; China University of Geosciences; Yunnan Agricultural University	Wang, YP (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	wangyp@ihb.ac.cn; lsslhr@mail.sysu.edu.cn; bhan@ncgr.ac.cn; zyzhu@ihb.ac.cn	Ning, Zemin/D-2411-2013; lin, haoran/GXH-3030-2022	Lu, Ying/0000-0002-2509-9209; Ning, Zemin/0000-0003-4359-776X; xia, xiao qin/0000-0002-8034-1096	National High-Technology Research and Development Program (863 Program) [2011AA100403]; National Natural Science Foundation of China [31130055]; Strategic Pilot Science and Technology Projects (A) Category, Chinese Academy of Science [XDA08030203]; Guangdong Provincial Science and Technology Program [20123090500008]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ18]	National High-Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Pilot Science and Technology Projects (A) Category, Chinese Academy of Science; Guangdong Provincial Science and Technology Program; State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	We thank S. Liu (Hunan Normal University) for providing a gynogenetic female individual. We thank Y. Xue and J. Torrance for their help in English-language editing of the manuscript. This work is supported by the National High-Technology Research and Development Program (863 Program, 2011AA100403), the National Natural Science Foundation of China (31130055), the Strategic Pilot Science and Technology Projects (A) Category, Chinese Academy of Science (XDA08030203), the Guangdong Provincial Science and Technology Program (20123090500008) and the State Key Laboratory of Freshwater Ecology and Biotechnology (2011FBZ18).	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Chen Y, 2014, FISH PHYSIOL BIOCHEM, V40, P45, DOI 10.1007/s10695-013-9822-6; CHILTON EW, 1992, REV FISH BIOL FISHER, V2, P283, DOI 10.1007/BF00043520; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; CUI YB, 1993, AQUACULTURE, V113, P57, DOI 10.1016/0044-8486(93)90340-5; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; DEMPSEY ME, 1974, ANNU REV BIOCHEM, V43, P967, DOI 10.1146/annurev.bi.43.070174.004535; Feng K, 2013, J EXP ZOOL PART A, V319A, P202, DOI 10.1002/jez.1784; Flores MV, 2007, GENE EXPR PATTERNS, V7, P535, DOI 10.1016/j.modgep.2007.02.001; Goodman BE, 2010, ADV PHYSIOL EDUC, V34, P44, DOI 10.1152/advan.00094.2009; Guo T, 2013, FISH SHELLFISH IMMUN, V35, P1624, DOI 10.1016/j.fsi.2013.09.012; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jang SH, 2010, MAR BIOTECHNOL, V12, P261, DOI 10.1007/s10126-010-9268-0; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Kurosawa G, 2006, GENE, V370, P75, DOI 10.1016/j.gene.2005.11.015; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nocusa S., 1960, MEM HYOGO U AGR, V3, P1; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; STANLEY JG, 1976, J FISH RES BOARD CAN, V33, P1372, DOI 10.1139/f76-175; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Statistics and Information Service Fisheries and Aquaculture Department Food and Agriculture Organization of the United Nations, 2013, FAO YB FISH AQ STAT; Tan Y, 2008, J NEUROGENET, V22, P149, DOI 10.1080/01677060802049738; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Wang TT, 2013, FISH SHELLFISH IMMUN, V35, P1421, DOI 10.1016/j.fsi.2013.08.006; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; Xu B, 2010, ANIM BIOTECHNOL, V21, P217, DOI 10.1080/10495398.2010.505843; Yu EM, 2014, J ANIM PHYSIOL AN N, V98, P755, DOI 10.1111/jpn.12132; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhong SS, 2013, GEN COMP ENDOCR, V185, P19, DOI 10.1016/j.ygcen.2013.01.016; Zhou Y, 2013, AQUACULTURE, V416, P1, DOI 10.1016/j.aquaculture.2013.08.023	45	265	303	7	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					625	631		10.1038/ng.3280	http://dx.doi.org/10.1038/ng.3280			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25938946	hybrid			2022-12-25	WOS:000355386500013
J	Zeitoun, RI; Garst, AD; Degen, GD; Pines, G; Mansell, TJ; Glebes, TY; Boyle, NR; Gill, RT				Zeitoun, Ramsey I.; Garst, Andrew D.; Degen, George D.; Pines, Gur; Mansell, Thomas J.; Glebes, Tirzah Y.; Boyle, Nanette R.; Gill, Ryan T.			Multiplexed tracking of combinatorial genomic mutations in engineered cell populations	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; ETHANOL TOLERANCE; GENETIC SYSTEMS; EMULSION-PCR; EVOLUTION; IDENTIFICATION; STRATEGY; AMPLIFICATION; CONSTRUCTION	Multiplexed genome engineering approaches can be used to generate targeted genetic diversity in cell populations on laboratory timescales, but methods to track mutations and link them to phenotypes have been lacking. We present an approach for tracking combinatorial engineered libraries (TRACE) through the simultaneous mapping of millions of combinatorially engineered genomes at single-cell resolution. Distal genomic sites are assembled into individual DNA constructs that are compatible with next-generation sequencing strategies. We used TRACE to map growth selection dynamics for Escherichia coli combinatorial libraries created by recursive multiplex recombineering at a depth 10(4)-fold greater than before. TRACE was used to identify genotype-to-phenotype correlations and to map the evolutionary trajectory of two individual combinatorial mutants in E. coli. Combinatorial mutations in the human ES2 ovarian carcinoma cell line were also assessed with TRACE. TRACE completes the combinatorial engineering cycle and enables more sophisticated approaches to genome engineering in both bacteria and eukaryotic cells than are currently possible.	[Zeitoun, Ramsey I.; Garst, Andrew D.; Pines, Gur; Mansell, Thomas J.; Glebes, Tirzah Y.; Gill, Ryan T.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Degen, George D.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Boyle, Nanette R.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA	University of Colorado System; University of Colorado Boulder; Carnegie Mellon University; Colorado School of Mines	Gill, RT (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	rtg@colorado.edu	Pines, Gur/X-7501-2019	Pines, Gur/0000-0002-1757-6722; MANSELL, THOMAS/0000-0001-8807-4570	DOE BER Genomic Sciences Program [DE-SC0008812]; C2B2/NSF REU Program (NSF) [1261303]	DOE BER Genomic Sciences Program; C2B2/NSF REU Program (NSF)	Special thanks to S.A. Lynch and W.C. Grau for support and advice on this work. We would like to thank J. Huntley and S. Gao at the Colorado Biofrontiers Advanced Sequencing Core Facility for assistance with high-throughput sequencing. We would like to thank J. Liddle for generously sharing the ES2 cancer cell line. This work was funded by DOE BER Genomic Sciences Program Award Number DE-SC0008812. We would also like to acknowledge the C2B2/NSF REU Program (NSF# 1261303) for funding G.D.D.	Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Eklund AC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1116; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Farasat I, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20134955; Gevertz JL, 2005, BIOTECHNOL BIOENG, V92, P346, DOI 10.1002/bit.20617; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/nmeth.2918, 10.1038/NMETH.2918]; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Miura F, 2005, BIOINFORMATICS, V21, P4363, DOI 10.1093/bioinformatics/bti716; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; PAABO S, 1990, J BIOL CHEM, V265, P4718; Pal C, 2014, NAT REV GENET, V15, P504, DOI 10.1038/nrg3746; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Wang BL, 2014, NAT BIOTECHNOL, V32, P473, DOI 10.1038/nbt.2857; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2011, METHOD ENZYMOL, V498, P409, DOI 10.1016/B978-0-12-385120-8.00018-8; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang X, 2013, P NATL ACAD SCI USA, V110, P4021, DOI 10.1073/pnas.1217958110; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Wetmur JG, 2005, NUCLEIC ACIDS RES, V33, P2615, DOI 10.1093/nar/gki556; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Woodruff LBA, 2013, METAB ENG, V15, P124, DOI 10.1016/j.ymben.2012.10.007; Yoo SM, 2013, NAT PROTOC, V8, P1694, DOI 10.1038/nprot.2013.105	41	33	43	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					631	+		10.1038/nbt.3177	http://dx.doi.org/10.1038/nbt.3177			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25798935				2022-12-25	WOS:000356019700023
J	Boulard, M; Edwards, JR; Bestor, TH				Boulard, Mathieu; Edwards, John R.; Bestor, Timothy H.			FBXL10 protects Polycomb-bound genes from hypermethylation	NATURE GENETICS			English	Article							DNA METHYLATION; H2A UBIQUITYLATION; PRC1 COMPLEX; VARIANT PRC1; GENOME-WIDE; CPG ISLANDS; TRANSCRIPTION; EXPRESSION; PROTEINS	Nearly all CpG-dense promoters are occupied by the multidomain chromosomal protein FBXL10. We show here that complete inactivation of the Fbxl10 gene leads to dense de novo methylation only of promoters that are co-occupied by both FBXL10 and Polycomb repressive complexes; this methylation results in pervasive defects in embryonic development and the death of homozygous Fbxl10-mutant embryos at midgestation. Deletion of key components of Polycomb repressive complexes 1 and 2 did not lead to ectopic genomic methylation. These results indicate that FBXL10 protects Polycomb-occupied promoters against ectopic de novo methylation. To our knowledge, FBXL10 is the first reported factor whose loss leads to a gain in genomic DNA methylation.	[Boulard, Mathieu; Bestor, Timothy H.] Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, New York, NY 10027 USA; [Edwards, John R.] Washington Univ, Sch Med, Dept Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Columbia University; Washington University (WUSTL)	Bestor, TH (corresponding author), Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, New York, NY 10027 USA.	thb12@columbia.edu	Boulard, Matthieu/H-8923-2017	Boulard, Matthieu/0000-0001-5135-8529	US National Institutes of Health; US Department of Defense; Phillippe Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108811] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Phillippe Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Okamoto, R. Margueron and E. Heard (Institut Curie) for Ezh2<SUP>-/</SUP> mutant ES cells, L. Di Croce (Centre for Genomic Regulation (CRG) and Pompeu Fabra University (UPF)) for DNA from Eed<SUP>-/-</SUP> and Ring1b<SUP>-/-</SUP> ES cells, K. Anderson and O. Yarychkivska for comments on the manuscript and V. Bardwell (University of Minnesota, Minneapolis) for her gift of antiserum to FBXL10. This study was supported by grants from the US National Institutes of Health to J.R.E. and T.H.B. and by a grant from the US Department of Defense to J.R.E. M.B. was supported in part by the Phillippe Foundation.	Beuchle D, 2001, DEVELOPMENT, V128, P993; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; Duffie R, 2014, GENE DEV, V28, P463, DOI 10.1101/gad.232058.113; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Morin-Kensicki E.M., 2002, GENESIS, V31, P142; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pemberton H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r23; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Testoni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045634; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	40	102	104	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					479	U73		10.1038/ng.3272	http://dx.doi.org/10.1038/ng.3272			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25848754				2022-12-25	WOS:000353635800010
J	Davis, KM; Pattanayak, V; Thompson, DB; Zuris, JA; Liu, DR				Davis, Kevin M.; Pattanayak, Vikram; Thompson, David B.; Zuris, John A.; Liu, David R.			Small molecule-triggered Cas9 protein with improved genome-editing specificity	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN-CELLS; NUCLEASE SPECIFICITY; DIRECTED EVOLUTION; MAMMALIAN-CELLS; RNA; NICKASES; CLEAVAGE; DELIVERY; INTEIN	Directly modulating the activity of genome-editing proteins has the potential to increase their specificity by reducing activity following target locus modification. We developed Cas9 nucleases that are activated by the presence of a cell-permeable small molecule by inserting an evolved 4-hydroxytamoxifen-responsive intein at specific positions in Cas9. In human cells, conditionally active Cas9s modify target genomic sites with up to 25-fold higher specificity than wild-type Cas9.	[Davis, Kevin M.; Thompson, David B.; Zuris, John A.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Davis, Kevin M.; Thompson, David B.; Zuris, John A.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Pattanayak, Vikram] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022		National Institutes of Health [R01 GM095501]; Defense Advanced Research Projects Agency [HR0011-11-2-0003, N66001-12-C-4207]; Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada (NSERC); Ruth L. Kirchstein National Research Service [F32 GM 106601-2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095501, F32GM106601, T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ruth L. Kirchstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 GM095501, Defense Advanced Research Projects Agency HR0011-11-2-0003 and N66001-12-C-4207 and the Howard Hughes Medical Institute. K.M.D. acknowledges the Natural Sciences and Engineering Research Council of Canada (NSERC) for a Postgraduate Scholarship-Doctoral (PGS D) award. J.A.Z. is a Ruth L. Kirchstein National Research Service Awards Postdoctoral Fellow (F32 GM 106601-2). We are grateful to J. Doudna, S. Sternberg, D. Taylor, M. Jinek and F. Jiang for providing the structural coordinates of Cas9 and to J. Guilinger, Y. Kim, M. Li and A. Badran for helpful discussions.	Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peck SH, 2011, CHEM BIOL, V18, P619, DOI 10.1016/j.chembiol.2011.02.014; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yuen CM, 2006, J AM CHEM SOC, V128, P8939, DOI 10.1021/ja062980e; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	26	274	310	5	160	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2015	11	5					316	U97		10.1038/NCHEMBIO.1793	http://dx.doi.org/10.1038/NCHEMBIO.1793			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG3FD	25848930	Green Submitted, Green Accepted			2022-12-25	WOS:000353162600006
J	Kang, XL; Lu, ZG; Cui, CH; Deng, M; Fan, YQ; Dong, BJ; Han, X; Xie, FC; Tyner, JW; Coligan, JE; Collins, RH; Xiao, XS; You, MJ; Zhang, CC				Kang, Xunlei; Lu, Zhigang; Cui, Changhao; Deng, Mi; Fan, Yuqi; Dong, Baijun; Han, Xin; Xie, Fuchun; Tyner, Jeffrey W.; Coligan, John E.; Collins, Robert H.; Xiao, Xiangshu; You, M. James; Zhang, Cheng Cheng			The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; IG-LIKE RECEPTOR-1; TYROSINE-PHOSPHATASE SHP-1; PROTEIN-KINASE-I; VIVO; BINDING; TRANSPLANTATION; IDENTIFICATION; MALIGNANCIES; RENEWAL	Conventional strategies are not particularly successful in the treatment of leukaemia, and identification of signalling pathways crucial to the activity of leukaemia stem cells will provide targets for the development of new therapies. Here we report that certain receptors containing the immunoreceptor tyrosine-based inhibition motif (ITIM) are crucial for the development of acute myeloid leukaemia (AML). Inhibition of expression of the ITIM-containing receptor LAIR1 does not affect normal haematopoiesis but abolishes leukaemia development. LAIR1 induces activation of SHP-1, which acts as a phosphatase-independent signalling adaptor to recruit CAMK1 for activation of downstream CREB in AML cells. The LAIR1-SHP-1-CAMK1-CREB pathway sustains the survival and self-renewal of AML stem cells. Intervention in the signalling initiated by ITIM-containing receptors such as LAIR1 may result in successful treatment of AML.	[Kang, Xunlei; Lu, Zhigang; Cui, Changhao; Deng, Mi; Fan, Yuqi; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Kang, Xunlei; Lu, Zhigang; Cui, Changhao; Deng, Mi; Fan, Yuqi; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Dong, Baijun; You, M. James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Div Pathol & Lab Med, Houston, TX 77030 USA; [Han, Xin] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Div Pathol & Lab Med, Houston, TX 77030 USA; [Xie, Fuchun; Xiao, Xiangshu] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Cell & Dev Biol, Portland, OR 97239 USA; [Coligan, John E.] NIAID, Receptor Cell Biol Sect, NIH, Rockville, MD 20852 USA; [Collins, Robert H.] Univ Texas SW Med Ctr Dallas, Internal Med, Dallas, TX 75390 USA; [You, M. James] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Cui, Changhao] Dalian Univ Technol, Sch Life Sci & Med, Panjin 124221, Liaoning, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Southwestern Medical Center Dallas; Dalian University of Technology	Zhang, CC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Alec.Zhang@UTSouthwestern.edu	Zhang, Cheng/GRS-8698-2022; Deng, Mi/K-8699-2012	Deng, Mi/0000-0003-4291-0144; Kang, Xunlei/0000-0003-1853-1881; Lu, Zhigang/0000-0002-2880-7848	NIH [1R01CA172268]; Leukemia & Lymphoma Society [1024-14, TRP-6024-14, CPRIT RP140402]; March of Dimes Foundation [1-FY14-201]; Robert A. Welch Foundation [I-1834]; When Everyone Survives Foundation; V Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; National Cancer Institute [4 R00CA151457-03]; Leukemia Lymphoma Society; Susan G. Komen Foundation [RO1GM087305]; National Institute Allergy and Infectious Diseases; NIH/NCI [R01 CA164346]; Ladies Leukemia Leaque, Developmental Research Awards in Leukemia [SPORE CA100632]; Center for Inflammation and Cancer; IRG; Center for Genetics and Genomics; Sister Institution Network fund; Physician Scientist Award of the Univmsity of Texas MD Anderson Care Center; NATIONAL CANCER INSTITUTE [P50CA100632, R01CA172268, R00CA151457, R01CA164346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087305] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); March of Dimes Foundation(March of Dimes); Robert A. Welch Foundation(The Welch Foundation); When Everyone Survives Foundation; V Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); National Institute Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ladies Leukemia Leaque, Developmental Research Awards in Leukemia; Center for Inflammation and Cancer; IRG; Center for Genetics and Genomics; Sister Institution Network fund; Physician Scientist Award of the Univmsity of Texas MD Anderson Care Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would lie to thank II. Saya from Keio University School of Medicine for the pMX-IG N-Myc vector. We appreciate the support of staff of the tissue bank at the Department of Hematopathology, the University of Texas MD Anderson Cancer Center. Support to C.C.Z. was from NIH grant 1R01CA172268, Leukemia & Lymphoma Society Awards 1024-14 and TRP-6024-14, CPRIT RP140402, March of Dimes Foundation grant 1-FY14-201, Robert A. Welch Foundation grant I-1834, and When Everyone Survives Foundation. J.W.T. is supported by grants from the V Foundation for Cancer Research, the William Lawrence and Blanche Hughes Fund, and the National Cancer Institute (4 R00CA151457-03), and the Leukemia Lymphoma Society. X.X. is supported by Susan G. Komen Foundation and RO1GM087305. J.W.C. is supported by the intramural program of the National Institute Allergy and Infectious Diseases. M.J.Y. is supported in part by NIH/NCI R01 CA164346, Ladies Leukemia Leaque, Developmental Research Awards in Leukemia SPORE CA100632, and Center for Inflammation and Cancer, IRG, Center for Genetics and Genomics, Sister Institution Network fund and Physician Scientist Award of the Univmsity of Texas MD Anderson Care Center.	Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Fathi A, 2011, CURR OPIN HEMATOL, V18, P71, DOI 10.1097/MOH.0b013e3283439a03; Heidel FH, 2011, INT J HEMATOL, V94, P109, DOI 10.1007/s12185-011-0901-0; Horton SJ, 2012, HAEMATOL-HEMATOL J, V97, P966, DOI 10.3324/haematol.2011.054734; Huynh H, 2011, BLOOD, V118, P3236, DOI 10.1182/blood-2011-01-331876; Imbesi S, 2013, EXPERT REV HEMATOL, V6, P317, DOI [10.1586/EHM.13.21, 10.1586/ehm.13.21]; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li BBX, 2009, CHEMBIOCHEM, V10, P2721, DOI 10.1002/cbic.200900552; LIU F, 1993, J BIOL CHEM, V268, P6714; Lorenz U, 1996, J EXP MED, V184, P1111, DOI 10.1084/jem.184.3.1111; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Maasho K, 2005, MOL IMMUNOL, V42, P1521, DOI 10.1016/j.molimm.2005.01.004; Maynadie M, 2011, HAEMATOL-HEMATOL J, V96, P55, DOI 10.3324/haematol.2010.026252; Meyaard L, 2010, IMMUNOL LETT, V128, P26, DOI 10.1016/j.imlet.2009.09.014; Miller PG, 2013, CANCER CELL, V24, P45, DOI 10.1016/j.ccr.2013.05.004; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; Nordkamp MJMO, 2014, J LEUKOCYTE BIOL, V96, P105, DOI 10.1189/jlb.3AB0213-092RR; Paulson RF, 1996, NAT GENET, V13, P309, DOI 10.1038/ng0796-309; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; Sands WA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-33; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stedman DR, 2004, FEBS LETT, V566, P275, DOI 10.1016/j.febslet.2004.04.042; Sugihara E, 2012, ONCOGENE, V31, P2849, DOI 10.1038/onc.2011.462; Takai T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/275302; Tang XB, 2012, J IMMUNOL, V188, P548, DOI 10.4049/jimmunol.1102044; Tapley P, 1997, EXP HEMATOL, V25, P122; Tibaldi E, 2011, LEUKEMIA, V25, P1768, DOI 10.1038/leu.2011.152; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Tyson DR, 2002, ENDOCRINOLOGY, V143, P674, DOI 10.1210/en.143.2.674; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xiao X., 2012, Pharmaceutical compositions comprising naphthamides as antitumor agents, Patent No. [WO 2013067379, 2013067379]; Xu MJ, 2000, J BIOL CHEM, V275, P17440, DOI 10.1074/jbc.M001313200; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zheng JK, 2011, CELL STEM CELL, V9, P119, DOI 10.1016/j.stem.2011.06.003; Zheng JK, 2011, BLOOD, V117, P470, DOI 10.1182/blood-2010-06-291716	57	76	81	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2015	17	5					665	U286		10.1038/ncb3158	http://dx.doi.org/10.1038/ncb3158			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH1HG	25915125	Green Accepted			2022-12-25	WOS:000353771500014
J	Mailly, L; Xiao, F; Lupberger, J; Wilson, GK; Aubert, P; Duong, FHT; Calabrese, D; Leboeuf, C; Fofana, I; Thumann, C; Bandiera, S; Lurgehetmann, M; Volz, T; Davis, C; Harris, HJ; Mee, CJ; Girardi, E; Chane-Woon-Ming, B; Ericsson, M; Fletcher, N; Bartenschlager, R; Pessaux, P; Vercauteren, K; Meuleman, P; Villa, P; Kaderali, L; Pfeffer, S; Heim, MH; Neunlist, M; Zeisel, MB; Dandri, M; McKeating, JA; Robinet, E; Baumert, TF				Mailly, Laurent; Xiao, Fei; Lupberger, Joachim; Wilson, Garrick K.; Aubert, Philippe; Duong, Franois H. T.; Calabrese, Diego; Leboeuf, Celine; Fofana, Isabel; Thumann, Christine; Bandiera, Simonetta; Luergehetmann, Marc; Volz, Tassilo; Davis, Christopher; Harris, Helen J.; Mee, Christopher J.; Girardi, Erika; Chane-Woon-Ming, Beatrice; Ericsson, Maria; Fletcher, Nicola; Bartenschlager, Ralf; Pessaux, Patrick; Vercauteren, Koen; Meuleman, Philip; Villa, Pascal; Kaderali, Lars; Pfeffer, Sebastien; Heim, Markus H.; Neunlist, Michel; Zeisel, Mirjam B.; Dandri, Maura; McKeating, Jane A.; Robinet, Eric; Baumert, Thomas F.			Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody	NATURE BIOTECHNOLOGY			English	Article							HUMAN HEPATOCYTES; NEUTRALIZING ANTIBODIES; ENTRY FACTORS; HUMAN LIVER; CELL ENTRY; IN-VIVO; RECEPTOR; CD81; CLAUDIN-1; EXPRESSION	Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and cancer(1). Cell entry of HCV2 and other pathogens(3-5) is mediated by tight junction (TJ) proteins, but successful therapeutic targeting of TJ proteins has not been reported yet. Using a human liver-chimeric mouse model(6), we show that a monoclonal antibody specific for the TJ protein claudin-1 (ref. 7) eliminates chronic HCV infection without detectable toxicity. This antibody inhibits HCV entry, cell-cell transmission and virus-induced signaling events. Antibody treatment reduces the number of HCV-infected hepatocytes in vivo, highlighting the need for de novo infection by means of host entry factors to maintain chronic infection. In summary, we demonstrate that an antibody targeting a virus receptor can cure chronic viral infection and uncover TJ proteins as targets for antiviral therapy.	[Mailly, Laurent; Xiao, Fei; Lupberger, Joachim; Leboeuf, Celine; Fofana, Isabel; Thumann, Christine; Bandiera, Simonetta; Pessaux, Patrick; Zeisel, Mirjam B.; Robinet, Eric; Baumert, Thomas F.] Inst Rech Malad Virales & Hepat, Inst Natl Sante & Rech Med, U1110, Strasbourg, France; [Mailly, Laurent; Xiao, Fei; Lupberger, Joachim; Leboeuf, Celine; Fofana, Isabel; Thumann, Christine; Bandiera, Simonetta; Girardi, Erika; Chane-Woon-Ming, Beatrice; Pessaux, Patrick; Villa, Pascal; Pfeffer, Sebastien; Zeisel, Mirjam B.; Robinet, Eric; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Wilson, Garrick K.; Davis, Christopher; Harris, Helen J.; Mee, Christopher J.; Fletcher, Nicola; McKeating, Jane A.] Univ Birmingham, Inst Biomed Res, Hepatitis C Res Grp, Birmingham, W Midlands, England; [Aubert, Philippe; Neunlist, Michel] Inst Natl Sante & Rech Med, U913, Nantes, France; [Aubert, Philippe; Neunlist, Michel] Univ Nantes, Nantes, France; [Aubert, Philippe; Neunlist, Michel] CHU Nantes, Hop Hotel Dieu, Inst Malad Appareil Digestif, F-44035 Nantes 01, France; [Duong, Franois H. T.; Calabrese, Diego; Heim, Markus H.] Univ Basel, Dept Biomed, Hepatol Lab, Basel, Switzerland; [Luergehetmann, Marc; Volz, Tassilo; Dandri, Maura] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Girardi, Erika; Chane-Woon-Ming, Beatrice; Pfeffer, Sebastien] CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, Strasbourg, France; [Ericsson, Maria] Harvard Univ, Sch Med, Elect Microscopy Facil, Boston, MA 02115 USA; [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Bartenschlager, Ralf] Heidelberg Univ, German Ctr Infect Res, Heidelberg, Germany; [Pessaux, Patrick; Baumert, Thomas F.] Hop Univ Strasbourg, Inst Hosp Univ, Pole Hepatodigestif, Strasbourg, France; [Vercauteren, Koen; Meuleman, Philip] Univ Ghent, Ctr Vaccinol, B-9000 Ghent, Belgium; [Villa, Pascal] UdS & FMTS, CNRS, Medalis, Plateforme Chim Biol Integrat Strasbourg,UMS 3286, Illkirch Graffenstaden, France; [Kaderali, Lars] Tech Univ Dresden, Fac Med, Inst Med Informat & Biometry, D-01062 Dresden, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; German Center for Infection Research; Ruprecht Karls University Heidelberg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Technische Universitat Dresden	Baumert, TF (corresponding author), Inst Rech Malad Virales & Hepat, Inst Natl Sante & Rech Med, U1110, Strasbourg, France.	thomas.baumert@unistra.fr	Volz, Tassilo/U-1942-2019; Pfeffer, Sébastien/H-3212-2019; Dandri, Maura/ABG-4773-2021; Villa, Pascal/GRE-9521-2022; Heim, Markus/A-7526-2008; Neunlist, Michel/K-2388-2015; Aubert, Philippe/K-2352-2015; Zeisel, Mirjam B/E-9205-2016; Baumert, Thomas/ABF-4718-2020; Lupberger, Joachim/AAL-7721-2020; Girardi, Erika/P-5748-2015; Meuleman, Philip/H-2899-2013; Bartenschlager, Ralf/L-2582-2015; Xiao, Fei/E-7133-2013	Pfeffer, Sébastien/0000-0002-8458-348X; Dandri, Maura/0000-0002-0073-6689; Villa, Pascal/0000-0003-3466-4852; Heim, Markus/0000-0002-7523-4894; Aubert, Philippe/0000-0001-7471-7694; Zeisel, Mirjam B/0000-0003-1606-0131; Baumert, Thomas/0000-0002-8864-2168; Lupberger, Joachim/0000-0003-3996-3907; Girardi, Erika/0000-0001-6871-6628; Meuleman, Philip/0000-0001-6821-234X; Bartenschlager, Ralf/0000-0001-5601-9307; DUONG, Hong Tuan Francois/0000-0003-0928-2123; davis, chris/0000-0002-7317-3266; Xiao, Fei/0000-0001-7353-2700; Fletcher, Nicola/0000-0001-5593-9742; Mee, Christopher/0000-0002-6359-2694; Kaderali, Lars/0000-0002-2359-2294; Aubert, Philippe/0000-0002-3126-6202; Mailly, Laurent/0000-0001-6957-7463; Bandiera, Simonetta/0000-0002-7368-8155; Calabrese, Diego/0000-0002-0259-8611; Eric, ROBINET/0000-0001-9765-805X; Volz, Tassilo/0000-0003-3120-8958; McKeating, Jane/0000-0002-7229-5886; Vercauteren, Koen O.A./0000-0003-1472-9938	European Union (INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net) [ERC-2008-AdG-233130-HEPCENT, ERC-2010-StG-260767-ncRNAVIR]; ANRS (ANRS) [2009/183, 2009/136, 2011/132, 2012/239, 2013/108]; ANR (Laboratoires d'excellence) [ANR-10-LABX-0028_HEPSYS, ANR-10-LABX-36 netRNA)]; Fondation ARC pour la recherche (NanoISI and TheraHCC IHUARC) [IHU201301187]; Institut Hospitalo-Universitaire (IHU) Strasbourg; Wilhelm Sander Foundation; Wilhelm Sander Foundation, Region Alsace; Institut National du CancerInstitut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite de Strasbourg; Ghent University [GOA 01G01712]; Research Foundation-Flanders [1500910N, G052112N]; GIS-IBiSA (Groupement d'Interet Scientifique - Infrastructure en Biologie Sante et Agronomie) program; MRC [G0400802, G0801976, G1100247] Funding Source: UKRI; Medical Research Council [G0801976, G1100247, G0400802] Funding Source: researchfish	European Union (INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net); ANRS (ANRS)(French National Research Agency (ANR)); ANR (Laboratoires d'excellence)(French National Research Agency (ANR)); Fondation ARC pour la recherche (NanoISI and TheraHCC IHUARC); Institut Hospitalo-Universitaire (IHU) Strasbourg; Wilhelm Sander Foundation; Wilhelm Sander Foundation, Region Alsace(Region Grand-Est); Institut National du CancerInstitut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Ghent University(Ghent University); Research Foundation-Flanders(FWO); GIS-IBiSA (Groupement d'Interet Scientifique - Infrastructure en Biologie Sante et Agronomie) program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Union (ERC-2008-AdG-233130-HEPCENT, ERC-2010-StG-260767-ncRNAVIR, INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009 and 2012), ANRS (ANRS 2009/183, 2009/136, 2011/132, 2012/239, 2013/108), ANR (Laboratoires d'excellence ANR-10-LABX-0028_HEPSYS and ANR-10-LABX-36 netRNA), Fondation ARC pour la recherche (NanoISI and TheraHCC IHUARC IHU201301187), Institut Hospitalo-Universitaire (IHU) Strasbourg, the Wilhelm Sander Foundation, Region Alsace, Institut National du Cancer, the Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite de Strasbourg, the Ghent University (GOA 01G01712) and the Research Foundation-Flanders (projects 1500910N and G052112N). We are grateful to S. Ito (Harvard Medical School) for electron microscopy studies, F.-L. Cosset (Inserm U1111, ENS Lyon, France) and J. Ball (University of Nottingham, Nottingham, UK) for retroviral vectors for HCVpp production, F. Chisari (The Scripps Research Institute, La Jolla, CA, USA) for the gift of Huh7.5.1 cells, A. Patel (MRC Virology Unit, Glasgow, UK) for E2-specific mAb AP33 and Huh7.5-GFP cells, S. Foung (Stanford Blood Center, Palo Alto, CA, USA) for E2-specific mAb CHB-23 and C.M. Rice and M. Evans (Rockefeller University and Mount Sinai School of Medicine, New York) for providing human and mouse CLDN1 expression constructs as well as Huh7.5 cells. We acknowledge S. Durand, L. Heydmann, E. Soulier, J. Barths, N. Brignon, S. Pernot (Inserm U1110, Strasbourg), O. Wendling and N. Messadeq (Institut Clinique de la Souris - ICS, Illkirch), C. Valencia (PCBIS, Illkirch), S. Kallis (University of Heidelberg, Germany) for technical work, F. Grunert and J. Thompson (Aldevron, Freiburg) for helpful discussions, H. Jacob and M.F. Champy (ICS, Illkirch) for histopathological, hematological and biochemical analyzes, P. Bachellier (Strasbourg University Hospitals) for providing liver resections for isolation of primary human hepatocytes, the Laboratoire Schuh-groupement Bio67, Strasbourg and the Plateau Technique de Microbiologie, Laboratoire de Virologie (S. Fafi-Kremer and F. Stoll-Keller), University Hospital Strasbourg for performing viral load analyses, and the IGBMC (Institut de Genetique et de Biologie Moleculaire et Cellulaire) microarray and sequencing platform, member of the France Genomique program, for the sequencing of our libraries. Part of the animal experiments was carried out within the small animal exploration facility Cardiex (Nantes), which is supported by the GIS-IBiSA (Groupement d'Interet Scientifique - Infrastructure en Biologie Sante et Agronomie) program.	Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; Che PL, 2013, VIROLOGY, V446, P303, DOI 10.1016/j.virol.2013.08.009; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Dill MT, 2012, GASTROENTEROLOGY, V143, P777, DOI 10.1053/j.gastro.2012.05.044; Dubel S, 2014, HDB THERAPEUTIC ANTI; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fletcher NF, 2014, HEPATOLOGY, V59, P1320, DOI 10.1002/hep.26911; Fofana I, 2013, J VIROL, V87, P10405, DOI 10.1128/JVI.01691-13; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Fukumatsu M, 2012, CELL HOST MICROBE, V11, P325, DOI 10.1016/j.chom.2012.03.001; Haid S, 2014, HEPATOLOGY, V59, P24, DOI 10.1002/hep.26567; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2013, HEPATOLOGY, V57, P854, DOI 10.1002/hep.25910; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Shi N, 2013, GUT, V62, P1055, DOI 10.1136/gutjnl-2012-302600; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770; Zahid MN, 2013, HEPATOLOGY, V57, P492, DOI 10.1002/hep.26097; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	37	101	104	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					549	U169		10.1038/nbt.3179	http://dx.doi.org/10.1038/nbt.3179			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25798937	Green Submitted, Green Accepted			2022-12-25	WOS:000354314500039
J	Wei, SC; Fattet, L; Tsai, JH; Guo, YR; Pai, VH; Majeski, HE; Chen, AC; Sah, RL; Taylor, SS; Engler, AJ; Yang, J				Wei, Spencer C.; Fattet, Laurent; Tsai, Jeff H.; Guo, Yurong; Pai, Vincent H.; Majeski, Hannah E.; Chen, Albert C.; Sah, Robert L.; Taylor, Susan S.; Engler, Adam J.; Yang, Jing			Matrix stiffness drives epithelial mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR SNAIL; CADHERIN GENE-EXPRESSION; BREAST-CANCER; MALIGNANT BREAST; DUCTAL CARCINOMA; FIBROTIC FOCUS; COLLAGEN; CELLS; MORPHOGENESIS; PROGRESSION	Matrix stiffness potently regulates cellular behaviour in various biological contexts. In breast tumours, the presence of dense clusters of collagen fibrils indicates increased matrix stiffness and correlates with poor survival. It is unclear how mechanical inputs are transduced into transcriptional outputs to drive tumour progression. Here we report that TWIST1 is an essential mechanomediator that promotes epithelial-mesenchymal transition (EMT) in response to increasing matrix stiffness. High matrix stiffness promotes nuclear translocation of TWIST1 by releasing TWIST1 from its cytoplasmic binding partner G36P2. Loss of G3BP2 leads to constitutive TWIST1 nuclear localization and synergizes with increasing matrix stiffness to induce EMT and promote tumour invasion and metastasis. In human breast tumours, collagen fibre alignment, a marker of increasing matrix stiffness, and reduced expression of G3BP2 together predict poor survival. Our findings reveal a TWIST1-G3BP2 mechanotransduction pathway that responds to biomechanical signals from the tumour microenvironment to drive EMT, invasion and metastasis.	[Wei, Spencer C.; Fattet, Laurent; Tsai, Jeff H.; Pai, Vincent H.; Majeski, Hannah E.; Taylor, Susan S.; Yang, Jing] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wei, Spencer C.; Pai, Vincent H.; Majeski, Hannah E.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Guo, Yurong; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Chen, Albert C.; Sah, Robert L.; Engler, Adam J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Yang, Jing] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Yang, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jingyang@ucsd.edu	Engler, Adam/AAF-4016-2019; FATTET, Laurent/W-8392-2019; Fattet, Laurent/ABH-5434-2020	Engler, Adam/0000-0003-1642-5380; Fattet, Laurent/0000-0001-5152-4937; Wei, Spencer/0000-0001-9673-9683	UCSD Cancer Center [P30CA231011]; NIH [DP2OD002420-01, 1RO16869, DK54441, P01AG007996]; DOD Breast Cancer Program [W81XWH-13-1-0132]; ACS [RSG-09-282-01-CSM]; DOD [W81XWH-13-1-0133]; HHMI; NIH Cancer Cell Biology Training grant [2T32CA067754]; NIH Molecular Pathology of Cancer Training grant [5T32CA077109]; ARCS Foundation Scholar; Fondation pour la Recherche Medicate [SPE20130326547]; NATIONAL CANCER INSTITUTE [P30CA023100, T32CA067754, R01CA168689, T32CA077109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG007996] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002420] Funding Source: NIH RePORTER	UCSD Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Program(United States Department of Defense); ACS(American Cancer Society); DOD(United States Department of Defense); HHMI(Howard Hughes Medical Institute); NIH Cancer Cell Biology Training grant; NIH Molecular Pathology of Cancer Training grant; ARCS Foundation Scholar; Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thankk members of the Yang laboratory, especially M. Eckert, for helptul discussions. We thank the UCSD Shared Microscone Facility (P30NS047101), the UCSD Cancer Center Support Grant P30CA231011 and the NCI Cancer Diagnosis Program (CDP) for providing breast tumour tissue microarrays. The shREP control pLKO.1 plasmid was a kind gift from S. Stewart (Washington University in St Louis, USA). This Work was supported by grants NIH (DP2OD002420-01, 1RO16869), DOD Breast Cancer Program W81XWH-13-1-0132, and ACS (RSG-09-282-01-CSM) to J.Y., from DOD W81XWH-13-1-0133 to A.J.F., from NIH (DK54441) and HHMI to S.S.T., and from NIH (P01AG007996) to R.L.S. S.C.W was supported by a NIH Cancer Cell Biology Training grant (2T32CA067754), NIH Molecular Pathology of Cancer Training grant (5T32CA077109), and was an ARCS Foundation Scholar. L.F. was supported by a postdoctoral fellowship from Fondation pour la Recherche Medicate (SPE20130326547).	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chaudhuri T, 2010, METHODS MOL BIOL, V621, P185, DOI 10.1007/978-1-60761-063-2_13; Colpaert C, 2001, AM J SURG PATHOL, V25, P1557, DOI 10.1097/00000478-200112000-00016; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Guo YR, 2005, PROTEOMICS, V5, P4608, DOI 10.1002/pmic.200500052; Hajra KM, 2002, CANCER RES, V62, P1613; Hasebe T, 2002, MODERN PATHOL, V15, P502, DOI 10.1038/modpathol.3880555; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kakkad SM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116017; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Singh S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-47; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Wu HY, 2009, ANAL CHEM, V81, P7778, DOI 10.1021/ac9013435; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu Y, 2013, AM J PATHOL, V183, P1281, DOI 10.1016/j.ajpath.2013.06.021; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	50	505	513	11	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2015	17	5					678	U306		10.1038/ncb3157	http://dx.doi.org/10.1038/ncb3157			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH1HG	25893917	Green Accepted, Green Published			2022-12-25	WOS:000353771500015
J	Kalantzaki, M; Kitamura, E; Zhang, TL; Mino, A; Novak, B; Tanaka, TU				Kalantzaki, Maria; Kitamura, Etsushi; Zhang, Tongli; Mino, Akihisa; Novak, Bele; Tanaka, Tomoyuki U.			Kinetochore-microtubule error correction is driven by differentially regulated interaction modes	NATURE CELL BIOLOGY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; CHROMOSOME BI-ORIENTATION; N-TERMINAL TAIL; AURORA-B; BUDDING YEAST; PLUS ENDS; MOLECULAR-MECHANISMS; RING COMPLEX; SKA COMPLEX; ATTACHMENT	For proper chromosome segregation, sister kinetochores must interact with microtubules from opposite spindle poles (bi-orientation). To establish bi-orientation, aberrant kinetochore-microtubule attachments are disrupted (error correction) by aurora B kinase (Ipl1 in budding yeast). Paradoxically, during this disruption, new attachments are still formed efficiently to enable fresh attempts at bi-orientation. How this is possible remains an enigma. Here we show that kinetochore attachment to the microtubule lattice (lateral attachment) is impervious to aurora B regulation, but attachment to the microtubule plus end (end-on attachment) is disrupted by this kinase. Thus, a new lateral attachment is formed without interference, then converted to end-on attachment and released if incorrect. This process continues until bi-orientation is established and stabilized by tension across sister kinetochores. We reveal how aurora B specifically promotes disruption of the end-on attachment through phospho-regulation of kinetochore components Dam1 and Ndc80. Our results reveal fundamental mechanisms for promoting error correction for bi-orientation.	[Kalantzaki, Maria; Kitamura, Etsushi; Mino, Akihisa; Tanaka, Tomoyuki U.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Zhang, Tongli; Novak, Bele] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Dundee; University of Oxford	Tanaka, TU (corresponding author), Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dow St, Dundee DD1 5EH, Scotland.	t.tanaka@dundee.ac.uk	Novak, Bela/D-5365-2009; Zhang, Tongli/ABC-6568-2020; Kitamura, Etsushi/E-6334-2013; Tanaka, Tomoyuki U/A-4775-2008	Novak, Bela/0000-0002-6961-1366; Zhang, Tongli/0000-0003-1773-6279; Kitamura, Etsushi/0000-0002-3669-2518; Tanaka, Tomoyuki/0000-0002-9886-5947	Wellcome Trust [096535, 083524, 097945]; Medical Research Council [84678]; EC FP7 MitoSys [241548]; ERC advanced grant [322682]; Cancer Research UK [A6996]; Human Frontier Science Program [RGP0035-2009]; BBSRC; MRC [G0701147] Funding Source: UKRI; Medical Research Council [G0701147] Funding Source: researchfish; Wellcome Trust [096535/Z/11/Z] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC FP7 MitoSys; ERC advanced grant(European Research Council (ERC)); Cancer Research UK(Cancer Research UK); Human Frontier Science Program(Human Frontier Science Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Gierlinski and the Tanaka and Novak groups for discussion, E.Griffis and L. Clayton for reading the manuscript and A. Musacchio for advising on ndc80-CH-K6A mutations. We thank J-F. Maurc tor constructing the T7427 strain and dam1C-4D mutant, N. Kobayashi for making and testing the ipl1-321-aid mutant, R. Ciosk, J. E. Haber, Kanemaki, U. K. Laemmli, K. Nasmyth, K. E. Sawin, R. Y. Tsien, Uhlmann EUROSCARF and the Yeast Resource Centre for reagents and S. Swift and A. F.M. Ibrahim for technical help. This work was supported by the Wellcome Trust (096535, 083524, 097945), the Medical Research Council (84678), EC FP7 MitoSys (241548), an ERC advanced grant (322682), Cancer Research UK (A6996) and the Human Frontier Science Program (RGP0035-2009). M.K. received a BBSRC studentship. T.U.T. is a Wellcome Trust Principal Research Fellow.	Akiyoshi B, 2009, GENETICS, V183, P1591, DOI 10.1534/genetics.109.109041; Amberg DC., 2005, METHODS YEAST GENETI; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Biggins S, 2013, GENETICS, V194, P817, DOI 10.1534/genetics.112.145276; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Chan YW, 2012, J CELL BIOL, V196, P563, DOI 10.1083/jcb.201109001; Cheerambathur DK, 2013, SCIENCE, V342, P1239, DOI 10.1126/science.1246232; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Demirel PB, 2012, GENETICS, V192, P753, DOI 10.1534/genetics.112.143818; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Gandhi SR, 2011, DEV CELL, V21, P920, DOI 10.1016/j.devcel.2011.09.006; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Keating P, 2009, J CELL SCI, V122, P4375, DOI 10.1242/jcs.055566; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kitamura E, 2010, DEV CELL, V18, P248, DOI 10.1016/j.devcel.2009.12.018; Lampert F, 2013, J CELL BIOL, V200, P21, DOI 10.1083/jcb.201210091; Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nogales E, 2009, J CELL SCI, V122, P3831, DOI 10.1242/jcs.004689; Ramey VH, 2011, MOL BIOL CELL, V22, P4335, DOI 10.1091/mbc.E11-07-0659; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Sarangapani KK, 2013, P NATL ACAD SCI USA, V110, P7282, DOI 10.1073/pnas.1220700110; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka K, 2010, METHODS, V51, P206, DOI 10.1016/j.ymeth.2010.01.017; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Zhang TL, 2013, BIOPHYS J, V104, P2595, DOI 10.1016/j.bpj.2013.05.005	57	47	48	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					421	+		10.1038/ncb3128	http://dx.doi.org/10.1038/ncb3128			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25751138	Green Accepted, Green Submitted			2022-12-25	WOS:000351920500012
J	Klutstein, M; Fennell, A; Fernandez-Alvarez, A; Cooper, JP				Klutstein, Michael; Fennell, Alex; Fernandez-alvarez, Alfonso; Cooper, Julia Promisel			The telomere bouquet regulates meiotic centromere assembly	NATURE CELL BIOLOGY			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; SPINDLE-POLE BODY; FISSION YEAST; CENP-A; GENE DISRUPTION; NUCLEAR-MOVEMENT; CHROMO DOMAIN; PROTEIN; KINETOCHORE; MEIOSIS	The role of the conserved meiotic telomere bouquet has been enigmatic for over a century. We showed previously that disruption of the fission yeast bouquet impairs spindle formation in approximately half of meiotic cells. Surprisingly, bouquet-deficient meiocytes with functional spindles harbour chromosomes that fail to achieve spindle attachment. Kinetochore proteins and the centromeric histone H3 variant Cnp1 fail to localize to those centromeres that exhibit spindle attachment defects in the bouquet's absence. The HP1 orthologue Swi6 also fails to bind these centromeres, suggesting that compromised pericentromeric heterochromatin underlies the kinetochore defects. We find that centromeres are prone to disassembly during meiosis, but this is reversed by localization of centromeres to the telomere-proximal microenvironment, which is conducive to heterochromatin formation and centromere reassembly. Accordingly, artificially tethering a centromere to a telomere rescues the tethered centromere but not other centromeres. These results reveal an unanticipated level of control of centromeres by telomeres.	[Klutstein, Michael; Fennell, Alex; Fernandez-alvarez, Alfonso; Cooper, Julia Promisel] NCI, NIH, Bethesda, MD 20892 USA; [Klutstein, Michael; Fennell, Alex; Fernandez-alvarez, Alfonso; Cooper, Julia Promisel] London Res Inst, Canc Res UK, London WC2A 3LY, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cancer Research UK	Cooper, JP (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	Julie.Cooper@nih.gov	Fernandez-Alvarez, Alfonso/N-1249-2016; Klutstein, Michael/AAY-1773-2020; Alvarez, Alfonso Fernandez/S-2227-2019	Fernandez-Alvarez, Alfonso/0000-0002-7455-1425; Klutstein, Michael/0000-0002-4041-3112; cooper, julia promisel/0000-0003-2171-2587	National Institutes of Health, Cancer Research UK; European Research Council; Marie Curie fellowhip; NATIONAL CANCER INSTITUTE [ZIABC011519] Funding Source: NIH RePORTER	National Institutes of Health, Cancer Research UK; European Research Council(European Research Council (ERC)European Commission); Marie Curie fellowhip; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank our current and former laboratory members for discussions and advice, and R. Allshire (Wellcome Trust, University of Edinburgh, UK), M. Sato (University of Tokyo, Japan), T. Toda (Cancer Research UK, UK) and Y. Watanabe (University of Tokyo, Japan) for strains and reagents. We thank M. Lichten, S. Grewal and their laboratory members for discussions and help with reagents and equipment during our recent move. This work was supported by the National Institutes of Health, Cancer Research UK, the European Research Council, and a Marie Curie fellowhip to M.K.	Asakawa H, 2005, MOL BIOL CELL, V16, P2325, DOI 10.1091/mbc.e04-11-0996; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Chikashige Y, 2014, CELL STRUCT FUNCT, V39, P93, DOI 10.1247/csf.14007; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Davis L, 2006, GENETICS, V174, P167, DOI 10.1534/genetics.106.059733; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dodgson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2813; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; Fennell A, 2015, J CELL BIOL, V208, P415, DOI 10.1083/jcb.201409058; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Hayashi A, 2006, MOL BIOL CELL, V17, P5173, DOI 10.1091/mbc.E06-05-0388; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hiraoka Y, 2000, CHROMOSOMA, V109, P103, DOI 10.1007/s004120050417; Jain D, 2010, NATURE, V467, P223, DOI 10.1038/nature09374; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klutstein M, 2014, CURR OPIN CELL BIOL, V26, P123, DOI 10.1016/j.ceb.2013.12.004; Liu L, 2002, EMBO REP, V3, P230, DOI 10.1093/embo-reports/kvf055; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nakashima H, 2005, J CELL SCI, V118, P5885, DOI 10.1242/jcs.02702; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Sadaie M, 2003, GENE DEV, V17, P2271, DOI 10.1101/gad.1112103; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Smith KM, 2011, MOL CELL BIOL, V31, P2528, DOI 10.1128/MCB.01285-10; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; Tomita K, 2013, EMBO REP, V14, P252, DOI 10.1038/embor.2012.218; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yoshida M, 2013, J CELL BIOL, V200, P385, DOI 10.1083/jcb.201207168	55	38	39	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					458	+		10.1038/ncb3132	http://dx.doi.org/10.1038/ncb3132			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25774833	Green Accepted			2022-12-25	WOS:000351920500016
J	Chand, MK; Nirwan, N; Diffin, FM; van Aelst, K; Kulkarni, M; Pernstich, C; Szczelkun, MD; Saikrishnan, K				Chand, Mahesh K.; Nirwan, Neha; Diffin, Fiona M.; van Aelst, Kara; Kulkarni, Manasi; Pernstich, Christian; Szczelkun, Mark D.; Saikrishnan, Kayarat			Translocation-coupled DNA cleavage by the Type ISP restriction-modification enzymes	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; MOLECULAR MACHINES; X-RAY; HELICASE; MECHANISM; SPECIFICITY; MOTOR; LLAGI; ECOR124I	Production of endonucleolytic double-strand DNA breaks requires separate strand cleavage events. Although catalytic mechanisms for simple, dimeric endonucleases are known, there are many complex nuclease machines that are poorly understood. Here we studied the single polypeptide Type ISP restriction-modification (RM) enzymes, which cleave random DNA between distant target sites when two enzymes collide after convergent ATP-driven translocation. We report the 2.7- resolution X-ray crystal structure of a Type ISP enzyme-DNA complex, revealing that both the helicase-like ATPase and nuclease are located upstream of the direction of translocation, an observation inconsistent with simple nuclease-domain dimerization. Using single-molecule and biochemical techniques, we demonstrate that each ATPase remodels its DNA-protein complex and translocates along DNA without looping it, leading to a collision complex in which the nuclease domains are distal. Sequencing of the products of single cleavage events suggests a previously undescribed endonuclease model, where multiple, stochastic strand-nicking events combine to produce DNA scission.	[Chand, Mahesh K.; Nirwan, Neha; Kulkarni, Manasi; Saikrishnan, Kayarat] Indian Inst Sci Educ & Res, Div Biol, Pune, Maharashtra, India; [Diffin, Fiona M.; van Aelst, Kara; Pernstich, Christian; Szczelkun, Mark D.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol, Avon, England	Indian Institute of Science Education & Research (IISER) Pune; University of Bristol	Chand, MK (corresponding author), Indian Inst Sci Educ & Res, Div Biol, Pune, Maharashtra, India.	mark.szczelkun@bristol.ac.uk; saikrishnan@iiserpune.ac.in		Nirwan, Neha/0000-0002-2337-1723; Szczelkun, Mark/0000-0002-2501-6602; Chand, Mahesh/0000-0001-9397-395X	Wellcome Trust-DBT India Alliance [500048-Z-09-Z]; Wellcome Trust [084086]; DBT India; CSIR India; Biotechnology and Biological Sciences Research Council [BB/D009715/1] Funding Source: researchfish; BBSRC [BB/D009715/1] Funding Source: UKRI	Wellcome Trust-DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); Wellcome Trust(Wellcome TrustEuropean Commission); DBT India(Department of Biotechnology (DBT) India); CSIR India(Council of Scientific & Industrial Research (CSIR) - India); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust-DBT India Alliance (500048-Z-09-Z to K.S.), Wellcome Trust (084086 to M.D.S., K.v.A., F.M.D. and C.P.), DBT India (to M.K.C.), and CSIR India (to N.N.). K.S. acknowledges K. Nagai and his group members at MRC Laboratory of Molecular Biology, Cambridge, UK, for hosting him as an India Alliance visiting scientist during the initial stage of this work. We thank K. Nagai, D. Wigley, L. Passmore and R. Chauhan for their comments on the manuscript. We acknowledge Diamond Light Source (DLS), Oxfordshire, UK, European Synchrotron	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Butterer A, 2014, NUCLEIC ACIDS RES, V42, P5139, DOI 10.1093/nar/gku122; Calisto RM, 2005, J MOL BIOL, V351, P749, DOI 10.1016/j.jmb.2005.06.050; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDLICH B, 1985, J BIOL CHEM, V260, P5729; Fagerburg MV, 2012, NUCLEIC ACIDS RES, V40, P8416, DOI 10.1093/nar/gks641; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Halford SE, 2004, ANNU REV BIOPH BIOM, V33, P1, DOI 10.1146/annurev.biophys.33.110502.132711; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jindrova E, 2005, NUCLEIC ACIDS RES, V33, P1760, DOI 10.1093/nar/gki322; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kennaway CK, 2012, GENE DEV, V26, P92, DOI 10.1101/gad.179085.111; Kim JS, 2005, P NATL ACAD SCI USA, V102, P3248, DOI 10.1073/pnas.0409851102; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; LINN S, 1968, P NATL ACAD SCI USA, V59, P1300, DOI 10.1073/pnas.59.4.1300; Lionnet Timothee, 2012, Cold Spring Harb Protoc, V2012, P133, DOI 10.1101/pdb.prot067496; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Park SY, 2012, ACTA CRYSTALLOGR D, V68, P1570, DOI 10.1107/S0907444912038826; Ramanathan SP, 2009, P NATL ACAD SCI USA, V106, P1748, DOI 10.1073/pnas.0807193106; Rao DN, 2014, NUCLEIC ACIDS RES, V42, P45, DOI 10.1093/nar/gkt616; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Schwarz FW, 2013, SCIENCE, V340, P353, DOI 10.1126/science.1231122; Seidel R, 2005, EMBO J, V24, P4188, DOI 10.1038/sj.emboj.7600881; Seidel R, 2004, NAT STRUCT MOL BIOL, V11, P838, DOI 10.1038/nsmb816; Shen BW, 2011, NUCLEIC ACIDS RES, V39, P8223, DOI 10.1093/nar/gkr543; Sisakova E, 2013, NUCLEIC ACIDS RES, V41, P1071, DOI 10.1093/nar/gks1209; Sisakova E, 2008, J MOL BIOL, V384, P1273, DOI 10.1016/j.jmb.2008.10.017; Smith RM, 2009, NUCLEIC ACIDS RES, V37, P7219, DOI 10.1093/nar/gkp794; Smith RM, 2009, NUCLEIC ACIDS RES, V37, P7231, DOI 10.1093/nar/gkp795; Smith RM, 2009, NUCLEIC ACIDS RES, V37, P7206, DOI 10.1093/nar/gkp790; Stanley LK, 2006, EMBO J, V25, P2230, DOI 10.1038/sj.emboj.7601104; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Aelst K, 2013, NUCLEIC ACIDS RES, V41, P1081, DOI 10.1093/nar/gks1210; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200	59	17	17	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					870	U93		10.1038/nchembio.1926	http://dx.doi.org/10.1038/nchembio.1926			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26389736	Green Submitted, Green Accepted			2022-12-25	WOS:000363272100013
J	Kyung, T; Lee, S; Kim, JE; Cho, T; Park, H; Jeong, YM; Kim, D; Shin, A; Kim, S; Baek, J; Kim, J; Kim, NY; Woo, D; Chae, S; Kim, CH; Shin, HS; Han, YM; Kim, D; Heo, WD				Kyung, Taeyoon; Lee, Sangkyu; Kim, Jung Eun; Cho, Taesup; Park, Hyerim; Jeong, Yun-Mi; Kim, Dongkyu; Shin, Anna; Kim, Sungsoo; Baek, Jinhee; Kim, Jihoon; Kim, Na Yeon; Woo, Doyeon; Chae, Sujin; Kim, Cheol-Hee; Shin, Hee-Sup; Han, Yong-Mahn; Kim, Daesoo; Heo, Won Do			Optogenetic control of endogenous Ca2+ channels in vivo	NATURE BIOTECHNOLOGY			English	Article							CRAC CHANNELS; NEURONAL-ACTIVITY; BLUE-LIGHT; STEM-CELLS; PROTEIN; CALCIUM; STIM1; SIGNALS; TRANSCRIPTION; ACTIVATION	Calcium (Ca2+) signals that are precisely modulated in space and time mediate a myriad of cellular processes, including contraction, excitation, growth, differentiation and apoptosis(1). However, study of Ca2+ responses has been hampered by technological limitations of existing Ca2+-modulating tools. Here we present OptoSTIM1, an optogenetic tool for manipulating intracellular Ca2+ levels through activation of Ca2+-selective endogenous Ca2+ release-activated Ca2+ (CRAC) channels. Using OptoSTIM1, which combines a plant photoreceptor(2,3) and the CRAC channel regulator STIM1 (ref. 4), we quantitatively and qualitatively controlled intracellular Ca2+ levels in various biological systems, including zebrafish embryos and human embryonic stem cells. We demonstrate that activating OptoSTIM1 in the CA1 hippocampal region of mice selectively reinforced contextual memory formation. The broad utility of OptoSTIM1 will expand our mechanistic understanding of numerous Ca2+-associated processes and facilitate screening for drug candidates that antagonize Ca2+ signals.	[Kyung, Taeyoon; Kim, Jung Eun; Park, Hyerim; Kim, Dongkyu; Shin, Anna; Kim, Sungsoo; Kim, Jihoon; Kim, Na Yeon; Woo, Doyeon; Han, Yong-Mahn; Kim, Daesoo; Heo, Won Do] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Lee, Sangkyu; Cho, Taesup; Baek, Jinhee; Shin, Hee-Sup; Heo, Won Do] Inst for Basic Sci Korea, Ctr Cognit & Social, Daejeon, South Korea; [Jeong, Yun-Mi; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Daejeon, South Korea; [Baek, Jinhee; Shin, Hee-Sup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Chae, Sujin; Heo, Won Do] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Daejeon, South Korea; [Heo, Won Do] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Canc Metastasis Control Ctr, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Han, YM (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea.	ymhan57@kaist.ac.kr; daesoo@kaist.ac.kr; wondo@kaist.ac.kr	Kim, Daesoo/C-1625-2011; Heo, Won-Do/C-1696-2011; Han, Yong-Mahn/C-1652-2011	Kim, Daesoo/0000-0001-9915-1463; Baek, Jinhee/0000-0002-0998-0047; KIM, SUNGSOO/0000-0003-0949-4214; Kim, Cheol-Hee/0000-0002-3019-0699; Lee, Sangkyu/0000-0002-6916-3372	Institute for Basic Science [IBS-R001-G1]; NRF Stem Cell Program - MSIP, KAIST Institute for the BioCentury [2011-0019509]; National Leading Research Laboratory Program - Ministry of Science, ICT and Future Planning, Republic of Korea [2011-0028772]	Institute for Basic Science; NRF Stem Cell Program - MSIP, KAIST Institute for the BioCentury; National Leading Research Laboratory Program - Ministry of Science, ICT and Future Planning, Republic of Korea	We thank C.L. Tucker (University of Colorado) for cDNA encoding CRY2PHR-mCherry, T.Inoue (Johns Hopkins University) for cDNA encoding Tom20-FRB, P. Gardner (Stanford University) for cDNA encoding NFATc1-GFP, D.Lee for fruitful discussions and N.Kim for advice on data analysis. This work was supported by the Institute for Basic Science (IBS-R001-G1), the NRF Stem Cell Program (2011-0019509) funded by MSIP, KAIST Institute for the BioCentury, and the National Leading Research Laboratory Program by the Ministry of Science, ICT and Future Planning (2011-0028772 to Daesoo K.), Republic of Korea.	Apati A, 2012, MOL CELL ENDOCRINOL, V353, P57, DOI 10.1016/j.mce.2011.08.038; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Chin-Smith EC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00169; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fukuda N, 2014, ACS CHEM BIOL, V9, P1197, DOI 10.1021/cb400849n; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hooper R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005556; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim N, 2014, CHEM BIOL, V21, P903, DOI 10.1016/j.chembiol.2014.05.013; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Muto A, 2013, CURR BIOL, V23, P307, DOI 10.1016/j.cub.2012.12.040; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Pham E, 2011, CHEM BIOL, V18, P880, DOI 10.1016/j.chembiol.2011.04.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Tsutajima J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083129; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	40	106	110	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1092	+		10.1038/nbt.3350	http://dx.doi.org/10.1038/nbt.3350			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26368050				2022-12-25	WOS:000362555700030
J	Ceglia, I; Reitz-, C; Gresack, J; Ahn, JH; Bustos, V; Bleck, M; Zhang, XZ; Martin, G; Simon, SM; Nairn, AC; Greengard, P; Kim, Y				Ceglia, Ilaria; Reitz-, Christiane; Gresack, Jodi; Ahn, Jung-Hyuck; Bustos, Victor; Bleck, Marina; Zhang, Xiaozhu; Martin, Grant; Simon, Sanford M.; Nairn, Angus C.; Greengard, Paul; Kim, Yong			APP intracellular domain-WAVE1 pathway reduces amyloid-beta production	NATURE MEDICINE			English	Article							PRECURSOR PROTEIN VARIANT; ALZHEIMERS-DISEASE; IN-VIVO; ENVIRONMENTAL ENRICHMENT; ACTIN POLYMERIZATION; GENE-EXPRESSION; GAMMA-SECRETASE; MEMBRANE; MICE; AICD	An increase in amyloid-beta (A beta) production is a major pathogenic mechanism associated with Alzheimer's disease (AD)(1,2), but little is known about possible homeostatic control of the amyloidogenic pathway. Here we report that the amyloid precursor protein (APP) intracellular domain (AICD) downregulates Wiskott-Aldrich syndrome protein (WASP)-family verprolin homologous protein 1 (WAVE1 or WASF1) as part of a negative feedback mechanism to limit A beta production. The AICD binds to the Wasf1 promoter, negatively regulates its transcription and downregulates Wasf1 mRNA and protein expression in Neuro 2a (N2a) cells. WAVE1 interacts and colocalizes with APP in the Golgi apparatus. Experimentally reducing WAVE1 in N2a cells decreased the budding of APP-containing vesicles and reduced cell-surface APP, thereby reducing the production of A beta. WAVE1 downregulation was observed in mouse models of AD. Reduction of Wasf1 gene expression dramatically reduced A beta levels and restored memory deficits in a mouse model of AD. A decrease in amounts of WASF1 mRNA was also observed in human AD brains, suggesting clinical relevance of the negative feedback circuit involved in homeostatic regulation of Ab production.	[Ceglia, Ilaria; Gresack, Jodi; Bustos, Victor; Zhang, Xiaozhu; Martin, Grant; Nairn, Angus C.; Greengard, Paul; Kim, Yong] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10021 USA; [Reitz-, Christiane] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Reitz-, Christiane] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Reitz-, Christiane] Columbia Univ, Dept Neurol, New York, NY USA; [Reitz-, Christiane] Columbia Univ, Dept Epidemiol, New York, NY USA; [Ahn, Jung-Hyuck] Ewha Womans Univ, Dept Biochem, Seoul, South Korea; [Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Seoul, South Korea; [Bleck, Marina; Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10021 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Rockefeller University; Columbia University; Columbia University; Columbia University; Columbia University; Ewha Womans University; Ewha Womans University; Rockefeller University; Yale University	Kim, Y (corresponding author), Rockefeller Univ, Lab Mol & Cellular Neurosci, 1230 York Ave, New York, NY 10021 USA.	kimyo@rockefeller.edu	Reitz, Christiane/GNP-0257-2022	Nairn, Angus/0000-0002-7075-0195; Greengard, Paul/0000-0002-4437-0893; Simon, Sanford/0000-0002-8615-4224; Ahn, Jung-Hyuck/0000-0001-9589-3881; Ceglia, Ilaria/0000-0003-0692-9518; Kim, Yong/0000-0002-1387-2962	US National Institutes of Health [AG009464, AG047270]; Fisher Center for Alzheimer's Research Foundation; US Department of Defense-USAMRAA [W81XWH-09-1-0392, W81XWH-09-1-0402]; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2010-0027945]; NATIONAL INSTITUTE ON AGING [P50AG047270, P01AG009464] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fisher Center for Alzheimer's Research Foundation; US Department of Defense-USAMRAA(United States Department of Defense); National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (grants AG009464 (to P.G.) and AG047270 (to A.C.N.)), the Fisher Center for Alzheimer's Research Foundation (to P.G.) and the US Department of Defense-USAMRAA (grants W81XWH-09-1-0392 (to Y.K.) and W81XWH-09-1-0402 (to P.G.)). J.-H.A. was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2010-0027945). We thank W. Luo for protocols for metabolic pulse labeling and chase and organelle fractionation; W.J. Netzer (The Rockefeller University, New York, New York, USA) for sAPP beta antibody and mNotch Delta E plasmid; D. Cai for the budding-assay protocol; and S.S. Sisodia for the pCB6-APP695wt and pCB6-APP695swe plasmids. We also thank A. Schaeffer, P. Kurup, P. Lombroso, D. Tampellini, G. Gouras and R. Moir for discussion or sharing of materials. We acknowledge R. Norinsky and The Rockefeller University Transgenics Services Laboratory for their excellent in vitro fertilization services, Z. Dong for research assistance and E. Griggs for graphics.	Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Gresack JE, 2007, NEUROBIOL LEARN MEM, V88, P393, DOI 10.1016/j.nlm.2007.07.015; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harburger LL, 2007, BEHAV BRAIN RES, V185, P43, DOI 10.1016/j.bbr.2007.07.009; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Konietzko U, 2012, CURR ALZHEIMER RES, V9, P200, DOI 10.2174/156720512799361673; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; LO ACY, 1994, J BIOL CHEM, V269, P30966; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 2012, TRENDS CELL BIOL, V22, P141, DOI 10.1016/j.tcb.2012.01.001; Suzuki T, 2000, GENOMICS, V63, P246, DOI 10.1006/geno.1999.6053; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Urmoneit B, 1998, J MOL NEUROSCI, V11, P141, DOI 10.1385/JMN:11:2:141; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011	41	27	27	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1054	+		10.1038/nm.3924	http://dx.doi.org/10.1038/nm.3924			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26280122	Green Accepted			2022-12-25	WOS:000360961300018
J	Choi, J; Goh, G; Walradt, T; Hong, BS; Bunick, CG; Chen, K; Bjornson, RD; Maman, Y; Wang, T; Tordoff, J; Carlson, K; Overton, JD; Liu, KJ; Lewis, JM; Devine, L; Barbarotta, L; Foss, FM; Subtil, A; Vonderheid, EC; Edelson, RL; Schatz, DG; Boggon, TJ; Girardi, M; Lifton, RP				Choi, Jaehyuk; Goh, Gerald; Walradt, Trent; Hong, Bok S.; Bunick, Christopher G.; Chen, Kan; Bjornson, Robert D.; Maman, Yaakov; Wang, Tiffany; Tordoff, Jesse; Carlson, Kacie; Overton, John D.; Liu, Kristina J.; Lewis, Julia M.; Devine, Lesley; Barbarotta, Lisa; Foss, Francine M.; Subtil, Antonio; Vonderheid, Eric C.; Edelson, Richard L.; Schatz, David G.; Boggon, Titus J.; Girardi, Michael; Lifton, Richard P.			Genomic landscape of cutaneous T cell lymphoma	NATURE GENETICS			English	Article							COPY-NUMBER ALTERATION; MUTATIONS; CANCER; IDENTIFICATION; RHOA; GENE; EXPRESSION; PROTEIN; KINASE; CD80	Cutaneous T cell lymphoma (CTCL) is a non-Hodgkin lymphoma of skin-homing T lymphocytes. We performed exome and whole-genome DNA sequencing and RNA sequencing on purified CTCL and matched normal cells. The results implicate mutations in 17 genes in CTCL pathogenesis, including genes involved in T cell activation and apoptosis, NF-kappa B signaling, chromatin remodeling and DNA damage response. CTCL is distinctive in that somatic copy number variants (SCNVs) comprise 92% of all driver mutations (mean of 11.8 pathogenic SCNVs versus 1.0 somatic single-nucleotide variant per CTCL). These findings have implications for new therapeutics.	[Choi, Jaehyuk; Walradt, Trent; Hong, Bok S.; Bunick, Christopher G.; Chen, Kan; Wang, Tiffany; Tordoff, Jesse; Carlson, Kacie; Liu, Kristina J.; Lewis, Julia M.; Foss, Francine M.; Subtil, Antonio; Edelson, Richard L.; Girardi, Michael] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Choi, Jaehyuk] Dept Vet Affairs Connecticut Healthcare, Dept Dermatol, West Haven, CT USA; [Goh, Gerald; Maman, Yaakov; Schatz, David G.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Goh, Gerald; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bjornson, Robert D.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Maman, Yaakov; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Overton, John D.] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Devine, Lesley] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Barbarotta, Lisa; Foss, Francine M.] Yale Univ, Sch Med, Dept Med Hematol, New Haven, CT USA; [Vonderheid, Eric C.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sydney Kimmel Canc Ctr, Baltimore, MD 21205 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Yale Ctr Mendelian Genom, New Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Johns Hopkins University; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Choi, Jaehyuk/N-6532-2019; Hong, Bok Sil/GYQ-5150-2022; Edelson, Richard/AAD-4826-2019; Goh, Gerald/N-1684-2015; Bunick, Christopher/AAD-3842-2021	Choi, Jaehyuk/0000-0003-2379-2226; Goh, Gerald/0000-0002-3832-6466; Bunick, Christopher/0000-0002-4011-8308; , Trent/0000-0003-1081-0923; Girardi, Michael/0000-0003-1887-9343; Hong, Bok Sil/0000-0002-2710-7727; Chen, Kan/0000-0002-5007-0205	Dermatology Foundation; Yale Specialized Program of Research Excellence (SPORE) in Skin Cancer Career Development Award; Yale SPORE in Skin Cancer [P50 CA121974]; Agency for Science, Technology and Research, Singapore; US National Institutes of Health (NIH) [RO1 CA102703]; NATIONAL CANCER INSTITUTE [R01CA102703, P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER	Dermatology Foundation; Yale Specialized Program of Research Excellence (SPORE) in Skin Cancer Career Development Award; Yale SPORE in Skin Cancer; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge the participation of the patients who made this research possible. We are grateful to I. Tikhonova and the staff of the Yale Center for Genome Analysis for their expert production of DNA and RNA sequence. Work was supported by the Dermatology Foundation and the Yale Specialized Program of Research Excellence (SPORE) in Skin Cancer Career Development Award (J.C.);. the Yale SPORE in Skin Cancer, P50 CA121974 (T.J.B.); the Agency for Science, Technology and Research, Singapore (G.G.); and US National Institutes of Health (NIH) grant RO1 CA102703 (M.G.). D.G.S. and R.P.L. are investigators of the Howard Hughes Medical Institute.	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Braun FCM, 2011, LEUKEMIA, V25, P1494, DOI 10.1038/leu.2011.101; Caprini E, 2009, CANCER RES, V69, P8438, DOI 10.1158/0008-5472.CAN-09-2367; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Choi J, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12197; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Girardi M, 2004, NEW ENGL J MED, V350, P1978, DOI 10.1056/NEJMra032810; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gregoire JM, 1999, J BIOL CHEM, V274, P6567, DOI 10.1074/jbc.274.10.6567; Guenova E, 2013, CLIN CANCER RES, V19, P3755, DOI 10.1158/1078-0432.CCR-12-3488; Haddad BR, 2013, AM J PATHOL, V182, P2264, DOI 10.1016/j.ajpath.2013.02.044; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hidaka T, 2008, BLOOD, V112, P383, DOI 10.1182/blood-2008-01-131185; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; Kopp KL, 2013, CELL CYCLE, V12, P1939, DOI 10.4161/cc.24987; Kozarewa I, 2011, METHODS MOL BIOL, V733, P257, DOI 10.1007/978-1-61779-089-8_18; Laharanne E, 2010, J INVEST DERMATOL, V130, P1707, DOI 10.1038/jid.2010.8; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Legarda-Addison D, 2007, J IMMUNOL, V178, P7767, DOI 10.4049/jimmunol.178.12.7767; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Lin WM, 2012, J INVEST DERMATOL, V132, P188, DOI 10.1038/jid.2011.254; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Mayer T, 1999, ONCOGENE, V18, P2117, DOI 10.1038/sj.onc.1202537; Mayrhofer M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r24; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meyer SC, 2014, CLIN CANCER RES, V20, P2051, DOI 10.1158/1078-0432.CCR-13-0279; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Neri A, 1996, LEUKEMIA LYMPHOMA, V23, P43, DOI 10.3109/10428199609054800; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Rangwala S, 2012, FUTURE MED CHEM, V4, P471, DOI [10.4155/FMC.12.6, 10.4155/fmc.12.6]; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Slavik JM, 1999, J BIOL CHEM, V274, P3116, DOI 10.1074/jbc.274.5.3116; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Wong HK, 2013, DISCOV MED, V16, P71; Wong HK, 2011, BRIT J HAEMATOL, V155, P150, DOI 10.1111/j.1365-2141.2011.08852.x; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang Q, 2014, J IMMUNOL, V192, P2913, DOI 10.4049/jimmunol.1302951; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110; Zinzani PL, 2007, J CLIN ONCOL, V25, P4293, DOI 10.1200/JCO.2007.11.4207	75	256	261	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1011	+		10.1038/ng.3356	http://dx.doi.org/10.1038/ng.3356			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26192916	Green Accepted			2022-12-25	WOS:000360394100011
J	Farrow, SC; Hagel, JM; Beaudoin, GAW; Burns, DC; Facchini, PJ				Farrow, Scott C.; Hagel, Jillian M.; Beaudoin, Guillaume A. W.; Burns, Darcy C.; Facchini, Peter J.			Stereochemical inversion of (S)-reticuline by a cytochrome P450 fusion in opium poppy	NATURE CHEMICAL BIOLOGY			English	Article							BENZYLISOQUINOLINE ALKALOID METABOLISM; (S)-TETRAHYDROPROTOBERBERINE OXIDASE; NOSCAPINE BIOSYNTHESIS; MORPHINE ALKALOIDS; MOLECULAR-CLONING; COPTIS-JAPONICA; CULTURED-CELLS; SYNTHASE; 1,2-DEHYDRORETICULINE; REDUCTASE	The gateway to morphine biosynthesis in opium poppy (Papaver somniferum) is the stereochemical inversion of (S)-reticuline since the enzyme yielding the first committed intermediate salutaridine is specific for (R)-reticuline. A fusion between a cytochrome P450 (CYP) and an aldo-keto reductase (AKR) catalyzes the S-to-R epimerization of reticuline via 1,2-dehydroreticuline. The reticuline epimerase (REPI) fusion was detected in opium poppy and in Papaver bracteatum, which accumulates thebaine. In contrast, orthologs encoding independent CYP and AKR enzymes catalyzing the respective synthesis and reduction of 1,2-dehydroreticuline were isolated from Papaver rhoeas, which does not accumulate morphinan alkaloids. An ancestral relationship between these enzymes is supported by a conservation of introns in the gene fusions and independent orthologs. Suppression of REPI transcripts using virus-induced gene silencing in opium poppy reduced levels of (R)-reticuline and morphinan alkaloids and increased the overall abundance of (S)-reticuline and its O-methylated derivatives. Discovery of REPI completes the isolation of genes responsible for known steps of morphine biosynthesis.	[Farrow, Scott C.; Hagel, Jillian M.; Beaudoin, Guillaume A. W.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Burns, Darcy C.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada	University of Calgary; University of Toronto	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca		Facchini, Peter/0000-0002-7693-290X; Farrow, Scott/0000-0001-7106-8924	Genome Canada; Genome Alberta; Government of Alberta; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures	Genome Canada(Genome Canada); Genome Alberta; Government of Alberta; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures	We thank D. Nelson (University of Tennessee) for assigning the CYP nomenclature. This work was supported by grants from Genome Canada, Genome Alberta, the Government of Alberta, the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada to P.J.F. S.C.F. and G.A. W.B. were recipients of scholarships from the Natural Sciences and Engineering Research Council of Canada. S.C.F. also received a scholarship from Alberta Innovates Technology Futures.	Akashi T, 1999, PLANT CELL PHYSIOL, V40, P1182, DOI 10.1093/oxfordjournals.pcp.a029505; Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; AMANN M, 1987, PHYTOCHEMISTRY, V26, P3235, DOI 10.1016/S0031-9422(00)82477-2; AMANN M, 1988, EUR J BIOCHEM, V175, P17, DOI 10.1111/j.1432-1033.1988.tb14160.x; BALLANCE GM, 1995, PLANT PHYSIOL, V107, P1027, DOI 10.1104/pp.107.3.1027; Battersby A.R., 1968, J CHEM SOC C, V1968, P210; BATTERSBY AR, 1965, J CHEM SOC, P3323, DOI 10.1039/jr9650003323; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Brodelius M, 2002, EUR J BIOCHEM, V269, P3570, DOI 10.1046/j.1432-1033.2002.03044.x; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Dang TTT, 2015, NAT CHEM BIOL, V11, P104, DOI [10.1038/NCHEMBIO.1717, 10.1038/nchembio.1717]; Dang TTT, 2014, J BIOL CHEM, V289, P2013, DOI 10.1074/jbc.M113.505099; Dang TTT, 2014, FEBS LETT, V588, P198, DOI 10.1016/j.febslet.2013.11.037; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; Desgagne-Penix I, 2012, PLANT J, V72, P331, DOI 10.1111/j.1365-313X.2012.05084.x; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Elleuche S, 2015, APPL MICROBIOL BIOT, V99, P1545, DOI 10.1007/s00253-014-6315-1; Facchini PJ, 2005, CURR OPIN PLANT BIOL, V8, P657, DOI 10.1016/j.pbi.2005.09.008; Farrow SC, 2013, J BIOL CHEM, V288, P28997, DOI 10.1074/jbc.M113.488585; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; HE XS, 1993, J NAT PROD, V56, P973, DOI 10.1021/np50096a029; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; Jirschitzka J, 2012, P NATL ACAD SCI USA, V109, P10304, DOI 10.1073/pnas.1200473109; KIRBY GW, 1967, SCIENCE, V155, P170, DOI 10.1126/science.155.3759.170; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; Mizutani M, 2011, ARCH BIOCHEM BIOPHYS, V507, P194, DOI 10.1016/j.abb.2010.09.026; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Morrison JP, 2005, BIOCHEMISTRY-US, V44, P5907, DOI 10.1021/bi050106c; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Peters RJ, 2003, BIOCHEMISTRY-US, V42, P2700, DOI 10.1021/bi020492n; Pillai B, 2006, P NATL ACAD SCI USA, V103, P8668, DOI 10.1073/pnas.0602537103; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Robinson, 1925, MEM P MANCHESTER LIT, V69, P79; Schiff PL, 1997, J NAT PROD, V60, P934, DOI 10.1021/np9700174; Sharma H, 2013, BIOCHEMISTRY-US, V52, P7305, DOI 10.1021/bi400576t; Stapon A, 2003, J AM CHEM SOC, V125, P15746, DOI 10.1021/ja037665w; Suhre Karsten, 2007, V396, P31; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang YC, 2011, J AM CHEM SOC, V133, P20684, DOI 10.1021/ja2085993; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757	51	76	96	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					728	+		10.1038/NCHEMBIO.1879	http://dx.doi.org/10.1038/NCHEMBIO.1879			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26147354				2022-12-25	WOS:000359954700018
J	Kourtidis, A; Ngok, SP; Pulimeno, P; Feathers, RW; Carpio, LR; Baker, TR; Carr, JM; Yan, IK; Borges, S; Perez, EA; Storz, P; Copland, JA; Patel, T; Thompson, EA; Citi, S; Anastasiadis, PZ				Kourtidis, Antonis; Ngok, Siu P.; Pulimeno, Pamela; Feathers, Ryan W.; Carpio, Lomeli R.; Baker, Tiffany R.; Carr, Jennifer M.; Yan, Irene K.; Borges, Sahra; Perez, Edith A.; Storz, Peter; Copland, John A.; Patel, Tushar; Thompson, E. Aubrey; Citi, Sandra; Anastasiadis, Panos Z.			Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; TYROSINE PHOSPHORYLATION; MESENCHYMAL TRANSITION; MICRORNA BIOGENESIS; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; C-MYC; P120-CATENIN; ADHESION; GROWTH	E-cadherin and p120 catenin (p120) are essential for epithelial homeostasis, but can also exert pro-tumorigenic activities. Here, we resolve this apparent paradox by identifying two spatially and functionally distinct junctional complexes in non-transformed polarized epithelial cells: one growth suppressing at the apical zonula adherens (ZA), defined by the p120 partner PLEKHA7 and a non-nuclear subset of the core microprocessor components DROSHA and DGCR8, and one growth promoting at basolateral areas of cell-cell contact containing tyrosine-phosphorylated p120 and active Src. Recruitment of DROSHA and DGCR8 to the ZA is PLEKHA7 dependent. The PLEKHA7-microprocessor complex co-precipitates with primary microRNAs (pri-miRNAs) and possesses pri-miRNA processing activity. PLEKHA7 regulates the levels of select miRNAs, in particular processing of miR-30b, to suppress expression of cell transforming markers promoted by the basolateral complex, including SNAI1, MYC and CCND1. Our work identifies a mechanism through which adhesion complexes regulate cellular behaviour and reveals their surprising association with the microprocessor.	[Kourtidis, Antonis; Ngok, Siu P.; Feathers, Ryan W.; Carpio, Lomeli R.; Baker, Tiffany R.; Carr, Jennifer M.; Yan, Irene K.; Borges, Sahra; Storz, Peter; Copland, John A.; Patel, Tushar; Thompson, E. Aubrey; Anastasiadis, Panos Z.] Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA; [Pulimeno, Pamela] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Perez, Edith A.] Mayo Clin, Div Hematol Oncol, Jacksonville, FL 32224 USA; [Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva 4, Switzerland	Mayo Clinic; University of Geneva; Mayo Clinic; University of Geneva; University of Geneva	Anastasiadis, PZ (corresponding author), Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	panos@mayo.edu	patel, tushar/J-3976-2013	patel, tushar/0000-0001-7021-9532; Kourtidis, Antonis/0000-0002-8128-6391; Shull, Lomeli/0000-0001-7537-8516; Citi, Sandra/0000-0002-6537-4818	NIH [R01 CA100467, R01 NS069753, P50 CA116201, R01 GM086435]; Florida Department of Health, Bankhead-Coley [10BG11]; NIH/NCI [R01CA104505, R01CA136665]; BCRF; Swiss Cancer League [KLS-2878-02-2012]; Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic; NATIONAL CANCER INSTITUTE [R01CA100467, P50CA116201, R01CA104505, R01CA136665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health, Bankhead-Coley; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCRF; Swiss Cancer League; Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 CA100467, R01 NS069753, P50 CA116201 (P.Z.A.); NIH R01 GM086435, Florida Department of Health, Bankhead-Coley 10BG11 (P.S.); NIH/NCI R01CA104505, R01CA136665 (J.A.C.); BCRF (E.A.P); the Swiss Cancer League (S.C., Project KLS-2878-02-2012). AK. is supported by the Jay and Deanie Stein Career Development Award for Cancer Research at Mayo Clinic. We thank Mayo Clinic's Protcomics Core and it Madden for assistance with mass spectrometry, B. Edenfield for immunohistochemistry M. Takeichi, D. Radisky and M. Cichon tor constructs, and D. Radisky, L. Lewis-Tuffin, J.C. Dachsel, B. Necela and the late G. Hayes tor suggestions and comments.	Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Eiseler T, 2012, J BIOL CHEM, V287, P32367, DOI 10.1074/jbc.M112.370999; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kourtidis A, 2013, PROG MOL BIOL TRANSL, V116, P409, DOI 10.1016/B978-0-12-394311-8.00018-2; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuphal S, 2012, ARCH BIOCHEM BIOPHYS, V524, P43, DOI 10.1016/j.abb.2011.10.020; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lan FF, 2011, INT J CANCER, V128, P319, DOI 10.1002/ijc.25336; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; Ma LW, 2012, J CLIN PATHOL, V65, P315, DOI 10.1136/jclinpath-2011-200516; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ozawa M, 2001, J CELL SCI, V114, P503; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tikhmyanova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022102; Wang Y, 2007, CANCER RES, V67, P3698, DOI 10.1158/0008-5472.CAN-06-4000; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	58	72	76	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1145	+		10.1038/ncb3227	http://dx.doi.org/10.1038/ncb3227			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26302406	Green Accepted			2022-12-25	WOS:000361113700008
J	Zanconato, F; Forcato, M; Battilana, G; Azzolin, L; Quaranta, E; Bodega, B; Rosato, A; Bicciato, S; Cordenonsi, M; Piccolo, S				Zanconato, Francesca; Forcato, Mattia; Battilana, Giusy; Azzolin, Luca; Quaranta, Erika; Bodega, Beatrice; Rosato, Antonio; Bicciato, Silvio; Cordenonsi, Michelangelo; Piccolo, Stefano			Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTIONAL COACTIVATOR; C-JUN; REGULATORY ELEMENTS; EPITHELIAL-CELLS; HIPPO PATHWAY; TAZ; CHROMATIN; COMPLEX; CANCER; DOMAIN	YAP/TAZ are nuclear effectors of the Hippo pathway regulating organ growth and tumorigenesis. Yet, their function as transcriptional regulators remains underinvestigated. By ChIP-seq analyses in breast cancer cells, we discovered that the YAP/TAZ transcriptional response is pervasively mediated by a dual element: TEAD factors, through which YAP/TAZ bind to DNA, co-occupying chromatin with activator protein-1 (AP-1, dimer of JUN and FOS proteins) at composite cis-regulatory elements harbouring both TEAD and AP-1 motifs. YAP/TAZ/TEAD and AP-1 form a complex that synergistically activates target genes directly involved in the control of S-phase entry and mitosis. This control occurs almost exclusively from distal enhancers that contact target promoters through chromatin looping. YAP/TAZ-induced oncogenic growth is strongly enhanced by gain of AP-1 and severely blunted by its loss. Conversely, AP-1-promoted skin tumorigenesis is prevented in YAP/TAZ conditional knockout mice. This work highlights a new layer of signalling integration, feeding on YAP/TAZ function at the chromatin level.	[Zanconato, Francesca; Battilana, Giusy; Azzolin, Luca; Quaranta, Erika; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Mol Med, I-35126 Padua, Italy; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Life Sci, Ctr Genome Res, I-41100 Modena, Italy; [Bodega, Beatrice] Ist Nazl Genet Mol INGM Romeo & Enrica Invernizzi, Genome Biol Unit, I-20126 Milan, Italy; [Rosato, Antonio] Univ Padua, Sch Med, Dept Surg Oncol & Gastroenterol, I-35126 Padua, Italy; [Rosato, Antonio] Ist Oncol Veneto IOV IRCCS, I-35126 Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua; IRCCS Istituto Oncologico Veneto (IOV)	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Mol Med, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Bicciato, Silvio/C-9825-2009; Rosato, Antonio/E-8626-2010; Azzolin, Luca/K-8012-2016; Forcato, Mattia/B-7733-2015; Cordenonsi, Michelangelo/K-7692-2016; Bodega, Beatrice/I-4644-2018	Bicciato, Silvio/0000-0002-1944-7078; Rosato, Antonio/0000-0002-5263-8386; Azzolin, Luca/0000-0002-2425-6153; Forcato, Mattia/0000-0002-7383-6576; Cordenonsi, Michelangelo/0000-0002-8253-5724; Bodega, Beatrice/0000-0003-0527-9234; Quaranta, Erika Giorgia/0000-0001-8112-2461; PICCOLO, STEFANO/0000-0002-2037-0004	Italian Association for Cancer Research (AIRC); AIRC-MFAG; AIRC Special Program Molecular Clinical Oncology '5 per mille'; Epigenetics Flagship project CNR-MIUR grants; AIRC-IG Grant; ERC-ADG; FIRB Accordi di Programma [RBAP11T3WB]	Italian Association for Cancer Research (AIRC); AIRC-MFAG; AIRC Special Program Molecular Clinical Oncology '5 per mille'; Epigenetics Flagship project CNR-MIUR grants; AIRC-IG Grant; ERC-ADG; FIRB Accordi di Programma	We thank O. Wessely, S. Dupont and G. Martello for comments; M. Morgante and E. Aleo for deep-sequencing (IGA, Udine); V. Guzzardo for histology; D. J. Pan (Johns Hopkins University, Maryland, USA) for gifts of Yap fl/fl mice; D. Metzger and P. Chambon (University of Strasbourg, France) for K14-Cre-ERT2 transgenics; L. Naldini (San Raffaele Scientific Institute, Italy) for lentiviral plasmids and L. Bakiri (Spanish National Cancer Research Centre (CNIO), Spain) for AP-1 expression constructs. We are grateful to C. Frasson for flow cytometry analyses. We acknowledge a donation in memoriam of L. Simonutti. F.Z. and L.A. are supported by a fellowship from the Italian Association for Cancer Research (AIRC). M.F. is supported by an assistant professorship from FIRB Accordi di Programma 2011 RBAP11T3WB. This work is supported by AIRC-MFAG to M.C.; from AIRC Special Program Molecular Clinical Oncology '5 per mille' to S.P. and S.B.; Epigenetics Flagship project CNR-MIUR grants to S.B. and S.P.; AIRC-IG Grant to S.P. Work in the laboratory of S.P. is also supported by ERC-2014-ADG.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; Bakiri L, 2015, CELL DEATH DIFFER, V22, P336, DOI 10.1038/cdd.2014.157; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Balmain Allan, 2014, J Invest Dermatol, V134, pE2, DOI 10.1038/skinbio.2014.2; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Briso EM, 2013, GENE DEV, V27, P1959, DOI 10.1101/gad.223339.113; BROWN PH, 1993, ONCOGENE, V8, P877; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen Y, 2001, J BIOL CHEM, V276, P8350, DOI 10.1074/jbc.M008431200; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang FQ, 2008, NAT PROTOC, V3, P1848, DOI 10.1038/nprot.2008.185; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rhie SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-331; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; SUDOL M, 1994, ONCOGENE, V9, P2145; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	60	610	623	7	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1218	+		10.1038/ncb3216	http://dx.doi.org/10.1038/ncb3216			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26258633	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000361113700017
J	Xu, C; Liberatore, KL; MacAlister, CA; Huang, ZJ; Chu, YH; Jiang, K; Brooks, C; Ogawa-Ohnishi, M; Xiong, GY; Pauly, M; Van Eck, J; Matsubayashi, Y; van der Knaap, E; Lippman, ZB				Xu, Cao; Liberatore, Katie L.; MacAlister, Cora A.; Huang, Zejun; Chu, Yi-Hsuan; Jiang, Ke; Brooks, Christopher; Ogawa-Ohnishi, Mari; Xiong, Guangyan; Pauly, Markus; Van Eck, Joyce; Matsubayashi, Yoshikatsu; van der Knaap, Esther; Lippman, Zachary B.			A cascade of arabinosyltransferases controls shoot meristem size in tomato	NATURE GENETICS			English	Article							RECEPTOR-LIKE KINASE; EXTREME FRUIT SIZE; ARABIDOPSIS-THALIANA; APICAL MERISTEM; INFLORESCENCE ARCHITECTURE; ORGAN DEVELOPMENT; GENE ENCODES; CELL; EVOLUTION; CLAVATA1	Shoot meristems of plants are composed of stem cells that are continuously replenished through a classical feedback circuit involving the homeobox WUSCHEL (WUS) gene and the CLAVATA (CLV) gene signaling pathway. In CLV signaling, the CLV1 receptor complex is bound by CLV3, a secreted peptide modified with sugars. However, the pathway responsible for modifying CLV3 and its relevance for CLV signaling are unknown. Here we show that tomato inflorescence branching mutants with extra flower and fruit organs due to enlarged meristems are defective in arabinosyltransferase genes. The most extreme mutant is disrupted in a hydroxyproline O-arabinosyltransferase and can be rescued with arabinosylated CLV3. Weaker mutants are defective in arabinosyltransferases that extend arabinose chains, indicating that CLV3 must be fully arabinosylated to maintain meristem size. Finally, we show that a mutation in CLV3 increased fruit size during domestication. Our findings uncover a new layer of complexity in the control of plant stem cell proliferation.	[Xu, Cao; Liberatore, Katie L.; MacAlister, Cora A.; Jiang, Ke; Brooks, Christopher; Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Liberatore, Katie L.; Lippman, Zachary B.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Huang, Zejun; Chu, Yi-Hsuan; van der Knaap, Esther] Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH USA; [Ogawa-Ohnishi, Mari; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Xiong, Guangyan; Pauly, Markus] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Pauly, Markus] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Van Eck, Joyce] Boyce Thompson Inst Plant Sci, Ithaca, NY USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; University System of Ohio; Ohio State University; Nagoya University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cornell University; Boyce Thompson Institute for Plant Research	Lippman, ZB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lippman@cshl.edu	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019; Pauly, Markus/B-5895-2008	Pauly, Markus/0000-0002-3116-2198; Huang, Zejun/0000-0002-8603-3684; Van Eck, Joyce/0000-0002-8005-365X; MacAlister, Cora/0000-0003-1470-0596; Matsubayashi, Yoshikatsu/0000-0002-2669-2119; van der Knaap, Esther/0000-0003-4963-7427; Chu, Yi-Hsuan/0000-0002-3809-4933; Ogawa-Ohnishi, Mari/0000-0002-7581-2607; Lippman, Zachary/0000-0001-7668-9025	Energy Biosciences Institute; Fred Dickinson Chair; National Science Foundation Graduate Research Fellowship [DGE-0914548]; Gordon and Betty Moore Foundation Fellowship from the Life Sciences Research Foundation; National Science Foundation Plant Genome Research Program [0922661, 1237880]; Agriculture and Food Research Initiative competitive grant of the US Department of Agriculture National Institute of Food and Agriculture [2015-67013-22823]; Grants-in-Aid for Scientific Research [15K21750] Funding Source: KAKEN	Energy Biosciences Institute; Fred Dickinson Chair; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Gordon and Betty Moore Foundation Fellowship from the Life Sciences Research Foundation; National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Agriculture and Food Research Initiative competitive grant of the US Department of Agriculture National Institute of Food and Agriculture; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of the Lippman laboratory, especially S. Thomain for her initial finding of FAB2 and for invaluable conversations that helped shape this work. We thank D. Zamir (Hebrew University of Jerusalem) for providing mutants and also Y. Eshed (Weizmann Institute of Science) for providing mutants and comments on the manuscript. We thank S. Hearn at the Cold Spring Harbor Laboratory St. Giles Advanced Microscopy Center for providing technical service for transmission electron microscopy. We thank W. Wang for assistance with tomato transformation, X. Song for advice on peptide assays, DuPont Pioneer for research support, and T. Mulligan, A. Krainer and staff from Cornell University's Long Island Horticultural Research and Extension Center in Riverhead, New York, for assistance with plant care. This research was supported by the Energy Biosciences Institute and the Fred Dickinson Chair for M.P., a National Science Foundation Graduate Research Fellowship (DGE-0914548) to K.L.L., a Gordon and Betty Moore Foundation Fellowship from the Life Sciences Research Foundation to C.A.M., grants from the National Science Foundation Plant Genome Research Program to E.v.d.K. (0922661) and to J.V.E. and Z.B.L. (1237880), and an Agriculture and Food Research Initiative competitive grant (2015-67013-22823) of the US Department of Agriculture National Institute of Food and Agriculture to Z.B.L.	Barrero LS, 2004, THEOR APPL GENET, V109, P669, DOI 10.1007/s00122-004-1676-y; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Betsuyaku S, 2011, PLANT CELL PHYSIOL, V52, P14, DOI 10.1093/pcp/pcq157; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chevalier L, 2010, PLANT J, V64, P977, DOI 10.1111/j.1365-313X.2010.04388.x; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Fan CC, 2014, MOL PLANT, V7, P1788, DOI 10.1093/mp/ssu090; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Huang ZJ, 2011, THEOR APPL GENET, V123, P465, DOI 10.1007/s00122-011-1599-3; Jackson DP., 1992, MOL PLANT PATHOLOGY, P163; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Lippman Z, 2001, GENETICS, V158, P413; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Matsubayashi Yoshikatsu, 2011, Arabidopsis Book, V9, pe0150, DOI 10.1199/tab.0150; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Muller R, 2006, PLANT CELL, V18, P1188, DOI 10.1105/tpc.105.040444; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nimchuk ZL, 2015, DEVELOPMENT, V142, P1043, DOI 10.1242/dev.119677; Nimchuk ZL, 2011, PLANT CELL, V23, P851, DOI 10.1105/tpc.110.075622; Ogawa-Ohnishi M, 2013, NAT CHEM BIOL, V9, P726, DOI [10.1038/nchembio.1351, 10.1038/NCHEMBIO.1351]; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Park SJ, 2014, CURR OPIN PLANT BIOL, V17, P70, DOI 10.1016/j.pbi.2013.11.006; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pautler M, 2013, PLANT CELL PHYSIOL, V54, P302, DOI 10.1093/pcp/pct025; Petersen B.L., 2011, ANN PLANT REV PLANT; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Reinhardt D, 2003, DEVELOPMENT, V130, P4073, DOI 10.1242/dev.00596; Rickett H. W., 1944, BOT REV, V10, P187, DOI 10.1007/BF02861094; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schnabel EL, 2011, PLANT PHYSIOL, V157, P328, DOI 10.1104/pp.111.178756; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shinohara H, 2013, PLANT CELL PHYSIOL, V54, P369, DOI 10.1093/pcp/pcs174; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; van der Knaap E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00227; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Xiong GY, 2013, MOL PLANT, V6, P1373, DOI 10.1093/mp/sst014; Xu C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1743; Xu TT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-225; Yin Y., 2011, ANN PLANT REV PLANT; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9; Zhang Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-827	62	226	244	26	258	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					784	+		10.1038/ng.3309	http://dx.doi.org/10.1038/ng.3309			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005869				2022-12-25	WOS:000357090300016
J	Depeille, P; Henricks, LM; van de Ven, RAH; Lemmens, E; Wang, CY; Matli, M; Werb, Z; Haigis, KM; Donner, D; Warren, R; Roose, JP				Depeille, Philippe; Henricks, Linda M.; van de Ven, Robert A. H.; Lemmens, Ed; Wang, Chih-Yang; Matli, Mary; Werb, Zena; Haigis, Kevin M.; Donner, David; Warren, Robert; Roose, Jeroen P.			RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth	NATURE CELL BIOLOGY			English	Article							FACTOR RECEPTOR; RAS ACTIVATION; EGF RECEPTOR; FEEDBACK ACTIVATION; ACQUIRED-RESISTANCE; TUMOR PROGRESSION; GENE-EXPRESSION; STEM-CELLS; K-RAS; CANCER	The character of EGFR signals can influence cell fate but mechanistic insights into intestinal EGFR-Ras signalling are limited. Here we show that two distinct Ras nucleotide exchange factors, RasGRP1 and SOS1, lie downstream of EGFR but act in functional opposition. RasGRP1 is expressed in intestinal crypts where it restricts epithelial growth. High RasGRP1 expression in colorectal cancer (CRC) patient samples correlates with a better clinical outcome. Biochemically, we find that RasGRP1 creates a negative feedback loop that limits proliferative EGFR-SOS1-Ras signals in CRC cells. Genetic Rasgrp1 depletion from mice with either an activating mutation in KRas or with aberrant Wnt signalling due to a mutation in Apc resulted in both cases in exacerbated Ras-ERK signalling and cell proliferation. The unexpected opposing cell biological effects of EGFR-RasGRP1 and EGFR-SOS1 signals in the same cell shed light on the intricacy of EGFR-Ras signalling in normal epithelium and carcinoma.	[Depeille, Philippe; Henricks, Linda M.; van de Ven, Robert A. H.; Lemmens, Ed; Wang, Chih-Yang; Werb, Zena; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Wang, Chih-Yang] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 70101, Taiwan; [Matli, Mary; Donner, David; Warren, Robert] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Haigis, Kevin M.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA	University of California System; University of California San Francisco; National Cheng Kung University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital	Depeille, P (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	philippe.depeille@ucsf.edu; jeroen.roose@ucsf.edu		Roose, Jeroen/0000-0003-4746-2811; Henricks, Linda/0000-0003-0141-7927; Wang, Chih-Yang/0000-0002-4137-5074	Sandler Program in Basic Science (start-up); NIH-NCI Physical Science Oncology Center grant [U54CA143874]; NIH grant [1P01AI091580-01]; Gabrielle's Angel Foundation grant; ECSI; ACS grant; UCSF Research Allocation Program (RAP) pilot grant; NCI [R01 CA057621, K01CA118425]; Jeannik M. Littlefield foundation; Ministry of Science and Technology, Taiwan [104-2917-1-006-002]; KWF (Dutch Cancer Society); Saal an Zwanenberg Foundation; NATIONAL CANCER INSTITUTE [U54CA143874, R01CA057621, K01CA118425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER	Sandler Program in Basic Science (start-up); NIH-NCI Physical Science Oncology Center grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation grant; ECSI; ACS grant; UCSF Research Allocation Program (RAP) pilot grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jeannik M. Littlefield foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); KWF (Dutch Cancer Society)(KWF Kankerbestrijding); Saal an Zwanenberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank J. Stone, T. Jacks and A. Ma for Rasgrp1-deficient, KRAS<SUP>LSL-G12D</SUP> and VillinCre mice, A. Karnczis and O. Yilmaz for helpful comments on the intestinal hyperplasia, L. Westerveld for technical support, and A. Balmain, M. McMahon, C. Bonnans, N. Duesbery and O. Klein for critically reading the manuscript. Our research was supported by the Sandler Program in Basic Science (start-up), NIH-NCI Physical Science Oncology Center grant U54CA143874, NIH grant 1P01AI091580-01, a Gabrielle's Angel Foundation grant, a ECSI, ACS grant, and a UCSF Research Allocation Program (RAP) pilot grant (all to J.P.R.), as well as by grants from the NCI (R01 CA057621 to Z.W. and K01CA118425 to K.M.H.), from the Jeannik M. Littlefield foundation (to R.W.), and from the Ministry of Science and Technology, Taiwan (104-2917-1-006-002 to C-Y.W.), and by the KWF (Dutch Cancer Society) (R.A.H.v.d.V., L.M.H.) and Saal an Zwanenberg Foundation (L.M.H.).	Ahmed Z, 2013, J CELL BIOL, V200, P493, DOI 10.1083/jcb.201204106; Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Daley SR, 2013, ELIFE, V2, DOI 10.7554/eLife.01020; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hartzell C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003848; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kortum RL, 2011, P NATL ACAD SCI USA, V108, P12407, DOI 10.1073/pnas.1104295108; Ksionda Olga, 2013, Front Biol (Beijing), V8, P508; Lee D, 2009, J CLIN INVEST, V119, P2702, DOI 10.1172/JCI36435; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Nishiyama Y, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/239617; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Oki-Idouchi CE, 2007, CANCER RES, V67, P276, DOI 10.1158/0008-5472.CAN-06-3080; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang ZQ, 2002, J BIOL CHEM, V277, P19470, DOI 10.1074/jbc.M201097200; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yang D., 2011, ONCOGENE; Yang DZ, 2010, CANCER RES, V70, P7905, DOI 10.1158/0008-5472.CAN-09-4729	69	40	43	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					804	+		10.1038/ncb3175	http://dx.doi.org/10.1038/ncb3175			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	26005835	Green Accepted			2022-12-25	WOS:000355277500012
J	Mifsud, B; Tavares-Cadete, F; Young, AN; Sugar, R; Schoenfelder, S; Ferreira, L; Wingett, SW; Andrews, S; Grey, W; Ewels, PA; Herman, B; Happe, S; Higgs, A; LeProust, E; Follows, GA; Fraser, P; Luscombe, NM; Osborne, CS				Mifsud, Borbala; Tavares-Cadete, Filipe; Young, Alice N.; Sugar, Robert; Schoenfelder, Stefan; Ferreira, Lauren; Wingett, Steven W.; Andrews, Simon; Grey, William; Ewels, Philip A.; Herman, Bram; Happe, Scott; Higgs, Andy; LeProust, Emily; Follows, George A.; Fraser, Peter; Luscombe, Nicholas M.; Osborne, Cameron S.			Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C	NATURE GENETICS			English	Article							ENHANCER; INFLAMMATION; LANDSCAPE; PROTEIN; GENES; CTCF	Transcriptional control in large genomes often requires looping interactions between distal DNA elements, such as enhancers and target promoters. Current chromosome conformation capture techniques do not offer sufficiently high resolution to interrogate these regulatory interactions on a genomic scale. Here we use Capture Hi-C (CHi-C), an adapted genome conformation assay, to examine the long-range interactions of almost 22,000 promoters in 2 human blood cell types. We identify over 1.6 million shared and cell type restricted interactions spanning hundreds of kilobases between promoters and distal loci. Transcriptionally active genes contact enhancer-like elements, whereas transcriptionally inactive genes interact with previously uncharacterized elements marked by repressive features that may act as long-range silencers. Finally, we show that interacting loci are enriched for disease-associated SNPs, suggesting how distal mutations may disrupt the regulation of relevant genes. This study provides new insights and accessible tools to dissect the regulatory interactions that underlie normal and aberrant gene regulation.	[Mifsud, Borbala; Sugar, Robert; Luscombe, Nicholas M.] Francis Crick Inst, London, England; [Mifsud, Borbala; Luscombe, Nicholas M.] UCL, UCL Genet Inst, London, England; [Young, Alice N.; Schoenfelder, Stefan; Ferreira, Lauren; Ewels, Philip A.; Fraser, Peter; Osborne, Cameron S.] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Wingett, Steven W.; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England; [Grey, William; Osborne, Cameron S.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London, England; [Herman, Bram; Happe, Scott; Higgs, Andy; LeProust, Emily] Agilent Technol, Diagnost & Genom Div, Santa Clara, CA USA; [Follows, George A.] Univ Cambridge, Hosp Natl Hlth Serv NHS Fdn Trust, Dept Haematol, Cambridge, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Okinawa, Japan	Francis Crick Institute; University of London; University College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; King's College London; Agilent Technologies; University of Cambridge; Okinawa Institute of Science & Technology Graduate University	Osborne, CS (corresponding author), Babraham Inst, Nucl Dynam Programme, Cambridge, England.	nicholas.luscombe@ucl.ac.uk; cameron.osborne@kcl.ac.uk	Mifsud, Borbala/AAB-5379-2020; Ewels, Philip/J-7771-2013; Osborne, Cameron/N-1398-2017; Tavares-Cadete, Filipe/G-4962-2015	Ewels, Philip/0000-0003-4101-2502; Osborne, Cameron/0000-0003-4126-2499; Tavares-Cadete, Filipe/0000-0002-3782-7170; Grey, William/0000-0001-8209-5645; Wingett, Steven/0000-0002-2343-0711; Fraser, Peter/0000-0002-0041-1227; Mifsud, Borbala/0000-0003-3429-3094	Leukaemia and Lymphoma Research Fellowship; Framework Programme 7 Epigenesys Network of Excellence; Cancer Research UK; UCL; OIST; Wellcome Trust; BBSRC [BBS/E/B/000C0405, BBS/E/B/0000H212, BBS/E/B/0000M738, BBS/E/B/000C0404] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H212, BBS/E/B/000C0404, BBS/E/B/000C0405, BBS/E/B/0000M738] Funding Source: researchfish; Cancer Research UK [16358] Funding Source: researchfish; The Francis Crick Institute [10110, 10111] Funding Source: researchfish	Leukaemia and Lymphoma Research Fellowship; Framework Programme 7 Epigenesys Network of Excellence; Cancer Research UK(Cancer Research UK); UCL; OIST; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank E. Darbo for assistance in data analysis and K. Tabbada for sequencing. This work was supported by a Leukaemia and Lymphoma Research Fellowship (C.S.O.), the Framework Programme 7 Epigenesys Network of Excellence (B.M., N.M.L.), Cancer Research UK (B.M., F.T.-C., N.M.L.), UCL (B.M., N.M.L.), OIST (F.T.-C., N.M.L.) and the Wellcome Trust (N.M.L.).	De Luca A, 2003, BIOCHEM J, V369, P477, DOI 10.1042/BJ20020057; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/NMETH.3205, 10.1038/nmeth.3205]; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Nautiyal J, 2013, TRENDS ENDOCRIN MET, V24, P451, DOI 10.1016/j.tem.2013.05.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yano K, 2000, GENOMICS, V65, P75, DOI 10.1006/geno.2000.6140; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427	36	561	573	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					598	606		10.1038/ng.3286	http://dx.doi.org/10.1038/ng.3286			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25938943				2022-12-25	WOS:000355386500010
J	Gudbjartsson, DF; Helgason, H; Gudjonsson, SA; Zink, F; Oddson, A; Gylfason, A; Besenbacher, S; Magnusson, G; Halldorsson, BV; Hjartarson, E; Sigurdsson, GT; Stacey, SN; Frigge, ML; Holm, H; Saemundsdottir, J; Helgadottir, HT; Johannsdottir, H; Sigfusson, G; Thorgeirsson, G; Sverrisson, JT; Gretarsdottir, S; Walters, GB; Rafnar, T; Thjodleifsson, B; Bjornsson, ES; Olafsson, S; Thorarinsdottir, H; Steingrimsdottir, T; Gudmundsdottir, TS; Theodors, A; Jonasson, JG; Sigurdsson, A; Bjornsdottir, G; Jonsson, JJ; Thorarensen, O; Ludvigsson, P; Gudbjartsson, H; Eyjolfsson, GI; Sigurdardottir, O; Olafsson, I; Arnar, DO; Magnusson, OT; Kong, A; Masson, G; Thorsteinsdottir, U; Helgason, A; Sulem, P; Stefansson, K				Gudbjartsson, Daniel F.; Helgason, Hannes; Gudjonsson, Sigurjon A.; Zink, Florian; Oddson, Asmundur; Gylfason, Arnaldur; Besenbacher, Soren; Magnusson, Gisli; Halldorsson, Bjarni V.; Hjartarson, Eirikur; Sigurdsson, Gunnar Th; Stacey, Simon N.; Frigge, Michael L.; Holm, Hilma; Saemundsdottir, Jona; Helgadottir, Hafdis Th; Johannsdottir, Hrefna; Sigfusson, Gunnlaugur; Thorgeirsson, Gudmundur; Sverrisson, Jon Th; Gretarsdottir, Solveig; Walters, G. Bragi; Rafnar, Thorunn; Thjodleifsson, Bjarni; Bjornsson, Einar S.; Olafsson, Sigurdur; Thorarinsdottir, Hildur; Steingrimsdottir, Thora; Gudmundsdottir, Thora S.; Theodors, Asgeir; Jonasson, Jon G.; Sigurdsson, Asgeir; Bjornsdottir, Gyda; Jonsson, Jon J.; Thorarensen, Olafur; Ludvigsson, Petur; Gudbjartsson, Hakon; Eyjolfsson, Gudmundur I.; Sigurdardottir, Olof; Olafsson, Isleifur; Arnar, David O.; Magnusson, Olafur Th; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Helgason, Agnar; Sulem, Patrick; Stefansson, Kari			Large-scale whole-genome sequencing of the Icelandic population	NATURE GENETICS			English	Article							VAN-LAERE-SYNDROME; GENETIC-VARIATION; LOW-FREQUENCY; HIGH-RISK; INTRAHEPATIC CHOLESTASIS; ATRIAL-FIBRILLATION; FUNCTIONAL IMPACT; PONTOBULBAR PALSY; WIDE ASSOCIATION; CODING VARIANTS	Here we describe the insights gained from sequencing the whole genomes of 2,636 Icelanders to a median depth of 20x. We found 20 million SNPs and 1.5 million insertions-deletions (indels). We describe the density and frequency spectra of sequence variants in relation to their functional annotation, gene position, pathway and conservation score. We demonstrate an excess of homozygosity and rare protein-coding variants in Iceland. We imputed these variants into 104,220 individuals down to a minor allele frequency of 0.1% and found a recessive frameshift mutation in MYL4 that causes early-onset atrial fibrillation, several mutations in ABCB4 that increase risk of liver diseases and an intronic variant in GNAS associating with increased thyroid-stimulating hormone levels when maternally inherited. These data provide a study design that can be used to determine how variation in the sequence of the human genome gives rise to human diversity.	[Gudbjartsson, Daniel F.; Helgason, Hannes; Gudjonsson, Sigurjon A.; Zink, Florian; Oddson, Asmundur; Gylfason, Arnaldur; Magnusson, Gisli; Halldorsson, Bjarni V.; Hjartarson, Eirikur; Sigurdsson, Gunnar Th; Stacey, Simon N.; Frigge, Michael L.; Holm, Hilma; Saemundsdottir, Jona; Helgadottir, Hafdis Th; Johannsdottir, Hrefna; Gretarsdottir, Solveig; Walters, G. Bragi; Rafnar, Thorunn; Sigurdsson, Asgeir; Bjornsdottir, Gyda; Gudbjartsson, Hakon; Magnusson, Olafur Th; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Helgason, Agnar; Sulem, Patrick; Stefansson, Kari] Amgen Inc, DeCODE Genet, Reykjavik, Iceland; [Gudbjartsson, Daniel F.; Helgason, Hannes; Gudbjartsson, Hakon; Kong, Augustine] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Besenbacher, Soren] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Halldorsson, Bjarni V.] Reykjavik Univ, Inst Biomed & Neural Engn, Reykjavik, Iceland; [Holm, Hilma] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Sigfusson, Gunnlaugur] Landspitali Univ Hosp, Childrens Hosp, Reykjavik, Iceland; [Thorgeirsson, Gudmundur; Thjodleifsson, Bjarni; Arnar, David O.] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Thorgeirsson, Gudmundur; Bjornsson, Einar S.; Olafsson, Sigurdur; Steingrimsdottir, Thora; Jonasson, Jon G.; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Sverrisson, Jon Th] Akureyri Hosp, Dept Internal Med, Akureyri, Iceland; [Bjornsson, Einar S.; Olafsson, Sigurdur; Thorarinsdottir, Hildur; Theodors, Asgeir] Landspitali Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Reykjavik, Iceland; [Steingrimsdottir, Thora; Gudmundsdottir, Thora S.] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Jonasson, Jon G.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Jonasson, Jon G.] Iceland Canc Registry, Reykjavik, Iceland; [Jonsson, Jon J.] Univ Iceland, Dept Biochem & Mol Biol, Fac Med, Reykjavik, Iceland; [Jonsson, Jon J.] Landspitali Univ Hosp, Dept Genet & Mol Med, Reykjavik, Iceland; [Thorarensen, Olafur; Ludvigsson, Petur] Landspitali Univ Hosp, Childrens Hosp Reykjavik, Sect Child Neurol, Dept Pediat, Reykjavik, Iceland; [Eyjolfsson, Gudmundur I.] Iceland Med Ctr Laeknasetrid, Lab Mjodd RAM, Reykjavik, Iceland; [Sigurdardottir, Olof] Akureyri Hosp, Dept Clin Biochem, Akureyri, Iceland; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland	University of Iceland; Aarhus University; Reykjavik University; Mayo Clinic; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland	Gudbjartsson, DF (corresponding author), Amgen Inc, DeCODE Genet, Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kari.stefansson@decode.is	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Helgadottir, Hafdis/0000-0003-4352-152X; Bjornsdottir, Gyda/0000-0002-8100-0306; Oddsson, Asmundur/0000-0002-4606-5163; Besenbacher, Soren/0000-0003-1455-1738; Jonasson, Jon G./0000-0002-2635-5032; Halldorsson, Bjarni/0000-0003-0756-0767; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Helgason, Agnar/0000-0002-8545-3767; Kong, Augustine/0000-0001-8193-5438	Villum Fonden [00007278] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z; Chan WM, 2011, HUM MOL GENET, V20, P1738, DOI 10.1093/hmg/ddr049; Chen FC, 2007, GENOME RES, V17, P16, DOI 10.1101/gr.5429606; Ciccolella M, 2013, J MED GENET, V50, P104, DOI 10.1136/jmedgenet-2012-101204; COHENHAGUENAUER O, 1989, HUM GENET, V81, P278, DOI 10.1007/BF00279004; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; da Silva FP, 2011, J NEUROL SCI, V300, P155, DOI 10.1016/j.jns.2010.10.010; Dakhil FO, 2010, AMYOTROPH LATERAL SC, V11, P397, DOI 10.3109/17482960903440775; Davit-Spraul A, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-1; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006; Gudbjartsson DF, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.11; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Haack TB, 2012, J INHERIT METAB DIS, V35, P943, DOI 10.1007/s10545-012-9513-y; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Johnson JO, 2012, BRAIN, V135, P2875, DOI 10.1093/brain/aws161; Johnson JO, 2010, AM J HUM GENET, V87, P567, DOI 10.1016/j.ajhg.2010.05.021; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lombaert A, 1976, Acta Neurol Belg, V76, P309; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mayr E., 1942, SYSTEMATICS ORIGIN S; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Nicolaou M, 2012, J PATHOL, V226, P300, DOI 10.1002/path.3019; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rotowski J., 1953, EDIN MED J, V60, P281; Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; STROHMAN RC, 1983, SCIENCE, V221, P955, DOI 10.1126/science.6879193; Stubbs Andrew, 2012, J Clin Bioinforma, V2, P19, DOI 10.1186/2043-9113-2-19; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; van Bogaert L., 1929, J NEUROL PSYCHIAT, V6, P380; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Zavolan M, 2006, CURR OPIN STRUC BIOL, V16, P362, DOI 10.1016/j.sbi.2006.05.002	79	445	451	2	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					435	U20		10.1038/ng.3247	http://dx.doi.org/10.1038/ng.3247			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25807286				2022-12-25	WOS:000353635800004
J	Zhu, YP; Liu, TW; Cecioni, S; Eskandari, R; Zandberg, WF; Vocadlo, DJ				Zhu, Yanping; Liu, Ta-Wei; Cecioni, Samy; Eskandari, Razieh; Zandberg, Wesley F.; Vocadlo, David J.			O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains	NATURE CHEMICAL BIOLOGY			English	Article							LINKED N-ACETYLGLUCOSAMINE; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; NUCLEOCYTOPLASMIC PROTEINS; RIBOSOMAL-PROTEINS; MAMMALIAN-CELLS; CIRCADIAN CLOCK; CROSS-TALK; GLYCOSYLATION; GLCNACYLATION	Nucleocytoplasmic glycosylation of proteins with O-linked N-acetylglucosamine residues (O-GlcNAc) is recognized as a conserved post-translational modification found in all metazoans. O-GlcNAc has been proposed to regulate diverse cellular processes. Impaired cellular O-GlcNAcylation has been found to lead to decreases in the levels of various proteins, which is one mechanism by which O-GlcNAc seems to exert its varied physiological effects. Here we show that O-GlcNAcylation also occurs cotranslationally. This process protects nascent polypeptide chains from premature degradation by decreasing cotranslational ubiquitylation. Given that hundreds of proteins are O-GlcNAcylated within cells, our findings suggest that cotranslational O-GlcNAcylation may be a phenomenon regulating proteostasis of an array of nucleocytoplasmic proteins. These findings set the stage to assess whether O-GlcNAcylation has a role in protein quality control in a manner that bears similarity with the role played by N-glycosylation within the secretory pathway.	[Zhu, Yanping; Liu, Ta-Wei; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Zhu, Yanping; Liu, Ta-Wei; Cecioni, Samy; Eskandari, Razieh; Zandberg, Wesley F.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Liu, Ta-Wei/GPX-8295-2022; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; Eskandari, Razieh/0000-0003-1292-4094	Natural Sciences and Engineering Research (NSERC) [RGPIN/298406-2010]; Canadian Institutes of Health Research (CIHR) [MOP-123341]; CIHR; Government of Canada; Alzheimer Society of Canada; Michael Smith Foundation for Health Research	Natural Sciences and Engineering Research (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Government of Canada(CGIAR); Alzheimer Society of Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Financial support through a Discovery Grant (grant number: RGPIN/298406-2010) the Natural Sciences and Engineering Research (NSERC) and the Canadian Institutes of Health Research (CIHR; grant number: MOP-123341) is gratefully acknowledged. Y.Z. thanks the CIHR for support through a postdoctoral fellowship. D.J.V. acknowledges the kind support of the Canada Research Chairs program for a Tier I Canada Research Chair in Chemical Glycobiology and NSERC for support as an E.W.R. Steacie Memorial Fellow. S.C. acknowledges the Government of Canada and the CIHR for postdoctoral fellowship support. R.E. acknowledges the Alzheimer Society of Canada and the Michael Smith Foundation for Health Research for postdoctoral fellowship support.	Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Chung SS, 2008, BIOCHEM BIOPH RES CO, V372, P713, DOI 10.1016/j.bbrc.2008.05.096; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardiville S, 2010, J BIOL CHEM, V285, P19205, DOI 10.1074/jbc.M109.080572; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HOBDEN AN, 1978, BIOCHEM J, V170, P57, DOI 10.1042/bj1700057; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kim EY, 2012, GENE DEV, V26, P490, DOI 10.1101/gad.182378.111; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Olivier-Van Stichelen S, 2014, FASEB J, V28, P3325, DOI 10.1096/fj.13-243535; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; STARR CM, 1990, J BIOL CHEM, V265, P6868; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	52	88	88	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2015	11	5					319	U105		10.1038/NCHEMBIO.1774	http://dx.doi.org/10.1038/NCHEMBIO.1774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG3FD	25774941				2022-12-25	WOS:000353162600007
J	Ren, X; Moser, PT; Gilpin, SE; Okamoto, T; Wu, T; Tapias, LF; Mercier, FE; Xiong, LJ; Ghawi, R; Scadden, DT; Mathisen, DJ; Ott, HC				Ren, Xi; Moser, Philipp T.; Gilpin, Sarah E.; Okamoto, Tatsuya; Wu, Tong; Tapias, Luis F.; Mercier, Francois E.; Xiong, Linjie; Ghawi, Raja; Scadden, David T.; Mathisen, Douglas J.; Ott, Harald C.			Engineering pulmonary vasculature in decellularized rat and human lungs	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; ORTHOTOPIC TRANSPLANTATION; LUMEN FORMATION; MATRIX; PERMEABILITY; PROGENITORS; TISSUE; DIFFERENTIATION; MORPHOGENESIS; REGENERATION	Bioengineered lungs produced from patient-derived cells may one day provide an alternative to donor lungs for transplantation therapy. Here we report the regeneration of functional pulmonary vasculature by repopulating the vascular compartment of decellularized rat and human lung scaffolds with human cells, including endothelial and perivascular cells derived from induced pluripotent stem cells. We describe improved methods for delivering cells into the lung scaffold and for maturing newly formed endothelium through co-seeding of endothelial and perivascular cells and a two-phase culture protocol. Using these methods we achieved similar to 75% endothelial coverage in the rat lung scaffold relative to that of native lung. The regenerated endothelium showed reduced vascular resistance and improved barrier function over the course of in vitro culture and remained patent for 3 days after orthotopic transplantation in rats. Finally, we scaled our approach to the human lung lobe and achieved efficient cell delivery, maintenance of cell viability and establishment of perfusable vascular lumens.	[Ren, Xi; Moser, Philipp T.; Gilpin, Sarah E.; Okamoto, Tatsuya; Wu, Tong; Tapias, Luis F.; Mercier, Francois E.; Xiong, Linjie; Ghawi, Raja; Scadden, David T.; Ott, Harald C.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Ren, Xi; Moser, Philipp T.; Gilpin, Sarah E.; Okamoto, Tatsuya; Wu, Tong; Tapias, Luis F.; Mercier, Francois E.; Xiong, Linjie; Ghawi, Raja; Scadden, David T.; Mathisen, Douglas J.; Ott, Harald C.] Harvard Univ, Sch Med, Boston, MA USA; [Tapias, Luis F.; Mathisen, Douglas J.; Ott, Harald C.] Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA; [Ghawi, Raja] Harvard Univ, Cambridge, MA USA; [Scadden, David T.; Ott, Harald C.] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Ott, HC (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	hott@mgh.harvard.edu		Gilpin, Sarah/0000-0003-3560-6910	United Therapeutics Corporation; National Institutes of Health (NIH) Director's New Innovator Award [DP2-OD008749-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008749] Funding Source: NIH RePORTER	United Therapeutics Corporation; National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the United Therapeutics Corporation and the National Institutes of Health (NIH) Director's New Innovator Award (DP2-OD008749-01). The authors thank the HSCI/MGH Flow Cytometry Core Facility for analysis and purification of hiPSC differentiation, the MGH Center for Skeletal Research Core (NIH P30 AR066261) for histological processing and MGH Wellman Center for Photomedicine for transmission electron microscopy.	Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bonvillain RW, 2013, JOVE-J VIS EXP, DOI 10.3791/50825; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Carter EP, 1998, BIOPHYS J, V74, P2121, DOI 10.1016/S0006-3495(98)77919-6; CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Ghaedi M, 2013, J CLIN INVEST, V123, P4950, DOI 10.1172/JCI68793; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kim SH, 2012, BLOOD, V120, P4892, DOI 10.1182/blood-2012-05-428243; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; MACKERSIE RC, 1987, J SURG RES, V43, P495, DOI 10.1016/0022-4804(87)90122-3; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; MEYRICK B, 1978, LAB INVEST, V38, P188; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Nichols JE, 2013, TISSUE ENG PT A, V19, P2045, DOI [10.1089/ten.tea.2012.0250, 10.1089/ten.TEA.2012.0250]; O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Prasain N, 2014, NAT BIOTECHNOL, V32, P1151, DOI 10.1038/nbt.3048; Price AP, 2015, TISSUE ENG PART C-ME, V21, P94, DOI [10.1089/ten.tec.2013.0756, 10.1089/ten.TEC.2013.0756]; Ren X, 2015, BIOMATERIALS, V52, P103, DOI 10.1016/j.biomaterials.2015.01.061; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Sahara M, 2014, CELL RES, V24, P820, DOI 10.1038/cr.2014.59; Salvagiotto G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017829; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; STONE KC, 1992, AM REV RESPIR DIS, V146, P454, DOI 10.1164/ajrccm/146.2.454; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wagner DE, 2014, BIOMATERIALS, V35, P3281, DOI 10.1016/j.biomaterials.2013.12.103; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328	39	140	143	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1097	+		10.1038/nbt.3354	http://dx.doi.org/10.1038/nbt.3354			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26368048				2022-12-25	WOS:000362555700031
J	Herranz, N; Gallage, S; Mellone, M; Wuestefeld, T; Klotz, S; Hanley, CJ; Raguz, S; Acosta, JC; Innes, AJ; Banito, A; Georgilis, A; Montoya, A; Wolter, K; Dharmalingam, G; Faull, P; Carroll, T; Martinez-Barbera, JP; Cutillas, P; Reisinger, F; Heikenwalder, M; Miller, RA; Withers, D; Zender, L; Thomas, GJ; Gill, J				Herranz, Nicolas; Gallage, Suchira; Mellone, Massimiliano; Wuestefeld, Torsten; Klotz, Sabrina; Hanley, Christopher J.; Raguz, Selina; Acosta, Juan Carlos; Innes, Andrew J.; Banito, Ana; Georgilis, Athena; Montoya, Alex; Wolter, Katharina; Dharmalingam, Gopuraja; Faull, Peter; Carroll, Thomas; Martinez-Barbera, Juan Pedro; Cutillas, Pedro; Reisinger, Florian; Heikenwalder, Mathias; Miller, Richard A.; Withers, Dominic; Zender, Lars; Thomas, Gareth J.; Gill, Jesus			mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype	NATURE CELL BIOLOGY			English	Article							GENETICALLY HETEROGENEOUS MICE; ONCOGENE-INDUCED SENESCENCE; EXTENDS LIFE-SPAN; NF-KAPPA-B; CELLULAR SENESCENCE; MESSENGER-RNA; PATHWAY ACTIVATION; LEUKEMIA-CELLS; CANCER; RAPAMYCIN	Senescent cells secrete a combination of factors collectively known as the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence and activates an immune surveillance response, but it can also show pro-tumorigenic properties and contribute to age-related pathologies. In a drug screen to find new SASP regulators, we uncovered the mTOR inhibitor rapamycin as a potent SASP suppressor. Here we report a mechanism by which mTOR controls the SASP by differentially regulating the translation of the MK2 (also known as MAPKAPK2) kinase through 4EBP1. In turn, MAPKAPK2 phosphorylates the RNA-binding protein ZFP36L1 during senescence, inhibiting its ability to degrade the transcripts of numerous SASP components. Consequently, mTOR inhibition or constitutive activation of ZFP36L1 impairs the non-cell-autonomous effects of senescent cells in both tumour-suppressive and tumour-promoting contexts. Altogether, our results place regulation of the SASP as a key mechanism by which mTOR could influence cancer, age-related diseases and immune responses.	[Herranz, Nicolas; Gallage, Suchira; Raguz, Selina; Acosta, Juan Carlos; Innes, Andrew J.; Banito, Ana; Georgilis, Athena; Gill, Jesus] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England; [Herranz, Nicolas; Gallage, Suchira; Raguz, Selina; Acosta, Juan Carlos; Innes, Andrew J.; Banito, Ana; Georgilis, Athena; Dharmalingam, Gopuraja; Carroll, Thomas; Gill, Jesus] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Epigenet Sect, London W12 0NN, England; [Gallage, Suchira; Withers, Dominic] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Metab Signalling Grp, London W12 0NN, England; [Mellone, Massimiliano; Hanley, Christopher J.; Thomas, Gareth J.] Univ Southampton, Canc Res UK Ctr, Canc Sci Unit, Southampton SO16 6YD, Hants, England; [Wuestefeld, Torsten; Klotz, Sabrina; Wolter, Katharina; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Mol Oncol Solid Tumors, D-72076 Tubingen, Germany; [Montoya, Alex; Faull, Peter; Cutillas, Pedro] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Proteom Facil, London W12 0NN, England; [Martinez-Barbera, Juan Pedro] UCL Inst Child Hlth, Birth Defects Res Ctr, Dev Biol & Canc Programme, London WC1N 1EH, England; [Reisinger, Florian; Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-81675 Munich, Germany; [Heikenwalder, Mathias] German Canc Res DKFZ, Div Chron Inflammat & Canc, D-69121 Heidelberg, Germany; [Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA	Imperial College London; Imperial College London; Imperial College London; Cancer Research UK; University of Southampton; Eberhard Karls University of Tubingen; Imperial College London; University of London; University College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gill, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Proliferat Grp, Hammersmith Campus, London W12 0NN, England.	jesus.gil@csc.mrc.ac.uk	Martinez-Barbera, Juan Pedro/AAE-9284-2020; Heikenwalder, Mathias/AAA-2269-2020; Hanley, Christopher/AAM-1961-2020; Banito, Ana/P-6168-2017; Gil, Jesus/C-7739-2012; Acosta, Juan/AAE-6320-2021; Withers, Dominic J/D-7671-2014	Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Hanley, Christopher/0000-0003-3816-7220; Gil, Jesus/0000-0002-4303-6260; Acosta, Juan/0000-0002-7989-7329; Withers, Dominic J/0000-0002-8009-7521; Faull, Peter/0000-0001-8491-8086; Innes, Andrew/0000-0003-0918-8882; Rodriguez Cutillas, Pedro/0000-0002-3426-2274; Gallage, Suchira/0000-0002-1956-3597; Banito, Ana/0000-0003-2188-0003; mellone, massimiliano/0000-0002-4964-9340	NIH [U01-AG022303]; MRC; EMBO fellowship; BBSRC [BB/H020527/2] Funding Source: UKRI; MRC [MC_U120085810, MC_U120097114, MR/M000125/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H020527/2] Funding Source: researchfish; Cancer Research UK [16243, 13315] Funding Source: researchfish; Medical Research Council [MC_U120097114, 1375544, MC_U120085810, MR/M000125/1, 1229061] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W1055] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG031736, P30AG024824, U01AG022303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO fellowship(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to T. Rodriguez, A. Nebreda, R. Agami, M. Gaestel, D. Engelberg, G. Wendel, J. Campisi, C. Moroni, C. Speck, A. Day and G. Peters for reagents, helpful comments and contributions to this project. R. Miller is funded by NIH Grant U01-AG022303. Core support from MRC funded the research in J. Gil's laboratory. N. Herranz was funded by an EMBO fellowship.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Acosta Juan Carlos, 2013, Methods Mol Biol, V965, P175, DOI 10.1007/978-1-62703-239-1_11; Alcolea MP, 2012, MOL CELL PROTEOMICS, V11, P453, DOI 10.1074/mcp.M112.017483; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Bundscherer A, 2010, ANTICANCER RES, V30, P4017; Casado P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003573; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cutillas PR, 2007, MOL CELL PROTEOMICS, V6, P1560, DOI 10.1074/mcp.M700037-MCP200; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maitra S, 2008, RNA, V14, P950, DOI 10.1261/rna.983708; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Montoya A, 2011, METHODS, V54, P370, DOI 10.1016/j.ymeth.2011.02.004; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pospelova TV, 2012, CELL CYCLE, V11, P2402, DOI 10.4161/cc.20882; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ross CR, 2012, AGEING RES REV, V11, P473, DOI 10.1016/j.arr.2012.02.005; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Tan FE, 2014, P NATL ACAD SCI USA, V111, pE1740, DOI 10.1073/pnas.1320873111; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	57	378	392	8	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1205	+		10.1038/ncb3225	http://dx.doi.org/10.1038/ncb3225			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26280535	Green Submitted, Green Accepted			2022-12-25	WOS:000361113700015
J	Ueno-Yokohata, H; Okita, H; Nakasato, K; Akimoto, S; Hata, J; Koshinaga, T; Fukuzawa, M; Kiyokawa, N				Ueno-Yokohata, Hitomi; Okita, Hajime; Nakasato, Keiko; Akimoto, Shingo; Hata, Jun-ichi; Koshinaga, Tsugumichi; Fukuzawa, Masahiro; Kiyokawa, Nobutaka			Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney	NATURE GENETICS			English	Article							TUMOR STUDY-GROUP; POLYCOMB GROUP; WILMS-TUMOR; SOMATIC MUTATIONS; COMPLEX; DURATION; THERAPY; REVEALS; SUBTYPE; SOCIETY	Clear cell sarcoma of the kidney (CCSK) is one of the major pediatric renal neoplasms, but its associated genetic abnormalities are largely unknown. We identified internal tandem duplications in the BCOR gene (BCL6 corepressor) affecting the C terminus in 100% (20/20) of CCSK tumors but in none (0/193) of the other pediatric renal tumors. CCSK tumors expressed only an aberrant BCOR allele, indicating a close correlation between BCOR aberration and CCSK tumorigenesis.	[Ueno-Yokohata, Hitomi; Okita, Hajime; Nakasato, Keiko; Akimoto, Shingo; Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Hata, Jun-ichi] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Koshinaga, Tsugumichi] Nihon Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Fukuzawa, Masahiro] Osaka Med Ctr, Osaka, Japan; [Fukuzawa, Masahiro] Res Inst Maternal & Child Hlth, Osaka, Japan	National Center for Child Health & Development - Japan; Nihon University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Okita, H (corresponding author), Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan.	okita-h@keio.jp			National Center for Child Health and Development [24-4, 26-20]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) [10-41, 10-42, 10-43, 10-44, 10-45]; research program of the Project for Development of Innovative Research on Cancer Therapeutics [11035153]; Tailor-Made Medical Treatment Program (BioBankJapan), Ministry of Education, Culture, Sports, Science and Technology of Japan	National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); research program of the Project for Development of Innovative Research on Cancer Therapeutics; Tailor-Made Medical Treatment Program (BioBankJapan), Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by the Grant from the National Center for Child Health and Development (24-4, 26-20), grants from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO; 10-41, 10-42, 10-43, 10-44, 10-45), and a research program of the Project for Development of Innovative Research on Cancer Therapeutics (11035153) and Tailor-Made Medical Treatment Program (BioBankJapan), Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Argani P, 2000, AM J SURG PATHOL, V24, P4, DOI 10.1097/00000478-200001000-00002; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Furtwangler R, 2013, EUR J CANCER, V49, P3497, DOI 10.1016/j.ejca.2013.06.036; Gadd S, 2010, LAB INVEST, V90, P724, DOI 10.1038/labinvest.2010.66; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Junco SE, 2013, STRUCTURE, V21, P665, DOI 10.1016/j.str.2013.02.013; O'Meara E, 2012, J PATHOL, V227, P72, DOI 10.1002/path.3985; Oue T, 2009, PEDIATR SURG INT, V25, P923, DOI 10.1007/s00383-009-2449-0; Perlman EJ, 2005, PEDIATR DEVEL PATHOL, V8, P320, DOI 10.1007/s10024-005-1156-7; Pierron G, 2012, NAT GENET, V44, P461, DOI 10.1038/ng.1107; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Seibel NL, 2004, J CLIN ONCOL, V22, P468, DOI 10.1200/JCO.2004.06.058; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Tournade MF, 2001, J CLIN ONCOL, V19, P488, DOI 10.1200/JCO.2001.19.2.488; Ueno H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062233; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	20	102	107	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					861	+		10.1038/ng.3338	http://dx.doi.org/10.1038/ng.3338			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26098867				2022-12-25	WOS:000358674100007
J	Wroblewska, L; Kitada, T; Endo, K; Siciliano, V; Stillo, B; Saito, H; Weiss, R				Wroblewska, Liliana; Kitada, Tasuku; Endo, Kei; Siciliano, Velia; Stillo, Breanna; Saito, Hirohide; Weiss, Ron			Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery	NATURE BIOTECHNOLOGY			English	Article							NONCYTOPATHIC REPLICATION; GENE-EXPRESSION; REPLICONS; BIOLOGY; DESIGN; SWITCH; VIRUS; CELLS	Synthetic regulatory circuits encoded in RNA rather than DNA could provide a means to control cell behavior while avoiding potentially harmful genomic integration in therapeutic applications. We create post-transcriptional circuits using RNA-binding proteins, which can be wired in a plug-and-play fashion to create networks of higher complexity. We show that the circuits function in mammalian cells when encoded in modified mRNA or self-replicating RNA.	[Wroblewska, Liliana; Kitada, Tasuku; Siciliano, Velia; Stillo, Breanna; Weiss, Ron] MIT, Synthet Biol Ctr, Dept Biol Engn, Cambridge, MA 02139 USA; [Endo, Kei; Saito, Hirohide] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Kyoto, Japan; [Saito, Hirohide] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan	Massachusetts Institute of Technology (MIT); Kyoto University; Kyoto University	Saito, H (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Kyoto, Japan.	hirohide.saito@cira.kyoto-u.ac.jp; rweiss@mit.edu	Siciliano, Velia/D-5671-2018; Kitada, Tasuku/B-8121-2009; Endo, Kei/C-7325-2015; Endo, Kei/AAT-2169-2020	Siciliano, Velia/0000-0001-7734-9153; Kitada, Tasuku/0000-0003-2265-3363; Endo, Kei/0000-0003-1020-7884; Endo, Kei/0000-0003-1020-7884; DiAndreth, Breanna/0000-0002-0302-6834	Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; US National Institutes of Health [P50-GM098792, 5-R01-CA155320-03]; National Science Foundation GRFP [1122374]; JSPS KAKENHI [23681042, 24104002]; Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE [R01CA173712, R01CA155320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05722, 15H02774] Funding Source: KAKEN	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation GRFP(National Science Foundation (NSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Hayashi and N. Nishimura (Kyoto University) for supporting modified mRNA experiments. We also thank A.C. Goldstrohm and C. Weidmann (University of Michigan Medical School) for sharing Drosophila constructs containing MS2-fused repressors and the corresponding reporter, X. Zhang (MIT) and O. Andries (Ghent University) for assisting in VEE replicon construction, T.E. Wagner, D. Densmore (Boston University) and S. Payne (MIT) for communicating results before publication, W.M. Gelbart, C.M. Knobler, A. Berk, O. Azizgolshani and J.M. Parker (University of California, Los Angeles) for sharing replicon constructs and expertise, as well as A. Graziano (MIT) for supporting pDNA experiments and H. Chung (Harvard University) for designing the intronic mKate construct. This work was supported by Defense Advanced Research Projects Agency DARPA-BAA-11-23, US National Institutes of Health grants no. P50-GM098792, 5-R01-CA155320-03, National Science Foundation GRFP grant no. 1122374 (R.W.) and JSPS KAKENHI grant numbers 23681042, 24104002, and Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency (H. S.).	An CI, 2006, RNA, V12, P710, DOI 10.1261/rna.2299306; [Anonymous], 2013, MATLAB STAT TOOLB RE; Aubel D, 2010, BIOESSAYS, V32, P332, DOI 10.1002/bies.200900149; Auslander S, 2014, NAT METHODS, V11, P1154, DOI [10.1038/NMETH.3136, 10.1038/nmeth.3136]; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Azizgolshani O, 2013, VIROLOGY, V441, P12, DOI 10.1016/j.virol.2013.03.001; Beal J, 2015, ACS SYNTH BIOL, V4, P48, DOI 10.1021/sb500173f; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Frolov I, 1999, J VIROL, V73, P3854, DOI 10.1128/JVI.73.5.3854-3865.1999; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Mortimer I, 1999, GENE THER, V6, P403, DOI 10.1038/sj.gt.3300837; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Van Etten J, 2012, J BIOL CHEM, V287, P36370, DOI 10.1074/jbc.M112.373522; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	26	121	129	5	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					839	+		10.1038/nbt.3301	http://dx.doi.org/10.1038/nbt.3301			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26237515	Green Accepted, Green Submitted			2022-12-25	WOS:000359274900022
J	Davis, SA; Vincent, BM; Endo, MM; Whitesell, L; Marchillo, K; Andes, DR; Lindquist, S; Burke, MD				Davis, Stephen A.; Vincent, Benjamin M.; Endo, Matthew M.; Whitesell, Luke; Marchillo, Karen; Andes, David R.; Lindquist, Susan; Burke, Martin D.			Nontoxic antimicrobials that evade drug resistance	NATURE CHEMICAL BIOLOGY			English	Article							DISSEMINATED-CANDIDIASIS MODEL; AMPHOTERICIN-B; POLYENE ANTIBIOTICS; ANTIFUNGAL ACTIVITY; WILD-TYPE; LIPID-II; ERGOSTEROL; YEAST; PHARMACODYNAMICS; DERIVATIVES	Drugs that act more promiscuously provide fewer routes for the emergence of resistant mutants. This benefit, however, often comes at the cost of serious off-target and dose-limiting toxicities. The classic example is the antifungal amphotericin B (AmB), which has evaded resistance for more than half a century. We report markedly less toxic amphotericins that nevertheless evade resistance. They are scalably accessed in just three steps from the natural product, and they bind their target (the fungal sterol ergosterol) with far greater selectivity than AmB. Hence, they are less toxic and far more effective in a mouse model of systemic candidiasis. To our surprise, exhaustive efforts to select for mutants resistant to these more selective compounds revealed that they are just as impervious to resistance as AmB. Thus, highly selective cytocidal action and the evasion of resistance are not mutually exclusive, suggesting practical routes to the discovery of less toxic, resistance-evasive therapies.	[Davis, Stephen A.; Endo, Matthew M.; Burke, Martin D.] Univ Illinois, Howard Hughes Med Inst, Dept Chem, Urbana, IL USA; [Davis, Stephen A.; Endo, Matthew M.; Burke, Martin D.] Univ Illinois, Dept Chem, Roger Adam Lab, Urbana, IL USA; [Vincent, Benjamin M.] MIT, Microbiol Grad Program, Cambridge, MA 02139 USA; [Vincent, Benjamin M.; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Marchillo, Karen; Andes, David R.] Univ Wisconsin, Dept Med, Madison, WI USA; [Marchillo, Karen; Andes, David R.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist@wi.mit.edu; burke@scs.illinois.edu	Andes, David/ABE-8033-2020	Andes, David/0000-0002-7927-9950	US National Institutes of Health [R01GM080436, R01GM080436-S]; Howard Hughes Medical Institute (HHMI); Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080436] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this work were supported by the US National Institutes of Health (R01GM080436, R01GM080436-S), the Howard Hughes Medical Institute (HHMI) and the Mathers Foundation. M.D.B. is an HHMI Early Career Scientist, and S.L. is an HHMI Investigator.	Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; Andes D, 1999, ANTIMICROB AGENTS CH, V43, P2116, DOI 10.1128/AAC.43.9.2116; Andes D, 2000, ANTIMICROB AGENTS CH, V44, P938, DOI 10.1128/AAC.44.4.938-942.2000; Andes D, 2001, ANTIMICROB AGENTS CH, V45, P922, DOI 10.1128/AAC.45.3.922-926.2001; BONNER DP, 1972, J ANTIBIOT, V25, P261, DOI 10.7164/antibiotics.25.261; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Byrne B, 2003, CHEM BIOL, V10, P1215, DOI 10.1016/j.chembiol.2003.12.001; Carmody M, 2005, J BIOL CHEM, V280, P34420, DOI 10.1074/jbc.M506689200; Clinical Laboratory Standards Institute (CLSI), 2007, M38A2 CLSI; CLSI, 2008, M27A3 CLSI; Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494; Cruz MC, 2000, ANTIMICROB AGENTS CH, V44, P143, DOI 10.1128/AAC.44.1.143-149.2000; Dailey I., 2012, THESIS U ILLINOIS UR; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Ellis D, 2002, J ANTIMICROB CHEMOTH, V49, P7, DOI 10.1093/jac/49.suppl_1.7; Ellis JK, 2011, MOL BIOSYST, V7, P247, DOI 10.1039/c0mb00146e; ERMISHKIN LN, 1976, NATURE, V262, P698, DOI 10.1038/262698a0; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Grongsaard P, 2012, ORG PROCESS RES DEV, V16, P1069, DOI 10.1021/op300031r; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Jarzembska KN, 2012, CRYST GROWTH DES, V12, P2336, DOI 10.1021/cg2017227; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; KEIM GR, 1976, ANTIMICROB AGENTS CH, V10, P687, DOI 10.1128/AAC.10.4.687; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; KOTLERBRAJTBURG J, 1979, ANTIMICROB AGENTS CH, V15, P716, DOI 10.1128/AAC.15.5.716; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lepak AJ, 2013, ANTIMICROB AGENTS CH, V57, P579, DOI 10.1128/AAC.01279-12; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; MacPherson D. T., 1993, ROYAL SOC CHEM SPECI, V119, P205; MAEDA H, 1988, SYNTHESIS-STUTTGART, P401; Matsumori N, 2005, J AM CHEM SOC, V127, P10667, DOI 10.1021/ja051597r; MOONIS M, 1992, INDIAN J BIOCHEM BIO, V29, P339; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Neumann A, 2010, J AM CHEM SOC, V132, P18266, DOI 10.1021/ja1074344; Palacios DS, 2007, J AM CHEM SOC, V129, P13804, DOI 10.1021/ja075739o; Palacios DS, 2011, P NATL ACAD SCI USA, V108, P6733, DOI 10.1073/pnas.1015023108; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Paquet V, 2008, CHEM-EUR J, V14, P2465, DOI 10.1002/chem.200701237; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2040, DOI 10.1128/JCM.00248-12; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pinto JP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00160; Power P, 2008, CHEM BIOL, V15, P78, DOI 10.1016/j.chembiol.2007.11.008; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Tevyashova AN, 2013, ANTIMICROB AGENTS CH, V57, P3815, DOI 10.1128/AAC.00270-13; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Volmer AA, 2010, NAT PROD REP, V27, P1329, DOI 10.1039/b820743g; Wilcock BC, 2013, J AM CHEM SOC, V135, P8488, DOI 10.1021/ja403255s; Zager RA, 2000, AM J KIDNEY DIS, V36, P238, DOI 10.1053/ajkd.2000.8967; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	56	62	65	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					481	+		10.1038/NCHEMBIO.1821	http://dx.doi.org/10.1038/NCHEMBIO.1821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26030729	Green Accepted, Green Submitted			2022-12-25	WOS:000356334600012
J	Ye, Z; Li, ZQ; Wang, YF; Mao, Y; Shen, M; Zhang, QL; Li, SQ; Zhou, LF; Shou, XF; Chen, JH; Song, ZJ; Ma, ZY; Zhang, ZY; Li, YM; Ye, HY; Huang, CX; Wang, T; He, WQ; Zhang, YC; Xie, R; Qiao, ND; Qiu, HJ; Huang, S; Wang, M; Shen, JW; Wen, ZJ; Li, WJ; Liu, K; Zhou, J; Wang, L; Ji, J; Wang, Y; Chen, H; Cheng, HX; Shi, ZF; Zhu, YQ; Geng, DY; Yao, ZW; Tang, WJ; Lu, B; Pan, L; Zhang, Y; Bao, WM; Wu, JS; Zheng, K; Shi, YY; Zhao, Y				Ye, Zhao; Li, Zhiqiang; Wang, Yongfei; Mao, Ying; Shen, Ming; Zhang, Qilin; Li, Shiqi; Zhou, Liangfu; Shou, Xuefei; Chen, Jianhua; Song, Zhijian; Ma, Zengyi; Zhang, Zhaoyun; Li, Yiming; Ye, Hongying; Huang, Chuanxin; Wang, Tao; He, Wenqiang; Zhang, Yichao; Xie, Rong; Qiao, Nidan; Qiu, Huijia; Huang, Shan; Wang, Meng; Shen, Jiawei; Wen, Zujia; Li, Wenjin; Liu, Ke; Zhou, Juan; Wang, Lin; Ji, Jue; Wang, Yin; Chen, Hong; Cheng, Haixia; Shi, Zhifeng; Zhu, Yuqian; Geng, Daoying; Yao, Zhenwei; Tang, Weijun; Lu, Bin; Pan, Li; Zhang, Yi; Bao, Weimin; Wu, Jinsong; Zheng, Kang; Shi, Yongyong; Zhao, Yao			Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; BETA-CATENIN; COLORECTAL-CANCER; GENE-EXPRESSION; CDK8; POPULATION; MUTATIONS; ADHESION; PCDH15	Pituitary adenoma is one of the most common intracranial neoplasms, and its genetic basis remains largely unknown. To identify genetic susceptibility loci for sporadic pituitary adenoma, we performed a three-stage genome-wide association study (GWAS) in the Han Chinese population. We first analyzed genome-wide SNP data in 771 pituitary adenoma cases and 2,788 controls and then carried forward the promising variants for replication in another 2 independent sets (2,542 cases and 3,620 controls in total). We identified three new susceptibility loci below the genome-wide significance threshold (P < 5 x 10(-8)) in the combined analyses: 10p12.31 (rs2359536, P-meta = 2.25 x 10(-10) and rs10828088, P-meta = 6.27 x 10(-10)), 10q21.1 (rs10763170, P-meta = 6.88 x 10(-10)) and 13q12.13 (rs17083838, P-meta = 1.89 x 10(-8)). This study is the first GWAS to our knowledge on sporadic pituitary adenoma, and our results provide insight into the genetic basis of this disease.	[Ye, Zhao; Wang, Yongfei; Mao, Ying; Shen, Ming; Zhang, Qilin; Li, Shiqi; Zhou, Liangfu; Shou, Xuefei; Ma, Zengyi; He, Wenqiang; Zhang, Yichao; Xie, Rong; Qiao, Nidan; Qiu, Huijia; Shi, Zhifeng; Zhu, Yuqian; Pan, Li; Zhang, Yi; Bao, Weimin; Wu, Jinsong; Zhao, Yao] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200433, Peoples R China; [Ye, Zhao; Wang, Yongfei; Mao, Ying; Shen, Ming; Zhang, Qilin; Li, Shiqi; Zhou, Liangfu; Shou, Xuefei; Ma, Zengyi; Zhang, Zhaoyun; Li, Yiming; Ye, Hongying; He, Wenqiang; Zhang, Yichao; Xie, Rong; Qiao, Nidan; Qiu, Huijia; Shi, Zhifeng; Zhu, Yuqian; Lu, Bin; Pan, Li; Zhang, Yi; Bao, Weimin; Wu, Jinsong; Zheng, Kang; Zhao, Yao] Shanghai Pituitary Tumor Ctr, Shanghai, Peoples R China; [Li, Zhiqiang; Chen, Jianhua; Song, Zhijian; Wang, Meng; Shen, Jiawei; Wen, Zujia; Li, Wenjin; Liu, Ke; Zhou, Juan; Wang, Lin; Ji, Jue; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Chen, Jianhua; Shi, Yongyong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Zhang, Zhaoyun; Li, Yiming; Ye, Hongying] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Endocrinol, Shanghai 200433, Peoples R China; [Huang, Chuanxin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China; [Wang, Tao; Huang, Shan] Fudan Univ, Shanghai Peoples Hosp 5, Dept Neurosurg, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Yin; Chen, Hong; Cheng, Haixia] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neuropathol, Shanghai, Peoples R China; [Geng, Daoying; Yao, Zhenwei; Tang, Weijun] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Radiol, Shanghai 200433, Peoples R China; [Shi, Yongyong] Shanghai Jiao Tong Univ, Inst Social Cognit & Behav Sci, Shanghai 200030, Peoples R China; [Shi, Yongyong] Shanghai Jiao Tong Univ, Inst Neuropsychiat Sci & Syst Biol Med, Shanghai 200030, Peoples R China; [Shi, Yongyong] Xinjiang Med Univ, Teaching Hosp 1, Dept Psychiat, Urumqi, Peoples R China; [Shi, Yongyong] Qingdao Univ, Affiliated Hosp, Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China	Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Xinjiang Medical University; Qingdao University	Shi, YY (corresponding author), Shanghai Pituitary Tumor Ctr, Shanghai, Peoples R China.	shiyongyong@gmail.com	Cao, Xin/AAX-8367-2021; Shi, Yongyong/GSO-1627-2022; Chen, Jianhua/AAS-8417-2020; Wang, Tao/ABB-7736-2021; Qiao, Nidan/ABD-3231-2020; Li, Zhiqiang/AAI-4003-2021	Shi, Yongyong/0000-0003-1710-1505; Wang, Tao/0000-0002-3725-4050; Li, Zhiqiang/0000-0002-0174-9254; Zhang, Qilin/0000-0002-0122-3201; Qiao, Nidan/0000-0001-5478-3555; Mao, Ying/0000-0001-8055-115X	China Pituitary Adenoma Specialist Council (CPASC); National High-Technology Research and Development Program of China [2014AA020611]; 973 Program [2015CB559100]; National Program for Support of Top-Notch Young Professionals; National Natural Science Foundation of China [81172391, 31325014, 81130022, 81272302]; Program for New-Century Excellent Talents in University [NCET-10-0356]; Shanghai Rising-Star Tracking Program [12QH1400400]; National 863 Program [2012AA02A515]; Shanghai Jiao Tong University Liberal Arts and Sciences Cross-Disciplinary Project [13JCRZ02]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12SG17]	China Pituitary Adenoma Specialist Council (CPASC); National High-Technology Research and Development Program of China(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Program for Support of Top-Notch Young Professionals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New-Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Tracking Program; National 863 Program(National High Technology Research and Development Program of China); Shanghai Jiao Tong University Liberal Arts and Sciences Cross-Disciplinary Project; Shanghai Key Laboratory of Psychotic Disorders; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation	We thank and acknowledge all of the participants in the study. We gratefully thank Y. Wang, Q. Song, Y. Zhang and Q. Zhu for sample collection. The research was supported by the China Pituitary Adenoma Specialist Council (CPASC) and has received funding from the National High-Technology Research and Development Program of China (2014AA020611), the 973 Program (2015CB559100), the National Program for Support of Top-Notch Young Professionals, the National Natural Science Foundation of China (81172391, 31325014, 81130022 and 81272302), the Program for New-Century Excellent Talents in University (NCET-10-0356), the Shanghai Rising-Star Tracking Program (12QH1400400), the National 863 Program (2012AA02A515), the Shanghai Jiao Tong University Liberal Arts and Sciences Cross-Disciplinary Project (13JCRZ02), the Shanghai Key Laboratory of Psychotic Disorders (13dz2260500), the 'Shu Guang' project supported by the Shanghai Municipal Education Commission and the Shanghai Education Development Foundation (12SG17).	Aflorei ED, 2014, J NEURO-ONCOL, V117, P379, DOI 10.1007/s11060-013-1354-5; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Altas M, 2010, ACTA NEUROCHIR, V152, P1611, DOI 10.1007/s00701-010-0671-0; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bliss KT, 2013, MOL BIOL CELL, V24, P995, DOI 10.1091/mbc.E12-10-0723; Chambers TJG, 2013, ENDOCR-RELAT CANCER, V20, pR101, DOI 10.1530/ERC-13-0005; Couldwell WT, 2010, PITUITARY, V13, P130, DOI 10.1007/s11102-009-0212-0; Daly AF, 2009, BEST PRACT RES CL EN, V23, P543, DOI 10.1016/j.beem.2009.05.008; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dobbins SE, 2011, NAT GENET, V43, P825, DOI 10.1038/ng.879; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Doucette L, 2009, EUR J HUM GENET, V17, P554, DOI 10.1038/ejhg.2008.231; Elston MS, 2008, ENDOCRINOLOGY, V149, P1235, DOI 10.1210/en.2007-0542; Elston MS, 2009, NAT REV ENDOCRINOL, V5, P453, DOI 10.1038/nrendo.2009.126; Fernando HS, 2010, UROL ONCOL-SEMIN ORI, V28, P320, DOI 10.1016/j.urolonc.2008.12.022; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Gomes Leonor, 2005, Acta Med Port, V18, P339; Hale JS, 2012, CELL ADHES MIGR, V6, P346, DOI 10.4161/cam.21294; Haruki S, 2010, CARCINOGENESIS, V31, P1027, DOI 10.1093/carcin/bgq053; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huertas-Vazquez A, 2010, HUM GENET, V127, P83, DOI 10.1007/s00439-009-0749-z; Jaffe Craig A, 2006, Pituitary, V9, P317, DOI 10.1007/s11102-006-0412-9; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kim MY, 2011, INT J ONCOL, V38, P1375, DOI 10.3892/ijo.2011.948; Lecoq AL, 2015, NAT REV ENDOCRINOL, V11, P43, DOI 10.1038/nrendo.2014.181; Lo HS, 2002, CANCER RES, V62, P4191; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Murcia CL, 2001, MECH DEVELOP, V105, P163, DOI 10.1016/S0925-4773(01)00388-4; Ortiz-Plata A, 2010, ANN DIAGN PATHOL, V14, P418, DOI 10.1016/j.anndiagpath.2010.06.008; Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Raverot G, 2014, EUR J ENDOCRINOL, V170, pR121, DOI 10.1530/EJE-13-1031; Taylor MA, 2013, BREAST CANCER RES TR, V142, P341, DOI 10.1007/s10549-013-2753-1; Teng Y, 2013, CARCINOGENESIS, V34, P1994, DOI 10.1093/carcin/bgt167; Xiao L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0888-5; Zhang Y, 2012, J CANCER RES CLIN, V138, P2035, DOI 10.1007/s00432-012-1274-3; Zhou YL, 2014, MOL CELL ENDOCRINOL, V386, P16, DOI 10.1016/j.mce.2013.09.006	46	30	33	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					793	+		10.1038/ng.3322	http://dx.doi.org/10.1038/ng.3322			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029870				2022-12-25	WOS:000357090300017
J	Craft, AM; Rockel, JS; Nartiss, Y; Kandel, RA; Alman, BA; Keller, GM				Craft, April M.; Rockel, Jason S.; Nartiss, Yulia; Kandel, Rita A.; Alman, Benjamin A.; Keller, Gordon M.			Generation of articular chondrocytes from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							CARTILAGE FORMATION; IN-VITRO; ENDOCHONDRAL OSSIFICATION; SYNOVIAL JOINT; II RECEPTOR; MOUSE LIMB; DIFFERENTIATION; COLLAGEN; BETA; BONE	The replacement of articular cartilage through transplantation of chondrogenic cells or preformed cartilage tissue represents a potential new avenue for the treatment of degenerative joint diseases. Although many studies have described differentiation of human pluripotent stem cells (hPSCs) to the chondrogenic lineage, the generation of chondrocytes able to produce stable articular cartilage in vivo has not been demonstrated. Here we show that activation of the TGF beta pathway in hPSC-derived chondrogenic progenitors promotes the efficient development of articular chondrocytes that can form stable cartilage tissue in vitro and in vivo. In contrast, chondrocytes specified by BMP4 signaling display characteristics of hypertrophy and give rise to cartilage tissues that initiate the endochondral ossification process in vivo. These findings provide a simple serum-free and efficient approach for the routine generation of hPSC-derived articular chondrocytes for modeling diseases of the joint and developing cell therapy approaches to treat them.	[Craft, April M.; Nartiss, Yulia; Keller, Gordon M.] McEwen Ctr Regenerat Med, Univ Hlth Network, Toronto, ON, Canada; [Craft, April M.; Nartiss, Yulia; Keller, Gordon M.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Rockel, Jason S.; Alman, Benjamin A.] Hosp Sick Children, Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Kandel, Rita A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Keller, Gordon M.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Craft, AM (corresponding author), Harvard Univ, Sch Med, Dept Orthoped Surg, Boston Childrens Hosp,Orthoped Res Labs, Boston, MA 02115 USA.	april.craft@childrens.harvard.edu; gkeller@uhnresearch.ca	Kandel, Rita/AAU-9908-2021; Kandel, Rita/E-2149-2017	Kandel, Rita/0000-0003-4047-3913; Kandel, Rita/0000-0003-4047-3913; Keller, Gordon/0000-0001-9309-9297	Canadian Institutes of Health Research [MOP 219710]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank D. Taylor for providing primary human chondrocyte samples, H. Whetstone for histological expertise and helpful discussions, and A. Grigoriadis, F. Beier and members of the Keller laboratory for critical reading of the manuscript. We thank T. Araki and B. Neel (Ontario Cancer Institute, Toronto) for the iBJ hiPSC line and M. Warman (Boston Children's Hospital) and G. Jay (Lifespan Health System, RI) for the lubricin antibody. This work was supported by a grant from Canadian Institutes of Health Research (MOP 219710) to B. A. A. and G.M.K., and a generous contribution from the Krembil Foundation to A.M.C. and G.M.K.	Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; Bernardo BC, 2011, J BIOL CHEM, V286, P37758, DOI 10.1074/jbc.M111.248039; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Enomoto-Iwamoto M, 1998, J CELL BIOL, V140, P409, DOI 10.1083/jcb.140.2.409; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Fukunaga T, 2003, BONE, V33, P911, DOI 10.1016/j.bone.2003.07.010; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; Janicki P, 2010, ACTA BIOMATER, V6, P3292, DOI 10.1016/j.actbio.2010.01.037; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Koch M, 2004, J BIOL CHEM, V279, P22514, DOI 10.1074/jbc.M400536200; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Kronenberg H M, 2001, Novartis Found Symp, V232, P144; Kronenberg HM, 2001, NOVART FDN SYMP, V232, P152; Li TS, 2013, STEM CELLS DEV, V22, P1342, DOI 10.1089/scd.2012.0207; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasano Y, 1996, ANAT EMBRYOL, V194, P247; Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Tanaka M, 2009, STEM CELL RES, V3, P126, DOI 10.1016/j.scr.2009.07.001; Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Wang X, 2011, INT J MOL MED, V27, P583, DOI 10.3892/ijmm.2011.611; Witty AD, 2014, NAT BIOTECHNOL, V32, P1026, DOI 10.1038/nbt.3002; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang QY, 2011, GENESIS, V49, P75, DOI 10.1002/dvg.20702	42	111	117	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					638	+		10.1038/nbt.3210	http://dx.doi.org/10.1038/nbt.3210			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25961409				2022-12-25	WOS:000356019700024
J	Gaide, O; Emerson, RO; Jiang, XD; Gulati, N; Nizza, S; Desmarais, C; Robins, H; Krueger, JG; Clark, RA; Kupper, TS				Gaide, Olivier; Emerson, Ryan O.; Jiang, Xiaodong; Gulati, Nicholas; Nizza, Suzanne; Desmarais, Cindy; Robins, Harlan; Krueger, James G.; Clark, Rachael A.; Kupper, Thomas S.			Common clonal origin of central and resident memory T cells following skin immunization	NATURE MEDICINE			English	Article							CONTACT HYPERSENSITIVITY; EFFECTOR; DIFFERENTIATION; GENERATION; INFECTION; FATE	Central memory T (T-CM) cells in lymph nodes (LNs) and resident memory T (T-RM) cells in peripheral tissues have distinct roles in protective immunity(1-5). Both are generated after primary infections, but their clonal origins have been unclear. To address this question, we immunized mice through the skin with a protein antigen, a chemical hapten, or a non-replicating poxvirus. We then analyzed antigen-activated T cells from different tissues using high-throughput sequencing (HIS) of the gene encoding the T cell receptor (TCR) beta-chain (Trb, also known as Tcrb) using CDR3 sequences to simultaneously track thousands of unique T cells(6). For every abundant T-RM cell clone generated in the skin, an abundant T-CM cell clone bearing the identical TCR was present in the LNs. Thus, antigen-reactive skin T-RM and LN T-CM cell clones were derived from a common naive T cell precursor after skin immunization, generating overlapping TCR repertoires. Although they bore the same TCR, T-RM cells mediated rapid contact hypersensitivity(7) responses, whereas T-CM cells mediated delayed and attenuated responses. Studies in human subjects confirmed the generation of skin T-RM cells in allergic contact dermatitis. Thus, immunization through skin simultaneously generates skin T-RM and LN T-CM cells in similar numbers from the same naive T cells.	[Gaide, Olivier; Jiang, Xiaodong; Nizza, Suzanne; Clark, Rachael A.; Kupper, Thomas S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Emerson, Ryan O.; Desmarais, Cindy] Adapt Biotech, Seattle, WA USA; [Gulati, Nicholas; Krueger, James G.] Rockefeller Univ, Lab Invest Dermatol, New York, NY 10021 USA; [Robins, Harlan] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rockefeller University; Fred Hutchinson Cancer Center	Kupper, TS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA.	tkupper@partners.org	Kupper, Thomas/O-4962-2019		US National Institutes of Health [R01 AR065807, TR01 AI097128, R01 AR063962, R01 AR056720]; Fondation Suisse pour lea Bourses en Medecine et Biologie [PASMP3-132622-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063962, R01AR056720, R01AR065807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Suisse pour lea Bourses en Medecine et Biologie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the US National Institutes of Health (R01 AR065807 to T.S.K., TR01 AI097128 to T.S.K. and R.A.C., R01 AR063962 and R01 AR056720 to R.A.C.). O.G. was supported in part by the Fondation Suisse pour lea Bourses en Medecine et Biologie (PASMP3-132622-1).	Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Gebhardt T, 2013, TRENDS IMMUNOL, V34, P27, DOI 10.1016/j.it.2012.08.008; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gulati N, 2014, J INVEST DERMATOL, V134, P2531, DOI 10.1038/jid.2014.196; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kupper TS, 2012, J INVEST DERMATOL, V132, P829, DOI 10.1038/jid.2011.400; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Popov A, 2012, IMMUNOL RES, V52, P127, DOI 10.1007/s12026-012-8277-7; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302	25	196	197	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					647	653		10.1038/nm.3860	http://dx.doi.org/10.1038/nm.3860			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25962122	Green Accepted			2022-12-25	WOS:000355778300021
J	Jimenez-Sanchez, M; Lam, W; Hannus, M; Sonnichsen, B; Imarisio, S; Fleming, A; Tarditi, A; Menzies, F; Dami, TE; Xu, C; Gonzalez-Couto, E; Lazzeroni, G; Heitz, F; Diamanti, D; Massai, L; Satagopam, VP; Marconi, G; Caramelli, C; Nencini, A; Andreini, M; Sardone, GL; Caradonna, NP; Porcari, V; Scali, C; Schneider, R; Pollio, G; O'Kane, CJ; Caricasole, A; Rubinsztein, DC				Jimenez-Sanchez, Maria; Lam, Wun; Hannus, Michael; Soennichsen, Birte; Imarisio, Sara; Fleming, Angeleen; Tarditi, Alessia; Menzies, Fiona; Dami, Teresa Ed; Xu, Catherine; Gonzalez-Couto, Eduardo; Lazzeroni, Giulia; Heitz, Freddy; Diamanti, Daniela; Massai, Luisa; Satagopam, Venkata P.; Marconi, Guido; Caramelli, Chiara; Nencini, Arianna; Andreini, Matteo; Sardone, Gian Luca; Caradonna, Nicola P.; Porcari, Valentina; Scali, Carla; Schneider, Reinhard; Pollio, Giuseppe; O'Kane, Cahir J.; Caricasole, Andrea; Rubinsztein, David C.			siRNA screen identifies QPCT as a druggable target for Huntington's disease	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-B-CRYSTALLIN; HUMAN GLUTAMINYL CYCLASE; HEAT-SHOCK-PROTEIN; MUTANT HUNTINGTIN; GENETIC ALGORITHM; POLYGLUTAMINE; DROSOPHILA; DOCKING; DOMAIN; BETA	Huntington's disease (HD) is a currently incurable neurodegenerative condition caused by an abnormally expanded polyglutamine tract in huntingtin (HTT). We identified new modifiers of mutant HTT toxicity by performing a large-scale 'druggable genome' siRNA screen in human cultured cells, followed by hit validation in Drosophila. We focused on glutaminyl cyclase (QPCT), which had one of the strongest effects on mutant HTT-induced toxicity and aggregation in the cell-based siRNA screen and also rescued these phenotypes in Drosophila. We found that QPCT inhibition induced the levels of the molecular chaperone. B-crystallin and reduced the aggregation of diverse proteins. We generated new QPCT inhibitors using in silico methods followed by in vitro screening, which rescued the HD-related phenotypes in cell, Drosophila and zebrafish HD models. Our data reveal a new HD druggable target affecting mutant HTT aggregation and provide proof of principle for a discovery pipeline from druggable genome screen to drug development.	[Jimenez-Sanchez, Maria; Lam, Wun; Imarisio, Sara; Fleming, Angeleen; Menzies, Fiona; Dami, Teresa Ed; Xu, Catherine; Rubinsztein, David C.] Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge, England; [Lam, Wun; Imarisio, Sara; O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Hannus, Michael; Soennichsen, Birte] Cenix BioSci GmbH, Dresden, Germany; [Fleming, Angeleen; Dami, Teresa Ed; Xu, Catherine] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Tarditi, Alessia; Gonzalez-Couto, Eduardo; Lazzeroni, Giulia; Heitz, Freddy; Diamanti, Daniela; Massai, Luisa; Marconi, Guido; Caramelli, Chiara; Nencini, Arianna; Andreini, Matteo; Sardone, Gian Luca; Caradonna, Nicola P.; Porcari, Valentina; Scali, Carla; Pollio, Giuseppe; Caricasole, Andrea] Siena Biotech, Siena, Italy; [Satagopam, Venkata P.; Schneider, Reinhard] EMBL, Struct & Computat Biol, Heidelberg, Germany; [Satagopam, Venkata P.; Schneider, Reinhard] Univ Luxembourg, LCSB, Luxembourg, Luxembourg	University of Cambridge; University of Cambridge; University of Cambridge; Siena Biotech; European Molecular Biology Laboratory (EMBL); University of Luxembourg	Caricasole, A (corresponding author), IRBM, Dept Neurosci, Rome, Italy.	a.caricasole@irbm.it; dcr1000@hermes.cam.ac.uk	O'Kane, Cahir/Q-6681-2019; Rubinsztein, David C/C-3472-2011; Jimenez-Sanchez, Maria/ABH-7666-2020; Schneider, Reinhard/C-5441-2009	O'Kane, Cahir/0000-0002-3488-2078; Jimenez-Sanchez, Maria/0000-0002-2287-1582; Schneider, Reinhard/0000-0002-8278-1618; Fleming, Angeleen/0000-0003-3721-7126; Satagopam, Venkata/0000-0002-6532-5880; Xu, Catherine/0000-0003-4726-636X	UK Medical Research Council [MR/J006904/1]; Wellcome Trust [095317/Z/11/Z, 100140]; National Institute of Health Research Biomedical Research Unit in Dementia at Addenbrooke's Hospital; European Community [03472, LSH-2005-2.1.3-8, 2012-305121]; Medical Research Council [MR/J006904/1] Funding Source: researchfish; MRC [MR/J006904/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research Biomedical Research Unit in Dementia at Addenbrooke's Hospital; European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful for funding from the UK Medical Research Council (COEN grant MR/J006904/1 to D.C.R. and C.J.O.'K.), the Wellcome Trust (Principal Fellowship 095317/Z/11/Z), to D.C.R., and strategic award 100140), the National Institute of Health Research Biomedical Research Unit in Dementia at Addenbrooke's Hospital, the TAMAHUD project (European Community FP6 grant no. 03472 under the Thematic Call LSH-2005-2.1.3-8 "Early markers and new targets for neurodegenerative diseases") and the NEUROMICS project (European Community Seventh Framework Programme under grant agreement no. 2012-305121). We thank J.L. Marsh, N. Perrimon and the Vienna Drosophila RNAi Center for fly stocks; M. Renna and S. Luo for helpful comments; M. Lichtenberg for help with flow cytometry assays; F. Siddiqi and M. Garcia-Arencibia for help with primary cultures; W. Fecke for advice and assistance; and S. Gotta for help in high-resolution MS analysis of compounds.	Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Buchholz M, 2006, J MED CHEM, V49, P664, DOI 10.1021/jm050756e; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; D'Agostino M, 2013, J CELL SCI, V126, P4160, DOI 10.1242/jcs.125443; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Huang KF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208595; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Lejeune FX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-91; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; Luo SQ, 2008, HUM MOL GENET, V17, P895, DOI 10.1093/hmg/ddm362; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Miller JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003042; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Tue NT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/252049; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Palm K, 1999, J PHARMACOL EXP THER, V291, P435; Polgar T, 2006, J CHEM INF MODEL, V46, P1795, DOI 10.1021/ci050412x; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rankin J, 2000, BIOCHEM J, V348, P15, DOI 10.1042/0264-6021:3480015; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Renna M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703778200; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Ruiz-Carrillo D, 2011, BIOCHEMISTRY-US, V50, P6280, DOI 10.1021/bi200249h; Saido TC, 2000, MED HYPOTHESES, V54, P427, DOI 10.1054/mehy.1999.0866; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schilling S, 2002, ANAL BIOCHEM, V303, P49, DOI 10.1006/abio.2001.5560; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2007, BIOCHEMISTRY-US, V46, P10921, DOI 10.1021/bi701043x; Song H, 2015, J ALZHEIMERS DIS, V43, P797, DOI 10.3233/JAD-141356; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yamanaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093891; Yoon S, 2004, J CHEM INF COMP SCI, V44, P88, DOI 10.1021/ci0341619; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	57	55	60	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2015	11	5					347	U144		10.1038/NCHEMBIO.1790	http://dx.doi.org/10.1038/NCHEMBIO.1790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG3FD	25848931	Green Submitted, Green Accepted			2022-12-25	WOS:000353162600011
J	Deidda, G; Parrini, M; Naskar, S; Bozarth, IF; Contestabile, A; Cancedda, L				Deidda, Gabriele; Parrini, Martina; Naskar, Shovan; Bozarth, Ignacio F.; Contestabile, Andrea; Cancedda, Laura			Reversing excitatory GABA(A)R signaling restores synaptic plasticity and memory in a mouse model of Down syndrome	NATURE MEDICINE			English	Article							CATION-CHLORIDE COTRANSPORTERS; TS65DN MOUSE; MEDIATED NEUROTRANSMISSION; HIPPOCAMPAL INTERNEURONS; DIURETIC BUMETANIDE; ALZHEIMERS-DISEASE; SYNDROME MICE; DEFICITS; INHIBITION; NKCC1	Down syndrome (DS) is the most frequent genetic cause of intellectual disability, and altered GABAergic transmission through Cl- permeable GABA(A) receptors (GABA(A)Rs) contributes considerably to learning and memory deficits in DS mouse models. However, the efficacy of GABAergic transmission has never been directly assessed in DS. Here GABA(A)R signaling was found to be excitatory rather than inhibitory, and the reversal potential for GABA(A)R-driven Cl- currents (E-Cl) was shifted toward more positive potentials in the hippocampi of adult DS mice. Accordingly, hippocampal expression of the cation Cl-cotransporter NKCC1 was increased in both trisomic mice and individuals with DS. Notably, NKCC1 inhibition by the FDA-approved drug bumetanide restored ECl, synaptic plasticity and hippocampus-dependent memory in adult DS mice. Our findings demonstrate that GABA is excitatory in adult DS mice and identify a new therapeutic approach for the potential rescue of cognitive disabilities in individuals with DS.	[Deidda, Gabriele; Parrini, Martina; Naskar, Shovan; Bozarth, Ignacio F.; Contestabile, Andrea; Cancedda, Laura] Ist Italiano Tecnol, Neurosci & Brain Technol Dept, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Cancedda, L (corresponding author), Ist Italiano Tecnol, Neurosci & Brain Technol Dept, Genoa, Italy.	andrea.contestabile@iit.it; laura.cancedda@iit.it	Contestabile, Andrea/F-9908-2013; Naskar, Shovan/AAJ-8740-2020; Deidda, Gabriele/GZH-0784-2022	Contestabile, Andrea/0000-0002-5417-4722; Deidda, Gabriele/0000-0002-0721-4971; Naskar, Shovan/0000-0002-4228-596X; Cancedda, Laura/0000-0003-0566-057X; Naskar, Shovan/0000-0002-1367-5993	Compagnia di San Paolo [2008.1267]; Jerome Lejeune Foundation [995-CA2012A, 1266_CL2014A]	Compagnia di San Paolo(Compagnia di San Paolo); Jerome Lejeune Foundation	This work was supported by Compagnia di San Paolo (grant 2008.1267 to L.C.) and the Jerome Lejeune Foundation (grants 995-CA2012A, to A.C., and 1266_CL2014A, to L.C.). Human Down syndrome and control samples were obtained from the Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore. We thank F. Benfenati (Istituto Italiano di Tecnologia (IIT)) for financial support, J. Assad (IIT) for critical reading of the manuscript, M. Pesce (IIT NBT imaging facility) for technical assistance with two-photon microscopy and the staff of the IIT animal facility and genotyping service for their valuable work. We also thank K. Kaila (University of Helsinki, Helsinki, Finland) for providing brain tissue from NKCC1-deficient and KCC2-deficient mice.	ALGER BE, 1991, ANN NY ACAD SCI, V627, P249; Best TK, 2012, EXP NEUROL, V233, P749, DOI 10.1016/j.expneurol.2011.11.033; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Castren E, 2012, J NEUROSCI, V32, P14074, DOI 10.1523/JNEUROSCI.3287-12.2012; Chakrabarti L, 2010, NAT NEUROSCI, V13, P927, DOI 10.1038/nn.2600; Cleary RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057148; Contestabile A, 2013, J CLIN INVEST, V123, P348, DOI 10.1172/JCI64650; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Costa ACS, 2013, CNS DRUGS, V27, P679, DOI 10.1007/s40263-013-0089-3; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Deidda G, 2015, NAT NEUROSCI, V18, P87, DOI 10.1038/nn.3890; Deidda G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00119; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Edwards DA, 2010, ANESTHESIOLOGY, V112, P567, DOI 10.1097/ALN.0b013e3181cf9138; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Hadjikhani N, 2015, AUTISM, V19, P149, DOI 10.1177/1362361313514141; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hanson JE, 2007, J PHYSIOL-LONDON, V579, P53, DOI 10.1113/jphysiol.2006.114868; Harashima C, 2006, J COMP NEUROL, V494, P815, DOI 10.1002/cne.20844; He Q, 2014, J NEUROSCI, V34, P446, DOI 10.1523/JNEUROSCI.4447-13.2014; Jean-Xavier C, 2007, P NATL ACAD SCI USA, V104, P11477, DOI 10.1073/pnas.0704832104; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Kleschevnikov AM, 2012, NEUROBIOL DIS, V45, P683, DOI 10.1016/j.nbd.2011.10.009; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Lemonnier E, 2013, ACTA PAEDIATR, V102, pe288, DOI 10.1111/apa.12235; Lemonnier E, 2010, ACTA PAEDIATR, V99, P1885, DOI 10.1111/j.1651-2227.2010.01933.x; Li YJ, 2011, J CHROMATOGR B, V879, P998, DOI 10.1016/j.jchromb.2011.02.018; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; Maa EH, 2011, EPILEPSIA, V52, P1559, DOI 10.1111/j.1528-1167.2011.03203.x; Mares P, 2009, PHYSIOL RES, V58, P927, DOI 10.33549/physiolres.931897; Mazarati A, 2009, EPILEPSIA, V50, P2117, DOI 10.1111/j.1528-1167.2009.02048.x; Mitra A, 2012, BRAIN RES, V1440, P1, DOI 10.1016/j.brainres.2011.12.034; OSTERGAARD EH, 1972, ARZNEI-FORSCHUNG, V22, P66; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; PENTIKAINEN PJ, 1977, BRIT J CLIN PHARMACO, V4, P39, DOI 10.1111/j.1365-2125.1977.tb00664.x; Peterson S.L., 1998, NEUROPHARMACOLOGY ME; Pozzi D, 2013, EMBO J, V32, P2994, DOI 10.1038/emboj.2013.231; PUESCHEL SM, 1991, ARCH NEUROL-CHICAGO, V48, P318, DOI 10.1001/archneur.1991.00530150088024; Puskarjov M, 2014, EPILEPSIA, V55, P806, DOI 10.1111/epi.12620; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rissman RA, 2011, J NEUROCHEM, V117, P613, DOI 10.1111/j.1471-4159.2011.07237.x; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Song IS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1377; Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595; Succol F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1744; Szemes M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-33; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Usowicz MM, 2012, BRAIN RES, V1465, P10, DOI 10.1016/j.brainres.2012.05.027; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERKMAN AS, 1989, ANAL BIOCHEM, V178, P355, DOI 10.1016/0003-2697(89)90652-0; Wang DD, 2011, CEREB CORTEX, V21, P574, DOI 10.1093/cercor/bhq124; WARD A, 1984, DRUGS, V28, P426, DOI 10.2165/00003495-198428050-00003; WARD OC, 1977, ARCH DIS CHILD, V52, P877, DOI 10.1136/adc.52.11.877; Westmark CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026549; Westmark CJ, 2010, J ALZHEIMERS DIS, V20, P1009, DOI 10.3233/JAD-2010-100087; Wlodarczyk AI, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00205	68	157	161	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					318	+		10.1038/nm.3827	http://dx.doi.org/10.1038/nm.3827			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25774849				2022-12-25	WOS:000352493600013
J	Dalli, J; Chiang, N; Serhan, CN				Dalli, Jesmond; Chiang, Nan; Serhan, Charles N.			Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections	NATURE MEDICINE			English	Article							INFLAMMATORY LIPID MEDIATORS; S-NITROSYLATION; NITRIC-OXIDE; NEUTROPHILS; EXERCISE	Endogenous mechanisms leading to host protection and resolution of infections without immunosuppression are of wide interest(1,2). Here we elucidate the structures of four new host-protective molecules produced in neutrophil-endothelial cocultures and present in human and mouse tissues after sterile inflammation or infection. The bioactive molecules contain conjugated triene and diene double bonds, carry an alcohol at C13 and are derived from n-3 docosapentaenoic acid (DPA, C22:5). These compounds, termed 13-series resolvins (RvTs), demonstrated potent protective actions increasing mice survival during Escherichia coli infections. RvTs also regulated human and mouse phagocyte responses stimulating bacterial phagocytosis and regulating inflammasome components. Their biosynthesis during neutrophil-endothelial cell interactions was initiated by endothelial cyclooxygenase-2 (COX-2), increased by atorvastatin via S-nitrosylation of COX-2 and reduced by COX-2 inhibitors. The actions of atorvastatin and RvTs were additive in E. coli infections in mice, where they accelerated resolution of inflammation and increased survival >60%. Taken together, these results document host-protective molecules in bacterial infections, namely RvTs, derived from n-3 DPA via transcellular biosynthesis and increased by atorvastatin. These molecules regulate key innate protective responses in the resolution of infectious inflammation.	[Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Dalli, Jesmond/0000-0001-6328-3640	National Institutes of Health [P01GM095467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R. Colas and I. Vlasakov for assistance with material preparation and lipid mediator metabololipidomics. This work was supported by the National Institutes of Health (P01GM095467 to C.N.S.).	Atar S, 2006, AM J PHYSIOL-HEART C, V290, pH1960, DOI 10.1152/ajpheart.01137.2005; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; COREY EJ, 1987, J AM CHEM SOC, V109, P5551, DOI 10.1021/ja00252a056; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Fullerton JN, 2014, TRENDS IMMUNOL, V35, P12, DOI 10.1016/j.it.2013.10.008; Gangemi S, 2003, J APPL PHYSIOL, V94, P2237, DOI 10.1152/japplphysiol.01004.2002; Gryglewski RJ, 2010, PHARMACOL REP, V62, P462, DOI 10.1016/S1734-1140(10)70301-7; HEMLER ME, 1980, ARCH BIOCHEM BIOPHYS, V201, P586, DOI 10.1016/0003-9861(80)90548-2; Henriksbo BD, 2014, DIABETES, V63, P3742, DOI 10.2337/db13-1398; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Kandasamy K, 2011, SHOCK, V36, P76, DOI 10.1097/SHK.0b013e31821a4002; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Lins RL, 2003, NEPHROL DIAL TRANSPL, V18, P967, DOI 10.1093/ndt/gfg048; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Morikawa Shigeru, 2002, J Atheroscler Thromb, V9, P178; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Ye Y, 2007, PROSTAG OTH LIPID M, V84, P43, DOI 10.1016/j.prostaglandins.2007.04.001	29	164	172	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1071	+		10.1038/nm.3911	http://dx.doi.org/10.1038/nm.3911			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26236990	Green Accepted, Green Submitted			2022-12-25	WOS:000360961300021
J	Humphrey, SJ; Azimifar, SB; Mann, M				Humphrey, Sean J.; Azimifar, S. Babak; Mann, Matthias			High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics	NATURE BIOTECHNOLOGY			English	Article							LARGE-SCALE ANALYSIS; PHOSPHORYLATION DYNAMICS; PROTEIN-PHOSPHORYLATION; KINASE; QUANTIFICATION; ACTIVATION; AKT/PKB	Mass spectrometry has enabled the study of cellular signaling on a systems-wide scale, through the quantification of post-translational modifications, such as protein phosphorylation(1). Here we describe EasyPhos, a scalable phosphoproteomics platform that now allows rapid quantification of hundreds of phosphoproteomes in diverse cells and tissues at a depth of >10,000 sites. We apply this technology to generate time-resolved maps of insulin signaling in the mouse liver. Our results reveal that insulin affects similar to 10% of the liver phosphoproteome and that many known functional phosphorylation sites, and an even larger number of unknown sites, are modified at very early time points (<15 s after insulin delivery). Our kinetic data suggest that the flow of signaling information from the cell surface to the nucleus can occur on very rapid timescales of less than 1 min in vivo. EasyPhos facilitates high-throughput phosphoproteomics studies, which should improve our understanding of dynamic cell signaling networks and how they are regulated and dysregulated in disease.	[Humphrey, Sean J.; Azimifar, S. Babak; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18A, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	Humphrey, Sean/AAC-1425-2019	Humphrey, Sean/0000-0002-2666-9744	EMBO (European Molecular Biology Organization) Long Term fellowship; Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF) [0315748]	EMBO (European Molecular Biology Organization) Long Term fellowship(European Molecular Biology Organization (EMBO)); Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank I. Paron, K. Mayr and G. Sowa for mass spectrometry technical assistance, J. Cox for bioinformatic tools and support, and E.S. Humphrey, M.Y. Hein, N. Kulak, G. Pichler and N. Nagaraj for helpful discussions. S.J.H. is supported by an EMBO (European Molecular Biology Organization) Long Term fellowship, and the project was supported by the Virtual Liver Network (grant 0315748) of the German Federal Ministry of Education and Research (BMBF).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; de Graaf EL, 2014, MOL CELL PROTEOMICS, V13, P2426, DOI 10.1074/mcp.O113.036608; Dickhut C, 2014, J PROTEOME RES, V13, P2761, DOI 10.1021/pr401181y; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kanshin E, 2015, CELL REP, V10, P1202, DOI 10.1016/j.celrep.2015.01.052; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Monetti M, 2011, NAT METHODS, V8, P655, DOI [10.1038/nmeth.1647, 10.1038/NMETH.1647]; Narvekar P, 2009, DIABETES, V58, P1040, DOI 10.2337/db08-1184; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Ortiz-Padilla C, 2013, ONCOGENE, V32, P2696, DOI 10.1038/onc.2012.271; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Russell WK, 2001, ANAL CHEM, V73, P2682, DOI 10.1021/ac001332p; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Vaga S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145112; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wang HX, 2005, J PROTEOME RES, V4, P2397, DOI 10.1021/pr050160f; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214	31	286	291	9	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					990	U142		10.1038/nbt.3327	http://dx.doi.org/10.1038/nbt.3327			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26280412				2022-12-25	WOS:000360990900028
J	Medema, MH; Kottmann, R; Yilmaz, P; Cummings, M; Biggins, JB; Blin, K; de Bruijn, I; Chooi, YH; Claesen, J; Coates, RC; Cruz-Morales, P; Duddela, S; Dusterhus, S; Edwards, DJ; Fewer, DP; Garg, N; Geiger, C; Gomez-Escribano, JP; Greule, A; Hadjithomas, M; Haines, AS; Helfrich, EJN; Hillwig, ML; Ishida, K; Jones, AC; Jones, CS; Jungmann, K; Kegler, C; Kim, HU; Kotter, P; Krug, D; Masschelein, J; Melnik, AV; Mantovani, SM; Monroe, EA; Moore, M; Moss, N; Nutzmann, HW; Pan, GH; Pati, A; Petras, D; Reen, FJ; Rosconi, F; Rui, Z; Tian, ZH; Tobias, NJ; Tsunematsu, Y; Wiemann, P; Wyckoff, E; Yan, XH; Yim, G; Yu, FG; Xie, YC; Aigle, B; Apel, AK; Balibar, CJ; Balskus, EP; Barona-Gomez, F; Bechthold, A; Bode, HB; Borriss, R; Brady, SF; Brakhage, AA; Caffrey, P; Cheng, YQ; Clardy, J; Cox, RJ; De Mot, R; Donadio, S; Donia, MS; van der Donk, WA; Dorrestein, PC; Doyle, S; Driessen, AJM; Ehling-Schulz, M; Entian, KD; Fischbach, MA; Gerwick, L; Gerwick, WH; Gross, H; Gust, B; Hertweck, C; Hofte, M; Jensen, SE; Ju, JH; Katz, L; Kaysser, L; Klassen, JL; Keller, NP; Kormanec, J; Kuipers, OP; Kuzuyama, T; Kyrpides, NC; Kwon, HJ; Lautru, S; Lavigne, R; Lee, CY; Linquan, B; Liu, XY; Liu, W; Luzhetskyy, A; Mahmud, T; Mast, Y; Mendez, C; Metsa-Ketela, M; Micklefield, J; Mitchell, DA; Moore, BS; Moreira, LM; Muller, R; Neilan, BA; Nett, M; Nielsen, J; O'Gara, F; Oikawa, H; Osbourn, A; Osburne, MS; Ostash, B; Payne, SM; Pernodet, JL; Petricek, M; Piel, J; Ploux, O; Raaijmakers, JM; Salas, JA; Schmitt, EK; Scott, B; Seipke, RF; Shen, B; Sherman, DH; Sivonen, K; Smanski, MJ; Sosio, M; Stegmann, E; Sussmuth, RD; Tahlan, K; Thomas, CM; Tang, Y; Truman, AW; Viaud, M; Walton, JD; Walsh, CT; Weber, T; van Wezel, GP; Wilkinson, B; Willey, JM; Wohlleben, W; Wright, GD; Ziemert, N; Zhang, CS; Zotchev, SB; Breitling, R; Takano, E; Glockner, FO				Medema, Marnix H.; Kottmann, Renzo; Yilmaz, Pelin; Cummings, Matthew; Biggins, John B.; Blin, Kai; de Bruijn, Irene; Chooi, Yit Heng; Claesen, Jan; Coates, R. Cameron; Cruz-Morales, Pablo; Duddela, Srikanth; Duesterhus, Stephanie; Edwards, Daniel J.; Fewer, David P.; Garg, Neha; Geiger, Christoph; Gomez-Escribano, Juan Pablo; Greule, Anja; Hadjithomas, Michalis; Haines, Anthony S.; Helfrich, Eric J. N.; Hillwig, Matthew L.; Ishida, Keishi; Jones, Adam C.; Jones, Carla S.; Jungmann, Katrin; Kegler, Carsten; Kim, Hyun Uk; Koetter, Peter; Krug, Daniel; Masschelein, Joleen; Melnik, Alexey V.; Mantovani, Simone M.; Monroe, Emily A.; Moore, Marcus; Moss, Nathan; Nuetzmann, Hans-Wilhelm; Pan, Guohui; Pati, Amrita; Petras, Daniel; Reen, F. Jerry; Rosconi, Federico; Rui, Zhe; Tian, Zhenhua; Tobias, Nicholas J.; Tsunematsu, Yuta; Wiemann, Philipp; Wyckoff, Elizabeth; Yan, Xiaohui; Yim, Grace; Yu, Fengan; Xie, Yunchang; Aigle, Bertrand; Apel, Alexander K.; Balibar, Carl J.; Balskus, Emily P.; Barona-Gomez, Francisco; Bechthold, Andreas; Bode, Helge B.; Borriss, Rainer; Brady, Sean F.; Brakhage, Axel A.; Caffrey, Patrick; Cheng, Yi-Qiang; Clardy, Jon; Cox, Russell J.; De Mot, Rene; Donadio, Stefano; Donia, Mohamed S.; van der Donk, Wilfred A.; Dorrestein, Pieter C.; Doyle, Sean; Driessen, Arnold J. M.; Ehling-Schulz, Monika; Entian, Karl-Dieter; Fischbach, Michael A.; Gerwick, Lena; Gerwick, William H.; Gross, Harald; Gust, Bertolt; Hertweck, Christian; Hofte, Monica; Jensen, Susan E.; Ju, Jianhua; Katz, Leonard; Kaysser, Leonard; Klassen, Jonathan L.; Keller, Nancy P.; Kormanec, Jan; Kuipers, Oscar P.; Kuzuyama, Tomohisa; Kyrpides, Nikos C.; Kwon, Hyung-Jin; Lautru, Sylvie; Lavigne, Rob; Lee, Chia Y.; Linquan, Bai; Liu, Xinyu; Liu, Wen; Luzhetskyy, Andriy; Mahmud, Taifo; Mast, Yvonne; Mendez, Carmen; Metsa-Ketela, Mikko; Micklefield, Jason; Mitchell, Douglas A.; Moore, Bradley S.; Moreira, Leonilde M.; Mueller, Rolf; Neilan, Brett A.; Nett, Markus; Nielsen, Jens; O'Gara, Fergal; Oikawa, Hideaki; Osbourn, Anne; Osburne, Marcia S.; Ostash, Bohdan; Payne, Shelley M.; Pernodet, Jean-Luc; Petricek, Miroslav; Piel, Joern; Ploux, Olivier; Raaijmakers, Jos M.; Salas, Jose A.; Schmitt, Esther K.; Scott, Barry; Seipke, Ryan F.; Shen, Ben; Sherman, David H.; Sivonen, Kaarina; Smanski, Michael J.; Sosio, Margherita; Stegmann, Evi; Suessmuth, Roderich D.; Tahlan, Kapil; Thomas, Christopher M.; Tang, Yi; Truman, Andrew W.; Viaud, Muriel; Walton, Jonathan D.; Walsh, Christopher T.; Weber, Tilmann; van Wezel, Gilles P.; Wilkinson, Barrie; Willey, Joanne M.; Wohlleben, Wolfgang; Wright, Gerard D.; Ziemert, Nadine; Zhang, Changsheng; Zotchev, Sergey B.; Breitling, Rainer; Takano, Eriko; Gloeckner, Frank Oliver			Minimum Information about a Biosynthetic Gene cluster	NATURE CHEMICAL BIOLOGY			English	Editorial Material							DATABASE; DISCOVERY; RESOURCE		[Medema, Marnix H.; Kottmann, Renzo; Yilmaz, Pelin; Gloeckner, Frank Oliver] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Res Grp, Bremen, Germany; [Cummings, Matthew; Breitling, Rainer; Takano, Eriko] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol,SYNBIOCHEM, Manchester Ctr Synthet Biol Fine & Special Chem, Manchester, Lancs, England; [Biggins, John B.; Brady, Sean F.] Rockefeller Univ, Howard Hughes Med Inst, Lab Genet Encoded Small Mol, New York, NY 10021 USA; [Blin, Kai; Kim, Hyun Uk; Nielsen, Jens; Weber, Tilmann] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [de Bruijn, Irene; Raaijmakers, Jos M.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Chooi, Yit Heng; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Chooi, Yit Heng] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia; [Claesen, Jan; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Claesen, Jan; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Coates, R. Cameron; Hadjithomas, Michalis; Pati, Amrita; Kyrpides, Nikos C.; van Wezel, Gilles P.] Joint Genome Inst, Dept Energy DOE, Walnut Creek, CA USA; [Cruz-Morales, Pablo; Barona-Gomez, Francisco] CINVESTAV, IPN, Unidad Genom Avanzada Langebio, Evolut Metab Div Lab, Guanajuato, Mexico; [Duddela, Srikanth; Jungmann, Katrin; Krug, Daniel; Luzhetskyy, Andriy; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res, D-66123 Saarbrucken, Germany; [Duddela, Srikanth; Jungmann, Katrin; Krug, Daniel; Luzhetskyy, Andriy; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Duesterhus, Stephanie; Geiger, Christoph; Koetter, Peter; Entian, Karl-Dieter] Goethe Univ Frankfurt, Inst Mol Biosci, D-60054 Frankfurt, Germany; [Edwards, Daniel J.] Calif State Univ Chico, Dept Chem & Biochem, Chico, CA 95929 USA; [Fewer, David P.; Sivonen, Kaarina] Univ Helsinki, Dept Food & Environm Sci, Microbiol & Biotechnol Div, Helsinki, Finland; [Garg, Neha; Melnik, Alexey V.; Dorrestein, Pieter C.; Gerwick, William H.; Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gomez-Escribano, Juan Pablo; Truman, Andrew W.; Wilkinson, Barrie] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England; [Greule, Anja; Bechthold, Andreas] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, D-79106 Freiburg, Germany; [Haines, Anthony S.; Thomas, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Helfrich, Eric J. N.; Piel, Joern] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Hillwig, Matthew L.; Liu, Xinyu] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Ishida, Keishi; Tsunematsu, Yuta; Brakhage, Axel A.; Hertweck, Christian; Nett, Markus] Leibniz Inst Nat Product Res & Infect Biol HK, Jena, Germany; [Jones, Adam C.] Gordon & Betty Moore Fdn, Palo Alto, CA USA; [Jones, Carla S.] Roosevelt Univ, Sustainable Studies Program, Chicago, IL 60605 USA; [Kegler, Carsten; Tobias, Nicholas J.; Bode, Helge B.] Goethe Univ Frankfurt, Fachbereich Biowissensch, Merck Stiftungsprof Mol Biotechnol, D-60054 Frankfurt, Germany; [Kim, Hyun Uk] Korea Adv Inst Sci & Technol, BioInformat Res Ctr, Daejeon 305701, South Korea; [Masschelein, Joleen; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Heverlee, Belgium; [Masschelein, Joleen] Katholieke Univ Leuven, Lab Food Microbiol, Heverlee, Belgium; [Mantovani, Simone M.; Moss, Nathan; Dorrestein, Pieter C.; Gerwick, Lena; Gerwick, William H.; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Monroe, Emily A.] William Paterson Univ, Dept Biol, Wayne, NJ USA; [Moore, Marcus; Tahlan, Kapil] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Nuetzmann, Hans-Wilhelm; Osbourn, Anne] John Innes Ctr, Dept Metab Biol, Norwich, Norfolk, England; [Pan, Guohui; Yan, Xiaohui; Shen, Ben] Scripps Res Inst, Dept Chem, Jupiter, FL USA; [Petras, Daniel; Suessmuth, Roderich D.] Tech Univ Berlin, Inst Chem, Berlin, Germany; [Reen, F. Jerry; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, BIOMERIT Res Ctr, Cork, Ireland; [Rosconi, Federico] IBCE, Dept Bioquim & Genom Microbianas, Montevideo, Uruguay; [Rui, Zhe] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Rui, Zhe] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Tian, Zhenhua; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Tsunematsu, Yuta] Univ Shizuoka, Dept Pharmaceut Sci, Shizuoka 4228526, Japan; [Wiemann, Philipp; Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Wyckoff, Elizabeth; Payne, Shelley M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Wyckoff, Elizabeth; Payne, Shelley M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Yim, Grace; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Yu, Fengan; Sherman, David H.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Yu, Fengan; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Yu, Fengan; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Yu, Fengan; Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Xie, Yunchang; Ju, Jianhua; Zhang, Changsheng] Chinese Acad Sci, South China Sea Inst Oceanol, RNAM Ctr Marine Microbiol, Key Lab Trop Marine Bioresources & Ecol,Guangdong, Guangzhou, Guangdong, Peoples R China; [Aigle, Bertrand] Univ Lorraine, Dynam Genomes & Adaptat Microbienne, Vandoeuvre Les Nancy, France; [Aigle, Bertrand] INRA, UMR 1128, Vandoeuvre Les Nancy, France; [Apel, Alexander K.; Gross, Harald; Gust, Bertolt; Kaysser, Leonard] Univ Tubingen, Inst Pharmazeut, Dept Pharmaceut Biol, Tubingen, Germany; [Apel, Alexander K.; Gross, Harald; Gust, Bertolt; Kaysser, Leonard; Stegmann, Evi; Wohlleben, Wolfgang; Ziemert, Nadine] Partner Site Tubingen, German Ctr Infect Res DZIF, Tubingen, Germany; [Balibar, Carl J.] Merck Res Labs, Infect Dis Res, Kenilworth, NJ USA; [Balskus, Emily P.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Bode, Helge B.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, D-60054 Frankfurt, Germany; [Borriss, Rainer] Humboldt Univ, Albrecht Thaer Inst, Fachbereich Phytomed, D-10099 Berlin, Germany; [Caffrey, Patrick] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Cheng, Yi-Qiang] Univ N Texas, Hlth Sci Ctr, UNT Syst Coll Pharm, Ft Worth, TX USA; [Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Cox, Russell J.] Leibniz Univ Hannover, Inst Organ Chem, Hannover, Germany; [Cox, Russell J.] Univ Bristol, Sch Chem, Bristol, Avon, England; [De Mot, Rene] Univ Leuven, Fac Biosci Engn, Ctr Microbial & Plant Genet, Heverlee, Belgium; [Donadio, Stefano; Sosio, Margherita] Naicons Srl, Milan, Italy; [Donia, Mohamed S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [van der Donk, Wilfred A.; Mitchell, Douglas A.] Univ Illinois, Dept Chem, Urbana, IL USA; [van der Donk, Wilfred A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Collaborat Mass Spectrometry Innovat Ctr, La Jolla, CA 92093 USA; [Doyle, Sean] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland; [Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, Groningen, Netherlands; [Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands; [Ehling-Schulz, Monika] Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Funct Microbiol, Vienna, Austria; [Hertweck, Christian] Univ Jena, Jena, Germany; [Hofte, Monica] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [Jensen, Susan E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Katz, Leonard] Univ Calif Emeryville, Synthet Biol Engn Res Ctr SynBERC, Emeryville, CA USA; [Klassen, Jonathan L.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Keller, Nancy P.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Kormanec, Jan] Slovak Acad Sci, Inst Mol Biol, Bratislava 84251, Slovakia; [Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands; [Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan; [Kyrpides, Nikos C.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Kwon, Hyung-Jin] Myongji Univ, Div Biosci & Bioinformat, Yongin, Gyeonggi Do, South Korea; [Lautru, Sylvie; Pernodet, Jean-Luc] Univ Paris Sud, CNRS, CEA, Inst Integrat Biol Cell I2BC, Orsay, France; [Lee, Chia Y.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Linquan, Bai] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Linquan, Bai] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Mahmud, Taifo] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Mast, Yvonne; Stegmann, Evi; Wohlleben, Wolfgang; Ziemert, Nadine] Univ Tubingen, Fac Sci, Interfaculty Inst Microbiol & Infect Med, Microbiology Biotechnol, Tubingen, Germany; [Mendez, Carmen; Salas, Jose A.] Univ Oviedo, Dept Biol Func, Oviedo, Spain; [Mendez, Carmen] Univ Oviedo, IUOPA, Oviedo, Spain; [Metsa-Ketela, Mikko] Univ Turku, Dept Biochem, Turku, Finland; [Micklefield, Jason] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Moreira, Leonilde M.] Univ Lisbon, Inst Super Tecn, Inst Bioengn & Biosci, P-1699 Lisbon, Portugal; [Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [O'Gara, Fergal] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia; [Oikawa, Hideaki] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido, Japan; [Osburne, Marcia S.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Ostash, Bohdan] Ivan Franko Natl Univ Lviv, Dept Genet & Biotechnol, Lvov, Ukraine; [Petricek, Miroslav] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Ploux, Olivier] Univ Paris Diderot, CNRS, LIED, UMR 8236, Paris, France; [Schmitt, Esther K.] Novartis Inst BioMed Res, Basel, Switzerland; [Scott, Barry] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Seipke, Ryan F.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Shen, Ben] Scripps Res Inst, Mol Therapeut & Nat Prod Lib Initiat, Jupiter, FL USA; [Smanski, Michael J.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, St Paul, MN USA; [Smanski, Michael J.] Univ Minnesota Twin Cities, BioTechnol Inst, St Paul, MN USA; [Viaud, Muriel] INRA, Unite Biol & GEst Risques Agr BIOGER, Grignon, France; [Walton, Jonathan D.] Michigan State Univ, Dept Energy Great Lakes, Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Walton, Jonathan D.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Walsh, Christopher T.] Stanford Univ, Chemistry Engn & Med Human Hlth ChEM H Inst, Stanford, CA 94305 USA; [van Wezel, Gilles P.] Leiden Univ, Inst Biol, Mol Biotechnol, Leiden, Netherlands; [Willey, Joanne M.] Hofstra North Shore Long Isl Jewish Sch Med, Hempstead, NY USA; [Zotchev, Sergey B.] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Gloeckner, Frank Oliver] Jacobs Univ Bremen, gGmbH, D-28759 Bremen, Germany	Max Planck Society; University of Manchester; Howard Hughes Medical Institute; Rockefeller University; Technical University of Denmark; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Western Australia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; Goethe University Frankfurt; California State University System; California State University Chico; University of Helsinki; University of California System; University of California San Diego; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Freiburg; University of Birmingham; Swiss Federal Institutes of Technology Domain; ETH Zurich; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hans Knoll Institute (HKI); Goethe University Frankfurt; Korea Advanced Institute of Science & Technology (KAIST); KU Leuven; KU Leuven; University of California System; University of California San Diego; Scripps Institution of Oceanography; Memorial University Newfoundland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Scripps Research Institute; Technical University of Berlin; University College Cork; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Shizuoka; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; McMaster University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Universite de Lorraine; INRAE; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research; Merck & Company; Harvard University; Goethe University Frankfurt; Humboldt University of Berlin; University College Dublin; University of North Texas System; University of North Texas Health Science Center; Harvard University; Harvard Medical School; Leibniz University Hannover; University of Bristol; KU Leuven; Princeton University; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of California System; University of California San Diego; Maynooth University; University of Groningen; University of Groningen; University of Veterinary Medicine Vienna; Friedrich Schiller University of Jena; Ghent University; University of Alberta; University of Connecticut; University of Wisconsin System; University of Wisconsin Madison; Slovak Academy of Sciences; University of Groningen; University of Tokyo; King Abdulaziz University; Myongji University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Arkansas System; University of Arkansas Medical Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Oregon State University; Eberhard Karls University of Tubingen; University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Finland National Institute for Health & Welfare; University of Turku; University of Manchester; Universidade de Lisboa; Instituto Superior Tecnico; University of New South Wales Sydney; Chalmers University of Technology; Curtin University; Hokkaido University; Tufts University; Ministry of Education & Science of Ukraine; Ivan Franko National University Lviv; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Novartis; Massey University; University of Leeds; Scripps Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; AgroParisTech; INRAE; Michigan State University; Michigan State University; Stanford University; Leiden University; Leiden University - Excl LUMC; Hofstra University; Norwegian University of Science & Technology (NTNU); Jacobs University	Medema, MH (corresponding author), Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Res Grp, Bremen, Germany.	marnix.medema@wur.nl	van Wezel, Gilles/ABC-7854-2021; Cox, Russell John/F-9190-2015; Garg, Neha/L-3120-2018; Rui, Zhe/D-9541-2013; Medema, Marnix H./AAR-3138-2021; Mendez-Fernandez, Carmen/ABE-5745-2020; Kyrpides, Nikos C./A-6305-2014; Blin, Kai/ABD-5377-2021; Keller, Nancy P./ABC-5911-2021; de Bruijn, Irene/A-7437-2014; Müller, Rolf/B-1559-2008; Bode, Helge B/F-7022-2014; Lautru, Sylvie/AAJ-1199-2020; Ostash, Bohdan/J-9875-2014; Wright, G/ABB-7666-2021; Institute, Zernike/W-7033-2019; Bechthold, Andreas/P-4199-2019; Weber, Tilmann/C-7159-2009; Zhang, Changsheng/B-5965-2012; Klassen, Jonathan/B-5060-2010; Raaijmakers, Jos M/D-1574-2014; Reen, Jerry/AAG-7155-2019; Kim, Hyun Uk/F-4509-2018; Mast, Yvonne/AAC-8145-2019; Tsunematsu, Yuta/AAI-1139-2020; Aigle, Bertrand/AAN-8229-2021; Truman, Andrew W/AAV-9509-2021; Neilan, Brett A/I-5767-2012; Petříček, Miroslav/H-8417-2014; van der Donk, Wilfred/K-2961-2015; Dorrestein, Pieter/ABF-2930-2020; Micklefield, Jason/I-8502-2016; Kormanec, Jan/AAA-7446-2019; Hofte, Monica MR/A-6154-2008; Driessen, Arnold J.M./D-1876-2012; Oikawa, Hideaki/F-9128-2012; Kaysser, Leonard/Q-2091-2019; Hertweck, Christian/AAZ-8452-2021; Chooi, Yit Heng/D-4338-2013; Thomas, Christopher M/J-8258-2017; Ehling-Schulz, Monika/J-3592-2014; Borriss, Rainer/C-5026-2012; Fewer, David P/A-8704-2008; de Fátima Morais Moreira, Leonilde/C-6744-2011; Ziemert, Nadine/H-1935-2015; Mahmud, Taifo/A-1492-2015; Kuipers, Oscar/B-6752-2009; Nielsen, Jens/Q-1347-2017; KNAW, NIOO-KNAW/A-4320-2012; Pernodet, Jean-Luc/A-4074-2015	van Wezel, Gilles/0000-0003-0341-1561; Cox, Russell John/0000-0002-1844-0157; Garg, Neha/0000-0002-2760-7123; Rui, Zhe/0000-0001-8113-2694; Medema, Marnix H./0000-0002-2191-2821; Mendez-Fernandez, Carmen/0000-0003-2729-841X; Kyrpides, Nikos C./0000-0002-6131-0462; Blin, Kai/0000-0003-3764-6051; de Bruijn, Irene/0000-0002-4889-3253; Müller, Rolf/0000-0002-1042-5665; Bode, Helge B/0000-0001-6048-5909; Lautru, Sylvie/0000-0002-7935-704X; Ostash, Bohdan/0000-0001-5904-5957; Weber, Tilmann/0000-0002-8260-5120; Zhang, Changsheng/0000-0003-2349-3138; Klassen, Jonathan/0000-0003-1745-8838; Raaijmakers, Jos M/0000-0003-1608-6614; Kim, Hyun Uk/0000-0001-7224-642X; Mast, Yvonne/0000-0003-3099-5777; Neilan, Brett A/0000-0001-6113-772X; Petříček, Miroslav/0000-0001-8757-2404; van der Donk, Wilfred/0000-0002-5467-7071; Micklefield, Jason/0000-0001-8951-4873; Oikawa, Hideaki/0000-0002-6947-3397; Kaysser, Leonard/0000-0002-3943-993X; Hertweck, Christian/0000-0002-0367-337X; Chooi, Yit Heng/0000-0001-7719-7524; Thomas, Christopher M/0000-0002-2810-0455; Borriss, Rainer/0000-0003-3726-1004; Fewer, David P/0000-0003-3978-4845; de Fátima Morais Moreira, Leonilde/0000-0002-6838-4245; Mahmud, Taifo/0000-0001-9639-526X; Kuipers, Oscar/0000-0001-5596-7735; O'Gara, Fergal/0000-0002-2659-0673; Nutzmann, Hans-Wilhelm/0000-0002-6855-7556; Mitchell, Douglas/0000-0002-9564-0953; Petras, Daniel/0000-0002-6561-3022; Tobias, Nicholas/0000-0003-2725-3043; Hofte, Monica/0000-0002-0850-3249; Hillwig, Matthew/0000-0002-1168-4191; Masschelein, Joleen/0000-0003-4366-3675; Reen, F. Jerry/0000-0002-7717-9892; Seipke, Ryan/0000-0002-6156-8498; Breitling, Rainer/0000-0001-7173-0922; Moore, Bradley/0000-0002-4652-1253; Wright, Gerard/0000-0002-9129-7131; Sosio, Margherita/0000-0003-4297-6936; Nielsen, Jens/0000-0002-9955-6003; Biggins, John B./0000-0002-0825-3593; Gomez-Escribano, Juan Pablo/0000-0002-2744-9129; Fischbach, Michael/0000-0003-3079-8247; Ehling-Schulz, Monika/0000-0001-7384-0594; Nett, Markus/0000-0003-0847-086X; Truman, Andrew/0000-0001-5453-7485; Zotchev, Sergey/0000-0002-9324-245X; Cummings, Matthew/0000-0002-4741-2630; Cruz-Morales, Pablo/0000-0002-6751-8897; Takano, Eriko/0000-0002-6791-3256; Ziemert, Nadine/0000-0002-7264-1857; Driessen, Arnold J.M./0000-0001-9258-9104; Sussmuth, Roderich/0000-0001-7027-2069; Lavigne, Rob/0000-0001-7377-1314; Aigle, Bertrand/0000-0001-5266-5926; KNAW, NIOO-KNAW/0000-0002-3835-159X; Barona Gomez, Francisco/0000-0003-1492-9497; Kuzuyama, Tomohisa/0000-0002-7221-5858; Cheng, Eric/0000-0001-9336-2593; Bechthold, Andreas/0000-0003-3594-6851; Kormanec, Jan/0000-0003-0377-6413; Metsa-Ketela, Mikko/0000-0003-3176-2908; Sivonen, Kaarina/0000-0002-2904-0458; Helfrich, Eric Jan Nikolaus/0000-0001-8751-3279; Rosconi, Federico/0000-0001-6760-9003; Claesen, Jan/0000-0002-0755-7974; Willey, Joanne/0000-0003-4544-4417; Pan, Guohui/0000-0002-8839-3886; Haines, Anthony/0000-0003-2736-6371; Krug, Daniel/0000-0002-3664-1884; Yilmaz, Pelin/0000-0003-4724-323X; Jones, Adam/0000-0001-7521-1863; Pernodet, Jean-Luc/0000-0002-6129-7093	Grants-in-Aid for Scientific Research [26292058] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550, R01GM107550] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/L014130/1, BB/M017702/1, BBS/E/J/00000614, BB/J014478/1, BB/E021611/1, BBS/B/07071] Funding Source: Medline; NCI NIH HHS [R01 CA108874] Funding Source: Medline; NIAID NIH HHS [R37 AI016935, R01 AI113766, R01 AI037027] Funding Source: Medline; NIGMS NIH HHS [T32 GM067550, R01 GM123998, R01 GM107550] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/K005952/1, BBS/E/J/000CA538, 1626770, BBS/E/J/000CA527, BB/L002299/1, BBS/E/J/000C0665, BB/M028860/1, BB/I014373/1, BBS/E/J/000C0666, 1338115, BB/J006289/1, BB/M028712/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K034359/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [New Bioactive Compounds] Funding Source: researchfish; BBSRC [BB/L014130/1, BB/E021611/1, BBS/E/J/000CA527, BB/L002299/1, BB/M028860/1, BBS/E/J/000C0665, BBS/E/J/000C0666, BB/J006289/1, BB/M017702/1, BB/M028712/1, BBS/E/J/000CA538, BB/K005952/1, BB/I014373/1] Funding Source: UKRI; EPSRC [EP/K034359/1] Funding Source: UKRI	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Baranasic D, 2014, J IND MICROBIOL BIOT, V41, P461, DOI 10.1007/s10295-013-1322-2; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bork P, 2015, SCIENCE, V348, P873, DOI 10.1126/science.aac5605; Charlop-Powers Z, 2015, ELIFE, V4, DOI 10.7554/eLife.05048; Charlop-Powers Z, 2014, CURR OPIN MICROBIOL, V19, P70, DOI 10.1016/j.mib.2014.05.021; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Conway KR, 2013, NUCLEIC ACIDS RES, V41, pD402, DOI 10.1093/nar/gks993; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gubbens J, 2014, CHEM BIOL, V21, P707, DOI 10.1016/j.chembiol.2014.03.011; Hadjithomas M, 2015, MBIO, V6, DOI 10.1128/mBio.00932-15; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Ichikawa N, 2013, NUCLEIC ACIDS RES, V41, pD408, DOI 10.1093/nar/gks1177; Inokuma Y, 2013, NATURE, V495, P461, DOI 10.1038/nature11990; Kersten RD, 2013, P NATL ACAD SCI USA, V110, pE4407, DOI 10.1073/pnas.1315492110; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Khayatt BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062136; Kopf A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0066-5; Pence HE, 2010, J CHEM EDUC, V87, P1123, DOI 10.1021/ed100697w; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Shao ZY, 2013, ACS SYNTH BIOL, V2, P662, DOI 10.1021/sb400058n; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Wilson MC, 2013, CHEM BIOL, V20, P636, DOI 10.1016/j.chembiol.2013.04.011; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	30	466	474	4	258	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					625	631		10.1038/nchembio.1890	http://dx.doi.org/10.1038/nchembio.1890			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26284661	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-25	WOS:000359954700003
J	Schramm, A; Koster, J; Assenov, Y; Althoff, K; Peifer, M; Mahlow, E; Odersky, A; Beisser, D; Ernst, C; Henssen, AG; Stephan, H; Schroder, C; Heukamp, L; Engesser, A; Kahlert, Y; Theissen, J; Hero, B; Roels, F; Altmullser, J; Nurnberg, P; Astrahantseff, K; Gloeckner, C; De Preter, K; Plass, C; Lee, S; Lode, HN; Henrich, KO; Gartlgruber, M; Speleman, F; Schmezer, P; Westermann, F; Rahmann, S; Fischer, M; Eggert, A; Schulte, JH				Schramm, Alexander; Koester, Johannes; Assenov, Yassen; Althoff, Kristina; Peifer, Martin; Mahlow, Ellen; Odersky, Andrea; Beisser, Daniela; Ernst, Corinna; Henssen, Anton G.; Stephan, Harald; Schroeder, Christopher; Heukamp, Lukas; Engesser, Anne; Kahlert, Yvonne; Theissen, Jessica; Hero, Barbara; Roels, Frederik; Altmuellser, Janine; Nuernberg, Peter; Astrahantseff, Kathy; Gloeckner, Christian; De Preter, Katleen; Plass, Christoph; Lee, Sangkyun; Lode, Holger N.; Henrich, Kai-Oliver; Gartlgruber, Moritz; Speleman, Frank; Schmezer, Peter; Westermann, Frank; Rahmann, Sven; Fischer, Matthias; Eggert, Angelika; Schulte, Johannes H.			Mutational dynamics between primary and relapse neuroblastomas	NATURE GENETICS			English	Article							DNA METHYLATION DATA; N-MYC; CANCER; ALK; PHENOTYPE; GENES; HETEROGENEITY; ASSOCIATION; SIGNATURES; RECEPTOR	Neuroblastoma is a malignancy of the developing sympathetic nervous system that is often lethal when relapse occurs. We here used whole-exome sequencing, mRNA expression profiling, array CGH and DNA methylation analysis to characterize 16 paired samples at diagnosis and relapse from individuals with neuroblastoma. The mutational burden significantly increased in relapsing tumors, accompanied by altered mutational signatures and reduced subclonal heterogeneity. Global allele frequencies at relapse indicated clonal mutation selection during disease progression. Promoter methylation patterns were consistent over disease course and were patient specific. Recurrent alterations at relapse included mutations in the putative CHD5 neuroblastoma tumor suppressor, chromosome 9p losses, DOCK8 mutations, inactivating mutations in PTPN14 and a relapse-specific activity pattern for the PTPN14 target YAP. Recurrent new mutations in HRAS, KRAS and genes mediating cell-cell interaction in 13 of 16 relapse tumors indicate disturbances in signaling pathways mediating mesenchymal transition. Our data shed light on genetic alteration frequency, identity and evolution in neuroblastoma.	[Schramm, Alexander; Althoff, Kristina; Mahlow, Ellen; Odersky, Andrea; Henssen, Anton G.; Stephan, Harald; Schulte, Johannes H.] Univ Duisburg Essen, Univ Childrens Hosp Essen, Pediat Oncol & Hematol, Essen, Germany; [Koester, Johannes; Beisser, Daniela; Ernst, Corinna; Schroeder, Christopher; Rahmann, Sven] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Genome Informat, Essen, Germany; [Assenov, Yassen; Plass, Christoph; Schmezer, Peter] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Peifer, Martin] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Peifer, Martin; Nuernberg, Peter; Fischer, Matthias] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Heukamp, Lukas; Gloeckner, Christian] NEO New Oncol, Cologne, Germany; [Engesser, Anne; Kahlert, Yvonne; Theissen, Jessica; Hero, Barbara; Roels, Frederik] Univ Childrens Hosp, Pediat Oncol & Hematol, Cologne, Germany; [Altmuellser, Janine; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Altmuellser, Janine] Univ Hosp Cologne, Human Genet, Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Astrahantseff, Kathy; Schulte, Johannes H.] Charite, Pediat Oncol & Hematol, D-13353 Berlin, Germany; [De Preter, Katleen; Westermann, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Plass, Christoph; Eggert, Angelika; Schulte, Johannes H.] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Lee, Sangkyun; Rahmann, Sven] TU Dortmund, Comp Sci, Dortmund, Germany; [Lode, Holger N.] Univ Med Greifswald, Pediat Oncol & Hematol, Greifswald, Germany; [Henrich, Kai-Oliver; Gartlgruber, Moritz; Westermann, Frank] German Canc Res Ctr, Neuroblastoma Genom, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Cologne; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Cologne; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ghent University; Ghent University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Dortmund University of Technology; Greifswald Medical School; Helmholtz Association; German Cancer Research Center (DKFZ)	Schulte, JH (corresponding author), Univ Duisburg Essen, Univ Childrens Hosp Essen, Pediat Oncol & Hematol, Essen, Germany.	alexander.schramm@uni-due.de; johannes.schulte@uni-due.de	Stephan, Harald/AAT-6802-2021; De Preter, Katleen/I-7135-2013; Schramm, Alexander/G-5688-2010; Westermann, Frank/F-7509-2013; Lee, Sangkyun/AAE-5272-2019; speleman, frank/AAR-5184-2020; Eggert, Angelika/AAE-6907-2022; Beisser, Daniela/AAR-8642-2020; Schulte, Johannes H./V-2474-2018; Ernst, Corinna/AAR-1053-2021; Heukamp, Lukas/G-9967-2012	De Preter, Katleen/0000-0002-7726-5096; Schramm, Alexander/0000-0001-7670-7529; Lee, Sangkyun/0000-0001-8415-6368; speleman, frank/0000-0002-6628-8559; Eggert, Angelika/0000-0003-3476-8184; Beisser, Daniela/0000-0002-0679-6631; Ernst, Corinna/0000-0001-7756-8815; Heukamp, Lukas/0000-0002-3388-3482; Lode, Holger/0000-0002-1201-208X; Altmuller, Janine/0000-0003-4372-1521; Peifer, Martin/0000-0002-5243-5503; Schulte, Johannes Hubertus/0000-0003-0671-1201; Henssen, Anton/0000-0003-1534-778X	Deutsche Forschungsgemeinschaft (DFG) [SFB876]; Mercator Foundation; German Cancer Aid [110122]; Kinderkrebs-Neuroblastomforschung Fordergesellschaft; Center for Molecular Medicine Cologne (CMMC); German Ministry of Science and Education (BMBF) as part of the e:Med initiative [01ZX1303A,B, 01ZX1307C,D,E, 01ZX1307]; ASSET consortium - European Union [259348]; German Consortium for Translational Cancer Research (DKTK); ENCCA consortium - European Union [261474]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Mercator Foundation; German Cancer Aid(Deutsche Krebshilfe); Kinderkrebs-Neuroblastomforschung Fordergesellschaft; Center for Molecular Medicine Cologne (CMMC); German Ministry of Science and Education (BMBF) as part of the e:Med initiative; ASSET consortium - European Union; German Consortium for Translational Cancer Research (DKTK); ENCCA consortium - European Union	A.S., S.R. and S.L. acknowledge the support of the Deutsche Forschungsgemeinschaft (DFG) within Collaborative Research Center SFB876, 'Providing Information by Resource-Constrained Analysis', subproject C1. J.K. and S.R. acknowledge support from the Mercator Foundation for project MERCUR Pe-2013-0012 (UA Ruhr Professorship 'Computational Biology'). M.F. was funded by German Cancer Aid (grant 110122), the Kinderkrebs-Neuroblastomforschung Fordergesellschaft and the Center for Molecular Medicine Cologne (CMMC). A.S., A. Eggert, M.F. and J.H.S. were supported by the German Ministry of Science and Education (BMBF) as part of the e:Med initiative (grant 01ZX1303A,B; 01ZX1307C,D,E; and 01ZX1307). A. Eggert and J.H.S. were supported by the ASSET consortium funded by the European Union (Framework Programme 7, grant 259348). A. Eggert was supported by the German Consortium for Translational Cancer Research (DKTK; joint funding pool and DKTK branch Berlin). A. Eggert and K. Astrahantseff were supported by the ENCCA consortium funded by the European Union (Framework Programme 7, grant 261474). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Althoff K, 2015, INT J CANCER, V136, P1308, DOI 10.1002/ijc.29091; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Belle L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005547; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Cobrinik D, 2013, GENE CHROMOSOME CANC, V52, P1150, DOI 10.1002/gcc.22110; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Koyama H, 2012, CLIN CANCER RES, V18, P1588, DOI 10.1158/1078-0432.CCR-11-2644; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Oakes CC, 2014, CANCER DISCOV, V4, P348, DOI 10.1158/2159-8290.CD-13-0349; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2014, J CLIN ONCOL, V32, P2727, DOI 10.1200/JCO.2013.54.0674; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Schulte JH, 2011, CLIN CANCER RES, V17, P5082, DOI 10.1158/1078-0432.CCR-10-2809; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Su XP, 2012, BIOINFORMATICS, V28, P2265, DOI 10.1093/bioinformatics/bts365; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Theissen J, 2014, GENE CHROMOSOME CANC, V53, P639, DOI 10.1002/gcc.22174; Theissen J, 2009, CLIN CANCER RES, V15, P2085, DOI 10.1158/1078-0432.CCR-08-1648; Vandesompele J, 1998, GENE CHROMOSOME CANC, V23, P141, DOI 10.1002/(SICI)1098-2264(199810)23:2<141::AID-GCC7>3.0.CO;2-2; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Wiestler B, 2014, NEURO-ONCOLOGY, V16, P1630, DOI 10.1093/neuonc/nou138; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	44	182	186	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					872	+		10.1038/ng.3349	http://dx.doi.org/10.1038/ng.3349			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26121086				2022-12-25	WOS:000358674100010
J	Yang, F; Xiao, X; Cheng, W; Yang, W; Yu, PL; Song, ZZ; Yarov-Yarovoy, V; Zheng, J				Yang, Fan; Xiao, Xian; Cheng, Wei; Yang, Wei; Yu, Peilin; Song, Zhenzhen; Yarov-Yarovoy, Vladimir; Zheng, Jie			Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel	NATURE CHEMICAL BIOLOGY			English	Article							VOLTAGE SENSOR; RECEPTOR; DOCKING; RESINIFERATOXIN; CONFORMATIONS; DETERMINANTS; SENSITIVITY; ENERGETICS; CAPSIATE; MUTANTS	Capsaicin bestows spiciness by activating TRPV1 channel with exquisite potency and selectivity. Although a capsaicin-bound channel structure was previously resolved by cryo-EM at 4.2-to 4.5-angstrom resolution, capsaicin was registered as a small electron density, reflecting neither its chemical structure nor specific ligand-channel interactions-important details required for mechanistic understanding. We obtained the missing atomic-level details by iterative computation and confirmed them by systematic site-specific functional tests. We observed that the bound capsaicin takes a 'tail-up, head-down' configuration. The vanillyl and amide groups form specific interactions to anchor its bound position, while the aliphatic tail may sample a range of conformations, making it invisible in cryo-EM images. Capsaicin stabilizes TRPV1's open state by 'pull-and-contact' interactions between the vanillyl group and the S4-S5 linker. Our study provides a structural mechanism for the agonistic function of capsaicin and its analogs, and demonstrates an effective approach to obtain atomic-level information from cryo-EM structures.	[Yang, Fan; Xiao, Xian; Yarov-Yarovoy, Vladimir; Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Cheng, Wei] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Yang, Wei] Zhejiang Univ, Sch Med, Minist Hlth China, Key Lab Med Neurobiol,Inst Neurosci, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Peilin] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Zhenzhen] Zhejiang Sci Tech Univ, Dept Chem, Hangzhou, Zhejiang, Peoples R China	University of California System; University of California Davis; Dalian Medical University; Zhejiang University; Zhejiang University; Zhejiang Sci-Tech University	Zheng, J (corresponding author), Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	jzheng@ucdavis.edu	Yang, Fan/J-4562-2015; Yang, Fan/GYU-4249-2022; Yang, Wei/HIA-0360-2022; Yang, Fan/C-6586-2012; Yarov-Yarovoy, Vladimir/ABE-5454-2020; Yang, Wei/GWV-4107-2022; Zhu, Ren-Yuan/V-8966-2019; chegn, maizy/GVU-3127-2022; Yang, Fan/AAA-6904-2022	Yang, Fan/0000-0002-9406-7710; Yang, Fan/0000-0002-9406-7710; Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Zhu, Ren-Yuan/0000-0003-3091-7461; Yang, Fan/0000-0002-0520-5254	National Institutes of Health [R01NS072377]; National Natural Science Foundation of China [31328011, 81301720, 81371302]; National Basic Research Program of China [2013CB910204]; China Scholarship Council; American Heart Association [14POST19820027]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); China Scholarship Council(China Scholarship Council); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Zheng laboratory for assistance and constructive discussion. This work was supported by funding from National Institutes of Health (R01NS072377) and National Natural Science Foundation of China (31328011) to J.Z., National Natural Science Foundation of China (31328011, 81301720) to W.C., National Basic Research Program of China (2013CB910204), National Natural Science Foundation of China (81371302), China Scholarship Council to W.Y. and American Heart Association (14POST19820027) to F.Y.	Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Appendino G, 2005, J MED CHEM, V48, P4663, DOI 10.1021/jm050139q; Appendino G, 2003, BRIT J PHARMACOL, V139, P1417, DOI 10.1038/sj.bjp.0705387; Barbero GF, 2010, J AGR FOOD CHEM, V58, P3342, DOI 10.1021/jf9035029; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Bronowska A. K., 2011, THERMODYNAMICS INTER, P5; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHALLIS AAL, 1947, J CHEM SOC, P613, DOI 10.1039/jr9470000613; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Davis IW, 2009, PROTEIN SCI, V18, P1998, DOI 10.1002/pro.192; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Diaz-Laviada I, 2014, PROG DRUG RES, V68, P181, DOI 10.1007/978-3-0348-0828-6_8; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Franks F., 2000, WATER MATRIX LIFE; GANNETT PM, 1988, J ORG CHEM, V53, P1064, DOI 10.1021/jo00240a024; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P463, DOI 10.1098/rspa.1924.0082; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kobata K, 1998, J AGR FOOD CHEM, V46, P1695, DOI 10.1021/jf980135c; Lalatonne Y, 2004, NAT MATER, V3, P121, DOI 10.1038/nmat1054; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lindert S, 2012, STRUCTURE, V20, P464, DOI 10.1016/j.str.2012.01.023; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Nilius B, 2013, REV PHYSIOL BIOCH P, V164, P1, DOI 10.1007/112_2013_11; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Sakmann B, 2009, SINGLE CHANNEL RECOR; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Steinberg X, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00171; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Tekpinar M, 2010, PROTEINS, V78, P2469, DOI 10.1002/prot.22755; Thomas KC, 2011, J PHARMACOL EXP THER, V337, P400, DOI 10.1124/jpet.110.178491; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zheng J, 2014, CURR TOP MEMBR, V74, P233, DOI 10.1016/B978-0-12-800181-3.00009-9; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zheng WJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001046	61	171	180	5	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					518	+		10.1038/NCHEMBIO.1835	http://dx.doi.org/10.1038/NCHEMBIO.1835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26053297	Green Accepted			2022-12-25	WOS:000356334600017
J	Dalmas, E; Toubal, A; Alzaid, F; Blazekt, K; Eames, HL; Lebozec, K; Pini, M; Hainault, I; Montastier, E; Denis, RGP; Ancel, P; Lacombe, A; Ling, Y; Allatif, O; Cruciani-Guglielmacci, C; Andre, S; Viguerie, N; Poitou, C; Stich, V; Torcivia, A; Foufelle, F; Luquet, S; Aron-Wisnewsky, J; Langin, D; Clement, K; Udalova, IA; Venteclef, N				Dalmas, Elise; Toubal, Amine; Alzaid, Fawaz; Blazekt, Katrina; Eames, Hayley L.; Lebozec, Kristen; Pini, Maria; Hainault, Isabelle; Montastier, Emilie; Denis, Raphael G. P.; Ancel, Patricia; Lacombe, Amelie; Ling, Yin; Allatif, Omran; Cruciani-Guglielmacci, Celine; Andre, Sebastien; Viguerie, Nathalie; Poitou, Christine; Stich, Vladimir; Torcivia, Alexandra; Foufelle, Fabienne; Luquet, Serge; Aron-Wisnewsky, Judith; Langin, Dominique; Clement, Karine; Udalova, Irina A.; Venteclef, Nicolas			Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity	NATURE MEDICINE			English	Article							ACTIVATED MACROPHAGES; EXTRACELLULAR-MATRIX; METABOLIC PROFILE; LIPID-METABOLISM; INFLAMMATION; RESISTANCE; FIBROSIS; DIFFERENTIATION; POLARIZATION; EXPRESSION	Accumulation of visceral adipose tissue correlates with elevated inflammation and increased risk of metabolic diseases. However, little is known about the molecular mechanisms that control its pathological expansion. Transcription factor interferon regulatory factor 5 (IRF5) has been implicated in polarizing macrophages towards an inflammatory phenotype. Here we demonstrate that mice lacking Irf5, when placed on a high-fat diet, show no difference in the growth of their epididymal white adipose tissue (epiWAT) but they show expansion of their subcutaneous white adipose tissue, as compared to wild-type (WT) mice on the same diet. EpiWAT from Irf5-deficient mice is marked by accumulation of alternatively activated macrophages, higher collagen deposition that restricts adipocyte size, and enhanced insulin sensitivity compared to epiWAT from WT mice. In obese individuals, IRF5 expression is negatively associated with insulin sensitivity and collagen deposition in visceral adipose tissue. Genome-wide analysis of gene expression in adipose tissue macrophages highlights the transforming growth factor beta 1 (TGFB1) gene itself as a direct target of IRF5-mediated inhibition. This study uncovers a new function for IRF5 in controlling the relative mass of different adipose tissue depots and thus insulin sensitivity in obesity, and it suggests that inhibition of IRF5 may promote a healthy metabolic state during this condition.	[Dalmas, Elise; Toubal, Amine; Pini, Maria; Ancel, Patricia; Ling, Yin; Allatif, Omran; Andre, Sebastien; Poitou, Christine; Aron-Wisnewsky, Judith; Clement, Karine] Univ Paris 06, Sorbonne Univ, INSERM, ICAN,UMR S 1166,Nutri, Paris, France; [Dalmas, Elise; Toubal, Amine; Alzaid, Fawaz; Lebozec, Kristen; Pini, Maria; Hainault, Isabelle; Ancel, Patricia; Lacombe, Amelie; Ling, Yin; Allatif, Omran; Andre, Sebastien; Poitou, Christine; Foufelle, Fabienne; Aron-Wisnewsky, Judith; Clement, Karine; Venteclef, Nicolas] Inst Cardiometab & Nutr, Paris, France; [Toubal, Amine; Alzaid, Fawaz; Lebozec, Kristen; Hainault, Isabelle; Foufelle, Fabienne; Venteclef, Nicolas] Univ Paris 06, Sorbonne Univ, INSERM, Cordeliers Res Ctr,UMR S 1138, Paris, France; [Toubal, Amine; Blazekt, Katrina; Eames, Hayley L.; Udalova, Irina A.] Univ Oxford, Kennedy Inst Trust Rheumatol, Oxford, England; [Montastier, Emilie] Univ Toulouse, Paul Sabatier Univ, INSERM, UMR 1048, Toulouse, France; [Montastier, Emilie; Viguerie, Nathalie] Toulouse Univ Hosp, Dept Clin Biochem, Toulouse, France; [Montastier, Emilie; Viguerie, Nathalie] Toulouse Univ Hosp, Dept Nutr, Toulouse, France; [Denis, Raphael G. P.; Cruciani-Guglielmacci, Celine; Luquet, Serge] Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat,UMR 8251, Paris, France; [Poitou, Christine; Aron-Wisnewsky, Judith; Langin, Dominique; Clement, Karine] Hop La Pitie Salpetriere, AP HP, Heart & Metab Div, Paris, France; [Stich, Vladimir; Langin, Dominique] Charles Univ Prague, Fac Med 3, Dept Sports Med, Prague, Czech Republic; [Stich, Vladimir] Charles Univ Prague, Fac Med 3, Franco Czech Lab Clin Res Obes, Prague, Czech Republic; [Torcivia, Alexandra] Hop La Pitie Salpetriere, AP HP, Visceral Surg Div, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Charles University Prague; Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Venteclef, N (corresponding author), Inst Cardiometab & Nutr, Paris, France.	irina.udalova@kennedy.ox.ac.uk; nicolas.venteclef@upmc.fr	Clément, karine/R-1120-2017; Poitou, Christine/GVT-6117-2022; Ancel, Patricia/AAK-4469-2020; Venteclef, Nicolas/K-8484-2017; Pini, Maria/O-8620-2019; Pini, Maria/T-6292-2018; ARON-WISNEWSKY, judith/AAH-7608-2020; Pini, Maria/AAC-2530-2021; Blazek, Katrina/AAU-6194-2020; Luquet, serge/AAT-1809-2021; Denis, Raphael/ABE-1758-2020; Viguerie, Nathalie/M-2422-2017	Poitou, Christine/0000-0001-7769-6331; Ancel, Patricia/0000-0001-5567-1539; Pini, Maria/0000-0002-9995-5370; Pini, Maria/0000-0002-9995-5370; Luquet, serge/0000-0001-8668-6645; Denis, Raphael/0000-0002-7677-7460; FOUFELLE, Fabienne/0000-0002-0752-622X; Udalova, Irina/0000-0002-6716-2528; Venteclef, Nicolas/0000-0002-6313-1214; Alzaid, Fawaz/0000-0003-3056-3640; Langin, Dominique/0000-0002-2669-7825; Montastier, Emilie/0000-0002-7303-3837; Viguerie, Nathalie/0000-0002-1730-9915; ALLATIF, Omran/0000-0002-2539-972X; Cruciani-Guglielmacci, Celine/0000-0002-2562-5360; Blazek, Katrina/0000-0002-4439-4756; ANDRE, Sebastien/0000-0002-7543-153X; Dalmas, Elise/0000-0003-0959-5648	Assistance Publique des Hopitaux de Paris, Programs of Clinical Investigation (Contrat de Recherche Clinique Fibrota) [AOO759-32 PI]; Assistance Publique des Hopitaux de Paris, Programs of Clinical Investigation (Programme Hospitalier de Recherche Clinique) [0702 PI]; French National Agency of Research; Region Ile de France; Midi-Pyrenees; French Foundation for Medical Research [Equipe FRM DEQ20140329504, Equipe FRM DEQ20120323701]; French Government [ANR-10-IAHU]; Kennedy Institute Trustees' Research Fund; Ministere de la Recherche et de l'Enseignement Superieur	Assistance Publique des Hopitaux de Paris, Programs of Clinical Investigation (Contrat de Recherche Clinique Fibrota); Assistance Publique des Hopitaux de Paris, Programs of Clinical Investigation (Programme Hospitalier de Recherche Clinique); French National Agency of Research(French National Research Agency (ANR)); Region Ile de France(Region Ile-de-France); Midi-Pyrenees(Region Occitanie); French Foundation for Medical Research(Fondation pour la Recherche Medicale); French Government; Kennedy Institute Trustees' Research Fund; Ministere de la Recherche et de l'Enseignement Superieur	We are grateful to C. Enond and H. Foher-Ting. We thank Assistance Publique des Hopitaux de Paris, Programs of Clinical Investigation (Contrat de Recherche Clinique Fibrota AOO759-32 PI to J.A.-W and Programme Hospitalier de Recherche Clinique 0702 PI to K.C.), the French National Agency of Research (CONRAD to N. Venteclef, ADIPOFIB to K.C. and OBELIP to D.L.), a fellowship from Region Ile de France (to F.A., N. Venteclef and K.C.), Midi-Pyrenees (to D.L.), and the French Foundation for Medical Research (Equipe FRM DEQ20140329504 to F.F. and N. Venteclef and Equipe FRM DEQ20120323701 to K.C.). This work has benefited from a French Government grant managed by the National Agency for Research (Investments for the Future' program, reference no. ANR-10-IAHU (to K.C. and F.F.) and from the Kennedy Institute Trustees' Research Fund (to K.B., H.L.E. and I.A.U.). Metabolic analyses in vivo were performed on the Functional & Physiological Exploration Platform (FPE) technical platform, unit 'Biologie Fonctionnelle et Adaptative: (Univ. Paris Diderot, Sorbonne Paris Cite, Paris, France), and on the ICAN PRECLINIC platform (Institute of Cardiometabolism and Nutrition, Pitie-Salpetriere Hospital, Paris, France). D.L. is a member of Institut Universitaire de France. A. Toubal is a recipient of a doctoral fellowship from the Ministere de la Recherche et de l'Enseignement Superieur.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lee JT, 2014, ENDOCRINOLOGY, V155, P3409, DOI 10.1210/en.2014-1037; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; PETRUSCHKE T, 1994, INT J OBESITY, V18, P532; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tordjman J, 2012, J HEPATOL, V56, P1152, DOI 10.1016/j.jhep.2011.12.015; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Wander PL, 2013, DIABETES CARE, V36, P289, DOI 10.2337/dc12-0198; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	39	127	132	0	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					610	618		10.1038/nm.3829	http://dx.doi.org/10.1038/nm.3829			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25939064				2022-12-25	WOS:000355778300017
J	Sehgal, A; Barros, S; Ivanciu, L; Cooley, B; Qin, J; Racie, T; Hettinger, J; Carioto, M; Jiang, YF; Brodsky, J; Prabhala, H; Zhang, XM; Attarwala, H; Hutabarat, R; Foster, D; Milstein, S; Charisse, K; Kuchimanchi, S; Maier, MA; Nechev, L; Kandasamy, P; Kel'in, AV; Nair, JK; Rajeev, KG; Manoharan, M; Meyers, R; Sorensen, B; Simon, AR; Dargaud, Y; Negrier, C; Camire, RM; Akinc, A				Sehgal, Alfica; Barros, Scott; Ivanciu, Lacramioara; Cooley, Brian; Qin, June; Racie, Tim; Hettinger, Julia; Carioto, Mary; Jiang, Yongfeng; Brodsky, Josh; Prabhala, Harsha; Zhang, Xuemei; Attarwala, Husain; Hutabarat, Renta; Foster, Don; Milstein, Stuart; Charisse, Klaus; Kuchimanchi, Satya; Maier, Martin A.; Nechev, Lubo; Kandasamy, Pachamuthu; Kel'in, Alexander V.; Nair, Jayaprakash K.; Rajeev, Kallanthottathil G.; Manoharan, Muthiah; Meyers, Rachel; Sorensen, Benny; Simon, Amy R.; Dargaud, Yesim; Negrier, Claude; Camire, Rodney M.; Akinc, Akin			An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia	NATURE MEDICINE			English	Article							FACTOR-V-LEIDEN; ACTIVATED PROTEIN-C; IN-VIVO HEMOSTASIS; FACTOR-VIII; THROMBIN GENERATION; VENOUS THROMBOEMBOLISM; CLINICAL EXPRESSION; BLEEDING MODEL; A MICE; DEFICIENCY	Hemophilia A and B are inherited bleeding disorders characterized by deficiencies in procoagulant factor VIII (FVIII) or factor IX (FIX), respectively. There remains a substantial unmet medical need in hemophilia, especially in patients with inhibitory antibodies against replacement factor therapy, for novel and improved therapeutic agents that can be used prophylactically to provide effective hemostasis. Guided by reports suggesting that co-inheritance of prothrombotic mutations may ameliorate the clinical phenotype in hemophilia(1-9), we developed an RNA interference (RNAi) therapeutic (ALN-AT3) targeting antithrombin (AT) as a means to promote hemostasis in hemophilia. When administered subcutaneously, ALN-AT3 showed potent, dose-dependent, and durable reduction of AT levels in wild-type mice, mice with hemophilia A, and nonhuman primates (NHPs). In NHPs, a 50% reduction in AT levels was achieved with weekly dosing at approximately 0.125 mg/kg, and a near-complete reduction in AT levels was achieved with weekly dosing at 1.5 mg/kg. Treatment with ALN-AT3 promoted hemostasis in mouse models of hemophilia and led to improved thrombin generation in an NHP model of hemophilia A with anti-factor VIII inhibitors. This investigational compound is currently in phase 1 clinical testing in subjects with hemophilia A or B.	[Sehgal, Alfica; Barros, Scott; Qin, June; Racie, Tim; Hettinger, Julia; Carioto, Mary; Jiang, Yongfeng; Brodsky, Josh; Prabhala, Harsha; Zhang, Xuemei; Attarwala, Husain; Hutabarat, Renta; Foster, Don; Milstein, Stuart; Charisse, Klaus; Kuchimanchi, Satya; Maier, Martin A.; Nechev, Lubo; Kandasamy, Pachamuthu; Kel'in, Alexander V.; Nair, Jayaprakash K.; Rajeev, Kallanthottathil G.; Manoharan, Muthiah; Meyers, Rachel; Sorensen, Benny; Simon, Amy R.; Akinc, Akin] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Ivanciu, Lacramioara; Camire, Rodney M.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Cooley, Brian] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Dargaud, Yesim; Negrier, Claude] Univ Lyon 1, Hop Edouard Herriot, Unite Hemostase Clin, F-69365 Lyon, France	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of North Carolina; University of North Carolina Chapel Hill; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Akinc, A (corresponding author), Alnylam Pharmaceut, Cambridge, MA 02142 USA.	aakinc@alnylam.com	Dargaud, Yesim/AAM-3619-2021	Dargaud, Yesim/0000-0002-4888-1463; Chamouard, Valerie/0000-0002-4443-1609; Negrier, Claude/0000-0003-3569-0366				Beltran-Miranda CP, 2005, HAEMOPHILIA, V11, P326, DOI 10.1111/j.1365-2516.2005.01107.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Bolliger D, 2010, THROMB HAEMOSTASIS, V103, P1233, DOI 10.1160/TH09-10-0732; Bucciarelli P, 1999, ARTERIOSCL THROM VAS, V19, P1026, DOI 10.1161/01.ATV.19.4.1026; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Di Micco B, 2000, EUR J PHARMACOL, V391, P1, DOI 10.1016/S0014-2999(00)00020-0; Ettingshausen CE, 2001, THROMB HAEMOSTASIS, V85, P218; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Feng DM, 2014, BLOOD, V123, P1764, DOI 10.1182/blood-2013-08-522987; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Franchini M, 2010, THROMB RES, V125, P119, DOI 10.1016/j.thromres.2009.11.003; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P307, DOI 10.1055/s-0029-1222609; Ghosh K, 2001, HAEMOPHILIA, V7, P9, DOI 10.1046/j.1365-2516.2001.00455.x; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Ivanciu L, 2011, NAT BIOTECHNOL, V29, P1028, DOI 10.1038/nbt.1995; Kurnik K, 2007, HAEMATOLOGICA, V92, P982, DOI 10.3324/haematol.11161; Landesman Yosef, 2010, Silence, V1, P16, DOI 10.1186/1758-907X-1-16; Langlois NJ, 2003, THROMB HAEMOSTASIS, V90, P17, DOI 10.1055/s-0037-1613594; Lee DH, 2000, THROMB HAEMOSTASIS, V83, P387; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; NEGRIER C, 1993, BLOOD, V81, P690; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pastoft AE, 2013, HAEMOPHILIA, V19, P913, DOI 10.1111/hae.12198; Pastoft AE, 2012, HAEMOPHILIA, V18, P782, DOI 10.1111/j.1365-2516.2012.02780.x; Patnaik MM, 2008, HAEMOPHILIA, V14, P1229, DOI 10.1111/j.1365-2516.2008.01830.x; Peng A, 2010, AAPS J, V12, P473, DOI 10.1208/s12248-010-9207-z; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Santagostino E, 2010, J THROMB HAEMOST, V8, P737, DOI 10.1111/j.1538-7836.2010.03767.x; Schlachterman A, 2005, J THROMB HAEMOST, V3, P2730, DOI 10.1111/j.1538-7836.2005.01639.x; Shetty S, 2007, BRIT J HAEMATOL, V138, P541, DOI 10.1111/j.1365-2141.2007.06693.x; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Tizzano EF, 2002, HAEMOPHILIA, V8, P250, DOI 10.1046/j.1365-2516.2002.00623.x; van Boven HH, 1999, BLOOD, V94, P2590, DOI 10.1182/blood.V94.8.2590.420k40_2590_2594; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Yang BY, 2008, BLOOD, V112, P3234, DOI 10.1182/blood-2008-01-136820	39	195	205	5	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					492	U293		10.1038/nm.3847	http://dx.doi.org/10.1038/nm.3847			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25849132				2022-12-25	WOS:000354068800016
J	Wang, P; Alvarez-Perez, JC; Felsenfeld, DP; Liu, HT; Sivendran, S; Bender, A; Kumar, A; Sanchez, R; Scott, DK; Garcia-Ocana, A; Stewart, AF				Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P.; Liu, Hongtao; Sivendran, Sharmila; Bender, Aaron; Kumar, Anil; Sanchez, Roberto; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.			A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication	NATURE MEDICINE			English	Article							C-MYC; CYCLE CONTROL; PROLIFERATION; APOPTOSIS; MOLECULE; GROWTH; MICE; MASS; IDENTIFICATION; REGENERATION	Types 1 and 2 diabetes affect some 380 million people worldwide. Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells. Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (similar to 2%) engaged in the cell cycle in the first year of life(1-4). In embryonic life and after early childhood, beta cell replication is barely detectable. Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts(1-8). Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo. Here, using a high-throughput small-molecule screen (HTS), we find that analogs of the small molecule harmine function as a new class of human beta cell mitogenic compounds. We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation. Using three different mouse and human islet in vivo-based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control. These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy. Enhancing the potency and beta cell specificity of these compounds are important future challenges.	[Wang, Peng; Alvarez-Perez, Juan-Carlos; Liu, Hongtao; Bender, Aaron; Kumar, Anil; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Wang, Peng; Alvarez-Perez, Juan-Carlos; Bender, Aaron; Kumar, Anil; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.] Icahn Sch Med Mt Sinai, Div Endocrinol & Bone Dis, New York, NY 10029 USA; [Felsenfeld, Dan P.; Sivendran, Sharmila; Sanchez, Roberto] Icahn Sch Med Mt Sinai, Expt Therapeut Inst, New York, NY 10029 USA; [Felsenfeld, Dan P.; Sivendran, Sharmila] Icahn Sch Med Mt Sinai, Integrated Screening Core, New York, NY 10029 USA; [Scott, Donald K.; Garcia-Ocana, Adolfo] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Stewart, AF (corresponding author), Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA.	andrew.stewart@mssm.edu	WANG, Peng/GSN-5263-2022; Perez, Juan Carlos Alvarez/AAE-4518-2021; Perez, Juan c Alvarez/J-8294-2016	Perez, Juan Carlos Alvarez/0000-0001-6396-311X; Perez, Juan c Alvarez/0000-0001-6396-311X	NIDDK; National Institutes of Health [R-01DK55023, U-01 DK089538, R-01 DK065149, R-01 DK067351, R-01 DK077096]; JDRF [17-2011-598, 1-2011-603]; American Diabetes Association [1-14-BS-059]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK065149, P30DK020541, R01DK055023, R01DK077096, R01DK067351, U01DK089538] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank R. Vasavada, N. Fiaschi-Taesch, H. Chen, K. Takane, M. Ohlmeyer, R. DeVita, E. Schadt, C. Argmann, B. Losic, D. Lebeche, S. Kim and B. Wagner for their many helpful discussions during this study. We thank the NIDDK-supported Integrated Islet Distribution Program (IIDP), T. Kin at the University of Alberta in Edmonton and P. Witkowski at the University of Chicago for providing human islets. Ad.GFP and Ad.NFATC1 were provided by D. Lebeche (Icahn School of Medicine at Mount Sinai). This work was supported by grants from the National Institutes of Health (R-01DK55023 (A.F.S.), U-01 DK089538 (A.F.S.), R-01 DK065149 (D. K. S.), R-01 DK067351 (A.G.-O.) and R-01 DK077096 (A.G.-O.)), the JDRF (17-2011-598 and 1-2011-603 (A.F.S.)) and the American Diabetes Association (1-14-BS-059) (A.G.-O.).	Alvarez-Perez JC, 2014, DIABETES, V63, P216, DOI 10.2337/db13-0333; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Brierley DI, 2012, PROG NEURO-PSYCHOPH, V39, P263, DOI 10.1016/j.pnpbp.2012.06.001; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Chamberlain CE, 2014, J CLIN INVEST, V124, P4093, DOI 10.1172/JCI69004; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Demozay D, 2011, DIABETES, V60, P2892, DOI 10.2337/db11-0341; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Fiaschi-Taesch NM, 2008, DIABETES, V57, P2745, DOI 10.2337/db08-1085; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Finch A, 2006, CANCER CELL, V10, P113, DOI 10.1016/j.ccr.2006.06.017; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Goktug A.N., 2013, DRUG DISCOVERY, P201; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Gregg BE, 2012, J CLIN ENDOCR METAB, V97, P3197, DOI 10.1210/jc.2012-1206; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Jain P, 2014, CURR DRUG TARGETS, V15, P539, DOI 10.2174/1389450115666140226112321; Karslioglu E, 2011, MOL ENDOCRINOL, V25, P1760, DOI 10.1210/me.2011-1074; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kohler CU, 2011, AM J PHYSIOL-ENDOC M, V300, pE221, DOI 10.1152/ajpendo.00496.2010; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Nica AC, 2013, GENOME RES, V23, P1554, DOI 10.1101/gr.150706.112; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Pelengaris S, 2001, ENDOCR-RELAT CANCER, V8, P307, DOI 10.1677/erc.0.0080307; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; Purwana I, 2014, DIABETES, V63, P4197, DOI 10.2337/db14-0153; Rachdi L, 2014, CELL CYCLE, V13, P2221, DOI 10.4161/cc.29250; Rachdi L, 2014, DIABETOLOGIA, V57, P960, DOI 10.1007/s00125-014-3174-3; Ricordi, 2000, METHODS CELL TRANSPL, P433; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Shen W, 2013, J AM CHEM SOC, V135, P1669, DOI 10.1021/ja309304m; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Walte A, 2013, FEBS J, V280, P4495, DOI 10.1111/febs.12411; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	51	233	244	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					383	+		10.1038/nm.3820	http://dx.doi.org/10.1038/nm.3820			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25751815	Green Accepted			2022-12-25	WOS:000352493600020
J	Suslov, NB; DasGupta, S; Huang, H; Fuller, JR; Lilley, DMJ; Rice, PA; Piccirilli, JA				Suslov, Nikolai B.; DasGupta, Saurja; Huang, Hao; Fuller, James R.; Lilley, David M. J.; Rice, Phoebe A.; Piccirilli, Joseph A.			Crystal structure of the Varkud satellite ribozyme	NATURE CHEMICAL BIOLOGY			English	Article							ACID-BASE CATALYSIS; ACTIVE-SITE; SECONDARY-STRUCTURE; HAIRPIN RIBOZYME; CLEAVAGE SITE; SELF-CLEAVAGE; SUBSTRATE RECOGNITION; RNA CRYSTALLOGRAPHY; NMR STRUCTURE; NEUROSPORA	The Varkud satellite (VS) ribozyme mediates rolling-circle replication of a plasmid found in the Neurospora mitochondrion. We report crystal structures of this ribozyme from Neurospora intermedia at 3.1 angstrom resolution, which revealed an intertwined dimer formed by an exchange of substrate helices. In each protomer, an arrangement of three-way helical junctions organizes seven helices into a global fold that creates a docking site for the substrate helix of the other protomer, resulting in the formation of two active sites in trans. This mode of RNA-RNA association resembles the process of domain swapping in proteins and has implications for RNA regulation and evolution. Within each active site, adenine and guanine nucleobases abut the scissile phosphate, poised to serve direct roles in catalysis. Similarities to the active sites of the hairpin and hammerhead ribozymes highlight the functional importance of active-site features, underscore the ability of RNA to access functional architectures from distant regions of sequence space, and suggest convergent evolution.	[Suslov, Nikolai B.; Fuller, James R.; Rice, Phoebe A.; Piccirilli, Joseph A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [DasGupta, Saurja; Huang, Hao; Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Lilley, David M. J.] Univ Dundee, Canc Res UK Nucle Acid Struct Res Grp, Dundee, Scotland	University of Chicago; University of Chicago; University of Dundee	Suslov, NB (corresponding author), Takeda Calif, Antibody & Prot Engn Grp, San Diego, CA 92121 USA.	jpicciri@uchicago.edu	DasGupta, Saurja/U-9054-2019	DasGupta, Saurja/0000-0002-9064-9131	US National Institutes of Health [R01AI081987, R01GM102489]; National Institute of General Medical Sciences from the National Institutes of Health and Advanced Light Source beamline SIBYLS [P41 GM103403]; US Department of Energy (DOE); Argonne National Laboratory [DE-AC02-06CH11357]; Lawrence Berkeley National Laboratory under Integrated Diffraction Analysis (IDAT) [DE-AC02-05CH11231]; Biotechnology and Biological Sciences Research Council [B17092] Funding Source: researchfish; Cancer Research UK [11722] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102489, P41GM103403] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences from the National Institutes of Health and Advanced Light Source beamline SIBYLS; US Department of Energy (DOE)(United States Department of Energy (DOE)); Argonne National Laboratory(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory under Integrated Diffraction Analysis (IDAT); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kieft for the gift of iridium hexamine; X. Yang, S. Montano, K. Perry, B. Dhakshnamoorthy and K. Dolan for advice with crystallographic data processing; R. Hulse, I. Dementieva, A. Mateja, F. Qufei, D. Urusova and G. Dobosz for recommendations on growing crystals; and J. Olvera for expression and purification of T7 RNA polymerase. We thank staff of the Advanced Photon Source at Argonne National Laboratory for providing technical advice on X-ray data collection: K. Perry, C. Ogata, N. Venugopalan, B. Nocek and S. Banerjee; and the staff of SIBYLS beam line at Lawrence Berkeley National Laboratory for SAXS data collection. We thank S. Koide, T. Sosnick and S. Crosson for their feedback and discussion on the project, A. Kossiakoff and K. Moffat for use of their data-processing stations, F.-C. Chao and R. Das for their aid with ERRASER software, S. Shelke for help with figures, Y. Shao for help with Amigos II, and N. Tuttle, Q. Dai, N.-S. Li, K. Ceslinski, S. Fica, R. Sengupta, T. Wilson, T. Cech and A. Pyle for discussion and comments on the manuscript. This work was supported by grants from the US National Institutes of Health (R01AI081987 and R01GM102489) to J.A.P. This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamline which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health and Advanced Light Source beamline SIBYLS, all supported by US Department of Energy (DOE). This research used resources of the Advanced Photon Source, a US DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357 and Advanced Light Source, a US DOE Office of Science User Facility operated for the DOE Office of Science by Lawrence Berkeley National Laboratory under Integrated Diffraction Analysis (IDAT) grant contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen AA, 2001, P NATL ACAD SCI USA, V98, P7730, DOI 10.1073/pnas.141039198; Andersen AA, 2000, MOL CELL, V5, P469, DOI 10.1016/S1097-2765(00)80441-4; BEATTIE TL, 1995, P NATL ACAD SCI USA, V92, P4686, DOI 10.1073/pnas.92.10.4686; Belousoff MJ, 2010, BIOCHEM SOC T, V38, P422, DOI 10.1042/BST0380422; Bonneau E, 2014, BIOCHEMISTRY-US, V53, P6264, DOI 10.1021/bi500826n; Bouchard P, 2008, RNA, V14, P736, DOI 10.1261/rna.824308; Bouchard P, 2014, RNA, V20, P1451, DOI 10.1261/rna.046144.114; Bujnicki JM, 2001, PROTEIN SCI, V10, P656, DOI 10.1110/ps.37101; Butcher SE, 1999, NAT STRUCT BIOL, V6, P212; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Desjardins G, 2011, NUCLEIC ACIDS RES, V39, P4427, DOI 10.1093/nar/gkq1244; Eiler D, 2014, P NATL ACAD SCI USA, V111, P13028, DOI 10.1073/pnas.1414571111; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flinders J, 2001, J MOL BIOL, V308, P665, DOI 10.1006/jmbi.2001.4627; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; GUO HCT, 1995, EMBO J, V14, P368, DOI 10.1002/j.1460-2075.1995.tb07011.x; Heldenbrand H, 2014, J AM CHEM SOC, V136, P7789, DOI 10.1021/ja500180q; Hiley SL, 2002, EMBO J, V21, P4691, DOI 10.1093/emboj/cdf462; Hoffmann B, 2003, P NATL ACAD SCI USA, V100, P7003, DOI 10.1073/pnas.0832440100; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jones FD, 2001, NUCLEIC ACIDS RES, V29, P5115, DOI 10.1093/nar/29.24.5115; Kath-Schorr S, 2012, J AM CHEM SOC, V134, P16717, DOI 10.1021/ja3067429; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Keel AY, 2007, STRUCTURE, V15, P761, DOI 10.1016/j.str.2007.06.003; KENNELL JC, 1995, GENE DEV, V9, P294, DOI 10.1101/gad.9.3.294; Koldobskaya Y, 2011, NAT STRUCT MOL BIOL, V18, P100, DOI 10.1038/nsmb.1945; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lafontaine DA, 2002, EMBO J, V21, P2461, DOI 10.1093/emboj/21.10.2461; Lafontaine DA, 2002, J MOL BIOL, V323, P23, DOI 10.1016/S0022-2836(02)00910-5; Lafontaine DA, 2001, EMBO J, V20, P1415, DOI 10.1093/emboj/20.6.1415; Lilley David M. J., 2008, P1; Lipfert J, 2008, STRUCTURE, V16, P1357, DOI 10.1016/j.str.2008.07.007; Liu YJ, 2014, NAT CHEM BIOL, V10, P739, DOI [10.1038/nchembio.1587, 10.1038/NCHEMBIO.1587]; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Michiels PJA, 2000, RNA, V6, P1821, DOI 10.1017/S1355838200001394; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellet J, 2009, RNA, V15, P1822, DOI 10.1261/rna.1759009; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pinard R., 2001, EMBO J, V20, P6334; Poon AHL, 2006, BIOCHEMISTRY-US, V45, P13394, DOI 10.1021/bi060769+; Rastogi T, 1996, EMBO J, V15, P2820, DOI 10.1002/j.1460-2075.1996.tb00642.x; Ren AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6534; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Sood VD, 2002, J MOL BIOL, V320, P443, DOI 10.1016/S0022-2836(02)00521-1; Suslov N.B., 2012, THESIS U CHICAGO; THOMPSON JE, 1994, J AM CHEM SOC, V116, P5467, DOI 10.1021/ja00091a060; Wadley LM, 2004, NUCLEIC ACIDS RES, V32, P6650, DOI 10.1093/nar/gkh1002; Wang SL, 1999, BIOCHEMISTRY-US, V38, P14363, DOI 10.1021/bi9913202; Wilson TJ, 2007, EMBO J, V26, P2489, DOI 10.1038/sj.emboj.7601698; Wilson TJ, 2011, RNA, V17, P213, DOI 10.1261/rna.2473711; Wilson TJ, 2010, P NATL ACAD SCI USA, V107, P11751, DOI 10.1073/pnas.1004255107; Zamel R, 2002, J MOL BIOL, V324, P903, DOI 10.1016/S0022-2836(02)01151-8	60	74	74	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					840	U51		10.1038/nchembio.1929	http://dx.doi.org/10.1038/nchembio.1929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26414446	Green Accepted			2022-12-25	WOS:000363272100009
J	Zoledziewska, M; Sidore, C; Chiang, CWK; Sanna, S; Mulas, A; Steri, M; Busonero, F; Marcus, JH; Marongiu, M; Maschio, A; Del Vecchyo, DO; Floris, M; Meloni, A; Delitala, A; Concas, MP; Murgia, F; Biino, G; Vaccargiu, S; Nagaraja, R; Lohmueller, KE; Timpson, NJ; Soranzo, N; Tachmazidou, I; Dedoussis, G; Zeggini, E; Uzzau, S; Jones, C; Lyons, R; Angius, A; Abecasis, GR; Novembre, J; Schlessinger, D; Cucca, F				Zoledziewska, Magdalena; Sidore, Carlo; Chiang, Charleston W. K.; Sanna, Serena; Mulas, Antonella; Steri, Maristella; Busonero, Fabio; Marcus, Joseph H.; Marongiu, Michele; Maschio, Andrea; Del Vecchyo, Diego Ortega; Floris, Matteo; Meloni, Antonella; Delitala, Alessandro; Concas, Maria Pina; Murgia, Federico; Biino, Ginevra; Vaccargiu, Simona; Nagaraja, Ramaiah; Lohmueller, Kirk E.; Timpson, Nicholas J.; Soranzo, Nicole; Tachmazidou, Ioanna; Dedoussis, George; Zeggini, Eleftheria; Uzzau, Sergio; Jones, Chris; Lyons, Robert; Angius, Andrea; Abecasis, Goncalo R.; Novembre, John; Schlessinger, David; Cucca, Francesco		UK10K Consortium; Understanding Soc Sci Grp	Height-reducing variants and selection for short stature in Sardinia	NATURE GENETICS			English	Article							HORMONE RECEPTOR DEFICIENCY; BECKWITH-WIEDEMANN-SYNDROME; LOCI	We report sequencing-based whole-genome association analyses to evaluate the impact of rare and founder variants on stature in 6,307 individuals on the island of Sardinia. We identify two variants with large effects. One variant, which introduces a stop codon in the GHR gene, is relatively frequent in Sardinia (0.87% versus <0.01% elsewhere) and in the homozygous state causes Laron syndrome involving short stature. We find that this variant reduces height in heterozygotes by an average of 4.2 cm (-0.64 s.d.). The other variant, in the imprinted KCNQ1 gene (minor allele frequency (MAF) = 7.7% in Sardinia versus <1% elsewhere) reduces height by an average of 1.83 cm (-0.31 s.d.) when maternally inherited. Additionally, polygenic scores indicate that known height-decreasing alleles are at systematically higher frequencies in Sardinians than would be expected by genetic drift. The findings are consistent with selection for shorter stature in Sardinia and a suggestive human example of the proposed 'island effect' reducing the size of large mammals.	[Zoledziewska, Magdalena; Sidore, Carlo; Sanna, Serena; Mulas, Antonella; Steri, Maristella; Busonero, Fabio; Marongiu, Michele; Maschio, Andrea; Floris, Matteo; Concas, Maria Pina; Murgia, Federico; Vaccargiu, Simona; Cucca, Francesco] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Sidore, Carlo; Maschio, Andrea; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Chiang, Charleston W. K.; Lohmueller, Kirk E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Mulas, Antonella; Floris, Matteo; Uzzau, Sergio; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Marcus, Joseph H.; Novembre, John] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Maschio, Andrea; Lyons, Robert] Univ Michigan, DNA Sequencing Core, Ann Arbor, MI 48109 USA; [Del Vecchyo, Diego Ortega] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA; [Floris, Matteo; Jones, Chris; Angius, Andrea] Parco Sci & Tecnol Sardegna, Adv Genom Comp Technol, Ctr Adv Studies Res & Dev Sardinia CRS4, Pula, Italy; [Meloni, Antonella] Osped Microcitemico, Clin Pediat 2, Cagliari, Italy; [Delitala, Alessandro] Azienda Osped Univ Sassari, Dept Clin & Expt Med, Sassari, Italy; [Biino, Ginevra] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Nagaraja, Ramaiah; Schlessinger, David] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; [Timpson, Nicholas J.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Soranzo, Nicole; Tachmazidou, Ioanna; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Human Genet, Hinxton, England; [Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge, England; [Dedoussis, George] Harokopio Univ, Dept Dietet Nutr, Athens, Greece; [Uzzau, Sergio] Porto Conte Ric, Tramariglio, Alghero, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of Sassari; University of Chicago; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bristol; Wellcome Trust Sanger Institute; University of Cambridge; Harokopio University Athens; Porto Conte Ricerche	Zoledziewska, M (corresponding author), CNR, Ist Ric Genet & Biomed, Cagliari, Italy.	magdalena.zoledziewska@irgb.cnr.it; schlessingerd@mail.nih.gov; fcucca@uniss.it	Attrill, Lauren/V-1688-2018; Floris, Matteo/ABH-1274-2020; Maschio, Andrea/AAX-8185-2020; Timpson, Nicholas John/O-7548-2015; Vecchyo, Diego Ortega-Del/AAB-8246-2019; Delitala, Alessandro/AAH-2697-2020; Dedoussis, George/AAN-7252-2021; Angius, Andrea/P-9549-2015; Sidore, Carlo/AAV-7967-2020; Steri, Maristella/AAX-8760-2020; Biino, Ginevra/B-5334-2013; Uzzau, Sergio/F-3233-2015; Delitala, Alessandro/L-3194-2016; Mulas, Antonella/B-4231-2015; Chiang, Charleston W. K./H-3169-2019; Fox, Laura J/C-6249-2016; Concas, Maria Pina/K-2266-2018; sanna, serena/H-3009-2019	Floris, Matteo/0000-0003-4385-9336; Timpson, Nicholas John/0000-0002-7141-9189; Vecchyo, Diego Ortega-Del/0000-0003-4054-3766; Dedoussis, George/0000-0002-7798-6221; Angius, Andrea/0000-0003-2596-6461; Sidore, Carlo/0000-0001-7504-7477; Steri, Maristella/0000-0001-5869-3872; Biino, Ginevra/0000-0002-9936-946X; Uzzau, Sergio/0000-0001-6246-2794; Delitala, Alessandro/0000-0003-1729-8969; Chiang, Charleston W. K./0000-0002-0668-7865; Concas, Maria Pina/0000-0003-3598-2537; sanna, serena/0000-0002-3768-1749; Murgia, Federico/0000-0002-3608-845X; Zeggini, Eleftheria/0000-0003-4238-659X; Zoledziewska, Magdalena/0000-0002-3033-6133; McKechanie, Andrew/0000-0003-4273-9906; Marcus, Joseph/0000-0002-0923-9881; Kelly, Kirsten/0000-0003-4234-543X; maschio, andrea/0000-0002-4238-9144; Mulas, Antonella/0000-0002-6856-1483; Soranzo, Nicole/0000-0003-1095-3852; CUCCA, Francesco/0000-0002-7414-1995; Marongiu, Michele/0000-0002-7289-9815	US National Institutes of Health (National Institute on Aging, National Heart, Lung, and Blood Institute); US National Institutes of Health (National Human Genome Research Institute); National Human Genome Research Institute [HG005581, HG005552, HG006513, HG007089, HG007022]; National Heart, Lung, and Blood Institute [HL117626]; Intramural Research Program of the US National Institutes of Health, National Institute on Aging [N01-AG-1-2109, HHSN271201100005C]; Sardinian Autonomous Region [cRP3-154, L.R.7/2009]; grant FaReBio 'Farmaci e Reti Biotecnologiche di Qualita'; InterOmics MIUR Flagship Project [PB05]; US National Institutes of Health National Research Service Award (NRSA) [F32GM106656]; UC MEXUS-CONACYT [213627]; Italian Ministry of Education, University and Research (MIUR) grant [5571/DSPAR/2002]; Wellcome Trust [098051, WT091310]; European Research Council [ERC-2011-StG 280559-SEPI]; European Union (European Social Fund (ESF)); Greek national funds through the Operational Programme 'Education and Lifelong Learning' of the National Strategic Reference Framework (NSRF) research funding programme Heracleitus II, Investing in Knowledge Society Through the European Social Fund; Economic and Social Research Council; UK10K; Medical Research Council [MC_UU_12013/3] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626, U01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005581, U01HG006513, R01HG007022, R01HG007089, RC2HG005552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; MRC [MC_UU_12013/3] Funding Source: UKRI	US National Institutes of Health (National Institute on Aging, National Heart, Lung, and Blood Institute); US National Institutes of Health (National Human Genome Research Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the US National Institutes of Health, National Institute on Aging; Sardinian Autonomous Region(Regione Sardegna); grant FaReBio 'Farmaci e Reti Biotecnologiche di Qualita'; InterOmics MIUR Flagship Project; US National Institutes of Health National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Italian Ministry of Education, University and Research (MIUR) grant(Ministry of Education, Universities and Research (MIUR)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); European Union (European Social Fund (ESF))(European Social Fund (ESF)European Commission); Greek national funds through the Operational Programme 'Education and Lifelong Learning' of the National Strategic Reference Framework (NSRF) research funding programme Heracleitus II, Investing in Knowledge Society Through the European Social Fund; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); UK10K; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the volunteers who generously participated in this study and made this research possible. All participants provided informed consent, and the studies were approved by local research ethic committees: Comitato Etico di Azienda Sanitaria Locale 8, Lanusei (2009/0016600) and Comitato Etico di Azienda Sanitaria Locale 1, Sassari (2171/CE). This study was funded in part by the US National Institutes of Health (National Institute on Aging, National Heart, Lung, and Blood Institute, and National Human Genome Research Institute). This research was supported by National Human Genome Research Institute grants HG005581, HG005552, HG006513, HG007089, HG007022 and HG007089; by National Heart, Lung, and Blood Institute grant HL117626; by the Intramural Research Program of the US National Institutes of Health, National Institute on Aging, contracts N01-AG-1-2109 and HHSN271201100005C; by Sardinian Autonomous Region (L.R.7/2009) grant cRP3-154; by grant FaReBio2011 'Farmaci e Reti Biotecnologiche di Qualita'; by the PB05 InterOmics MIUR Flagship Project; by a US National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship (F32GM106656) to C.W.K.C.; by UC MEXUS-CONACYT doctoral fellowship 213627 to D.O.D.V.; and by Italian Ministry of Education, University and Research (MIUR) grant 5571/DSPAR/2002. The HELIC study was funded by the Wellcome Trust (098051) and the European Research Council (ERC-2011-StG 280559-SEPI). The TEENAGE study has been supported by the Wellcome Trust (098051), European Union (European Social Fund (ESF)) and Greek national funds through the Operational Programme 'Education and Lifelong Learning' of the National Strategic Reference Framework (NSRF) research funding programme Heracleitus II, Investing in Knowledge Society Through the European Social Fund. The UK Household Longitudinal Study is led by the Institute for Social and Economic Research at the University of Essex and funded by the Economic and Social Research Council. Information on how to access the data can be found on the Understanding Society website (https://www.understandingsociety.ac.uk/). This study makes use of data generated by the UK10K Consortium, derived from samples from UK10K_COHORTS_TWINSUK (the TwinsUK cohort) and UK10K_COHORT_ALSPAC (the Avon Longitudinal Study of Parents and Children cohort). A full list of the investigators who contributed to the generation of the data is available from http://www.UK10K.org/. Funding for UK10K was provided by the Wellcome Trust under award WT091310. We thank J. Berg for scripts and suggestions on the polygenic score analysis.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Arcaleni E, 2012, J ANTHROPOL SCI, V90, P233, DOI 10.4436/jass.90014; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Guevara-Aguirre J, 2007, GROWTH HORM IGF RES, V17, P261, DOI 10.1016/j.ghir.2007.01.016; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Laron Z, 2011, LARON SYNDROME - FROM MAN TO MOUSE: LESSONS FROM CLINICAL AND EXPERIEMENTAL EXPERIENCE, P1, DOI 10.1007/978-3-642-11183-9; LARON Z, 1974, Birth Defects Original Article Series, V10, P231; LARON Z, 1989, ACTA ENDOCRINOL-COP, V121, P603, DOI 10.1530/acta.0.1210603; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Mathieson I, 2015, 8000 YEARS NATURAL S, DOI [10.1101/016477, DOI 10.1101/016477]; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pistis G, 2015, EUR J HUM GENET, V23, P975, DOI 10.1038/ejhg.2014.216; ROSENBLOOM AL, 1990, NEW ENGL J MED, V323, P1367, DOI 10.1056/NEJM199011153232002; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Soejima H, 2013, J HUM GENET, V58, P402, DOI 10.1038/jhg.2013.51; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Szpiech ZA, 2014, MOL BIOL EVOL, V31, P2824, DOI 10.1093/molbev/msu211; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; van der Geer A., 2010, EVOLUTION ISLAND MAM, P103; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	35	63	63	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1352	+		10.1038/ng.3403	http://dx.doi.org/10.1038/ng.3403			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26366551	Green Accepted			2022-12-25	WOS:000363988200020
J	Yang, J; Bakshi, A; Zhu, Z; Hemani, G; Vinkhuyzen, AAE; Lee, SH; Robinson, MR; Perry, JRB; Nolte, IM; van Vliet-Ostaptchouk, JV; Snieder, H; Esko, T; Milani, L; Magi, R; Metspalu, A; Hamsten, A; Magnusson, PKE; Pedersen, NL; Ingelsson, E; Soranzo, N; Keller, MC; Wray, NR; Goddard, ME; Visscher, PM				Yang, Jian; Bakshi, Andrew; Zhu, Zhihong; Hemani, Gibran; Vinkhuyzen, Anna A. E.; Lee, Sang Hong; Robinson, Matthew R.; Perry, John R. B.; Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold; Esko, Tonu; Milani, Lili; Maegi, Reedik; Metspalu, Andres; Hamsten, Anders; Magnusson, Patrik K. E.; Pedersen, Nancy L.; Ingelsson, Erik; Soranzo, Nicole; Keller, Matthew C.; Wray, Naomi R.; Goddard, Michael E.; Visscher, Peter M.		LifeLines Cohort Study	Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE-IMPUTATION; COMPLEX DISEASES; COMMON SNPS; ARCHITECTURE; PROPORTION; TRAIT; LOCI	We propose a method (GREML-LDMS) to estimate heritability for human complex traits in unrelated individuals using whole-genome sequencing data. We demonstrate using simulations based on whole-genome sequencing data that similar to 97% and similar to 68% of variation at common and rare variants, respectively, can be captured by imputation. Using the GREML-LDMS method, we estimate from 44,126 unrelated individuals that all similar to 17 million imputed variants explain 56% (standard error (s.e.) = 2.3%) of variance for height and 27% (s.e. = 2.5%) of variance for body mass index (BMI), and we find evidence that height- and BMI-associated variants have been under natural selection. Considering the imperfect tagging of imputation and potential overestimation of heritability from previous family-based studies, heritability is likely to be 60-70% for height and 30-40% for BMI. Therefore, the missing heritability is small for both traits. For further discovery of genes associated with complex traits, a study design with SNP arrays followed by imputation is more cost-effective than whole-genome sequencing at current prices.	[Yang, Jian; Bakshi, Andrew; Zhu, Zhihong; Hemani, Gibran; Vinkhuyzen, Anna A. E.; Lee, Sang Hong; Robinson, Matthew R.; Wray, Naomi R.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Hemani, Gibran] Univ Bristol, Sch Social & Community Med, IEU, MRC, Bristol, Avon, England; [Lee, Sang Hong] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Perry, John R. B.] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Esko, Tonu; Milani, Lili; Maegi, Reedik; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA USA; [Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Cardiovasc Genet & Genom Grp, Stockholm, Sweden; [Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Soranzo, Nicole] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, England; [Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge, England; [Keller, Matthew C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Goddard, Michael E.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Jobs Transport & Resources, Dept Econ Dev, Biosci Res Div, Bundoora, Vic, Australia	University of Queensland; University of Queensland; University of Bristol; University of New England; University of Cambridge; University of Groningen; University of Groningen; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Tartu; Karolinska Institutet; Karolinska Institutet; Uppsala University; Stanford University; Wellcome Trust Sanger Institute; University of Cambridge; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Melbourne	Yang, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	Jian.yang@uq.edu.au	Magnusson, Patrik KE/C-4458-2017; Milani, Lili/N-1097-2019; Yang, Jian/A-5852-2010; Wray, Naomi/C-8639-2015; Zhu, Zhihong/F-8720-2015; Lee, Sang Hong/A-2569-2011; Mägi, Reedik/AAJ-9679-2021; Visscher, Peter/ABB-6151-2020; Vinkhuyzen, Anna/N-8691-2013	Magnusson, Patrik KE/0000-0002-7315-7899; Milani, Lili/0000-0002-5323-3102; Yang, Jian/0000-0003-2001-2474; Wray, Naomi/0000-0001-7421-3357; Zhu, Zhihong/0000-0002-6783-3037; Lee, Sang Hong/0000-0001-9701-2718; Visscher, Peter/0000-0002-2143-8760; Bakshi, Andrew/0000-0001-5650-7036; Vinkhuyzen, Anna/0000-0003-3352-0603; Hemani, Gibran/0000-0003-0920-1055; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Magi, Reedik/0000-0002-2964-6011; Robinson, Matthew/0000-0001-8982-8813; Goddard, Michael/0000-0001-9917-7946; Soranzo, Nicole/0000-0003-1095-3852	Australian National Health and Medical Research Council [1052684, 1078037, 1050218]; Australian Research Council [130102666]; US National Institutes of Health [R01MH100141]; Sylvia and Charles Viertel Charitable Foundation; University of Queensland Foundation; Medical Research Council [MC_UU_12015/2, MC_PC_15018, MC_U106179472] Funding Source: researchfish; MRC [MC_U106179472, MC_UU_12015/2] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100141] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sylvia and Charles Viertel Charitable Foundation; University of Queensland Foundation(University of Queensland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Australian National Health and Medical Research Council (grants 1052684, 1078037 and 1050218), the Australian Research Council (grant 130102666), the US National Institutes of Health (R01MH100141), the Sylvia and Charles Viertel Charitable Foundation and the University of Queensland Foundation. This study makes use of data from the database of Genotypes and Phenotypes (dbGaP) available under accessions phs000090, phs000091 and phs000428 and the EGCUT, LifeLines, TwinGene and UK10K studies (see the Supplementary Note for the full set of acknowledgments for these data).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lynch M., 1998, GENETICS ANAL QUANTI; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; UK10K Consortium, NATURE IN PRESS; Uricchio L.H., 2015, BIORXIV, DOI [10.1101/015917, DOI 10.1101/015917]; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2014, NAT GENET, V46, P1356, DOI 10.1038/ng.3139; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	39	446	451	5	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1114	+		10.1038/ng.3390	http://dx.doi.org/10.1038/ng.3390			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26323059	Green Accepted, Green Submitted			2022-12-25	WOS:000361969900006
J	Beltran, J; Kloss, B; Hosler, JP; Geng, JF; Liu, AM; Modi, A; Dawson, JH; Sono, M; Shumskaya, M; Ampomah-Dwamena, C; Love, JD; Wurtzel, ET				Beltran, Jesus; Kloss, Brian; Hosler, Jonathan P.; Geng, Jiafeng; Liu, Aimin; Modi, Anuja; Dawson, John H.; Sono, Masanori; Shumskaya, Maria; Ampomah-Dwamena, Charles; Love, James D.; Wurtzel, Eleanore T.			Control of carotenoid biosynthesis through a heme-based cis-trans isomerase	NATURE CHEMICAL BIOLOGY			English	Article							MAGNETIC CIRCULAR-DICHROISM; NITRIC-OXIDE; PHYTOENE SYNTHASE; LIGAND COMPLEXES; RESONANCE RAMAN; CYTOCHROME-C; PROTEINS; COORDINATION; STRESS; IDENTIFICATION	Plants synthesize carotenoids, which are essential for plant development and survival. These metabolites also serve as essential nutrients for human health. The biosynthetic pathway for all plant carotenoids occurs in chloroplasts and other plastids and requires 15-cis-zeta-carotene isomerase (Z-ISO). It was not known whether Z-ISO catalyzes isomerization alone or in combination with other enzymes. Here we show that Z-ISO is a bona fide enzyme and integral membrane protein. Z-ISO independently catalyzes the cis-trans isomerization of the 15-15' carbon-carbon double bond in 9,15,9'-cis-zeta-carotene to produce the substrate required by the subsequent biosynthetic-pathway enzyme. We discovered that isomerization depends upon a ferrous heme b cofactor that undergoes redox-regulated ligand switching between the heme iron and alternate Z-ISO amino acid residues. Heme b-dependent isomerization of a large hydrophobic compound in a membrane was previously undescribed. As an isomerase, Z-ISO represents a new prototype for heme b proteins and potentially uses a new chemical mechanism.	[Beltran, Jesus; Shumskaya, Maria; Ampomah-Dwamena, Charles; Wurtzel, Eleanore T.] CUNY, Lehman Coll, Dept Biol Sci, Bronx, NY 10468 USA; [Beltran, Jesus; Wurtzel, Eleanore T.] CUNY, Grad Sch, Bronx, NY USA; [Beltran, Jesus; Wurtzel, Eleanore T.] CUNY, Univ Ctr, Bronx, NY USA; [Kloss, Brian; Love, James D.] New York Struct Biol Ctr, New York, NY USA; [Hosler, Jonathan P.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Geng, Jiafeng; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Modi, Anuja; Dawson, John H.; Sono, Masanori] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; University of Mississippi; University of Mississippi Medical Center; University System of Georgia; Georgia State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Beltran, J (corresponding author), CUNY, Lehman Coll, Dept Biol Sci, Bronx, NY 10468 USA.	wurtzel@lehman.cuny.edu	Shumskaya, Maria/P-5972-2017; Ampomah-Dwamena, Charles/G-6418-2017; Dawson, John/HDM-6702-2022; Geng, Jiafeng/G-4948-2015; Modi, Anuja/R-3788-2017; Liu, Aimin/C-1572-2017	Shumskaya, Maria/0000-0001-7916-462X; Ampomah-Dwamena, Charles/0000-0001-8054-9383; Geng, Jiafeng/0000-0001-9488-0974; Liu, Aimin/0000-0002-4182-8176; Beltran, Jesus/0000-0002-8095-4757; Wurtzel, Eleanore/0000-0002-9186-3260; Kloss, Brian/0000-0003-0130-8739; Beltran, Jesus/0000-0001-8804-3125	US National Institutes of Health [GM081160, GM 26730, R01GM108988]; CUNY; Lehman College; Gordon Research Conferences; US National Institutes of General Medical Sciences Protein Structure Initiative (PSI) program [GM095315]; Georgia Research Alliance Distinguished Scholar Program; New Zealand Institute for Plant and Food Research Limited, New Zealand; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, SC1GM081160, R01GM108988, R01GM026730] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CUNY; Lehman College; Gordon Research Conferences; US National Institutes of General Medical Sciences Protein Structure Initiative (PSI) program; Georgia Research Alliance Distinguished Scholar Program; New Zealand Institute for Plant and Food Research Limited, New Zealand; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Hendrickson (Columbia University and New York Consortium on Membrane Protein Structure) for helpful discussions and use of the New York Structural Biology Center facilities. We thank M. Inouye (University of Medicine and Dentistry of New Jersey) for valuable advice on codon optimization and L. Bradbury (Lehman College and CUNY) for helpful discussions. E.T.W. was funded by the US National Institutes of Health (grant GM081160), CUNY and Lehman College. E.T.W. was also supported by travel funds from the Gordon Research Conferences to attend the Metals in Biology Gordon Research Conference, where E.T.W. was able to initiate collaborations with heme experts J.P. Hosler, A. Liu and J.H. Dawson through much-appreciated help from H. Gray (California Institute of Technology). The New York Consortium on Membrane protein structure (B.K. and J.D.L.) was supported through funds obtained from the US National Institutes of General Medical Sciences Protein Structure Initiative (PSI) program (grant GM095315). J.H.D. was funded by the US National Institutes of Health grant GM 26730; A. L. was funded by US National Institutes of Health grant R01GM108988 and the Georgia Research Alliance Distinguished Scholar Program. C.A.-D. was funded by The New Zealand Institute for Plant and Food Research Limited, New Zealand.	BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boffi A, 1997, BIOCHEMISTRY-US, V36, P4505, DOI 10.1021/bi9618880; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; Chang HL, 2013, PLANT CELL PHYSIOL, V54, P1296, DOI 10.1093/pcp/pct078; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Crabtree RH, 2005, ORGANOMETALLIC CHEMISTRY OF THE TRANSITION METALS, 4TH EDITION, P125; D'Angelo P, 2004, BIOPHYS J, V86, P3882, DOI 10.1529/biophysj.103.034876; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Doyle SA, 2005, METH MOL B, V310, P107; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; Fanciullino AL, 2014, PLANT CELL ENVIRON, V37, P273, DOI 10.1111/pce.12153; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gen JF, 2012, J AM CHEM SOC, V134, P12209, DOI 10.1021/ja304164b; Geng JF, 2014, J BIOL INORG CHEM, V19, P1057, DOI 10.1007/s00775-014-1123-8; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Heipieper HJ, 2004, APPL MICROBIOL BIOT, V66, P285, DOI 10.1007/s00253-004-1734-z; Janick-Buckner D, 2001, MAYDICA, V46, P41; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Khatsenko O, 1998, BIOCHEMISTRY-MOSCOW+, V63, P833; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Madej MG, 2006, EMBO J, V25, P4963, DOI 10.1038/sj.emboj.7601361; Moise AR, 2014, CHEM REV, V114, P164, DOI 10.1021/cr400106y; Munro Andrew W., 2009, P160, DOI 10.1007/978-0-387-78518-9_10; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; PEARSON RG, 1968, J CHEM EDUC, V45, P643, DOI 10.1021/ed045p643; Pond AE, 2000, INORG CHEM, V39, P6061, DOI 10.1021/ic0007198; Quinlan RF, 2012, PLANT PHYSIOL, V160, P204, DOI 10.1104/pp.112.198556; Richter AS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00371; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shumskaya M, 2013, PLANT SCI, V208, P58, DOI 10.1016/j.plantsci.2013.03.012; Shumskaya M, 2012, PLANT CELL, V24, P3725, DOI 10.1105/tpc.112.104174; Smith AT, 2012, J BIOL INORG CHEM, V17, P1071, DOI 10.1007/s00775-012-0920-1; SONO M, 1986, BIOCHEMISTRY-US, V25, P347, DOI 10.1021/bi00350a011; SUN J, 1993, BIOCHEMISTRY-US, V32, P14151, DOI 10.1021/bi00214a012; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; ter Horst R, 2010, BBA-BIOMEMBRANES, V1798, P672, DOI 10.1016/j.bbamem.2009.11.010; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; TSAI AL, 1993, J BIOL CHEM, V268, P8554; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; Varanasi L, 2012, BBA-BIOENERGETICS, V1817, P545, DOI 10.1016/j.bbabio.2011.10.001; VICKERY L, 1976, J AM CHEM SOC, V98, P351, DOI 10.1021/ja00418a006; VICKERY L, 1976, J AM CHEM SOC, V98, P343, DOI 10.1021/ja00418a005; Walter MH, 2010, PLANTA, V232, P1, DOI 10.1007/s00425-010-1156-3; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Wouters J, 2003, J BIOL CHEM, V278, P11903, DOI 10.1074/jbc.M212823200; Wurtzel ET, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00029; YONETANI T, 1972, J BIOL CHEM, V247, P2447; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	56	62	63	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					598	U104		10.1038/NCHEMBIO.1840	http://dx.doi.org/10.1038/NCHEMBIO.1840			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26075523	Green Accepted			2022-12-25	WOS:000358255300017
J	Weinert, T; Huwiler, SG; Kung, JW; Weidenweber, S; Hellwig, P; Stark, HJ; Biskup, T; Weber, S; Cotelesage, JJH; George, GN; Ermler, U; Boll, M				Weinert, Tobias; Huwiler, Simona G.; Kung, Johannes W.; Weidenweber, Sina; Hellwig, Petra; Staerk, Hans-Joachim; Biskup, Till; Weber, Stefan; Cotelesage, Julien J. H.; George, Graham N.; Ermler, Ulrich; Boll, Matthias			Structural basis of enzymatic benzene ring reduction	NATURE CHEMICAL BIOLOGY			English	Article							ANAEROBIC AROMATIC METABOLISM; ABSORPTION FINE-STRUCTURE; BENZOYL-COENZYME; ELECTRON-TRANSFER; BIRCH REDUCTION; ACTIVE-SITE; FERREDOXIN OXIDOREDUCTASE; CRYSTAL-STRUCTURE; COA; DEGRADATION	In chemical synthesis, the widely used Birch reduction of aromatic compounds to cyclic dienes requires alkali metals in ammonia as extremely low-potential electron donors. An analogous reaction is catalyzed by benzoyl-coenzyme A reductases (BCRs) that have a key role in the globally important bacterial degradation of aromatic compounds at anoxic sites. Because of the lack of structural information, the catalytic mechanism of enzymatic benzene ring reduction remained obscure. Here, we present the structural characterization of a dearomatizing BCR containing an unprecedented tungsten cofactor that transfers electrons to the benzene ring in an aprotic cavity. Substrate binding induces proton transfer from the bulk solvent to the active site by expelling a Zn2+ that is crucial for active site encapsulation. Our results shed light on the structural basis of an electron transfer process at the negative redox potential limit in biology. They open the door for biological or biomimetic alternatives to a basic chemical synthetic tool.	[Weinert, Tobias; Weidenweber, Sina; Ermler, Ulrich] Max Planck Inst Biophys, Frankfurt, Germany; [Huwiler, Simona G.; Kung, Johannes W.; Boll, Matthias] Univ Freiburg, Fac Biol, Microbiol, D-79106 Freiburg, Germany; [Hellwig, Petra] Univ Strasbourg, CNRS, Lab Bioelectrochim & Spectroscopie, UMR 7140, Strasbourg, France; [Staerk, Hans-Joachim] UFZ, Helmholtz Ctr Environm Res, Dept Analyt Chem, Leipzig, Germany; [Biskup, Till; Weber, Stefan] Univ Freiburg, Inst Phys Chem, D-79106 Freiburg, Germany; [Cotelesage, Julien J. H.; George, Graham N.] Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 0W0, Canada; [Cotelesage, Julien J. H.] Canadian Light Source, Saskatoon, SK, Canada	Max Planck Society; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg; University of Saskatchewan; University of Saskatchewan	Weinert, T (corresponding author), Max Planck Inst Biophys, Frankfurt, Germany.	ulrich.ermler@biophys.mpg.de; matthias.boll@biologie.uni-freiburg.de	Biskup, Till/D-5249-2012; Huwiler, Simona G./AAK-1322-2020; Weinert, Tobias/J-6353-2017; Biskup, Till/AAX-1107-2020; Weber, Stefan/G-6164-2010	Biskup, Till/0000-0003-2913-0004; Huwiler, Simona G./0000-0002-4876-9308; Weinert, Tobias/0000-0002-0339-3722; Biskup, Till/0000-0003-2913-0004; hellwig, petra/0000-0001-6294-5163; George, Graham/0000-0002-0420-7493	German Research Foundation (DFG) [SPP1319 (BO 1565/10-2), SPP1319 (ER 222/5)]; European Cooperation in Science and Technology Action [CM1201]; Swiss National Foundation [P1SKP3-148452, P1SKP3-155073]; Canadian Research Chairs Program; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Health Research Using Synchrotron Techniques (THRUST) Associate; US Department of Energy; German Federal Ministry of Education and Research; Centre International de Recherche aux Frontieres de la Chimie (RFC); Centre National des Recherches Scientifiques (CNRS); National Institutes of Health	German Research Foundation (DFG)(German Research Foundation (DFG)); European Cooperation in Science and Technology Action; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Canadian Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Health Research Using Synchrotron Techniques (THRUST) Associate; US Department of Energy(United States Department of Energy (DOE)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Centre International de Recherche aux Frontieres de la Chimie (RFC); Centre National des Recherches Scientifiques (CNRS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the German Research Foundation (DFG) in the SPP1319 (BO 1565/10-2 and ER 222/5), by the European Cooperation in Science and Technology Action CM1201 and the Swiss National Foundation for Scientific Research (SNF) (Doc.Mobility grant nos. P1SKP3-148452 and P1SKP3-155073). Work at the University of Saskatchewan was supported by the Canadian Research Chairs Program (G.N.G.), the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. J.J.H.C. is a CIHR-Training grant in Health Research Using Synchrotron Techniques (THRUST) Associate. The Stanford Synchrotron Radiation Lightsource is supported by the US Department of Energy and the National Institutes of Health. Work at the Helmholtz Center for Environmental Research, Leipzig, Germany (Department of Analytical Chemistry), was funded by the German Federal Ministry of Education and Research. Work at the University of Strasbourg was supported by the Centre International de Recherche aux Frontieres de la Chimie (RFC) and the Centre National des Recherches Scientifiques (CNRS). We thank H. Michel for continuous support and the staff of beamline PXII at the Swiss Light Source for help during data collection.	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Birch AJ, 1944, J CHEM SOC, P430, DOI 10.1039/jr9440000430; Birch AJ, 1996, PURE APPL CHEM, V68, P553, DOI 10.1351/pac199668030553; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; Buckel W, 2014, CHEMBIOCHEM, V15, P2188, DOI 10.1002/cbic.201402270; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Cotelesage JJH, 2012, J INORG BIOCHEM, V115, P127, DOI 10.1016/j.jinorgbio.2012.06.019; DELEON JM, 1991, PHYS REV B, V44, P4146, DOI 10.1103/PhysRevB.44.4146; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; Hille R, 2013, DALTON T, V42, P3029, DOI 10.1039/c2dt32376a; Hu YL, 1999, J MOL BIOL, V286, P899, DOI 10.1006/jmbi.1998.2488; Joshi DK, 2005, ORG PROCESS RES DEV, V9, P997, DOI 10.1021/op050155x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim J, 2008, NATURE, V452, P239, DOI 10.1038/nature06637; KOCH J, 1993, EUR J BIOCHEM, V211, P649, DOI 10.1111/j.1432-1033.1993.tb17593.x; Kung JW, 2010, J AM CHEM SOC, V132, P9850, DOI 10.1021/ja103448u; Kung JW, 2009, P NATL ACAD SCI USA, V106, P17687, DOI 10.1073/pnas.0905073106; Loffler C, 2011, ENVIRON MICROBIOL, V13, P696, DOI 10.1111/j.1462-2920.2010.02374.x; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Messerschmidt A, 2004, P NATL ACAD SCI USA, V101, P11571, DOI 10.1073/pnas.0404378101; Mobitz H, 2002, BIOCHEMISTRY-US, V41, P1752, DOI 10.1021/bi0113770; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nandi P, 2009, J ORG CHEM, V74, P5790, DOI 10.1021/jo900904f; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Pushie MJ, 2014, METALLOMICS, V6, P15, DOI 10.1039/c3mt00177f; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; Romao MJ, 2009, DALTON T, P4053, DOI 10.1039/b821108f; SANO A, 1989, BIOMED CHROMATOGR, V3, P209, DOI 10.1002/bmc.1130030507; Seiffert GB, 2007, P NATL ACAD SCI USA, V104, P3073, DOI 10.1073/pnas.0610407104; Smith DM, 1999, J AM CHEM SOC, V121, P1383, DOI 10.1021/ja983512a; Thiele B, 2008, J BIOL CHEM, V283, P20713, DOI 10.1074/jbc.M802841200; Tracqui A, 2002, J ANAL TOXICOL, V26, P144, DOI 10.1093/jat/26.3.144; Unciuleac M, 2001, P NATL ACAD SCI USA, V98, P13619, DOI 10.1073/pnas.241375598; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; Wischgoll S, 2005, MOL MICROBIOL, V58, P1238, DOI 10.1111/j.1365-2958.2005.04909.x; ZIMMERMAN HE, 1993, J AM CHEM SOC, V115, P2205, DOI 10.1021/ja00059a015; Zimmerman HE, 2012, ACCOUNTS CHEM RES, V45, P164, DOI 10.1021/ar2000698	45	43	43	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					586	591		10.1038/nchembio.1849	http://dx.doi.org/10.1038/nchembio.1849			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26120796				2022-12-25	WOS:000358255300013
J	Case, LB; Baird, MA; Shtengel, G; Campbell, SL; Hess, HF; Davidson, MW; Waterman, CM				Case, Lindsay B.; Baird, Michelle A.; Shtengel, Gleb; Campbell, Sharon L.; Hess, Harald F.; Davidson, Michael W.; Waterman, Clare M.			Molecular mechanism of vinculin activation and nanoscale spatial organization in focal adhesions	NATURE CELL BIOLOGY			English	Article							CELL-MATRIX ADHESIONS; INTRAMOLECULAR ASSOCIATION; PAXILLIN PHOSPHORYLATION; INTEGRIN ACTIVATION; NASCENT ADHESIONS; ACTIN INTERACTION; BINDING PROTEIN; TALIN BINDING; ALPHA-ACTININ; TAIL DOMAINS	Focal adhesions (FAs) link the extracellular matrix to the actin cytoskeleton to mediate cell adhesion, migration, mechanosensing and signalling. FAs have conserved nanoscale protein organization, suggesting that the position of proteins within FAs regulates their activity and function. Vinculin binds different FA proteins to mediate distinct cellular functions, but how vinculin's interactions are spatiotemporally organized within FAs is unknown. Using interferometric photoactivation localization super-resolution microscopy to assay vinculin nanoscale localization and a FRET biosensor to assay vinculin conformation, we found that upward repositioning within the FA during FA maturation facilitates vinculin activation and mechanical reinforcement of FAs. Inactive vinculin localizes to the lower integrin signalling layer in FAs by binding to phospho-paxillin. Talin binding activates vinculin and targets active vinculin higher in FAs where vinculin can engage retrograde actin flow. Thus, specific protein interactions are spatially segregated within FAs at the nanoscale to regulate vinculin activation and function.	[Case, Lindsay B.; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Shtengel, Gleb; Hess, Harald F.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Campbell, Sharon L.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University System of Florida; Florida State University; State University System of Florida; Florida State University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Waterman, CM (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	watermancm@nhlbi.nih.gov		Case, Lindsay/0000-0003-3166-1138; campbell, sharon/0000-0003-0311-409X; Waterman, Clare/0000-0001-6142-6775	Division of Intramural Research, NHLBI; Howard Hughes Medical Institute;  [GM081764];  [GM080568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005105, ZIAHL005104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080568, R01GM081764] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Division of Intramural Research, NHLBI (L.B.C. and C.M.W.); Howard Hughes Medical Institute (G.S. and H.F.H.); GM081764 (S.L.C.), GM080568 (S.L.C.).	Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bachir AI, 2014, CURR BIOL, V24, P1845, DOI 10.1016/j.cub.2014.07.011; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Byron A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001827; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Ciobanasu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4095; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Diez G, 2011, BIOCHEM BIOPH RES CO, V406, P85, DOI 10.1016/j.bbrc.2011.01.115; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goldmann WH, 1997, EUR J BIOCHEM, V250, P447, DOI 10.1111/j.1432-1033.1997.0447a.x; Hoffmann JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02257; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; JOCKUSCH BM, 1981, P NATL ACAD SCI-BIOL, V78, P3005, DOI 10.1073/pnas.78.5.3005; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Yao MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04610; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655	50	165	166	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					880	892		10.1038/ncb3180	http://dx.doi.org/10.1038/ncb3180			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26053221	Green Accepted, Green Submitted			2022-12-25	WOS:000357353400009
J	Ottolini, CS; Newnham, LJ; Capalbo, A; Natesan, SA; Joshi, HA; Cimadomo, D; Griffin, DK; Sage, K; Summers, MC; Thornhill, AR; Housworth, E; Herbert, AD; Rienzi, L; Ubaldi, FM; Handyside, AH; Hoffmann, ER				Ottolini, Christian S.; Newnham, Louise J.; Capalbo, Antonio; Natesan, Senthilkumar A.; Joshi, Hrishikesh A.; Cimadomo, Danilo; Griffin, Darren K.; Sage, Karen; Summers, Michael C.; Thornhill, Alan R.; Housworth, Elizabeth; Herbert, Alex D.; Rienzi, Laura; Ubaldi, Filippo M.; Handyside, Alan H.; Hoffmann, Eva R.			Genome-wide maps of recombination and chromosome segregation in human oocytes and embryos show selection for maternal recombination rates	NATURE GENETICS			English	Article							HIGHLY EFFICIENT VITRIFICATION; MEIOTIC DRIVE; INVERTED MEIOSIS; NONRANDOM SEGREGATION; HUMAN ANEUPLOIDY; DOWN-SYNDROME; X-CHROMOSOME; IN-VITRO; AGE; TRISOMY	Crossover recombination reshuffles genes and prevents errors in segregation that lead to extra or missing chromosomes (aneuploidy) in human eggs, a major cause of pregnancy failure and congenital disorders. Here we generate genome-wide maps of crossovers and chromosome segregation patterns by recovering all three products of single female meioses. Genotyping >4 million informative SNPs from 23 complete meioses allowed us to map 2,032 maternal and 1,342 paternal crossovers and to infer the segregation patterns of 529 chromosome pairs. We uncover a new reverse chromosome segregation pattern in which both homologs separate their sister chromatids at meiosis I; detect selection for higher recombination rates in the female germ line by the elimination of aneuploid embryos; and report chromosomal drive against non-recombinant chromatids at meiosis II. Collectively, our findings show that recombination not only affects homolog segregation at meiosis I but also the fate of sister chromatids at meiosis II.	[Ottolini, Christian S.; Sage, Karen; Summers, Michael C.; Handyside, Alan H.] Bridge Ctr, London, England; [Ottolini, Christian S.; Griffin, Darren K.; Summers, Michael C.; Handyside, Alan H.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Newnham, Louise J.; Herbert, Alex D.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Capalbo, Antonio; Cimadomo, Danilo; Rienzi, Laura; Ubaldi, Filippo M.] Ctr Reprod Med, GENERA, Gynecol Endocrinol & Assisted Reprod, Rome, Italy; [Natesan, Senthilkumar A.; Joshi, Hrishikesh A.; Thornhill, Alan R.; Handyside, Alan H.] Illumina Inc, Fulbourn, England; [Housworth, Elizabeth] Indiana Univ, Dept Math & Stat, Bloomington, IN USA; [Handyside, Alan H.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Kent; University of Sussex; Illumina; Indiana University System; Indiana University Bloomington; University of Leeds	Hoffmann, ER (corresponding author), Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	ahandyside@illumina.com; eh58@sussex.ac.uk	hoffmann, eva/AAM-6594-2020; Capalbo, Antonio/ABE-9842-2020	hoffmann, eva/0000-0002-2588-0652; Capalbo, Antonio/0000-0003-0109-323X; Newnham, Louise/0000-0002-1627-5530	UK Medical Research Council [G0902043]; European Molecular Biology Organization (EMBO); Biotechnology and Biological Sciences Research Council [G19438/2, BB/E024211/1] Funding Source: researchfish; Medical Research Council [G0902043] Funding Source: researchfish; BBSRC [BB/E024211/1] Funding Source: UKRI; MRC [G0902043] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge C. May, A. Eyre-Walker, J. Gruhn, R. Rowsey, J. Turner, F. Cole and members of the Hoffmann laboratory for discussion and critical reading of the manuscript. We thank Y. Hou, W. Fan and S. Xie for freely sharing data and discussion on their study of female pronucleus-PB trios. Financial support for this research was provided by the UK Medical Research Council (Senior Research Fellowship to E.R.H.; G0902043) and a European Molecular Biology Organization (EMBO) Young Investigator award to E.R.H.	Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Angell R, 1997, AM J HUM GENET, V61, P23, DOI 10.1086/513890; ANGELL RR, 1991, HUM GENET, V86, P383; Bongiorni S, 2004, CHROMOSOMA, V112, P331, DOI 10.1007/s00412-004-0278-4; Brandvain Y, 2012, GENETICS, V190, P709, DOI 10.1534/genetics.111.136721; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cabral G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6070; Campbell CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7260; Capalbo A, 2014, HUM REPROD, V29, P1173, DOI 10.1093/humrep/deu033; Capalbo A, 2013, HUM REPROD, V28, P509, DOI 10.1093/humrep/des394; Cheng EY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000661; Chmatal L, 2014, CURR BIOL, V24, P2295, DOI 10.1016/j.cub.2014.08.017; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Copsey A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004071; Dawe RK, 1996, P NATL ACAD SCI USA, V93, P8512, DOI 10.1073/pnas.93.16.8512; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; Franasiak JM, 2014, FERTIL STERIL, V101, P656, DOI 10.1016/j.fertnstert.2013.11.004; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; Garcia-Cruz R, 2010, HUM REPROD, V25, P2316, DOI 10.1093/humrep/deq180; Garcia-Cruz R, 2010, HUM REPROD, V25, P179, DOI 10.1093/humrep/dep347; Gruhn JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085075; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; HAIG D, 1991, J THEOR BIOL, V153, P531, DOI 10.1016/S0022-5193(05)80155-9; Handyside AH, 2012, EUR J HUM GENET, V20, P742, DOI 10.1038/ejhg.2011.272; Handyside AH, 2010, J MED GENET, V47, P651, DOI 10.1136/jmg.2009.069971; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Heckmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5979; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; HUGHESSC.S, 1969, CHROMOSOMA, V27, P109, DOI 10.1007/BF00326139; Hulten MA, 2010, REPRODUCTION, V139, P1, DOI 10.1530/REP-09-0088; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; LeMaire-Adkins R, 2000, GENETICS, V156, P775; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Middlebrooks CD, 2014, HUM MOL GENET, V23, P408, DOI 10.1093/hmg/ddt433; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Natesan SA, 2014, GENET MED, V16, P838, DOI 10.1038/gim.2014.45; Reiger R., 1968, GLOSSARY GENETICS CY; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; Viera A., 2009, V5, P137, DOI 10.1159/000166639; Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolstenholme J, 2000, CHROMOSOMA, V109, P435, DOI 10.1007/s004120000088; ZARAGOZA RV, 1994, HUM GENET, V94, P411	60	162	167	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					727	+		10.1038/ng.3306	http://dx.doi.org/10.1038/ng.3306			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	25985139	Green Accepted			2022-12-25	WOS:000357090300009
J	Bustamante, CD; Rasmussen, M				Bustamante, Carlos D.; Rasmussen, Morten			Beyond the reference genome	NATURE BIOTECHNOLOGY			English	Editorial Material									[Bustamante, Carlos D.; Rasmussen, Morten] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Bustamante, CD (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu		Bustamante, Carlos D./0000-0002-4187-7920				Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Cao HZ, 2015, NAT BIOTECHNOL, V33, P617, DOI 10.1038/nbt.3200; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	9	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					605	606		10.1038/nbt.3249	http://dx.doi.org/10.1038/nbt.3249			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057977				2022-12-25	WOS:000356019700017
J	Li, L; Liu, Y; Chen, HZ; Li, FW; Wu, JF; Zhang, HK; He, JP; Xing, YZ; Chen, Y; Wang, WJ; Tian, XY; Li, AZ; Zhang, Q; Huang, PQ; Han, JH; Lin, TW; Wu, Q				Li, Li; Liu, Yuan; Chen, Hang-zi; Li, Feng-wei; Wu, Jian-feng; Zhang, Hong-kui; He, Jian-ping; Xing, Yong-zhen; Chen, Yan; Wang, Wei-jia; Tian, Xu-yang; Li, An-zhong; Zhang, Qian; Huang, Pei-qiang; Han, Jiahuai; Lin, Tianwei; Wu, Qiao			Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation	NATURE CHEMICAL BIOLOGY			English	Article							KAPPA-B-ALPHA; MAP KINASE; NUCLEAR-LOCALIZATION; ACTIVATION; MACROPHAGES; INHIBITORS; REFINEMENT; PATHWAY; PHOSPHORYLATION; EXPRESSION	Sepsis, a hyperinflammatory response that can result in multiple organ dysfunctions, is a leading cause of mortality from infection. Here, we show that orphan nuclear receptor Nur77 (also known as TR3) can enhance resistance to lipopolysaccharide (LPS)-induced sepsis in mice by inhibiting NF-kappa B activity and suppressing aberrant cytokine production. Nur77 directly associates with p65 to block its binding to the kappa B element. However, this function of Nur77 is countered by the LPS-activated p38 alpha phosphorylation of Nur77. Dampening the interaction between Nur77 and p38 alpha would favor Nur77 suppression of the hyperinflammatory response. A compound, n-pentyl 2-[3,5-dihydroxy-2-(1-nonanoyl) phenyl]acetate, screened from a Nur77-biased library, blocked the Nur77-p38 alpha interaction by targeting the ligand-binding domain of Nur77 and restored the suppression of the hyperinflammatory response through Nur77 inhibition of NF-kappa B. This study associates the nuclear receptor with immune homeostasis and implicates a new therapeutic strategy to treat hyperinflammatory responses by targeting a p38 alpha substrate to modulate p38 alpha-regulated functions.	[Li, Li; Liu, Yuan; Chen, Hang-zi; Li, Feng-wei; Wu, Jian-feng; He, Jian-ping; Xing, Yong-zhen; Chen, Yan; Wang, Wei-jia; Tian, Xu-yang; Li, An-zhong; Zhang, Qian; Han, Jiahuai; Lin, Tianwei; Wu, Qiao] Xiamen Univ, State Prov Joint Engn Lab Targeted Drugs Nat Prod, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol,Sch Life Sci, Xiamen, Fujian Province, Peoples R China; [Zhang, Hong-kui; Huang, Pei-qiang] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Fujian Province, Peoples R China	Xiamen University; Xiamen University	Lin, TW (corresponding author), Xiamen Univ, State Prov Joint Engn Lab Targeted Drugs Nat Prod, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol,Sch Life Sci, Xiamen, Fujian Province, Peoples R China.	twlin@xmu.edu; qiaow@xmu.edu.cn	Han, J/G-4671-2010	Li, Li/0000-0002-7720-6731; Huang, Pei-Qiang/0000-0003-3230-0457	National Natural Science Fund of China; Ministry of Science and Technology [91413113, 2014CB910602, 31370724, 31221065]; Program of Introducing Talents of Discipline to Universities [B12001]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Natural Science Fund of China, the '973' Project of the Ministry of Science and Technology (91413113, 2014CB910602, 31370724, 31221065) and the Program of Introducing Talents of Discipline to Universities (B12001). The crystallographic data collection at Beamline BL17U1 at Shanghai Synchrotron Radiation Facility is gratefully acknowledged.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Davidson W, 2004, BIOCHEMISTRY-US, V43, P11658, DOI 10.1021/bi0495073; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dogne JM, 2005, J MED CHEM, V48, P2251, DOI 10.1021/jm0402059; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Hamers A. A., 2012, CIRC RES, V110, pe46; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Hynes J, 2005, CURR TOP MED CHEM, V5, P967, DOI 10.2174/1568026054985920; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu B, 2007, ENDOCRINOLOGY, V148, P34, DOI 10.1210/en.2006-0800; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeth ZH, 2003, J PHARMACOL EXP THER, V306, P1042, DOI 10.1124/jpet.103.052944; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Peifer C, 2006, CURR TOP MED CHEM, V6, P113, DOI 10.2174/156802606775270323; Pettus LH, 2008, CURR TOP MED CHEM, V8, P1452, DOI 10.2174/156802608786264245; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang AB, 2009, J IMMUNOL, V183, P3268, DOI 10.4049/jimmunol.0900894; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang WJ, 2014, NAT CHEM BIOL, V10, P133, DOI [10.1038/nchembio.1406, 10.1038/NCHEMBIO.1406]; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008	58	99	103	1	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2015	11	5					339	U133		10.1038/NCHEMBIO.1788	http://dx.doi.org/10.1038/NCHEMBIO.1788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG3FD	25822914				2022-12-25	WOS:000353162600010
J	Tarrago, L; Peterfi, Z; Lee, BC; Michel, T; Gladyshev, VN				Tarrago, Lionel; Peterfi, Zalan; Lee, Byung Cheon; Michel, Thomas; Gladyshev, Vadim N.			Monitoring methionine sulfoxide with stereospecific mechanism-based fluorescent sensors	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; HYDROGEN-PEROXIDE; OXIDIZED PROTEINS; ESCHERICHIA-COLI; REDUCTASE; INDICATORS; OXIDATION; CELLS; HOMEOSTASIS; REPAIR	Methionine can be reversibly oxidized to methionine sulfoxide (MetO) under physiological and pathophysiological conditions, but its use as a redox marker suffers from the lack of tools to detect and quantify MetO within cells. In this work, we created a pair of complementary stereospecific genetically encoded mechanism-based ratiometric fluorescent sensors of MetO by inserting a circularly permuted yellow fluorescent protein between yeast methionine sulfoxide reductases and thioredoxins. The two sensors, respectively named MetSOx and MetROx for their ability to detect S and R forms of MetO, were used for targeted analysis of protein oxidation, regulation and repair as well as for monitoring MetO in bacterial and mammalian cells, analyzing compartment-specific changes in MetO and examining responses to physiological stimuli.	[Tarrago, Lionel; Peterfi, Zalan; Lee, Byung Cheon; Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Michel, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA; [Lee, Byung Cheon] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Korea University	Gladyshev, VN (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Tarrago, Lionel/CAH-1308-2022; Tarrago, Lionel/N-3534-2016	Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; Lee, Byung Cheon/0000-0003-1467-1940; Lee, Byung Cheon/0000-0001-6788-8030; Peterfi, Zalan/0000-0002-7432-2438; Gladyshev, Vadim/0000-0002-0372-7016	US National Institutes of Health [AG021518, GM065204, HL48743]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046457, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM065204, R01GM065204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Rey (Laboratoire d'Ecophysiologie Moleculaire des Plantes, UMR7265 CEA-CNRS-Aix-Marseille Universite) for the kind gift of dabsyl-MetO and V. Belousov and V. Verkhusha for discussion. This study was supported by US National Institutes of Health grants AG021518 and GM065204 to V.N.G. and HL48743 to T.M.	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hung RJ, 2013, NAT CELL BIOL, V15, P1445, DOI 10.1038/ncb2871; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Ma XX, 2011, J BIOL CHEM, V286, P13430, DOI 10.1074/jbc.M110.205161; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Maron BA, 2012, CIRC J, V76, P2497, DOI 10.1253/circj.CJ-12-1207; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Mishina NM, 2013, METHOD ENZYMOL, V526, P175, DOI 10.1016/B978-0-12-405883-5.00011-9; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/nchembio.1142, 10.1038/NCHEMBIO.1142]; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Schwarzlander M, 2014, NATURE, V514, pE12, DOI 10.1038/nature13858; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Tantama M, 2012, PROG BRAIN RES, V196, P235, DOI 10.1016/B978-0-444-59426-6.00012-4; Tarrago L, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1097, DOI 10.1134/S0006297912100021; Tarrago L, 2012, J BIOL CHEM, V287, P24448, DOI 10.1074/jbc.M112.374520; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Wehr NB, 2012, FREE RADICAL BIO MED, V53, P1222, DOI 10.1016/j.freeradbiomed.2012.06.036; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	40	41	45	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2015	11	5					332	U123		10.1038/NCHEMBIO.1787	http://dx.doi.org/10.1038/NCHEMBIO.1787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG3FD	25799144	Green Submitted, Green Accepted			2022-12-25	WOS:000353162600009
J	Almonacid, M; Ahmed, WW; Bussonnier, M; Mailly, P; Betz, T; Voituriez, R; Gov, NS; Verlhac, MH				Almonacid, Maria; Ahmed, Wylie W.; Bussonnier, Matthias; Mailly, Philippe; Betz, Timo; Voituriez, Raphael; Gov, Nir S.; Verlhac, Marie-Helene			Active diffusion positions the nucleus in mouse oocytes	NATURE CELL BIOLOGY			English	Article							CELLS; REORGANIZATION; MICROTUBULE; OOGENESIS; TRANSPORT; FILAMENTS; NETWORKS; MOVEMENT; SYMMETRY; MESHWORK	In somatic cells, the position of the cell centroid is dictated by the centrosome. The centrosome is instrumental in nucleus positioning, the two structures being physically connected. Mouse oocytes have no centrosomes, yet harbour centrally located nuclei. We demonstrate how oocytes define their geometric centre in the absence of centrosomes. Using live imaging of oocytes, knockout for the formin 2 actin nucleator, with off-centred nuclei, together with optical trapping and modelling, we discover an unprecedented mode of nucleus positioning. We document how active diffusion of actin-coated vesicles, driven by myosin Vb, generates a pressure gradient and a propulsion force sufficient to move the oocyte nucleus. It promotes fluidization of the cytoplasm, contributing to nucleus directional movement towards the centre. Our results highlight the potential of active diffusion, a prominent source of intracellular transport, able to move large organelles such as nuclei, providing in vivo evidence of its biological function.	[Almonacid, Maria; Mailly, Philippe; Verlhac, Marie-Helene] Coll France, CIRB, F-75005 Paris, France; [Almonacid, Maria; Mailly, Philippe; Verlhac, Marie-Helene] CNRS, UMR7241, F-75005 Paris, France; [Almonacid, Maria; Mailly, Philippe; Verlhac, Marie-Helene] INSERM, U1050, Equipe Labellisee Ligue Canc, F-75005 Paris, France; [Ahmed, Wylie W.; Bussonnier, Matthias; Betz, Timo] Inst Curie, Ctr Rech, Lab Physicochim, F-75248 Paris, France; [Ahmed, Wylie W.; Bussonnier, Matthias; Betz, Timo] CNRS, UMR168, F-75248 Paris, France; [Ahmed, Wylie W.; Bussonnier, Matthias; Betz, Timo] UPMC, F-75005 Paris, France; [Voituriez, Raphael] UPMC, CNRS, UMR7600, F-75005 Paris, France; [Gov, Nir S.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Weizmann Institute of Science	Verlhac, MH (corresponding author), Coll France, CIRB, F-75005 Paris, France.	marie-helene.verlhac@college-de-france.fr	ALMONACID, Maria/R-6708-2017; Betz, Timo/ABF-9946-2021; ALMONACID, Maria/Z-1316-2019; voituriez, raphael/V-3418-2017; GOV, NIR/K-1415-2012	ALMONACID, Maria/0000-0001-6245-2510; ALMONACID, Maria/0000-0001-6245-2510; VERLHAC, Marie-Helene/0000-0001-8377-9010; GOV, NIR/0000-0001-7774-1139; Ahmed, Wylie/0000-0001-5243-5864; Betz, Timo/0000-0002-1548-0655; voituriez, raphael/0000-0001-8746-5713	Ligue Nationale contre le Cancer; Ligue Nationale Contre le Cancer [EL/2012/LNCC/MHV]; Fondation Bettencourt Schueller; program 'Investissements d'Avenir'; ANR [ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02]; La Fondation Pierre-Gilles de Gennes; Marie Curie Actions; Axa PhD fellowship; French Agence Nationale de la Recherche [ANR-11-JSV5-0002]; ISF [500112]	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation Bettencourt Schueller; program 'Investissements d'Avenir'(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); La Fondation Pierre-Gilles de Gennes; Marie Curie Actions(European Commission); Axa PhD fellowship(AXA Research Fund); French Agence Nationale de la Recherche(French National Research Agency (ANR)); ISF(Israel Science Foundation)	We thank J-Y. Tinevez (Institut Pasteur, Paris) for sharing the resources to TrackMate and MSD analysis, J. Unruh (Stowers Institute for Medical Research, Kansas City) tor sharing the resources tor STICS analysis, M. Schuh (MRC Cambridge) for providing the MyoVa and Vb tail plasmids and M-E. Terret for critical reading of the manuscript. M. Almonacid is a recipient of post-doctoral fellowship from the Ligue Nationale contre le Cancer. This work was supported by a grant from the Ligue Nationale Contre le Cancer (EL/2012/LNCC/MHV). This work has received support from the Fondation Bettencourt Schueller, and support under the program 'Investissements d'Avenir' launched by the French Government and implemented by the ANR, with the references: ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02 PSL Research University. W.W.A. is a recipient of Postdoctoral fellowships from La Fondation Pierre-Gilles de Gennes and Marie Curie Actions. M.B. is a recipient of an Axa PhD fellowship. T.B. was supported by the French Agence Nationale de la Recherche (ANR-11-JSV5-0002). N.S.G. gratetully as financial support from the ISF (grant number 500112).	Ajduk A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1424; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2011, DEVELOPMENT, V138, P2903, DOI 10.1242/dev.060269; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; Brangwynne CP, 2009, TRENDS CELL BIOL, V19, P423, DOI 10.1016/j.tcb.2009.04.004; Breuer M, 2010, J CELL BIOL, V191, P1251, DOI 10.1083/jcb.201005065; Brunet S, 2007, REPRODUCTION, V133, P1069, DOI 10.1530/REP-07-0036; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chaigne A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7027; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fakhri N, 2014, SCIENCE, V344, P1031, DOI 10.1126/science.1250170; Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gonczy P, 2004, CURR BIOL, V14, pR268, DOI 10.1016/j.cub.2004.03.020; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; GUTZEIT HO, 1986, J CELL SCI, V80, P159; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Huelsmann S, 2013, DEV CELL, V26, P604, DOI 10.1016/j.devcel.2013.08.014; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Luksza M, 2013, DEV BIOL, V382, P48, DOI 10.1016/j.ydbio.2013.07.029; Mas J, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/046006; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Tang N, 2012, J CELL SCI, V125, P4951, DOI 10.1242/jcs.038083; Terret ME, 2003, DEVELOPMENT, V130, P5169, DOI 10.1242/dev.00731; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; Verlhac M. H., 2010, OOGENESIS UNIVERSAL, P291; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320	43	100	100	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					470	+		10.1038/ncb3131	http://dx.doi.org/10.1038/ncb3131			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25774831				2022-12-25	WOS:000351920500017
J	Hariharan, IK				Hariharan, Iswar K.			Energy stress tames the Hippo pathway	NATURE CELL BIOLOGY			English	Editorial Material							YAP; PROTEIN; MAMMALS; CANCER; SIZE	The kinase AMPK, a sensor of cellular energy stress, has been shown to oppose the growth-promoting activity of YAP, the transcriptional co-activator downstream of the Hippo signalling pathway. This finding may help to explain why the antidiabetic drug metformin, for which AMPK is a key effector, is linked to cancer-protective activity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hariharan, IK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ikh@berkeley.edu						Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Meynet O, 2014, TRENDS MOL MED, V20, P419, DOI 10.1016/j.molmed.2014.05.001; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	16	7	9	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					362	363		10.1038/ncb3141	http://dx.doi.org/10.1038/ncb3141			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25812520				2022-12-25	WOS:000351920500006
J	Day, FR; Ruth, KS; Thompson, DJ; Lunetta, KL; Pervjakova, N; Chasman, DI; Stolk, L; Finucane, HK; Sulem, P; Bulik-Sullivan, B; Esko, T; Johnson, AD; Elks, CE; Franceschini, N; He, CY; Altmaier, E; Brody, JA; Franke, LL; Huffman, JE; Keller, MF; McArdle, PF; Nutile, T; Porcu, E; Robino, A; Rose, LM; Schick, UM; Smith, JA; Teumer, A; Traglia, M; Vuckovic, D; Yao, J; Zhao, W; Albrecht, E; Amin, N; Corre, T; Hottenga, JJ; Mangino, M; Smith, AV; Tanaka, T; Abecasis, GR; Andrulis, IL; Anton-Culver, H; Antoniou, AC; Arndt, V; Arnold, AM; Barbieri, C; Beckmann, MW; Beeghly-Fadiel, A; Benitez, J; Bernstein, L; Bielinski, SJ; Blomqvist, C; Boerwinkle, E; Bogdanova, NV; Bojesen, SE; Bolla, MK; Borresen-Dale, AL; Boutin, TS; Brauch, H; Brenner, H; Bruning, T; Burwinkel, B; Campbell, A; Campbell, H; Chanock, SJ; Chapman, JR; Chen, YDI; Chenevix-Trench, G; Couch, FJ; Coviello, AD; Cox, A; Czene, K; Darabi, H; De Vivo, I; Demerath, EW; Dennis, J; Devilee, P; Dork, T; Dos-Santos-Silva, I; Dunning, AM; Eicher, JD; Fasching, PA; Faul, JD; Figueroa, J; Flesch-Janys, D; Gandin, I; Garcia, ME; Garcia-Closas, M; Giles, GG; Girotto, GG; Goldberg, MS; Gonzalez-Neira, A; Goodarzi, MO; Grove, ML; Gudbjartsson, DF; Guenel, P; Guo, XQ; Haiman, CA; Hall, P; Hamann, U; Henderson, BE; Hocking, LJ; Hofman, A; Homuth, G; Hooning, MJ; Hopper, JL; Hu, FB; Huang, JY; Humphreys, K; Hunter, DJ; Jakubowska, A; Jones, SE; Kabisch, M; Karasik, D; Knight, JA; Kolcic, I; Kooperberg, C; Kosma, VM; Kriebel, J; Kristensen, V; Lambrechts, D; Langenberg, C; Li, JM; Li, X; Lindstrom, S; Liu, YM; Luan, JN; Lubinski, J; Magi, R; Mannermaa, A; Manz, J; Margolin, S; Marten, J; Martin, NG; Masciullo, C; Meindl, A; Michailidou, K; Mihailov, E; Milani, L; Milne, RL; Muller-Nurasyid, M; Nalls, M; Neale, BM; Nevanlinna, H; Neven, P; Newman, AB; Nordestgaard, BG; Olson, JE; Padmanabhan, S; Peterlongo, P; Peters, U; Petersmann, A; Peto, J; Pharoah, PDP; Pirastu, NN; Pirie, A; Pistis, G; Polasek, O; Porteous, D; Psaty, BM; Pylkas, K; Radice, P; Raffel, LJ; Rivadeneira, F; Rudan, I; Rudolph, A; Ruggiero, D; Sala, CF; Sanna, S; Sawyer, EJ; Schlessinger, D; Schmidt, MK; Schmidt, F; Schmutzler, RK; Schoemaker, MJ; Scott, RA; Seynaeve, CM; Simard, J; Sorice, R; Southey, MC; Stockl, D; Strauch, K; Swerdlow, A; Taylor, KD; Thorsteinsdottir, U; Toland, AE; Tomlinson, I; Truong, T; Tryggvadottir, L; Turner, ST; Vozzi, D; Wang, Q; Wellons, M; Willemsen, G; Wilson, JF; Winqvist, R; Wolffenbuttel, BBHR; Wright, AF; Yannoukakos, D; Zemunik, T; Zheng, W; Zygmunt, M; Bergmann, S; Boomsma, DI; Buring, JE; Ferrucci, L; Montgomery, GW; Gudnason, V; Spector, TD; van Duijn, CM; Alizadeh, BZ; Ciullo, M; Crisponi, L; Easton, DF; Gasparini, PP; Gieger, C; Harris, TB; Hayward, C; Kardia, SLR; Kraft, P; McKnight, B; Metspalu, A; Morrison, AC; Reiner, AP; Ridker, PM; Rotter, JI; Toniolo, D; Uitterlinden, AG; Ulivi, S; Volzke, H; Wareham, NJ; Weir, DR; Yerges-Armstrong, LM; Price, AL; Stefansson, K; Visser, JA; Ong, KK; Chang-Claude, J; Murabito, JM; Perry, JRB; Murray, A				Day, Felix R.; Ruth, Katherine S.; Thompson, Deborah J.; Lunetta, Kathryn L.; Pervjakova, Natalia; Chasman, Daniel I.; Stolk, Lisette; Finucane, Hilary K.; Sulem, Patrick; Bulik-Sullivan, Brendan; Esko, Tonu; Johnson, Andrew D.; Elks, Cathy E.; Franceschini, Nora; He, Chunyan; Altmaier, Elisabeth; Brody, Jennifer A.; Franke, Lude L.; Huffman, Jennifer E.; Keller, Margaux F.; McArdle, Patrick F.; Nutile, Teresa; Porcu, Eleonora; Robino, Antonietta; Rose, Lynda M.; Schick, Ursula M.; Smith, Jennifer A.; Teumer, Alexander; Traglia, Michela; Vuckovic, Dragana; Yao, Jie; Zhao, Wei; Albrecht, Eva; Amin, Najaf; Corre, Tanguy; Hottenga, Jouke-Jan; Mangino, Massimo; Smith, Albert V.; Tanaka, Toshiko; Abecasis, Goncalo R.; Andrulis, Irene L.; Anton-Culver, Hoda; Antoniou, Antonis C.; Arndt, Volker; Arnold, Alice M.; Barbieri, Caterina; Beckmann, Matthias W.; Beeghly-Fadiel, Alicia; Benitez, Javier; Bernstein, Leslie; Bielinski, Suzette J.; Blomqvist, Carl; Boerwinkle, Eric; Bogdanova, Natalia V.; Bojesen, Stig E.; Bolla, Manjeet K.; Borresen-Dale, Anne-Lise; Boutin, Thibaud S.; Brauch, Hiltrud; Brenner, Hermann; Bruening, Thomas; Burwinkel, Barbara; Campbell, Archie; Campbell, Harry; Chanock, Stephen J.; Chapman, J. Ross; Chen, Yii-Der Ida; Chenevix-Trench, Georgia; Couch, Fergus J.; Coviello, Andrea D.; Cox, Angela; Czene, Kamila; Darabi, Hatef; De Vivo, Immaculata; Demerath, Ellen W.; Dennis, Joe; Devilee, Peter; Doerk, Thilo; dos-Santos-Silva, Isabel; Dunning, Alison M.; Eicher, John D.; Fasching, Peter A.; Faul, Jessica D.; Figueroa, Jonine; Flesch-Janys, Dieter; Gandin, Ilaria; Garcia, Melissa E.; Garcia-Closas, Montserrat; Giles, Graham G.; Girotto, Giorgia G.; Goldberg, Mark S.; Gonzalez-Neira, Anna; Goodarzi, Mark O.; Grove, Megan L.; Gudbjartsson, Daniel F.; Guenel, Pascal; Guo, Xiuqing; Haiman, Christopher A.; Hall, Per; Hamann, Ute; Henderson, Brian E.; Hocking, Lynne J.; Hofman, Albert; Homuth, Georg; Hooning, Maartje J.; Hopper, John L.; Hu, Frank B.; Huang, Jinyan; Humphreys, Keith; Hunter, David J.; Jakubowska, Anna; Jones, Samuel E.; Kabisch, Maria; Karasik, David; Knight, Julia A.; Kolcic, Ivana; Kooperberg, Charles; Kosma, Veli-Matti; Kriebel, Jennifer; Kristensen, Vessela; Lambrechts, Diether; Langenberg, Claudia; Li, Jingmei; Li, Xin; Lindstroem, Sara; Liu, Yongmei; Luan, Jian'an; Lubinski, Jan; Maegi, Reedik; Mannermaa, Arto; Manz, Judith; Margolin, Sara; Marten, Jonathan; Martin, Nicholas G.; Masciullo, Corrado; Meindl, Alfons; Michailidou, Kyriaki; Mihailov, Evelin; Milani, Lili; Milne, Roger L.; Mueller-Nurasyid, Martina; Nalls, Michael; Neale, Benjamin M.; Nevanlinna, Heli; Neven, Patrick; Newman, Anne B.; Nordestgaard, Borge G.; Olson, Janet E.; Padmanabhan, Sandosh; Peterlongo, Paolo; Peters, Ulrike; Petersmann, Astrid; Peto, Julian; Pharoah, Paul D. P.; Pirastu, Nicola N.; Pirie, Ailith; Pistis, Giorgio; Polasek, Ozren; Porteous, David; Psaty, Bruce M.; Pylkas, Katri; Radice, Paolo; Raffel, Leslie J.; Rivadeneira, Fernando; Rudan, Igor; Rudolph, Anja; Ruggiero, Daniela; Sala, Cinzia F.; Sanna, Serena; Sawyer, Elinor J.; Schlessinger, David; Schmidt, Marjanka K.; Schmidt, Frank; Schmutzler, Rita K.; Schoemaker, Minouk J.; Scott, Robert A.; Seynaeve, Caroline M.; Simard, Jacques; Sorice, Rossella; Southey, Melissa C.; Stoeckl, Doris; Strauch, Konstantin; Swerdlow, Anthony; Taylor, Kent D.; Thorsteinsdottir, Unnur; Toland, Amanda E.; Tomlinson, Ian; Truong, Therese; Tryggvadottir, Laufey; Turner, Stephen T.; Vozzi, Diego; Wang, Qin; Wellons, Melissa; Willemsen, Gonneke; Wilson, James F.; Winqvist, Robert; Wolffenbuttel, Bruce B. H. R.; Wright, Alan F.; Yannoukakos, Drakoulis; Zemunik, Tatijana; Zheng, Wei; Zygmunt, Marek; Bergmann, Sven; Boomsma, Dorret I.; Buring, Julie E.; Ferrucci, Luigi; Montgomery, Grant W.; Gudnason, Vilmundur; Spector, Tim D.; van Duijn, Cornelia M.; Alizadeh, Behrooz Z.; Ciullo, Marina; Crisponi, Laura; Easton, Douglas F.; Gasparini, Paolo P.; Gieger, Christian; Harris, Tamara B.; Hayward, Caroline; Kardia, Sharon L. R.; Kraft, Peter; McKnight, Barbara; Metspalu, Andres; Morrison, Alanna C.; Reiner, Alex P.; Ridker, Paul M.; Rotter, Jerome I.; Toniolo, Daniela; Uitterlinden, Andre G.; Ulivi, Sheila; Voelzke, Henry; Wareham, Nicholas J.; Weir, David R.; Yerges-Armstrong, Laura M.; Price, Alkes L.; Stefansson, Kari; Visser, Jenny A.; Ong, Ken K.; Chang-Claude, Jenny; Murabito, Joanne M.; Perry, John R. B.; Murray, Anna		EPIC-InterAct Consortium; LifeLines Cohort Study	Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair	NATURE GENETICS			English	Article							OVARIAN FAILURE; HOMOLOGOUS RECOMBINATION; NATURAL MENOPAUSE; WIDE ASSOCIATION; CELL-TYPES; BRCA1; LOCI; AGE; RECEPTOR; INSUFFICIENCY	Menopause timing has a substantial impact on infertility and risk of disease, including breast cancer, but the underlying mechanisms are poorly understood. We report a dual strategy in similar to 70,000 women to identify common and low-frequency protein-coding variation associated with age at natural menopause (ANM). We identified 44 regions with common variants, including two regions harboring additional rare missense alleles of large effect. We found enrichment of signals in or near genes involved in delayed puberty, highlighting the first molecular links between the onset and end of reproductive lifespan. Pathway analyses identified major association with DNA damage response (DDR) genes, including the first common coding variant in BRCA1 associated with any complex trait. Mendelian randomization analyses supported a causal effect of later ANM on breast cancer risk (similar to 6% increase in risk per year; P = 3 x 10(-14)), likely mediated by prolonged sex hormone exposure rather than DDR mechanisms.	[Day, Felix R.; Elks, Cathy E.; Langenberg, Claudia; Luan, Jian'an; Scott, Robert A.; Wareham, Nicholas J.; Ong, Ken K.; Perry, John R. B.] Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med,Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England; [Ruth, Katherine S.; Jones, Samuel E.; Murray, Anna] Univ Exeter, Sch Med, Genet Complex Traits, Exeter, Devon, England; [Thompson, Deborah J.; Antoniou, Antonis C.; Bolla, Manjeet K.; Dennis, Joe; Michailidou, Kyriaki; Pharoah, Paul D. P.; Pirie, Ailith; Wang, Qin; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Lunetta, Kathryn L.; Johnson, Andrew D.; Huffman, Jennifer E.; Eicher, John D.; Murabito, Joanne M.] NHLBI, Framingham, MA USA; [Lunetta, Kathryn L.; Johnson, Andrew D.; Huffman, Jennifer E.; Eicher, John D.; Murabito, Joanne M.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [Pervjakova, Natalia; Esko, Tonu; Maegi, Reedik; Mihailov, Evelin; Milani, Lili; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Pervjakova, Natalia] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Chasman, Daniel I.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Chasman, Daniel I.; Karasik, David; Buring, Julie E.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Stolk, Lisette; Rivadeneira, Fernando; Uitterlinden, Andre G.; Visser, Jenny A.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stolk, Lisette; Rivadeneira, Fernando; Uitterlinden, Andre G.] Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Stolk, Lisette; Rivadeneira, Fernando; Uitterlinden, Andre G.] Natl Genom Initiat, Leiden, Netherlands; [Finucane, Hilary K.; De Vivo, Immaculata; Hu, Frank B.; Hunter, David J.; Li, Xin; Lindstroem, Sara; Kraft, Peter; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Sulem, Patrick; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Bulik-Sullivan, Brendan; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Bulik-Sullivan, Brendan; Neale, Benjamin M.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Bulik-Sullivan, Brendan; Neale, Benjamin M.] Broad Inst, Med & Populat Genet, Cambridge, MA USA; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Esko, Tonu; Hunter, David J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [He, Chunyan] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [He, Chunyan] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Altmaier, Elisabeth; Kriebel, Jennifer; Manz, Judith] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Altmaier, Elisabeth; Albrecht, Eva; Mueller-Nurasyid, Martina; Strauch, Konstantin] Helmholtz Zenntrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Franke, Lude L.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Huffman, Jennifer E.; Boutin, Thibaud S.; Marten, Jonathan; Wilson, James F.; Wright, Alan F.; Hayward, Caroline] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Keller, Margaux F.] Merck Pharmaceut, Boston, MA USA; [McArdle, Patrick F.; Yerges-Armstrong, Laura M.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Program Personalized Med, Baltimore, MD 21201 USA; [Nutile, Teresa; Ruggiero, Daniela; Sorice, Rossella; Ciullo, Marina] CNR, Inst Genet & Biophys, Naples, Italy; [Porcu, Eleonora; Pistis, Giorgio; Sanna, Serena; Crisponi, Laura] CNR, Inst Genet & Biomed Res, Cagliari, Italy; [Porcu, Eleonora; Pistis, Giorgio] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Porcu, Eleonora; Abecasis, Goncalo R.; Pistis, Giorgio] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Robino, Antonietta; Vuckovic, Dragana; Barbieri, Caterina; Gandin, Ilaria; Pirastu, Nicola N.; Vozzi, Diego; Gasparini, Paolo P.; Ulivi, Sheila] Sci Inst Res Hospitalisat & Hlth Care Burlo Garof, Inst Maternal & Child Hlth, Trieste, Italy; [Schick, Ursula M.; Kooperberg, Charles; Peters, Ulrike; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Smith, Jennifer A.; Zhao, Wei; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Teumer, Alexander; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Traglia, Michela; Barbieri, Caterina; Masciullo, Corrado; Sala, Cinzia F.; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Vuckovic, Dragana; Gandin, Ilaria; Girotto, Giorgia G.; Pirastu, Nicola N.; Gasparini, Paolo P.] Univ Trieste, Dept Clin Med Sci Surg & Hlth, Trieste, Italy; [Yao, Jie; Chen, Yii-Der Ida; Guo, Xiuqing; Taylor, Kent D.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Inst Translat Genom & Populat Sci, LABioMed, Torrance, CA 90509 USA; [Amin, Najaf; Hofman, Albert; Rivadeneira, Fernando; van Duijn, Cornelia M.; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Corre, Tanguy; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Corre, Tanguy; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Hottenga, Jouke-Jan; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Mangino, Massimo; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Smith, Albert V.; Gudnason, Vilmundur] Icelandic Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Thorsteinsdottir, Unnur; Gudnason, Vilmundur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Translat Gerontol Branch, Baltimore, MD 21224 USA; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Arndt, Volker; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Arnold, Alice M.; McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Beckmann, Matthias W.; Fasching, Peter A.] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Obstet & Gynaecol, D-91054 Erlangen, Germany; [Beeghly-Fadiel, Alicia; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA; [Bielinski, Suzette J.; Olson, Janet E.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Blomqvist, Carl; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Boerwinkle, Eric; Grove, Megan L.; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Borresen-Dale, Anne-Lise; Kristensen, Vessela] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Borresen-Dale, Anne-Lise; Kristensen, Vessela] Univ Oslo, Fac Med, Dept Clin Med, Oslo, Norway; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Inst Clin Pharmacol, Tubingen, Germany; [Brauch, Hiltrud; Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Bruening, Thomas] Univ Bochum IPA, Inst Ruhr, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Burwinkel, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, Mol Biol Breast Canc, Heidelberg, Germany; [Campbell, Archie; Porteous, David] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Med Genet Sect, Edinburgh, Midlothian, Scotland; [Campbell, Harry; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chapman, J. Ross; Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld, Australia; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MI USA; [Coviello, Andrea D.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Coviello, Andrea D.] Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA; [Cox, Angela] Univ Sheffield, Dept Oncol, Sheffield Canc Res, Sheffield, S Yorkshire, England; [Czene, Kamila; Darabi, Hatef; Hall, Per; Humphreys, Keith; Li, Jingmei] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [De Vivo, Immaculata; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [De Vivo, Immaculata; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Demerath, Ellen W.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Devilee, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [dos-Santos-Silva, Isabel; Peto, Julian] London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Dept, London WC1, England; [Dunning, Alison M.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Figueroa, Jonine] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Clin Canc Registry, Dept Canc Epidemiol, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Garcia, Melissa E.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat; Schoemaker, Minouk J.; Swerdlow, Anthony] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Div Canc Studies, London SW3 6JB, England; [Giles, Graham G.; Hopper, John L.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Dept Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Guenel, Pascal; Truong, Therese] INSERM, Ctr Res Epidemiol & Populat Hlth, Environm Epidemiol Canc, Villejuif, France; [Guenel, Pascal; Truong, Therese] Univ Paris Sud, UMRS 1018, Villejuif, France; [Haiman, Christopher A.; Henderson, Brian E.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hamann, Ute; Kabisch, Maria] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Hocking, Lynne J.] Univ Aberdeen, Div Appl Med, Musculoskeletal Res Programme, Aberdeen, Scotland; [Homuth, Georg; Schmidt, Frank] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, Greifswald, Germany; [Hooning, Maartje J.; Seynaeve, Caroline M.] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; [Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Dept Nutr, Boston, MA USA; [Huang, Jinyan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Karasik, David] Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Kolcic, Ivana; Polasek, Ozren; Zemunik, Tatijana] Univ Split, Fac Med, Split, Croatia; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Pathol & Forens Med, Inst Clin Med, Sch Med, Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Kriebel, Jennifer] German Ctr Diabet Res, Neuherberg, Germany; [Kristensen, Vessela] Univ Oslo, Oslo Univ Hosp, Dept Clin Mol Biol, Oslo, Norway; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Ctr Human Genet, Winston Salem, NC USA; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Martin, Nicholas G.; Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Meindl, Alfons] Tech Univ Munich, Div Obstet & Gynecol, D-80290 Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany; [Nalls, Michael] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Neven, Patrick] Univ Hosp Leuven, Dept Oncol, Leuven, Belgium; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Newman, Anne B.] Univ Pittsburgh, Dept Clin & Translat Sci, Pittsburgh, PA USA; [Padmanabhan, Sandosh] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci,Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Peterlongo, Paolo] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy; [Petersmann, Astrid] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Psaty, Bruce M.; Reiner, Alex P.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Dept Clin Chem, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Pylkas, Katri; Winqvist, Robert] Ctr NordLab, Northern Finland Lab, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Radice, Paolo] Fdn IRCCS, Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Raffel, Leslie J.] Cedars Sinai Med Ctr, Med Genet Res Ctr, Los Angeles, CA 90048 USA; [Raffel, Leslie J.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Clin & Translat Sci Inst, Los Angeles, CA 90048 USA; [Rudolph, Anja; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Sawyer, Elinor J.] Kings Coll London, Guys Hosp, Res Oncol, London WC2R 2LS, England; [Schlessinger, David] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Schmutzler, Rita K.] Univ Hosp Cologne, Dept Gynecol & Obstet, Div Mol Gynecooncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Simard, Jacques] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Toland, Amanda E.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Munich, Germany; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Toland, Amanda E.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Tomlinson, Ian] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Tryggvadottir, Laufey] Icelandic Canc Registry, Reykjavik, Iceland; [Turner, Stephen T.] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA; [Wellons, Melissa] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Wolffenbuttel, Bruce B. H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Wolffenbuttel, Bruce B. H. R.] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study & Biobank, Groningen, Netherlands; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Inst Radioisotopes & Radiodiagnost Prod, Mol Diagnost Lab, Athens, Greece; [Zygmunt, Marek] Univ Med Greifswald, Dept Gynecol & Obstet, Greifswald, Germany; [Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Kraft, Peter; Ong, Ken K.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Ong, Ken K.] Univ Cambridge, Dept Paediat, Cambridge, England; [Murabito, Joanne M.] Boston Univ, Sch Med, Dept Med, Gen Internal Med Sect, Boston, MA 02118 USA	University of Cambridge; University of Exeter; University of Cambridge; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; University of Tartu; University of Tartu; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Washington; University of Washington Seattle; University of Groningen; University of Edinburgh; Merck & Company; University System of Maryland; University of Maryland Baltimore; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of Michigan System; University of Michigan; IRCCS Burlo Garofolo; Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan; Greifswald Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Trieste; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Lausanne; Swiss Institute of Bioinformatics; Vrije Universiteit Amsterdam; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of California System; University of California Irvine; Helmholtz Association; German Cancer Research Center (DKFZ); University of Washington; University of Washington Seattle; University of Erlangen Nuremberg; Vanderbilt University; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; City of Hope; Beckman Research Institute of City of Hope; Mayo Clinic; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Hannover Medical School; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Oslo; University of Oslo; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Edinburgh; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; Wellcome Centre for Human Genetics; QIMR Berghofer Medical Research Institute; Mayo Clinic; Boston University; Boston University; University of Sheffield; Karolinska Institutet; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Melbourne; Cancer Council Victoria; McGill University; McGill University; Royal Victoria Hospital; Cedars Sinai Medical Center; University of Iceland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); University of Aberdeen; Greifswald Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Jiao Tong University; Pomeranian Medical University; Harvard University; Hebrew SeniorLife; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Split; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oslo; Flanders Institute for Biotechnology (VIB); KU Leuven; Wake Forest University; Karolinska Institutet; QIMR Berghofer Medical Research Institute; Technical University of Munich; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Helsinki; KU Leuven; University Hospital Leuven; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Glasgow; IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); Greifswald Medical School; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Oulu; Fondazione IRCCS Istituto Nazionale Tumori Milan; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Helmholtz Association; German Cancer Research Center (DKFZ); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Netherlands Cancer Institute; University of Cologne; University of Cologne; University of Cologne; Laval University; University of Melbourne; University of Munich; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Oxford; Mayo Clinic; Vanderbilt University; University of Groningen; University of Groningen; National Centre of Scientific Research "Demokritos"; Greifswald Medical School; University of Groningen; Harvard University; Harvard T.H. Chan School of Public Health; University of Cambridge; Boston University	Perry, JRB (corresponding author), Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med,Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England.	john.perry@mrc-epid.cam.ac.uk	Arndt, Volker/AAI-7282-2020; DEVILEE, PETER/ABR-2140-2022; Rotter, Jerome/AAY-6598-2021; /AAM-5330-2020; Bogdanova, Natalia V./Y-2205-2019; Radice, Paolo/O-3119-2013; Traglia, Michela/AAX-5816-2020; Goodarzi, Mark/AAH-7106-2021; Langenberg, Claudia/ABG-9067-2021; Padmanabhan, Sandosh/S-3963-2016; Schmidt, Marjanka K/G-9058-2011; Guenel, Pascal/H-3728-2018; Müller-Nurasyid, Martina/I-8735-2018; Johnson, Andrew D/G-6520-2013; Kraft, Peter/GQH-8448-2022; Crisponi, Laura/AAC-2642-2019; ruggiero, daniela/K-5638-2016; Dörk, Thilo/J-8620-2012; Porteous, David/AAA-3446-2021; Mägi, Reedik/AAJ-9679-2021; Gandin, Ilaria/B-2634-2017; Visser, Jenny A./F-8156-2011; Turner, Stephen/GXM-4654-2022; Rudan, Igor/I-1467-2012; Li, Jingmei/I-2904-2012; Campbell, Harry/E-2959-2010; Gasparini, Paolo/B-6173-2014; Boomsma, Dorret I/AAX-4470-2020; Gonzalez-Neira, Anna/C-5791-2015; Toniolo, Daniela/AAE-2969-2019; Michailidou, Kyriaki/ABD-5122-2020; truong, therese/A-2837-2013; Bowtell, David/H-1007-2016; Mangino, Massimo/F-5134-2011; Kolcic, Ivana/E-2713-2017; Figueroa, Jonine/AFK-2752-2022; Ruth, Katherine/K-2745-2019; Devilee, Peter/GXV-8005-2022; Zemunik, Tatijana/D-8584-2017; Montgomery, Grant W/B-7148-2008; Brenner, Hermann/B-4627-2017; Chapman, Ross/GYD-7815-2022; Arndt, Volker/B-4999-2014; Sala, Cinzia Felicita/AAN-1900-2020; Brenner, Hermann/ABE-6383-2020; Frank, ZIK FunGene Schmidt/B-6075-2009; Pirastu, Nicola/AHB-6226-2022; Ciullo, Marina/AAE-3041-2020; Stefansson, Kari/AAE-7187-2019; Gudnason, Vilmundur/AAE-7126-2019; Newman, Anne B./C-6408-2013; Zheng, Wei/O-3351-2013; Guenel, Pascal/AAS-7688-2021; Garcia-Closas, Montserrat/AAZ-6930-2021; Lambrechts, Diether/AAJ-3167-2020; Bielinski, Suzette/A-2238-2009; Figueroa, Jonine/GWD-1322-2022; zhang, weihua/GXV-1334-2022; Franke, Lude/P-7036-2016; Zheng, Wei/GQQ-8951-2022; Fasching, Peter A/ABH-9912-2020; Rivadeneira, Fernando/O-5385-2015; Milani, Lili/N-1097-2019; Polasek, Ozren/B-6002-2011; Brüning, Thomas/G-8120-2015; Jones, Samuel/AAF-3100-2019; Knight, Julia/R-5617-2019; Wilson, James F/A-5704-2009; Knight, Julia/A-6843-2012; Campbell, Archie/AAZ-1757-2021; Chenevix-Trench, Georgia/AAV-2014-2020; Haviv, Izhak/E-3782-2015; Andrulis, Irene L./E-7267-2013; Kriebel, Jennifer/N-4782-2017; Jakubowska, Anna/O-8050-2014; Figueroa, Jonine/AAG-1065-2022; Pharoah, Paul/V-6658-2019; Peterlongo, Paolo/Q-4717-2018; Margolin, Sara/AAX-9034-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Teumer, Alexander/S-7438-2019; Girotto, Giorgia/I-9452-2018; Robino, Antonietta/K-9398-2016; benitez, javier/H-5232-2015; Smith, Albert Vernon/K-5150-2015	Arndt, Volker/0000-0001-9320-8684; Radice, Paolo/0000-0001-6298-4111; Goodarzi, Mark/0000-0001-6364-5103; Langenberg, Claudia/0000-0002-5017-7344; Schmidt, Marjanka K/0000-0002-2228-429X; Guenel, Pascal/0000-0002-8359-518X; Müller-Nurasyid, Martina/0000-0003-3793-5910; Johnson, Andrew D/0000-0001-6369-5178; Crisponi, Laura/0000-0001-9128-8537; ruggiero, daniela/0000-0003-3898-7827; Dörk, Thilo/0000-0002-9458-0282; Porteous, David/0000-0003-1249-6106; Gandin, Ilaria/0000-0003-3196-2491; Rudan, Igor/0000-0001-6993-6884; Li, Jingmei/0000-0001-8587-7511; Campbell, Harry/0000-0002-6169-6262; Gonzalez-Neira, Anna/0000-0002-5421-2020; Toniolo, Daniela/0000-0001-9545-6032; Michailidou, Kyriaki/0000-0001-7065-1237; truong, therese/0000-0002-2943-6786; Bowtell, David/0000-0001-9089-7525; Mangino, Massimo/0000-0002-2167-7470; Kolcic, Ivana/0000-0001-7918-6052; Figueroa, Jonine/0000-0002-5100-623X; Ruth, Katherine/0000-0003-4966-9170; Zemunik, Tatijana/0000-0001-8120-2891; Montgomery, Grant W/0000-0002-4140-8139; Brenner, Hermann/0000-0002-6129-1572; Chapman, Ross/0000-0002-6477-4254; Arndt, Volker/0000-0001-9320-8684; Brenner, Hermann/0000-0002-6129-1572; Ciullo, Marina/0000-0002-9621-9984; Gudnason, Vilmundur/0000-0001-5696-0084; Newman, Anne B./0000-0002-0106-1150; Zheng, Wei/0000-0003-1226-070X; Guenel, Pascal/0000-0002-8359-518X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Lambrechts, Diether/0000-0002-3429-302X; Bielinski, Suzette/0000-0002-2905-5430; Figueroa, Jonine/0000-0002-5100-623X; Franke, Lude/0000-0002-5159-8802; Fasching, Peter A/0000-0003-4885-8471; Rivadeneira, Fernando/0000-0001-9435-9441; Milani, Lili/0000-0002-5323-3102; Polasek, Ozren/0000-0002-5765-1862; Brüning, Thomas/0000-0001-9560-5464; Jones, Samuel/0000-0003-0153-922X; Knight, Julia/0000-0002-7610-7635; Wilson, James F/0000-0001-5751-9178; Chenevix-Trench, Georgia/0000-0002-1878-2587; Haviv, Izhak/0000-0002-0837-5005; Kriebel, Jennifer/0000-0003-4270-018X; Jakubowska, Anna/0000-0002-5650-0501; Figueroa, Jonine/0000-0002-5100-623X; Pharoah, Paul/0000-0001-8494-732X; Peterlongo, Paolo/0000-0001-6951-6855; Teumer, Alexander/0000-0002-8309-094X; Vuckovic, Dragana/0000-0001-9343-6142; Cox, Angela/0000-0002-5138-1099; Pylkas, Katri/0000-0002-2449-0521; vozzi, diego/0000-0002-2902-8184; Morrison, Alanna/0000-0001-6381-4296; Lunetta, Kathryn/0000-0002-9268-810X; Giles, Graham/0000-0003-4946-9099; Bojesen, Stig/0000-0002-4061-4133; Campbell, Archie/0000-0003-0198-5078; Eeles, Rosalind/0000-0002-3698-6241; Girotto, Giorgia/0000-0003-4507-6589; Faul, Jessica/0000-0002-6969-6478; Pirastu, Nicola/0000-0002-5363-3886; Padmanabhan, Sandosh/0000-0003-3869-5808; Demerath, Ellen/0000-0002-4585-4064; Gasparini, Paolo/0000-0002-0859-0856; Bergmann, Sven/0000-0002-6785-9034; Dunning, Alison Margaret/0000-0001-6651-7166; Marten, Jonathan/0000-0001-6916-2014; Murray, Anna/0000-0002-2351-2522; Turner, Stephen/0000-0002-1002-0000; Thorne, Heather/0000-0003-3610-2511; Swerdlow, Anthony/0000-0001-5550-4159; batra, Jyotsna/0000-0003-4646-6247; Southey, Melissa/0000-0002-6313-9005; Winqvist, Robert/0000-0003-0932-9104; Durocher, Francine/0000-0001-8012-4641; Van Duijn, Cornelia/0000-0002-2374-9204; Amin, Najaf/0000-0002-8944-1771; Gieger, Christian/0000-0001-6986-9554; Blomqvist, Carl/0000-0003-3041-1938; Nordestgaard, Borge/0000-0002-1954-7220; Margolin, Sara/0000-0002-5526-5570; Devilee, Peter/0000-0002-8023-2009; dos Santos Silva, Isabel/0000-0002-6596-8798; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; Brauch, Hiltrud/0000-0001-7531-2736; Lubinski, Jan/0000-0003-2931-3003; Robino, Antonietta/0000-0003-2152-2353; benitez, javier/0000-0002-0923-7202; Simard, Jacques/0000-0001-6906-3390; Karasik, David/0000-0002-8826-0530; Kraft, Peter/0000-0002-4472-8103; Schmidt, Frank/0000-0001-5406-3988; Ewing, Ailith/0000-0002-2272-1277; Hocking, Lynne J/0000-0002-2414-2826; NUTILE, TERESA/0000-0001-7062-8352; Schoemaker, Minouk/0000-0001-8403-2234; Tryggvadottir, Laufey/0000-0001-8067-9030; De Vivo, Immaculata/0000-0002-7185-7402; Smith, Jennifer Ann/0000-0002-3575-5468; Willemsen, Gonneke/0000-0003-3755-0236; Yannoukakos, Drakoulis/0000-0001-7509-3510; Smith, Albert Vernon/0000-0003-1942-5845; Boutin, Thibaud/0000-0003-4754-1675; Magi, Reedik/0000-0002-2964-6011; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Day, Felix/0000-0003-3789-7651	Cancer Research UK [16561, 16459, 16565, 15007, 16563, 17528] Funding Source: researchfish; Medical Research Council [1233641, MC_PC_13048] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51, NF-SI-0514-10027, NF-SI-0512-10135] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; Cancer Foundation Finland sr [130168] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085082, N01HC055222, N01HC085080, N01HC095160, N01HC025195, N01HC085083, N01HC085081, N01HC095159, N01HC085079, N01HC095161, N01HC085086] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U19CA148112, UM1CA164920, U01CA164920, UM1CA182913, ZIACP010126, P30CA015704, R01CA128978, UM1CA182910, U19CA148537, U19CA148065] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR000124, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084756, U01HL072515, U10HL054457, R01HL105756, R01HL080467, R01HL064278, R01HL087652, R01HL043851, R01HL059367, R01HL080295, U01HL054457, R01HL087660, RC2HL102419, U01HL080295, K01HL116770, U01HL054464, R01HL119443, R01HL087641, U10HL054464, U01HL054481, U10HL054481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005581, U01HG006513, U01HG004402, RC2HG005552, R01HG007022, R01HG007089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787, P30DK072488, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032598, R01AG032098, N01AG012111, R01AG023629, ZIAAG000675, U01AG009740, N01AG062101, RC4AG039029, R56AG023629, R01AG029451, N01AG062106, RC2AG036495, N01AG062103] Funding Source: NIH RePORTER; Cancer Research UK [C1287/A 10710, C1287/A10118, C8197/A16565, 10124, C5047/A8384, 11174, C5047/A10692, C1281/A12014, C12292/A11174, C5047/A15007] Funding Source: Medline; Medical Research Council [MC_UU_12015/1, MC_UU_12015/2, MC_U106179472, MC_PC_U127561128, MC_U106179471] Funding Source: Medline; NCATS NIH HHS [UL1 TR001108, UL1TR000124, UL1 TR000124] Funding Source: Medline; NCI NIH HHS [1U19 CA148112, 1U19 CA148065, CA128978, 1U19 CA148537, CA164920, UM1 CA182910, UM1 CA182913, P30 CA015704] Funding Source: Medline; NCRR NIH HHS [UL1RR025005] Funding Source: Medline; NHGRI NIH HHS [HG006513, HG005552, HG005581, HG007089, HHSN268200782096C, U01HG004402, HG007022] Funding Source: Medline; NHLBI NIH HHS [N01-HC-95161, HHSN268201200036C, HL080295, R01 HL119443, HHSN268201100010C, HL087652, N01-HC-95159, K01-HL116770, N01HC85083, R01 HL087660, HL105756, HHSN268201100009C, U01-HL72515, N01HC85086, HHSN268201100007C, N01HC85082, U01-HL84756, R01HL59367, HHSN268201100006C, HL054457, N01HC55222, N02-HL-6-4278, N01-HC-25195, HL054481, N01-HC-95160, HL043851, 5RC2HL102419, N01HC85080, HL087660, HL054464, R01HL087641, HHSN268201100012C, HHSN268201100008C, N01HC85079, HHSN268201100005C, N01HC85081, HHSN268200800007C, HL080467, HHSN268201100011C, HHSN268201100046C] Funding Source: Medline; NIA NIH HHS [R21 AG032598, AG009740, N01AG62103, N01AG62106, N.1-AG-1-2111, 1R01AG032098-01A1, R21AG032598, R01AG29451, HHSN271201100004C, RC2 AG036495, AG023629, U01 AG009740, RC4 AG039029, N01-AG-1-2109, N.1-AG-1-1, N01-AG-5-0002, N01AG62101, U01AG009740] Funding Source: Medline; NIDA NIH HHS [HHSN271201100005C] Funding Source: Medline; NIDDK NIH HHS [DK063491, P30 DK063491, R01DK075787, P30 DK072488, P30-DK072488] Funding Source: Medline; PHS HHS [HHSN268200960009C, R01-088119, HHSN268200625226C] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline; WHI NIH HHS [HHSN268201100002C, HHSN268201100001C, HHSN268201100003C, HHSN268201100004C] Funding Source: Medline; Chief Scientist Office [CZD/16/6/4] Funding Source: Medline; MRC [MC_PC_U127561128, MC_UU_12015/1, MC_UU_12015/2, MC_U106179472] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; National Breast Cancer Foundation; Chief Scientist Office; Cancer Foundation Finland sr; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); WHI NIH HHS; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AlAsiri S, 2015, J CLIN INVEST, V125, P258, DOI 10.1172/JCI78473; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Collins IM, 2013, J CLIN ONCOL, V31, P3920, DOI 10.1200/JCO.2013.49.3007; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Garcia-Ortega J, 2014, HUM REPROD, V29, P2736, DOI 10.1093/humrep/deu247; Gaytan F, 2014, ENDOCRINOLOGY, V155, P3088, DOI 10.1210/en.2014-1110; Ghoussaini M, 2013, AM J PATHOL, V183, P1038, DOI 10.1016/j.ajpath.2013.07.003; Guler GD, 2012, J BIOL CHEM, V287, P6469, DOI 10.1074/jbc.M111.324582; Hartge P, 2009, NAT GENET, V41, P637, DOI 10.1038/ng0609-637; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lambalk CB, 2009, MATURITAS, V63, P280, DOI 10.1016/j.maturitas.2009.06.007; Levy-Lahad E, 2007, BRIT J CANCER, V96, P11, DOI 10.1038/sj.bjc.6603535; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Mandon-Pepin B, 2008, EUR J ENDOCRINOL, V158, P107, DOI 10.1530/EJE-07-0400; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Monteiro ANA, 2013, J INTERN MED, V274, P414, DOI 10.1111/joim.12085; Morris DH, 2012, AM J EPIDEMIOL, V175, P998, DOI 10.1093/aje/kwr447; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Oktem O, 2008, ANN NY ACAD SCI, V1127, P1, DOI 10.1196/annals.1434.009; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Perry JRB, 2014, HUM MOL GENET, V23, P2490, DOI 10.1093/hmg/ddt620; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rance NE, 2009, PEPTIDES, V30, P111, DOI 10.1016/j.peptides.2008.05.016; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Silveira LFG, 2013, J CLIN ENDOCR METAB, V98, P1781, DOI 10.1210/jc.2012-3550; Simandlova J, 2013, J BIOL CHEM, V288, P34168, DOI 10.1074/jbc.M113.484493; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Tsutsui Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004542; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5; Weischer M, 2008, J CLIN ONCOL, V26, P542, DOI 10.1200/JCO.2007.12.5922; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood-Trageser MA, 2014, AM J HUM GENET, V95, P754, DOI 10.1016/j.ajhg.2014.11.002; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532; Zhou Jin J, 2014, BMC Proc, V8, pS33, DOI 10.1186/1753-6561-8-S1-S33	60	215	219	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1294	+		10.1038/ng.3412	http://dx.doi.org/10.1038/ng.3412			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26414677	Green Accepted, Green Submitted			2022-12-25	WOS:000363988200013
J	Janes, H; Herbeck, JT; Tovanabutra, S; Thomas, R; Frahm, N; Duerr, A; Hural, J; Corey, L; Self, SG; Buchbinder, SP; McElrath, MJ; O'Connell, RJ; Paris, RM; Rerks-Ngarm, S; Nitayaphan, S; Pitisuttihum, P; Kaewkungwal, J; Robb, ML; Michael, NL; Mullins, JI; Kim, JH; Gilbert, PB; Rolland, M				Janes, Holly; Herbeck, Joshua T.; Tovanabutra, Sodsai; Thomas, Rasmi; Frahm, Nicole; Duerr, Ann; Hural, John; Corey, Lawrence; Self, Steve G.; Buchbinder, Susan P.; McElrath, M. Juliana; O'Connell, Robert J.; Paris, Robert M.; Rerks-Ngarm, Supachai; Nitayaphan, Sorachai; Pitisuttihum, Punnee; Kaewkungwal, Jaranit; Robb, Merlin L.; Michael, Nelson L.; Mullins, James I.; Kim, Jerome H.; Gilbert, Peter B.; Rolland, Morgane			HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders	NATURE MEDICINE			English	Article							DISEASE PROGRESSION; VACCINE EFFICACY; VIRUS; TRIAL; DIVERSITY; VARIANTS; AIDSVAX; ALVAC; STEP	Given the variation in the HIV-1 viral load (VL) set point across subjects, as opposed to a fairly stable VL over time within an infected individual, it is important to identify the characteristics of the host and virus that affect VL set point. Although recently infected individuals with multiple phylogenetically linked HIV-1 founder variants represent a minority of HIV-1 infections, we found-in two different cohorts-that more diverse HIV-1 populations in early infection were associated with significantly higher VL 1 year after HIV-1 diagnosis.	[Janes, Holly; Frahm, Nicole; Duerr, Ann; Hural, John; Corey, Lawrence; Self, Steve G.; Buchbinder, Susan P.; McElrath, M. Juliana; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Herbeck, Joshua T.; Frahm, Nicole; McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Tovanabutra, Sodsai; Thomas, Rasmi; Paris, Robert M.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Rolland, Morgane] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Tovanabutra, Sodsai; Thomas, Rasmi; Robb, Merlin L.; Rolland, Morgane] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA USA; [McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [O'Connell, Robert J.; Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Royal Thai Army Component, Bangkok 10400, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Nonthaburi, Thailand; [Pitisuttihum, Punnee; Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Mahidol University; University of Washington; University of Washington Seattle	Rolland, M (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.	mrolland@hivresearch.org	Corey, Lawrence/AAE-1796-2020; Thomas, Rasmi/AAI-4921-2020	Corey, Lawrence/0000-0002-2179-2436; Kaewkungwal, Jaranit/0000-0001-7916-8460	National Institute of Allergy and Infectious Diseases: US Public Health Service [AI41505]; US Army Medical Research and Material Command [Y1-AI-2642-12]; US National Institutes of Health (NIH) [2R37AI05465-10]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; US Department of Defense [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, UM1AI068618, R37AI054165, N01AI002642, UM1AI068614] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases: US Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the participants in the Step study and the RV144 trial for their contributions to this research and Lisa Reilly for editorial help. Sequencing and analysis were performed under grants from the National Institute of Allergy and Infectious Diseases: US Public Health Service grant AI41505; Interagency Agreement Y1-AI-2642-12 with the US Army Medical Research and Material Command; US National Institutes of Health (NIH) grant 2R37AI05465-10 to P.B.G. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the US Department of Defense. The opinions expressed herein are those of the authors and should not be construed as official or representing the views of the US Department of Defense or the Department of the Army. This does not alter our adherence to policies on sharing data and materials.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Edlefsen PT, 2013, CURR OPIN HIV AIDS, V8, P432, DOI 10.1097/COH.0b013e328362db2b; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Hodcroft E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004112; Janes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043396; Jost S., 2002, 9 C RETR OPP INF SEA; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prentice HA, 2014, IMMUNOGENETICS, V66, P299, DOI 10.1007/s00251-014-0765-6; Rerks-Ngarm S, 2013, J INFECT DIS, V207, P1195, DOI 10.1093/infdis/jis478; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003	22	29	31	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1139	+		10.1038/nm.3932	http://dx.doi.org/10.1038/nm.3932			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26322580	Green Accepted			2022-12-25	WOS:000362355400014
J	Kleiner, RE; Verma, P; Molloy, KR; Chait, BT; Kapoor, TM				Kleiner, Ralph E.; Verma, Priyanka; Molloy, Kelly R.; Chait, Brian T.; Kapoor, Tarun M.			Chemical proteomics reveals a gamma H2AX-53BP1 interaction in the DNA damage response	NATURE CHEMICAL BIOLOGY			English	Article							BRCT DOMAIN; GENOMIC STABILITY; HISTONE H2AX; 53BP1; CHECKPOINT; BINDING; REPAIR; UBIQUITIN; BREAKS; PHOSPHORYLATION	DNA double-strand break repair involves phosphorylation of histone variant H2AX ('gamma H2AX'), which accumulates in foci at sites of DNA damage. In current models, the recruitment of multiple DNA repair proteins to gamma H2AX foci depends mainly on recognition of this 'mark' by a single protein, MDC1. However, DNA repair proteins accumulate at gH2AX sites without MDC1, suggesting that other 'readers' of this mark exist. Here, we use a quantitative chemical proteomics approach to profile direct, phospho-selective gamma H2AX binders in native proteomes. We identify gamma H2AX binders, including the DNA repair mediator 53BP1, which we show recognizes gamma H2AX through its BRCT domains. Furthermore, we investigate the targeting of wild-type 53BP1, or a mutant form deficient in gamma H2AX binding, to chromosomal breaks resulting from endogenous and exogenous DNA damage. Our results show how direct recognition of gamma H2AX modulates protein localization at DNA damage sites, and suggest how specific chromatin mark-reader interactions contribute to essential mechanisms ensuring genome stability.	[Kleiner, Ralph E.; Verma, Priyanka; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; [Molloy, Kelly R.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Kleiner, RE (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	kapoor@rockefeller.edu			US National Institutes of Health [GM98579, P41 GM103314, GM109824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM109824, R01GM098579, P41GM103314] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to T. de Lange for the generous gift of 53BP1- and MDC1-deficient MEFs and for helpful discussions. We thank F. Lottersberger for advice and assistance with DNA damage assays. We thank S. Jackson for graciously providing a plasmid encoding MDC1-BRCT cDNA. Live-cell imaging was performed at the Rockefeller University Bio-Imaging Resource Center. We thank P. Ariel for technical assistance with laser scissors. Peptide synthesis was performed by the Rockefeller University Proteomics Resource Center. We thank R. Pisa for assistance with peptide probe synthesis and E. Foley for assistance with pilot experiments. R.E.K. is the Miles S. Nadal Fellow of the Damon Runyon Cancer Research Foundation (DRG-2118-12). The authors acknowledge support from the US National Institutes of Health (GM98579 to T.M.K. and P41 GM103314 and GM109824 to B.T.C.).	Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cotsiki M, 2004, P NATL ACAD SCI USA, V101, P947, DOI 10.1073/pnas.0308006100; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Hu B, 2014, NUCLEIC ACIDS RES, V42, P5582, DOI 10.1093/nar/gku230; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li X, 2013, PROTEIN SCI, V22, P287, DOI 10.1002/pro.2210; Li X, 2012, J AM CHEM SOC, V134, P1982, DOI 10.1021/ja210528v; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Murray JM, 2012, BIOCHEM SOC T, V40, P173, DOI 10.1042/BST20110631; Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sanders SL, 2010, MOL CELL BIOL, V30, P4722, DOI 10.1128/MCB.00404-10; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Spycher C., J CELL BIOL, V181; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Yang YY, 2010, CHEM BIOL, V17, P1212, DOI 10.1016/j.chembiol.2010.09.012; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	51	64	66	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					807	+		10.1038/NCHEMBIO.1908	http://dx.doi.org/10.1038/NCHEMBIO.1908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26344695	Green Accepted			2022-12-25	WOS:000361536500014
J	Dankbar, B; Fennen, M; Brunert, D; Hayer, S; Frank, S; Wehmeyer, C; Beckmann, D; Paruzel, P; Bertrand, J; Redlich, K; Koers-Wunrau, C; Stratis, A; Korb-Pap, A; Pap, T				Dankbar, Berno; Fennen, Michelle; Brunert, Daniela; Hayer, Silvia; Frank, Svetlana; Wehmeyer, Corinna; Beckmann, Denise; Paruzel, Peter; Bertrand, Jessica; Redlich, Kurt; Koers-Wunrau, Christina; Stratis, Athanasios; Korb-Pap, Adelheid; Pap, Thomas			Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; BONE-RESORPTION; ACTIVIN-A; KAPPA-B; EXPRESSION; CELLS; RECEPTORS; KNOCKOUT; REGENERATION; STIMULATION	Myostatin (also known as growth and differentiation factor 8) is a secreted member of the transforming growth factor-beta (TGF-beta) family that is mainly expressed in skeletal muscle, which is also its primary target tissue. Deletion of the myostatin gene (Mstn) in mice leads to muscle hypertrophy, and animal studies support the concept that myostatin is a negative regulator of muscle growth and regeneration(1-5). However, myostatin deficiency also increases bone formation, mainly through loading-associated effects on bone(6-11). Here we report a previously unknown direct role for myostatin in osteoclastogenesis and in the progressive loss of articular bone in rheumatoid arthritis (RA). We demonstrate that myostatin is highly expressed in the synovial tissues of RA subjects and of human tumor necrosis factor (TNF)-alpha transgenic (hTNFtg) mice, a model for human RA(12). Myostatin strongly accelerates receptor activator of nuclear factor kappa B ligand (RANKL)-mediated osteoclas-dependent regulation of nuclear factor of activated T-cells (NFATC1). Myostatin deficiency or antibody-mediated inhibition leads to an amelioration of arthritis severity in hTNFtg mice, chiefly reflected by less bone destruction. Consistent with these effects in hTNFtg mice, the lack of myostatin leads to increased grip strength and less bone erosion in the K/BxN serum-induced arthritis model in mice. The results strongly suggest that myostatin is a potent therapeutic target for interfering with osteoclast formation and joint destruction in RA.	[Dankbar, Berno; Fennen, Michelle; Brunert, Daniela; Frank, Svetlana; Wehmeyer, Corinna; Beckmann, Denise; Paruzel, Peter; Bertrand, Jessica; Koers-Wunrau, Christina; Stratis, Athanasios; Korb-Pap, Adelheid; Pap, Thomas] Univ Hosp Muenster, IEMM, Munster, Germany; [Hayer, Silvia; Redlich, Kurt] Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, Vienna, Austria	University of Munster; Medical University of Vienna	Pap, T (corresponding author), Univ Hosp Muenster, IEMM, Munster, Germany.	thomas.pap@uni-muenster.de		Bertrand, Jessica/0000-0001-9511-4999; Brunert, Daniela/0000-0003-2797-0528	German Research Foundation (Deutsche Forschungsgemeinschaft) [DA 1143/4-1, DA 1143/4-2, SPP 1468]; Collaborative Research Center [SFB 1009]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Collaborative Research Center	We thank S.-J. Lee (Johns Hopkins University School of Medicine) for providing us with the Mstn<SUP>-/-</SUP> mice, and G. Kollias (Alexander Fleming Biomedical Sciences Research Center) for the hTNF transgenic mice. We also thank Pfizer, Inc. for providing us with the myostatin-specific antibody. We thank X. Lin (Department of Surgery, Baylor College of Medicine) for providing us with the SMAD2 constructs. We thank V. Eckervogt and B. Truckenbrod for excellent technical support. This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft; DA 1143/4-1 and DA 1143/4-2 to B.D. and T.P. as part of the Priority Programme SPP 1468, IMMUNOBONE) and by the Collaborative Research Center SFB 1009 granted to T.P.	BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Bialek P, 2014, BONE, V60, P162, DOI 10.1016/j.bone.2013.12.002; Bradley L, 2008, CELL MOL LIFE SCI, V65, P2119, DOI 10.1007/s00018-008-8077-3; Fuller K, 2000, BIOCHEM BIOPH RES CO, V268, P2, DOI 10.1006/bbrc.2000.2075; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; Goldring SR, 2002, CURR OPIN RHEUMATOL, V14, P406, DOI 10.1097/00002281-200207000-00013; Hamrick MW, 2007, BONE, V40, P1544, DOI 10.1016/j.bone.2007.02.012; Hamrick MW, 2003, J ORTHOP RES, V21, P1025, DOI 10.1016/S0736-0266(03)00105-0; Hamrick MW, 2003, ANAT REC PART A, V272A, P388, DOI 10.1002/ar.a.10044; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kaneto H, 1999, KIDNEY INT, V56, P2137, DOI 10.1046/j.1523-1755.1999.00790.x; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kellum E, 2009, BONE, V44, P17, DOI 10.1016/j.bone.2008.08.126; Korb-Pap A, 2012, ANN RHEUM DIS, V71, P1004, DOI 10.1136/annrheumdis-2011-200386; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; Machida H, 2000, EUR J ENDOCRINOL, V143, P705, DOI 10.1530/eje.0.1430705; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Nicholson EK, 2006, ARCH ORAL BIOL, V51, P37, DOI 10.1016/j.archoralbio.2005.05.008; Omata Y, 2015, J BONE MINER RES, V30, P869, DOI 10.1002/jbmr.2418; Polzer K, 2010, ANN RHEUM DIS, V69, P284, DOI 10.1136/ard.2008.104786; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Scott DL, 2000, RHEUMATOLOGY, V39, P122, DOI 10.1093/rheumatology/39.2.122; Sugatani T, 2003, J CELL BIOCHEM, V90, P59, DOI 10.1002/jcb.10613; Suzuki Y, 1998, J RHEUMATOL, V25, P1154; Tani-Ishii N, 1999, J DENT RES, V78, P1617, DOI 10.1177/00220345990780100601; Tsuboi H, 2003, ANN RHEUM DIS, V62, P196, DOI 10.1136/ard.62.3.196; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x	41	136	144	5	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1085	+		10.1038/nm.3917	http://dx.doi.org/10.1038/nm.3917			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26236992				2022-12-25	WOS:000360961300023
J	Maitre, JL; Niwayama, R; Turlier, H; Nedelec, F; Hiiragi, T				Maitre, Jean-Leon; Niwayama, Ritsuya; Turlier, Herve; Nedelec, Francois; Hiiragi, Takashi			Pulsatile cell-autonomous contractility drives compaction in the mouse embryo	NATURE CELL BIOLOGY			English	Article							SURFACE; MYOSIN; PROTEIN; ORGANIZATION	Mammalian embryos initiate morphogenesis with compaction, which is essential for specifying the first lineages of the blastocyst. The 8-cell-stage mouse embryo compacts by enlarging its cell-cell contacts in a Cdh1-dependent manner. It was therefore proposed that Cdh1 adhesion molecules generate the forces driving compaction. Using micropipette aspiration to map all tensions in a developing embryo, we show that compaction is primarily driven by a twofold increase in tension at the cell-medium interface. We show that the principal force generator of compaction is the actomyosin cortex, which gives rise to pulsed contractions starting at the 8-cell stage. Remarkably, contractions emerge as periodic cortical waves when cells are disengaged from adhesive contacts. In line with this, tension mapping of mzCdh1(-/-) embryos suggests that Cdh1 acts by redirecting contractility away from cell-cell contacts. Our study provides a framework to understand early mammalian embryogenesis and original perspectives on evolutionary conserved pulsed contractions.	[Maitre, Jean-Leon; Niwayama, Ritsuya; Turlier, Herve; Nedelec, Francois; Hiiragi, Takashi] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Maitre, JL (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	maitre@embl.de; hiiragi@embl.de	Turlier, Hervé/Y-7600-2019; Nedelec, Francois/AAC-1673-2019; Maître, Jean-Léon/C-4372-2017; Nedelec, Francois J/H-3317-2011	Turlier, Hervé/0000-0002-9332-9125; Nedelec, Francois/0000-0002-8141-5288; Maître, Jean-Léon/0000-0002-3688-1474; Nedelec, Francois J/0000-0002-8141-5288; Hiiragi, Takashi/0000-0003-4964-7203	EMBO [ALTF1195-2012]; HumboldtStiftung [JAN-1149654-STP-2]; EIPOD; Hiiragi group by VolkswagenStiftung	EMBO(European Molecular Biology Organization (EMBO)); HumboldtStiftung; EIPOD; Hiiragi group by VolkswagenStiftung	We are grateful to all members of the Hiiragi laboratory and EMBL animal facility for their support. We thank J. E. Dietrich for providing images used for volume measurement. We thank A. G. Clark, A. Aulehla and C-P. Heisenberg for comments on an earlier version of the manuscript. J-L.M. is supported by EMBO (ALTF1195-2012), R.N. by HumboldtStiftung (JAN-1149654-STP-2), H.T. by EIPOD, and the Hiiragi group by VolkswagenStiftung.	[Anonymous], 2011, PRINCIPLES DEV; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Clark AG, 2014, CURR BIOL, V24, pR484, DOI 10.1016/j.cub.2014.03.059; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; DUCIBELLA T, 1977, J CELL BIOL, V74, P153, DOI 10.1083/jcb.74.1.153; Fierro-Gonzalez JC, 2013, NAT CELL BIOL, V15, P1424, DOI 10.1038/ncb2875; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; GOEL NS, 1986, B MATH BIOL, V48, P167, DOI 10.1016/S0092-8240(86)80005-2; HYAFIL F, 1980, CELL, V21, P927, DOI 10.1016/0092-8674(80)90456-0; JOHNSON MH, 1979, J EMBRYOL EXP MORPH, V54, P241; Kawai Y, 2002, BIOL PHARM BULL, V25, P179, DOI 10.1248/bpb.25.179; KEMLER R, 1977, P NATL ACAD SCI USA, V74, P4449, DOI 10.1073/pnas.74.10.4449; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Maitre JL, 2013, CURR BIOL, V23, pR626, DOI 10.1016/j.cub.2013.06.019; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; MITCHISON JM, 1954, J EXP BIOL, V31, P443; Ohsugi M, 1999, DEV DYNAM, V216, P168, DOI 10.1002/(SICI)1097-0177(199910)216:2<168::AID-DVDY7>3.0.CO;2-R; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; SOBEL JS, 1983, DEV BIOL, V95, P227, DOI 10.1016/0012-1606(83)90021-0; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; Stirbat TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052554; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; WINKEL GK, 1990, DEV BIOL, V138, P1, DOI 10.1016/0012-1606(90)90171-E; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; YEUNG A, 1989, BIOPHYS J, V56, P139, DOI 10.1016/S0006-3495(89)82659-1	30	170	172	4	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					849	855		10.1038/ncb3185	http://dx.doi.org/10.1038/ncb3185			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26075357				2022-12-25	WOS:000357353400006
J	Pallett, LJ; Gill, US; Quaglia, A; Sinclair, LV; Jover-Cobos, M; Schurich, A; Singh, KP; Thomas, N; Das, A; Chen, A; Fusai, G; Bertoletti, A; Cantrell, DA; Kennedy, PT; Davies, NA; Haniffa, M; Maini, MK				Pallett, Laura J.; Gill, Upkar S.; Quaglia, Alberto; Sinclair, Linda V.; Jover-Cobos, Maria; Schurich, Anna; Singh, Kasha P.; Thomas, Nidas; Das, Abhishek; Chen, Antony; Fusai, Giuseppe; Bertoletti, Antonio; Cantrell, Doreen A.; Kennedy, Patrick T.; Davies, Nathan A.; Haniffa, Muzlifah; Maini, Mala K.			Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells	NATURE MEDICINE			English	Article							T-CELL; VIRUS-INFECTION; ARGININE AVAILABILITY; STELLATE CELLS; LIVER-DAMAGE; BONE-MARROW; ARGINASE-I; DIFFERENTIATION; MICROENVIRONMENT; GRANULOCYTES	Infection with hepatitis B virus (HBV) results in disparate degrees of tissue injury: the virus can either replicate without pathological consequences or trigger immune-mediated necroinflammatory liver damage. We investigated the potential for myeloid-derived suppressor cells (MDSCs) to suppress T cell mediated immunopathology in this setting. Granulocytic MDSCs (gMDSCs) expanded transiently in acute resolving HBV, decreasing in frequency prior to peak hepatic injury. In persistent infection, arginase-expressing gMDSCs (and circulating arginase) increased most in disease phases characterized by HBV replication without immunopathology, whilst L-arginine decreased. gMDSCs expressed liver-homing chemokine receptors and accumulated in the liver, their expansion supported by hepatic stellate cells. We provide in vitro and ex vivo evidence that gMDSCs potently inhibited T cells in a partially arginase-dependent manner. L-arginine deprived T cells upregulated system L amino acid transporters to increase uptake of essential nutrients and attempt metabolic reprogramming. These data demonstrate the capacity of expanded arginase-expressing gMDSCs to regulate liver immunopathology in HBV infection.	[Pallett, Laura J.; Schurich, Anna; Singh, Kasha P.; Thomas, Nidas; Das, Abhishek; Chen, Antony; Maini, Mala K.] UCL, Inst Immun & Transplantat, Div Infect & Immun, London, England; [Gill, Upkar S.; Kennedy, Patrick T.] Barts & London Queen Marys Sch Med & Dent, Ctr Digest Dis, Blizard Inst, London, England; [Quaglia, Alberto] Kings Coll Hosp London, Inst Liver Studies, London, England; [Sinclair, Linda V.; Cantrell, Doreen A.] Univ Dundee, Div Cell Signaling & Immunol, Dundee, Scotland; [Jover-Cobos, Maria; Fusai, Giuseppe; Davies, Nathan A.] UCL, Inst Liver & Digest Hlth, London, England; [Bertoletti, Antonio] Duke Nus Med Sch, Emerging Infect Dis Program, Singapore, Singapore; [Bertoletti, Antonio; Haniffa, Muzlifah] Agcy Sci & Technol, Singapore Inst Clin Sci, Singapore, Singapore; [Haniffa, Muzlifah] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of London; University College London; University of London; Queen Mary University London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Dundee; University of London; University College London; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Newcastle University - UK	Maini, MK (corresponding author), UCL, Inst Immun & Transplantat, Div Infect & Immun, London, England.	m.maini@ucl.ac.uk	Bertoletti, Antonio/AAD-4830-2022	Bertoletti, Antonio/0000-0002-2942-0485; Schurich, Anna/0000-0002-2525-3114; Singh, Kasha/0000-0002-5199-9331; Maini, Mala/0000-0001-6384-1462; Das, Abhishek/0000-0002-8798-035X; /0000-0002-4161-9462	UK Medical Research Council [G0801213]; UK Medical Research Council; Medical Research Council/AStar [G0901374]; Wellcome Trust [101849/Z/13/Z, 097418/Z/11/Z]; National Health and Medical Research Council; London Charity [723/1795]; MRC [G0801213, G0901374, MR/M020126/1] Funding Source: UKRI; Medical Research Council [G0901374, MR/M020126/1, G0801213, 1023710] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council/AStar(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); London Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by UK Medical Research Council grant G0801213 to M.K.M., a UK Medical Research Council studentship to L.J.P., Medical Research Council/AStar grant G0901374 to M.K.M. and A.B., a Wellcome Trust Senior Investigator Award (no. 101849/Z/13/Z) to M.K.M., a National Health and Medical Research Council Postgraduate Research Scholarship to K.P.S., a Wellcome Trust grant 097418/Z/11/Z to D.A.C. and The London Charity (723/1795) to P.T.K. We thank P. Kropf for advice on the assessment of gMDSC arginase I release, R. Milne, E. Nastouli, and the Clinical Virology Departments at University College Hospital and the Royal Free Hospital for CMV serology and HBsAg quantification, and O. Pop and C. Starling for assistance with immunostaining. We are very grateful to all patients and control volunteers who participated in this study and to clinical staff who helped with participant recruitment and monitoring.	Bertoletti A, 2000, CURR OPIN IMMUNOL, V12, P403, DOI 10.1016/S0952-7915(00)00108-4; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Campbell WA, 2000, J BIOL CHEM, V275, P5347, DOI 10.1074/jbc.275.8.5347; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; CHISARI FV, 1985, HEPATOLOGY, V5, P735, DOI 10.1002/hep.1840050506; Chou HS, 2011, HEPATOLOGY, V53, P1007, DOI 10.1002/hep.24162; CHU CM, 1993, CLIN INFECT DIS, V16, P709, DOI 10.1093/clind/16.5.709; Cloke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048939; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Das A, 2008, J EXP MED, V205, P2111, DOI 10.1084/jem.20072076; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; FOLLEY SJ, 1948, BIOCHEM J, V43, P537, DOI 10.1042/bj0430537; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hayashi K, 2013, J IMMUNOL, V191, P4080, DOI 10.4049/jimmunol.1300923; Hochst B, 2013, J HEPATOL, V59, P528, DOI 10.1016/j.jhep.2013.04.033; Ikemoto M, 2001, CLIN BIOCHEM, V34, P455, DOI 10.1016/S0009-9120(01)00254-5; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009; Kong XH, 2014, J IMMUNOL, V193, P1645, DOI 10.4049/jimmunol.1303432; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Mieulet V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000934; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Norris BA, 2013, IMMUNITY, V38, P309, DOI 10.1016/j.immuni.2012.10.022; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Poll MCGND, 2008, CLIN SCI, V114, P231, DOI 10.1042/CS20070143; Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Rotondo R, 2011, J LEUKOCYTE BIOL, V89, P721, DOI 10.1189/jlb.1109737; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Sandalova E, 2012, GASTROENTEROLOGY, V143, P78, DOI 10.1053/j.gastro.2012.03.041; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; SCHUMACHER K, 1974, NATURE, V251, P655, DOI 10.1038/251655a0; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sitia G, 2004, J CLIN INVEST, V113, P1158, DOI 10.1172/JCI200421087; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f; Walker LJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00223; Zhao WX, 2014, LAB INVEST, V94, P182, DOI 10.1038/labinvest.2013.139	49	173	181	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					591	600		10.1038/nm.3856	http://dx.doi.org/10.1038/nm.3856			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25962123	Green Accepted, Green Submitted			2022-12-25	WOS:000355778300015
J	Schiffer, M; Teng, BN; Gu, C; Shchedrina, VA; Kasaikina, M; Pham, VA; Hanke, N; Rong, S; Gueler, F; Schroder, P; Tossidou, I; Park, JK; Staggs, L; Haller, H; Erschow, S; Hilfiker-Kleiner, D; Wei, CL; Chen, C; Tardi, N; Hakroush, S; Selig, MK; Vasilyev, A; Merscher, S; Reiser, J; Sever, S				Schiffer, Mario; Teng, Beina; Gu, Changkyu; Shchedrina, Valentina A.; Kasaikina, Marina; Pham, Vincent A.; Hanke, Nils; Rong, Song; Gueler, Faikah; Schroder, Patricia; Tossidou, Irini; Park, Joon-Keun; Staggs, Lynne; Haller, Hermann; Erschow, Sergej; Hilfiker-Kleiner, Denise; Wei, Changli; Chen, Chuang; Tardi, Nicholas; Hakroush, Samy; Selig, Martin K.; Vasilyev, Aleksandr; Merscher, Sandra; Reiser, Jochen; Sever, Sanja			Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models	NATURE MEDICINE			English	Article							KINASE-C-EPSILON; SLIT DIAPHRAGM; GLOMERULAR BARRIER; PODOCYTE BIOLOGY; GTPASE ACTIVITY; NEPHRIN; ALPHA-ACTININ-4; PATHOGENESIS; PROTEINURIA; ENDOPHILIN	Dysregulation of the actin cytoskeleton in podocytes represents a common pathway in the pathogenesis of proteinuria across a spectrum of chronic kidney diseases (CKD). The GTPase dynamin has been implicated in the maintenance of cellular architecture in podocytes through its direct interaction with actin. Furthermore, the propensity of dynamin to oligomerize into higher-order structures in an actin-dependent manner and to cross-link actin microfilaments into higher-order structures has been correlated with increased actin polymerization and global organization of the actin cytoskeleton in the cell. We found that use of the small molecule Bis-T-23, which promotes actin-dependent dynamin oligomerization and thus increased actin polymerization in injured podocytes, was sufficient to improve renal health in diverse models of both transient kidney disease and CKD. In particular, administration of Bis-T-23 in these renal disease models restored the normal ultrastructure of podocyte foot processes, lowered proteinuria, lowered collagen IV deposits in the mesangial matrix, diminished mesangial matrix expansion and extended lifespan. These results further establish that alterations in the actin cytoskeleton of kidney podocytes is a common hallmark of CKD, while also underscoring the substantial regenerative potential of injured glomeruli and identifying the oligomerization cycle of dynamin as an attractive potential therapeutic target to treat CKD.	[Schiffer, Mario; Teng, Beina; Hanke, Nils; Rong, Song; Gueler, Faikah; Schroder, Patricia; Tossidou, Irini; Park, Joon-Keun; Staggs, Lynne; Haller, Hermann] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Schiffer, Mario; Schroder, Patricia; Staggs, Lynne; Haller, Hermann] Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; [Gu, Changkyu; Shchedrina, Valentina A.; Kasaikina, Marina; Pham, Vincent A.; Sever, Sanja] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Gu, Changkyu; Shchedrina, Valentina A.; Kasaikina, Marina; Pham, Vincent A.; Sever, Sanja] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Erschow, Sergej; Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol, Hannover, Germany; [Wei, Changli; Chen, Chuang; Tardi, Nicholas; Reiser, Jochen] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Hakroush, Samy] Univ Med Ctr Gottingen, Dept Pathol, Gottingen, Germany; [Selig, Martin K.] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA USA; [Vasilyev, Aleksandr] NYIT, COM, Dept Biomed Sci, Old Westbury, NY USA; [Merscher, Sandra] Leonard M Miller Sch Med, Dept Med, Div Nephrol & Hypertens, Miami, FL USA	Hannover Medical School; Mount Desert Island Biological Laboratory; Harvard University; Harvard University; Massachusetts General Hospital; Hannover Medical School; Rush University; University of Gottingen; Harvard University; Massachusetts General Hospital; New York Institute Technology	Sever, S (corresponding author), Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA.	schiffer.mario@mh-hannover.de; ssever@partners.org	Pham, Vincent A/M-5351-2013; Schiffer, Mario/U-7050-2019; shchedrina, valentina a/B-8398-2015	Pham, Vincent A/0000-0001-7083-9360; Schiffer, Mario/0000-0002-8414-1470; shchedrina, valentina a/0000-0003-1627-982X; Merscher, Sandra/0000-0002-4757-7494; Hakroush, Samy/0000-0002-2843-3567; /0000-0001-9985-1515	National Institutes of Health [R01 DK093773, DK087985]; NephCure Foundation; Deutsche Forschungsgemeinschaft [SCHI587/3, SCHI587/4, SCHI587/6, REBIRTH 2]; Mount Desert Island Biological Laboratory; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073495, R01DK087985, R01DK093773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NephCure Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Mount Desert Island Biological Laboratory; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01 DK093773 and DK087985 to S.S.), the NephCure Foundation (S.S.), and Deutsche Forschungsgemeinschaft (SCHI587/3, 4,6 to M.S. and REBIRTH 2 to D.H.-K. and S.E.). N.H. is the recipient of the New Investigator Award from Mount Desert Island Biological Laboratory. The DNA encoding genes for PKC epsilon and mutant with impaired kinase activity were gifts from J.-W Soh, Inha University, Incheon, South Korea. Immortalized podocytes from ACTN4 mice, ACTN4 mice and morpholino to downregulate inf2 were gifts from M. Pollak, Beth Israel Deaconess Medical Center, Boston, MA. Tg (L-FABP:DBP-EGFP) and Tg (1-fabp:DBP-EGFP) zebrafish were gifts from J. Xie and B. Anand-Apte, Cleveland Clinic, Cleveland, OH. PKC epsilon<SUP>KO</SUP> mice were gifts from M. Leitges, University of Oslo, Oslo, Norway. CD2AP<SUP>KO</SUP> mice were gifts from A. Shaw, Washington University, St. Louis, MO.	Akita Y, 2008, FEBS J, V275, P3987, DOI 10.1111/j.1742-4658.2008.06555.x; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Boyer O, 2011, J AM SOC NEPHROL, V22, P239, DOI 10.1681/ASN.2010050518; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Byron A, 2014, J AM SOC NEPHROL, V25, P953, DOI 10.1681/ASN.2013070795; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Gibbs EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055888; Giganti Adeline, 2003, Prog Cell Cycle Res, V5, P511; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Graham ML, 2011, COMPARATIVE MED, V61, P356; Gu C, 2014, TRAFFIC, V15, P819, DOI 10.1111/tra.12178; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hanke N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/658270; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Henderson J, 2008, KIDNEY INT, V73, P741, DOI 10.1038/sj.ki.5002751; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hill T, 2005, J MED CHEM, V48, P7781, DOI 10.1021/jm040208l; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jefferson JA, 2011, AM J KIDNEY DIS, V58, P835, DOI 10.1053/j.ajkd.2011.03.033; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kirsch T, 2013, HYPERTENSION, V62, P726, DOI 10.1161/HYPERTENSIONAHA.113.01882; Meier M, 2007, J AM SOC NEPHROL, V18, P1190, DOI 10.1681/ASN.2005070694; Menon MC, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/749010; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; Ross JA, 2011, BIOPHYS J, V100, P729, DOI 10.1016/j.bpj.2010.12.3717; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Santin S, 2009, KIDNEY INT, V76, P1268, DOI 10.1038/ki.2009.381; Saran R, 2010, ADV CHRONIC KIDNEY D, V17, P271, DOI 10.1053/j.ackd.2010.03.001; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SEILER MW, 1977, LAB INVEST, V36, P48; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Sever S, 2013, TRAFFIC, V14, P1194, DOI 10.1111/tra.12116; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Tossidou I, 2010, J BIOL CHEM, V285, P25285, DOI 10.1074/jbc.M109.087239; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167	49	83	88	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					601	609		10.1038/nm.3843	http://dx.doi.org/10.1038/nm.3843			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25962121	Green Accepted, Green Submitted			2022-12-25	WOS:000355778300016
J	Liu, XM; Fu, YX				Liu, Xiaoming; Fu, Yun-Xin			Exploring population size changes using SNP frequency spectra	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BAYESIAN COALESCENT INFERENCE; WHOLE-GENOME SEQUENCES; DEMOGRAPHIC HISTORY; GENETIC-VARIATION; HUMAN-EVOLUTION; MULTIPLE LOCI; SKYLINE-PLOT; MUTATION; DYNAMICS	Inferring demographic history is an important task in population genetics. Many existing inference methods are based on predefined simplified population models, which are more suitable for hypothesis testing than exploratory analysis. We developed a novel model-flexible method called stairway plot, which infers changes in population size over time using SNP frequency spectra. This method is applicable for whole-genome sequences of hundreds of individuals. Using extensive simulation, we demonstrate the usefulness of the method for inferring demographic history, especially recent changes in population size. We apply the method to the whole-genome sequence data of 9 populations from the 1000 Genomes Project and show a pattern of fluctuations in human populations from 10,000 to 200,000 years ago.	[Liu, Xiaoming] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Fu, Yun-Xin] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Liu, XM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	xiaoming.liu@uth.tmc.edu	Liu, Xiaoming/C-2743-2008	Liu, Xiaoming/0000-0001-8285-5528	US National Institutes of Health [1U01HG005728, 2U54HG003273]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005728, U54HG003273] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge the Texas Advanced Computing Center (TACC; https://www.tacc.utexas.edu/) at the University of Texas at Austin for providing highperformance computing resources that have contributed to the research results reported within this paper. The authors acknowledge the 1000 Genomes Project Consortium for generating and providing the DNA sequence resources used in this study. The authors thank S. Barton for copyediting the manuscript. The authors thank S. Xu, Y. Guan, T.J. Maxwell, F. Yu and E. Boerwinkle for helpful discussions and encouragement. This study was supported by US National Institutes of Health grants 1U01HG005728 and 2U54HG003273.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Davidon WC, 1991, SIAM J OPTIMIZ, V1, P1, DOI 10.1137/0801001; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Gayral P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003457; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Liu XM, 2010, GENOME RES, V20, P101, DOI 10.1101/gr.097543.109; Matsumura S, 2008, P ROY SOC B-BIOL SCI, V275, P1501, DOI 10.1098/rspb.2007.1724; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Nielsen R, 2000, GENETICS, V154, P931; Opgen-Rhein R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-6; Palo JU, 2009, EUR J HUM GENET, V17, P1336, DOI 10.1038/ejhg.2009.53; Pedersen M. E. H., 2010, THESIS U SOUTHAMPTON; Polanski A, 2003, GENETICS, V165, P427; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pybus OG, 2000, GENETICS, V155, P1429; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776	46	204	206	8	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					555	U172		10.1038/ng.3254	http://dx.doi.org/10.1038/ng.3254			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25848749	Green Accepted			2022-12-25	WOS:000353635800022
J	Rama, N; Dubrac, A; Mathivet, T; Charthaigh, RAN; Genet, G; Cristofaro, B; Pibouin-Fragner, L; Ma, L; Eichmann, A; Chedotal, A				Rama, Nicolas; Dubrac, Alexandre; Mathivet, Thomas; Charthaigh, Roisin-Ana Ni; Genet, Gael; Cristofaro, Brunella; Pibouin-Fragner, Laurence; Ma, Le; Eichmann, Anne; Chedotal, Alain			Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization	NATURE MEDICINE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; AXON GUIDANCE; PATHOLOGICAL ANGIOGENESIS; INHIBITS ANGIOGENESIS; MACULAR DEGENERATION; CELL-MIGRATION; MIDLINE; EXPRESSION; RECEPTOR	Ocular neovascular diseases are a leading cause of blindness. Vascular endothelial growth factor (VEGF) blockade improves vision, but not all individuals respond to anti-VEGF treatment, making additional means to prevent neovascularization necessary. Slit-family proteins (Slits) are ligands of Roundabout (Robo) receptors that repel developing axons in the nervous system. Robo1 expression is altered in ocular neovascular diseases, and previous in vitro studies have reported both pro-and anti-angiogenic effects of Slits. However, genetic evidence supporting a role for Slits in ocular neovascularization is lacking. Here we generated conditional knockout mice deficient in various Slit and Robo proteins and found that Slit2 potently and selectively promoted angiogenesis via Robo1 and Robo2 in mouse postnatal retina and in a model of ocular neovascular disease. Mechanistically, Slit2 acting through Robo1 and Robo2 promoted the migration of endothelial cells. These receptors are required for both Slit2- and VEGF-induced Rac1 activation and lamellipodia formation. Thus, Slit2 blockade could potentially be used therapeutically to inhibit angiogenesis in individuals with ocular neovascular disease.	[Rama, Nicolas; Charthaigh, Roisin-Ana Ni; Chedotal, Alain] INSERM, Inst Vis, UMR S968, Paris, France; [Rama, Nicolas; Charthaigh, Roisin-Ana Ni; Chedotal, Alain] Univ Paris 06, Sorbonne Univ, Paris, France; [Rama, Nicolas; Charthaigh, Roisin-Ana Ni; Chedotal, Alain] CNRS, UMR 7210, Paris, France; [Dubrac, Alexandre; Genet, Gael; Eichmann, Anne] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Mathivet, Thomas; Cristofaro, Brunella; Pibouin-Fragner, Laurence; Eichmann, Anne] Coll France, CIRB, F-75231 Paris, France; [Ma, Le] Thomas Jefferson Univ, Dept Neurosci, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Eichmann, Anne] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Yale University; UDICE-French Research Universities; PSL Research University Paris; College de France; Jefferson University; Yale University	Chedotal, A (corresponding author), INSERM, Inst Vis, UMR S968, Paris, France.	anne.eichmann@yale.edu; alain.chedotal@inserm.fr	Ní Chárthaigh, Róisín-Ana/J-7529-2017; Dubrac, Alexandre/AAQ-9515-2021; Mathivet, Thomas/L-2663-2016; Chedotal, Alain/F-2750-2017	Ní Chárthaigh, Róisín-Ana/0000-0002-5688-3530; Dubrac, Alexandre/0000-0002-3829-2577; Chedotal, Alain/0000-0001-7577-3794; Rama, Nicolas/0000-0003-1614-7755; Ma, Le/0000-0003-2769-9416; GENET, Gael/0000-0003-0016-5887; Pibouin-Fragner, Laurence/0000-0001-5771-3958; Mathivet, Thomas/0000-0001-7761-1684	Agence Nationale de la Recherche (ANR) [ANR-11BSV102502]; Fondation pour la Recherche Medicale ("Programme Equipe FRM") [DEQ20120323700]; Sanofi-Fovea; Fondation Leducq (Artemis Transatlantic Network of Excellence); Thome Foundation for Age-Related Macular Degeneration; French state funds [ANR-11-IDEX-0004-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062047] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale ("Programme Equipe FRM"); Sanofi-Fovea; Fondation Leducq (Artemis Transatlantic Network of Excellence)(Leducq Foundation); Thome Foundation for Age-Related Macular Degeneration; French state funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by grants from the Agence Nationale de la Recherche (ANR; ANR-11BSV102502 to A.C. and A.E.), the Fondation pour la Recherche Medicale ("Programme Equipe FRM" to A. C.; DEQ20120323700), Sanofi-Fovea (to A. C.), Fondation Leducq (Artemis Transatlantic Network of Excellence, to A. E.) and the Thome Foundation for Age-Related Macular Degeneration (to A. E.). It was performed in the frame of the LABEX LIFESENSES (reference ANR-10-LABX-65), supported by French state funds managed by the ANR within the Investissements d'Avenir program under reference ANR-11-IDEX-0004-02. We thank F. Sennlaub for help with OIR experiments; J. Sahel and T. Debeir for helpful suggestions; Y. Zagar, M. Belle and C. Dominici for technical help; and K. Lyer for help with the initial phenotypic analysis. We also thank M. Tessier-Lavigne for the Slit1-and Slit2-knockout mice, J. Livet for the CAG: CreERTM mouse line and R. Adams for the Cdh5: CreERT2 mouse line. VEGF-A-AP constructs were provided by C. Ruiz de Almodovar (Vesalius Research Center, Leuven, Belgium). pGEX-PAK-CRIB was a kind gift from M. Schwartz (Yale University, New Haven, Connecticut, USA). The Slit2(lox) mutant mouse line was established at the Mouse Clinical Institute (Institut Clinique de la Souris, Strasbourg, France) in the Targeted Mutagenesis and Transgenesis Department.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Di Meglio T, 2008, J NEUROSCI, V28, P6285, DOI 10.1523/JNEUROSCI.0078-08.2008; Domyan ET, 2013, DEV CELL, V24, P52, DOI 10.1016/j.devcel.2012.11.018; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Fouquet C, 2007, J NEUROSCI, V27, P3037, DOI 10.1523/JNEUROSCI.0172-07.2007; Germain S, 2010, CURR OPIN HEMATOL, V17, P245, DOI 10.1097/MOH.0b013e32833865b9; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Guijarro-Munoz I, 2012, EXP CELL RES, V318, P371, DOI 10.1016/j.yexcr.2011.12.005; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Huang LZ, 2009, MOL VIS, V15, P1057; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Jones EAV, 2008, DEVELOPMENT, V135, P2479, DOI 10.1242/dev.014902; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu D, 2006, CIRC RES, V98, P480, DOI 10.1161/01.RES.0000205764.85931.4b; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yang XM, 2010, BIOCHEM BIOPH RES CO, V396, P571, DOI 10.1016/j.bbrc.2010.04.152; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zelina P, 2014, NEURON, V84, P1258, DOI 10.1016/j.neuron.2014.11.004; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhou WY, 2011, MOL VIS, V17, P1526	51	111	120	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					483	U266		10.1038/nm.3849	http://dx.doi.org/10.1038/nm.3849			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25894826	Green Accepted			2022-12-25	WOS:000354068800015
J	Roostalu, J; Cade, NI; Surrey, T				Roostalu, Johanna; Cade, Nicholas I.; Surrey, Thomas			Complementary activities of TPX2 and chTOG constitute an efficient importin-regulated microtubule nucleation module	NATURE CELL BIOLOGY			English	Article							SLOWLY HYDROLYZABLE ANALOG; SPINDLE POLE ORGANIZATION; XENOPUS EGG EXTRACTS; ALPHA-BETA-TUBULIN; AURORA-A KINASE; SELF-ORGANIZATION; GTP HYDROLYSIS; PROTEIN; RAN; END	Spindle assembly and function require precise control of microtubule nucleation and dynamics. The chromatin-driven spindle assembly pathway exerts such control locally in the vicinity of chromosomes. One of the key targets of this pathway is TPX2. The molecular mechanism of how TPX2 stimulates microtubule nucleation is not understood. Using microscopy-based dynamic in vitro reconstitution assays with purified proteins, we find that human TPX2 directly stabilizes growing microtubule ends and stimulates microtubule nucleation by stabilizing early microtubule nucleation intermediates. Human microtubule polymerase chTOG (XMAP215/Msps/Stu2p/Dis1/A1p14 homologue) only weakly promotes nucleation, but acts synergistically with TPX2. Hence, a combination of distinct and complementary activities is sufficient for efficient microtubule formation in vitro. Importins control the efficiency of the microtubule nucleation by selectively blocking the interaction of TPX2 with microtubule nucleation intermediates. This in vitro reconstitution reveals the molecular mechanism of regulated microtubule formation by a minimal nucleation module essential for chromatin-dependent microtubule nucleation in cells.	[Roostalu, Johanna; Cade, Nicholas I.; Surrey, Thomas] Francis Crick Inst, London WC2A 3LY, England	Francis Crick Institute	Roostalu, J (corresponding author), Francis Crick Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	johanna.roostalu@crick.ac.uk	Surrey, Thomas/AAC-4608-2021	Roostalu, Johanna/0000-0002-6757-0468; Surrey, Thomas/0000-0001-9082-1870	ERG [323042]; Cancer Research UK; Cancer Research UK postdoctoral fellowship; EMBO Long-Term Fellowship [LTF-615-2012]; Sir Henry Wellcome Postdoctoral Fellowship [100145/Z/12/Z]; Cancer Research UK [14256] Funding Source: researchfish; The Francis Crick Institute [10163, 10164, 10165] Funding Source: researchfish	ERG; Cancer Research UK(Cancer Research UK); Cancer Research UK postdoctoral fellowship(Cancer Research UK); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Postdoctoral Fellowship; Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank I. Luke and C. Thomas for insect cell culture maintenance; C. Thomas for help with protein expression, and cloning and purification of the biotinylated Kin1<SUP>ngor</SUP> construct; C. Duellberg (The Francis Crick Institute, UK) for a partially purified MonoQ fraction of the untagged human EB1 protein. We are grateful to R. Heald (University of California at Berkeley, USA), D. Gorlich (Max Planck Institute for Biophysical Chemistry, Germany), S. Royle (Warwick Medical School, UK), G. Stier (European Molecular Biology Laboratory, Germany) and I. Vernos (Centre for Genomic Regulation, Spain) for providing various plasmids. We thank all the members of the Surrey laboratory for discussions, and F. Fourniol and C. Duellberg for critical reading of the manuscript. T.S. acknowledges the ERG (Project 323042) and Cancer Research UK for funding; J.R. was supported by a Cancer Research UK postdoctoral fellowship, an EMBO Long-Term Fellowship (LTF-615-2012), and a Sir Henry Wellcome Postdoctoral Fellowship (100145/Z/12/Z).	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Al-Bassam J, 2012, MOL BIOL CELL, V23, P2878, DOI 10.1091/mbc.E12-03-0205; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bechstedt S, 2014, CURR BIOL, V24, P2366, DOI 10.1016/j.cub.2014.08.039; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Coombes CE, 2013, CURR BIOL, V23, P1342, DOI 10.1016/j.cub.2013.05.059; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Ghosh S, 2013, ACS CHEM BIOL, V8, P673, DOI 10.1021/cb300583p; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Helmke KJ, 2014, J CELL BIOL, V206, P385, DOI 10.1083/jcb.201401014; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kronja I, 2009, MOL BIOL CELL, V20, P2684, DOI 10.1091/mbc.E08-10-1051; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Mozziconacci J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003821; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Podolski M, 2014, J BIOL CHEM, V289, P28087, DOI 10.1074/jbc.M114.584300; Reber SB, 2013, NAT CELL BIOL, V15, P1116, DOI 10.1038/ncb2834; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Scrofani J, 2015, CURR BIOL, V25, P131, DOI 10.1016/j.cub.2014.11.025; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; VOTER WA, 1984, J BIOL CHEM, V259, P430; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wieczorek M, 2015, NAT CELL BIOL, V17, P907, DOI 10.1038/ncb3188; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	62	90	91	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1422	1434		10.1038/ncb3241	http://dx.doi.org/10.1038/ncb3241			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26414402	Green Submitted, Green Accepted			2022-12-25	WOS:000364270500008
J	Zheng, YH; Li, XJ; Qian, X; Wang, YG; Lee, JH; Xia, Y; Hawke, DH; Zhang, G; Lyu, JX; Lu, ZM				Zheng, Yanhua; Li, Xinjian; Qian, Xu; Wang, Yugang; Lee, Jong-Ho; Xia, Yan; Hawke, David H.; Zhang, Gang; Lyu, Jianxin; Lu, Zhimin			Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN BREAST-CANCER; MATRIX METALLOPROTEINASES; LIGAND SEQUESTRATION; DOWN-REGULATION; ARGOS; DEPHOSPHORYLATION; PHOSPHORYLATION; RESOLUTION; PROMOTES	Activation of epidermal growth factor receptor (EGFR), which occurs in many types of tumour, promotes tumour progression(1,2). However, no extracellular antagonist of human EGFR has been identified. We found that human macrophage migration inhibitory factor (MIF) is O-GlcNAcylated at Ser 112/Thr 113 at its carboxy terminus. The naturally secreted and O-GlcNAcylated MIF binds to EGFR, thereby inhibiting the binding of EGF to EGFR and EGF-induced EGFR activation, phosphorylation of ERK and c-Jun, cell invasion, proliferation and brain tumour formation. Activation of EGFR through mutation or its ligand binding enhances the secretion of MMP13, which degrades extracellular MIF, and results in abrogation of the negative regulation of MIF on EGFR. The finding that EGFR activation downregulates its antagonist in the tumour microenvironment represents an important feedforward mechanism for human tumour cells to enhance EGFR signalling and promote tumorigenesis.	[Zheng, Yanhua; Li, Xinjian; Qian, Xu; Wang, Yugang; Lee, Jong-Ho; Xia, Yan; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Zhang, Gang] Hebei Univ, Affiliated Hosp, Dept Surg Oncol, Baoding 071000, Hebei, Peoples R China; [Lyu, Jianxin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Key Lab Lab Med,Minist Educ, Wenzhou 325035, Peoples R China; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Hebei University; Wenzhou Medical University; University of Texas System; UTMD Anderson Cancer Center	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.	zhimintu@mdanderson.rog	yang, zheng/HGC-7753-2022	Hawke, David/0000-0002-6102-7843	National Cancer Institute [2R01 CA109035, 1R0 CA169603]; National Institute of Neurological Disorders and Stroke [1R01 NS089754]; MD Anderson Support Grant [CA016672]; James S. McDonnell Foundation [220020318, 2P50 CA127001]; MD Anderson; National Institutes of Health [1S10 OD012304-01]; Cancer Prevention and Research Institute of Texas research grant [RP130397]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA169603, P50CA127001, R01CA109035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089754] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MD Anderson Support Grant; James S. McDonnell Foundation; MD Anderson; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Yu (University of Michigan Medical School) for the pCMV-Myc-OGT plasmid, D. M. F. Van Aalten (University of Dundee, UK) for the pEBG-6P-hOGA plasmid, and M. Wade in the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for critically reading this manuscript. We thank J. Gumin in the Department of Neurosurgery at The University of Texas MD Anderson Cancer Center for her help in mice intracranial injection. This work was supported by National Cancer Institute grants 2R01 CA109035 (Z.L.) and 1R0 CA169603 (Z.L.), National Institute of Neurological Disorders and Stroke grant 1R01 NS089754 (Z.L.), MD Anderson Support Grant CA016672, the James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award 220020318 (Z.L.), 2P50 CA127001 (Brain Cancer SPORE), a Sister Institution Network Fund from MD Anderson (Z.L.), National Institutes of Health Grant 1S10 OD012304-01 (D.H.H.), and Cancer Prevention and Research Institute of Texas research grant RP130397 (D.H.H.). Z.L. is a Ruby E. Rutherford Distinguished Professor.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Gilmour AM, 2013, CELL SIGNAL, V25, P2587, DOI 10.1016/j.cellsig.2013.08.008; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Hofer S, 2014, CHIN J CANCER, V33, P4, DOI 10.5732/cjc.013.10218; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Klein DE, 2008, NATURE, V453, P1271, DOI 10.1038/nature06978; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; Krockenberger M, 2010, J CANCER RES CLIN, V136, P651, DOI 10.1007/s00432-009-0702-5; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Moy FJ, 2000, J MOL BIOL, V302, P671, DOI 10.1006/jmbi.2000.4082; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sugimoto H, 1996, FEBS LETT, V389, P145, DOI 10.1016/0014-5793(96)00553-4; Suzuki H, 2013, CHIN J CANCER, V32, P136, DOI 10.5732/cjc.012.10160; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Xu XD, 2008, CANCER LETT, V261, P147, DOI 10.1016/j.canlet.2007.11.028; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang Yong Ryoul, 2014, Advances in Biological Regulation, V54, P68, DOI 10.1016/j.jbior.2013.09.007; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	29	36	38	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1348	+		10.1038/ncb3222	http://dx.doi.org/10.1038/ncb3222			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26280537	Green Accepted			2022-12-25	WOS:000362213500015
J	Garber, K				Garber, Ken			RIKEN suspends first clinical trial involving induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	News Item																		2012, NATURE, V471, P46	1	130	133	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					890	891		10.1038/nbt0915-890	http://dx.doi.org/10.1038/nbt0915-890			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348942				2022-12-25	WOS:000360990900003
J	Alipanahi, B; Delong, A; Weirauch, MT; Frey, BJ				Alipanahi, Babak; Delong, Andrew; Weirauch, Matthew T.; Frey, Brendan J.			Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning	NATURE BIOTECHNOLOGY			English	Article							TERT PROMOTER MUTATIONS; TRANSCRIPTION FACTORS; RECOGNITION; COMPLEXITY; NETWORKS; SEARCH; MODELS; CANCER; SITES	Knowing the sequence specificities of DNA- and RNA-binding proteins is essential for developing models of the regulatory processes in biological systems and for identifying causal disease variants. Here we show that sequence specificities can be ascertained from experimental data with 'deep learning' techniques, which offer a scalable, flexible and unified computational approach for pattern discovery. Using a diverse array of experimental data and evaluation metrics, we find that deep learning outperforms other state-of-the-art methods, even when training on in vitro data and testing on in vivo data. We call this approach DeepBind and have built a stand-alone software tool that is fully automatic and handles millions of sequences per experiment. Specificities determined by DeepBind are readily visualized as a weighted ensemble of position weight matrices or as a 'mutation map' that indicates how variations affect binding within a specific sequence.	[Alipanahi, Babak; Delong, Andrew; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Alipanahi, Babak; Frey, Brendan J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Weirauch, Matthew T.; Frey, Brendan J.] Canadian Inst Adv Res, Program Genet Networks, Toronto, ON, Canada; [Weirauch, Matthew T.; Frey, Brendan J.] Canadian Inst Adv Res, Program Neural Computat, Toronto, ON, Canada; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR); Canadian Institute for Advanced Research (CIFAR); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Frey, BJ (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada.	frey@psi.toronto.edu	Weirauch, Matthew/M-5459-2019	Alipanahi, Babak/0000-0001-8216-7178	Canadian Institutes of Health Research [OGP-106690]; John C. Polanyi Fellowship Grant; Canadian Institutes for Advanced Research; Autism Research Training and NeuroDevNet Fellowship; Natural Science and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); John C. Polanyi Fellowship Grant; Canadian Institutes for Advanced Research; Autism Research Training and NeuroDevNet Fellowship; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We are grateful to K.B. Cook, Q.D. Morris and T.R. Hughes for helpful discussions. This work was supported by a grant from the Canadian Institutes of Health Research (OGP-106690) to B.J.F., a John C. Polanyi Fellowship Grant to B.J.F., and funding from the Canadian Institutes for Advanced Research to B.J.F. and M.T.W.B.A. was supported by a joint Autism Research Training and NeuroDevNet Fellowship. A.D. was supported by a Fellowship from the Natural Science and Engineering Research Council of Canada..	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Cotter A., 2011, P NEURIPS GRAN SPAIN; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; De Castro-Oros I, 2011, HUM MUTAT, V32, P868, DOI 10.1002/humu.21520; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Gupta A, 2011, J MOL BIOL, V409, P574, DOI 10.1016/j.jmb.2011.04.007; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kyronlahti A, 2008, ENDOCRINOLOGY, V149, P5635, DOI 10.1210/en.2008-0148; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Levitsky VG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-80; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893	51	1289	1323	33	304	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					831	+		10.1038/nbt.3300	http://dx.doi.org/10.1038/nbt.3300			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26213851	Bronze			2022-12-25	WOS:000359274900021
J	Nelson, MR; Tipney, H; Painter, JL; Shen, JD; Nicoletti, P; Shen, YF; Floratos, A; Sham, PC; Li, MJ; Wang, JW; Cardon, LR; Whittaker, JC; Sanseau, P				Nelson, Matthew R.; Tipney, Hannah; Painter, Jeffery L.; Shen, Judong; Nicoletti, Paola; Shen, Yufeng; Floratos, Aris; Sham, Pak Chung; Li, Mulin Jun; Wang, Junwen; Cardon, Lon R.; Whittaker, John C.; Sanseau, Philippe			The support of human genetic evidence for approved drug indications	NATURE GENETICS			English	Article							PHASE-II; VARIANTS; DATABASE; RATES	Over a quarter of drugs that enter clinical development fail because they are ineffective. Growing insight into genes that influence human disease may affect how drug targets and indications are selected. However, there is little guidance about how much weight should be given to genetic evidence in making these key decisions. To answer this question, we investigated how well the current archive of genetic evidence predicts drug mechanisms. We found that, among well-studied indications, the proportion of drug mechanisms with direct genetic support increases significantly across the drug development pipeline, from 2.0% at the preclinical stage to 8.2% among mechanisms for approved drugs, and varies dramatically among disease areas. We estimate that selecting genetically supported targets could double the success rate in clinical development. Therefore, using the growing wealth of human genetic data to select the best targets and indications should have a measurable impact on the successful development of new drugs.	[Nelson, Matthew R.; Painter, Jeffery L.; Shen, Judong] GlaxoSmithKline, Quantitat Sci, Res Triangle Pk, NC 27709 USA; [Tipney, Hannah; Whittaker, John C.; Sanseau, Philippe] GlaxoSmithKline, Quantitat Sci, Stevenage, Herts, England; [Nicoletti, Paola; Shen, Yufeng; Floratos, Aris] Columbia Univ, Dept Syst Biol, New York, NY USA; [Shen, Yufeng; Floratos, Aris] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Sham, Pak Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak Chung; Li, Mulin Jun; Wang, Junwen] Univ Hong Kong, LKS Fac Med, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Mulin Jun; Wang, Junwen] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Cardon, Lon R.] GlaxoSmithKline, Alternat Discovery & Dev, Upper Merion, PA USA	GlaxoSmithKline; GlaxoSmithKline; Columbia University; Columbia University; University of Hong Kong; University of Hong Kong; University of Hong Kong; GlaxoSmithKline	Nelson, MR (corresponding author), GlaxoSmithKline, Quantitat Sci, Res Triangle Pk, NC 27709 USA.	matthew.r.nelson@gsk.com	Wang, Junwen/D-3700-2011; Whittaker, John C/B-8609-2012	Wang, Junwen/0000-0002-4432-4707; Whittaker, John C/0000-0002-3529-2379; Painter, Jeffery/0000-0001-9651-9904	Research Grants Council, Hong Kong SAR, China [781511M, 17121414M]; National Natural Science Foundation of China [91229105]	Research Grants Council, Hong Kong SAR, China(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We would like to thank N. Srivastava for much of the manual mapping of GWASdb traits and Pharmaprojects indications to MeSH terms and P. Agarwal for many helpful conversations. GWASdb-related work was supported by the Research Grants Council, Hong Kong SAR, China (781511M, 17121414M) and the National Natural Science Foundation of China (91229105).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lin D, 1998, P INT C MACH LEARN; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McInnes Bridget T, 2009, AMIA Annu Symp Proc, V2009, P431; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; R Development Core Team, 2014, R LANG ENV STAT COMP; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Wang ZY, 2013, NAT BIOTECHNOL, V31, P1080, DOI 10.1038/nbt.2758; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	24	645	649	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					856	+		10.1038/ng.3314	http://dx.doi.org/10.1038/ng.3314			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26121088				2022-12-25	WOS:000358674100006
J	Ogawa, M; Ogawa, S; Bear, CE; Ahmadi, S; Chin, S; Li, B; Grompe, M; Keller, G; Kamath, BM; Ghanekar, A				Ogawa, Mina; Ogawa, Shinichiro; Bear, Christine E.; Ahmadi, Saumel; Chin, Stephanie; Li, Bin; Grompe, Markus; Keller, Gordon; Kamath, Binita M.; Ghanekar, Anand			Directed differentiation of cholangiocytes from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							HEPATIC PROGENITOR CELLS; BILE-DUCT DEVELOPMENT; ALAGILLE-SYNDROME; LIVER DEVELOPMENT; CYSTIC-FIBROSIS; IN-VITRO; TRANSCRIPTION FACTORS; NOTCH2 MUTATIONS; FATE DECISION; HEPATOCYTES	Although bile duct disorders are well-recognized causes of liver disease, the molecular and cellular events leading to biliary dysfunction are poorly understood. To enable modeling and drug discovery for biliary disease, we describe a protocol that achieves efficient differentiation of biliary epithelial cells (cholangiocytes) from human pluripotent stem cells (hPSCs) through delivery of developmentally relevant cues, including NOTCH signaling. Using three-dimensional culture, the protocol yields cystic and/or ductal structures that express mature biliary markers, including apical sodium-dependent bile acid transporter, secretin receptor, cilia and cystic fibrosis transmembrane conductance regulator (CFTR). We demonstrate that hPSC-derived cholangiocytes possess epithelial functions, including rhodamine efflux and CFTR-mediated fluid secretion. Furthermore, we show that functionally impaired hPSC-derived cholangiocytes from cystic fibrosis patients are rescued by CFTR correctors. These findings demonstrate that mature cholangiocytes can be differentiated from hPSCs and used for studies of biliary development and disease.	[Ogawa, Mina; Ogawa, Shinichiro; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Ogawa, Mina; Ghanekar, Anand] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Bear, Christine E.; Ahmadi, Saumel; Chin, Stephanie] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Li, Bin; Grompe, Markus] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Keller, Gordon] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Keller, Gordon] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Kamath, Binita M.] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Kamath, Binita M.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Ghanekar, Anand] Univ Hlth Network, Div Gen Surg, Toronto, ON, Canada; [Ghanekar, Anand] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Oregon Health & Science University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ghanekar, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	sogawa@uhnresearch.ca; anand.ghanekar@uhn.ca	Li, Bin/P-8992-2015; OGAWA, SHINICHIRO/G-2914-2019; Ahmadi, Saumel/O-3570-2018	Li, Bin/0000-0002-4884-6967; OGAWA, SHINICHIRO/0000-0002-4527-4764; Ahmadi, Saumel/0000-0002-5800-6945; Keller, Gordon/0000-0001-9309-9297; Grompe, Markus/0000-0002-6616-4345	McEwen Centre for Regenerative Medicine; Canadian Institutes of Health Research [MOP133620, MOP:97954, GPG:102171]; University Health Network Multi-Organ Transplant Program Academic Enrichment Fund; Astellas Pharma Canada; Alagille Syndrome Alliance; SickKids Research Institute; Rare Disease Foundation; Childhood Liver Disease Research and Education Network; National Institute of Diabetes, Digestive and Kidney Diseases [U01 DK062453]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062453] Funding Source: NIH RePORTER	McEwen Centre for Regenerative Medicine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University Health Network Multi-Organ Transplant Program Academic Enrichment Fund; Astellas Pharma Canada(Astellas Pharmaceuticals); Alagille Syndrome Alliance; SickKids Research Institute; Rare Disease Foundation; Childhood Liver Disease Research and Education Network; National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank J. Rossant, J. Ellis and A.P. Wong (Hospital for Sick Children, Toronto, ON, Canada) for providing CF patient iPSCs (C1 and GM00997). We thank members of the G.K. and A.G. laboratories for discussion and feedback on the manuscript. We would like to thank F. Xu (Advanced Optical Microscopy Facility, University Health Network) for technical assistance with the time-lapse video. In addition, we would also like to thank O. Adeyi and the members of Department Pathology, University Health Network for technical assistance with immunohistochemistry. H9 hESC was obtained from The Wicell Research Institute (Madison, WI, USA), and MSC-iPSC1 cells were obtained from G.Q. Daley (Harvard Stem Cell Institute). This work was supported by funding from the McEwen Centre for Regenerative Medicine and the Canadian Institutes of Health Research MOP133620, (G.K.), the University Health Network Multi-Organ Transplant Program Academic Enrichment Fund (sponsored by Astellas Pharma Canada), Alagille Syndrome Alliance, SickKids Research Institute, Rare Disease Foundation and the Childhood Liver Disease Research and Education Network, U01 DK062453 (Sokol) from the National Institute of Diabetes, Digestive and Kidney Diseases (B.M.K. and A.G.) and the Canadian Institutes of Health Research (MOP:97954 and GPG:102171 to C.E.B.).	Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Fernandez-Sanchez V, 2011, BLOOD CELL MOL DIS, V47, P205, DOI 10.1016/j.bcmd.2011.08.003; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kamath BM, 2012, LIVER TRANSPLANT, V18, P940, DOI 10.1002/lt.23437; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Leeuwen L, 2014, PAEDIATR RESPIR REV, V15, P69, DOI 10.1016/j.prrv.2013.05.001; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Ludtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; O'Hara SP, 2013, J HEPATOL, V58, P575, DOI 10.1016/j.jhep.2012.10.011; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Raynaud P, 2011, INT J BIOCHEM CELL B, V43, P245, DOI 10.1016/j.biocel.2009.07.020; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Takayama K, 2014, DEVELOPMENT, V141, P91, DOI 10.1242/dev.103168; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Yanagida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067541; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	44	185	189	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					853	+		10.1038/nbt.3294	http://dx.doi.org/10.1038/nbt.3294			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26167630				2022-12-25	WOS:000359274900025
J	Waltz, E				Waltz, Emily			Oxitec trials GM sterile moth to combat agricultural infestations	NATURE BIOTECHNOLOGY			English	News Item																		2015, PLOS NEGL TROP DIS, V9, P3864; 2012, J ECON ENTOM, V105, P1115; 2011, NAT BIOTECHNOL, V29, P9	3	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					792	793		10.1038/nbt0815-792c	http://dx.doi.org/10.1038/nbt0815-792c			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252124				2022-12-25	WOS:000359274900007
J	Guemez-Gamboa, A; Nguyen, LN; Yang, HB; Zaki, MS; Kara, M; Ben-Omran, T; Akizu, N; Rosti, RO; Rosti, B; Scott, E; Schroth, J; Copeland, B; Vaux, KK; Cazenave-Gassiot, A; Quek, DQY; Wong, BH; Tan, BC; Wenk, MR; Gunel, M; Gabriel, S; Chi, NC; Silver, DL; Gleeson, JG				Guemez-Gamboa, Alicia; Nguyen, Long N.; Yang, Hongbo; Zaki, Maha S.; Kara, Majdi; Ben-Omran, Tawfeg; Akizu, Naiara; Rosti, Rasim Ozgur; Rosti, Basak; Scott, Eric; Schroth, Jana; Copeland, Brett; Vaux, Keith K.; Cazenave-Gassiot, Amaury; Quek, Debra Q. Y.; Wong, Bernice H.; Tan, Bryan C.; Wenk, Markus R.; Gunel, Murat; Gabriel, Stacey; Chi, Neil C.; Silver, David L.; Gleeson, Joseph G.			Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome	NATURE GENETICS			English	Article							FATTY-ACID COMPOSITION; DOCOSAHEXAENOIC ACID; BARRIER; PERICYTES; NEUROGENESIS; EXPRESSION; DISCOVERY; MOUSE	Docosahexanoic acid (DHA) is the most abundant omega-3 fatty acid in brain, and, although it is considered essential, deficiency has not been linked to disease(1,2). Despite the large mass of DHA in phospholipids, the brain does not synthesize it. DHA is imported across the blood-brain barrier (BBB) through the major facilitator superfamily domain-containing 2a (MFSD2A) protein(3). MFSD2A transports DHA as well as other fatty acids in the form of lysophosphatidylcholine (LPC). We identify two families displaying MFSD2A mutations in conserved residues. Affected individuals exhibited a lethal microcephaly syndrome linked to inadequate uptake of LPC lipids. The MFSD2A mutations impaired transport activity in a cell-based assay. Moreover, when expressed in mfsd2aa-morphant zebrafish, mutants failed to rescue microcephaly, BBB breakdown and lethality. Our results establish a link between transport of DHA and LPCs by MFSD2A and human brain growth and function, presenting the first evidence of monogenic disease related to transport of DHA in humans.	[Guemez-Gamboa, Alicia; Akizu, Naiara; Rosti, Rasim Ozgur; Rosti, Basak; Scott, Eric; Schroth, Jana; Copeland, Brett; Vaux, Keith K.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92103 USA; [Guemez-Gamboa, Alicia; Akizu, Naiara; Rosti, Rasim Ozgur; Rosti, Basak; Scott, Eric; Schroth, Jana; Copeland, Brett; Vaux, Keith K.; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Nguyen, Long N.; Quek, Debra Q. Y.; Wong, Bernice H.; Tan, Bryan C.; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Dis, Singapore, Singapore; [Yang, Hongbo; Chi, Neil C.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo, Egypt; [Kara, Majdi] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet Div, Doha, Qatar; [Cazenave-Gassiot, Amaury; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg Neurobiol & Genet, Yale Program Neurogenet, New Haven, CT USA; [Gabriel, Stacey] MIT & Harward, Broad Inst, Cambridge, MA USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; National University of Singapore; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hamad Medical Corporation; National University of Singapore; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92103 USA.	david.silver@duke-nus.edu.sg; jogleeson@rockefeller.edu	Nguyen, Long/AAY-6172-2021; Wang, Guilin/G-8794-2018; Vaux, Keith/R-2716-2019; Zaki, Maha S/B-9361-2013; Cazenave-Gassiot, Amaury/E-4536-2014	Vaux, Keith/0000-0001-8738-5940; Cazenave-Gassiot, Amaury/0000-0002-3050-634X; Silver, David/0000-0002-7289-9890; Copeland, Brett/0000-0003-2933-6061; Nguyen, Long N/0000-0002-9857-2239; Guemez-Gamboa, Alicia/0000-0001-6890-4661; Zaki, Maha/0000-0001-7840-0002; TAN, BRYAN CASSIDY/0000-0001-6399-8814; Wong, Bernice/0000-0001-8981-1376	US National Institutes of Health [P01HD070494, R01NS048453, K99NS089943, U54HG003067, U54HG006504]; Singapore Ministry of Health's National Medical Research Council [CBRG/069/2014]; Singapore National Research Foundation Competitive Research Program [2007-04]; National University of Singapore's Life Sciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS089943, R01NS048453] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Singapore National Research Foundation Competitive Research Program(National Research Foundation, Singapore); National University of Singapore's Life Sciences Institute(National University of Singapore); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health, including P01HD070494 (to J.G.G. and N.C.C.), R01NS048453 (to J.G.G.), K99NS089943 (to A.G.-G.), and U54HG003067 to the Broad Institute and U54HG006504 to the Yale Center for Mendelian Disorders (M.G.), grant CBRG/069/2014 from the Singapore Ministry of Health's National Medical Research Council (to D.L.S.), Singapore National Research Foundation Competitive Research Program grant 2007-04 (to M.R.W.) and the National University of Singapore's Life Sciences Institute (to M.R.W.). Sequencing was provided in part by a gift from BGI to Rady Children's Hospital, San Diego for undiagnosed patients. Human brain samples were provided by S. Roy (University of California, San Diego).	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Cordat E, 2000, BIOCHEMISTRY-US, V39, P4493, DOI 10.1021/bi991852i; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Fleming A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077548; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Harata N, 1996, METAB BRAIN DIS, V11, P55, DOI 10.1007/BF02080931; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; SVENNERHOLM L, 1968, J LIPID RES, V9, P570; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240	23	141	147	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					809	+		10.1038/ng.3311	http://dx.doi.org/10.1038/ng.3311			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005868	Green Accepted			2022-12-25	WOS:000357090300020
J	Kaushik, S; Cuervo, AM				Kaushik, Susmita; Cuervo, Ana Maria			Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis	NATURE CELL BIOLOGY			English	Article							DIFFERENTIATION-RELATED PROTEIN; RAT-LIVER LYSOSOMES; CYTOSOLIC PROTEINS; SELECTIVE PATHWAY; PERILIPIN; RECEPTOR; CELLS; PROTEOLYSIS; MEMBRANE; LIPASE	Chaperone-mediated autophagy (CMA) selectively degrades a subset of cytosolic proteins in lysosomes. A potent physiological activator of CMA is nutrient deprivation, a condition in which intracellular triglyceride stores or lipid droplets (LDs) also undergo hydrolysis (lipolysis) to generate free fatty acids for energetic purposes. Here we report that the LD-associated proteins perilipin 2 (PLIN2) and perilipin 3 (PLIN3) are CMA substrates and their degradation through CMA precedes lipolysis. In vivo studies revealed that CMA degradation of PLIN2 and PLIN3 was enhanced during starvation, concurrent with elevated levels of cytosolic adipose triglyceride lipase (ATGL) and macroautophagy proteins on LDs. CMA blockage both in cultured cells and mouse liver or expression of CMA-resistant PLINs leads to reduced association of ATGL and macrolipophagy-related proteins with LDs and the subsequent decrease in lipid oxidation and accumulation of LDs. We propose a role for CMA in LD biology and in the maintenance of lipid homeostasis.	[Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	ana-maria.cuervo@einstein.yu.edu	Kaushik, Susmita/GVS-3186-2022	Kaushik, Susmita/0000-0002-6096-5387; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [AG021904, AG031782, AG038072, DK098408]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098408, P30DK041296, P60DK020541, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, R01AG021904, P01AG031782, P30AG038072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health AG021904, AG031782, AG038072, DK098408 and the generous support of Robert and Renee Belfer. We thank B. Patel for performing the electron microscopy, R. Singh for assistance in biochemical lipid assays and the Analytical Imaging Facility for support with live-cell imaging.	Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Anguiano J, 2013, NAT CHEM BIOL, V9, P374, DOI 10.1038/nchembio.1230; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; [Anonymous], 2013, AUTOPHAGY; Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; BLANCHETTEMACKIE EJ, 1983, J LIPID RES, V24, P229; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; Dupont N, 2014, CURR BIOL, V24, P609, DOI 10.1016/j.cub.2014.02.008; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Greussing R., 2012, JOVE-J VIS EXP, V69, pe3327; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Ogasawara J, 2012, NAT PROD COMMUN, V7, P1193; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Ranall MV, 2011, BIOTECHNIQUES, V51, P35, DOI 10.2144/000113702; Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109; Salvador N, 2000, J BIOL CHEM, V275, P27447; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	58	362	380	11	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					759	+		10.1038/ncb3166	http://dx.doi.org/10.1038/ncb3166			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25961502	Green Accepted			2022-12-25	WOS:000355277500008
J	Legati, A; Giovannini, D; Nicolas, G; Lopez-Sanchez, U; Quintans, B; Oliveira, JRM; Sears, RL; Ramos, EM; Spiteri, E; Sobrido, MJ; Carracedo, A; Castro-Fernandez, C; Cubizolle, S; Fogel, BL; Goizet, C; Jen, JC; Kirdlarp, S; Lang, AE; Miedzybrodzka, Z; Mitarnun, W; Paucar, M; Paulson, H; Pariente, J; Richard, AC; Salins, NS; Simpson, SA; Striano, P; Svenningsson, P; Tison, F; Unni, VK; Vanakker, O; Wessels, MW; Wetchaphanphesat, S; Yang, M; Boller, F; Campion, D; Hannequin, D; Sitbon, M; Geschwind, DH; Battini, JL; Coppola, G				Legati, Andrea; Giovannini, Donatella; Nicolas, Gael; Lopez-Sanchez, Uriel; Quintans, Beatriz; Oliveira, Joao R. M.; Sears, Renee L.; Ramos, Eliana Marisa; Spiteri, Elizabeth; Sobrido, Maria-Jesus; Carracedo, Angel; Castro-Fernandez, Cristina; Cubizolle, Stephanie; Fogel, Brent L.; Goizet, Cyril; Jen, Joanna C.; Kirdlarp, Suppachok; Lang, Anthony E.; Miedzybrodzka, Zosia; Mitarnun, Witoon; Paucar, Martin; Paulson, Henry; Pariente, Jeremie; Richard, Anne-Claire; Salins, Naomi S.; Simpson, Sheila A.; Striano, Pasquale; Svenningsson, Per; Tison, Francois; Unni, Vivek K.; Vanakker, Olivier; Wessels, Marja W.; Wetchaphanphesat, Suppachok; Yang, Michele; Boller, Francois; Campion, Dominique; Hannequin, Dither; Sitbon, Marc; Geschwind, Daniel H.; Battini, Jean-Luc; Coppola, Giovanni			Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export	NATURE GENETICS			English	Article							BASAL GANGLIA CALCIFICATION; DOMAIN-CONTAINING PROTEINS; MURINE LEUKEMIA VIRUSES; CELL-SURFACE RECEPTOR; RETROVIRUS; HOMEOSTASIS; TRANSPORT; GENE; MICE	Primary familial brain calcification (PFBC) is a neurological disease characterized by calcium phosphate deposits in the basal ganglia and other brain regions and has thus far been associated with SLC20A2, PDGFB or PDGFRB mutations. We identified in multiple families with PFBC mutations in XPR1, a gene encoding a retroviral receptor with phosphate export function. These mutations alter phosphate export, implicating XPR1 and phosphate homeostasis in PFBC.	[Legati, Andrea; Sears, Renee L.; Ramos, Eliana Marisa; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Giovannini, Donatella; Lopez-Sanchez, Uriel; Battini, Jean-Luc] CNRS, UMR 5535, Inst Genet Mol Montpellier, Montpellier, France; [Giovannini, Donatella; Sitbon, Marc; Battini, Jean-Luc] Univ Montpellier, F-34059 Montpellier, France; [Giovannini, Donatella; Sitbon, Marc; Battini, Jean-Luc] Lab Excellence GR Ex, Paris, France; [Giovannini, Donatella; Lopez-Sanchez, Uriel; Sitbon, Marc; Battini, Jean-Luc] Lab Excellence EpiGenMed, Montpellier, France; [Nicolas, Gael; Hannequin, Dither] Univ Rouen, IRIB, INSERM, U1079, Rouen, France; [Richard, Anne-Claire; Campion, Dominique; Hannequin, Dither] Rouen Univ Hosp, CNR MAJ, Rouen, France; [Nicolas, Gael; Hannequin, Dither] Rouen Univ Hosp, Dept Genet, Rouen, France; [Quintans, Beatriz; Sobrido, Maria-Jesus; Carracedo, Angel; Castro-Fernandez, Cristina] Hosp Clin Univ, IDIS, Inst Invest Sanitaria, Fundac Publ Galega Med Xenom,Serv Galego Saude SE, Santiago De Compostela, Spain; [Quintans, Beatriz; Sobrido, Maria-Jesus; Carracedo, Angel; Castro-Fernandez, Cristina] Univ Santiago de Compostela, CIBERER, Grp Med Xenom, Santiago De Compostela, Spain; [Oliveira, Joao R. M.] Univ Fed Pernambuco, Keizo Asami Lab, Recife, PE, Brazil; [Spiteri, Elizabeth; Fogel, Brent L.; Jen, Joanna C.; Geschwind, Daniel H.; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Cubizolle, Stephanie; Tison, Francois] Bordeaux Univ Hosp, Neurol & Inst Neurodegenerat Dis, Bordeaux, France; [Cubizolle, Stephanie; Tison, Francois] Bordeaux Univ, Bordeaux, France; [Goizet, Cyril] Bordeaux Hosp Univ Ctr, Serv Genet Med, Bordeaux, France; [Kirdlarp, Suppachok; Mitarnun, Witoon] Buriram Hosp, Div Med, Buriram, Thailand; [Lang, Anthony E.] Toronto Western Hosp, Morton & Gloria Movement Disorders Clin, Toronto, ON M5T 2S8, Canada; [Lang, Anthony E.] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada; [Miedzybrodzka, Zosia; Simpson, Sheila A.] Univ Aberdeen, Sch Med & Dent, Med Genet Grp, Aberdeen, Scotland; [Paucar, Martin] Karolinska Inst, Ctr Mol Med, Clin Neurosci, Translat Neuropharmacol, Stockholm, Sweden; [Paucar, Martin; Svenningsson, Per] Karolinska Univ Hosp Huddinge, Dept Neurol, Stockholm, Sweden; [Paulson, Henry] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Pariente, Jeremie] CHU Purpan, Pole Neurosci, Imagene Cerebrale & Handicaps Neurol, INSERM,UMR 825, Toulouse, France; [Pariente, Jeremie] Univ Toulouse, CHU Toulouse, Toulouse, France; [Salins, Naomi S.] Barrow Neurol Inst, Phoenix, AZ USA; [Striano, Pasquale] Univ Genoa, G Gaslini Inst, Pediat Neurol & Muscular Dis Unit, Dept Neurosci Rehabil Ophthalmol Genet & Mat & Ch, Genoa, Italy; [Unni, Vivek K.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Vanakker, Olivier] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Wessels, Marja W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Yang, Michele] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [Yang, Michele] Univ Colorado Denver, Aurora, CO USA; [Boller, Francois] George Washington Univ, Sch Med, Dept Neurol, Washington, DC USA; [Campion, Dominique] Rouvray Psychiat Hosp, Dept Res, Sotteville Les Rouen, France; [Hannequin, Dither] Rouen Univ Hosp, Dept Neurol, Rouen, France	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Universidade Federal de Pernambuco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CHU Bordeaux; CHU Bordeaux; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Aberdeen; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Michigan System; University of Michigan; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Barrow Neurological Institute; University of Genoa; IRCCS Istituto Giannina Gaslini; Oregon Health & Science University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; George Washington University; CHU de Rouen	Battini, JL (corresponding author), CNRS, UMR 5535, Inst Genet Mol Montpellier, Montpellier, France.	jean-luc.battini@igmm.cnrs.fr; gcoppola@ucla.edu	Carracedo, Angel/D-4257-2012; Mitarnun, Witoon/GYA-0578-2022; Oliveira, João/GXN-3304-2022; Legati, Andrea/K-2181-2016; Striano, Pasquale/F-9117-2014; Lang, Anthony/ABF-8114-2021; Sitbon, Marc/A-6771-2010; GOIZET, Cyril/M-4576-2014; Vanakker, Olivier M./AAN-2900-2021; Svenningsson, Per JL/K-5210-2014; Legati, Andrea/ABA-6968-2021	Carracedo, Angel/0000-0003-1085-8986; Mitarnun, Witoon/0000-0003-0855-3235; Legati, Andrea/0000-0002-8178-6126; Striano, Pasquale/0000-0002-6065-1476; Sitbon, Marc/0000-0003-3616-2338; GOIZET, Cyril/0000-0002-1913-889X; Vanakker, Olivier M./0000-0003-4491-0332; Legati, Andrea/0000-0002-8178-6126; Nicolas, Gael/0000-0001-9391-7800; Battini, Jean-Luc/0000-0002-5884-9934; Sears, Renee/0000-0003-0523-9291; Lang, Anthony/0000-0003-1229-3667; Boller, Francois/0000-0002-4973-2996; Lopez-Sanchez, Uriel/0000-0003-4937-7055; Paucar, Martin/0000-0003-3735-1480; Kirdlarp, Suppachok/0000-0003-3444-4796	Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; US National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS040752]; Association Francaise contre les Myopathies (AFM); Ligue Nationale contre le Cancer (Comite de l'Herault); Fondation pour la Recherche Medicale (FRM); FEDER European Union Languedoc-Roussillon grant; National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics [PSNS062691]; FRM; Institut National du Cancer (INCa); Labex GR-Ex [ANR-11-LABX-0051]; Labex EpiGenMed [ANR-10-LABX-12-01]; program 'Investissements d'Avenie' of the French National Research Agency; INSERM; Fondo de Investigacion Sanitaria [PI12/00742]; INNOPHARMA project MINECO-USC; FEDER funds; Institute of Health Carlos III-SERGAS; FACEPE [APQ 1831-4.01/12]; CNPq [457556/2013-7, 480255/2013-0, 307909/2012-3]; US National Institutes of Health (National Institute of Mental Health) [K08MH086297]; US National Institutes of Health (National Institute of Neurological Disorders and Stroke) [R01NS082094]; University Hospital of Rouen; French CNR-MAJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103010, RC2HL102923, UC2HL102925, UC2HL102924, UC2HL103010, RC2HL102924, UC2HL102926, UC2HL102923, RC2HL102925, RC2HL102926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH086297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040752, R01NS082094, P30NS062691] Funding Source: NIH RePORTER	Lung GO Sequencing Project; Women's Health Initiative (WHI) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ligue Nationale contre le Cancer (Comite de l'Herault); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); FEDER European Union Languedoc-Roussillon grant; National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics; FRM(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Labex GR-Ex; Labex EpiGenMed; program 'Investissements d'Avenie' of the French National Research Agency(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); INNOPHARMA project MINECO-USC; FEDER funds(European Commission); Institute of Health Carlos III-SERGAS; FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); US National Institutes of Health (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University Hospital of Rouen; French CNR-MAJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge and thank all of the participants and families for their valuable contributions to our study; our clinical staff and laboratory members, J. DeYoung and the University of California Los Angeles (UCLA) Neuroscience Genomics Core, J. Touhami and J. Laval for their assistance and constant support; and the National Heart, Lung, and Blood Institute (NHLBI) GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). We are also indebted to the Montpellier Rio Imaging (MRI) platform for flow cytometry experiments. This work was funded by the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01NS040752 to D.H.G.), by Association Francaise contre les Myopathies (AFM) and Ligue Nationale contre le Cancer (Comite de l'Herault; to J.-L.B.), and by tomeFondation pour la Recherche Medicale (FRM) and a FEDER European Union Languedoc-Roussillon grant (Transpor; to M.S.). We also, acknowledge the support of the National Institute of Neurological Disorders and Stroke Informatics Center for Neurogenetics and Neurogenomics (PSNS062691). D.G. was supported by FRM, Institut National du Cancer (INCa) and Labex GR-Ex (ANR-11-LABX-0051) fellowships, and U.L.-S. was supported by a Labex EpiGenMed (ANR-10-LABX-12-01) fellowship; Labex is funded by the program 'Investissements d'Avenie' of the French National Research Agency. J.-L.B. and M.S. were supported by INSERM. M.-J.S. and B.Q. are supported by the Fondo de Investigacion Sanitaria, grant PI12/00742; INNOPHARMA project MINECO-USC; and FEDER funds. M.-J.S. and B.Q. hold research contracts from the Institute of Health Carlos III-SERGAS. J.R.M.O. acknowledges funding from FACEPE (APQ 1831-4.01/12) and CNPq (457556/2013-7; 480255/2013-0; 307909/2012-3). B.L.F. is funded by US National Institutes of Health grants K08MH086297 (National Institute of Mental Health) and R01NS082094 (National Institute of Neurological Disorders and Stroke). G.N., A.-C.R., D.H. and D.C. are supported by INSERM, the University Hospital of Rouen and the French CNR-MAJ.	Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; BOLLER F, 1977, J NEUROL NEUROSUR PS, V40, P280, DOI 10.1136/jnnp.40.3.280; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Hsu SC, 2013, NEUROGENETICS, V14, P11, DOI 10.1007/s10048-012-0349-2; Kakita A, 2004, ATHEROSCLEROSIS, V174, P17, DOI 10.1016/j.atherosclerosis.2003.12.039; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Lagrue E, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-91; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; Oliveira JRM, 2004, NEUROLOGY, V63, P2165, DOI 10.1212/01.WNL.0000145601.88274.88; Secco D, 2012, FEBS LETT, V586, P289, DOI 10.1016/j.febslet.2012.01.036; Secco D, 2012, NEW PHYTOL, V193, P842, DOI 10.1111/j.1469-8137.2011.04002.x; Sobrido MJ, 2014, GENEREVIEWS; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; Vaughan AE, 2012, J VIROL, V86, P1661, DOI 10.1128/JVI.06073-11; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wege S, 2014, FEBS LETT, V588, P482, DOI 10.1016/j.febslet.2013.12.013	20	181	189	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					579	581		10.1038/ng.3289	http://dx.doi.org/10.1038/ng.3289			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25938945	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000355386500007
J	Srinivasan, B; Baratashvili, M; van der Zwaag, M; Kanon, B; Colombelli, C; Lambrechts, RA; Schaap, O; Nollen, EA; Podgorsek, A; Kosec, G; Petkovic, H; Hayflick, S; Tiranti, V; Reijngoud, DJ; Grzeschik, NA; Sibon, OCM				Srinivasan, Balaji; Baratashvili, Madina; van der Zwaag, Marianne; Kanon, Bart; Colombelli, Cristina; Lambrechts, Roald A.; Schaap, Onno; Nollen, Ellen A.; Podgorsek, Ajda; Kosec, Gregor; Petkovic, Hrvoje; Hayflick, Susan; Tiranti, Valeria; Reijngoud, Dirk-Jan; Grzeschik, Nicola A.; Sibon, Ody C. M.			Extracellular 4 '-phosphopantetheine is a source for intracellular coenzyme A synthesis	NATURE CHEMICAL BIOLOGY			English	Article							KINASE-ASSOCIATED NEURODEGENERATION; PANTOTHENATE KINASE; ACETYL-COENZYME; NUDIX HYDROLASE; ALKALINE-PHOSPHATASE; COA BIOSYNTHESIS; METABOLISM; PANTETHINE; DROSOPHILA; RAT	The metabolic cofactor coenzyme A (CoA) gained renewed attention because of its roles in neurodegeneration, protein acetylation, autophagy and signal transduction. The long-standing dogma is that eukaryotic cells obtain CoA exclusively via the uptake of extracellular precursors, especially vitamin B5, which is intracellularly converted through five conserved enzymatic reactions into CoA. This study demonstrates an alternative mechanism that allows cells and organisms to adjust intracellular CoA levels by using exogenous CoA. Here CoA was hydrolyzed extracellularly by ectonucleotide pyrophosphatases to 4'-phosphopantetheine, a biologically stable molecule able to translocate through membranes via passive diffusion. Inside the cell, 4'-phosphopantetheine was enzymatically converted back to CoA by the bifunctional enzyme CoA synthase. Phenotypes induced by intracellular CoA deprivation were reversed when exogenous CoA was provided. Our findings answer long-standing questions in fundamental cell biology and have major implications for the understanding of CoA-related diseases and therapies.	[Srinivasan, Balaji; Baratashvili, Madina; van der Zwaag, Marianne; Kanon, Bart; Lambrechts, Roald A.; Schaap, Onno; Grzeschik, Nicola A.; Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Colombelli, Cristina; Tiranti, Valeria] Fdn IRCCS Neurol Inst C Besta, Unit Mol Neurogenet, Milan, Italy; [Nollen, Ellen A.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Aging, Groningen, Netherlands; [Podgorsek, Ajda; Kosec, Gregor; Petkovic, Hrvoje] Acies Bio Doo, Ljubljana, Slovenia; [Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Ctr Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Groningen	Srinivasan, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands.	o.c.m.sibon@umcg.nl	Tiranti, Valeria/J-8233-2016; Tiranti, Valeria/AFN-5783-2022; Srinivasan, Balaji/D-6082-2011	Tiranti, Valeria/0000-0002-3584-7338; Tiranti, Valeria/0000-0002-3584-7338; Sibon, Ody/0000-0002-6836-6063; Srinivasan, Balaji/0000-0001-9378-0525; Reijngoud, Dirk-Jan/0000-0003-1157-4491	European Commission [277984, FP7/2007-2013, HEALTH-F2-2011, TIRCON]; VICI grant (NWO-grant) [865.10.012]; Telethon [GGP11088]; NWO [175-010-2009-023]; GUIDE research school grant	European Commission(European CommissionEuropean Commission Joint Research Centre); VICI grant (NWO-grant); Telethon(Fondazione Telethon); NWO(Netherlands Organization for Scientific Research (NWO)); GUIDE research school grant	This work was supported by the European Commission's Seventh Framework Programme (grant number FP7/2007-2013, HEALTH-F2-2011, grant agreement number 277984, TIRCON to V.T., H.P., S.H. and O.C.M.S.), a GUIDE research school grant (to B.S.), a VICI grant (NWO-grant 865.10.012 to O.S.) and Telethon GGP11088 (to V.T.). Part of the work was performed at the UMCG Microscopy and Imaging Center (UMIC), which is sponsored by NWO grant 175-010-2009-023. We thank P.G. Tepper and R. Van Merkerk (Pharmaceutical Biology, University of Groningen) for providing HPLC technical assistance and J.-W. Kok and D. Hoekstra (Department of Cell Biology, UMCG) for helpful discussions. We also thank T. de Boer and F. Oostebring from the Analytical Biochemical Laboratory BV (ABL, Assen, the Netherlands) for mass spectrometry analysis. We are grateful to the PKAN patients and their families who contributed samples to this study.	AbdelRaheim SR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-5; BADDILEY J, 1953, NATURE, V171, P76, DOI 10.1038/171076a0; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Brunetti D, 2014, BRAIN, V137, P57, DOI 10.1093/brain/awt325; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; Davaapil H, 2014, BIOCHEM SOC T, V42, P1056, DOI 10.1042/BST20140146; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Fernandez NJ, 2007, VET CLIN PATH, V36, P223, DOI 10.1111/j.1939-165X.2007.tb00216.x; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Grobben B, 2000, BRIT J PHARMACOL, V130, P139, DOI 10.1038/sj.bjp.0703289; Gu XG, 2013, ANALYST, V138, P2427, DOI 10.1039/c3an36784c; HOAGLAND MB, 1954, J BIOL CHEM, V207, P767; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; JACKOWSKI S, 1984, J BACTERIOL, V158, P115, DOI 10.1128/JB.158.1.115-120.1984; Jansen S, 2012, STRUCTURE, V20, P1948, DOI 10.1016/j.str.2012.09.001; Kupke T, 2003, J BIOL CHEM, V278, P38229, DOI 10.1074/jbc.M306321200; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Mandel AL, 2004, ORG LETT, V6, P4801, DOI 10.1021/ol048853+; Manolopoulos P, 2008, PLATELETS, V19, P134, DOI 10.1080/09537100701708498; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Mccoy F, 2013, MOL CELL, V52, P325, DOI 10.1016/j.molcel.2013.08.043; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mensch J, 2010, EUR J PHARM BIOPHARM, V74, P495, DOI 10.1016/j.ejpb.2010.01.003; Moolman WJA, 2014, BIOCHEM SOC T, V42, P1080, DOI 10.1042/BST20140131; NOVELLI GD, 1954, J BIOL CHEM, V206, P533; Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107; Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rubio S, 2008, PLANT PHYSIOL, V148, P546, DOI 10.1104/pp.108.124057; Rucker B, 2007, MOL CELL BIOCHEM, V306, P247, DOI 10.1007/s11010-007-9576-5; Saliba KJ, 2014, BIOCHEM SOC T, V42, P1087, DOI 10.1042/BST20140158; Shi L, 2013, P NATL ACAD SCI USA, V110, P7318, DOI 10.1073/pnas.1302490110; SHIBATA K, 1983, J NUTR, V113, P2107, DOI 10.1093/jn/113.10.2107; Shibata K, 2012, ANAL BIOCHEM, V430, P151, DOI 10.1016/j.ab.2012.08.010; SHIMIZU S, 1973, AGR BIOL CHEM TOKYO, V37, P2863, DOI 10.1080/00021369.1973.10861092; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; SKREDE S, 1973, EUR J BIOCHEM, V38, P401, DOI 10.1111/j.1432-1033.1973.tb03073.x; SKREDE S, 1979, BIOCHEM BIOPH RES CO, V91, P1536, DOI 10.1016/0006-291X(79)91239-7; Srinivasan B, 2014, BIOCHEM SOC T, V42, P1075, DOI 10.1042/BST20140125; Strauss E, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P351; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TRAMS EG, 1968, BIOCHIM BIOPHYS ACTA, V163, P472, DOI 10.1016/0005-2736(68)90076-X; WITTWER CT, 1985, J CLIN INVEST, V76, P1665, DOI 10.1172/JCI112152; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zhyvoloup A, 2002, J BIOL CHEM, V277, P22107, DOI 10.1074/jbc.C200195200	48	80	83	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					784	+		10.1038/NCHEMBIO.1906	http://dx.doi.org/10.1038/NCHEMBIO.1906			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26322826				2022-12-25	WOS:000361536500011
J	Walsh, CT				Walsh, Christopher T.			A chemocentric view of the natural product inventory	NATURE CHEMICAL BIOLOGY			English	Editorial Material							NONRIBOSOMAL PEPTIDE ANTIBIOTICS; BIOSYNTHETIC-PATHWAY; POLYKETIDE; ENZYME; MECHANISMS; MACHINERY; INHIBITOR; DIVERSITY; SCAFFOLDS; POTENT		Stanford Univ, ChEM H Inst, Stanford, CA 94305 USA	Stanford University	Walsh, CT (corresponding author), Stanford Univ, ChEM H Inst, Stanford, CA 94305 USA.	cwalsh2@stanford.edu						Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; Baumann S, 2014, ANGEW CHEM INT EDIT, V53, P14605, DOI 10.1002/anie.201409964; Bowers AA, 2010, J AM CHEM SOC, V132, P12182, DOI 10.1021/ja104524q; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Cociancich S, 2015, NAT CHEM BIOL, V11, P195, DOI 10.1038/nchembio.1734; Elshahawi SI, 2015, CHEM SOC REV, V44, P7591, DOI 10.1039/c4cs00426d; Fage CD, 2015, NAT CHEM BIOL, V11, P256, DOI [10.1038/NCHEMBIO.1768, 10.1038/nchembio.1768]; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Hamamoto H, 2015, NAT CHEM BIOL, V11, P127, DOI [10.1038/NCHEMBIO.1710, 10.1038/nchembio.1710]; Herkommer D, 2015, J AM CHEM SOC, V137, P4086, DOI 10.1021/jacs.5b01894; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Klein AP, 2013, ANGEW CHEM INT EDIT, V52, P13625, DOI 10.1002/anie.201307454; Kling A, 2015, SCIENCE, V348, P1106, DOI 10.1126/science.aaa4690; Lin HC, 2015, ANGEW CHEM INT EDIT, V54, P3004, DOI 10.1002/anie.201411297; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Matsuda Y, 2014, J AM CHEM SOC, V136, P15326, DOI 10.1021/ja508127q; Phillips JW, 2011, CHEM BIOL, V18, P955, DOI 10.1016/j.chembiol.2011.06.011; Rui Z, 2014, P NATL ACAD SCI USA, V111, P18237, DOI 10.1073/pnas.1419701112; Seyedsayamdost MR, 2014, J AM CHEM SOC, V136, P15150, DOI 10.1021/ja508782y; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Tanner ME, 2015, NAT PROD REP, V32, P88, DOI 10.1039/c4np00099d; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/NCHEMBIO.1366, 10.1038/nchembio.1366]; Walsh CT, 2014, ACS CHEM BIOL, V9, P2718, DOI 10.1021/cb500695k; Walsh CT, 2013, ACS CHEM BIOL, V8, P1366, DOI 10.1021/cb4001684; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wever WJ, 2015, J AM CHEM SOC, V137, P3494, DOI 10.1021/jacs.5b00940; Xu W, 2014, NAT PROD REP, V31, P1474, DOI 10.1039/c4np00073k; Xu YQ, 2014, P NATL ACAD SCI USA, V111, P12354, DOI 10.1073/pnas.1406999111; Zhu XJ, 2015, NAT CHEM BIOL, V11, P115, DOI [10.1038/NCHEMBIO.1718, 10.1038/nchembio.1718]	34	44	44	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					620	624		10.1038/nchembio.1894	http://dx.doi.org/10.1038/nchembio.1894			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26284660				2022-12-25	WOS:000359954700002
J	Berghuis, BA; Dulin, D; Xu, ZQ; van Laar, T; Cross, B; Janissen, R; Jergic, S; Dixon, NE; Depken, M; Dekker, NH				Berghuis, Bojk A.; Dulin, David; Xu, Zhi-Qiang; van Laar, Theo; Cross, Bronwen; Janissen, Richard; Jergic, Slobodan; Dixon, Nicholas E.; Depken, Martin; Dekker, Nynke H.			Strand separation establishes a sustained lock at the Tus-Ter replication fork barrier	NATURE CHEMICAL BIOLOGY			English	Article							SEQUENCE-SPECIFIC TERMINATION; ESCHERICHIA-COLI; DNA-REPLICATION; BACILLUS-SUBTILIS; IN-VITRO; ANTIGEN HELICASE; PROTEIN IMPEDES; BINDING PROTEIN; ARREST; CONTRAHELICASE	The bidirectional replication of a circular chromosome by many bacteria necessitates proper termination to avoid the head-on collision of the opposing replisomes. In Escherichia coli, replisome progression beyond the termination site is prevented by Tus proteins bound to asymmetric Ter sites. Structural evidence indicates that strand separation on the blocking (nonpermissive) side of Tus-Ter triggers roadblock formation, but biochemical evidence also suggests roles for protein-protein interactions. Here DNA unzipping experiments demonstrate that nonpermissively oriented Tus-Ter forms a tight lock in the absence of replicative proteins, whereas permissively oriented Tus-Ter allows nearly unhindered strand separation. Quantifying the lock strength reveals the existence of several intermediate lock states that are impacted by mutations in the lock domain but not by mutations in the DNA-binding domain. Lock formation is highly specific and exceeds reported in vivo efficiencies. We postulate that protein-protein interactions may actually hinder, rather than promote, proper lock formation.	[Berghuis, Bojk A.; Dulin, David; van Laar, Theo; Cross, Bronwen; Janissen, Richard; Depken, Martin; Dekker, Nynke H.] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands; [Xu, Zhi-Qiang; Jergic, Slobodan; Dixon, Nicholas E.] Univ Wollongong, Ctr Med & Mol Biosci, Wollongong, NSW, Australia	Delft University of Technology; University of Wollongong	Berghuis, BA (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	n.h.dekker@tudelft.nl	Dixon, Nicholas E/A-1226-2008; Janissen, Richard/V-4973-2019	Dixon, Nicholas E/0000-0002-5958-6945; Janissen, Richard/0000-0003-0901-3433; Dulin, David/0000-0003-4209-0377; Berghuis, Bojk/0000-0002-7797-0553; Xu, Zhi-Qiang/0000-0002-5884-0569; van Laar, Theo/0000-0002-0990-6234; Dekker, Nynke/0000-0003-4029-0973	Australian Research Council [DP0877658]; Netherlands Organisation for Scientific Research (NWO); European Research Council	Australian Research Council(Australian Research Council); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	We thank J. Cnossen for his countless efforts in adjusting the MT software to our needs, J. Kerssemakers for discussions and S. Hamdan for his contribution to the discussion by generously sharing his own experimental observations. This study was supported by a grant from the Australian Research Council (DP0877658) to N.E.D. and by Vici and TOP grants from the Netherlands Organisation for Scientific Research (NWO) and ERC Starting Grant DynGenome from the European Research Council to N.H.D.	Andersen PA, 2000, MOL MICROBIOL, V36, P1327, DOI 10.1046/j.1365-2958.2000.01945.x; Arasaki Y, 2001, J CHEM PHYS, V114, P7941, DOI 10.1063/1.1361067; Bastia D, 2008, P NATL ACAD SCI USA, V105, P12831, DOI 10.1073/pnas.0805898105; BEDROSIAN CL, 1991, P NATL ACAD SCI USA, V88, P2618, DOI 10.1073/pnas.88.7.2618; Cnossen JP, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898178; COSKUNARI FF, 1994, J BIOL CHEM, V269, P4027; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Cowan G, 1998, STAT DATA ANAL; DANTUS M, 1990, NATURE, V343, P737, DOI 10.1038/343737a0; Dulin D, 2015, CELL REP, V10, P983, DOI 10.1016/j.celrep.2015.01.031; HIDAKA M, 1989, J BIOL CHEM, V264, P21031; HIDAKA M, 1992, J BIOL CHEM, V267, P5361; HILL TM, 1987, P NATL ACAD SCI USA, V84, P1754, DOI 10.1073/pnas.84.7.1754; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; HILL TM, 1992, ANNU REV MICROBIOL, V46, P603, DOI 10.1146/annurev.micro.46.1.603; HILL TM, 1996, ESCHERICHIA COLI SAL, P1602; Janissen R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku677; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; KAUL S, 1994, P NATL ACAD SCI USA, V91, P11143, DOI 10.1073/pnas.91.23.11143; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; LEE EH, 1992, J BIOL CHEM, V267, P8778; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; Lee JY, 2014, MOL CELL, V54, P832, DOI 10.1016/j.molcel.2014.03.033; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Middleton CT, 2009, ANNU REV PHYS CHEM, V60, P217, DOI 10.1146/annurev.physchem.59.032607.093719; Mohanty BK, 1998, J BIOL CHEM, V273, P3051, DOI 10.1074/jbc.273.5.3051; Mohanty BK, 1996, EMBO J, V15, P2530, DOI 10.1002/j.1460-2075.1996.tb00610.x; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Press W. H., 1992, ART SCI COMPUTING; SAHOO T, 1995, J BIOL CHEM, V270, P29138, DOI 10.1074/jbc.270.49.29138; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Velthuis AJWT, 2010, BIOPHYS J, V99, P1292, DOI 10.1016/j.bpj.2010.06.008; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103; Yu ZB, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904148	38	25	25	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2015	11	8					579	U75		10.1038/NCHEMBIO.1857	http://dx.doi.org/10.1038/NCHEMBIO.1857			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN2MJ	26147356	Green Submitted			2022-12-25	WOS:000358255300012
J	Eleveld, TF; Oldridge, DA; Bernard, V; Koster, J; Daage, LC; Diskin, SJ; Schild, L; Bentahar, NB; Bellini, A; Chicard, M; Lapouble, E; Combaret, V; Legoix-Ne, P; Michon, J; Pugh, TJ; Hart, LS; Rader, J; Attiyeh, EF; Wei, JS; Zhang, SL; Naranjo, A; Gastier-Foster, JM; Hogarty, MD; Asgharzadeh, S; Smith, MA; Auvil, JMG; Watkins, TBK; Zwijnenburg, DA; Ebus, ME; van Sluis, P; Hakkert, A; van Wezel, E; van der Schoot, CE; Westerhout, EM; Schulte, JH; Tytgat, GA; Dolman, MEM; Janoueix-Lerosey, I; Gerhard, DS; Caron, HN; Delattre, O; Khan, J; Versteeg, R; Schleiermacher, G; Molenaar, JJ; Maris, JM				Eleveld, Thomas F.; Oldridge, Derek A.; Bernard, Virginie; Koster, Jan; Daage, Leo Colmet; Diskin, Sharon J.; Schild, Linda; Bentahar, Nadia Bessoltane; Bellini, Angela; Chicard, Mathieu; Lapouble, Eve; Combaret, Valerie; Legoix-Ne, Patricia; Michon, Jean; Pugh, Trevor J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Wei, Jun S.; Zhang, Shile; Naranjo, Arlene; Gastier-Foster, Julie M.; Hogarty, Michael D.; Asgharzadeh, Shahab; Smith, Malcolm A.; Auvil, Jaime M. Guidry; Watkins, Thomas B. K.; Zwijnenburg, Danny A.; Ebus, Marli E.; van Sluis, Peter; Hakkert, Anne; van Wezel, Esther; van der Schoot, C. Ellen; Westerhout, Ellen M.; Schulte, Johannes H.; Tytgat, Godelieve A.; Dolman, M. Emmy M.; Janoueix-Lerosey, Isabelle; Gerhard, Daniela S.; Caron, Huib N.; Delattre, Olivier; Khan, Javed; Versteeg, Rogier; Schleiermacher, Gudrun; Molenaar, Jan J.; Maris, John M.			Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations	NATURE GENETICS			English	Article							SEQUENCING DATA; CHROMOSOME 1P; ALK MUTATIONS; HUMAN CANCER; THERAPY; COMBINATION; PROGRESSION; ASSOCIATION; SENSITIVITY; CRIZOTINIB	The majority of patients with neuroblastoma have tumors that initially respond to chemotherapy, but a large proportion will experience therapy-resistant relapses. The molecular basis of this aggressive phenotype is unknown. Whole-genome sequencing of 23 paired diagnostic and relapse neuroblastomas showed clonal evolution from the diagnostic tumor, with a median of 29 somatic mutations unique to the relapse sample. Eighteen of the 23 relapse tumors (78%) showed mutations predicted to activate the RAS-MAPK pathway. Seven of these events were detected only in the relapse tumor, whereas the others showed clonal enrichment. In neuroblastoma cell lines, we also detected a high frequency of activating mutations in the RAS-MAPK pathway (11/18; 61%), and these lesions predicted sensitivity to MEK inhibition in vitro and in vivo. Our findings provide a rationale for genetic characterization of relapse neuroblastomas and show that RAS-MAPK pathway mutations may function as a biomarker for new therapeutic approaches to refractory disease.	[Eleveld, Thomas F.; Koster, Jan; Schild, Linda; Zwijnenburg, Danny A.; Ebus, Marli E.; van Sluis, Peter; Hakkert, Anne; Westerhout, Ellen M.; Dolman, M. Emmy M.; Versteeg, Rogier; Molenaar, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Oldridge, Derek A.; Diskin, Sharon J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; Diskin, Sharon J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; Diskin, Sharon J.; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bernard, Virginie; Daage, Leo Colmet; Bentahar, Nadia Bessoltane; Legoix-Ne, Patricia] Inst Curie, ICGEX Platform, Paris, France; [Daage, Leo Colmet; Bellini, Angela; Chicard, Mathieu; Schleiermacher, Gudrun] Inst Curie, Transfer Dept, Lab RTOP, Paris, France; [Lapouble, Eve] Inst Curie, Unite Genet Somat, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translat Lyon, F-69373 Lyon, France; [Michon, Jean; Schleiermacher, Gudrun] Inst Curie, Dept Pediat, Paris, France; [Pugh, Trevor J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Wei, Jun S.; Zhang, Shile; Khan, Javed] NIH, Pediat Oncol Branch, Oncogen Sect, Ctr Canc Res, Gaithersburg, MD USA; [Naranjo, Arlene] Univ Florida, Dept Biostat, COG, Gainesville, FL USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.; Gerhard, Daniela S.] Nationwide Childrens Hosp, Biopathol Ctr, Columbus, OH USA; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Smith, Malcolm A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Auvil, Jaime M. Guidry] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Watkins, Thomas B. K.] Canc Res UK, Translat Canc Therapeut Lab, London, England; [van Wezel, Esther; van der Schoot, C. Ellen] Sanquin Res, Dept Expt Immunohematol, Amsterdam, Netherlands; [van Wezel, Esther; van der Schoot, C. Ellen] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Schulte, Johannes H.] Charite, Dept Pediat Oncol & Hematol, D-13353 Berlin, Germany; [Schulte, Johannes H.] German Consortium Translat Canc Res DKTK, Heidelberg, Germany; [Schulte, Johannes H.] Univ Childrens Hosp Essen, Dept Pediat Oncol & Hematol, Essen, Germany; [Schulte, Johannes H.] Univ Hosp Essen, West German Canc Ctr WTZ, Translat Neurooncol, Essen, Germany; [Tytgat, Godelieve A.; Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Janoueix-Lerosey, Isabelle; Delattre, Olivier; Schleiermacher, Gudrun] Inst Curie, Lab Genet & Biol Canc, INSERM U830, Paris, France	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of Florida; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Cancer Research UK; University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Duisburg Essen; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Schleiermacher, G (corresponding author), Inst Curie, Transfer Dept, Lab RTOP, Paris, France.	gudrun.schleiermacher@curie.fr; j.j.molenaar@amc.uva.nl; maris@chop.edu	Schleiermacher, Gudrun/AAN-4711-2021; Schulte, Johannes H./V-2474-2018; Eleveld, Thomas/AAA-5416-2021; Versteeg, Rogier/AAQ-1765-2020; Khan, Javed/P-9157-2014; Janoueix-Lerosey, Isabelle/G-1758-2018; Koster, Jan/C-5934-2008; Eleveld, Thomas/AGV-7775-2022; tytgat, g/ABF-6481-2020; Pugh, Trevor/Y-2535-2019	Schleiermacher, Gudrun/0000-0002-0133-5879; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Koster, Jan/0000-0002-0890-7585; Eleveld, Thomas/0000-0001-8580-4822; Pugh, Trevor/0000-0002-8073-5888; COLMET DAAGE, Leo/0000-0002-5472-4616; delattre, olivier/0000-0002-8730-2276; Dolman, Emmy/0000-0002-0567-5918; Schulte, Johannes Hubertus/0000-0003-0671-1201; Tytgat, Lieve/0000-0003-4452-0748; Smith, Malcolm/0000-0001-9880-9876; Chicard, Mathieu/0000-0002-0697-8611; Zwijnenburg, Danny/0000-0002-9353-8904; Versteeg, Rogier/0000-0001-7172-0388	US National Institutes of Health [RC1MD004418, HHSN261200800001E]; University of Pennsylvania Genome Frontiers Institute; National Cancer Institute; Annenberg Foundation; Nelia and Amadeo Barletta Foundation; SiRIC/INCa [INCa-DGOS-4654]; Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie; Associations Enfants et Sante; Association Hubert Gouin Enfance et Cancer; Les Bagouz a Manon; Les Amis de Claire; EQUIPEX Investissements d'Avenir program [ANR-10-EQPX-03]; Agence Nationale de le Recherche [ANR10-INBS-09-08]; Canceropole Ile-de-France; Villa Joep Foundation; Kinderen Kankervrij Foundation; Netherlands Cancer Foundation; NATIONAL CANCER INSTITUTE [F30CA192831, U10CA180886, U10CA098413, U10CA098543] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004418] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Genome Frontiers Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Annenberg Foundation; Nelia and Amadeo Barletta Foundation; SiRIC/INCa; Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie; Associations Enfants et Sante; Association Hubert Gouin Enfance et Cancer; Les Bagouz a Manon; Les Amis de Claire; EQUIPEX Investissements d'Avenir program(French National Research Agency (ANR)); Agence Nationale de le Recherche(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); Villa Joep Foundation; Kinderen Kankervrij Foundation; Netherlands Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank N. Ross for sample preparation and quality control. This study was supported in part by US National Institutes of Health grants RC1MD004418 to the TARGET consortium and CA98543 and CA98413 to the Children's Oncology Group and was supported in part by a grant throughout the University of Pennsylvania Genome Frontiers Institute. In addition, this project was funded in part with federal funds from the National Cancer Institute, US National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services nor does mention of trade names, commercial products or organizations imply endorsement by the US government. The binimetinib xenograft studies were supported through a research collaborative agreement between the Children's Hospital of Philadelphia and Novartis Pharmaceuticals. In France, this study was supported by the Annenberg Foundation and the Nelia and Amadeo Barletta Foundation. Funding was also obtained from SiRIC/INCa (grant INCa-DGOS-4654) and from the Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie. This study was also funded by the Associations Enfants et Sante, Association Hubert Gouin Enfance et Cancer, Les Bagouz a Manon and Les Amis de Claire. Deep sequencing experiments were conducted on the ICGex next-generation sequencing platform at the Institut Curie funded by the EQUIPEX Investissements d'Avenir program (ANR-10-EQPX-03) and ANR10-INBS-09-08 from the Agence Nationale de le Recherche and by the Canceropole Ile-de-France. In the Netherlands, this study was supported by grants from the Villa Joep Foundation, the Kinderen Kankervrij Foundation and the Netherlands Cancer Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Boca SM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r112; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamers F, 2012, EUR J CANCER, V48, P763, DOI 10.1016/j.ejca.2011.10.012; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moore NF, 2014, ONCOTARGET, V5, P8737, DOI 10.18632/oncotarget.2372; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2014, J CLIN ONCOL, V32, P2727, DOI 10.1200/JCO.2013.54.0674; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Taggart D, 2008, Q J NUCL MED MOL IM, V52, P403; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	42	313	320	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					864	+		10.1038/ng.3333	http://dx.doi.org/10.1038/ng.3333			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26121087	Green Accepted			2022-12-25	WOS:000358674100008
J	Helgason, H; Rafnar, T; Olafsdottir, HS; Jonasson, JG; Sigurdsson, A; Stacey, SN; Jonasdottir, A; Tryggvadottir, L; Alexiusdottir, K; Haraldsson, A; Le Roux, L; Gudmundsson, J; Johannsdottir, H; Oddsson, A; Gylfason, A; Magnusson, OT; Masson, G; Jonsson, T; Skuladottir, H; Gudbjartsson, DF; Thorsteinsdottir, U; Sulem, P; Stefansson, K				Helgason, Hannes; Rafnar, Thorunn; Olafsdottir, Halla S.; Jonasson, Jon G.; Sigurdsson, Asgeir; Stacey, Simon N.; Jonasdottir, Adalbjorg; Tryggvadottir, Laufey; Alexiusdottir, Kristin; Haraldsson, Asgeir; Le Roux, Louise; Gudmundsson, Julius; Johannsdottir, Hrefna; Oddsson, Asmundur; Gylfason, Arnaldur; Magnusson, Olafur T.; Masson, Gisli; Jonsson, Thorvaldur; Skuladottir, Halla; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Sulem, Patrick; Stefansson, Kari			Loss-of-function variants in ATM confer risk of gastric cancer	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA; GENETIC-VARIATION; MUC1; MUTATIONS; FREQUENCY; FRAMEWORK; PLCE1; LOCUS; RARE	Gastric cancer is a serious health problem worldwide, with particularly high prevalence in eastern Asia. Genome-wide association studies (GWAS) in Asian populations have identified several loci that associate with gastric cancer risk. Here we report a GWAS of gastric cancer in a European population, using information on 2,500 population-based gastric cancer cases and 205,652 controls. We found a new gastric cancer association with loss-of-function mutations in ATM (gene test, P = 8.0 x 10(-12); odds ratio (OR) = 4.74). The combination of the loss-of-function variants p.Gln852*, p.Ser644* and p.Tyr103* (combined minor allele frequency (MAF) = 0.3%) also associates with pancreatic and prostate cancers (OR = 3.81 and 2.18, respectively) and gives an indication of risk of breast and colorectal cancers (OR = 1.82 and 1.97, respectively). Cancers in those carrying loss-of-function ATM mutations are diagnosed at a significantly earlier age than in non-carriers. Our results confirm an association between gastric cancer in Europeans and three loci previously reported in Asians, MUC1, PRKAA1 and PSCA, refine the association signal at PRKAA1 and support a pathogenic role for the tandem repeat identified in MUC1.	[Helgason, Hannes; Rafnar, Thorunn; Sigurdsson, Asgeir; Stacey, Simon N.; Jonasdottir, Adalbjorg; Le Roux, Louise; Gudmundsson, Julius; Johannsdottir, Hrefna; Oddsson, Asmundur; Gylfason, Arnaldur; Magnusson, Olafur T.; Masson, Gisli; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Sulem, Patrick; Stefansson, Kari] deCODE Genet Amgen, Reykjavik, Iceland; [Helgason, Hannes; Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Olafsdottir, Halla S.; Alexiusdottir, Kristin] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Jonasson, Jon G.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Jonasson, Jon G.] Iceland Canc Registry, Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey; Haraldsson, Asgeir; Jonsson, Thorvaldur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Haraldsson, Asgeir] Childrens Hosp Iceland, Landspitali Univ Hosp, Reykjavik, Iceland; [Jonsson, Thorvaldur] Landspitali Univ Hosp, Dept Surg, Reykjavik, Iceland; [Skuladottir, Halla] Reg Hosp West Jutland, Dept Oncol, Herning, Denmark	University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital	Helgason, H (corresponding author), deCODE Genet Amgen, Reykjavik, Iceland.	hannes.helgason@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019	Jonasson, Jon G./0000-0002-2635-5032; Tryggvadottir, Laufey/0000-0001-8067-9030; Oddsson, Asmundur/0000-0002-4606-5163; Skuladottir, Halla/0000-0001-8703-9407; le Roux, Louise/0000-0002-9491-9653; Haraldsson, Asgeir/0000-0001-5364-7877				Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Carvalho F, 1997, GLYCOCONJUGATE J, V14, P107, DOI 10.1023/A:1018573201347; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Hemminki K, 2007, BRIT J CANCER, V96, P1272, DOI 10.1038/sj.bjc.6603722; HOLM S, 1979, SCAND J STAT, V6, P65; Jia YB, 2010, CANCER CAUSE CONTROL, V21, P313, DOI 10.1007/s10552-009-9463-3; Jin GF, 2012, AM J HUM GENET, V91, P928, DOI 10.1016/j.ajhg.2012.09.009; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Li AR, 2000, AM J MED GENET, V92, P170, DOI 10.1002/(SICI)1096-8628(20000529)92:3<170::AID-AJMG3>3.0.CO;2-#; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Majithia AR, 2014, P NATL ACAD SCI USA, V111, P13127, DOI 10.1073/pnas.1410428111; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ng W, 2008, BRIT J CANCER, V99, P978, DOI 10.1038/sj.bjc.6604617; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; PARKIN DM, 1984, B WORLD HEALTH ORGAN, V62, P163, DOI 10.1139/b84-027; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Roberts NJ, 2012, CANCER DISCOV, V2, P41, DOI 10.1158/2159-8290.CD-11-0194; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sala N, 2012, INT J CANCER, V130, P2417, DOI 10.1002/ijc.26243; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Sigurdardottir LG, 2012, ACTA ONCOL, V51, P880, DOI 10.3109/0284186X.2012.698751; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108	37	100	102	3	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					906	+		10.1038/ng.3342	http://dx.doi.org/10.1038/ng.3342			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26098866				2022-12-25	WOS:000358674100015
J	Yang, Z; Wang, SJ; Halim, A; Schulz, MA; Frodin, M; Rahman, SH; Vester-Christensen, MB; Behrens, C; Kristensen, C; Vakhrushev, SY; Bennett, EP; Wandall, HH; Clausen, H				Yang, Zhang; Wang, Shengjun; Halim, Adnan; Schulz, Morten Alder; Frodin, Morten; Rahman, Shamim H.; Vester-Christensen, Malene B.; Behrens, Carsten; Kristensen, Claus; Vakhrushev, Sergey Y.; Bennett, Eric Paul; Wandall, Hans H.; Clausen, Henrik			Engineered CHO cells for production of diverse, homogeneous glycoproteins	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; RECOMBINANT ERYTHROPOIETIN; GLYCOSYLATION; LINES; FUT8	Production of glycoprotein therapeutics in Chinese hamster ovary (CHO) cells is limited by the cells' generic capacity for N-glycosylation, and production of glycoproteins with desirable homogeneous glycoforms remains a challenge. We conducted a comprehensive knockout screen of glycosyltransferase genes controlling N-glycosylation in CHO cells and constructed a design matrix that facilitates the generation of desired glycosylation, such as human-like alpha 2,6-linked sialic acid capping. This engineering approach will aid the production of glycoproteins with improved properties and therapeutic potential.	[Yang, Zhang; Wang, Shengjun; Halim, Adnan; Schulz, Morten Alder; Rahman, Shamim H.; Vester-Christensen, Malene B.; Kristensen, Claus; Vakhrushev, Sergey Y.; Bennett, Eric Paul; Wandall, Hans H.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Ctr Glyc Cellular & Mol Med & Odontol, Copenhagen N, Denmark; [Yang, Zhang; Wang, Shengjun; Halim, Adnan; Clausen, Henrik] Danish Tech Univ, Novo Nordisk Fdn, Ctr Biosustainabil, Copenhagen, Denmark; [Frodin, Morten] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Rahman, Shamim H.; Vester-Christensen, Malene B.; Behrens, Carsten] Novo Nordisk AS, Malov, Denmark	University of Copenhagen; Novo Nordisk Foundation; Technical University of Denmark; University of Copenhagen; Novo Nordisk	Yang, Z (corresponding author), Univ Copenhagen, Fac Hlth Sci, Ctr Glyc Cellular & Mol Med & Odontol, Copenhagen N, Denmark.	yang@sund.ku.dk; hclau@sund.ku.dk	Bennett, Eric/AAG-6120-2020; Vakhrushev, Sergey Y/A-7638-2014; Kristensen, Claus/O-8047-2015; clausen, henrik/AAD-8016-2021; Yang, Zhang/I-8934-2016	Bennett, Eric/0000-0002-4976-0647; Vakhrushev, Sergey Y/0000-0002-0418-5765; Frodin, Morten/0000-0003-3691-9820; Kristensen, Claus/0000-0002-2594-7722; Clausen, Henrik/0000-0002-0915-5055; Yang, Zhang/0000-0002-4756-5813; Halim, Adnan/0000-0003-1629-187X; Wandall, Hans H./0000-0003-0240-9232	Novo Nordisk Foundation; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Copenhagen University Excellence Programme for Interdisciplinary Research [CDO2016]; Danish National Research Foundation [DNRF107]; Danish Councils for Strategic and Independent Research; Lundbeck Foundation [R108-2012-10312] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kirsten og Freddy Johansen Fonden; Mizutani Foundation; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Copenhagen University Excellence Programme for Interdisciplinary Research; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Councils for Strategic and Independent Research; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	We would like to express our sincere gratitude to the SAFC Sigma team including K. Kayser and N. Sealover for their help with ZFN targeting constructs. We are also grateful to B. Palsson for help throughout this work and critical comments on the manuscript. We are grateful to M. Uhlen, L.E. Pedersen and B. Voldborg at the Novo Nordisk Foundation Center for Biosustainability, Danish Technical University, for RNA-seq analysis. This work was supported by the Novo Nordisk Foundation, Kirsten og Freddy Johansen Fonden, The Mizutani Foundation, A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, Copenhagen University Excellence Programme for Interdisciplinary Research (CDO2016), the Danish National Research Foundation (DNRF107) and The Danish Councils for Strategic and Independent Research. All reagents and cell lines used in the study are available upon request for research purposes under a material transfer agreement.	Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; El Mai Nassimal, 2013, Methods Mol Biol, V988, P19, DOI 10.1007/978-1-62703-327-5_2; FUKUDA MN, 1989, BLOOD, V73, P84; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Narimatsu H, 2006, CURR OPIN STRUC BIOL, V16, P567, DOI 10.1016/j.sbi.2006.09.001; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; SASAKI H, 1988, BIOCHEMISTRY-US, V27, P8618, DOI 10.1021/bi00423a017; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Steentoft C, 2014, GLYCOBIOLOGY, V24, P663, DOI 10.1093/glycob/cwu046; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126	19	163	169	3	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					842	+		10.1038/nbt.3280	http://dx.doi.org/10.1038/nbt.3280			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26192319				2022-12-25	WOS:000359274900023
J	Cha-Molstad, H; Sung, KS; Hwang, J; Kim, KA; Yu, JE; Yoo, YD; Jang, JM; Han, DH; Molstad, M; Kim, JG; Lee, YJ; Zakrzewska, A; Kim, SH; Kim, ST; Kim, SY; Lee, HG; Soung, NK; Ahn, JS; Ciechanover, A; Kim, BY; Kwon, YT				Cha-Molstad, Hyunjoo; Sung, Ki Sa; Hwang, Joonsung; Kim, Kyoung A.; Yu, Ji Eun; Yoo, Young Dong; Jang, Jun Min; Han, Dong Hoon; Molstad, Michael; Kim, Jung Gi; Lee, Yoon Jee; Zakrzewska, Adriana; Kim, Su-Hyeon; Kim, Sung Tae; Kim, Sun Yong; Lee, Hee Gu; Soung, Nak Kyun; Ahn, Jong Seog; Ciechanover, Aaron; Kim, Bo Yeon; Kwon, Yong Tae			Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding	NATURE CELL BIOLOGY			English	Article							END RULE PATHWAY; UBIQUITIN-PROTEASOME SYSTEM; UNFOLDED PROTEIN RESPONSE; MOLECULAR PRINCIPLES; MEDIATED AUTOPHAGY; CELLULAR-PROTEINS; DEGRADATION; COMPONENT; CALRETICULIN; RECEPTORS	We show that ATE1-encoded Arg-transfer RNA transferase (R-transferase) of the N-end rule pathway mediates N-terminal arginylation of multiple endoplasmic reticulum (ER)-residing chaperones, leading to their cytosolic relocalization and turnover. N-terminal arginylation of BiP (also known as GRP78), protein disulphide isomerase and calreticulin is co-induced with autophagy during innate immune responses to cytosolic foreign DNA or proteasomal inhibition, associated with increased ubiquitylation. Arginylated BiP (R-BiP) is induced by and associated with cytosolic misfolded proteins destined for p62 (also known as sequestosome 1, SQSTM1) bodies. R-BiP binds the autophagic adaptor p62 through the interaction of its N-terminal arginine with the p62 ZZ domain. This allosterically induces self-oligomerization and aggregation of p62 and increases p62 interaction with LC3, leading to p62 targeting to autophagosomes and selective lysosomal co-degradation of R-BiP and p62 together with associated cargoes. In this autophagic mechanism, Nt-arginine functions as a delivery determinant, a degron and an activating ligand. Bioinformatics analysis predicts that many ER residents use arginylation to regulate non-ER processes.	[Cha-Molstad, Hyunjoo; Hwang, Joonsung; Kim, Kyoung A.; Yu, Ji Eun; Kim, Jung Gi; Kim, Su-Hyeon; Soung, Nak Kyun; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, World Class Inst, Ochang 363883, Cheongwon, South Korea; [Sung, Ki Sa; Yoo, Young Dong; Molstad, Michael; Lee, Yoon Jee; Kim, Sung Tae; Ciechanover, Aaron; Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul 110799, South Korea; [Sung, Ki Sa; Yoo, Young Dong; Molstad, Michael; Lee, Yoon Jee; Kim, Sung Tae; Ciechanover, Aaron; Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Sung, Ki Sa; Zakrzewska, Adriana; Kim, Sung Tae] Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Sung, Ki Sa; Zakrzewska, Adriana; Kim, Sung Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Yu, Ji Eun] Chungbuk Natl Univ, Coll Pharm, Dept Drug Discovery & Dev, Cheonju 361736, Chungbuk, South Korea; [Jang, Jun Min] Seoul Natl Univ, World Class Univ WCU Program, Dept Mol Med & Biopharmaceut Sci, Seoul 110799, South Korea; [Han, Dong Hoon] Kyung Hee Univ, Coll Appl Sci, Dept Appl Chem, Yongin 446701, South Korea; [Kim, Sun Yong] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 443380, South Korea; [Lee, Hee Gu] Korea Res Inst Biosci & Biotechnol, Genom Struct Res Ctr, Ochang 363883, Cheongwon, South Korea; [Ahn, Jong Seog] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, Ochang 363883, Cheongwon, South Korea; [Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med, Polak Tumor & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Ciechanover, Aaron] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chungbuk National University; Seoul National University (SNU); Kyung Hee University; Ajou University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Seoul National University (SNU)	Kim, BY (corresponding author), Korea Res Inst Biosci & Biotechnol, World Class Inst, Ochang 363883, Cheongwon, South Korea.	bykim@kribb.re.kr; yok5@snu.ac.kr	han, donghoon/AAU-8725-2021; Ciechanover, Aaron J/C-9166-2017		World Class Institute (WCI) Program [WCI 2009-002]; Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MSIP) of Korea [NRF-2014M3A9B5073938]; Global R&D Center (GRDC) Program; KRIBB Research Initiative Program; NIH [HL083365]; Basic Science Research Programs of the NRF - MSIP [NRF-2013R1A2A2A01014170]; Ministry of Education [NRF-2013R1A1A2058983]; Brain Korea 21 PLUS Program; SNU Nobel Laureates Invitation Program; Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER	World Class Institute (WCI) Program; Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MSIP) of Korea; Global R&D Center (GRDC) Program; KRIBB Research Initiative Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Programs of the NRF - MSIP; Ministry of Education; Brain Korea 21 PLUS Program; SNU Nobel Laureates Invitation Program; Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF)(Israel Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. K. Ko (KRIBB) for providing HeLa cells stably expressing RFP-GFP-LC3, Suhyun Lee (Seoul National University) for immunoblotting analysis of R-BiP, W. T. Kwon (Columbia University) for bioinformatics analysis of N-degrons in the ER, H. J. Jeong (KAIST) for immunostaining analysis of R-BiP and KDEL, S. Hong (Yonsei University) for immunostaining analysis of NF kappa B, and S. J. Yoo (Middleton High School) for technical assistance. This work was supported by the World Class Institute (WCI) Program (WCI 2009-002 to B.Y.K.) and the Bio and Medical Technology Development Program (NRF-2014M3A9B5073938 to B.Y.K.) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea, the Global R&D Center (GRDC) Program (to J.S.A.), the KRIBB Research Initiative Program, NIH grant HL083365 (to Y.T.K. and S. Li), the Basic Science Research Programs of the NRF funded by the MSIP (NRF-2013R1A2A2A01014170 to Y.T.K.) and by the Ministry of Education (NRF-2013R1A1A2058983 to Y.D.Y.), the Brain Korea 21 PLUS Program (to SNU), the SNU Nobel Laureates Invitation Program (to A.C.), the Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) (to A.C.) and the Israel Science Foundation (ISF) (to A.C.). A.C. is an Israel Cancer Research Fund (ICRF) USA Professor.	An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Ciechanover A, 2013, BIOORGAN MED CHEM, V21, P3400, DOI 10.1016/j.bmc.2013.01.056; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim ST, 2013, AUTOPHAGY, V9, P1100, DOI 10.4161/auto.24643; Kitzler TM, 2012, BBA-MOL CELL RES, V1823, P1007, DOI 10.1016/j.bbamcr.2012.03.001; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2012, J BIOL CHEM, V287, P24043, DOI 10.1074/jbc.M112.364117; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Scott M, 2004, BIOINFORMATICS, V20, P937, DOI 10.1093/bioinformatics/bth010; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	49	142	149	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					917	929		10.1038/ncb3177	http://dx.doi.org/10.1038/ncb3177			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26075355	Green Accepted			2022-12-25	WOS:000357353400012
J	Khosla, C				Khosla, Chaitan			Quo vadis, enzymology?	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; BIOSYNTHESIS; ENERGY		Stanford Univ, Dept Chem Chem Engn & Biochem, Stanford, CA 94305 USA	Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem Chem Engn & Biochem, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	US National Institutes of Health [R01 GM087934, R01 DK063158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087934] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am grateful to C. Walsh for numerous discussions on the subject and for his feedback on an early draft of this article. Research on enzymology in my laboratory has been generously supported by the US National Institutes of Health (R01 GM087934 and R01 DK063158).	Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Clausen AR, 2015, NAT STRUCT MOL BIOL, V22, P185, DOI 10.1038/nsmb.2957; Jencks W P, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P75; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; KORNBERG A, 1987, BIOCHEMISTRY-US, V26, P6888, DOI 10.1021/bi00396a002; Leroux AE, 2013, J BIOL CHEM, V288, P23751, DOI 10.1074/jbc.M113.483289; Lin CI, 2013, CHEM SOC REV, V42, P4377, DOI 10.1039/c2cs35438a; Lowry B, 2015, SYNLETT, V26, P1008, DOI 10.1055/s-0034-1380264; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Ramesh A, 2014, BBA-GENE REGUL MECH, V1839, P989, DOI 10.1016/j.bbagrm.2014.04.015; Ringe D, 2008, SCIENCE, V320, P1428, DOI 10.1126/science.1159747; Roberts AA, 2010, TOP CURR CHEM, V297, P149, DOI 10.1007/128_2010_79; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; Spudich JA, 2012, NAT MED, V18, P1478, DOI 10.1038/nm.2924; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; Tibrewal N, 2014, ANNU REV CHEM BIOMOL, V5, P347, DOI 10.1146/annurev-chembioeng-060713-040008; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Walsh C., 2006, POSTTRANSLATIONAL MO; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344	20	11	11	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					438	441		10.1038/nchembio.1844	http://dx.doi.org/10.1038/nchembio.1844			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26083060	Green Accepted			2022-12-25	WOS:000356334600001
J	Rogerson, DT; Sachdeva, A; Wang, KH; Haq, T; Kazlauskaite, A; Hancock, SM; Huguenin-Dezot, N; Muqit, MMK; Fry, AM; Bayliss, R; Chin, JW				Rogerson, Daniel T.; Sachdeva, Amit; Wang, Kaihang; Haq, Tamanna; Kazlauskaite, Agne; Hancock, Susan M.; Huguenin-Dezot, Nicolas; Muqit, Miratul M. K.; Fry, Andrew M.; Bayliss, Richard; Chin, Jason W.			Efficient genetic encoding of phosphoserine and its nonhydrolyzable analog	NATURE CHEMICAL BIOLOGY			English	Article							DEPENDENT CYSTEINE BIOSYNTHESIS; RNA SYNTHETASE/TRNA PAIRS; UNNATURAL AMINO-ACIDS; ESCHERICHIA-COLI; CODON REASSIGNMENT; ACTIVATE PARKIN; PHOSPHORYLATION; UBIQUITIN; MUTAGENESIS; KINASE	Serine phosphorylation is a key post-translational modification that regulates diverse biological processes. Powerful analytical methods have identified thousands of phosphorylation sites, but many of their functions remain to be deciphered. A key to understanding the function of protein phosphorylation is access to phosphorylated proteins, but this is often challenging or impossible. Here we evolve an orthogonal aminoacyl-tRNA synthetase/tRNACUA pair that directs the efficient incorporation of phosphoserine (pSer (1)) into recombinant proteins in Escherichia coli. Moreover, combining the orthogonal pair with a metabolically engineered Escherichia coli enables the site-specific incorporation of a nonhydrolyzable analog of pSer. Our approach enables quantitative decoding of the amber stop codon as pSer, and we purify, with yields of several milligrams per liter of culture, proteins bearing biologically relevant phosphorylations that were previously challenging or impossible to access-including phosphorylated ubiquitin and the kinase Nek7, which is synthetically activated by a genetically encoded phosphorylation in its activation loop.	[Rogerson, Daniel T.; Sachdeva, Amit; Wang, Kaihang; Hancock, Susan M.; Huguenin-Dezot, Nicolas; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge, England; [Haq, Tamanna; Fry, Andrew M.; Bayliss, Richard] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Kazlauskaite, Agne; Muqit, Miratul M. K.] Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland; [Muqit, Miratul M. K.] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland	MRC Laboratory Molecular Biology; University of Leicester; University of Dundee; University of Dundee	Chin, JW (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge, England.	chin@mrc-lmb.cam.ac.uk	Singh, Pramod K./F-1379-2016	Singh, Pramod K./0000-0002-3155-6621; Huguenin-Dezot, Nicolas/0000-0001-8816-2159; Wang, Kaihang/0000-0001-7657-8755; Bayliss, Richard/0000-0003-0604-2773	UK Medical Research Council [U105181009, UD99999908]; European Research Council; Wellcome Trust [101022/Z/13/Z]; Worldwide Cancer Research grant [13-0042]; Cancer Research UK Programme Award [C24461/A12772]; Cancer Research UK [12772] Funding Source: researchfish; Medical Research Council [MC_UP_A024_1008, MC_U105181009] Funding Source: researchfish; Parkinson&quot;s UK [H-1403, G-1506] Funding Source: researchfish; Worldwide Cancer Research [13-0042] Funding Source: researchfish; MRC [MC_UP_A024_1008, MC_U105181009] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Worldwide Cancer Research grant; Cancer Research UK Programme Award(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the UK Medical Research Council Laboratory of Molecular Biology (MRC-LMB) Mass Spectrometry for extensive assistance. M. Richards (University of Leicester) for the Nek7 plasmid, T. Elliott (MRC-LMB), J. Madrzak (MRC-LMB) and M. Mahesh (MRC-LMB) for assistance. This work was supported by grants to J. W.C. from the UK Medical Research Council (U105181009 and UD99999908) and the European Research Council. M.M. K.M. is supported by the Wellcome Trust (101022/Z/13/Z), J. Macdonald Menzies Charitable Trust and Tenovus (Scotland). A.F.M. is supported by a Worldwide Cancer Research grant (13-0042) and R.B. by a Cancer Research UK Programme Award (C24461/A12772).	Aerni HR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1087; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Chatterjee A, 2012, P NATL ACAD SCI USA, V109, P14841, DOI 10.1073/pnas.1212454109; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Eargle J, 2008, J MOL BIOL, V377, P1382, DOI 10.1016/j.jmb.2008.01.073; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Hejjaoui M, 2012, J AM CHEM SOC, V134, P5196, DOI 10.1021/ja210866j; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Klingberg R, 2015, ACS CHEM BIOL, V10, P138, DOI 10.1021/cb500563n; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lee S, 2013, ANGEW CHEM INT EDIT, V52, P5771, DOI 10.1002/anie.201300531; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu F, 2011, NAT CHEM BIOL, V7, P595, DOI 10.1038/nchembio.614; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Neumann H, 2010, J AM CHEM SOC, V132, P2142, DOI 10.1021/ja9068722; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nguyen DP, 2009, J AM CHEM SOC, V131, P14194, DOI 10.1021/ja906603s; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ottesen JJ, 2004, BIOCHEMISTRY-US, V43, P5698, DOI 10.1021/bi0498407; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; PIZER LI, 1963, J BIOL CHEM, V238, P3934; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; SWANSON R, 1988, SCIENCE, V242, P1548, DOI 10.1126/science.3144042; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423	39	130	133	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					496	+		10.1038/NCHEMBIO.1823	http://dx.doi.org/10.1038/NCHEMBIO.1823			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26030730	Green Accepted			2022-12-25	WOS:000356334600014
J	Berlin, K; Koren, S; Chin, CS; Drake, JP; Landolin, JM; Phillippy, AM				Berlin, Konstantin; Koren, Sergey; Chin, Chen-Shan; Drake, James P.; Landolin, Jane M.; Phillippy, Adam M.			Assembling large genomes with single-molecule sequencing and locality-sensitive hashing	NATURE BIOTECHNOLOGY			English	Article							MICROBIAL GENOMES; IDENTIFICATION; CHROMOSOME; ALGORITHM; ALIGNMENT	Long-read, single-molecule real-time (SMRT) sequencing is routinely used to finish microbial genomes, but available assembly methods have not scaled well to larger genomes. We introduce the MinHash Alignment Process (MHAP) for overlapping noisy, long reads using probabilistic, locality-sensitive hashing. Integrating MHAP with the Celera Assembler enabled reference-grade de novo assemblies of Saccharomyces cerevisiae, Arabidopsis thaliana, Drosophila melanogaster and a human hydatidiform mole cell line (CHM1) from SMRT sequencing. The resulting assemblies are highly continuous, include fully resolved chromosome arms and close persistent gaps in these reference genomes. Our assembly of D. melanogaster revealed previously unknown heterochromatic and telomeric transition sequences, and we assembled low-complexity sequences from CHM1 that fill gaps in the human GRCh38 reference. Using MHAP and the Celera Assembler, single-molecule sequencing can produce de novo near-complete eukaryotic assemblies that are 99.99% accurate when compared with available reference genomes.	[Berlin, Konstantin] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Berlin, Konstantin] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Berlin, Konstantin] Invincea Labs, Arlington, VA USA; [Koren, Sergey; Phillippy, Adam M.] Natl Biodefense Anal & Countermeasures Ctr, Frederick, MD USA; [Chin, Chen-Shan; Drake, James P.; Landolin, Jane M.] Pacif Biosci Calif Inc, Menlo Pk, CA USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Koren, S (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	korens@nbacc.net	Koren, Sergey/AAE-8314-2019; Phillippy, Adam M/U-5731-2018	Phillippy, Adam M/0000-0003-2983-8934; Chin, Chen-Shan/0000-0003-4394-2455	Department of Homeland Security Science and Technology Directorate (DHS/ST) [HSHQDC-07-C-00020]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200398] Funding Source: NIH RePORTER	Department of Homeland Security Science and Technology Directorate (DHS/ST)(United States Department of Homeland Security (DHS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are indebted to C. Bergman of the University of Manchester for his considered advice throughout this project and editing of an early version of this manuscript. We also thank Pacific Biosciences and all those involved in generating and freely releasing the data analyzed here. The contributions of S.K. and A.M.P. were funded under Agreement No. HSHQDC-07-C-00020 awarded by the Department of Homeland Security Science and Technology Directorate (DHS/S&T) for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the US Department of Homeland Security. In no event shall the DHS, NBACC or Battelle National Biodefense Institute (BNBI) have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; [Anonymous], 2011, ARXIV11115572; Anson EL, 1997, J COMPUT BIOL, V4, P369, DOI 10.1089/cmb.1997.4.369; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bohringer S., 2002, ONLINE J BIOINFORMAT, V1, P51; Broder AZ, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P21, DOI 10.1109/SEQUEN.1997.666900; Broder AZ, 2000, LECT NOTES COMPUT SC, V1848, P1; Buhler J, 2001, BIOINFORMATICS, V17, P419, DOI 10.1093/bioinformatics/17.5.419; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; CHENG RCH, 1983, J ROY STAT SOC B MET, V45, P394; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Chum O., 2008, BMVC, P812, DOI [DOI 10.5244/C.22.50, 10.5244/C.22.50]; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/nnano.2009.12, 10.1038/NNANO.2009.12]; Denton JF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003998; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; George JA, 2006, GENOME RES, V16, P1231, DOI 10.1101/gr.5348806; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KAMINKER JS, 2002, GENOME BIOL, V0003; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim KE, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.45; Koch P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku210; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam KK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S9-S4; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Lee H., 2014, BIORXIV; Li H., 2013, ARXIV PREPRINT; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Myers EW, 1986, ALGORITHMICA, V1, P251, DOI 10.1007/BF01840446; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Myers G, 2014, LECT N BIOINFORMAT, V8701, P52, DOI 10.1007/978-3-662-44753-6_5; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Narayanan M, 2004, LECT NOTES COMPUT SC, V3240, P74; PacBio, 2014, DAT REL PREL NOV HAP; PacBio DevNet, 2014, PAC BIOSC DEVNET DAT; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Rasheed Z., 2013, SIAM INT C DAT MIN; Rasmussen KR, 2006, J COMPUT BIOL, V13, P296, DOI 10.1089/cmb.2006.13.296; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steinberg KM, 2014, GENOME RES, V24, P2066, DOI 10.1101/gr.180893.114; UKKONEN E, 1992, THEOR COMPUT SCI, V92, P191, DOI 10.1016/0304-3975(92)90143-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Weese D, 2012, BIOINFORMATICS, V28, P2592, DOI 10.1093/bioinformatics/bts505; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475	68	574	584	8	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					623	+		10.1038/nbt.3238	http://dx.doi.org/10.1038/nbt.3238			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26006009	Green Submitted			2022-12-25	WOS:000356019700022
J	Zhu, D; Wang, ZQ; Zhao, JJ; Calimeri, T; Meng, J; Hideshima, T; Fulciniti, M; Kang, Y; Ficarro, SB; Tai, YT; Hunter, Z; McMilin, D; Tong, HX; Mitsiades, CS; Wu, CJ; Treon, SP; Dorfman, DM; Pinkus, G; Munshi, NC; Tassone, P; Marto, JA; Anderson, KC; Carrasco, RD				Zhu, Di; Wang, Zhongqiu; Zhao, Jian-Jun; Calimeri, Teresa; Meng, Jiang; Hideshima, Teru; Fulciniti, Mariateresa; Kang, Yue; Ficarro, Scott B.; Tai, Yu-Tzu; Hunter, Zachary; McMilin, Douglas; Tong, Haoxuan; Mitsiades, Constantine S.; Wu, Catherine J.; Treon, Steven P.; Dorfman, David M.; Pinkus, Geraldine; Munshi, Nikhil C.; Tassone, Pierfrancesco; Marto, Jarrod A.; Anderson, Kenneth C.; Carrasco, Ruben D.			The Cyclophilin A-CD 147 complex promotes the proliferation and homing of multiple myeloma cells	NATURE MEDICINE			English	Article							MARROW ENDOTHELIAL-CELLS; MICROENVIRONMENT; CD147; MECHANISMS; CANCER; ANGIOGENESIS; PATHOGENESIS; EXPRESSION; DISEASE; CATENIN	B cell malignancies frequently colonize the bone marrow. The mechanisms responsible for this preferential homing are incompletely understood. Here we studied multiple myeloma (MM) as a model of a terminally differentiated B cell malignancy that selectively colonizes the bone marrow. We found that extracellular CyPA (eCyPA), secreted by bone marrow endothelial cells (BMECs), promoted the colonization and proliferation of MM cells in an in vivo scaffold system via binding to its receptor, CD147, on MM cells. The expression and secretion of eCyPA by BMECs was enhanced by BCL9, a Wnt-beta-catenin transcriptional coactivator that is selectively expressed by these cells. eCyPA levels were higher in bone marrow serum than in peripheral blood in individuals with MM, and eCyPA-CD147 blockade suppressed MM colonization and tumor growth in the in vivo scaffold system. eCyPA also promoted the migration of chronic lymphocytic leukemia and lymphoplasmacytic lymphoma cells, two other B cell malignancies that colonize the bone marrow and express CD147. These findings suggest that eCyPA-CD147 signaling promotes the bone marrow homing of B cell malignancies and offer a compelling rationale for exploring this axis as a therapeutic target for these malignancies.	[Zhu, Di; Wang, Zhongqiu; Zhao, Jian-Jun; Meng, Jiang; Hideshima, Teru; Fulciniti, Mariateresa; Kang, Yue; Tai, Yu-Tzu; Hunter, Zachary; McMilin, Douglas; Mitsiades, Constantine S.; Wu, Catherine J.; Treon, Steven P.; Munshi, Nikhil C.; Anderson, Kenneth C.; Carrasco, Ruben D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wang, Zhongqiu] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Calimeri, Teresa; Tassone, Pierfrancesco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Calimeri, Teresa; Tassone, Pierfrancesco] Ctr Canc, Catanzaro, Italy; [Meng, Jiang] Harbin Med Univ, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Hideshima, Teru; Fulciniti, Mariateresa; Tai, Yu-Tzu; McMilin, Douglas; Munshi, Nikhil C.; Anderson, Kenneth C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA; [Kang, Yue] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Ficarro, Scott B.; Tong, Haoxuan; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ficarro, Scott B.; Tong, Haoxuan; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Dorfman, David M.; Pinkus, Geraldine; Carrasco, Ruben D.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Southern Medical University - China; Magna Graecia University of Catanzaro; Harbin Medical University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Chinese Academy of Sciences; Institute of Biophysics, CAS; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Carrasco, RD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	ruben_carrasco@dfci.harvard.edu	Munshi, Nikhil/ABE-2338-2021; Tassone, Pierfrancesco/AIA-5373-2022; Hunter, Zachary Richard/H-3018-2013	Tassone, Pierfrancesco/0000-0002-8298-6787; Hunter, Zachary Richard/0000-0002-1689-1691; Zhao, Jianjun/0000-0003-3008-3655; Calimeri, Teresa/0000-0003-0833-4761	Multiple Myeloma Research Foundation; Doctors Cancer Foundation; National Institutes of Health [1R01 CA151391-01, 1P01 CA155258-01]; NATIONAL CANCER INSTITUTE [P01CA155258, R01CA196783, P50CA100707, R01CA151391] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; Doctors Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.D.C. is supported by a senior award from the Multiple Myeloma Research Foundation, by the Doctors Cancer Foundation, and by grants 1R01 CA151391-01 and 1P01 CA155258-01 from the National Institutes of Health. Human bone marrow-derived endothelial cell lines BMEC-60 and BMEC-1 were kindly provided by Dr. van der Schoot (University of Amsterdam, Amsterdam, the Netherlands) and Dr. Giuliani (University of Parma, Parma, Italy), respectively.	Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Anderson KC, 2011, CLIN CANCER RES, V17, P1225, DOI 10.1158/1078-0432.CCR-10-3366; Arendt BK, 2012, LEUKEMIA, V26, P2286, DOI 10.1038/leu.2012.91; Broek IV, 2008, CLIN EXP METASTAS, V25, P325, DOI 10.1007/s10585-007-9108-4; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Comerford I, 2014, BRIT J HAEMATOL, V164, P329, DOI 10.1111/bjh.12616; Damsker JM, 2009, IMMUNOLOGY, V126, P55, DOI 10.1111/j.1365-2567.2008.02877.x; de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680; DEBRUYNE E, 2007, CURR IMMUNOL REV, V3, P41; Ghobrial IM, 2012, BLOOD, V120, P20, DOI 10.1182/blood-2012-01-379024; Giuliani Nicola, 2004, Hematology, V9, P377, DOI 10.1080/10245330400018524; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Jakob C, 2006, EUR J CANCER, V42, P1581, DOI 10.1016/j.ejca.2006.02.017; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; Muller-Hermelink HK, 2008, WHO CLASSIFICATION T, P180; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Niu HZ, 2013, ONCOL REP, V30, P246, DOI 10.3892/or.2013.2418; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Ria R, 2009, CLIN CANCER RES, V15, P5369, DOI 10.1158/1078-0432.CCR-09-0040; Ribatti D, 2006, ONCOGENE, V25, P4257, DOI 10.1038/sj.onc.1209456; Ribatti D, 2008, GENES NUTR, V3, P29, DOI 10.1007/s12263-008-0076-3; Rood PML, 2000, EUR J CLIN INVEST, V30, P618; Sanderson RD, 2002, ANN HEMATOL, V81, P125, DOI 10.1007/s00277-002-0437-8; Song F, 2011, J BIOL CHEM, V286, P8197, DOI 10.1074/jbc.C110.181347; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P157; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x	37	61	68	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					572	580		10.1038/nm.3867	http://dx.doi.org/10.1038/nm.3867			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	26005854	Green Accepted, Green Submitted			2022-12-25	WOS:000355778300013
J	Luxenburg, C; Heller, E; Pasolli, HA; Chai, S; Nikolova, M; Stokes, N; Fuchs, E				Luxenburg, Chen; Heller, Evan; Pasolli, H. Amalia; Chai, Sophia; Nikolova, Maria; Stokes, Nicole; Fuchs, Elaine			Wdr1-mediated cell shape dynamics and cortical tension are essential for epidermal planar cell polarity	NATURE CELL BIOLOGY			English	Article							ACTIN DEPOLYMERIZING FACTOR; F-ACTIN; COFILIN PHOSPHORYLATION; CAENORHABDITIS-ELEGANS; WING EPITHELIUM; TISSUE POLARITY; LIM-KINASE; IN-VIVO; MORPHOGENESIS; MOUSE	During mouse development, core planar cell polarity (PCP) proteins become polarized in the epidermal plane to guide angling/morphogenesis of hair follicles. How PCP is established is poorly understood. Here, we identify a key role for Wdrl (also known as Aipl), an F-actin-binding protein that enhances cofilin/destrin-mediated F-actin disassembly. We show that cofilin and destrin function redundantly in developing epidermis, but their combined depletion perturbs cell adhesion, cytokinesis, apicobasal polarity and PCP. Although Wdri depletion accentuates single-loss-of-cofilin/destrin phenotypes, alone it resembles core PCP mutations. Seeking a mechanism, we find that Wdrl and cofilin/destrin-mediated actomyosin remodelling are essential for generating or maintaining cortical tension within the developing epidermal sheet and driving the cell shape and planar orientation changes that accompany establishment of PCP in mammalian epidermis. Our findings suggest intriguing evolutionary parallels but mechanistic modifications to the distal wing hinge-mediated mechanical forces that drive cell shape change and orient PCP in the Drosophila wing disc.	[Luxenburg, Chen; Heller, Evan; Pasolli, H. Amalia; Chai, Sophia; Nikolova, Maria; Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Pasolli, Hilda Amalia/0000-0003-3899-3530	NIH [R37-AR27883]; Starr Stem Cell Posidoctitral Fellowship; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883, R01AR027883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Stem Cell Posidoctitral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Devenport, S. Williams, S. Beronja, A. R. Folgueras, D. Schramek, I. Matos and E. Ezratty for intellectual it and A. Aldeguer as mouse specialists; Comparative Bioscience Center edited) for care of mice in accordance with National Institutes of (NIH) guidelines; Bioimaging Center IT North, director) tor advice; Flow Cytometry S. Mazel, director) For FAGS sorting. Cfl-CFP was a generous gift from J. Condeelis (Albert Einstein college of Medicine, New York, USA); E.F. is an Investigator of the Howard Hughes Medical Institute. This research was supported by a grant from the NIH (R37-AR27883, E.F.), a Starr Stem Cell Posidoctitral Fellowship (C.L.) and a GenetHs Training Grant by the NIH (E.H.).	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Aizawa H, 1999, GENES CELLS, V4, P311, DOI 10.1046/j.1365-2443.1999.00262.x; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Augustine RC, 2011, PLANT CELL, V23, P3696, DOI 10.1105/tpc.111.090753; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen Q, 2015, J BIOL CHEM, V290, P2289, DOI 10.1074/jbc.M114.612978; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chu DD, 2012, DEVELOPMENT, V139, P3561, DOI 10.1242/dev.079491; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Devenport D, 2011, NAT CELL BIOL, V13, P893, DOI 10.1038/ncb2284; Eaton S, 2011, CURR OPIN GENET DEV, V21, P747, DOI 10.1016/j.gde.2011.08.010; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Ikeda S, 2003, HUM MOL GENET, V12, P1029, DOI 10.1093/hmg/ddg112; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Mahaffey JP, 2013, DEVELOPMENT, V140, P1262, DOI 10.1242/dev.085316; Matis M, 2013, GENE DEV, V27, P2207, DOI 10.1101/gad.228098.113; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Michelot A, 2013, DEV CELL, V24, P182, DOI 10.1016/j.devcel.2012.12.008; Mohri K, 2003, J CELL SCI, V116, P4107, DOI 10.1242/jcs.00717; Moriyama K, 2002, BIOCHEM J, V365, P147, DOI 10.1042/BJ20020231; Nadkarni AV, 2014, CURR BIOL, V24, P2749, DOI 10.1016/j.cub.2014.09.048; Nagaoka R, 1996, CELL MOTIL CYTOSKEL, V35, P200, DOI 10.1002/(SICI)1097-0169(1996)35:3<200::AID-CM3>3.0.CO;2-C; Okada K, 1999, J CELL SCI, V112, P1553; Ono K, 2014, CYTOSKELETON, V71, P36, DOI 10.1002/cm.21152; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Smith RS, 1996, INVEST OPHTH VIS SCI, V37, P397; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuan BY, 2014, AM J PATHOL, V184, P1967, DOI 10.1016/j.ajpath.2014.04.007	50	47	50	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2015	17	5					592	U139		10.1038/ncb3146	http://dx.doi.org/10.1038/ncb3146			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH1HG	25915128	Green Accepted			2022-12-25	WOS:000353771500008
J	Schulze, K; Imbeaud, S; Letouze, E; Alexandrov, LB; Calderaro, J; Rebouissou, S; Couchy, G; Meiller, C; Shinde, J; Soysouvanh, F; Calatayud, AL; Pinyol, R; Pelletier, L; Balabaud, C; Laurent, A; Blanc, JF; Mazzaferro, V; Calvo, F; Villanueva, A; Nault, JC; Bioulac-Sage, P; Stratton, MR; Llovet, JM; Zucman-Rossi, J				Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Alexandrov, Ludmil B.; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pinyol, Roser; Pelletier, Laura; Balabaud, Charles; Laurent, Alexis; Blanc, Jean-Frederic; Mazzaferro, Vincenzo; Calvo, Fabien; Villanueva, Augusto; Nault, Jean-Charles; Bioulac-Sage, Paulette; Stratton, Michael R.; Llovet, Josep M.; Zucman-Rossi, Jessica			Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets	NATURE GENETICS			English	Article							GROWTH-FACTOR 19; SOMATIC MUTATIONS; MOLECULAR CLASSIFICATION; RECURRENT MUTATIONS; P53 GENE; CANCER; MECHANISMS; EXPRESSION; LANDSCAPE; PROGNOSIS	Genomic analyses promise to improve tumor characterization to optimize personalized treatment for patients with hepatocellular carcinoma (HCC). Exome sequencing analysis of 243 liver tumors identified mutational signatures associated with specific risk factors, mainly combined alcohol and tobacco consumption and exposure to aflatoxin B-1. We identified 161 putative driver genes associated with 11 recurrently altered pathways. Associations of mutations defined 3 groups of genes related to risk factors and centered on CTNNB1 (alcohol), TP53 (hepatitis B virus, HBV) and AXIN1. Analyses according to tumor stage progression identified TERT promoter mutation as an early event, whereas FGF3, FGF4, FGF19 or CCND1 amplification and TP53 and CDKN2A alterations appeared at more advanced stages in aggressive tumors. In 28% of the tumors, we identified genetic alterations potentially targetable by US Food and Drug Administration (FDA)-approved drugs. In conclusion, we identified risk factor-specific mutational signatures and defined the extensive landscape of altered genes and pathways in HCC, which will be useful to design clinical trials for targeted therapy.	[Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Inst Univ Hematol, Equipe Labellisee Ligue Canc, Genom Fonct Tumeurs Solides, INSERM,UMR 1162, Paris, France; [Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Univ Paris 05, Labex Immunooncol, Sorbonne Paris Cite, Fac Med, Paris, France; [Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Univ Paris 13, Sorbonne Paris Cite, Unite Format & Rech Sante, Med,Biol Humaine, Bobigny, France; [Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Univ Paris Diderot, Paris, France; [Alexandrov, Ludmil B.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Calderaro, Julien] Ctr Hosp Univ Henri Mondor, Assistance Publ Hop Paris, Dept Pathol, Creteil, France; [Pinyol, Roser; Villanueva, Augusto] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer,Liver Unit, Hepatocellular Carcinoma Translat Res Lab,Barcelo, Barcelona, Spain; [Balabaud, Charles; Blanc, Jean-Frederic; Bioulac-Sage, Paulette] Univ Bordeaux, INSERM, UMR 1053, Bordeaux, France; [Laurent, Alexis] Ctr Hosp Univ Henri Mondor, Assistance Publ Hop Paris, Dept Digest & Hepatobiliary Surg, Creteil, France; [Laurent, Alexis] Hop Henri Mondor, INSERM, UMR 955, F-94010 Creteil, France; [Blanc, Jean-Frederic] Hop St Andre, Ctr Hosp Univ Bordeaux, Dept Hepatol, Bordeaux, France; [Mazzaferro, Vincenzo] Fdn Ist Tumori, Dept Liver Surg & Transplant, Milan, Italy; [Villanueva, Augusto; Llovet, Josep M.] Mt Sinai Sch Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY USA; [Nault, Jean-Charles] Hop Univ Paris Seine St Denis, Assistance Publ Hop Paris, Pole Activite Cancerol Specialisee, Serv Hepatol, Bondy, France; [Bioulac-Sage, Paulette] Pellegrin Hosp, Ctr Hosp Univ Bordeaux, Dept Pathol, Bordeaux, France; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Zucman-Rossi, Jessica] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; Fondazione IRCCS Istituto Nazionale Tumori Milan; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Bordeaux; ICREA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Zucman-Rossi, J (corresponding author), Inst Univ Hematol, Equipe Labellisee Ligue Canc, Genom Fonct Tumeurs Solides, INSERM,UMR 1162, Paris, France.	jessica.zucman-rossi@inserm.fr	Alexandrov, Ludmil/AAS-1454-2021; j, zucman-rossi/AAV-3594-2021; Rebouissou, Sandra/O-5938-2017; Pinyol, Roser/AAA-4404-2019; zucman-rossi, Jessica/B-5098-2009; Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021; Letouzé, Eric/AAP-9924-2020; Mazzaferro, Vincenzo/AAL-4707-2020; Mazzaferro, Vincenzo/C-2726-2017; Laurent, Alexis/O-3657-2016; Imbeaud, Sandrine/P-8780-2017	Alexandrov, Ludmil/0000-0003-3596-4515; j, zucman-rossi/0000-0002-5687-0334; Rebouissou, Sandra/0000-0003-0188-2271; zucman-rossi, Jessica/0000-0002-5687-0334; Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Letouzé, Eric/0000-0002-6369-2839; Mazzaferro, Vincenzo/0000-0002-4013-8085; Laurent, Alexis/0000-0003-1372-0843; Soysouvanh, Frederic/0000-0001-8197-1615; nault, jean charles/0000-0002-4875-9353; calvo, fabien/0000-0002-0298-7633; Imbeaud, Sandrine/0000-0001-8439-6732; Shinde, Jayendra/0000-0002-9219-0483; Villanueva, Augusto/0000-0003-3585-3727; Pelletier, Laura/0000-0002-9668-718X; Pinyol, Roser/0000-0002-0288-6314	Institut National du Cancer (INCa); ICGC project; PAIR-CHC project NoFLIC - (INCa and Association pour la Recherche contre le Cancer, ARC); HEPTROMIC (Framework Programme 7); Canceropole Ile de France; Centres de Ressources Biologiques (CRB) Liver Tumors; Tumorotheque Centre Hospitalier Universitaire Bordeaux; Centre Hospitalier Universitaire Henri Mondor; BioIntelligence (OSEO); INSERM; INCa; Deutsche Forschungsgemeinschaft (DFG) [SCHU 2893/2-1]; AIRC (Italian Association for Cancer Research); European Comission Framework Programme 7 (HEPTROMIC); Samuel Waxman Cancer Research Foundation; Spanish National Health Institute [SAF-2010-16055, SAF-2013-41027]; Asociacion Espanola Contra el Cancer (AECC); National Nuclear Security Administration of the US Department of Energy; ICREA Funding Source: Custom	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); ICGC project; PAIR-CHC project NoFLIC - (INCa and Association pour la Recherche contre le Cancer, ARC); HEPTROMIC (Framework Programme 7); Canceropole Ile de France(Region Ile-de-France); Centres de Ressources Biologiques (CRB) Liver Tumors; Tumorotheque Centre Hospitalier Universitaire Bordeaux; Centre Hospitalier Universitaire Henri Mondor; BioIntelligence (OSEO); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INCa(Institut National du Cancer (INCA) France); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); European Comission Framework Programme 7 (HEPTROMIC); Samuel Waxman Cancer Research Foundation; Spanish National Health Institute(Spanish Government); Asociacion Espanola Contra el Cancer (AECC); National Nuclear Security Administration of the US Department of Energy(National Nuclear Security Administration); ICREA(ICREA)	We warmly thank A. Boulais, C. Guichard, I. Ben Maad and C. Pilati for helpful participation in this work. We thank L. de Koning, C. Baldeyron, A. Barbet and C. Lecerf from the Institut Curie for the reverse-phase protein array experiments. We also thank J. Saric, C. Laurent, L. Chiche, B. Le Bail and C. Castain (Centre Hospitalier Universitaire Bordeaux) and D. Cherqui and J. Tran Van Nhieu (Centre Hospitalier Universitaire Henri Mondor, Creteil) for contributing to the tissue collection. This work was supported by Institut National du Cancer (INCa) with the ICGC project, the PAIR-CHC project NoFLIC (funded by INCa and Association pour la Recherche contre le Cancer, ARC), HEPTROMIC (Framework Programme 7), Canceropole Ile de France, Centres de Ressources Biologiques (CRB) Liver Tumors, Tumorotheque Centre Hospitalier Universitaire Bordeaux and Centre Hospitalier Universitaire Henri Mondor, BioIntelligence (OSEO) and INSERM. J.-C.N. was supported by a fellowship from INCa. K.S. is supported by the Deutsche Forschungsgemeinschaft (DFG grant SCHU 2893/2-1). Research performed at Los Alamos National Laboratory was carried out under the auspices of the National Nuclear Security Administration of the US Department of Energy. V.M. is supported by a grant from AIRC (Italian Association for Cancer Research). J.M.L. is supported by grants from the European Comission Framework Programme 7 (HEPTROMIC, proposal 259744), The Samuel Waxman Cancer Research Foundation, the Spanish National Health Institute (SAF-2010-16055 and SAF-2013-41027) and the Asociacion Espanola Contra el Cancer (AECC).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Hyeon J, 2013, DIGEST DIS SCI, V58, P1916, DOI 10.1007/s10620-013-2609-x; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Nault JC, 2013, GASTROENTEROLOGY, V144, P888, DOI 10.1053/j.gastro.2013.02.032; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005; Roncalli M, 2011, DIGEST LIVER DIS, V43, pS361, DOI 10.1016/S1590-8658(11)60592-6; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Totoki Y, 2014, GENOME RES, V24, P1411, DOI 10.1101/gr.160598.113; Troncale S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038686; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	40	983	1012	8	192	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					505	U106		10.1038/ng.3252	http://dx.doi.org/10.1038/ng.3252			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25822088	Green Accepted, Green Submitted			2022-12-25	WOS:000353635800013
J	Mo, JS; Meng, ZP; Kim, YC; Park, HW; Hansen, CG; Kim, S; Lim, DS; Guan, KL				Mo, Jung-Soo; Meng, Zhipeng; Kim, Young Chul; Park, Hyun Woo; Hansen, Carsten Gram; Kim, Soohyun; Lim, Dae-Sik; Guan, Kun-Liang			Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-CONTROL; CONTACT INHIBITION; SIGNALING PATHWAY; SIZE-CONTROL; DNA-DAMAGE; PROLIFERATION; METFORMIN; CANCER; PHOSPHORYLATION	YAP (Yes-associated protein) is a transcription co-activator in the Hippo tumour suppressor pathway and controls cell growth, tissue homeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to induce its cytoplasmic localization and proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors. Dysregulation of the Hippo-YAP pathway is frequently observed in human cancers. Here we show that cellular energy stress induces YAP phosphorylation, in part due to AMPK-dependent Lats activation, thereby inhibiting YAP activity. Moreover, AMPK directly phosphorylates YAP Ser 94, a residue essential for the interaction with TEAD, thus disrupting the YAP-TEAD interaction. AMPK-induced YAP inhibition can suppress oncogenic transformation of Lats-null cells with high YAP activity. Our study establishes a molecular mechanism and functional significance of AMPK in linking cellular energy status to the Hippo-YAP pathway.	[Mo, Jung-Soo; Meng, Zhipeng; Park, Hyun Woo; Hansen, Carsten Gram; Kim, Soohyun; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Mo, Jung-Soo; Meng, Zhipeng; Park, Hyun Woo; Hansen, Carsten Gram; Kim, Soohyun; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Kim, Young Chul] Vet Med Res Fdn, Dept Cardiol, San Diego, CA 92161 USA; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr, Dept Biol Sci, Taejon 305701, South Korea	University of California System; University of California San Diego; University of California System; University of California San Diego; Veterans Medical Research Foundation; Korea Advanced Institute of Science & Technology (KAIST)	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Hansen, Carsten/0000-0003-0746-7482; Park, Hyun Woo/0000-0001-7736-2286; Kim, Young Chul/0000-0002-6782-2186	National Institutes of Health [CA 132809, EY022611, DEO15964, CA23100]; Danish Council for Independent Research, Natural Sciences; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA132809] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We would like to thank A. Hong and F. Flores for critical reading of the manuscript. This work was supported by grants from National Institutes of Health (CA 132809, EY022611, DEO15964 and CA23100, K-L.G.). C.G.H. is supported by a Postdoctoral Fellowship from the Danish Council for Independent Research, Natural Sciences.	Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Stambolic V, 2009, BREAST CANCER RES TR, V114, P387, DOI 10.1007/s10549-008-0015-4; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang W., 2015, NAT CELL BIOL, V17; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	328	344	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					500	+		10.1038/ncb3111	http://dx.doi.org/10.1038/ncb3111			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25751140	Green Submitted, Green Accepted			2022-12-25	WOS:000351920500020
J	Kataoka, K; Nagata, Y; Kitanaka, A; Shiraishi, Y; Shimamura, T; Yasunaga, JI; Totoki, Y; Chiba, K; Sato-Otsubo, A; Nagae, G; Ishii, R; Muto, S; Kotani, S; Watatani, Y; Takeda, J; Sanada, M; Tanaka, H; Suzuki, H; Sato, Y; Shiozawa, Y; Yoshizato, T; Yoshida, K; Makishima, H; Iwanaga, M; Ma, GY; Nosaka, K; Hishizawa, M; Itonaga, H; Imaizumi, Y; Munakata, W; Ogasawara, H; Sato, T; Sasai, K; Muramoto, K; Penova, M; Kawaguchi, T; Nakamura, H; Hama, N; Shide, K; Kubuki, Y; Hidaka, T; Kameda, T; Nakamaki, T; Ishiyama, K; Miyawaki, S; Yoon, SS; Tobinai, K; Miyazaki, Y; Takaori-Kondo, A; Matsuda, F; Takeuchi, K; Nureki, O; Aburatani, H; Watanabe, T; Shibata, T; Matsuoka, M; Miyano, S; Shimoda, K; Ogawa, S				Kataoka, Keisuke; Nagata, Yasunobu; Kitanaka, Akira; Shiraishi, Yuichi; Shimamura, Teppei; Yasunaga, Jun-Ichirou; Totoki, Yasushi; Chiba, Kenichi; Sato-Otsubo, Aiko; Nagae, Genta; Ishii, Ryohei; Muto, Satsuki; Kotani, Shinichi; Watatani, Yosaku; Takeda, June; Sanada, Masashi; Tanaka, Hiroko; Suzuki, Hiromichi; Sato, Yusuke; Shiozawa, Yusuke; Yoshizato, Tetsuichi; Yoshida, Kenichi; Makishima, Hideki; Iwanaga, Masako; Ma, Guangyong; Nosaka, Kisato; Hishizawa, Masakatsu; Itonaga, Hidehiro; Imaizumi, Yoshitaka; Munakata, Wataru; Ogasawara, Hideaki; Sato, Toshitaka; Sasai, Ken; Muramoto, Kenzo; Penova, Marina; Kawaguchi, Takahisa; Nakamura, Hiromi; Hama, Natsuko; Shide, Kotaro; Kubuki, Yoko; Hidaka, Tomonori; Kameda, Takuro; Nakamaki, Tsuyoshi; Ishiyama, Ken; Miyawaki, Shuichi; Yoon, Sung-Soo; Tobinai, Kensei; Miyazaki, Yasushi; Takaori-Kondo, Akifumi; Matsuda, Fumihiko; Takeuchi, Kengo; Nureki, Osamu; Aburatani, Hiroyuki; Watanabe, Toshiki; Shibata, Tatsuhiro; Matsuoka, Masao; Miyano, Satoru; Shimoda, Kazuya; Ogawa, Seishi			Integrated molecular analysis of adult T cell leukemia/lymphoma	NATURE GENETICS			English	Article							KAPPA-B ACTIVATION; VIRUS TYPE-I; PROTEIN-KINASE; MUTATIONS; CANCER; EXPRESSION; IDENTIFICATION; DYSFUNCTION; MECHANISMS; RECEPTORS	Adult T cell leukemia/lymphoma (ATL) is a peripheral T cell neoplasm of largely unknown genetic basis, associated with human T cell leukemia virus type-1 (HTLV-1) infection. Here we describe an integrated molecular study in which we performed whole-genome, exome, transcriptome and targeted resequencing, as well as array-based copy number and methylation analyses, in a total of 426 ATL cases. The identified alterations overlap significantly with the HTLV-1 Tax interactome and are highly enriched for T cell receptor-NF-kappa B signaling, T cell trafficking and other T cell-related pathways as well as immunosurveillance. Other notable features include a predominance of activating mutations (in PLCG1, PRKCB, CARD11, VAV1, IRF4, FYN, CCR4 and CCR7) and gene fusions (CTLA4-CD28 and ICOS-CD28). We also discovered frequent intragenic deletions involving IKZF2, CARD11 and TP73 and mutations in GATA3, HNRNPA2B1, GPR183, CSNK2A1, CSNK2B and CSNK1A1. Our findings not only provide unique insights into key molecules in T cell signaling but will also guide the development of new diagnostics and therapeutics in this intractable tumor.	[Kataoka, Keisuke; Nagata, Yasunobu; Sato-Otsubo, Aiko; Kotani, Shinichi; Watatani, Yosaku; Takeda, June; Sanada, Masashi; Suzuki, Hiromichi; Sato, Yusuke; Shiozawa, Yusuke; Yoshizato, Tetsuichi; Yoshida, Kenichi; Makishima, Hideki; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Kitanaka, Akira; Shide, Kotaro; Kubuki, Yoko; Hidaka, Tomonori; Kameda, Takuro; Shimoda, Kazuya] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Shimamura, Teppei] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Syst Biol, Nagoya, Aichi 4648601, Japan; [Yasunaga, Jun-Ichirou; Ma, Guangyong; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 606, Japan; [Totoki, Yasushi; Nakamura, Hiromi; Hama, Natsuko; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo 104, Japan; [Nagae, Genta; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Ishii, Ryohei; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Muto, Satsuki; Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan; [Sanada, Masashi] Nagoya Med Ctr, Clin Res Ctr, Dept Adv Diag, Nagoya, Aichi, Japan; [Iwanaga, Masako] Nagasaki Univ, Grad Sch Biomed Sci, Dept Frontier Life Sci, Nagasaki 852, Japan; [Nosaka, Kisato] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 860, Japan; [Hishizawa, Masakatsu; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Itonaga, Hidehiro] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan; [Imaizumi, Yoshitaka; Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis & Hibakusya Med Unit, Dept Hematol, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Munakata, Wataru] Natl Canc Ctr, Dept Hematol, Tokyo, Japan; [Ogasawara, Hideaki; Sato, Toshitaka; Sasai, Ken; Muramoto, Kenzo] KAN Res Inst Inc, Kobe, Hyogo, Japan; [Penova, Marina; Kawaguchi, Takahisa; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Nakamaki, Tsuyoshi] Showa Univ, Sch Med, Dept Med, Div Hematol, Tokyo 142, Japan; [Ishiyama, Ken] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Miyawaki, Shuichi] Tokyo Metropolitan Otsuka Hosp, Dept Internal Med, Div Hematol, Tokyo, Japan; [Yoon, Sung-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan	Kyoto University; University of Miyazaki; University of Tokyo; Nagoya University; Kyoto University; National Cancer Center - Japan; University of Tokyo; University of Tokyo; University of Tokyo; Nagoya Medical Center; Nagasaki University; Kumamoto University; Kyoto University; Nagasaki University; National Cancer Center - Japan; KAN Research Institute; Kyoto University; Showa University; Kanazawa University; Seoul National University (SNU); Japanese Foundation for Cancer Research; University of Tokyo	Ogawa, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan.	sogawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019; Shibata, Tatsuhiro/ABA-8234-2020; Yoon, Sung-Soo/J-2773-2012; Kataoka, Keisuke/AAS-2546-2020; Suzuki, Hiromichi/AAO-4664-2021; Shide, Kotaro/AAG-7133-2020; Shibata, Tatsuhiro/AAO-1278-2021; Nagae, Genta/H-6579-2019; Yoshizato, Tetsuichi/AAD-7308-2019; Nagae, Genta/AAN-1167-2021; NUREKI, OSAMU/G-4960-2014; Takeuchi, Kengo/C-3614-2008	Kataoka, Keisuke/0000-0002-8263-9902; Suzuki, Hiromichi/0000-0002-8858-0294; Shide, Kotaro/0000-0002-0046-3254; Nagae, Genta/0000-0002-2929-7990; Yoshizato, Tetsuichi/0000-0003-4283-2983; Miyano, Satoru/0000-0002-1753-6616; Takeuchi, Kengo/0000-0002-1599-5800; Shimamura, Teppei/0000-0003-2994-872X; Matsuoka, Masao/0000-0002-0473-754X; Yoshida, Kenichi/0000-0003-4612-2778; Ishii, Ryohei/0000-0003-2486-1393	Ministry of Health, Labour and Welfare of Japan; Japanese Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer); Japanese Society for the Promotion of Science (JSPS) KAKENHI [22134006]; National Cancer Center Research and Development Funds [26-A-6]; Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST); National Cancer Center Research and Development Fund, Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer); Japanese Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Funds; Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST); National Cancer Center Research and Development Fund, Japan	We thank S. Sakaguchi for expert opinion and M. Sago, M. Nakamura, H. Higashi, Y. Ogino, Y. Mori and S. Baba for technical assistance. This work was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan and the Japanese Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer), Japanese Society for the Promotion of Science (JSPS) KAKENHI (22134006), National Cancer Center Research and Development Funds (26-A-6) and the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST). The National Cancer Center Biobank was supported by the National Cancer Center Research and Development Fund, Japan. This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (hp140230). Supercomputing resources were also provided by the Human Genome Center, the Institute of Medical Science, The University of Tokyo.	Accomando WP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r50; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Asanuma S, 2013, CANCER SCI, V104, P1097, DOI 10.1111/cas.12181; Bangham CRM, 2005, ONCOGENE, V24, P6035, DOI 10.1038/sj.onc.1208970; Bhatia A, 2014, EXPERT REV CLIN IMMU, V10, P41, DOI 10.1586/1744666X.2014.865519; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Fu J, 2011, BLOOD, V117, P1652, DOI 10.1182/blood-2010-08-303073; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Ishitsuka K, 2014, LANCET ONCOL, V15, pE517, DOI 10.1016/S1470-2045(14)70202-5; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; Kaida D, 2012, CANCER SCI, V103, P1611, DOI 10.1111/j.1349-7006.2012.02356.x; Kinpara S, 2015, LEUKEMIA, V29, P1425, DOI 10.1038/leu.2015.1; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Mallory MJ, 2011, MOL CELL BIOL, V31, P2184, DOI 10.1128/MCB.05170-11; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Nakagawa M, 2014, J EXP MED, V211, P2497, DOI 10.1084/jem.20140987; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Orel L, 2010, J CELL MOL MED, V14, P1555, DOI 10.1111/j.1582-4934.2009.00866.x; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Paul S, 2013, TRENDS IMMUNOL, V34, P269, DOI 10.1016/j.it.2013.02.002; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Phillips-Mason PJ, 2011, J CELL BIOCHEM, V112, P39, DOI 10.1002/jcb.22710; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Swerdllow S, 2008, WHO CLASSIFICATION T, P2008; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Tong X, 2011, EMBO REP, V12, P428, DOI 10.1038/embor.2011.49; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; WALL KA, 1988, P NATL ACAD SCI USA, V85, P5644, DOI 10.1073/pnas.85.15.5644; Yamagishi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00334; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Z, 2007, BLOOD, V109, P2190, DOI 10.1182/blood-2005-01-031930	61	483	489	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1304	+		10.1038/ng.3415	http://dx.doi.org/10.1038/ng.3415			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26437031				2022-12-25	WOS:000363988200014
J	Poepsel, S; Sprengel, A; Sacca, B; Kaschani, F; Kaiser, M; Gatsogiannis, C; Raunser, S; Clausen, T; Ehrmann, M				Poepsel, Simon; Sprengel, Andreas; Sacca, Barbara; Kaschani, Farnusch; Kaiser, Markus; Gatsogiannis, Christos; Raunser, Stefan; Clausen, Tim; Ehrmann, Michael			Determinants of amyloid fibril degradation by the PDZ protease HTRA1	NATURE CHEMICAL BIOLOGY			English	Article							SERINE-PROTEASE; QUALITY-CONTROL; ALZHEIMERS-DISEASE; EMERGING ROLES; TAU-PROTEIN; CHAPERONE; ASSOCIATION; STRESS; DOMAIN; DEGP	Excessive aggregation of proteins has a major impact on cell fate and is a hallmark of amyloid diseases in humans. To resolve insoluble deposits and to maintain protein homeostasis, all cells use dedicated protein disaggregation, protein folding and protein degradation factors. Despite intense recent research, the underlying mechanisms controlling this key metabolic event are not well understood. Here, we analyzed how a single factor, the highly conserved serine protease HTRA1, degrades amyloid fibrils in an ATP-independent manner. This PDZ protease solubilizes protein fibrils and disintegrates the fibrillar core structure, allowing productive interaction of aggregated polypeptides with the active site for rapid degradation. The aggregate burden in a cellular model of cytoplasmic tau aggregation is thus reduced. Mechanistic aspects of ATP-independent proteolysis and its implications in amyloid diseases are discussed.	[Poepsel, Simon; Sprengel, Andreas; Sacca, Barbara; Kaschani, Farnusch; Kaiser, Markus; Ehrmann, Michael] Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, Essen, Germany; [Gatsogiannis, Christos; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44139 Dortmund, Germany; [Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Ehrmann, Michael] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	University of Duisburg Essen; Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Cardiff University	Poepsel, S (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, Essen, Germany.	michael.ehrmann@uni-due.de	Raunser, Stefan/AHE-1573-2022; Gatsogiannis, Christos/K-1012-2018; Poepsel, Simon/AAG-2009-2019; Baell, Jonathan/E-5844-2017; Ehrmann, Michael/A-7307-2012	Gatsogiannis, Christos/0000-0002-4922-4545; Baell, Jonathan/0000-0003-2114-8242; Ehrmann, Michael/0000-0002-1927-260X; Poepsel, Simon/0000-0002-8304-4062; Kaschani, Farnusch/0000-0001-6572-3232; Raunser, Stefan/0000-0001-9373-3016; Clausen, Tim/0000-0003-1582-6924; Dichgans, Martin/0000-0002-0654-387X	Deutsche Forschungsgemeinschaft [EH 100/14-1, SFB 1093, INST 20876/127-1 FUGG]; Boehringer Ingelheim	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim(Boehringer Ingelheim)	We thank N. Schulze and M. Graessl for help with TIRFM, D. Grum and M. Merdanovic with ITC, S. Blaskowski with MS, V. Lux (University Duisburg-Essen) for providing purified PDZ domain and M. Breiden (University Duisburg-Essen) for providing tau. This work was supported by grants EH 100/14-1 (to M.E.) and SFB 1093 (to M.E., M.K. and B.S.) and INST 20876/127-1 FUGG (to M.K.) from Deutsche Forschungsgemeinschaft. The Research Institute of Molecular Pathology is funded by Boehringer Ingelheim.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2009, J CELL BIOCHEM, V107, P253, DOI 10.1002/jcb.22121; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Clawson GA, 2008, J CELL BIOCHEM, V105, P81, DOI 10.1002/jcb.21804; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Friedman R, 2011, BIOCHEM J, V438, P415, DOI 10.1042/BJ20110369; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Johnson GVW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P243; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Malet H, 2012, NAT STRUCT MOL BIOL, V19, P152, DOI 10.1038/nsmb.2210; Meltzer M, 2008, ANGEW CHEM INT EDIT, V47, P1332, DOI 10.1002/anie.200703273; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Michalski A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.013698; Milner JM, 2008, ARTHRITIS RHEUM-US, V58, P3644, DOI 10.1002/art.24046; Miyata Y, 2011, FUTURE MED CHEM, V3, P1523, DOI [10.4155/fmc.11.88, 10.4155/FMC.11.88]; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Risor MW, 2014, BIOCHEMISTRY-US, V53, P3851, DOI 10.1021/bi401633w; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Searcy JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089970; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Tennstaedt A, 2012, J BIOL CHEM, V287, P20931, DOI 10.1074/jbc.M111.316232; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tiaden AN, 2013, AM J PATHOL, V182, P1482, DOI 10.1016/j.ajpath.2013.02.003; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	56	67	68	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					862	U83		10.1038/NCHEMBIO.1931	http://dx.doi.org/10.1038/NCHEMBIO.1931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26436840	Green Accepted			2022-12-25	WOS:000363272100012
J	Dao, T; Pankov, D; Scott, A; Korontsvit, T; Zakhaleva, V; Xu, YY; Xiang, JY; Yan, S; Guerreiro, MDD; Veomett, N; Dubrovsky, L; Curcio, M; Doubrovina, E; Ponomarev, V; Liu, C; O'Reilly, RJ; Scheinberg, DA				Dao, Tao; Pankov, Dmitry; Scott, Andrew; Korontsvit, Tatyana; Zakhaleva, Victoriya; Xu, Yiyang; Xiang, Jingyi; Yan, Su; Guerreiro, Manuel Direito de Morais; Veomett, Nicholas; Dubrovsky, Leonid; Curcio, Michael; Doubrovina, Ekaterina; Ponomarev, Vladimir; Liu, Cheng; O'Reilly, Richard J.; Scheinberg, David A.			Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1	NATURE BIOTECHNOLOGY			English	Article							TUMOR-CELLS; CD4+T CELLS; CANCER; IMMUNOTHERAPY; BLOCKADE; PEPTIDE; IDENTIFICATION; LYMPHOCYTES; GENERATION; RESPONSES	Intracellular tumor antigens presented on the cell surface in the context of human leukocyte antigen (HLA) molecules have been targeted by T cell-based therapies, but there has been little progress in developing small-molecule drugs or antibodies directed to these antigens. Here we describe a bispecific T-cell engager (BiTE) antibody derived from a T-cell receptor (TCR)-mimic monoclonal antibody (mAb) ESK1, which binds a peptide derived from the intracellular oncoprotein WT1 presented on HLA-A*02:01. Despite the very low density of the complexes at the cell surface, ESK1-BiTE selectively activated and induced proliferation of cytolytic human T cells that killed cells from multiple leukemias and solid tumors in vitro and in mice. We also discovered that in an autologous in vitro setting, ESK1-BiTE induced a robust secondary CD8 T-cell response specific for tumor-associated antigens other than WT1. Our study provides an approach that targets tumor-specific intracellular antigens without using cell therapy and suggests that epitope spreading could contribute to the therapeutic efficacy of this BiTE.	[Dao, Tao; Pankov, Dmitry; Scott, Andrew; Korontsvit, Tatyana; Zakhaleva, Victoriya; Guerreiro, Manuel Direito de Morais; Veomett, Nicholas; Dubrovsky, Leonid; Curcio, Michael; Doubrovina, Ekaterina; Ponomarev, Vladimir; O'Reilly, Richard J.; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Scott, Andrew; Veomett, Nicholas; O'Reilly, Richard J.; Scheinberg, David A.] Weill Cornell Med Coll, New York, NY USA; [Xu, Yiyang; Xiang, Jingyi; Yan, Su; Liu, Cheng] Eureka Therapeut, Emeryville, CA USA	Memorial Sloan Kettering Cancer Center; Cornell University	Scheinberg, DA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org		Scott, Andrew/0000-0002-3090-9704; Liu, Cheng/0000-0002-2219-1018; Direito de Morais Guerreiro, Manuel Nuno/0000-0001-5978-2578; Ponomarev, Vladimir/0000-0002-9119-9128	US National Institutes of Health [R01 CA 55349, P01 CA23766, P30 CA008748, MARF]; Memorial Sloan Kettering Cancer Center's (MSKCC's) Experimental Therapeutics Center; Lymphoma Foundation; Glades fund; Tudor fund; NATIONAL CANCER INSTITUTE [R01CA055349, T32CA062948, P30CA008748, P01CA023766] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center's (MSKCC's) Experimental Therapeutics Center; Lymphoma Foundation; Glades fund; Tudor fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by US National Institutes of Health grant R01 CA 55349, P01 CA23766, MARF, P30 CA008748, Memorial Sloan Kettering Cancer Center's (MSKCC's) Experimental Therapeutics Center and the Lymphoma Foundation and Tudor and Glades funds. We thank D Levine, F. Dao and M. Mattar for their efforts and help in collecting clinical samples. We also thank the MSKCC Small-Animal Imaging Core Facility, R. Gejman for statistical analyses, T.-Y. Kuo for helpful discussions for Renilla transduction, A. Selvakumar and A. Yeh for their expert HLA typing.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Brischwein K, 2007, J IMMUNOTHER, V30, P798, DOI 10.1097/CJI.0b013e318156750c; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Curran KJ, 2012, J GENE MED, V14, P405, DOI 10.1002/jgm.2604; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Dao T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006730; Doubrovina E, 2012, BLOOD, V120, P1633, DOI 10.1182/blood-2011-11-394619; Doubrovina E, 2012, BLOOD, V119, P2644, DOI 10.1182/blood-2011-08-371971; Dubrovsky L, 2014, BLOOD, V123, P3296, DOI 10.1182/blood-2014-01-549022; Fan LC, 2012, BIOTECHNOL BIOENG, V109, P1007, DOI 10.1002/bit.24365; Frankel SR, 2013, CURR OPIN CHEM BIOL, V17, P385, DOI 10.1016/j.cbpa.2013.03.029; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Mittendorf EA, 2008, CANCER IMMUNOL IMMUN, V57, P1511, DOI 10.1007/s00262-008-0540-3; Morris E, 2006, BLOOD REV, V20, P61, DOI 10.1016/j.blre.2005.05.001; Nagorsen D, 2011, EXP CELL RES, V317, P1255, DOI 10.1016/j.yexcr.2011.03.010; Oka Y, 2007, THESCIENTIFICWORLDJO, V7, P649, DOI 10.1100/tsw.2007.119; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Pedersen AE, 2011, J IMMUNOTHER, V34, P629, DOI 10.1097/CJI.0b013e3182281381; Peralbo E, 2007, EXP GERONTOL, V42, P703, DOI 10.1016/j.exger.2007.05.002; Quintarelli C, 2011, BLOOD, V117, P3353, DOI 10.1182/blood-2010-08-300376; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Selenko N, 2001, LEUKEMIA, V15, P1619, DOI 10.1038/sj.leu.2402226; Sergeeva A, 2011, BLOOD, V117, P4262, DOI 10.1182/blood-2010-07-299248; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Veomett N, 2014, CLIN CANCER RES, V20, P4036, DOI 10.1158/1078-0432.CCR-13-2756	36	99	101	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1079	+		10.1038/nbt.3349	http://dx.doi.org/10.1038/nbt.3349			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26389576	Green Accepted			2022-12-25	WOS:000362555700028
J	Luo, CW; Knight, R; Siljander, H; Knip, M; Xavier, RJ; Gevers, D				Luo, Chengwei; Knight, Rob; Siljander, Heli; Knip, Mikael; Xavier, Ramnik J.; Gevers, Dirk			ConStrains identifies microbial strains in metagenomic datasets	NATURE BIOTECHNOLOGY			English	Article							GENOME SEQUENCE	An important fraction of microbial diversity is harbored in strain individuality, so identification of conspecific bacterial strains is imperative for improved understanding of microbial community functions. Limitations in bioinformatics and sequencing technologies have to date precluded strain identification owing to difficulties in phasing short reads to faithfully recover the original strain-level genotypes, which have highly similar sequences. We present ConStrains, an open-source algorithm that identifies conspecific strains from metagenomic sequence data and reconstructs the phylogeny of these strains in microbial communities. The algorithm uses single-nucleotide polymorphism (SNP) patterns in a set of universal genes to infer within-species structures that represent strains. Applying ConStrains to simulated and host-derived datasets provides insights into microbial community dynamics.	[Luo, Chengwei; Xavier, Ramnik J.; Gevers, Dirk] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA; [Luo, Chengwei; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Luo, Chengwei; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Luo, Chengwei; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA USA; [Luo, Chengwei; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Siljander, Heli; Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Siljander, Heli; Knip, Mikael] Helsinki Univ Hosp, Helsinki, Finland; [Siljander, Heli] Univ Helsinki, Diabet & Obes, Res Programs Unit, Helsinki, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center; Tampere University; Tampere University Hospital; Massachusetts Institute of Technology (MIT)	Xavier, RJ (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.	xavier@molbio.mgh.harvard.edu; dirk.gevers@gmail.com	Knip, Mikael/AAL-3773-2020; Knight, Rob/D-1299-2010; Gevers, Dirk/C-1451-2009	Knip, Mikael/0000-0003-0474-0033; Knight, Rob/0000-0002-0975-9019	Crohn's and Colitis Foundation of America; Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health [U54 DK102557, R01 DK092405]; Howard Hughes Medical Institute; Finnish Centre of Excellence in Molecular Systems Immunology and Physiology Research (Academy of Finland) [250114]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102557, R01DK092405, P30DK043351, P01DK078669] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Finnish Centre of Excellence in Molecular Systems Immunology and Physiology Research (Academy of Finland); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Nedelsky for editorial support. This work was supported in part by the Crohn's and Colitis Foundation of America, the Leona M. and Harry B. Helmsley Charitable Trust, US National Institutes of Health grants U54 DK102557 (R.J.X.) and R01 DK092405 (R.J.X.)., the Howard Hughes Medical Institute (R.K.) and the Finnish Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-17 (Academy of Finland, Decision No. 250114; M.K.).	Ahn TH, 2015, BIOINFORMATICS, V31, P170, DOI 10.1093/bioinformatics/btu641; Beitel CW, 2014, PEERJ, V2, DOI 10.7717/peerj.415; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Di Gioia D, 2014, APPL MICROBIOL BIOT, V98, P563, DOI 10.1007/s00253-013-5405-9; Eren A.M., 2014, ISME J, P968; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Han DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107371; Hong CJ, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-33; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Karlsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085417; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lasken RS, 2014, NAT REV GENET, V15, P577, DOI 10.1038/nrg3785; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Luo CW, 2012, ISME J, V6, P898, DOI 10.1038/ismej.2011.147; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Maslunka C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105390; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nandi T, 2015, GENOME RES, V25, P129, DOI 10.1101/gr.177543.114; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Nijkamp JF, 2013, BIOINFORMATICS, V29, P2826, DOI 10.1093/bioinformatics/btt502; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]	40	149	154	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1045	+		10.1038/nbt.3319	http://dx.doi.org/10.1038/nbt.3319			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26344404	Bronze, Green Submitted, Green Accepted			2022-12-25	WOS:000362555700023
J	Saliba, J; Saint-Martin, C; Di Stefano, A; Lenglet, G; Marty, C; Keren, B; Pasquier, F; Della Valle, V; Secardin, L; Leroy, G; Mahfoudhi, E; Grosjean, S; Droin, N; Diop, M; Dessen, P; Charrier, S; Palazzo, A; Merlevede, J; Meniane, JC; Delaunay-Darivon, C; Fuseau, P; Isnard, F; Casadevall, N; Solary, E; Debili, N; Bernard, OA; Raslova, H; Najman, A; Vainchenker, W; Bellanne-Chantelot, C; Plo, I				Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Keren, Boris; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Leroy, Gwendoline; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Charrier, Sabine; Palazzo, Alberta; Merlevede, Jane; Meniane, Jean-Come; Delaunay-Darivon, Christine; Fuseau, Pascal; Isnard, Francoise; Casadevall, Nicole; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Najman, Albert; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle			Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; MYELOPROLIFERATIVE NEOPLASMS; SOMATIC MUTATIONS; ESSENTIAL THROMBOCYTHEMIA; CLONAL HEMATOPOIESIS; GENOMIC ABERRATIONS; NEGATIVE REGULATOR; GATA2 MUTATIONS; JAK2 HAPLOTYPE; IN-VITRO	No major predisposition gene for familial myeloproliferative neoplasms (MPN) has been identified. Here we demonstrate that the autosomal dominant transmission of a 700-kb duplication in four genetically related families predisposes to myeloid malignancies, including MPN, frequently progressing to leukemia. Using induced pluripotent stem cells and primary cells, we demonstrate that overexpression of ATG2B and GSKIP enhances hematopoietic progenitor differentiation, including of megakaryocytes, by increasing progenitor sensitivity to thrombopoietin (TPO). ATG2B and GSKIP cooperate with acquired JAK2, MPL and CALR mutations during MPN development. Thus, the germline duplication may change the fitness of cells harboring signaling pathway mutations and increases the probability of disease development.	[Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Palazzo, Alberta; Merlevede, Jane; Casadevall, Nicole; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle] INSERM, UMR 1170, Villejuif, France; [Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Palazzo, Alberta; Merlevede, Jane; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle] Univ Paris 11, UMR 1170, Villejuif, France; [Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Palazzo, Alberta; Merlevede, Jane; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle] Gustave Roussy, Villejuif, France; [Saliba, Joseph; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Vainchenker, William; Plo, Isabelle] Lab Excellence GR Ex, Villejuif, France; [Saint-Martin, Cecile; Keren, Boris; Leroy, Gwendoline; Bellanne-Chantelot, Christine] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Mahfoudhi, Emna] Inst Pasteur Tunis, Lab Hematol Mol & Cellulaire Salem Abbes, Belvedere, France; [Charrier, Sabine] Genethon, Evry, France; [Meniane, Jean-Come; Delaunay-Darivon, Christine] CHU Ft de France, Serv Med Interne, Fort De France, France; [Fuseau, Pascal] CHU Ft de France, Lab Hematol, Fort De France, France; [Isnard, Francoise; Najman, Albert] Hop St Antoine, AP HP, Dept Hematol Clin & Therapie Cellulaire, F-75571 Paris, France; [Isnard, Francoise; Bernard, Olivier A.; Najman, Albert; Bellanne-Chantelot, Christine] Univ Paris 06, Sorbonne Univ, Grp Rech Clin Myeloproliferat Aigues & Chron GRC, MYPAC, Paris, France; [Casadevall, Nicole] Hop St Antoine, AP HP, Lab Hematol, F-75571 Paris, France; [Vainchenker, William] Hop St Louis, AP HP, Consultat Immuno Hematol, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Martinique; CHU Martinique; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Vainchenker, W (corresponding author), INSERM, UMR 1170, Villejuif, France.	verpre@igr.fr; christine.bellanne-chantelot@aphp.fr; isabelle.plo@gustaveroussy.fr	Raslova, Hana/N-3562-2018; MARTY, Caroline/I-1721-2017; Plo, Isabelle/AAT-6742-2021; Droin, Nathalie M/Y-5506-2018; Di Stefano, Antonio/M-1478-2018; Plo, Isabelle/C-9056-2017	Raslova, Hana/0000-0001-8846-5299; MARTY, Caroline/0000-0003-4350-2302; Droin, Nathalie M/0000-0002-6099-5324; Plo, Isabelle/0000-0002-5915-6910; Solary, Eric/0000-0002-8629-1341; CHARRIER, Sabine/0000-0001-9399-7492; Bernard, Olivier/0000-0002-0463-9747; Vainchenker, William/0000-0003-4705-202X	Agence Nationale de la Recherche (ANR) [ANR-13-JVSV1-GERMPN-01]; Association pour la Recherche contre le Cancer (ARC) (Fondation ARC Libre) [2012-SL220120605292]; Groupe Information Sante (GIS)-Institute for Rare Diseases for High-Throughput Sequencing [AO9102LS]; Association de Recherche sur la Moelle Osseuse (ARMO); regional Programme Hospitalier de Recherche Clinique (PHRC) [AOR07014]; Association Laurette Fugain; program 'Investissements d'Avenir'; Ile-de-France Canceropole; ANR Molecular Medicine in Oncology (MMO) (program 'Investissements d'Avenir'); ARC; Fondation pour la Recherche Medicale (FRM); Ile-de-France region (Canceropole); Ile-de-France region (DIM Cellule Souche);  [INCa-DGOS-INSERM 6043]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer (ARC) (Fondation ARC Libre); Groupe Information Sante (GIS)-Institute for Rare Diseases for High-Throughput Sequencing; Association de Recherche sur la Moelle Osseuse (ARMO); regional Programme Hospitalier de Recherche Clinique (PHRC); Association Laurette Fugain; program 'Investissements d'Avenir'(French National Research Agency (ANR)); Ile-de-France Canceropole(Region Ile-de-France); ANR Molecular Medicine in Oncology (MMO) (program 'Investissements d'Avenir')(French National Research Agency (ANR)); ARC(Australian Research Council); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Ile-de-France region (Canceropole)(Region Ile-de-France); Ile-de-France region (DIM Cellule Souche)(Region Ile-de-France); 	This work was supported by grants from Agence Nationale de la Recherche (ANR) (Blanc Megon 2009, Thrombocytosis 2011; ANR-13-JVSV1-GERMPN-01), Association pour la Recherche contre le Cancer (ARC) (Fondation ARC Libre 2012-SL220120605292), Groupe Information Sante (GIS)-Institute for Rare Diseases for High-Throughput Sequencing (AO9102LS), Association de Recherche sur la Moelle Osseuse (ARMO), regional Programme Hospitalier de Recherche Clinique (PHRC) AOR07014, Association Laurette Fugain and INCa-DGOS-INSERM 6043. Labex GR-Ex (I.P. and W.V.) is funded by the program 'Investissements d'Avenir'. G. Lenglet was supported by a postdoctoral fellowship from Ile-de-France Canceropole and ANR Molecular Medicine in Oncology (MMO) (funded by the program 'Investissements d'Avenir'). F.P. was supported by ARC. L.S. and J.S. were supported by doctoral grants from the Ile-de-France region (Canceropole and DIM Cellule Souche) and from Fondation pour la Recherche Medicale (FRM). C.M. was supported by ANR-13-JVSV1-GERMPN-01.	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Bellanne-Chantelot C, 2008, LEUKEMIA, V22, P450, DOI 10.1038/sj.leu.2404896; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; Bluteau D, 2014, J CLIN INVEST, V124, P580, DOI 10.1172/JCI71861; Cabagnols X, 2015, NEW ENGL J MED, V372, P688, DOI 10.1056/NEJMc1413718; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Chou ST, 2012, P NATL ACAD SCI USA, V109, P17573, DOI 10.1073/pnas.1211175109; Cui W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/365318; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Harutyunyan AS, 2012, HEMATOL ONCOL CLIN N, V26, P1037, DOI 10.1016/j.hoc.2012.07.005; Jager R, 2014, AM J HEMATOL, V89, P1107, DOI 10.1002/ajh.23842; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2013, THER ADV HEMATOL, V4, P237, DOI 10.1177/2040620713489144; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kishi-Itakura C, 2014, J CELL SCI, V127, P4089, DOI 10.1242/jcs.156034; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Lin CC, 2009, J CELL BIOCHEM, V108, P1325, DOI 10.1002/jcb.22362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundberg P, 2014, J EXP MED, V211, P2213, DOI 10.1084/jem.20131371; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; MacLean GA, 2012, P NATL ACAD SCI USA, V109, P17567, DOI 10.1073/pnas.1215468109; Malak S, 2012, BLOOD CELL MOL DIS, V49, P170, DOI 10.1016/j.bcmd.2012.06.004; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; MANCINI M, 1993, CANCER GENET CYTOGEN, V66, P39, DOI 10.1016/0165-4608(93)90146-D; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; MERTENS F, 1990, LEUKEMIA, V4, P117; Mortensen M, 2011, AUTOPHAGY, V7, P1069, DOI 10.4161/auto.7.9.15886; Oddsson A, 2014, LEUKEMIA, V28, P1371, DOI 10.1038/leu.2014.48; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Rice KL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.39; Rumi E, 2014, BLOOD, V123, P2416, DOI 10.1182/blood-2014-01-550434; Rumi E, 2011, AM J HEMATOL, V86, P974, DOI 10.1002/ajh.22166; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Saliba J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074257; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Soda M, 2008, CELL SIGNAL, V20, P2317, DOI 10.1016/j.cellsig.2008.09.001; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Toze CL, 1997, BRIT J HAEMATOL, V98, P177, DOI 10.1046/j.1365-2141.1997.1863003.x; Krepischi ACV, 2012, FUTURE ONCOL, V8, P441, DOI [10.2217/FON.12.34, 10.2217/fon.12.34]; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yamada O, 2014, J CLIN ONCOL, V32, pE76, DOI 10.1200/JCO.2012.47.8669; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759	62	88	91	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1131	+		10.1038/ng.3380	http://dx.doi.org/10.1038/ng.3380			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26280900	Green Submitted			2022-12-25	WOS:000361969900008
J	Eduati, F; Mangravite, LM; Wang, T; Tang, H; Bare, JC; Huang, RL; Norman, T; Kellen, M; Menden, MP; Yang, JC; Zhan, XW; Zhong, R; Xiao, GH; Xia, MH; Abdo, N; Kosyk, O; Friend, S; Dearry, A; Simeonov, A; Tice, RR; Rusyn, I; Wright, FA; Stolovitzky, G; Xie, Y; Saez-Rodriguez, J; Aittokallio, T; Alaimo, S; Amadoz, A; Ammad-ud-din, M; Azencott, CA; Bacardit, J; Barron, P; Bernard, E; Beyer, A; Bin, S; van Bommel, A; Borgwardt, K; Brys, AM; Caffrey, B; Chang, J; Chang, J; Chheda, H; Christodoulou, EG; Clement-Ziza, M; Cohen, T; Cowherd, M; Demeyer, S; Dopazo, J; Elhard, JD; Falcao, AO; Ferro, A; Friedenberg, DA; Giugno, R; Gong, YG; Gorospe, JW; Granville, CA; Grimm, D; Heinig, M; Hernansaiz, RD; Hintsanen, P; Hochreiter, S; Huang, LC; Huska, M; Jaiswal, A; Jiao, YL; Kaski, S; Kaur, I; Khan, SA; Klambauer, G; Krasnogor, N; Kuhn, M; Kursa, MB; Kutum, R; Lazzarini, N; Lee, I; Leung, MKK; Lim, WK; Liu, C; Lopez, FL; Mammana, A; Mayr, A; Michoel, T; Mongiovi, M; Moore, JD; Mpindi, JP; Narasimhan, R; Opiyo, SO; Pandey, G; Peabody, AL; Perner, J; Poso, A; Pulvirenti, A; Rawlik, K; Reinhardt, S; Riffle, CG; Ruderfer, D; Sander, AJ; Savage, RS; Scornet, E; Sebastian-Leon, P; Sharan, R; Simon-Gabriel, CJ; Stoven, V; Sun, JC; Tang, J; Teixeira, AL; Tenesa, A; Vert, JP; Vingron, M; Walter, T; Wennerberg, K; Whalen, S; Wisniewska, Z; Wu, YH; Xu, H; Zhang, SH; Zhao, JF; Zheng, WJ; Dai, ZW				Eduati, Federica; Mangravite, Lara M.; Wang, Tao; Tang, Hao; Bare, J. Christopher; Huang, Ruili; Norman, Thea; Kellen, Mike; Menden, Michael P.; Yang, Jichen; Zhan, Xiaowei; Zhong, Rui; Xiao, Guanghua; Xia, Menghang; Abdo, Nour; Kosyk, Oksana; Friend, Stephen; Dearry, Allen; Simeonov, Anton; Tice, Raymond R.; Rusyn, Ivan; Wright, Fred A.; Stolovitzky, Gustavo; Xie, Yang; Saez-Rodriguez, Julio; Aittokallio, Tero; Alaimo, Salvatore; Amadoz, Alicia; Ammad-ud-din, Muhammad; Azencott, Chloe-Agathe; Bacardit, Jaume; Barron, Pelham; Bernard, Elsa; Beyer, Andreas; Bin, Shao; van Boemmel, Alena; Borgwardt, Karsten; Brys, April M.; Caffrey, Brian; Chang, Jeffrey; Chang, Jungsoo; Chheda, Himanshu; Christodoulou, Eleni G.; Clement-Ziza, Mathieu; Cohen, Trevor; Cowherd, Marianne; Demeyer, Sofie; Dopazo, Joaquin; Elhard, Joel D.; Falcao, Andre O.; Ferro, Alfredo; Friedenberg, David A.; Giugno, Rosalba; Gong, Yunguo; Gorospe, Jenni W.; Granville, Courtney A.; Grimm, Dominik; Heinig, Matthias; Hernansaiz, Rosa D.; Hintsanen, Petteri; Hochreiter, Sepp; Huang, Liang-Chin; Huska, Matthew; Jaiswal, Alok; Jiao, Yunlong; Kaski, Samuel; Kaur, Ismeet; Khan, Suleiman Ali; Klambauer, Guenter; Krasnogor, Natalio; Kuhn, Michael; Kursa, Miron Bartosz; Kutum, Rintu; Lazzarini, Nicola; Lee, Inhan; Leung, Michael K. K.; Lim, Weng Khong; Liu, Charlie; Lopez, Felipe Llinares; Mammana, Alessandro; Mayr, Andreas; Michoel, Tom; Mongiovi, Misael; Moore, Jonathan D.; Mpindi, John-Patrick; Narasimhan, Ravi; Opiyo, Stephen O.; Pandey, Gaurav; Peabody, Andrea L.; Perner, Juliane; Poso, Antti; Pulvirenti, Alfredo; Rawlik, Konrad; Reinhardt, Susanne; Riffle, Carol G.; Ruderfer, Douglas; Sander, Aaron J.; Savage, Richard S.; Scornet, Erwan; Sebastian-Leon, Patricia; Sharan, Roded; Simon-Gabriel, Carl Johann; Stoven, Veronique; Sun, Jingchun; Tang, Jing; Teixeira, Ana L.; Tenesa, Albert; Vert, Jean-Philippe; Vingron, Martin; Walter, Thomas; Wennerberg, Krister; Whalen, Sean; Wisniewska, Zofia; Wu, Yonghui; Xu, Hua; Zhang, Shihua; Zhao, Junfei; Zheng, W. Jim; Dai Ziwei		NIEHS-NCATS-UNC DREAM	Prediction of human population responses to toxic compounds by a collaborative competition	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; SENSITIVITY; KNOWLEDGE; LIBRARY; MODEL; SET	The ability to computationally predict the effects of toxic compounds on humans could help address the deficiencies of current chemical safety testing. Here, we report the results from a community-based DREAM challenge to predict toxicities of environmental compounds with potential adverse health effects for human populations. We measured the cytotoxicity of 156 compounds in 884 lymphoblastoid cell lines for which genotype and transcriptional data are available as part of the Tox21 1000 Genomes Project. The challenge participants developed algorithms to predict interindividual variability of toxic response from genomic profiles and population-level cytotoxicity data from structural attributes of the compounds. 179 submitted predictions were evaluated against an experimental data set to which participants were blinded. Individual cytotoxicity predictions were better than random, with modest correlations (Pearson's r < 0.28), consistent with complex trait genomic prediction. In contrast, predictions of population-level response to different compounds were higher (r < 0.66). The results highlight the possibility of predicting health risks associated with unknown compounds, although risk estimation accuracy remains suboptimal.	[Eduati, Federica; Menden, Michael P.; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Mangravite, Lara M.; Bare, J. Christopher; Norman, Thea; Kellen, Mike; Friend, Stephen] Sage Bionetworks, Seattle, WA USA; [Wang, Tao; Tang, Hao; Yang, Jichen; Zhong, Rui; Xiao, Guanghua; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Tang, Hao; Xie, Yang] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Huang, Ruili; Xia, Menghang; Simeonov, Anton] NIH, Div Preclin Innovat, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Zhan, Xiaowei] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Abdo, Nour; Kosyk, Oksana; Rusyn, Ivan] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Abdo, Nour] Jordan Univ Sci & Technol, Fac Med, Dept Publ Hlth, Irbid, Jordan; [Dearry, Allen; Tice, Raymond R.] NIEHS, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Wright, Fred A.] N Carolina State Univ, Bioinformat Res Ctr, Dept Stat & Biol Sci, Raleigh, NC 27695 USA; [Stolovitzky, Gustavo] IBM Corp, IBM TJ Watson Res Ctr, Yorktown Hts, NY USA; [Aittokallio, Tero; Chheda, Himanshu; Hintsanen, Petteri; Jaiswal, Alok; Mpindi, John-Patrick; Tang, Jing; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Alaimo, Salvatore; Mongiovi, Misael] Univ Catania, Dept Math & Comp Sci, Catania, Italy; [Amadoz, Alicia; Dopazo, Joaquin; Hernansaiz, Rosa D.; Sebastian-Leon, Patricia] CIPF, Computat Genom Dept, Valencia, Spain; [Ammad-ud-din, Muhammad; Kaski, Samuel; Khan, Suleiman Ali] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland; [Azencott, Chloe-Agathe; Borgwardt, Karsten; Grimm, Dominik; Lopez, Felipe Llinares; Simon-Gabriel, Carl Johann] Max Planck Inst Dev Biol, Machine Learning & Computat Biol Res Grp, Tubingen, Germany; [Azencott, Chloe-Agathe; Borgwardt, Karsten; Grimm, Dominik; Lopez, Felipe Llinares; Simon-Gabriel, Carl Johann] Max Planck Inst Intelligent Syst, Machine Learning & Computat Biol Res Grp, Tubingen, Germany; [Bacardit, Jaume; Krasnogor, Natalio; Lazzarini, Nicola] Newcastle Univ, Interdisciplinary Comp & Complex BioSystems ICOS, Newcastle Upon Tyne, Tyne & Wear, England; [Barron, Pelham; Chang, Jungsoo; Cowherd, Marianne; Lee, Inhan] MiRcore, Ann Arbor, MI USA; [Bernard, Elsa; Jiao, Yunlong; Scornet, Erwan; Stoven, Veronique; Vert, Jean-Philippe; Walter, Thomas] Ctr Computat Biol, Mines ParisTech, Fontainebleau, France; [Bernard, Elsa; Jiao, Yunlong; Scornet, Erwan; Stoven, Veronique; Vert, Jean-Philippe; Walter, Thomas] Inst Curie, Paris, France; [Bernard, Elsa; Jiao, Yunlong; Scornet, Erwan; Stoven, Veronique; Vert, Jean-Philippe; Walter, Thomas] INSERM U900, Paris, France; [Beyer, Andreas; Christodoulou, Eleni G.; Clement-Ziza, Mathieu; Kuhn, Michael; Reinhardt, Susanne] Tech Univ Dresden, BIOTEC, Dresden, Germany; [Beyer, Andreas; Clement-Ziza, Mathieu] Univ Cologne, CECAD, Cologne, Germany; [Bin, Shao; Dai Ziwei] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China; [van Boemmel, Alena; Caffrey, Brian; Heinig, Matthias; Huska, Matthew; Mammana, Alessandro; Perner, Juliane; Vingron, Martin] Max Planck Inst Mol Genet, Berlin, Germany; [Brys, April M.; Elhard, Joel D.; Friedenberg, David A.; Gorospe, Jenni W.; Granville, Courtney A.; Peabody, Andrea L.; Riffle, Carol G.; Sander, Aaron J.] Battelle Mem Inst, Columbus, OH USA; [Chang, Jeffrey; Cohen, Trevor; Gong, Yunguo; Huang, Liang-Chin; Sun, Jingchun; Wu, Yonghui; Xu, Hua; Zheng, W. Jim] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Chang, Jeffrey] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Demeyer, Sofie; Michoel, Tom; Rawlik, Konrad; Tenesa, Albert] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh, Midlothian, Scotland; [Falcao, Andre O.; Teixeira, Ana L.] Univ Lisbon, Dept Informat, LaSIGE, Fac Ciencias, Lisbon, Portugal; [Ferro, Alfredo; Giugno, Rosalba; Pulvirenti, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Heinig, Matthias] Max Delbruck Ctr Mol Med, Berlin, Germany; [Hochreiter, Sepp; Klambauer, Guenter; Mayr, Andreas] Johannes Kepler Univ Linz, Inst Bioinformat, Linz, Austria; [Kaur, Ismeet] Adobe, San Jose, CA USA; [Kursa, Miron Bartosz; Wisniewska, Zofia] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Kutum, Rintu] CSIR, Inst Genom Integrat Biol, New Delhi, India; [Leung, Michael K. K.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Lim, Weng Khong] Natl Canc Ctr Singapore, Singapore, Singapore; [Liu, Charlie] Stepping Stone Genom, Mclean, VA USA; [Moore, Jonathan D.; Savage, Richard S.] Univ Warwick, Syst Biol Ctr, Coventry, W Midlands, England; [Narasimhan, Ravi] Vital Connect Inc, Campbell, CA USA; [Opiyo, Stephen O.] Ohio State Univ, Mol & Mol Imaging Ctr, Columbus, OH 43210 USA; [Pandey, Gaurav; Ruderfer, Douglas; Whalen, Sean] Mt Sinai, New York, NY USA; [Poso, Antti] Univ Eastern Finland, Sch Pharm, Fac Hlth Sci, Kuopio, Finland; [Savage, Richard S.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Scornet, Erwan] Univ Paris 06, Paris, France; [Sharan, Roded] Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel; [Teixeira, Ana L.] Univ Lisbon, Ctr Quim Bioquim, Fac Ciencias, Lisbon, Portugal; [Whalen, Sean] Gladstone Inst, San Francisco, CA USA; [Zhang, Shihua; Zhao, Junfei] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China	European Molecular Biology Laboratory (EMBL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Jordan University of Science & Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; North Carolina State University; International Business Machines (IBM); University of Helsinki; University of Catania; Prince Felipe Research Center; Aalto University; University of Helsinki; Max Planck Society; Max Planck Society; Newcastle University - UK; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; University of Cologne; Peking University; Max Planck Society; Battelle Memorial Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Universidade de Lisboa; University of Catania; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Johannes Kepler University Linz; Adobe Systems Inc.; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Toronto; National Cancer Centre Singapore (NCCS); University of Warwick; University System of Ohio; Ohio State University; University of Eastern Finland; University of Warwick; UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Universidade de Lisboa; University of California System; University of California San Francisco; The J David Gladstone Institutes; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Saez-Rodriguez, J (corresponding author), Rhein Westfal TH Aachen, Joint Res Ctr Computat Biomed JRC COMBINE, Aachen, Germany.	Yang.Xie@utsouthwestern.edu; saezrodriguez@combine.rwth-aachen.de	Moore, Jonathan D/D-1796-2013; Beyer, Andreas/AAQ-5519-2020; Wennerberg, Krister/AAH-2919-2022; Lim, Weng Khong/Q-8661-2019; Rusyn, Ivan/S-2426-2016; Clément-Ziza, Mathieu/J-4146-2012; Ruderfer, Douglas M/M-5795-2016; SEBASTIAN-LEON, PATRICIA/AAA-8009-2020; Mongiovì, Misael/GNP-0059-2022; ALAIMO, Salvatore/K-4745-2017; Bernard, Elsa/AAD-8682-2020; Bacardit, Jaume/F-9293-2014; Pulvirenti, Alfredo/I-7272-2018; Saez-Rodriguez, Julio/H-7114-2019; Motsinger-Reif, Alison/I-4167-2018; Hochreiter, Sepp/AAI-5904-2020; Zhao, Junfei/J-1425-2018; Tang, Jing/H-4084-2012; SHAO, BIN/ABE-4975-2021; Tang, Jing/W-1764-2019; Kursa, Miron/B-4405-2013; tang, jing/HHR-9815-2022; Kaski, Samuel/B-6684-2008; Scornet, Erwan/AAE-7811-2020; Falcao, Andre O./A-3545-2010; Aittokallio, Tero/B-6583-2009; Wennerberg, Krister/AFM-0539-2022; Eduati, Federica/AAH-6526-2021; Wang, Tao/K-3518-2016; Amadoz, Alicia/A-9598-2014; Grimm, Dominik/L-9088-2019; yang, jichen/HDL-9203-2022; Walter, Thomas/B-9079-2015	Moore, Jonathan D/0000-0002-5486-0407; Beyer, Andreas/0000-0002-3891-2123; Wennerberg, Krister/0000-0002-1352-4220; Lim, Weng Khong/0000-0003-4391-1130; Clément-Ziza, Mathieu/0000-0003-2763-249X; Ruderfer, Douglas M/0000-0002-2365-386X; SEBASTIAN-LEON, PATRICIA/0000-0001-7299-3660; Mongiovì, Misael/0000-0003-0528-5490; ALAIMO, Salvatore/0000-0003-4825-7617; Bernard, Elsa/0000-0002-2057-7187; Bacardit, Jaume/0000-0002-2692-7205; Pulvirenti, Alfredo/0000-0002-9764-0295; Saez-Rodriguez, Julio/0000-0002-8552-8976; Motsinger-Reif, Alison/0000-0003-1346-2493; Hochreiter, Sepp/0000-0001-7449-2528; Tang, Jing/0000-0001-7480-7710; SHAO, BIN/0000-0001-8697-2174; Tang, Jing/0000-0001-7480-7710; Kursa, Miron/0000-0001-7672-648X; Kaski, Samuel/0000-0003-1925-9154; Falcao, Andre O./0000-0002-3588-8746; Aittokallio, Tero/0000-0002-0886-9769; Wennerberg, Krister/0000-0002-1352-4220; Eduati, Federica/0000-0002-7822-3867; Amadoz, Alicia/0000-0003-3915-0404; Grimm, Dominik/0000-0003-2085-4591; Demeyer, Sofie/0000-0002-8193-5734; Kutum, Rintu/0000-0001-8667-6199; Bare, J. Christopher/0000-0003-1006-1491; Hernansaiz Ballesteros, Rosa/0000-0001-8536-8848; Michoel, Tom/0000-0003-4749-4725; Rusyn, Ivan/0000-0001-9340-7384; Heinig, Matthias/0000-0002-5612-1720; Cowherd, Marianne/0000-0002-3165-4504; van Bommel, Alena/0000-0002-8434-8586; Dai, Ziwei/0000-0002-0858-638X; Vert, Jean-Philippe/0000-0001-9510-8441; Friedenberg, David/0000-0002-4404-8941; Poso, Antti/0000-0003-4196-4204; Azencott, Chloe-Agathe/0000-0003-1003-301X; Tenesa, Albert/0000-0003-4884-4475; Walter, Thomas/0000-0001-7419-7879; Giugno, Rosalba/0000-0001-9843-7638; Borgwardt, Karsten/0000-0001-7221-2393; Mangravite, Lara/0000-0001-7841-3612; Chang, Jungsoo/0000-0001-5901-6929	US National Institutes of Health (NIH); National Institute of Environmental Health Sciences (NIEHS) [Y2-ES-7020-01]; US Environmental Protection Agency [STAR RD83516601, RD83382501]; NIH [R01CA161608, R01HG006292, 5R01CA152301, 1R01CA172211]; European Molecular Biology Laboratory Interdisciplinary Post-Docs (EMBL EIPOD); Marie Curie Actions (COFUND); MRC [G0902104] Funding Source: UKRI; Medical Research Council [G0902104] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA161608, R01CA172211, R01CA152301] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000038, ZICTR000040] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, T32ES007020] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Environmental Protection Agency(United States Environmental Protection Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Laboratory Interdisciplinary Post-Docs (EMBL EIPOD); Marie Curie Actions (COFUND); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the US National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS). This work was made possible by US Environmental Protection Agency grants STAR RD83516601 and RD83382501, NIH grants R01CA161608 and R01HG006292, and through an interagency agreement (IAG #Y2-ES-7020-01) from NIEHS to NCATS. F.E. thanks European Molecular Biology Laboratory Interdisciplinary Post-Docs (EMBL EIPOD) and Marie Curie Actions (COFUND) for funding. Best performing team was funded by NIH grants 5R01CA152301 and 1R01CA172211.	Abdo N, 2015, ENVIRON HEALTH PERSP, V123, P458, DOI 10.1289/ehp.1408775; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brown CC, 2014, PHARMACOGENOMICS, V15, P137, DOI 10.2217/pgs.13.213; Burczynski ME, 2000, TOXICOL SCI, V58, P399, DOI 10.1093/toxsci/58.2.399; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Derry JMJ, 2012, NAT GENET, V44, P127, DOI 10.1038/ng.1089; Dorne JLCM, 2010, TOXICOLOGY, V268, P156, DOI 10.1016/j.tox.2009.11.004; Gamazon ER, 2013, BLOOD, V121, P4366, DOI 10.1182/blood-2012-10-464149; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Jacobs AC, 2013, VET PATHOL, V50, P324, DOI 10.1177/0300985812450727; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914; Kuz'min VE, 2008, J COMPUT AID MOL DES, V22, P403, DOI 10.1007/s10822-008-9179-6; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Meyer P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-13; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todeschini R., 2004, WEB VERSION, V3; Uehara T, 2011, TOXICOL APPL PHARM, V255, P297, DOI 10.1016/j.taap.2011.07.001; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687; Zheng WF, 2000, J CHEM INF COMP SCI, V40, P185, DOI 10.1021/ci980033m	38	68	69	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					933	+		10.1038/nbt.3299	http://dx.doi.org/10.1038/nbt.3299			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26258538	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000360990900021
J	Patkar, RN; Benke, PI; Qu, ZW; Chen, YYC; Yang, F; Swarup, S; Naqvi, NI				Patkar, Rajesh N.; Benke, Peter I.; Qu, Ziwei; Chen, Yuan Yi Constance; Yang, Fan; Swarup, Sanjay; Naqvi, Naweed I.			A fungal monooxygenase-derived jasmonate attenuates host innate immunity	NATURE CHEMICAL BIOLOGY			English	Article							MAGNAPORTHE-ORYZAE; BLAST FUNGUS; 12-OXO-PHYTODIENOIC ACID; FUSARIUM-OXYSPORUM; SALICYLIC-ACID; RICE; DEFENSE; LEAVES; PLANTS; GENES	Distinct modifications fine-tune the activity of jasmonic acid (JA) in regulating plant growth and immunity. Hydroxylated JA (12OH-JA) promotes flower and tuber development but prevents induction of JA signaling, plant defense or both. However, biosynthesis of 12OH-JA has remained elusive. We report here an antibiotic biosynthesis monooxygenase (Abm) that converts endogenous free JA into 12OH-JA in the model rice blast fungus Magnaporthe oryzae. Such fungal 12OH-JA is secreted during host penetration and helps evade the defense response. Loss of Abm in M. oryzae led to accumulation of methyl JA (MeJA), which induces host defense and blocks invasive growth. Exogenously added 12OH-JA markedly attenuated abm Delta-induced immunity in rice. Notably, Abm itself is secreted after invasion and most likely converts plant JA into 12OH-JA to facilitate host colonization. This study sheds light on the chemical arms race during plant-pathogen interaction, reveals Abm as an antifungal target and outlines a synthetic strategy for transformation of a versatile small-molecule phytohormone.	[Patkar, Rajesh N.; Qu, Ziwei; Chen, Yuan Yi Constance; Yang, Fan; Naqvi, Naweed I.] Temasek Life Sci Lab, Singapore, Singapore; [Benke, Peter I.; Qu, Ziwei; Swarup, Sanjay; Naqvi, Naweed I.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Benke, Peter I.; Swarup, Sanjay] Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Benke, Peter I.; Swarup, Sanjay] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore; [Naqvi, Naweed I.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Patkar, RN (corresponding author), Temasek Life Sci Lab, Singapore, Singapore.	naweed@tll.org.sg	Swarup, Sanjay/I-1592-2012; Naqvi, Naweed/CAG-5662-2022; Patkar, Rajesh/AAA-4332-2019	Swarup, Sanjay/0000-0001-6391-0624; Patkar, Rajesh/0000-0001-7266-2394; Naqvi, Naweed/0000-0002-3619-4906; YANG, Fan/0000-0002-9664-3953	Temasek Life Sciences Laboratory (Singapore); National Research Foundation (Prime Minister's Office), Singapore [NRF-CRP7-2010-02]	Temasek Life Sciences Laboratory (Singapore)(National University of Singapore); National Research Foundation (Prime Minister's Office), Singapore(National Research Foundation, Singapore)	We thank P. Staswick (University of Nebraska) for the chemically synthesized 12OH-JA and L. Laplaze (Institut de recherche pour le developpement, France) for sharing Jas9-VENUS plasmids and transgenic Arabidopsis seeds. We thank L. Yixin and Z. Bo for help with ChemDraw. We also thank the Fungal Patho-Biology group for helpful discussions and suggestions. We are grateful to M. Calvert for help in spinning-disk confocal microscopy. This research was carried out using funds from the Temasek Life Sciences Laboratory (Singapore) and the National Research Foundation (Prime Minister's Office; NRF-CRP7-2010-02), Singapore.	Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; CROSS BE, 1970, J CHEM SOC C, P1839, DOI 10.1039/j39700001839; CUCUROU C, 1991, BIOCHEMISTRY-US, V30, P8964, DOI 10.1021/bi00101a008; Dayton L, 2014, NATURE, V514, pS52, DOI 10.1038/514S52a; Deng YZ, 2012, AUTOPHAGY, V8, P1058, DOI 10.4161/auto.20217; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Letelier ME, 2010, CHEM-BIOL INTERACT, V185, P208, DOI 10.1016/j.cbi.2010.03.020; FELIX G, 1995, PLANT J, V7, P381, DOI 10.1046/j.1365-313X.1995.7030381.x; Fernandez J, 2014, MOL MICROBIOL, V94, P70, DOI 10.1111/mmi.12743; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; Giraldo MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2996; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hedden P, 2000, CURR OPIN BIOTECH, V11, P130, DOI 10.1016/S0958-1669(00)00071-9; Horie K, 2015, J AGR FOOD CHEM, V63, P4050, DOI 10.1021/acs.jafc.5b00785; Huang K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001335; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; KODA Y, 1991, PHYTOCHEMISTRY, V30, P1435, DOI 10.1016/0031-9422(91)84180-Z; Krol P, 2015, J PLANT PHYSIOL, V179, P122, DOI 10.1016/j.jplph.2015.01.018; Larrieu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7043; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; MIERSCH O, 1991, PHYTOCHEMISTRY, V30, P4049, DOI 10.1016/0031-9422(91)83464-V; Miersch O, 1999, PHYTOCHEMISTRY, V50, P1147, DOI 10.1016/S0031-9422(98)00698-0; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Moyen C, 1996, PLANT CELL ENVIRON, V19, P464, DOI 10.1111/j.1365-3040.1996.tb00338.x; Narvaez-Vasquez J, 1999, PLANT CELL, V11, P2249, DOI 10.1105/tpc.11.11.2249; Park JW, 2014, BIOCHEM J, V464, P241, DOI 10.1042/BJ20140787; Patkar RN, 2012, MOL MICROBIOL, V86, P1345, DOI 10.1111/mmi.12060; Patkar RN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002888; Patkar RN, 2010, EUKARYOT CELL, V9, P1029, DOI 10.1128/EC.00292-09; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pozo MJ, 2004, J PLANT GROWTH REGUL, V23, P211, DOI 10.1007/s00344-004-003105; Radhika V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009265; Riemann M, 2013, PLANT J, V74, P226, DOI 10.1111/tpj.12115; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; SCHWEIZER P, 1993, PLANT PHYSIOL, V102, P503, DOI 10.1104/pp.102.2.503; Schweizer P, 1997, PLANT PHYSIOL, V114, P79, DOI 10.1104/pp.114.1.79; Sembdner G., 1993, NAT PROD LETT, V2, P293, DOI [10.1080/10575639308043825, DOI 10.1080/10575639308043825]; SNYDER BA, 1991, PHYSIOL MOL PLANT P, V39, P463, DOI 10.1016/0885-5765(91)90012-7; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Tanaka S, 2014, ELIFE, V3, DOI 10.7554/eLife.01355; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; THEOHARIDES AD, 1981, J BIOL CHEM, V256, P2168; Umemura K, 2003, BIOSCI BIOTECH BIOCH, V67, P899, DOI 10.1271/bbb.67.899; VALENT B, 1991, GENETICS, V127, P87; Weber H, 1997, P NATL ACAD SCI USA, V94, P10473, DOI 10.1073/pnas.94.19.10473; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Werck-Reichhart Daniele, 2002, Arabidopsis Book, V1, pe0028, DOI 10.1199/tab.0028; Xin XN, 2004, J BIOL CHEM, V279, P48159, DOI 10.1074/jbc.M407486200; Yang F, 2014, FUNGAL GENET BIOL, V68, P71, DOI 10.1016/j.fgb.2014.04.005; YOSHIHARA T, 1989, AGR BIOL CHEM TOKYO, V53, P2835, DOI 10.1080/00021369.1989.10869712; Zhang YT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1363-1	55	89	95	4	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					733	+		10.1038/NCHEMBIO.1885	http://dx.doi.org/10.1038/NCHEMBIO.1885			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26258762				2022-12-25	WOS:000359954700019
J	Burggraaf, J; Kamerling, IMC; Gordon, PB; Schrier, L; de Kam, ML; Kales, AJ; Bendiksen, R; Indrevoll, B; Bjerke, RM; Moestue, SA; Yazdanfar, S; Langers, AMJ; Swaerd-Nordmo, M; Torheim, G; Warren, MV; Morreau, H; Voorneveld, PW; Buckle, T; van Leeuwen, FWB; Odegardstuen, LI; Dalsgaard, GT; Healey, A; Hardwick, JCH				Burggraaf, Jacobus; Kamerling, Ingrid M. C.; Gordon, Paul B.; Schrier, Lenneke; de Kam, Marieke L.; Kales, Andrea J.; Bendiksen, Ragnar; Indrevoll, Bard; Bjerke, Roger M.; Moestue, Siver A.; Yazdanfar, Siavash; Langers, Alexandra M. J.; Swaerd-Nordmo, Marit; Torheim, Geir; Warren, Madhuri V.; Morreau, Hans; Voorneveld, Philip W.; Buckle, Tessa; van Leeuwen, Fijs W. B.; Odegardstuen, Liv-Ingrid; Dalsgaard, Grethe T.; Healey, Andrew; Hardwick, James C. H.			Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met	NATURE MEDICINE			English	Article							COLONIC DYSPLASIA; COLONOSCOPY; ENDOSCOPY; CANCER; ADENOMA	Colon cancer prevention currently relies on colonoscopy using white light to detect and remove polyps, but small and flat polyps are difficult to detect and frequently missed when using this technique. Fluorescence colonoscopy combined with a fluorescent probe specific for a polyp biomarker may improve polyp detection. Here we describe GE-137, a water-soluble probe consisting of a 26 amino acid cyclic peptide that binds the human tyrosine kinase c-Met conjugated to a fluorescent cyanine dye. Intravenous administration of GE-137 leads to its accumulation specifically in c-Met expressing tumors in mice, and it is safe and well tolerated in humans. Fluorescence colonoscopy in patients receiving intravenous GE-137 enabled visualization of all neoplastic polyps that were visible with white light (38), as well as an additional nine polyps that were not visible with white light. This first-in-human pilot study shows that molecular imaging using an intravenous fluorescent agent specific for c-Met is feasible and safe, and that it may enable the detection of polyps missed by other techniques.	[Burggraaf, Jacobus; Kamerling, Ingrid M. C.; Schrier, Lenneke; de Kam, Marieke L.; Kales, Andrea J.] Ctr Human Drug Res, Leiden, Netherlands; [Gordon, Paul B.; Bendiksen, Ragnar; Indrevoll, Bard; Bjerke, Roger M.; Moestue, Siver A.; Swaerd-Nordmo, Marit; Torheim, Geir; Odegardstuen, Liv-Ingrid; Healey, Andrew] GE Healthcare, Oslo, Norway; [Yazdanfar, Siavash] GE Global Res Ctr, Niskayuna, NY USA; [Langers, Alexandra M. J.; Voorneveld, Philip W.; Hardwick, James C. H.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Warren, Madhuri V.] St Johns Innovat Ctr, Pathol Diagnost Ltd, Cambridge, England; [Morreau, Hans] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Buckle, Tessa; van Leeuwen, Fijs W. B.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Dalsgaard, Grethe T.] GE Healthcare, Amersham, England	General Electric; General Electric; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St Johns Innovation Centre - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; General Electric	Hardwick, JCH (corresponding author), Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands.	j.c.h.hardwick@lumc.nl	Yazdanfar, Siavash/A-9013-2009; van leeuwen, Fijs/AAX-2098-2021; Moestue, Siver Anderas/F-2369-2015; Langers, Alexandra/AAV-9371-2020; Hardwick, James/J-4862-2013	Yazdanfar, Siavash/0000-0003-2768-6199; van leeuwen, Fijs/0000-0002-6844-4025; Moestue, Siver Anderas/0000-0002-1940-5695; Langers, Alexandra/0000-0003-1627-4324; Hardwick, James/0000-0002-9575-5099; Voorneveld, Philip/0000-0002-3881-4435; Buckle, Tessa/0000-0003-2980-6895	Research Council of Norway [GE-137, 192984/BIA]; SkatteFUNN grant [201108]; Netherlands Organisation for Scientific Research (NWO) VIDI [STW BGT11272]; Education and Research Foundation for Nuclear Medicine and Molecular Imaging	Research Council of Norway(Research Council of Norway); SkatteFUNN grant; Netherlands Organisation for Scientific Research (NWO) VIDI(Netherlands Organization for Scientific Research (NWO)); Education and Research Foundation for Nuclear Medicine and Molecular Imaging	The authors would like to acknowledge the contributions of T. Attramadal, E. Johannesen and H. Dirven, who were the Project Leaders at GE Healthcare in the screening, lead selection and the translational/early clinical phases of the project, respectively. GE Healthcare AS received support for the GE-137 project from The Research Council of Norway grant no. 192984/BIA and SkatteFUNN grant no. 201108. F.W.B.v.L. and T.B. were supported by the The Netherlands Organisation for Scientific Research (NWO) VIDI (grant no. STW BGT11272) and a Postdoctoral Molecular Imaging Scholarship from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging.	Adler A, 2008, GUT, V57, P59, DOI 10.1136/gut.2007.123539; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Chen K, 2010, CURR TOP MED CHEM, V10, P1227, DOI 10.2174/156802610791384225; Clapper ML, 2011, NEOPLASIA, V13, P685, DOI 10.1593/neo.11400; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Endlicher E, 2004, GASTROINTEST ENDOSC, V60, P449, DOI 10.1016/S0016-5107(04)01723-7; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Foersch S, 2010, GUT, V59, P1046, DOI 10.1136/gut.2009.202986; Goetz M, 2010, GASTROENTEROLOGY, V138, P828, DOI 10.1053/j.gastro.2010.01.009; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Imaizumi K, 2012, GASTROINTEST ENDOSC, V75, P110, DOI 10.1016/j.gie.2011.08.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kahi CJ, 2011, CLIN GASTROENTEROL H, V9, P42, DOI 10.1016/j.cgh.2010.09.013; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Keller R, 2002, ENDOSCOPY, V34, P801, DOI 10.1055/s-2002-34254; Kiesslich R, 2011, NAT REV GASTRO HEPAT, V8, P547, DOI 10.1038/nrgastro.2011.152; Kuiper T, 2011, GASTROENTEROLOGY, V140, P1887, DOI 10.1053/j.gastro.2011.03.008; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Liu ZY, 2013, GUT, V62, P395, DOI 10.1136/gutjnl-2011-301913; Marten K, 2002, GASTROENTEROLOGY, V122, P406, DOI 10.1053/gast.2002.30990; Mayinger B, 2010, ENDOSCOPY, V42, P28, DOI 10.1055/s-0029-1243804; Mitsunaga M, 2013, GUT, V62, P1179, DOI 10.1136/gutjnl-2011-301795; Moestue S, 2009, CONTRAST MEDIA MOL I, V4, P73, DOI 10.1002/cmmi.264; Nanjappan A. K. S., 2004, Peptides that specifically bind HGF receptor (cMet) and uses thereof, Patent No. [WO 2004/078778, 2004078778]; Rex DK, 2009, LANCET ONCOL, V10, P1135, DOI 10.1016/S1470-2045(09)70342-0; van den Berg Nynke S, 2011, Transl Oncol, V4, P234; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1; Wu AM, 2008, CANCER J, V14, P191, DOI 10.1097/PPO.0b013e31817b07ae	31	186	191	3	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					955	961		10.1038/nm.3641	http://dx.doi.org/10.1038/nm.3641			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26168295	Green Published			2022-12-25	WOS:000359181000024
J	Laberge, RM; Sun, Y; Orjalo, AV; Patil, CK; Freund, A; Zhou, LL; Curran, SC; Davalos, AR; Wilson-Edell, KA; Liu, S; Limbad, C; Demaria, M; Li, P; Hubbard, GB; Ikeno, Y; Javors, M; Desprez, PY; Benz, CC; Kapahi, P; Nelson, PS; Campisi, J				Laberge, Remi-Martin; Sun, Yu; Orjalo, Arturo V.; Patil, Christopher K.; Freund, Adam; Zhou, Lili; Curran, Samuel C.; Davalos, Albert R.; Wilson-Edell, Kathleen A.; Liu, Su; Limbad, Chandani; Demaria, Marco; Li, Patrick; Hubbard, Gene B.; Ikeno, Yuji; Javors, Martin; Desprez, Pierre-Yves; Benz, Christopher C.; Kapahi, Pankaj; Nelson, Peter S.; Campisi, Judith			MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation	NATURE CELL BIOLOGY			English	Article							CELLULAR SENESCENCE; TUMOR-CELLS; DNA-DAMAGE; HUMAN FIBROBLASTS; GROWTH ARREST; CANCER; P53; INFLAMMATION; EXPRESSION; PATHWAY	The TOR (target of rapamycin) kinase limits longevity by poorly understood mechanisms. Rapamycin suppresses the mammalian TORC1 complex, which regulates translation, and extends lifespan in diverse species, including mice. We show that rapamycin selectively blunts the pro-inflammatory phenotype of senescent cells. Cellular senescence suppresses cancer by preventing cell proliferation. However, as senescent cells accumulate with age, the senescence-associated secretory phenotype (SASP) can disrupt tissues and contribute to age-related pathologies, including cancer. MTOR inhibition suppressed the secretion of inflammatory cytokines by senescent cells. Rapamycin reduced IL6 and other cytokine mRNA levels, but selectively suppressed translation of the membrane-bound cytokine IL1A. Reduced IL1A diminished NF-kappa B transcriptional activity, which controls much of the SASP; exogenous IL1A restored IL6 secretion to rapamycin-treated cells. Importantly, rapamycin suppressed the ability of senescent fibroblasts to stimulate prostate tumour growth in mice. Thus, rapamycin might ameliorate age-related pathologies, including late-life cancer, by suppressing senescence-associated inflammation.	[Laberge, Remi-Martin; Orjalo, Arturo V.; Patil, Christopher K.; Freund, Adam; Zhou, Lili; Curran, Samuel C.; Davalos, Albert R.; Wilson-Edell, Kathleen A.; Liu, Su; Limbad, Chandani; Demaria, Marco; Li, Patrick; Desprez, Pierre-Yves; Benz, Christopher C.; Kapahi, Pankaj; Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA; [Sun, Yu; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Sun, Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China; [Hubbard, Gene B.; Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Hubbard, Gene B.; Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ikeno, Yuji] Res Serv, San Antonio, TX 78229 USA; [Ikeno, Yuji] Audio Murphy VA Hosp STVHCS, GRECC, San Antonio, TX 78229 USA; [Javors, Martin] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Desprez, Pierre-Yves] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	Buck Institute for Research on Aging; Fred Hutchinson Cancer Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; California Pacific Medical Center; California Pacific Medical Center Research Institute	Campisi, J (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	jcampisi@buckinstitute.org	Limbad, Chandani/S-8476-2017; Demaria, Marco/AAH-9235-2019	Demaria, Marco/0000-0002-8429-4813; sun, yu/0000-0001-7121-9112	National institutes of Health (NIH) [AG045288, AG909266-16, CP143858, CA155679, CA071468, AG032113, AG025961, CA164188, CA165573, CA097186, AG09909, AG017212, AG041122]; Hillblom Medical Foundation; DOD-PCRP grant [PC111703]; National Natural Science Foundation of China [81472799]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA097186, R21CA155679, U01CA164188, U24CA143858, R01CA165573, R01CA071468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266, R56AG009909, RL1AG032113, P30AG013319, R37AG009909, P01AG017242, R01AG009909, K99AG045288, P01AG025901, R01AG045835, P01AG041122] Funding Source: NIH RePORTER	National institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Medical Foundation; DOD-PCRP grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Rogers, B. Kennedy, G. Lithgow, S. Melov and members of the Campisi laboratory (Buck Institute) for comments and discussions, I Coleman for assistance with figure preparation and data analysis, and R. Strong (1; Texas Health Science Center) for providing the rapamycin encapsulated chow. I his work was supported by grants from the National institutes of Health (NIH) AG045288 to R.-M.T., Hillblom Medical Foundation (CP), NIH T32 training grant AG909266-16 to K.A.W-E., NIH grants CP143858, CA155679 and CA071468 to C.C.B., NIH grants AG032113 and AG025961 to P.K., DOD-PCRP grant PC111703 and National Natural Science Foundation of China 81472799 to Y.S., NIH grants CA164188, CA165573 and CA097186 and the Prostate Cancer Foundation to P.S.N., and NIH grants AG09909 and AG017212 to J.C. and AG041122 to J.C. and Y.J.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chang BD, 1999, CANCER RES, V59, P3761; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding GH, 2001, EXP MOL PATHOL, V70, P43, DOI 10.1006/exmp.2000.2346; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sheiban I, 2008, VASC HEALTH RISK MAN, V4, P31, DOI 10.2147/vhrm.2008.04.01.31; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; te Poele RH, 2002, CANCER RES, V62, P1876; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	70	596	616	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1049	U416		10.1038/ncb3195	http://dx.doi.org/10.1038/ncb3195			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26147250	Green Accepted			2022-12-25	WOS:000358847700012
J	Sun, LJ; Miao, ZY; Cai, CM; Zhang, DJ; Zhao, MX; Wu, YY; Zhang, XL; Swarm, SA; Zhou, LW; Zhang, ZYJ; Nelson, RL; Ma, JX				Sun, Lianjun; Miao, Zhenyan; Cai, Chunmei; Zhang, Dajian; Zhao, Meixia; Wu, Yanyan; Zhang, Xueling; Swarm, Stephen A.; Zhou, Liwen; Zhang, Zhanyuan J.; Nelson, Randall L.; Ma, Jianxin			GmHs1-1, encoding a calcineurin-like protein, controls hard-seededness in soybean	NATURE GENETICS			English	Article							DOMESTICATION-RELATED TRAITS; GLYCINE-MAX; SEED COATS; GENETIC-ANALYSIS; GRAIN LEGUMES; GENOME; WATER; DIVERSITY; SELECTION; WILD	Loss of seed-coat impermeability was essential in the domestication of many leguminous crops to promote the production of their highly nutritious seeds. Here we show that seed-coat impermeability in wild soybean is controlled by a single gene, GmHs1-1, which encodes a calcineurin-like metallophosphoesterase transmembrane protein. GmHs1-1 is primarily expressed in the Malpighian layer of the seed coat and is associated with calcium content. The transition from impermeability to permeability in domesticated soybean was caused by artificial selection of a point mutation in GmHs1-1. Interestingly, a number of soybean landraces evaded selection for permeability because of an alternative selection for seed-coat cracking that also enables seed imbibition. Despite the single origin of the mutant allele Gmhs1-1, the distribution pattern of allelic variants in the context of soybean population structure and the detected signature of genomic introgression between wild and cultivated soybeans suggest that Gmhs1-1 may have experienced reselection for seed-coat permeability.	[Sun, Lianjun; Miao, Zhenyan; Zhang, Dajian; Zhao, Meixia; Ma, Jianxin] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Cai, Chunmei; Wu, Yanyan; Zhang, Xueling; Ma, Jianxin] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China; [Swarm, Stephen A.; Nelson, Randall L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Zhou, Liwen; Zhang, Zhanyuan J.] Univ Missouri, Div Plant Sci, Plant Transformat Core Facil, Columbia, MO USA; [Nelson, Randall L.] USDA ARS, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Qingdao Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Ma, JX (corresponding author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.	maj@purdue.edu	ZHAO, MEIXIA/N-3124-2015	ZHAO, MEIXIA/0000-0001-8812-8217	Indiana Soybean Alliance [00049970, 14055567]; Taishan Scholarship and High-Level Talents Foundation of Qingdao Agricultural University [631304]; North Central Soybean Research Program [58-3611-4-017]; Ag Alumni Seed and the Purdue Agricultural Research Program	Indiana Soybean Alliance; Taishan Scholarship and High-Level Talents Foundation of Qingdao Agricultural University; North Central Soybean Research Program; Ag Alumni Seed and the Purdue Agricultural Research Program	We thank Z. Tian, J. Du, F. Lin, J. Ping, L. Zhu and A. Johnson for their involvement in developing the mapping populations at Purdue University, and we thank D. Szymanski for valuable comments on the manuscript. This work was mainly supported by soybean checkoff funds from the Indiana Soybean Alliance (00049970 and 14055567) and was partially supported by the Taishan Scholarship and High-Level Talents Foundation of Qingdao Agricultural University (631304), the North Central Soybean Research Program (58-3611-4-017), Ag Alumni Seed and the Purdue Agricultural Research Program. The US Department of Agriculture-Agricultural Research Service is an equal-opportunity provider and employer.	Abbo S, 2003, Q REV BIOL, V78, P435, DOI 10.1086/378927; Abbo S, 2014, TRENDS PLANT SCI, V19, P351, DOI 10.1016/j.tplants.2013.12.002; Andargie M, 2014, EUPHYTICA, V200, P401, DOI 10.1007/s10681-014-1170-9; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Bosse M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5392; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Carter T.E., 2004, AGRONOMY, P303, DOI DOI 10.2134/AGR0NM0N0GR16.3ED.C8; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flores T, 2008, TRANSGENIC RES, V17, P839, DOI 10.1007/s11248-008-9167-6; Foley ME, 2001, WEED SCI, V49, P305, DOI 10.1614/0043-1745(2001)049[0305:SDAUOT]2.0.CO;2; Fuller D. Q., 2009, ANN PLANT REV, V38, P238, DOI DOI 10.1002/9781444314557.CH7; Gepts P., 1991, Common beans: research for crop improvement., P7; HARRIS WM, 1987, BOT GAZ, V148, P324, DOI 10.1086/337660; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; KEIM P, 1990, THEOR APPL GENET, V79, P465, DOI 10.1007/BF00226154; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LADIZINSKY G, 1979, EUPHYTICA, V28, P179, DOI 10.1007/BF00029189; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; LUSH WM, 1980, FIELD CROP RES, V3, P267, DOI 10.1016/0378-4290(80)90034-9; Ma FS, 2004, ANN BOT-LONDON, V94, P213, DOI 10.1093/aob/mch133; Miller SS, 1999, ANN BOT-LONDON, V84, P297, DOI 10.1006/anbo.1999.0915; Nakamura T, 2003, EUPHYTICA, V133, P179, DOI 10.1023/A:1025541610329; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Ping JQ, 2014, PLANT CELL, V26, P2831, DOI 10.1105/tpc.114.126938; POTTS HC, 1978, CROP SCI, V18, P221, DOI 10.2135/cropsci1978.0011183X001800020006x; ROLSTON MP, 1978, BOT REV, V44, P365, DOI 10.1007/BF02957854; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Russi L., 1992, Seed Science Research, V2, P243; SAIO K, 1973, CEREAL SCI TODAY, V18, P197; SAIO K, 1976, CEREAL FOOD WORLD, V21, P168; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shi H, 2013, PLANT CELL, V25, P1143, DOI 10.1105/tpc.112.107904; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; VALENTI GS, 1989, SEED SCI TECHNOL, V17, P563; Watanabe S, 2004, BREEDING SCI, V54, P399, DOI 10.1270/jsbbs.54.399; Weeden NF, 2007, ANN BOT-LONDON, V100, P1017, DOI 10.1093/aob/mcm122; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang B, 2008, CROP SCI, V48, P1341, DOI 10.2135/cropsci2007.10.0544; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096; Ziegler G, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.07.0012	45	58	71	3	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					939	+		10.1038/ng.3339	http://dx.doi.org/10.1038/ng.3339			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26098868				2022-12-25	WOS:000358674100021
J	Wheway, G; Schmidts, M; Mans, DA; Szymanska, K; Nguyen, TMT; Racher, H; Phelps, IG; Toedts, G; Kennedy, J; Wunderlich, KA; Sorusch, N; Abdelhamed, ZA; Natarajan, S; Herridge, W; van Reeuwijk, J; Horn, N; Boldt, K; Parry, DA; Letteboer, SJF; Roosing, S; Adams, M; Bell, SM; Bond, J; Higgins, J; Morrison, EE; Tomlinson, DC; Slaats, GG; van Dam, TJP; Huang, LJ; Kessler, K; Giessl, A; Logan, CV; Boyle, EA; Shendure, J; Anazi, S; Aldahmesh, M; Al Hazzaa, S; Hegele, RA; Ober, C; Frosk, P; Mhanni, AA; Chodirker, BN; Chudley, AE; Lamont, R; Bernier, FP; Beaulieu, CL; Gordon, P; Pon, RT; Donahue, C; Barkovich, AJ; Wolf, L; Toomes, C; Thiel, CT; Boycott, KM; McKibbin, M; Inglehearn, CF; Stewart, F; Omran, H; Huynen, MA; Sergouniotis, PI; Alkuraya, FS; Parboosingh, JS; Innes, AM; Willoughby, CE; Giles, RH; Webster, AR; Ueffing, M; Blacque, O; Gleeson, JG; Wolfrum, U; Beales, PL; Gibson, T; Doherty, D; Mitchison, HM; Roepman, R; Johnson, CA				Wheway, Gabrielle; Schmidts, Miriam; Mans, Dorus A.; Szymanska, Katarzyna; Nguyen, Thanh-Minh T.; Racher, Hilary; Phelps, Ian G.; Toedts, Grischa; Kennedy, Julie; Wunderlich, Kirsten A.; Sorusch, Nasrin; Abdelhamed, Zakia A.; Natarajan, Subaashini; Herridge, Warren; van Reeuwijk, Jeroen; Horn, Nicola; Boldt, Karsten; Parry, David A.; Letteboer, Stef J. F.; Roosing, Susanne; Adams, Matthew; Bell, Sandra M.; Bond, Jacquelyn; Higgins, Julie; Morrison, Ewan E.; Tomlinson, Darren C.; Slaats, Gisela G.; van Dam, Teunis J. P.; Huang, Lijia; Kessler, Kristin; Giessl, Andreas; Logan, Clare V.; Boyle, Evan A.; Shendure, Jay; Anazi, Shamsa; Aldahmesh, Mohammed; Al Hazzaa, Selwa; Hegele, Robert A.; Ober, Carole; Frosk, Patrick; Mhanni, Aizeddin A.; Chodirker, Bernard N.; Chudley, Albert E.; Lamont, Ryan; Bernier, Francois P.; Beaulieu, Chandree L.; Gordon, Paul; Pon, Richard T.; Donahue, Clem; Barkovich, A. James; Wolf, Louis; Toomes, Carmel; Thiel, Christian T.; Boycott, Kym M.; McKibbin, Martin; Inglehearn, Chris F.; Stewart, Fiona; Omran, Heymut; Huynen, Martijn A.; Sergouniotis, Panagiotis I.; Alkuraya, Fowzan S.; Parboosingh, Jillian S.; Innes, A. Micheil; Willoughby, Cohn E.; Giles, Rachel H.; Webster, Andrew R.; Ueffing, Marius; Blacque, Oliver; Gleeson, Joseph G.; Wolfrum, Uwe; Beales, Philip L.; Gibson, Toby; Doherty, Dan; Mitchison, Hannah M.; Roepman, Ronald; Johnson, Colin A.		UK10K Consortium; Univ Washington Ctr Mendelian Geno	An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes	NATURE CELL BIOLOGY			English	Article							JOUBERT SYNDROME; PRIMARY CILIA; CENTRIOLE BIOGENESIS; MASTER REGULATOR; PROTEIN; MUTATIONS; TRANSPORT; MICROSCOPY; DISORDER; RPGRIP1L	Defects in primary cilium biogenesis underlie the ciliopathies, a growing group of genetic disorders. We describe a whole-genome siRNA-based reverse genetics screen for defects in biogenesis and/or maintenance of the primary cilium, obtaining a global resource. We identify 112 candidate ciliogenesis and ciliopathy genes, including 44 components of the ubiquitin-proteasome system, 12 G-protein-coupled receptors, and 3 pre-mRNA processing factors (PRPF6, PRPF8 and PRPF31) mutated in autosomal dominant retinitis pigmentosa. The PRPFs localize to the connecting cilium, and PRPF8- and PRPF31-mutated cells have ciliary defects. Combining the screen with exome sequencing data identified recessive mutations in PIBF1, also known as CEP90, and C21orf2, also known as LRRC76, as causes of the ciliopathies Joubert and Jeune syndromes. Biochemical approaches place C21orf2 within key ciliopathy-associated protein modules, offering an explanation for the skeletal and retinal involvement observed in individuals with C21orf2 variants. Our global, unbiased approaches provide insights into ciliogenesis complexity and identify roles for unanticipated pathways in human genetic disease.	[Wheway, Gabrielle; Szymanska, Katarzyna; Abdelhamed, Zakia A.; Natarajan, Subaashini; Herridge, Warren; Logan, Clare V.; Toomes, Carmel; Inglehearn, Chris F.; Johnson, Colin A.] Univ Leeds, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Schmidts, Miriam; Beales, Philip L.; Mitchison, Hannah M.] Univ London, Genet & Genom Med, Inst Child Hlth, London WC1N 1EH, England; [Schmidts, Miriam; Beales, Philip L.; Mitchison, Hannah M.] Univ London, Birth Defects Res Ctr, Inst Child Hlth, London WC1N 1EH, England; [Schmidts, Miriam; Mans, Dorus A.; Nguyen, Thanh-Minh T.; van Reeuwijk, Jeroen; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Schmidts, Miriam; Mans, Dorus A.; Nguyen, Thanh-Minh T.; van Reeuwijk, Jeroen; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Schmidts, Miriam] Univ Hosp, Ctr Pediat & Adolescent Med, Pediat Genet Sect, D-79112 Freiburg, Germany; [Racher, Hilary; Lamont, Ryan; Bernier, Francois P.; Gordon, Paul; Pon, Richard T.; Parboosingh, Jillian S.; Innes, A. Micheil] Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Racher, Hilary; Lamont, Ryan; Bernier, Francois P.; Gordon, Paul; Pon, Richard T.; Parboosingh, Jillian S.; Innes, A. Micheil] Alberta Childrens Prov Gen Hosp, Res Inst Child & Maternal Hlth, Calgary, AB T3B 6AB, Canada; [Phelps, Ian G.; Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Toedts, Grischa; Gibson, Toby] European Mol Biol Lab, Struct & Computat Biol, D-69117 Heidelberg, Germany; [Kennedy, Julie; Blacque, Oliver] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Wunderlich, Kirsten A.; Sorusch, Nasrin; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Cell & Matrix Biol, D-55122 Mainz, Germany; [Horn, Nicola; Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Div Expt Ophthalmol, D-72074 Tubingen, Germany; [Horn, Nicola; Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Ctr Ophthalmol, Med Proteome Ctr, D-72074 Tubingen, Germany; [Parry, David A.] Univ Leeds, Leeds Inst Mol Med, Genet Sect, Leeds LS9 7TF, W Yorkshire, England; [Roosing, Susanne; Gleeson, Joseph G.] Rockefeller Univ, Howard Hughes Med Inst, Lab Pediat Brain Dis, New York, NY 10065 USA; [Adams, Matthew; Bell, Sandra M.; Bond, Jacquelyn; Higgins, Julie; Morrison, Ewan E.; Tomlinson, Darren C.] St James Univ Hosp, Biomed Hlth Res Ctr, BioScreening Technol Grp, Leeds LS9 7TF, W Yorkshire, England; [Slaats, Gisela G.; Beaulieu, Chandree L.; Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, NL-3584 CX Utrecht, Netherlands; [van Dam, Teunis J. P.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Huang, Lijia; Beaulieu, Chandree L.; Boycott, Kym M.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada; [Kessler, Kristin; Thiel, Christian T.] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Giessl, Andreas] Univ Erlangen Nurnberg, Anim Physiol, D-91054 Erlangen, Germany; [Boyle, Evan A.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Anazi, Shamsa; Aldahmesh, Mohammed; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Al Hazzaa, Selwa] King Faisal Specialist Hosp & Res Ctr, Dept Ophthalmol, Riyadh 11211, Saudi Arabia; [Al Hazzaa, Selwa] Alfaisal Univ, Coll Med, Dept Ophthalmol, Riyadh 11533, Saudi Arabia; [Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON N6G 2V4, Canada; [Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Frosk, Patrick; Mhanni, Aizeddin A.; Chodirker, Bernard N.; Chudley, Albert E.] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB R3E 3P5, Canada; [Frosk, Patrick; Mhanni, Aizeddin A.; Chodirker, Bernard N.; Chudley, Albert E.] Univ Manitoba, Fac Med, Dept Biochem & Med Genet, Winnipeg, MB R3E 3P5, Canada; [Donahue, Clem] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 92093 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 92093 USA; [Wolf, Louis] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands; [McKibbin, Martin] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Dept Ophthalmol, Leeds LS9 7TF, W Yorkshire, England; [UK10K Consortium] Welcome Trust Sanger Inst, Consortium UK10K, Hinxton CB10 1SA, England; [Univ Washington Ctr Mendelian Geno] Univ Washington, Ctr Medelian Genom, Seattle, WA 98195 USA; [Stewart, Fiona] Belfast City Hosp, Dept Med Genet, Belfast BT12 6BA, Antrim, North Ireland; [Stewart, Fiona] Queens Univ, Belfast BT12 6BA, Antrim, North Ireland; [Omran, Heymut] Univ Hosp Muenster, Dept Pediat & Adolescent Med, D-48149 Munster, Germany; [Sergouniotis, Panagiotis I.; Webster, Andrew R.] Moorfields Eye Hosp NHS Fdn Trust, London EC1V 2PD, England; [Sergouniotis, Panagiotis I.; Webster, Andrew R.] NIHR Ophthalmol Biomed Res Ctr, London EC1V 2PD, England; [Sergouniotis, Panagiotis I.; Webster, Andrew R.] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Willoughby, Cohn E.] Univ Liverpool, Fac Hlth & Life Sci, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool L69 3BX, Merseyside, England; [Ueffing, Marius] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Res Unit Prot Sci, D-85764 Neuherberg, Germany; [Doherty, Dan] Univ Washington, Seattle Childrens Res Inst, Div Dev Med, Seattle, WA 98105 USA; [Doherty, Dan] Univ Washington, Seattle Childrens Res Inst, Div Med Genet, Seattle, WA 98105 USA	University of Leeds; University of London; University College London; University of London; University College London; Radboud University Nijmegen; Radboud University Nijmegen; University of Freiburg; Alberta Childrens Hospital; University of Calgary; University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); University College Dublin; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Leeds; Howard Hughes Medical Institute; Rockefeller University; Saint James's University Hospital; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Ottawa; Children's Hospital of Eastern Ontario; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Washington; University of Washington Seattle; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Western University (University of Western Ontario); University of Chicago; University of Manitoba; University of Manitoba; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Radboud University Nijmegen; Saint James's University Hospital; University of Leeds; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Belfast City Hospital; Queens University Belfast; University of Munster; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Alfaisal University; University of Liverpool; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Doherty, D (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	ddoher@uw.edu; h.mitchison@ucl.ac.uk; ronald.roepman@radboudumc.nl; c.johnson@leesd.ac.uk	Slaats, Gisela/HDO-1608-2022; Roosing, Susanne/F-1616-2018; Hegele, Robert/G-3301-2011; Blacque, Oliver/AAL-8860-2021; Schmidts, Miriam/A-3777-2012; innes, allan micheil/A-9955-2017; Hegele, Robert/AAF-6482-2020; van Reeuwijk, Jeroen/P-8665-2015; Bernier, Francois/V-7150-2018; Inglehearn, Chris/GYD-9783-2022; Roepman, Ronald/B-1339-2014; Thiel, Christian T/H-8964-2012; Roosing, Susanne/AAK-3454-2020; Roosing, Susanne/ABF-9604-2021; Shendure, Jay/AAU-3684-2021; Beales, Philip L/C-7367-2009; van Dam, Teunis JP/P-6049-2015; Bernier, Francois/AAP-2174-2020; Letteboer, Stef JF/P-8272-2015; Huynen, Martijn A/A-1530-2014	Slaats, Gisela/0000-0002-4567-0134; Roosing, Susanne/0000-0001-9038-0067; Schmidts, Miriam/0000-0002-1714-6749; Hegele, Robert/0000-0003-2861-5325; van Reeuwijk, Jeroen/0000-0002-0658-4399; Roepman, Ronald/0000-0002-5178-8163; Thiel, Christian T/0000-0003-3817-7277; Roosing, Susanne/0000-0001-9038-0067; Roosing, Susanne/0000-0001-9038-0067; van Dam, Teunis JP/0000-0002-8122-190X; Huynen, Martijn A/0000-0001-6189-5491; Blue, Elizabeth/0000-0002-0633-0305; Gibson, Toby James/0000-0003-0657-5166; Omran, Heymut/0000-0003-0282-6765; Blacque, Oliver/0000-0003-1598-2695; Kelly, Kirsten/0000-0003-4234-543X; Bell, Sandra/0000-0002-3022-9864; Innes, Micheil/0000-0001-9881-5467; Giles, Rachel/0000-0001-9133-2008; Giessl, Andreas/0000-0002-9768-2049; Tomlinson, Darren/0000-0003-4134-7484; Parry, David/0000-0003-0376-7736; Wheway, Gabrielle/0000-0002-0494-0783; Natarajan, Subaashini/0000-0002-4259-7680; Willoughby, Colin/0000-0002-1246-4166; Johnson, Colin/0000-0002-2979-8234; Bernier, Francois/0000-0001-7063-4269; Logan, Clare/0000-0003-4323-1602; Aldahmesh, Mohammed Abdullah/0000-0003-0130-9029; Frosk, Patrick/0000-0002-9673-795X; Toomes, Carmel/0000-0001-8373-9545; Ober, Carole/0000-0003-4626-9809; Mitchison, Hannah/0000-0002-3163-6293	European Community's Seventh Framework Programme [241955]; Sir Jules Thorn Award for Biomedical Research [JTA/09]; Medical Research Council [MR/K011154/1]; Action Medical Research Clinical Training Fellowship [RTF-1411]; Radboud University Excellence fellowship; Radboud UMC Hypatia Tenure Track fellowship; Deutsche Forschungsgemeinschaft (DFG) [SFB 1140, TH 896/3-3]; Netherlands Organization for Scientific Research [NWO Vici-865.12.005]; Foundation Fighting Blindness [C-CMM-0811-0546-RAD02]; Dutch Kidney Foundation [CP11.18]; IZKF (Interdisciplinary Centre for Clinical Research of the Universitat of Erlangen-Nurnberg) grant [F4]; FAUN foundation, Nuernberg; Rosetree's Trust [A210, A465]; Great Ormond Street Hospital Children's Charity; Milena Carvajal Pro-Kartagener Foundation; Action Medical Research [GN2101]; Canadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute (ACHRI); Alberta Children's Hospital Foundation; RP Fighting Blindness; Moorfields Eye Hospital Special Trustees; National Institute for Health Research (NIHR; Moorfields Eye Hospital and Institute of Ophthalmology, London, UK); Foundation Fighting Blindness (US); NINDS [R01NS064077]; University of Washington Intellectual and Developmental Disabilities Research Center Genetics Core [P30HD002274]; NCI [R21CA160080]; Wellcome Trust [ME041596, WT091310]; NHGRI [U54HG006493]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091, P30HD002274] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA160080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS064077] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M020991/1] Funding Source: researchfish; Medical Research Council [G0801843, G0700073, MR/M000532/1] Funding Source: researchfish; National Institute for Health Research [ACF-2013-06-009] Funding Source: researchfish; Rosetrees Trust [M279-F1] Funding Source: researchfish; Action Medical Research [1794, 2101] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; Newlife [12-13/11] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish; BBSRC [BB/M020991/1] Funding Source: UKRI; MRC [G0700073, MR/M000532/1, MR/K011154/1, G0801843] Funding Source: UKRI	European Community's Seventh Framework Programme(European Commission); Sir Jules Thorn Award for Biomedical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Medical Research Clinical Training Fellowship; Radboud University Excellence fellowship; Radboud UMC Hypatia Tenure Track fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness(European Commission); Dutch Kidney Foundation; IZKF (Interdisciplinary Centre for Clinical Research of the Universitat of Erlangen-Nurnberg) grant; FAUN foundation, Nuernberg; Rosetree's Trust(Rosetrees Trust); Great Ormond Street Hospital Children's Charity; Milena Carvajal Pro-Kartagener Foundation; Action Medical Research; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Children's Hospital Research Institute (ACHRI); Alberta Children's Hospital Foundation; RP Fighting Blindness; Moorfields Eye Hospital Special Trustees; National Institute for Health Research (NIHR; Moorfields Eye Hospital and Institute of Ophthalmology, London, UK); Foundation Fighting Blindness (US); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Washington Intellectual and Developmental Disabilities Research Center Genetics Core; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Action Medical Research; The Sir Jules Thorn Charitable Trust; Newlife; Great Ormond Street Hospital Childrens Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Our deepest thanks go to all of the families and individuals with Joubert syndrome, Jeune syndrome and retinitis pigmentosa. We thank P. Barker, M. Jackson, K. Roberts and A. Jones from PerkinElmer Inc. for technical support. The research received funding from the European Community's Seventh Framework Programme FP7/2009 under grant agreement no: 241955 SYSCILIA towards C.A.J., R.R., M.U., T.G., P.L.B., O.E.B., U.W., R.H.G., M.A.H. and H.O. This work was supported by a Sir Jules Thorn Award for Biomedical Research (JTA/09, to C.F.I. and C.A.J.) and a Medical Research Council grant (MR/K011154/1, to C.A.J.). M.S. was financially supported by an Action Medical Research Clinical Training Fellowship (RTF-1411), a Radboud University Excellence fellowship, a Radboud UMC Hypatia Tenure Track fellowship and acknowledges funding from the Deutsche Forschungsgemeinschaft (DFG; grant SFB 1140 (KIDGEM)). R.R. is funded by the Netherlands Organization for Scientific Research (NWO Vici-865.12.005), and by the Foundation Fighting Blindness (C-CMM-0811-0546-RAD02). P.L.B. is a Wellcome Trust Senior Research Fellow, and P.L.B., M.S., R.H.G. and R.R. acknowledge funding from the Dutch Kidney Foundation (CP11.18, 'Kouncil'). C.T.T. is financially supported by DFG grant TH 896/3-3 and IZKF (Interdisciplinary Centre for Clinical Research of the Universitat of Erlangen-Nurnberg) grant F4. U.W. is financially supported by the FAUN foundation, Nuernberg. Z.A.A. and W.H. are supported by grants from the Rosetree's Trust (A210 and A465). H.M.M. is supported by the Great Ormond Street Hospital Children's Charity and received grants from the Milena Carvajal Pro-Kartagener Foundation and Action Medical Research (GN2101). H.R. is financially supported by the Canadian Institutes of Health Research (CIHR) Training Program in Genetics, Child Development and Health, Alberta Children's Hospital Research Institute (ACHRI) and Alberta Children's Hospital Foundation. A.R.W. is financially supported by RP Fighting Blindness, Moorfields Eye Hospital Special Trustees, the National Institute for Health Research (NIHR; Moorfields Eye Hospital and Institute of Ophthalmology, London, UK) and the Foundation Fighting Blindness (US). D.D. is financially supported by NINDS grant R01NS064077, the University of Washington Intellectual and Developmental Disabilities Research Center Genetics Core P30HD002274, and private donations from families of individuals with Joubert syndrome. J.S. is financially supported by NCI grant R21CA160080. Access to the B6;129P2-Tmem67<SUP>tm1Dgen/H</SUP> line was financially supported by the Wellcome Trust Knock-out Mouse Resource scheme (C.A.J. and C.F.I.; grant ME041596). The UK10K project is financially supported by the Wellcome Trust under grant agreement WT091310. A full list of UK10k investigators can be accessed at http://www.uk10k.org. The University of Washington Center for Mendelian Genomics is supported by NHGRI grant U54HG006493.	Abdelhamed ZA, 2013, HUM MOL GENET, V22, P1358, DOI 10.1093/hmg/dds546; Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adams M, 2008, J MED GENET, V45, P257, DOI 10.1136/jmg.2007.054999; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Coene KLM, 2011, HUM MOL GENET, V20, P3592, DOI 10.1093/hmg/ddr280; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Eblimit A, 2015, HUM MOL GENET, V24, P1584, DOI 10.1093/hmg/ddu573; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guadiana SM, 2013, J NEUROSCI, V33, P2626, DOI 10.1523/JNEUROSCI.2906-12.2013; Hebeisen M, 2008, RNA, V14, P2618, DOI 10.1261/rna.1168408; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048196; Kostic I, 2002, DEVELOPMENT, V129, P2155; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Overlack N, 2011, BBA-MOL CELL RES, V1813, P1883, DOI 10.1016/j.bbamcr.2011.05.015; Pelisch F, 2013, BRIEF FUNCT GENOMICS, V12, P66, DOI 10.1093/bfgp/els053; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Romani M, 2013, LANCET NEUROL, V12, P894, DOI 10.1016/S1474-4422(13)70136-4; Sedmak T, 2009, METHOD CELL BIOL, V94, P259, DOI 10.1016/S0091-679X(08)94013-9; Shaheen R, 2015, HUM MOL GENET, V24, P1410, DOI 10.1093/hmg/ddu555; Shaheen R, 2014, J MED GENET, V51, P814, DOI 10.1136/jmedgenet-2014-102790; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Trojan P, 2008, PROG RETIN EYE RES, V27, P237, DOI 10.1016/j.preteyeres.2008.01.003; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014	46	147	157	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					1074	U483		10.1038/ncb3201	http://dx.doi.org/10.1038/ncb3201			43	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26167768	Green Accepted, Green Submitted			2022-12-25	WOS:000358847700014
J	Copeland, RA				Copeland, Robert A.			DRUG-TARGET INTERACTIONS Stay tuned	NATURE CHEMICAL BIOLOGY			English	News Item							RESIDENCE TIME; MECHANISMS; BINDING		Epizyme Inc, Cambridge, MA 02139 USA		Copeland, RA (corresponding author), Epizyme Inc, Cambridge, MA 02139 USA.	rcopeland@epizyme.com						Bradshaw JM, 2015, NAT CHEM BIOL, V11, P525, DOI [10.1038/NCHEMBIO.1817, 10.1038/nchembio.1817]; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Swinney DC, 2004, NAT REV DRUG DISCOV, V3, P801, DOI 10.1038/nrd1500; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; Walkup GK, 2015, NAT CHEM BIOL, V11, P416, DOI 10.1038/nchembio.1796; Zhang R, 2009, CURR OPIN DRUG DISC, V12, P488	10	12	12	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					451	452		10.1038/nchembio.1831	http://dx.doi.org/10.1038/nchembio.1831			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26006012				2022-12-25	WOS:000356334600005
J	Nihongaki, Y; Kawano, F; Nakajima, T; Sato, M				Nihongaki, Yuta; Kawano, Fuun; Nakajima, Takahiro; Sato, Moritoshi			Photoactivatable CRISPR-Cas9 for optogenetic genome editing	NATURE BIOTECHNOLOGY			English	Article							NUCLEASE-INDUCED MUTATIONS; HUMAN-CELLS; TARGET DNA; GUIDE RNA; CAS9; PROTEIN; SPECIFICITY; SYSTEM; ENDONUCLEASE; ACTIVATION	We describe an engineered photoactivatable Cas9 (paCas9) that enables optogenetic control of CRISPR-Cas9 genome editing in human cells. paCas9 consists of split Cas9 fragments and photoinducible dimerization domains named Magnets. In response to blue light irradiation, paCas9 expressed in human embryonic kidney 293T cells induces targeted genome sequence modifications through both nonhomologous end joining and homology-directed repair pathways. Genome editing activity can be switched off simply by extinguishing the light. We also demonstrate activation of paCas9 in spatial patterns determined by the sites of irradiation. Optogenetic control of targeted genome editing should facilitate improved understanding of complex gene networks and could prove useful in biomedical applications.	[Nihongaki, Yuta; Kawano, Fuun; Nakajima, Takahiro; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Sato, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp	Sato, Moritoshi/O-2735-2018; Kawano, Fuun/U-5777-2019	Sato, Moritoshi/0000-0002-3095-5831; Nihongaki, Yuta/0000-0002-9818-9344	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [15J05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank J. Galipon for technical assistance. This work was supported by Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and by grants from Japan Society for the Promotion of Science (JSPS).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee HM, 2009, ACS CHEM BIOL, V4, P409, DOI 10.1021/cb900036s; Lin YC, 2013, ANGEW CHEM INT EDIT, V52, P6450, DOI 10.1002/anie.201301219; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; Voon DC, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni030; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	30	380	419	7	258	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					755	760		10.1038/nbt.3245	http://dx.doi.org/10.1038/nbt.3245			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26076431				2022-12-25	WOS:000358396100032
J	Cote, CD; Rasmussen, BA; Duca, FA; Zadeh-Tahmasebi, M; Baur, JA; Daljeet, M; Breen, DM; Filippi, BM; Lam, TKT				Cote, Clemence D.; Rasmussen, Brittany A.; Duca, Frank A.; Zadeh-Tahmasebi, Melika; Baur, Joseph A.; Daljeet, Mira; Breen, Danna M.; Filippi, Beatrice M.; Lam, Tony K. T.			Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network	NATURE MEDICINE			English	Article							PROTEIN-KINASE; GLUCOSE-HOMEOSTASIS; AMPK ACTIVATION; SUPPLEMENTATION; MICE; METABOLISM; PHARMACOKINETICS; SENSITIVITY; DEACETYLASE; PHENOTYPES	Resveratrol improves insulin sensitivity and lowers hepatic glucose production (HGP) in rat models of obesity and diabetes(1-5), but the underlying mechanisms for these antidiabetic effects remain elusive. One process that is considered a key feature of resveratrol action is the activation of the nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase sirtuin 1 (SIRT1) in various tissues(1,3,6-8). However, the low bioavailability of resveratrol raises questions about whether the antidiabetic effects of oral resveratrol can act directly on these tissues(9,10). We show here that acute intraduodenal infusion of resveratrol reversed a 3 d high fat diet (HFD)-induced reduction in duodenal-mucosal Sirt1 protein levels while also enhancing insulin sensitivity and lowering HGP. Further, we found that duodenum-specific knockdown of Sirt1 expression for 14 d was sufficient to induce hepatic insulin resistance in rats fed normal chow. We also found that the glucoregulatory role of duodenally acting resveratrol required activation of Sirt1 and AMP-activated protein kinase (Ampk) in this tissue to initiate a gut-brain-liver neuronal axis that improved hypothalamic insulin sensitivity and in turn, reduced HGP. In addition to the effects of duodenally acting resveratrol in an acute 3 d HFD-fed model of insulin resistance, we also found that short-term infusion of resveratrol into the duodenum lowered HGP in two other rat models of insulin resistance-a 28 d HFD-induced model of obesity and a nicotinamide (NA)-streptozotocin (STZ)-HFD-induced model of mild type 2 diabetes. Together, these studies highlight the therapeutic relevance of targeting duodenal SIRT1 to reverse insulin resistance and improve glucose homeostasis in obesity and diabetes.	[Cote, Clemence D.; Rasmussen, Brittany A.; Duca, Frank A.; Zadeh-Tahmasebi, Melika; Daljeet, Mira; Breen, Danna M.; Filippi, Beatrice M.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Cote, Clemence D.; Rasmussen, Brittany A.; Duca, Frank A.; Zadeh-Tahmasebi, Melika; Daljeet, Mira; Breen, Danna M.; Filippi, Beatrice M.; Lam, Tony K. T.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Cote, Clemence D.; Rasmussen, Brittany A.; Zadeh-Tahmasebi, Melika; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Baur, Joseph A.] Univ Penn, Dept Physiol, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	tony.lam@uhnres.utoronto.ca		Cote, Clemence/0000-0001-9200-7688; Filippi, Beatrice Maria/0000-0002-8816-1559	Canadian Institute of Health Research [MOP-82701]; Banting and Best Diabetes Centre graduate studentship; Canadian Institute of Health Research Doctoral Vanier Canada scholarship; Canadian Diabetes Association postdoctoral fellowship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre graduate studentship; Canadian Institute of Health Research Doctoral Vanier Canada scholarship; Canadian Diabetes Association postdoctoral fellowship	The authors are grateful to E. Burdett for technical assistance and to L. Schaffer (Novo Nordisk) for providing us with the insulin receptor antagonist (S961). This work is supported by a research grant to T.K.T.L. from the Canadian Institute of Health Research (MOP-82701). C.D.C. is supported by a Banting and Best Diabetes Centre graduate studentship. B.A.R. is supported by a Canadian Institute of Health Research Doctoral Vanier Canada scholarship. F.A.D. is a Banting Fellow. M.Z.-T. is supported by a Banting and Best Diabetes Centre graduate studentship. D.M.B. is supported by a Canadian Diabetes Association postdoctoral fellowship. T.K.T.L. holds the John Kitson McIvor (1915-1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Cote CD, 2014, J BIOL CHEM, V289, P11642, DOI 10.1074/jbc.O114.556068; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Duca F.A., 2015, NAT MED IN PRESS; Filippi BM, 2012, CELL METAB, V16, P500, DOI 10.1016/j.cmet.2012.09.005; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Knight CM, 2011, DIABETES, V60, P2691, DOI 10.2337/db10-0987; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liang L, 2013, PHYTOMEDICINE, V20, P558, DOI 10.1016/j.phymed.2012.12.012; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patel KR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005870; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ramadori G, 2009, ENDOCRINOLOGY, V150, P5326, DOI 10.1210/en.2009-0528; Rasmussen BA, 2014, CELL METAB, V19, P155, DOI 10.1016/j.cmet.2013.11.014; Rasmussen BA, 2012, GASTROENTEROLOGY, V142, P834, DOI 10.1053/j.gastro.2011.12.053; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sale S, 2004, BRIT J CANCER, V90, P736, DOI 10.1038/sj.bjc.6601568; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015	44	104	109	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					498	U284		10.1038/nm.3821	http://dx.doi.org/10.1038/nm.3821			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25849131				2022-12-25	WOS:000354068800017
J	Tee, YH; Shemesh, T; Thiagarajan, V; Hariadi, RF; Anderson, KL; Page, C; Volkmann, N; Hanein, D; Sivaramakrishnan, S; Kozlov, MM; Bershadsky, AD				Tee, Yee Han; Shemesh, Tom; Thiagarajan, Visalatchi; Hariadi, Rizal Fajar; Anderson, Karen L.; Page, Christopher; Volkmann, Niels; Hanein, Dorit; Sivaramakrishnan, Sivaraj; Kozlov, Michael M.; Bershadsky, Alexander D.			Cellular chirality arising from the self-organization of the actin cytoskeleton	NATURE CELL BIOLOGY			English	Article							LEFT-RIGHT ASYMMETRY; DORSAL STRESS FIBERS; LEFT-RIGHT SYMMETRY; UNCONVENTIONAL MYOSIN; EXTRACELLULAR-MATRIX; ADHESION MATURATION; ARP2/3 COMPLEX; CELLS EXHIBIT; FORMIN MDIA1; FILAMENT	Cellular mechanisms underlying the development of left-right asymmetry in tissues and embryos remain obscure. Here, the development of a chiral pattern of actomyosin was revealed by studying actin cytoskeleton self-organization in cells with isotropic circular shape. A radially symmetrical system of actin bundles consisting of ff -actinin-enriched radial fibres (RFs) and myosin-IIA-enriched transverse fibres (TFs) evolved spontaneously into the chiral system as a result of the unidirectional tilting of all RFs, which was accompanied by a tangential shift in the retrograde movement of TFs. We showed that myosin-IIA-dependent contractile stresses within TFs drive their movement along RFs, which grow centripetally in a formin-dependent fashion. The handedness of the chiral pattern was shown to be regulated by alpha-actinin-1. Computational modelling demonstrated that the dynamics of the RF-TF system can explain the pattern transition from radial to chiral. Thus, actin cytoskeleton self-organization provides built-in machinery that potentially allows cells to develop left-right asymmetry.	[Tee, Yee Han; Thiagarajan, Visalatchi; Bershadsky, Alexander D.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Shemesh, Tom] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Hariadi, Rizal Fajar; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Anderson, Karen L.; Page, Christopher; Volkmann, Niels; Hanein, Dorit] Sanford Burnham Med Res Inst, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA; [Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Bershadsky, Alexander D.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	National University of Singapore; Technion Israel Institute of Technology; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Shemesh, T (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	tomsh@technion.ac.il; alexander.bershadsky@weizmann.ac.il		Bershadsky, Alexander/0000-0002-9571-7375; Hariadi, Rizal/0000-0001-7840-859X	National Research Foundation Singapore, Ministry of Education of Singapore [R-714-006-006-271]; National Institutes of Health (NIH) [P01-GM098412]; NIH [P01-GM066311]; Israel Science Foundation [758/11, 956/10]; Marie Curie network Virus Entry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM098412, P01GM066311] Funding Source: NIH RePORTER	National Research Foundation Singapore, Ministry of Education of Singapore; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Marie Curie network Virus Entry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Lappalainen for discussion, S. Hanks, B. M. Jockush, I. Kaverina, C. Otey, P. Roca-Cusachs, M. J. Schell and R. Wedlich-Soldner for providing reagents, C. Lu for writing the custom script for velocities measurement, Z. Z. Lieu for help in the knockdown study, S. Wolf for expert help in paper editing, the microscopy core facility at the Mechanobiology Institute for technical help and Sanford Burnham Medical Research Institute for electron microscopy work. This research has been supported by the National Research Foundation Singapore, Ministry of Education of Singapore, Grant R-714-006-006-271, and administrated by the National University of Singapore. K.L.A. and D.H. were supported by National Institutes of Health (NIH) grant P01-GM098412. C.P. and N.V. were supported by NIH grant P01-GM066311. M.M.K. was supported by the Israel Science Foundation (grant No. 758/11) and the Marie Curie network Virus Entry, and holds the Joseph Klafter Chair in Biophysics. M.M.K. thanks the Mechanobiology Institute, National University of Singapore, for hospitality. A.D.B. holds the Joseph Moss Professorial Chair in Biomedical Research at the Weizmann Institute and is a Visiting Professor at the National University of Singapore and acknowledges support from the Israel Science Foundation (grant No. 956/10).	ANDERSON TF, 1951, T NEW YORK ACAD SCI, V13, P130, DOI 10.1111/j.2164-0947.1951.tb01007.x; Blum M, 2014, DEVELOPMENT, V141, P1603, DOI 10.1242/dev.100560; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; BUCKLEY IK, 1975, J MICROSC-OXFORD, V104, P107, DOI 10.1111/j.1365-2818.1975.tb04010.x; Burnette DT, 2014, J CELL BIOL, V205, P83, DOI 10.1083/jcb.201311104; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Chen TH, 2012, CIRC RES, V110, P551, DOI 10.1161/CIRCRESAHA.111.255927; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Courtemanche N, 2013, P NATL ACAD SCI USA, V110, P9752, DOI 10.1073/pnas.1308257110; Coutelis JB, 2014, EMBO REP, V15, P926, DOI 10.15252/embr.201438972; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Furthauer S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.048103; Gateva G, 2014, J CELL SCI, V127, P1887, DOI 10.1242/jcs.135780; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HAGMANN J, 1993, P NATL ACAD SCI USA, V90, P3280, DOI 10.1073/pnas.90.8.3280; Hariadi RF, 2014, P NATL ACAD SCI USA, V111, P4091, DOI 10.1073/pnas.1315923111; HEACOCK AM, 1977, SCIENCE, V198, P64, DOI 10.1126/science.897684; HEATH JP, 1983, NATURE, V302, P532, DOI 10.1038/302532a0; Henley CL, 2012, J STAT PHYS, V148, P740, DOI 10.1007/s10955-012-0520-z; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Jegou A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2888; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Low SH, 2010, EXP CELL RES, V316, P1925, DOI 10.1016/j.yexcr.2010.03.004; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mizuno H, 2011, SCIENCE, V331, P80, DOI 10.1126/science.1197692; Naganathan SR, 2014, ELIFE, V3, DOI 10.7554/eLife.04165; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Shemesh T, 2007, BIOPHYS J, V92, P1512, DOI 10.1529/biophysj.106.098459; Shemesh T, 2009, BIOPHYS J, V97, P2115, DOI 10.1016/j.bpj.2009.09.016; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; SORANNO T, 1982, J CELL BIOL, V95, P127, DOI 10.1083/jcb.95.1.127; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Speder P, 2007, CURR OPIN CELL BIOL, V19, P82, DOI 10.1016/j.ceb.2006.12.006; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tamada A, 2010, J CELL BIOL, V188, P429, DOI 10.1083/jcb.200906043; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; TINT IS, 1991, J CELL SCI, V98, P375; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001; Vandenberg Laura N, 2013, Commun Integr Biol, V6, pe27155, DOI 10.4161/cib.27155; VASILIEV JM, 1984, BIOCHIM BIOPHYS ACTA, V780, P21, DOI 10.1016/0304-419X(84)90006-4; Wan Leo Q, 2011, Commun Integr Biol, V4, P745; Wan LQ, 2011, P NATL ACAD SCI USA, V108, P12295, DOI 10.1073/pnas.1103834108; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamanaka H, 2015, GENES CELLS, V20, P29, DOI 10.1111/gtc.12194; Yoshiba S, 2014, TRENDS GENET, V30, P10, DOI 10.1016/j.tig.2013.09.001	70	230	231	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					445	+		10.1038/ncb3137	http://dx.doi.org/10.1038/ncb3137			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25799062				2022-12-25	WOS:000351920500015
J	Dahlman, JE; Abudayyeh, OO; Joung, J; Gootenberg, JS; Zhang, F; Konermann, S				Dahlman, James E.; Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana			Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease	NATURE BIOTECHNOLOGY			English	Article							GUIDE RNA; GENOME; CRISPR-CAS9; SPECIFICITY; COMPLEX; DNA; TRANSCRIPTION; ENDONUCLEASE; IMMUNITY; CELLS	We have developed a CRISPR-based method that uses catalytically active Cas9 and distinct single guide (sgRNA) constructs to knock out and activate different genes in the same cell. These sgRNAs, with 14- to 15-bp target sequences and MS2 binding loops, can activate gene expression using an active Streptococcus pyogenes Cas9 nuclease, without inducing doublestranded breaks. We use these 'dead RNAs' to perform orthogonal gene knockout and transcriptional activation in human cells.	[Dahlman, James E.; Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Dahlman, James E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Dahlman, JE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	james.dahlman@bme.gatech.edu; silvanakonermann@gmail.com	Gootenberg, Jonathan/AAY-8174-2021; Joung, Julia/HCH-8944-2022; Abudayyeh, Omar/ABF-1746-2020; Macrae, Rhiannon/AAX-1536-2020	Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220; 	Life Science Research Foundation post-doctoral fellowship of the Cystic Fibrosis Foundation; Friends of the McGovern Institute Fellowship; Department of Energy (DOE) Computational Science Graduate Fellowship; National Institute of Mental Health (NIMH) [1DP1-MH100706]; David R. Cheng and Bob Metcalfe; Poitras Foundation; Vallee Foundation; Simons Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	Life Science Research Foundation post-doctoral fellowship of the Cystic Fibrosis Foundation; Friends of the McGovern Institute Fellowship; Department of Energy (DOE) Computational Science Graduate Fellowship(United States Department of Energy (DOE)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); David R. Cheng and Bob Metcalfe; Poitras Foundation; Vallee Foundation; Simons Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank K. Zheng and I. Slaymaker for their support and input. J.E.D. is supported by a Life Science Research Foundation post-doctoral fellowship of the Cystic Fibrosis Foundation. O.O.A. is supported by a Friends of the McGovern Institute Fellowship. J.S.G. is supported by a Department of Energy (DOE) Computational Science Graduate Fellowship. F.Z. is supported by the National Institute of Mental Health (NIMH) (1DP1-MH100706), the Poitras, Vallee, Simons, Paul G. Allen and New York Stem Cell Foundations, and David R. Cheng and Bob Metcalfe. The authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang laboratory website (http://www.genome-engineering.org/).	Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	22	165	185	5	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1159	U147		10.1038/nbt.3390	http://dx.doi.org/10.1038/nbt.3390			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26436575	Green Submitted, Green Accepted			2022-12-25	WOS:000364916000022
J	Orr, DL; Vargas, L; Turk, CN; Baaten, JE; Matzen, JT; Dardov, VJ; Attle, SJ; Li, J; Quackenbush, DC; Goncalves, RLS; Perevoshchikova, IV; Petrassi, HM; Meeusen, SL; Ainscow, EK; Brand, MD				Orr, Dam L.; Vargas, Leonardo; Turk, Carolina N.; Baaten, Janine E.; Matzen, Jason T.; Dardov, Victoria J.; Attle, Stephen J.; Li, Jing; Quackenbush, Douglas C.; Goncalves, Renata L. S.; Perevoshchikova, Irina V.; Petrassi, H. Michael; Meeusen, Shelly L.; Ainscow, Edward K.; Brand, Martin D.			Suppressors of superoxide production from mitochondrial complex III	NATURE CHEMICAL BIOLOGY			English	Article							OXYGEN SPECIES GENERATION; T-CELL-ACTIVATION; OXIDATIVE STRESS; ROS PRODUCTION; RESPIRATION; INHIBITION; MECHANISM; TOXICITY; DEATH; RATES	Mitochondrial electron transport drives ATP synthesis but also generates reactive oxygen species, which are both cellular signals and damaging oxidants. Superoxide production by respiratory complex III is implicated in diverse signaling events and pathologies, but its role remains controversial. Using high-throughput screening, we identified compounds that selectively eliminate superoxide production by complex III without altering oxidative phosphorylation; they modulate retrograde signaling including cellular responses to hypoxic and oxidative stress.	[Orr, Dam L.; Goncalves, Renata L. S.; Perevoshchikova, Irina V.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA USA; [Vargas, Leonardo; Turk, Carolina N.; Baaten, Janine E.; Matzen, Jason T.; Dardov, Victoria J.; Attle, Stephen J.; Li, Jing; Quackenbush, Douglas C.; Petrassi, H. Michael; Meeusen, Shelly L.; Ainscow, Edward K.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Buck Institute for Research on Aging; Novartis	Orr, DL (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	mbrand@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153	US National Institutes of Health [R01 AG033542, TL1 AG032116]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE ON AGING [TL1AG032116, R01AG033542] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Institutes of Health grants R01 AG033542 (M.D.B.) and TL1 AG032116 (A.L.O.) and the Ellison Medical Foundation grant AG-SS-2288-09 (M.D.B.).	Adam-Vizi V, 2013, NEUROCHEM INT, V62, P757, DOI 10.1016/j.neuint.2013.01.012; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Heather LC, 2010, CARDIOVASC RES, V85, P127, DOI 10.1093/cvr/cvp276; Ishii T, 2005, CANCER RES, V65, P203; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jung HJ, 2010, J BIOL CHEM, V285, P11584, DOI 10.1074/jbc.M109.087809; Kaluz S, 2008, BIOCHEM BIOPH RES CO, V370, P613, DOI 10.1016/j.bbrc.2008.03.147; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Lambert AJ, 2010, AGING CELL, V9, P78, DOI 10.1111/j.1474-9726.2009.00538.x; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Orr AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089938; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Quinlan CL, 2013, METHOD ENZYMOL, V526, P189, DOI 10.1016/B978-0-12-405883-5.00012-0; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Swiss R, 2013, TOXICOL IN VITRO, V27, P1789, DOI 10.1016/j.tiv.2013.05.007; Viola HM, 2010, J MOL CELL CARDIOL, V49, P875, DOI 10.1016/j.yjmcc.2010.07.015; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Win S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.522	31	118	123	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					834	U36		10.1038/NCHEMBIO.1910	http://dx.doi.org/10.1038/NCHEMBIO.1910			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26368590	Green Accepted			2022-12-25	WOS:000363272100007
J	Robinson, MR; Hemani, G; Medina-Gomez, C; Mezzavilla, M; Esko-, T; Shakhbazov, K; Powell, JE; Vinkhuyzen, A; Berndt, SI; Gustafsson, S; Justice, AE; Kahali, B; Locke, AE; Pers, TH; Vedantam, S; Wood, AR; van Rheenen, W; Andreassen, OA; Gasparini, P; Metspalu, A; van den Berg, LH; Veldink, JH; Rivadeneira, F; Werge, TM; Abecasis, GR; Boomsma, DI; Chasman, DI; de Geus, EJC; Frayling, TM; Hirschhorn, JN; Hottenga, JJ; Ingelsson, E; Loos, RJF; Magnusson, PKE; Martin, NG; Montgomery, GW; North, KE; Pedersen, NL; Spector, TD; Speliotes, EK; Goddard, ME; Yang, J; Visscher, PM				Robinson, Matthew R.; Hemani, Gibran; Medina-Gomez, Carolina; Mezzavilla, Massimo; Esko-, Tonu; Shakhbazov, Konstantin; Powell, Joseph E.; Vinkhuyzen, Anna; Berndt, Sonja I.; Gustafsson, Stefan; Justice, Anne E.; Kahali, Bratati; Locke, Adam E.; Pers, Tune H.; Vedantam, Sailaja; Wood, Andrew R.; van Rheenen, Wouter; Andreassen, Ole A.; Gasparini, Paolo; Metspalu, Andres; van den Berg, Leonard H.; Veldink, Jan H.; Rivadeneira, Fernando; Werge, Thomas M.; Abecasis, Goncalo R.; Boomsma, Dorret I.; Chasman, Daniel I.; de Geus, Eco J. C.; Frayling, Timothy M.; Hirschhorn, Joel N.; Hottenga, Jouke Jan; Ingelsson, Erik; Loos, Ruth J. F.; Magnusson, Patrik K. E.; Martin, Nicholas G.; Montgomery, Grant W.; North, Kari E.; Pedersen, Nancy L.; Spector, Timothy D.; Speliotes, Elizabeth K.; Goddard, Michael E.; Yang, Jian; Visscher, Peter M.			Population genetic differentiation of height and body mass index across Europe	NATURE GENETICS			English	Article							ESTIMATING F-STATISTICS; NATURAL-SELECTION; NONCOMMUNICABLE DISEASES; SYSTEMATIC ANALYSIS; GLOBAL VARIATION; COMPLEX TRAITS; HUMAN GENOME; COMMON SNPS; BURDEN; MORTALITY	Across-nation differences in the mean values for complex traits are common(1-8), but the reasons for these differences are unknown. Here we find that many independent loci contribute to population genetic differences in height and body mass index (BMI) in 9,416 individuals across 14 European countries. Using discovery data on over 250,000 individuals and unbiased effect size estimates from 17,500 sibling pairs, we estimate that 24% (95% credible interval (CI) = 9%, 41%) and 8% (95% CI = 4%, 16%) of the captured additive genetic variance for height and BMI, respectively, reflect population genetic differences. Population genetic divergence differed significantly from that in a null model (height, P < 3.94 x 10(-8); BMI, P < 5.95 x 10(-4)), and we find an among-population genetic correlation for tall and slender individuals (r = -0.80, 95% CI = -0.95, -0.60), consistent with correlated selection for both phenotypes. Observed differences in height among populations reflected the predicted genetic means (r = 0.51; P < 0.001), but environmental differences across Europe masked genetic differentiation for BMI (P < 0.58).	[Robinson, Matthew R.; Hemani, Gibran; Shakhbazov, Konstantin; Powell, Joseph E.; Vinkhuyzen, Anna; Yang, Jian; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Medina-Gomez, Carolina; Rivadeneira, Fernando] Erasmus Univ, Dept Internal Med, Med Ctr, Rotterdam, Netherlands; [Mezzavilla, Massimo; Gasparini, Paolo] Ist Ricovero & Cura Carattere Sci IRCCS, Inst Maternal & Child Hlth, Trieste, Italy; [Mezzavilla, Massimo] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Esko-, Tonu; Metspalu, Andres; Hirschhorn, Joel N.] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko-, Tonu; Pers, Tune H.; Vedantam, Sailaja; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Esko-, Tonu; Pers, Tune H.; Vedantam, Sailaja; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Esko-, Tonu; Pers, Tune H.; Chasman, Daniel I.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Powell, Joseph E.; Yang, Jian; Visscher, Peter M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Gustafsson, Stefan] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Justice, Anne E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Kahali, Bratati; North, Kari E.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Kahali, Bratati; North, Kari E.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Locke, Adam E.; Abecasis, Goncalo R.; Speliotes, Elizabeth K.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Frayling, Timothy M.] Univ Exeter, Sch Med, Genet Complex Traits, Exeter, Devon, England; [van Rheenen, Wouter; van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Andreassen, Ole A.] Univ Oslo, Oslo Univ Hosp, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res,Div Mental Hlth & Add, Oslo, Norway; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Werge, Thomas M.] Mental Hlth Devices Copenhagen, MHC Sct Hans, Inst Biol Psychiat, Roskilde, Denmark; [Werge, Thomas M.] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Werge, Thomas M.] Lundbeck Fdn Initiat Integrat Psychiat Res iPSYCH, Aarhus, Denmark; [Boomsma, Dorret I.; de Geus, Eco J. C.; Hottenga, Jouke Jan] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Boomsma, Dorret I.; de Geus, Eco J. C.; Hottenga, Jouke Jan] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Boomsma, Dorret I.; de Geus, Eco J. C.; Hottenga, Jouke Jan] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Ingelsson, Erik] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Loos, Ruth J. F.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC,Epidemiol Unit, Cambridge CB2 2QQ, England; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Martin, Nicholas G.; Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Spector, Timothy D.] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Melbourne, Vic, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Melbourne, Vic, Australia	University of Queensland; Erasmus University Rotterdam; Erasmus MC; Fondazione IRCCS Istituto Nazionale Tumori Milan; Wellcome Trust Sanger Institute; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Technical University of Denmark; University of Exeter; Utrecht University; Utrecht University Medical Center; University of Oslo; University of Oslo; University of Copenhagen; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; QIMR Berghofer Medical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Melbourne	Robinson, MR (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	m.robinson11@uq.edu.au; peter.visscher@uq.edu.au	Gasparini, Paolo/B-6173-2014; de Geus, Eco J.C./M-9318-2015; Loos, Ruth J F/Q-2862-2016; Yang, Jian/A-5852-2010; Mezzavilla, Massimo/AAL-8225-2020; Andreassen, Ole A./AAY-7531-2020; Mezzavilla, Massimo/J-2948-2018; Berndt, Sonja I/J-8423-2016; Loos, Ruth/GON-5877-2022; Medina-Gomez, Carolina/I-1725-2019; Locke, Adam/K-2000-2019; Wood, Andrew R/AAB-3807-2019; Magnusson, Patrik KE/C-4458-2017; Boomsma, Dorret I/AAX-4470-2020; Rivadeneira, Fernando/O-5385-2015; Montgomery, Grant W/B-7148-2008; Visscher, Peter/ABB-6151-2020; Vinkhuyzen, Anna/N-8691-2013	de Geus, Eco J.C./0000-0001-6022-2666; Loos, Ruth J F/0000-0002-8532-5087; Yang, Jian/0000-0003-2001-2474; Mezzavilla, Massimo/0000-0002-9000-4595; Mezzavilla, Massimo/0000-0002-9000-4595; Medina-Gomez, Carolina/0000-0001-7999-5538; Locke, Adam/0000-0001-6227-198X; Wood, Andrew R/0000-0003-1726-948X; Magnusson, Patrik KE/0000-0002-7315-7899; Rivadeneira, Fernando/0000-0001-9435-9441; Montgomery, Grant W/0000-0002-4140-8139; Visscher, Peter/0000-0002-2143-8760; Hemani, Gibran/0000-0003-0920-1055; Gasparini, Paolo/0000-0002-0859-0856; Pers, Tune/0000-0003-0207-4831; Robinson, Matthew/0000-0001-8982-8813; Goddard, Michael/0000-0001-9917-7946; Vinkhuyzen, Anna/0000-0003-3352-0603; Justice, Anne/0000-0002-8903-8712	Australian National Health and Medical Research Council (NHMRC) [1078037, 1048853, 1050218]; Australian Research Council [DE130100691]; Charles and Sylvia Viertel Senior Medical Research Fellowship; NHMRC [1052684]; Swedish Research Council [M-2005-1112]; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; US National Institutes of Health (NIH) [DK U01-066134]; Swedish Foundation for Strategic Research (SSF); Heart and Lung Foundation [20070481]; Netherlands Organization for Scientific Research (NWO; MagW/ZonMW) [904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008, Middelgroot-11-09-032, Spinozapremie 56-464-14192]; Center for Medical Systems Biology (CSMB; NWO Genomics); NBIC/BioAssist/RK [2008.024]; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL) [184.021.007]; VU University's Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Science Foundation (ESF) [EU/QLRT-2001-01254]; European Community [HEALTH-F4-2007-201413]; European Research Council (ERC) [230374]; Rutgers University Cell and DNA Repository (National Institute for Mental Health (NIMH)) [U24-MH068457-06]; Avera Institute (Sioux Falls, South Dakota, USA); US NIH [R01-D0042157-01A, 1RC2-MH089951-01, 1RC2-MH089995-01, AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, DA12854]; Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health; Wellcome Trust; UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; King's College London; National Eye Institute via a US NIH/Center for Inherited Disease Research (CIDR); National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; Illumina; Australian NHMRC [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485]; Health Research Board, Ireland; National Institute on Aging (NIA) [U01-AG09740]; ALS Foundation Netherlands; MRC [MC_UU_12015/1, MC_UU_12013/1] Funding Source: UKRI; Lundbeck Foundation [R155-2014-1724, R190-2014-3904] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1, MC_U106179471, MC_UU_12015/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Charles and Sylvia Viertel Senior Medical Research Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); GenomEUtwin; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Netherlands Organization for Scientific Research (NWO; MagW/ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Center for Medical Systems Biology (CSMB; NWO Genomics); NBIC/BioAssist/RK; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); VU University's Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Science Foundation (ESF)(European Science Foundation (ESF)); European Community(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Rutgers University Cell and DNA Repository (National Institute for Mental Health (NIMH)); Avera Institute (Sioux Falls, South Dakota, USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; King's College London(General Electric); National Eye Institute via a US NIH/Center for Inherited Disease Research (CIDR); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Illumina; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Health Research Board, Ireland; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ALS Foundation Netherlands; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	We thank the reviewers for their very helpful and insightful comments that greatly improved the manuscript. We also thank B. Hill and O. Ovaskainen for useful discussions. The University of Queensland group is supported by the Australian National Health and Medical Research Council (NHMRC; grants 1078037, 1048853 and 1050218). J.E.P. is supported by Australian Research Council grant DE130100691. J.Y. is supported by a Charles and Sylvia Viertel Senior Medical Research Fellowship and by NHMRC grant 1052684. We thank our colleagues at the Centre for Neurogenetics and Statistical Genomics for comments and suggestions. We are grateful to the twins and their families for their generous participation in the full-sibling family data set, which includes data from many cohorts and received support from many funding bodies. TWINGENE was supported by the Swedish Research Council (M-2005-1112), GenomEUtwin (EU/QLRT-2001-01254 and QLG2-CT-2002-01254), US National Institutes of Health (NIH) grant DK U01-066134, the Swedish Foundation for Strategic Research (SSF), and the Heart and Lung Foundation (20070481). For the Netherlands Twin Register (NTR), funding was obtained from the Netherlands Organization for Scientific Research (NWO; MagW/ZonMW grants 904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008, Middelgroot-11-09-032 and Spinozapremie 56-464-14192), the Center for Medical Systems Biology (CSMB; NWO Genomics), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL; 184.021.007), the VU University's Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA), the European Science Foundation (ESF; EU/QLRT-2001-01254), the European Community's Seventh Framework Programme (FP7/2007-2013) under the ENGAGE project grant agreement (HEALTH-F4-2007-201413), the European Research Council (ERC Advanced; 230374), the Rutgers University Cell and DNA Repository (National Institute for Mental Health (NIMH), U24-MH068457-06), the Avera Institute (Sioux Falls, South Dakota, USA) and the US NIH (R01-D0042157-01A, Grand Opportunity grants 1RC2-MH089951-01 and 1RC2-MH089995-01). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health. The TwinsUK study was funded by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007-2013) under the ENGAGE project grant agreement (HEALTH-F4-2007-201413). TwinsUK also receives support from the UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London. T.D.S. is the holder of an ERC Advanced Principal Investigator award. Genotyping for the TwinsUK study was performed by the Wellcome Trust Sanger Institute, with the support of the National Eye Institute via a US NIH/Center for Inherited Disease Research (CIDR) genotyping project. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (contract N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University or NHLBI. Funding for SHARe Affymetrix genotyping was provided by NHLBI contract N02-HL-64278.; Funding for SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. The QIMR researchers acknowledge funding from the Australian NHMRC (grants 241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688 and 552485) and the US NIH (grants AA07535, AA10248, AA014041, AA13320, AA13321, AA13326 and DA12854). We are grateful to M. Gill (Trinity College Dublin) and K. Nicodemus (University of Edinburgh) for access to the ISC-Trinity College Dublin cohort, which was supported by the Wellcome Trust and the Health Research Board, Ireland. Access to the Bulgarian cohort data was kindly facilitated by G. Kirov and V. Excott-Price. For the Danish cohort, the Danish Scientific Committees and the Danish Data Protection Agency approved the study and all the patients gave written informed consent before inclusion in the project. The National Institute on Aging (NIA) provided funding for the Health and Retirement Study (HRS; U01-AG09740). The HRS is performed at the Institute for Social Research at the University of Michigan. This manuscript was not prepared in collaboration with investigators of the HRS and does not necessarily reflect the opinions or views of the HRS, University of Michigan or NIA. The Netherlands genotype samples were part of Project MinE, which was supported by the ALS Foundation Netherlands. Research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013).	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amato R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027588; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Baten J, 2012, ECON HIST DEV REG, V27, pS66, DOI 10.1080/20780389.2012.657489; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; COCKERHAM CC, 1987, P NATL ACAD SCI USA, V84, P8512, DOI 10.1073/pnas.84.23.8512; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Esko T, 2013, EUR J HUM GENET, V21, P659, DOI 10.1038/ejhg.2012.229; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kim AS, 2013, STROKE, V44, pS123, DOI 10.1161/STROKEAHA.111.000067; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McGee DL, 2005, AM J PHYS ANTHROPOL, V128, P220, DOI 10.1002/ajpa.20107; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Ovaskainen O, 2011, GENETICS, V189, P621, DOI 10.1534/genetics.111.129387; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Vasseur E, 2013, EVOL APPL, V6, P596, DOI 10.1111/eva.12045; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang JA, 2010, EUR J HUM GENET, V18, P1039, DOI 10.1038/ejhg.2009.177	58	119	118	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1357	+		10.1038/ng.3401	http://dx.doi.org/10.1038/ng.3401			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26366552	Green Submitted, Green Accepted			2022-12-25	WOS:000363988200021
J	Raman, M; Sergeev, M; Garnaas, M; Lydeard, JR; Huttlin, EL; Goessling, W; Shah, JV; Harper, JW				Raman, Malavika; Sergeev, Mikhail; Garnaas, Maija; Lydeard, John R.; Huttlin, Edward L.; Goessling, Wolfram; Shah, Jagesh V.; Harper, J. Wade			Systematic proteomics of the VCP-UBXD adaptor network identifies a role for UBXN10 in regulating ciliogenesis	NATURE CELL BIOLOGY			English	Article							PLANAR CELL POLARITY; INTRAFLAGELLAR TRANSPORT; AAA-ATPASE; PROTEASOMAL DEGRADATION; MEMBRANE-FUSION; PROTEIN; CILIA; P97; IFT; DISEASE	The AAA-ATPase VCP (also known as p97 or CDC48) uses ATP hydrolysis to 'segregate' ubiquitylated proteins from their binding partners. VCP acts through UBX-domain-containing adaptors that provide target specificity, but the targets and functions of UBXD proteins remain poorly understood. Through systematic proteomic analysis of UBXD proteins in human cells, we reveal a network of over 195 interacting proteins, implicating VCP in diverse cellular pathways. We have explored one such complex between an unstudied adaptor UBXN10 and the intraflagellar transport B (IFT-B) complex, which regulates anterograde transport into cilia. UBXN10 localizes to cilia in a VCP-dependent manner and both VCP and UBXN10 are required for ciliogenesis. Pharmacological inhibition of VCP destabilized the IFT-B complex and increased trafficking rates. Depletion of UBXN10 in zebrafish embryos causes defects in left-right asymmetry, which depends on functional cilia. This study provides a resource for exploring the landscape of UBXD proteins in biology and identifies an unexpected requirement for VCP-UBXN10 in ciliogenesis.	[Raman, Malavika; Lydeard, John R.; Huttlin, Edward L.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Sergeev, Mikhail; Shah, Jagesh V.] Harvard Inst Med, Dept Syst Biol, Boston, MA 02115 USA; [Sergeev, Mikhail; Shah, Jagesh V.] Brigham & Womens Hosp, Harvard Inst Med, Div Renal, Boston, MA 02115 USA; [Garnaas, Maija; Goessling, Wolfram] Dept Med, Boston, MA 02115 USA; [Garnaas, Maija; Goessling, Wolfram] Dept Hlth Sci & Technol, Boston, MA 02115 USA; [Shah, Jagesh V.] Harvard Inst Med, Div Hlth Sci & Technol, Harvard MIT, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Sergeev, Mikhail/0000-0001-7047-2378; Goessling, Wolfram/0000-0001-9972-1569; raman, malavika/0000-0002-4773-8673; Huttlin, Edward/0000-0002-1822-1173; Harper, Jeffrey/0000-0002-6944-7236	NIH [R37-NS083524, RO1-AG011085]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R37-NS083524 and RO1-AG011085 to J.W.H. We would like to thank the Nikon Imaging Center (Harvard Medical School) for microscopy assistance. We would like to thank J. Wallingford (UT Austin) for the Xenopus laevis IFT-43 construct and M. Nachury and A. Nager (Stanford) for helpful discussions.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Backer CB, 2012, MOL BIOL CELL, V23, P2122, DOI 10.1091/mbc.E11-11-0931; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Brooks ER, 2012, J CELL BIOL, V198, P37, DOI 10.1083/jcb.201204072; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kaneko Y, 2010, BIOCHEM BIOPH RES CO, V402, P37, DOI 10.1016/j.bbrc.2010.09.097; Kang W, 2011, BIOCHEM BIOPH RES CO, V407, P531, DOI 10.1016/j.bbrc.2011.03.052; Kasahara K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6081; Kim S, 2013, CURR OPIN CELL BIOL, V25, P506, DOI 10.1016/j.ceb.2013.04.011; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kuhlmann K, 2014, MOL CELL PROTEOMICS, V13, P1828, DOI 10.1074/mcp.M113.035378; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Liu YP, 2014, J CLIN INVEST, V124, P2059, DOI 10.1172/JCI71898; Madsen L, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-31; Madsen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025061; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mahuzier A, 2012, J CELL BIOL, V198, P927, DOI 10.1083/jcb.201111009; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Patil M, 2013, CELL CYCLE, V12, P166, DOI 10.4161/cc.23053; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Wigley WC, 1999, J CELL BIOL, V145, P481; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062	53	50	54	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1356	+		10.1038/ncb3238	http://dx.doi.org/10.1038/ncb3238			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26389662	Green Accepted			2022-12-25	WOS:000362213500016
J	Cantalupo, A; Zhang, Y; Kothiya, M; Galvani, S; Obinata, H; Bucci, M; Giordano, FJ; Jiang, XC; Hla, T; Di Lorenzo, A				Cantalupo, Anna; Zhang, Yi; Kothiya, Milankumar; Galvani, Sylvain; Obinata, Hideru; Bucci, Mariarosaria; Giordano, Frank J.; Jiang, Xian-Cheng; Hla, Timothy; Di Lorenzo, Annarita			Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure	NATURE MEDICINE			English	Article							NITRIC-OXIDE; SPHINGOSINE 1-PHOSPHATE; SERINE PALMITOYLTRANSFERASE; ORAL FINGOLIMOD; MICE LACKING; HYPERTENSION; RECEPTOR; ACTIVATION; SPHINGOSINE-1-PHOSPHATE; CERAMIDE	Endothelial dysfunction is a critical factor in many cardiovascular diseases, including hypertension. Although lipid signaling has been implicated in endothelial dysfunction and cardiovascular disease, specific molecular mechanisms are poorly understood. Here we report that Nogo-B, a membrane protein of the endoplasmic reticulum, regulates endothelial sphingolipid biosynthesis with direct effects on vascular function and blood pressure. Nogo-B inhibits serine palmitoyltransferase, the rate-limiting enzyme of the de novo sphingolipid biosynthetic pathway, thereby controlling production of endothelial sphingosine 1-phosphate and autocrine, G protein-coupled receptor-dependent signaling by this metabolite. Mice lacking Nogo-B either systemically or specifically in endothelial cells are hypotensive, resistant to angiotensin II-induced hypertension and have preserved endothelial function and nitric oxide release. In mice that lack Nogo-B, pharmacological inhibition of serine palmitoyltransferase with myriocin reinstates endothelial dysfunction and angiotensin II-induced hypertension. Our study identifies Nogo-B as a key inhibitor of local sphingolipid synthesis and shows that autocrine sphingolipid signaling within the endothelium is critical for vascular function and blood pressure homeostasis.	[Cantalupo, Anna; Zhang, Yi; Kothiya, Milankumar; Galvani, Sylvain; Obinata, Hideru; Hla, Timothy; Di Lorenzo, Annarita] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10021 USA; [Bucci, Mariarosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Giordano, Frank J.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Giordano, Frank J.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT USA; [Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Cornell University; University of Naples Federico II; Yale University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Di Lorenzo, A (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10021 USA.	and2039@med.cornell.edu	Kothiya, Milankumar/K-5491-2019; Hla, Timothy/G-5873-2012	Zhang, Yi/0000-0003-3795-4812; Hla, Timothy/0000-0001-8355-4065; Di Lorenzo, Annarita/0000-0003-1239-4222; Kothiya, Milankumar/0000-0001-6233-4696	European Cooperation in Science and Technology (COST) Action European Network on Gasotransmitters (ENOG) [BM1005]; US National Institutes of Health (NIH) [R37-HL67330, R01HL89934]; NIH [R01HL126913-01]; Harold S. Geneen Charitable Trust Award for Coronary Heart Disease Research; American Heart Association [11SDG5710010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067330, R01HL089934, R01HL126913] Funding Source: NIH RePORTER	European Cooperation in Science and Technology (COST) Action European Network on Gasotransmitters (ENOG); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold S. Geneen Charitable Trust Award for Coronary Heart Disease Research; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by European Cooperation in Science and Technology (COST) Action BM1005 European Network on Gasotransmitters (ENOG) to M.B.; US National Institutes of Health (NIH) R37-HL67330 and R01HL89934 to T.H.; NIH R01HL126913-01, a Harold S. Geneen Charitable Trust Award for Coronary Heart Disease Research and American Heart Association grant 11SDG5710010 to A.D.L.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; AISAKA K, 1989, BIOCHEM BIOPH RES CO, V160, P881, DOI 10.1016/0006-291X(89)92517-5; BEVAN JA, 1994, ANNU REV PHARMACOL, V34, P173, DOI 10.1146/annurev.pa.34.040194.001133; Beverelli F, 1997, FUNDAM CLIN PHARM, V11, P252, DOI 10.1111/j.1472-8206.1997.tb00193.x; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolz SS, 2003, CIRCULATION, V108, P342, DOI 10.1161/01.CIR.0000080324.12530.0D; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Butler T, 2013, AM J PHYSIOL-CELL PH, V304, pC485, DOI 10.1152/ajpcell.00161.2012; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Cao X, 2012, HYPERTENSION, V59, P869, DOI 10.1161/HYPERTENSIONAHA.111.182071; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Dantas APV, 2003, AM J PHYSIOL-HEART C, V284, pH2045, DOI 10.1152/ajpheart.01089.2002; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2000, BIOCHEM PHARMACOL, V59, P1211, DOI 10.1016/S0006-2952(00)00251-3; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HAYNES WG, 1993, LANCET, V342, P931, DOI 10.1016/0140-6736(93)91981-Q; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Igarashi J, 2008, BBA-MOL CELL BIOL L, V1781, P489, DOI 10.1016/j.bbalip.2008.06.008; Igarashi J, 2007, AM J PHYSIOL-CELL PH, V292, pC740, DOI 10.1152/ajpcell.00117.2006; Jiang XC, 2011, ADV EXP MED BIOL, V721, P19, DOI 10.1007/978-1-4614-0650-1_2; Jozsef L, 2014, J BIOL CHEM, V289, P9380, DOI 10.1074/jbc.M114.548602; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; LAIS LT, 1978, EUR J PHARMACOL, V47, P177, DOI 10.1016/0014-2999(78)90389-8; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Nofer JR, 2007, CIRCULATION, V115, P501, DOI 10.1161/CIRCULATIONAHA.106.641407; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Pavoine C, 2009, CARDIOVASC RES, V82, P175, DOI 10.1093/cvr/cvp030; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rikitake Y, 2002, ARTERIOSCL THROM VAS, V22, P108, DOI 10.1161/hq0102.101843; Salomone S, 2003, EUR J PHARMACOL, V469, P125, DOI 10.1016/S0014-2999(03)01731-X; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; Taddei S, 1996, CLIN EXP HYPERTENS, V18, P323, DOI 10.3109/10641969609088966; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Vanhoutte PM, 1996, J HYPERTENS, V14, pS83; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Walchli T, 2013, P NATL ACAD SCI USA, V110, pE1943, DOI 10.1073/pnas.1216203110; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Wright PL, 2010, J EXP MED, V207, P2595, DOI 10.1084/jem.20100786; Young RM, 2002, DEV DYNAM, V223, P298, DOI 10.1002/dvdy.10060; Zhang DH, 2011, HEPATOLOGY, V53, P1306, DOI 10.1002/hep.24200; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	61	65	69	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1028	+		10.1038/nm.3934	http://dx.doi.org/10.1038/nm.3934			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26301690	Green Accepted			2022-12-25	WOS:000360961300015
J	Shen, H; Zhong, XB; Zhao, FF; Wang, YM; Yan, BX; Li, Q; Chen, GY; Mao, BZ; Wang, JJ; Li, YS; Xiao, GY; He, YK; Xiao, H; Li, JM; He, ZH				Shen, Hui; Zhong, Xiangbin; Zhao, Fangfang; Wang, Yanmei; Yan, Bingxiao; Li, Qun; Chen, Genyun; Mao, Bizeng; Wang, Jianjun; Li, Yangsheng; Xiao, Guoying; He, Yuke; Xiao, Han; Li, Jianming; He, Zuhua			Overexpression of receptor-like kinase ERECTA improves thermotolerance in rice and tomato	NATURE BIOTECHNOLOGY			English	Article							WATER-USE EFFICIENCY; TRANSCRIPTION FACTOR; HEAT-STRESS; TEMPERATURE PERCEPTION; ARABIDOPSIS; GENE; PROTEIN; TOLERANCE; ADAPTATION; LEAF	The detrimental effects of global warming on crop productivity threaten to reduce the world's food supply(1-3). Although plant responses to changes in temperature have been studied(4), genetic modification of crops to improve thermotolerance has had little success to date. Here we demonstrate that overexpression of the Arabidopsis thaliana receptor-like kinase ERECTA (ER) in Arabidopsis, rice and tomato confers thermotolerance independent of water loss and that Arabidopsis er mutants are hypersensitive to heat. A loss-of-function mutation of a rice ER homolog and reduced expression of a tomato ER allele decreased thermotolerance of both species. Transgenic tomato and rice lines overexpressing Arabidopsis ER showed improved heat tolerance in the greenhouse and in field tests at multiple locations in China during several seasons. Moreover, ER-overexpressing transgenic Arabidopsis, tomato and rice plants had increased biomass. Our findings could contribute to engineering or breeding thermotolerant crops with no growth penalty.	[Shen, Hui; Zhong, Xiangbin; Zhao, Fangfang; Wang, Yanmei; Yan, Bingxiao; Li, Qun; Chen, Genyun; He, Yuke; Xiao, Han; He, Zuhua] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Shen, Hui; Zhong, Xiangbin; Zhao, Fangfang; Wang, Yanmei; Yan, Bingxiao; Li, Qun; Chen, Genyun; He, Yuke; Xiao, Han; He, Zuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Plant Gene Res, Shanghai, Peoples R China; [Shen, Hui] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Mao, Bizeng] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jianjun] Zhejiang Acad Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Yangsheng] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Xiao, Guoying] Chinese Acad Sci, Inst Subtrop Agr, Changsha, Hunan, Peoples R China; [Li, Jianming] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [He, Zuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Zhejiang Academy of Agricultural Sciences; Wuhan University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	He, ZH (corresponding author), Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	zhhe@sibs.ac.cn	Xiao, Han/AAH-1549-2022; li, yong/HDN-3885-2022; mao, bizeng/U-3958-2017; Xiao, Han/C-3295-2012; Li, Yang/GWM-7879-2022; Li, Jianming/O-1772-2014; Xiao, Han/AFL-9447-2022; Li, Yuan/GXV-1310-2022	mao, bizeng/0000-0001-9852-6171; Xiao, Han/0000-0001-5937-6510; Li, Jianming/0000-0003-3231-0778; He, Zuhua/0000-0002-6098-7893	National Key Basic Research and Development Program [2011CB100700, 2015CB150104]; National Natural Science Foundation of China [3130061]; Ministry of Science and Technology of China [2012AA10A302]; National GMO project [2013ZX08009-003-001]; National High Technology Research and Development Program of China [2012AA100104-6]; Chinese Academy of Sciences [KSCX2-EW-N-01, 2009OHTP07]; Shanghai Committee of Science and Technology [11PJ1410900]	National Key Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National GMO project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	We thank J.-S. Jeon and C.Y. Wu for the rice T-DNA mutants, X.L. Wang for the er-105 line, X.G. Zhu, Y.J. Zhang and M.Z. Lv for help in statistical analysis, D.Y. Sun and H.X. Lin for helpful discussions, and L. Lin for help in experiments. This work was supported by the National Key Basic Research and Development Program (2011CB100700 to H.Z.), the National Natural Science Foundation of China (3130061 to H.Z.), the Ministry of Science and Technology of China (2012AA10A302 to Z.H.), the National GMO project (2013ZX08009-003-001 to Z.H.), the National High Technology Research and Development Program of China (2012AA100104-6 to H.X.), the Chinese Academy of Sciences (KSCX2-EW-N-01 to H.Z. and 2009OHTP07 to H.X.), the Shanghai Committee of Science and Technology (11PJ1410900 to H.X.), and the National Key Basic Research and Development Program (2015CB150104 to G.C.).	Burke JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122933; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Finka A, 2012, PLANT CELL, V24, P3333, DOI 10.1105/tpc.112.095844; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Grover A, 2013, PLANT SCI, V205, P38, DOI 10.1016/j.plantsci.2013.01.005; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Ishikawa T, 2013, METHOD ENZYMOL, V527, P239, DOI 10.1016/B978-0-12-405882-8.00013-1; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kim M, 2012, PLANT CELL, V24, P3349, DOI 10.1105/tpc.112.101006; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Li SX, 2014, PLANT CELL, V26, P1764, DOI 10.1105/tpc.114.124883; Li XM, 2015, NAT GENET, V47, P827, DOI 10.1038/ng.3305; Lin L, 2012, PLANT J, V72, P707, DOI 10.1111/j.1365-313X.2012.05109.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Qi YP, 2004, PLANTA, V219, P270, DOI 10.1007/s00425-004-1248-z; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Tisne S, 2008, PLANT PHYSIOL, V148, P1117, DOI 10.1104/pp.108.124271; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uchida N, 2012, P NATL ACAD SCI USA, V109, P6337, DOI 10.1073/pnas.1117537109; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Villagarcia H, 2012, J EXP BOT, V63, P6493, DOI 10.1093/jxb/ers305; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Weng L, 2015, PLANT PHYSIOL, V167, P931, DOI 10.1104/pp.114.255174; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; Yan CS, 2006, PLANTA, V224, P889, DOI 10.1007/s00425-006-0272-6; Zhang HK, 2004, CELL RES, V14, P27, DOI 10.1038/sj.cr.7290199; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110	47	108	123	14	182	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					996	U153		10.1038/nbt.3321	http://dx.doi.org/10.1038/nbt.3321			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26280413				2022-12-25	WOS:000360990900029
J	Wong, ASL; Choi, GCG; Cheng, AA; Purcell, O; Lu, TK				Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.			Massively parallel high-order combinatorial genetics in human cells	NATURE BIOTECHNOLOGY			English	Article							MISSING HERITABILITY; INTERACTION NETWORKS; TARGET INTERACTIONS; MAMMALIAN-CELLS; BREAST-CANCER; RNA DECAY; MICRORNA; EXPRESSION; CRISPR-CAS9; RESISTANCE	The systematic functional analysis of combinatorial genetics has been limited by the throughput that can be achieved and the order of complexity that can be studied. To enable massively parallel characterization of genetic combinations in human cells, we developed a technology for rapid, scalable assembly of high-order barcoded combinatorial genetic libraries that can be quantified with high-throughput sequencing. We applied this technology, combinatorial genetics en masse (CombiGEM), to create high-coverage libraries of 1,521 two-wise and 51,770 three-wise barcoded combinations of 39 human microRNA (miRNA) precursors. We identified miRNA combinations that synergistically sensitize drug-resistant cancer cells to chemotherapy and/or inhibit cancer cell proliferation, providing insights into complex miRNA networks. More broadly, our method will enable high-throughput profiling of multifactorial genetic combinations that regulate phenotypes of relevance to biomedicine, biotechnology and basic science.	[Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.] MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, Cambridge, MA 02139 USA; [Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.] MIT, Dept Biol Engn & Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu		Wong, Alan S.L./0000-0003-1790-3233	US National Institutes of Health [OD008435, P50 GM098792]; Office of Naval Research [N00014-13-1-0424]; Ellison Foundation New Scholar in Aging Award; Defense Advanced Research Projects Agency; Defense Threat Reduction Agency [HDTRA1-15-1-0050]; Croucher Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Ellison Foundation New Scholar in Aging Award; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Croucher Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Lu laboratory and H. Ding for helpful discussions. We thank S. Patnaik of the Roswell Park Cancer Institute for processing miRNA expression data from the ArrayExpress database of European Bioinformatics Institute, the Massachusetts Institute of Technology BioMicroCenter for technical support on Illumina HiSeq, J. Weis for assisting computational analysis of next-generation sequencing data and C. Cui for technical assistance on cell viability assays. This work was supported by the US National Institutes of Health (DP2 OD008435 and P50 GM098792), the Office of Naval Research (N00014-13-1-0424), the Ellison Foundation New Scholar in Aging Award, the Defense Advanced Research Projects Agency and the Defense Threat Reduction Agency (HDTRA1-15-1-0050). A.S.L.W. was supported by the Croucher Foundation. The pAWp6 vector backbone (pFUGW-UBCp-GFP) was a gift from L. Nissim of the T.K. Lu laboratory, MIT; miR-128 was a gift from M.F. Wilkinson, University of California San Diego, USA and miR-132 was a gift from R.H. Goodman, Oregon Health and Science University, USA; HOSE 11-12 and HOSE 17-1 cells were gifts from G.S.W. Tsao, University of Hong Kong, Hong Kong; OVCAR8 and OVCAR8-ADR cells were gifts from S.N. Bhatia, MIT, and T. Ochiya, Japanese National Cancer Center Research Institute, Japan, respectively.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Cheng AA, 2014, P NATL ACAD SCI USA, V111, P12462, DOI 10.1073/pnas.1400093111; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Guillamot M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00189; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049918; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu FF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1290; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	61	36	37	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					952	U196		10.1038/nbt.3326	http://dx.doi.org/10.1038/nbt.3326			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26280411	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000360990900023
J	Bachhuber, T; Katzmarski, N; McCarter, JF; Loreth, D; Tahirovic, S; Kamp, F; Abou-Ajram, C; Nuscher, B; Serrano-Pozo, A; Muller, A; Prinz, M; Steiner, H; Hyman, BT; Haass, C; Meyer-Luehmann, M				Bachhuber, Teresa; Katzmarski, Natalie; McCarter, Joanna F.; Loreth, Desiree; Tahirovic, Sabina; Kamp, Frits; Abou-Ajram, Claudia; Nuscher, Brigitte; Serrano-Pozo, Alberto; Mueller, Alexandra; Prinz, Marco; Steiner, Harald; Hyman, Bradley T.; Haass, Christian; Meyer-Luehmann, Melanie			Inhibition of amyloid-beta plaque formation by alpha-synuclein	NATURE MEDICINE			English	Article							LEWY BODY VARIANT; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; SYNAPSE DENSITY; MICE; DEMENTIA; PRECURSOR; PATHOLOGY	Amyloid-beta (A beta) plaques and alpha-synuclein (alpha-syn)-rich Lewy bodies are the major neuropathological hallmarks of Alzheimer's disease (AD) and Parkinson's disease, respectively. An overlap of pathologies is found in most individuals with dementia with Lewy bodies (DLB) 1 and in more than 50% of AD cases(2). Their brains display substantial alpha-syn accumulation not only in Lewy bodies, but also in dystrophic neurites decorating A beta plaques(2-4). Several studies report binding and coaggregation of A beta and alpha-syn(5-7), yet the precise role of alpha-syn in amyloid plaque formation remains elusive. Here we performed intracerebral injections of alpha-syn-containing preparations into amyloid precursor protein (APP) transgenic mice (expressing APP695(KM670/671NL) and PSEN1(L166P) under the control of the neuron-specific Thy-1 promoter; referred to here as 'APPPS1'). Unexpectedly, alpha-syn failed to cross-seed A. plaques in vivo, but rather it inhibited plaque formation in APPPS1 mice coexpressing SNCA(A30P) (referred to here as 'APPPS1 x [A30P]aSYN' double-transgenic mice). This was accompanied by increased A beta levels in cerebrospinal fluid despite unchanged overall A beta levels. Notably, the seeding activity of A beta-containing brain homogenates was considerably reduced by alpha-syn, and A beta deposition was suppressed in grafted tissue from [A30P]aSYN transgenic mice. Thus, we conclude that an interaction between A beta and alpha-syn leads to inhibition of A. deposition and to reduced plaque formation.	[Bachhuber, Teresa; McCarter, Joanna F.; Abou-Ajram, Claudia; Meyer-Luehmann, Melanie] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Munich, Germany; [Katzmarski, Natalie; Loreth, Desiree; Meyer-Luehmann, Melanie] Univ Freiburg, Dept Neurol, Neuroctr, Freiburg, Germany; [Katzmarski, Natalie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Tahirovic, Sabina; Steiner, Harald; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Kamp, Frits; Nuscher, Brigitte; Steiner, Harald; Haass, Christian] Univ Munich, Dept Metab Biochem, Munich, Germany; [Serrano-Pozo, Alberto; Hyman, Bradley T.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA; [Serrano-Pozo, Alberto; Hyman, Bradley T.] Harvard Univ, Sch Med, Charlestown, MA USA; [Mueller, Alexandra; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany; [Haass, Christian] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; University of Freiburg; University of Freiburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Harvard University; Massachusetts General Hospital; Harvard University; University of Freiburg; University of Freiburg; University of Munich	Meyer-Luehmann, M (corresponding author), Univ Munich, Dept Biochem, Adolf Butenandt Inst, Munich, Germany.	melanie.meyer-luehmann@uniklinik-freiburg.de	Serrano-Pozo, Alberto/L-1519-2019	Serrano-Pozo, Alberto/0000-0003-0899-7530; Meyer-Luehmann, Melanie/0000-0003-3661-2220	Emmy Noether Program of the Deutsche Forschungsgemeinschaft; European Research Council (ERC) under the EU's Seventh Framework Programme (FP7)/ERC [321366]; Kompetenznetz Degenerative Demenzen of the German Federal Ministry of Education and Research; Hans and Ilse Breuer Foundation; Graduate School of Systemic Neurosciences; International Max Planck Research School	Emmy Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (ERC) under the EU's Seventh Framework Programme (FP7)/ERC; Kompetenznetz Degenerative Demenzen of the German Federal Ministry of Education and Research; Hans and Ilse Breuer Foundation; Graduate School of Systemic Neurosciences; International Max Planck Research School	We thank A. Wenninger-Weinzierl, S. Diederich, S. Waldkirch and R. Ziegler for technical assistance. This work was supported by the Emmy Noether Program of the Deutsche Forschungsgemeinschaft (M.M.-L.), the European Research Council (ERC) under the EU's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 321366-Amyloid (advanced grant to C.H.), the Kompetenznetz Degenerative Demenzen of the German Federal Ministry of Education and Research (C.H. and H.S.), the Hans and Ilse Breuer Foundation (M.M.-L.), the Graduate School of Systemic Neurosciences (J.F.M.) and the International Max Planck Research School (J.F.M.). We also would like to thank T. Iwatsubo (University of Tokyo) for the phospho-Ser129 antibody, E. Kremmer (Ludwig-Maximilians University, Munich) for the 3552 and 15G7 antibodies, N. Exner (Ludwig-Maximilians University, Munich) for the a-synuclein cDNA constructs and M. Jucker (University of Tubingen) for generously providing the APPPS1 transgenic mice.	Bibl M, 2006, BRAIN, V129, P1177, DOI 10.1093/brain/awl063; Brown DF, 1998, J NEUROPATH EXP NEUR, V57, P955, DOI 10.1097/00005072-199810000-00007; Compta Y, 2013, MOVEMENT DISORD, V28, P263, DOI 10.1002/mds.25283; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hansen LA, 1998, J NEUROL NEUROSUR PS, V64, P653, DOI 10.1136/jnnp.64.5.653; Heyman A, 1999, NEUROLOGY, V52, P1839, DOI 10.1212/WNL.52.9.1839; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kallhoff V, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-6; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Maia LF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006446; McCarter JF, 2013, ACTA NEUROPATHOL, V126, P179, DOI 10.1007/s00401-013-1137-2; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; Page RM, 2012, J NEUROSCI, V32, P18204, DOI 10.1523/JNEUROSCI.2681-12.2012; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Samuel W, 1997, J NEUROPATH EXP NEUR, V56, P499, DOI 10.1097/00005072-199705000-00006; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Takeda A, 1998, AM J PATHOL, V152, P367; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006	41	78	79	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					802	+		10.1038/nm.3885	http://dx.doi.org/10.1038/nm.3885			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26099047				2022-12-25	WOS:000357604600023
J	Li, AH; Morrison, AC; Kovar, C; Cupples, LA; Brody, JA; Polfus, LM; Yu, B; Metcalf, G; Muzny, D; Veeraraghavan, N; Liu, XM; Lumley, T; Mosley, TH; Gibbs, RA; Boerwinkle, E				Li, Alexander H.; Morrison, Alanna C.; Kovar, Christie; Cupples, L. Adrienne; Brody, Jennifer A.; Polfus, Linda M.; Yu, Bing; Metcalf, Ginger; Muzny, Donna; Veeraraghavan, Narayanan; Liu, Xiaoming; Lumley, Thomas; Mosley, Thomas H.; Gibbs, Richard A.; Boerwinkle, Eric			Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease	NATURE GENETICS			English	Article							GENES; PREDICTIONS; MUTATIONS; DATABASE; DBNSFP	A typical human exome harbors dozens of loss-of-function (LOF) variants(1), which can lower disease risk factor levels and affect drug efficacy(2). We hypothesized that LOF variants are enriched in genes influencing risk factor levels and the onset of common chronic diseases, such as cardiovascular disease and diabetes. To test this hypothesis, we sequenced the exomes of 8,554 individuals and analyzed the effects of predicted LOF variants on 20 chronic disease risk factor phenotypes. Analysis of this sample as discovery and replication strata of equal size verified two relationships in well-studied genes (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included elevated fasting glucose in carriers of heterozygous LOF variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on serum magnesium levels. These data demonstrate the utility of functional-variant annotation within a large sample of deeply phenotyped individuals for gene discovery.	[Li, Alexander H.; Morrison, Alanna C.; Polfus, Linda M.; Yu, Bing; Liu, Xiaoming; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Kovar, Christie; Metcalf, Ginger; Muzny, Donna; Veeraraghavan, Narayanan; Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Cupples, L. Adrienne] NHLBI Framingham Heart Study, Framingham, MA USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Brody, Jennifer A.; Lumley, Thomas] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med Geriatr, Jackson, MS 39216 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; University of Washington; University of Washington Seattle; University of Auckland; University of Mississippi; University of Mississippi Medical Center	Boerwinkle, E (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA.	eric.boerwinkle@uth.tmc.edu	Liu, Xiaoming/C-2743-2008	Liu, Xiaoming/0000-0001-8285-5528; Cupples, L. Adrienne/0000-0003-0273-7965; Morrison, Alanna/0000-0001-6381-4296	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institutes of Health through the American Recovery and Reinvestment Act of 2009 (AREA) [5RC2HL102419]; Baylor College of Medicine Human Genome Sequencing Center [U54 HG003273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health through the American Recovery and Reinvestment Act of 2009 (AREA); Baylor College of Medicine Human Genome Sequencing Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Atherosclerosis Risk in Communities (ARIC) study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C). We thank the staff and participants of the ARIC study for their important contributions. Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE Consortium" was provided by the National Institutes of Health through the American Recovery and Reinvestment Act of 2009 (AREA) (5RC2HL102419). Sequencing was carried out at the Baylor College of Medicine Human Genome Sequencing Center (U54 HG003273).	Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dang VT, 2008, EUR J HUM GENET, V16, P1350, DOI 10.1038/ejhg.2008.111; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Gizer IR, 2011, PSYCHOL MED, V41, P799, DOI 10.1017/S0033291710001273; Jin YL, 2014, DIABETES, V63, P2506, DOI 10.2337/db13-1716; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MARGARITTE P, 1992, AM J HUM GENET, V50, P1231; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Sheridan C, 2013, NAT BIOTECHNOL, V31, P1057, DOI 10.1038/nbt1213-1057	16	36	40	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					640	642		10.1038/ng.3270	http://dx.doi.org/10.1038/ng.3270			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915599	Green Accepted			2022-12-25	WOS:000355386500015
J	Zentner, GE; Henikoff, S				Zentner, Gabriel E.; Henikoff, Steven			Epigenome editing made easy	NATURE BIOTECHNOLOGY			English	Editorial Material							ENHANCERS; FUSION; GENES		[Zentner, Gabriel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Zentner, GE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	steveh@fredhutch.org		Henikoff, Steven/0000-0002-7621-8685; Zentner, Gabriel/0000-0002-0801-7646				Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; McKay DJ, 2015, DEV CELL, V32, P373, DOI 10.1016/j.devcel.2014.12.025; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Zentner GE, 2014, NAT REV GENET, V15, P814, DOI 10.1038/nrg3798	10	12	14	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					606	607		10.1038/nbt.3248	http://dx.doi.org/10.1038/nbt.3248			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057978				2022-12-25	WOS:000356019700018
J	Achim, K; Pettit, JB; Saraiva, LR; Gavriouchkina, D; Larsson, T; Arendt, D; Marioni, JC				Achim, Kaia; Pettit, Jean-Baptiste; Saraiva, Luis R.; Gavriouchkina, Daria; Larsson, Tomas; Arendt, Detlev; Marioni, John C.			High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin	NATURE BIOTECHNOLOGY			English	Article							ANNELID PLATYNEREIS-DUMERILII; EXPRESSION PATTERNS; MARINE ZOOPLANKTON; COMMON ORIGIN; IN-SITU; EVOLUTION; GENES; RESOLUTION; INSIGHTS; LARVAE	Understanding cell type identity in a multicellular organism requires the integration of gene expression profiles from individual cells with their spatial location in a particular tissue. Current technologies allow whole-transcriptome sequencing of spatially identified cells but lack the throughput needed to characterize complex tissues. Here we present a high-throughput method to identify the spatial origin of cells assayed by single-cell RNA-sequencing within a tissue of interest. Our approach is based on comparing complete, specificity-weighted mRNA profiles of a cell with positional gene expression profiles derived from a gene expression atlas. We show that this method allocates cells to precise locations in the brain of the marine annelid Platynereis dumerilii with a success rate of 81%. Our method is applicable to any system that has a reference gene expression database of sufficiently high resolution.	[Achim, Kaia; Pettit, Jean-Baptiste; Saraiva, Luis R.; Marioni, John C.] EMBL EBI, Hinxton, Cambs, England; [Achim, Kaia; Gavriouchkina, Daria; Larsson, Tomas; Arendt, Detlev; Marioni, John C.] EMBL, Dev Biol Unit, Heidelberg, Germany; [Saraiva, Luis R.; Marioni, John C.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Arendt, D (corresponding author), EMBL, Dev Biol Unit, Heidelberg, Germany.	arendt@embl.de; marioni@ebi.ac.uk	Gavriouchkina, Daria/K-8471-2019; Gavriouchkina, Daria/K-8256-2019; Saraiva, Luis R./H-1712-2012	Gavriouchkina, Daria/0000-0002-7488-5898; Saraiva, Luis R./0000-0003-4079-0396; Achim, Kaia/0000-0003-3723-4065; Marioni, John/0000-0001-9092-0852	European Molecular Biology Laboratory; EMBL International PhD Programme; EMBL Interdisciplinary Postdoc Programme under Marie Curie Actions COFUND; Wellcome Trust Sanger Institute; European Union's Seventh Framework Programme [ERCEA-AdG-2011-294810_'BrainEvoDevo']	European Molecular Biology Laboratory; EMBL International PhD Programme; EMBL Interdisciplinary Postdoc Programme under Marie Curie Actions COFUND; Wellcome Trust Sanger Institute(Wellcome Trust); European Union's Seventh Framework Programme	The sequencing and expression analysis of P. dumerilii EST clones was carried out by H. Snyman and R. Tomer. K. Tessmar-Raible, K. Guy and M. A. Tosches provided the sequence data and plasmids for P. dumerilii Lhx3, Sepiapterin reductase, Eya and Pnr. H. Martinez-Vergara assisted with the image registration and averaging of the WMISH signal for Ten3, Cux1/2 and Fezf. We thank the members of the Marioni and Arendt groups for helpful discussions. We also thank D. Logan, the Sanger-EBI single-cell genomics centre and the EMBL Genomics core for technical support. The work was supported by the European Molecular Biology Laboratory (J.B.P., L.R.R., K.A., T.L., D.A., J.C.M.); the EMBL International PhD Programme (J.B.P., D.G.); the EMBL Interdisciplinary Postdoc Programme under Marie Curie Actions COFUND (K.A., T.L.); the Wellcome Trust Sanger Institute (L.R.R.) and by the European Union's Seventh Framework Programme project: ERCEA-AdG-2011-294810_'BrainEvoDevo' to D. A.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Asadulina A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-27; Backfisch B, 2013, P NATL ACAD SCI USA, V110, P193, DOI 10.1073/pnas.1209657109; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Biffar L, 2014, DEV BIOL, V388, P103, DOI 10.1016/j.ydbio.2014.01.028; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Conzelmann M, 2013, P NATL ACAD SCI USA, V110, P8224, DOI 10.1073/pnas.1220285110; Conzelmann M, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-23; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Ferrier DEK, 2012, DEVELOPMENT, V139, P2643, DOI 10.1242/dev.074724; Fonseca N.A., IRAP INTEGRATED RNA; Garcia-Solache M, 2010, DEV BIOL, V344, P306, DOI 10.1016/j.ydbio.2010.04.019; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kerner P, 2006, DEV GENES EVOL, V216, P821, DOI 10.1007/s00427-006-0100-9; Kerner P, 2009, EVOL DEV, V11, P513, DOI 10.1111/j.1525-142X.2009.00359.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Pettit JB, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003824; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Puniyani K, 2010, BIOINFORMATICS, V26, pi47, DOI 10.1093/bioinformatics/btq172; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Randel N, 2013, INTEGR COMP BIOL, V53, P7, DOI 10.1093/icb/ict046; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Simionato E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-170; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Steinmetz PRH, 2011, EVOL DEV, V13, P72, DOI 10.1111/j.1525-142X.2010.00457.x; Tan SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064084; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Tosches MA, 2014, CELL, V159, P46, DOI 10.1016/j.cell.2014.07.042	47	240	271	4	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					503	U215		10.1038/nbt.3209	http://dx.doi.org/10.1038/nbt.3209			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25867922	Bronze			2022-12-25	WOS:000354314500031
J	De Jonge, B; Louwaars, NP; Kinderlerer, J				De Jonge, Bram; Louwaars, Niels P.; Kinderlerer, Julian			A solution to the controversy on plant variety protection in Africa	NATURE BIOTECHNOLOGY			English	Editorial Material									[De Jonge, Bram; Louwaars, Niels P.] Wageningen Univ, Law & Governance Grp, NL-6700 AP Wageningen, Netherlands; [Louwaars, Niels P.] Plantum NL, Gouda, Netherlands; [Kinderlerer, Julian] Univ Cape Town, Dept Private Law, ZA-7925 Cape Town, South Africa	Wageningen University & Research; University of Cape Town	De Jonge, B (corresponding author), Wageningen Univ, Law & Governance Grp, NL-6700 AP Wageningen, Netherlands.	bram.dejonge@wur.nl							0	6	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					487	489		10.1038/nbt.3213	http://dx.doi.org/10.1038/nbt.3213			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965755	Bronze			2022-12-25	WOS:000354314500026
J	Sulem, P; Helgason, H; Oddson, A; Stefansson, H; Gudjonsson, SA; Zink, F; Hjartarson, E; Sigurdsson, GT; Jonasdottir, A; Jonasdottir, A; Sigurdsson, A; Magnusson, OT; Kong, A; Helgason, A; Holm, H; Thorsteinsdottir, U; Masson, G; Gudbjartsson, DF; Stefansson, K				Sulem, Patrick; Helgason, Hannes; Oddson, Asmundur; Stefansson, Hreinn; Gudjonsson, Sigurjon A.; Zink, Florian; Hjartarson, Eirikur; Sigurdsson, Gunnar Th; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Magnusson, Olafur Th; Kong, Augustine; Helgason, Agnar; Holm, Hilma; Thorsteinsdottir, Unnur; Masson, Gisli; Gudbjartsson, Daniel F.; Stefansson, Kari			Identification of a large set of rare complete human knockouts	NATURE GENETICS			English	Article							FUNCTIONAL IMPACT; VARIANTS; DISEASE; MOUSE; EVOLUTION; ONTOLOGY; GENETICS; MUTATION; DATABASE; ORIGIN	Loss-of-function mutations cause many mendelian diseases. Here we aimed to create a catalog of autosomal genes that are completely knocked out in humans by rare loss-of-function mutations. We sequenced the whole genomes of 2,636 Icelanders and imputed the sequence variants identified in this set into 101,584 additional chip-genotyped and phased Icelanders. We found a total of 6,795 autosomal loss-of-function SNPs and indels in 4,924 genes. Of the genotyped Icelanders, 7.7% are homozygotes or compound heterozygotes for loss-offunction mutations with a minor allele frequency (MAF) below 2% in 1,171 genes (complete knockouts). Genes that are highly expressed in the brain are less often completely knocked out than other genes. Homozygous loss-of-function offspring of two heterozygous parents occurred less frequently than expected (deficit of 136 per 10,000 transmissions for variants with MAF <2%, 95% confidence interval (CI) = 10-261).	[Sulem, Patrick; Helgason, Hannes; Oddson, Asmundur; Stefansson, Hreinn; Gudjonsson, Sigurjon A.; Zink, Florian; Hjartarson, Eirikur; Sigurdsson, Gunnar Th; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Magnusson, Olafur Th; Kong, Augustine; Helgason, Agnar; Holm, Hilma; Thorsteinsdottir, Unnur; Masson, Gisli; Gudbjartsson, Daniel F.; Stefansson, Kari] Amgen Inc, DeCODE Genet, Reykjavik, Iceland; [Helgason, Hannes; Kong, Augustine; Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Holm, Hilma] Landspitali Natl Univ Hosp Iceland, Dept Internal Med, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Iceland; University of Iceland; University of Iceland	Sulem, P (corresponding author), Amgen Inc, DeCODE Genet, Reykjavik, Iceland.	patrick.sulem@decode.is; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019	Stefansson, Hreinn/0000-0002-9331-6666; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Helgason, Agnar/0000-0002-8545-3767; Oddsson, Asmundur/0000-0002-4606-5163; Kong, Augustine/0000-0001-8193-5438				Abraira VE, 2008, DEVELOPMENT, V135, P4091, DOI 10.1242/dev.029330; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Chen FC, 2007, GENOME RES, V17, P16, DOI 10.1101/gr.5429606; Cooper DN, 1996, HUM GENET, V98, P629, DOI 10.1007/s004390050272; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2015, NAT GENET, V47, P453, DOI 10.1038/ng.3171; Hurle B, 2003, HUM MOL GENET, V12, P777, DOI 10.1093/hmg/ddg087; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Loffler J, 2000, AM J MED GENET, V95, P174, DOI 10.1002/1096-8628(20001113)95:2<174::AID-AJMG16>3.0.CO;2-9; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	35	151	155	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					448	U30		10.1038/ng.3243	http://dx.doi.org/10.1038/ng.3243			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25807282				2022-12-25	WOS:000353635800006
J	Marquard, J; Otter, S; Welters, A; Stirban, A; Fischer, A; Eglinger, J; Herebian, D; Kletke, O; Klemen, MS; Stozer, A; Wnendt, S; Piemonti, L; Kohler, M; Ferrer, J; Thorens, B; Schliess, F; Rupnik, MS; Heise, T; Berggren, PO; Klocker, N; Meissner, T; Mayatepek, E; Eberhard, D; Kragl, M; Lammert, E				Marquard, Jan; Otter, Silke; Welters, Alena; Stirban, Alin; Fischer, Annelie; Eglinger, Jan; Herebian, Diran; Kletke, Olaf; Klemen, Masa Skelin; Stozer, Andraz; Wnendt, Stephan; Piemonti, Lorenzo; Kohler, Martin; Ferrer, Jorge; Thorens, Bernard; Schliess, Freimut; Rupnik, Marjan Slak; Heise, Tim; Berggren, Per-Olof; Kloecker, Nikolaj; Meissner, Thomas; Mayatepek, Ertan; Eberhard, Daniel; Kragl, Martin; Lammert, Eckhard			Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment	NATURE MEDICINE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; INSULIN-SECRETION; BETA-CELL; GLUCOSE-TOLERANCE; CYTOPLASMIC CA2+; INHIBITION; CHANNELS; DEXTROMETHORPHAN; GLUCAGON; RELEASE	In the nervous system, NMDA receptors (NMDARs) participate in neurotransmission and modulate the viability of neurons. In contrast, little is known about the role of NMDARs in pancreatic islets and the insulin-secreting beta cells whose functional impairment contributes to diabetes mellitus. Here we found that inhibition of NMDARs in mouse and human islets enhanced their glucose-stimulated insulin secretion (GSIS) and survival of islet cells. Further, NMDAR inhibition prolonged the amount of time that glucose-stimulated beta cells spent in a depolarized state with high cytosolic Ca2+ concentrations. We also noticed that, in vivo, the NMDAR antagonist dextromethorphan (DXM) enhanced glucose tolerance in mice, and that in vitro dextrorphan, the main metabolite of DXM, amplified the stimulatory effect of exendin-4 on GSIS. In a mouse model of type 2 diabetes mellitus (T2DM), long-term treatment with DXM improved islet insulin content, islet cell mass and blood glucose control. Further, in a small clinical trial we found that individuals with T2DM treated with DXM showed enhanced serum insulin concentrations and glucose tolerance. Our data highlight the possibility that antagonists of NMDARs may provide a useful adjunct treatment for diabetes.	[Marquard, Jan; Otter, Silke; Welters, Alena; Eglinger, Jan; Eberhard, Daniel; Kragl, Martin; Lammert, Eckhard] Univ Dusseldorf, Inst Metab Physiol, Dusseldorf, Germany; [Marquard, Jan; Welters, Alena; Herebian, Diran; Meissner, Thomas; Mayatepek, Ertan] Univ Childrens Hosp Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany; [Otter, Silke; Welters, Alena; Eglinger, Jan; Lammert, Eckhard] German Diabet Ctr, Leibniz Ctr Diabet Res, Inst Beta Cell Biol, Dusseldorf, Germany; [Otter, Silke; Welters, Alena; Eglinger, Jan; Kragl, Martin; Lammert, Eckhard] German Ctr Diabet Res, Partner Dusseldorf, Dusseldorf, Germany; [Stirban, Alin; Fischer, Annelie; Schliess, Freimut; Heise, Tim] Profil Inst Metab Res, Neuss, Germany; [Kletke, Olaf; Kloecker, Nikolaj] Univ Hosp Dusseldorf, Inst Neuro & Sensory Physiol, Dusseldorf, Germany; [Klemen, Masa Skelin; Stozer, Andraz; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Stozer, Andraz; Rupnik, Marjan Slak] Univ Maribor, Ctr Open Innovat & Res, SLO-2000 Maribor, Slovenia; [Wnendt, Stephan] MLM Med Labs GmbH, Monchengladbach, Germany; [Piemonti, Lorenzo] Ist Sci San Raffaele, Ist Ricovero & Cura Carattere Sci, Diabet Res Inst, I-20132 Milan, Italy; [Kohler, Martin; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Ferrer, Jorge] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Inst Invest Biomed August Pi i Sunyer, Genom Programming Beta Cells Lab, Barcelona, Spain; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Rupnik, Marjan Slak] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Physiol, Vienna, Austria	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Deutsches Diabetes-Zentrum (DDZ); Profil; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Maribor; University of Maribor; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Karolinska Institutet; Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Lausanne; Medical University of Vienna	Lammert, E (corresponding author), Univ Dusseldorf, Inst Metab Physiol, Dusseldorf, Germany.	lammert@hhu.de	Rupnik, Marjan Slak/R-4738-2019; Ferrer, Jorge/A-3176-2012; Piemonti, Lorenzo/P-7605-2017; Eglinger, Jan/P-3560-2019; Eglinger, Jan/C-2707-2014; Slak Rupnik, Marjan/E-6246-2015; Herebian, Diran/A-1440-2017	Rupnik, Marjan Slak/0000-0002-3744-4882; Ferrer, Jorge/0000-0002-5959-5729; Piemonti, Lorenzo/0000-0002-2172-2198; Eglinger, Jan/0000-0001-7234-1435; Eglinger, Jan/0000-0001-7234-1435; Slak Rupnik, Marjan/0000-0002-3744-4882; Kletke, Olaf/0000-0002-7825-1278; Berggren, Per-Olof/0000-0001-8991-413X; Dr. Herebian, Diran/0000-0002-8528-0122; Kohler, Martin/0000-0001-6487-4303	Swedish Research Council; Family Erling-Persson Foundation; Heinrich Heine University Dusseldorf; German Center for Diabetes Research; German Diabetes Center; Federal Ministry of Health; Ministry for Innovation, Science and Research of North Rhine-Westphalia; Ipsen Pharma GmbH; Anton-Betz Foundation; European Regional Development Fund; German Research Foundation [La1216/6-1]; Competence Network Diabetes Mellitus from the Federal Ministry for Education and Research; JDRF [31-2008-416]; NIDDK-funded Integrated Islet Distribution Program (IIDP) at City of Hope; MRC [MR/L02036X/1] Funding Source: UKRI; Medical Research Council [MR/L02036X/1] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Heinrich Heine University Dusseldorf; German Center for Diabetes Research; German Diabetes Center; Federal Ministry of Health; Ministry for Innovation, Science and Research of North Rhine-Westphalia; Ipsen Pharma GmbH(Ipsen); Anton-Betz Foundation; European Regional Development Fund(European Commission); German Research Foundation(German Research Foundation (DFG)); Competence Network Diabetes Mellitus from the Federal Ministry for Education and Research; JDRF(Juvenile Diabetes Research Foundation); NIDDK-funded Integrated Islet Distribution Program (IIDP) at City of Hope; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C.B. Wollheim and P. Maechler (University of Geneva) for providing INS1E cells, J. Roeper (Goethe University Frankfurt) and S. Seino (Kobe University) for providing Kir6.2-deficient mice, H. Bading (University of Heidelberg) and his colleagues for providing us with a GluN1-positive control and for helpful discussions, and S. Jakob, B. Bartosinska and A. Leinweber (Heinrich Heine University Dusseldorf) for technical support. We also thank O. Kuss (German Diabetes Center Dusseldorf) and B. Kronhage (Profil Institute for Metabolic Research) for supporting the statistical analyses of the clinical and preclinical data, respectively. P.-O.B. and M. Kohler are supported by the Swedish Research Council and the Family Erling-Persson Foundation. This study was supported by the Heinrich Heine University Dusseldorf; its research training group entitled "In vivo investigations in metabolic pathomechanisms and diseases in Dusseldorf" and its research commission of the medical faculty; the German Center for Diabetes Research; the German Diabetes Center; the Federal Ministry of Health; the Ministry for Innovation, Science and Research of North Rhine-Westphalia; Ipsen Pharma GmbH; and the Anton-Betz Foundation. Research from M.S.K., A. Stozer and M.S.R. was produced within the framework of an operation entitled "Centre of Open Innovation and Research UM (CORE@UM)" (3330-13-500032) and co-funded by the European Regional Development Fund. D.E. and E.L. are supported by the German Research Foundation (La1216/6-1), and M. Kragl and E.L. are supported by the Competence Network Diabetes Mellitus from the Federal Ministry for Education and Research. Human islets were obtained either by L.P. (ECIT consortium, supported by JDRF, Grant Name: Islets for Research; Grant Number: 31-2008-416) or from the NIDDK-funded Integrated Islet Distribution Program (IIDP) at City of Hope. A list of all participating IIDP laboratories can be found here: https://iidp.coh.org/center_info.aspx.	Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x; ASHCROFT FM, 1991, BRIT J PHARMACOL, V104, P579, DOI 10.1111/j.1476-5381.1991.tb12472.x; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Bardy G, 2013, BRIT J PHARMACOL, V169, P1102, DOI 10.1111/bph.12194; Bartlett TE, 2013, NEUROPHARMACOLOGY, V74, P59, DOI 10.1016/j.neuropharm.2013.01.012; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Burris RE, 2007, NEUROSCIENCE, V150, P592, DOI 10.1016/j.neuroscience.2007.09.079; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Coleman D L, 1967, Diabetologia, V3, P238, DOI 10.1007/BF01222201; Cryer PE, 2013, NEW ENGL J MED, V369, P362, DOI 10.1056/NEJMra1215228; Dadi PK, 2014, J BIOL CHEM, V289, P12435, DOI 10.1074/jbc.M114.562587; DeFronzo RA, 2010, AM J MED, V123, pS38, DOI 10.1016/j.amjmed.2009.12.008; Di Cairano ES, 2011, J BIOL CHEM, V286, P14007, DOI 10.1074/jbc.M110.183517; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Dufer M, 2009, DIABETES, V58, P1835, DOI 10.2337/db08-1324; Feldmann N, 2011, MOL CELL ENDOCRINOL, V338, P46, DOI 10.1016/j.mce.2011.02.019; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Garnock-Jones KP, 2011, CNS DRUGS, V25, P435, DOI 10.2165/11207260-000000000-00000; GARRINO MG, 1987, BRIT J PHARMACOL, V90, P583, DOI 10.1111/j.1476-5381.1987.tb11209.x; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; GILON P, 1993, J BIOL CHEM, V268, P22265; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hamosh A, 1998, J PEDIATR-US, V132, P709, DOI 10.1016/S0022-3476(98)70365-8; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jain R, 2013, DIABETOLOGIA, V56, P1350, DOI 10.1007/s00125-013-2877-1; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Konrad D, 2000, DIABETOLOGIA, V43, P261; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lechin F, 2009, DIABETES METAB SYNDR, V2, P203, DOI 10.2147/DMSO.S7606; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Li L, 2013, CELL, V153, P86, DOI 10.1016/j.cell.2013.02.051; Loos WJ, 2011, J PHARMACEUT BIOMED, V54, P387, DOI 10.1016/j.jpba.2010.08.033; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; Nelson KA, 1997, NEUROLOGY, V48, P1212, DOI 10.1212/WNL.48.5.1212; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Pechnick RN, 2004, J PHARMACOL EXP THER, V309, P515, DOI 10.1124/jpet.103.060038; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Retnakaran R, 2014, DIABETES CARE, V37, P3270, DOI 10.2337/dc14-0893; Rodriguez-Diaz R, 2013, ENDOCRIN METAB CLIN, V42, P39, DOI 10.1016/j.ecl.2012.11.001; Rodriguez-Diaz R, 2012, NAT PROTOC, V7, P1015, DOI 10.1038/nprot.2012.040; Rodriguez-Moreno Antonio, 2010, Front Synaptic Neurosci, V2, P18, DOI 10.3389/fnsyn.2010.00018; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Schiemann J, 2012, NAT NEUROSCI, V15, P1272, DOI 10.1038/nn.3185; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shen KZ, 2010, J NEUROSCI, V30, P1882, DOI 10.1523/JNEUROSCI.3200-09.2010; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Stozer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054638; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556	70	96	105	1	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					363	+		10.1038/nm.3822	http://dx.doi.org/10.1038/nm.3822			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25774850				2022-12-25	WOS:000352493600018
J	Nishikawa, H; Iijima, T; Kajitani, R; Yamaguchi, J; Ando, T; Suzuki, Y; Sugano, S; Fujiyama, A; Kosugi, S; Hirakawa, H; Tabata, S; Ozaki, K; Morimoto, H; Ihara, K; Obara, M; Hori, H; Itoh, T; Fujiwara, H				Nishikawa, Hideki; Iijima, Takuro; Kajitani, Rei; Yamaguchi, Junichi; Ando, Toshiya; Suzuki, Yutaka; Sugano, Sumio; Fujiyama, Asao; Kosugi, Shunichi; Hirakawa, Hideki; Tabata, Satoshi; Ozaki, Katsuhisa; Morimoto, Hiroya; Ihara, Kunio; Obara, Madoka; Hori, Hiroshi; Itoh, Takehiko; Fujiwara, Haruhiko			A genetic mechanism for female-limited Batesian mimicry in Papilio butterfly	NATURE GENETICS			English	Article							ALIGNMENT; DOUBLESEX; SUPERGENE; EYESPOT; GENOME; LENGTH; SEX; DNA	In Batesian mimicry, animals avoid predation by resembling distasteful models. In the swallowtail butterfly Papilio polytes, only mimetic-form females resemble the unpalatable butterfly Pachliopta aristolochiae. A recent report showed that a single gene, doublesex (dsx), controls this mimicry(1); however, the detailed molecular mechanisms remain unclear. Here we determined two whole-genome sequences of P. polytes and a related species, Papilio xuthus, identifying a single similar to 130-kb autosomal inversion, including dsx, between mimetic (H-type) and non-mimetic (h-type) chromosomes in P. polytes. This inversion is associated with the mimicry-related locus H, as identified by linkage mapping. Knockdown experiments demonstrated that female-specific dsx isoforms expressed from the inverted H allele (dsx(H)) induce mimetic coloration patterns and simultaneously repress non-mimetic patterns. In contrast, dsx(h) does not alter mimetic patterns. We propose that dsx(H) switches the coloration of predetermined wing patterns and that female-limited polymorphism is tightly maintained by chromosomal inversion.	[Nishikawa, Hideki; Iijima, Takuro; Yamaguchi, Junichi; Ando, Toshiya; Fujiwara, Haruhiko] Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Kajitani, Rei; Morimoto, Hiroya; Itoh, Takehiko] Tokyo Inst Technol, Dept Biol Informat, Meguro Ku, Tokyo, Japan; [Ando, Toshiya] RIKEN, Ctr Dev Biol, Lab Morphogenet Signaling, Kobe, Hyogo, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol, Kashiwa, Chiba, Japan; [Sugano, Sumio] Univ Tokyo, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Fujiyama, Asao] Natl Inst Informat, Principle Informat, Chiyoda Ku, Tokyo, Japan; [Kosugi, Shunichi; Hirakawa, Hideki; Tabata, Satoshi] Kazusa DNA Res Inst, Kisarazu, Japan; [Ozaki, Katsuhisa] JT Biohist Res Hall, Takatsuki, Osaka, Japan; [Ihara, Kunio; Obara, Madoka; Hori, Hiroshi] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648601, Japan	University of Tokyo; Tokyo Institute of Technology; RIKEN; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Kazusa DNA Research Institute; Nagoya University	Fujiwara, H (corresponding author), Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	haruh@k.u-tokyo.ac.jp	IHARA, Kunio/D-1952-2011; Ando, Toshiya/AAL-4781-2020; Itoh, Takehiko/E-8873-2014	Ando, Toshiya/0000-0003-4558-8904; Itoh, Takehiko/0000-0002-6113-557X; Kosugi, Shunichi/0000-0002-5882-9255; Kajitani, Rei/0000-0002-5013-0052	Ministry of Education, Culture, Sports, Science and Technology of Japan [18017007, 20017007];  [22128005];  [221S0002]; Grants-in-Aid for Scientific Research [26430200] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Toyoda, Y. Kohara, R. Futahashi, T. Kojima, K.K. Kojima, H. Yoshikawa, M. Hasebe, Y. Kondo, S. Kawamura, H. Maekawa and J.M. Otaki for helpful suggestions on our research. We also thank R. Kurokawa for technical assistance with data analysis in the association study. We also thank T. Kojima for helpful comments on the manuscript. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas 'Comparative Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan 18017007 and 20017007 (to H.F.), Grant-in-Aid for Scientific Research 22128005 (to H.F.) and KAKENHI for Innovative Areas 221S0002.	An WQ, 1996, MOL CELL BIOL, V16, P3106; Ando T, 2013, DEVELOPMENT, V140, P454, DOI 10.1242/dev.085241; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; CLARKE C. A., 1960, HEREDITY, V14, P175, DOI 10.1038/hdy.1960.15; CLARKE CA, 1972, PHILOS T ROY SOC B, V263, P431, DOI 10.1098/rstb.1972.0006; Golden K, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5301; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Kunte K, 2009, EVOLUTION, V63, P2707, DOI 10.1111/j.1558-5646.2009.00752.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loehlin DW, 2014, NATURE, V507, P172, DOI 10.1038/nature13066; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Yamaguchi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025469; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403	28	149	153	4	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					405	U169		10.1038/ng.3241	http://dx.doi.org/10.1038/ng.3241			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25751626	hybrid			2022-12-25	WOS:000351922900019
J	Schoenfelder, S; Sugar, R; Dimond, A; Javierre, BM; Armstrong, H; Mifsud, B; Dimitrova, E; Matheson, L; Tavares-Cadete, F; Furlan-Magaril, M; Segonds-Pichon, A; Jurkowski, W; Wingett, SW; Tabbada, K; Andrews, S; Herman, B; LeProust, E; Osborne, CS; Koseki, H; Fraser, P; Luscombe, NM; Elderkin, S				Schoenfelder, Stefan; Sugar, Robert; Dimond, Andrew; Javierre, Biola-Maria; Armstrong, Harry; Mifsud, Borbala; Dimitrova, Emilia; Matheson, Louise; Tavares-Cadete, Filipe; Furlan-Magaril, Mayra; Segonds-Pichon, Anne; Jurkowski, Wiktor; Wingett, Steven W.; Tabbada, Kristina; Andrews, Simon; Herman, Bram; LeProust, Emily; Osborne, Cameron S.; Koseki, Haruhiko; Fraser, Peter; Luscombe, Nicholas M.; Elderkin, Sarah			Polycomb repressive complex PRC1 spatially constrains the mouse embryonic stem cell genome	NATURE GENETICS			English	Article							GROUP PROTEINS RING1A/B; REGULATORY CIRCUITRY; CHROMATIN-STRUCTURE; H2A UBIQUITYLATION; HIGH-RESOLUTION; HOX GENES; CONTACTS; TARGETS; RECRUITMENT; PRINCIPLES	The Polycomb repressive complexes PRC1 and PRC2 maintain embryonic stem cell (ESC) pluripotency by silencing lineage-specifying developmental regulator genes(1). Emerging evidence suggests that Polycomb complexes act through controlling spatial genome organization(2-9). We show that PRC1 functions as a master regulator of mouse ESC genome architecture by organizing genes in three-dimensional interaction networks. The strongest spatial network is composed of the four Hox gene clusters and early developmental transcription factor genes, the majority of which contact poised enhancers. Removal of Polycomb repression leads to disruption of promoter-promoter contacts in the Hox gene network. In contrast, promoter-enhancer contacts are maintained in the absence of Polycomb repression, with accompanying widespread acquisition of active chromatin signatures at network enhancers and pronounced transcriptional upregulation of network genes. Thus, PRC1 physically constrains developmental transcription factor genes and their enhancers in a silenced but poised spatial network. We propose that the selective release of genes from this spatial network underlies cell fate specification during early embryonic development.	[Schoenfelder, Stefan; Dimond, Andrew; Javierre, Biola-Maria; Armstrong, Harry; Dimitrova, Emilia; Matheson, Louise; Furlan-Magaril, Mayra; Jurkowski, Wiktor; Wingett, Steven W.; Tabbada, Kristina; Osborne, Cameron S.; Fraser, Peter; Elderkin, Sarah] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Sugar, Robert; Luscombe, Nicholas M.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Mifsud, Borbala; Tavares-Cadete, Filipe; Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Mifsud, Borbala; Luscombe, Nicholas M.] UCL, Dept Genet Evolut & Environm, London, England; [Dimitrova, Emilia] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Segonds-Pichon, Anne; Wingett, Steven W.; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England; [Herman, Bram; LeProust, Emily] Agilent Technol, Santa Clara, CA USA; [Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol Grad Univ, Okinawa, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; European Molecular Biology Laboratory (EMBL); Cancer Research UK; University of London; University College London; University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Agilent Technologies; RIKEN; Okinawa Institute of Science & Technology Graduate University	Elderkin, S (corresponding author), Babraham Inst, Nucl Dynam Programme, Cambridge, England.	sarah.elderkin@babraham.ac.uk	JAVIERRE, BIOLA M/A-2974-2017; Osborne, Cameron/N-1398-2017; Koseki, Haruhiko/I-3825-2014; Mifsud, Borbala/AAB-5379-2020; Tavares-Cadete, Filipe/G-4962-2015	JAVIERRE, BIOLA M/0000-0002-8682-6748; Osborne, Cameron/0000-0003-4126-2499; Koseki, Haruhiko/0000-0001-8424-5854; Mifsud, Borbala/0000-0003-3429-3094; Wingett, Steven/0000-0002-2343-0711; Dimond, Andrew/0000-0002-2996-2479; Fraser, Peter/0000-0002-0041-1227; Tavares-Cadete, Filipe/0000-0002-3782-7170; Furlan-Magaril, Mayra/0000-0002-6771-6631	Wellcome Trust [WT085102MA]; Biotechnology and Biological Science Research Council; Medical Research Council UK; European Union Framework Programme 7 Epigenesys Network of Excellence; BBSRC [BBS/E/B/0000H234, BBS/E/B/000C0405, BBS/E/B/000C0404, BBS/E/B/0000L748, BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0404, BBS/E/T/000PR5885, BBS/E/B/0000L748, BBS/E/B/000C0405, BBS/E/T/000PR6193, BBS/E/B/0000H234] Funding Source: researchfish; Cancer Research UK [16358] Funding Source: researchfish; Medical Research Council [1128090] Funding Source: researchfish; The Francis Crick Institute [10110, 10111] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Framework Programme 7 Epigenesys Network of Excellence; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We thank members of the Elderkin, Fraser and Luscombe groups for discussions and J. Houseley and P. Rugg-Gunn for commenting on the manuscript. We thank F. Krueger for help with data processing and formatting. We thank R.J. Klose and N. Brockdorff for sequencing. We thank D. Bolland, J. Martins and A. Corcoran for help and advice with the three-dimensional DNA FISH and MetaCyte data analyses. This work was funded by the Wellcome Trust (WT085102MA) (S.E.), the Biotechnology and Biological Science Research Council, the Medical Research Council UK (P.F.) and the European Union Framework Programme 7 Epigenesys Network of Excellence (N.M.L.).	Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bolland DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50587; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rosa S, 2013, GENE DEV, V27, P1845, DOI 10.1101/gad.221713.113; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vieux-Rochas M, 2015, P NATL ACAD SCI USA, V112, P4672, DOI 10.1073/pnas.1504783112; Williamson I, 2012, DEVELOPMENT, V139, P3157, DOI 10.1242/dev.081174; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440	43	230	231	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1179	+		10.1038/ng.3393	http://dx.doi.org/10.1038/ng.3393			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26323060	Green Submitted, Green Accepted			2022-12-25	WOS:000361969900013
J	Blanco, E; Shen, H; Ferrari, M				Blanco, Elvin; Shen, Haifa; Ferrari, Mauro			Principles of nanoparticle design for overcoming biological barriers to drug delivery	NATURE BIOTECHNOLOGY			English	Article							ALBUMIN-BOUND PACLITAXEL; PHASE-III TRIAL; MULTIDRUG-RESISTANCE; SURFACE-CHARGE; BREAST-CANCER; GENE-THERAPY; IN-VIVO; MACROMOLECULAR THERAPEUTICS; TUMORITROPIC ACCUMULATION; SILICON MICROPARTICLES	Biological barriers to drug transport prevent successful accumulation of nanotherapeutics specifically at diseased sites, limiting efficacious responses in disease processes ranging from cancer to inflammation. Although substantial research efforts have aimed to incorporate multiple functionalities and moieties within the overall nanoparticle design, many of these strategies fail to adequately address these barriers. Obstacles, such as nonspecific distribution and inadequate accumulation of therapeutics, remain formidable challenges to drug developers. A reimagining of conventional nanoparticles is needed to successfully negotiate these impediments to drug delivery. Site-specific delivery of therapeutics will remain a distant reality unless nanocarrier design takes into account the majority, if not all, of the biological barriers that a particle encounters upon intravenous administration. By successively addressing each of these barriers, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.	[Blanco, Elvin; Shen, Haifa; Ferrari, Mauro] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Ferrari, Mauro] Weill Cornell Med Coll, Dept Med, New York, NY USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University	Ferrari, M (corresponding author), Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA.	mferrari@HoustonMethodist.org			Department of Defense [W81XWH-12-1-0414]; US National Institutes of Health [NIH U54CA143837, NIH U54CA151668]; Susan G. Komen Breast Cancer Foundation [KG101394]; NATIONAL CANCER INSTITUTE [U54CA143837, U54CA151668] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.F. is grateful for the Ernest Cockrell Jr. Distinguished Endowed Chair in the Department of Nanomedicine at the Houston Methodist Research Institute. The authors acknowledge financial support from Department of Defense grant W81XWH-12-1-0414, and US National Institutes of Health grants NIH U54CA143837 and NIH U54CA151668. E.B. is grateful for the support of the Susan G. Komen Breast Cancer Foundation (grant KG101394). The authors are grateful for the assistance of F.E. Cara, V. Segura-Ibarra and Suhong Wu in manuscript preparation. M.G. Landry is acknowledged for manuscript schematics.	Alexiou C, 2000, CANCER RES, V60, P6641; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374; Attia ABE, 2013, BIOMATERIALS, V34, P3132, DOI 10.1016/j.biomaterials.2013.01.042; Azzopardi EA, 2013, J ANTIMICROB CHEMOTH, V68, P257, DOI 10.1093/jac/dks379; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009; Black KCL, 2014, ACS NANO, V8, P4385, DOI 10.1021/nn406258m; Braet F, 2007, MICROSC RES TECHNIQ, V70, P230, DOI 10.1002/jemt.20408; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2009, PHARM RES-DORDR, V26, P244, DOI 10.1007/s11095-008-9626-z; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; CHEN LT, 1973, BLOOD, V41, P529, DOI 10.1182/blood.V41.4.529.529; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chiappini C, 2010, CHEMPHYSCHEM, V11, P1029, DOI 10.1002/cphc.200900914; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Christian DA, 2009, MOL PHARMACEUT, V6, P1343, DOI 10.1021/mp900022m; Cui JW, 2014, ADV MATER, V26, P7295, DOI 10.1002/adma.201402753; Dauty E, 2002, BIOCONJUGATE CHEM, V13, P831, DOI 10.1021/bc0255182; Dave B, 2014, P NATL ACAD SCI USA, V111, P8838, DOI 10.1073/pnas.1320769111; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Decuzzi P, 2005, ANN BIOMED ENG, V33, P179, DOI 10.1007/s10439-005-8976-5; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Docter D, 2014, NAT PROTOC, V9, P2030, DOI 10.1038/nprot.2014.139; Ferrari M, 2010, TRENDS BIOTECHNOL, V28, P181, DOI 10.1016/j.tibtech.2009.12.007; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gentile F, 2008, J BIOMECH, V41, P2312, DOI 10.1016/j.jbiomech.2008.03.021; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Gradishar WJ, 2006, EXPERT OPIN PHARMACO, V7, P1041, DOI 10.1517/14656566.7.8.1041; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Guo ST, 2011, J NANOMATER, V2011, DOI 10.1155/2011/742895; Hamilton A, 2002, ANN ONCOL, V13, P910, DOI 10.1093/annonc/mdf157; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108; Hu YX, 2013, ACS NANO, V7, P5376, DOI 10.1021/nn4012384; Ibrahim NK, 2005, J CLIN ONCOL, V23, P6019, DOI 10.1200/JCO.2005.11.013; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Lee Y, 2007, J AM CHEM SOC, V129, P5362, DOI 10.1021/ja071090b; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; Levine RM, 2013, LANGMUIR, V29, P9208, DOI 10.1021/la400859e; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Martens TF, 2014, NANO TODAY, V9, P344, DOI 10.1016/j.nantod.2014.04.011; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Merkel TJ, 2012, J CONTROL RELEASE, V162, P37, DOI 10.1016/j.jconrel.2012.06.009; Miller CR, 1998, BIOCHEMISTRY-US, V37, P12875, DOI 10.1021/bi980096y; Moghimi SM, 1998, ADV DRUG DELIVER REV, V32, P45, DOI 10.1016/S0169-409X(97)00131-2; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Monsky WL, 1999, CANCER RES, V59, P4129; Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/NMAT3776, 10.1038/nmat3776]; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Osaka T, 2009, COLLOID SURFACE B, V71, P325, DOI 10.1016/j.colsurfb.2009.03.004; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Park K, 2013, ACS NANO, V7, P7442, DOI 10.1021/nn404501g; Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212; Patel NR, 2011, INT J PHARMACEUT, V416, P296, DOI 10.1016/j.ijpharm.2011.05.082; Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006; Prapainop K, 2012, J AM CHEM SOC, V134, P4100, DOI 10.1021/ja300537u; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019; Shah S, 2011, J NANOSCI NANOTECHNO, V11, P919, DOI 10.1166/jnn.2011.3536; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sosnik A, 2013, ADV DRUG DELIVER REV, V65, P1828, DOI 10.1016/j.addr.2013.09.002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tan JF, 2013, MICROFLUID NANOFLUID, V14, P77, DOI 10.1007/s10404-012-1024-5; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Thurston G, 1998, J CLIN INVEST, V101, P1401, DOI 10.1172/JCI965; Tian Y, 2007, J CONTROL RELEASE, V121, P137, DOI 10.1016/j.jconrel.2007.05.010; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; van Nostrum CF, 2011, SOFT MATTER, V7, P3246, DOI 10.1039/c0sm00999g; Venditto VJ, 2013, ADV DRUG DELIVER REV, V65, P80, DOI 10.1016/j.addr.2012.09.038; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Wong HL, 2006, J CONTROL RELEASE, V116, P275, DOI 10.1016/j.jconrel.2006.09.007; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Wu J, 2007, J PHARM PHARM SCI, V10, P350; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Xiong XB, 2011, ACS NANO, V5, P5202, DOI 10.1021/nn2013707; Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5; Yao C, 2014, ANAL CHEM, V86, P9749, DOI 10.1021/ac5023259; Yokoi K, 2014, CANCER RES, V74, P4239, DOI 10.1158/0008-5472.CAN-13-3494; Yokoi K, 2014, CANCER LETT, V345, P48, DOI 10.1016/j.canlet.2013.11.015; Yuan YY, 2012, ADV MATER, V24, P5476, DOI 10.1002/adma.201202296; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhang L, 2012, ACS NANO, V6, P6681, DOI 10.1021/nn301159a	121	3611	3671	138	2065	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					941	951		10.1038/nbt.3330	http://dx.doi.org/10.1038/nbt.3330			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348965	Green Accepted			2022-12-25	WOS:000360990900022
J	Chen, SH; Cao, PX; Dong, NZ; Peng, JH; Zhang, CY; Wang, H; Zhou, TT; Yang, JH; Zhang, Y; Martelli, EE; Prasad, SVN; Miller, RE; Malfait, AM; Zhou, YQ; Wu, QY				Chen, Shenghan; Cao, Pengxiu; Dong, Ningzheng; Peng, Jianhao; Zhang, Chunyi; Wang, Hao; Zhou, Tiantian; Yang, Junhua; Zhang, Yue; Martelli, Elizabeth E.; Prasad, Sathyamangla V. Naga; Miller, Rachel E.; Malfait, Anne-Marie; Zhou, Yiqing; Wu, Qingyu			PCSK6-mediated corin activation is essential for normal blood pressure	NATURE MEDICINE			English	Article							PROATRIAL NATRIURETIC PEPTIDE; SALT-SENSITIVE HYPERTENSION; ZYMOGEN ACTIVATION; SERINE-PROTEASE; CARDIAC-HYPERTROPHY; HEART-FAILURE; VARIANT; ASSOCIATION; MICE; CONVERTASES	Hypertension is the most common cardiovascular disease, afflicting >30% of adults(1). The cause of hypertension in most individuals remains unknown(2,3), suggesting that additional contributing factors have yet to be discovered. Corin is a serine protease that activates the natriuretic peptides, thereby regulating blood pressure(4). It is synthesized as a zymogen that is activated by proteolytic cleavage. CORIN variants and mutations impairing corin activation have been identified in people with hypertension and pre-eclampsia(5-9). To date, however, the identity of the protease that activates corin remains elusive. Here we show that proprotein convertase subtilisin/kexin-6 (PCSK6, also named PACE4; ref. 10) cleaves and activates corin. In cultured cells, we found that corin activation was inhibited by inhibitors of PCSK family proteases and by small interfering RNAs blocking PCSK6 expression. Conversely, PCSK6 overexpression enhanced corin activation. In addition, purified PCSK6 cleaved wild-type corin but not the R801A variant that lacks the conserved activation site. Pcsk6-knockout mice developed salt-sensitive hypertension, and corin activation and pro-atrial natriuretic peptide processing activity were undetectable in these mice. Moreover, we found that CORIN variants in individuals with hypertension and pre-eclampsia were defective in PCSK6-mediated activation. We also identified a PCSK6 mutation that impaired corin activation activity in a hypertensive patient. Our results indicate that PCSK6 is the long-sought corin activator and is important for sodium homeostasis and normal blood pressure.	[Chen, Shenghan; Cao, Pengxiu; Peng, Jianhao; Zhang, Chunyi; Wang, Hao; Martelli, Elizabeth E.; Prasad, Sathyamangla V. Naga; Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Dong, Ningzheng; Zhou, Tiantian; Zhang, Yue; Zhou, Yiqing; Wu, Qingyu] Soochow Univ, Collaborat Innovat Ctr Hematol, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China; [Dong, Ningzheng] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Key Lab Thrombosis & Hemostasis, Suzhou, Peoples R China; [Yang, Junhua] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, Suzhou, Peoples R China; [Miller, Rachel E.; Malfait, Anne-Marie] Rush Univ, Med Ctr, Dept Internal Med Rheumatol, Chicago, IL 60612 USA; [Miller, Rachel E.; Malfait, Anne-Marie] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	Cleveland Clinic Foundation; Soochow University - China; Soochow University - China; Soochow University - China; Rush University; Rush University	Wu, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	wuq@ccf.org		Wu, Qingyu/0000-0003-0561-9315; CAO, PENGXIU/0000-0002-5900-5645; Miller, Rachel/0000-0002-4486-5757; Wang, Hao/0000-0001-6881-9977; Zhang, Yue/0000-0001-7096-5463; Malfait, Anne-Marie/0000-0003-1428-0384	US National Institutes of Health [R01HL089298, R01HD064634, R01HL126697]; Rush University Pilot Grant; National Natural Science Foundation of China [81170247, 81370718]; Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126697, R01HL089298] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rush University Pilot Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Yin of the Lerner Imaging Core at the Cleveland Clinic for electron microscopic analysis and W. Claycomb of Louisiana State University Medical Center for HL-1 cells. This work was supported in part by grants from the US National Institutes of Health (R01HL089298, R01HD064634, R01HL126697) (Q.W.), a Rush University Pilot Grant (A.-M.M.), the National Natural Science Foundation of China (81170247, 81370718) (N.D.), and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Barbato E, 2012, J AM COLL CARDIOL, V59, P1763, DOI 10.1016/j.jacc.2012.02.017; BEAUBIEN G, 1995, CELL TISSUE RES, V279, P539; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chen HH, 2007, J AM COLL CARDIOL, V49, P1089, DOI 10.1016/j.jacc.2006.12.013; Chen SH, 2010, AM J PHYSIOL-HEART C, V299, pH1687, DOI 10.1152/ajpheart.00399.2010; Cohen JC, 2013, SCIENCE, V340, P689, DOI 10.1126/science.1239101; Constam DB, 2000, GENE DEV, V14, P1146; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Davidson MH, 2013, NAT REV CARDIOL, V10, P618, DOI 10.1038/nrcardio.2013.139; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Dong NZ, 2014, J BIOL CHEM, V289, P17909, DOI 10.1074/jbc.M114.551424; Dong NZ, 2013, J BIOL CHEM, V288, P7867, DOI 10.1074/jbc.M112.411512; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2011, CIRC-HEART FAIL, V4, P107, DOI 10.1161/CIRCHEARTFAILURE.111.960948; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gladysheva IP, 2013, HYPERTENSION, V61, P327, DOI 10.1161/HYPERTENSIONAHA.112.193631; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Jiang JJ, 2010, CLIN CHEM, V56, P959, DOI 10.1373/clinchem.2009.140558; Knappe S, 2003, J BIOL CHEM, V278, P52363, DOI 10.1074/jbc.M309991200; Li JP, 2004, CHINESE MED J-PEKING, V117, P382; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lynch AI, 2009, CURR HYPERTENS REP, V11, P35, DOI 10.1007/s11906-009-0008-7; Malfait AM, 2012, ANN RHEUM DIS, V71, P1042, DOI 10.1136/annrheumdis-2011-200300; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; Mullins LJ, 2006, PHYSIOL REV, V86, P709, DOI 10.1152/physrev.00016.2005; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; TANEDA H, 1994, J BIOCHEM-TOKYO, V116, P589, DOI 10.1093/oxfordjournals.jbchem.a124565; Vasudevan NT, 2013, CIRCULATION, V128, P377, DOI 10.1161/CIRCULATIONAHA.113.003183; Wang W, 2012, HYPERTENSION, V60, P1352, DOI 10.1161/HYPERTENSIONAHA.112.201244; Wang W, 2012, KIDNEY INT, V82, P26, DOI 10.1038/ki.2012.41; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097	49	84	86	0	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2015	21	9					1048	+		10.1038/nm.3920	http://dx.doi.org/10.1038/nm.3920			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CQ9US	26259032	Green Accepted			2022-12-25	WOS:000360961300017
J	Ross-Innes, CS; Becq, J; Warren, A; Cheetham, RK; Northen, H; O'Donovan, M; Malhotra, S; di Pietro, M; Ivakhno, S; He, M; Weaver, JMJ; Lynch, AG; Kingsbury, Z; Ross, M; Humphray, S; Bentley, D; Fitzgerald, RC				Ross-Innes, Caryn S.; Becq, Jennifer; Warren, Andrew; Cheetham, R. Keira; Northen, Helen; O'Donovan, Maria; Malhotra, Shalini; di Pietro, Massimiliano; Ivakhno, Sergii; He, Miao; Weaver, Jamie M. J.; Lynch, Andy G.; Kingsbury, Zoya; Ross, Mark; Humphray, Sean; Bentley, David; Fitzgerald, Rebecca C.		Oesophageal Canc Clinical & Mol St	Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma	NATURE GENETICS			English	Article							21 BREAST CANCERS; NEOPLASTIC PROGRESSION; MUTATIONAL PROCESSES; INCREASED RISK; P53; CARCINOGENESIS; SURVEILLANCE; CARCINOMA; P16	The molecular genetic relationship between esophageal adenocarcinoma (EAC) and its precursor lesion, Barrett's esophagus, is poorly understood. Using whole-genome sequencing on 23 paired Barrett's esophagus and EAC samples, together with one in-depth Barrett's esophagus case study sampled over time and space, we have provided the following new insights: (i) Barrett's esophagus is polyclonal and highly mutated even in the absence of dysplasia; (ii) when cancer develops, copy number increases and heterogeneity persists such that the spectrum of mutations often shows surprisingly little overlap between EAC and adjacent Barrett's esophagus; and (iii) despite differences in specific coding mutations, the mutational context suggests a common causative insult underlying these two conditions. From a clinical perspective, the histopathological assessment of dysplasia appears to be a poor reflection of the molecular disarray within the Barrett's epithelium, and a molecular Cytosponge technique overcomes sampling bias and has the capacity to reflect the entire clonal architecture.	[Ross-Innes, Caryn S.; di Pietro, Massimiliano; Weaver, Jamie M. J.; Fitzgerald, Rebecca C.] Univ Cambridge, Hutchison Med Res Council Res Ctr, Med Res Council Canc Unit, Cambridge, England; [Becq, Jennifer; Warren, Andrew; Cheetham, R. Keira; Northen, Helen; Ivakhno, Sergii; He, Miao; Kingsbury, Zoya; Ross, Mark; Humphray, Sean; Bentley, David] Illumina, Saffron Walden, England; [O'Donovan, Maria; Malhotra, Shalini] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; [Lynch, Andy G.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England	University of Cambridge; Illumina; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Fitzgerald, RC (corresponding author), Univ Cambridge, Hutchison Med Res Council Res Ctr, Med Res Council Canc Unit, Cambridge, England.	rcf29@mrc-cu.cam.ac.uk	Bornschein, Jan/U-9402-2018; Lovat, Laurence/C-1986-2009	Bornschein, Jan/0000-0001-8673-3122; Lovat, Laurence/0000-0003-4542-3915; Zylstra, Janine/0000-0002-9839-7629; KUMAR, BHASKAR/0000-0001-5705-1384; Davies, Jim/0000-0003-4664-6862; Fitzgerald, Rebecca/0000-0002-3434-3568; Lynch, Andy/0000-0002-7876-7338; Abdullahi, Zarah/0000-0002-7077-2781; Ang, Yeng/0000-0003-0496-6710; Ragunath, Krish/0000-0001-6571-5435; Hindmarsh, Andrew/0000-0002-3209-6591; Chang, Fuju/0000-0003-0973-6949; Underwood, Tim/0000-0001-9455-2188; Crichton, Charles/0000-0002-9171-1427; Secrier, Maria/0000-0003-2758-1741	National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Cancer Research UK; Medical Research Council; Cancer Research UK [15874] Funding Source: researchfish; Medical Research Council [G1002565] Funding Source: researchfish; National Institute for Health Research [05/12/01, NF-SI-0611-10065] Funding Source: researchfish; Versus Arthritis [20406] Funding Source: researchfish	National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	We thank the Human Research Tissue Bank, which is supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. This study was partly funded by a project grant from Cancer Research UK. R.C.F. has programmatic funding from the Medical Research Council and infrastructure support from the Biomedical Research Centre and the Experimental Medicine Centre. We would like to thank all the patients who took part in the study. We thank M. Dunning for his bioinformatics assistance. We thank the Edinburgh Experimental Cancer Medicine Centre.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chong IY, 2013, J PATHOL, V231, P301, DOI 10.1002/path.4247; Corley DA, 2013, GASTROENTEROLOGY, V145, P312, DOI 10.1053/j.gastro.2013.05.004; Desai TK, 2012, GUT, V61, P970, DOI 10.1136/gutjnl-2011-300730; Dolan K, 2003, DIS ESOPHAGUS, V16, P83, DOI 10.1046/j.1442-2050.2003.00302.x; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Esserman LJ, 2014, LANCET ONCOL, V15, pE234, DOI 10.1016/S1470-2045(13)70598-9; Fitzgerald RC, 2008, GUT, V57, P1033, DOI 10.1136/gut.2008.151530; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kastelein F, 2013, GUT, V62, P1676, DOI 10.1136/gutjnl-2012-303594; Leedham SJ, 2008, GUT, V57, P1041, DOI 10.1136/gut.2007.143339; Li XH, 2014, CANCER PREV RES, V7, P114, DOI 10.1158/1940-6207.CAPR-13-0289; Maley CC, 2007, CANCER LETT, V245, P22, DOI 10.1016/j.canlet.2006.03.018; Maley CC, 2004, CANCER RES, V64, P3414, DOI 10.1158/0008-5472.CAN-03-3249; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Orman ES, 2013, CLIN GASTROENTEROL H, V11, P1245, DOI 10.1016/j.cgh.2013.03.039; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schneider PM, 1996, J THORAC CARDIOV SUR, V111, P323, DOI 10.1016/S0022-5223(96)70441-5; Schulmann K, 2005, ONCOGENE, V24, P4138, DOI 10.1038/sj.onc.1208598; Shaheen NJ, 2013, GASTROENTEROLOGY, V145, P273, DOI 10.1053/j.gastro.2013.06.028; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013	30	180	183	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1038	+		10.1038/ng.3357	http://dx.doi.org/10.1038/ng.3357			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26192915	Green Accepted, Green Submitted			2022-12-25	WOS:000360394100014
J	Stachler, MD; Taylor-Weiner, A; Peng, SY; McKenna, A; Agoston, AT; Odze, RD; Davison, JM; Nason, KS; Loda, M; Leshchiner, I; Stewart, C; Stojanov, P; Seepo, S; Lawrence, MS; Ferrer-Torres, D; Lin, J; Chang, AC; Gabriel, SB; Lander, ES; Beer, DG; Getz, G; Carter, SL; Bass, AJ				Stachler, Matthew D.; Taylor-Weiner, Amaro; Peng, Shouyong; McKenna, Aaron; Agoston, Agoston T.; Odze, Robert D.; Davison, Jon M.; Nason, Katie S.; Loda, Massimo; Leshchiner, Ignaty; Stewart, Chip; Stojanov, Petar; Seepo, Sara; Lawrence, Michael S.; Ferrer-Torres, Daysha; Lin, Jules; Chang, Andrew C.; Gabriel, Stacey B.; Lander, Eric S.; Beer, David G.; Getz, Gad; Carter, Scott L.; Bass, Adam J.			Paired exome analysis of Barrett's esophagus and adenocarcinoma	NATURE GENETICS			English	Article							CIRCULAR BINARY SEGMENTATION; HIGH-GRADE DYSPLASIA; PROSTATE-CANCER; COPY NUMBER; GASTROESOPHAGEAL-REFLUX; NEOPLASTIC PROGRESSION; GENOMIC INSTABILITY; PANCREATIC-CANCER; SOMATIC MUTATIONS; CLONAL EXPANSION	Barrett's esophagus is thought to progress to esophageal adenocarcinoma (EAC) through a stepwise progression with loss of CDKN2A followed by TP53 inactivation and aneuploidy. Here we present whole-exome sequencing from 25 pairs of EAC and Barrett's esophagus and from 5 patients whose Barrett's esophagus and tumor were extensively sampled. Our analysis showed that oncogene amplification typically occurred as a late event and that TP53 mutations often occurred early in Barrett's esophagus progression, including in non-dysplastic epithelium. Reanalysis of additional EAC exome data showed that the majority (62.5%) of EACs emerged following genome doubling and that tumors with genomic doubling had different patterns of genomic alterations, with more frequent oncogenic amplification and less frequent inactivation of tumor suppressors, including CDKN2A. These data suggest that many EACs emerge not through the gradual accumulation of tumor-suppressor alterations but rather through a more direct path whereby a TP53-mutant cell undergoes genome doubling, followed by the acquisition of oncogenic amplifications.	[Stachler, Matthew D.; Agoston, Agoston T.; Odze, Robert D.; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Stachler, Matthew D.; Agoston, Agoston T.; Odze, Robert D.; Loda, Massimo] Harvard Univ, Sch Med, Boston, MA USA; [Stachler, Matthew D.; Peng, Shouyong; Loda, Massimo; Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Taylor-Weiner, Amaro; Leshchiner, Ignaty; Stewart, Chip; Stojanov, Petar; Seepo, Sara; Lawrence, Michael S.; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad; Carter, Scott L.; Bass, Adam J.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [McKenna, Aaron] Univ Washington, Seattle, WA 98195 USA; [Davison, Jon M.; Nason, Katie S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Ferrer-Torres, Daysha; Lin, Jules; Chang, Andrew C.; Beer, David G.] Univ Michigan, Sect Thorac Surg, Ann Arbor, MI 48109 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Carter, Scott L.] Harvard Univ, Brigham & Womens Hosp, Sch Med,Broad Inst Harvard & MIT, Joint Ctr Canc Precis Med,Dana Farber Canc Inst, Boston, MA 02115 USA; [Carter, Scott L.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Carter, Scott L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Carter, SL (corresponding author), Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org; scarter@broadinstitute.org; adam_bass@dfci.harvard.edu	Lin, Jules/AAK-3200-2021; Stojanov, Petar/GQI-4462-2022; Lawrence, Michael/AAC-8202-2020	Stojanov, Petar/0000-0001-7815-776X; Lin, Jules/0000-0003-4733-0659; Chang, Andrew/0000-0001-9506-0425; Leshchiner, Ignaty/0000-0001-8942-9265	US National Institutes of Health [T32 HL007627]; Dana-Farber/Harvard Gastrointestinal Cancer Specialized Programs of Research Excellence [P50CA127003]; National Human Genome Research Institute (NHGRI) Large-Scale Sequencing Program [U54 HG0003067]; National Cancer Institute [U54 CA163059, P01 CA098101, U54 CA163004]; Broad Institute SPARC; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009676, K07CA151613, P01CA098101, P50CA127003, U54CA163059, K08CA134931, U54CA163004] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Gastrointestinal Cancer Specialized Programs of Research Excellence; National Human Genome Research Institute (NHGRI) Large-Scale Sequencing Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Broad Institute SPARC; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Broad Institute Genome Sequencing Platform and the molecular laboratories at Brigham and Women's Hospital and Massachusetts General Hospital for their assistance. We are grateful to the patients and families who agreed to contribute their samples to enable this research and to the physicians and hospital staff whose efforts in collecting these samples are essential to this work. This work was supported by US National Institutes of Health grant T32 HL007627 and the Dana-Farber/Harvard Gastrointestinal Cancer Specialized Programs of Research Excellence P50CA127003 (M.D.S.), the National Human Genome Research Institute (NHGRI) Large-Scale Sequencing Program (U54 HG0003067; E.S.L.), National Cancer Institute grant U54 CA163059 (D.G.B.), Broad Institute SPARC funding (A.J.B., S.L.C. and G.G.), a Research Scholar Grant from the American Cancer Society (A.J.B.) and the National Cancer Institute (P01 CA098101 and U54 CA163004; A.J.B.).	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bytzer P, 1999, AM J GASTROENTEROL, V94, P86; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Davelaar AL, 2015, GENE CHROMOSOME CANC, V54, P82, DOI 10.1002/gcc.22220; Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Deramaudt T, 2005, BBA-REV CANCER, V1756, P97, DOI 10.1016/j.bbcan.2005.08.003; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Etemadmoghadam D, 2013, CLIN CANCER RES, V19, P5960, DOI 10.1158/1078-0432.CCR-13-1337; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1999, J NATL CANCER I, V91, P2087, DOI 10.1093/jnci/91.24.2087; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Gu JA, 2010, CANCER PREV RES, V3, P1176, DOI 10.1158/1940-6207.CAPR-09-0265; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li XH, 2014, CANCER PREV RES, V7, P114, DOI 10.1158/1940-6207.CAPR-13-0289; Li XH, 2008, CANCER PREV RES, V1, P413, DOI 10.1158/1940-6207.CAPR-08-0121; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Luttges J, 1999, CANCER-AM CANCER SOC, V85, P1703; Maley CC, 2004, CANCER RES, V64, P3414, DOI 10.1158/0008-5472.CAN-03-3249; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nehra D, 1999, GUT, V44, P598, DOI 10.1136/gut.44.5.598; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Olshen AB, 2011, BIOINFORMATICS, V27, P2038, DOI 10.1093/bioinformatics/btr329; Ormsby AH, 2000, MODERN PATHOL, V13, P614, DOI 10.1038/modpathol.3880106; Paulson TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003809; Prestlow T.P., 2005, BIOCHIM BIOPHYS ACTA, V1756, P83; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; Reid BJ, 1996, EUR J CANCER PREV, V5, P57, DOI 10.1097/00008469-199612002-00009; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; van Wyk R, 2000, GENE CHROMOSOME CANC, V27, P202, DOI 10.1002/(SICI)1098-2264(200002)27:2<202::AID-GCC13>3.0.CO;2-3; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013; Weston AP, 2000, AM J GASTROENTEROL, V95, P1888; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166; Wong DJ, 2001, CANCER RES, V61, P8284; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang S, 2013, ANN CLIN LAB SCI, V43, P373	63	212	212	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1047	+		10.1038/ng.3343	http://dx.doi.org/10.1038/ng.3343			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26192918	Green Submitted, Green Accepted			2022-12-25	WOS:000360394100015
J	Ramaswamy, V; Taylor, MD				Ramaswamy, Vijay; Taylor, Michael D.			Pediatric cancer genomics, a play rather than a portrait	NATURE GENETICS			English	Editorial Material							EVOLUTION	Relapsed neuroblastoma is common, frequently lethal and poorly studied and poses a major treatment challenge. Two new studies shed light on the genomic landscape of recurrent neuroblastoma and demonstrate profound differences between the disease at diagnosis and relapse.	[Ramaswamy, Vijay] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ramaswamy, V (corresponding author), Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada.	mdtaylor@sickkids.ca		Ramaswamy, Vijay/0000-0002-6557-895X; Taylor, Michael/0000-0001-7009-3466				Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Eleveld TF, 2015, NAT GENET, V47, P864, DOI 10.1038/ng.3333; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Schramm A, 2015, NAT GENET, V47, P872, DOI 10.1038/ng.3349; Sinha G, 2008, J NATL CANCER I, V100, P84, DOI 10.1093/jnci/djm317	7	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					851	852		10.1038/ng.3366	http://dx.doi.org/10.1038/ng.3366			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26220132				2022-12-25	WOS:000358674100003
J	Bar-Nur, O; Verheul, C; Sommer, AG; Brumbaugh, J; Schwarz, BA; Lipchina, I; Huebner, AJ; Mostoslavsky, G; Hochedlinger, K				Bar-Nur, Ori; Verheul, Cassandra; Sommer, Andreia G.; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Mostoslavsky, Gustavo; Hochedlinger, Konrad			Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage	NATURE BIOTECHNOLOGY			English	Article							SMALL MOLECULES FACILITATE; MOUSE FIBROBLASTS; STEM-CELLS; GENERATION; NANOG	Brief expression of pluripotency-associated factors such as Oct4, Klf4, Sox2 and c-Myc (OKSM), in combination with differentiation-inducing signals, has been reported to trigger transdifferentiation of fibroblasts into other cell types. Here we show that OKSM expression in mouse fibroblasts gives rise to both induced pluripotent stem cells (iPSCs) and induced neural stem cells (iNSCs) under conditions previously shown to induce only iNSCs. Fibroblast-derived iNSC colonies silenced retroviral transgenes and reactivated silenced X chromosomes, both hallmarks of pluripotent stem cells. Moreover, lineage tracing with an Oct4-CreER labeling system demonstrated that virtually all iNSC colonies originated from cells transiently expressing Oct4, whereas ablation of Oct4(+) cells prevented iNSC formation. Lastly, an alternative transdifferentiation cocktail that lacks Oct4 and was reportedly unable to support induced pluripotency yielded iPSCs and iNSCs carrying the Oct4-CreER-derived lineage label. Together, these data suggest that iNSC generation from fibroblasts using OKSM and other pluripotency-related reprogramming factors requires passage through a transient iPSC state.	[Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA USA; [Sommer, Andreia G.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA; [Sommer, Andreia G.; Mostoslavsky, Gustavo] Boston Med Ctr, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Boston University; Boston Medical Center	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	khochedlinger@mgh.harvard.edu	Bar-Nur, Ori/GWQ-5917-2022	Brumbaugh, Justin/0000-0002-9605-2010	EGL foundation; Postdoctoral Fellowship Award by MGH Executive Committee on Research Fund; US National Institutes of Health (NIH) [1F32HD078029-01A1, 1F32HD079225-01A1]; NIH [R01HD058013]; Howard Hughes Medical Institute;  [T32 (5-T32-CA-9216-33)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD078029, F32HD079225, R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER	EGL foundation; Postdoctoral Fellowship Award by MGH Executive Committee on Research Fund; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Hochedlinger laboratory for critical evaluation and discussion of this manuscript. We thank E. Apostolou and S. Cheloufi for helpful comments and N. Maherali for suggesting the idea of X chromosome reactivation. We are also grateful to B. Payer and J. Lee for providing tail-tip fibroblasts carrying an X-linked GFP reporter and to A. Brack for sharing Rosa26-lsl-DTA mice. We are grateful to L. Prickett, M. Weglarz and K. Folz-Donahue at the MGH/HSCI flow cytometry core for their constant assistance and support. O.B.-N, is supported by a Gruss-Lipper postdoctoral fellowship from the EGL foundation. B.A.S. has been supported by a T32 (5-T32-CA-9216-33) grant and through a Postdoctoral Fellowship Award by the MGH Executive Committee on Research Fund for Medical Discovery. J.B. and I.L. are supported by Ruth L. Kirschstein F32 Post-doctoral Fellowships from the US National Institutes of Health (NIH) (1F32HD078029-01A1 to J.B. and 1F32HD079225-01A1 to I.L.). Support to K.H. is from the NIH (R01HD058013) and Howard Hughes Medical Institute.	Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Greder LV, 2012, STEM CELLS, V30, P2596, DOI 10.1002/stem.1216; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weissbein U, 2014, CELL STEM CELL, V15, P687, DOI 10.1016/j.stem.2014.10.018; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	27	84	86	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					761	768		10.1038/nbt.3247	http://dx.doi.org/10.1038/nbt.3247			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098450	Green Accepted, Green Submitted			2022-12-25	WOS:000358396100033
J	Hu, GW; McQuiston, T; Bernard, A; Park, YD; Qiu, J; Vural, A; Zhang, NN; Waterman, SR; Blewett, NH; Myers, TG; Maraia, RJ; Kehrl, JH; Uzel, G; Klionsky, DJ; Williamson, PR				Hu, Guowu; McQuiston, Travis; Bernard, Amelie; Park, Yoon-Dong; Qiu, Jin; Vural, Ali; Zhang, Nannan; Waterman, Scott R.; Blewett, Nathan H.; Myers, Timothy G.; Maraia, Richard J.; Kehrl, John H.; Uzel, Gulbu; Klionsky, Daniel J.; Williamson, Peter R.			A conserved mechanism of TOR-dependent RCK-mediated mRNA degradation regulates autophagy	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; PHOSPHOPROTEOME REVEALS; TRANSCRIPTION FACTOR; PULMONARY INFECTION; PROTEIN; TRANSLATION; INDUCTION; COMPLEX; INFLAMMASOMES	Autophagy is an essential eukaryotic pathway requiring tight regulation to maintain homeostasis and preclude disease. Using yeast and mammalian cells, we report a conserved mechanism of autophagy regulation by RNA helicase RCK family members in association with the decapping enzyme Dcp2. Under nutrient-replete conditions, Dcp2 undergoes TOR-dependent phosphorylation and associates with RCK members to form a complex with autophagy-related (ATG) mRNA transcripts, leading to decapping, degradation and autophagy suppression. Simultaneous with the induction of ATG mRNA synthesis, starvation reverses the process, facilitating ATG mRNA accumulation and autophagy induction. This conserved post-transcriptional mechanism modulates fungal virulence and the mammalian inflammasome, the latter providing mechanistic insight into autoimmunity reported in a patient with a PIK3CD/p110 delta gain-of-function mutation. We propose a dynamic model wherein RCK family members, in conjunction with Dcp2, function in controlling ATG mRNA stability to govern autophagy, which in turn modulates vital cellular processes affecting inflammation and microbial pathogenesis.	[Hu, Guowu; McQuiston, Travis; Park, Yoon-Dong; Qiu, Jin; Zhang, Nannan; Waterman, Scott R.; Uzel, Gulbu; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Bernard, Amelie; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Vural, Ali; Kehrl, John H.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Blewett, Nathan H.; Maraia, Richard J.] NICHHD, Intramural Res Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Williamson, PR (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov	Maraia, Richard/ABC-1442-2020; Kehrl, John/AAE-6292-2019; Bernard, Amelie/N-4787-2016	Myers, Timothy Gene/0000-0002-7059-5906; Maraia, Richard/0000-0002-5209-0066; Bernard, Amelie/0000-0001-7073-2440	University of Michigan, National Institutes of Health [GM088565]; Intramural Research Program of the NIH, NIAID, NICHD; National Institutes of Health [GM053396]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739, ZIAAI001123, ZICAI001051, ZIAAI001124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396, R01GM088565] Funding Source: NIH RePORTER	University of Michigan, National Institutes of Health; Intramural Research Program of the NIH, NIAID, NICHD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Kim (University of Michigan, National Institutes of Health grant GM088565) for providing the RBP knockout library and V. Nagarajan (Genomic Technologies Section, Research Technologies Branch, NIAID, NIH) for genomic analysis. This work was financially supported, in part, by the Intramural Research Program of the NIH, NIAID, NICHD and by National Institutes of Health grant GM053396 (to D.J.K.).	Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bartholomew CR, 2012, P NATL ACAD SCI USA, V109, P11206, DOI 10.1073/pnas.1200313109; Chan TF, 2001, J BIOL CHEM, V276, P6463, DOI 10.1074/jbc.M008162200; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Freeberg MA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r13; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; Panepinto J, 2005, J CLIN INVEST, V115, P632, DOI 10.1172/JCI200523048; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sharif H, 2013, NUCLEIC ACIDS RES, V41, P8377, DOI 10.1093/nar/gkt600; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SHULMAN GI, 1985, J CLIN INVEST, V76, P757, DOI 10.1172/JCI112032; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Weston A, 2006, NUCLEIC ACIDS RES, V34, P3082, DOI 10.1093/nar/gkl409; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485	44	71	84	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					930	942		10.1038/ncb3189	http://dx.doi.org/10.1038/ncb3189			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26098573	Green Accepted			2022-12-25	WOS:000357353400013
J	Houlard, M; Godwin, J; Metson, J; Lee, J; Hirano, T; Nasmyth, K				Houlard, Martin; Godwin, Jonathan; Metson, Jean; Lee, Jibak; Hirano, Tatsuya; Nasmyth, Kim			Condensin confers the longitudinal rigidity of chromosomes	NATURE CELL BIOLOGY			English	Article							MITOTIC CHROMOSOME; CHROMATID SEGREGATION; STRUCTURAL INTEGRITY; SISTER CHROMATIDS; TOPOISOMERASE-II; MOUSE OOCYTES; PROTEIN; MITOSIS; CELLS; ARCHITECTURE	In addition to inter-chromatid cohesion, mitotic and meiotic chromatids must have three physical properties: compaction into 'threads' roughly co-linear with their DNA sequence, intra-chromatid cohesion determining their rigidity, and a mechanism to promote sister chromatid disentanglement. A fundamental issue in chromosome biology is whether a single molecular process accounts for all three features. There is universal agreement that a pair of Smc-kleisin complexes called condensin I and II facilitate sister chromatid disentanglement, but whether they also confer thread formation or longitudinal rigidity is either controversial or has never been directly addressed respectively. We show here that condensin II (beta-kleisin) has an essential role in all three processes during meiosis I in mouse oocytes and that its function overlaps with that of condensin I (gamma-kleisin), which is otherwise redundant. Pre-assembled meiotic bivalents unravel when condensin is inactivated by TEV cleavage, proving that it actually holds chromatin fibres together.	[Houlard, Martin; Godwin, Jonathan; Metson, Jean; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Lee, Jibak] Kobe Univ, Grad Sch Agr Sci, Lab Dev Biotechnol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hirano, Tatsuya] RIKEN, Chromosome Dynam Lab, Wako, Saitama 3510198, Japan	University of Oxford; Kobe University; RIKEN	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Hirano, Tatsuya/F-6008-2011	Hirano, Tatsuya/0000-0002-4219-6473; Nasmyth, Kim/0000-0001-7030-4403	Wellcome Trust [091859/Z/10/Z]; ERC [294401]; MRC [84673]; MRC [G0701161] Funding Source: UKRI; Medical Research Council [G0701161] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Micron microscopy facility and especially I. Dobbie for his technical support; all the staff of the BSB facility; B. Novak and all the members of the K.N. laboratory for discussions and comments on the manuscript. This work was supported by the Wellcome Trust (Grant Ref 091859/Z/10/Z), ERC grant (Proposal No 294401) and MRC (Grant ID 84673).	Almagro S, 2004, J BIOL CHEM, V279, P5118, DOI 10.1074/jbc.M307221200; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Charbin A, 2014, NUCLEIC ACIDS RES, V42, P340, DOI 10.1093/nar/gkt882; CREMER T, 1988, EXP CELL RES, V176, P199, DOI 10.1016/0014-4827(88)90325-4; Cuyien S, 2013, DEV CELL, V27, P469, DOI 10.1016/j.devcel.2013.10.018; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; FLEMMING W, 1880, ARCH MIKROSK ANAT, V18, P151, DOI DOI 10.1007/BF02952594; Fujiwara T, 2013, MOL BIOL CELL, V24, P2515, DOI 10.1091/mbc.E13-04-0208; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293, DOI 10.1091/mbc.11.4.1293; Lee J, 2011, MOL BIOL CELL, V22, P3465, DOI 10.1091/mbc.E11-05-0423; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Nagy A., 2003, MANIPULATING MOUSE E; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Poirier M, 2000, MOL BIOL CELL, V11, P269, DOI 10.1091/mbc.11.1.269; Poirier MG, 2003, CURR TOP DEV BIOL, V55, P75, DOI 10.1016/S0070-2153(03)01002-0; Rattani A, 2013, ELIFE, V2, DOI 10.7554/eLife.01133; Renshaw MJ, 2010, DEV CELL, V19, P232, DOI 10.1016/j.devcel.2010.07.013; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052	44	72	73	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					771	+		10.1038/ncb3167	http://dx.doi.org/10.1038/ncb3167			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25961503	Green Accepted			2022-12-25	WOS:000355277500009
J	Klompstra, D; Anderson, DC; Yeh, JY; Zilberman, Y; Nance, J				Klompstra, Diana; Anderson, Dorian C.; Yeh, Justin Y.; Zilberman, Yuliya; Nance, Jeremy			An instructive role for C. elegans E-cadherin in translating cell contact cues into cortical polarity	NATURE CELL BIOLOGY			English	Article							ADHESION MOLECULE UVOMORULIN; TIGHT-JUNCTION BIOGENESIS; PAR PROTEINS; POLARIZATION; ESTABLISHMENT; MAINTENANCE; ACTIVATION; MECHANISM; COMPLEX; EMBRYO	Cell contacts provide spatial cues that polarize early embryos and epithelial cells. The homophilic adhesion protein E-cadherin is required for contact-induced polarity in many cells. However, it is debated whether E-cadherin functions instructively as a spatial cue, or permissively by ensuring adequate adhesion so that cells can sense other contact signals. In Caenorhabditis elegans, contacts polarize early embryonic cells by recruiting the RhoGAP PAC-1 to the adjacent cortex, inducing PAR protein asymmetry. Here we show that the E-cadherin HMR-1, which is dispensable for adhesion, functions together with the alpha-catenin HMP-1, the p120 catenin JAC-1, and the previously uncharacterized linker PICC-1 (human CCDC85A-C) to bind PAC-1 and recruit it to contacts. Mislocalizing the HMR-1 intracellular domain to contact-free surfaces draws PAC-1 to these sites and depolarizes cells, demonstrating an instructive role for HMR-1 in polarization. Our findings identify an E-cadherin-mediated pathway that translates cell contacts into cortical polarity by directly recruiting a symmetry-breaking factor to the adjacent cortex.	[Klompstra, Diana; Anderson, Dorian C.; Yeh, Justin Y.; Zilberman, Yuliya; Nance, Jeremy] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Nance, Jeremy] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Nance, J (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA.	Jeremy.Nance@med.nyu.edu		Nance, Jeremy/0000-0003-4212-7731	National Science Foundation [12-A0-00-000165-01]; American Heart Association; NIH [R01GM098492, R01GM078341, T32HD007520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078341, R01GM098492] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Fisher (University of Pittsburgh, USA), K. Gieseler (Universite Claude Bernard Lyon 1, France), G. Hermann (Lewis and Clark College, USA), O. Hobert (Columbia University Medical Center, USA), J. Hubbard (New York University School of Medicine, USA), T. Hyman (Max Planck Institute for Molecular Cell Biology and Genetics, Germany) and E. Jorgensen (University of Utah, USA) for their generous gifts of strains, plasmids or antibodies. Special thanks to M. Burel for help in examining GFP-PAC-1<SUP>Delta PH</SUP> localization. Thanks to L. Christiaen, T. Hurd, and members of the Nance laboratory for comments on the manuscript. This study was financially supported by a National Science Foundation Graduate Research Fellowship under grant No. 12-A0-00-000165-01 (D.K.), an American Heart Association postdoctoral fellowship (Y.Z.), and NIH grants R01GM098492 (J.N.), R01GM078341 (J.N.) and T32HD007520 (D.C.A.).	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; Chan E, 2013, J CELL SCI, V126, P1692, DOI 10.1242/jcs.124594; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chihara D, 2012, DEVELOPMENT, V139, P2547, DOI 10.1242/dev.079863; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Fesenko I, 2000, MECH DEVELOP, V96, P51, DOI 10.1016/S0925-4773(00)00368-3; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Grana TM, 2010, DEV BIOL, V344, P731, DOI 10.1016/j.ydbio.2010.05.507; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; Johnson MH, 2009, ANNU REV CELL DEV BI, V25, P483, DOI 10.1146/annurev.cellbio.042308.113348; JOHNSON MH, 1986, J EMBRYOL EXP MORPH, V93, P239; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Le Bivic A, 2005, TRENDS CELL BIOL, V15, P237, DOI 10.1016/j.tcb.2005.03.001; Markham NO, 2014, MOL BIOL CELL, V25, P2592, DOI 10.1091/mbc.E13-08-0492; Markham NO, 2012, HYBRIDOMA, V31, P246, DOI 10.1089/hyb.2012.0009; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mori N, 2012, AM J PATHOL, V180, P314, DOI 10.1016/j.ajpath.2011.09.014; MULLER HAJ, 1995, DEV DYNAM, V202, P405; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Nance J, 2002, DEVELOPMENT, V129, P387; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Nejsum LN, 2009, FRONT BIOSCI-LANDMRK, V14, P1088, DOI 10.2741/3295; Nelson WJ, 2013, PROG MOL BIOL TRANSL, V116, P3, DOI 10.1016/B978-0-12-394311-8.00001-7; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Praitis V, 2001, GENETICS, V157, P1217; Roignot J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013789; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Theard D, 2007, MOL BIOL CELL, V18, P2313, DOI 10.1091/mbc.E06-11-1040; Thomas FC, 2004, J CELL SCI, V117, P5599, DOI 10.1242/jcs.01424; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Van Itallie CM, 2014, J CELL SCI, V127, P885, DOI 10.1242/jcs.140475; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Zhang Y, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-119	62	31	37	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					726	+		10.1038/ncb3168	http://dx.doi.org/10.1038/ncb3168			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25938815	Green Accepted			2022-12-25	WOS:000355277500005
J	Rosenfeld, ME				Rosenfeld, Michael E.			Converting smooth muscle cells to macrophage-like cells with KLF4 in atherosclerotic plaques	NATURE MEDICINE			English	Editorial Material							TRANSDIFFERENTIATION; ATHEROGENESIS; MICE	Atherosclerosis is the primary cause of heart attacks and strokes and is caused by a chronic inflammatory response in the coronary and carotid arteries. A new study shows that smooth muscle cells within atherosclerotic plaques can change phenotypes to become macrophage-like cells, thereby revealing the remarkable plasticity of these cells.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rosenfeld, ME (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	ssmjm@u.washington.edu						Breyer A, 2006, EXP HEMATOL, V34, P1596, DOI 10.1016/j.exphem.2006.07.013; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Sharma N, 2012, ARTERIOSCL THROM VAS, V32, P2836, DOI 10.1161/ATVBAHA.112.300471; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	11	14	14	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					549	551		10.1038/nm.3875	http://dx.doi.org/10.1038/nm.3875			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	26046571				2022-12-25	WOS:000355778300007
J	Wu, YS; Li, Y; Zhang, H; Huang, YH; Zhao, P; Tang, YJ; Qiu, XH; Ying, Y; Li, W; Ni, S; Zhang, M; Liu, LQ; Xu, Y; Zhuang, Q; Luo, ZW; Benda, C; Song, H; Liu, BH; Lai, LX; Liu, XG; Tse, HF; Bao, XC; Chan, WY; Esteban, MA; Qin, BM; Pei, DQ				Wu, Yasong; Li, Yuan; Zhang, Hui; Huang, Yinghua; Zhao, Ping; Tang, Yujia; Qiu, Xiaohui; Ying, Yue; Li, Wen; Ni, Su; Zhang, Meng; Liu, Longqi; Xu, Yan; Zhuang, Qiang; Luo, Zhiwei; Benda, Christina; Song, Hong; Liu, Baohua; Lai, Liangxue; Liu, Xingguo; Tse, Hung-Fat; Bao, Xichen; Chan, Wai-Yee; Esteban, Miguel A.; Qin, Baoming; Pei, Duanqing			Autophagy and mTORC1 regulate the stochastic phase of somatic cell reprogramming	NATURE CELL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; ACTIVATION; KINASE; STRESS; TARGET; CONTRIBUTES; BIOGENESIS; MECHANISMS; PROTEINS; COMPLEX	We describe robust induction of autophagy during the reprogramming of mouse fibroblasts to induced pluripotent stem cells by four reprogramming factors (Sox2, Oct4, Klf4 and c-Myc), henceforth 4F. This process occurs independently of p53 activation, and is mediated by the synergistic downregulation of mechanistic target of rapamycin complex 1 (mTORC1) and the induction of autophagy-related genes. The 4F coordinately repress mTORC1, but bifurcate in their regulation of autophagy-related genes, with Klf4 and c-Myc inducing them but Sox2 and Oct4 inhibiting them. On one hand, inhibition of mTORC1 facilitates reprogramming by promoting cell reshaping (mitochondrial remodelling and cell size reduction). On the other hand, mTORC1 paradoxically impairs reprogramming by triggering autophagy. Autophagy does not participate in cell reshaping in reprogramming but instead degrades p62, whose accumulation in autophagy-deficient cells facilitates reprogramming. Our results thus reveal a complex signalling network involving mTORC1 inhibition and autophagy induction in the early phase of reprogramming, whose delicate balance ultimately determines reprogramming efficiency.	[Wu, Yasong; Li, Yuan; Zhang, Hui; Huang, Yinghua; Zhao, Ping; Tang, Yujia; Qiu, Xiaohui; Ying, Yue; Ni, Su; Zhang, Meng; Liu, Longqi; Xu, Yan; Zhuang, Qiang; Luo, Zhiwei; Benda, Christina; Song, Hong; Lai, Liangxue; Liu, Xingguo; Bao, Xichen; Esteban, Miguel A.; Qin, Baoming; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Wu, Yasong; Li, Yuan; Zhang, Hui; Huang, Yinghua; Zhao, Ping; Tang, Yujia; Qiu, Xiaohui; Ying, Yue; Ni, Su; Zhang, Meng; Liu, Longqi; Xu, Yan; Zhuang, Qiang; Luo, Zhiwei; Benda, Christina; Song, Hong; Lai, Liangxue; Liu, Xingguo; Bao, Xichen; Esteban, Miguel A.; Qin, Baoming; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Li, Yuan] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Li, Wen; Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Li, Wen] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Liu, Baohua] Anhui Univ, Sch Life Sci, Hefei 230601, Peoples R China; [Liu, Baohua] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China; [Tse, Hung-Fat] Univ Hong Kong, Shenzhen Inst Res, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat] Univ Hong Kong, Shenzhen Inst Innovat, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat; Esteban, Miguel A.; Qin, Baoming; Pei, Duanqing] Univ Hong Kong, Hong Kong Guangdong Joint Lab Stem Cell & Regener, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat; Esteban, Miguel A.; Qin, Baoming; Pei, Duanqing] Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Chan, Wai-Yee] Chinese Univ Hong Kong, CUHK GIBH Joint Res Lab Stem Cells & Regenerat Me, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Hong Kong; University of Hong Kong; Anhui University; Shenzhen University; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese University of Hong Kong	Qin, BM (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	qin_baoming@gibh.ac.cn; pei_duanqing@gibh.ac.cn	Chan, Wai Yee/R-7442-2018; Qin, Baoming/G-1553-2015; Liu, Baohua/AAH-3685-2020; Liu, Baohua/C-9594-2014; Tse, Hung-Fat/C-4426-2009; NI, Su/AAH-8267-2020	Chan, Wai Yee/0000-0002-9714-0936; Qin, Baoming/0000-0001-7652-161X; Liu, Baohua/0000-0002-1599-8059; Liu, Baohua/0000-0002-1599-8059; Tse, Hung-Fat/0000-0002-9578-7808; Xu, Yan/0000-0001-5653-291X; Ni, Su/0000-0003-2883-574X; Tse, Hung Fat/0000-0003-4665-7887	National Basic Research Program of China (973 Program of China) [2011CBA01106, 2011CBA01004, 2011CB965201, 2012CB966802]; Chinese Academy of Sciences [XDA01020106, XDA01020202, XDA01020401]; National Natural Science Foundation of China [31301057, 31421004, 91213304, 31371513]; Ministry of Science and Technology International Technology Cooperation Program [2012DFH30050]; German Academic Exchange Service (DAAD); German Ministry of Research; Ministry of Science and Technology of China; Theme Based Research Scheme [T12-705/11]; Innovation and Technology Support Programme (Tier 3) [ITS/303/12]	National Basic Research Program of China (973 Program of China)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Technology Cooperation Program; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Ministry of Research; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Theme Based Research Scheme; Innovation and Technology Support Programme (Tier 3)	We thank W. Lee and J. CY. Ho from the University of Hong Kong for their technical support with the electron microscopy. We thank all members of the Pei and Esteban laboratory for their support, and J. Chen, Y. Chen, S. Chu, F. Cui, S. Huang, D. P. Ibanez, K. Lai, R. Luo, X. Qing and F. Zhang for technical assistance. We also thank A. Schambach from the Department of Experimental Hematology, Hannover Medical School for providing the polycistronic 4F-dT lentiviral vector, Y. Chen from Tsinghua University for providing the Atg5 KO mice (with permission from N. Mizushima and RIKEN BioResource Center) and Q. Chen from the Institute of Zoology, Chinese Academy of Sciences. This work was financially supported by the National Basic Research Program of China (973 Program of China, 2011CBA01106, 2011CBA01004, 2011CB965201 and 2012CB966802), the 'Strategic Priority Research Program' of the Chinese Academy of Sciences (XDA01020106, XDA01020202 and XDA01020401), the National Natural Science Foundation of China (31301057, 31421004, 91213304 and 31371513), the Ministry of Science and Technology International Technology Cooperation Program (2012DFH30050) and a joint German-Chinese grant from the German Academic Exchange Service (DAAD), the German Ministry of Research and the Ministry of Science and Technology of China to D. P. and A. Schambach. H-F.T. is financially supported by the Theme Based Research Scheme (T12-705/11) and the Innovation and Technology Support Programme (Tier 3) (ITS/303/12).	Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Cai J., 2013, CELL REGEN, V2, P1; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Cho YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057172; Cho YH, 2014, STEM CELLS, V32, P424, DOI 10.1002/stem.1589; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He J, 2012, STEM CELLS DEV, V21, P2630, DOI 10.1089/scd.2012.0015; Ho JCY, 2011, AGING-US, V3, P380, DOI 10.18632/aging.100277; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ji JF, 2014, STEM CELL REP, V2, P44, DOI 10.1016/j.stemcr.2013.11.004; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu LQ, 2014, CELL STEM CELL, V15, P574, DOI 10.1016/j.stem.2014.09.018; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; March HN, 2011, GASTROENTEROLOGY, V140, P1387, DOI 10.1053/j.gastro.2011.03.027; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Planello Aline C, 2014, Cell Regen, V3, P4, DOI 10.1186/2045-9769-3-4; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Row PE, 2001, BIOCHEM J, V353, P655, DOI 10.1042/0264-6021:3530655; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Tahmasebi S, 2014, CELL STEM CELL, V14, P606, DOI 10.1016/j.stem.2014.02.005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; Tsuneoka M, 2003, CELL STRUCT FUNCT, V28, P195; Urabe M, 2000, ANAL BIOCHEM, V278, P91, DOI 10.1006/abio.1999.4429; Vazquez-Martin A, 2012, CELL CYCLE, V11, P974, DOI 10.4161/cc.11.5.19450; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wu Y., 2015, PROTOC EXCH; Xu XX, 2013, CELL RES, V23, P131, DOI 10.1038/cr.2012.143; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	64	62	69	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					715	+		10.1038/ncb3172	http://dx.doi.org/10.1038/ncb3172			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CJ1XD	25985393				2022-12-25	WOS:000355277500004
J	Merrell, AJ; Ellis, BJ; Fox, ZD; Lawson, JA; Weiss, JA; Kardon, G				Merrell, Allyson J.; Ellis, Benjamin J.; Fox, Zachary D.; Lawson, Jennifer A.; Weiss, Jeffrey A.; Kardon, Gabrielle			Muscle connective tissue controls development of the diaphragm and is a source of congenital diaphragmatic hernias	NATURE GENETICS			English	Article							HEART TUBE FORMATION; VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; MET RECEPTOR; LIMB BUD; C-MET; GATA4; DEFECTS; MOUSE	The diaphragm is an essential mammalian skeletal muscle, and defects in diaphragm development are the cause of congenital diaphragmatic hernias (CDHs), a common and often lethal birth defect. The diaphragm is derived from multiple embryonic sources, but how these give rise to the diaphragm is unknown, and, despite the identification of many CDH-associated genes, the etiology of CDH is incompletely understood. Using mouse genetics, we show that the pleuroperitoneal folds (PPFs), which are transient embryonic structures, are the source of the diaphragm's muscle connective tissue and regulate muscle development, and we show that the striking migration of PPF cells controls diaphragm morphogenesis. Furthermore, Gata4 mosaic mutations in PPF-derived muscle connective tissue fibroblasts result in the development of localized amuscular regions that are biomechanically weaker and more compliant, leading to CDH. Thus, the PPFs and muscle connective tissue are critical for diaphragm development, and mutations in PPF-derived fibroblasts are a source of CDH.	[Merrell, Allyson J.; Fox, Zachary D.; Lawson, Jennifer A.; Kardon, Gabrielle] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Ellis, Benjamin J.; Weiss, Jeffrey A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Ellis, Benjamin J.; Weiss, Jeffrey A.] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kardon, G (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	gkardon@genetics.utah.edu			University of Utah Graduate Fellowship; US National Institutes of Health (NIH) grant [R01GM083925]; US NIH grant [R01GM098151, R01HD053728]; Dimes grant [FY12-405]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083925] Funding Source: NIH RePORTER	University of Utah Graduate Fellowship; US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dimes grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Rodesch at the University of Utah Imaging Core for help with microscopy, S. Merchant for help with microCT imaging, Y. Wan and C. Hansen for Fluorender analysis, M. Hockin and M.R. Capecchi for Cre protein, and M. Colasanto, N. Elde, L.B. Jorde, A. Keefe, A. Letsou, L.C. Murtaugh and C.J. Tabin for critical comments on the manuscript. A.J.M. was supported by a University of Utah Graduate Fellowship, FEBio analysis is supported by US National Institutes of Health (NIH) grant R01GM083925 to J.A.W. and G.A. Ateshian, and Fluorender analysis is supported by US NIH grant R01GM098151 to C. Hansen. This research was supported by US NIH grant R01HD053728 and March of Dimes grant FY12-405 to G.K.	Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Ackerman KG, 2007, AM J MED GENET C, V145C, P109, DOI 10.1002/ajmg.c.30128; Ackerman KG, 2012, PEDIATR DEVEL PATHOL, V15, P265, DOI 10.2350/11-05-1041-OA.1; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Allan DW, 1997, J COMP NEUROL, V382, P459, DOI 10.1002/(SICI)1096-9861(19970616)382:4<459::AID-CNE3>3.0.CO;2-1; Arrington CB, 2012, AM J MED GENET A, V158A, P3137, DOI 10.1002/ajmg.a.35664; Babiuk RP, 2003, J COMP NEUROL, V455, P477, DOI 10.1002/cne.10503; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bosch N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008269; Campbell E. J. M., 1970, RESP MUSCLES MECH NE; Clugston Robin D, 2007, Semin Pediatr Surg, V16, P94, DOI 10.1053/j.sempedsurg.2007.01.004; Clugston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL665, DOI 10.1152/ajplung.00027.2008; Coles GL, 2013, P NATL ACAD SCI USA, V110, pE1898, DOI 10.1073/pnas.1222797110; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Domyan ET, 2013, DEV CELL, V24, P52, DOI 10.1016/j.devcel.2012.11.018; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Greer JJ, 2000, J APPL PHYSIOL, V89, P2123, DOI 10.1152/jappl.2000.89.6.2123; Holder AM, 2007, AM J HUM GENET, V80, P825, DOI 10.1086/513442; Jay PY, 2007, DEV BIOL, V301, P602, DOI 10.1016/j.ydbio.2006.09.050; Kantarci S, 2010, AM J MED GENET A, V152A, P2493, DOI 10.1002/ajmg.a.33618; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Keijzer R, 2000, AM J PATHOL, V156, P1299, DOI 10.1016/S0002-9440(10)65000-6; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Longoni M, 2012, AM J MED GENET A, V158A, P3148, DOI 10.1002/ajmg.a.35665; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Merrell AJ, 2013, FEBS J, V280, P4026, DOI 10.1111/febs.12274; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakamura K, 2011, INT J CANCER, V128, P2613, DOI 10.1002/ijc.25606; Perry SF, 2010, RESP PHYSIOL NEUROBI, V171, P1, DOI 10.1016/j.resp.2010.01.004; Pober BR, 2007, AM J MED GENET C, V145C, P158, DOI 10.1002/ajmg.c.30126; Pober BR, 2005, AM J MED GENET A, V138A, P81, DOI 10.1002/ajmg.a.30904; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Raval MV, 2011, J PEDIATR SURG, V46, P617, DOI 10.1016/j.jpedsurg.2010.09.047; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Russell MK, 2012, P NATL ACAD SCI USA, V109, P2978, DOI 10.1073/pnas.1121621109; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STRUMPF RK, 1993, AM J PHYSIOL, V265, pH469, DOI 10.1152/ajpheart.1993.265.2.H469; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TORFS CP, 1992, TERATOLOGY, V46, P555, DOI 10.1002/tera.1420460605; Veenma DCM, 2012, PEDIATR PULM, V47, P534, DOI 10.1002/ppul.22553; Veenma D, 2012, EUR J HUM GENET, V20, P298, DOI 10.1038/ejhg.2011.194; Veenma D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015348; VERONDA DR, 1970, J BIOMECH, V3, P111, DOI 10.1016/0021-9290(70)90055-2; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; Wan Y, 2009, IEEE T VIS COMPUT GR, V15, P1489, DOI 10.1109/TVCG.2009.118; Wat MJ, 2012, HUM MOL GENET, V21, P4115, DOI 10.1093/hmg/dds241; Wat MJ, 2009, AM J MED GENET A, V149A, P1661, DOI 10.1002/ajmg.a.32896; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Yamak A, 2012, AM J PHYSIOL-HEART C, V303, pH1057, DOI 10.1152/ajpheart.00250.2012; You LR, 2005, P NATL ACAD SCI USA, V102, P16351, DOI 10.1073/pnas.0507832102; Yu L, 2013, HUM GENET, V132, P285, DOI 10.1007/s00439-012-1249-0; Zhang B, 2014, J CLIN INVEST, V124, P209, DOI 10.1172/JCI71090	62	79	81	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					496	U96		10.1038/ng.3250	http://dx.doi.org/10.1038/ng.3250			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25807280	Green Accepted			2022-12-25	WOS:000353635800012
J	Chen, WZ; Wu, JF; Li, LS; Zhang, ZM; Ren, JM; Liang, YJ; Chen, FF; Yang, C; Zhou, ZR; Su, SS; Zheng, XR; Zhang, ZR; Zhong, CQ; Wan, HQ; Xiao, M; Lin, X; Feng, XH; Han, JH				Chen, Wanze; Wu, Jianfeng; Li, Lisheng; Zhang, Zhengmao; Ren, Junming; Liang, Yaoji; Chen, Fenfang; Yang, Chao; Zhou, Zhenru; Su, Sheng Sean; Zheng, Xinru; Zhang, Zhirong; Zhong, Chuan-Qi; Wan, Haoqiang; Xiao, Mu; Lin, Xia; Feng, Xin-Hua; Han, Jiahuai			Ppm1b negatively regulates necroptosis through dephosphorylating Rip3	NATURE CELL BIOLOGY			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; TNF-INDUCED NECROPTOSIS; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; L929 CELLS; PHOSPHATASE; NECROSIS; MLKL; PHOSPHORYLATION	The auto-phosphorylation of murine receptor-interacting protein 3 (Rip3) on Thr 231 and Ser 232 in the necrosome is required to trigger necroptosis. However, how Rip3 phosphorylation is regulated is still largely unknown. Here we identified protein phosphatase 1B (Ppm1b) as a Rip3 phosphatase and found that Ppm1b restricts necroptosis in two settings: spontaneous necroptosis caused by Rip3 auto-phosphorylation in resting cells, and tumour necrosis factor-alpha (TNF)-induced necroptosis in cultured cells. We revealed that Ppm1b selectively suppresses necroptosis through the dephosphorylation of Rip3, which then prevents the recruitment of mixed lineage kinase domain-like protein (Mlkl) to the necrosome. We further showed that Ppm1b deficiency (Ppm1b(d/d)) in mice enhanced TNF-induced death in a Rip3-dependent manner, and the role of Ppm1b in inhibiting necroptosis was evidenced by elevated Rip3 phosphorylation and tissue damage in the caecum of TNF-treated Ppm1b(d/d) mice. These data indicate that Ppm1b negatively regulates necroptosis through dephosphorylating Rip3 in vitro and in vivo.	[Chen, Wanze; Wu, Jianfeng; Li, Lisheng; Ren, Junming; Liang, Yaoji; Yang, Chao; Zhou, Zhenru; Su, Sheng Sean; Zheng, Xinru; Zhang, Zhirong; Zhong, Chuan-Qi; Wan, Haoqiang; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Zhang, Zhengmao; Chen, Fenfang; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Zhengmao; Chen, Fenfang; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Zhengmao; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA	Xiamen University; Zhejiang University; Zhejiang University; Baylor College of Medicine	Han, JH (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.	jhan@xmu.edu.cn	Ren, Junming/AAN-2968-2020; Han, J/G-4671-2010; ZHANG, Zhirong/A-3422-2015	ZHANG, Zhirong/0000-0002-7331-783X; Chen, Wanze/0000-0002-7946-3336; Xiao, Mu/0000-0003-3058-2905; ZHANG, ZHENGMAO/0000-0003-4035-0331; Li, Lisheng/0000-0002-0793-272X; Su, Sheng "Sean"/0000-0002-6773-467X	National Basic Research Program of China (973 Program) [2015CB553800]; National Scientific and Technological Major Project [2013ZX10002-002]; National Natural Scientific Foundation of China [91429301, 31420103910, 31330047, 91029304, 31221065, 31090360]; Hi-Tech Research and Development Program of China (863 program) [2012AA02A201]; 111 Project [B12001]; Science and Technology Foundation of Xiamen [3502Z20130027]; National Science Foundation of China for Fostering Talents in Basic Research [J1310027]; Open Research Fund of State Key Laboratory of Cellular Stress MOST [2012CB966600]; NIH [R01GM63773, R01AR053591, R01CA108454]; Zhejiang University; Xiamen University; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Scientific and Technological Major Project; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); 111 Project(Ministry of Education, China - 111 Project); Science and Technology Foundation of Xiamen; National Science Foundation of China for Fostering Talents in Basic Research(National Natural Science Foundation of China (NSFC)); Open Research Fund of State Key Laboratory of Cellular Stress MOST; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zhejiang University; Xiamen University(Xiamen University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Tamura and M. Ohnshi for Ppm1b<SUP>+/-</SUP> mice. This work was supported by the National Basic Research Program of China (973 Program; 2015CB553800), the National Scientific and Technological Major Project (2013ZX10002-002), the National Natural Scientific Foundation of China (91429301, 31420103910, 31330047, 91029304, 31221065, and 31090360), the Hi-Tech Research and Development Program of China (863 program; 2012AA02A201), the 111 Project (B12001), the Science and Technology Foundation of Xiamen (No. 3502Z20130027), the National Science Foundation of China for Fostering Talents in Basic Research (Grant No. J1310027) and the Open Research Fund of State Key Laboratory of Cellular Stress MOST (2012CB966600) and NIH (R01GM63773, R01AR053591, R01CA108454). The collaborative research is also supported by the special funds for Innovation Center for Cell Biology from Zhejiang University and Xiamen University.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choi HK, 2013, BIOCHEM BIOPH RES CO, V436, P473, DOI 10.1016/j.bbrc.2013.05.129; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Klumpp S, 1998, FEBS LETT, V437, P229, DOI 10.1016/S0014-5793(98)01237-X; Kusuda K, 1998, BIOCHEM J, V332, P243, DOI 10.1042/bj3320243; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li LS, 2014, CELL RES, V24, P417, DOI 10.1038/cr.2014.17; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Sasaki M, 2007, MECH DEVELOP, V124, P489, DOI 10.1016/j.mod.2007.04.001; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Tanaka A, 2005, BLOOD, V105, P2324, DOI 10.1182/blood-2004-08-3247; TERASAWA T, 1993, ARCH BIOCHEM BIOPHYS, V307, P342, DOI 10.1006/abbi.1993.1598; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Wu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094634; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	52	93	97	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					434	+		10.1038/ncb3120	http://dx.doi.org/10.1038/ncb3120			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25751141	Green Accepted			2022-12-25	WOS:000351920500013
J	Michailidou, K; Beesley, J; Lindstrom, S; Canisius, S; Dennis, J; Lush, MJ; Maranian, MJ; Bolla, MK; Wang, Q; Shah, M; Perkins, BJ; Czene, K; Eriksson, M; Darabi, H; Brand, JS; Bojesen, SE; Nordestgaard, BG; Flyger, H; Nielsen, SF; Rahman, N; Turnbull, C; Fletcher, O; Peto, J; Gibson, L; dos-Santos-Silva, I; Chang-Claude, J; Flesch-Janys, D; Rudolph, A; Eilber, U; Behrens, S; Nevanlinna, H; Muranen, TA; Aittomaki, K; Blomqvist, C; Khan, S; Aaltonen, K; Ahsan, H; Kibriya, MG; Whittemore, AS; John, EM; Malone, KE; Gammon, MD; Santella, RM; Ursin, G; Makalic, E; Schmidt, DF; Casey, G; Hunter, DJ; Gapstur, SM; Gaudet, MM; Diver, WR; Haiman, CA; Schumacher, F; Henderson, BE; Le Marchand, L; Berg, CD; Chanock, SJ; Figueroa, J; Hoover, RN; Lambrechts, D; Neven, P; Wildiers, H; van Limbergen, E; Schmidt, MK; Broeks, A; Verhoef, S; Cornelissen, S; Couch, FJ; Olson, JE; Hallberg, E; Vachon, C; Waisfisz, Q; Meijers-Heijboer, H; Adank, MA; van der Luijt, RB; Li, JM; Liu, JJ; Humphreys, K; Kang, D; Choi, JY; Park, SK; Yoo, KY; Matsuo, K; Ito, H; Iwata, H; Tajima, K; Guenel, P; Truong, T; Mulot, C; Sanchez, M; Burwinkel, B; Marme, F; Surowy, H; Sohn, C; Wu, AH; Tseng, CC; Van den Berg, D; Stram, DO; Gonzalez-Neira, A; Benitez, J; Zamora, MP; Perez, JIA; Shu, XO; Lu, W; Gao, YT; Cai, H; Cox, A; Cross, SS; Reed, MWR; Andrulis, IL; Knight, JA; Glendon, G; Mulligan, AM; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Lindblom, A; Margolin, S; Teo, SH; Yip, CH; Taib, NAM; Tan, GH; Hooning, MJ; Hollestelle, A; Martens, JWM; Collee, JM; Blot, W; Signorello, LB; Cai, QY; Hopper, JL; Southey, MC; Tsimiklis, H; Apicella, C; Shen, CY; Hsiung, CN; Wu, PE; Hou, MF; Kristensen, VN; Nord, S; Alnaes, GIG; Giles, GG; Milne, RL; McLean, C; Canzian, F; Trichopoulos, D; Peeters, P; Lund, E; Sund, M; Khaw, KT; Gunter, MJ; Palli, D; Mortensen, LM; Dossus, L; Huerta, JM; Meindl, A; Schmutzler, RK; Sutter, C; Yang, R; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Hartman, M; Miao, H; Chia, KS; Chan, CW; Fasching, PA; Hein, A; Beckmann, MW; Haeberle, L; Brenner, H; Dieffenbach, AK; Arndt, V; Stegmaier, C; Ashworth, A; Orr, N; Schoemaker, MJ; Swerdlow, AJ; Brinton, L; Garcia-Closas, M; Zheng, W; Halverson, SL; Shrubsole, M; Long, J; Goldberg, MS; Labreche, F; Dumont, M; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Brauch, H; Hamann, U; Bruning, T; Radice, P; Peterlongo, P; Manoukian, S; Bernard, L; Bogdanova, NV; Dork, T; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Devilee, P; Tollenaar, RAEM; Seynaeve, C; Van Asperen, CJ; Jakubowska, A; Lubinski, J; Jaworska, K; Huzarski, T; Sangrajrang, S; Gaborieau, V; Brennan, P; Mckay, J; Slager, S; Toland, AE; Ambrosone, CB; Yannoukakos, D; Kabisch, M; Torres, D; Neuhausen, SL; Anton-Culver, H; Luccarini, C; Baynes, C; Ahmed, S; Healey, CS; Tessier, DC; Vincent, D; Bacot, F; Pita, G; Alonso, MR; Alvarez, N; Herrero, D; Simard, J; Pharoah, PPDP; Kraft, P; Dunning, AM; Chenevix-Trench, G; Hall, P; Easton, DF				Michailidou, Kyriaki; Beesley, Jonathan; Lindstrom, Sara; Canisius, Sander; Dennis, Joe; Lush, Michael J.; Maranian, Mel J.; Bolla, Manjeet K.; Wang, Qin; Shah, Mitul; Perkins, Barbara J.; Czene, Kamila; Eriksson, Mikael; Darabi, Hatef; Brand, Judith S.; Bojesen, Stig E.; Nordestgaard, Borge G.; Flyger, Henrik; Nielsen, Sune F.; Rahman, Nazneen; Turnbull, Clare; Fletcher, Olivia; Peto, Julian; Gibson, Lorna; dos-Santos-Silva, Isabel; Chang-Claude, Jenny; Flesch-Janys, Dieter; Rudolph, Anja; Eilber, Ursula; Behrens, Sabine; Nevanlinna, Heli; Muranen, Taru A.; Aittomaki, Kristiina; Blomqvist, Carl; Khan, Sofia; Aaltonen, Kirsimari; Ahsan, Habibul; Kibriya, Muhammad G.; Whittemore, Alice S.; John, Esther M.; Malone, Kathleen E.; Gammon, Marilie D.; Santella, Regina M.; Ursin, Giske; Makalic, Enes; Schmidt, Daniel F.; Casey, Graham; Hunter, David J.; Gapstur, Susan M.; Gaudet, Mia M.; Diver, W. Ryan; Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Le Marchand, Loic; Berg, Christine D.; Chanock, Stephen J.; Figueroa, Jonine; Hoover, Robert N.; Lambrechts, Diether; Neven, Patrick; Wildiers, Hans; van Limbergen, Erik; Schmidt, Marjanka K.; Broeks, Annegien; Verhoef, Senno; Cornelissen, Sten; Couch, Fergus J.; Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.; van der Luijt, Rob B.; Li, Jingmei; Liu, Jianjun; Humphreys, Keith; Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Yoo, Keun-Young; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Tajima, Kazuo; Guenel, Pascal; Truong, Therese; Mulot, Claire; Sanchez, Marie; Burwinkel, Barbara; Marme, Frederik; Surowy, Harald; Sohn, Christof; Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.; Gonzalez-Neira, Anna; Benitez, Javier; Zamora, M. Pilar; Arias Perez, Jose Ignacio; Shu, Xiao-Ou; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Cox, Angela; Cross, Simon S.; Reed, Malcolm W. R.; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Mulligan, Anna Marie; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Lindblom, Annika; Margolin, Sara; Teo, Soo Hwang; Yip, Cheng Har; Taib, Nur Aishah Mohd; Tan, Gie-Hooi; Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.; Collee, J. Margriet; Blot, William; Signorello, Lisa B.; Cai, Qiuyin; Hopper, John L.; Southey, Melissa C.; Tsimiklis, Helen; Apicella, Carmel; Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei; Hou, Ming-Feng; Kristensen, Vessela N.; Nord, Silje; Alnaes, Grethe I. Grenaker; Giles, Graham G.; Milne, Roger L.; McLean, Catriona; Canzian, Federico; Trichopoulos, Dimitrios; Peeters, Petra; Lund, Eiliv; Sund, Malin; Khaw, Kay-Tee; Gunter, Marc J.; Palli, Domenico; Mortensen, Lotte Maxild; Dossus, Laure; Huerta, Jose-Maria; Meindl, Alfons; Schmutzler, Rita K.; Sutter, Christian; Yang, Rongxi; Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pornthep; Hartman, Mikael; Miao, Hui; Chia, Kee Seng; Chan, Ching Wan; Fasching, Peter A.; Hein, Alexander; Beckmann, Matthias W.; Haeberle, Lothar; Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker; Stegmaier, Christa; Ashworth, Alan; Orr, Nick; Schoemaker, Minouk J.; Swerdlow, Anthony J.; Brinton, Louise; Garcia-Closas, Montserrat; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Brauch, Hiltrud; Hamann, Ute; Bruening, Thomas; Radice, Paolo; Peterlongo, Paolo; Manoukian, Siranoush; Bernard, Loris; Bogdanova, Natalia V.; Doerk, Thilo; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Devilee, Peter; Tollenaar, Robert A. E. M.; Seynaeve, Caroline; Van Asperen, Christi J.; Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Huzarski, Tomasz; Sangrajrang, Suleeporn; Gaborieau, Valerie; Brennan, Paul; Mckay, James; Slager, Susan; Toland, Amanda E.; Ambrosone, Christine B.; Yannoukakos, Drakoulis; Kabisch, Maria; Torres, Diana; Neuhausen, Susan L.; Anton-Culver, Hoda; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel; Simard, Jacques; Pharoah, Paul P. D. P.; Kraft, Peter; Dunning, Alison M.; Chenevix-Trench, Georgia; Hall, Per; Easton, Douglas F.		BOCS; KConFab Investigators; AOCS Grp; NBCS; GENICA Network	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer	NATURE GENETICS			English	Article							CONFER SUSCEPTIBILITY; GENOTYPE IMPUTATION; COMMON VARIANTS; OVARIAN-CANCER; RISK; ESTROGEN; CHEK2-ASTERISK-1100DELC; METAANALYSIS; ALLELES; BRCA1	Genome-wide association studies (GWAS) and large-scale replication studies have identified common variants in 79 loci associated with breast cancer, explaining similar to 14% of the familial risk of the disease. To identify new susceptibility loci, we performed a meta-analysis of 11 GWAS, comprising 15,748 breast cancer cases and 18,084 controls together with 46,785 cases and 42,892 controls from 41 studies genotyped on a 211,155-marker custom array (iCOGS). Analyses were restricted to women of European ancestry. We generated genotypes for more than 11 million SNPs by imputation using the 1000 Genomes Project reference panel, and we identified 15 new loci associated with breast cancer at P < 5 x 10(-8). Combining association analysis with ChIP-seq chromatin binding data in mammary cell lines and ChIA-PET chromatin interaction data from ENCODE, we identified likely target genes in two regions: SETBP1 at 18q12.3 and RNF115 and PDZK1 at 1q21.1. One association appears to be driven by an amino acid substitution encoded in EXO1.	[Michailidou, Kyriaki; Dennis, Joe; Lush, Michael J.; Bolla, Manjeet K.; Wang, Qin; Pharoah, Paul P. D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Beesley, Jonathan; Chenevix-Trench, Georgia] Queensland Inst Med Res, Berghofer Med Res Inst, Dept Genet, Brisbane, Qld 4006, Australia; [Lindstrom, Sara; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Canisius, Sander] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Maranian, Mel J.; Shah, Mitul; Perkins, Barbara J.; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Pharoah, Paul P. D. P.; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Czene, Kamila; Eriksson, Mikael; Darabi, Hatef; Brand, Judith S.; Li, Jingmei; Humphreys, Keith; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Herlev, Denmark; [Rahman, Nazneen; Turnbull, Clare; Schoemaker, Minouk J.; Swerdlow, Anthony J.; Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Fletcher, Olivia; Ashworth, Alan; Orr, Nick; Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian; Gibson, Lorna; dos-Santos-Silva, Isabel] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Chang-Claude, Jenny; Rudolph, Anja; Eilber, Ursula; Behrens, Sabine] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Nevanlinna, Heli; Muranen, Taru A.; Khan, Sofia; Aaltonen, Kirsimari] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli; Muranen, Taru A.; Blomqvist, Carl; Khan, Sofia; Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Ctr Canc Epidemiol & Prevent, Chicago, IL 60637 USA; [Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Whittemore, Alice S.; John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Whittemore, Alice S.; John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [John, Esther M.] Canc Prevent Inst Calif, Dept Epidemiol, Fremont, CA USA; [Malone, Kathleen E.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Gammon, Marilie D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Santella, Regina M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Ursin, Giske] Canc Registry Norway, Oslo, Norway; [Makalic, Enes; Schmidt, Daniel F.] Melbourne Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Casey, Graham; Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gapstur, Susan M.; Gaudet, Mia M.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Berg, Christine D.] Johns Hopkins Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Chanock, Stephen J.; Figueroa, Jonine; Hoover, Robert N.; Brinton, Louise] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Neven, Patrick; Wildiers, Hans; van Limbergen, Erik] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium; [Schmidt, Marjanka K.; Broeks, Annegien; Cornelissen, Sten] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Oncogenet, Amsterdam, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Div Biomed Genet, Utrecht, Netherlands; [Liu, Jianjun] Genome Inst Singapore, Human Genet Div, Singapore, Singapore; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Surowy, Harald] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Yoo, Keun-Young] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Ito, Hidemi] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Tajima, Kazuo] Mie Univ Hosp, Epidemiol Ctr Dis Control & Prevent, Tsu, Mie, Japan; [Guenel, Pascal; Truong, Therese; Sanchez, Marie] INSERM, Environm Epidemiol Canc, CESP, Ctr Res Epidemiol & Populat Hlth,U1018, Villejuif, France; [Guenel, Pascal; Truong, Therese; Sanchez, Marie] Univ Paris Sud, UMRS 1018, Villejuif, France; [Mulot, Claire] Univ Paris Sorbonne Cite, INSERM, UMRS 775, Paris, France; [Burwinkel, Barbara; Marme, Frederik; Surowy, Harald; Sohn, Christof; Yang, Rongxi] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Burwinkel, Barbara; Yang, Rongxi] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Gonzalez-Neira, Anna; Benitez, Javier; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Zamora, M. Pilar] Hosp Univ La Paz, Med Oncol Serv, Madrid, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Shu, Xiao-Ou; Cai, Hui; Blot, William; Cai, Qiuyin; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Cai, Hui; Blot, William; Cai, Qiuyin; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Changning, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Sheffield Canc Res Ctr, Sheffield, S Yorkshire, England; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Sawyer, Elinor J.] Guys Hosp, Kings Coll London, Div Canc Studies, Res Oncol, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland, Sch Med, Dept Surg, Galway, Ireland; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Teo, Soo Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo Hwang; Yip, Cheng Har; Taib, Nur Aishah Mohd; Tan, Gie-Hooi] Univ Malaya Med Ctr, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur, Malaysia; [Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Signorello, Lisa B.; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hopper, John L.; Apicella, Carmel; Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.; Tsimiklis, Helen] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Shen, Chen-Yang; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Kristensen, Vessela N.; Nord, Silje; Alnaes, Grethe I. Grenaker] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Radiumhosp, N-0450 Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Dept Clin Mol Biol EpiGen, Oslo, Norway; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [McLean, Catriona] Monash Univ, Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Trichopoulos, Dimitrios] Acad Athens, Bureau Epidemiol Res, Athens, Greece; [Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Peeters, Petra] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Peeters, Petra; Gunter, Marc J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Lund, Eiliv] Univ Tromso, Arct Univ Norway, Fac Hlth Sci, Dept Commun Med, Tromso, Norway; [Sund, Malin] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Khaw, Kay-Tee] Univ Cambridge, Cambridge Inst Publ Hlth, Sch Clin Med, Cambridge, England; [Palli, Domenico] Ist Studio Prevenz Oncol, Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Mortensen, Lotte Maxild] Aarhus Univ, Sect Epidemiol, Aarhus, Denmark; [Dossus, Laure] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, Nutr Hormones & Womens Hlth Team, U1018, Villejuif, France; [Dossus, Laure] Univ Paris 11, Villejuif, France; [Huerta, Jose-Maria] CIBER Epidemiol & Salud Publ, Consejeria Sanidad & Polit Social, Dept Epidemiol, Murcia, Spain; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-80290 Munich, Germany; [Schmutzler, Rita K.; Radice, Paolo] Univ Hosp Cologne, Ctr Hereditary Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Sutter, Christian] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Germany; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Nonthaburi, Thailand; [Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael; Miao, Hui; Chia, Kee Seng] Natl Univ Hlth Syst, Singapore, Singapore; [Hartman, Mikael; Miao, Hui; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Chan, Ching Wan] Natl Univ Hlth Syst, Div Gen Surg, Singapore, Singapore; [Fasching, Peter A.; Hein, Alexander; Beckmann, Matthias W.; Haeberle, Lothar] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen Nuremberg Metropolit, Univ Hosp Erlangen, Dept Gynecol & Obstet,Univ Breast,Ctr Franconia, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina; Brauch, Hiltrud] German Canc Consortium DKTK, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Swerdlow, Anthony J.] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Ecole Sante Publ, Dept Sante Environnementale & Sante Travail, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Ecole Sante Publ, Dept Social & Prevent Med, Montreal, PQ, Canada; [Dumont, Martine; Simard, Jacques] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Dumont, Martine; Simard, Jacques] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Winqvist, Robert] Univ Oulu, Dept Clin Chem & Bioctr Oulu, Lab Canc Genet & Tumor Biol, NordLab Oulu,Oulu Univ Hosp, Oulu, Finland; [Pylkas, Katri; Jukkola-Vuorinen, Arja] Univ Oulu, Oulu Univ Hosp, Dept Oncol, Oulu, Finland; [Grip, Mervi] Univ Oulu, Dept Surg, Oulu Univ Hosp, Oulu, Finland; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Brauch, Hiltrud] German Canc Res Ctr, Heidelberg, Germany; [Hamann, Ute; Kabisch, Maria; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med, German Social Accid Insurance, Bochum, Germany; [Radice, Paolo] Ist Nazl Tumori, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Fdn IRCCS, I-20133 Milan, Italy; [Peterlongo, Paolo] Italian Fdn Canc Res Oncol Mol IFOM, Fdn Ist FIRC, Milan, Italy; [Manoukian, Siranoush] Ist Nazl Tumori, Unit Med Genet, Dept Prevent & Predict Med, Fdn IRCCS, I-20133 Milan, Italy; [Bernard, Loris] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Bernard, Loris] Cogentech Canc Genet Test Lab, Milan, Italy; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Sch Med, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Kataja, Vesa] Jyvaskyla Cent Hosp, Cent Finland Hosp Dist, Jyvaskyla, Finland; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Canc Inst, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Huzarski, Tomasz] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst Thailand, Bangkok, Thailand; [Gaborieau, Valerie; Brennan, Paul; Mckay, James] Int Agcy Res Canc, F-69372 Lyon, France; [Toland, Amanda E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, Inst Radioisotopes & Radiodiagnost Prod, Athens, Greece; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] McGill Univ, Montreal, PQ, Canada; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	University of Cambridge; QIMR Berghofer Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Netherlands Cancer Institute; University of Cambridge; Karolinska Institutet; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Stanford University; Stanford Cancer Institute; Stanford University; Cancer Prevention Institute of California; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of Oslo; University of Southern California; American Cancer Society; Cancer Research Center of Hawaii; University of Hawaii System; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Netherlands Cancer Institute; Mayo Clinic; Mayo Clinic; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyushu University; Aichi Cancer Center; Aichi Cancer Center; Mie University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; University of Sheffield; University of Sheffield; University of Sheffield; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Karolinska Institutet; Karolinska Institutet; Universiti Malaya; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Melbourne; University of Melbourne; Academia Sinica - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Oslo; University of Oslo; University of Oslo; Cancer Council Victoria; Florey Institute of Neuroscience & Mental Health; Monash University; Helmholtz Association; German Cancer Research Center (DKFZ); Academy of Athens; Utrecht University; Utrecht University Medical Center; Imperial College London; UiT The Arctic University of Tromso; Umea University; University of Cambridge; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg; University of Warwick; University of Manchester; Ministry of Public Health - Thailand; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; McGill University; McGill University; Royal Victoria Hospital; Universite de Montreal; Universite de Montreal; Laval University; Laval University; University of Oulu; University of Oulu; University of Oulu; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); Hannover Medical School; Hannover Medical School; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pomeranian Medical University; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); University System of Ohio; Ohio State University; Roswell Park Cancer Institute; National Centre of Scientific Research "Demokritos"; Pontificia Universidad Javeriana; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Irvine; McGill University	Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.	dfe20@medschl.cam.ac.uk	Diver, Ryan/AAG-3469-2019; Flyger, Henrik/AAM-6494-2021; Figueroa, Jonine/AFK-2752-2022; Dossus, Laure/AAW-9097-2021; Fasching, Peter A/ABH-9912-2020; van Asperen, Christi J/D-3970-2012; Huerta, José María/N-8654-2015; Schumacher, Fredrick/R-6043-2019; Guenel, Pascal/H-3728-2018; DEVILEE, PETER/ABR-2140-2022; Figueroa, Jonine/GWD-1322-2022; Nord, Silje/R-5212-2016; Ursin, Giske/U-6637-2017; Garcia-Closas, Montserrat/AAZ-6930-2021; Brinton, Louise A/G-7486-2015; Knight, Julia/R-5617-2019; Chan, Ching Wan/C-7606-2011; Brüning, Thomas/G-8120-2015; Reed, Malcolm Walter/AAG-9219-2020; Guenel, Pascal/AAS-7688-2021; Khaw, Kay-Tee/AAZ-3209-2021; Haviv, Izhak/E-3782-2015; Kraft, Peter/GQH-8448-2022; manoukian, siranoush/E-7132-2017; Gao, Yu/HGE-1937-2022; Arndt, Volker/B-4999-2014; /AAM-5330-2020; Matsuo, Keitaro/H-6758-2019; Taib, Nur Aishah Mohd/B-2370-2010; Yip, Cheng-Har/B-1909-2010; gao, yi/HCI-8298-2022; wildiers, hans/AAV-8158-2021; Brenner, Hermann/ABE-6383-2020; Teo, Soo-hwang/H-2353-2014; truong, therese/A-2837-2013; Arndt, Volker/AAI-7282-2020; Margolin, Sara/AAX-9034-2020; Brenner, Hermann/B-4627-2017; Bogdanova, Natalia V./Y-2205-2019; Turnbull, Clare/AAA-6596-2019; Helland, Åslaug/H-3910-2015; Andrulis, Irene L./E-7267-2013; wang, edwin/G-5372-2010; Knight, Julia/A-6843-2012; Zheng, Wei/O-3351-2013; Gao, Y./GWZ-3665-2022; Dörk, Thilo/J-8620-2012; Hein, Alexander/F-6999-2010; Michailidou, Kyriaki/ABD-5122-2020; Schmidt, Marjanka K/G-9058-2011; Li, Jingmei/I-2904-2012; Devilee, Peter/GXV-8005-2022; Shrubsole, Martha J/K-5052-2015; Liu, Jianjun/AAK-4989-2020; Pharoah, Paul/V-6658-2019; Lu, Wei/AAE-2921-2022; Muranen, Taru/AAC-8418-2019; Garcia-Closas, Montserrat/F-3871-2015; Van Den Berg, David J/G-8598-2017; Radice, Paolo/O-3119-2013; Chenevix-Trench, Georgia/AAV-2014-2020; Peterlongo, Paolo/Q-4717-2018; zhang, weihua/GXV-1334-2022; Huzarski, Tomasz/AAQ-2161-2021; Bowtell, David/H-1007-2016; Miller, Nicola/F-4009-2018; Gunter, Marc/AAP-8621-2020; Lambrechts, Diether/AAJ-3167-2020; Saunders, Christobel M/H-5779-2014; Figueroa, Jonine/AAG-1065-2022; Gonzalez-Neira, Anna/C-5791-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Jakubowska, Anna/O-8050-2014; Tischkowitz, Marc/O-4452-2018; Hartikainen, Jaana M/E-6256-2015; Hartman, Mikael/B-4324-2011; benitez, javier/H-5232-2015; Rahman, Nazneen/D-2802-2013	Diver, Ryan/0000-0002-5418-9000; Figueroa, Jonine/0000-0002-5100-623X; Dossus, Laure/0000-0003-2716-5748; Fasching, Peter A/0000-0003-4885-8471; van Asperen, Christi J/0000-0002-1436-7650; Huerta, José María/0000-0002-9637-3869; Schumacher, Fredrick/0000-0002-3073-7463; Guenel, Pascal/0000-0002-8359-518X; Figueroa, Jonine/0000-0002-5100-623X; Nord, Silje/0000-0002-3271-5356; Ursin, Giske/0000-0002-0835-9507; Garcia-Closas, Montserrat/0000-0003-1033-2650; Brinton, Louise A/0000-0003-3853-8562; Knight, Julia/0000-0002-7610-7635; Chan, Ching Wan/0000-0002-9250-1296; Brüning, Thomas/0000-0001-9560-5464; Reed, Malcolm Walter/0000-0001-7442-2132; Guenel, Pascal/0000-0002-8359-518X; Haviv, Izhak/0000-0002-0837-5005; manoukian, siranoush/0000-0002-6034-7562; Arndt, Volker/0000-0001-9320-8684; Matsuo, Keitaro/0000-0003-1761-6314; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Brenner, Hermann/0000-0002-6129-1572; truong, therese/0000-0002-2943-6786; Arndt, Volker/0000-0001-9320-8684; Brenner, Hermann/0000-0002-6129-1572; Helland, Åslaug/0000-0002-5520-0275; Zheng, Wei/0000-0003-1226-070X; Dörk, Thilo/0000-0002-9458-0282; Hein, Alexander/0000-0003-2601-3398; Michailidou, Kyriaki/0000-0001-7065-1237; Schmidt, Marjanka K/0000-0002-2228-429X; Li, Jingmei/0000-0001-8587-7511; Shrubsole, Martha J/0000-0002-5591-7575; Liu, Jianjun/0000-0002-3255-3019; Pharoah, Paul/0000-0001-8494-732X; Lu, Wei/0000-0002-4150-8674; Muranen, Taru/0000-0002-5895-1808; Garcia-Closas, Montserrat/0000-0003-1033-2650; Van Den Berg, David J/0000-0002-5404-5218; Radice, Paolo/0000-0001-6298-4111; Chenevix-Trench, Georgia/0000-0002-1878-2587; Peterlongo, Paolo/0000-0001-6951-6855; Huzarski, Tomasz/0000-0003-3857-4854; Bowtell, David/0000-0001-9089-7525; Miller, Nicola/0000-0002-5416-7047; Lambrechts, Diether/0000-0002-3429-302X; Saunders, Christobel M/0000-0003-2281-9829; Figueroa, Jonine/0000-0002-5100-623X; Gonzalez-Neira, Anna/0000-0002-5421-2020; Jakubowska, Anna/0000-0002-5650-0501; Tischkowitz, Marc/0000-0002-7880-0628; Hartikainen, Jaana M/0000-0001-8267-1905; Cross, Simon/0000-0003-2044-1754; PALLI, Domenico/0000-0002-5558-2437; Waisfisz, Quinten/0000-0002-7384-9182; Canzian, Federico/0000-0002-4261-4583; Hartman, Mikael/0000-0001-5726-9965; Durocher, Francine/0000-0001-8012-4641; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Kataja, Vesa/0000-0003-4846-4843; dos Santos Silva, Isabel/0000-0002-6596-8798; tumino, rosario/0000-0003-2666-414X; Hou, Ming-Feng/0000-0001-6030-9702; Cox, Angela/0000-0002-5138-1099; Bojesen, Stig/0000-0002-4061-4133; Margolin, Sara/0000-0002-5526-5570; Nordestgaard, Borge/0000-0002-1954-7220; Devilee, Peter/0000-0002-8023-2009; Kerin, Michael/0000-0003-4164-5561; Yannoukakos, Drakoulis/0000-0001-7509-3510; Surowy, Harald/0000-0002-3595-9188; Brand, Judith S./0000-0002-3720-1274; Fletcher, Olivia/0000-0001-9387-7116; Adlard, Julian/0000-0002-1693-0435; Simard, Jacques/0000-0001-6906-3390; Pylkas, Katri/0000-0002-2449-0521; Mulligan, Anna Marie/0000-0002-7239-5297; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Dunning, Alison Margaret/0000-0001-6651-7166; Beesley, Jonathan/0000-0003-1942-325X; Long, Jirong/0000-0002-7433-9766; van der Luijt, Rob/0000-0002-0018-1089; Schoemaker, Minouk/0000-0001-8403-2234; benitez, javier/0000-0002-0923-7202; Blomqvist, Carl/0000-0003-3041-1938; Lund, Eiliv/0000-0002-8071-8711; Hollestelle, Antoinette/0000-0003-1166-1966; Thorne, Heather/0000-0003-3610-2511; Labreche, France/0000-0001-8722-0433; Lubinski, Jan/0000-0003-2931-3003; Turnbull, Clare/0000-0002-1734-5772; Gunter, Marc/0000-0001-5472-6761; Khan, Sofia/0000-0003-4185-8882; eriksson, mikael/0000-0001-8135-4270; Lotz, Anne/0000-0002-8715-0743; Sawyer, Elinor/0000-0001-8285-4111; Brauch, Hiltrud/0000-0001-7531-2736; Evans, Gareth/0000-0002-8482-5784; Swerdlow, Anthony/0000-0001-5550-4159; Rahman, Nazneen/0000-0003-4376-0440; Ito, Hidemi/0000-0002-8023-4581; McLean, Catriona/0000-0002-0302-5727; Makalic, Enes/0000-0003-3017-0871; Pita, Guillermo/0000-0003-2393-0510; Southey, Melissa/0000-0002-6313-9005; Winqvist, Robert/0000-0003-0932-9104; Kang, Daehee/0000-0003-4031-5878	Cancer Research UK [C1287/A10118, C1287/A12014, C1287/A10710, C8197/A16565]; European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175) (COGS)]; European Union COST programme [BM0606]; European Union [HEALTH-F2-2009-223175]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program; Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative [1 U19 CA148065-01 (DRIVE, part of the GAME-ON initiative)]; Cancer Research UK [16565, 16563, 14136, 15106, 16561] Funding Source: researchfish; Medical Research Council [G0700491, MC_PC_14105, G1000143, G0401527] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51, NF-SI-0512-10114] Funding Source: researchfish; Cancer Foundation Finland sr [130168] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0700491, MC_PC_14105] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA176785, P30CA016056, P50CA116201, U01CA116167, ZIACP010126, R01CA148667, U19CA148065, R01CA092447, UM1CA164920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); European Community's Seventh Framework Programme(European Commission); European Union COST programme; European Union(European Commission); Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade of Quebec; US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; National Breast Cancer Foundation; The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	BCAC is funded by Cancer Research UK (C1287/A10118, C1287/A12014) and by the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS). Meetings of the BCAC have been funded by the European Union COST programme (BM0606). Genotyping on the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710, C8197/A16565), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program and the Ministry of Economic Development, Innovation and Export Trade of Quebec, grant PSR-SIIRI-701. Combination of the GWAS data was supported in part by the US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative, grant 1 U19 CA148065-01 (DRIVE, part of the GAME-ON initiative). For a full description of funding and acknowledgments, see the the Supplementary Note.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Ahsan H, 2014, CANCER EPIDEM BIOMAR, V23, P658, DOI 10.1158/1055-9965.EPI-13-0340; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim HY, 2013, MOL MED, V19, P253, DOI 10.2119/molmed.2011.00001; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Lin WY, 2015, HUM MOL GENET, V24, P285, DOI 10.1093/hmg/ddu431; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2014, HUM MOL GENET, V23, P6096, DOI 10.1093/hmg/ddu311; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Udler MS, 2010, GENET EPIDEMIOL, V34, P463, DOI 10.1002/gepi.20504; Wang ZH, 2013, NEOPLASIA, V15, P1028, DOI 10.1593/neo.13678; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	38	365	374	2	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					373	U127		10.1038/ng.3242	http://dx.doi.org/10.1038/ng.3242			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25751625	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000351922900013
J	Yu, HJ; Takeuchi, M; LeBarron, J; Kantharia, J; London, E; Bakker, H; Haltiwanger, RS; Li, HL; Takeuchi, H				Yu, Hongjun; Takeuchi, Megumi; LeBarron, Jamie; Kantharia, Joshua; London, Erwin; Bakker, Hans; Haltiwanger, Robert S.; Li, Huilin; Takeuchi, Hideyuki			Notch-modifying xylosyltransferase structures support an S(N)i-like retaining mechanism	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN O-GLUCOSYLTRANSFERASE; ENZYMATIC GLYCOSYL TRANSFER; FACTOR-LIKE DOMAIN; FACTOR-IX; GLYCOSYLTRANSFERASE; ALPHA; CONFIGURATION; TRYPTOPHAN; MUTATIONS; SUBSTRATE	A major question remaining in glycobiology is how a glycosyltransferase (GT) that retains the anomeric linkage of a sugar catalyzes the reaction. Xyloside alpha-1,3-xylosyltransferase (XXYLT1) is a retaining GT that regulates Notch receptor activation by adding xylose to the Notch extracellular domain. Here, using natural acceptor and donor substrates and active Mus musculus XXYLT1, we report a series of crystallographic snapshots along the reaction, including an unprecedented natural and competent Michaelis reaction complex for retaining enzymes. These structures strongly support the S(N)i-like reaction as the retaining mechanism for XXYLT1. Unexpectedly, the epidermal growth factor-like repeat acceptor substrate undergoes a large conformational change upon binding to the active site, providing a structural basis for substrate specificity. Our improved understanding of this retaining enzyme will accelerate the design of retaining GT inhibitors that can modulate Notch activity in pathological situations in which Notch dysregulation is known to cause cancer or developmental disorders.	[Yu, Hongjun; Li, Huilin] Brookhaven Natl Lab, Biosci Dept, Upton, NY 11973 USA; [Takeuchi, Megumi; Kantharia, Joshua; London, Erwin; Haltiwanger, Robert S.; Li, Huilin; Takeuchi, Hideyuki] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [LeBarron, Jamie] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Bakker, Hans] Hannover Med Sch, Dept Cellular Chem, Hannover, Germany	United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hannover Medical School	Yu, HJ (corresponding author), Brookhaven Natl Lab, Biosci Dept, Upton, NY 11973 USA.	hli@bnl.gov; takeuchi@uga.edu	Takeuchi, Hideyuki/AAZ-9210-2020; Bakker, Hans/AAA-1623-2020; Bakker, Hans/A-1787-2017	Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154; Li, Huilin/0000-0001-8085-8928; Yu, Hongjun/0000-0002-1483-2962	US National Institutes of Health [GM061126, AG029979]; Stony Brook University-Brookhaven National Laboratory Seed grant; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG) [BA4091/5-1]; National Science Foundation [DMR 1404985]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; US Department of Energy [DE-FG02-93ER20097]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029979] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Brook University-Brookhaven National Laboratory Seed grant; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Li and Haltiwanger labs for critical comments on this work. The work was supported by US National Institutes of Health grants GM061126 (R.S.H.) and AG029979 (H.L.), Stony Brook University-Brookhaven National Laboratory Seed grant (R.S.H. and H.L.), German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) grant BA4091/5-1 (H.B.) and National Science Foundation grant DMR 1404985 (E.L.). We acknowledge access to beamlines X25, X29 and X6A at the National Synchrotron Light Source (NSLS) and thank the staff at these beamlines. NSLS were supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-98CH10886. UDP-xylose isolation by the Carbosource Services at the Complex Carbohydrate Research Center, University of Georgia was supported in part by the US Department of Energy grant DE-FG02-93ER20097. The results published here are in part based upon data generated by the Cancer Genome Atlas Research Network (http://cancergenome.nih.gov/).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ardevol A, 2011, ANGEW CHEM INT EDIT, V50, P10897, DOI 10.1002/anie.201104623; Bram O, 2010, J PHYS CHEM A, V114, P9034, DOI 10.1021/jp101778u; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Gloster TM, 2012, NAT CHEM BIOL, V8, P683, DOI [10.1038/nchembio.1029, 10.1038/NCHEMBIO.1029]; Gomez H, 2012, J AM CHEM SOC, V134, P4743, DOI 10.1021/ja210490f; Hurtado-Guerrero R, 2012, CURR OPIN CHEM BIOL, V16, P479, DOI 10.1016/j.cbpa.2012.10.013; Jung K.-H., 2003, CARBOHYDRATE BASED D, V2, P609; Kitamura M, 2004, GLYCOCONJUGATE J, V21, P197, DOI 10.1023/B:GLYC.0000045092.37417.0f; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Lira-Navarrete E, 2014, ANGEW CHEM INT EDIT, V53, P8206, DOI 10.1002/anie.201402781; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Minamida S, 1996, J BIOCHEM-TOKYO, V120, P1002; NISHIMURA H, 1992, J BIOL CHEM, V267, P17520; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Schrodinger L., 2020, PYMOL; Schuman B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071077; Sethi MK, 2012, J BIOL CHEM, V287, P2739, DOI 10.1074/jbc.M111.302406; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005	47	43	44	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					847	U61		10.1038/nchembio.1927	http://dx.doi.org/10.1038/nchembio.1927			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26414444	Green Accepted, Green Submitted			2022-12-25	WOS:000363272100010
J	Cardaci, S; Zheng, L; MacKay, G; Van den Broek, NJF; MacKenzie, ED; Nixon, C; Stevenson, D; Tumanov, S; Bulusu, V; Kamphorst, JJ; Vazquez, A; Fleming, S; Schiavi, F; Kalna, G; Blyth, K; Strathdee, D; Gottlieb, E				Cardaci, Simone; Zheng, Liang; MacKay, Gillian; Van den Broek, Niels J. F.; MacKenzie, Elaine D.; Nixon, Colin; Stevenson, David; Tumanov, Sergey; Bulusu, Vinay; Kamphorst, Jurre J.; Vazquez, Alexei; Fleming, Stewart; Schiavi, Francesca; Kalna, Gabriela; Blyth, Karen; Strathdee, Douglas; Gottlieb, Eyal			Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis	NATURE CELL BIOLOGY			English	Article							GERMLINE MUTATIONS; CANCER-CELLS; SUCCINATE; CARCINOMA; FUMARATE; MOUSE; GENE; PHEOCHROMOCYTOMA; PARAGANGLIOMA; METABOLISM	Succinate dehydrogenase (SDH) is a heterotetrameric nuclear-encoded complex responsible for the oxidation of succinate to fumarate in the tricarboxylic acid cycle. Loss-of-function mutations in any of the SDH genes are associated with cancer formation. However, the impact of SDH loss on cell metabolism and the mechanisms enabling growth of SDH-defective cells are largely unknown. Here, we generated Sdhb-ablated kidney mouse cells and used comparative metabolomics and stable-isotope-labelling approaches to identify nutritional requirements and metabolic adaptations to SDH loss. We found that lack of SDH activity commits cells to consume extracellular pyruvate, which sustains Warburg-like bioenergetic features. We further demonstrated that pyruvate carboxylation diverts glucose-derived carbons into aspartate biosynthesis, thus sustaining cell growth. By identifying pyruvate carboxylase as essential for the proliferation and tumorigenic capacity of SDH-deficient cells, this study revealed a metabolic vulnerability for potential future treatment of SDH-associated malignancies.	[Cardaci, Simone; Zheng, Liang; MacKay, Gillian; Van den Broek, Niels J. F.; MacKenzie, Elaine D.; Nixon, Colin; Stevenson, David; Tumanov, Sergey; Bulusu, Vinay; Kamphorst, Jurre J.; Vazquez, Alexei; Kalna, Gabriela; Blyth, Karen; Strathdee, Douglas; Gottlieb, Eyal] Univ Glasgow, Beatson Inst, Canc Res UK, Glasgow G61 1BD, Lanark, Scotland; [Tumanov, Sergey; Bulusu, Vinay; Kamphorst, Jurre J.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland; [Fleming, Stewart] Univ Dundee, Ninewells Hosp, Dept Pathol, Dundee DD1 9SY, Scotland; [Schiavi, Francesca] Veneto Inst Oncol IRCCS, Familial Canc Clin, I-35128 Padua, Italy; [Schiavi, Francesca] Veneto Inst Oncol IRCCS, Oncoendocrinol, I-35128 Padua, Italy	Beatson Institute; Cancer Research UK; University of Glasgow; University of Glasgow; University of Dundee; IRCCS Istituto Oncologico Veneto (IOV); IRCCS Istituto Oncologico Veneto (IOV)	Gottlieb, E (corresponding author), Univ Glasgow, Beatson Inst, Canc Res UK, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010; Cardaci, Simone/J-2295-2018; Tumanov, Sergey/AAP-8003-2021; Schiavi, Francesca/AAB-9908-2022	Gottlieb, Eyal/0000-0002-9770-0956; Cardaci, Simone/0000-0002-5955-3422; Schiavi, Francesca/0000-0001-8529-4455; Tumanov, Sergey/0000-0002-0557-3153; Bulusu, Vinay/0000-0002-6006-8766; Blyth, Karen/0000-0002-9304-439X; Kamphorst, Jurre/0000-0002-2042-5474	Cancer Research UK; FEBS long-term fellowship; Cancer Research UK [17728, 18278, 22311] Funding Source: researchfish; Versus Arthritis [21140] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); FEBS long-term fellowship; Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis)	S.C. conceived the study, designed and carried out the experiments, the data and Wrote the manuscript; NZ. carried out the a antargeted metabolomic analysis; G.M., N.J.F.v.d.B. S.T., V.B., J.J.K. and A.V supervised the targeted LC-MS and GC-MS analyses; E.D.M. supervised the generation of kidney cells; D. Strathdee and D. Stevenson generated genetically modified Sdhb<SUP>fl/fl</SUP> mice; G.K. carried out the bioinformatics and statistical analyses; C.N. carried out immunohistochemistry of human SDHB-associated RCC; S.F. carried out histopathological analysis of SDHB-related RCC; F.S. collected and provided human paraganglioma and pheochromocytoma samples; K.B. supervised animal work; E.G. conceived and supervised BR study, in the data and rev sed the manuscript. All the as discussed the results and commented on the manuscript. This work was funded by Cancer Research UK. S.C. is the recipient of a FEBS long-term fellowship.	Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Gaude E, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-10; Gill AJ, 2011, NEW ENGL J MED, V364, P885, DOI 10.1056/NEJMc1012357; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Housley SL, 2010, HISTOPATHOLOGY, V56, P405, DOI 10.1111/j.1365-2559.2010.03482.x; Izquierdo-Garcia JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108289; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Mitra Kasturi, 2010, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0425s46; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Nagy A, 2003, MANIPULATING MOUSE E, P453; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; Ricketts CJ, 2012, J UROLOGY, V188, P2063, DOI 10.1016/j.juro.2012.08.030; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Williamson SR, 2015, MODERN PATHOL, V28, P80, DOI 10.1038/modpathol.2014.86; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yang C., 2013, PLOS ONE, V8; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001; Zheng L, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-12	42	169	176	5	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1317	+		10.1038/ncb3233	http://dx.doi.org/10.1038/ncb3233			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26302408	Green Accepted			2022-12-25	WOS:000362213500012
J	Xiao, L; Feng, Q; Liang, SS; Sonne, SB; Xia, ZK; Qiu, XM; Li, XP; Long, H; Zhang, JF; Zhang, DY; Liu, C; Fang, ZW; Chou, J; Glanville, J; Hao, Q; Kotowska, D; Colding, C; Licht, TR; Wu, DH; Yu, J; Sung, JJY; Liang, QY; Li, JH; Jia, HJ; Lan, Z; Tremaroli, V; Dworzynski, P; Nielsen, HB; Backhed, F; Dore, J; Le Chatelier, E; Ehrlich, SD; Lin, JC; Arumugam, M; Wang, J; Madsen, L; Kristiansen, K				Xiao, Liang; Feng, Qiang; Liang, Suisha; Sonne, Si Brask; Xia, Zhongkui; Qiu, Xinmin; Li, Xiaoping; Long, Hua; Zhang, Jianfeng; Zhang, Dongya; Liu, Chuan; Fang, Zhiwei; Chou, Joyce; Glanville, Jacob; Hao, Qin; Kotowska, Dorota; Colding, Camilla; Licht, Tine Rask; Wu, Donghai; Yu, Jun; Sung, Joseph Jao Yiu; Liang, Qiaoyi; Li, Junhua; Jia, Huijue; Lan, Zhou; Tremaroli, Valentina; Dworzynski, Piotr; Nielsen, H. Bjorn; Backhed, Fredrik; Dore, Joel; Le Chatelier, Emmanuelle; Ehrlich, S. Dusko; Lin, John C.; Arumugam, Manimozhiyan; Wang, Jun; Madsen, Lise; Kristiansen, Karsten			A catalog of the mouse gut metagenome	NATURE BIOTECHNOLOGY			English	Article							HIGH-FAT; MICROBIOTA; OBESITY; HOST; DIET; INFLAMMATION; ANNOTATION; GENERATION; HEALTH; IMPACT	We established a catalog of the mouse gut metagenome comprising similar to 2.6 million nonredundant genes by sequencing DNA from fecal samples of 184 mice. To secure high microbiome diversity, we used mouse strains of diverse genetic backgrounds, from different providers, kept in different housing laboratories and fed either a low-fat or high-fat diet. Similar to the human gut microbiome, >99% of the cataloged genes are bacterial. We identified 541 metagenomic species and defined a core set of 26 metagenomic species found in 95% of the mice. The mouse gut microbiome is functionally similar to its human counterpart, with 95.2% of its Kyoto Encyclopedia of Genes and Genomes (KEGG) orthologous groups in common. However, only 4.0% of the mouse gut microbial genes were shared (95% identity, 90% coverage) with those of the human gut microbiome. This catalog provides a useful reference for future studies.	[Xiao, Liang; Feng, Qiang; Liang, Suisha; Xia, Zhongkui; Qiu, Xinmin; Li, Xiaoping; Zhang, Jianfeng; Zhang, Dongya; Liu, Chuan; Fang, Zhiwei; Li, Junhua; Jia, Huijue; Lan, Zhou; Arumugam, Manimozhiyan; Madsen, Lise; Kristiansen, Karsten] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Feng, Qiang; Sonne, Si Brask; Hao, Qin; Kotowska, Dorota; Colding, Camilla; Wang, Jun; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Lab Genom & Mol Biomed, Dept Biol, Copenhagen, Denmark; [Long, Hua; Chou, Joyce; Glanville, Jacob; Lin, John C.] Pfizer Inc, Pfizer Expt Med, San Francisco, CA USA; [Colding, Camilla] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Yu, Jun; Sung, Joseph Jao Yiu; Liang, Qiaoyi] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun; Sung, Joseph Jao Yiu; Liang, Qiaoyi] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Li Ka Shing Inst Hlth Sci,Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China; [Tremaroli, Valentina; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Dworzynski, Piotr; Nielsen, H. Bjorn] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Backhed, Fredrik; Arumugam, Manimozhiyan] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Dore, Joel] Inst Natl Rech Agron Microbiol Aliment Serv Sante, Jouy En Josas, France; [Dore, Joel; Le Chatelier, Emmanuelle; Ehrlich, S. Dusko] INRA, Metagenopolis, Jouy En Josas, France; [Ehrlich, S. Dusko; Wang, Jun] Kings Coll London, Dent Inst Cent Off, Guys Hosp, Ctr Host Microbiome Interact, London, England; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway	Beijing Genomics Institute (BGI); University of Copenhagen; Pfizer; Technical University of Denmark; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Gothenburg; Technical University of Denmark; Novo Nordisk Foundation; University of Copenhagen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King Abdulaziz University; Macau University of Science & Technology	Kristiansen, K (corresponding author), Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.cn; Lise.Madsen@nifes.no; kk@bio.ku.dk	Backhed, Fredrik/ABE-6613-2020; Liang, Qiaoyi Jessie/G-9612-2019; Nielsen, Henrik/B-8961-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Kristiansen, Karsten/J-5148-2014; Li, Junhua/AAG-3919-2019; Jia, Huijue/M-3991-2015; Madsen, Lise/C-6246-2012; Yu, Jun/D-8569-2015; Ehrlich, S./Y-2423-2019; Sonne, Si Brask/A-4851-2012; Sung, Joseph J. Y./R-3203-2018; LE CHATELIER, Emmanuelle/O-1243-2017; Tremaroli, Valentina/AAE-8001-2019; Arumugam, Manimozhiyan/E-1211-2011; Dore, Joel/ABA-8921-2020; Xiao, Liang/L-5614-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Backhed, Fredrik/0000-0002-4871-8818; Liang, Qiaoyi Jessie/0000-0001-8496-3442; Nielsen, Henrik/0000-0003-2281-5713; Arumugam, Manimozhiyan/0000-0002-0886-9101; Kristiansen, Karsten/0000-0002-6024-0917; Li, Junhua/0000-0001-6784-1873; Jia, Huijue/0000-0002-3592-126X; Madsen, Lise/0000-0003-4468-1947; Yu, Jun/0000-0001-5008-2153; Ehrlich, S./0000-0002-7563-4046; Sonne, Si Brask/0000-0003-3194-3805; Sung, Joseph J. Y./0000-0003-3125-5199; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Tremaroli, Valentina/0000-0002-9150-4233; Arumugam, Manimozhiyan/0000-0002-0886-9101; Liu, Chuan/0000-0003-3716-7050; Colding-Christensen, Camilla Skettrup/0000-0003-2777-6725; Liang, Suisha/0000-0003-0426-9827; Xiao, Liang/0000-0003-0836-4397; Wang, Jun/0000-0002-8540-8931; Dworzynski, Piotr/0000-0002-6717-8052; Hao, Qin/0000-0002-6775-2181; Licht, Tine Rask/0000-0002-6399-9574; Wang, Jun/0000-0002-2113-5874	Danish Natural Science Research Foundation; Carlsberg Foundation; Danish Council for Strategic Research [11-116163]; National Basic Research Program of China (973 Program) [2013CB531400, 2011CB504004, 2010CB945500]; Shenzhen Municipal Government of China (the research and development of the novel personalized gut microbiota probiotic production) [CXZZ20150330171521403]; Theme-based Research Scheme of the Hong Kong Research Grants Council [T12-403-11]; Metagenopolis grant [ANR-11-DPBS-0001]; Knut and Alice Wallenberg Foundation; Swedish Research Council; Novo Nordisk foundation; Torsten Soderberg's foundation; ERC Consolidator Grant (European Research Council) [615362-METABASE]	Danish Natural Science Research Foundation(Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenzhen Municipal Government of China (the research and development of the novel personalized gut microbiota probiotic production); Theme-based Research Scheme of the Hong Kong Research Grants Council; Metagenopolis grant; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Torsten Soderberg's foundation; ERC Consolidator Grant (European Research Council)(European Research Council (ERC))	We thank the sequencing and bioinformatics staff at BGI-Shenzhen for help and advice. This study was supported by the Danish Natural Science Research Foundation, the Carlsberg Foundation, The Danish Council for Strategic Research (grant 11-116163), the National Basic Research Program of China (973 Program, 2013CB531400, 2011CB504004 and 2010CB945500), the Shenzhen Municipal Government of China (the research and development of the novel personalized gut microbiota probiotic production, CXZZ20150330171521403), Theme-based Research Scheme of the Hong Kong Research Grants Council (T12-403-11), the Metagenopolis grant (ANR-11-DPBS-0001), Knut and Alice Wallenberg Foundation, Swedish Research Council, the Novo Nordisk foundation, Torsten Soderberg's foundation. F.B. is a recipient of ERC Consolidator Grant (European Research Council, Consolidator grant 615362-METABASE).	Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lacombe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067497; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Patrone V, 2012, MICROBIOL-SGM, V158, P983, DOI 10.1099/mic.0.054247-0; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schwab C, 2014, ISME J, V8, P1101, DOI 10.1038/ismej.2013.223; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	46	272	281	5	172	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1103	+		10.1038/nbt.3353	http://dx.doi.org/10.1038/nbt.3353			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26414350				2022-12-25	WOS:000362555700032
J	Aminkeng, F; Bhavsar, AP; Visscher, H; Rassekh, SR; Li, YL; Lee, JW; Brunham, LR; Caron, HN; van Dalen, EC; Kremer, LC; van der Pal, HJ; Amstutz, U; Rieder, MJ; Bernstein, D; Carleton, BC; Hayden, MR; Ross, CJD				Aminkeng, Folefac; Bhavsar, Amit P.; Visscher, Henk; Rassekh, Shahrad R.; Li, Yuling; Lee, Jong W.; Brunham, Liam R.; Caron, Huib N.; van Dalen, Elvira C.; Kremer, Leontien C.; van der Pal, Helena J.; Amstutz, Ursula; Rieder, Michael J.; Bernstein, Daniel; Carleton, Bruce C.; Hayden, Michael R.; Ross, Colin J. D.		Canadian Pharmacogenomics Network	A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer	NATURE GENETICS			English	Article							TRANS-RETINOIC ACID; GENETIC POLYMORPHISMS; DOXORUBICIN THERAPY; HEART-FAILURE; HIGH-RISK; SURVIVORS; LEUKEMIA; ASSOCIATION; CHILDREN; VISUALIZATION	Anthracyclines are used in over 50% of childhood cancer treatment protocols(1), but their clinical usefulness is limited by anthracycline-induced cardiotoxicity (ACT) manifesting as asymptomatic cardiac dysfunction and congestive heart failure in up to 57% and 16% of patients, respectively(2,3). Candidate gene studies have reported genetic associations with ACT(4-22), but these studies have in general lacked robust patient numbers, independent replication or functional validation. Thus, the individual variability in ACT susceptibility remains largely unexplained(12,13). We performed a genome-wide association study in 280 patients of European ancestry treated for childhood cancer, with independent replication in similarly treated cohorts of 96 European and 80 non-European patients. We identified a nonsynonymous variant (rs2229774, p.Ser427Leu) in RARG highly associated with ACT (P = 5.9 x 10(-8), odds ratio (95% confidence interval) = 4.7 (2.7-8.3)). This variant alters RARG function, leading to derepression of the key ACT genetic determinant Top2b, and provides new insight into the pathophysiology of this severe adverse drug reaction.	[Aminkeng, Folefac; Visscher, Henk; Lee, Jong W.; Hayden, Michael R.; Ross, Colin J. D.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [Aminkeng, Folefac; Bhavsar, Amit P.; Rassekh, Shahrad R.; Li, Yuling; Lee, Jong W.; Amstutz, Ursula; Carleton, Bruce C.; Hayden, Michael R.; Ross, Colin J. D.] Child & Family Res Inst, Vancouver, BC, Canada; [Bhavsar, Amit P.; Li, Yuling; Amstutz, Ursula; Carleton, Bruce C.; Ross, Colin J. D.] Univ British Columbia, Dept Pediat, Div Translat Therapeut, Vancouver, BC V6T 1W5, Canada; [Visscher, Henk] Radboud Univ Nijmegen, Med Ctr, Amalia Childrens Hosp, Dept Pediat, NL-6525 ED Nijmegen, Netherlands; [Rassekh, Shahrad R.] Univ British Columbia, Dept Pediat, Div Pediat Hematol Oncol Blood & Marrow Transplan, Vancouver, BC V6T 1W5, Canada; [Brunham, Liam R.; Hayden, Michael R.] Natl Univ Singapore, Translat Lab Genet Med, Singapore 117548, Singapore; [Brunham, Liam R.; Hayden, Michael R.] ASTAR, Singapore, Singapore; [Caron, Huib N.; van Dalen, Elvira C.; Kremer, Leontien C.; van der Pal, Helena J.] Emma Childrens Hosp, Dept Pediat Oncol, Acad Med Ctr, Amsterdam, Netherlands; [van der Pal, Helena J.] Emma Childrens Hosp, Dept Med Oncol, Acad Med Ctr, Amsterdam, Netherlands; [Rieder, Michael J.] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Bernstein, Daniel] Stanford Univ, Div Pediat Cardiol, Palo Alto, CA 94304 USA; [Carleton, Bruce C.; Ross, Colin J. D.] British Columbia Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC V6H 3V4, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia; Radboud University Nijmegen; University of British Columbia; National University of Singapore; Agency for Science Technology & Research (A*STAR); Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Western University (University of Western Ontario); Stanford University; BC Childrens Hospital; University of British Columbia	Ross, CJD (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada.	colin.ross@ubc.ca	Amstutz, Ursula/J-4179-2014; Hayden, Michael R/D-8581-2011; Rieder, Michael J/L-2397-2013; GARCIA-BOURNISSEN, FACUNDO/E-8286-2015; Rassekh, Shahrad Rod/G-5301-2010	Amstutz, Ursula/0000-0002-0880-456X; Hayden, Michael R/0000-0001-5159-1419; GARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X; Rassekh, Shahrad Rod/0000-0001-8005-2641; Kowalec, Kaarina/0000-0003-3928-9879; Bhavsar, Amit/0000-0003-3336-9288; kremer, leontien/0000-0002-7619-7845; Ross, Colin/0000-0003-1476-7037; Bernstein, Daniel/0000-0001-7761-5853; Carleton, Bruce/0000-0002-4485-4054; Visscher, Henk/0000-0001-8407-2893; Aminkeng, Folefac/0000-0001-8916-9758; Kremer, Leontien/0000-0001-7422-3248	Canadian Institutes of Health Research (CIHR) [FRN-88362]; CIHR Drug Safety and Effectiveness Network [FRN-117588]; US National Institutes of Health [1R21HL123655-01, HL123655]; Stanford Comprehensive Cancer Center Translation Research Grant; Child & Family Research Institute (Vancouver, British Columbia, Canada); Michael Smith Foundation for Health Research; CIHR Training Program in Bridging Scientific Domains for Drug Safety and Effectiveness-DSECT program; Canada Foundation for Innovation, Genome British Columbia; Provincial Health Service Authority; Faculty of Medicine of the University of British Columbia; Canadian Gene Cure Foundation; C17 Research Network; Childhood Cancer Foundation-Candlelighters Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL123655, R21HL123655] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Drug Safety and Effectiveness Network(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Comprehensive Cancer Center Translation Research Grant; Child & Family Research Institute (Vancouver, British Columbia, Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR Training Program in Bridging Scientific Domains for Drug Safety and Effectiveness-DSECT program; Canada Foundation for Innovation, Genome British Columbia; Provincial Health Service Authority; Faculty of Medicine of the University of British Columbia; Canadian Gene Cure Foundation; C17 Research Network; Childhood Cancer Foundation-Candlelighters Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the participation of all the patients and families who took part in this study across Canada, the Netherlands and the United States. This work was supported by the Canadian Institutes of Health Research (CIHR; FRN-88362 to B.C.C., M.R.H. and C.J.D.R.), the CIHR Drug Safety and Effectiveness Network (FRN-117588 to B.C.C. and C.J.D.R.), the US National Institutes of Health (1R21HL123655-01 and HL123655 to D.B., B.C.C. and C.J.D.R.), a Stanford Comprehensive Cancer Center Translation Research Grant (to D.B.), the Child & Family Research Institute (Vancouver, British Columbia, Canada; Bertram Hoffmeister Postdoctoral Fellowship Award for F.A.), the Michael Smith Foundation for Health Research (Postdoctoral Fellowship Award for F.A.), the CIHR Training Program in Bridging Scientific Domains for Drug Safety and Effectiveness-DSECT program (Postdoctoral Fellowship Award for F.A.), the Canada Foundation for Innovation, Genome British Columbia and the Provincial Health Service Authority. Additional funding was provided by the Child & Family Research Institute (Vancouver, British Columbia, Canada), the Faculty of Medicine of the University of British Columbia, the Canadian Gene Cure Foundation, the C17 Research Network and the Childhood Cancer Foundation-Candlelighters Canada.	Agarwala S, 2000, J PEDIATR SURG, V35, P1786, DOI 10.1053/jpsu.2000.19253; Altman A.J., 2004, SUPPORTIVE CARE CHIL, P139; Arima K, 2005, DEV DYNAM, V232, P414, DOI 10.1002/dvdy.20231; Armenian SH, 2013, BRIT J HAEMATOL, V163, P205, DOI 10.1111/bjh.12516; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barry E, 2007, EXPERT OPIN PHARMACO, V8, P1039, DOI 10.1517/14656566.8.8.1039; Bilbija D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044740; Blanco JG, 2008, CANCER-AM CANCER SOC, V112, P2789, DOI 10.1002/cncr.23534; Blanco JG, 2012, J CLIN ONCOL, V30, P1415, DOI 10.1200/JCO.2011.34.8987; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cascales A, 2013, ONCOLOGIST, V18, P446, DOI 10.1634/theoncologist.2012-0239; Cascales A, 2012, INT J CARDIOL, V154, P282, DOI 10.1016/j.ijcard.2010.09.046; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duan SW, 2007, CANCER RES, V67, P5425, DOI 10.1158/0008-5472.CAN-06-4431; Hasan S, 2004, J NATL MED ASSOC, V96, P196; Hershman D, 2005, J CLIN ONCOL, V23, P6639, DOI 10.1200/JCO.2005.12.633; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Krischer JP, 1997, J CLIN ONCOL, V15, P1544, DOI 10.1200/JCO.1997.15.4.1544; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; Lipshultz SE, 2013, CANCER-AM CANCER SOC, V119, P3555, DOI 10.1002/cncr.28256; Lubieniecka Joanna M., 2013, Frontiers in Genetics, V4, P231, DOI 10.3389/fgene.2013.00231; Lubieniecka JM, 2012, CANCER EPIDEM BIOMAR, V21, P2118, DOI 10.1158/1055-9965.EPI-12-1037; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Nelson MR, 2009, PHARMACOGENOMICS J, V9, P23, DOI 10.1038/tpj.2008.4; Ortega JJ, 2005, J CLIN ONCOL, V23, P7632, DOI 10.1200/JCO.2005.01.3359; Palm-Leis A, 2004, J BIOL CHEM, V279, P54905, DOI 10.1074/jbc.M407383200; Pellicori Pierpaolo, 2012, Congest Heart Fail, V18, P217, DOI 10.1111/j.1751-7133.2011.00278.x; Peters EJ, 2011, PHARMACOGENOMICS, V12, P1407, DOI [10.2217/PGS.11.92, 10.2217/pgs.11.92]; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rajic V, 2009, LEUKEMIA LYMPHOMA, V50, P1693, DOI 10.3109/10428190903177212; RODVOLD KA, 1988, J CLIN ONCOL, V6, P1321, DOI 10.1200/JCO.1988.6.8.1321; Rossi D, 2009, LEUKEMIA, V23, P1118, DOI 10.1038/leu.2008.398; Sachidanandam Kamakshi, 2013, J Oncol Pharm Pract, V19, P269, DOI 10.1177/1078155212461022; Semsei AF, 2012, CELL BIOL INT, V36, P79, DOI 10.1042/CBI20110264; Shaikh AS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003663; Simandi Z, 2010, FEBS LETT, V584, P3123, DOI 10.1016/j.febslet.2010.05.052; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Visscher H, 2013, PEDIATR BLOOD CANCER, V60, P1375, DOI 10.1002/pbc.24505; Visscher H, 2009, PHARMACOGENOMICS J, V9, P362, DOI 10.1038/tpj.2009.36; Visscher H., PHARMACOGENOMICS; Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467; Vivenza D, 2013, INT J BIOL MARKER, V28, pE336, DOI [10.5301/JBM.5000041, 10.5301/jbm.5000041]; Volkan-Salanci B, 2012, J CHEMOTHERAPY, V24, P285, DOI 10.1179/1973947812Y.0000000037; Wang XX, 2014, J CLIN ONCOL, V32, P647, DOI 10.1200/JCO.2013.50.3557; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Windsor RE, 2012, CANCER-AM CANCER SOC, V118, P1856, DOI 10.1002/cncr.26472; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	59	155	159	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1079	+		10.1038/ng.3374	http://dx.doi.org/10.1038/ng.3374			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26237429	Green Accepted			2022-12-25	WOS:000360394100020
J	Jiang, YH; Qian, X; Shen, JF; Wang, YG; Li, XJ; Liu, R; Xia, Y; Chen, QM; Peng, G; Lin, SY; Lu, ZM				Jiang, Yuhui; Qian, Xu; Shen, Jianfeng; Wang, Yugang; Li, Xinjian; Liu, Rui; Xia, Yan; Chen, Qianming; Peng, Guang; Lin, Shiaw-Yih; Lu, Zhimin			Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; DAMAGE; METHYLATION; PROGRESSION; ACTIVATION; HYDRATASE; 53BP1; H2A.Z	Histone methylation regulates DNA repair. However, the mechanisms that underlie the regulation of histone methylation during this repair remain to be further defined. Here, we show that exposure to ionizing radiation induces DNA-PK-dependent phosphorylation of nuclear fumarase at Thr 236, which leads to an interaction between fumarase and the histone variant H2A.Z at DNA double-strand break (DSB) regions. Locally generated fumarate inhibits KDM2B histone demethylase activity, resulting in enhanced dimethylation of histone H3 Lys 36; in turn, this increases the accumulation of the Ku70-containing DNA-PK at DSB regions for non-homologous end-joining DNA repair and cell survival. These findings reveal a feedback mechanism that underlies DNA-PK regulation by chromatin-associated fumarase and an instrumental function of fumarase in regulating histone H3 methylation and DNA repair.	[Jiang, Yuhui; Qian, Xu; Wang, Yugang; Li, Xinjian; Liu, Rui; Xia, Yan; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Jiang, Yuhui; Qian, Xu; Wang, Yugang; Li, Xinjian; Liu, Rui; Xia, Yan; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Jiang, Yuhui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Canc,Inst Cell Metab, Shanghai 200080, Peoples R China; [Shen, Jianfeng; Peng, Guang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Liu, Rui; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China; [Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Sichuan University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	Zhiminlu@mdanderson.org		Jiang, Yuhui/0000-0001-6165-4524	National Cancer Institute [2R01CA109035, 1R0CA169603]; National Institute of Neurological Disorders and Stroke [1R01NS089754]; MD Anderson Cancer Center Support [CA016672]; Janus S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award [220020318, 2P50CA127001]; Sister Institution Network Fund from The University of Texas MD Anderson Cancer Center; Oclyssey Fellowship Dom MD Anderson; NATIONAL CANCER INSTITUTE [R01CA169603, R01CA109035, P30CA016672, P50CA127001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089754] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MD Anderson Cancer Center Support; Janus S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award; Sister Institution Network Fund from The University of Texas MD Anderson Cancer Center; Oclyssey Fellowship Dom MD Anderson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Hawke, B.-F Pan and M.B Hossain at MD Anderson tor their technical assistance and A. Sutton tor her critical reading of this manuscript. This work was supported by National Cancer Institute grants 2R01CA109035 (Z.L.) and 1R0CA169603 (Z.L.), National Institute of Neurological Disorders and Stroke grant 1R01NS089754 (Z.L.), the MD Anderson Cancer Center Support Grant CA016672, Janus S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award 220020318 (Z.L.), 2P50CA127001 (Brain Cancer SPORE), a Sister Institution Network Fund from The University of Texas MD Anderson Cancer Center (Z.L.), and the Oclyssey Fellowship Dom MD Anderson (Y.J). Z.L. is a R. E. Rutherford Distinguished Professor.	Adam J, 2013, CELL REP, V3, P1440, DOI 10.1016/j.celrep.2013.04.006; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Gibson BA, 2011, MOL CELL, V41, P497, DOI 10.1016/j.molcel.2011.02.019; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6566; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lu ZM, 2012, CELL CYCLE, V11, P4101, DOI 10.4161/cc.22325; Lu ZM, 2012, CHIN J CANCER, V31, P5, DOI 10.5732/cjc.011.10446; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; O'Flaherty L, 2010, HUM MOL GENET, V19, P3844, DOI 10.1093/hmg/ddq305; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu Y, 2012, MOL CELL, V48, P723, DOI 10.1016/j.molcel.2012.09.026; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328	30	117	118	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1158	+		10.1038/ncb3209	http://dx.doi.org/10.1038/ncb3209			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26237645	Green Accepted			2022-12-25	WOS:000361113700009
J	Krauthammer, M; Kong, Y; Bacchiocchi, A; Evans, P; Pornputtapong, N; Wu, C; McCusker, JP; Ma, SG; Cheng, E; Straub, R; Serin, M; Bosenberg, M; Ariyan, S; Narayan, D; Sznol, M; Kluger, HM; Mane, S; Schlessinger, J; Lifton, RP; Halaban, R				Krauthammer, Michael; Kong, Yong; Bacchiocchi, Antonella; Evans, Perry; Pornputtapong, Natapol; Wu, Cen; McCusker, James P.; Ma, Shuangge; Cheng, Elaine; Straub, Robert; Serin, Merdan; Bosenberg, Marcus; Ariyan, Stephan; Narayan, Deepak; Sznol, Mario; Kluger, Harriet M.; Mane, Shrikant; Schlessinger, Joseph; Lifton, Richard P.; Halaban, Ruth			Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas	NATURE GENETICS			English	Article							TERT PROMOTER MUTATIONS; AU-LAIT SPOTS; NOONAN-SYNDROME; CUTANEOUS MELANOMA; NEUROFIBROMATOSIS TYPE-1; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; PTPN11 MUTATIONS; LEGIUS SYNDROME; RAF INHIBITION	We report on whole-exome sequencing (WES) of 213 melanomas. Our analysis established NF1, encoding a negative regulator of RAS, as the third most frequently mutated gene in melanoma, after BRAF and NRAS. Inactivating NF1 mutations were present in 46% of melanomas expressing wild-type BRAF and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2. Functional studies showed that NF1 suppression led to increased RAS activation in most, but not all, melanoma cases. In addition, loss of NF1 did not predict sensitivity to MEK or ERK inhibitors. The rebound pathway, as seen by the induction of phosphorylated MEK, occurred in cells both sensitive and resistant to the studied drugs. We conclude that NF1 is a key tumor suppressor lost in melanomas, and that concurrent RASopathy gene mutations may enhance its role in melanomagenesis.	[Krauthammer, Michael; Evans, Perry] Yale Univ, Sch Med, Program Computat Biol & Bioinformat, New Haven, CT USA; [Krauthammer, Michael; Pornputtapong, Natapol; McCusker, James P.; Bosenberg, Marcus] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kong, Yong] Yale Univ, Sch Med, Mol Biophys & Biochem, New Haven, CT USA; [Bacchiocchi, Antonella; Cheng, Elaine; Straub, Robert; Serin, Merdan; Bosenberg, Marcus; Halaban, Ruth] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Wu, Cen; Ma, Shuangge] Yale Univ, Sch Med, Sch Publ Hlth, New Haven, CT USA; [Ariyan, Stephan; Narayan, Deepak] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Sznol, Mario; Kluger, Harriet M.] Yale Univ, Sch Med, Ctr Comprehens Canc, Sect Med Oncol, New Haven, CT 06510 USA; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Mane, Shrikant; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Schlessinger, Joseph] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Halaban, R (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	michael.krauthammer@yale.edu; ruth.halaban@yale.edu	Kong, Yong/B-5105-2014; serin, merdan/AAP-5073-2021; Pornputtapong, Natapol/B-2335-2017	Kong, Yong/0000-0002-2881-5274; Pornputtapong, Natapol/0000-0002-3833-0537; McCusker, Jamie/0000-0003-1085-6059; Sznol, Mario/0000-0002-4359-8749; Krauthammer, Michael/0000-0002-4808-1845	Yale SPORE in Skin Cancer; National Cancer Institute, US National Institutes of Health [1 P50 CA121974]; Melanoma Research Alliance; Gilead Sciences, Inc.; Howard Hughes Medical Institute; Department of Dermatology; Yale Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER	Yale SPORE in Skin Cancer; National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance; Gilead Sciences, Inc.(Gilead Sciences); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Dermatology; Yale Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the Yale SPORE in Skin Cancer, funded by the National Cancer Institute, US National Institutes of Health, under award number 1 P50 CA121974 (R.H.); the Melanoma Research Alliance (Team award to R.H., M.B. and M.K.); Gilead Sciences, Inc. (J.S. and R.H.); the Howard Hughes Medical Institute (R.P.L.); the Department of Dermatology; and the Yale Comprehensive Cancer Center. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brems H, 2012, HUM MUTAT, V33, P1538, DOI 10.1002/humu.22152; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen PC, 2014, P NATL ACAD SCI USA, V111, P11473, DOI 10.1073/pnas.1324128111; Chou CH, 2012, CELL CYCLE, V11, P532, DOI 10.4161/cc.11.3.19051; Davis MJ, 2013, P NATL ACAD SCI USA, V110, P912, DOI 10.1073/pnas.1220895110; De Schepper S, 2008, J INVEST DERMATOL, V128, P1050, DOI 10.1038/sj.jid.5701095; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dong L, 2014, ONCOGENE, V33, P4756, DOI 10.1038/onc.2013.420; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Gallino G, 2000, TUMORI J, V86, P70, DOI 10.1177/030089160008600113; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Gold HL, 2014, MOL CANCER RES, V12, P433, DOI 10.1158/1541-7786.MCR-13-0422; Guen VJ, 2013, P NATL ACAD SCI USA, V110, P19525, DOI 10.1073/pnas.1306814110; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hammond D, 2013, J CELL SCI, V126, P3429, DOI 10.1242/jcs.128397; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Ji ZY, 2012, TRENDS MOL MED, V18, P27, DOI 10.1016/j.molmed.2011.08.001; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; Ko JM, 2008, J HUM GENET, V53, P999, DOI 10.1007/s10038-008-0343-6; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lepri F, 2011, HUM MUTAT, V32, P760, DOI 10.1002/humu.21492; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Marees T, 2009, EUR J CANCER, V45, P3245, DOI 10.1016/j.ejca.2009.05.011; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; McHugh JB, 2007, J CUTAN PATHOL, V34, P597, DOI 10.1111/j.1600-0560.2006.00678.x; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Nystrom AM, 2009, ACTA PAEDIATR, V98, P693, DOI 10.1111/j.1651-2227.2008.01170.x; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Prada CE, 2011, AM J MED GENET A, V155A, P1360, DOI 10.1002/ajmg.a.33996; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Ranzani M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12316; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Seminog OO, 2013, BRIT J CANCER, V108, P193, DOI 10.1038/bjc.2012.535; Shibuya M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009092; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stites EC, 2015, CELL REP, V10, P307, DOI 10.1016/j.celrep.2014.12.035; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Thiel C, 2009, AM J MED GENET A, V149A, P1263, DOI 10.1002/ajmg.a.32837; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Wu Q, 2013, CELL REP, V5, P637, DOI 10.1016/j.celrep.2013.10.006; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	66	234	240	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					996	+		10.1038/ng.3361	http://dx.doi.org/10.1038/ng.3361			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26214590	Green Accepted			2022-12-25	WOS:000360394100009
J	Wang, QA; Tao, C; Jiang, L; Shao, ML; Ye, RS; Zhu, Y; Gordillo, R; Ali, A; Lian, Y; Holland, WL; Gupta, RK; Scherer, PE				Wang, Qiong A.; Tao, Caroline; Jiang, Lei; Shao, Mengle; Ye, Risheng; Zhu, Yi; Gordillo, Ruth; Ali, Aktar; Lian, Yun; Holland, William L.; Gupta, Rana K.; Scherer, Philipp E.			Distinct regulatory mechanisms governing embryonic versus adult adipocyte maturation	NATURE CELL BIOLOGY			English	Article							ACTIVATED RECEPTOR-GAMMA; CCAAT/ENHANCER-BINDING-PROTEIN; ADIPONECTIN GENE-EXPRESSION; PPAR-GAMMA; INSULIN-RESISTANCE; C/EBP-ALPHA; ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; PRECURSOR CELLS; FAT	Pathological expansion of adipose tissue contributes to the metabolic syndrome. Distinct depots develop at various times under different physiological conditions. The transcriptional cascade mediating adipogenesis is established in vitro, and centres around a core program involving PPAR gamma and C/EBP alpha. We developed an inducible, adipocyte-specific knockout system to probe the requirement of key adipogenic transcription factors at various stages of adipogenesis in vivo. C/EBP alpha is essential for all white adipogenic conditions in the adult stage, such as adipose tissue regeneration, adipogenesis in muscle and unhealthy expansion of white adipose tissue during high-fat feeding or due to leptin deficiency. Surprisingly, terminal embryonic adipogenesis is fully C/EBP alpha independent, but does however depend on PPAR gamma; cold-induced beige adipogenesis is also C/EBP alpha independent. Moreover, C/EBP alpha is not vital for adipocyte survival in the adult stage. We reveal a surprising diversity of transcriptional signals required at different stages of adipogenesis in vivo.	[Wang, Qiong A.; Tao, Caroline; Shao, Mengle; Ye, Risheng; Zhu, Yi; Gordillo, Ruth; Ali, Aktar; Holland, William L.; Gupta, Rana K.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Jiang, Lei] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Zhu, Yi] Lilly Res Labs, LIFA Diabet, Indianapolis, IN 46285 USA; [Lian, Yun] Univ Texas SW Med Ctr Dallas, Ctr Immunol, Dallas, TX 75390 USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Eli Lilly; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	Philipp.Scherer@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; Shao, Mengle/AAH-8392-2019; Gupta, Rana/R-3051-2019	Scherer, Philipp E/0000-0003-0680-3392; Shao, Mengle/0000-0002-5488-9904; Gupta, Rana/0000-0002-9001-4531; Gordillo, Ruth/0000-0001-6533-2493; Wang, Qiong/0000-0003-2224-4287	US National Institutes of Health (NIH) [R01-DK55758, P01-DK088761, R01-DK099110]; American Diabetes Association [7-11-MN-47]; NIH [R01-DK104789, R03-DK099128]; Searle Scholars Program (Chicago, IL); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055758, P01DK088761, R01DK099110, R01DK104789, R00DK094973, R03DK099428] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program (Chicago, IL); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the UT Southwestern Histology Core for assistance in embedding and processing of tissue samples. We would also like to thank Shimadzu Scientific Instruments for the collaborative effort and advice on the mass spectrometric instrumentation side. This study seas supported by US National Institutes of Health (NIH) grants R01-DK55758, P01-DK088761 and R01-DK099110 (P.E.S.). Q.A.W is supported by a postdoctoral fellowship from the American Diabetes Association (7-11-MN-47). R.K.G. is supported by NIH grants R01-DK104789 and R03-DK099128 and the Searle Scholars Program (Chicago, IL).	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Chatterjee R, 2011, J MOL ENDOCRINOL, V46, P175, DOI 10.1530/JME-10-0172; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Lukjanenko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071084; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wang QO, 2010, J LIPID RES, V51, P2516, DOI 10.1194/jlr.M003335; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang QA, 2014, J LIPID RES, V55, P605, DOI 10.1194/jlr.R046441; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Ye RS, 2014, ELIFE, V3, DOI 10.7554/eLife.03851; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	61	92	92	1	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2015	17	9					1099	+		10.1038/ncb3217	http://dx.doi.org/10.1038/ncb3217			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CR1VQ	26280538	Green Accepted			2022-12-25	WOS:000361113700004
J	Santos-Cortez, RLP; Chiong, CM; Reyes-Quintos, MRT; Tantoco, MLC; Wang, X; Acharya, A; Abbe, I; Giese, AP; Smith, JD; Allen, EK; Li, B; Cutiongco-de la Paz, EM; Garcia, MC; Llanes, EGDV; Labra, PJ; Gloria-Cruz, TLI; Chan, AL; Wang, GT; Daly, KA; Shendure, J; Bamshad, MJ; Nickerson, DA; Patel, JA; Riazuddin, S; Sale, MM; Chonmaitree, T; Ahmed, ZM; Abes, GT; Leal, SM				Santos-Cortez, Regie Lyn P.; Chiong, Charlotte M.; Reyes-Quintos, Ma Rina T.; Tantoco, Ma Leah C.; Wang, Xin; Acharya, Anushree; Abbe, Izoduwa; Giese, Arnaud P.; Smith, Joshua D.; Allen, E. Kaitlynn; Li, Biao; Maria Cutiongco-de la Paz, Eva; Garcia, Marieflor Cristy; Llanes, Erasmo Gonzalo D. V.; Labra, Patrick John; Gloria-Cruz, Teresa Luisa I.; Chan, Abner L.; Wang, Gao T.; Daly, Kathleen A.; Shendure, Jay; Bamshad, Michael J.; Nickerson, Deborah A.; Patel, Janak A.; Riazuddin, Saima; Sale, Michele M.; Chonmaitree, Tasnee; Ahmed, Zubair M.; Abes, Generoso T.; Leal, Suzanne M.		Univ Washington Ctr Mendelian Geno	Rare A2ML1 variants confer susceptibility to otitis media	NATURE GENETICS			English	Article							ASSOCIATION; MUTATIONS; FRAMEWORK; EFFUSION; CHILDREN; PROTEIN	A duplication variant within the middle ear-specific gene A2ML1 cosegregates with otitis media in an indigenous Filipino pedigree (LOD score = 7.5 at reduced penetrance) and lies within a founder haplotype that is also shared by 3 otitisprone European-American and Hispanic-American children but is absent in non-otitis-prone children and >62,000 next-generation sequences. We identified seven additional A2ML1 variants in six otitis-prone children. Collectively, our studies support a role for A2ML1 in the pathophysiology of otitis media.	[Santos-Cortez, Regie Lyn P.; Wang, Xin; Acharya, Anushree; Abbe, Izoduwa; Li, Biao; Wang, Gao T.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Chiong, Charlotte M.; Reyes-Quintos, Ma Rina T.; Tantoco, Ma Leah C.; Llanes, Erasmo Gonzalo D. V.; Gloria-Cruz, Teresa Luisa I.; Chan, Abner L.; Abes, Generoso T.] Univ Philippines, Philippine Natl Ear Inst, NIH, Manila, Philippines; [Chiong, Charlotte M.; Reyes-Quintos, Ma Rina T.; Garcia, Marieflor Cristy; Llanes, Erasmo Gonzalo D. V.; Labra, Patrick John; Gloria-Cruz, Teresa Luisa I.; Chan, Abner L.; Abes, Generoso T.] Univ Philippines, Coll Med, Philippine Gen Hosp, Dept Otorhinolaryngol, Manila, Philippines; [Giese, Arnaud P.; Riazuddin, Saima; Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Smith, Joshua D.; Shendure, Jay; Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Allen, E. Kaitlynn; Sale, Michele M.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Sale, Michele M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Maria Cutiongco-de la Paz, Eva] Univ Philippines, Inst Human Genet, NIH, Manila, Philippines; [Maria Cutiongco-de la Paz, Eva] Univ Philippines, Coll Med, Philippine Gen Hosp, Dept Pediat, Manila, Philippines; [Daly, Kathleen A.] Univ Minnesota, Dept Otolaryngol Head & Neck Surg, Minneapolis, MN USA; [Patel, Janak A.] Univ Texas Med Branch, Dept Pediat, Div Pediat Infect Dis & Immunol, Galveston, TX 77555 USA; [Sale, Michele M.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA	Baylor College of Medicine; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of Virginia; University of Virginia; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Medical Branch Galveston; University of Virginia	Santos-Cortez, RLP (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA.	santosco@bcm.edu	Shendure, Jay/AAU-3684-2021; Stumvoll, Michael/ABE-1121-2021; Giese, Arnaud P.J./P-1683-2019; ACHARYA, ANUSHREE/AAU-4739-2021; Acharya, Anushree/AAY-2391-2021	Stumvoll, Michael/0000-0001-6225-8240; Giese, Arnaud/0000-0001-7228-9542	Hearing Health Foundation; Action On Hearing Loss; National Organization for Hearing Research Foundation; University of the Philippines Manila-National Institutes of Health; US National Institutes of Health [U54 HG006493, R01 DK084350, R01 DC003166, R01 DC005841, R01 DC011803, R01 DC012564, R01 DC011651, R01 DC003594]; RNID [F27] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003594, R01DC011651, R01DC003166, R01DC012564, R01DC011803, R01DC005841] Funding Source: NIH RePORTER	Hearing Health Foundation; Action On Hearing Loss; National Organization for Hearing Research Foundation; University of the Philippines Manila-National Institutes of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RNID; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are very grateful to the indigenous community, families and individuals who participated in this study. We also thank M. Pedro, S.M. Lagrana, V. Ostan, and the surgical residents and audiology students who assisted in data collection and J. Belmont and S. Lalani for overall support. This study was supported by the Hearing Health Foundation, Action On Hearing Loss and the National Organization for Hearing Research Foundation (to R.L.P.S.-C.); the University of the Philippines Manila-National Institutes of Health (to G.T.A. and R.L.P.S.-C.); and US National Institutes of Health grants U54 HG006493 (to D.A.N.), R01 DK084350 (to M.M.S.), R01 DC003166 (to K.A.D.), R01 DC005841 (to T.C.), R01 DC011803 and R01 DC012564 (to S.R. and Z.M.A.), and R01 DC011651 and R01 DC003594 (to S.M.L.).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Allen EK, 2013, JARO-J ASSOC RES OTO, V14, P791, DOI 10.1007/s10162-013-0411-2; BONDESTAM M, 1988, ACTA PAEDIATR SCAND, V77, P94, DOI 10.1111/j.1651-2227.1988.tb10605.x; CARLSSON B, 1983, ACTA OTO-LARYNGOL, V95, P341, DOI 10.3109/00016488309130952; Casey JR, 2014, CLIN PEDIATR, V53, P865, DOI 10.1177/0009922814533592; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kvestad E, 2004, TWIN RES, V7, P239, DOI 10.1375/twin.7.3.239; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; MARYNEN P, 1984, J BIOL CHEM, V259, P7075; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Patel JA, 2006, PEDIATRICS, V118, P2273, DOI 10.1542/peds.2006-0764; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; SAKAGAMI M, 1990, ANN OTO RHINOL LARYN, V99, P654, DOI 10.1177/000348949009900813; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; van Dongen TMA, 2014, NEW ENGL J MED, V370, P723, DOI 10.1056/NEJMoa1301630; Vissers LELM, 2015, EUR J HUM GENET, V23, P317, DOI 10.1038/ejhg.2014.115; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; World Health Organization, 2004, CHRON SUPP OT MED CS	23	29	29	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					917	+		10.1038/ng.3347	http://dx.doi.org/10.1038/ng.3347			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26121085	Green Accepted			2022-12-25	WOS:000358674100017
J	Shiratori-Hayashi, M; Koga, K; Tozaki-Saitoh, H; Kohro, Y; Toyonaga, H; Yamaguchi, C; Hasegawa, A; Nakahara, T; Hachisuka, J; Akira, S; Okano, H; Furue, M; Inoue, K; Tsuda, M				Shiratori-Hayashi, Miho; Koga, Keisuke; Tozaki-Saitoh, Hidetoshi; Kohro, Yuta; Toyonaga, Honami; Yamaguchi, Chiharu; Hasegawa, Ayumi; Nakahara, Takeshi; Hachisuka, Junichi; Akira, Shizuo; Okano, Hideyuki; Furue, Masutaka; Inoue, Kazuhide; Tsuda, Makoto			STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch	NATURE MEDICINE			English	Article							DERMATITIS; RESPONSES; CIRCUITS; BEHAVIOR; RECEPTOR; MOUSE; CELLS; SKIN	Chronic itch is an intractable symptom of inflammatory skin diseases, such as atopic and contact dermatitis(1-3). Recent studies have revealed neuronal pathways selective for itch(4-8), but the mechanisms by which itch turns into a pathological chronic state are poorly understood. Using mouse models of atopic and contact dermatitis, we demonstrate a long-term reactive state of astrocytes in the dorsal horn of the spinal segments that corresponds to lesioned, itchy skin. We found that reactive astrogliosis depended on the activation of signal transducer and activator of transcription 3 (STAT3). Conditional disruption of astrocytic STAT3 suppressed chronic itch, and pharmacological inhibition of spinal STAT3 ameliorated the fully developed chronic itch. Mice with atopic dermatitis exhibited an increase in scratching elicited by intrathecal administration of the itch-inducer gastrin-releasing peptide (GRP)(4), and this enhancement was normalized by suppressing STAT3-mediated reactive astrogliosis. Moreover, we identified lipocalin-2 (LCN2) as an astrocytic STAT3-dependent upregulated factor that was crucial for chronic itch, and we demonstrated that intrathecal administration of LCN2 to normal mice increased spinal GRP-evoked scratching. Our findings indicate that STAT3-dependent reactive astrocytes act as critical amplifiers of itching through a mechanism involving the enhancement of spinal itch signals by LCN2, thereby providing a previously unrecognized target for treating chronic itch.	[Shiratori-Hayashi, Miho; Koga, Keisuke; Tozaki-Saitoh, Hidetoshi; Toyonaga, Honami; Yamaguchi, Chiharu; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka 812, Japan; [Shiratori-Hayashi, Miho; Koga, Keisuke; Tozaki-Saitoh, Hidetoshi; Kohro, Yuta; Toyonaga, Honami; Yamaguchi, Chiharu; Hasegawa, Ayumi; Inoue, Kazuhide; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 812, Japan; [Nakahara, Takeshi; Hachisuka, Junichi; Furue, Masutaka] Kyushu Univ, Grad Sch Med, Dept Dermatol, Fukuoka 812, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Lab Host Def, Osaka, Japan; [Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	Kyushu University; Kyushu University; Kyushu University; Osaka University; Osaka University; Keio University	Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka 812, Japan.	tsuda@phar.kyushu-u.ac.jp	Hachisuka, Junichi/ABC-9513-2020; Okano, Hideyuki/X-9131-2019; Tsuda, Makoto/AAE-7256-2020; Okano, Hideyuki/I-7584-2019; Akira, Shizuo/C-3134-2009	Hachisuka, Junichi/0000-0003-3987-4381; Okano, Hideyuki/0000-0001-7482-5935; Kohro, Yuta/0000-0002-3128-7388; Koga, Keisuke/0000-0003-3729-3030; , hidetoshi/0000-0003-0423-2143	Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)'; Council for Science and Technology Policy (CSTP); Ministry of Education, Culture, Sports, Science and Technology of Japan; Kyushu University; Japan Science and Technology Agency (JST) through the Core Research for Evolutional Science and Technology (CREST) program; Grants-in-Aid for Scientific Research [15K15203] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)'; Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University; Japan Science and Technology Agency (JST) through the Core Research for Evolutional Science and Technology (CREST) program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)' initiated by the Council for Science and Technology Policy (CSTP) (M.T.), from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.T. and K.I.), from Kyushu University (Progress 100) (M.T.), and from the Japan Science and Technology Agency (JST) through the Core Research for Evolutional Science and Technology (CREST) program (K.I.). We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University. We thank S. Akira (Osaka University) and H. Okano (Keio University) air providing critical materials (Lcn2<SUP>-/-</SUP> and Stat3<SUP>flox/flox</SUP> mice). We thank S. Takeuchi, H. Esalci and Y. Eguchi for providing critical advice on behavioral measurements and performing histological experiments. MS-H. is a research fellow of the JSPS.	Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Dhand A, 2014, BRAIN, V137, P313, DOI 10.1093/brain/awt158; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Ikoma A, 2013, BIOL PHARM BULL, V36, P1235, DOI 10.1248/bpb.b13-00435; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Miller G, 2007, SCIENCE, V318, P188, DOI 10.1126/science.318.5848.188; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Sandor K, 2009, NEUROSCI LETT, V451, P204, DOI 10.1016/j.neulet.2009.01.016; Seike M, 2005, EXP DERMATOL, V14, P169, DOI 10.1111/j.0906-6705.2005.00247.x; Shibata T, 1997, J NEUROSCI, V17, P9212; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Takano N, 2005, J PHARMACOL SCI, V99, P277, DOI 10.1254/jphs.FP0050564; VANDERSTEEN PHM, 1991, J AM ACAD DERMATOL, V24, P253, DOI 10.1016/0190-9622(91)70037-3; Yosipovitch G, 2013, NEW ENGL J MED, V368, P1625, DOI 10.1056/NEJMcp1208814; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	27	111	115	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					927	931		10.1038/nm.3912	http://dx.doi.org/10.1038/nm.3912			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26193341				2022-12-25	WOS:000359181000020
J	Liu, J; Han, QK; Peng, TR; Peng, MX; Wei, B; Li, DW; Wang, XS; Yu, SY; Yang, JQ; Cao, ST; Huang, KM; Hutchins, AP; Liu, H; Kuang, JQ; Zhou, ZW; Chen, J; Wu, HY; Guo, L; Chen, YQ; Chen, Y; Li, XJ; Wu, HL; Liao, BJ; He, W; Song, H; Yao, HJ; Pan, GJ; Chen, JK; Pei, DQ				Liu, Jing; Han, Qingkai; Peng, Tianran; Peng, Meixiu; Wei, Bei; Li, Dongwei; Wang, Xiaoshan; Yu, Shengyong; Yang, Jiaqi; Cao, Shangtao; Huang, Kaimeng; Hutchins, Andrew Paul; Liu, He; Kuang, Junqi; Zhou, Zhiwei; Chen, Jing; Wu, Haoyu; Guo, Lin; Chen, Yongqiang; Chen, You; Li, Xuejia; Wu, Hongling; Liao, Baojian; He, Wei; Song, Hong; Yao, Hongjie; Pan, Guangjin; Chen, Jiekai; Pei, Duanqing			The oncogene c-Jun impedes somatic cell reprogramming	NATURE CELL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTIONAL REGULATORY CIRCUITRY; DOMINANT-NEGATIVE MUTANT; MOUSE DEVELOPMENT; TUMOR-SUPPRESSOR; AP-1 REPRESSOR; FOS; PROTEIN; GENERATION; P53	Oncogenic transcription factors are known to mediate the conversion of somatic cells to tumour or induced pluripotent stem cells (iPSCs). Here we report c-Jun as a barrier for iPSC formation. c-Jun is expressed by and required for the proliferation of mouse embryonic fibroblasts (MEFs), but not mouse embryonic stem cells (mESCs). Consistently, c-Jun is induced during mESC differentiation, drives mESCs towards the endoderm lineage and completely blocks the generation of iPSCs from MEFs. Mechanistically, c-Jun activates mesenchymal-related genes, broadly suppresses the pluripotent ones, and derails the obligatory mesenchymal to epithelial transition during reprogramming. Furthermore, inhibition of c-Jun by shRNA, dominant-negative c-Jun or Jdp2 enhances reprogramming and replaces Oct4 among the Yamanaka factors. Finally, Jdp2 anchors 5 non-Yamanaka factors (Id1, Jhdm1b, Lrh1, Sall4 and Glis1) to reprogram MEFs into iPSCs. Our studies reveal c-Jun as a guardian of somatic cell fate and its suppression opens the gate to pluripotency.	[Liu, Jing; Han, Qingkai; Peng, Tianran; Peng, Meixiu; Wei, Bei; Li, Dongwei; Wang, Xiaoshan; Yu, Shengyong; Yang, Jiaqi; Cao, Shangtao; Huang, Kaimeng; Hutchins, Andrew Paul; Liu, He; Kuang, Junqi; Zhou, Zhiwei; Chen, Jing; Wu, Haoyu; Guo, Lin; Chen, Yongqiang; Chen, You; Li, Xuejia; Wu, Hongling; Liao, Baojian; He, Wei; Song, Hong; Yao, Hongjie; Pan, Guangjin; Chen, Jiekai; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Liu, Jing; Han, Qingkai; Peng, Tianran; Peng, Meixiu; Wei, Bei; Li, Dongwei; Wang, Xiaoshan; Yang, Jiaqi; Cao, Shangtao; Huang, Kaimeng; Hutchins, Andrew Paul; Liu, He; Zhou, Zhiwei; Chen, Jing; Guo, Lin; Chen, Yongqiang; Chen, You; Li, Xuejia; Wu, Hongling; Liao, Baojian; He, Wei; Song, Hong; Yao, Hongjie; Pan, Guangjin; Chen, Jiekai; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Xiaoshan; Hutchins, Andrew Paul; Chen, Jiekai; Pei, Duanqing] Chinese Acad Sci, Guangzhou Branch, Supercomp Ctr, Guangzhou 510530, Guangdong, Peoples R China; [Yu, Shengyong; Kuang, Junqi] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Wu, Haoyu] Jilin Univ, Coll Pharm, Dept Biol Engn, Changchun 130021, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; South China University of Technology; Jilin University	Chen, JK (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	chen_jiekai@gibh.ac.cn; pei_duanqing@gibh.ac.cn	Peng, Tianran/AES-0353-2022; Huang, Kaimeng/K-6572-2014; Peng, Tianran/AAG-9825-2022; Liao, Baojian/AAI-6286-2021; Hutchins, Andrew/O-5708-2018	Huang, Kaimeng/0000-0002-0552-209X; Hutchins, Andrew/0000-0001-7784-2255; Wei, Bei/0000-0003-1516-8802	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020401]; National Basic Research Program of China [2014CB965200, 2012CB966802, 2015CB964800]; National Natural Science Foundation of China [31421004, 31401264, 91419310, 31271357, 91413110, 31471210]; Guangdong Natural Science Funds for Distinguished Young Scholars [S2013050014040]; Bureau of Science and Technology of Guangzhou Municipality [2014J2200077, 2012J2200070]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholars; Bureau of Science and Technology of Guangzhou Municipality	We thank H. Zheng, M. Esteban, B. Qin and X. Shu for their critical comments. We appreciate the contributions of K. Mo, S. Chu, J. Xie, X. Zhao, H. Pang, S. Huang, R. Luo, Y. Li and K. Lai for technical assistance. We are grateful to other members in our laboratory for their supporting work. This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDA01020401), the National Basic Research Program of China (grants 2014CB965200, 2012CB966802, 2015CB964800), the National Natural Science Foundation of China (grants 31421004, 31401264, 91419310, 31271357, 91413110, 31471210), Guangdong Natural Science Funds for Distinguished Young Scholars (grant S2013050014040), and Bureau of Science and Technology of Guangzhou Municipality (grants 2014J2200077, 2012J2200070).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ALANI R, 1991, MOL CELL BIOL, V11, P6286, DOI 10.1128/MCB.11.12.6286; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Breitenlechner C, 2003, STRUCTURE, V11, P1595, DOI 10.1016/j.str.2003.11.002; BROWN PH, 1994, ONCOGENE, V9, P791; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HIRAI SI, 1990, ONCOGENE, V5, P39; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang KM, 2013, J BIOL CHEM, V288, P26067, DOI 10.1074/jbc.M113.486175; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; JING L, 2015, NAT PROTOC EXCH; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Johnson R, 1996, MOL CELL BIOL, V16, P4504; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	69	75	81	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2015	17	7					856	867		10.1038/ncb3193	http://dx.doi.org/10.1038/ncb3193			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CM0FI	26098572				2022-12-25	WOS:000357353400007
J	van der Meulen, T; Donaldson, CJ; Caceres, E; Hunter, AE; Cowing-Zitron, C; Pound, LD; Adams, MW; Zembrzycki, A; Grove, KL; Huising, MO				van der Meulen, Talitha; Donaldson, Cynthia J.; Caceres, Elena; Hunter, Anna E.; Cowing-Zitron, Christopher; Pound, Lynley D.; Adams, Michael W.; Zembrzycki, Andreas; Grove, Kevin L.; Huising, Mark O.			Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion	NATURE MEDICINE			English	Article							MOUSE PANCREATIC-ISLETS; ENDOCRINE PANCREAS; BETA-CELLS; GLUCAGON-SECRETION; ALPHA-CELLS; IMMUNOREACTIVE SOMATOSTATIN; DELTA-CELLS; B-CELL; GLUCOSE; RELEASE	The peptide hormone urocortin3 (Ucn3) is abundantly expressed by mature beta cells, yet its physiological role is unknown. Here we demonstrate that Ucn3 is stored and co-released with insulin and potentiates glucose-stimulated somatostatin secretion via cognate receptors on delta cells. Further, we found that islets lacking endogenous Ucn3 have fewer delta cells, reduced somatostatin content, impaired somatostatin secretion, and exaggerated insulin release, and that these defects are rectified by treatment with synthetic Ucn3 in vitro. Our observations indicate that the paracrine actions of Ucn3 activate a negative feedback loop that promotes somatostatin release to ensure the timely reduction of insulin secretion upon normalization of plasma glucose. Moreover, Ucn3 is markedly depleted from beta cells in mouse and macaque models of diabetes and in human diabetic islets. This suggests that Ucn3 is a key contributor to stable glycemic control, whose reduction during diabetes aggravates glycemic volatility and contributes to the pathophysiology of this disease.	[van der Meulen, Talitha; Hunter, Anna E.; Cowing-Zitron, Christopher; Huising, Mark O.] Univ Calif Davis, Coll Biol Sci, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [van der Meulen, Talitha; Donaldson, Cynthia J.; Caceres, Elena; Hunter, Anna E.; Huising, Mark O.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Pound, Lynley D.; Grove, Kevin L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Diabet Obes & Metab, Beaverton, OR USA; [Adams, Michael W.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Zembrzycki, Andreas] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Huising, Mark O.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; Salk Institute; Oregon Health & Science University; Oregon National Primate Research Center; Salk Institute; Salk Institute; University of California System; University of California Davis	Huising, MO (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	mhuising@ucdavis.edu	Zembrzycki, Andreas/D-7607-2013; Huising, Mark O./H-3885-2019	Zembrzycki, Andreas/0000-0001-8468-4195; Huising, Mark O./0000-0002-6594-2205; Caceres, Elena/0000-0002-2353-4350	Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative Type 1 diabetes research project - Juvenile Diabetes Research Foundation (JDRF); JDRF; JDRF [17-2012-424, 2-2013-54]; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P01-DK026741]; Clayton Medical Research Foundation, Inc.; US National Institutes of Health/Office of the Director grant [P51 OD011092]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative Type 1 diabetes research project - Juvenile Diabetes Research Foundation (JDRF); JDRF(Juvenile Diabetes Research Foundation); JDRF(Juvenile Diabetes Research Foundation); US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clayton Medical Research Foundation, Inc.; US National Institutes of Health/Office of the Director grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We dedicate this work to the memory of Wylie W. Vale (W.W.V.), who co-discovered both somatostatin (in 1973) and urocortin 3 (in 2001) and who would have been delighted by their participation in the same feedback loop. We acquired images at the Waitt Advanced Biophotonics Center at the Salk Institute and at the Veterinary Medicine Advanced Imaging Facility and Plant Biology core facilities at University of California Davis. We acknowledge N. Justice (University of Texas Health Science Center, Houston, Texas, USA) for generating the BAC construct used to generate the Crhr2 alpha-mCherry-Cre reporter line. We acknowledge J. Vaughan for iodination of tracers and H. Park, K. Tigyi and S. Dolleman for their excellent assistance with various aspects of these studies. We thank R. Yang and K. Nakamura at Dexcom Inc. for their assistance in unblinding CGM data at the conclusion of the CGM experiment. We performed this research with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative Type 1 diabetes research project sponsored by the Juvenile Diabetes Research Foundation (JDRF). We obtained human islets through the integrated islet distribution program (IIDP). M.O.H. is the recipient of a Career Development Award of the JDRF. These studies were supported by grants 17-2012-424 and 2-2013-54 from the JDRF (to M.O.H.), P01-DK026741 from the US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (to W.W.V.) and the Clayton Medical Research Foundation, Inc. (to M.O.H. and W.W.V.) The nonhuman primate studies at the Oregon National Primate Research Center (ONPRC) Obese Resource were funded by US National Institutes of Health/Office of the Director grant P51 OD011092 (to K.L.G.). We first reported these findings at the Emerging Concepts and Targets in Islet Biology meeting in Keystone, Colorado on April 8, 2014 and the 73rd and 74th Scientific Sessions of the American Diabetes Association in Chicago on June 23, 2013 and San Francisco on June 16, 2014, respectively.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; BARDEN N, 1976, BIOCHEM BIOPH RES CO, V71, P840, DOI 10.1016/0006-291X(76)90907-4; Benner C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-620; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Braun M, 2009, DIABETOLOGIA, V52, P1566, DOI 10.1007/s00125-009-1382-z; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Caicedo A, 2013, SEMIN CELL DEV BIOL, V24, P11, DOI 10.1016/j.semcdb.2012.09.007; Cescato R, 2008, J MED CHEM, V51, P4030, DOI 10.1021/jm701618q; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P497, DOI 10.1111/j.1469-7793.2000.00497.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Huising MO, 2011, ENDOCRINOLOGY, V152, P138, DOI 10.1210/en.2010-0791; Huising M. O, 2009, ENCY NEUROSCIENCE, P231, DOI [10.1016/B978-008045046-9.01444-3, DOI 10.1016/B978-008045046-9.01444-3]; Huising MO, 2008, J BIOL CHEM, V283, P8902, DOI 10.1074/jbc.M709904200; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; IPP E, 1977, J CLIN INVEST, V60, P760, DOI 10.1172/JCI108829; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2003, ENDOCRINOLOGY, V144, P3216, DOI 10.1210/en.2002-0087; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; LIU YM, 1993, PANCREAS, V8, P15, DOI 10.1097/00006676-199301000-00005; MURAKAMI T, 1993, ARCH HISTOL CYTOL, V56, P127, DOI 10.1679/aohc.56.127; Nygaard EB, 2014, INT J OBESITY, V38, P183, DOI 10.1038/ijo.2013.79; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; OHTANI O, 1986, ARCH HISTOL CYTOL, V49, P45, DOI 10.1679/aohc.49.45; Padmanabhan K, 2010, J NEUROSCI METH, V193, P380, DOI 10.1016/j.jneumeth.2010.08.031; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PATTON GS, 1977, P NATL ACAD SCI USA, V74, P2140, DOI 10.1073/pnas.74.5.2140; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Reubi JC, 2000, P NATL ACAD SCI USA, V97, P13973, DOI 10.1073/pnas.250483897; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rozzo A, 2009, ANN NY ACAD SCI, V1152, P53, DOI 10.1111/j.1749-6632.2008.04003.x; Salehi A, 2007, REGUL PEPTIDES, V144, P43, DOI 10.1016/j.regpep.2007.06.003; SAMOLS E, 1990, METABOLISM, V39, P55, DOI 10.1016/0026-0495(90)90212-U; SCHAUDER P, 1976, FEBS LETT, V68, P225, DOI 10.1016/0014-5793(76)80441-3; SCHUIT FC, 1989, DIABETOLOGIA, V32, P207, DOI 10.1007/BF00265096; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STAGNER JI, 1988, DIABETES, V37, P1715, DOI 10.2337/diabetes.37.12.1715; TABORSKY GJ, 1978, METABOLISM, V27, P1299, DOI 10.1016/0026-0495(78)90062-8; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; VALE W, 1978, METABOLISM, V27, P1391, DOI 10.1016/0026-0495(78)90081-1; van der Meulen Talitha, 2014, Rev Diabet Stud, V11, P115, DOI 10.1900/RDS.2014.11.115; van der Meulen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052181; VAUGHAN JM, 1989, METHOD ENZYMOL, V168, P588; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Yang YHC, 2011, DIABETOLOGIA, V54, P828, DOI 10.1007/s00125-010-2012-5; Yang YHC, 2013, P NATL ACAD SCI USA, V110, P16480, DOI 10.1073/pnas.1214312110; Zhang J, 2014, GENE DEV, V28, P829, DOI 10.1101/gad.235499.113; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014	68	152	152	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2015	21	7					769	+		10.1038/nm.3872	http://dx.doi.org/10.1038/nm.3872			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CM3SO	26076035	Green Accepted, Green Submitted			2022-12-25	WOS:000357604600018
J	Jones, KB				Jones, Kevin B.			Transposon mutagenesis disentangles osteosarcoma genetic drivers	NATURE GENETICS			English	Editorial Material									[Jones, Kevin B.] Univ Utah, Dept Orthoped, Salt Lake City, UT 84112 USA; [Jones, Kevin B.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Jones, KB (corresponding author), Univ Utah, Dept Orthoped, Salt Lake City, UT 84112 USA.	kevin.jones@hci.utah.edu						Bridge JA, 1997, CANCER GENET CYTOGEN, V95, P74, DOI 10.1016/S0165-4608(96)00306-8; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Egas-Bejar Daniela, 2014, Oncoscience, V1, P167; Jaffe N, 2014, ADV EXP MED BIOL, V804, P1, DOI 10.1007/978-3-319-04843-7_1; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Mann MB, 2015, NAT GENET, V47, P486, DOI 10.1038/ng.3275; Moriarity BS, 2015, NAT GENET, V47, P615, DOI 10.1038/ng.3293; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; TARKKANEN M, 1995, CANCER RES, V55, P1334	10	4	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					564	565		10.1038/ng.3317	http://dx.doi.org/10.1038/ng.3317			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	26018893				2022-12-25	WOS:000355386500003
J	Kotini, AG; Chang, CJ; Boussaad, I; Delrow, JJ; Dolezal, EK; Nagulapally, AB; Perna, F; Fishbein, GA; Klimek, VM; Hawkins, RD; Huangfu, D; Murry, CE; Graubert, T; Nimer, SD; Papapetrou, EP				Kotini, Andriana G.; Chang, Chan-Jung; Boussaad, Ibrahim; Delrow, Jeffrey J.; Dolezal, Emily K.; Nagulapally, Abhinav B.; Perna, Fabiana; Fishbein, Gregory A.; Klimek, Virginia M.; Hawkins, R. David; Huangfu, Danwei; Murry, Charles E.; Graubert, Timothy; Nimer, Stephen D.; Papapetrou, Eirini P.			Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							METHYLTRANSFERASE GENE EZH2; TUMOR-SUPPRESSOR; MUTATIONS; GENERATION; IMPACT; 7Q; HAPLOINSUFFICIENCY; IDENTIFICATION; EVOLUTION; REVEALS	Chromosomal deletions associated with human diseases, such as cancer, are common, but synteny issues complicate modeling of these deletions in mice. We use cellular reprogramming and genome engineering to functionally dissect the loss of chromosome 7q (del(7q)), a somatic cytogenetic abnormality present in myelodysplastic syndromes (MDS). We derive del(7q)- and isogenic karyotypically normal induced pluripotent stem cells (iPSCs) from hematopoietic cells of MDS patients and show that the del(7q) iPSCs recapitulate disease-associated phenotypes, including impaired hematopoietic differentiation. These disease phenotypes are rescued by spontaneous dosage correction and can be reproduced in karyotypically normal cells by engineering hemizygosity of defined chr7q segments in a 20-Mb region. We use a phenotype-rescue screen to identify candidate haploinsufficient genes that might mediate the del(7q)-hematopoietic defect. Our approach highlights the utility of human iPSCs both for functional mapping of disease-associated large-scale chromosomal deletions and for discovery of haploinsufficient genes.	[Kotini, Andriana G.; Chang, Chan-Jung; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Kotini, Andriana G.; Chang, Chan-Jung; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Kotini, Andriana G.; Chang, Chan-Jung] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Boussaad, Ibrahim; Papapetrou, Eirini P.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Boussaad, Ibrahim; Nagulapally, Abhinav B.; Hawkins, R. David; Murry, Charles E.; Papapetrou, Eirini P.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Delrow, Jeffrey J.] Fred Hutchinson Canc Res Ctr, Genom Resource, Seattle, WA 98104 USA; [Dolezal, Emily K.; Nimer, Stephen D.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Nagulapally, Abhinav B.; Hawkins, R. David] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Perna, Fabiana] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Fishbein, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Klimek, Virginia M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Huangfu, Danwei] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Murry, Charles E.; Papapetrou, Eirini P.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Graubert, Timothy] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Miami; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai	Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.	eirini.papapetrou@mssm.edu	Boussaad, Ibrahim/GZH-0742-2022	Graubert, Timothy/0000-0002-7710-1171; Perna, Fabiana/0000-0002-3744-8672; KOTINI, ANDRIANA/0000-0001-9148-6015; Huangfu, Danwei/0000-0002-1145-6199; Fishbein, Gregory/0000-0002-3632-5654; Boussaad, Ibrahim/0000-0002-3512-3364	National Institutes of Health (NIH) [R00 DK087923, R01 HL121570, P30 CA15704]; University of Washington Royalty Research Fund; American Society of Hematology; Sidney Kimmel Foundation for Cancer Research; Aplastic Anemia & MDS International Foundation; Ellison Medical Foundation; Damon Runyon Cancer Research Foundation; John H. Tietze Stem Cell Scientist Award; NATIONAL CANCER INSTITUTE [R01CA166835, P30CA008748, P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK087923, R01DK096239] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Royalty Research Fund(University of Washington); American Society of Hematology; Sidney Kimmel Foundation for Cancer Research; Aplastic Anemia & MDS International Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Damon Runyon Cancer Research Foundation; John H. Tietze Stem Cell Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grants R00 DK087923 (E.P.P.), R01 HL121570 (E.P.P.), P30 CA15704 and by awards from the University of Washington Royalty Research Fund (E.P.P.), the American Society of Hematology (E.P.P.), the Sidney Kimmel Foundation for Cancer Research (E.P.P.), the Aplastic Anemia & MDS International Foundation (E.P.P.), the Ellison Medical Foundation (E.P.P.), the Damon Runyon Cancer Research Foundation (E.P.P.) and a John H. Tietze Stem Cell Scientist Award (E.P.P.). We thank D. Russell and L. Li for sharing their expertise in AAV-mediated gene targeting and T. Papayannopoulou for sharing her expertise in assessment of May-Giemsa slides and for useful discussions. We thank C. Husser, C. Sather and R. Basom for excellent technical assistance and J. Overbey for statistical advice.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Flores-Figueroa E, 1999, LEUKEMIA RES, V23, P385, DOI 10.1016/S0145-2126(98)00176-3; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hosono N, 2014, LEUKEMIA, V28, P1348, DOI 10.1038/leu.2014.25; Jerez A, 2012, BLOOD, V119, P6109, DOI 10.1182/blood-2011-12-397620; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; LeBeau MM, 1996, BLOOD, V88, P1930; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Lindsley RC, 2013, BLOOD, V122, P3741, DOI 10.1182/blood-2013-06-460295; Lindsley RC, 2013, ANNU REV PATHOL-MECH, V8, P21, DOI 10.1146/annurev-pathol-011811-132436; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Sato T, 1998, LEUKEMIA, V12, P1187, DOI 10.1038/sj.leu.2401084; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Singh H, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.16; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002	50	106	113	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					646	+		10.1038/nbt.3178	http://dx.doi.org/10.1038/nbt.3178			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25798938	Green Accepted			2022-12-25	WOS:000356019700025
J	Noetzli, L; Lo, RW; Lee-Sherick, AB; Callaghan, M; Noris, P; Savoia, A; Rajpurkar, M; Jones, K; Gowan, K; Balduini, CL; Pecci, A; Gnan, C; De Rocco, D; Doubek, M; Li, L; Lu, L; Leung, R; Landolt-Marticorena, C; Hunger, S; Heller, P; Gutierrez-Hartmann, A; Liang, XY; Pluthero, FG; Rowley, JW; Weyrich, AS; Kahr, WHA; Porter, CC; Di Paola, J				Noetzli, Leila; Lo, Richard W.; Lee-Sherick, Alisa B.; Callaghan, Michael; Noris, Patrizia; Savoia, Anna; Rajpurkar, Madhvi; Jones, Kenneth; Gowan, Katherine; Balduini, Carlo L.; Pecci, Alessandro; Gnan, Chiara; De Rocco, Daniela; Doubek, Michael; Li, Ling; Lu, Lily; Leung, Richard; Landolt-Marticorena, Carolina; Hunger, Stephen; Heller, Paula; Gutierrez-Hartmann, Arthur; Liang Xiayuan; Pluthero, Fred G.; Rowley, Jesse W.; Weyrich, Andrew S.; Kahr, Walter H. A.; Porter, Christopher C.; Di Paola, Jorge			Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia	NATURE GENETICS			English	Article							FAMILIAL THROMBOCYTOPENIA; MEGAKARYOCYTE DEVELOPMENT; TEL ETV6; PROTEIN; FUSION; HEMATOPOIESIS; TRANSCRIPTION; INDUCTION; TEL/ETV6; BINDING	Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia(1,2). We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell-precursor acute lymphoblastic leukemia (ALL). Whole-exome sequencing identified a heterozygous single-nucleotide change in ETV6 (ets variant 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregating with thrombocytopenia and elevated MCV. A screen of 23 families with similar phenotypes identified 2 with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.	[Noetzli, Leila; Lee-Sherick, Alisa B.; Hunger, Stephen; Porter, Christopher C.; Di Paola, Jorge] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA; [Noetzli, Leila; Di Paola, Jorge] Univ Colorado AMC, Human Med Genet & Genom Program, Aurora, CO USA; [Lo, Richard W.; Li, Ling; Lu, Lily; Leung, Richard; Pluthero, Fred G.; Kahr, Walter H. A.] Hosp Sick Children, Res Inst, Program Cell Biol, Toronto, ON M5G 1X8, Canada; [Lo, Richard W.; Kahr, Walter H. A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Callaghan, Michael; Rajpurkar, Madhvi] Wayne State Univ, Dept Pediat, Childrens Hosp Michigan, Detroit, MI 48202 USA; [Noris, Patrizia; Balduini, Carlo L.; Pecci, Alessandro] Univ Pavia, Dept Internal Med, IRCCS Policlin San Matteo Fdn, I-27100 Pavia, Italy; [Savoia, Anna; Gnan, Chiara; De Rocco, Daniela] Univ Trieste, Dept Med Sci, Trieste, Italy; [Savoia, Anna; Gnan, Chiara; De Rocco, Daniela] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Jones, Kenneth; Gowan, Katherine; Gutierrez-Hartmann, Arthur] Univ Colorado AMC, Dept Biochem & Mol Genet, Aurora, CO USA; [Doubek, Michael] Univ Hosp Brno, Dept Internal Med, Haematol Oncol, Brno, Czech Republic; [Landolt-Marticorena, Carolina] Univ Toronto, Dept Med, Div Rheumatol, Univ Hlth Network, Toronto, ON, Canada; [Heller, Paula] Univ Buenos Aires, Inst Invest Med Alfredo Lanar, Buenos Aires, DF, Argentina; [Gutierrez-Hartmann, Arthur] Univ Colorado AMC, Dept Med, Aurora, CO USA; [Liang Xiayuan] Univ Colorado AMC, Dept Pathol, Aurora, CO USA; [Rowley, Jesse W.; Weyrich, Andrew S.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Rowley, Jesse W.; Weyrich, Andrew S.] Univ Utah, Mol Med Program, Salt Lake City, UT USA; [Kahr, Walter H. A.] Univ Toronto, Dept Paediat, Div Haematol Oncol, Toronto, ON M5S 1A1, Canada; [Kahr, Walter H. A.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Colorado System; University of Colorado Anschutz Medical Campus; AMC Cancer Research Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Children's Hospital of Michigan; Wayne State University; IRCCS Fondazione San Matteo; University of Pavia; University of Trieste; IRCCS Burlo Garofolo; AMC Cancer Research Center; University Hospital Brno; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Buenos Aires; AMC Cancer Research Center; AMC Cancer Research Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Di Paola, J (corresponding author), Univ Colorado, Dept Pediat, Anschutz Med Campus AMC, Aurora, CO 80045 USA.	walter.kahr@sickkids.ca; chris.porter@ucdenver.edu; jorge.dipaola@ucdenver.edu	Pluthero, Fred/T-8593-2019; De Rocco, Daniela/K-6753-2016; Kahr, Walter/K-9040-2019; Porter, Christopher/AAE-8918-2020; Callaghan, Michael/AAH-2059-2019; Savoia, Anna/AIC-4560-2022; Jones, Kenneth/GXF-4945-2022; Pecci, Alessandro/E-9288-2012; Gutierrez-Hartmann, Arthur/F-1295-2011; Doubek, Michael/J-7011-2018	De Rocco, Daniela/0000-0002-4536-9798; Porter, Christopher/0000-0001-8774-0180; Savoia, Anna/0000-0002-2407-2696; Pecci, Alessandro/0000-0001-9202-7013; Lo, Richard/0000-0001-5325-5590; Lee Sherick, Alisa/0000-0002-1177-7208; Weyrich, Andrew/0000-0001-9622-4647; Noris, Patrizia/0000-0002-5035-3707; Pluthero, Fred/0000-0002-0451-5840; Heller, Paula G./0000-0002-6829-1313; Lu, Lily/0000-0001-9306-1563	Postle Family Chair in Pediatric Cancer and Blood Disorders; US National Institutes of Health [HL112311, GM103806]; Canadian Institutes of Health Research (CIHR) [MOP-81208, MOP-259952]; Telethon Foundation [GGP13082]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112311, R01HL120728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM103806] Funding Source: NIH RePORTER	Postle Family Chair in Pediatric Cancer and Blood Disorders; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Telethon Foundation(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the families studied for their contribution to this project. We are also grateful to T. Shaikh, R. Spritz and J. Murray for their insightful comments. This work was supported by the Postle Family Chair in Pediatric Cancer and Blood Disorders (J.D.P.) and by US National Institutes of Health grants HL112311 (A.S.W.) and GM103806 (J.W.R.). W.H.A.K. was supported by operating grants from the Canadian Institutes of Health Research (CIHR; MOP-81208 and MOP-259952). P.N. and A.S. were supported by grant GGP13082 from the Telethon Foundation.	Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Kahr WHA, 2013, BLOOD, V122, P3349, DOI 10.1182/blood-2013-04-499491; Kar A, 2013, CRIT REV BIOCHEM MOL, V48, P522, DOI 10.3109/10409238.2013.838202; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Million RP, 2004, MOL CELL BIOL, V24, P4685, DOI 10.1128/MCB.24.11.4685-4695.2004; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Patel N, 2003, BRIT J HAEMATOL, V122, P94, DOI 10.1046/j.1365-2141.2003.04399.x; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Rasighaemi P, 2015, HAEMATOLOGICA, V100, P23, DOI 10.3324/haematol.2014.104091; Raslova H, 2004, J CLIN INVEST, V114, P77, DOI 10.1172/JCI200421197; Romana SP, 1996, LEUKEMIA, V10, P167; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Strehl S, 2003, LEUKEMIA, V17, P1121, DOI 10.1038/sj.leu.2402923; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Urban D, 2012, BLOOD, V120, P5032, DOI 10.1182/blood-2012-05-431205; van Doorn-Khosrovani SBV, 2005, ONCOGENE, V24, P4129, DOI 10.1038/sj.onc.1208588; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Wilcox DA, 2003, J THROMB HAEMOST, V1, P2477, DOI 10.1111/j.1538-7836.2003.00534.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177	37	184	187	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					535	U143		10.1038/ng.3253	http://dx.doi.org/10.1038/ng.3253			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25807284	Green Accepted, Green Submitted			2022-12-25	WOS:000353635800018
J	Wang, WQ; Xiao, ZD; Li, X; Aziz, KE; Gan, B; Johnson, RL; Chen, JJ				Wang, Wenqi; Xiao, Zhen-Dong; Li, Xu; Aziz, Kathryn E.; Gan, Boyi; Johnson, Randy L.; Chen, Junjie			AMPK modulates Hippo pathway activity to regulate energy homeostasis	NATURE CELL BIOLOGY			English	Article							SIGNALING PATHWAY; TUMOR-SUPPRESSOR; GLUCOSE TRANSPORTERS; RHOA ACTIVATION; SIZE-CONTROL; YAP PATHWAY; ORGAN SIZE; GROWTH; PHOSPHORYLATION; EXPRESSION	The Hippo pathway was discovered as a conserved tumour suppressor pathway restricting cell proliferation and apoptosis. However, the upstream signals that regulate the Hippo pathway in the context of organ size control and cancer prevention are largely unknown. Here, we report that glucose, the ubiquitous energy source used for ATP generation, regulates the Hippo pathway downstream effector YAP. We show that both the Hippo pathway and AMP-activated protein kinase (AMPK) were activated during glucose starvation, resulting in phosphorylation of YAP and contributing to its inactivation. We also identified glucose-transporter 3 (GLUT3) as a YAP-regulated gene involved in glucose metabolism. Together, these results demonstrate that glucose-mediated energy homeostasis is an upstream event involved in regulation of the Hippo pathway and, potentially, an oncogenic function of YAP in promoting glycolysis, thereby providing an exciting link between glucose metabolism and the Hippo pathway in tissue maintenance and cancer prevention.	[Wang, Wenqi; Xiao, Zhen-Dong; Li, Xu; Aziz, Kathryn E.; Gan, Boyi; Chen, Junjie] Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Gan, Boyi; Johnson, Randy L.; Chen, Junjie] Univ Texas Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org	肖, 振东/HCI-5410-2022; Gan, Boyi/HDM-4206-2022	肖, 振东/0000-0003-1630-612X; Wang, Wenqi/0000-0003-4053-5088	US Department of Defense Era of Hope research scholar award [W81XWH-09-1-0409, W81XWH-05-1-0470]; U.S. National Cancer Institute through the MD Anderson Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA181196, R01CA089239, R01CA092312] Funding Source: NIH RePORTER	US Department of Defense Era of Hope research scholar award; U.S. National Cancer Institute through the MD Anderson Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all of our colleagues in the Chen laboratory for insightful discussion and technical assistance, especially J. Yuan, G. Ghosal and B. C. Nair. We also thank J-I. Park, L. Ma, Y. Sun, J. Zhang, A. Lin and H. Lee for reagents, insightful suggestions and comments on this work. We thank F-X. Yu (University of California, San Diego) Tor technical help. We thank the shRNA-ORFeome Core Facility at MD Anderson Cancer Center tor the ORFs and shRNAs. We thank B. Viollet tor providing AMPK wild-typc and knockout MEFs. We thank K. Hale for proof-reading the manuscript. We thank R. Tomaino for assistance with the mass spectrometry analysis. This work was supported in part by the US Department of Defense Era of Hope research scholar award to J.C. (W81XWH-09-1-0409 and W81XWH-05-1-0470). This work is partly supported by the U.S. National Cancer Institute through the MD Anderson Cancer Center Support Grant (CA016672).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BOADO RJ, 1994, MOL BRAIN RES, V27, P51, DOI 10.1016/0169-328X(94)90183-X; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Ha TK, 2012, AUTOPHAGY, V8, P1684, DOI 10.4161/auto.21487; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; MELLANEN P, 1994, INT J CANCER, V56, P622, DOI 10.1002/ijc.2910560503; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Ayala FRR, 2010, MOLECULES, V15, P2374, DOI 10.3390/molecules15042374; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Wu SZ, 2014, AM J PHYSIOL-RENAL, V306, pF1308, DOI 10.1152/ajprenal.00447.2013; YAMAMOTO T, 1990, BIOCHEM BIOPH RES CO, V170, P223, DOI 10.1016/0006-291X(90)91263-R; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhang Y, 2012, AM J PHYSIOL-RENAL, V302, pF159, DOI 10.1152/ajprenal.00749.2010; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	40	323	342	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					490	+		10.1038/ncb3113	http://dx.doi.org/10.1038/ncb3113			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25751139	Green Submitted, Green Accepted			2022-12-25	WOS:000351920500019
J	Alanko, J; Mai, A; Jacquemet, G; Schauer, K; Kaukonen, R; Saari, M; Goud, B; Ivaska, J				Alanko, Jonna; Mai, Anja; Jacquemet, Guillaume; Schauer, Kristine; Kaukonen, Riina; Saari, Markku; Goud, Bruno; Ivaska, Johanna			Integrin endosomal signalling suppresses anoikis	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX; CANCER PROGRESSION; CELL-ADHESION; ENDOCYTOSIS; MIGRATION; TRANSDUCTION; ADHESOME; DYNAMIN; RAB21	Integrin-containing focal adhesions transmit extracellular signals across the plasma membrane to modulate cell adhesion, signalling and survival. Although integrins are known to undergo continuous endo/exocytic traffic, the potential impact of endocytic traffic on integrin-induced signals is unknown. Here, we demonstrate that integrin signalling is not restricted to cell-ECM adhesions and identify an endosomal signalling platform that supports integrin signalling away from the plasma membrane. We show that active focal adhesion kinase (FAK), an established marker of integrin-ECM downstream signalling, localizes with active integrins on endosomes. Integrin endocytosis positively regulates adhesion-induced FAK activation, which is early endosome antigen-1 and small GTPase Rab21 dependent. FAK binds directly to purified endosomes and becomes activated on them, suggesting a role for endocytosis in enhancing distinct integrin downstream signalling events. Finally, endosomal integrin signalling contributes to cancer-related processes such as anoikis resistance, anchorage independence and metastasis.	[Alanko, Jonna; Mai, Anja; Jacquemet, Guillaume; Kaukonen, Riina; Saari, Markku; Ivaska, Johanna] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Alanko, Jonna; Saari, Markku; Ivaska, Johanna] VTT Tech Res Ctr Finland, FIN-20520 Turku, Finland; [Schauer, Kristine; Goud, Bruno] Inst Curie, Mol Mech Intracellular Transport, F-75248 Paris, France; [Ivaska, Johanna] Univ Turku, Dept Biochem & Food Chem, FIN-20520 Turku, Finland	University of Turku; VTT Technical Research Center Finland; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Turku	Ivaska, J (corresponding author), Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland.	johanna.ivaska@utu.fi	Jacquemet, Guillaume/M-4881-2019; Goud, Bruno/GWC-4807-2022	Jacquemet, Guillaume/0000-0002-9286-920X; Schauer, Kristine/0000-0002-6102-8790; Alanko, Jonna/0000-0002-7698-3061; Ivaska, Johanna/0000-0002-6295-6556	Academy of Finland; ERC Starting Grant; ERC Consolidator Grant; Sigrid Juselius Foundation; Finnish Cancer Organization; Turku Doctoral Program of Biomedical Sciences; EMBO Short-Term Fellowship; EMBO Long-Term Fellowship	Academy of Finland(Academy of Finland); ERC Starting Grant(European Research Council (ERC)); ERC Consolidator Grant(European Research Council (ERC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organization; Turku Doctoral Program of Biomedical Sciences; EMBO Short-Term Fellowship(European Molecular Biology Organization (EMBO)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO))	We thank J. Siivonen and P. Laasola for excellent technical assistance, M. Georgiadou, D. Schlaepfer and J. Heino for insightful comments on the manuscript and H. Hamidi for scientific writing and editing of the manuscript. S. Corvera is acknowledged for the GFP-EEA1 plasmid (Addgene), D. Schlaepfer for the FAK wt and -/- MEFs and the GFP-FAK plasmids, T. Nareoja and S. Koho for assistance with the STED instrument, and Cell Imaging Core facility, University of Turku Centre for Biotechnology, and the Nikon Imaging Centre at Institut Curie-CNRS for help with the imaging. Turku Centre for Disease Modelling is acknowledged for help with the metastasis assays. This study has been supported by the Academy of Finland, ERC Starting Grant, ERC Consolidator Grant, the Sigrid Juselius Foundation, and the Finnish Cancer Organization. J.A. has been supported by the Turku Doctoral Program of Biomedical Sciences and an EMBO Short-Term Fellowship. G.J. is supported by an EMBO Long-Term Fellowship.	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Bass MD, 2011, DEV CELL, V21, P681, DOI 10.1016/j.devcel.2011.08.007; Bridgewater RE, 2012, J CELL SCI, V125, P3695, DOI 10.1242/jcs.095810; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Christoforides C, 2012, DEV CELL, V23, P560, DOI 10.1016/j.devcel.2012.08.008; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Prutzman KC, 2004, STRUCTURE, V12, P881, DOI 10.1016/S0969-2126(04)00097-8; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Schauer K, 2010, NAT METHODS, V7, P560, DOI [10.1038/NMETH.1462, 10.1038/nmeth.1462]; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	39	137	138	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1412	1421		10.1038/ncb3250	http://dx.doi.org/10.1038/ncb3250			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26436690	Green Accepted			2022-12-25	WOS:000364270500007
J	Finucane, HK; Bulik-Sullivan, B; Gusev, A; Trynka, G; Reshef, Y; Loh, PR; Anttila, V; Xu, H; Zang, CZ; Farh, K; Ripke, S; Day, FR; Purcell, S; Stahl, E; Lindstrom, S; Perry, JRB; Okada, Y; Raychaudhuri, S; Daly, MJ; Patterson, N; Neale, BM; Price, AL				Finucane, Hilary K.; Bulik-Sullivan, Brendan; Gusev, Alexander; Trynka, Gosia; Reshef, Yakir; Loh, Po-Ru; Anttila, Verneri; Xu, Han; Zang, Chongzhi; Farh, Kyle; Ripke, Stephan; Day, Felix R.; Purcell, Shaun; Stahl, Eli; Lindstrom, Sara; Perry, John R. B.; Okada, Yukinori; Raychaudhuri, Soumya; Daly, Mark J.; Patterson, Nick; Neale, Benjamin M.; Price, Alkes L.		ReproGen Consortium; Psychiat Genomics Consortium; RACI Consortium	Partitioning heritability by functional annotation using genome-wide association summary statistics	NATURE GENETICS			English	Article							BODY-MASS INDEX; GENETIC ARCHITECTURE; HUMAN HEIGHT; COMMON SNPS; CELL-TYPES; VARIANTS; LOCI; DISEASE; SUSCEPTIBILITY; PROPORTION	Recent work has demonstrated that some functional categories of the genome contribute disproportionately to the heritability of complex diseases. Here we analyze a broad set of functional elements, including cell type-specific elements, to estimate their polygenic contributions to heritability in genome-wide association studies (GWAS) of 17 complex diseases and traits with an average sample size of 73,599. To enable this analysis, we introduce a new method, stratified LD score regression, for partitioning heritability from GWAS summary statistics while accounting for linked markers. This new method is computationally tractable at very large sample sizes and leverages genome-wide information. Our findings include a large enrichment of heritability in conserved regions across many traits, a very large immunological disease-specific enrichment of heritability in FANTOM5 enhancers and many cell type-specific enrichments, including significant enrichment of central nervous system cell types in the heritability of body mass index, age at menarche, educational attainment and smoking behavior.	[Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Finucane, Hilary K.; Gusev, Alexander; Loh, Po-Ru; Lindstrom, Sara; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bulik-Sullivan, Brendan; Anttila, Verneri; Farh, Kyle; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Bulik-Sullivan, Brendan; Anttila, Verneri; Farh, Kyle; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Harvard Univ, Sch Med, Boston, MA USA; [Bulik-Sullivan, Brendan; Anttila, Verneri; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Trynka, Gosia; Purcell, Shaun; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA USA; [Trynka, Gosia; Purcell, Shaun; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Rheumatol, Brigham & Womens Hosp, Boston, MA USA; [Trynka, Gosia; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Trynka, Gosia; Anttila, Verneri; Raychaudhuri, Soumya; Daly, Mark J.; Patterson, Nick; Neale, Benjamin M.; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Trynka, Gosia] Wellcome Trust Sanger Inst, Cambridge, England; [Reshef, Yakir] Harvard Univ, Dept Comp Sci, Cambridge, MA 02138 USA; [Xu, Han; Zang, Chongzhi] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Xu, Han; Zang, Chongzhi] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Farh, Kyle] Broad Inst MIT & Harvard, Epigen Program, Cambridge, MA USA; [Day, Felix R.; Perry, John R. B.] Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med,Inst Metab Sci, Cambridge, England; [Purcell, Shaun; Stahl, Eli] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Cambridge; Icahn School of Medicine at Mount Sinai; Tokyo Medical & Dental University (TMDU); RIKEN; University of Manchester	Finucane, HK (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.	hilaryf@mit.edu; bulik@broadinstitute.org; bneale@broadinstitute.org; aprice@hsph.harvard.edu	Daly, Mark J/B-2453-2017; Ripke, Stephan/AAK-5486-2021; Webb, Bradley T/B-1459-2009; Zang, Chongzhi/D-1445-2011; Hansen, Thomas Folkmann/O-5965-2014; Grove, Jakob/K-8112-2015	Daly, Mark J/0000-0002-0949-8752; Webb, Bradley T/0000-0002-0576-5366; Zang, Chongzhi/0000-0003-4812-3627; Hansen, Thomas Folkmann/0000-0001-6703-7762; Grove, Jakob/0000-0003-2284-5744; ripke, stephan/0000-0003-3622-835X; Raychaudhuri, Soumya/0000-0002-1901-8265; Day, Felix/0000-0003-3789-7651; Gusev, Alexander/0000-0002-7980-4620; Anttila, Verneri/0000-0002-0073-4675	US National Institutes of Health [R01 MH101244, R01 HG006399, R03 CA173785, R21 CA182821, F32 GM106584, U01 HG0070033]; Fannie and John Hertz Foundation; Wellcome Trust Sanger Institute [WT098051]; National Institute of General Medical Sciences [T32 GM007753]; Arthritis Foundation; Doris Duke Clinical Scientist Development Award; Wellcome Trust [076113]; US National Institutes of Health [R01 MH101244, R01 HG006399, R03 CA173785, R21 CA182821, F32 GM106584, U01 HG0070033]; Fannie and John Hertz Foundation; Wellcome Trust Sanger Institute [WT098051]; National Institute of General Medical Sciences [T32 GM007753]; Arthritis Foundation; Doris Duke Clinical Scientist Development Award; Wellcome Trust [076113]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MC_U106179472, MC_UU_12015/2] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R21CA182821, R03CA173785] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106584, T32GM007748, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05670] Funding Source: KAKEN; MRC [MC_U106179472, MC_UU_12015/2] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arthritis Foundation; Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arthritis Foundation; Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); Wellcome Trust(Wellcome TrustEuropean Commission); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Bernstein, M. Finucane, A. Forrest, E. Hodis, D. Kotliar, X.S. Liu, M. Kellis, M. O'Donovan, B. Pasaniuc, A. Sandelin, A. Sarkar, P. Sullivan, B. Vilhjalmsson, A. Veres and the anonymous reviewers for helpful discussions and/or comments. This research was funded by US National Institutes of Health grants R01 MH101244, R01 HG006399, R03 CA173785, R21 CA182821, F32 GM106584 and U01 HG0070033. H.K.F. was also supported by the Fannie and John Hertz Foundation. G.T. is supported by the Wellcome Trust Sanger Institute (WT098051). Y.R. was supported by award T32 GM007753 from the National Institute of General Medical Sciences. S. Raychaudhuri is supported by funding from the Arthritis Foundation and by a Doris Duke Clinical Scientist Development Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. This study made use of data generated by the Wellcome Trust Case Control Consortium (WTCCC) and the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the WTCCC data is available at http://www.wtccc.org.uk/. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Farooqi IS, 2014, CLIN MED, V14, P286, DOI 10.7861/clinmedicine.14-3-286; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kettyle William M., 1998, ENDOCRINE PATHOPHYSI; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lilly L. S., 2012, PATHOPHYSIOLOGY HEAR; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	49	928	928	5	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1228	+		10.1038/ng.3404	http://dx.doi.org/10.1038/ng.3404			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26414678	Green Submitted, Green Accepted			2022-12-25	WOS:000363988200005
J	Klein, NP; Sattely, ES				Klein, Ndrew P.; Sattely, Elizabeth S.			Two cytochromes P450 catalyze S-heterocyclizations in cabbage phytoalexin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							GLUCOSINOLATE METABOLISM; ARABIDOPSIS-THALIANA; STRESS METABOLITES; YEAST EXPRESSION; PATHWAY; BRASSININ; BRASSICACEAE; INHIBITION; CAMALEXIN; GENES	Phytoalexins are abundant in edible crucifers and have important biological activities, yet no dedicated gene for their biosynthesis is known. Here, we report two new cytochromes P450 from Brassica rapa (Chinese cabbage) that catalyze unprecedented S-heterocyclizations in cyclobrassinin and spirobrassinin biosynthesis. Our results provide genetic and biochemical insights into the biosynthesis of a prominent pair of dietary metabolites and have implications for pathway discovery across >20 recently sequenced crucifers.	[Klein, Ndrew P.; Sattely, Elizabeth S.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Klein, NP (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	sattely@stanford.edu		Klein, Andrew/0000-0002-9866-2357	US National Institutes of Health [R00 GM089985, DP2 AT008321]; US National Defense Science and Engineering Graduate Fellowship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [DP2AT008321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM089985] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Defense Science and Engineering Graduate Fellowship; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health grants R00 GM089985 and DP2 AT008321 (E.S.S.). A.P.K. was supported by the US National Defense Science and Engineering Graduate Fellowship. We thank M. Jin (Korea Brassica Genome Project) and H.B. Lauffer (Wisconsin Fast Plants Program) for providing seeds. We thank X. Ji (Stanford Functional Genomics Facility) for RNA sequencing services. We thank L. Meyer-Teruel for help in initial metabolic profiling of B. rapa, J.-G. Kim and L. Sassoubre for qRT-PCR assistance, D. Nelson for CYP nomenclature assignment and S. Galanie and members of the Sattely Group for helpful comments on the manuscript.	Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Banerjee T, 2008, ONCOGENE, V27, P2851, DOI 10.1038/sj.onc.1210939; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2012, CHEMBIOCHEM, V13, P1846, DOI 10.1002/cbic.201200086; Bednarek P, 2011, NEW PHYTOL, V192, P713, DOI 10.1111/j.1469-8137.2011.03824.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradbury LMT, 2013, CURR OPIN BIOTECH, V24, P278, DOI 10.1016/j.copbio.2012.07.005; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Izutani Y, 2012, INT J ONCOL, V40, P816, DOI 10.3892/ijo.2011.1246; Kiefer M, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct158; Kim SM, 2014, PHYTOTHER RES, V28, P423, DOI 10.1002/ptr.5010; Klein AP, 2013, ANGEW CHEM INT EDIT, V52, P13625, DOI 10.1002/anie.201307454; MEHTA RG, 1995, CARCINOGENESIS, V16, P399, DOI 10.1093/carcin/16.2.399; Mikkelsen MD, 2012, METAB ENG, V14, P104, DOI 10.1016/j.ymben.2012.01.006; MONDE K, 1994, J AM CHEM SOC, V116, P6650, DOI 10.1021/ja00094a021; Nelson David R., 2009, Human Genomics, V4, P59; Pedras MSC, 2006, BIOORGAN MED CHEM, V14, P4958, DOI 10.1016/j.bmc.2006.03.014; Pedras MSC, 2011, NAT PROD REP, V28, P1381, DOI 10.1039/c1np00020a; Pedras MSC, 2011, BIOORGAN MED CHEM, V19, P1390, DOI 10.1016/j.bmc.2011.01.011; Pedras MSC, 2010, ORG BIOMOL CHEM, V8, P5150, DOI 10.1039/c0ob00265h; Pedras MSC, 2006, ORG BIOMOL CHEM, V4, P691, DOI 10.1039/b515331j; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Soledade M, 2015, PHYTOCHEMISTRY, V113, P57, DOI 10.1016/j.phytochem.2014.07.024; TAKASUGI M, 1988, B CHEM SOC JPN, V61, P285, DOI 10.1246/bcsj.61.285; Traka MH, 2013, NEW PHYTOL, V198, P1085, DOI 10.1111/nph.12232; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/NCHEMBIO.1366, 10.1038/nchembio.1366]; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wiesner M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-124; WILLIAMS PH, 1986, SCIENCE, V232, P1385, DOI 10.1126/science.232.4756.1385	35	27	28	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					837	U42		10.1038/NCHEMBIO.1914	http://dx.doi.org/10.1038/NCHEMBIO.1914			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26389737	Green Accepted			2022-12-25	WOS:000363272100008
J	Tan, J; Ong, CK; Lim, WK; Ng, CCY; Thike, AA; Ng, LM; Rajasegaran, V; Myint, SS; Nagarajan, S; Thangaraju, S; Dey, S; Nasir, NDM; Wijaya, GC; Lim, JQ; Huang, DC; Li, ZM; Wong, BH; Chan, JYS; McPherson, JR; Cutcutache, I; Poore, G; Tay, ST; Tan, WJ; Putti, TC; Ahmad, BS; Iau, P; Chan, CW; Tang, APH; Yong, WS; Madhukumar, P; Ho, GH; Tan, VKM; Wong, CY; Hartman, M; Ong, KW; Tan, BKT; Rozen, SG; Tan, P; Tan, PH; Teh, BT				Tan, Jing; Ong, Choon Kiat; Lim, Weng Khong; Ng, Cedric Chuan Young; Thike, Aye Aye; Ng, Ley Moy; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Thangaraju, Saranya; Dey, Sucharita; Nasir, Nur Diyana Md; Wijaya, Giovani Claresta; Lim, Jing Quan; Huang, Dachuan; Li, Zhimei; Wong, Bernice Huimin; Chan, Jason Yong Sheng; McPherson, John R.; Cutcutache, Ioana; Poore, Gregory; Tay, Su Ting; Tan, Wai Jin; Putti, Thomas Choudary; Ahmad, Buhari Shaik; Iau, Philip; Chan, Ching Wan; Tang, Anthony P. H.; Yong, Wei Sean; Madhukumar, Preetha; Ho, Gay Hui; Tan, Veronique Kiak Mien; Wong, Chow Yin; Hartman, Mikael; Ong, Kong Wee; Tan, Benita K. T.; Rozen, Steven G.; Tan, Patrick; Tan, Puay Hoon; Teh, Bin Tean			Genomic landscapes of breast fibroepithelial tumors	NATURE GENETICS			English	Article							MALIGNANT PHYLLODES TUMORS; FREQUENT MED12 MUTATIONS; ESTROGEN-RECEPTOR; SOMATIC MUTATIONS; COPY NUMBER; FIBROADENOMA; PROGRESSION; ABERRATIONS; REVEALS; FILAMIN	Breast fibroepithelial tumors comprise a heterogeneous spectrum of pathological entities, from benign fibroadenomas to malignant phyllodes tumors(1). Although MED12 mutations have been frequently found in fibroadenomas and phyllodes tumors(2-7), the landscapes of genetic alterations across the fibroepithelial tumor spectrum remain unclear. Here, by performing exome sequencing of 22 phyllodes tumors followed by targeted sequencing of 100 breast fibroepithelial tumors, we observed three distinct somatic mutation patterns. First, we frequently observed MED12 and RARA mutations in both fibroadenomas and phyllodes tumors, emphasizing the importance of these mutations in fibroepithelial tumorigenesis. Second, phyllodes tumors exhibited mutations in FLNA, SETD2 and KMT2D, suggesting a role in driving phyllodes tumor development. Third, borderline and malignant phyllodes tumors harbored additional mutations in cancer-associated genes. RARA mutations exhibited clustering in the portion of the gene encoding the ligand-binding domain, functionally suppressed RARA-mediated transcriptional activation and enhanced RARA interactions with transcriptional co-repressors. This study provides insights into the molecular pathogenesis of breast fibroepithelial tumors, with potential clinical implications.	[Tan, Jing; Ong, Choon Kiat; Lim, Weng Khong; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Thangaraju, Saranya; Wijaya, Giovani Claresta; Lim, Jing Quan; Huang, Dachuan; Li, Zhimei; Wong, Bernice Huimin; Teh, Bin Tean] Natl Canc Ctr Singapore, Lab Canc Epigenome, Singapore, Singapore; [Tan, Jing; Ong, Choon Kiat; Lim, Weng Khong; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Thangaraju, Saranya; Wijaya, Giovani Claresta; Lim, Jing Quan; Huang, Dachuan; Li, Zhimei; McPherson, John R.; Cutcutache, Ioana; Tay, Su Ting; Rozen, Steven G.; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore, Grad Sch Med, Div Canc & Stem Cell Biol, Singapore, Singapore; [Thike, Aye Aye; Nasir, Nur Diyana Md; Tan, Wai Jin; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Ng, Ley Moy; Tan, Patrick; Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Dey, Sucharita; Chan, Jason Yong Sheng] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Poore, Gregory] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Putti, Thomas Choudary] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Ahmad, Buhari Shaik; Iau, Philip; Chan, Ching Wan; Tang, Anthony P. H.] Natl Univ Singapore Hosp, Dept Surg, Singapore 117548, Singapore; [Yong, Wei Sean; Madhukumar, Preetha; Ho, Gay Hui; Tan, Veronique Kiak Mien; Wong, Chow Yin; Ong, Kong Wee; Tan, Benita K. T.] Natl Canc Ctr Singapore, Dept Surg Oncol, Singapore, Singapore; [Yong, Wei Sean; Madhukumar, Preetha; Ho, Gay Hui; Tan, Veronique Kiak Mien; Wong, Chow Yin; Ong, Kong Wee; Tan, Benita K. T.] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Yong, Wei Sean; Madhukumar, Preetha; Ho, Gay Hui; Tan, Veronique Kiak Mien; Wong, Chow Yin; Ong, Kong Wee; Tan, Benita K. T.] SingHlth Duke Natl Univ Singapore, Breast Ctr, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Teh, Bin Tean] Inst Mol & Cellular Biol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); Duke University; National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Teh, BT (corresponding author), Natl Canc Ctr Singapore, Lab Canc Epigenome, Singapore, Singapore.	steve.rozen@duke-nus.edu.sg; gmstanp@duke-nus.edu.sg; tan.puay.hoon@sgh.com.sg; teh.bin.tean@singhealth.com.sg	Chan, Ching Wan/C-7606-2011; Lim, Weng Khong/Q-8661-2019; Chan, Jason Yongsheng/AAC-4863-2020; Iau, Philip/B-4641-2011; Rozen, Steven G./J-5939-2013; Hartman, Mikael/B-4324-2011	Chan, Ching Wan/0000-0002-9250-1296; Lim, Weng Khong/0000-0003-4391-1130; Chan, Jason Yongsheng/0000-0002-4801-3703; Lim, Jing Quan/0000-0003-3732-8707; NG, CEDRIC CHUAN YOUNG/0000-0002-7150-4674; Rozen, Steven G./0000-0002-4288-0056; Teh, Bin Tean/0000-0003-1514-1124; Ong, Choon Kiat/0000-0001-6402-4288; Tan, Jing/0000-0002-4605-4624; HUANG, DACHUAN/0000-0002-7518-4081; Myint, Swe Swe/0000-0002-2430-088X; Hartman, Mikael/0000-0001-5726-9965; Wong, Bernice/0000-0001-8981-1376	Singapore National Medical Research Council [NMRC/STAR/0006/2009]; Singapore National Cancer Centre Research Fund; Lee Foundation; Tanoto Foundation; Verdant Foundation	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore National Cancer Centre Research Fund; Lee Foundation; Tanoto Foundation; Verdant Foundation	This work was supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), the Singapore National Cancer Centre Research Fund, the Lee Foundation, the Tanoto Foundation and the Verdant Foundation. We thank the Duke-National University of Singapore Genome Biology Facility for sequencing services rendered, as well as the Advanced Molecular Pathology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, for providing laser-capture microdissection resources and the SingHealth Tissue Repository for frozen tissue samples.	Abe M, 2011, BREAST CANCER-TOKYO, V18, P268, DOI 10.1007/s12282-009-0185-x; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Boeva V, 2014, BIOINFORMATICS, V30, P3443, DOI 10.1093/bioinformatics/btu436; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Cani AK, 2015, MOL CANCER RES, V13, P613, DOI 10.1158/1541-7786.MCR-14-0578; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cimino-Mathews A, 2013, HUM PATHOL, V44, P2494, DOI 10.1016/j.humpath.2013.06.009; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Feakins RM, 1999, HISTOPATHOLOGY, V35, P162, DOI 10.1046/j.1365-2559.1999.00682.x; Hodges KB, 2009, APPL IMMUNOHISTO M M, V17, P345, DOI 10.1097/PAI.0b013e318194d992; Jara-Lazaro AR, 2009, AM J TRANSL RES, V1, P23; Jones A, 2008, J PATHOL, V214, P533, DOI 10.1002/path.2320; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Kasami M, 1998, BREAST CANCER RES TR, V50, P185, DOI 10.1023/A:1006050208157; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krishnamurthy S, 2000, CANCER CYTOPATHOL, V90, P342, DOI 10.1002/1097-0142(20001225)90:6<342::AID-CNCR4>3.3.CO;2-9; Kuijper A, 2002, J PATHOL, V197, P575, DOI 10.1002/path.1161; Lakhani S, 2012, WHO CLASSIFICATION T, V4, P142; Lien HC, 2016, HISTOPATHOLOGY, V68, P433, DOI 10.1111/his.12764; Lim WK, 2014, NAT GENET, V46, P877, DOI 10.1038/ng.3037; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Markowski DN, 2012, INT J CANCER, V131, P1528, DOI 10.1002/ijc.27424; Millar EKA, 1999, HISTOPATHOLOGY, V34, P491, DOI 10.1111/j.1365-2559.1999.00666.x; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Nagasawa S, 2015, CANCER MED-US, V4, P1117, DOI 10.1002/cam4.462; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Ng CCY, 2015, J CLIN PATHOL, V68, P685, DOI 10.1136/jclinpath-2015-202896; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; NOGUCHI S, 1995, CANCER, V76, P1779, DOI 10.1002/1097-0142(19951115)76:10<1779::AID-CNCR2820761015>3.0.CO;2-0; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Piscuoglio S, 2015, HISTOPATHOLOGY, V67, P719, DOI 10.1111/his.12712; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Sawyer EJ, 2000, AM J PATHOL, V156, P1093, DOI 10.1016/S0002-9440(10)64977-2; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tan PH, 2005, AM J CLIN PATHOL, V123, P529, DOI 10.1309/U6DVBFM81MLJC1FN; Tan WJ, 2014, BREAST CANCER RES TR, V145, P635, DOI 10.1007/s10549-014-2982-y; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Yoshida M, 2015, BRIT J CANCER, V112, P1703, DOI 10.1038/bjc.2015.116; Zhu HH, 2014, NEW ENGL J MED, V370, P1864, DOI 10.1056/NEJMc1316382; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	50	118	123	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1341	+		10.1038/ng.3409	http://dx.doi.org/10.1038/ng.3409			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26437033				2022-12-25	WOS:000363988200018
J	Chen, HC; Kanai, M; Inoue-Yamauchi, A; Tu, HC; Huang, YF; Ren, DC; Kim, HJ; Takeda, S; Reyna, DE; Chan, PM; Ganesan, YT; Liao, CP; Gavathiotis, E; Hsieh, JJ; Cheng, EH				Chen, Hui-Chen; Kanai, Masayuki; Inoue-Yamauchi, Akane; Tu, Ho-Chou; Huang, Yafen; Ren, Decheng; Kim, Hyungjin; Takeda, Shugaku; Reyna, Denis E.; Chan, Po M.; Ganesan, Yogesh Tengarai; Liao, Chung-Ping; Gavathiotis, Evripidis; Hsieh, James J.; Cheng, Emily H.			An interconnected hierarchical model of cell death regulation by the BCL-2 family	NATURE CELL BIOLOGY			English	Article							BH3 DOMAINS; MITOCHONDRIAL APOPTOSIS; BH3-ONLY PROTEINS; MEMBRANE PERMEABILIZATION; CONFORMATIONAL-CHANGE; PROAPOPTOTIC BAX; CYTOCHROME-C; ACTIVATION; MEMBERS; PUMA	Multidomain pro-apoptotic BAX and BAK, once activated, permeabilize mitochondria to trigger apoptosis, whereas anti-apoptotic BCL-2 members preserve mitochondrial integrity. The BH3-only molecules (BH3s) promote apoptosis by either activating BAX-BAK or inactivating anti-apoptotic members. Here, we present biochemical and genetic evidence that NOXA is a bona fide activator BH3. Using combinatorial gain-of-function and loss-of-function approaches in Bid(-/-) Bim(-/-) Puma(-/-) Noxa(-/-) and Bax(-/-) Bak(-/-) cells, we have constructed an interconnected hierarchical model that accommodates and explains how the intricate interplays between the BCL-2 members dictate cellular survival versus death. BID, BIM, PUMA and NOXA directly induce stepwise, bimodal activation of BAX-BAK. BCL-2, BCL-X-L and MCL-1 inhibit both modes of BAX-BAK activation by sequestering activator BH3s and 'BH3-exposed' monomers of BAX-BAK, respectively. Furthermore, autoactivation of BAX and BAK can occur independently of activator BH3s through downregulation of BCL-2, BCL-X-L and MCL-1. Our studies lay a foundation for targeting the BCL-2 family for treating diseases with dysregulated apoptosis.	[Chen, Hui-Chen; Kanai, Masayuki; Inoue-Yamauchi, Akane; Tu, Ho-Chou; Huang, Yafen; Takeda, Shugaku; Chan, Po M.; Ganesan, Yogesh Tengarai; Liao, Chung-Ping; Hsieh, James J.; Cheng, Emily H.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Ren, Decheng] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kim, Hyungjin] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Reyna, Denis E.; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Cheng, Emily H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Cheng, Emily H.] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; University of Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Cheng, EH (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	cheng1@mskcc.org		Gavathiotis, Evripidis/0000-0001-6319-8331; Takeda, Shugaku/0000-0003-4730-9390	NIH [R01CA125562, R01CA178394, P30CA008748]; American Cancer Society [118518-RSG-10-030-01-CCG]; NATIONAL CANCER INSTITUTE [R01CA178394, R01CA125562, P30CA013330, P30CA008748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We apologize to all of the investigators whose research could not be appropriately cited owing to space limitation. We thank H.-F. Chen and S. Han for technical assistance. This work was supported by grants to E.H.C. from the NIH (R01CA125562) and the American Cancer Society (118518-RSG-10-030-01-CCG), and to E.G. from the NIH (R01CA178394) This work was also supported by the NIH P30CA008748.	Anderson MA, 2014, SEMIN HEMATOL, V51, P219, DOI 10.1053/j.seminhematol.2014.05.008; Brouwer JM, 2014, MOL CELL, V55, P938, DOI 10.1016/j.molcel.2014.07.016; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Davids MS, 2012, J CLIN ONCOL, V30, P3127, DOI 10.1200/JCO.2011.37.0981; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Edwards AL, 2013, CHEM BIOL, V20, P888, DOI 10.1016/j.chembiol.2013.06.007; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2012, J CLIN ONCOL, V30, P554, DOI 10.1200/JCO.2011.37.9339; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	56	171	187	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1270	+		10.1038/ncb3236	http://dx.doi.org/10.1038/ncb3236			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26344567	Green Accepted			2022-12-25	WOS:000362213500007
J	Coelho, C; Foti, A; Hartmann, T; Santos-Silva, T; Leimkuhler, S; Romao, MJ				Coelho, Catarina; Foti, Alessandro; Hartmann, Tobias; Santos-Silva, Teresa; Leimkuehler, Silke; Romao, Maria Joao			Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase	NATURE CHEMICAL BIOLOGY			English	Article							MOLYBDENUM HYDROXYLASES; XANTHINE OXIDOREDUCTASE; CRYSTAL-STRUCTURE; IN-VITRO; LIVER; OXIDATION; FLAVOENZYMES; METABOLISM; EXPRESSION; MECHANISM	Aldehyde oxidase (AOX) is a xanthine oxidase (XO)-related enzyme with emerging importance due to its role in the metabolism of drugs and xenobiotics. We report the first crystal structures of human AOX1, substrate free (2.6-angstrom resolution) and in complex with the substrate phthalazine and the inhibitor thioridazine (2.7-angstrom resolution). Analysis of the protein active site combined with steady-state kinetic studies highlight the unique features, including binding and substrate orientation at the active site, that characterize human AOX1 as an important drug-metabolizing enzyme. Structural analysis of the complex with the noncompetitive inhibitor thioridazine revealed a new, unexpected and fully occupied inhibitor-binding site that is structurally conserved among mammalian AOXs and XO. The new structural insights into the catalytic and inhibition mechanisms of human AOX that we now report will be of great value for the rational analysis of clinical drug interactions involving inhibition of AOX1 and for the prediction and design of AOX-stable putative drugs.	[Coelho, Catarina; Santos-Silva, Teresa; Romao, Maria Joao] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Res Unit Appl Mol Biosci Rede Quim & Tecnol UCIBI, Caparica, Portugal; [Foti, Alessandro; Hartmann, Tobias; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, Potsdam, Germany	Universidade Nova de Lisboa; University of Potsdam	Coelho, C (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Res Unit Appl Mol Biosci Rede Quim & Tecnol UCIBI, Caparica, Portugal.	mjr@fct.unl.pt	Romao, Maria J/A-4115-2013; Santos-Silva, Teresa/AAE-1795-2019; Coelho, Catarina M C/D-2073-2013; UCIBIO, U Cienc Biom Apl/F-7948-2017; Santos-Silva, Teresa/D-2050-2013	Romao, Maria J/0000-0002-3004-0543; Santos-Silva, Teresa/0000-0003-3060-8378; Coelho, Catarina M C/0000-0003-1852-5406; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Santos-Silva, Teresa/0000-0003-3060-8378; Leimkuhler, Silke/0000-0003-3238-2122	Fundacao para a Ciencia e Tecnologia (FCT-MEC) [UID/Multi/04378/2013, EXCL/QEQ-COM/0394/2012, PTDC/BIA-PRO/118377/2010, SFRH/BPD/84581/2012, DAAD-441.00]; Deutsche Forschungsgemeinschaft Grant [Le1171/8-1]; European Community [283570]	Fundacao para a Ciencia e Tecnologia (FCT-MEC); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); European Community(European Commission)	This work was financially supported by the Fundacao para a Ciencia e Tecnologia (FCT-MEC) through projects UID/Multi/04378/2013, EXCL/QEQ-COM/0394/2012, PTDC/BIA-PRO/118377/2010 (M.J.R., T.S.-S., C.C.), SFRH/BPD/84581/2012 (C.C.) and DAAD-441.00 (M.J.R., T.S.-S., S.L.) and by Deutsche Forschungsgemeinschaft Grant Le1171/8-1 (S.L.). We thank the I02 staff of the Diamond Light Source (DLS, Didcot, United Kingdom) and X06DA-PXIII staff from the Swiss Light Source (SLS, Paul Scherrer Institut, Villigen, Switzerland) for assistance during data collection. We also thank the staff from beamlines ID14-1, ID29-1 and ID23-1 from the European Synchrotron Radiation Facility (ESRF, Grenoble, France). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement no. 283570). We thank R. Hille (University of California, Riverside) for providing bXO for the inhibition experiments and A. Palma (Universidade Nova de Lisboa, Portugal) for critical reading of the manuscript.	Amaral L, 2012, INT J ANTIMICROB AG, V39, P376, DOI 10.1016/j.ijantimicag.2012.01.012; Baral PK, 2014, STRUCTURE, V22, P291, DOI 10.1016/j.str.2013.11.009; Barr JT, 2011, DRUG METAB DISPOS, V39, P2381, DOI 10.1124/dmd.111.041806; Basu LR, 2005, MICROBIOL RES, V160, P95, DOI 10.1016/j.micres.2004.10.002; Beedham C, 1998, BIOM HLTH R, V25, P39; Beedham C, 1997, PHARM WORLD SCI, V19, P255, DOI 10.1023/A:1008668913093; Christensen J.B., 2014, US patent, Patent No. [8,623,864, 8623864]; Christensen JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057493; Coelho C, 2012, J BIOL CHEM, V287, P40690, DOI 10.1074/jbc.M112.390419; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fu CX, 2013, DRUG METAB DISPOS, V41, P1797, DOI 10.1124/dmd.113.053082; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Garattini E, 2012, EXPERT OPIN DRUG MET, V8, P487, DOI 10.1517/17425255.2012.663352; Garattini E, 2011, DRUG METAB REV, V43, P374, DOI 10.3109/03602532.2011.560606; Garattini Enrico, 2009, Human Genomics, V4, P119; Hartmann T, 2012, DRUG METAB DISPOS, V40, P856, DOI 10.1124/dmd.111.043828; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Ishikita H, 2012, J AM CHEM SOC, V134, P999, DOI 10.1021/ja207173p; Jones RM, 1999, INORG CHEM, V38, P4963, DOI 10.1021/ic990154j; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mahro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082285; Mahro M, 2011, DRUG METAB DISPOS, V39, P1939, DOI 10.1124/dmd.111.040873; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obach RS, 2005, J CLIN PSYCHOPHARM, V25, P605, DOI 10.1097/01.jcp.0000186740.22395.50; Obach RS, 2004, J CLIN PHARMACOL, V44, P7, DOI 10.1177/0091270003260336; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Pryde DC, 2010, J MED CHEM, V53, P8441, DOI 10.1021/jm100888d; Rashidi MR, 1997, DRUG METAB DISPOS, V25, P805; Romao MJ, 2009, DALTON T, P4053, DOI 10.1039/b821108f; Schlauderer F, 2013, ANGEW CHEM INT EDIT, V52, P10384, DOI 10.1002/anie.201304290; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Terao M, 2006, J BIOL CHEM, V281, P19748, DOI 10.1074/jbc.M600850200; WAHL RC, 1982, J BIOL CHEM, V257, P1354; Wang A, 2015, J BIOL CHEM, V290, P5092, DOI 10.1074/jbc.M114.627661; Wilder Paul T, 2010, Int J High Throughput Screen, V2010, P109	43	65	67	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2015	11	10					779	+		10.1038/NCHEMBIO.1895	http://dx.doi.org/10.1038/NCHEMBIO.1895			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR7NG	26322824				2022-12-25	WOS:000361536500010
J	Moutsianas, L; Jostins, L; Beecham, AH; Dilthey, AT; Xifara, DK; Ban, M; Shah, TS; Patsopoulos, NA; Alfredsson, L; Anderson, CA; Attfield, KE; Baranzini, SE; Barrett, J; Binder, TMC; Booth, D; Buck, D; Celius, EG; Cotsapas, C; D'Alfonso, S; Dendrou, CA; Donnelly, P; Dubois, B; Fontaine, B; Fugger, L; Goris, A; Gourraud, PA; Graetz, C; Hemmer, B; Hillert, J; Kockum, I; Leslie, S; Lill, CM; Martinelli-Boneschi, F; Oksenberg, JR; Olsson, T; Oturai, A; Saarela, J; Sondergaard, HB; Spurkland, A; Taylor, B; Winkelmann, J; Zipp, F; Haines, JL; Pericak-Vance, MA; Spencer, CCA; Stewart, G; Hafler, DA; Ivinson, AJ; Harbo, HF; Hauser, SL; De Jager, PL; Compston, A; McCauley, JL; Sawcer, S; McVean, G				Moutsianas, Loukas; Jostins, Luke; Beecham, Ashley H.; Dilthey, Alexander T.; Xifara, Dionysia K.; Ban, Maria; Shah, Tejas S.; Patsopoulos, Nikolaos A.; Alfredsson, Lars; Anderson, Carl A.; Attfield, Katherine E.; Baranzini, Sergio E.; Barrett, Jeffrey; Binder, Thomas M. C.; Booth, David; Buck, Dorothea; Celius, Elisabeth G.; Cotsapas, Chris; D'Alfonso, Sandra; Dendrou, Calliope A.; Donnelly, Peter; Dubois, Benedicte; Fontaine, Bertrand; Fugger, Lars; Goris, An; Gourraud, Pierre-Antoine; Graetz, Christiane; Hemmer, Bernhard; Hillert, Jan; Kockum, Ingrid; Leslie, Stephen; Lill, Christina M.; Martinelli-Boneschi, Filippo; Oksenberg, Jorge R.; Olsson, Tomas; Oturai, Annette; Saarela, Janna; Sondergaard, Helle Bach; Spurkland, Anne; Taylor, Bruce; Winkelmann, Juliane; Zipp, Frauke; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Spencer, Chris C. A.; Stewart, Graeme; Hafler, David A.; Ivinson, Adrian J.; Harbo, Hanne F.; Hauser, Stephen L.; De Jager, Philip L.; Compston, Alastair; McCauley, Jacob L.; Sawcer, Stephen; McVean, Gil		Int IBD Genetics Consortium IIBDGC; Int Multiple Sclerosis Genetics	Class II HLA interactions modulate genetic risk for multiple sclerosis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DISEASE; MHC; EPISTASIS; ERAP1; METAANALYSIS; POPULATION; VARIANTS; HLA-DRB1	Association studies have greatly refined the understanding of how variation within the human leukocyte antigen (HLA) genes influences risk of multiple sclerosis. However, the extent to which major effects are modulated by interactions is poorly characterized. We analyzed high-density SNP data on 17,465 cases and 30,385 controls from 11 cohorts of European ancestry, in combination with imputation of classical HLA alleles, to build a high-resolution map of HLA genetic risk and assess the evidence for interactions involving classical HLA alleles. Among new and previously identified class II risk alleles (HLA-DRB1*15:01, HLA-DRB1*13:03, HLA-DRB1*03:01, HLA-DRB1*08:01 and HLA-DQB1*03:02) and class I protective alleles (HLA-A*02:01, HLA-B*44:02, HLA-B*38:01 and HLA-B*55:01), we find evidence for two interactions involving pairs of class II alleles: HLA-DQA1*01:01-HLA-DRB1*15:01 and HLA-DQB1*03:01-HLA-DQB1*03:02. We find no evidence for interactions between classical HLA alleles and non-HLA risk-associated variants and estimate a minimal effect of polygenic epistasis in modulating major risk alleles.	[Moutsianas, Loukas; Jostins, Luke; Dilthey, Alexander T.; Xifara, Dionysia K.; Donnelly, Peter; Spencer, Chris C. A.; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Beecham, Ashley H.; Pericak-Vance, Margaret A.; McCauley, Jacob L.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Gen, Miami, FL 33136 USA; [Ban, Maria; Compston, Alastair; Sawcer, Stephen] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Shah, Tejas S.; Anderson, Carl A.; Barrett, Jeffrey] Wellcome Trust Sanger Inst, Hinxton, England; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Patsopoulos, Nikolaos A.; Cotsapas, Chris; Hafler, David A.; De Jager, Philip L.] Broad Inst Harvard Univ & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med IMM, Stockholm, Sweden; [Attfield, Katherine E.; Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Baranzini, Sergio E.; Gourraud, Pierre-Antoine; Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, Sandler Neurosci Ctr, San Francisco, CA USA; [Binder, Thomas M. C.] Univ Med Ctr Hamburg Eppendorf, Dept Transfus Med, HLA Lab, Hamburg, Germany; [Booth, David; Stewart, Graeme] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Buck, Dorothea; Hemmer, Bernhard; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany; [Celius, Elisabeth G.; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, N-0450 Oslo, Norway; [Cotsapas, Chris; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol & Immunol, New Haven, CT USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [D'Alfonso, Sandra] Univ Piemonte Orientale, Dept Hlth Sci, IRCAD, Novara, Italy; [Dendrou, Calliope A.; Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Dubois, Benedicte; Goris, An] Katholieke Univ Leuven, Dept Neurosci, Lab Neuroimmunol, Leuven, Belgium; [Fontaine, Bertrand] Univ Paris 06, INSERM, CNRS, AP HP,Dept Malad Syst Nerveux, Paris, France; [Fontaine, Bertrand] Pitie Salpetriere, UMRS 1127 7225, Inst Cerveau Moelle Spinal Cord, Paris, France; [Fontaine, Bertrand] Pitie Salpetriere, Inst Brain, Paris, France; [Graetz, Christiane; Lill, Christina M.; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Med Ctr, Rhine Main Neurosci Network Rmn2, Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany; [Hemmer, Bernhard; Winkelmann, Juliane] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Hemmer, Bernhard] German Competence Network Multiple Sclerosis KKNM, Munich, Germany; [Hillert, Jan; Kockum, Ingrid; Olsson, Tomas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Leslie, Stephen] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Leslie, Stephen] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Lill, Christina M.] Univ Lubeck, Inst Neurogenet & Integrat, Platform Genome Analyt, Lubeck, Germany; [Lill, Christina M.] Univ Lubeck, Inst Expt Gen, Platform Genome Analyt, Lubeck, Germany; [Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Lab Genet Neurol Complex Disorders, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Dept Neurol, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Oturai, Annette; Sondergaard, Helle Bach] Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, Dept Neurol, Copenhagen, Denmark; [Saarela, Janna] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Spurkland, Anne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Taylor, Bruce] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-80290 Munich, Germany; [Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, Munich, Germany; [Winkelmann, Juliane] Stanford Univ, Ctr Sleep Sci & Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Hafler, David A.] Broad Inst Harvard Univ & MIT, Cambridge, MA USA; [Ivinson, Adrian J.] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Boston, MA USA; [Harbo, Hanne F.] Univ Oslo, Oslo, Norway	University of Oxford; Wellcome Centre for Human Genetics; University of Miami; University of Cambridge; Wellcome Trust Sanger Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karolinska Institutet; University of Oxford; University of California System; University of California San Francisco; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sydney; Westmead Institute for Medical Research; Technical University of Munich; University of Oslo; Yale University; Yale University; University of Eastern Piedmont Amedeo Avogadro; University of Oxford; KU Leuven; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Johannes Gutenberg University of Mainz; University of Munich; Karolinska Institutet; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Lubeck; University of Lubeck; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Copenhagen; University of Helsinki; University of Oslo; University of Tasmania; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University; Vanderbilt University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Oslo	McVean, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mcvean@well.ox.ac.uk	Celius, Elisabeth Gulowsen/S-1387-2019; Hemmer, Bernhard/GPX-8451-2022; Haines, Jonathan/C-3374-2012; Hauser, Stephen L/J-2978-2016; Hemmer, Bernhard/AAT-8388-2021; Alfredsson, Lars/AAC-9007-2019; D'Amato, Mauro/F-2450-2010; Andersen, Vibeke/I-7932-2012; D'Amato, Mauro/B-5050-2019; Gourraud, Pierre-Antoine FD/O-3024-2015; Spurkland, Anne/L-3369-2019; Lill, Christina M/GSI-4054-2022; Goris, An/L-5852-2019; Kockum, Ingrid/O-8781-2018; Franke, Andre/B-2151-2010; Goris, An/F-2943-2010; Dubois, Benedicte/A-4338-2019; Zipp, Frauke/C-9968-2015; D'Alfonso, Sandra/K-7295-2014; Lill, Christina/J-9449-2015	Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Hemmer, Bernhard/0000-0001-5985-6784; Haines, Jonathan/0000-0002-4351-4728; Alfredsson, Lars/0000-0003-1688-6697; D'Amato, Mauro/0000-0003-2743-5197; Andersen, Vibeke/0000-0002-0127-2863; D'Amato, Mauro/0000-0003-2743-5197; Spurkland, Anne/0000-0003-4421-0766; Goris, An/0000-0002-1276-6682; Kockum, Ingrid/0000-0002-0867-4726; Franke, Andre/0000-0003-1530-5811; Goris, An/0000-0002-1276-6682; Dendrou, Calliope/0000-0003-1179-4021; Dubois, Benedicte/0000-0003-0604-8702; Zipp, Frauke/0000-0002-1231-1928; Sawcer, Stephen/0000-0001-7685-0974; Sondergaard, Helle Bach/0000-0001-9435-0658; Attfield, Kathrine/0000-0003-3387-521X; Winkelmann, Juliane/0000-0003-2667-9691; Saarela, Janna/0000-0002-0853-6219; D'Alfonso, Sandra/0000-0002-3983-9925; Patsopoulos, Nikolaos/0000-0003-3757-8941; Lill, Christina/0000-0002-2805-1307; Rapa, Anna/0000-0002-5523-5224; Anderson, Carl/0000-0003-1719-7009; Harrison, Pille/0000-0003-4117-6910; Gourraud, Pierre-Antoine/0000-0003-1131-9554; martinelli boneschi, filippo/0000-0002-9955-1368; Dilthey, Alexander/0000-0002-6394-4581; Olsson, Tomas/0000-0002-2938-1877; Moutsianas, Loukas/0000-0001-5453-345X; McCauley, Jacob/0000-0002-1805-1733; Baranzini, Sergio/0000-0003-0067-194X	US National Institutes of Health [NS049477, NS26799, R01NS032830, RC2NS070340, R01NS067305, RC2GM093080]; Wellcome Trust [085475/B/08/Z, 085475/Z/08/Z, 084702/Z/08/Z, 098051]; UK MS Society [857/07, 861/07, 862/07, 894/08, 898/08, 955/11]; UK Medical Research Council [G0700061]; NMSS (South Florida chapter) [RG 4198-A-1, 4680-A-1, FG 1938-A-1, JF2138A1, JF-2137A4]; Cambridge National Institute for Health Research (NIHR) British Research Council (BRC); DeNDRon; Bibbi and Niels Jensens Foundation; Swedish Brain Foundation; Swedish Research and County Council; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; AFA Foundation; Foundation for Strategic Research; Stockholm County Council [592229]; Strategic Cardiovascular and Diabetes Programmes of Karolinska Institutet; Swedish Council for Working Life and Social Research; INSERM; ARSEP; AFM; GIS-IBISA; BMBF; KKNMS [01GI0917]; Deutsche Forschungsgemeinschaft [530/1-1]; Munich Biotec Cluster M4; Fidelity Biosciences Research Initiative; FWO-Vlaanderen; Research Fund KU Leuven [OT/11/087]; Belgian Neurological Society; Belgian Charcot Foundation; Gemeinnutzige Hertie Stiftung; CRPPMS University Zurich; Danish MS Society; Danish Council for Strategic Research; Center of Excellence for Disease Genetics of the Academy of Finland; Sigrid Juselius Foundation; FISM [2011/R/14]; Fondazione Cariplo [2010-0728]; MIUR (PRIN); CRT Foundation Turin; Italian Ministry of Health [502/92]; Italian Foundation for Multiple Sclerosis; Multiple Sclerosis Association of Oslo; Norwegian Research Council [143153, 143410]; South-Eastern Norwegian Health Authorities [51852/ILM]; Australian National Health and Medical Research Council [633275, 1053756]; INSPE; Helsinki University Central Hospital Research Foundation; MRC [G0700061] Funding Source: UKRI; Medical Research Council [G0700061, G0000934] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, RC2NS070340, R01NS032830, R25NS070680, R01NS067305, R01NS049477] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); UK MS Society; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NMSS (South Florida chapter); Cambridge National Institute for Health Research (NIHR) British Research Council (BRC); DeNDRon; Bibbi and Niels Jensens Foundation; Swedish Brain Foundation; Swedish Research and County Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); AFA Foundation; Foundation for Strategic Research; Stockholm County Council(Stockholm County Council); Strategic Cardiovascular and Diabetes Programmes of Karolinska Institutet; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ARSEP; AFM(Association Francaise contre les Myopathies); GIS-IBISA; BMBF(Federal Ministry of Education & Research (BMBF)); KKNMS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Munich Biotec Cluster M4; Fidelity Biosciences Research Initiative; FWO-Vlaanderen(FWO); Research Fund KU Leuven(KU Leuven); Belgian Neurological Society; Belgian Charcot Foundation; Gemeinnutzige Hertie Stiftung; CRPPMS University Zurich; Danish MS Society; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Center of Excellence for Disease Genetics of the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Fondazione Cariplo(Fondazione Cariplo); MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CRT Foundation Turin(Fondazione CRT); Italian Ministry of Health(Ministry of Health, Italy); Italian Foundation for Multiple Sclerosis; Multiple Sclerosis Association of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norwegian Health Authorities; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); INSPE; Helsinki University Central Hospital Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals, nurses and referring physicians who participated in this study. This project was supported by the US National Institutes of Health (NS049477, NS26799, R01NS032830, RC2NS070340, R01NS067305 and RC2GM093080), the Wellcome Trust (085475/B/08/Z, 085475/Z/08/Z, 084702/Z/08/Z and 098051), the UK MS Society (857/07, 861/07, 862/07, 894/08, 898/08 and 955/11), the UK Medical Research Council (G0700061), Naomi Branson, the Sainsbury Foundation, NMSS (RG 4198-A-1 and 4680-A-1, FG 1938-A-1, JF2138A1, JF-2137A4 and South Florida chapter), the Cambridge National Institute for Health Research (NIHR) British Research Council (BRC), DeNDRon, the Bibbi and Niels Jensens Foundation, the Swedish Brain Foundation, the Swedish Research and County Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the AFA Foundation, the Foundation for Strategic Research, the Stockholm County Council (592229), the Strategic Cardiovascular and Diabetes Programmes of Karolinska Institutet, the Swedish Council for Working Life and Social Research, INSERM, ARSEP, AFM, GIS-IBISA, BMBF, KKNMS (01GI0917), Deutsche Forschungsgemeinschaft (530/1-1), Munich Biotec Cluster M4, the Fidelity Biosciences Research Initiative, FWO-Vlaanderen, Research Fund KU Leuven (OT/11/087), the Belgian Neurological Society, the Belgian Charcot Foundation, Gemeinnutzige Hertie Stiftung, CRPPMS University Zurich, the Danish MS Society, the Danish Council for Strategic Research, the Center of Excellence for Disease Genetics of the Academy of Finland, the Sigrid Juselius Foundation, the Helsinki University Central Hospital Research Foundation, FISM (2011/R/14), Fondazione Cariplo (2010-0728), MIUR (PRIN08), CRT Foundation Turin, the Italian Ministry of Health (502/92), the Italian Foundation for Multiple Sclerosis, INSPE, the Multiple Sclerosis Association of Oslo, the Norwegian Research Council (143153 and 143410), the South-Eastern Norwegian Health Authorities (51852/ILM) and the Australian National Health and Medical Research Council (633275 and 1053756).	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Field J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013454; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; JERSILD C, 1972, LANCET, V1, P1240; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kwon OJ, 1999, ARCH NEUROL-CHICAGO, V56, P555, DOI 10.1001/archneur.56.5.555; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Ligers A, 2001, AM J HUM GENET, V69, P900, DOI 10.1086/323480; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marrosu M, 2006, J NEUROL, V253, P208, DOI 10.1007/s00415-005-0957-y; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	36	206	210	6	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1107	+		10.1038/ng.3395	http://dx.doi.org/10.1038/ng.3395			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26343388	Green Accepted			2022-12-25	WOS:000361969900005
J	Will, B; Vogler, TO; Narayanagari, S; Bartholdy, B; Todorova, TI; Ferreira, MD; Chen, JH; Yu, YT; Mayer, J; Barreyro, L; Carvajal, L; Ben Neriah, D; Roth, M; van Oers, J; Schaetzlein, S; McMahon, C; Edelmann, W; Verma, A; Steidl, U				Will, Britta; Vogler, Thomas O.; Narayanagari, Swathi; Bartholdy, Boris; Todorova, Tihomira I.; Ferreira, Mariana da Silva; Chen, Jiahao; Yu, Yiting; Mayer, Jillian; Barreyro, Laura; Carvajal, Luis; Ben Neriah, Daniela; Roth, Michael; van Oers, Johanna; Schaetzlein, Sonja; McMahon, Christine; Edelmann, Winfried; Verma, Amit; Steidl, Ulrich			Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR PU.1; SEQUENCE BINDING-PROTEIN; MSH2 DEFICIENT MICE; SELF-RENEWAL; EXPRESSION; MUTATIONS; GENE; AGE; LEUKEMOGENESIS	Modest transcriptional changes caused by genetic or epigenetic mechanisms are frequent in human cancer. Although loss or near-complete loss of the hematopoietic transcription factor PU. 1 induces acute myeloid leukemia (AML) in mice, a similar degree of PU. 1 impairment is exceedingly rare in human AML; yet, moderate PU. 1 inhibition is common in AML patients. We assessed functional consequences of modest reductions in PU. 1 expression on leukemia development in mice harboring DNA lesions resembling those acquired during human stem cell aging. Heterozygous deletion of an enhancer of PU. 1, which resulted in a 35% reduction of PU. 1 expression, was sufficient to induce myeloid-biased preleukemic stem cells and their subsequent transformation to AML in a DNA mismatch repair-deficient background. AML progression was mediated by inhibition of expression of a PU. 1-cooperating transcription factor, Irf8. Notably, we found marked molecular similarities between the disease in these mice and human myelodysplastic syndrome and AML. This study demonstrates that minimal reduction of a key lineage-specific transcription factor, which commonly occurs in human disease, is sufficient to initiate cancer development, and it provides mechanistic insight into the formation and progression of preleukemic stem cells in AML.	[Will, Britta; Vogler, Thomas O.; Narayanagari, Swathi; Bartholdy, Boris; Todorova, Tihomira I.; Ferreira, Mariana da Silva; Chen, Jiahao; Mayer, Jillian; Barreyro, Laura; Carvajal, Luis; Ben Neriah, Daniela; Roth, Michael; van Oers, Johanna; Schaetzlein, Sonja; Edelmann, Winfried; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Yu, Yiting; Verma, Amit; Steidl, Ulrich] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med Oncol, Div Hematooncol, Bronx, NY 10467 USA; [McMahon, Christine] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Edelmann, Winfried; Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA; [Edelmann, Winfried] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Verma, Amit] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Inst Stem Cell & Regenerat Med Res, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Will, B (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.	britta.will@einstein.yu.edu; ulrich.steidl@einstein.yu.edu		Barreyro, Laura/0000-0002-9515-5579; Will, Britta/0000-0002-9534-6690; Chen, Jiahao/0000-0001-7719-3216; Ben Neriah, Daniela/0000-0003-4871-0098	New York Stem Cell Science (NYSTEM) [C029154]; US National Institutes of Health (NIH) [R00CA131503]; Albert Einstein Cancer Center [P30CA013330]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA166429, R00CA131503, P30CA013330] Funding Source: NIH RePORTER	New York Stem Cell Science (NYSTEM); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank K. Ozato for kindly providing the Irf8 expression vector. We thank A. Skoultchi, K. Gritsman and members of the Steidl laboratory for very helpful discussions and suggestions. We also thank G. Simkin and D. Sun of the Einstein Stem Cell Isolation and Xenotransplantation Facility (funded through New York Stem Cell Science (NYSTEM) grant no. C029154), C. Montagna and Z.X. Yang from the Einstein Genome Imaging Facility, D. Reynolds and W. Tran from the Einstein Genomics Core Facility and P. Schultes from the Einstein Department of Cell Biology for expert technical assistance. This work was supported by US National Institutes of Health (NIH) grant R00CA131503 (U.S.), Albert Einstein Cancer Center Core Support grant P30CA013330 and The Gabrielle's Angel Foundation for Cancer Research (U.S.). U.S. is a Research Scholar of the Leukemia and Lymphoma Society and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine.	Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Bonadies N, 2010, BLOOD, V115, P331, DOI 10.1182/blood-2009-03-212225; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Genik PC, 2014, RADIAT RES, V182, P310, DOI 10.1667/RR13738.1; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; Mao GG, 2008, CELL RES, V18, P281, DOI 10.1038/cr.2008.14; Meraro D, 2002, J IMMUNOL, V168, P6224, DOI 10.4049/jimmunol.168.12.6224; MERCOLA M, 1983, SCIENCE, V221, P663, DOI 10.1126/science.6306772; Metcalf D, 2006, P NATL ACAD SCI USA, V103, P1486, DOI 10.1073/pnas.0510616103; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; Montagna C, 2003, CANCER RES, V63, P2179; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Mueller BU, 2006, BLOOD, V107, P3330, DOI 10.1182/blood-2005-07-3068; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shimizu R, 2004, MOL CELL BIOL, V24, P10814, DOI 10.1128/MCB.24.24.10814-10825.2004; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Staber PB, 2013, MOL CELL, V49, P934, DOI 10.1016/j.molcel.2013.01.007; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yoshida H, 2007, MOL CELL BIOL, V27, P5819, DOI 10.1128/MCB.02422-06; Zhang SL, 2002, MUTAT RES-FUND MOL M, V500, P67, DOI 10.1016/S0027-5107(01)00297-4; Zhu YM, 1999, BLOOD, V94, P733, DOI 10.1182/blood.V94.2.733.414k03_733_740	55	86	86	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1172	+		10.1038/nm.3936	http://dx.doi.org/10.1038/nm.3936			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26343801	Green Accepted			2022-12-25	WOS:000362355400019
J	Medema, MH; Fischbach, MA				Medema, Marnix H.; Fischbach, Michael A.			Computational approaches to natural product discovery	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; BIOSYNTHETIC GENE CLUSTERS; COMPLETE GENOME SEQUENCE; IN-SILICO PREDICTION; MASS-SPECTROMETRY; SECONDARY METABOLISM; SUBSTRATE-SPECIFICITY; ADENYLATION DOMAINS; MINIMUM INFORMATION; DATABASE	Starting with the earliest Streptomyces genome sequences, the promise of natural product genome mining has been captivating: genomics and bioinformatics would transform compound discovery from an ad hoc pursuit to a high-throughput endeavor. Until recently, however, genome mining has advanced natural product discovery only modestly. Here, we argue that the development of algorithms to mine the continuously increasing amounts of (meta) genomic data will enable the promise of genome mining to be realized. We review computational strategies that have been developed to identify biosynthetic gene clusters in genome sequences and predict the chemical structures of their products. We then discuss networking strategies that can systematize large volumes of genetic and chemical data and connect genomic information to metabolomic and phenotypic data. Finally, we provide a vision of what natural product discovery might look like in the future, specifically considering longstanding questions in microbial ecology regarding the roles of metabolites in interspecies interactions.	[Medema, Marnix H.] Wageningen Univ, Bioinformat Grp, NL-6700 AP Wageningen, Netherlands; [Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	Wageningen University & Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Medema, MH (corresponding author), Wageningen Univ, Bioinformat Grp, NL-6700 AP Wageningen, Netherlands.	marnix.medema@wur.nl; fischbach@fischbachgroup.org	Medema, Marnix H./AAR-3138-2021	Medema, Marnix H./0000-0002-2191-2821; Fischbach, Michael/0000-0003-3079-8247	Rubicon grant of the Netherlands Organization for Scientific Research (NWO) [Rubicon 825.13.001]; W.M. Keck Foundation; David and Lucile Packard Foundation; Glenn Foundation; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease program; Program for Breakthrough Biomedical Research; US Defense Advanced Research Projects Agency (DARPA) award [HR0011-12-C-0067]; US National Institutes of Health [OD007290, AI101018, GM081879, DK101674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	Rubicon grant of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); W.M. Keck Foundation(W.M. Keck Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Glenn Foundation; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease program; Program for Breakthrough Biomedical Research; US Defense Advanced Research Projects Agency (DARPA) award(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to P. Cimermancic, M. Donia and members of the Fischbach group for helpful conversations. This work was supported by a Rubicon grant of the Netherlands Organization for Scientific Research (NWO; Rubicon 825.13.001) to M.H.M. and by grants from the W.M. Keck Foundation (M.A.F.), the David and Lucile Packard Foundation (M.A.F.), the Glenn Foundation (M.A.F.), the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease program (M.A.F.), the Program for Breakthrough Biomedical Research (M.A.F.), US Defense Advanced Research Projects Agency (DARPA) award HR0011-12-C-0067 (M.A.F.) and US National Institutes of Health grants OD007290, AI101018, GM081879 and DK101674 (M.A.F.).	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Baranasic D, 2014, J IND MICROBIOL BIOT, V41, P461, DOI 10.1007/s10295-013-1322-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Blin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089420; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Boddy CN, 2014, J IND MICROBIOL BIOT, V41, P443, DOI 10.1007/s10295-013-1368-1; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Bouslimani A, 2014, NAT PROD REP, V31, P718, DOI 10.1039/c4np00044g; Caboche S, 2008, NUCLEIC ACIDS RES, V36, pD326, DOI 10.1093/nar/gkm792; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Cardenas ME, 1999, CLIN MICROBIOL REV, V12, P583, DOI 10.1128/CMR.12.4.583; Charlop-Powers Z, 2014, CURR OPIN MICROBIOL, V19, P70, DOI 10.1016/j.mib.2014.05.021; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Conway KR, 2013, NUCLEIC ACIDS RES, V41, pD402, DOI 10.1093/nar/gks993; Crawford JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/c1cc11574j; Cruz-Morales P, 2015, BIORXIV, DOI [10.1101/020503, DOI 10.1101/020503, 10.1101/0205]; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Diminic J, 2013, J IND MICROBIOL BIOT, V40, P653, DOI 10.1007/s10295-013-1252-z; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Epstein SS, 2013, CURR OPIN MICROBIOL, V16, P636, DOI 10.1016/j.mib.2013.08.003; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Frasch HJ, 2013, CURR OPIN BIOTECH, V24, P1144, DOI 10.1016/j.copbio.2013.03.006; Guthals A, 2012, MOL BIOSYST, V8, P2535, DOI 10.1039/c2mb25085c; Hadjithomas M, 2015, MBIO, V6, DOI 10.1128/mBio.00932-15; Harborne J. B., 2015, DICT NATURAL PRODUCT; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Ichikawa N, 2013, NUCLEIC ACIDS RES, V41, pD408, DOI 10.1093/nar/gks1177; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kampa A, 2013, P NATL ACAD SCI USA, V110, pE3129, DOI 10.1073/pnas.1305867110; Kersten RD, 2013, P NATL ACAD SCI USA, V110, pE4407, DOI 10.1073/pnas.1315492110; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Khayatt BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062136; Klassen JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-14; Krug D, 2014, NAT PROD REP, V31, P768, DOI 10.1039/c3np70127a; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kwan JC, 2012, P NATL ACAD SCI USA, V109, P20655, DOI 10.1073/pnas.1213820109; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Lin K, 2006, BIOINFORMATICS, V22, P2081, DOI 10.1093/bioinformatics/btl366; Lucas X, 2013, NUCLEIC ACIDS RES, V41, pD1130, DOI 10.1093/nar/gks1253; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Medema MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003822; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Medema MH, 2011, NAT REV MICROBIOL, V9, P131, DOI 10.1038/nrmicro2478; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Mohimani H, 2014, J NAT PROD, V77, P1902, DOI 10.1021/np500370c; Mohimani H, 2014, ACS CHEM BIOL, V9, P1545, DOI 10.1021/cb500199h; Mohimani H, 2011, J PROTEOME RES, V10, P4505, DOI 10.1021/pr200323a; Nakamura Y, 2014, PLANT CELL PHYSIOL, V55, DOI [10.1093/pcp/pct176, 10.1093/pcp/pct140]; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Owen JG, 2013, P NATL ACAD SCI USA, V110, P11797, DOI 10.1073/pnas.1222159110; Pelzer S, 2005, E SCHERING RES FDN W, V51, P233; Pence HE, 2010, J CHEM EDUC, V87, P1123, DOI 10.1021/ed100697w; Piel J, 2005, J NAT PROD, V68, P472, DOI 10.1021/np049612d; Potts MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004657; Poulsen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016763; Prieto C, 2012, BIOINFORMATICS, V28, P426, DOI 10.1093/bioinformatics/btr659; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reddy BVB, 2014, CHEM BIOL, V21, P1023, DOI 10.1016/j.chembiol.2014.06.007; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Schulze CJ, 2013, CHEM BIOL, V20, P285, DOI 10.1016/j.chembiol.2012.12.007; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002; Tae H, 2009, BIOPROC BIOSYST ENG, V32, P723, DOI 10.1007/s00449-008-0296-3; Takeda I, 2014, DNA RES, V21, P447, DOI 10.1093/dnares/dsu010; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Weber T, 2014, INT J MED MICROBIOL, V304, P230, DOI 10.1016/j.ijmm.2014.02.001; Weng J-K, 2012, Cold Spring Harb Symp Quant Biol, V77, P309, DOI 10.1101/sqb.2012.77.014787; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Wilson MC, 2013, CHEM BIOL, V20, P636, DOI 10.1016/j.chembiol.2013.04.011; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	94	266	272	7	188	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					639	648		10.1038/NCHEMBIO.1884	http://dx.doi.org/10.1038/NCHEMBIO.1884			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26284671	Green Accepted			2022-12-25	WOS:000359954700007
J	Elsner, M				Elsner, Markus			New PAMs for Cas	NATURE BIOTECHNOLOGY			English	Editorial Material							NUCLEASES							Elsner, Markus/0000-0001-7227-5212				Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117	3	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					829	829		10.1038/nbt.3317	http://dx.doi.org/10.1038/nbt.3317			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252142	Bronze			2022-12-25	WOS:000359274900019
J	Lyon, RP; Bovee, TD; Doronina, SO; Burke, PJ; Hunter, JH; Neff-LaFord, HD; Jonas, M; Anderson, ME; Setter, JR; Senter, PD				Lyon, Robert P.; Bovee, Tim D.; Doronina, Svetlana O.; Burke, Patrick J.; Hunter, Joshua H.; Neff-LaFord, Haley D.; Jonas, Mechthild; Anderson, Martha E.; Setter, Jocelyn R.; Senter, Peter D.			Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index	NATURE BIOTECHNOLOGY			English	Article							SITE-SPECIFIC CONJUGATION; LINKERS	The in vitro potency of antibody-drug conjugates (ADCs) increases with the drug-to-antibody ratio (DAR); however, ADC plasma clearance also increases with DAR, reducing exposure and in vivo efficacy. Here we show that accelerated clearance arises from ADC hydrophobicity, which can be modulated through drug-linker design. We exemplify this using hydrophilic auristatin drug linkers and PEGylated ADCs that yield uniform, high-DAR ADCs with superior in vivo performance.	[Lyon, Robert P.; Bovee, Tim D.; Doronina, Svetlana O.; Burke, Patrick J.; Hunter, Joshua H.; Setter, Jocelyn R.; Senter, Peter D.] Seattle Genet, Dept Chem, Bothell, WA 98021 USA; [Neff-LaFord, Haley D.] Seattle Genet, Dept Pharmacol & Toxicol, Bothell, WA USA; [Jonas, Mechthild] Seattle Genet, Dept Translat Res, Bothell, WA USA; [Anderson, Martha E.] Seattle Genet, Dept Preclin Res, Bothell, WA USA	Seattle Genetics; Seattle Genetics; Seattle Genetics; Seattle Genetics	Lyon, RP (corresponding author), Seattle Genet, Dept Chem, Bothell, WA 98021 USA.	rlyon@seagen.com						Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Herbertson RA, 2009, CLIN CANCER RES, V15, P6709, DOI 10.1158/1078-0432.CCR-09-0536; Jeffrey SC, 2006, BIOCONJUGATE CHEM, V17, P831, DOI 10.1021/bc0600214; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; King HD, 2002, J MED CHEM, V45, P4336, DOI 10.1021/jm020149g; Lyori R.P., 2012, METHOD ENZYMOL, V502, P123; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Miller ML, 2004, J MED CHEM, V47, P4802, DOI 10.1021/jm049705s; Moon SJ, 2008, J MED CHEM, V51, P6916, DOI 10.1021/jm800719t; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; Wang LT, 2005, PROTEIN SCI, V14, P2436, DOI 10.1110/ps.051478705; Zhao RY, 2011, J MED CHEM, V54, P3606, DOI 10.1021/jm2002958	14	279	296	10	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					733	735		10.1038/nbt.3212	http://dx.doi.org/10.1038/nbt.3212			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26076429				2022-12-25	WOS:000358396100028
J	Tan, YP; Hoon, S; Guerette, PA; Wei, W; Ghadban, A; Hao, C; Miserez, A; Waite, JH				Tan, YerPeng; Hoon, Shawn; Guerette, Paul A.; Wei, Wei; Ghadban, Ali; Hao, Cai; Miserez, Ali; Waite, J. Herbert			Infiltration of chitin by protein coacervates defines the squid beak mechanical gradient	NATURE CHEMICAL BIOLOGY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLEX COACERVATION; CROSS-LINKING; RNA-SEQ; DESIGN; CHEMISTRY; TISSUE; POLYELECTROLYTES; IDENTIFICATION; TROPOELASTIN	The beak of the jumbo squid Dosidicus gigas is a fascinating example of how seamlessly nature builds with mechanically mismatched materials. A 200-fold stiffness gradient begins in the hydrated chitin of the soft beak base and gradually increases to maximum stiffness in the dehydrated distal rostrum. Here, we combined RNA-Seq and proteomics to show that the beak contains two protein families. One family consists of chitin-binding proteins (DgCBPs) that physically join chitin chains, whereas the other family comprises highly modular histidine-rich proteins (DgHBPs). We propose that DgHBPs play multiple key roles during beak bioprocessing, first by forming concentrated coacervate solutions that diffuse into the DgCBP-chitin scaffold, and second by inducing crosslinking via an abundant GHG sequence motif. These processes generate spatially controlled desolvation, resulting in the impressive biomechanical gradient. Our findings provide novel molecular-scale strategies for designing functional gradient materials.	[Tan, YerPeng; Waite, J. Herbert] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Hoon, Shawn] ASTAR, Inst Biomed Sci, Mol Engn Lab, Singapore, Singapore; [Hoon, Shawn; Miserez, Ali] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Guerette, Paul A.] Nanyang Technol Univ, Energy Res Inst, ERI N, Singapore 639798, Singapore; [Guerette, Paul A.; Ghadban, Ali; Hao, Cai; Miserez, Ali] Nanyang Technol Univ, Sch Mat Sci & Engn, Biol & Biomimet Mat Lab, Singapore 639798, Singapore; [Wei, Wei; Waite, J. Herbert] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Agency for Science Technology & Research (A*STAR); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Waite, JH (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.	ali.miserez@ntu.edu.sg; herbert.waite@lifesci.ucsb.edu	Miserez, Ali/CAF-2662-2022; Miserez, Ali/D-1074-2010	Miserez, Ali/0000-0003-0864-8170; Miserez, Ali/0000-0003-0864-8170	University California, Santa Barbara; University of California, Office of the President; US National Institutes of Health Grant [R01-DE018468]; Materials Research Science & Engineering Centers (MRSEC) Program of the US National Science Foundation [DMR 1121053]; Singapore National Research Foundation (NRF); Biomedical Research Council, A*STAR, Singapore; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	University California, Santa Barbara; University of California, Office of the President(University of California System); US National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Materials Research Science & Engineering Centers (MRSEC) Program of the US National Science Foundation; Singapore National Research Foundation (NRF)(National Research Foundation, Singapore); Biomedical Research Council, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank J. Pavlovich of the UCSB Mass Spectrometry Facility for his help with obtaining nanoLC-MS/MS data. We thank D. DeMartini (UCSB) and the crew of the R/V New Horizon for obtaining squid beak samples from the Guayamas Basin (Mexico), and K.W. Kong and V. Gangu (Molecular Engineering Lab, Agency for Science, Technology and Research (A*STAR), Singapore) for technical assistance with the RNA-Seq analysis. Some of the work was conducted in the Biological NanoStructures Laboratory within the California NanoSystems Institute, supported by the University California, Santa Barbara, and the University of California, Office of the President. This work was supported in whole or in part by US National Institutes of Health Grant R01-DE018468 and the Materials Research Science & Engineering Centers (MRSEC) Program of the US National Science Foundation under Award No. DMR 1121053 (J.H.W.). A.M. was supported by the Singapore National Research Foundation (NRF) through a NRF Fellowship, and S.H. by the Biomedical Research Council, A*STAR, Singapore.	Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037; BSmith B.J., 2002, PROTEIN PROTOCOLS HD, P507; d' Orbigny A.D., 1847, VOYAGE AM MERIDIONAL; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Kruif CG, 2004, CURR OPIN COLLOID IN, V9, P340, DOI 10.1016/j.cocis.2004.09.006; DILLY PN, 1976, CELL TISSUE RES, V167, P229; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farren L, 2004, J EXP BIOL, V207, P735, DOI 10.1242/jeb.00814; Fleckman P, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034006; Fournier R.L., 2012, BASIC TRANSPORT PHEN; Fox JD, 2013, J AM CHEM SOC, V135, P5167, DOI 10.1021/ja4002713; Giesa T, 2013, ANNU REV BIOPHYS, V42, P651, DOI 10.1146/annurev-biophys-083012-130345; Goodarzi MT, 2009, SPRINGER PROTOC HAND, P1205, DOI 10.1007/978-1-59745-198-7_127; Gosline JM, 1999, J EXP BIOL, V202, P3295; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guerette PA, 2013, NAT BIOTECHNOL, V31, P908, DOI 10.1038/nbt.2671; Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P632; Hwang DS, 2010, SOFT MATTER, V6, P3232, DOI 10.1039/c002632h; Hwang DS, 2010, BIOMATERIALS, V31, P1080, DOI 10.1016/j.biomaterials.2009.10.041; Kaibara K, 2000, BIOMACROMOLECULES, V1, P100, DOI 10.1021/bm990006k; Kerwin JL, 1999, ANAL BIOCHEM, V268, P229, DOI 10.1006/abio.1998.3069; Kizilay E, 2011, ADV COLLOID INTERFAC, V167, P24, DOI 10.1016/j.cis.2011.06.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li AQ, 2001, ANAL CHEM, V73, P5395, DOI 10.1021/ac010619z; LIN J, 1993, APPL SPECTROSC, V47, P239, DOI 10.1366/0003702934048208; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Lu HH, 2013, ANNU REV BIOMED ENG, V15, P201, DOI 10.1146/annurev-bioeng-071910-124656; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Miserez A, 2007, ACTA BIOMATER, V3, P139, DOI 10.1016/j.actbio.2006.09.004; Miserez A, 2010, J BIOL CHEM, V285, P38115, DOI 10.1074/jbc.M110.161174; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Oparin AI., 1957, ORIGIN LIFE EARTH; Ortony JH, 2013, BIOMACROMOLECULES, V14, P1395, DOI 10.1021/bm4000579; PAZ MA, 1991, J BIOL CHEM, V266, P689; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Rubin DJ, 2010, ADV INSECT PHYSIOL, V38, P75, DOI 10.1016/S0065-2806(10)38003-9; Sahal D, 2002, ANAL BIOCHEM, V308, P405, DOI 10.1016/S0003-2697(02)00210-5; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spruijt E, 2010, SOFT MATTER, V6, P172, DOI 10.1039/b911541b; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200; Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716; Tan Y, 2013, BIOMACROMOLECULES, V14, P1715, DOI 10.1021/bm400448w; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei W, 2014, ACTA BIOMATER, V10, P1663, DOI 10.1016/j.actbio.2013.09.007; Weinbreck F, 2003, BIOMACROMOLECULES, V4, P293, DOI 10.1021/bm025667n; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zajac FE, 1989, CRC CRITICAL REV BIO, V17, P359; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zvarec O, 2013, LANGMUIR, V29, P10899, DOI 10.1021/la401858s	57	107	111	5	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					488	+		10.1038/NCHEMBIO.1833	http://dx.doi.org/10.1038/NCHEMBIO.1833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26053298	Green Published			2022-12-25	WOS:000356334600013
J	Cao, HZ; Wu, HL; Luo, RB; Huang, SJ; Sun, YH; Tong, X; Xie, YL; Liu, BH; Yang, HL; Zheng, HC; Li, J; Li, B; Wang, Y; Yang, F; Sun, P; Liu, SY; Gao, P; Huang, HD; Sun, J; Chen, D; He, GZ; Huang, WH; Huang, Z; Li, Y; Tellier, LCAM; Liu, X; Feng, Q; Xu, X; Zhang, XQ; Bolund, L; Krogh, A; Kristiansen, K; Drmanac, R; Drmanac, S; Nielsen, R; Li, SG; Wang, J; Yang, HM; Li, YR; Wong, GKS; Wang, J				Cao, Hongzhi; Wu, Honglong; Luo, Ruibang; Huang, Shujia; Sun, Yuhui; Tong, Xin; Xie, Yinlong; Liu, Binghang; Yang, Hailong; Zheng, Hancheng; Li, Jian; Li, Bo; Wang, Yu; Yang, Fang; Sun, Peng; Liu, Siyang; Gao, Peng; Huang, Haodong; Sun, Jing; Chen, Dan; He, Guangzhu; Huang, Weihua; Huang, Zheng; Li, Yue; Tellier, Laurent C. A. M.; Liu, Xiao; Feng, Qiang; Xu, Xun; Zhang, Xiuqing; Bolund, Lars; Krogh, Anders; Kristiansen, Karsten; Drmanac, Radoje; Drmanac, Snezana; Nielsen, Rasmus; Li, Songgang; Wang, Jian; Yang, Huanming; Li, Yingrui; Wong, Gane Ka-Shu; Wang, Jun			De novo assembly of a haplotype-resolved human genome	NATURE BIOTECHNOLOGY			English	Article							SEQUENCE; SNP; CANCER	The human genome is diploid, and knowledge of the variants on each chromosome is important for the interpretation of genomic information. Here we report the assembly of a haplotype-resolved diploid genome without using a reference genome. Our pipeline relies on fosmid pooling together with whole-genome shotgun strategies, based solely on next-generation sequencing and hierarchical assembly methods. We applied our sequencing method to the genome of an Asian individual and generated a 5.15-Gb assembled genome with a haplotype N50 of 484 kb. Our analysis identified previously undetected indels and 7.49 Mb of novel coding sequences that could not be aligned to the human reference genome, which include at least six predicted genes. This haplotype-resolved genome represents the most complete de novo human genome assembly to date. Application of our approach to identify individual haplotype differences should aid in translating genotypes to phenotypes for the development of personalized medicine.	[Cao, Hongzhi; Wu, Honglong; Luo, Ruibang; Huang, Shujia; Sun, Yuhui; Tong, Xin; Xie, Yinlong; Liu, Binghang; Yang, Hailong; Zheng, Hancheng; Li, Jian; Li, Bo; Wang, Yu; Yang, Fang; Sun, Peng; Liu, Siyang; Gao, Peng; Huang, Haodong; Sun, Jing; Chen, Dan; He, Guangzhu; Huang, Weihua; Huang, Zheng; Li, Yue; Tellier, Laurent C. A. M.; Liu, Xiao; Feng, Qiang; Xu, Xun; Zhang, Xiuqing; Bolund, Lars; Krogh, Anders; Kristiansen, Karsten; Nielsen, Rasmus; Li, Songgang; Wang, Jian; Yang, Huanming; Li, Yingrui; Wong, Gane Ka-Shu; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Cao, Hongzhi; Wu, Honglong] BGI Tianjin, Tianjin, Peoples R China; [Zheng, Hancheng; Li, Jian; Liu, Siyang; Tellier, Laurent C. A. M.; Liu, Xiao; Feng, Qiang; Krogh, Anders; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Luo, Ruibang; Xie, Yinlong; Liu, Binghang] HKU BGI Bioinformat Algorithms & Core Technol Res, Hong Kong, Hong Kong, Peoples R China; [Huang, Shujia; Sun, Yuhui; Wang, Yu; Huang, Haodong] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Bolund, Lars] Univ Aarhus, Inst Biomed, Aarhus, Denmark; [Bolund, Lars] Danish Ctr Translat Breast Canc Res, Copenhagen, Denmark; [Drmanac, Radoje; Drmanac, Snezana] Complete Genom Inc, Mountain View, CA USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Wang, Jian; Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Huanming; Wang, Jun] King Abdulaziz Univ, Princess AI Jawhara Albrahim Ctr Excellence Res H, Jeddah 21413, Saudi Arabia; [Li, Yingrui] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); University of Copenhagen; University of Hong Kong; South China University of Technology; Aarhus University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; King Abdulaziz University; University of Queensland; University of Alberta; University of Alberta; Macau University of Science & Technology; University of Hong Kong; University of Hong Kong	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	liyr@genomics.cn; gane@ualberta.ca; wangj@genomics.cn	WONG, Gane Ka-Shu/G-5784-2013; Li, Yingrui/K-1064-2015; Liu, Xiao/P-2732-2015; Xu, Xun/AAI-6763-2020; Nielsen, Rasmus/D-4405-2009; Kristiansen, Karsten/J-5148-2014; yang, hailong/GXH-9625-2022; Huang, Shujia/GXG-8583-2022; Liu, Siyang/M-6127-2014; Krogh, Anders/M-1541-2014; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	WONG, Gane Ka-Shu/0000-0001-6108-5560; Liu, Xiao/0000-0002-8073-0534; Xu, Xun/0000-0002-5338-5173; Nielsen, Rasmus/0000-0003-0513-6591; Kristiansen, Karsten/0000-0002-6024-0917; Huang, Shujia/0000-0003-2100-2534; Liu, Siyang/0000-0001-6780-9419; Luo, Ruibang/0000-0001-9711-6533; Melchior Tellier, Laurent Christian Asker/0000-0003-3240-4926; Krogh, Anders/0000-0002-5147-6282; Wang, Jun/0000-0002-2113-5874; liu, bh/0000-0002-4948-2835; Wang, Jun/0000-0002-8540-8931	State Key Development Program for Basic Research of China-973 Program [2011CB809202]; Shenzhen Municipal Government of China [JC201005260191A]; International Science and Technology Cooperation Program of Shenzhen [GJHZ20130417140835564]; Tianjin Municipal Science and Technology special funds for Enterprise Development [14ZXLJSY00320]; Alberta Innovates Technology Futures; Lundbeck Foundation [R151-2013-14439] Funding Source: researchfish	State Key Development Program for Basic Research of China-973 Program(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); Shenzhen Municipal Government of China; International Science and Technology Cooperation Program of Shenzhen; Tianjin Municipal Science and Technology special funds for Enterprise Development; Alberta Innovates Technology Futures; Lundbeck Foundation(Lundbeckfonden)	We wish to recognize BGI-Shenzhen's sequencing platform for generating the data in this study. We thank the faculty and staff at BGI-Shenzhen who contributed to this project especially to H. Jiang and B. Wang, who helped on the experimental part, D. Cao, L. Lin and M. Li, who helped on the validation part, and L. Goodman, W. Chen and H. Jia, who provided critical comments on the manuscript. This work was supported by the State Key Development Program for Basic Research of China-973 Program (no. 2011CB809202); the Shenzhen Municipal Government of China (no. JC201005260191A); International Science and Technology Cooperation Program of Shenzhen (GJHZ20130417140835564); Tianjin Municipal Science and Technology special funds for Enterprise Development (no. 14ZXLJSY00320). G.W. was also supported by Alberta Innovates Technology Futures.	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aghaei M, 2005, CLIN BIOCHEM, V38, P887, DOI 10.1016/j.clinbiochem.2005.05.015; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Cao HZ, 2013, HUM MUTAT, V34, P1715, DOI 10.1002/humu.22439; Dapprich J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn345; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Han WL, 2001, BIOCHEM J, V357, P127, DOI 10.1042/0264-6021:3570127; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Rusk N, 2012, NAT METHODS, V9, P36, DOI 10.1038/nmeth.1822; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Yang Mihi, 2012, Methods Mol Biol, V863, P67, DOI 10.1007/978-1-61779-612-8_5; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	50	47	51	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					617	+		10.1038/nbt.3200	http://dx.doi.org/10.1038/nbt.3200			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26006006	Green Published			2022-12-25	WOS:000356019700021
J	Cristescu, R; Lee, J; Nebozhyn, M; Kim, KM; Ting, JC; Wong, SS; Liu, JG; Yue, YG; Wang, J; Yu, K; Ye, XS; Do, IG; Liu, S; Gong, L; Fu, J; Jin, JG; Choi, MG; Sohn, TS; Lee, JH; Bae, JM; Kim, ST; Park, SH; Sohn, I; Jung, SH; Tan, P; Chen, RH; Hardwick, J; Kang, WK; Ayers, M; Dai, HY; Reinhard, C; Loboda, A; Kim, S; Aggarwal, A				Cristescu, Razvan; Lee, Jeeyun; Nebozhyn, Michael; Kim, Kyoung-Mee; Ting, Jason C.; Wong, Swee Seong; Liu, Jiangang; Yue, Yong Gang; Wang, Jian; Yu, Kun; Ye, Xiang S.; Do, In-Gu; Liu, Shawn; Gong, Lara; Fu, Jake; Jin, Jason Gang; Choi, Min Gew; Sohn, Tae Sung; Lee, Joon Ho; Bae, Jae Moon; Kim, Seung Tae; Park, Se Hoon; Sohn, Insuk; Jung, Sin-Ho; Tan, Patrick; Chen, Ronghua; Hardwick, James; Kang, Won Ki; Ayers, Mark; Dai Hongyue; Reinhard, Christoph; Loboda, Andrey; Kim, Sung; Aggarwal, Amit			Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes	NATURE MEDICINE			English	Article							GENE-EXPRESSION PATTERNS; MICROSATELLITE INSTABILITY; PREDICT SURVIVAL; REVEALS; ADENOCARCINOMA; CARCINOMAS; MUTATIONS; LANDSCAPE; PHENOTYPE; SIGNATURE	Gastric cancer, a leading cause of cancer-related deaths, is a heterogeneous disease. We aim to establish clinically relevant molecular subtypes that would encompass this heterogeneity and provide useful clinical information. We use gene expression data to describe four molecular subtypes linked to distinct patterns of molecular alterations, disease progression and prognosis. The mesenchymal-like type includes diffuse-subtype tumors with the worst prognosis, the tendency to occur at an earlier age and the highest recurrence frequency (63%) of the four subtypes. Microsatellite-unstable tumors are hyper-mutated intestinal-subtype tumors occurring in the antrum; these have the best overall prognosis and the lowest frequency of recurrence (22%) of the four subtypes. The tumor protein 53 (TP53)-active and TP53-inactive types include patients with intermediate prognosis and recurrence rates (with respect to the other two subtypes), with the TP53-active group showing better prognosis. We describe key molecular alterations in each of the four subtypes using targeted sequencing and genome-wide copy number microarrays. We validate these subtypes in independent cohorts in order to provide a consistent and unified framework for further clinical and preclinical translational research.	[Cristescu, Razvan; Nebozhyn, Michael; Chen, Ronghua; Hardwick, James; Ayers, Mark; Dai Hongyue; Loboda, Andrey] Merck Sharpe & Dohme, Merck Res Labs, Dept Genet & Pharmacogen, Boston, MA 02115 USA; [Lee, Jeeyun; Kim, Seung Tae; Park, Se Hoon; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Kim, Kyoung-Mee; Do, In-Gu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea; [Ting, Jason C.; Wong, Swee Seong; Liu, Jiangang; Yue, Yong Gang; Wang, Jian; Yu, Kun; Ye, Xiang S.; Reinhard, Christoph; Aggarwal, Amit] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Liu, Shawn; Gong, Lara] BGI Tech Solut, Hong Kong, Hong Kong, Peoples R China; [Fu, Jake; Jin, Jason Gang] Shanghai Biocorp, Shanghai, Peoples R China; [Choi, Min Gew; Sohn, Tae Sung; Lee, Joon Ho; Bae, Jae Moon; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg,Gastr Canc Ctr, Seoul, South Korea; [Sohn, Insuk; Jung, Sin-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol, Seoul, South Korea; [Tan, Patrick] Duke Natl Univ Singapore NUS Grad Sch Med, Program Canc & Stem Cell Biol, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore	Merck & Company; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Eli Lilly; Beijing Genomics Institute (BGI); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Loboda, A (corresponding author), Merck Sharpe & Dohme, Merck Res Labs, Dept Genet & Pharmacogen, Boston, MA 02115 USA.	Andrey_Loboda@merck.com; sungkimm@skku.edu; amit@lilly.com	Lee, Jee Yun/C-9646-2011; Park, Se Hoon/GMX-1199-2022; Kim, Sung/G-4114-2014; Liu, Xiao/P-2732-2015; kim, st/O-5928-2014	Park, Se Hoon/0000-0001-5084-9326; Liu, Xiao/0000-0002-8073-0534; 	Samsung Medical Center [GF01140111]; ACRG	Samsung Medical Center(Samsung); ACRG	The Asian Cancer Research Group (ACRG, http://www.asiancancerresearchgroup. org/about us.html) is a non-profit consortium of pharmaceutical industry and academic medical centers and genomics companies dedicated to accelerating research, and ultimately improving treatment for patients affected with the most commonly-diagnosed cancers in Asia. ACRG seeks to increase and improve the knowledge of cancers prevalent in Asia by generating comprehensive genomic data sets and sharing them freely with the scientific community in order to accelerate drug discovery efforts. This study is primarily supported by the ACRG. Samsung Medical Center provided partial support through grant no. GF01140111 (K.-M.K. and J. Lee).	An CH, 2005, CLIN CANCER RES, V11, P656; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [DOI 10.1038/NATURE11252, 10.1038/nature11252]; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee J, 2007, ANN ONCOL, V18, P886, DOI 10.1093/annonc/mdl501; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090133; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Li TH, 2013, J CLIN ONCOL, V31, P1039, DOI 10.1200/JCO.2012.45.3753; Liu JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4830; Liu ZJ, 2014, CLIN CANCER RES, V20, P4598, DOI 10.1158/1078-0432.CCR-13-3380; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mori Y, 2003, CANCER RES, V63, P4577; Mori Y, 2002, CANCER RES, V62, P3641; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Russell Sm, 2013, Head Neck Oncol, V5, P24; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Song HJ, 2010, GASTROENTEROLOGY, V139, P84, DOI 10.1053/j.gastro.2010.04.002; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Tay ST, 2003, CANCER RES, V63, P3309; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446; Wang GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063826; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wong SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6477; Wu YH, 2013, GUT, V62, P1100, DOI 10.1136/gutjnl-2011-301373; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	48	1141	1193	18	191	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					449	U217		10.1038/nm.3850	http://dx.doi.org/10.1038/nm.3850			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25894828				2022-12-25	WOS:000354068800011
J	Pepper, AR; Gala-Lopez, B; Pawlick, R; Merani, S; Kin, T; Shapiro, AMJ				Pepper, Andrew R.; Gala-Lopez, Boris; Pawlick, Rena; Merani, Shaheed; Kin, Tatsuya; Shapiro, A. M. James			A prevascularized subcutaneous device-less site for islet and cellular transplantation	NATURE BIOTECHNOLOGY			English	Article							PANCREATIC-ISLETS; TISSUE; IMPLANTS; NEOVASCULARIZATION; REVASCULARIZATION; REVERSAL; GROWTH; MICE	Transplantation of donor-derived islets into the liver is a successful cellular replacement therapy for individuals with diabetes. However, the hepatic vasculature is not an optimal transplant site for several reasons, including graft attrition and the inability to retrieve or image the islets. Here we describe islet transplantation into a prevascularized, subcutaneous site created by temporary placement of a medically approved vascular access catheter. In mice with streptozotocin (STZ)-induced diabetes, transplantation of similar to 500 syngeneic islets into the resulting 'device-less' space reversed diabetes in 91% of mice and maintained normoglycemia for >100 days. The approach was also effective in mice with pre-existing diabetes, in another mouse strain that mounts a more vigorous inflammatory response, and across an allogeneic barrier. These results demonstrate that transient priming of a subcutaneous site supports diabetes-reversing islet transplantation in mouse models without the need for a permanent cell-encapsulation device.	[Pepper, Andrew R.; Gala-Lopez, Boris; Pawlick, Rena; Merani, Shaheed; Kin, Tatsuya; Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Alberta Diabet Inst, Edmonton, AB, Canada; [Kin, Tatsuya; Shapiro, A. M. James] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta	Shapiro, AMJ (corresponding author), Univ Alberta, Clin Islet Transplant Program, Alberta Diabet Inst, Edmonton, AB, Canada.	amjs@islet.ca	Kin, Tatsuya/A-3776-2012; Merani, Shaheed/AFO-2184-2022	Kin, Tatsuya/0000-0002-5179-6067; Merani, Shaheed/0000-0002-3374-5303	Diabetes Research Institute Foundation of Canada; Collaborative Research & Innovation Opportunities (CRIO)-Alberta Innovates Healthcare Solutions; University Hospital Foundation/C.F; "Curly" and Gladys B. MacLachlan Fund; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Senior Clinical Scholarship from Alberta Innovates Healthcare Solutions; Alberta Innovates [201400106, 201400496, 201201154] Funding Source: researchfish	Diabetes Research Institute Foundation of Canada; Collaborative Research & Innovation Opportunities (CRIO)-Alberta Innovates Healthcare Solutions; University Hospital Foundation/C.F; "Curly" and Gladys B. MacLachlan Fund; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Senior Clinical Scholarship from Alberta Innovates Healthcare Solutions; Alberta Innovates	The authors thank H. Tanaka for Figure 1. We thank the Clinical Islet Laboratory and Alberta Health Services for providing human islet research preparations. This work was supported in part by the Diabetes Research Institute Foundation of Canada, Collaborative Research & Innovation Opportunities (CRIO)-Alberta Innovates Healthcare Solutions, and from University Hospital Foundation/C.F. "Curly" and Gladys B. MacLachlan Fund. All authors are members of the Alberta Diabetes Institute, and of the Canadian National Transplant Research Program. A.M.J.S. is supported through a Canada Research Chair in Transplantation Surgery and Regenerative Medicine, and through a Senior Clinical Scholarship from Alberta Innovates Healthcare Solutions.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Brekken RA, 2000, CANCER RES, V60, P5117; Brissova M, 2008, DIABETES, V57, P2269, DOI 10.2337/db08-0814; Costa PZ, 2013, LIFE SCI, V92, P1037, DOI 10.1016/j.lfs.2013.04.001; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; HELLERSTROM C, 1989, BAILLIERE CLIN GASTR, V3, P851, DOI 10.1016/0950-3528(89)90037-7; Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Nishimura R, 2011, TRANSPL P, V43, P3239, DOI 10.1016/j.transproceed.2011.09.095; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Pileggi A, 2001, CLIN CHIM ACTA, V310, P3, DOI 10.1016/S0009-8981(01)00503-4; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Plesner A, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/979527; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Saito T, 2011, TRANSPLANTATION, V92, P1231, DOI 10.1097/TP.0b013e3182375835; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Shapiro A.M., 2014, TXB ORGAN TRANSPLANT, V1, P904; Shapiro A. M., 2007, ISLET TRANSPLANTATIO; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.3.CO;2-V; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P598, DOI 10.1002/(SICI)1097-4636(19980615)40:4<598::AID-JBM11>3.3.CO;2-N; SIMEONOVIC CJ, 1986, AUST J EXP BIOL MED, V64, P37, DOI 10.1038/icb.1986.4; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224; Veriter S, 2013, CURR DIABETES REP, V13, P745, DOI 10.1007/s11892-013-0412-x; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580	38	204	210	12	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					518	U233		10.1038/nbt.3211	http://dx.doi.org/10.1038/nbt.3211			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25893782				2022-12-25	WOS:000354314500033
J	Teixeira, FK; Sanchez, CG; Hurd, TR; Seifert, JRK; Czech, B; Preall, JB; Hannon, GJ; Lehmann, R				Teixeira, Felipe K.; Sanchez, Carlos G.; Hurd, Thomas R.; Seifert, Jessica R. K.; Czech, Benjamin; Preall, Jonathan B.; Hannon, Gregory J.; Lehmann, Ruth			ATP synthase promotes germ cell differentiation independent of oxidative phosphorylation	NATURE CELL BIOLOGY			English	Article							STEM-CELL; DROSOPHILA OVARY; TRANSGENIC RNAI; GENE-EXPRESSION; SELF-RENEWAL; PROTEIN; GENOME; MITOCHONDRIA; MEMBRANE; PATHWAY	The differentiation of stem cells is a tightly regulated process essential for animal development and tissue homeostasis. Through this process, attainment of new identity and function is achieved by marked changes in cellular properties. Intrinsic cellular mechanisms governing stem cell differentiation remain largely unknown, in part because systematic forward genetic approaches to the problem have not been widely used(1,2). Analysing genes required for germline stem cell differentiation in the Drosophila ovary, we find that the mitochondrial ATP synthase plays a critical role in this process. Unexpectedly, the ATP synthesizing function of this complex was not necessary for differentiation, as knockdown of other members of the oxidative phosphorylation system did not disrupt the process. Instead, the ATP synthase acted to promote the maturation of mitochondrial cristae during differentiation through dimerization and specific upregulation of the ATP synthase complex. Taken together, our results suggest that ATP synthase-dependent crista maturation is a key developmental process required for differentiation independent of oxidative phosphorylation.	[Teixeira, Felipe K.; Sanchez, Carlos G.; Hurd, Thomas R.; Seifert, Jessica R. K.; Lehmann, Ruth] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Teixeira, Felipe K.; Sanchez, Carlos G.; Hurd, Thomas R.; Seifert, Jessica R. K.; Lehmann, Ruth] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst,Dept Cell Biol, New York, NY 10016 USA; [Czech, Benjamin; Preall, Jonathan B.; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, HHMI, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; New York University; New York University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Hurd, TR (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	thomas.hurd@med.nyu.edu; ruth.lehmann@med.nyu.edu	Czech, Benjamin/AAJ-8592-2020; Hannon, Gregory/AAB-3568-2019	Czech, Benjamin/0000-0001-8471-0007; Lehmann, Ruth/0000-0002-8454-5651; Karam Teixeira, Felipe/0000-0001-7651-1657	NCATS NIH grant [UL1 TR00038]; NCI NIH grant [P30CA016087]; NIH [2P40OD010949-10A1, F31/HD080380, F32/GM082169, 5R01GM062534, R01/R37HD41900]; Bloomington Stock Center for reagents; EMBO; HFSP long-term fellowship; CIHR; Boehringer Ingelheim Fonds; ACS award [121614-PF-11-277-01-RMC]; Cancer Research UK [21143] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD080380, R01HD041900, R37HD041900] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534, F32GM082169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER	NCATS NIH grant; NCI NIH grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloomington Stock Center for reagents; EMBO(European Molecular Biology Organization (EMBO)); HFSP long-term fellowship; CIHR(Canadian Institutes of Health Research (CIHR)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); ACS award; Cancer Research UK(Cancer Research UK); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Malone, M. Murphy, J. Carroll, A. Sfeir, E. Skolnik, R. Cinalli, A. Zamparini and A. Blum for comments on the manuscript and advice. We thank F. Liang, C. Petzold and K. Dancel of the NYULMC OCS Microscopy Core for their assistance with transmission electron microscopy, and the NYULMC Immune Monitoring Core supported in part by NCATS NIH grant UL1 TR00038 and NCI NIH grant P30CA016087. We acknowledge the DGRC supported by NIH 2P40OD010949-10A1 and Bloomington Stock Center for reagents. F.K.T. was supported by EMBO and HFSP long-term fellowships, C.G.S. by NIH F31/HD080380, T.R.H. by CIHR, J.R.K.S. by NIH F32/GM082169, B.C. by a PhD fellowship from the Boehringer Ingelheim Fonds and J.B.P. by ACS award 121614-PF-11-277-01-RMC. This work was supported by the NIH (5R01GM062534) and a kind gift from K. W. Davis to G.J.H. G.J.H. is an investigator of the HHMI. R.L. is an HHMI investigator and is supported by NIH R01/R37HD41900.	Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Gilboa L, 2003, DEVELOPMENT, V130, P6625, DOI 10.1242/dev.00853; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; Liu NK, 2009, GENE DEV, V23, P2742, DOI 10.1101/gad.1820709; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018; Mitra K, 2012, J CELL BIOL, V197, P487, DOI 10.1083/jcb.201110058; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Rieger B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4103; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Suhai T, 2009, ELECTROPHORESIS, V30, P3622, DOI 10.1002/elps.200900114; Van Doren M, 1998, CURR BIOL, V8, P243; Vinayagam A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003629; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; Yan D, 2014, DEV CELL, V28, P459, DOI 10.1016/j.devcel.2014.01.020; Zaccai M, 1996, ZYGOTE, V4, P159, DOI 10.1017/S096719940000304X	41	70	75	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2015	17	5					689	U323		10.1038/ncb3165	http://dx.doi.org/10.1038/ncb3165			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CH1HG	25915123	Green Accepted			2022-12-25	WOS:000353771500016
J	Dullo, I; Phang, BH; Othman, R; Tan, SY; Vijayaraghavan, A; Goh, LK; Martin-Lopez, M; Marques, MM; Li, CW; Wang, DY; Marin, MC; Xian, W; McKeon, F; Sabapathy, K				Dullo, Iqbal; Phang, Beng Hooi; Othman, Rashidah; Tan, Soo Yong; Vijayaraghavan, Aadhitthya; Goh, Liang Kee; Martin-Lopez, Marta; Marques, Margarita M.; Li, Chun Wei; Wang, De Yun; Carmen Marin, Maria; Xian, Wa; McKeon, Frank; Sabapathy, Kanaga			Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome	NATURE CELL BIOLOGY			English	Article							WILD-TYPE P73; KINASE C-ABL; TUMOR-SUPPRESSOR; APOPTOTIC RESPONSE; FACTOR 1-ALPHA; IN-VITRO; CANCER; EXPRESSION; GROWTH; P53	The functional significance of the overexpression of unmutated TAp73, a homologue of the tumour suppressor p53, in multiple human cancers is unclear, but raises the possibility of unidentified roles in promoting tumorigenesis. We show here that TAp73 is stabilized by hypoxia, a condition highly prevalent in tumours, through HIF-1 ff -mediated repression of the ubiquitin ligase Siah1, which targets TAp73 for degradation. Consequently, TAp73-deficient tumours are less vascular and reduced in size, and conversely, TAp73 overexpression leads to increased vasculature. Moreover, we show that TAp73 is a critical regulator of the angiogenic transcriptome and is sufficient to directly activate the expression of several angiogenic genes. Finally, expression of TAp73 positively correlates with these angiogenic genes in several human tumours, and the angiogenic gene signature is sufficient to segregate the TAp73Hi-from TAp73Low-expressing tumours. These data demonstrate a pro-angiogenic role for TAp73 in supporting tumorigenesis, providing a rationale for its overexpression in cancers.	[Dullo, Iqbal; Phang, Beng Hooi; Othman, Rashidah; Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Tan, Soo Yong] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore; [Vijayaraghavan, Aadhitthya; Goh, Liang Kee; Sabapathy, Kanaga] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Martin-Lopez, Marta; Marques, Margarita M.; Carmen Marin, Maria] Inst Biomed IBIOMED, Leon 24071, Spain; [Li, Chun Wei; Wang, De Yun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Otolaryngol, Singapore 119228, Singapore; [Xian, Wa] ASTAR, Inst Med Biol, Singapore 138672, Singapore; [McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Sabapathy, Kanaga] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119228, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Sabapathy, K (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore.	cmrksb@nccs.com.sg	Marín Vieira, María del Carmen/B-8108-2015; Marin, Maria C/G-1040-2010; martin, marta/AAF-4198-2021; Marques, Margarita M/I-1260-2015	Marín Vieira, María del Carmen/0000-0002-7149-287X; Marin, Maria C/0000-0002-7149-287X; martin, marta/0000-0003-4430-8173; Marques, Margarita M/0000-0003-2818-035X; Dulloo, Iqbal/0000-0001-6899-8338; Tan, Soo-Yong/0000-0002-6348-2823	National Medical Research Council; Spanish Ministerio de Economia y Competitividad [SAF2012-36143]; FEDER funds	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministerio de Economia y Competitividad(Spanish Government); FEDER funds(European Commission)	We thank Y. Li (NUS), E. Mationg-Kalaw (SGH Path-NCCS Translational Laboratory) and M. Koh (Singhealth Tissue Repository) for technical assistance, and C. Lim and X. Min for help with statistical analysis. We are grateful to F. Mechta-Grigoriou, T. Hagen, S-I. Matsuzawa and T. W. Mak for the vegf-A promoter-luciferase, dnHIF-1 alpha, siah1 WT/Delta RING mutant plasmids, and the TAp73<SUP>-/-</SUP> and TAp73<SUP>+/+</SUP> MEFs, respectively. We also acknowledge the Advanced Molecular Pathology Laboratory (AMPL) for the histological services provided. This study was supported by grants from the National Medical Research Council to K.S., and by grant SAF2012-36143 from the Spanish Ministerio de Economia y Competitividad, co-financed by FEDER funds to M.C.M.	Agami R, 1999, NATURE, V399, P809; Amelio I, 2015, P NATL ACAD SCI USA, V112, P226, DOI 10.1073/pnas.1410609111; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bisso A, 2011, CURR PHARM DESIGN, V17, P578, DOI 10.2174/138161211795222667; Buhlmann S, 2008, BBA-REV CANCER, V1785, P207, DOI 10.1016/j.bbcan.2008.01.002; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Farhang Ghahremani M, 2013, CELL CYCLE, V12, P1331, DOI 10.4161/cc.24579; Fernandez-Alonso R., 2015, CELL DEATH DIFFER; Gong JG, 1999, NATURE, V399, P806; Hsiao TH, 2013, TRANSL CANCER RES, V2, P6, DOI 10.3978/j.issn.2218-676X.2012.12.04; Hsu YC, 2007, AM J OTOLARYNG, V28, P379, DOI 10.1016/j.amjoto.2006.11.004; Hu G, 1999, MOL CELL BIOL, V19, P724; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kang MJ, 2000, CLIN CANCER RES, V6, P1767; Kitadai Y, 2010, J ONCOL, V2010, DOI 10.1155/2010/468725; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Levrero M, 2000, J CELL SCI, V113, P1661; Li CW, 2011, J ALLERGY CLIN IMMUN, V127, P765, DOI 10.1016/j.jaci.2010.12.011; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lin KW, 2004, NEOPLASIA, V6, P546, DOI 10.1593/neo.04205; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Potter C, 2004, CELL CYCLE, V3, P164; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Salimath B., 2001, ONCOGENE, V20, P7293; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Senoo M, 2002, ONCOGENE, V21, P2455, DOI 10.1038/sj.onc.1205330; Stantic M, 2015, P NATL ACAD SCI USA, V112, P220, DOI 10.1073/pnas.1421697112; Stiewe T, 2002, CELL DEATH DIFFER, V9, P237, DOI 10.1038/sj.cdd.4400995; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Toh WH, 2008, NUCLEIC ACIDS RES, V36, P4498, DOI 10.1093/nar/gkn414; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vikhanskaya F, 2001, ONCOGENE, V20, P7293, DOI 10.1038/sj.onc.1204896; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; Weiss RH, 2001, CELL SIGNAL, V13, P727, DOI 10.1016/S0898-6568(01)00195-4; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 1999, CANCER RES, V59, P3257; Zhang LL, 2000, CANCER RES, V60, P3655	56	39	43	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					511	+		10.1038/ncb3130	http://dx.doi.org/10.1038/ncb3130			36	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25774835				2022-12-25	WOS:000351920500021
J	Lomakin, AJ; Lee, KC; Han, SJ; Bui, DA; Davidson, M; Mogilner, A; Danuser, G				Lomakin, Alexis J.; Lee, Kun-Chun; Han, Sangyoon J.; Bui, Duyen A.; Davidson, Michael; Mogilner, Alex; Danuser, Gaudenz			Competition for actin between two distinct F-actin networks defines a bistable switch for cell polarization	NATURE CELL BIOLOGY			English	Article							MYOSIN-II; ARP2/3 COMPLEX; ADHESION DYNAMICS; MIGRATING CELLS; LIGHT-CHAIN; IN-VIVO; CONTRACTILITY; FIBROBLASTS; PROTRUSION; ACTOMYOSIN	Symmetry-breaking polarization enables functional plasticity of cells and tissues and is yet not well understood. Here we show that epithelial cells, hard-wired to maintain a static morphology and to preserve tissue organization, can spontaneously switch to a migratory polarized phenotype after relaxation of the actomyosin cytoskeleton. We find that myosin II engages actin in the formation of cortical actomyosin bundles and thus makes it unavailable for deployment in the process of dendritic growth normally driving cell motility. Under low-contractility regimes, epithelial cells polarize in a front back manner owing to the emergence of actin retrograde flows powered by dendritic polymerization of actin. Coupled to cell movement, the flows transport myosin II from the front to the back of the cell, where the motor locally 'locks' actin in contractile bundles. This polarization mechanism could be employed by embryonic and cancer epithelial cells in microenvironments where high-contractility-driven cell motion is inefficient.	[Lomakin, Alexis J.; Han, Sangyoon J.; Bui, Duyen A.; Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lomakin, Alexis J.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Lee, Kun-Chun; Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Lee, Kun-Chun; Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Davidson, Michael] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis; University of California System; University of California Davis; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Mogilner, A (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, 1 Shields Ave, Davis, CA 95616 USA.	mogilner@cims.nyu.edu; Gaudenz.Danuser@UTSouthwestern.edu		Han, Sangyoon/0000-0002-1384-665X; Danuser, Gaudenz/0000-0001-8583-2014; Lomakin, Alexis/0000-0002-5346-3426	Leukemia & Lymphoma Society [5388-13]; National Institutes of Health [R01 GM071868, GM068952]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952, R01GM071868] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to acknowledge E. Bonder (Rutgers University, Newark, New Jersey, USA), T. Omelchenko (Sloan-Kettering Institute, New York, New York, USA) and J. Vasiliev (National Cancer Research Center, Moscow, Russia) for providing epithelial cell lines. We are grateful to I. Ethell (University of California Riverside, California, USA), S. Narumiya (Kyoto University, Japan), K. Kaibuchi (Nagoya University, Japan) and R. Horwitz (University of Virginia, Charlottesville, Virginia, USA) for sharing genetic constructs. We also thank M. Piel (Institut Curie, Paris, France) and D. Bonazzi (Institut Pasteur, Paris, France) for comments on the manuscript. This research was supported by a postdoctoral fellowship from the Leukemia & Lymphoma Society (grant no. 5388-13) to A.J.L., and the National Institutes of Health grants R01 GM071868 to G.D. and GM068952 to A.M. All light microscopy experiments described in the present work were performed at the Nikon Imaging Center of Harvard Medical School, Boston, Massachusetts.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Asokan SB, 2014, DEV CELL, V31, P747, DOI 10.1016/j.devcel.2014.10.024; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Barnhart E, 2015, P NATL ACAD SCI USA, V112, P5045, DOI 10.1073/pnas.1417257112; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Burke TA, 2014, CURR BIOL, V24, P579, DOI 10.1016/j.cub.2014.01.072; Carlsson AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228102; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; Croft DR, 2008, CANCER CELL, V14, P349, DOI 10.1016/j.ccr.2008.10.009; Edelstein-Keshet L, 2005, MATH MODELS BIOL; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gause G. F., 1934, STRUGGLE EXISTENCE; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Henson JH, 2015, MOL BIOL CELL, V26, P887, DOI 10.1091/mbc.E14-07-1244; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Koestler SA, 2013, MOL BIOL CELL, V24, P2861, DOI 10.1091/mbc.E12-12-0857; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Lou SS, 2015, J CELL BIOL, V209, P275, DOI 10.1083/jcb.201409001; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Omelchenko T, 2002, P NATL ACAD SCI USA, V99, P10452, DOI 10.1073/pnas.152339899; Peng GE, 2011, MOL BIOL CELL, V22, P3986, DOI 10.1091/mbc.E11-04-0379; Pollard TD, 2001, J CELL SCI, V114, P3; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sambeth R, 2001, PHYS REV LETT, V86, P5196, DOI 10.1103/PhysRevLett86.5196; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Shutova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040814; Suarez C, 2015, DEV CELL, V32, P43, DOI 10.1016/j.devcel.2014.10.027; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yang CS, 2011, NAT CELL BIOL, V13, P1012, DOI 10.1038/ncb2321	54	112	112	4	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1435	1445		10.1038/ncb3246	http://dx.doi.org/10.1038/ncb3246			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26414403	Green Accepted, Green Submitted			2022-12-25	WOS:000364270500009
J	Okoye-Okafor, UC; Bartholdy, B; Cartier, J; Gao, EN; Pietrak, B; Rendina, AR; Rominger, C; Quinn, C; Smallwood, A; Wiggall, KJ; Reif, AJ; Schmidt, SJ; Qi, HW; Zhao, HZ; Joberty, G; Faelth-Savitski, M; Bantscheff, M; Drewes, G; Duraiswami, C; Brady, P; Groy, A; Narayanagari, SR; Antony-Debre, I; Mitchell, K; Wang, HR; Kao, YR; Christopeit, M; Carvajal, L; Barreyro, L; Paietta, E; Makishima, H; Will, B; Concha, N; Adams, ND; Schwartz, B; McCabe, MT; Maciejewski, J; Verma, A; Steidl, U				Okoye-Okafor, Ujunwa C.; Bartholdy, Boris; Cartier, Jessy; Gao, Enoch N.; Pietrak, Beth; Rendina, Alan R.; Rominger, Cynthia; Quinn, Chad; Smallwood, Angela; Wiggall, Kenneth J.; Reif, Alexander J.; Schmidt, Stanley J.; Qi, Hongwei; Zhao, Huizhen; Joberty, Gerard; Faelth-Savitski, Maria; Bantscheff, Marcus; Drewes, Gerard; Duraiswami, Chaya; Brady, Pat; Groy, Arthur; Narayanagari, Swathi-Rao; Antony-Debre, Ileana; Mitchell, Kelly; Wang, Heng Rui; Kao, Yun-Ruei; Christopeit, Maximilian; Carvajal, Luis; Barreyro, Laura; Paietta, Elisabeth; Makishima, Hideki; Will, Britta; Concha, Nestor; Adams, Nicholas D.; Schwartz, Benjamin; McCabe, Michael T.; Maciejewski, Jaroslav; Verma, Amit; Steidl, Ulrich			New IDH1 mutant inhibitors for treatment of acute myeloid leukemia	NATURE CHEMICAL BIOLOGY			English	Article							ISOCITRATE DEHYDROGENASE 1; ACUTE PROMYELOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; CLINICAL-IMPLICATIONS; CELL-DIFFERENTIATION; SELECTIVE-INHIBITION; KINASE INHIBITORS; PROGENITOR CELLS; DNA METHYLATION; SMALL-MOLECULE	Neomorphic mutations in isocitrate dehydrogenase 1 (IDH1) are driver mutations in acute myeloid leukemia (AML) and other cancers. We report the development of new allosteric inhibitors of mutant IDH1. Crystallographic and biochemical results demonstrated that compounds of this chemical series bind to an allosteric site and lock the enzyme in a catalytically inactive conformation, thereby enabling inhibition of different clinically relevant IDH1 mutants. Treatment of IDH1 mutant primary AML cells uniformly led to a decrease in intracellular 2-HG, abrogation of the myeloid differentiation block and induction of granulocytic differentiation at the level of leukemic blasts and more immature stem-like cells, in vitro and in vivo. Molecularly, treatment with the inhibitors led to a reversal of the DNA cytosine hypermethylation patterns caused by mutant IDH1 in the cells of individuals with AML. Our study provides proof of concept for the molecular and biological activity of novel allosteric inhibitors for targeting different mutant forms of IDH1 in leukemia.	[Okoye-Okafor, Ujunwa C.; Bartholdy, Boris; Cartier, Jessy; Narayanagari, Swathi-Rao; Antony-Debre, Ileana; Mitchell, Kelly; Wang, Heng Rui; Kao, Yun-Ruei; Carvajal, Luis; Barreyro, Laura; Will, Britta; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Gao, Enoch N.; Pietrak, Beth; Rendina, Alan R.; Quinn, Chad; Smallwood, Angela; Qi, Hongwei; Zhao, Huizhen; Faelth-Savitski, Maria; Duraiswami, Chaya; Brady, Pat; Groy, Arthur; Concha, Nestor; Schwartz, Benjamin] GlaxoSmithKline, Dept Mol Discovery Res, Collegeville, PA USA; [Rominger, Cynthia; Wiggall, Kenneth J.; Reif, Alexander J.; Schmidt, Stanley J.; Adams, Nicholas D.; McCabe, Michael T.] GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Collegeville, PA USA; [Joberty, Gerard; Bantscheff, Marcus; Drewes, Gerard] Cellzome, Heidelberg, Germany; [Christopeit, Maximilian] Univ Med Ctr, Dept Stem Cell Transplantat, Hamburg, Germany; [Paietta, Elisabeth; Verma, Amit; Steidl, Ulrich] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med Oncol, Div Hematooncol, Bronx, NY 10467 USA; [Makishima, Hideki; Maciejewski, Jaroslav] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Verma, Amit] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA; [Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Gottesman Inst Stem Cell & Regenerat Med Res, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Cellzome GmbH; University of Hamburg; University Medical Center Hamburg-Eppendorf; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Cleveland Clinic Foundation; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Okoye-Okafor, UC (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.	ulrich.steidl@einstein.yu.edu	Bantscheff, Marcus/AAQ-2903-2021; Antony-debré, Ileana/B-1551-2018; Antony-debré, Ileana/HGB-6673-2022	Bantscheff, Marcus/0000-0002-8343-8977; Drewes, Gerard/0000-0003-0575-6766; Mitchell, Kelly/0000-0002-1124-7864; Will, Britta/0000-0002-9534-6690; CARTIER, Jessy/0000-0002-0366-8546; Barreyro, Laura/0000-0002-9515-5579; Okoye-Okafor, Ujunwa/0000-0001-8824-1666; Christopeit, Maximilian/0000-0003-4627-0412	NYSTEM [C024172]; Albert Einstein Cancer Center Core Support grant [P30CA013330]; NYSTEM grant [24306]; GlaxoSmithKline (GSK); US National Institutes of Health (NIH) [U24CA114737, U10CA180827]; NIH [F31CA162770]; MSTP grant [T32 GM007288]; NATIONAL CANCER INSTITUTE [F31CA162770, U10CA180827, R01CA166429, U24CA114737, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, T32GM007491] Funding Source: NIH RePORTER	NYSTEM; Albert Einstein Cancer Center Core Support grant; NYSTEM grant; GlaxoSmithKline (GSK)(GlaxoSmithKline); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Sun of the Einstein Human Stem Cell FACS and Xenotransplantation facility (supported by NYSTEM grant C024172) and J. Chen, C.K. Sheridan and F. Garrett-Bakelman of the Weill Cornell Medical College Epigenomics Core, and the Albert Einstein College of Medicine Epigenomics Core for expert technical assistance and advice. Funding: this work was supported by the Albert Einstein Cancer Center Core Support grant (P30CA013330), NYSTEM grant no. 24306 and GlaxoSmithKline (GSK). E.P. is supported by US National Institutes of Health (NIH) U24CA114737 and U10CA180827. U.C.O.-O. is supported by NIH F31CA162770 and the MSTP grant T32 GM007288. U.S. is a Research Scholar of the Leukemia & Lymphoma Society and is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine.	Abdel-Wahab O, 2011, HEMATOL ONCOL CLIN N, V25, P1119, DOI 10.1016/j.hoc.2011.09.013; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Barreyro L, 2012, BLOOD, V120, P1290, DOI 10.1182/blood-2012-01-404699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks E, 2014, J BIOMOL SCREEN, V19, P1193, DOI 10.1177/1087057114541148; Burnett AK, 2012, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2012.1.1; CHEN SJ, 1991, BLOOD, V78, P2696; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Deng GJ, 2015, J BIOL CHEM, V290, P762, DOI 10.1074/jbc.M114.608497; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gupta R, 2013, MODERN PATHOL, V26, P619, DOI 10.1038/modpathol.2012.210; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Kruse U, 2011, LEUKEMIA, V25, P89, DOI 10.1038/leu.2010.233; Kuendgen A, 2009, CANCER TREAT REV, V35, P97, DOI 10.1016/j.ctrv.2008.09.001; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luchman HA, 2012, NEURO-ONCOLOGY, V14, P184, DOI 10.1093/neuonc/nor207; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; MCCARTHY NC, 1985, BIOSCIENCE REP, V5, P933, DOI 10.1007/BF01119906; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Molenaar RJ, 2014, BBA-REV CANCER, V1846, P326, DOI 10.1016/j.bbcan.2014.05.004; Pandolfi A, 2013, STEM CELL TRANSL MED, V2, P143, DOI 10.5966/sctm.2012-0109; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Rakheja D, 2012, HUM PATHOL, V43, P1541, DOI 10.1016/j.humpath.2012.05.003; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Roth M, 2012, BLOOD, V120, P386, DOI 10.1182/blood-2011-12-399667; Sandes AF, 2013, CYTOM PART B-CLIN CY, V84B, P157, DOI 10.1002/cyto.b.21087; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Savitski MM, 2010, J AM SOC MASS SPECTR, V21, P1668, DOI 10.1016/j.jasms.2010.01.012; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shibata T, 2011, AM J PATHOL, V178, P1395, DOI 10.1016/j.ajpath.2010.12.011; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Tallman MS, 1997, NEW ENGL J MED, V337, P1021, DOI 10.1056/NEJM199710093371501; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van Westen GJP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003559; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Will B, 2009, BLOOD, V114, P3899, DOI 10.1182/blood-2009-04-219493; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Ye D, 2013, CANCER CELL, V23, P274, DOI 10.1016/j.ccr.2013.03.005; Yen K, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.240.240; Zheng BS, 2013, ACS MED CHEM LETT, V4, P542, DOI 10.1021/ml400036z	59	122	131	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					878	U107		10.1038/nchembio.1930	http://dx.doi.org/10.1038/nchembio.1930			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26436839	Green Accepted			2022-12-25	WOS:000363272100014
J	Domenech, E; Maestre, C; An-Martinez, LE; Partidal, D; Pascual, R; Fernandez-Miranda, G; Seco, E; Campos-Olivas, R; Perez, M; Megias, D; Allen, K; Lopez, M; Saha, AK; Velasco, G; Rial, E; Mendez, R; Boya, P; Salazar-Roa, M; Malumbres, M				Domenech, Elena; Maestre, Carolina; Esteb An-Martinez, Lorena; Partidal, David; Pascual, Rosa; Fernandez-Miranda, Gonzalo; Seco, Esther; Campos-Olivas, Ramon; Perez, Manuel; Megias, Diego; Allen, Katherine; Lopez, Miguel; Saha, Asish K.; Velasco, Guillermo; Rial, Eduardo; Mendez, Raul; Boya, Patricia; Salazar-Roa, Maria; Malumbres, Marcos			AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; IN-VIVO; TRANSLATIONAL CONTROL; TARGETING MITOSIS; CANCER-CELLS; SOLID TUMORS; AUTOPHAGY; PHOSPHORYLATION; APOPTOSIS	Blocking mitotic progression has been proposed as an attractive therapeutic strategy to impair proliferation of tumour cells. However, how cells survive during prolonged mitotic arrest is not well understood. We show here that survival during mitotic arrest is affected by the special energetic requirements of mitotic cells. Prolonged mitotic arrest results in mitophagy-dependent loss of mitochondria, accompanied by reduced ATP levels and the activation of AMPK. Oxidative respiration is replaced by glycolysis owing to AMPK-dependent phosphorylation of PFKFB3 and increased production of this protein as a consequence of mitotic-specific translational activation of its mRNA. Induction of autophagy or inhibition of AMPK or PFKFB3 results in enhanced cell death in mitosis and improves the anti-tumoral efficiency of microtubule poisons in breast cancer cells. Thus, survival of mitotic-arrested cells is limited by their metabolic requirements, a feature with potential implications in cancer therapies aimed to impair mitosis or metabolism in tumour cells.	[Domenech, Elena; Maestre, Carolina; Partidal, David; Salazar-Roa, Maria; Malumbres, Marcos] Spanish Natl Canc Res Ctr CNIO, Cell Div, Madrid 28029, Spain; [Domenech, Elena; Maestre, Carolina; Partidal, David; Salazar-Roa, Maria; Malumbres, Marcos] Spanish Natl Canc Res Ctr CNIO, Canc Grp, Madrid 28029, Spain; [Esteb An-Martinez, Lorena; Seco, Esther; Rial, Eduardo; Boya, Patricia] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, E-28040 Madrid, Spain; [Pascual, Rosa; Fernandez-Miranda, Gonzalo; Mendez, Raul] ICREA, Barcelona 08028, Spain; [Pascual, Rosa; Fernandez-Miranda, Gonzalo; Mendez, Raul] IRB, Barcelona 08028, Spain; [Campos-Olivas, Ramon] CNIO, Spect & Nucl Magnet Resonance Unit, Madrid 28029, Spain; [Perez, Manuel; Megias, Diego] CNIO, Confocal Microscopy Unit, Madrid 28029, Spain; [Allen, Katherine; Saha, Asish K.] Boston Univ, Sch Med, Div Endocrinol Diabet & Nutr, Boston, MA 02215 USA; [Lopez, Miguel] Univ Santiago de Compostela, Inst Invest Sanitaria, Dept Physiol, CIMUS, Santiago De Compostela 15782, Spain; [Lopez, Miguel] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela 15706, Spain; [Velasco, Guillermo] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Velasco, Guillermo] IdISSC, Madrid 28040, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Boston University; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complutense University of Madrid	Salazar-Roa, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Cell Div, Madrid 28029, Spain.	msalazar@cnio.es; malumbres@cnio.es	Malumbres, Marcos/E-8834-2011; López, Miguel/ABF-4844-2021; mendez, ramon/L-7415-2014; Campos-Olivas, Ramón/L-9173-2014; Velasco, Guillermo/AAU-9189-2020; Boya, Patricia/P-8345-2019; MARTÍN, ESTHER SECO/AAB-7240-2020; Roa, Maria Salazar/I-1168-2015; Rial, Eduardo/A-4242-2008; Esteban-Martínez, Lorena/B-1854-2017; Megías, Diego/L-6008-2014; Martínez, Lorena Esteban/AAJ-5280-2021; Velasco, Guillermo/H-5260-2012; Boya, Patricia/K-2911-2014	Malumbres, Marcos/0000-0002-0829-6315; López, Miguel/0000-0002-7823-1648; mendez, ramon/0000-0002-1419-1165; Campos-Olivas, Ramón/0000-0002-5743-2221; Velasco, Guillermo/0000-0002-1994-2386; Boya, Patricia/0000-0003-3045-951X; Roa, Maria Salazar/0000-0001-6784-9541; Rial, Eduardo/0000-0001-8634-8902; Esteban-Martínez, Lorena/0000-0002-8163-6259; Velasco, Guillermo/0000-0002-1994-2386; Boya, Patricia/0000-0003-3045-951X; Pascual, Rosa/0000-0002-7316-5696; Seco, Esther/0000-0001-5127-4886; Mendez, Raul/0000-0002-1952-6905; Perez-Martinez, Manuel/0000-0001-8839-6895; Megias, Diego/0000-0003-0755-0518	Spanish Fondo de Investigaciones Sanitarias (Madrid); MINECO (Juan de la Cierva programme); Asociacion Espanola contra el Cancer (AECC); JAE predoctoral fellowship from the CSIC; USPHS [RO1DK19514, RO1DK67509]; Spanish Ministry of Economy and Competitiveness (MINECO); Fondo Europeo de Desarrollo Regional (FEDER) [PI12/02248]; Fundacio La Marato de TV3 [m12 20134031]; Fundacion Mutua Madrilena [AP101042012]; European Community's Seventh Framework Programme [281854]; ObERStress (European Research Council project); MINECO [SAF 2010-20256, BFU2011-30121, BFU2014-52125-REDT, Consolider RNAREG CSD2009-00080, SAF2012-38215]; Fundacion Boton; Banco Santander; Spanish Ministry for Economy and Competitiveness (MINECO) [SAF2012-36079]; Consolider-Ingenio Programme [SAF2014-57791-REDC]; Excellence Network CellSYS [BFU2014-52125-REDT]; OncoCycle Programme from the Comunidad de Madrid [S2010/BMD-2470]; Worldwide Cancer Research (WCR) [15-0278]; European Union Seventh Framework Programme (MitoSys project) [HEALTH-F5-2010-241548]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514, R01DK067509] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Spanish Fondo de Investigaciones Sanitarias (Madrid); MINECO (Juan de la Cierva programme); Asociacion Espanola contra el Cancer (AECC); JAE predoctoral fellowship from the CSIC; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Fundacio La Marato de TV3; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); European Community's Seventh Framework Programme(European Commission); ObERStress (European Research Council project); MINECO(Spanish Government); Fundacion Boton; Banco Santander; Spanish Ministry for Economy and Competitiveness (MINECO)(Spanish Government); Consolider-Ingenio Programme(Spanish Government); Excellence Network CellSYS; OncoCycle Programme from the Comunidad de Madrid; Worldwide Cancer Research (WCR); European Union Seventh Framework Programme (MitoSys project); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	We thank M. Soengas (Spanish National Cancer Research Centre, Spain), J. P. Bolanos (Institute of Functional Biology and Genomics, Spain) and N. Mizushima (The University of Tokyo, Japan) for reagents. We also thank S. Velasco for help with the Seahorse apparatus, J. Munoz and M. P. Ximenez for their support in phospho-proteomics experiments, and F. Escobar and B. Pou for help with electron microscopy. E.D., C.M. and M.S.-R. were supported by the Spanish Fondo de Investigaciones Sanitarias (Madrid), MINECO (Juan de la Cierva programme) and Asociacion Espanola contra el Cancer (AECC), respectively. L.E.-M. is a recipient of a JAE predoctoral fellowship from the CSIC. A.K.S. was supported by USPHS grants RO1DK19514, RO1DK67509. G.V. was supported by grants from the Spanish Ministry of Economy and Competitiveness (MINECO) and Fondo Europeo de Desarrollo Regional (FEDER) (PI12/02248), Fundacio La Marato de TV3 (m12 20134031), and Fundacion Mutua Madrilena (AP101042012). M.L. was supported by the European Community's Seventh Framework Programme under grant agreement no. 281854-the ObERStress (European Research Council project). E.R. was financially supported by a MINECO grant (SAF 2010-20256). Work in the R.M. laboratory was supported by the Fundacion Boton, Banco Santander and MINECO (BFU2011-30121, BFU2014-52125-REDT and Consolider RNAREG CSD2009-00080). Work in the P.B. laboratory is supported by a grant from the Spanish Ministry for Economy and Competitiveness (MINECO; SAF2012-36079). Work in the M.M. laboratory was supported by grants from the MINECO (SAF2012-38215), Consolider-Ingenio 2010 Programme (SAF2014-57791-REDC), Excellence Network CellSYS (BFU2014-52125-REDT), the OncoCycle Programme (S2010/BMD-2470) from the Comunidad de Madrid, Worldwide Cancer Research (WCR no. 15-0278), and the European Union Seventh Framework Programme (MitoSys project; HEALTH-F5-2010-241548).	Alvarez-Fernandez M, 2014, BIOESSAYS, V36, P757, DOI 10.1002/bies.201400040; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Bradley SA, 2010, J AM CHEM SOC, V132, P9531, DOI 10.1021/ja101962c; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Buytaert E, 2006, AUTOPHAGY, V2, P238, DOI 10.4161/auto.2730; Campone M, 2009, BRIT J CANCER, V100, P315, DOI 10.1038/sj.bjc.6604851; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; Davila D, 2012, CELL DEATH DIFFER, V19, P1677, DOI 10.1038/cdd.2012.49; Diaz-Martinez LA, 2014, EMBO J, V33, P1960, DOI 10.15252/embj.201487826; Domenech E, 2013, CURR OPIN PHARMACOL, V13, P519, DOI 10.1016/j.coph.2013.03.011; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Esteban-Martinez L, 2015, METHODS, V75, P79, DOI 10.1016/j.ymeth.2015.01.008; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Galluzzi L, 2014, NAT CELL BIOL, V16, P728, DOI 10.1038/ncb3005; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Kilbride SM, 2010, J BIOL CHEM, V285, P36199, DOI 10.1074/jbc.M110.138107; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Lieber J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-362; Liu LY, 2009, CELL CYCLE, V8, P1616, DOI 10.4161/cc.8.10.8577; MAIZELS EZ, 1977, BIOCHEM J, V162, P557, DOI 10.1042/bj1620557; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Matthess Y, 2010, MOL CELL BIOL, V30, P5726, DOI 10.1128/MCB.00731-10; Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403; Meier F, 2009, J AM ACAD DERMATOL, V60, P863, DOI 10.1016/j.jaad.2008.09.053; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rieder CL, 2009, CANCER CELL, V16, P274, DOI 10.1016/j.ccr.2009.09.021; ROSE KM, 1977, NATURE, V267, P178, DOI 10.1038/267178a0; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tasdemir E, 2008, CELL CYCLE, V7, P3006, DOI 10.4161/cc.7.19.6702; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wan LX, 2014, DEV CELL, V29, P377, DOI 10.1016/j.devcel.2014.04.022; Wang PB, 2014, CELL REP, V7, P661, DOI 10.1016/j.celrep.2014.03.050; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	71	170	174	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1304	+		10.1038/ncb3231	http://dx.doi.org/10.1038/ncb3231			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26322680				2022-12-25	WOS:000362213500010
J	Jing, J; He, L; Sun, AM; Quintana, A; Ding, YH; Ma, GL; Tan, P; Liang, XW; Zheng, XL; Chen, LY; Shi, XD; Zhang, SL; Zhong, L; Huang, Y; Dong, MQ; Walker, CL; Hogan, PG; Wang, YJ; Zhou, YB				Jing, Ji; He, Lian; Sun, Aomin; Quintana, Ariel; Ding, Yuehe; Ma, Guolin; Tan, Peng; Liang, Xiaowen; Zheng, Xiaolu; Chen, Liangyi; Shi, Xiaodong; Zhang, Shenyuan L.; Zhong, Ling; Huang, Yun; Dong, Meng-Qiu; Walker, Cheryl L.; Hogan, Patrick G.; Wang, Youjun; Zhou, Yubin			Proteomic mapping of ER-PM junctions identifies STIMATE as a regulator of Ca2+ influx	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; PROTEINS; ACTIVATION; ORAI; CLUSTERS; DOMAINS; SCREEN	Specialized junctional sites that connect the plasma membrane (PM) and endoplasmic reticulum (ER) play critical roles in controlling lipid metabolism and Ca2+ signalling(1-4). Store-operated Ca2+ entry mediated by dynamic STIM1-ORAI1 coupling represents a classical molecular event occurring at ER-PM junctions, but the protein composition and how previously unrecognized protein regulators facilitate this process remain ill-defined. Using a combination of spatially restricted biotin labelling in situ coupled with mass spectrometry(5,6) and a secondary screen based on bimolecular fluorescence complementation(7), we mapped the proteome of intact ER-PM junctions in living cells without disrupting their architectural integrity. Our approaches led to the discovery of an ER-resident multi-transmembrane protein that we call STIMATE (STIM-activating enhancer, encoded by TMEM110) as a positive regulator of Ca2+ influx in vertebrates. STIMATE physically interacts with STIM1 to promote STIM1 conformational switch. Genetic depletion of STIMATE substantially reduces STIM1 puncta formation at ER-PM junctions and suppresses the Ca2+-NFAT signalling. Our findings enable further genetic studies to elucidate the function of STIMATE in normal physiology and disease, and set the stage to uncover more uncharted functions of hitherto underexplored ER-PM junctions.	[Jing, Ji; He, Lian; Ma, Guolin; Tan, Peng; Liang, Xiaowen; Zhong, Ling; Huang, Yun; Walker, Cheryl L.; Zhou, Yubin] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Sun, Aomin; Wang, Youjun] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Quintana, Ariel; Hogan, Patrick G.] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Ding, Yuehe; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zheng, Xiaolu; Chen, Liangyi] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Shi, Xiaodong] W Virginia Univ, Dept Chem, Morgantown, WV 26506 USA; [Zhang, Shenyuan L.; Zhou, Yubin] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76504 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Beijing Normal University; La Jolla Institute for Immunology; National Institute of Biological Sciences, Beijing; Peking University; West Virginia University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, YJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.	wyoujun@bnu.edu.cn; yzhou@ibt.tamhsc.edu	Tan, Peng/P-3825-2015; Chen, Liangyi/F-1352-2010; Tan, Peng/ABD-8190-2020; Zhou, Yubin/D-4748-2011; Wang, Youjun/H-4016-2013; Shi, Xiaodong/B-4424-2012; Tan, Peng/P-3856-2015; Ma, Guolin/D-2504-2018; ding, yuehe/AAZ-6994-2021	Tan, Peng/0000-0002-7005-1896; Chen, Liangyi/0000-0003-1270-7321; Zhou, Yubin/0000-0001-7962-0517; Wang, Youjun/0000-0003-0961-1716; Shi, Xiaodong/0000-0002-3189-1315; Tan, Peng/0000-0001-6992-9000; Ma, Guolin/0000-0001-5460-3446; Liang, Xiaowen/0000-0002-6174-2951; He, Lian/0000-0002-8842-235X; Huang, Yun/0000-0001-5950-9168	National Institutes of Health [R01 GM112003, R01 AI084167, R01 CA143811, R01 GM110397]; Leukemia & Lymphoma Society [LLS 3013-12]; Robert A. Welch Endowed Chair in Chemistry [BE-0023]; China Scholarship Council; National Natural Science Foundation of China [NSFC31471279, NSFC-81222020]; Recruitment Program for Young Professionals of China; Program for New Century Excellent Talents in University [NCET-13-0061]; American Heart Association SDG [13SDG17200006]; Cancer Prevention Research Institute of Texas grant; Texas A&M University Health Science Center Startup Fund; NATIONAL CANCER INSTITUTE [R01CA143811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110397, R01GM112003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Robert A. Welch Endowed Chair in Chemistry; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruitment Program for Young Professionals of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); American Heart Association SDG(American Heart Association); Cancer Prevention Research Institute of Texas grant; Texas A&M University Health Science Center Startup Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to R. Lewis at Stanford University for the HRP-STIM1, mCherry-STIM1, and mCherry-CAD constructs. We thank J. Liou at University of Texas Southwestern Medical Center for sharing with us the MAPPERs construct, and Z. Songyang at Baylor College of Medicine for the BiFc-related constructs. We thank M. Hook at Texas A&M University for access to the Biacore 3000, D. Liu at Baylor College of Medicine for access to the Cell Based Assay Screening Facility and advice on BiFc, and R. Payne at Texas A&M University for technical support in electron microscopy studies. This work was supported by National Institutes of Health grants (R01 GM112003 to Y.Z., R01 AI084167, R01 CA143811 to C.L.W., and R01 GM110397 to P.G.H.), a Special Fellow Award from the Leukemia & Lymphoma Society (LLS 3013-12 to Y.Z.), a Robert A. Welch Endowed Chair in Chemistry (BE-0023) to C.L.W., the China Scholarship Council (to J. J.), the National Natural Science Foundation of China (NSFC31471279 to Y.W. and NSFC-81222020 to L.C.), the Recruitment Program for Young Professionals of China (to Y.W.), the Program for New Century Excellent Talents in University (NCET-13-0061 to Y.W.), the American Heart Association SDG (13SDG17200006 to S.L.Z.), a Cancer Prevention Research Institute of Texas grant (to Y.H.), and by an allocation from the Texas A&M University Health Science Center Startup Fund (to Y.Z.).	Bendayan M, 2001, SCIENCE, V291, P1363, DOI 10.1126/science.291.5507.1363; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee OH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001628; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Ma GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8826; Maleth J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6843; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Mayer G, 1997, J HISTOCHEM CYTOCHEM, V45, P1449, DOI 10.1177/002215549704501101; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Wang XiaoKun, 2014, Journal of Henan Agricultural Sciences, V43, P1; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	40	145	154	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2015	17	10					1339	+		10.1038/ncb3234	http://dx.doi.org/10.1038/ncb3234			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CS6SZ	26322679	Green Accepted			2022-12-25	WOS:000362213500014
J	Fischer, U; Forster, M; Rinaldi, A; Risch, T; Sungalee, S; Warnatz, HJ; Bornhauser, B; Gombert, M; Kratsch, C; Stutz, AM; Sultan, M; Tchinda, J; Worth, CL; Amstislavskiy, V; Badarinarayan, N; Baruchel, A; Bartram, T; Basso, G; Canpolat, C; Cario, G; Cave, H; Dakaj, D; Delorenzi, M; Dobay, MP; Eckert, C; Ellinghaus, E; Eugster, S; Frismantas, V; Ginzel, S; Haas, OA; Heidenreich, O; Hemmrich-Stanisak, G; Hezaveh, K; Holl, JI; Hornhardt, S; Husemann, P; Kachroo, P; Kratz, CP; te Kronnie, G; Marovca, B; Niggli, F; McHardy, AC; Moorman, AV; Panzer-Grumayer, R; Petersen, BS; Raeder, B; Ralser, M; Rosenstiel, P; Schafer, D; Schrappe, M; Schreiber, S; Schutte, M; Stade, B; Thiele, R; von der Weid, N; Vora, A; Zaliova, M; Zhang, LH; Zichner, T; Zimmermann, M; Lehrach, H; Borkhardt, A; Bourquin, JP; Franke, A; Korbel, JO; Stanulla, M; Yaspo, ML				Fischer, Ute; Forster, Michael; Rinaldi, Anna; Risch, Thomas; Sungalee, Stephanie; Warnatz, Hans-Joerg; Bornhauser, Beat; Gombert, Michael; Kratsch, Christina; Stuetz, Adrian M.; Sultan, Marc; Tchinda, Joelle; Worth, Catherine L.; Amstislavskiy, Vyacheslav; Badarinarayan, Nandini; Baruchel, Andre; Bartram, Thies; Basso, Giuseppe; Canpolat, Cengiz; Cario, Gunnar; Cave, Helene; Dakaj, Dardane; Delorenzi, Mauro; Dobay, Maria Pamela; Eckert, Cornelia; Ellinghaus, Eva; Eugster, Sabrina; Frismantas, Viktoras; Ginzel, Sebastian; Haas, Oskar A.; Heidenreich, Olaf; Hemmrich-Stanisak, Georg; Hezaveh, Kebria; Hoell, Jessica I.; Hornhardt, Sabine; Husemann, Peter; Kachroo, Priyadarshini; Kratz, Christian P.; te Kronnie, Geertruy; Marovca, Blerim; Niggli, Felix; McHardy, Alice C.; Moorman, Anthony V.; Panzer-Gruemayer, Renate; Petersen, Britt S.; Raeder, Benjamin; Ralser, Meryem; Rosenstiel, Philip; Schaefer, Daniel; Schrappe, Martin; Schreiber, Stefan; Schuette, Moritz; Stade, Bjoern; Thiele, Ralf; von der Weid, Nicolas; Vora, Ajay; Zaliova, Marketa; Zhang, Langhui; Zichner, Thomas; Zimmermann, Martin; Lehrach, Hans; Borkhardt, Arndt; Bourquin, Jean-Pierre; Franke, Andre; Korbel, Jan O.; Stanulla, Martin; Yaspo, Marie-Laure			Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options	NATURE GENETICS			English	Article							B-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR; CHROMOSOMAL TRANSLOCATIONS; HEMATOPOIETIC STEM; PROGENITOR CELLS; GENE-EXPRESSION; RAS PATHWAY; E2A-HLF; PRECURSOR; LINEAGE	TCF3-HLF-positive acute lymphoblastic leukemia (ALL) is currently incurable. Using an integrated approach, we uncovered distinct mutation, gene expression and drug response profiles in TCF3-HLF-positive and treatment-responsive TCF3-PBX1-positive ALL. We identified recurrent intragenic deletions of PAX5 or VPREB1 in constellation with the fusion of TCF3 and HLF. Moreover somatic mutations in the non-translocated allele of TCF3 and a reduction of PAX5 gene dosage in TCF3-HLF ALL suggest cooperation within a restricted genetic context. The enrichment for stem cell and myeloid features in the TCF3-HLF signature may reflect reprogramming by TCF3-HLF of a lymphoid-committed cell of origin toward a hybrid, drug-resistant hematopoietic state. Drug response profiling of matched patient-derived xenografts revealed a distinct profile for TCF3-HLF ALL with resistance to conventional chemotherapeutics but sensitivity to glucocorticoids, anthracyclines and agents in clinical development. Striking on-target sensitivity was achieved with the BCL2-specific inhibitor venetoclax (ABT-199). This integrated approach thus provides alternative treatment options for this deadly disease.	[Fischer, Ute; Gombert, Michael; Ginzel, Sebastian; Hezaveh, Kebria; Hoell, Jessica I.; Husemann, Peter; Schaefer, Daniel; Zhang, Langhui; Borkhardt, Arndt] Univ Dusseldorf, Fac Med, Clin Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Forster, Michael; Badarinarayan, Nandini; Ellinghaus, Eva; Hemmrich-Stanisak, Georg; Kachroo, Priyadarshini; Petersen, Britt S.; Rosenstiel, Philip; Schreiber, Stefan; Stade, Bjoern; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Rinaldi, Anna; Bornhauser, Beat; Tchinda, Joelle; Dakaj, Dardane; Eugster, Sabrina; Frismantas, Viktoras; Marovca, Blerim; Niggli, Felix; Bourquin, Jean-Pierre] Univ Childrens Hosp Zurich, Childrens Res Ctr, Pediat Oncol, Zurich, Switzerland; [Risch, Thomas; Warnatz, Hans-Joerg; Sultan, Marc; Worth, Catherine L.; Amstislavskiy, Vyacheslav; Ralser, Meryem; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Sungalee, Stephanie; Stuetz, Adrian M.; Raeder, Benjamin; Zichner, Thomas; Korbel, Jan O.] European Mol Biol Lab EMBL, Genome Biol Unit, Heidelberg, Germany; [Kratsch, Christina; McHardy, Alice C.] Univ Dusseldorf, Dept Algorithm Bioinformat, Dusseldorf, Germany; [Baruchel, Andre] Hop Robert Debre, Dept Pediat Hematoimmunol, F-75019 Paris, France; [Baruchel, Andre; Cave, Helene] Paris Diderot Univ, Paris, France; [Bartram, Thies; Cario, Gunnar; Schrappe, Martin] Univ Kiel, Dept Pediat, Kiel, Germany; [Bartram, Thies; Cario, Gunnar; Schrappe, Martin] Univ Med Ctr Schleswig Holstein, Kiel, Germany; [Basso, Giuseppe; te Kronnie, Geertruy] Univ Padua, Dept Pediat, Lab Pediat Hematol Oncol, Padua, Italy; [Canpolat, Cengiz] Acibadem Univ, Sch Med, Dept Pediat, Istanbul, Turkey; [Cave, Helene] Hop Robert Debre, Dept Genet, F-75019 Paris, France; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Delorenzi, Mauro; Dobay, Maria Pamela] Swiss Inst Bioinformat SIB, Lausanne, Switzerland; [Eckert, Cornelia] Charite, Pediat Hematol & Oncol, Berlin, Germany; [Ginzel, Sebastian; Thiele, Ralf] Bonn Rhine Sieg Univ Appl Sci, Dept Comp Sci, St Augustin, Germany; [Haas, Oskar A.; Panzer-Gruemayer, Renate] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Heidenreich, Olaf; Moorman, Anthony V.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hornhardt, Sabine] Fed Off Radiat Protect, Oberschleissheim, Germany; [Kratz, Christian P.; Zaliova, Marketa; Zimmermann, Martin; Stanulla, Martin] Hannover Med Sch, Pediatr Hematol & Oncol, Hannover, Germany; [Schuette, Moritz; Lehrach, Hans] Alacris Theranost GmbH, Berlin, Germany; [von der Weid, Nicolas] Univ Kinderspital Beider Basel UKBB, Basel, Switzerland; [Vora, Ajay] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; [Zaliova, Marketa] Charles Univ Prague, Childhood Leukaemia Invest Prague CLIP, Dept Pediat Hematol Oncol, Fac Med 2, Prague, Czech Republic; [Zhang, Langhui] Fujian Med Univ, Union Hosp, Dept Hematol, Fuzhou, Peoples R China; [Lehrach, Hans] Dahlem Ctr Genome Res & Med Syst Biol, Berlin, Germany	Heinrich Heine University Dusseldorf; University of Kiel; University Children's Hospital Zurich; Max Planck Society; European Molecular Biology Laboratory (EMBL); Heinrich Heine University Dusseldorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Padua; Acibadem University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Swiss Institute of Bioinformatics; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hochschule Bonn Rhein Sieg; Saint Anna Children's Hospital; Newcastle University - UK; Hannover Medical School; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Charles University Prague; Fujian Medical University	Stanulla, M (corresponding author), Hannover Med Sch, Pediatr Hematol & Oncol, Hannover, Germany.	jean-pierre.bourquin@kispi.uzh.ch; stanulla.martin@mh-hannover.de	Rosenstiel, Philip/A-5137-2009; Franke, Andre/B-2151-2010; Moorman, Anthony/F-5518-2010; Bourquin, Jean-Pierre/C-2802-2011; Stanulla, Martin/N-4674-2017; Niggli, Felix/L-6547-2017; Cario, Gunnar/D-2535-2010; Kronnie, Geertruy te/L-1014-2016; Bornhauser, Beat/M-4437-2014; Hoell, Jessica/J-8136-2016; Kratz, Christian/AAC-9726-2021; Heidenreich, Olaf/AAP-5045-2021; Haas, Oskar/AAM-5794-2020; Schrappe, Martin/ABA-6144-2020; McHardy, Alice/ABF-2322-2020; Kachroo, Priyadarshini/M-1923-2019; McHardy, Alice C/K-9377-2018; Löscher, Britt-Sabina/I-1671-2012; Ellinghaus, Eva/E-6490-2012; Kronnie, Geertruij te/O-5251-2019; Eckert, Cornelia/R-8623-2019	Rosenstiel, Philip/0000-0002-9692-8828; Franke, Andre/0000-0003-1530-5811; Bourquin, Jean-Pierre/0000-0001-6571-6227; Stanulla, Martin/0000-0002-3834-0727; Niggli, Felix/0000-0002-7553-3712; Hoell, Jessica/0000-0002-5532-9845; Heidenreich, Olaf/0000-0001-5404-6483; McHardy, Alice/0000-0003-2370-3430; Kachroo, Priyadarshini/0000-0002-5807-1333; McHardy, Alice C/0000-0003-2370-3430; Löscher, Britt-Sabina/0000-0001-9022-9017; Ellinghaus, Eva/0000-0003-2914-3382; Worth, Catherine/0000-0002-1796-9606; te Kronnie, Geertruy/0000-0001-7143-4795; Badarinarayan, Nandini/0000-0002-6944-748X; Cave, Helene/0000-0003-2840-1511; Rinaldi, Anna/0000-0003-4106-8127; Sungalee, Stephanie/0000-0001-5633-8826; Bornhauser, Beat/0000-0003-2890-3191; BASSO, GIUSEPPE/0000-0002-2634-9302; /0000-0001-5636-1006; Forster, Michael/0000-0001-9927-5124; Raeder, Benjamin/0000-0002-9494-8884; Zichner, Thomas/0000-0001-9848-7598; Kratsch, Christina/0000-0003-0565-1112	German Federal Office for Radiation Protection [St.Sch. 3611S70014]; Swiss National Research Foundation [SNF 310030-133108]; foundation 'Kinderkrebsforschung Schweiz'; Krebsliga Zurich; Sassella Foundation; Fondation Panacee; clinical research focus program 'Human Hemato-Lymphatic Diseases' of the University of Zurich; Deutsche Forschungsgemeinschaft (DFG), Clusters of Excellence 'Inflammation at Interfaces'; EU [262055, 261474, 260791]; Katharina Hardt Stiftung; Deutsche Jose Carreras Leukamie-Stiftung; Madeleine Schickedanz-Kinderkrebs-Stiftung; Deutsche Krebshilfe - Dr. Mildred Scheel Stiftung [108613, 102588, 108588]; Foundation of Experimental Biomedicine in Zurich; Max Planck Society; Verein fur krebskranke Kinder Hannover e.V.; Cancer Research UK [12788] Funding Source: researchfish	German Federal Office for Radiation Protection; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); foundation 'Kinderkrebsforschung Schweiz'; Krebsliga Zurich; Sassella Foundation; Fondation Panacee; clinical research focus program 'Human Hemato-Lymphatic Diseases' of the University of Zurich; Deutsche Forschungsgemeinschaft (DFG), Clusters of Excellence 'Inflammation at Interfaces'(German Research Foundation (DFG)); EU(European Commission); Katharina Hardt Stiftung; Deutsche Jose Carreras Leukamie-Stiftung; Madeleine Schickedanz-Kinderkrebs-Stiftung; Deutsche Krebshilfe - Dr. Mildred Scheel Stiftung(Deutsche Krebshilfe); Foundation of Experimental Biomedicine in Zurich; Max Planck Society(Max Planck SocietyFoundation CELLEX); Verein fur krebskranke Kinder Hannover e.V.; Cancer Research UK(Cancer Research UK)	We thank all participants and personnel involved in the clinical trials in Austria, France, Germany, United Kingdom and Switzerland. We thank T. Radimerski and Novartis for providing essential compounds. We thank the Leukaemia & Lymphoma Research (LLR) Childhood Leukaemia Cell Bank in the UK for providing primary patient samples. This work was supported by the German Federal Office for Radiation Protection (grant St.Sch. 3611S70014), by the Swiss National Research Foundation SNF 310030-133108, the foundation 'Kinderkrebsforschung Schweiz', the 'Krebsliga Zurich', the Sassella Foundation, the Fondation Panacee, the clinical research focus program 'Human Hemato-Lymphatic Diseases' of the University of Zurich, the Deutsche Forschungsgemeinschaft (DFG), Clusters of Excellence 'Inflammation at Interfaces', the EU Seventh Framework Program (FP7/2007-2013, grant 262055, ESGI; FP7-HEALTH-F2-2011 grant 261474, ENCCA; ERA-Net Transcan, Validation of biomarkers for personalized cancer medicine, TRANSCALL; Health-F2-2010 grant 260791, EUROCANPLATFORM), the 'Katharina Hardt Stiftung', the 'Deutsche Jose Carreras Leukamie-Stiftung', the 'Madeleine Schickedanz-Kinderkrebs-Stiftung', the 'Deutsche Krebshilfe - Dr. Mildred Scheel Stiftung' (grants 108613, 102588 and 108588), the Foundation of Experimental Biomedicine in Zurich, the Max Planck Society, and the 'Verein fur krebskranke Kinder Hannover e.V.'. We thank A. Dehos, B. Grosche, T. Jung, W. Weiss and G. Ziegelberger, German Federal Office for Radiation Protection, as well as B. Heinzow, State Office for Social Services of Schleswig-Holstein, and A. Bottger, German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety for their support and critical discussions. We are grateful for the excellent technical assistance offered by the sequencing team of the Department of Vertebrate Genomics of the Max Planck Institute for Molecular Genetics (Berlin) and by the team of the Genomics Core facility of the European Molecular Biology Laboratory. We thank K. Alemazkour for excellent technical assistance regarding whole exome sequencing at the Department of Pediatric Oncology, Hematology and Clinical Immunology (Dusseldorf, Germany). We thank N. Forgo, Institute for Legal Informatics, Leibniz University Hannover, and H.-D. Troger, Hannover Medical School, for legal and ethical counselling.	Akahane K, 2010, LEUKEMIA, V24, P865, DOI 10.1038/leu.2010.8; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Balbin OA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3617; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bauer M. J., 2010, ISMB ISBC; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Boutter J, 2014, ONCOTARGET, V5, P11501, DOI 10.18632/oncotarget.2572; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clappier E, 2014, LEUKEMIA, V28, P70, DOI 10.1038/leu.2013.277; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dorge P, 2013, HAEMATOLOGICA, V98, P428, DOI 10.3324/haematol.2011.056135; El Omari K, 2013, CELL REP, V4, P135, DOI 10.1016/j.celrep.2013.06.008; Felice MS, 2011, LEUKEMIA LYMPHOMA, V52, P1215, DOI 10.3109/10428194.2011.565436; Festing Michael F W, 2002, ILAR J, V43, P244; Forster M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks836; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Harrison CJ, 2010, BRIT J HAEMATOL, V151, P132, DOI 10.1111/j.1365-2141.2010.08314.x; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Honda H, 1999, BLOOD, V93, P2780; Hunger SP, 1996, BLOOD, V87, P1211, DOI 10.1182/blood.V87.4.1211.bloodjournal8741211; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Inukai T, 2007, LEUKEMIA, V21, P288, DOI 10.1038/sj.leu.2404496; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Irving J, 2014, BLOOD, V124, P3420, DOI 10.1182/blood-2014-04-531871; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu DH, 2014, J BIOL CHEM, V289, P23809, DOI 10.1074/jbc.M114.568170; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Mangum DS, 2014, LEUKEMIA, V28, P216, DOI 10.1038/leu.2013.223; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Moorman AV, 2014, BLOOD, V124, P1434, DOI 10.1182/blood-2014-03-562918; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Nissim S, 2014, DEV CELL, V28, P423, DOI 10.1016/j.devcel.2014.01.006; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Peirs S, 2014, BLOOD, V124, P3738, DOI 10.1182/blood-2014-05-574566; Ratei R, 2013, KLIN PADIATR, V225, pS34, DOI 10.1055/s-0033-1337961; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schmitz M, 2011, BLOOD, V118, P1854, DOI 10.1182/blood-2010-11-320309; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Simmons S, 2012, BLOOD, V120, P3688, DOI 10.1182/blood-2012-03-414821; Smith KS, 1999, MOL CELL BIOL, V19, P4443; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stade B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S8; Stark Z, 2012, CLIN GENET, V81, P590, DOI 10.1111/j.1399-0004.2011.01754.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	84	131	133	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1020	+		10.1038/ng.3362	http://dx.doi.org/10.1038/ng.3362			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26214592	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000360394100012
J	Ramani, V; Qiu, RL; Shendure, J				Ramani, Vijay; Qiu, Ruolan; Shendure, Jay			High-throughput determination of RNA structure by proximity ligation	NATURE BIOTECHNOLOGY			English	Article							SECONDARY STRUCTURE; GENOME-WIDE; REVEALS; PRINCIPLES; MAP; VISUALIZATION; TRANSCRIPTOME; PREDICTION; RESOLUTION; SOFTWARE	We present an unbiased method to globally resolve RNA structures through pairwise contact measurements between interacting regions. RNA proximity ligation (RPL) uses proximity ligation of native RNA followed by deep sequencing to yield chimeric reads with ligation junctions in the vicinity of structurally proximate bases. We apply RPL in both baker's yeast (Saccharomyces cerevisiae) and human cells and generate contact probability maps for ribosomal and other abundant RNAs, including yeast snoRNAs, the RNA subunit of the signal recognition particle and the yeast U2 spliceosomal RNA homolog. RPL measurements correlate with established secondary structures for these RNA molecules, including stemloop structures and long-range pseudoknots. We anticipate that RPL will complement the current repertoire of computational and experimental approaches in enabling the high-throughput determination of secondary and tertiary RNA structures.	[Ramani, Vijay; Qiu, Ruolan; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu	Shendure, Jay/AAU-3684-2021		National Institutes of Health (NIH) [1DP1HG007811]; NIH National Human Genome Research Institute (NHGRI) [5T32HG000035]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, DP1HG007811] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Shendure laboratory (particularly D. Cusanovich, M. Kircher, A. McKenna and M. Snyder), D. Fowler, C. Trapnell and J. Underwood for helpful discussions and comments on the manuscript. We thank G. Kudla, A. Helwak and D. Tollervey for answering questions pertaining to the CLASH protocol. We would also like to acknowledge A. Dobin for making auxiliary scripts for processing STAR alignments publicly available. This work was funded by National Institutes of Health (NIH) Director's Pioneer Award (1DP1HG007811 to J.S.) and an NIH National Human Genome Research Institute (NHGRI) Genome Training Grant (5T32HG000035 to V.R.).	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CAMERON V, 1977, BIOCHEMISTRY-US, V16, P5120, DOI 10.1021/bi00642a027; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Cordero P, 2012, BIOINFORMATICS, V28, P3006, DOI 10.1093/bioinformatics/bts554; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kladwang W, 2011, NAT CHEM, V3, P954, DOI [10.1038/nchem.1176, 10.1038/NCHEM.1176]; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Latham MP, 2005, CHEMBIOCHEM, V6, P1492, DOI 10.1002/cbic.200500123; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; WANG YH, 1994, J MOL BIOL, V236, P64, DOI 10.1006/jmbi.1994.1118; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	74	77	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					980	U236		10.1038/nbt.3289	http://dx.doi.org/10.1038/nbt.3289			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26237516	Green Accepted			2022-12-25	WOS:000360990900026
J	[Anonymous]				[Anonymous]			Revamp biotech rules, says White House	NATURE BIOTECHNOLOGY			English	News Item																		ANGRIST M, 2015, FUSION           080; HOLT N, 2015, NY TIMES; LORING J, 2015, BUZZFEED NEWS   0809; SABLE, 2015, FORBES	4	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					894	894						1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VC0VG	26348945	Bronze			2022-12-25	WOS:000427612400001
J	Chambers, VS; Marsico, G; Boutell, JM; Di Antonio, M; Smith, GP; Balasubramanian, S				Chambers, Vicki S.; Marsico, Giovanni; Boutell, Jonathan M.; Di Antonio, Marco; Smith, Geoffrey P.; Balasubramanian, Shankar			High-throughput sequencing of DNA G-quadruplex structures in the human genome	NATURE BIOTECHNOLOGY			English	Article							C-KIT ONCOGENE; SMALL-MOLECULE; STABILITY; TRANSCRIPTION; CHEMISTRY; PROMOTER; CANCER; CELLS	G-quadruplexes (G4s) are nucleic acid secondary structures that form within guanine-rich DNA or RNA sequences. G4 formation can affect chromatin architecture and gene regulation and has been associated with genomic instability, genetic diseases and cancer progression(1-4). Here we present a high-resolution sequencing-based method to detect G4s in the human genome. We identified 716,310 distinct G4 structures, 451,646 of which were not predicted by computational methods(5-7). These included previously uncharacterized noncanonical long loop and bulged structures(8,9). We observed a high G4 density in functional regions, such as 5' untranslated regions and splicing sites, as well as in genes previously not predicted to contain these structures (such as BRCA2). G4 formation was significantly associated with oncogenes, tumor suppressors and somatic copy number alterations related to cancer development(10). The G4s identified in this study may therefore represent promising targets for cancer intervention.	[Chambers, Vicki S.; Di Antonio, Marco; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Marsico, Giovanni; Di Antonio, Marco; Balasubramanian, Shankar] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Boutell, Jonathan M.; Smith, Geoffrey P.] Illumina Cambridge Ltd, Saffron Walden, Essex, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Illumina; University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sb10031@cam.ac.uk	Balasubramanian, Shankar/C-1671-2009	Balasubramanian, Shankar/0000-0002-0281-5815; Di Antonio, Marco/0000-0002-7321-1867; Chambers, Vicki/0000-0003-3339-1813	Biotechnology and Biological Sciences Research Council (BBSRC); Illumina [BB/I015477/1]; Cancer Research UK; European Research Council; BBSRC; Biotechnology and Biological Sciences Research Council [1235154] Funding Source: researchfish; Cancer Research UK [11961, 12488, 18618] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Illumina; Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank C. Lowe and D. Tannahill for critical reading of the manuscript and D. Beraldi for technical support. We thank P. McCauley (Illumina) who prepared the custom sequencing buffers. We are grateful to the Biotechnology and Biological Sciences Research Council (BBSRC) and Illumina for the studentship supporting V.S.C. (BB/I015477/1). The S.B. research group is supported by program funding from Cancer Research UK and the European Research Council and project funding from BBSRC.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bugaut A, 2008, BIOCHEMISTRY-US, V47, P689, DOI 10.1021/bi701873c; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; De Cian A, 2007, J AM CHEM SOC, V129, P1856, DOI 10.1021/ja067352b; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Maizels N, 2008, CURR BIOL, V18, pR613, DOI 10.1016/j.cub.2008.06.011; Marchand A, 2015, J AM CHEM SOC, V137, P750, DOI 10.1021/ja5099403; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Rodriguez R, 2014, NAT REV GENET, V15, P783, DOI 10.1038/nrg3796; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Weitzmann MN, 1996, J BIOL CHEM, V271, P20958, DOI 10.1074/jbc.271.34.20958; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	31	681	688	9	229	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					877	+		10.1038/nbt.3295	http://dx.doi.org/10.1038/nbt.3295			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26192317				2022-12-25	WOS:000359274900028
J	Smith, LK; He, YB; Park, JS; Bieri, G; Snethlage, CE; Lin, K; Gontier, G; Wabl, R; Plambeck, KE; Udeochu, J; Wheatley, EG; Bouchard, J; Eggel, A; Narasimha, R; Grant, JL; Luo, J; Wyss-Coray, T; Villeda, SA				Smith, Lucas K.; He, Yingbo; Park, Jeong-Soo; Bieri, Gregor; Snethlage, Cedric E.; Lin, Karin; Gontier, Geraldine; Wabl, Rafael; Plambeck, Kristopher E.; Udeochu, Joe; Wheatley, Elizabeth G.; Bouchard, Jill; Eggel, Alexander; Narasimha, Ramya; Grant, Jacqueline L.; Luo, Jian; Wyss-Coray, Tony; Villeda, Saul A.			beta 2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis	NATURE MEDICINE			English	Article							MHC CLASS-I; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; DENTATE GYRUS; REJUVENATION; AGE; CELLS; DEFICIENT; BRAIN; MICE	Aging drives cognitive and regenerative impairments in the adult brain, increasing susceptibility to neurodegenerative disorders in healthy individuals(1-4). Experiments using heterochronic parabiosis, in which the circulatory systems of young and old animals are joined, indicate that circulating pro-aging factors in old blood drive aging phenotypes in the brain(5,6). Here we identify beta 2-microglobulin (B2M), a component of major histocompatibility complex class 1 (MHC I) molecules, as a circulating factor that negatively regulates cognitive and regenerative function in the adult hippocampus in an age-dependent manner. B2M is elevated in the blood of aging humans and mice, and it is increased within the hippocampus of aged mice and young heterochronic parabionts. Exogenous B2M injected systemically, or locally in the hippocampus, impairs hippocampal-dependent cognitive function and neurogenesis in young mice. The negative effects of B2M and heterochronic parabiosis are, in part, mitigated in the hippocampus of young transporter associated with antigen processing 1 (Tap1)-deficient mice with reduced cell surface expression of MHC I. The absence of endogenous B2M expression abrogates age-related cognitive decline and enhances neurogenesis in aged mice. Our data indicate that systemic B2M accumulation in aging blood promotes age-related cognitive dysfunction and impairs neurogenesis, in part via MHC I, suggesting that B2M may be targeted therapeutically in old age.	[Smith, Lucas K.; Bieri, Gregor; Snethlage, Cedric E.; Lin, Karin; Gontier, Geraldine; Plambeck, Kristopher E.; Udeochu, Joe; Wheatley, Elizabeth G.; Bouchard, Jill; Villeda, Saul A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Smith, Lucas K.; Bieri, Gregor; Snethlage, Cedric E.; Lin, Karin; Gontier, Geraldine; Plambeck, Kristopher E.; Udeochu, Joe; Wheatley, Elizabeth G.; Bouchard, Jill; Villeda, Saul A.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Smith, Lucas K.; Udeochu, Joe; Villeda, Saul A.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [He, Yingbo; Park, Jeong-Soo; Bieri, Gregor; Wabl, Rafael; Narasimha, Ramya; Grant, Jacqueline L.; Luo, Jian; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Park, Jeong-Soo] Dankook Univ, Coll Med, Dept Biochem, Cheonan, South Korea; [Bieri, Gregor; Grant, Jacqueline L.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Neurosci Grad Program, Stanford, CA 94305 USA; [Lin, Karin; Villeda, Saul A.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Wheatley, Elizabeth G.; Villeda, Saul A.] Univ Calif San Francisco, Dev & Stem Cell Biol Grad Program, San Francisco, CA 94143 USA; [Eggel, Alexander] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, CH-3010 Bern, Switzerland; [Wyss-Coray, Tony] Vet Affairs VA Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA; [Villeda, Saul A.] Calif Inst Quantitat Biosci QB3, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Dankook University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Bern; University Hospital of Bern; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Villeda, SA (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	saul.villeda@ucsf.edu	Luo, Jian/B-8449-2014; Wyss-Coray, Tony/AAF-3380-2019; Eggel, Alexander/J-8177-2019	Luo, Jian/0000-0002-2064-8467; Wyss-Coray, Tony/0000-0001-5893-0831; Eggel, Alexander/0000-0001-8746-3339; Wabl, Rafael/0000-0002-3701-7848	California Institute for Regenerative Medicine (CIRM); National Science Foundation; National Research Service Award fellowship [1F31-AG050415]; Veterans Affairs; National Institute on Aging [AG027505]; CIRM; Sandler Foundation; University of California San Francisco Clinical and Translational Science Institute [UL1-TR000004]; US National Institutes of Health Director's Independence Award [DP5-OD12178]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027505, F31AG050415, R01AG045034] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012178] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF)); National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CIRM(California Institute for Regenerative Medicine); Sandler Foundation; University of California San Francisco Clinical and Translational Science Institute(University of California System); US National Institutes of Health Director's Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D.R. Galasko (University of California San Diego), J.A. Kaye (Oregon Health Sciences University), G. Li (Veterans Affairs Northwest Network Mental Illness Research, Education and Clinical Center), E.R. Peskind (University of Washington and Veterans Affairs Northwest Network Mental Illness Research, Education and Clinical Center), and J.F. Quinn (Oregon Health Sciences University) for generously providing human plasma and CSF samples. We are grateful to numerous unnamed human subjects and staff for their contributions. We thank D. Dubal and M. Thomson for critically reading manuscript. This work was funded by a California Institute for Regenerative Medicine (CIRM) fellowship (K.L.), a National Science Foundation fellowship (J.U.), a National Research Service Award fellowship (1F31-AG050415, E.G.W.), Anonymous (T.W.-C.), Veterans Affairs (T.W.-C.), the National Institute on Aging (AG027505, T.W.-C.), CIRM (T.W.-C.), the Sandler Foundation (S.A.V.), a gift from Marc and Lynne Benioff, (S.A.V.), the University of California San Francisco Clinical and Translational Science Institute (UL1-TR000004, S.A.V.), and the US National Institutes of Health Director's Independence Award (DP5-OD12178, S.A.V.).	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; Bouchard J, 2015, J NEUROCHEM, V132, P5, DOI 10.1111/jnc.12969; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brew BJ, 1996, J INFECT DIS, V174, P294, DOI 10.1093/infdis/174.2.294; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Corlin DB, 2005, CLIN CHEM, V51, P1177, DOI 10.1373/clinchem.2005.049544; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Goya RL, 2010, NEUROREPORT, V21, P349, DOI 10.1097/WNR.0b013e3283377463; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Laviano A, 2014, NEW ENGL J MED, V371, P573, DOI 10.1056/NEJMcibr1407158; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MCARTHUR JC, 1992, NEUROLOGY, V42, P1707, DOI 10.1212/WNL.42.9.1707; Merrill DA, 2003, J COMP NEUROL, V459, P201, DOI 10.1002/cne.10616; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	36	255	271	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					932	937		10.1038/nm.3898	http://dx.doi.org/10.1038/nm.3898			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	26147761	Green Accepted			2022-12-25	WOS:000359181000021
J	Usher, CL; Handsaker, RE; Esko, T; Tuke, MA; Weedon, MN; Hastie, AR; Cao, H; Moon, JE; Kashin, S; Fuchsberger, C; Metspalu, A; Pato, CN; Pato, MT; McCarthy, MI; Boehnke, M; Altshuler, DM; Frayling, TM; Hirschhorn, JN; McCarroll, SA				Usher, Christina L.; Handsaker, Robert E.; Esko, Tonu; Tuke, Marcus A.; Weedon, Michael N.; Hastie, Alex R.; Cao, Han; Moon, Jennifer E.; Kashin, Seva; Fuchsberger, Christian; Metspalu, Andres; Pato, Carlos N.; Pato, Michele T.; McCarthy, Mark I.; Boehnke, Michael; Altshuler, David M.; Frayling, Timothy M.; Hirschhorn, Joel N.; McCarroll, Steven A.			Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity	NATURE GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; COPY NUMBER VARIATION; WIDE ASSOCIATION; MULTIGENE FAMILY; GENE; EVOLUTION; REPLICATION; DIVERSITY; VARIANTS; INSIGHTS	Hundreds of genes reside in structurally complex, poorly understood regions of the human genome(1-3). One such region contains the three amylase genes (AMY2B, AMY2A and AMY1) responsible for digesting starch into sugar. Copy number of AMY1 is reported to be the largest genomic influence on obesity(4), although genome-wide association studies for obesity have found this locus unremarkable. Using whole-genome sequence analysis(3,5), droplet digital PCR6 and genome mapping(7), we identified eight common structural haplotypes of the amylase locus that suggest its mutational history. We found that the AMY1 copy number in an individual's genome is generally even (rather than odd) and partially correlates with nearby SNPs, which do not associate with body mass index (BMI). We measured amylase gene copy number in 1,000 obese or lean Estonians and in 2 other cohorts totaling similar to 3,500 individuals. We had 99% power to detect the lower bound of the reported effects on BMI4, yet found no association.	[Usher, Christina L.; Handsaker, Robert E.; Esko, Tonu; Moon, Jennifer E.; Altshuler, David M.; Hirschhorn, Joel N.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02139 USA; [Handsaker, Robert E.; Esko, Tonu; Moon, Jennifer E.; Kashin, Seva; Altshuler, David M.; Hirschhorn, Joel N.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Handsaker, Robert E.; Kashin, Seva; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Esko, Tonu; Moon, Jennifer E.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Esko, Tonu; Moon, Jennifer E.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Tuke, Marcus A.; Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Sch Med, Genet Complex Traits, Exeter, Devon, England; [Hastie, Alex R.; Cao, Han] BioNano Genom, San Diego, CA USA; [Fuchsberger, Christian; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Fuchsberger, Christian; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Pato, Carlos N.; Pato, Michele T.] Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA USA; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res NIHR, Oxford OX3 7LJ, England; [Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Tartu; University of Exeter; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tartu; University of Southern California; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Harvard University; Massachusetts General Hospital	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02139 USA.	joelh@broadinstitute.org; mccarroll@genetics.med.harvard.edu	Fuchsberger, Christian/ABD-7127-2021; Altshuler, David M/A-4476-2009; Handsaker, Bob/AAX-9095-2021; McCarthy, Mark/M-3763-2015	Fuchsberger, Christian/0000-0002-5918-8947; Altshuler, David M/0000-0002-7250-4107; Handsaker, Bob/0000-0002-3128-3547; Frayling, Timothy/0000-0001-8362-2603; McCarthy, Mark/0000-0002-4393-0510; Esko, Tonu/0000-0003-1982-6569; Weedon, Michael/0000-0002-6174-6135; Moon, Jennifer/0000-0003-3209-4702	National Human Genome Research Institute [R01 HG006855]; Estonian Ministry of Science and Education [SF0180142s08]; Development Fund of the University of Tartu (SP1GVARENG); European Regional Development Fund [3.2.0304.11-0312, 313010]; US National Institutes of Health [R01 DK075787, DK062370]; European Research Council [SZ-50371-GLUCOSEGENES]; Wellcome Trust [WT097835MF]; MRC [G0601261, G0500070] Funding Source: UKRI; Medical Research Council [G0500070, G0601261] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R56DK062370, R01DK062370, R01DK075787, U01DK062370] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Estonian Ministry of Science and Education(Ministry of Education and Research, Estonia); Development Fund of the University of Tartu (SP1GVARENG); European Regional Development Fund(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Human Genome Research Institute (R01 HG006855) to S.A.M. to support C.L.U., R.E.H. and S.A.M. Work by T.E. and A.M. was supported through the Estonian Genome Center of the University of Tartu (EGCUT) by Targeted Financing from the Estonian Ministry of Science and Education (SF0180142s08), the Development Fund of the University of Tartu (SP1GVARENG) and the European Regional Development Fund to the Centre of Excellence in Genomics (3.2.0304.11-0312) and through Framework Programme 7 grant 313010. T.E., A.M. and J.N.H. were further supported by the US National Institutes of Health (R01 DK075787). T.M.F. is supported by European Research Council funding (Framework Programme 7, SZ-50371-GLUCOSEGENES), M.A.T. and M.N.W. are supported by the Wellcome Trust Institutional Strategic Support Award (WT097835MF), and M.B. is supported by US National Institutes of Health grant DK062370.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantsilieris S, 2013, HUM MUTAT, V34, P1, DOI 10.1002/humu.22172; Cao HZ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-34; Carpenter D, 2015, HUM MOL GENET, V24, P3472, DOI 10.1093/hmg/ddv098; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GROOT PC, 1990, GENOMICS, V8, P97, DOI 10.1016/0888-7543(90)90230-R; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; GROOT PC, 1991, GENOMICS, V10, P779, DOI 10.1016/0888-7543(91)90463-O; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hastie AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055864; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Iskow RC, 2012, TRENDS GENET, V28, P245, DOI 10.1016/j.tig.2012.03.002; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Mottus R, 2012, HEALTH PSYCHOL, V31, P806, DOI 10.1037/a0027041; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Team R.D.C., 2015, R LANG ENV STAT COMP; Tognon G, 2014, NUTR METAB CARDIOVAS, V24, P205, DOI 10.1016/j.numecd.2013.04.013; Zanda M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004367; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	51	87	87	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					921	+		10.1038/ng.3340	http://dx.doi.org/10.1038/ng.3340			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26098870	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000358674100018
J	Wittrup, A; Ai, A; Liu, X; Hamar, P; Trifonova, R; Charisse, K; Manoharan, M; Kirchhausen, T; Lieberman, J				Wittrup, Anders; Ai, Angela; Liu, Xing; Hamar, Peter; Trifonova, Radiana; Charisse, Klaus; Manoharan, Muthiah; Kirchhausen, Tomas; Lieberman, Judy			Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown	NATURE BIOTECHNOLOGY			English	Article							INTRACELLULAR TRAFFICKING; RNAI THERAPEUTICS; DELIVERY; NANOPARTICLES; AUTOPHAGY; PROTEIN; CELLS; GLYCOSPHINGOLIPIDS; MATURATION; REPORTER	A central hurdle in developing small interfering RNAs (siRNAs) as therapeutics is the inefficiency of their delivery across the plasma and endosomal membranes to the cytosol, where they interact with the RNA interference machinery. With the aim of improving endosomal release, a poorly understood and inefficient process, we studied the uptake and cytosolic release of siRNAs, formulated in lipoplexes or lipid nanoparticles, by live-cell imaging and correlated it with knockdown of a target GFP reporter. siRNA release occurred invariably from maturing endosomes within similar to 5-15 min of endocytosis. Cytosolic galectins immediately recognized the damaged endosome and targeted it for autophagy. However, inhibiting autophagy did not enhance cytosolic siRNA release. Gene knockdown occurred within a few hours of release and required <2,000 copies of cytosolic siRNAs. The ability to detect cytosolic release of siRNAs and understand how it is regulated will facilitate the development of rational strategies for improving the cytosolic delivery of candidate drugs.	[Wittrup, Anders; Ai, Angela; Liu, Xing; Hamar, Peter; Trifonova, Radiana; Kirchhausen, Tomas; Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA; [Wittrup, Anders] Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, Lund, Sweden; [Hamar, Peter] Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary; [Charisse, Klaus; Manoharan, Muthiah] Alnylam Pharmaceut, Cambridge, MA USA; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Kirchhausen, Tomas; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Lund University; Semmelweis University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA.	anders.wittrup@med.lu.se; judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015; Hamar, Peter/A-8996-2010	Hamar, Peter/0000-0002-1095-3564; Wittrup, Anders/0000-0003-4918-0500	US National Institutes of Health (NIH) [AI090671, CA139444]; Swedish Research Council; NIH [GM075252]; New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease [AI057159]; NATIONAL CANCER INSTITUTE [R01CA139444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI090671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank E. Marino for maintaining the Imaging Resource used in this study and K. Ketman and N. Barteneva for technical assistance. This work was supported by US National Institutes of Health (NIH) grants AI090671 and CA139444 (J.L.), the Swedish Research Council (A.W.), NIH grant GM075252 (T.K.) and New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease, Core Imaging Facility grant AI057159 (T.K.).	Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Alabi CA, 2013, P NATL ACAD SCI USA, V110, P12881, DOI 10.1073/pnas.1306529110; Chen X, 2014, J BIOL CHEM, V289, P11162, DOI 10.1074/jbc.M113.531855; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nechaev S, 2013, J CONTROL RELEASE, V170, P307, DOI 10.1016/j.jconrel.2013.06.007; Payne CK, 2007, TRAFFIC, V8, P389, DOI 10.1111/j.1600-0854.2007.00540.x; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rehman ZU, 2013, ACS NANO, V7, P3767, DOI 10.1021/nn3049494; Roberts R, 2013, AUTOPHAGY, V9, P667, DOI 10.4161/auto.23877; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	29	311	319	11	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					870	+		10.1038/nbt.3298	http://dx.doi.org/10.1038/nbt.3298			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26192320	Green Accepted			2022-12-25	WOS:000359274900027
J	Vitturi, DA; Minarrieta, L; Salvatore, SR; Postlethwait, EM; Fazzari, M; Ferrer-Sueta, G; Lancaster, JR; Freeman, BA; Schopfer, FJ				Vitturi, Dario A.; Minarrieta, Lucia; Salvatore, Sonia R.; Postlethwait, Edward M.; Fazzari, Marco; Ferrer-Sueta, Gerardo; Lancaster, Jack R., Jr.; Freeman, Bruce A.; Schopfer, Francisco J.			Convergence of biological nitration and nitrosation via symmetrical nitrous anhydride	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE; TYROSINE NITRATION; SIGNALING ACTIONS; REACTION-KINETICS; ISOMERIC FORMS; CYTOCHROME-C; NO SOLUTIONS; FATTY-ACIDS; IN-VIVO; N2O3	The current perspective holds that the generation of secondary signaling mediators from nitrite (NO2-) requires acidification to nitrous acid (HNO2) or metal catalysis. Herein, the use of stable isotope-labeled NO2- and LC-MS/MS analysis of products reveals that NO2- also participates in fatty acid nitration and thiol S-nitrosation at neutral pH. These reactions occur in the absence of metal centers and are stimulated by autoxidation of nitric oxide ((NO)-N-center dot) via the formation of symmetrical dinitrogen trioxide (nitrous anhydride, symN(2)O(3)). Although theoretical models have predicted physiological symN(2)O(3) formation, its generation is now demonstrated in aqueous reaction systems, cell models and in vivo, with the concerted reactions of (NO)-N-center dot and NO2- shown to be critical for symN(2)O(3) formation. These results reveal new mechanisms underlying the NO2- propagation of (NO)-N-center dot signaling and the regulation of both biomolecule function and signaling network activity via NO2--dependent nitrosation and nitration reactions.	[Vitturi, Dario A.; Salvatore, Sonia R.; Fazzari, Marco; Lancaster, Jack R., Jr.; Freeman, Bruce A.; Schopfer, Francisco J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Minarrieta, Lucia] Univ Republica, Catedra Inmunol, Montevideo, Uruguay; [Postlethwait, Edward M.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL USA; [Fazzari, Marco] Fdn RiMED, Palermo, Italy; [Ferrer-Sueta, Gerardo] Univ Republica, Lab Fisicoquim Biol, Montevideo, Uruguay; [Ferrer-Sueta, Gerardo] Univ Republica, Ctr Free Radical & Biomed Res, Montevideo, Uruguay; [Lancaster, Jack R., Jr.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Lancaster, Jack R., Jr.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidad de la Republica, Uruguay; University of Alabama System; University of Alabama Birmingham; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	freerad@pitt.edu; fjs2@pitt.edu	Schopfer, Francisco/AAW-6505-2021; Ferrer-Sueta, Gerardo/C-3316-2011; Vitturi, Dario/Z-3469-2019; Marco, Fazzari/AAA-2229-2019; Schopfer, Francisco Jose/AAE-8125-2020	Ferrer-Sueta, Gerardo/0000-0002-8663-8480; Marco, Fazzari/0000-0002-4051-4431; Schopfer, Francisco Jose/0000-0001-9526-695X; Vitturi, Dario/0000-0003-0354-4567; Salvatore, Sonia/0000-0002-9942-3905; Minarrieta, Lucia/0000-0002-8767-2269	US National Institutes of Health [R01-HL058115, R01-HL64937, P01-HL103455, R01-AT006822]; AHA [14GRNT20170024]; National Center for Complementary & Integrative Health [R01AT006822] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058115, P01HL103455, R01HL064937, R01HL058115] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	<SUP>T</SUP>his study was supported by US National Institutes of Health grants R01-HL058115, R01-HL64937, P01-HL103455 (B.A.F.), R01-AT006822 (F.J.S.) and AHA # 14GRNT20170024 (F.J.S.). We thank M.T. Gladwin, J. Tejero, A.M. Ferreira and B. Alvarez for helpful discussions and T. Sparwasser for expert assistance with flow cytometry experiments.	Akaike T, 2013, J BIOCHEM, V153, P131, DOI 10.1093/jb/mvs145; Amatore C, 2001, CHEM-EUR J, V7, P4171, DOI 10.1002/1521-3765(20011001)7:19<4171::AID-CHEM4171>3.0.CO;2-5; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Bonczynski JJ, 2003, VET SURG, V32, P161, DOI 10.1053/jvet.2003.50005; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Broniowska KA, 2012, BIOCHEM J, V442, P191, DOI 10.1042/BJ20111294; Castro L, 2004, ARCH BIOCHEM BIOPHYS, V421, P99, DOI 10.1016/j.abb.2003.08.033; Charles RL, 2014, P NATL ACAD SCI USA, V111, P8167, DOI 10.1073/pnas.1402965111; d'Ischia M, 2011, CHEM RES TOXICOL, V24, P2071, DOI 10.1021/tx2003118; Delmastro-Greenwood M, 2014, ANNU REV PHYSIOL, V76, P79, DOI 10.1146/annurev-physiol-021113-170341; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; FATELEY WG, 1959, J CHEM PHYS, V31, P204, DOI 10.1063/1.1730296; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Ford PC, 2010, INORG CHEM, V49, P6226, DOI 10.1021/ic902073z; Galliker B, 2009, CHEM-EUR J, V15, P6161, DOI 10.1002/chem.200801819; GOLDSTEIN S, 1995, J AM CHEM SOC, V117, P12078, DOI 10.1021/ja00154a007; Goldstein S, 1996, J AM CHEM SOC, V118, P3419, DOI 10.1021/ja9536680; HOLLAND RF, 1983, J CHEM PHYS, V78, P2928, DOI 10.1063/1.445252; HORAKH J, 1995, CHEM-EUR J, V1, P389, DOI 10.1002/chem.19950010610; HUIE RE, 1994, TOXICOLOGY, V89, P193, DOI 10.1016/0300-483X(94)90098-1; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; JUBERT AH, 1984, THEOR CHIM ACTA, V64, P313, DOI 10.1007/BF00551015; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Koppenol WH, 2012, INORG CHEM, V51, P5637, DOI 10.1021/ic202561f; Lancaster JR, 2008, NITRIC OXIDE-BIOL CH, V19, P68, DOI 10.1016/j.niox.2008.04.028; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Lundberg JO, 2013, GUT, V62, P616, DOI 10.1136/gutjnl-2011-301649; Maron BA, 2013, ANTIOXID REDOX SIGN, V18, P270, DOI 10.1089/ars.2012.4744; Moller MN, 2007, CHEM RES TOXICOL, V20, P709, DOI 10.1021/tx700010h; Nedospasov AA, 2002, J BIOCHEM MOL TOXIC, V16, P109, DOI 10.1002/jbt.10029; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PRYOR WA, 1982, J AM CHEM SOC, V104, P6685, DOI 10.1021/ja00388a035; Salvatore SR, 2013, J LIPID RES, V54, P1998, DOI 10.1194/jlr.M037804; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; SENNESAEL JJ, 1994, PERITON DIALYSIS INT, V14, P61; SHAW AW, 1971, J CHEM SOC A, P1592, DOI 10.1039/j19710001592; Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010; Sun Z, 2009, J MOL STRUC-THEOCHEM, V908, P107, DOI 10.1016/j.theochem.2009.05.012; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; VARETTI EL, 1971, J CHEM PHYS, V55, P3813, DOI 10.1063/1.1676666; Vitturi DA, 2011, FREE RADICAL BIO MED, V51, P805, DOI 10.1016/j.freeradbiomed.2011.05.037; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wink David A., 1995, Methods (Orlando), V7, P14, DOI 10.1006/meth.1995.1003; Woodcock SR, 2013, FREE RADICAL BIO MED, V59, P14, DOI 10.1016/j.freeradbiomed.2012.11.015; Zakharov II, 2009, J STRUCT CHEM+, V50, P212, DOI 10.1007/s10947-009-0031-1	50	49	50	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					504	+		10.1038/NCHEMBIO.1814	http://dx.doi.org/10.1038/NCHEMBIO.1814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26006011	Green Accepted			2022-12-25	WOS:000356334600015
J	Houslay, M				Houslay, Miles			Hypertension linked to PDE3A activation	NATURE GENETICS			English	Editorial Material							PHOSPHODIESTERASE; ASSOCIATION; STROKE; PDE4D		[Houslay, Miles] Kings Coll London, Inst Pharmaceut Sci, London, England; [Houslay, Miles] Mironid Ltd, Biocity, Scotland	University of London; King's College London	Houslay, M (corresponding author), Kings Coll London, Inst Pharmaceut Sci, London, England.	miles.houslay@kcl.ac.uk	Houslay, Miles/AAM-5281-2020	Houslay, Miles/0000-0002-3826-8091				Abbott-Banner KH, 2014, BASIC CLIN PHARMACOL, V114, P365, DOI 10.1111/bcpt.12209; Bolger GB, 2015, CELL SIGNAL, V27, P756, DOI 10.1016/j.cellsig.2014.12.009; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Cedervall P, 2015, P NATL ACAD SCI USA, V112, pE1414, DOI 10.1073/pnas.1419906112; Francis Sharron H, 2005, Expert Opin Drug Metab Toxicol, V1, P283, DOI 10.1517/17425255.1.2.283; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Kaname T, 2014, CELL SIGNAL, V26, P2446, DOI 10.1016/j.cellsig.2014.07.025; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Maass PG, 2015, NAT GENET, V47, P647, DOI 10.1038/ng.3302; McPhee I, 1999, J BIOL CHEM, V274, P11796, DOI 10.1074/jbc.274.17.11796; Schafer PH, 2010, BRIT J PHARMACOL, V159, P842, DOI 10.1111/j.1476-5381.2009.00559.x; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Vidal SGM, 2013, NEUROL CLIN, V31, P633, DOI 10.1016/j.ncl.2013.03.004; Yan Y, 2014, J NEUROL SCI, V338, P3, DOI 10.1016/j.jns.2013.12.012	15	12	14	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					562	563		10.1038/ng.3316	http://dx.doi.org/10.1038/ng.3316			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	26018892				2022-12-25	WOS:000355386500002
J	Aono, R; Sato, T; Imanaka, T; Atomi, H				Aono, Riku; Sato, Takaaki; Imanaka, Tadayuki; Atomi, Haruyuki			A pentose bisphosphate pathway for nucleoside degradation in Archaea	NATURE CHEMICAL BIOLOGY			English	Article							ADP-DEPENDENT GLUCOKINASE; RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; HYPERTHERMOPHILIC ARCHAEON; PYROCOCCUS-FURIOSUS; THERMOCOCCUS-KODAKARAENSIS; BIOCHEMICAL-CHARACTERIZATION; RIBOSE-1,5-BISPHOSPHATE ISOMERASE; SULFOLOBUS-SOLFATARICUS; SUBSTRATE-SPECIFICITY; AMP PHOSPHORYLASE	Owing to the absence of the pentose phosphate pathway, the degradation pathway for the ribose moieties of nucleosides is unknown in Archaea. Here, in the archaeon Thermococcus kodakarensis, we identified a metabolic network that links the pentose moieties of nucleosides or nucleotides to central carbon metabolism. The network consists of three nucleoside phosphorylases, an ADP-dependent ribose-1-phosphate kinase and two enzymes of a previously identified NMP degradation pathway, ribose-1,5-bisphosphate isomerase and type III ribulose-1,5-bisphosphate carboxylase/oxygenase. Ribose 1,5-bisphosphate and ribulose 1,5-bisphosphate are intermediates of this pathway, which is thus designated the pentose bisphosphate pathway.	[Aono, Riku; Sato, Takaaki; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Aono, Riku] Japan Soc Promot Sci, Tokyo, Japan; [Sato, Takaaki; Imanaka, Tadayuki; Atomi, Haruyuki] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo, Japan; [Imanaka, Tadayuki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST); Ritsumeikan University	Atomi, H (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan.	atomi@sbchem.kyoto-u.ac.jp		Aono, Riku/0000-0003-4235-0968; Atomi, Haruyuki/0000-0001-9687-6426	Core Research for Evolutional Science and Technology program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [14J05097] Funding Source: KAKEN	Core Research for Evolutional Science and Technology program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by the Core Research for Evolutional Science and Technology program of the Japan Science and Technology Agency to H.A. within the research area 'Creation of Basic Technology for Improved Bioenergy Production through Functional Analysis and Regulation of Algae and Other Aquatic Microorganisms'. R.A. is a Research Fellow of the Japan Society for the Promotion of Science.	Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Aono R, 2012, J BACTERIOL, V194, P6847, DOI 10.1128/JB.01335-12; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Cacciapuoti G, 2005, FEBS J, V272, P1886, DOI 10.1111/j.1742-4658.2005.04619.x; Cacciapuoti G, 2003, EXTREMOPHILES, V7, P159, DOI 10.1007/s00792-002-0307-2; CACCIAPUOTI G, 1994, J BIOL CHEM, V269, P24762; Cacciapuoti G, 2007, FEBS J, V274, P2482, DOI 10.1111/j.1742-4658.2007.05784.x; Camici M, 2006, J BIOCHEM BIOPH METH, V68, P145, DOI 10.1016/j.jbbm.2006.07.001; Castro-Fernandez V, 2014, FEBS J, V281, P2017, DOI 10.1111/febs.12757; Elkin SR, 2013, PROTEINS, V81, P568, DOI 10.1002/prot.24212; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hansen T, 2007, EXTREMOPHILES, V11, P105, DOI 10.1007/s00792-006-0018-1; Ipata PL, 2011, CURR TOP MED CHEM, V11, P909; Kanai T, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703424200; Kanai T, 2010, J BIOCHEM, V147, P361, DOI 10.1093/jb/mvp177; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kengen SWM, 2001, METHOD ENZYMOL, V331, P41; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Merino F, 2012, BIOCHIMIE, V94, P516, DOI 10.1016/j.biochi.2011.08.021; MINAKAMI S, 1965, BIOCHEM BIOPH RES CO, V18, P345, DOI 10.1016/0006-291X(65)90711-4; Nakamura A, 2012, J BIOL CHEM, V287, P20784, DOI 10.1074/jbc.M112.349423; Nishitani Y, 2013, J MOL BIOL, V425, P2709, DOI 10.1016/j.jmb.2013.04.026; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Park J, 2008, CELL MOL LIFE SCI, V65, P2875, DOI 10.1007/s00018-008-8123-1; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Robb F.T., 1995, ARCHAEA LAB MANUAL; ROBBINS EA, 1957, J BIOL CHEM, V224, P121; Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103; Sakuraba H, 2002, J BIOL CHEM, V277, P12495, DOI 10.1074/jbc.C200059200; Sambrook J, 2001, MOL CLONING LAB MANU; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; Tozzi MG, 2006, FEBS J, V273, P1089, DOI 10.1111/j.1742-4658.2006.05155.x; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Walther T, 2012, FEBS LETT, V586, P4114, DOI 10.1016/j.febslet.2012.09.042; Wamelink M, 2008, J INHERIT METAB DIS, V31, P703, DOI 10.1007/s10545-008-1015-6; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999	43	41	44	3	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2015	11	5					355	U153		10.1038/NCHEMBIO.1786	http://dx.doi.org/10.1038/NCHEMBIO.1786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG3FD	25822915				2022-12-25	WOS:000353162600012
J	Bonner, C; Kerr-Conte, J; Gmyr, V; Queniat, G; Moerman, E; Thevenet, J; Beaucamps, C; Delalleau, N; Popescu, I; Malaisse, WJ; Sener, A; Deprez, B; Abderrahmani, A; Staels, B; Pattou, F				Bonner, Caroline; Kerr-Conte, Julie; Gmyr, Valery; Queniat, Gurvan; Moerman, Ericka; Thevenet, Julien; Beaucamps, Cedric; Delalleau, Nathalie; Popescu, Iuliana; Malaisse, Willy J.; Sener, Abdullah; Deprez, Benoit; Abderrahmani, Amar; Staels, Bart; Pattou, Francois			Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion	NATURE MEDICINE			English	Article							DEPENDENT DIABETES-MELLITUS; IMPROVES GLYCEMIC CONTROL; INSULIN-RESISTANCE; BETA-CELLS; RATS; MICE; POTENT; PATHOPHYSIOLOGY; HYPERGLYCEMIA; TOFOGLIFLOZIN	Type 2 diabetes (T2D) is characterized by chronic hyperglycemia resulting from a deficiency in insulin signaling, because of insulin resistance and/or defects in insulin secretion; it is also associated with increases in glucagon and endogenous glucose production (EGP)(1). Gliflozins, including dapagliflozin, are a new class of approved oral antidiabetic agents that specifically inhibit sodium-glucose co-transporter 2 (SGLT2) function in the kidney(2-5), thus preventing renal glucose reabsorption and increasing glycosuria in diabetic individuals while reducing hyperglycemia. However, gliflozin treatment in subjects with T2D increases both plasma glucagon and EGP(6,7) by unknown mechanisms. In spite of the rise in EGP, T2D patients treated with gliflozin have lower blood glucose levels than those receiving placebo, possibly because of increased glycosuria(6,7); however, the resulting increase in plasma glucagon levels represents a possible concerning side effect, especially in a patient population already affected by hyperglucagonemia. Here we demonstrate that SGLT2 is expressed in glucagon-secreting alpha cells of the pancreatic islets. We further found that expression of SLC5A2 (which encodes SGLT2) was lower and glucagon (GCG) gene expression was higher in islets from T2D individuals and in normal islets exposed to chronic hyperglycemia than in islets from non-diabetics. Moreover, hepatocyte nuclear factor 4-alpha (HNF4A) is specifically expressed in human alpha cells, in which it controls SLC5A2 expression, and its expression is downregulated by hyperglycemia. In addition, inhibition of either SLC5A2 via siRNA-induced gene silencing or SGLT2 via dapagliflozin treatment in human islets triggered glucagon secretion through K-ATP channel activation. Finally, we found that dapagliflozin treatment further promotes glucagon secretion and hepatic gluconeogenesis in healthy mice, thereby limiting the decrease of plasma glucose induced by fasting. Collectively, these results identify a heretofore unknown role of SGLT2 and designate dapagliflozin an alpha cell secretagogue.	[Bonner, Caroline; Kerr-Conte, Julie; Gmyr, Valery; Queniat, Gurvan; Moerman, Ericka; Thevenet, Julien; Beaucamps, Cedric; Delalleau, Nathalie; Abderrahmani, Amar; Staels, Bart; Pattou, Francois] European Genom Inst Diabet, Lille, France; [Bonner, Caroline; Kerr-Conte, Julie; Gmyr, Valery; Queniat, Gurvan; Moerman, Ericka; Thevenet, Julien; Beaucamps, Cedric; Delalleau, Nathalie; Pattou, Francois] INSERM, UMR 1190, F-59045 Lille, France; [Bonner, Caroline; Kerr-Conte, Julie; Beaucamps, Cedric; Pattou, Francois] Ctr Hosp Reg Univ, Lille, France; [Kerr-Conte, Julie; Gmyr, Valery; Queniat, Gurvan; Moerman, Ericka; Thevenet, Julien; Delalleau, Nathalie; Deprez, Benoit; Abderrahmani, Amar; Staels, Bart; Pattou, Francois] Univ Lille, Lille, France; [Popescu, Iuliana; Malaisse, Willy J.; Sener, Abdullah] Univ Libre Bruxelles, Sch Med, Lab Expt Hormonol, Brussels, Belgium; [Deprez, Benoit] INSERM, UMR 1177, F-59045 Lille, France; [Deprez, Benoit; Staels, Bart] Inst Pasteur, F-59019 Lille, France; [Abderrahmani, Amar] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8199, F-59019 Lille, France; [Staels, Bart] INSERM, UMR 1011, F-59045 Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Pattou, F (corresponding author), European Genom Inst Diabet, Lille, France.	bart.staels@univ-lille2.fr; fpattou@univ-lille2.fr	Staels, Bart/N-9497-2016; Abderrahmani, Amar/O-3124-2017; Pattou, Francois/O-6151-2017; Bonner, Caroline/A-9819-2015	Staels, Bart/0000-0002-3784-1503; Abderrahmani, Amar/0000-0003-0752-0343; Pattou, Francois/0000-0001-8388-3766; Bonner, Caroline/0000-0002-4430-8280; Deprez, Benoit/0000-0002-2777-4538	Conseil Regional Nord-Pas-de-Calais; European Commission [FEDER 12003944]; Fondation de l'Avenir; European Genomic Institute for Diabetes [ANR-10-LABX-46]; Juvenile Diabetes Research Foundation International	Conseil Regional Nord-Pas-de-Calais(Region Hauts-de-France); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation de l'Avenir; European Genomic Institute for Diabetes; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation)	We thank the Agence de la Biomedecine and Lille University core facilities for biotherapy, experimental research, and histology; R. Boutry for excellent technical assistance; and L. Schaffer (Novo Nordisk, Bagsvaerd, Denmark) for providing the S961 insulin receptor antagonist. We are grateful to J. Girard (Institut Cochin, Paris, France) and J.-C. Henquin (Universite de Louvain, Brussels, Belgium) for their comments and stimulating discussions. This work was presented in part at the 2014 annual meetings of the American Diabetes Association and the European Association to Study Diabetes. This work was supported by grants from the Conseil Regional Nord-Pas-de-Calais and the European Commission (FEDER 12003944 to F.P.), the Fondation de l'Avenir (Matmut Award to F.P.), and the European Genomic Institute for Diabetes (ANR-10-LABX-46 to F.P.). The European Consortium for Islet Transplantation is funded by the Juvenile Diabetes Research Foundation International. B.S. is a member of the Institut Universitaire de France. International.	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; ALFORD FP, 1974, LANCET, V2, P974; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; CAMPBELL PJ, 1988, METABOLISM, V37, P15, DOI 10.1016/0026-0495(88)90023-6; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DEFRONZO RA, 1989, METABOLISM, V38, P387, DOI 10.1016/0026-0495(89)90129-7; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; Demaris KM, 2013, DRUG TODAY, V49, P289, DOI 10.1358/dot.2013.49.5.1964714; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; DINNEEN S, 1995, DIABETOLOGIA, V38, P337, DOI 10.1007/BF00400639; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; Gargani S, 2013, DIABETOLOGIA, V56, P350, DOI 10.1007/s00125-012-2775-y; Gylfe E, 2014, DIABETES RES CLIN PR, V103, P1, DOI 10.1016/j.diabres.2013.11.019; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Jabbour SA, 2008, INT J CLIN PRACT, V62, P1279, DOI 10.1111/j.1742-1241.2008.01829.x; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Jurysta C, 2012, CELL PHYSIOL BIOCHEM, V29, P325, DOI 10.1159/000338487; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kerr-Conte J, 2010, TRANSPLANTATION, V89, P1154, DOI 10.1097/TP.0b013e3181d154ac; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P513, DOI 10.1038/clpt.2008.250; Lefebvre B, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-28; Leibiger B, 2012, P NATL ACAD SCI USA, V109, P20925, DOI 10.1073/pnas.1212870110; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Luippold G, 2012, DIABETES OBES METAB, V14, P601, DOI 10.1111/j.1463-1326.2012.01569.x; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Magen D, 2005, KIDNEY INT, V67, P34, DOI 10.1111/j.1523-1755.2005.00053.x; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nagata T, 2013, AM J PHYSIOL-ENDOC M, V304, pE414, DOI 10.1152/ajpendo.00545.2012; Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473; Obermeier M, 2010, DRUG METAB DISPOS, V38, P405, DOI 10.1124/dmd.109.029165; Powell DR, 2013, AM J PHYSIOL-ENDOC M, V304, pE117, DOI 10.1152/ajpendo.00439.2012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rui CX, 2013, DIABETES, V62, P1612, DOI 10.2337/db12-0347; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Suzuki M, 2012, J PHARMACOL EXP THER, V341, P692, DOI 10.1124/jpet.112.191593; Tahara A, 2012, J PHARMACOL SCI, V120, P36, DOI 10.1254/jphs.12089FP; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; Weedon MN, 2004, DIABETES, V53, P3002, DOI 10.2337/diabetes.53.11.3002; Yamaguchi K, 2013, J PHARMACOL EXP THER, V345, P52, DOI 10.1124/jpet.113.203125; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014	50	426	446	3	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					512	U139		10.1038/nm.3828	http://dx.doi.org/10.1038/nm.3828			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25894829				2022-12-25	WOS:000354068800020
J	Blennow, K; Zetterberg, H				Blennow, Kaj; Zetterberg, Henrik			Ultrasensitive detection techniques pave the way for mechanistic understanding	NATURE MEDICINE			English	Editorial Material							ALZHEIMERS; PROTEINS; BRAIN	New methods for detecting indications of neurodegeneration are necessary to diagnose neurodegenerative diseases. In identifying suitable biomarkers that can be monitored by these techniques, the pathogenic mechanisms that lead to these diseases may also be elucidated.	[Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London, England	University of Gothenburg; University of London; University College London	Blennow, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden.	kaj.blennow@neuro.gu.se						Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; Meredith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076523; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	9	44	47	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					217	219		10.1038/nm.3810	http://dx.doi.org/10.1038/nm.3810			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25742456				2022-12-25	WOS:000350362000012
J	Mazur, PK; Herner, A; Mello, SS; Wirth, M; Hausmann, S; Sanchez-Rivera, FJ; Lofgren, SM; Kuschma, T; Hahn, SA; Vangala, D; Trajkovic-Arsic, M; Gupta, A; Heid, I; Noel, PB; Braren, R; Erkan, M; Kleeff, J; Sipos, B; Sayles, LC; Heikenwalder, M; Hessmann, E; Ellenrieder, V; Esposito, I; Jacks, T; Bradner, JE; Khatri, P; Sweet-Cordero, EA; Attardi, LD; Schmid, RM; Schneider, G; Sage, J; Siveke, JT				Mazur, Pawel K.; Herner, Alexander; Mello, Stephano S.; Wirth, Matthias; Hausmann, Simone; Sanchez-Rivera, Francisco J.; Lofgren, Shane M.; Kuschma, Timo; Hahn, Stephan A.; Vangala, Deepak; Trajkovic-Arsic, Marija; Gupta, Aayush; Heid, Irina; Noel, Peter B.; Braren, Rickmer; Erkan, Mert; Kleeff, Joerg; Sipos, Bence; Sayles, Leanne C.; Heikenwalder, Mathias; Hessmann, Elisabeth; Ellenrieder, Volker; Esposito, Irene; Jacks, Tyler; Bradner, James E.; Khatri, Purvesh; Sweet-Cordero, E. Alejandro; Attardi, Laura D.; Schmid, Roland M.; Schneider, Guenter; Sage, Julien; Siveke, Jens T.			Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma	NATURE MEDICINE			English	Article							INTRAEPITHELIAL NEOPLASIA; BROMODOMAIN INHIBITION; SELECTIVE-INHIBITION; MOUSE MODEL; CANCER; KRAS; PROMOTES; BIOLOGY; PROGRESSION; P57(KIP2)	Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human cancers and shows resistance to any therapeutic strategy used. Here we tested small-molecule inhibitors targeting chromatin regulators as possible therapeutic agents in PDAC. We show that JQ1, an inhibitor of the bromodomain and extraterminal (BET) family of proteins, suppresses PDAC development in mice by inhibiting both MYC activity and inflammatory signals. The histone deacetylase (HDAC) inhibitor SAHA synergizes with JQ1 to augment cell death and more potently suppress advanced PDAC. Finally, using a CRISPR-Cas9-based method for gene editing directly in the mouse adult pancreas, we show that de-repression of p57 (also known as KIP2 or CDKN1C) upon combined BET and HDAC inhibition is required for the induction of combination therapy-induced cell death in PDAC. SAHA is approved for human use, and molecules similar to JQ1 are being tested in clinical trials. Thus, these studies identify a promising epigenetic-based therapeutic strategy that may be rapidly implemented in fatal human tumors.	[Mazur, Pawel K.; Kuschma, Timo; Sayles, Leanne C.; Sweet-Cordero, E. Alejandro; Sage, Julien] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Mazur, Pawel K.; Mello, Stephano S.; Kuschma, Timo; Attardi, Laura D.; Sage, Julien] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Herner, Alexander; Wirth, Matthias; Trajkovic-Arsic, Marija; Gupta, Aayush; Schmid, Roland M.; Schneider, Guenter; Siveke, Jens T.] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80290 Munich, Germany; [Mello, Stephano S.; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Hausmann, Simone; Erkan, Mert; Kleeff, Joerg] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany; [Sanchez-Rivera, Francisco J.; Jacks, Tyler] MIT, Dept Biol, David H Koch Inst Integrat Canc Res, Cambridge, MA USA; [Sanchez-Rivera, Francisco J.; Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Lofgren, Shane M.; Khatri, Purvesh] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Lofgren, Shane M.; Khatri, Purvesh] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Hahn, Stephan A.] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, Bochum, Germany; [Vangala, Deepak] Ruhr Univ Bochum, Med Clin, Knappschaftskrankenhaus, Bochum, Germany; [Heid, Irina; Noel, Peter B.; Braren, Rickmer] Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-80290 Munich, Germany; [Sipos, Bence] Univ Tubingen, Inst Pathol, Tubingen, Germany; [Heikenwalder, Mathias] Tech Univ Munich, Klinikum Rechts Isar, Inst Virol, D-80290 Munich, Germany; [Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [Hessmann, Elisabeth; Ellenrieder, Volker] Univ Med Ctr Gottingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany; [Esposito, Irene] Tech Univ Munich, Klinikum Rechts Isar, Inst Pathol, D-80290 Munich, Germany; [Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Schmid, Roland M.; Siveke, Jens T.] German Canc Consortium DKTK, Heidelberg, Germany; [Schmid, Roland M.; Siveke, Jens T.] German Canc Res Ctr, Heidelberg, Germany	Stanford University; Stanford University; Technical University of Munich; Stanford University; Technical University of Munich; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Ruhr University Bochum; Ruhr University Bochum; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Gottingen; Technical University of Munich; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Mazur, PK (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	pmazur@stanford.edu; julsage@stanford.edu; j.siveke@dkfz.de	Vangala, Deepak/HHS-5988-2022; Hahn, Stephan/E-3880-2010; Braren, Rickmer/U-3254-2018; Vangala, Deepak/AAV-5780-2021; Mazur, Pawel K./AAU-6343-2021; Hahn, Stephan A./AAV-6062-2021; Sánchez-Rivera, Francisco J./AAV-6985-2020; Wirth, Matthias/AEG-6333-2022; Mello, Stephano Spano/ABF-9477-2020; Heid, Irina/GZA-7294-2022; Kleeff, Jorg/B-2124-2009; Siveke, Jens/AAQ-6170-2021; Heikenwalder, Mathias/AAA-2269-2020	Hahn, Stephan/0000-0003-0855-9741; Braren, Rickmer/0000-0001-6039-6957; Vangala, Deepak/0000-0002-4175-5683; Mazur, Pawel K./0000-0002-5820-8344; Hahn, Stephan A./0000-0003-0855-9741; Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Kleeff, Jorg/0000-0003-3432-6669; Khatri, Purvesh/0000-0002-4143-4708; Noel, Peter/0000-0002-9671-6171; Siveke, Jens/0000-0002-8772-4778; Mello, Stephano Spano/0000-0002-2484-086X	German Research Foundation [SFB824/C4]; European Union [602783]; German Cancer Consortium (DKTK); Lustgarten Foundation; Tobacco-Related Disease Research Program; Stanford University; Child Health Research Institute; Lucile Packard Foundation for Children's Health at Stanford; Boehringer Ingelheim Fonds MD Fellowship; NATIONAL CANCER INSTITUTE [R00CA197816, K99CA197816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109662] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); German Cancer Consortium (DKTK); Lustgarten Foundation; Tobacco-Related Disease Research Program(University of California System); Stanford University(Stanford University); Child Health Research Institute; Lucile Packard Foundation for Children's Health at Stanford; Boehringer Ingelheim Fonds MD Fellowship(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	P.K.M. and A.H. significantly contributed to the work and are listed as co-first authors based on a previous agreement. We thank C. Vakoc (Cold Spring Harbor Laboratory) for sharing shRNA plasmids, M. Winslow (Stanford University) for the R26<SUP>CAG-tdTomato</SUP> reporter mice and I. Moreno de Alboran (Spanish National Biotechnology Centre) for Myc<SUP>loxP</SUP> mice. This work was supported by the German Research Foundation (SFB824/C4 to J.T.S.), the European Union's Seventh Framework Program for research, technological development and demonstration (FP7/CAM-PaC) under grant agreement 602783, the German Cancer Consortium (DKTK) (to R.M.S. and J.T.S.), and the Lustgarten Foundation (J.S.). P.K.M. was supported by the Tobacco-Related Disease Research Program, a Dean's Fellowship from Stanford University, and the Child Health Research Institute and Lucile Packard Foundation for Children's Health at Stanford. J.S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases. T.K. was supported by a Boehringer Ingelheim Fonds MD Fellowship.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5279; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Collins MA, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00407; Cook N, 2012, DRUG DISCOV TODAY, V17, P253, DOI 10.1016/j.drudis.2012.02.003; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Garcia PL, 2016, ONCOGENE, V35, P833, DOI 10.1038/onc.2015.126; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Infante JR, 2014, EUR J CANCER, V50, P2072, DOI 10.1016/j.ejca.2014.04.024; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Jose A, 2013, ONCOTARGET, V4, P94, DOI 10.18632/oncotarget.795; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; McCleary-Wheeler AL, 2013, CANCER LETT, V328, P212, DOI 10.1016/j.canlet.2012.10.005; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rielland M, 2014, J CLIN INVEST, V124, P2125, DOI 10.1172/JCI72619; Roy N, 2015, GENE DEV, V29, P658, DOI 10.1101/gad.256628.114; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sahai V, 2014, MOL CANCER THER, V13, P1907, DOI 10.1158/1535-7163.MCT-13-0925; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471; Schleger C, 2002, MODERN PATHOL, V15, P462, DOI 10.1038/modpathol.3880547; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vlachos P, 2007, CELL DEATH DIFFER, V14, P1497, DOI 10.1038/sj.cdd.4402158; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhao RY, 2013, CELL CYCLE, V12, P935, DOI 10.4161/cc.23883; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	79	262	267	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1163	+		10.1038/nm.3952	http://dx.doi.org/10.1038/nm.3952			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26390243	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000362355400018
J	Min, SW; Chen, X; Tracy, TE; Li, YQ; Zhou, YG; Wang, C; Shirakawa, K; Minami, SS; Defensor, E; Mok, SA; Sohn, PD; Schilling, B; Cong, X; Ellerby, L; Gibson, BW; Johnson, J; Krogan, N; Shamloo, M; Gestwicki, J; Masliah, E; Verdin, E; Gan, L				Min, Sang-Won; Chen, Xu; Tracy, Tara E.; Li, Yaqiao; Zhou, Yungui; Wang, Chao; Shirakawa, Kotaro; Minami, S. Sakura; Defensor, Erwin; Mok, Sue Ann; Sohn, Peter Dongmin; Schilling, Birgit; Cong, Xin; Ellerby, Lisa; Gibson, Bradford W.; Johnson, Jeffrey; Krogan, Nevan; Shamloo, Mehrdad; Gestwicki, Jason; Masliah, Eliezer; Verdin, Eric; Gan, Li			Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits	NATURE MEDICINE			English	Article							ALZHEIMER-DISEASE; WILD-TYPE; MOUSE MODEL; PROTEIN; OLIGOMERS; MEMORY; AGGREGATION; ATROPHY; IDENTIFICATION; ACCUMULATION	Tauopathies, including frontotemporal dementia (FTD) and Alzheimer's disease (AD), are neurodegenerative diseases in which tau fibrils accumulate. Recent evidence supports soluble tau species as the major toxic species. How soluble tau accumulates and causes neurodegeneration remains unclear. Here we identify tau acetylation at Lys174 (K174) as an early change in AD brains and a critical determinant in tau homeostasis and toxicity in mice. The acetyl-mimicking mutant K174Q slows tau turnover and induces cognitive deficits in vivo. Acetyltransferase p300-induced tau acetylation is inhibited by salsalate and salicylate, which enhance tau turnover and reduce tau levels. In the PS19 transgenic mouse model of FTD, administration of salsalate after disease onset inhibited p300 activity, lowered levels of total tau and tau acetylated at K174, rescued tau-induced memory deficits and prevented hippocampal atrophy. The tau-lowering and protective effects of salsalate were diminished in neurons expressing K174Q tau. Targeting tau acetylation could be a new therapeutic strategy against human tauopathies.	[Min, Sang-Won; Chen, Xu; Tracy, Tara E.; Li, Yaqiao; Zhou, Yungui; Wang, Chao; Minami, S. Sakura; Sohn, Peter Dongmin; Gan, Li] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Min, Sang-Won; Chen, Xu; Tracy, Tara E.; Wang, Chao; Minami, S. Sakura; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Shirakawa, Kotaro; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Defensor, Erwin; Shamloo, Mehrdad] Stanford Univ, Sch Med, Stanford Inst Neuroinnovat & Translat Neurosci, Stanford, CA 94305 USA; [Mok, Sue Ann; Gestwicki, Jason] Univ Calif San Francisco, Dept Pharmaceut Chem, Inst Neurodegenerat Dis, San Francisco, CA USA; [Sohn, Peter Dongmin; Gan, Li] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Schilling, Birgit; Cong, Xin; Ellerby, Lisa; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA USA; [Johnson, Jeffrey; Krogan, Nevan] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Buck Institute for Research on Aging; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego	Gan, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	eric.verdin@gladstone.ucsf.edu; lgan@gladstone.ucsf.edu	Wang, Chao/A-4626-2016; Verdin, Eric/AAB-7999-2019	Wang, Chao/0000-0003-0357-4096; Mok, Sue-Ann/0000-0003-4593-3368; Verdin, Eric/0000-0003-3703-3183	Tau Consortium; US National Institutes of Health (NIH) [1R01AG036884, R01AG030207]; NIH [NIH NS40251, NIH NS062413, P30NS065780]; NCRR [S10 RR024615]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040251, RL1NS062413, P30NS065780, R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG036884, R01AG030207] Funding Source: NIH RePORTER	Tau Consortium; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank V. Haroutunian (The Icahn School of Medicine at Mount Sinai) and W.W. Seeley (UCSF) for human brain samples; B. Hann and J. Freimuth (UCSF) for oral gavage; L. Petrucelli (Mayo Clinic) for ac-KIGS antibody; P. Davies (Feinstein Institute for Medical Research) for MC1 and PHF-1 antibodies, Prothena Biosciences for 12E8 antibody; R. Ponnusamy and N. Devidze for advice on behavioral analyses; D. Song for PK analysis (PPL Inc); M. Finucane and S. Liu for advice on statistical analysis; L. Mucke and S. Meada for insightful discussions; L. Grinberg for technical advice on pathological analysis; C. Brennecka, G. Howard and S. Ordway for editorial review; J. Carroll and G. Maki for graphics assistance; E. Nguyen for administrative assistance and AB SCIEX for evaluation of the TripleTOF 5600 at the Buck Institute. This work was supported by a grant from the Tau Consortium (to L.G.) and US National Institutes of Health (NIH) grants 1R01AG036884 and R01AG030207 (to L.G.). We acknowledge the support of the NIH to L.E. (NIH NS40251 and NIH NS062413), and instrumentation from the NCRR shared instrumentation grant S10 RR024615 (to B.W.G.). Behavioral data were obtained with the help of the Gladstone Institutes' Neurobehavioral Core (supported by NIH grant P30NS065780).	Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Faizi M, 2012, BRAIN BEHAV, V2, P142, DOI 10.1002/brb3.41; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Grinberg LT, 2013, ACTA NEUROPATHOL, V125, P581, DOI 10.1007/s00401-013-1080-2; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kasper LH, 2014, NUCLEIC ACIDS RES, V42, P11363, DOI 10.1093/nar/gku827; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kerchner GA, 2010, NEUROLOGY, V75, P1381, DOI 10.1212/WNL.0b013e3181f736a1; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kim SW, 2011, MOL PHARMACOL, V79, P220, DOI 10.1124/mol.110.067520; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lecourtier L, 2012, NEUROSCIENCE, V207, P110, DOI 10.1016/j.neuroscience.2012.01.040; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee H, 2004, J NEUROIMMUNOL, V156, P88, DOI 10.1016/j.jneuroim.2004.07.008; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Lim JY, 2012, J CELL PHYSIOL, V227, P1081, DOI 10.1002/jcp.22824; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Moore CL, 2011, BIOCHEMISTRY-US, V50, P10876, DOI 10.1021/bi2014745; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ren Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00102; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Sydow A, 2011, J MOL NEUROSCI, V45, P432, DOI 10.1007/s12031-011-9604-5; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Wang B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4479; Wang YP, 2012, BIOCHEM SOC T, V40, P644, DOI 10.1042/BST20120071; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Yeung F, 2015, ONCOGENE, V34, P798, DOI 10.1038/onc.2014.39; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yoshiyama Y, 2010, J ALZHEIMERS DIS, V22, P295, DOI 10.3233/JAD-2010-100681; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453; Zhao Y, 2014, MOL CELL BIOL, V34, P315, DOI 10.1128/MCB.00956-13	59	305	311	4	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1154	+		10.1038/nm.3951	http://dx.doi.org/10.1038/nm.3951			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CS8RG	26390242	Green Accepted, Green Submitted			2022-12-25	WOS:000362355400017
J	Chung, HK; Jacobs, CL; Huo, YW; Yang, J; Krumm, SA; Plemper, RK; Tsien, RY; Lin, MZ				Chung, Hokyung K.; Jacobs, Conor L.; Huo, Yunwen; Yang, Jin; Krumm, Stefanie A.; Plemper, Richard K.; Tsien, Roger Y.; Lin, Michael Z.			Tunable and reversible drug control of protein production via a self-excising degron	NATURE CHEMICAL BIOLOGY			English	Article							MEASLES-VIRUS; INHIBITOR; TAGS; PHOSPHOPROTEIN; REPLICATION; FLUORESCENT; ASUNAPREVIR; EXPRESSION; STABILITY; ABUNDANCE	An effective method for direct chemical control over the production of specific proteins would be widely useful. We describe small molecule-assisted shutoff (SMASh), a technique in which proteins are fused to a degron that removes itself in the absence of drug, resulting in the production of an untagged protein. Clinically tested HCV protease inhibitors can then block degron removal, inducing rapid degradation of subsequently synthesized copies of the protein. SMASh allows reversible and dose-dependent shutoff of various proteins in multiple mammalian cell types and in yeast. We also used SMASh to confer drug responsiveness onto an RNA virus for which no licensed inhibitors exist. As SMASh does not require the permanent fusion of a large domain, it should be useful when control over protein production with minimal structural modification is desired. Furthermore, as SMASh involves only a single genetic modification and does not rely on modulating protein-protein interactions, it should be easy to generalize to multiple biological contexts.	[Chung, Hokyung K.; Jacobs, Conor L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Huo, Yunwen; Lin, Michael Z.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Yang, Jin; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Krumm, Stefanie A.; Plemper, Richard K.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Plemper, Richard K.] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California San Diego; Emory University; University System of Georgia; Georgia State University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Stanford University	Lin, MZ (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	mzlin@stanford.edu		Lin, Michael/0000-0002-0492-1961; Chung, H. Kay/0000-0002-7028-2432	Stanford Graduate Fellowships; US National Science Foundation Graduate Research Fellowship; NIAID, US National Institutes of Health (NIH) [5R01AI071002, 5R01AI083402]; NIGMS, NIH EUREKA grant [5R01GM098734]; Burroughs Wellcome Foundation Career Award for Medical Scientists; Alliance for Cancer Gene Therapy Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071002, R01AI083402, R21AI119196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098734, P50GM107615] Funding Source: NIH RePORTER	Stanford Graduate Fellowships; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIAID, US National Institutes of Health (NIH); NIGMS, NIH EUREKA grant; Burroughs Wellcome Foundation Career Award for Medical Scientists; Alliance for Cancer Gene Therapy Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Billeter (University of Zurich) for p(+)-MeV plasmid, Y. Yanagi (Kyushu University) for Vero-hSLAM cells, M. Takeda (Kyushu University) for the MeV IC-B strain, J. Glenn (Stanford University) for BILN-2061, and A. Gitler, T. Stearns, A. Morrison and J. Skotheim (Stanford University) for yeast plasmids and reagents. We also thank Y. Geng of the Lin laboratory for performing brain dissections, other members of the Lin laboratory for advice, S. Beckwith of the Morrison laboratory for training on yeast procedures and A. Gitler and G. Sherlock (Stanford University) for critical reading of the manuscript. This work was supported by Stanford Graduate Fellowships (H.K.C. and C.L.J.); a US National Science Foundation Graduate Research Fellowship (C.L.J.); NIAID, US National Institutes of Health (NIH) grants 5R01AI071002 and 5R01AI083402 (R.K.P.); NIGMS, NIH EUREKA grant 5R01GM098734 (M.Z.L.); a Burroughs Wellcome Foundation Career Award for Medical Scientists (M.Z.L.); and an Alliance for Cancer Gene Therapy Young Investigator Award (M.Z.L.).	Andresen M, 2004, MOL BIOL CELL, V15, P5616, DOI 10.1091/mbc.E04-06-0454; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/NCHEMBIO.598, 10.1038/nchembio.598]; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Brindley MA, 2013, J VIROL, V87, P11693, DOI 10.1128/JVI.01945-13; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Cattaneo R, 2008, NAT REV MICROBIOL, V6, P529, DOI 10.1038/nrmicro1927; Chen A, 2003, VIRUS RES, V98, P123, DOI 10.1016/j.virusres.2003.09.003; Chen NH, 2011, VIROLOGY, V409, P328, DOI 10.1016/j.virol.2010.10.021; Cong F, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-10; Devaux P, 2004, J VIROL, V78, P11632, DOI 10.1128/JVI.78.21.11632-11640.2004; Garas M, 2008, RNA, V14, P2671, DOI 10.1261/rna.1293008; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jiang YT, 2014, J MED CHEM, V57, P1753, DOI 10.1021/jm400164c; Krumm SA, 2013, J BIOL CHEM, V288, P29943, DOI 10.1074/jbc.M113.503862; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lampson MA, 2006, CELL, V126, P827, DOI 10.1016/j.cell.2006.08.023; Limenitakis J, 2011, FEBS LETT, V585, P1579, DOI 10.1016/j.febslet.2011.05.002; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Lin YH, 2014, CHEMBIOCHEM, V15, P805, DOI 10.1002/cbic.201400006; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; Meng X, 2010, MOL THER, V18, P544, DOI 10.1038/mt.2009.296; Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Msaouel P, 2013, EXPERT OPIN BIOL TH, V13, P483, DOI 10.1517/14712598.2013.749851; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Plemper RK, 2002, J VIROL, V76, P5051, DOI 10.1128/JVI.76.10.5051-5061.2002; Pratt MR, 2007, P NATL ACAD SCI USA, V104, P11209, DOI 10.1073/pnas.0700816104; Rima BK, 2009, CURR TOP MICROBIOL, V329, P77; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shoulders MD, 2013, J AM CHEM SOC, V135, P8129, DOI 10.1021/ja402756p; Shu YL, 2012, J BIOL CHEM, V287, P11951, DOI 10.1074/jbc.M111.333088; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Tae HS, 2012, CHEMBIOCHEM, V13, P538, DOI 10.1002/cbic.201100793; Talwani R, 2013, DRUG TODAY, V49, P769, DOI 10.1358/dot.2013.49.12.2067249; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yuan L, 2013, J CHROMATOGR B, V921, P81, DOI 10.1016/j.jchromb.2013.01.029; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67; Zuniga A, 2007, VACCINE, V25, P2974, DOI 10.1016/j.vaccine.2007.01.064	56	118	128	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					713	+		10.1038/NCHEMBIO.1869	http://dx.doi.org/10.1038/NCHEMBIO.1869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26214256	Green Submitted, Green Accepted			2022-12-25	WOS:000359954700016
J	Clain, E; Trosman, JR; Douglas, MP; Weldon, CB; Phillips, KA				Clain, Elizabeth; Trosman, Julia R.; Douglas, Michael P.; Weldon, Christine B.; Phillips, Kathryn A.			Availability and payer coverage of BRCA1/2 tests and gene panels	NATURE BIOTECHNOLOGY			English	Letter							CANCER-RISK ASSESSMENT; POLICIES; BREAST		[Clain, Elizabeth] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Trosman, Julia R.; Weldon, Christine B.] Ctr Business Models Healthcare, Chicago, IL USA; [Trosman, Julia R.; Douglas, Michael P.; Weldon, Christine B.; Phillips, Kathryn A.] Univ Calif San Francisco, Dept Clin Pharm, Ctr Translat & Policy Res Personalized Med TRANSP, San Francisco, CA 94143 USA; [Phillips, Kathryn A.] UCSF Philip R Lee Inst Hlth Policy, San Francisco, CA USA; [Phillips, Kathryn A.] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Clain, E (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	kathryn.phillips@ucsf.edu		Douglas, Michael/0000-0001-8517-6678; Weldon, Christine/0000-0003-3918-0048	NCI NIH HHS [5P30CA082013-15] Funding Source: Medline; NHGRI NIH HHS [R01HG007063, R01 HG007063] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R43CA082013] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007063] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Curnutte MA, 2014, NAT BIOTECHNOL, V32, P980, DOI 10.1038/nbt.3030; Daly M.B., 2015, NCCN CLIN PRACTICE G; Domchek SM, 2013, J CLIN ONCOL, V31, P1267, DOI 10.1200/JCO.2012.46.9403; Graf MD, 2013, PERS MED, V10, P235, DOI [10.2217/pme.13.9, 10.2217/PME.13.9]; Heger M., 2014, OFFICIAL DISCUSSES W; Hiraki S, 2014, J GENET COUNS, V23, P604, DOI 10.1007/s10897-014-9695-6; Kurian AW, 2015, CURR OPIN OBSTET GYN, V27, P23, DOI 10.1097/GCO.0000000000000141; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Ratner M, 2013, NAT BIOTECHNOL, V31, P663, DOI 10.1038/nbt0813-663; Trosman JR, 2015, J NATL COMPR CANC NE, V13, P311, DOI 10.6004/jnccn.2015.0043; Trosman JR, 2011, J ONCOL PRACT, V7, p18S, DOI 10.1200/JOP.2011.000300; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Wang G, 2011, GENET MED, V13, P1045, DOI 10.1097/GIM.0b013e31822a8113; Weldon CB, 2012, J ONCOL PRACT, V8, pE24, DOI 10.1200/JOP.2011.000448	15	19	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					900	902		10.1038/nbt.3322	http://dx.doi.org/10.1038/nbt.3322			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348951	Green Accepted, Green Published			2022-12-25	WOS:000360990900009
J	Lavallee, VP; Baccelli, I; Krosl, J; Wilhelm, B; Barabe, F; Gendron, P; Boucher, G; Lemieux, S; Marinier, A; Meloche, S; Hebert, J; Sauvageau, G				Lavallee, Vincent-Philippe; Baccelli, Irsne; Krosl, Jana; Wilhelm, Brian; Barabe, Frederic; Gendron, Patrick; Boucher, Genevieve; Lemieux, Sebastien; Marinier, Anne; Meloche, Sylvain; Hebert, Josee; Sauvageau, Guy			The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias	NATURE GENETICS			English	Article							PARTIAL TANDEM DUPLICATION; RESIDUAL DISEASE DETECTION; POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION PROFILE; ACQUIRED-RESISTANCE; PATHWAY MUTATIONS; MEK INHIBITION; PU.1 MUTATIONS; DISTINCT; CANCER	Using next-generation sequencing of primary acute myeloid leukemia (AML) specimens, we identified to our knowledge the first unifying genetic network common to the two subgroups of KMT2A (MLL)-rearranged leukemia, namely having MLL fusions or partial tandem duplications. Within this network, we experimentally confirmed upregulation of the gene with the most subtype-specific increase in expression, LOC100289656, and identified cryptic MLL fusions, including a new MLL-ENAH fusion. We also identified a subset of MLL fusion specimens carrying mutations in SPI1 accompanied by inactivation of its transcriptional network, as well as frequent RAS pathway mutations, which sensitized the leukemias to synthetic lethal interactions between MEK and receptor tyrosine kinase inhibitors. This transcriptomics-based characterization and chemical interrogation of human MLL-rearranged AML was a valuable approach for identifying complementary features that define this disease.	[Lavallee, Vincent-Philippe; Baccelli, Irsne; Krosl, Jana; Wilhelm, Brian; Barabe, Frederic; Gendron, Patrick; Boucher, Genevieve; Lemieux, Sebastien; Marinier, Anne; Hebert, Josee; Sauvageau, Guy] Univ Montreal, Leucegene Project, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Hebert, Josee; Sauvageau, Guy] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada; [Wilhelm, Brian; Hebert, Josee; Sauvageau, Guy] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada; [Barabe, Frederic] Ctr Hosp Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Barabe, Frederic] Hop Enfants Jesus, Quebec City, PQ, Canada; [Barabe, Frederic] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Lemieux, Sebastien] Univ Montreal, Dept Comp Sci & Operat Res, Montreal, PQ, Canada; [Marinier, Anne] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Hebert, Josee; Sauvageau, Guy] Maisonneuve Rosemont Hosp, Quebec Leukemia Cell Bank, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Leucegene Project, Inst Res Immunol & Canc, Montreal, PQ, Canada.	josee.hebert@umontreal.ca; guy.sauvageau@umontreal.ca		Sauvageau, Guy/0000-0002-4333-7266; Lemieux, Sebastien/0000-0001-5477-1386; Boucher, Genevieve/0000-0001-6389-9007; Gendron, Patrick/0000-0001-9829-2600	Genome Canada; Genome Quebec; Amorchem; Canadian Cancer Society Research Institute (CCSRI); Industrielle-Alliance (Universite de Montreal); Canada Research Chair program; Cancer Research Network of the Fonds de Recherche du Quebec-Sante; Canada Foundation for Innovation (CFI); NanoQuebec; RMGA; Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT); Hopital Maisonneuve-Rosemont Foundation; Cole Foundation; Human Frontier Science Program	Genome Canada(Genome Canada); Genome Quebec; Amorchem; Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Industrielle-Alliance (Universite de Montreal); Canada Research Chair program(Canada Research Chairs); Cancer Research Network of the Fonds de Recherche du Quebec-Sante; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); NanoQuebec; RMGA; Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT); Hopital Maisonneuve-Rosemont Foundation; Cole Foundation; Human Frontier Science Program(Human Frontier Science Program)	We thank M. Draoui for project coordination, S. Corneau for sample coordination and I. Boivin for data validation as well as M. Arteau and R. Lambert at the IRIC genomics platform for RNA sequencing. We acknowledge the dedicated work of the Quebec Leukemia Cell Bank (BCLQ) staff, namely G. d'Angelo for morphological diagnoses, C. Rondeau and S. Lavallee; M. Marquis for qRT-PCR validations, and H. Chaker for FISH analyses on AML samples. We thank J. Duchaine and D. Salois at the IRIC high-throughput screening platform. This work was mostly supported by Genome Canada and Genome Quebec with supplementary funds from Amorchem and the Canadian Cancer Society Research Institute (CCSRI). Contribution was provided by Ministeres de l'Economie, de l'Innovation et des Exportations du Quebec and the Leukemia Lymphoma Society of Canada. G.S. and J.H. are recipients of research chairs from Industrielle-Alliance (Universite de Montreal) and the Canada Research Chair program, respectively. BCLQ is supported by grants from the Cancer Research Network of the Fonds de Recherche du Quebec-Sante. RNA sequencing read mapping and transcript quantification were performed on the supercomputer Briaree from Universite de Montreal, managed by Calcul Quebec and Compute Canada. The operation of this supercomputer is funded by the Canada Foundation for Innovation (CFI), NanoQuebec, RMGA and Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT). V.P.L. is supported by a postdoctoral fellowship jointly supported by the Hopital Maisonneuve-Rosemont Foundation and the Cole Foundation. I.B. is supported by a postdoctoral fellowship from the Human Frontier Science Program.	Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Basecke J, 2006, BRIT J HAEMATOL, V135, P438, DOI 10.1111/j.1365-2141.2006.06301.x; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Borthakur G, 2012, BLOOD, V120; Burgess MR, 2014, BLOOD, V124, P3947, DOI 10.1182/blood-2014-05-574582; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dohner K, 2003, BLOOD, V102, P3850, DOI 10.1182/blood-2003-08-2654; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Groschel S, 2013, J CLIN ONCOL, V31, P95, DOI 10.1200/JCO.2011.41.5505; Grossmann V, 2013, LEUKEMIA, V27, P1933, DOI 10.1038/leu.2013.90; Grossmann V, 2012, BLOOD, V120, P2963, DOI 10.1182/blood-2012-03-419622; Irving J, 2014, BLOOD, V124, P3420, DOI 10.1182/blood-2014-04-531871; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Jain N, 2014, CLIN CANCER RES, V20, P490, DOI 10.1158/1078-0432.CCR-13-1311; Kampen KR, 2014, LEUKEMIA, V28, P589, DOI 10.1038/leu.2013.342; KERN DH, 1988, CANCER RES, V48, P117; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuhn Michael W M, 2015, Haematologica, V100, pe190, DOI 10.3324/haematol.2014.115337; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lamandin C, 2002, BLOOD, V100, P4680, DOI 10.1182/blood-2002-08-2563; Lavallee VP, 2015, BLOOD, V125, P140, DOI 10.1182/blood-2014-07-591529; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2003, P NATL ACAD SCI USA, V100, P14275, DOI 10.1073/pnas.2335924100; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Mullighan CG, 2007, LEUKEMIA, V21, P2000, DOI 10.1038/sj.leu.2404808; Pabst C, 2014, NAT METHODS, V11, P436, DOI 10.1038/nmeth.2847; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Kladniew BR, 2014, CHEM-BIOL INTERACT, V214, P57, DOI 10.1016/j.cbi.2014.02.013; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Sandhofer N, 2015, LEUKEMIA, V29, P828, DOI 10.1038/leu.2014.305; Steudel C, 2003, GENE CHROMOSOME CANC, V37, P237, DOI 10.1002/gcc.10219; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vegesna VA, 2002, LEUKEMIA RES, V26, P451, DOI 10.1016/S0145-2126(01)00150-3; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhou J, 2014, LEUKEMIA, V28, P1436, DOI 10.1038/leu.2013.384	43	94	98	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1030	+		10.1038/ng.3371	http://dx.doi.org/10.1038/ng.3371			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26237430				2022-12-25	WOS:000360394100013
J	Smith, AT; Barupala, D; Stemmler, TL; Rosenzweig, AC				Smith, Aaron T.; Barupala, Dulmini; Stemmler, Timothy L.; Rosenzweig, Amy C.			A new metal binding domain involved in cadmium, cobalt and zinc transport	NATURE CHEMICAL BIOLOGY			English	Article							SECONDARY STRUCTURE ANALYSES; CUPRIAVIDUS-METALLIDURANS; COPPER-BINDING; ATPASES; SYSTEM; ROLES; IDENTIFICATION; P-1B-ATPASES; RESISTANCE; MECHANISM	The P-1B-ATPases, which couple cation transport across membranes to ATP hydrolysis, are central to metal homeostasis in all organisms. An important feature of P-1B-ATPases is the presence of soluble metal binding domains (MBDs) that regulate transport activity. Only one type of MBD has been characterized extensively, but bioinformatics analyses indicate that a diversity of MBDs may exist in nature. Here we report the biochemical, structural and functional characterization of a new MBD from the Cupriavidus metallidurans P1B-4-ATPase CzcP (CzcP MBD). The CzcP MBD binds two Cd2+, Co2+ or Zn2+ ions in distinct and unique sites and adopts an unexpected fold consisting of two fused ferredoxin-like domains. Both in vitro and in vivo activity assays using full-length CzcP, truncated CzcP and several variants indicate a regulatory role for the MBD and distinct functions for the two metal binding sites. Taken together, these findings elucidate a previously unknown MBD and suggest new regulatory mechanisms for metal transport by P-1B-ATPases.	[Smith, Aaron T.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60201 USA; [Smith, Aaron T.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL USA; [Barupala, Dulmini; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Pharmaceut Sci, Detroit, MI USA; [Barupala, Dulmini; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA	Northwestern University; Northwestern University; Wayne State University; Wayne State University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60201 USA.	amyr@northwestern.edu		Smith, Aaron/0000-0002-9332-8683; Stemmler, Timothy/0000-0002-6298-088X	US National Institutes of Health [GM58518, DK068139, F32GM105339, T32HL120822]; US Department of Energy, Division of Materials Sciences; US Department of Energy, Division of Chemical Sciences [DE-AC02-98CH10886]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105339, R01GM058518] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Division of Materials Sciences(United States Department of Energy (DOE)); US Department of Energy, Division of Chemical Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants GM58518 (A.C.R.), DK068139 (T.L.S.), F32GM105339 (A.T.S.) and T32HL120822 (D.B.). Sequence searches used both database and analysis functions of the Universal Protein Resource (UniProt) Knowledgebase and Reference Clusters (http://www.uniprot.org/) and the US National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). Portions of this research were carried out at the National Synchrotron Light Source (NSLS). NSLS, located at Brookhaven National Laboratory, is supported by the US Department of Energy, Division of Materials Sciences and Division of Chemical Sciences under contract no. DE-AC02-98CH10886.	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Banci L, 2006, J MOL BIOL, V356, P638, DOI 10.1016/j.jmb.2005.11.055; Banci L, 2002, J MOL BIOL, V323, P883, DOI 10.1016/S0022-2836(02)01007-0; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; DeSilva TM, 2005, PROTEINS, V61, P1038, DOI 10.1002/prot.20639; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; FRANKEL AD, 1987, P NATL ACAD SCI USA, V84, P4841, DOI 10.1073/pnas.84.14.4841; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; GIEDROC DP, 1986, J INORG BIOCHEM, V28, P155, DOI 10.1016/0162-0134(86)80079-4; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Gupta A, 2012, CURR GENOMICS, V13, P124, DOI 10.2174/138920212799860661; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; LEE PA, 1981, REV MOD PHYS, V53, P769, DOI 10.1103/RevModPhys.53.769; Lukehart, 2007, APPL PHYS METHODS IN, P513; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; MARET W, 1993, METHOD ENZYMOL, V226, P52; Mattle D, 2013, J MOL BIOL, V425, P2299, DOI 10.1016/j.jmb.2013.03.008; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Petit-Haertlein I, 2010, BIOCHEMISTRY-US, V49, P1913, DOI 10.1021/bi100001z; Raimunda D, 2014, MOL MICROBIOL, V91, P185, DOI 10.1111/mmi.12454; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Rosenzweig AC, 2012, CURR TOP MEMBR, V69, P113, DOI 10.1016/B978-0-12-394390-3.00005-7; Scherer J, 2009, MOL MICROBIOL, V73, P601, DOI 10.1111/j.1365-2958.2009.06792.x; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Singleton C, 2007, BIOMETALS, V20, P275, DOI 10.1007/s10534-006-9068-1; Smith AT, 2014, J BIOL INORG CHEM, V19, P947, DOI 10.1007/s00775-014-1129-2; Traverso ME, 2010, BIOCHEMISTRY-US, V49, P7060, DOI 10.1021/bi100866b; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wang KT, 2014, NATURE, V514, P518, DOI 10.1038/nature13618; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; ZELAZOWSKI AJ, 1984, J BIOL CHEM, V259, P2960; Zielazinski EL, 2012, BIOCHEMISTRY-US, V51, P7891, DOI 10.1021/bi3006708; Zoropogui A, 2008, BIOCHEM BIOPH RES CO, V365, P735, DOI 10.1016/j.bbrc.2007.11.030	52	22	22	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2015	11	9					678	+		10.1038/NCHEMBIO.1863	http://dx.doi.org/10.1038/NCHEMBIO.1863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP5WC	26192600	Green Submitted, Green Accepted			2022-12-25	WOS:000359954700011
J	Mohankumar, KM; Currle, DS; White, E; Boulos, N; Dapper, J; Eden, C; Nimmervoll, B; Thiruvenkatam, R; Connelly, M; Kranenburg, TA; Neale, G; Olsen, S; Wang, YD; Finkelstein, D; Wright, K; Gupta, K; Ellison, DW; Thomas, AO; Gilbertson, RJ				Mohankumar, Kumarasamypet M.; Currle, David S.; White, Elsie; Boulos, Nidal; Dapper, Jason; Eden, Christopher; Nimmervoll, Birgit; Thiruvenkatam, Radhika; Connelly, Michele; Kranenburg, Tanya A.; Neale, Geoffrey; Olsen, Scott; Wang, Yong-Dong; Finkelstein, David; Wright, Karen; Gupta, Kirti; Ellison, David W.; Thomas, Arzu Onar; Gilbertson, Richard J.			An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes	NATURE GENETICS			English	Article							CANCER; SURVIVAL; DNA; PROGRESSION; TRAFFICKING; TRANSPORT; HOMOLOGY; GENOMICS; MEDIATOR; PATHWAY	Cancers are characterized by non-random chromosome copy number alterations that presumably contain oncogenes and tumor-suppressor genes (TSGs). The affected loci are often large, making it difficult to pinpoint which genes are driving the cancer. Here we report a cross-species in vivo screen of 84 candidate oncogenes and 39 candidate TSGs, located within 28 recurrent chromosomal alterations in ependymoma. Through a series of mouse models, we validate eight new ependymoma oncogenes and ten new ependymoma TSGs that converge on a small number of cell functions, including vesicle trafficking, DNA modification and cholesterol biosynthesis, identifying these as potential new therapeutic targets.	[Mohankumar, Kumarasamypet M.; Currle, David S.; White, Elsie; Boulos, Nidal; Dapper, Jason; Eden, Christopher; Nimmervoll, Birgit; Thiruvenkatam, Radhika; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Connelly, Michele; Kranenburg, Tanya A.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Neale, Geoffrey; Olsen, Scott] St Jude Childrens Res Hosp, Hartwell Ctr Biotechnol & Bioinformat, Memphis, TN 38105 USA; [Wang, Yong-Dong; Finkelstein, David] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Wright, Karen; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Gupta, Kirti; Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Thomas, Arzu Onar] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.gilbertson@stjude.org	Kranenburg, Tanya/F-7138-2012; Gilbertson, Richard James/ABE-1346-2021; Ellison, David/N-4806-2018; Wang, Yong-Dong/K-3563-2013	Kranenburg, Tanya/0000-0002-5329-4968; Gilbertson, Richard James/0000-0001-7539-9472; Nimmervoll, Birgit/0000-0002-3324-092X; KM, Mohankumar/0000-0001-9407-1800	US National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities (ALSAC); Cancer Research UK [22492] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA129541, P01CA096832, P30CA021765] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to F.B. Gertler (Massachusetts Institute of Technology) and S. Gupton (University of North Carolina) for the generous gift of the VAMP7-phlorin construct and the staffs of the Hartwell Center for Bioinformatics and Biotechnology, the Small Animal Imaging Center, the Animal Resources Center, the Cell and Tissue Imaging Center, and the Flow Cytometry and Cell Sorting Shared Resource at St. Jude Children's Research Hospital for technical assistance. This work was supported by grants from the US National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765, R.J.G.), by the Collaborative Ependymoma Research Network (CERN) and by the American Lebanese Syrian Associated Charities (ALSAC).	Anazawa Y, 2004, ONCOGENE, V23, P7621, DOI 10.1038/sj.onc.1207270; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Chautard E, 2014, J NEURO-ONCOL, V117, P205, DOI 10.1007/s11060-014-1382-9; Donson AM, 2009, J IMMUNOL, V183, P7428, DOI 10.4049/jimmunol.0902811; Eggers CT, 2009, J BIOL CHEM, V284, P32869, DOI 10.1074/jbc.M109.022582; Gaist D, 2013, BRIT J CANCER, V108, P715, DOI 10.1038/bjc.2012.536; Gaist D, 2014, CANCER EPIDEMIOL, V38, P722, DOI 10.1016/j.canep.2014.09.010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldenring JR, 2013, NAT REV CANCER, V13, P813, DOI 10.1038/nrc3601; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Hu RZ, 2013, CELL CYCLE, V12, P2033, DOI 10.4161/cc.25064; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88; Lu WD, 2014, MOL CELL BIOCHEM, V387, P261, DOI 10.1007/s11010-013-1891-4; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Muller M, 2011, NEURON, V69, P749, DOI 10.1016/j.neuron.2011.01.025; Nam KT, 2010, J CLIN INVEST, V120, P840, DOI 10.1172/JCI40728; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Poage GM, 2012, CANCER RES, V72, P2728, DOI 10.1158/0008-5472.CAN-11-4121-T; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Sie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122555; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Tabori U, 2006, J CLIN ONCOL, V24, P1522, DOI 10.1200/JCO.2005.04.2127; Tian M, 2012, J NEUROSCI, V32, P6931, DOI 10.1523/JNEUROSCI.0265-12.2012; Tsutsui T, 2013, J BIOL CHEM, V288, P20955, DOI 10.1074/jbc.M113.486746; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Wojtal KA, 2006, MOL BIOL CELL, V17, P3638, DOI 10.1091/mbc.E06-03-0230; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104	38	45	45	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					878	+		10.1038/ng.3323	http://dx.doi.org/10.1038/ng.3323			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26075792	Green Accepted, Green Submitted			2022-12-25	WOS:000358674100011
J	Patsch, C; Challet-Meylan, L; Thoma, EC; Urich, E; Heckel, T; O'Sullivan, JF; Grainger, SJ; Kapp, FG; Sun, L; Christensen, K; Xia, YL; Florido, MHC; He, W; Pan, W; Prummer, M; Warren, CR; Jakob-Roetne, R; Certa, U; Jagasia, R; Freskgard, PO; Adatto, I; Kling, D; Huang, P; Zon, LI; Chaikof, EL; Gerszten, RE; Graf, M; Iacone, R; Cowan, CA				Patsch, Christoph; Challet-Meylan, Ludivine; Thoma, Eva C.; Urich, Eduard; Heckel, Tobias; O'Sullivan, John F.; Grainger, Stephanie J.; Kapp, Friedrich G.; Sun, Lin; Christensen, Klaus; Xia, Yulei; Florido, Mary H. C.; He, Wei; Pan, Wei; Prummer, Michael; Warren, Curtis R.; Jakob-Roetne, Roland; Certa, Ulrich; Jagasia, Ravi; Freskgard, Per-Ola; Adatto, Isaac; Kling, Dorothee; Huang, Paul; Zon, Leonard I.; Chaikof, Elliot L.; Gerszten, Robert E.; Graf, Martin; Iacone, Roberto; Cowan, Chad A.			Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells	NATURE CELL BIOLOGY			English	Article							DIRECTED DIFFERENTIATION; DEFINITIVE ENDODERM; IN-VITRO; WNT; GROWTH; DERIVATION; RECEPTOR; LINES; GENE; FUNCTIONALITY	The use of human pluripotent stem cells for in vitro disease modelling and clinical applications requires protocols that convert these cells into relevant adult cell types. Here, we report the rapid and efficient differentiation of human pluripotent stem cells into vascular endothelial and smooth muscle cells. We found that GSK3 inhibition and BMP4 treatment rapidly committed pluripotent cells to a mesodermal fate and subsequent exposure to VEGF-A or PDGF-BB resulted in the differentiation of either endothelial or vascular smooth muscle cells, respectively. Both protocols produced mature cells with efficiencies exceeding 80% within six days. On purification to 99% via surface markers, endothelial cells maintained their identity, as assessed by marker gene expression, and showed relevant in vitro and in vivo functionality. Global transcriptional and metabolomic analyses confirmed that the cells closely resembled their in vivo counterparts. Our results suggest that these cells could be used to faithfully model human disease.	[Patsch, Christoph; Thoma, Eva C.; Urich, Eduard; Heckel, Tobias; Christensen, Klaus; He, Wei; Pan, Wei; Prummer, Michael; Jakob-Roetne, Roland; Certa, Ulrich; Jagasia, Ravi; Freskgard, Per-Ola; Kling, Dorothee; Graf, Martin; Iacone, Roberto] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, CH-4070 Basel, Switzerland; [Challet-Meylan, Ludivine; Xia, Yulei; Florido, Mary H. C.; Warren, Curtis R.; Zon, Leonard I.; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Challet-Meylan, Ludivine; Xia, Yulei; Florido, Mary H. C.; Warren, Curtis R.; Zon, Leonard I.; Cowan, Chad A.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [O'Sullivan, John F.; Sun, Lin; Adatto, Isaac; Huang, Paul; Gerszten, Robert E.; Cowan, Chad A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [O'Sullivan, John F.; Sun, Lin; Adatto, Isaac; Huang, Paul; Gerszten, Robert E.; Cowan, Chad A.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [O'Sullivan, John F.; Sun, Lin; Adatto, Isaac; Huang, Paul; Gerszten, Robert E.; Cowan, Chad A.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Grainger, Stephanie J.; Chaikof, Elliot L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; [Grainger, Stephanie J.; Chaikof, Elliot L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Kapp, Friedrich G.; Zon, Leonard I.; Cowan, Chad A.] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Kapp, Friedrich G.; Zon, Leonard I.; Cowan, Chad A.] Boston Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Kapp, Friedrich G.; Zon, Leonard I.; Cowan, Chad A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA	Roche Holding; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Patsch, C (corresponding author), Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, CH-4070 Basel, Switzerland.	christoph.patsch@roche.com; chad_cowan@harvard.edu	Freskgård, Per-Ola/AAY-4194-2021; Prummer, Michael/G-6464-2011	Prummer, Michael/0000-0001-9896-3929; Kapp, Friedrich/0000-0002-2729-6177; Huang, Paul/0000-0002-5436-8658; O'Sullivan, John/0000-0001-8016-5128; Heckel, Tobias/0000-0002-2433-8319; Florido, Mary Heather Celine/0000-0002-4547-618X	Roche Postdoctoral Fellowships (RPF); Innovative Medicines Initiative Joint Undertaking [115439]; European Union; EFPIA companies; Swiss National Science Foundation; German Cancer Aid; HHMI; NIH [R01 HL04880, 5P30 DK49216, 5R01 DK53298, 5U01 HL10001-05, R24 DK092760, HL106018, HL083867, HL60963, 2R01DK081572, R01DK097768, U01HL100408]; Harvard Stem Cell Institute and Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083867, R01HL048801, R01HL106018, U01HL100408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572, P30DK049216, R24DK092760, R01DK097768, R01DK053298] Funding Source: NIH RePORTER	Roche Postdoctoral Fellowships (RPF); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Cancer Aid(Deutsche Krebshilfe); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute and Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Einhaus, S. Zimmermann, C. Stucki and N. Dahm for excellent technical support and all members of the Roche Stem Cell Platform for helpful discussions. We thank C. MacGillivray at the HSCRB Histology Core facility. We also thank S. Aigner and C. Warren for critically reviewing the manuscript and A. Gundner, C. Hudak and K. Song for help with the illustrations. We acknowledge the continued support of H.-L. Roche and thank M. Steger from Roche Pharma Partnering for his input and support of the project. C.P. and E.C.T. were supported by Roche Postdoctoral Fellowships (RPF). A part of the research received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement number 115439, resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and EFPIA companies' in kind contribution. L.C.-M. was supported by a fellowship from the Swiss National Science Foundation. F.G.K. was supported by a fellowship from the German Cancer Aid. This work was supported by HHMI and NIH grants R01 HL04880, 5P30 DK49216, 5R01 DK53298, 5U01 HL10001-05, and R24 DK092760 (to L.I.Z.); HL106018, HL083867, HL60963 (E.L.C.); 2R01DK081572 and an AHA Established Investigator Award (R.E.G.); R01DK097768, U01HL100408, the Harvard Stem Cell Institute and Harvard University (C.A.C.).	Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Challet Meylan L., 2015, NAT PROTOC EXCH; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; Englund MCO, 2010, IN VITRO CELL DEV-AN, V46, P217, DOI 10.1007/s11626-010-9289-z; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; GOTLIEB AI, 1981, AM J PATHOL, V103, P271; Grainger SJ, 2013, TISSUE ENG PT A, V19, P1209, DOI [10.1089/ten.TEA.2012.0281, 10.1089/ten.tea.2012.0281]; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Levenberg S, 2007, BLOOD, V110, P806, DOI 10.1182/blood-2006-08-019190; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Liu Y, 2004, GENESIS, V40, P118, DOI 10.1002/gene.20072; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Orlova VV, 2014, ARTERIOSCL THROM VAS, V34, P177, DOI 10.1161/ATVBAHA.113.302598; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; RASMUSSEN LM, 1995, AM J PATHOL, V147, P1041; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thoma E. C., 2015, NAT PROTOC EXCH; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang H, 2006, CIRC RES, V98, P1331, DOI 10.1161/01.RES.0000220650.26555.1d; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	55	307	318	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2015	17	8					994	U294		10.1038/ncb3205	http://dx.doi.org/10.1038/ncb3205			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CO0NE	26214132	Green Accepted			2022-12-25	WOS:000358847700007
J	Wang, SK; Li, S; Liu, Q; Wu, K; Zhang, JQ; Wang, SS; Wang, Y; Chen, XB; Zhang, Y; Gao, CX; Wang, F; Huang, HX; Fu, XD				Wang, Shaokui; Li, Shan; Liu, Qian; Wu, Kun; Zhang, Jianqing; Wang, Shuansuo; Wang, Yi; Chen, Xiangbin; Zhang, Yi; Gao, Caixia; Wang, Feng; Huang, Haixiang; Fu, Xiangdong			The OsSPL16-GW7 regulatory module determines grain shape and simultaneously improves rice yield and grain quality	NATURE GENETICS			English	Article							GREEN-REVOLUTION; ARABIDOPSIS; PROTEIN; GENE; QTL; COMPLEX; ORGANIZATION; ARCHITECTURE; ELONGATION; EXPRESSION	The deployment of heterosis in the form of hybrid rice varieties has boosted grain yield, but grain quality improvement still remains a challenge. Here we show that a quantitative trait locus for rice grain quality, qGW7, reflects allelic variation of GW7, a gene encoding a TONNEAU1-recruiting motif protein with similarity to C-terminal motifs of the human centrosomal protein CAP350. Upregulation of GW7 expression was correlated with the production of more slender grains, as a result of increased cell division in the longitudinal direction and decreased cell division in the transverse direction. OsSPL16 (GW8), an SBP-domain transcription factor that regulates grain width, bound directly to the GW7 promoter and repressed its expression. The presence of a semidominant GW7TFA allele from tropical japonica rice was associated with higher grain quality without the yield penalty imposed by the Basmati gw8 allele. Manipulation of the OsSPL16-GW7 module thus represents a new strategy to simultaneously improve rice yield and grain quality.	[Wang, Shaokui; Li, Shan; Liu, Qian; Wu, Kun; Zhang, Jianqing; Wang, Shuansuo; Wang, Yi; Chen, Xiangbin; Zhang, Yi; Gao, Caixia; Fu, Xiangdong] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Wang, Shaokui] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Wang, Feng] Acad Agr Sci, Rice Res Inst Guangdong, Guangzhou, Guangdong, Peoples R China; [Huang, Haixiang] Jiaxing Acad Agr Sci, Jiaxing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Fu, XD (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	xdfu@genetics.ac.cn	Gao, Caixia/AAG-8577-2019; Li, Shan/AAU-4104-2020; Qian, Liu/GPS-5502-2022; wang, shaokui/GPX-7207-2022	Gao, Caixia/0000-0003-3169-8248; wang, shaokui/0000-0002-7767-4033; Li, Shan/0000-0003-2837-9027; Chen, Xiangbin/0000-0002-0725-368X; QIAN, LIU/0000-0003-0560-4287; Zhang, Yi/0000-0002-0745-3497	National Natural Science Foundation of China [91335207, 31130070]; Ministry of Science and Technology of China [2012AA10A301]; National Special Project of China [2014ZX0800935B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Special Project of China	We thank G. Zhang (South China Agricultural University) for providing the single-segment substitution lines (W23-19-6-7-19-3 and W3-20-28-2-8). This work was supported by grants from the National Natural Science Foundation of China (91335207 and 31130070), the Ministry of Science and Technology of China (2012AA10A301) and the National Special Project of China (2014ZX0800935B).	AHN SN, 1993, THEOR APPL GENET, V87, P27, DOI 10.1007/BF00223739; Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Azimzadeh J, 2008, PLANT CELL, V20, P2146, DOI 10.1105/tpc.107.056812; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Cai XL, 1998, PLANT J, V14, P459, DOI 10.1046/j.1365-313X.1998.00126.x; Chern M, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-6; Drevensek S, 2012, PLANT CELL, V24, P178, DOI 10.1105/tpc.111.089748; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Lu ZF, 2013, PLANT CELL, V25, P3743, DOI 10.1105/tpc.113.113639; Nelson JC, 2011, THEOR APPL GENET, V122, P291, DOI 10.1007/s00122-010-1445-z; Patel H, 2005, J CELL SCI, V118, P175, DOI 10.1242/jcs.01600; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Spinner L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2831; Sun HY, 2014, NAT GENET, V46, P652, DOI 10.1038/ng.2958; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0	32	360	441	24	338	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					949	+		10.1038/ng.3352	http://dx.doi.org/10.1038/ng.3352			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26147620				2022-12-25	WOS:000358674100023
J	Bradshaw, JM; McFarland, JM; Paavilainen, VO; Bisconte, A; Tam, D; Phan, VT; Romanov, S; Finkle, D; Shu, J; Patel, V; Ton, T; Li, XY; Loughhead, DG; Nunn, PA; Karr, DE; Gerritsen, ME; Funk, JO; Owens, TD; Verner, E; Brameld, KA; Hill, RJ; Goldstein, DM; Taunton, J				Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Romanov, Sergei; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.; Taunton, Jack			Prolonged and tunable residence time using reversible covalent kinase inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							BRUTONS TYROSINE KINASE; B-CELL; SELECTIVE-INHIBITION; BINDING-KINETICS; DRUG DISCOVERY; BTK INHIBITION; TARGETING BTK; RECEPTOR; IBRUTINIB; ACTIVATION	Drugs with prolonged on-target residence times often show superior efficacy, yet general strategies for optimizing drug-target residence time are lacking. Here we made progress toward this elusive goal by targeting a noncatalytic cysteine in Bruton's tyrosine kinase (BTK) with reversible covalent inhibitors. Using an inverted orientation of the cysteine-reactive cyano-acrylamide electrophile, we identified potent and selective BTK inhibitors that demonstrated biochemical residence times spanning from minutes to 7 d. An inverted cyanoacrylamide with prolonged residence time in vivo remained bound to BTK for more than 18 h after clearance from the circulation. The inverted cyanoacrylamide strategy was further used to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with residence times of several days, demonstrating the generalizability of the approach. Targeting of noncatalytic cysteines with inverted cyanoacrylamides may serve as a broadly applicable platform that facilitates 'residence time by design', the ability to modulate and improve the duration of target engagement in vivo.	[Bradshaw, J. Michael; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.] Principia Biopharma, San Francisco, CA 94080 USA; [McFarland, Jesse M.; Paavilainen, Ville O.; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [McFarland, Jesse M.; Paavilainen, Ville O.; Taunton, Jack] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Romanov, Sergei] Nanosyn Inc, Santa Clara, CA USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bradshaw, JM (corresponding author), Principia Biopharma, San Francisco, CA 94080 USA.	michael.bradshaw@principiabio.com; jack.taunton@ucsf.edu	Paavilainen, Ville/I-9131-2019	Paavilainen, Ville/0000-0002-3160-7767; Brameld, Ken/0000-0001-8643-3218; McFarland, Jesse/0000-0003-2393-3789	US National Institutes of Health (NIH) [GM071434, F32GM087052]; University of California San Francisco (UCSF) Stephen & Nancy Grand Multiple Myeloma Translational Initiative; Academy of Finland; Sigrid Juselius Foundation; NIH [P41RR001614]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087052, R01GM071434] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco (UCSF) Stephen & Nancy Grand Multiple Myeloma Translational Initiative; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (NIH) (grants GM071434 to J.T. and F32GM087052 to J.M.M.), the University of California San Francisco (UCSF) Stephen & Nancy Grand Multiple Myeloma Translational Initiative (to J.T.), the Academy of Finland (to V.O.P.) and the Sigrid Juselius Foundation (to V.O.P.). We acknowledge the UCSF Mass Spectrometry Facility (supported by NIH grant P41RR001614).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-59; Barf T, 2012, J MED CHEM, V55, P6243, DOI 10.1021/jm3003203; Benson MJ, 2014, J IMMUNOL, V193, P185, DOI 10.4049/jimmunol.1302570; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS DA, 1984, J AM CHEM SOC, V106, P1154, DOI 10.1021/ja00316a077; Evans EK, 2013, J PHARMACOL EXP THER, V346, P219, DOI 10.1124/jpet.113.203489; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guo D, 2014, MED RES REV, V34, P856, DOI 10.1002/med.21307; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalgutkar AS, 2012, EXPERT OPIN DRUG DIS, V7, P561, DOI 10.1517/17460441.2012.688744; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; Kuglstatter A, 2011, PROTEIN SCI, V20, P428, DOI 10.1002/pro.575; Lannine BR, 2014, NAT CHEM BIOL, V10, P760, DOI [10.1038/NCHEMBIO.1582, 10.1038/nchembio.1582]; Lebakken CS, 2009, J BIOMOL SCREEN, V14, P924, DOI 10.1177/1087057109339207; Leproult E, 2011, J MED CHEM, V54, P1347, DOI 10.1021/jm101396q; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Lou Y, 2012, J MED CHEM, V55, P4539, DOI 10.1021/jm300035p; Louvel J, 2014, J MED CHEM, V57, P3213, DOI 10.1021/jm401643m; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Mah R, 2014, BIOORG MED CHEM LETT, V24, P33, DOI 10.1016/j.bmcl.2013.10.003; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller RM, 2013, J AM CHEM SOC, V135, P5298, DOI 10.1021/ja401221b; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Nakayama S, 2009, DRUG METAB DISPOS, V37, P1970, DOI 10.1124/dmd.109.027797; Rankin AL, 2013, J IMMUNOL, V191, P4540, DOI 10.4049/jimmunol.1301553; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Swinney DC, 2006, LETT DRUG DES DISCOV, V3, P569, DOI 10.2174/157018006778194754; Swinney DC, 2014, BRIT J PHARMACOL, V171, P3364, DOI 10.1111/bph.12683; Takakusa H, 2008, DRUG METAB DISPOS, V36, P1770, DOI 10.1124/dmd.108.021725; Vauquelin G, 2012, N-S ARCH PHARMACOL, V385, P337, DOI 10.1007/s00210-012-0734-2; Vilums M, 2013, J MED CHEM, V56, P7706, DOI 10.1021/jm4011737; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wu H, 2014, ACS CHEM BIOL, V9, P1086, DOI 10.1021/cb4008524; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; Zhou WJ, 2010, CHEM BIOL, V17, P285, DOI 10.1016/j.chembiol.2010.02.007	51	242	246	16	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2015	11	7					525	+		10.1038/NCHEMBIO.1817	http://dx.doi.org/10.1038/NCHEMBIO.1817			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK6JO	26006010	Green Accepted, Green Submitted			2022-12-25	WOS:000356334600018
J	Han, YC; Vidigal, JA; Mu, P; Yao, E; Singh, I; Gonzalez, AJ; Concepcion, CP; Bonetti, C; Ogrodowski, P; Carver, B; Selleri, L; Betel, D; Leslie, C; Ventura, A				Han, Yoon-Chi; Vidigal, Joana A.; Mu, Ping; Yao, Evelyn; Singh, Irtisha; Gonzalez, Alvaro J.; Concepcion, Carla P.; Bonetti, Ciro; Ogrodowski, Paul; Carver, Brett; Selleri, Licia; Betel, Doron; Leslie, Christina; Ventura, Andrea			An allelic series of miR-17 similar to 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron	NATURE GENETICS			English	Article							CHROMOSOMAL-ANOMALIES; GENE; CLUSTER; MUTATIONS; LIMB; AMPLIFICATION; DEFECTS; TARGET; CARCINOMA; MIR-17-92	Polycistronic microRNA (miRNA) clusters are a common feature of vertebrate genomes. The coordinated expression of miRNAs belonging to different seed families from a single transcriptional unit suggests functional cooperation, but this hypothesis has not been experimentally tested. Here we report the characterization of an allelic series of genetically engineered mice harboring selective targeted deletions of individual components of the miR-17 similar to 92 cluster. Our results demonstrate the coexistence of functional cooperation and specialization among members of this cluster, identify a previously undescribed function for the miR-17 seed family in controlling axial patterning in vertebrates and show that loss of miR-19 selectively impairs Myc-driven tumorigenesis in two models of human cancer. By integrating phenotypic analysis and gene expression profiling, we provide a genome-wide view of how the components of a polycistronic miRNA cluster affect gene expression in vivo. The reagents and data sets reported here will accelerate exploration of the complex biological functions of this important miRNA cluster.	[Han, Yoon-Chi; Vidigal, Joana A.; Mu, Ping; Yao, Evelyn; Concepcion, Carla P.; Bonetti, Ciro; Ogrodowski, Paul; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Han, Yoon-Chi] Pfizer Inc, Oncol Res Unit, Pearl River, NY USA; [Mu, Ping; Yao, Evelyn; Concepcion, Carla P.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Singh, Irtisha; Gonzalez, Alvaro J.; Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Selleri, Licia] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Betel, Doron] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY USA; [Betel, Doron] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA	Memorial Sloan Kettering Cancer Center; Pfizer; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Ventura, A (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	venturaa@mskcc.org	Singh, Irtisha/W-6182-2019	A. Vidigal, Joana/0000-0003-2765-6985; Ventura, Andrea/0000-0003-4320-9907; Betel, Doron/0000-0002-8006-7752; Singh, Irtisha/0000-0002-9460-3587; Mu, Ping/0000-0003-0955-0896	US National Institutes of Health/National Cancer Institute [R01CA149707, P30CA008748]; STARR Consortium; Geoffrey Beene Cancer Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society; American Italian Cancer Foundation; US National Institutes of Health [F31CA168356]; NATIONAL CANCER INSTITUTE [R01CA182503, P30CA008748, F31CA168356, R01CA149707] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); STARR Consortium; Geoffrey Beene Cancer Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); American Italian Cancer Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Hollenstein for editing the manuscript and members of the Ventura laboratory for helpful discussions. The authors greatly acknowledge the contribution of the Weill Cornell Epigenomics Core. This work was funded by grants from the US National Institutes of Health/National Cancer Institute (R01CA149707 to A.V. and Core grant P30CA008748), the STARR Consortium (to A.V. and D.B.), the Geoffrey Beene Cancer Foundation (to A.V.), the Gabrielle's Angel Foundation (to A.V.), the Leukemia Lymphoma Society (to Y.-C.H.), the American Italian Cancer Foundation (to C.B.) and a US National Institutes of Health training grant (F31CA168356 to C.P.C.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feingold M, 1997, AM J MED GENET, V69, P245, DOI 10.1002/(SICI)1096-8628(19970331)69:3<245::AID-AJMG7>3.3.CO;2-U; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Jenkins RB, 1997, CANCER RES, V57, P524; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jin HY, 2013, EMBO J, V32, P2377, DOI 10.1038/emboj.2013.178; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumps C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052321; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Meneghini V, 2006, EUR J MED GENET, V49, P151, DOI 10.1016/j.ejmg.2005.04.021; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2013, ELIFE, V2, DOI 10.7554/eLife.00822; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Qian JQ, 1997, MODERN PATHOL, V10, P1113; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sandhu SK, 2013, P NATL ACAD SCI USA, V110, P18208, DOI 10.1073/pnas.1315365110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400	65	79	80	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					766	+		10.1038/ng.3321	http://dx.doi.org/10.1038/ng.3321			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029871	Green Published, Green Accepted			2022-12-25	WOS:000357090300014
J	Katainen, R; Dave, K; Pitkanen, E; Palin, K; Kivioja, T; Valimaki, N; Gylfe, AE; Ristolainen, H; Hanninen, UA; Cajuso, T; Kondelin, J; Tanskanen, T; Mecklin, JP; Jarvinen, H; Renkonen-Sinisalo, L; Lepisto, A; Kaasinen, E; Kilpivaara, O; Tuupanen, S; Enge, M; Taipale, J; Aaltonen, LA				Katainen, Riku; Dave, Kashyap; Pitkanen, Esa; Palin, Kimmo; Kivioja, Teemu; Valimaki, Niko; Gylfe, Alexandra E.; Ristolainen, Heikki; Hanninen, Ulrika A.; Cajuso, Tatiana; Kondelin, Johanna; Tanskanen, Tomas; Mecklin, Jukka-Pekka; Jarvinen, Heikki; Renkonen-Sinisalo, Laura; Lepisto, Anna; Kaasinen, Eevi; Kilpivaara, Outi; Tuupanen, Sari; Enge, Martin; Taipale, Jussi; Aaltonen, Lauri A.			CTCF/cohesin-binding sites are frequently mutated in cancer	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR-BINDING; MUTATIONAL PROCESSES; CHROMATIN; COHESIN; GENOME; SIGNATURES; RESOLUTION; CTCF; SPECIFICITIES; DISCOVERY	Cohesin is present in almost all active enhancer regions, where it is associated with transcription factors(1,2). Cohesin frequently colocalizes with CTCF (CCCTC-binding factor), affecting genomic stability, expression and epigenetic homeostasis(3-6). Cohesin subunits are mutated in cancer(7,8), but CTCF/cohesin-binding sites (CBSs) in DNA have not been examined for mutations. Here we report frequent mutations at CBSs in cancers displaying a mutational signature where mutations in A.T base pairs predominate. Integration of whole-genome sequencing data from 213 colorectal cancer (CRC) samples and chromatin immunoprecipitation sequencing (ChIP-exo) data identified frequent point mutations at CBSs. In contrast, CRCs showing an ultramutator phenotype caused by defects in the exonuclease domain of DNA polymerase epsilon (POLE) displayed significantly fewer mutations at and adjacent to CBSs. Analysis of public data showed that multiple cancer types accumulate CBS mutations. CBSs are a major mutational hotspot in the noncoding cancer genome.	[Katainen, Riku; Pitkanen, Esa; Palin, Kimmo; Kivioja, Teemu; Valimaki, Niko; Gylfe, Alexandra E.; Ristolainen, Heikki; Hanninen, Ulrika A.; Cajuso, Tatiana; Kondelin, Johanna; Tanskanen, Tomas; Renkonen-Sinisalo, Laura; Kaasinen, Eevi; Kilpivaara, Outi; Tuupanen, Sari; Taipale, Jussi; Aaltonen, Lauri A.] Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland; [Katainen, Riku; Pitkanen, Esa; Palin, Kimmo; Valimaki, Niko; Gylfe, Alexandra E.; Ristolainen, Heikki; Hanninen, Ulrika A.; Cajuso, Tatiana; Kondelin, Johanna; Tanskanen, Tomas; Kaasinen, Eevi; Kilpivaara, Outi; Tuupanen, Sari; Aaltonen, Lauri A.] Univ Helsinki, Dept Med & Clin Genet Med, Helsinki, Finland; [Dave, Kashyap; Enge, Martin; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Mecklin, Jukka-Pekka] Univ Eastern Finland, Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; [Jarvinen, Heikki; Renkonen-Sinisalo, Laura; Lepisto, Anna] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Dept Surg, Helsinki, Finland	University of Helsinki; University of Helsinki; Karolinska Institutet; Central Finland Central Hospital; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital	Aaltonen, LA (corresponding author), Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland.	jussi.taipale@ki.se; lauri.aaltonen@helsinki.fi	Mecklin, Jukka-Pekka/AAB-5378-2020; Enge, Martin/GYQ-5073-2022; Mecklin, Jukka-Pekka/AAC-9650-2019; Aaltonen, Lauri/A-5375-2010; Palin, Kimmo/ABG-5710-2020; Katainen, Riku/GYR-0921-2022; Pitkanen, Esa/H-2435-2018	Mecklin, Jukka-Pekka/0000-0003-4895-2249; Aaltonen, Lauri/0000-0001-6839-4286; Palin, Kimmo/0000-0002-4621-6128; Lepisto, Anna Henriikka/0000-0002-5866-4059; Cajuso, Tatiana/0000-0002-6354-5572; Katainen, Riku/0000-0003-4575-4239; Enge, Martin/0000-0001-8748-8931; Pitkanen, Esa/0000-0002-9818-6370; Kaasinen, Eevi/0000-0002-1333-8049; Hanninen, Ulrika/0000-0003-1558-0450	Academy of Finland (Finnish Center of Excellence Program) [250345, 137680, 274474]; University of Helsinki; Finnish Cancer Society; European Research Council (ERC) [268648]; Sigrid Juselius Foundation; SYSCOL (a European Union Framework Programme 7 Collaborative Project) [258236]; Nordic Information for Action eScience Center (NIASC); Nordic Center of Excellence - NordForsk [62721]; State Research Funding of Kuopio University Hospital [B1401]; Academy of Finland [271642, 263164]; Ministry of Education and Culture, Finland	Academy of Finland (Finnish Center of Excellence Program); University of Helsinki; Finnish Cancer Society; European Research Council (ERC)(European Research Council (ERC)European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); SYSCOL (a European Union Framework Programme 7 Collaborative Project); Nordic Information for Action eScience Center (NIASC); Nordic Center of Excellence - NordForsk; State Research Funding of Kuopio University Hospital; Academy of Finland(Academy of Finland); Ministry of Education and Culture, Finland	We thank S. Augsten, L. Hu, H. Metsola, S. Nieminen, A. Ollikainen, M. Rajalaakso, S. Soisalo, I.-L. Svedberg, M. Turunen, I. Vuoristo and A. Zetterlund for technical assistance. Further, we thank M. Aavikko, I. Donner, A. Karhu and M. Mehine for additional help with the manuscript. We acknowledge the International Cancer Genome Consortium (ICGC) for the somatic mutation data. This work was supported by grants from the Academy of Finland (Finnish Center of Excellence Program 2012-2017, 250345, personal grants 137680 and 274474 to O.K.), the University of Helsinki (personal grant to S.T.), the Finnish Cancer Society (also a personal grant to K.P.), the European Research Council (ERC; 268648), the Sigrid Juselius Foundation, SYSCOL (a European Union Framework Programme 7 Collaborative Project, 258236), the Nordic Information for Action eScience Center (NIASC), the Nordic Center of Excellence financed by NordForsk (project 62721, personal grant to K.P.) and State Research Funding of Kuopio University Hospital (B1401). We acknowledge the computational resources provided by the ELIXIR node, hosted at the CSC-IT Center for Science, Finland, and funded by the Academy of Finland (grants 271642 and 263164), the Ministry of Education and Culture, Finland.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Satou K, 2007, FREE RADICAL BIO MED, V42, P1552, DOI 10.1016/j.freeradbiomed.2007.02.024; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	29	258	263	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					818	+		10.1038/ng.3335	http://dx.doi.org/10.1038/ng.3335			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053496	Green Accepted			2022-12-25	WOS:000357090300022
J	Li, BS; Li, H; Bai, Y; Kirschner-Schwabe, R; Yang, JJ; Chen, Y; Lu, G; Tzoneva, G; Ma, XT; Wu, TM; Li, WJ; Lu, HS; Ding, LX; Liang, HH; Huang, XH; Yang, MJ; Jin, L; Kang, H; Chen, ST; Du, A; Shen, SH; Ding, JP; Chen, HZ; Chen, J; von Stackelberg, A; Gu, LJ; Zhang, JH; Ferrando, A; Tang, JY; Wang, SY; Zhou, BBS				Li, Benshang; Li, Hui; Bai, Yun; Kirschner-Schwabe, Renate; Yang, Jun J.; Chen, Yao; Lu, Gang; Tzoneva, Gannie; Ma, Xiaotu; Wu, Tongmin; Li, Wenjing; Lu, Haisong; Ding, Lixia; Liang, Huanhuan; Huang, Xiaohang; Yang, Minjun; Jin, Lei; Kang, Hui; Chen, Shuting; Du, Alicia; Shen, Shuhong; Ding, Jianping; Chen, Hongzhuan; Chen, Jing; von Stackelberg, Arend; Gu, Longjun; Zhang, Jinghui; Ferrando, Adolfo; Tang, Jingyan; Wang, Shengyue; Zhou, Bin-Bing S.			Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY; NOVO NUCLEOTIDE BIOSYNTHESIS; CANCER; CHILDREN; PURIFICATION; MUTATIONS; ENZYME; FIBROBLASTS; METABOLISM	Relapse is the leading cause of mortality in children with acute lymphoblastic leukemia (ALL). Among chemotherapeutics, thiopurines are key drugs in ALL combination therapy. Using whole-exome sequencing, we identified relapse-specific mutations in the phosphoribosyl pyrophosphate synthetase 1 gene (PRPS1), which encodes a rate-limiting purine biosynthesis enzyme, in 24/358 (6.7%) relapsed childhood B cell ALL (B-ALL) cases. All individuals who harbored PRPS1 mutations relapsed early during treatment, and mutated ALL clones expanded exponentially before clinical relapse. Our functional analyses of PRPS1 mutants uncovered a new chemotherapy-resistance mechanism involving reduced feedback inhibition of de novo purine biosynthesis and competitive inhibition of thiopurine activation. Notably, the de novo purine synthesis inhibitor lometrexol effectively abrogated PRPS1 mutant driven drug resistance. These results highlight the importance of constitutive activation of the de novo purine synthesis pathway in thiopurine resistance, and they offer therapeutic strategies for the treatment of relapsed and thiopurine-resistant ALL.	[Li, Benshang; Li, Hui; Chen, Yao; Wu, Tongmin; Ding, Lixia; Liang, Huanhuan; Huang, Xiaohang; Shen, Shuhong; Chen, Jing; Gu, Longjun; Tang, Jingyan; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr,Minist Hlth, Dept Hematol & Oncol,Key Lab Pediat Hematol & Onc, Shanghai 200030, Peoples R China; [Li, Benshang; Bai, Yun; Lu, Gang; Yang, Minjun; Jin, Lei; Kang, Hui; Chen, Shuting; Wang, Shengyue] Chinese Natl Human Genome Ctr Shanghai, Key Lab Hlth & Dis Genom, Shanghai Minist Sci & Technol, Shanghai 200030, Peoples R China; [Li, Benshang; Li, Hui; Chen, Yao; Wu, Tongmin; Ding, Lixia; Shen, Shuhong; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Pediat Translat Med Inst, Shanghai 200030, Peoples R China; [Li, Hui; Wu, Tongmin; Chen, Hongzhuan; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Sch Basic Med, Dept Pharmacol, Shanghai 200030, Peoples R China; [Li, Hui; Wu, Tongmin; Chen, Hongzhuan; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Translat Med, Shanghai 200030, Peoples R China; [Kirschner-Schwabe, Renate; von Stackelberg, Arend] Charite, Dept Pediat Oncol & Hematol, D-13353 Berlin, Germany; [Kirschner-Schwabe, Renate] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Yang, Jun J.; Ma, Xiaotu; Zhang, Jinghui] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Tzoneva, Gannie; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY USA; [Li, Wenjing] Chinese Acad Sci, Natl Ctr Prot Sci Shanghai, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Lu, Haisong; Du, Alicia] ChemPartner Co, Shanghai, Peoples R China; [Chen, Hongzhuan; Wang, Shengyue; Zhou, Bin-Bing S.] Natl Res Ctr Translat Med, Collaborat Innovat Ctr Syst Biomed, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); St Jude Children's Research Hospital; Columbia University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, BBS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr,Minist Hlth, Dept Hematol & Oncol,Key Lab Pediat Hematol & Onc, Shanghai 200030, Peoples R China.	tangingyan@scmc.com.cn; wangsy@chgc.sh.cn; binbing_s_zhou@yahoo.com	Yang, Jun J./ABG-5646-2020; Yang, Minjun/AGJ-3201-2022; tang, jing/HHR-9815-2022; Zhang, Jing/GWZ-7332-2022	Yang, Jun J./0000-0002-0770-9659; Tzoneva, Gannie/0000-0001-5784-7796; ding, jian ping/0000-0001-7029-7346; Yang, Minjun/0000-0002-3324-1498; Kirschner-Schwabe, Renate/0000-0001-6335-3274	National Basic Research Program of China (973 program) [2015CB553904]; National Natural Science Foundation of China [81372349, 81470313]; Science and Technology Commission of Shanghai Municipality [13431900502, 14411950600, 10411965100, 11JC1408100, 13431902000, 13DZ2291800, 11DZ2292600]; Science and Technology Commission of Pudong New Area Foundation [PKJ2014-Y02]; Project HOPE-Hospital Foundation Supporting Children with Cancer Program; Shanghai Municipal Education Commission [12ZZ111]; US National Institutes of Health [CA21765]; ALSAC (American Lebanese Syria Associated Charities); German Foundation for Childhood Cancer [DKS 2003.08, 2007.02, 2011.14]; Charite-Universitatsmedizin Berlin; Alex's Lemonade Stand Foundation; Leukemia and Lymphoma Society; China Postdoctoral Science Foundation [2014M561484]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Commission of Pudong New Area Foundation; Project HOPE-Hospital Foundation Supporting Children with Cancer Program; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC (American Lebanese Syria Associated Charities); German Foundation for Childhood Cancer; Charite-Universitatsmedizin Berlin; Alex's Lemonade Stand Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the BioBank staff at Shanghai Children's Medical Center for the clinical sample collection, W.L. Carroll (New York University) for providing the NT5C2 R238 plasmid, Y. Zhang and Z. Tang for making reagents, Z. Carpenter for suggesting PRPS1 superactivity references, and G. Wu and X. Chen for assisting in genomics data analysis. We are grateful to W.E. Evans, C.H. Pui, X.M. Tong, and G.L. Waldrop for critical comments and constructive suggestions on the manuscript. This work is supported by grants from the National Basic Research Program of China (973 program 2015CB553904 to B.-B.S.Z.), the National Natural Science Foundation of China (81372349 to B.-B.S.Z., 81470313 to J.C.), the Science and Technology Commission of Shanghai Municipality (13431900502 to B.-B.S.Z.; 14411950600 to J.C.; 10411965100 to B.S.L.; 11JC1408100 to J.Y.T.; 13431902000, 13DZ2291800 and 11DZ2292600 to S.Y.W.), the Science and Technology Commission of Pudong New Area Foundation (PKJ2014-Y02 to B.S.L.), the Project HOPE-Hospital Foundation Supporting Children with Cancer Program (to B.S.L.), the Programs of Shanghai Municipal Education Commission (12ZZ111 to B.S.L.), US National Institutes of Health grants CA21765 and ALSAC (American Lebanese Syria Associated Charities; to C. H. Pui), the German Foundation for Childhood Cancer (DKS 2003.08, 2007.02 to A.v.S. and 2011.14 to R.K.-S.), the Charite-Universitatsmedizin Berlin (Rahel Hirsch Fellowship to R.K.-S.), the Innovative Research Award by the Alex's Lemonade Stand Foundation and the Quest for Cures grant by the Leukemia and Lymphoma Society (both to A.F.), the China Postdoctoral Science Foundation (2014M561484 to H.L.), and a Howard Hughes Medical Institute International Student Research Fellowship (to G.T.).	Aarbakke J, 1997, TRENDS PHARMACOL SCI, V18, P3, DOI 10.1016/S0165-6147(96)01007-3; Adams J, 2000, ONCOGENE, V19, P6687, DOI 10.1038/sj.onc.1204088; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; BECKER MA, 1987, J BIOL CHEM, V262, P14531; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; de Brouwer APM, 2010, AM J HUM GENET, V86, P506, DOI 10.1016/j.ajhg.2010.02.024; Escherich G, 2013, PEDIATR BLOOD CANCER, V60, P254, DOI 10.1002/pbc.24273; FOX IH, 1971, J BIOL CHEM, V246, P5739; Gerhart J, 2014, FEBS J, V281, P612, DOI 10.1111/febs.12483; Gu LJ, 2008, LEUKEMIA LYMPHOMA, V49, P488, DOI 10.1080/10428190701784730; Henze G, 2013, KLIN PADIATR, V225, pS73, DOI 10.1055/s-0033-1337967; Hof J., 2014, 56 AM SOC HEM ANN M; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Kozhevnikova EN, 2012, MOL CELL, V47, P133, DOI 10.1016/j.molcel.2012.04.030; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; Moran R, 2012, AM J MED GENET A, V158A, P455, DOI 10.1002/ajmg.a.34428; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Pui C H, 1998, Curr Opin Hematol, V5, P292; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Reddy BA, 2014, MOL CELL, V53, P458, DOI 10.1016/j.molcel.2013.12.017; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Tang J.Y., 2012, J CHIN MED ASSOC, V92, P546; Tang WY, 2006, ACTA CRYSTALLOGR F, V62, P432, DOI 10.1107/S1744309106009067; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; WINTZERITH M, 1976, J NEUROCHEM, V26, P205; Wyngaarden J B, 1976, Adv Enzyme Regul, V14, P25, DOI 10.1016/0065-2571(76)90006-6; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZOREF E, 1975, J CLIN INVEST, V56, P1093, DOI 10.1172/JCI108183	36	104	120	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2015	21	6					563	571		10.1038/nm.3840	http://dx.doi.org/10.1038/nm.3840			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CJ8UF	25962120	Green Accepted			2022-12-25	WOS:000355778300012
J	Shi, JW; Wang, E; Milazzo, JP; Wang, ZH; Kinney, JB; Vakoc, CR				Shi, Junwei; Wang, Eric; Milazzo, Joseph P.; Wang, Zihua; Kinney, Justin B.; Vakoc, Christopher R.			Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains	NATURE BIOTECHNOLOGY			English	Article							MLL-REARRANGED LEUKEMIA; HUMAN-CELLS; INHIBITION; SYSTEM; GENE; CAS9	CRISPR-Cas9 genome editing technology holds great promise for discovering therapeutic targets in cancer and other diseases. Current screening strategies target CRISPR-Cas9-induced mutations to the 5' exons of candidate genes(1-5), but this approach often produces in-frame variants that retain functionality, which can obscure even strong genetic dependencies. Here we overcome this limitation by targeting CRISPR-Cas9 mutagenesis to exons encoding functional protein domains. This generates a higher proportion of null mutations and substantially increases the potency of negative selection. We also show that the magnitude of negative selection can be used to infer the functional importance of individual protein domains of interest. A screen of 192 chromatin regulatory domains in murine acute myeloid leukemia cells identifies six known drug targets and 19 additional dependencies. A broader application of this approach may allow comprehensive identification of protein domains that sustain cancer cells and are suitable for drug targeting.	[Shi, Junwei; Wang, Eric; Milazzo, Joseph P.; Wang, Zihua; Kinney, Justin B.; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Shi, Junwei] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	vakoc@cshl.edu	Wang, Zhiquan/HHS-6768-2022	Kinney, Justin/0000-0003-1897-3778; Wang, Eric/0000-0001-7865-6702	National Institutes of Health [NIH CA174793]; Burroughs-Wellcome Fund Career Award for Medical Scientists; Alex's Lemonade Stand Foundation 'A' Award; National Cancer Institute Cancer Center Support Grant Development Funds [CA45508]; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA174793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Alex's Lemonade Stand Foundation 'A' Award; National Cancer Institute Cancer Center Support Grant Development Funds; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Y. Jin for assistance with pooled sgRNA screen analysis. C.R.V. is supported by National Institutes of Health NIH CA174793, Burroughs-Wellcome Fund Career Award for Medical Scientists, Alex's Lemonade Stand Foundation 'A' Award and the National Cancer Institute Cancer Center Support Grant Development Funds CA45508. J.B.K. is supported by the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McJunkin K, 2011, P NATL ACAD SCI USA, V108, P7113, DOI 10.1073/pnas.1104097108; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi J, 2013, ONCOGENE, V32, P930, DOI 10.1038/onc.2012.110; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Wang E, 2013, P NATL ACAD SCI USA, V110, P3901, DOI 10.1073/pnas.1301045110; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xu BW, 2015, BLOOD, V125, P346, DOI 10.1182/blood-2014-06-581082; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	27	432	449	6	210	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					661	+		10.1038/nbt.3235	http://dx.doi.org/10.1038/nbt.3235			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25961408	Green Accepted			2022-12-25	WOS:000356019700027
J	Duca, FA; Cote, CD; Rasmussen, BA; Zadeh-Tahmasebi, M; Rutter, GA; Filippi, BM; Lam, TKT				Duca, Frank A.; Cote, Clemence D.; Rasmussen, Brittany A.; Zadeh-Tahmasebi, Melika; Rutter, Guy A.; Filippi, Beatrice M.; Lam, Tony K. T.			Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats	NATURE MEDICINE			English	Article							PROTEIN-KINASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; GLUCONEOGENESIS; HOMEOSTASIS; MECHANISMS; EXPRESSION; MOUSE; LIVER; LKB1	Metformin is a first-line therapeutic option for the treatment of type 2 diabetes, even though its underlying mechanisms of action are relatively unclear(1-6). Metformin lowers blood glucose levels by inhibiting hepatic glucose production (HGP), an effect originally postulated to be due to a hepatic AMP-activated protein kinase (AMPK)-dependent mechanism(5,6). However, studies have questioned the contribution of hepatic AMPK to the effects of metformin on lowering hyperglycemia(1,3,4), and a gut-brain-liver axis that mediates intestinal nutrient-and hormone-induced lowering of HGP has been identified(7). Thus, it is possible that metformin affects HGP through this inter-organ crosstalk. Here we show that intraduodenal infusion of metformin for 50 min activated duodenal mucosal Ampk and lowered HGP in a rat 3 d high fat diet (HFD)-induced model of insulin resistance. Inhibition of duodenal Ampk negated the HGP-lowering effect of intraduodenal metformin, and both duodenal glucagon-like peptide-1 receptor (Glp-1r)-protein kinase A (Pka) signaling and a neuronal-mediated gut-brain-liver pathway were required for metformin to lower HGP. Preabsorptive metformin also lowered HGP in rat models of 28 d HFD-induced obesity and insulin resistance and nicotinamide (NA)-streptozotocin (STZ)-HFD-induced type 2 diabetes. In an unclamped setting, inhibition of duodenal Ampk reduced the glucose-lowering effects of a bolus metformin treatment in rat models of diabetes. These findings show that, in rat models of both obesity and diabetes, metformin activates a previously unappreciated duodenal Ampk-dependent pathway to lower HGP and plasma glucose levels.	[Duca, Frank A.; Cote, Clemence D.; Rasmussen, Brittany A.; Zadeh-Tahmasebi, Melika; Filippi, Beatrice M.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Duca, Frank A.; Cote, Clemence D.; Rasmussen, Brittany A.; Zadeh-Tahmasebi, Melika; Filippi, Beatrice M.; Lam, Tony K. T.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Cote, Clemence D.; Rasmussen, Brittany A.; Zadeh-Tahmasebi, Melika; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Imperial Ctr Translat & Expt Med,Dept Med, Sect Cell Biol,Div Diabet Endocrinol & Metab, London, England; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Imperial College London; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	tony.lam@uhnres.utoronto.ca		Filippi, Beatrice Maria/0000-0002-8816-1559; Cote, Clemence/0000-0001-9200-7688; Rutter, Guy/0000-0001-6360-0343	Canadian Institute of Health Research [MOP-82701]; Canadian Institute of Health Research Doctoral Vanier Canada scholarship; Banting and Best Diabetes Centre graduate studentship; Wellcome Trust [WT098424AIA]; Medical Research Council [MR/J0003042/1]; Diabetes UK [11/0004210]; Royal Society; MRC [MR/K001981/1] Funding Source: UKRI; Medical Research Council [MR/K001981/1] Funding Source: researchfish	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research Doctoral Vanier Canada scholarship(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre graduate studentship; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to E. Burdett for technical assistance. This work is supported by a research grant from the Canadian Institute of Health Research (MOP-82701 to T.T.K.L.). F.A.D. is a Banting Fellow. B.A.R. is supported by a Canadian Institute of Health Research Doctoral Vanier Canada scholarship. C.D.C. is supported by a Banting and Best Diabetes Centre graduate studentship. M.Z.-T. is supported by a Banting and Best Diabetes Centre graduate studentship. G.A.R. is supported by the Wellcome Trust Senior Investigator (WT098424AIA), the Medical Research Council Programme (MR/J0003042/1), the Diabetes UK Project Grant (11/0004210) and Royal Society Wolfson Research Merit awards. T.K.T.L. holds the John Kitson McIvor (1915-1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Choi YH, 2006, J PHARM SCI-US, V95, P2543, DOI 10.1002/jps.20744; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Filippi BM, 2012, CELL METAB, V16, P500, DOI 10.1016/j.cmet.2012.09.005; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Harmel E, 2014, ENDOCRINOLOGY, V155, P873, DOI 10.1210/en.2013-1750; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; He GF, 2014, MOL CELL BIOL, V34, P148, DOI 10.1128/MCB.00670-13; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mulherin AJ, 2011, ENDOCRINOLOGY, V152, P4610, DOI 10.1210/en.2011-1485; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pollak M, 2014, NAT MED, V20, P591, DOI 10.1038/nm.3596; Radziuk J, 1997, DIABETES, V46, P1406, DOI 10.2337/diabetes.46.9.1406; Rasmussen BA, 2014, CELL METAB, V19, P155, DOI 10.1016/j.cmet.2013.11.014; Rasmussen BA, 2012, GASTROENTEROLOGY, V142, P834, DOI 10.1053/j.gastro.2011.12.053; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Salpeter SR, 2008, AM J MED, V121, P149, DOI 10.1016/j.amjmed.2007.09.016; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Stepensky D, 2002, DRUG METAB DISPOS, V30, P861, DOI 10.1124/dmd.30.8.861; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Vardarli I, 2014, DIABETES, V63, P663, DOI 10.2337/db13-0805; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Xavier GD, 2003, BIOCHEM J, V371, P761; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	45	257	275	3	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2015	21	5					506	U130		10.1038/nm.3787	http://dx.doi.org/10.1038/nm.3787			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CH5IL	25849133	Green Accepted			2022-12-25	WOS:000354068800018
J	Obenaus, M; Leitao, C; Leisegang, M; Chen, XJ; Gavvovidis, I; van der Bruggen, P; Uckert, W; Schendel, DJ; Blankenstein, T				Obenaus, Matthias; Leitao, Catarina; Leisegang, Matthias; Chen, Xiaojing; Gavvovidis, Ioannis; van der Bruggen, Pierre; Uckert, Wolfgang; Schendel, Dolores J.; Blankenstein, Thomas			Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice	NATURE BIOTECHNOLOGY			English	Article							ANTITUMOR-ACTIVITY; GENE-TRANSFER; TCR; LYMPHOCYTES; PEPTIDE; MHC; DIVERSE; EXPRESSION; EFFICIENT; RECOGNIZE	Identifying T-cell receptors (TCRs) that bind tumor-associated antigens (TAAs) with optimal affinity is a key bottleneck in the development of adoptive T-cell therapy of cancer(1). TAAs are unmutated self proteins, and T cells bearing high-affinity TCRs specific for such antigens are commonly deleted in the thymus(2). To identify optimal-affinity TCRs, we generated antigen-negative humanized mice with a diverse human TCR repertoire restricted to the human leukocyte antigen (HLA) A*02:01 (ref. 3). These mice were immunized with human TAAs, for which they are not tolerant, allowing induction of CD8(+) T cells with optimal-affinity TCRs. We isolate TCRs specific for the cancer/testis (CT) antigen MAGE-A1 (ref. 4) and show that two of them have an anti-tumor effect in vivo. By comparison, human-derived TCRs have lower affinity and do not mediate substantial therapeutic effects. We also identify optimal-affinity TCRs specific for the CT antigen NY-ESO. Our humanized mouse model provides a useful tool for the generation of optimal-affinity TCRs for T-cell therapy.	[Obenaus, Matthias; Leitao, Catarina; Leisegang, Matthias; Chen, Xiaojing; Gavvovidis, Ioannis; Uckert, Wolfgang; Blankenstein, Thomas] Max Delbruck Ctr Mol Med, Berlin, Germany; [van der Bruggen, Pierre] Ludwig Inst Canc Res, Brussels, Belgium; [van der Bruggen, Pierre] WELBIO, Brussels, Belgium; [van der Bruggen, Pierre] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium; [Uckert, Wolfgang] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Schendel, Dolores J.] Medigene AG, Planegg Martinsried, Germany; [Blankenstein, Thomas] Charite Campus Buch, Inst Immunol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ludwig Institute for Cancer Research; WELBIO; Universite Catholique Louvain; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Blankenstein, T (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	tblanke@mdc-berlin.de	Leisegang, Matthias/S-5635-2017	Leisegang, Matthias/0000-0003-3692-7142; Gavvovidis, Ioannis/0000-0001-5644-9788; Leitao, Catarina/0000-0001-9884-2983	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich) [TR36]; Berlin Institute of Health (BIH)	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich)(German Research Foundation (DFG)); Berlin Institute of Health (BIH)	The authors thank G. Willimsky for discussion, S. Kupsch and S. Furl for technical assistance, and I. Hoeft for animal caretaking. C. Linnemann and T. Schumacher kindly provided the NY-ESO-1<INF>157</INF>/HLA-A2 multimer. This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich TR36) and the Berlin Institute of Health (BIH).	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Bredenbeck A, 2008, GENE, V415, P68, DOI 10.1016/j.gene.2008.02.019; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chinnasamy N, 2011, J IMMUNOL, V186, P685, DOI 10.4049/jimmunol.1001775; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Engels B, 2012, MOL THER, V20, P652, DOI 10.1038/mt.2011.286; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; HERIN M, 1987, INT J CANCER, V39, P390, DOI 10.1002/ijc.2910390320; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Huang LQ, 1999, J IMMUNOL, V162, P6849; Huijbers IJ, 2012, J IMMUNOL, V188, P111, DOI 10.4049/jimmunol.1002612; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kammertoens T, 2013, CANCER CELL, V23, P429, DOI 10.1016/j.ccr.2013.04.004; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Li LP, 2010, NAT MED, V16, P1029, DOI 10.1038/nm.2197; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Offringa R, 2009, CURR OPIN IMMUNOL, V21, P190, DOI 10.1016/j.coi.2009.02.006; Ottaviani S, 2005, CANCER IMMUNOL IMMUN, V54, P1214, DOI 10.1007/s00262-005-0705-2; Parkhurst MR, 2009, CLIN CANCER RES, V15, P169, DOI 10.1158/1078-0432.CCR-08-1638; Pascolo S, 2001, CANCER RES, V61, P4072; Pellat-Deceunynck C, 2000, EUR J IMMUNOL, V30, P803, DOI 10.1002/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P; Sadovnikova E, 1996, P NATL ACAD SCI USA, V93, P13114, DOI 10.1073/pnas.93.23.13114; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sommermeyer D, 2013, INT J CANCER, V132, P1360, DOI 10.1002/ijc.27792; Sommermeyer D, 2010, J IMMUNOL, V184, P6223, DOI 10.4049/jimmunol.0902055; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Toso JF, 1996, CANCER RES, V56, P16; Uckert W, 2000, HUM GENE THER, V11, P1005, DOI 10.1089/10430340050015310; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; Wang BM, 2009, SCIENCE, V326, P871, DOI 10.1126/science.1177627; Weynants P, 1999, AM J RESP CRIT CARE, V159, P55, DOI 10.1164/ajrccm.159.1.9805073; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Zarour H, 1996, J INVEST DERMATOL, V107, P63, DOI 10.1111/1523-1747.ep12298177	46	68	74	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					402	U116		10.1038/nbt.3147	http://dx.doi.org/10.1038/nbt.3147			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25774714				2022-12-25	WOS:000352348500027
J	Zhao, H; Feng, JF; Ho, TV; Grimes, W; Urata, M; Chai, Y				Zhao, Hu; Feng, Jifan; Thach-Vu Ho; Grimes, Weston; Urata, Mark; Chai, Yang			The suture provides a niche for mesenchymal stem cells of craniofacial bones	NATURE CELL BIOLOGY			English	Article							SAETHRE-CHOTZEN-SYNDROME; STROMAL CELLS; CRANIOSYNOSTOSIS; TWIST; TISSUE; BIOLOGY; MARROW; REGENERATION; OSSIFICATION; HOMEOSTASIS	Bone tissue undergoes constant turnover supported by stem cells. Recent studies showed that perivascular mesenchymal stem cells (MSCs) contribute to the turnover of long bones. Craniofacial bones are flat bones derived from a different embryonic origin than the long bones. The identity and regulating niche for craniofacial-bone MSCs remain unknown. Here, we identify Gli1+ cells within the suture mesenchyme as the main MSC population for craniofacial bones. They are not associated with vasculature, give rise to all craniofacial bones in the adult and are activated during injury repair. Gli1+ cells are typical MSCs in vitro. Ablation of Gli1+ cells leads to craniosynostosis and arrest of skull growth, indicating that these cells are an indispensable stem cell population. Twist1+ mice with craniosynostosis show reduced Gli1+ MSCs in sutures, suggesting that craniosynostosis may result from diminished suture stem cells. Our study indicates that craniofacial sutures provide a unique niche for MSCs for craniofacial bone homeostasis and repair.	[Zhao, Hu; Feng, Jifan; Thach-Vu Ho; Grimes, Weston; Urata, Mark; Chai, Yang] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Chai, Y (corresponding author), Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	ychai@usc.edu		Hu, Zhao/0000-0002-2961-0086	National Institute of Dental and Craniofacial Research, NIH [R90 DE022528, DE022503, DE020065, DE012711]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012711, U01DE020065, U01DE024421, R01DE022503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Mayo and B. Samuels for critical reading of the manuscript and M. Zhang for thc support. We thank R. Yang, X. Xu and S. Shi for technical support on the FACS analysis. We thank A. McMahon for providing Ihh-LucZ mice. H.Z. acknowledges training grant support from the National Institute of Dental and Craniofacial Research, NIH (R90 DE022528). This study was supported by grants from the National Institute of Dental and Craniofacial Research, NIH (DE022503, DE020065 and DE012711) to Y.C.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Badve CA, 2013, PEDIATR RADIOL, V43, P728, DOI 10.1007/s00247-013-2673-6; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bajwa M, 2013, J CRANIOFAC SURG, V24, P1201, DOI 10.1097/SCS.0b013e31829975c6; Behr B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070240; Behr B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00037; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bianco P, 2015, BONE, V70, P2, DOI 10.1016/j.bone.2014.08.011; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Ciurea Alexandru Vlad, 2009, J Med Life, V2, P5; Clark BR, 1995, ANN NY ACAD SCI, V770, P70, DOI 10.1111/j.1749-6632.1995.tb31044.x; ElGhouzzi V, 1997, NAT GENET, V15, P42; Forrest CR, 2013, PLAST RECONSTR SURG, V131, p86E, DOI 10.1097/PRS.0b013e318272c12b; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; Grova M, 2012, J CRANIOFAC SURG, V23, P1954, DOI 10.1097/SCS.0b013e318258ba53; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hankinson TC, 2010, J NEUROSURG-PEDIATR, V6, P193, DOI 10.3171/2010.5.PEDS09313; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hogan MV, 2011, J AM ACAD ORTHOP SUR, V19, P134, DOI 10.5435/00124635-201103000-00002; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; James AW, 2008, PLAST RECONSTR SURG, V122, P53, DOI 10.1097/PRS.0b013e31817747b5; Jezela-Stanek A, 2013, EUR J PAEDIATR NEURO, V17, P221, DOI 10.1016/j.ejpn.2012.09.009; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Lattanzi W, 2012, CHILD NERV SYST, V28, P1301, DOI 10.1007/s00381-012-1781-1; Lenton K, 2011, GENESIS, V49, P784, DOI 10.1002/dvg.20768; Levi B, 2012, J CRANIOFAC SURG, V23, P13, DOI 10.1097/SCS.0b013e318240c6c0; Lin Z, 2014, J DENT RES, V93, P109, DOI 10.1177/0022034513506445; Long FX, 2001, DEVELOPMENT, V128, P5099; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martou G, 2011, CURR OPIN OTOLARYNGO, V19, P242, DOI 10.1097/MOO.0b013e328347f895; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miraoui H, 2010, GENE, V468, P1, DOI 10.1016/j.gene.2010.07.013; Ochareon P, 2011, J ANAT, V218, P285, DOI 10.1111/j.1469-7580.2010.01336.x; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; OPPERMAN LA, 1993, DEV DYNAM, V198, P312, DOI 10.1002/aja.1001980408; Pagni G, 2012, ADV DRUG DELIVER REV, V64, P1310, DOI 10.1016/j.addr.2012.03.005; Pan A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00061; Paznekas WA, 1998, AM J HUM GENET, V62, P1370, DOI 10.1086/301855; Petrovic V, 2012, OR SURG OR MED OR PA, V114, pE1, DOI 10.1016/j.oooo.2012.02.030; Posnick Jeffrey C, 2010, Atlas Oral Maxillofac Surg Clin North Am, V18, P109, DOI 10.1016/j.cxom.2010.08.006; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Riminucci M, 2015, BONE, V70, P55, DOI 10.1016/j.bone.2014.09.009; Robey PG, 2011, TISSUE ENG PART B-RE, V17, P423, DOI 10.1089/ten.teb.2011.0199; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Senarath-Yapa K, 2012, ORGANOGENESIS, V8, P103, DOI 10.4161/org.23307; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Slater BJ, 2009, CELLS TISSUES ORGANS, V190, P336, DOI 10.1159/000228157; Slater BJ, 2008, PLAST RECONSTR SURG, V121, p170E, DOI 10.1097/01.prs.0000304441.99483.97; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stotland MA, 2012, J CRANIOFAC SURG, V23, P2015, DOI 10.1097/SCS.0b013e318262d6ad; Tatum SA, 2008, ARCH FACIAL PLAST S, V10, P376, DOI 10.1001/archfaci.10.6.376; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wan Derrick C., 2008, V12, P209, DOI 10.1159/000115043; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Xu Y, 2007, PLAST RECONSTR SURG, V119, P819, DOI 10.1097/01.prs.0000255540.91987.a0; Yang MB, 2014, CURR STEM CELL RES T, V9, P150, DOI 10.2174/1574888X09666140213142258; Yousfi M, 2002, HUM MOL GENET, V11, P359, DOI 10.1093/hmg/11.4.359; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	62	216	228	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					386	+		10.1038/ncb3139	http://dx.doi.org/10.1038/ncb3139			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25799059	Green Accepted			2022-12-25	WOS:000351920500009
